PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Murchland, I; Ahlgren-Berg, A; Priest, DG; Dodd, IB; Shearwin, KE				Murchland, Iain; Ahlgren-Berg, Alexandra; Priest, David G.; Dodd, Ian B.; Shearwin, Keith E.			Promoter Activation by CII, a Potent Transcriptional Activator from Bacteriophage 186	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Transcription; Bacteriophage; Gene Transcription; Promoter; Proteolysis; RNA Polymerase; Mutational Screen; Protein Structure-Function	AMP RECEPTOR PROTEIN; ESCHERICHIA-COLI; RNA-POLYMERASE; LAMBDA-CII; SCANNING MUTAGENESIS; STRUCTURAL BASIS; SIGMA-SUBUNIT; TARGET SITE; DNA COMPLEX; FTSH HFLB	Background: CII strongly activates transcription, binding an unusual spacing of recognition sites. Results: Genetic screens reveal insights into the CII domain structure, activation mechanism, and proteolytic degradation. Conclusion: CII contains two independent activation epitopes, contacting the sigma(70) and -subunits of RNA polymerase. CII degradation compromises self-association. Significance: A novel arrangement of factors at the promoter is proposed, which is highly sensitive to altered CII levels. The lysogeny promoting protein CII from bacteriophage 186 is a potent transcriptional activator, capable of mediating at least a 400-fold increase in transcription over basal activity. Despite being functionally similar to its counterpart in phage , it shows no homology at the level of protein sequence and does not belong to any known family of transcriptional activators. It also has the unusual property of binding DNA half-sites that are separated by 20 base pairs, center to center. Here we investigate the structural and functional properties of CII using a combination of genetics, in vitro assays, and mutational analysis. We find that 186 CII possesses two functional domains, with an independent activation epitope in each. 186 CII owes its potent activity to activation mechanisms that are dependent on both the sigma(70) and C-terminal domain (CTD) components of RNA polymerase, contacting different functional domains. We also present evidence that like CII, 186 CII is proteolytically degraded in vivo, but unlike CII, 186 CII proteolysis results in a specific, transcriptionally inactive, degradation product with altered self-association properties.	[Murchland, Iain; Ahlgren-Berg, Alexandra; Priest, David G.; Dodd, Ian B.; Shearwin, Keith E.] Univ Adelaide, Sch Mol & Biomed Sci, Dept Biochem, Adelaide, SA 5005, Australia	University of Adelaide	Shearwin, KE (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Dept Biochem, Adelaide, SA 5005, Australia.	keith.shearwin@adelaide.edu.au	Shearwin, Keith/AAS-1247-2021	Shearwin, Keith/0000-0002-7736-2742; Priest, David/0000-0003-0095-6718; Dodd, Ian/0000-0003-2969-6841	Australian Research Council [DP0665185, DP110100824]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grants DP0665185 and DP110100824.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; Anton BP, 2004, J BACTERIOL, V186, P5699, DOI 10.1128/JB.186.17.5699-5707.2004; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Bhende PM, 2000, J BACTERIOL, V182, P4959, DOI 10.1128/JB.182.17.4959-4969.2000; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Cao YH, 1997, J MOL BIOL, V274, P39, DOI 10.1006/jmbi.1997.1380; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Cui L, 2013, P NATL ACAD SCI USA, V110, P2922, DOI 10.1073/pnas.1221322110; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; GENT ME, 1987, BIOCHEM J, V242, P645, DOI 10.1042/bj2420645; Grainger DC, 2004, MOL MICROBIOL, V51, P1297, DOI 10.1111/j.1365-2958.2003.03929.x; Guota R S, 1975, Antimicrob Agents Chemother, V7, P748; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hao N, 2011, NUCLEIC ACIDS RES, V39, P3695, DOI 10.1093/nar/gkq1336; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; HERMAN C, 1993, P NATL ACAD SCI USA, V90, P10861, DOI 10.1073/pnas.90.22.10861; HO YS, 1983, NATURE, V304, P703, DOI 10.1038/304703a0; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; INGROSSO D, 1989, BIOCHEM BIOPH RES CO, V162, P1528, DOI 10.1016/0006-291X(89)90848-6; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jain D, 2005, MOL CELL, V19, P259, DOI 10.1016/j.molcel.2005.06.006; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; Kedzierska B, 2004, NUCLEIC ACIDS RES, V32, P834, DOI 10.1093/nar/gkh230; Kobiler O, 2002, P NATL ACAD SCI USA, V99, P14964, DOI 10.1073/pnas.222172499; LAMONT I, 1993, J BACTERIOL, V175, P5286, DOI 10.1128/JB.175.16.5286-5288.1993; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LINN T, 1990, J BACTERIOL, V172, P1077, DOI 10.1128/jb.172.2.1077-1084.1990; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Neufing PJ, 1996, MOL MICROBIOL, V21, P751, DOI 10.1046/j.1365-2958.1996.351394.x; Neufing PJ, 2001, J BACTERIOL, V183, P2376, DOI 10.1128/JB.183.7.2376-2379.2001; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2006, MOL CELL, V21, P605, DOI 10.1016/j.molcel.2006.01.019; Ptashne M, 2004, GENETIC SWITCH PHAGE; RATTRAY A, 1984, J BACTERIOL, V159, P238, DOI 10.1128/JB.159.1.238-242.1984; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; Shearwin KE, 2002, J BIOL CHEM, V277, P3186, DOI 10.1074/jbc.M107740200; Shearwin KE, 2000, J BIOL CHEM, V275, P29113, DOI 10.1074/jbc.M004574200; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Trusina A, 2005, PLOS COMPUT BIOL, V1, P599, DOI 10.1371/journal.pcbi.0010074; van Dijk M, 2010, NUCLEIC ACIDS RES, V38, P5634, DOI 10.1093/nar/gkq222	54	4	4	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32094	32108		10.1074/jbc.M114.608026	http://dx.doi.org/10.1074/jbc.M114.608026			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25294872	Green Published, hybrid			2022-12-25	WOS:000345314700038
J	Climent, B; Moreno, L; Martinez, P; Contreras, C; Sanchez, A; Perez-Vizcaino, F; Garcia-Sacristan, A; Rivera, L; Prieto, D				Climent, Belen; Moreno, Laura; Martinez, Pilar; Contreras, Cristina; Sanchez, Ana; Perez-Vizcaino, Francisco; Garcia-Sacristan, Albino; Rivera, Luis; Prieto, Dolores			Upregulation of SK3 and IK1 Channels Contributes to the Enhanced Endothelial Calcium Signaling and the Preserved Coronary Relaxation in Obese Zucker Rats	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; NITRIC-OXIDE RELEASE; BRADYKININ-INDUCED RELAXATION; SMALL-CONDUCTANCE; HYPERPOLARIZING FACTOR; K(CA)3.1 CHANNELS; FUNCTIONAL-ROLE; TRPV4 CHANNELS; EDHF RESPONSES	Background and Aims: Endothelial small- and intermediate-conductance K-Ca channels, SK3 and IK1, are key mediators in the endothelium-derived hyperpolarization and relaxation of vascular smooth muscle and also in the modulation of endothelial Ca2+ signaling and nitric oxide (NO) release. Obesity is associated with endothelial dysfunction and impaired relaxation, although how obesity influences endothelial SK3/IK1 function is unclear. Therefore we assessed whether the role of these channels in the coronary circulation is altered in obese animals. Methods and Results: In coronary arteries mounted in microvascular myographs, selective blockade of SK3/IK1 channels unmasked an increased contribution of these channels to the ACh- and to the exogenous NO-induced relaxations in arteries of Obese Zucker Rats (OZR) compared to Lean Zucker Rats (LZR). Relaxant responses induced by the SK3/IK1 channel activator NS309 were enhanced in OZR and NO- endothelium-dependent in LZR, whereas an additional endothelium-independent relaxant component was found in OZR. Fura2-AM fluorescence revealed a larger ACh-induced intracellular Ca2+ mobilization in the endothelium of coronary arteries from OZR, which was inhibited by blockade of SK3/IK1 channels in both LZR and OZR. Western blot analysis showed an increased expression of SK3/IK1 channels in coronary arteries of OZR and immunohistochemistry suggested that it takes place predominantly in the endothelial layer. Conclusions: Obesity may induce activation of adaptive vascular mechanisms to preserve the dilator function in coronary arteries. Increased function and expression of SK3/IK1 channels by influencing endothelial Ca2+ dynamics might contribute to the unaltered endothelium-dependent coronary relaxation in the early stages of obesity.	[Climent, Belen; Contreras, Cristina; Sanchez, Ana; Garcia-Sacristan, Albino; Rivera, Luis; Prieto, Dolores] Univ Complutense, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain; [Moreno, Laura; Perez-Vizcaino, Francisco] Univ Complutense, Fac Med, Dept Farmacol, E-28040 Madrid, Spain; [Martinez, Pilar] Univ Complutense, Fac Vet, Dept Anat & Anat Patol Comparadas, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	Climent, B (corresponding author), Univ Complutense, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain.	bcliment@farm.ucm.es; dprieto@farm.ucm.es	de los Arcos, Luis Rivera/T-2247-2018; Contreras, Cristina/N-7257-2019; Climent, Belen/P-2416-2015; Moreno, Laura/A-9433-2010; Pilar Martinez, P Martinez/E-8591-2016; Perez-Vizcaino, Francisco/A-9735-2011; PRIETO, DOLORES/S-8172-2018	de los Arcos, Luis Rivera/0000-0002-0187-707X; Contreras, Cristina/0000-0002-7015-7922; Climent, Belen/0000-0003-0852-9227; Moreno, Laura/0000-0001-9028-2299; Pilar Martinez, P Martinez/0000-0001-9063-3191; Perez-Vizcaino, Francisco/0000-0001-6309-7418; PRIETO, DOLORES/0000-0001-7049-5991	Spanish Ministry of Science and Innovation [SAF2009-10448]; Spanish Ministry of Economy [SAF2012-31631]; MS program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy(Spanish Government); MS program	This study was supported by: 1. Grant no SAF2009-10448 from the Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es/portal/site/MICINN/). 2. Grant no SAF2012-31631 of the Spanish Ministry of Economy (http://www.mineco.gob.es/portal/site/mineco/). 3. LM was supported by MS program (http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-comunicacion/fd-notas-prensa/15mar011XIIIPromocionMiguelServet.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alda JO, 2009, J PHARM PHARMACOL, V61, P641, DOI 10.1211/jpp/61.05.0013; Bagher P, 2012, P NATL ACAD SCI USA, V109, P18174, DOI 10.1073/pnas.1211946109; Bagi Z, 2009, AM J PHYSIOL-REG I, V10595, P556; Bagi Z, 2012, BRIT J PHARMACOL, V165, P544, DOI 10.1111/j.1476-5381.2011.01606.x; Batenburg WW, 2004, BRIT J PHARMACOL, V142, P125, DOI 10.1038/sj.bjp.0705747; Behringer EJ, 2013, ARTERIOSCL THROM VAS, V33, P1892, DOI 10.1161/ATVBAHA.113.301514; Bishara NB, 2010, AM J PHYSIOL-HEART C, V298, pH171, DOI 10.1152/ajpheart.00699.2009; Borbouse L, 2009, AM J PHYSIOL-HEART C, V297, pH1629, DOI 10.1152/ajpheart.00466.2009; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Campia U, 2012, BRIT J PHARMACOL, V165, P561, DOI 10.1111/j.1476-5381.2011.01661.x; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Climent B, 2014, CURRVASC PHARM, V12, P1, DOI DOI 10.2174/1570161112666140423221622; Climent B, 2012, BIOCHEM BIOPH RES CO, V417, P1007, DOI 10.1016/j.bbrc.2011.12.076; Contreras C, 2011, ATHEROSCLEROSIS, V217, P331, DOI 10.1016/j.atherosclerosis.2011.03.036; Dalsgaard T, 2010, BRIT J PHARMACOL, V160, P1496, DOI 10.1111/j.1476-5381.2010.00803.x; Danser AHJ, 2000, BRIT J PHARMACOL, V131, P195, DOI 10.1038/sj.bjp.0703555; DAUT J, 1994, J CARDIOVASC ELECTR, V5, P154, DOI 10.1111/j.1540-8167.1994.tb01156.x; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Ellis A, 2008, EUR J PHARMACOL, V601, P111, DOI 10.1016/j.ejphar.2008.10.042; Erdos B, 2002, AM J PHYSIOL-HEART C, V283, pH2472, DOI 10.1152/ajpheart.00516.2002; Feher A, 2010, CARDIOVASC RES, V87, P732, DOI 10.1093/cvr/cvq088; Feletou M, 2012, ANN MED, V44, P694, DOI 10.3109/07853890.2011.585658; Frisbee J, 2002, AM J PHYSIOL-HEART C, V53226, P2160; Fulop T, 2007, ARTERIOSCL THROM VAS, V27, P2348, DOI 10.1161/ATVBAHA.107.147991; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; Ghisdal P, 2001, BRIT J PHARMACOL, V134, P1021, DOI 10.1038/sj.bjp.0704348; Haddock RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016423; Katakam PVG, 2005, AM J PHYSIOL-HEART C, V288, pH854, DOI 10.1152/ajpheart.00715.2004; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kurian MM, 2011, EXP BIOL MED, V236, P621, DOI 10.1258/ebm.2011.010351; LASKEY RE, 1990, J BIOL CHEM, V265, P2613; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; LUCKHOFF A, 1990, N-S ARCH PHARMACOL, V342, P94; Ma X, 2013, HYPERTENSION, V62, P134, DOI 10.1161/HYPERTENSIONAHA.113.01500; McSherry IN, 2005, CELL CALCIUM, V38, P23, DOI 10.1016/j.ceca.2005.03.007; Mishra RC, 2013, CARDIOVASC RES, V97, P339, DOI 10.1093/cvr/cvs326; Morimura K, 2006, J PHARMACOL SCI, V100, P237, DOI 10.1254/jphs.SC0060011; Motivala AA, 2008, J NUCL CARDIOL, V15, P510, DOI 10.1016/j.nuclcard.2008.02.020; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Oltman CL, 2006, AM J PHYSIOL-HEART C, V291, pH1780, DOI 10.1152/ajpheart.01297.2005; Prieto D, 2014, CURR VASC PHARMACOL, V12, P401, DOI 10.2174/157016111203140518154828; Qian X, 2014, ARTERIOSCL THROM VAS, V34, P127, DOI 10.1161/ATVBAHA.113.302506; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Santiago E, 2013, FREE RADICAL BIO MED, V60, P136, DOI 10.1016/j.freeradbiomed.2013.02.014; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Schuster A, 2001, AM J PHYSIOL-HEART C, V280, pH1088, DOI 10.1152/ajpheart.2001.280.3.H1088; Sheng JZ, 2007, AM J PHYSIOL-CELL PH, V293, pC458, DOI 10.1152/ajpcell.00036.2007; Sheng JZ, 2009, FASEB J, V23, P1138, DOI 10.1096/fj.08-120451; Simonsen U, 1997, EUR J PHARMACOL, V329, P153; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stankevicius E, 2006, BRIT J PHARMACOL, V149, P560, DOI 10.1038/sj.bjp.0706886; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Takai J, 2013, AM J PHYSIOL-HEART C, V305, pH484, DOI 10.1152/ajpheart.00642.2012; Tharp D. L., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P1; Villalba N, 2009, AM J PHYSIOL-HEART C, V297, pH696, DOI 10.1152/ajpheart.01308.2008; Weston AH, 2005, BRIT J PHARMACOL, V145, P775, DOI 10.1038/sj.bjp.0706256; Wolfle SE, 2005, J VASC RES, V42, P475, DOI 10.1159/000088101; Young EJ, 2008, DIABETOLOGIA, V51, P872, DOI 10.1007/s00125-008-0934-y; Zhao LM, 2012, PFLUG ARCH EUR J PHY, V464, P613, DOI 10.1007/s00424-012-1165-0	64	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109432	10.1371/journal.pone.0109432	http://dx.doi.org/10.1371/journal.pone.0109432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302606	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400057
J	Shi, P; Grobe, JL; Desland, FA; Zhou, GN; Shen, XZ; Shan, ZY; Liu, M; Raizada, MK; Sumners, C				Shi, Peng; Grobe, Justin L.; Desland, Fiona A.; Zhou, Guannan; Shen, Xiao Z.; Shan, Zhiying; Liu, Meng; Raizada, Mohan K.; Sumners, Colin			Direct Pro-Inflammatory Effects of Prorenin on Microglia	PLOS ONE			English	Article							II-INDUCED HYPERTENSION; FACTOR-KAPPA-B; (PRO)RENIN RECEPTOR; ANGIOTENSIN-II; NEUROGENIC HYPERTENSION; PARAVENTRICULAR NUCLEUS; DIABETIC-NEPHROPATHY; NERVOUS-SYSTEM; BLOOD-PRESSURE; CYTOKINES	Neuroinflammation has been implicated in hypertension, and microglia have been proposed to play an important role in the progression of this disease. Here, we have studied whether microglia are activated within cardiovascular regulatory area(s) of the brain during hypertension, especially in high blood pressure that is associated with chronic activation of the renin-angiotensin-system. In addition, we determined whether prorenin, an essential component of the renin-angiotensin-system, exerts direct pro-inflammatory effects on these microglia. Our data indicate that two rodent models which display neurogenic hypertension and over activation of the renin-angiotensin-system in the brain (sRA mice and spontaneously hypertensive rats) exhibit microglial activation, and increased levels of pro-inflammatory cytokines, in the paraventricular nucleus of the hypothalamus, an area crucial for regulation of sympathetic outflow. Further, the renin-angiotensin-system component prorenin elicits direct activation of hypothalamic microglia in culture and induction of pro-inflammatory mechanisms in these cells, effects that involve prorenin receptor-induced NFkB activation. In addition, the prorenin-elicited increases in cytokine expression were fully abolished by microglial inhibitor minocycline, and were potentiated by pretreatment of cells with angiotensin II. Taken together with our previous data which indicate that pro-inflammatory processes in the paraventricular nucleus are involved in the hypertensive action of renin-angiotensin-system, the novel discovery that prorenin exerts direct stimulatory effects on microglial activation and pro-inflammatory cytokine production provides support for the idea that renin-angiotensin-system -induced neurogenic hypertension is not restricted to actions of angiotensin II alone.	[Shi, Peng; Desland, Fiona A.; Zhou, Guannan; Shan, Zhiying; Liu, Meng; Raizada, Mohan K.; Sumners, Colin] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Shi, Peng] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Grobe, Justin L.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA USA; [Shen, Xiao Z.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Shan, Zhiying] Michigan Technol Univ, Dept Kinesiol & Integrat Physiol, Houghton, MI 49931 USA	State University System of Florida; University of Florida; Cedars Sinai Medical Center; University of Iowa; Cedars Sinai Medical Center; Michigan Technological University	Sumners, C (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	csumners@ufl.edu		Sumners, Colin/0000-0002-9689-2255; Grobe, Justin/0000-0001-9737-0873	American Heart Association [AHA11SDG6770006]; UCLA CTSI [UL1TR000124]; National Institutes of Health [HL093186, HL076803, HL033610, HL098276, HL084207]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL033610, K99HL098276, P01HL084207, R01HL033610, R01HL093186, R00HL098276, R01HL076803] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); UCLA CTSI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by grants from the American Heart Association (AHA11SDG6770006 to P. S.), UCLA CTSI (UL1TR000124 to P. S.) and the National Institutes of Health (HL093186 and HL076803 to C. S., HL033610 to M. K. R., and HL098276 and HL084207 to J. L. G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batenburg WW, 2007, J HYPERTENS, V25, P2441, DOI 10.1097/HJH.0b013e3282f05bae; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Cates MJ, 2012, CURR HYPERTENS REP, V14, P261, DOI 10.1007/s11906-012-0267-6; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Diana A, 1999, NEUROSCIENCE, V89, P137, DOI 10.1016/S0306-4522(98)00274-7; Esler M, 2011, EXP PHYSIOL, V96, P1, DOI 10.1113/expphysiol.2011.052332; Ferri CC, 2003, J NEUROENDOCRINOL, V15, P126, DOI 10.1046/j.1365-2826.2003.00870.x; Grobe JL, 2010, CELL METAB, V12, P431, DOI 10.1016/j.cmet.2010.09.011; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Kitamura Y, 2001, J NEUROSCI RES, V64, P553, DOI 10.1002/jnr.1107; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Li WC, 2014, HYPERTENSION, V63, P316, DOI 10.1161/HYPERTENSIONAHA.113.02041; Li WC, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/290635; Li WC, 2012, HYPERTENSION, V59, P1188, DOI 10.1161/HYPERTENSIONAHA.111.190108; LIEW FY, 1990, J IMMUNOL, V145, P4306; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Marvar PJ, 2011, CURR OPIN PHARMACOL, V11, P156, DOI 10.1016/j.coph.2010.12.001; Matavelli LC, 2010, CLIN EXP PHARMACOL P, V37, P277, DOI 10.1111/j.1440-1681.2009.05292.x; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Osborn JW, 2007, CURR HYPERTENS REP, V9, P228, DOI 10.1007/s11906-007-0041-3; Paton JFR, 2010, EXP PHYSIOL, V95, P569, DOI 10.1113/expphysiol.2009.047282; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Satofuka S, 2007, INVEST OPHTH VIS SCI, V48, P422, DOI 10.1167/iovs.06-0534; Shan ZY, 2010, CIRC RES, V107, P934, DOI 10.1161/CIRCRESAHA.110.226977; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Takahashi H, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/242786; Ufnal M, 2005, NEUROPEPTIDES, V39, P581, DOI 10.1016/j.npep.2005.08.001; Waki H, 2008, AUTON NEUROSCI-BASIC, V142, P40, DOI 10.1016/j.autneu.2008.07.001; Wilkinson-Berka JL, 2011, CURR OPIN NEPHROL HY, V20, P69, DOI 10.1097/MNH.0b013e328341328a; Yu Y, 2010, HYPERTENSION, V55, P652, DOI 10.1161/HYPERTENSIONAHA.109.142836; Zubcevic J, 2013, HYPERTENSION, V61, P622, DOI 10.1161/HYPERTENSIONAHA.111.199836; Zubcevic J, 2011, HYPERTENSION, V57, P1026, DOI 10.1161/HYPERTENSIONAHA.111.169748	38	49	49	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e92937	10.1371/journal.pone.0092937	http://dx.doi.org/10.1371/journal.pone.0092937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302502	Green Published, gold			2022-12-25	WOS:000343730400001
J	Wang, XL; Ding, C; Wang, SH; Han, XG; Hou, WW; Yue, JP; Zou, JC; Yu, SQ				Wang, Xiaolan; Ding, Chan; Wang, Shaohui; Han, Xiangan; Hou, Wanwan; Yue, Jiaping; Zou, Jiechi; Yu, Shengqing			The AS87_04050 Gene Is Involved in Bacterial Lipopolysaccharide Biosynthesis and Pathogenicity of Riemerella anatipestifer	PLOS ONE			English	Article							MAJOR VIRULENCE FACTOR; ESCHERICHIA-COLI K-12; ABORTUS ROUGH MUTANTS; SERUM-RESISTANCE; BIOFILM FORMATION; HAEMOPHILUS-PARASUIS; CAMPYLOBACTER-JEJUNI; GLIDING MOTILITY; RFA LOCUS; IDENTIFICATION	Riemerella anatipestifer is reported worldwide as a cause of septicemic and exucitive diseases of domestic ducks. In this study, we identified a mutant strain RA2640 by Tn4351 transposon mutagenesis in which the AS87 04050 gene was inactivated by insertion of the transposon. Southern blot analysis indicated that only one insertion was found in the genome of the mutant strain RA2640. SDS-PAGE followed by silver staining showed that the lipopolysaccharide (LPS) pattern of mutant strain RA2640 was different from its wild-type strain Yb2, suggesting the LPS was defected. In addition, the phenotype of the mutant strain RA2640 was changed to roLigh-type, evident by altered colony morphology, autoaggregation ability and crystal violet staining characteristics. Bacterial LPS is a key factor in virulence as well as in both innate and acquired host responses to infection. The rough-type mutant strain RA2640 showed higher sensitivity to antibiotics, disinfectants and normal duck serum, and higher capability of adherence and invasion to Vero cells, compared to its wild type strain Yb2. Moreover, the mutant strain RA2640 lost the agglutination ability of its wild-type strain Yb2 to R. anatipestifer serotype 2 positive sera, suggesting that the 0-antigen is defected. Animal experiments indicated that the the mutant strain RA2640 was attenuated by more than 100,000-fold, compared to its wild-type strain Y132. suggested that the AS87_04050 gene in R. anatipestifer is associated with the LPS biosynthesis and bacterial pathogenicity.	[Wang, Xiaolan; Ding, Chan; Wang, Shaohui; Han, Xiangan; Hou, Wanwan; Yue, Jiaping; Zou, Jiechi; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Yu, SQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.	yus@shvri.ac.cn		Han, Xiangan/0000-0001-5625-637X	National Natural Science Foundation of China [31272591]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31272591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; AUSTIN EA, 1990, J BACTERIOL, V172, P5312, DOI 10.1128/jb.172.9.5312-5325.1990; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Cerda-Cuellar M, 2008, VET J, V175, P384, DOI 10.1016/j.tvjl.2007.01.016; Chang CF, 1998, AVIAN PATHOL, V27, P339, DOI 10.1080/03079459808419349; Crasta KC, 2002, J BACTERIOL, V184, P1932, DOI 10.1128/JB.184.7.1932-1939.2002; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Ding JiaBo, 2008, Scientia Agricultura Sinica, V41, P2448; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Grozdanov L, 2002, J BACTERIOL, V184, P5912, DOI 10.1128/JB.184.21.5912-5925.2002; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039805; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu QH, 2010, VET MICROBIOL, V144, P429, DOI 10.1016/j.vetmic.2010.02.023; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hunnicutt DW, 2002, J BACTERIOL, V184, P2370, DOI 10.1128/JB.184.9.2370-2378.2002; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Merino S, 1996, MICROB PATHOGENESIS, V20, P325, DOI 10.1006/mpat.1996.0031; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Pei JW, 2006, INFECT IMMUN, V74, P2667, DOI 10.1128/IAI.74.5.2667-2675.2006; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; RONCERO C, 1992, J BACTERIOL, V174, P3250, DOI 10.1128/jb.174.10.3250-3260.1992; Sandhu TS., 1986, DUCK PRODUCTION SCI, P111; Thoden JB, 1998, BIOCHEMISTRY-US, V37, P11469, DOI 10.1021/bi9808969; Wang X, 2012, CHIN J ANIM INFECT D, V20, P54; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Wells TJ, 2008, ENVIRON MICROBIOL, V10, P589, DOI 10.1111/j.1462-2920.2007.01479.x; Weng SC, 1999, FEMS MICROBIOL LETT, V179, P11, DOI 10.1111/j.1574-6968.1999.tb08701.x; Zhang B, 2012, VET MICROBIOL, V157, P237, DOI 10.1016/j.vetmic.2011.12.002; Zhang M, 2013, VET MICROBIOL, V164, P322, DOI 10.1016/j.vetmic.2013.02.017; Zuppardo AB, 1998, INFECT IMMUN, V66, P2601, DOI 10.1128/IAI.66.6.2601-2606.1998	39	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109962	10.1371/journal.pone.0109962	http://dx.doi.org/10.1371/journal.pone.0109962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303276	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400096
J	Goodwin, JE; Feng, Y; Velazquez, H; Zhou, H; Sessa, WC				Goodwin, Julie E.; Feng, Yan; Velazquez, Heino; Zhou, Han; Sessa, William C.			Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS	PLOS ONE			English	Article							NF-KAPPA-B; BETA-ISOFORM; EXPRESSION; RESISTANCE; MICE; TRANSCRIPTION; ENDOTOXEMIA; INFLAMMATION; METABOLISM; INDUCTION	Glucocorticoids are normally regarded as anti-inflammatory therapy for a wide variety of conditions and have been used with some success in treating sepsis and sepsis-like syndromes. We previously demonstrated that mice lacking the glucocorticoid receptor in the endothelium (GR (EC KO) mice) are extremely sensitive to low-dose LPS and demonstrate prolonged activation and up regulation of NF-kappa B. In this study we pre-treated these GR (EC KO) mice with dexamethasone and assessed their response to an identical dose of LPS. Surprisingly, the GR (EC KO) mice fared even worse than when given LPS alone demonstrating increased mortality, increased levels of the inflammatory cytokines TNF-alpha and IL-6 and increased nitric oxide release after the dexamethasone pre-treatment. As expected, control animals pre-treated with dexamethasone showed improvement in all parameters assayed. Mechanistically we demonstrate that GR (EC KO) mice show increased iNOS production and NF-kappa B activation despite treatment with dexamethasone.	[Goodwin, Julie E.; Feng, Yan; Zhou, Han] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Velazquez, Heino] Vet Affairs Hosp, Dept Internal Med, West Haven, CT USA; [Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Goodwin, JE (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	julie.goodwin@yale.edu	Sessa, William C/B-6844-2011; Goodwin, Julie/AAF-5754-2020	Sessa, William C/0000-0001-5759-1938; 	NIH Mentored Clinical Scientist Research Award [K08-DK078623]; Bartner Research Discovery Scholar Award; National Institutes of Health [HL64793, HL61371, HL081190, HL096670, PO1 HL107205]; Yale Mouse Metabolic Phenotyping Core [U24 DK59635]; George M. O'Brien Kidney Center at Yale: NIH [P30 DK079310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081190, P01HL107205, R37HL061371, R01HL096670, R01HL064793, R01HL061371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, U24DK059635, K08DK078623] Funding Source: NIH RePORTER	NIH Mentored Clinical Scientist Research Award; Bartner Research Discovery Scholar Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Mouse Metabolic Phenotyping Core; George M. O'Brien Kidney Center at Yale: NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an NIH Mentored Clinical Scientist Research Award (K08-DK078623), a Bartner Research Discovery Scholar Award to JG and HL64793, HL61371, HL081190, HL096670 and PO1 HL107205 from the National Institutes of Health to WS. The authors also acknowledge the Yale Mouse Metabolic Phenotyping Core: U24 DK59635 and the George M. O'Brien Kidney Center at Yale: NIH grant P30 DK079310. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BERRY LJ, 1964, J EXP MED, V120, P721, DOI 10.1084/jem.120.5.721; Bonin CP, 2013, BIOCHEM BIOPH RES CO, V432, P256, DOI 10.1016/j.bbrc.2013.02.002; Chauhan SD, 2003, FASEB J, V17, P773, DOI 10.1096/fj.02-0668fje; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; FIGLEWICZ DP, 1978, CIRC SHOCK, V5, P317; Goodwin JE, 2013, P NATL ACAD SCI USA, V110, P306, DOI 10.1073/pnas.1210200110; Goodwin JE, 2011, J HYPERTENS, V29, P1347, DOI [10.1093/gerona/glr171, 10.1097/HJH.0b013e328347da54]; Guerrero J, 2013, CRIT CARE, V17, DOI 10.1186/cc12774; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Haim YO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04323; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Kaddoura S, 1996, BIOCHEM BIOPH RES CO, V218, P641, DOI 10.1006/bbrc.1996.0115; Langklotz S, 2011, J BACTERIOL, V193, P1090, DOI 10.1128/JB.01043-10; Laubach VE, 1998, AM J PHYSIOL-HEART C, V275, pH2211, DOI 10.1152/ajpheart.1998.275.6.H2211; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee JI, 1998, J CLIN PHARMACOL, V38, P981, DOI 10.1177/009127009803801101; Ling J, 2012, CANCER LETT, V322, P119, DOI 10.1016/j.canlet.2012.02.033; Oakley RH, 1996, J BIOL CHEM, V271, P9550, DOI 10.1074/jbc.271.16.9550; Oakley RH, 1997, ENDOCRINOLOGY, V138, P5028, DOI 10.1210/en.138.11.5028; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sorrells SF, 2013, J NEUROSCI, V33, P7877, DOI 10.1523/JNEUROSCI.4705-12.2013; SPINK WW, 1954, J CLIN INVEST, V33, P540, DOI 10.1172/JCI102924; Stolte EH, 2006, J ENDOCRINOL, V190, P17, DOI 10.1677/joe.1.06703; Taniguchi Y, 2010, ENDOCRINOLOGY, V151, P3204, DOI 10.1210/en.2009-1254; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098	30	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108126	10.1371/journal.pone.0108126	http://dx.doi.org/10.1371/journal.pone.0108126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299055	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200010
J	Wang, S; Liu, XM; Zhang, J; Zhang, YQ				Wang, Shu; Liu, Xian-Ming; Zhang, Jian; Zhang, Yu-Qing			An Efficient Preparation of Mulberroside A from the Branch Bark of Mulberry and Its Effect on the Inhibition of Tyrosinase Activity	PLOS ONE			English	Article							MUSHROOM TYROSINASE; RAMULUS-MORI; IN-VITRO; OXYRESVERATROL; 2,5-DIHYDROXY-4,3'-DI(BETA-D-GLUCOPYRANOSYLOXY)-TRANS-STILBENE; METABOLITES	A bioactive ingredient in an ethanol extract from the branch bark of cultivated mulberry Husang-32 (Morus multicaulis Perr.) was isolated using a macroporous resin column. The primary component, which was purified by semi-preparative high-performance liquid chromatography diode array detection (HPLC-DAD), was identified as mulberroside A (MA) by liquid chromatograph-mass spectrometer (LC-MS), H-1 and C-13 nuclear magnetic resonance (NMR) spectra. In total, 4.12 g MA was efficiently extracted from one kilogram of mulberry bark. The enzymatic analysis showed that MA inhibited the generation of dopachrome by affecting the activities of monophenolase and diphenolase of tyrosinase in vitro. This analysis indicated that MA and oxyresveratrol (OR), which is the the aglycone of mulberroside A, exhibited strong inhibition of the monophenolase activity with IC50 values of 1.29 mu mol/L and 0.12 mu mol/L, respectively. However, the former showed weaker inhibitory activity than the latter for diphenolase. For the monophenolase activity, the inhibitory activity of MA and OR was reversible and showed mixed type 1 inhibition. Additionally, the inhibition constant K-I (the inhibition constant of the effectors on tyrosinase) values were 0.385 mu mol/L and 0.926 mu mol/L, respectively, and the K-IS (the inhibition constants of the enzyme-substrate complex) values were 0.177 mu mol/L and 0.662 mu mol/L, respectively. However, MA showed competitive inhibition of diphenolase activity, and K-I was 4.36 mu mol/L. In contrast, OR showed noncompetitive inhibition and K-I = K-IS = 2.95 mu mol/L. Taken together, these results provide important information concerning the inhibitory mechanism of MA on melanin synthesis, which is widely used in whitening cosmetics.	[Wang, Shu; Liu, Xian-Ming; Zhang, Yu-Qing] Soochow Univ, Sch Basic Med & Biol Sci, Silk Biotechnol Lab, Suzhou, Peoples R China; [Zhang, Jian] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Zhang, J (corresponding author), Soochow Univ, Sch Basic Med & Biol Sci, Silk Biotechnol Lab, Suzhou, Peoples R China.	jianzhang@suda.edu.cn; sericult@suda.edu.cn		Zhang, Yu-Qing/0000-0001-7670-386X	earmarked fund for China Agriculture Research System (CARS) [CARS-22-ZJ0504]; Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China	earmarked fund for China Agriculture Research System (CARS); Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China	The authors gratefully acknowledge the earmarked fund (CARS-22-ZJ0504) for China Agriculture Research System (CARS) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen QX, 2003, J ENZYM INHIB MED CH, V18, P491, DOI 10.1080/14756360310001613094; Chung KO, 2003, J PHARM PHARMACOL, V55, P1695, DOI 10.1211/0022357022313; de Rigal D, 2001, INT J FOOD SCI TECH, V36, P677, DOI 10.1046/j.1365-2621.2001.00498.x; Heo SI, 2007, J MED FOOD, V10, P602, DOI 10.1089/jmf.2006.0241; Jin YS, 2007, PHYTOTHER RES, V21, P605, DOI 10.1002/ptr.2121; Jin YS, 2006, FREE RADICAL RES, V40, P986, DOI 10.1080/10715760600803823; Jin Ying-Shan, 2009, Journal of Yangzhou University (Agricultural and Life Science Edition), V30, P18; [阚启明 KAN Qiming], 2006, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V23, P388; Kim J-H, 2006, Patent No. [US2006216253A1, 2006216253]; Kim JK, 2012, J ENZYM INHIB MED CH, V27, P495, DOI 10.3109/14756366.2011.598866; Kim JK, 2010, J IND MICROBIOL BIOT, V37, P631, DOI 10.1007/s10295-010-0722-9; Kim JS, 2012, BIOSCI BIOTECH BIOCH, V76, P1425, DOI 10.1271/bbb.111002; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Lee KT, 2003, J COSMET SCI, V54, P133; MAYER AM, 1987, PHYTOCHEMISTRY, V26, P11; Mei M, 2012, J AGR FOOD CHEM, V60, P2299, DOI 10.1021/jf204495t; Qiu F, 1996, BIOL PHARM BULL, V19, P1463, DOI 10.1248/bpb.19.1463; Qiu F, 2005, China Patent, Patent No. [CN1679597, 1679597]; Qiu Feng, 1996, Natural Medicines, V50, P103; Satooka H, 2011, J AGR FOOD CHEM, V59, P8908, DOI 10.1021/jf2014149; Shu S-M, 2008, CHINESE TRADITIONAL, V39, P35; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; [吴石磊 WU Shi-Lei], 2009, [蚕业科学, Acta Sericologica Sinica], V35, P671; Yang ZZ, 2012, FOOD CHEM, V131, P617, DOI 10.1016/j.foodchem.2011.09.040; Zhang M, 2009, FITOTERAPIA, V80, P475, DOI 10.1016/j.fitote.2009.06.009; Zhang Y-Q, 2009, China Patent, Patent No. [CN10133694A, 10133694]; Zhang ZF, 2008, ENVIRON TOXICOL PHAR, V26, P325, DOI 10.1016/j.etap.2008.06.008; Zhaxi MC, 2010, PLANTA MED, V76, P362, DOI 10.1055/s-0029-1186160	28	13	14	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109396	10.1371/journal.pone.0109396	http://dx.doi.org/10.1371/journal.pone.0109396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299075	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200051
J	Peng, ZC; Andersson, K; Lindholm, J; Bodin, I; Pramana, S; Pawitan, Y; Nister, M; Nilsson, S; Li, CD				Peng, Zhuochun; Andersson, Karl; Lindholm, Johan; Bodin, Inger; Pramana, Setia; Pawitan, Yudi; Nister, Monica; Nilsson, Sten; Li, Chunde			Operator Dependent Choice of Prostate Cancer Biopsy Has Limited Impact on a Gene Signature Analysis for the Highly Expressed Genes IGFBP3 and F3 in Prostate Cancer Epithelial Cells	PLOS ONE			English	Article							PROGNOSTIC-FACTORS	Background: Predicting the prognosis of prostate cancer disease through gene expression analysis is receiving increasing interest. In many cases, such analyses are based on formalin-fixed, paraffin embedded (FFPE) core needle biopsy material on which Gleason grading for diagnosis has been conducted. Since each patient typically has multiple biopsy samples, and since Gleason grading is an operator dependent procedure known to be difficult, the impact of the operator's choice of biopsy was evaluated. Methods: Multiple biopsy samples from 43 patients were evaluated using a previously reported gene signature of IGFBP3, F3 and VGLL3 with potential prognostic value in estimating overall survival at diagnosis of prostate cancer. A four multiplex one-step qRT-PCR test kit, designed and optimized for measuring the signature in FFPE core needle biopsy samples was used. Concordance of gene expression levels between primary and secondary Gleason tumor patterns, as well as benign tissue specimens, was analyzed. Results: The gene expression levels of IGFBP3 and F3 in prostate cancer epithelial cell-containing tissue representing the primary and secondary Gleason patterns were high and consistent, while the low expressed VGLL3 showed more variation in its expression levels. Conclusion: The assessment of IGFBP3 and F3 gene expression levels in prostate cancer tissue is independent of Gleason patterns, meaning that the impact of operator's choice of biopsy is low.	[Peng, Zhuochun; Bodin, Inger; Nister, Monica; Nilsson, Sten; Li, Chunde] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Andersson, Karl] Uppsala Univ, Dept Oncol Radiol & Radiat Sci, Uppsala, Sweden; [Lindholm, Johan; Nister, Monica; Nilsson, Sten; Li, Chunde] Karolinska Univ Hosp, Stockholm, Sweden; [Pramana, Setia; Pawitan, Yudi] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Li, Chunde] Chundsell Med AB, Stockholm, Sweden; [Andersson, Karl] Ridgeview Instruments AB, Uppsala, Sweden; [Pramana, Setia] Sekolah Tinggi Ilmu Stat Inst Stat, Jakarta, Indonesia	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Li, CD (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Chunde.li@ki.se		Pramana, Setia/0000-0002-8590-1451; Li, Chunde/0000-0003-4331-079X	Uppsala Bio; Swedish Cancer Society; King Gustaf V Jubilee Foundation; Stockholm county council	Uppsala Bio; Swedish Cancer Society(Swedish Cancer Society); King Gustaf V Jubilee Foundation; Stockholm county council(Stockholm County Council)	This work was financed by Uppsala Bio (http://www.uppsalabio.com/), the Swedish Cancer Society (http://www.cancerfonden.se/sv/Information-in-English/), the King Gustaf V Jubilee Foundation (http://www.rahfo.se/Metamenyn/In-English/), and the Stockholm county council (http://www.sll.se/om-landstinget/Information-in-English1/). The funders provided support in the form of salaries for Zhuochun Peng, Karolinska Institutet, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crook J, 2013, SEMIN RADIAT ONCOL, V23, P165, DOI 10.1016/j.semradonc.2013.01.002; Fischer A. H., 2008, CSH PROTOC; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Peng Z, 2014, PROSTATE CANCER P D, V17, P81, DOI 10.1038/pcan.2013.57; Sooriakumaran P, 2005, CLIN ONCOL-UK, V17, P655, DOI 10.1016/j.clon.2005.06.011; Yeo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089395	8	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109610	10.1371/journal.pone.0109610	http://dx.doi.org/10.1371/journal.pone.0109610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296164	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000087
J	Trier, S; Linderoth, L; Bjerregaard, S; Andresen, TL; Rahbek, UL				Trier, Sofie; Linderoth, Lars; Bjerregaard, Simon; Andresen, Thomas Lars; Rahbek, Ulrik Lytt			Acylation of Glucagon-Like Peptide-2: Interaction with Lipid Membranes and In Vitro Intestinal Permeability	PLOS ONE			English	Article							FATTY-ACIDS; TRYPTOPHAN FLUORESCENCE; REVERSIBLE LIPIDIZATION; DRUG-DELIVERY; ABSORPTION; PREDICTION; ANALOG; GLP-2; CHROMATOGRAPHY; PROTRACTION	Background: Acylation of peptide drugs with fatty acid chains has proven beneficial for prolonging systemic circulation as well as increasing enzymatic stability without disrupting biological potency. Acylation has furthermore been shown to increase interactions with the lipid membranes of mammalian cells. The extent to which such interactions hinder or benefit delivery of acylated peptide drugs across cellular barriers such as the intestinal epithelia is currently unknown. The present study investigates the effect of acylating peptide drugs from a drug delivery perspective. Purpose: We hypothesize that the membrane interaction is an important parameter for intestinal translocation, which may be used to optimize the acylation chain length for intestinal permeation. This work aims to characterize acylated analogues of the intestinotrophic Glucagon-like peptide-2 by systematically increasing acyl chain length, in order to elucidate its influence on membrane interaction and intestinal cell translocation in vitro. Results: Peptide self-association and binding to both model lipid and cell membranes was found to increase gradually with acyl chain length, whereas translocation across Caco-2 cells depended non-linearly on chain length. Short and medium acyl chains increased translocation compared to the native peptide, but long chain acylation displayed no improvement in translocation. Co-administration of a paracellular absorption enhancer was found to increase translocation irrespective of acyl chain length, whereas a transcellular enhancer displayed increased synergy with the long chain acylation. Conclusions: These results show that membrane interactions play a prominent role during intestinal translocation of an acylated peptide. Acylation benefits permeation for shorter and medium chains due to increased membrane interactions, however, for longer chains insertion in the membrane becomes dominant and hinders translocation, i.e. the peptides get 'stuck' in the cell membrane. Applying a transcellular absorption enhancer increases the dynamics of membrane insertion and detachment by fluidizing the membrane, thus facilitating its effects primarily on membrane associated peptides.	[Trier, Sofie; Andresen, Thomas Lars] Tech Univ Denmark, Ctr Nanomed & Theranost, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Trier, Sofie; Linderoth, Lars; Bjerregaard, Simon; Rahbek, Ulrik Lytt] Diabet Res Unit, Novo Nordisk, Maaloev, Denmark	Technical University of Denmark; Novo Nordisk	Rahbek, UL (corresponding author), Diabet Res Unit, Novo Nordisk, Maaloev, Denmark.	ulyr@novonordisk.com	Andresen, Thomas L/B-5324-2012	FCCN, Bogus/0000-0001-6282-8004; Andresen, Thomas Lars/0000-0002-1048-127X	Danish Agency for Science, Technology and Innovation; Technical University of Denmark; Novo Nordisk A/S	Danish Agency for Science, Technology and Innovation; Technical University of Denmark; Novo Nordisk A/S(Novo Nordisk)	ST was partially funded by The Danish Agency for Science, Technology and Innovation, and TLA was funded by the Technical University of Denmark. The funder Novo Nordisk A/S provided support in the form of salaries for authors ST, LL, SB and ULR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Balon K, 1999, PHARMACEUT RES, V16, P882, DOI 10.1023/A:1018882221008; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Dasgupta P, 2002, BIOL PHARM BULL, V25, P29, DOI 10.1248/bpb.25.29; Deli MA, 2009, BBA-BIOMEMBRANES, V1788, P892, DOI 10.1016/j.bbamem.2008.09.016; Drucker DJ, 1999, TRENDS ENDOCRIN MET, V10, P153, DOI 10.1016/S1043-2760(98)00136-2; Etzerodt T, 2011, BIOPHYS J, V100, P399, DOI 10.1016/j.bpj.2010.11.040; FUJINARI EM, 1992, J CHROMATOGR, V592, P209, DOI 10.1016/0021-9673(92)85087-A; Gozes I, 1996, P NATL ACAD SCI USA, V93, P427, DOI 10.1073/pnas.93.1.427; Hartmann B, 2000, PEPTIDES, V21, P73, DOI 10.1016/S0196-9781(99)00176-X; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jeppesen PB, 2012, THER ADV GASTROENTER, V5, P159, DOI 10.1177/1756283X11436318; Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Kramer SD, 1999, PHARM SCI TECHNOL TO, V2, P373, DOI 10.1016/S1461-5347(99)00188-1; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; Palasek SA, 2007, J PEPT SCI, V13, P143, DOI 10.1002/psc.804; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Pinheiro CIC, 2012, IND ENG CHEM RES, V51, P1, DOI 10.1021/ie200743c; ROGERS JA, 1980, INT J PHARM, V6, P339, DOI 10.1016/0378-5173(80)90117-9; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sakai M, 1998, J PHARM PHARMACOL, V50, P1101, DOI 10.1111/j.2042-7158.1998.tb03319.x; Sams A, 2006, EUR J PHARMACOL, V532, P18, DOI 10.1016/j.ejphar.2005.12.001; Tavares W, 2000, AM J PHYSIOL-ENDOC M, V278, pE134, DOI 10.1152/ajpendo.2000.278.1.E134; te Welscher YM, 2014, J CONTROL RELEASE, V175, P72, DOI 10.1016/j.jconrel.2013.12.013; Thulesen J, 2002, REGUL PEPTIDES, V103, P9, DOI 10.1016/S0167-0115(01)00316-0; Uchiyama T, 2000, PHARM RES, V17; Wallis K, 2007, ALIMENT PHARM THER, V25, P365, DOI 10.1111/j.1365-2036.2006.03193.x; Wang J, 2000, INT J PHARM, V204, P111, DOI 10.1016/S0378-5173(00)00489-0; Wang J, 2003, J CONTROL RELEASE, V88, P369, DOI 10.1016/S0168-3659(03)00008-7; Yuan LY, 2005, PHARM RES-DORDR, V22, P220, DOI 10.1007/s11095-004-1189-z; Zhang L, 2012, CURR MED CHEM, V19, P1602	38	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109939	10.1371/journal.pone.0109939	http://dx.doi.org/10.1371/journal.pone.0109939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295731	gold, Green Submitted, Green Published			2022-12-25	WOS:000345204000105
J	Wobser, D; Ali, L; Grohmann, E; Huebner, J; Sakinc, T				Wobser, Dominique; Ali, Liaqat; Grohmann, Elisabeth; Huebner, Johannes; Sakinc, Tuerkan			A Novel Role for D-Alanylation of Lipoteichoic Acid of Enterococcus faecalis in Urinary Tract Infection	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; TEICHOIC-ACIDS; D-ALANINE; POLYSACCHARIDE BIOSYNTHESIS; ANTIMICROBIAL PEPTIDES; BACILLUS-SUBTILIS; BIOFILM FORMATION; GENE-CLUSTER; MOUSE MODEL; VIRULENCE	Background: Enterococci are the third most common cause of healthcare-associated infections, which include urinary tract infections, bacteremia and endocarditis. Cell-surface structures such as lipoteichoic acid (LTA) have been poorly examined in E. faecalis, especially with respect to urinary tract infections (UTIs). The dlt operon is responsible for the D-alanylation of LTA and includes the gene dltA, which encodes the D-alanyl carrier protein ligase (Dcl). The involvement of LTA in UTI infection by E. faecalis has not been studied so far. Here, we examined the role of teichoic acid alanylation in the adhesion of enterococci to uroepithelial cells. Results: In a mouse model of urinary tract infection, we showed that E. faecalis 12030 Delta dltA mutant colonizes uroepithelial surfaces more efficiently than wild type bacteria. We also demonstrated that this mutant adhered four fold better to human bladder carcinoma cell line T24 compared to the wild type strain. Bacterial adherence could be significantly inhibited by purified lipoteichoic acid (LTA) and inhibition was specific. Conclusion: In contrast to bacteraemia model and adherence to colon surfaces, E. faecalis 12030 Delta dltA mutant colonized uroepithelial surfaces more efficiently than wild-type bacteria. In the case of the uroepithelial surface the adherence to specific host cells could be prevented by purified LTA. Our results therefore suggest a novel function of alanylation of LTA in E. faecalis.	[Wobser, Dominique; Ali, Liaqat; Grohmann, Elisabeth; Huebner, Johannes; Sakinc, Tuerkan] Univ Hosp Freiburg, Dept Internal Med 2, Div Infect Dis, Freiburg, Germany; [Ali, Liaqat; Grohmann, Elisabeth] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Huebner, Johannes] Univ Munich, Dr Von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany	University of Freiburg; University of Freiburg; University of Munich	Sakinc, T (corresponding author), Univ Hosp Freiburg, Dept Internal Med 2, Div Infect Dis, Freiburg, Germany.	tuerkan.sakinc@uniklinik-freiburg.de		Grohmann, Elisabeth/0000-0003-3061-6490; Huebner, Johannes/0000-0003-1232-4646	German Ministry of Science and Education [BMBF:UroGenOmics0315833C]	German Ministry of Science and Education	This work was supported by grants from the German Ministry of Science and Education (BMBF:UroGenOmics0315833C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; FISCHER W, 1990, BIOCHEM CELL BIOL, V68, P33, DOI 10.1139/o90-005; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Guiton PS, 2010, INFECT IMMUN, V78, P4166, DOI 10.1128/IAI.00711-10; GUZMAN CA, 1991, MICROB PATHOGENESIS, V11, P399, DOI 10.1016/0882-4010(91)90036-A; HIDRON AI, 2009, INFECT CONT HOSP EP, V30, P107; Hufnagel M, 2006, INFECTION, V34, P22, DOI 10.1007/s15010-006-4100-5; Johnson JR, 2004, INFECT IMMUN, V72, P2445, DOI 10.1128/IAI.72.4.2445-2448.2004; Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005; Koch S, 2004, VACCINE, V22, P822, DOI 10.1016/j.vaccine.2003.11.027; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; KUNIN CM, 1994, CLIN INFECT DIS, V18, P1, DOI 10.1093/clinids/18.1.1; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Sillanpaa J, 2004, MICROBIOL-SGM, V150, P2069, DOI 10.1099/mic.0.27074-0; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; Svenborg Eden C, 1993, PROG ALLERGY, V33, P175; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Torelli R, 2012, J INFECT DIS, V206, P952, DOI 10.1093/infdis/jis440; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000	38	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107827	10.1371/journal.pone.0107827	http://dx.doi.org/10.1371/journal.pone.0107827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296179	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000010
J	Houldcroft, CJ; Petrova, V; Liu, JZ; Frampton, D; Anderson, CA; Gall, A; Kellam, P				Houldcroft, Charlotte J.; Petrova, Velislava; Liu, Jimmy Z.; Frampton, Dan; Anderson, Carl A.; Gall, Astrid; Kellam, Paul			Host Genetic Variants and Gene Expression Patterns Associated with Epstein-Barr Virus Copy Number in Lymphoblastoid Cell Lines	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HODGKIN LYMPHOMA; SUSCEPTIBILITY; DIFFERENTIATION; DETERMINANTS; POLYMORPHISM; GENOTYPES; LATENCY; GROWTH; PCR	Lymphoblastoid cell lines (LCLs) are commonly used in molecular genetics, supplying DNA for the HapMap and 1000 Genomes Projects, used to test chemotherapeutic agents, and informing the basis of a number of population genetics studies of gene expression. The process of transforming human B cells into LCLs requires the presence of Epstein-Barr virus (EBV), a double-stranded DNA virus which through B-cell immortalisation maintains an episomal virus genome in every cell of an LCL at variable copy numbers. Previous studies have reported that EBV alters host-gene expression and EBV copy number may be under host genetic control. We performed a genome-wide association study of EBV genome copy number in LCLs and found the phenotype to be highly heritable, although no individual SNPs achieved a significant association with EBV copy number. The expression of two host genes (CXCL16 and AGL) was positively correlated and expression of ADARB2 was negatively correlated with EBV copy number in a genotype-independent manner. This study shows an association between EBV copy number and the gene expression profile of LCLs, and suggests that EBV copy number should be considered as a covariate in future studies of host gene expression in LCLs.	[Houldcroft, Charlotte J.; Petrova, Velislava; Liu, Jimmy Z.; Anderson, Carl A.; Gall, Astrid; Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England; [Houldcroft, Charlotte J.] Univ Cambridge, Div Biol Anthropol, Dept Archaeol & Anthropol, Cambridge, England; [Frampton, Dan; Kellam, Paul] UCL, Dept Infect, Div Infect & Immun, London, England	Wellcome Trust Sanger Institute; University of Cambridge; University of London; University College London	Kellam, P (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	pk5@sanger.ac.uk	Houldcroft, Charlotte/L-2497-2019	Houldcroft, Charlotte/0000-0002-1833-5285; Kellam, Paul/0000-0003-3166-4734; Gall, Astrid/0000-0001-6452-5816; Anderson, Carl/0000-0003-1719-7009	Wellcome Trust [098051]; MRC Doctoral Training Grant [G0900209]; ERC FP7 [261213]	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC FP7	This work is supported by the Wellcome Trust (grant 098051), providing funding to CJH, VP, JZL, CAA, AG and PK. CJH is also supported by MRC Doctoral Training Grant G0900209 and ERC FP7 grant 261213. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or in the decision to publish.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Arguello M, 2003, ONCOGENE, V22, P964, DOI 10.1038/sj.onc.1206270; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Besson C, 2009, J INFECT DIS, V199, P1121, DOI 10.1086/597424; Caignard G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003637; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Davies ML, 2010, VIROLOGY, V400, P53, DOI 10.1016/j.virol.2010.01.002; Dolken L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001150; Du Y, 2013, GENE, V512, P64, DOI 10.1016/j.gene.2012.09.094; Durovic B, 2013, J VIROL; Elefant N, 2011, NUCLEIC ACIDS RES, V39, pD188, DOI 10.1093/nar/gkq1233; Fafi-Kremer S, 2005, J INFECT DIS, V191, P985, DOI 10.1086/428097; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; Friborg JT, 2010, CLIN VACCINE IMMUNOL, V17, P1484, DOI 10.1128/CVI.00527-09; Ghesquieres H, 2013, LEUK LYMPHOMA; Ghesquieres H, 2013, CYTOKINE; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hatta K, 2007, HAEMATOLOGICA, V92, P1470, DOI 10.3324/haematol.11147; Hobbs MR, 2008, J INFECT DIS, V197, P340, DOI 10.1086/525540; Holmoy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075021; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hwang AE, 2012, EPIDEMIOL INFECT, V140, P2089, DOI 10.1017/S0950268811002457; Im HK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002525; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kriesel JD, 2011, J INFECT DIS, V204, P1654, DOI 10.1093/infdis/jir633; Kuparinen T, 2012, GENES IMMUN, V13, P184, DOI 10.1038/gene.2011.71; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Li DF, 2012, ANIM GENET; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Shen GP, 2011, INT J CANCER, V129, P1459, DOI 10.1002/ijc.25759; Stark AL, 2010, AM J HUM GENET, V87, P829, DOI 10.1016/j.ajhg.2010.10.018; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Wojkowska DW, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/590409; Wolc A, 2013, AVIAN DIS, V57, P395, DOI 10.1637/10409-100312-Reg.1	55	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108384	10.1371/journal.pone.0108384	http://dx.doi.org/10.1371/journal.pone.0108384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290448	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000017
J	Wang, YP; Wang, MC; Lin, HC; Chou, P				Wang, Ying-Piao; Wang, Mao-Che; Lin, Hung-Ching; Chou, Pesus			The Impact of Prior Tonsillitis and Treatment Modality on the Recurrence of Peritonsillar Abscess: A Nationwide Cohort Study	PLOS ONE			English	Article							DEEP NECK INFECTION; MANAGEMENT; TONSILLECTOMY; CHILDREN; GUIDELINES; EXPERIENCE; DIAGNOSIS; INCISION; DRAINAGE; HEALTH	Background: Studies suggest an increased risk of peritonsillar abscess (PTA) recurrence in patients with prior tonsillitis. However, this association is inconsistent and could be confounded by different treatment modalities. This study aimed to assess the risk of recurrence among PTA patients with different degrees of prior tonsillitis and treatment modalities, and the role of tonsillectomy in current practice. Methods: All in-patients with peritonsillar abscess between January 2001 and December 2009 were identified in a nationwide, retrospective cohort study. Recurrence was defined as the first occurrence of PTA >= 30 days from the initial PTA. Factors independently associated with recurrence were analyzed using Cox proportional hazard model after adjusting for demographic and clinical data. Results: There were 28,837 patients, with a 5.15% recurrence rate and 4.74 years of follow-up. The recurrence rates were significantly higher among subjects with more than five prior tonsillitis or 1-4 prior tonsillitis compared to those without prior tonsillitis (adjusted hazard ratio, 2.82 [95% confidence interval, 2.39-3.33] and 1.59 [95% CI: 1.38-1.82]). The adjusted HR in patients treated with needle aspiration was 1.08 compared to those treated with incision & drainage (95% CI: 0.85-1.38). After age stratification, the adjusted HRs of more than five prior tonsillitis increased to 2.92 and 3.50 in patients aged <= 18 and 19-29 years respectively. The adjusted HR ofneedle aspiration only increased in patients <= 18 years old (aHR: 1.98 [95% CI: 0.99-3.97]). The overall tonsillectomy rate was 1.48% during our study period. Conclusions: The risk of PTA recurrence increases with higher degrees of prior tonsillitis in all age groups and management by needle aspiration only in the pediatric population. Patients younger than 30 years old with PTA and more than five prior tonsillitis have the greatest risk of recurrence.	[Wang, Ying-Piao; Lin, Hung-Ching] Mackay Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Wang, Ying-Piao; Wang, Mao-Che; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wang, Ying-Piao; Wang, Mao-Che; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching] Mackay Med Coll, Sch Med, New Taipei City, Taiwan; [Wang, Mao-Che] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei 112, Taiwan; [Wang, Mao-Che] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw			Mackay Memorial Hospital [MMH-100-063]	Mackay Memorial Hospital	This study was funded by the Mackay Memorial Hospital (MMH-100-063), and no additional external funding was received for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussaini A, 2013, EUR ARCH OTO-RHINO-L, V270, P1959, DOI 10.1007/s00405-013-2345-z; APOSTOLPOULOS NJ, 1995, INT J PEDIATR OTORHI, V31, P129, DOI 10.1016/0165-5876(94)01077-B; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Bottin R, 2003, EUR ARCH OTO-RHINO-L, V260, P576, DOI 10.1007/s00405-003-0634-7; EPPERLY TD, 1990, AM FAM PHYSICIAN, V42, P102; HARRIS WE, 1991, CLIN OTOLARYNGOL, V16, P271, DOI 10.1111/j.1365-2273.1991.tb00928.x; HERBILD O, 1981, ARCH OTOLARYNGOL, V107, P540; HERZON FS, 1995, LARYNGOSCOPE, V105, P1, DOI 10.1288/00005537-199508002-00001; Huang TT, 2004, HEAD NECK-J SCI SPEC, V26, P854, DOI 10.1002/hed.20014; Johnson RF, 2003, OTOLARYNG HEAD NECK, V128, P332, DOI 10.1067/mhn.2003.93; Johnson Romaine F, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P157, DOI 10.1097/01.moo.0000162259.42115.38; Khayr Walid, 2005, Am J Ther, V12, P344, DOI 10.1097/01.mjt.00001= 67430.81464.04; KRONENBERG J, 1987, AM J OTOLARYNG, V8, P82, DOI 10.1016/S0196-0709(87)80028-5; MAHARAJ D, 1991, J LARYNGOL OTOL, V105, P743, DOI 10.1017/S0022215100117189; Mak CCY, 2012, CLIN OTOLARYNGOL, V37, P87, DOI 10.1111/j.1749-4486.2011.02426.x; Mehanna HM, 2002, POSTGRAD MED J, V78, P545, DOI 10.1136/pmj.78.923.545; Powell J, 2012, CLIN OTOLARYNGOL, V37, P136, DOI 10.1111/j.1749-4486.2012.02452.x; Rana RS, 2011, RADIOL CLIN N AM, V49, P165, DOI 10.1016/j.rcl.2010.07.013; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Raut V V, 2000, Ear Nose Throat J, V79, P206; Ridder GJ, 2005, OTOLARYNG HEAD NECK, V133, P709, DOI 10.1016/j.otohns.2005.07.001; SAVOLAINEN S, 1993, ARCH OTOLARYNGOL, V119, P521; Schraff S, 2001, INT J PEDIATR OTORHI, V57, P213, DOI 10.1016/S0165-5876(00)00447-X; Steyer TE, 2002, AM FAM PHYSICIAN, V65, P93; STRINGER SP, 1988, ARCH OTOLARYNGOL, V114, P296; Szuhay G, 1998, J OTOLARYNGOL, V27, P206; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wiksten J, 2012, EUR ARCH OTO-RHINO-L, V269, P1281, DOI 10.1007/s00405-011-1807-4; WOLF M, 1994, ANN OTO RHINOL LARYN, V103, P554, DOI 10.1177/000348949410300709; WOLF M, 1988, INT J PEDIATR OTORHI, V16, P113, DOI 10.1016/S0165-5876(98)90034-9	30	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109887	10.1371/journal.pone.0109887	http://dx.doi.org/10.1371/journal.pone.0109887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291179	gold, Green Submitted, Green Published			2022-12-25	WOS:000342798000096
J	Montigny, C; Decottignies, P; Le Marechal, P; Capy, P; Bublitz, M; Olesen, C; Moller, JV; Nissen, P; le Maire, M				Montigny, Cedric; Decottignies, Paulette; Le Marechal, Pierre; Capy, Pierre; Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul; le Maire, Marc			S-Palmitoylation and S-Oleoylation of Rabbit and Pig Sarcolipin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium ATPase; Mass Spectrometry (MS); Membrane Protein; Protein Acylation; Protein Palmitoylation; Sarcoplasmic Reticulum (SR); Protein Oleoylation; Sarcolipin	SARCOPLASMIC-RETICULUM CA2+-ATPASE; HELICAL TRANSMEMBRANE PROTEINS; SKELETAL-MUSCLE; MEMBRANE-PROTEINS; CALCIUM-PUMP; PHYLOGENETIC TREES; DETERGENT BINDING; ATPASE SERCA; CA2+; SITES	Background: Many functions are subjected to regulation by protein-protein interactions. An example is the SERCA1a-SLN8 complex. Results: Rabbit and pig SLN have two types of fatty acid anchors (palmitic and oleic acid) attached to an intramembranous cysteine residue. Conclusion: A role and evolutionary significance of these S-acylations are suggested. Significance: First demonstration of SLN S-acylation and of the intramembranous S-oleoylation of a membrane protein. Sarcolipin (SLN) is a regulatory peptide present in sarcoplasmic reticulum (SR) from skeletal muscle of animals. We find that native rabbit SLN is modified by a fatty acid anchor on Cys-9 with a palmitic acid in about 60% and, surprisingly, an oleic acid in the remaining 40%. SLN used for co-crystallization with SERCA1a (Winther, A. M., Bublitz, M., Karlsen, J. L., Moller, J. V., Hansen, J. B., Nissen, P., and Buch-Pedersen, M. J. (2013) Nature 495, 265-2691; Ref. 1) is also palmitoylated/oleoylated, but is not visible in crystal structures, probably due to disorder. Treatment with 1 m hydroxylamine for 1 h removes the fatty acids from a majority of the SLN pool. This treatment did not modify the SERCA1a affinity for Ca2+ but increased the Ca2+-dependent ATPase activity of SR membranes indicating that the S-acylation of SLN or of other proteins is required for this effect on SERCA1a. Pig SLN is also fully palmitoylated/oleoylated on its Cys-9 residue, but in a reverse ratio of about 40/60. An alignment of 67 SLN sequences from the protein databases shows that 19 of them contain a cysteine and the rest a phenylalanine at position 9. Based on a cladogram, we postulate that the mutation from phenylalanine to cysteine in some species is the result of an evolutionary convergence. We suggest that, besides phosphorylation, S-acylation/deacylation also regulates SLN activity.	[Montigny, Cedric; le Maire, Marc] Univ Paris 11, CEA, UMR 8221, Lab Prot Membranaires, F-91191 Gif Sur Yvette, France; [Montigny, Cedric; le Maire, Marc] CENS, Lab Leon Brillouin, CNRS, F-91191 Gif Sur Yvette, France; [Decottignies, Paulette; Le Marechal, Pierre] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91400 Orsay, France; [Capy, Pierre] Ctr Rech Gif, CNRS, UPR 9034, Lab Evolut Genomes & Speciat, F-91190 Gif Sur Yvette, France; [Capy, Pierre] Univ Paris 11, F-91190 Gif Sur Yvette, France; [Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul] Danish Natl Res Fdn, PUMPKIN, Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus, Denmark; [Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Olesen, Claus] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Danmarks Grundforskningsfond; Aarhus University; Aarhus University	le Maire, M (corresponding author), CEA, UMR 8221, F-91191 Gif Sur Yvette, France.	marc.lemaire@cea.fr	MONTIGNY, Cédric/AAH-4216-2021	Nissen, Poul/0000-0003-0948-6628; Bublitz, Maike/0000-0003-3161-418X; Olesen, Claus/0000-0002-0462-1686	Agence Nationale de la Recherche; Domaines d'Interet Majeur Maladies Infectieuses Region Ile de France	Agence Nationale de la Recherche(French National Research Agency (ANR)); Domaines d'Interet Majeur Maladies Infectieuses Region Ile de France(Region Ile-de-France)	This work was supported by grants from the Agence Nationale de la Recherche (to M. l. M. and C. M.) and the Domaines d'Interet Majeur Maladies Infectieuses Region Ile de France (to M. l. M. and C. M.).	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN JP, 1977, BIOCHIM BIOPHYS ACTA, V485, P188, DOI 10.1016/0005-2744(77)90206-6; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Buffy JJ, 2006, BIOCHEMISTRY-US, V45, P10939, DOI 10.1021/bi060728d; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chaube R, 2014, J BIOL CHEM, V289, P8612, DOI 10.1074/jbc.M114.548925; DONNELLY D, 1993, PROTEIN SCI, V2, P55; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; Kazmin D, 2002, ANAL BIOCHEM, V301, P91, DOI 10.1006/abio.2001.5488; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lee AG, 2002, CURR OPIN STRUC BIOL, V12, P547, DOI 10.1016/S0959-440X(02)00360-3; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; MACLENNAN DH, 1973, COLD SPRING HARB SYM, V37, P469, DOI 10.1101/SQB.1973.037.01.058; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; MEIS LD, 1971, J BIOL CHEM, V246, P4759; MEISSNER G, 1973, BIOCHEM BIOPH RES CO, V52, P913, DOI 10.1016/0006-291X(73)91024-3; Mokrab Y, 2010, PROTEINS, V78, P2895, DOI 10.1002/prot.22809; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Montigny C, 2004, J BIOL CHEM, V279, P43971, DOI 10.1074/jbc.M407142200; Montigny C, 2008, BIOCHEMISTRY-US, V47, P12159, DOI 10.1021/bi8006498; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Musgaard M, 2012, BIOPHYS J, V102, P268, DOI 10.1016/j.bpj.2011.12.009; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2013, CURR BIOL, V23, pR431, DOI 10.1016/j.cub.2013.04.024; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schey KL, 2010, BIOCHEMISTRY-US, V49, P9858, DOI 10.1021/bi101415w; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Stevens TJ, 2001, PROTEIN SCI, V10, P2507, DOI 10.1110/ps.ps.10501; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; TONG SW, 1977, BIOCHEM BIOPH RES CO, V74, P1242, DOI 10.1016/0006-291X(77)91651-5; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900	59	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33850	33861		10.1074/jbc.M114.590307	http://dx.doi.org/10.1074/jbc.M114.590307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301946	hybrid, Green Published			2022-12-25	WOS:000346077600012
J	Yu, HJ; Zhou, JJ; Takahashi, H; Yao, W; Suzuki, Y; Yuan, X; Yoshimura, SH; Zhang, Y; Liu, Y; Emmett, N; Bond, V; Wang, DM; Ding, X; Takeyasu, K; Yao, XB				Yu, Huijuan; Zhou, Jiajia; Takahashi, Hirohide; Yao, William; Suzuki, Yuki; Yuan, Xiao; Yoshimura, Shige H.; Zhang, Yin; Liu, Ya; Emmett, Nerimiah; Bond, Vincent; Wang, Dongmei; Ding, Xia; Takeyasu, Kunio; Yao, Xuebiao			Spatial Control of Proton Pump H,K-ATPase Docking at the Apical Membrane by Phosphorylation-coupled Ezrin-Syntaxin 3 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC PARIETAL-CELLS; BIOCHEMICAL-CHARACTERIZATION; ACTIN INTERACTION; ACID-SECRETION; ERM PROTEINS; FERM DOMAIN; ACTIVATION; LOCALIZATION; TUBULOVESICLES; RADIXIN	The digestive function of the stomach depends on acidification of the gastric lumen. Acid secretion into the lumen is triggered by activation of a cAMP-dependent protein kinase (PKA) cascade, which ultimately results in the insertion of gastric H,K-ATPases into the apical plasma membranes of parietal cells. A coupling protein is ezrin whose phosphorylation at Ser-66 by PKA is required for parietal cell activation. However, little is known regarding the molecular mechanism(s) by which ezrin operates in gastric acid secretion. Here we show that phosphorylation of Ser-66 induces a conformational change of ezrin that enables its association with syntaxin 3 (Stx3) and provides a spatial cue for H, K-ATPase trafficking. This conformation-dependent association is specific for Stx3, and the binding interface is mapped to the N-terminal region. Biochemical analyses show that inhibition of ezrin phosphorylation at Ser-66 prevents ezrin-Stx3 association and insertion of H, K-ATPase into the apical plasma membrane of parietal cells. Using atomic force microscopic analyses, our study revealed that phosphorylation of Ser-66 induces unfolding of ezrin molecule to allow Stx3 binding to its N terminus. Given the essential role of Stx3 in polarized secretion, our study presents the first evidence in which phosphorylation-induced conformational rearrangement of the ezrin molecule provides a spatial cue for polarized membrane trafficking in epithelial cells.	[Yu, Huijuan; Zhou, Jiajia; Yuan, Xiao; Zhang, Yin; Liu, Ya; Wang, Dongmei; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Takahashi, Hirohide; Suzuki, Yuki; Yoshimura, Shige H.; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane, Kyoto 6068502, Japan; [Zhou, Jiajia; Yao, William; Emmett, Nerimiah; Bond, Vincent] Morehouse Sch Med, Atlanta, GA 30310 USA; [Zhang, Yin; Ding, Xia] Beijing Univ Chinese Med, Grad Sch, Beijing 100086, Peoples R China; [Yao, William] Amer Digest Hlth Fdn, Cincinnati, OH USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Kyoto University; Morehouse School of Medicine; Beijing University of Chinese Medicine	Takeyasu, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane, Kyoto 6068502, Japan.	takeyasu@kyoto.ac.jp; yaoxb@ustc.edu.cn	Yoshimura, Shige H./AAF-5463-2019; Yao, Xuebiao/P-5771-2014; Suzuki, Yuki/H-9950-2015	Yoshimura, Shige H./0000-0001-6033-1301; Suzuki, Yuki/0000-0003-1848-0105; Takahashi, Hirohide/0000-0002-2553-8806	National Institutes of Health [CA164133, DK56292, G12RR03034]; Chinese 973 Projects [2012CB945002, 2012CB917204, 2010CB912103]; MOST [2009DFA31010]; Ministry of Education [20113402130010]; Anhui Project [08040102005]; Chinese Natural Science Foundation [31320103904, 31430054, 31271518, 91313303, 91129714, 81270466, 31301105]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101, G12MD007602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Projects(National Basic Research Program of China); MOST; Ministry of Education; Anhui Project; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants CA164133, DK56292, and G12RR03034. This work was also supported by Chinese 973 Projects 2012CB945002, 2012CB917204, and 2010CB912103, MOST 2009DFA31010, Ministry of Education 20113402130010, Anhui Project 08040102005, Chinese Natural Science Foundation Grants 31320103904, 31430054, 31271518, 91313303, 91129714, 81270466, and 31301105.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Calhoun BC, 1997, BIOCHEM J, V325, P559, DOI 10.1042/bj3250559; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; Karvar S, 2005, TRAFFIC, V6, P654, DOI 10.1111/j.1600-0854.2005.00306.x; Karvar S, 2002, J BIOL CHEM, V277, P50030, DOI 10.1074/jbc.M207694200; Karvar S, 2002, GASTROENTEROLOGY, V123, P281, DOI 10.1053/gast.2002.34217; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Peng XR, 1997, MOL BIOL CELL, V8, P399, DOI 10.1091/mbc.8.3.399; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; YAO X, 1995, MOL BIOL CELL, V6, P140; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	29	15	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33333	33342		10.1074/jbc.M114.581280	http://dx.doi.org/10.1074/jbc.M114.581280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301939	hybrid, Green Published			2022-12-25	WOS:000345636600024
J	Badiga, S; Johanning, GL; Macaluso, M; Azuero, A; Chambers, MM; Siddiqui, NR; Piyathilake, CJ				Badiga, Suguna; Johanning, Gary L.; Macaluso, Maurizio; Azuero, Andres; Chambers, Michelle M.; Siddiqui, Nuzhat R.; Piyathilake, Chandrika J.			A Lower Degree of PBMC Li Methylation in Women with Lower Folate Status May Explain the MTHFR C677T Polymorphism Associated Higher Risk of CIN in the US Post Folic Acid Fortification Era	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; REPETITIVE DNA HYPOMETHYLATION; CERVICAL-CANCER; PERIPHERAL-BLOOD; COMMON MUTATION; DISEASE; GENE; MS	Background: Studies in populations unexposed to folic acid (FA) fortification have demonstrated that MTHFR C677T polymorphism is associated with increased risk of higher grades of cervical intraepithelial neoplasia (CIN 2+). However, it is unknown whether exposure to higher folate as a result of the FA fortification program has altered the association between IVITHFR C677T and risk of CIN, or the mechanisms involved with such alterations. The current study investigated the following in a FA fortified population: 1) The association between MTHFR C677T polymorphism and risk of CIN 2+; 2) The modifying effects of plasma folate concentrations on this association; and 3) The modifying effects of plasma folate on the association between the polymorphism and degree of methylation of long interspersed nucleotide elements (Us), in peripheral blood mononuclear cell (PBMC) DNA, a documented biomarker of CIN risk. Methods: The study included 457 US women diagnosed with either CIN 2+ (cases) or < CIN 1 (non-cases). Unconditional logistic regression models were used to test the associations after adjusting for relevant risk factors for CIN. Results: The 677CT11T MTHFR genotypes were not associated with the risk of CIN 2+. Women with CT/TT genotype with lower folate, however, were more likely to be diagnosed with CIN 2+ compared to women with CTaT genotype with higher folate (OR =2.41, P =0.030). Women with CT/TT genotype with lower folate were less likely to have a higher degree of PBMC Li methylation compared to women with CT/TT genotype with higher folate (OR =0.28, P =0.017). Conclusions: This study provides the first evidence that the MTHFR 677CT/TT genotype-associated lower degree of PBMC Li methylation increases the risk of CIN 2+ in women in the US post-FA fortification era. Thus, even in the post-FA fortification era, not all women have adequate folate status to overcome MTHFR 677CT/TT genotype-associated lower degree of L1 methylation.	[Badiga, Suguna; Chambers, Michelle M.; Siddiqui, Nuzhat R.; Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Johanning, Gary L.] SRI Int, Ctr Canc & Metab, Biosci Div, Menlo Pk, CA 94025 USA; [Macaluso, Maurizio] Univ Cincinnati, Coll Med, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH USA; [Azuero, Andres] Univ Alabama Birmingham, Dept Community Hlth Outcomes & Syst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; SRI International; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham	Piyathilake, CJ (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	piyathic@uab.edu	Macaluso, Maurizio/J-2076-2015	Macaluso, Maurizio/0000-0002-2977-9690	National Cancer Institute [R01 CA105448]; UAB Comprehensive Cancer Center Collaborative Programmatic Developmental Award, CCSG [P30 CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA105448] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Comprehensive Cancer Center Collaborative Programmatic Developmental Award, CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01 CA105448 funded by the National Cancer Institute and the UAB Comprehensive Cancer Center Collaborative Programmatic Developmental Award, CCSG P30 CA013148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Berry RJ, 2010, FOOD NUTR BULL, V31, pS22, DOI 10.1177/15648265100311S103; Botezatu A, 2013, J CELL MOL MED, V17, P543, DOI 10.1111/jcmm.12032; Cash HL, 2011, EPIGENETICS-US, V6, P1257, DOI 10.4161/epi.6.10.17728; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Friso S, 2005, CANCER EPIDEM BIOMAR, V14, P938, DOI 10.1158/1055-9965.EPI-04-0601; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gonzalez-Herrera L, 2014, INT J BIOL MARKER, V29, pE142, DOI 10.5301/jbm.5000070; Goodman MT, 2001, CANCER EPIDEM BIOMAR, V10, P1275; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Henao OL, 2005, INT J CANCER, V113, P991, DOI 10.1002/ijc.20695; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Hughes LB, 2006, ANN RHEUM DIS, V65, P1213, DOI 10.1136/ard.2005.046797; Jackson K, 2004, CANCER BIOL THER, V3, P1225, DOI 10.4161/cbt.3.12.1222; KANG SS, 1988, AM J HUM GENET, V43, P414; Kennedy DA, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/952508; Lambropoulos AF, 2003, CANCER LETT, V191, P187, DOI 10.1016/S0304-3835(02)00675-4; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Long SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052381; Manshadi SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084635; McDowell Margaret A, 2008, NCHS Data Brief, P1; Park SY, 2009, J PATHOL, V219, P410, DOI 10.1002/path.2596; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Piyathilake CJ, 2007, NUTRITION, V23, P203, DOI 10.1016/j.nut.2006.12.002; Piyathilake CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054544; Piyathilake CJ, 2011, NUTRITION, V27, P513, DOI 10.1016/j.nut.2010.08.018; Piyathilake CJ, 2010, INT J WOMENS HEALTH, V2, P7; Piyathilake CJ, 2004, CANCER RES, V64, P8788, DOI 10.1158/0008-5472.CAN-04-2402; Piyathilake CJ, 2000, ANTICANCER RES, V20, P1751; Rao GG, 2006, GYNECOL ONCOL, V101, P250, DOI 10.1016/j.ygyno.2005.10.019; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Sull JW, 2004, GYNECOL ONCOL, V95, P557, DOI 10.1016/j.ygyno.2004.08.008; Tong SY, 2011, CANCER CAUSE CONTROL, V22, P63, DOI 10.1007/s10552-010-9675-6; Tong SY, 2010, CANCER CAUSE CONTROL, V21, P23, DOI 10.1007/s10552-009-9430-z; Ulrich CM, 1999, CANCER EPIDEM BIOMAR, V8, P659; Ulrich CM, 2006, CANCER EPIDEM BIOMAR, V15, P189, DOI 10.1158/1055-9965.EPI-152CO; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257; Yu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055835; Zhu J, 2013, MOL MED REP, V8, P919, DOI 10.3892/mmr.2013.1589; Zhuo WL, 2012, MOL BIOL REP, V39, P8723, DOI 10.1007/s11033-012-1732-7; Zoodsma M, 2005, HUM GENET, V116, P247, DOI 10.1007/s00439-004-1233-4	50	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110093	10.1371/journal.pone.0110093	http://dx.doi.org/10.1371/journal.pone.0110093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302494	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400111
J	Derksen, A; Hensel, A; Hafezi, W; Herrmann, F; Schmidt, TJ; Ehrhardt, C; Ludwig, S; Kuhn, J				Derksen, Andrea; Hensel, Andreas; Hafezi, Wali; Herrmann, Fabian; Schmidt, Thomas J.; Ehrhardt, Christina; Ludwig, Stephan; Kuehn, Joachim			3-0-Galloylated Procyanidins from Rumex acetosa L. Inhibit the Attachment of Influenza A Virus	PLOS ONE			English	Article							ACTIVITY IN-VITRO; ANTIVIRAL ACTIVITY; GREEN TEA; COLORIMETRIC ASSAY; DERMAL FIBROBLASTS; SCREENING ASSAYS; B VIRUSES; POLYPHENOLS; AGENTS; RESISTANCE	Infections by influenza A viruses (IAV) are a major health burden to mankind. The current antiviral arsenal against IAV is limited and novel drugs are urgently required. Medicinal plants are known as an abundant source for bioactive compounds, including antiviral agents. The aim of the present study was to characterize the anti-IAV potential of a proanthocyanidinenriched extract derived from the aerial parts of Rumex acetosa (RA), and to identify active compounds of RA, their mode of action, and structural features conferring anti-AV activity. In a modified KU (MTTIAv) assay, RA was shown to inhibit growth of the IAV strain PR8 (H1N1) and a clinical isolate of lAV(H1N1)pdm09 with a half-maximal inhibitory concentration (IC50) of 2.5 pg/mL and 2.2;Ag/mL, and a selectivity index (SD (half-maximal cytotoxic concentration (CC50)/1(50)) of 32 and 36, respectively. At RA concentrations>1 pg/mL plaque formation of lAV(H1N1)pdm09 was abrogated. RA was also active against an oseltamivir-resistant isolate of lAV(H1N1)pdm09. TNF-iy. and EGF-induced signal transduction in A549 cells was not affected by RA. The dimeric proanthocyanidin epicatechin-3-0-gallate-(4f1 >8)-epicatechin-3'-0-gallate (procyanidin B2di-gallate) was identified as the main active principle of RA (IC50 approx. 15 uM, SI_?..13). RA and procyanidin B2-di-gallate blocked attachment of IAV and interfered with viral penetration at higher concentrations. Galloylation of the procyanidin core structure was shown to be a prerequisite for anti-AV activity; o-trihydroxylation in the B-ring increased the anti-IAV activity. In silico docking studies indicated that procyanidin B2-di-gallate is able to interact with the receptor binding site of IAV(H1N1)pdm09 hemagglutinin (HA). In conclusion, the proanthocyanidin-enriched extract RA and its main active constituent procyanidin B2-di-gallate protect cells from IAV infection by inhibiting viral entry into the host cell. RA and procyanidin B2-di-gallate appear to be a promising expansion of the currently available anti-influenza agents.	[Derksen, Andrea; Hensel, Andreas; Herrmann, Fabian; Schmidt, Thomas J.] Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany; [Hafezi, Wali; Kuehn, Joachim] Univ Hosp Munster, Inst Med Microbiol Clin Virol, Munster, Germany; [Ehrhardt, Christina; Ludwig, Stephan] Univ Munster, Inst Mol Virol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Kuhn, J (corresponding author), Univ Hosp Munster, Inst Med Microbiol Clin Virol, Munster, Germany.	kuehnj@uni-muenster.de	Schmidt, Thomas J/M-1678-2016	Schmidt, Thomas J/0000-0003-2634-9705; Ludwig, Stephan/0000-0003-4490-3052; Herrmann, Fabian/0000-0002-2411-7671	Deutsche Forschungsgemeinschaft; University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyare C, 2011, PHYTOMEDICINE, V18, P617, DOI 10.1016/j.phymed.2010.08.020; Beyleveld G, 2013, ANTIVIR RES, V100, P120, DOI 10.1016/j.antiviral.2013.07.018; Bicker J, 2009, FITOTERAPIA, V80, P483, DOI 10.1016/j.fitote.2009.08.015; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; DANNE A, 1994, PHYTOCHEMISTRY, V37, P533, DOI 10.1016/0031-9422(94)85094-1; De Bruyne T, 1999, J NAT PROD, V62, P954, DOI 10.1021/np980481o; De Clercq E, 2013, MED RES REV, V33, P1249, DOI 10.1002/med.21281; De Clercq E, 2013, BIOCHEM PHARMACOL, V85, P727, DOI 10.1016/j.bcp.2012.12.011; Dixit Rashmi, 2013, Infectious Disorders - Drug Targets, V13, P34; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Ehrhardt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063657; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ge H, 2010, NAT PROD REP, V27, P1758, DOI 10.1039/c0np00005a; Gescher K, 2011, J ETHNOPHARMACOL, V134, P468, DOI 10.1016/j.jep.2010.12.038; Gescher K, 2011, ANTIVIR RES, V89, P9, DOI 10.1016/j.antiviral.2010.10.007; Glatthaar-Saalmuller B, 2011, PHYTOMEDICINE, V19, P1, DOI 10.1016/j.phymed.2011.10.010; Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Imanishi N, 2002, MICROBIOL IMMUNOL, V46, P491, DOI 10.1111/j.1348-0421.2002.tb02724.x; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Kamali Amanda, 2013, Infect Drug Resist, V6, P187, DOI 10.2147/IDR.S36601; Karoline D, 2007, ANTIVIR RES, V76, P1, DOI 10.1016/j.antiviral.2007.04.001; Khandaker I, 2013, VIRUS GENES; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Pabst D, 2011, EUR J INTERN MED, V22, pE119, DOI 10.1016/j.ejim.2011.08.014; Pariani E, 2013, HUM VACCIN IMMUNOTHE, V9; Park S, 2013, BIOCHEM BIOPH RES CO, V440, P14, DOI 10.1016/j.bbrc.2013.08.090; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Song JM, 2007, EXPERT REV ANTI-INFE, V5, P497, DOI 10.1586/14787210.5.3.497; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Theisen LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088062; Theisen LL, 2012, ANTIVIR RES, V94, P147, DOI 10.1016/j.antiviral.2012.03.006; Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134; Ubillas R, 1994, Phytomedicine, V1, P77, DOI 10.1016/S0944-7113(11)80026-7; Wang RX, 2013, FITOTERAPIA, V84, P308, DOI 10.1016/j.fitote.2012.12.020; Wang XY, 2006, PHYTOTHER RES, V20, P335, DOI 10.1002/ptr.1892; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zumdick S, 2012, FITOTERAPIA, V83, P1210, DOI 10.1016/j.fitote.2012.06.013	51	33	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110089	10.1371/journal.pone.0110089	http://dx.doi.org/10.1371/journal.pone.0110089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303676	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400110
J	Stawski, L; Haines, P; Fine, A; Rudnicka, L; Trojanowska, M				Stawski, Lukasz; Haines, Paul; Fine, Alan; Rudnicka, Lidia; Trojanowska, Maria			MMP-12 Deficiency Attenuates Angiotensin II-Induced Vascular Injury, M2 Macrophage Accumulation, and Skin and Heart Fibrosis	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; MATRIX METALLOPROTEINASE-12; ENDOTHELIAL-CELLS; PULMONARY-FIBROSIS; CARDIAC FIBROSIS; DISEASE; TISSUE; ANGIOGENESIS; EXPRESSION; SCLERODERMA	MMP-12, a macrophage-secreted elastase, is elevated in fibrotic diseases, including systemic sclerosis (SSc) and correlates with vasculopathy and fibrosis. The goal of this study was to investigate the role of MMP-12 in cardiac and cutaneous fibrosis induced by angiotensin II infusion. Ang II-induced heart and skin fibrosis was accompanied by a marked increase of vascular injury markers, including vWF, Thrombospondin-1 (TSP-1) and MMP-12, as well as increased number of PDGFR beta(+) cells. Furthermore Ang II infusion led to an accumulation of macrophages (Mac(3+)) in the skin and in the perivascular and interstitial fibrotic regions of the heart. However, alternatively activated (Arg 1(+)) macrophages were mainly present in the Ang II infused mice and were localized to the perivascular heart regions and to the skin, but were not detected in the interstitial heart regions. Elevated expression of MMP-12 was primarily found in macrophages and endothelial cells (CD31(+)) cells, but MMP-12 was not expressed in the collagen producing cells. MMP-12 deficient mice (MMP12KO) showed markedly reduced expression of vWF, TSP1, and PDGFR beta around vessels and attenuation of dermal fibrosis, as well as the perivascular fibrosis in the heart. However, MMP-12 deficiency did not affect interstitial heart fibrosis, suggesting a heterogeneous nature of the fibrotic response in the heart. Furthermore, MMP-12 deficiency almost completely prevented accumulation of Arg 1(+) cells, whereas the number of Mac(3+) cells was partially reduced. Moreover production of profibrotic mediators such as PDGFBB, TGF beta 1 and pSMAD2 in the skin and perivascular regions of the heart was also inhibited. Together, the results of this study show a close correlation between vascular injury markers, Arg 1(+) macrophage accumulation and fibrosis and suggest an important role of MMP-12 in regulating these processes.	[Stawski, Lukasz; Haines, Paul; Trojanowska, Maria] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA; [Fine, Alan] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Rudnicka, Lidia] Med Univ Warsaw, Fac Hlth Sci, Warsaw, Poland; [Rudnicka, Lidia] Polish Acad Sci, Mossakowski Med Res, Dept Neuropeptides, Warsaw, Poland	Boston University; Boston University; Medical University of Warsaw; Polish Academy of Sciences	Trojanowska, M (corresponding author), Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA.	trojanme@bu.edu	Rudnicka, Lidia/L-7529-2019	Rudnicka, Lidia/0000-0002-8308-1023	National Institutes of Health (NIAMS) [RO1 AR42334, AR044883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044883, R56AR044883, R01AR042334] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health (NIAMS) grant RO1 AR42334 and AR044883 to M. Trojanowska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2006, JOINT BONE SPINE, V73, P363, DOI 10.1016/j.jbspin.2005.12.003; ALPERT MA, 1992, CHEST, V102, P1407, DOI 10.1378/chest.102.5.1407; Amaral Tn, 2013, SEMIN ARTHRITIS RHEU; [Anonymous], 1991, ANN INTERN MED, V114, P249; Asano Y, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0382-7; Avouac J, 2011, RHEUMATOLOGY, V50, P1494, DOI 10.1093/rheumatology/keq448; BANDA MJ, 1981, BIOCHEM J, V193, P589, DOI 10.1042/bj1930589; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Braitsch CM, 2013, J MOL CELL CARDIOL, V65, P108, DOI 10.1016/j.yjmcc.2013.10.005; Brecher P, 1996, TRENDS CARDIOVAS MED, V6, P193, DOI 10.1016/S1050-1738(96)00072-2; Chan MF, 2013, J CELL SCI, V126, P3948, DOI [10.1242/jcs.28033, 10.1242/jcs.128033]; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dimmeler S, 1997, CIRC RES, V81, P970; England KA, 2011, AM J PHYSIOL-LUNG C, V301, pL519, DOI 10.1152/ajplung.00383.2009; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Garbacki N, 2009, PULM PHARMACOL THER, V22, P267, DOI 10.1016/j.pupt.2009.03.001; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsu YH, 2004, J VASC RES, V41, P64, DOI 10.1159/000076247; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kawaguchi Y, 2004, ARTHRITIS RHEUM-US, V50, P216, DOI 10.1002/art.11364; Kim S, 2000, PHARMACOL REV, V52, P11; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Konttinen YT, 2003, CLIN RHEUMATOL, V22, P196, DOI 10.1007/s10067-003-0698-1; Leach Hg, 2013, AM J RESP CELL MOL B; Ma X, 2014, INT J CARDIOL; Macko RF, 2002, J RHEUMATOL, V29, P2565; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Manetti M, 2013, ANN RHEUM DIS; Manetti M, 2012, ANN RHEUM DIS, V71, P1064, DOI 10.1136/annrheumdis-2011-200837; Manoury Boris, 2006, J Inflamm (Lond), V3, P2, DOI 10.1186/1476-9255-3-2; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Matute-Bello G, 2007, AM J RESP CELL MOL, V37, P210, DOI 10.1165/rcmb.2006-0471OC; Meznarich J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057837; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Morgan-Rowe L, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-13; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Nakashima Hidekatsu, 2006, Current Vascular Pharmacology, V4, P67, DOI 10.2174/157016106775203126; Pignone A, 2007, ANN RHEUM DIS, V66, P1305, DOI 10.1136/ard.2006.064493; Rajkumar VS, 1999, ARTHRITIS RHEUM-US, V42, P930, DOI 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1; Richard L, 1999, Methods Mol Med, V18, P261, DOI 10.1385/0-89603-516-6:261; Samuel Chrishan S., 2009, V466, P223, DOI 10.1007/978-1-59745-352-3_16; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shivshankar P, 2014, J MOL CELL CARDIOL; Soria A, 2008, DERMATOLOGY, V216, P109, DOI 10.1159/000111507; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Stawski L, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4028; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu ZW, 2008, ONCOL REP, V20, P81; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	57	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109763	10.1371/journal.pone.0109763	http://dx.doi.org/10.1371/journal.pone.0109763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302498	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400078
J	Zhang, ZJ; Ng, GYF; Lee, WC; Fu, SN				Zhang, Zhi Jie; Ng, Gabriel Yin-fat; Lee, Wai Chun; Fu, Siu Ngor			Changes in Morphological and Elastic Properties of Patellar Tendon in Athletes with Unilateral Patellar Tendinopathy and Their Relationships with Pain and Functional Disability	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; JUMPERS KNEE; VOLLEYBALL PLAYERS; ACHILLES-TENDON; SONOELASTOGRAPHY; ULTRASONOGRAPHY; PREVALENCE; STIFFNESS	Background: Patellar tendinopathy (PT) is one of the most common knee disorders among athletes. Changes in morphology and elasticity of the painful tendon and how these relate to the self-perceived pain and dysfunction remain unclear. Objectives: To compare the morphology and elastic properties of patellar tendons between athlete with and without unilateral PT and to examine its association with self-perceived pain and dysfunction. Methods: In this cross-sectional study, 33 male athletes (20 healthy and 13 with unilateral PT) were enrolled. The morphology and elastic properties of the patellar tendon were assessed by the grey and elastography mode of supersonic shear imaging (SSI) technique while the intensity of pressure pain, self-perceived pain and dysfunction were quantified with a 10-lb force to the most painful site and the Victorian Institute of Sport Assessment-patella (VISA-P) questionnaire, respectively. Results: In athletes with unilateral PT, the painful tendons had higher shear elastic modulus (SEM) and larger tendon than the non-painful side (p<0.05) or the dominant side of the healthy athletes (p<0.05). Significant correlations were found between tendon SEM ratio (SEM of painful over non-painful tendon) and the intensity of pressure pain (rho = 0.62; p = 0.024), VISA-P scores (rho = -0.61; p = 0.026), and the sub-scores of the VISA-P scores on going down stairs, lunge, single leg hopping and squatting (rho ranged from -0.63 to -0.67; p<0.05). Conclusions: Athletes with unilateral PT had stiffer and larger tendon on the painful side than the non-painful side and the dominant side of healthy athletes. No significant differences on the patellar tendon morphology and elastic properties were detected between the dominant and non-dominant knees of the healthy control. The ratio of the SEM of painful to non-painful sides was associated with pain and dysfunction among athletes with unilateral PT.	[Zhang, Zhi Jie; Ng, Gabriel Yin-fat; Lee, Wai Chun; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Zhi Jie] Guangdong Prov Work Injury Rehabil Hosp, Guangdong Hongkong Joint Sports Rehabil & Res Ctr, Guangzhou, Guangdong, Peoples R China	Hong Kong Polytechnic University	Fu, SN (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	amy.fu@polyu.edu.hk		FU, Amy/0000-0003-4405-015X				Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bjornaraa J, 2011, INT J SPORTS PHYS TH, V6, P271; Chen XM, 2013, J ULTRAS MED, V32, P449, DOI 10.7863/jum.2013.32.3.449; Cook JL, 2000, SCAND J MED SCI SPOR, V10, P216, DOI 10.1034/j.1600-0838.2000.010004216.x; Cook JL, 1998, CLIN J SPORT MED, V8, P73, DOI 10.1097/00042752-199804000-00001; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Couppe C, 2013, SCAND J MED SCI SPOR, V23, pe89, DOI 10.1111/sms.12023; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; De Zordo T, 2009, AM J ROENTGENOL, V193, P180, DOI 10.2214/AJR.08.2020; DeWall RJ, 2014, ULTRASOUND MED BIOL, V40, P158, DOI 10.1016/j.ultrasmedbio.2013.08.022; Fredberg U, 2008, SCAND J MED SCI SPOR, V18, P3, DOI 10.1111/j.1600-0838.2007.00746.x; Frohm A, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-49; Gisslen K, 2005, BRIT J SPORT MED, V39, P298, DOI 10.1136/bjsm.2004.014290; Goncalves-Neto J, 2002, JOINT BONE SPINE, V69, P189, DOI 10.1016/S1297-319X(02)00369-X; Helland C, 2013, BRIT J SPORT MED, V47, P862, DOI 10.1136/bjsports-2013-092275; HOOLEY CJ, 1979, INT J BIOL MACROMOL, V1, P123, DOI 10.1016/0141-8130(79)90028-X; Ireland D, 2001, MATRIX BIOL, V20, P159, DOI 10.1016/S0945-053X(01)00128-7; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Kader D, 2002, BRIT J SPORT MED, V36, P239, DOI 10.1136/bjsm.36.4.239; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Klauser AS, 2010, SEMIN MUSCULOSKEL R, V14, P323, DOI 10.1055/s-0030-1254521; Kongsgaard M, 2009, SCAND J MED SCI SPOR, V19, P790, DOI 10.1111/j.1600-0838.2009.00949.x; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kulig K, 2013, SCAND J MED SCI SPOR, V23, pe81, DOI 10.1111/sms.12021; Lian O, 1996, SCAND J MED SCI SPOR, V6, P291; Lian OB, 2005, AM J SPORT MED, V33, P561, DOI 10.1177/0363546504270454; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Maffulli N, 2004, MED SCI SPORT EXER, V36, P1470, DOI 10.1249/01.MSS.0000139895.94846.8D; Magnusson SP, 2003, SCAND J MED SCI SPOR, V13, P211, DOI 10.1034/j.1600-0838.2003.00308.x; Malliaras P, 2010, BRIT J SPORT MED, V44, P944, DOI 10.1136/bjsm.2008.054916; Nyland J, 2006, CLIN IMAG, V30, P335, DOI 10.1016/j.clinimag.2006.02.004; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Sconfienza LM, 2010, CLIN EXP RHEUMATOL, V28, P373; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Visentini P J, 1998, J Sci Med Sport, V1, P22, DOI 10.1016/S1440-2440(98)80005-4; Warden SJ, 2007, AM J SPORT MED, V35, P427, DOI 10.1177/0363546506294858; Witvrouw E, 2001, AM J SPORT MED, V29, P190, DOI 10.1177/03635465010290021201; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066301; Zwerver J, 2011, AM J SPORT MED, V39, P1191, DOI 10.1177/0363546510395492	41	71	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108337	10.1371/journal.pone.0108337	http://dx.doi.org/10.1371/journal.pone.0108337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303466	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400010
J	Kagawa, T; Narita, N; Iwaki, S; Kawasaki, S; Kamiya, K; Minakuchi, S				Kagawa, Tomonori; Narita, Noriyuki; Iwaki, Sunao; Kawasaki, Shingo; Kamiya, Kazunobu; Minakuchi, Shunsuke			Does Shape Discrimination by the Mouth Activate the Parietal and Occipital Lobes? - Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VISUAL WORKING-MEMORY; TACTILE PERCEPTION; FUNCTIONAL BRAIN; MASTICATORY PERFORMANCE; STEREOGNOSTIC ABILITY; CORTICAL ACTIVITY; MINDS EYE; CORTEX; MRI	A cross-modal association between somatosensory tactile sensation and parietal and occipital activities during Braille reading was initially discovered in tests with blind subjects, with sighted and blindfolded healthy subjects used as controls. However, the neural background of oral stereognosis remains unclear. In the present study, we investigated whether the parietal and occipital cortices are activated during shape discrimination by the mouth using functional near-infrared spectroscopy (fNIRS). Following presentation of the test piece shape, a sham discrimination trial without the test pieces induced posterior parietal lobe (BA7), extrastriate cortex (BA18, BA19), and striate cortex (BA17) activation as compared with the rest session, while shape discrimination of the test pieces markedly activated those areas as compared with the rest session. Furthermore, shape discrimination of the test pieces specifically activated the posterior parietal cortex (precuneus/BA7), extrastriate cortex (BA18, 19), and striate cortex (BA17), as compared with sham sessions without a test piece. We concluded that oral tactile sensation is recognized through tactile/visual cross-modal substrates in the parietal and occipital cortices during shape discrimination by the mouth.	[Kagawa, Tomonori; Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Gerodontol & Oral Rehabil Dept Gerontol & Gerodon, Tokyo, Japan; [Narita, Noriyuki; Kamiya, Kazunobu] Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba 271, Japan; [Iwaki, Sunao] Natl Inst Adv Ind Sci & Technol, AIST, Human Technol Res Inst, Cognit & Act Res Grp, Tsukuba, Japan; [Kawasaki, Shingo] Hitachi Med Corp, Applicat Dev Off, Chiba, Japan	Tokyo Medical & Dental University (TMDU); Nihon University; National Institute of Advanced Industrial Science & Technology (AIST); Hitachi Limited	Narita, N (corresponding author), Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba 271, Japan.	narita.noriyuki@nihon-u.ac.jp	Iwaki, Sunao/B-1079-2011	Iwaki, Sunao/0000-0002-7123-7203	Grants-in-Aid for Scientific Research [23300102] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amarasena J, 2010, J ORAL BIOSCI, V52, P181, DOI 10.2330/joralbiosci.52.181; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Engelen L, 2004, J DENT RES, V83, P388, DOI 10.1177/154405910408300507; Fujii R, 2011, J CLIN NEUROSCI, V18, P1520, DOI 10.1016/j.jocn.2011.03.005; Garrett N R, 1994, Int J Prosthodont, V7, P567; Hannula H, 2008, NEUROSCI LETT, V437, P144, DOI 10.1016/j.neulet.2008.03.093; Hirano K, 2004, J ORAL REHABIL, V31, P199, DOI 10.1111/j.1365-2842.2004.01175.x; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Ichikawa N, 2001, MEDIX, V34, P47; Ikebe K, 2007, J ORAL REHABIL, V34, P345, DOI 10.1111/j.1365-2842.2007.01687.x; Ikebe K, 2007, INT J PROSTHODONT, V20, P245; Jacobs R, 1998, Clin Oral Investig, V2, P3, DOI 10.1007/s007840050035; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Kaiba Yoshinori, 2006, Journal of Medical and Dental Sciences, V53, P1; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Kawagishi S, 2009, J ORAL REHABIL, V36, P872, DOI 10.1111/j.1365-2842.2009.02005.x; Keehner M, 2006, NEUROIMAGE, V33, P391, DOI 10.1016/j.neuroimage.2006.06.043; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kojima H, 2010, NEUROPSYCHOLOGIA, V48, P349, DOI 10.1016/j.neuropsychologia.2009.09.028; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kumamoto Y, 2010, J PROSTHODONT RES, V54, P92, DOI 10.1016/j.jpor.2009.11.006; Lacey S, 2012, NEURAL BASES MULTISE; Leung KCM, 2002, J ORAL REHABIL, V29, P497, DOI 10.1046/j.1365-2842.2002.00879.x; Maehara G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2815720; Marumo K, 2014, NEUROIMAGE, V85, P518, DOI 10.1016/j.neuroimage.2013.04.050; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Narita N, 2009, J PROSTHODONT RES, V53, P126, DOI 10.1016/j.jpor.2009.02.005; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Parra MA, 2014, NEUROPSYCHOLOGIA, V52, P27, DOI 10.1016/j.neuropsychologia.2013.09.036; Pasalar S, 2010, EUR J NEUROSCI, V31, P1783, DOI 10.1111/j.1460-9568.2010.07193.x; Pow E H, 2001, Clin Oral Investig, V5, P112, DOI 10.1007/s007840100110; Prather SC, 2004, NEUROPSYCHOLOGIA, V42, P1079, DOI 10.1016/j.neuropsychologia.2003.12.013; Ptito M, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/304045; Qin W, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/864920; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sawa M, 2012, EUR ARCH PSY CLIN N, V262, P493, DOI 10.1007/s00406-012-0296-9; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Stoesz MR, 2003, INT J PSYCHOPHYSIOL, V50, P41, DOI 10.1016/S0167-8760(03)00123-5; Stokes M, 2011, NEUROIMAGE, V56, P1540, DOI 10.1016/j.neuroimage.2011.02.071; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Takahashi K, 2000, J BIOMED OPT, V5, P93, DOI 10.1117/1.429973; Tamura M, 1997, PHILOS T ROY SOC B, V352, P737, DOI 10.1098/rstb.1997.0056; Tian FH, 2014, NEUROIMAGE, V85, P166, DOI 10.1016/j.neuroimage.2013.07.016; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven V, 2013, BEHAV BRAIN RES, V236, P67, DOI 10.1016/j.bbr.2012.08.001; Weisser V, 2005, EXP BRAIN RES, V166, P572, DOI 10.1007/s00221-005-2397-4; Yamamura K, 2008, IADR 86 GEN SESS EXH; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108685	10.1371/journal.pone.0108685	http://dx.doi.org/10.1371/journal.pone.0108685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299397	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200021
J	Kasonta, R; Holsteg, M; Duchow, K; Dekker, JW; Cussler, K; Bendall, JG; Bastian, M				Kasonta, Rahel; Holsteg, Mark; Duchow, Karin; Dekker, James W.; Cussler, Klaus; Bendall, Justin G.; Bastian, Max			Colostrum from Cows Immunized with a Vaccine Associated with Bovine Neonatal Pancytopenia Contains Allo-Antibodies that Cross-React with Human MHC-I Molecules	PLOS ONE			English	Article							FC-RECEPTOR; IGG; BNP; EXPRESSION; ANTIBODIES; TRANSPORT	In 2006, a new haemorrhagic syndrome affecting newborn calves, Bovine Neonatal Pancytopenia (BNP), was reported in southern Germany. It is characterized by severe bleeding, destruction of the red bone marrow, and a high case fatality rate. The syndrome is caused by alloreactive, maternal antibodies that are ingested by the calf with colostrum and result from a dam vaccination with one particular vaccine against Bovine-Viral-Diarrhoea-Virus. Because bovine colostrum is increasingly gaining interest as a dietary supplement for human consumption, the current study was initiated to elucidate whether BNP alloantibodies from BNP dams (i.e. animals that gave birth to a BNP-affected calf) cross-react with human cells, which could pose a health hazard for human consumers of colostral products. The present study clearly demonstrates that BNP alloantibodies cross-react with human lymphocytes in vitro. In agreement with previous reports on BNP, the cross-reactive antibodies are specific for MHC-I molecules, and sensitize opsonised human cells for in vitro complement lysis. Cross-reactive antibodies are present in serum and colostrum of individual BNP dams. They can be traced in commercial colostrum powder manufactured from cows immunized with the vaccine associated with BNP, but are absent from commercial powder manufactured from colostrum excluding such vaccinated cows. In humans alloreactive, MHC-I specific antibodies are generally not believed to cause severe symptoms. However, to minimize any theoretical risk for human consumers, manufacturers of bovine colostrum for human consumption should consider using only colostrum from animals that have not been exposed to the vaccine associated with BNP.	[Kasonta, Rahel; Duchow, Karin; Cussler, Klaus; Bastian, Max] Paul Ehrlich Inst, Div Vet Med, Langen, Germany; [Dekker, James W.; Bendall, Justin G.] Fonterra Res & Dev Ctr, Palmerston North, New Zealand; [Holsteg, Mark] Landwirtschaftskammer Nordrhein Westfalen, Bonn, Germany	Paul Ehrlich Institute; Fonterra	Bastian, M (corresponding author), Paul Ehrlich Inst, Div Vet Med, Langen, Germany.	basma@pei.de	Bastian, Max/AGB-3131-2022	Bastian, Max/0000-0001-7926-8568	Paul-Ehrlich-Institut; Fonterra Research and Development Centre	Paul-Ehrlich-Institut; Fonterra Research and Development Centre(Fonterra)	The authors received no specific funding for this work. Funding for this work was provided by the Paul-Ehrlich-Institut and the Fonterra Research and Development Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad A, 2012, VET IMMUNOL IMMUNOP, V147, P25, DOI 10.1016/j.vetimm.2012.04.012; Bastian M, 2011, VACCINE, V29, P5267, DOI 10.1016/j.vaccine.2011.05.012; Bridger PS, 2011, VET IMMUNOL IMMUNOP, V141, P1, DOI 10.1016/j.vetimm.2011.01.001; Butler I, 2011, RECALL DVD VACCINE N; Butler JE, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1763, DOI 10.1016/B978-012491543-5/50107-8; Curtis BR, 2014, VOX SANG, V106, P93, DOI 10.1111/vox.12085; Davison G, 2010, BRIT J NUTR, V103, P1425, DOI 10.1017/S0007114509993503; Deutskens F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-97; Diaz TM, 2004, TRANSPL IMMUNOL, V13, P313, DOI 10.1016/j.trim.2004.09.001; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; *EMA, 2010, OP FOLL ART 78 PROC; Evans C, 2004, EUR J ENDOCRINOL, V150, P265, DOI 10.1530/eje.0.1500265; Foucras G, 2011, J IMMUNOL, V187, P6564, DOI 10.4049/jimmunol.1102533; Friedrich A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-10; Friedrich A, 2009, TIERAERZTL UMSCHAU, V64, P423; Gill RK, 1999, INDIAN J BIOCHEM BIO, V36, P252; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; Kasonta R, 2014, VET RECORD CASE REPO, V2, DOI DOI 10.1136/VETRECCR-2014-000082; Kasonta R, 2012, VACCINE, V30, P6649, DOI 10.1016/j.vaccine.2012.08.069; Kelly Gregory S, 2003, Altern Med Rev, V8, P378; Khan Z, 2002, ALIMENT PHARM THER, V16, P1917, DOI 10.1046/j.1365-2036.2002.01354.x; Klauninger R, 2009, LUPUS, V18, P792, DOI 10.1177/0961203309103188; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Pardon B, 2011, VET IMMUNOL IMMUNOP, V141, P293, DOI 10.1016/j.vetimm.2011.02.017; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Peterson JA, 2013, BRIT J HAEMATOL, V161, P3, DOI 10.1111/bjh.12235; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; REESE J, 1994, J PAEDIATR CHILD H, V30, P447, DOI 10.1111/j.1440-1754.1994.tb00700.x; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Shah U, 2003, PEDIATR RES, V53, P295, DOI 10.1203/01.PDR.0000047663.81816.E3; Shainwright_Consulting, 2007, COL STRAT REV OPP AP; Uruakpa FO, 2002, NUTR RES, V22, P755, DOI 10.1016/S0271-5317(02)00373-1; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109239	10.1371/journal.pone.0109239	http://dx.doi.org/10.1371/journal.pone.0109239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299190	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200044
J	Koseki, H; Yonekura, A; Shida, T; Yoda, I; Horiuchi, H; Morinaga, Y; Yanagihara, K; Sakoda, H; Osaki, M; Tomita, M				Koseki, Hironobu; Yonekura, Akihiko; Shida, Takayuki; Yoda, Itaru; Horiuchi, Hidehiko; Morinaga, Yoshitomo; Yanagihara, Katsunori; Sakoda, Hideyuki; Osaki, Makoto; Tomita, Masato			Early Staphylococcal Biofilm Formation on Solid Orthopaedic Implant Materials: In Vitro Study	PLOS ONE			English	Article							SURFACE-FREE-ENERGY; STREPTOCOCCUS-SANGUIS CH3; OF-THE-LITERATURE; BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; QUANTITATIVE-ANALYSIS; HYDROPHOBIC SURFACES; EPIDERMIDIS BIOFILM; INFECTION	Biofilms forming on the surface of biomaterials can cause intractable implant-related infections. Bacterial adherence and early biofilm formation are influenced by the type of biomaterial used and the physical characteristics of implant surface. In this in vitro research, we evaluated the ability of Staphylococcus epidermidis, the main pathogen in implant-related infections, to form biofilms on the surface of the solid orthopaedic biomaterials, oxidized zirconium-niobium alloy, cobalt-chromium- molybdenum alloy (Co-Cr-Mo), titanium alloy (Ti-6Al-4V), commercially pure titanium (cp-Ti) and stainless steel. A bacterial suspension of Staphylococcus epidermidis strain RP62A (ATCC35984) was added to the surface of specimens and incubated. The stained biofilms were imaged with a digital optical microscope and the biofilm coverage rate (BCR) was calculated. The total amount of biofilm was determined with the crystal violet assay and the number of viable cells in the biofilm was counted using the plate count method. The BCR of all the biomaterials rose in proportion to culture duration. After culturing for 2-4 hours, the BCR was similar for all materials. However, after culturing for 6 hours, the BCR for Co-CrMo alloy was significantly lower than for Ti-6Al-4V, cp-Ti and stainless steel (P < 0.05). The absorbance value determined in the crystal violet assay and the number of viable cells on Co-Cr-Mo were not significantly lower than for the other materials (P > 0.05). These results suggest that surface properties, such as hydrophobicity or the low surface free energy of Co-Cr-Mo, may have some influence in inhibiting or delaying the two-dimensional expansion of biofilm on surfaces with a similar degree of smoothness.	[Koseki, Hironobu; Yonekura, Akihiko; Shida, Takayuki; Yoda, Itaru; Horiuchi, Hidehiko; Osaki, Makoto; Tomita, Masato] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Nagasaki 852, Japan; [Morinaga, Yoshitomo; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 852, Japan; [Sakoda, Hideyuki] Natl Inst Hlth Sci, Div Med Devices, Tokyo, Japan	Nagasaki University; Nagasaki University; National Institute of Health Sciences - Japan	Koseki, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Nagasaki 852, Japan.	koseki@nagasaki-u.ac.jp		Sakoda, Hideyuki/0000-0002-2665-4665	JSPS KAKENHI [24592236]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24592236 (http://www.jsps.go.jp/j-grantsinaid/16_rule/rule.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031; Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533; Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; Braem A, 2013, J BIOMED MAT RES A; Busscher H J, 1997, Adv Dent Res, V11, P24; BUSSCHER HJ, 1986, APPL ENVIRON MICROB, V51, P910, DOI 10.1128/AEM.51.5.910-914.1986; Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007; CHANG CC, 1991, J ORTHOPAED RES, V9, P284, DOI 10.1002/jor.1100090217; Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3; Chu Vivian H, 2005, Am J Med, V118, P1416, DOI 10.1016/j.amjmed.2005.06.011; Clint JH, 2001, CURR OPIN COLLOID IN, V6, P28, DOI 10.1016/S1359-0294(00)00084-4; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2005, CLIN ORTHOP RELAT R, P12, DOI 10.1097/01.blo.0000175120.66051.29; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GLANTZ PO, 1971, J COLLOID INTERF SCI, V37, P281, DOI 10.1016/0021-9797(71)90294-3; Gottenbos B, 1999, J MATER SCI-MATER M, V10, P853, DOI 10.1023/A:1008989416939; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014; Ha KY, 2005, SPINE, V30, P38, DOI 10.1097/01.brs.0000147801.63304.8a; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Henrique MA, 2004, COLLOIDS SURF BIOINT, V33, P7; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; Hoyle B D, 1991, Prog Drug Res, V37, P91; HUNTER G, 2005, J ASTM INT, V2; Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019; Lee BC, 2011, J ADV PROSTHODONT, V3, P81, DOI 10.4047/jap.2011.3.2.81; Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103; Phillips CB, 2003, J BONE JOINT SURG AM, V85A, P20, DOI 10.2106/00004623-200301000-00004; Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1; Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081; QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x; Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2; Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717; Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616; Tang PF, 2011, J NANOMATER, V2011, DOI 10.1155/2011/178921; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005; VANPELT AWJ, 1985, APPL ENVIRON MICROB, V49, P1270, DOI 10.1128/AEM.49.5.1270-1275.1985; Wijekoon CP, 2008, J MICROBIOL METH, V74, P94, DOI 10.1016/j.mimet.2008.03.008; WYMENGA AB, 1992, ACTA ORTHOP SCAND, V63, P665, DOI 10.1080/17453679209169732; Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9	60	61	61	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107588	10.1371/journal.pone.0107588	http://dx.doi.org/10.1371/journal.pone.0107588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299658	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200008
J	Park, MJ; Aja, S; Li, Q; Degano, AL; Penati, J; Zhuo, J; Roe, CR; Ronnett, GV				Park, Min Jung; Aja, Susan; Li, Qun; Degano, Alicia L.; Penati, Judith; Zhuo, Justin; Roe, Charles R.; Ronnett, Gabriele V.			Anaplerotic Triheptanoin Diet Enhances Mitochondrial Substrate Use to Remodel the Metabolome and Improve Lifespan, Motor Function, and Sociability in MeCP2-Null Mice	PLOS ONE			English	Article							FAT OXIDATION DISORDERS; CPG-BINDING PROTEIN-2; RETT-SYNDROME; MOUSE MODEL; PHOSPHOENOLPYRUVATE CARBOXYKINASE; PERMEABILITY TRANSITION; ENTERAL METABOLISM; REPERFUSION INJURY; DISEASE; DYSFUNCTION	Rett syndrome (RTT) is an autism spectrum disorder (ASD) caused by mutations in the X-linked MECP2 gene that encodes methyl-CpG binding protein 2 (MeCP2). Symptoms range in severity and include psychomotor disabilities, seizures, ataxia, and intellectual disability. Symptom onset is between 6-18 months of age, a critical period of brain development that is highly energy-dependent. Notably, patients with RTT have evidence of mitochondrial dysfunction, as well as abnormal levels of the adipokines leptin and adiponectin, suggesting overall metabolic imbalance. We hypothesized that one contributor to RTT symptoms is energy deficiency due to defective nutrient substrate utilization by the TCA cycle. This energy deficit would lead to a metabolic imbalance, but would be treatable by providing anaplerotic substrates to the TCA cycle to enhance energy production. We show that dietary therapy with triheptanoin significantly increased longevity and improved motor function and social interaction in male mice hemizygous for Mecp2 knockout. Anaplerotic therapy in Mecp2 knockout mice also improved indicators of impaired substrate utilization, decreased adiposity, increased glucose tolerance and insulin sensitivity, decreased serum leptin and insulin, and improved mitochondrial morphology in skeletal muscle. Untargeted metabolomics of liver and skeletal muscle revealed increases in levels of TCA cycle intermediates with triheptanoin diet, as well as normalizations of glucose and fatty acid biochemical pathways consistent with the improved metabolic phenotype in Mecp2 knockout mice on triheptanoin. These results suggest that an approach using dietary supplementation with anaplerotic substrate is effective in improving symptoms and metabolic health in RTT.	[Park, Min Jung; Aja, Susan; Li, Qun; Degano, Alicia L.; Roe, Charles R.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21218 USA; [Park, Min Jung; Aja, Susan; Li, Qun; Degano, Alicia L.; Penati, Judith; Zhuo, Justin; Roe, Charles R.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; [Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA; [Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Degano, Alicia L.] Univ Nacl Cordoba, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina; [Ronnett, Gabriele V.] DGIST, Dept Brain Sci, Taegu, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Aja, S (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21218 USA.	saja1@jhmi.edu		Park, Min Jung/0000-0001-5644-9585; Degano, Alicia/0000-0001-5338-9118	SA; Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center - Korean Ministry of Education, Science, and Technology [10-BD-04]; National Institutes of Health National Institute of Neurological Disorders and Stroke [R01 NS041079]; Agilent Technologies Research [2703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041079] Funding Source: NIH RePORTER	SA; Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center - Korean Ministry of Education, Science, and Technology; National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Agilent Technologies Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Research Collaboration between SA and the Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center, funded by grant #10-BD-04 from Korean Ministry of Education, Science, and Technology; by National Institutes of Health National Institute of Neurological Disorders and Stroke Grant R01 NS041079 to GVR; and by Agilent Technologies Research Gift #2703 to GVR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Blardi P, 2007, J PEDIATR-US, V150, P37, DOI 10.1016/j.jpeds.2006.10.061; Blardi P, 2009, CLIN ENDOCRINOL, V70, P706, DOI 10.1111/j.1365-2265.2008.03386.x; Borges K, 2011, EPILEPSY RES; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Buchovecky CM, 2013, NAT GENET; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; COKER SB, 1991, J CHILD NEUROL, V6, P164, DOI 10.1177/088307389100600216; CORNFORD ME, 1994, J CHILD NEUROL, V9, P424, DOI 10.1177/088307389400900419; De Felice C, 2012, EUR HEART J-CARD IMG, V13, P339, DOI 10.1093/ejechocard/jer256; De Filippis B, 2012, NEUROPSYCHOPHARMACOL, V37, P1152, DOI 10.1038/npp.2011.301; Degano AL, 2014, MOL CELL NEUROSCI, V59, P63, DOI 10.1016/j.mcn.2014.01.005; Degano AL, 2009, MOL CELL NEUROSCI, V42, P243, DOI 10.1016/j.mcn.2009.07.009; Deng S, 2009, J BIOL CHEM, V284, P27799, DOI 10.1074/jbc.M109.048744; Dhar SS, 2009, BBA-MOL CELL RES, V1793, P1604, DOI 10.1016/j.bbamcr.2009.07.001; DOTTI MT, 1993, BRAIN DEV-JPN, V15, P103, DOI 10.1016/0387-7604(93)90045-A; EEGOLOFSSON O, 1990, J CHILD NEUROL, V5, P210, DOI 10.1177/088307389000500311; EEGOLOFSSON O, 1988, BRAIN DEV-JPN, V10, P260, DOI 10.1016/S0387-7604(88)80010-X; EEGOLOFSSON O, 1989, AM J MED GENET, V32, P142, DOI 10.1002/ajmg.1320320131; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Grosser E, 2012, NEUROBIOL DIS, V48, P102, DOI 10.1016/j.nbd.2012.06.007; Gu L, 2010, AM J PHYSIOL-ENDOC M, V298, pE362, DOI 10.1152/ajpendo.00384.2009; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAAS RH, 1986, AM J MED GENET, V24, P225; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Heilstedt HA, 2002, AM J MED GENET, V111, P238, DOI 10.1002/ajmg.10633; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; Johnston Michael V., 2001, Indian Journal of Pediatrics, V68, P423, DOI 10.1007/BF02723021; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kaufmann WE, 2005, BRAIN DEV-JPN, V27, pS77, DOI 10.1016/j.braindev.2004.10.008; Kim TH, 2013, EPILEPSY RES, V103, P101, DOI 10.1016/j.eplepsyres.2012.09.016; Kinman RP, 2006, AM J PHYSIOL-ENDOC M, V291, pE860, DOI 10.1152/ajpendo.00366.2005; KOZINETZ CA, 1993, PEDIATRICS, V91, P445; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; Landi S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00045; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Liebhaber GM, 2003, J CHILD NEUROL, V18, P74, DOI 10.1177/08830738030180011801; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; LOPES-CARDOZO M, 1972, Biochimica et Biophysica Acta, V283, P1, DOI 10.1016/0005-2728(72)90092-8; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mochel F, 2005, MOL GENET METAB, V84, P305, DOI 10.1016/j.ymgme.2004.09.007; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; NOMURA Y, 1984, BRAIN DEV-JPN, V6, P475, DOI 10.1016/S0387-7604(84)80030-3; Nomura Y, 2001, BRAIN DEV-JPN, V23, pS50, DOI 10.1016/S0387-7604(01)00379-5; NOMURA Y, 1992, BRAIN DEV-JPN, V14, pS21; NOSADINI R, 1989, DIABETES METAB REV, V5, P299, DOI 10.1002/dmr.5610050307; OBRIEN RM, 1990, DIABETES CARE, V13, P327, DOI 10.2337/diacare.13.3.327; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Percy AK, 2001, BRAIN DEV-JPN, V23, pS202, DOI 10.1016/S0387-7604(01)00350-3; Pitcher MR, 2013, HUM MOL GENET, V22, P2626, DOI 10.1093/hmg/ddt111; Pratte M, 2011, BEHAV BRAIN RES, V216, P313, DOI 10.1016/j.bbr.2010.08.011; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; RIDGE KD, 1988, P NATL ACAD SCI USA, V85, P9489, DOI 10.1073/pnas.85.24.9489; Roe CR, 2008, NEUROLOGY, V71, P260, DOI 10.1212/01.wnl.0000318283.42961.e9; Roe CR, 2007, MOL GENET METAB, V92, P346, DOI 10.1016/j.ymgme.2007.07.012; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Roe CR, 2010, MOL GENET METAB, V101, P246, DOI 10.1016/j.ymgme.2010.06.017; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; RUCH A, 1989, PEDIATR NEUROL, V5, P320, DOI 10.1016/0887-8994(89)90027-1; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Segawa M, 2001, BRAIN DEV-JPN, V23, pS94, DOI 10.1016/S0387-7604(01)00352-7; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Sirikul B, 2006, AM J PHYSIOL-ENDOC M, V291, pE724, DOI 10.1152/ajpendo.00364.2005; Valenti D., 2014, NEUROSCI BIOBEHAV RE; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Willis S, 2010, NEUROBIOL DIS, V40, P565, DOI 10.1016/j.nbd.2010.07.017; Yamada T, 2010, AM J PHYSIOL-ENDOC M, V299, pE364, DOI 10.1152/ajpendo.00142.2010; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005; ZIMMER DB, 1990, J HISTOCHEM CYTOCHEM, V38, P171, DOI 10.1177/38.2.1688895	82	42	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109527	10.1371/journal.pone.0109527	http://dx.doi.org/10.1371/journal.pone.0109527			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299635	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200056
J	Soonsawad, P; Paavolainen, L; Upla, P; Weerachatyanukul, W; Rintanen, N; Espinoza, J; McNerney, G; Marjomaki, V; Cheng, RH				Soonsawad, Pan; Paavolainen, Lassi; Upla, Paula; Weerachatyanukul, Wattana; Rintanen, Nina; Espinoza, Juan; McNerney, Gregory; Marjomaki, Varpu; Cheng, R. Holland			Permeability Changes of Integrin-Containing Multivesicular Structures Triggered by Picornavirus Entry	PLOS ONE			English	Article							CALPAIN; REPLICATION; ECHOVIRUS-1; ACTIVATION; REQUIRES; RAFTS	Cellular uptake of clustered alpha 2 beta 1-integrin induces the formation of membrane compartments that subsequently mature into a multivesicular body (MVB). Enhanced internalization mediated by clustered integrins was observed upon infection by the picornavirus echovirus 1 (EVI). We elucidated the structural features of virus-induced MVBs (vMVBs) in comparison to antibody-induced control MVBs (mock infection) by means of high-pressure cryo fixation of cells followed by immuno electron tomography during early entry of the virus. Three-dimensional tomograms revealed a marked increase in the size and complexity of these vMVBs and the intraluminal vesicles (ILVs) at 2 and 3.5 hours post infection (p.i.), in contrast to the control MVBs without virus. Breakages in the membranes of vMVBs were detected from tomograms after 2 and especially after 3.5 h suggesting that these breakages could facilitate the genome release to the cytoplasm. The in situ neutral-red labeling of viral genome showed that virus uncoating starts as early as 30 min p.i., while an increase of permeability was detected in the vMVBs between 1 and 3 hours p.i., based on a confocal microscopy assay. Altogether, the data show marked morphological changes in size and permeability of the endosomes in the infectious entry pathway of this non-enveloped enterovirus and suggest that the formed breakages facilitate the transfer of the genome to the cytoplasm for replication.	[Soonsawad, Pan; Weerachatyanukul, Wattana; Espinoza, Juan; McNerney, Gregory; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Paavolainen, Lassi; Upla, Paula; Rintanen, Nina; McNerney, Gregory; Marjomaki, Varpu] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm, Jyvaskyla, Finland; [Soonsawad, Pan; Weerachatyanukul, Wattana] Mahidol Univ, Fac Dent, Dept Anat, Bangkok 10700, Thailand	University of California System; University of California Davis; University of Jyvaskyla; Mahidol University	Cheng, RH (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	rhch@ucdavis.edu	Cheng, Holland/A-8973-2008	Marjomaki, Varpu/0000-0002-4592-5926	National Institutes of Health [AI095382]; Academy of Finland; Tekes FiDiPro [1913/31/2012]; Discovery Grant [UCDG178969]; NSF fellowship; Thailand Commission of Higher Education scholarship; Thailand Research Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Tekes FiDiPro(Finnish Funding Agency for Technology & Innovation (TEKES)); Discovery Grant; NSF fellowship(National Science Foundation (NSF)); Thailand Commission of Higher Education scholarship; Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by National Institutes of Health (AI095382) http://www.nih.gov/, Academy of Finland http://www.aka.fi/en-gb/a/, Tekes FiDiPro, (1913/31/2012) http://www.tekes.fi/en/fidipro/, Discovery Grant (UCDG178969), NSF fellowship for doctoral dissertation enhancement program (G.M.), Thailand Commission of Higher Education scholarship and Thailand Research Fund (P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabec M, 2005, J VIROL, V79, P1008, DOI 10.1128/JVI.79.2.1008-1016.2005; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Debiasi RL, 1999, J VIROL, V73, P695, DOI 10.1128/JVI.73.1.695-701.1999; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; Kalamvoki M, 2004, J VIROL, V78, P11865, DOI 10.1128/JVI.78.21.11865-11878.2004; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Karjalainen M, 2011, CELL MICROBIOL, V13, P1975, DOI 10.1111/j.1462-5822.2011.01685.x; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Rintanen N, 2012, MOL BIOL CELL, V23, P448, DOI 10.1091/mbc.E11-06-0548; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Soonsawad P, 2010, J VIROL, V84, P11145, DOI 10.1128/JVI.00036-10; Teranishi F, 2003, BIOCHEM BIOPH RES CO, V303, P940, DOI 10.1016/S0006-291X(03)00447-9; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Upla P, 2008, J VIROL, V82, P1581, DOI 10.1128/JVI.01375-07; Urata S, 2006, J VIROL, V80, P4191, DOI 10.1128/JVI.80.8.4191-4195.2006; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108948	10.1371/journal.pone.0108948	http://dx.doi.org/10.1371/journal.pone.0108948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299706	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200025
J	Houben, T; Coomans, CP; Meijer, JH				Houben, Thijs; Coomans, Claudia P.; Meijer, Johanna H.			Regulation of Circadian and Acute Activity Levels by the Murine Suprachiasmatic Nuclei	PLOS ONE			English	Article							REST-ACTIVITY RHYTHM; SLEEP-PHASE SYNDROME; IN-VIVO; ELECTRICAL-ACTIVITY; FUNCTIONAL-ANALYSIS; PERIPHERAL-TISSUES; LOCOMOTOR-ACTIVITY; PACEMAKER NEURONS; NOCTURNAL RODENTS; CELL AUTONOMY	The suprachiasmatic nuclei (SCN) coordinate the daily sleep-wake cycle by generating a circadian rhythm in electrical impulse frequency. While period and phase of the SCN rhythm have been considered as major output parameters, we propose that the waveform of the rhythm of the SCN also has significance. Using implanted micro-electrodes, we recorded SCN impulse frequency in freely moving mice and manipulated its circadian waveform by exposing mice to light-dark (LD) cycle durations ranging from 22 hours (LD 11:11) to 26 hours (LD 13:13). Adaptation to long T-cycles (>24 h) resulted in a trough in electrical activity at the beginning of the night while in short T-cycles (<24 h), SCN activity reached a trough at the end of night. In all T-cycle durations, the intensity of behavioral activity was maximal during the trough of SCN electrical activity and correlated negatively with increasing levels of SCN activity. Interestingly, small changes in T-cycle duration could induce large changes in waveform and in the time of trough (about 3.5 h), and accordingly in the timing of behavioral activity. At a smaller timescale (minutes to hours), we observed a negative correlation between SCN activity and behavioral activity, and acute silencing of SCN neurons by tetrodotoxin (TTX) during the inactive phase of the animal triggered behavioral activity. Thus, the SCN electrical activity levels appear crucially involved in determining the temporal profile of behavioral activity and controls behavior beyond the circadian time domain.	[Houben, Thijs; Coomans, Claudia P.; Meijer, Johanna H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Meijer, JH (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands.	J.H.Meijer@lumc.nl	Coomans, Claudia/A-4458-2013	Coomans, Claudia/0000-0003-0883-458X	European Commission [018741]; Netherlands Organization for Scientific Research [818.02.016]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the European Commission (http://europa.eu) grant EUCLOCK to JHM (no. 018741) and by the Netherlands Organization for Scientific Research (http://www.nwo.nl/en), TOPGO grant to JHM (no. 818.02.016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2006, MOL CELL ENDOCRINOL, V252, P46, DOI 10.1016/j.mce.2006.03.036; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Granada AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059464; Houben T, 2009, J BIOL RHYTHM, V24, P477, DOI 10.1177/0748730409349895; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2008, J BIOL RHYTHM, V23, P265, DOI 10.1177/0748730408316166; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kalsbeek A, 2000, EUR J NEUROSCI, V12, P3146, DOI 10.1046/j.1460-9568.2000.00202.x; Kalsbeek A, 1996, J NEUROENDOCRINOL, V8, P299, DOI 10.1046/j.1365-2826.1996.04597.x; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Lee CH, 2008, CHANNELS, V2, P407, DOI 10.4161/chan.2.6.7429; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Molyneux PC, 2008, BRAIN RES, V1228, P127, DOI 10.1016/j.brainres.2008.05.091; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakamura W, 2008, CURR BIOL, V18, P381, DOI 10.1016/j.cub.2008.02.024; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Oosterman JM, 2009, J SLEEP RES, V18, P129, DOI 10.1111/j.1365-2869.2008.00704.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Todd WD, 2012, J COMP NEUROL, V520, P3277, DOI 10.1002/cne.23098; Tribukait B, 1956, J COMP PHYSIOL A, V38, P479; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	46	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110172	10.1371/journal.pone.0110172	http://dx.doi.org/10.1371/journal.pone.0110172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295522	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000117
J	Kwon, J; Ogawa, K; Miyake, Y				Kwon, Jinhwan; Ogawa, Ken-ichiro; Miyake, Yoshihiro			The Effect of Visual Apparent Motion on Audiovisual Simultaneity	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENTS; TIME PERCEPTION; SENSORY MODALITY; SHORT-RANGE; PRIOR ENTRY; ATTENTION; VENTRILOQUISM; MOVEMENT; STIMULI; INFORMATION	Visual motion information from dynamic environments is important in multisensory temporal perception. However, it is unclear how visual motion information influences the integration of multisensory temporal perceptions. We investigated whether visual apparent motion affects audiovisual temporal perception. Visual apparent motion is a phenomenon in which two flashes presented in sequence in different positions are perceived as continuous motion. Across three experiments, participants performed temporal order judgment (TOJ) tasks. Experiment 1 was a TOJ task conducted in order to assess audiovisual simultaneity during perception of apparent motion. The results showed that the point of subjective simultaneity (PSS) was shifted toward a sound - lead stimulus, and the just noticeable difference (JND) was reduced compared with a normal TOJ task with a single flash. This indicates that visual apparent motion affects audiovisual simultaneity and improves temporal discrimination in audiovisual processing. Experiment 2 was a TOJ task conducted in order to remove the influence of the amount of flash stimulation from Experiment 1. The PSS and JND during perception of apparent motion were almost identical to those in Experiment 1, but differed from those for successive perception when long temporal intervals were included between two flashes without motion. This showed that the result obtained under the apparent motion condition was unaffected by the amount of flash stimulation. Because apparent motion was produced by a constant interval between two flashes, the results may be accounted for by specific prediction. In Experiment 3, we eliminated the influence of prediction by randomizing the intervals between the two flashes. However, the PSS and JND did not differ from those in Experiment 1. It became clear that the results obtained for the perception of visual apparent motion were not attributable to prediction. Our findings suggest that visual apparent motion changes temporal simultaneity perception and improves temporal discrimination in audiovisual processing.	[Kwon, Jinhwan; Ogawa, Ken-ichiro; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology	Kwon, J (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	kwon@myk.dis.titech.ac.jp						Allik J, 1998, PSYCHOL SCI, V9, P135, DOI 10.1111/1467-9280.00025; ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; BRIGGS RM, 1972, J EXP PSYCHOL, V92, P83, DOI 10.1037/h0032148; Busse L, 2008, P NATL ACAD SCI USA, V105, P16380, DOI 10.1073/pnas.0707369105; Coull JT, 1998, J NEUROSCI, V18, P7426; DAWSON MRW, 1991, PSYCHOL REV, V98, P569, DOI 10.1037/0033-295X.98.4.569; DUNCAN J, 1980, COGNITIVE PSYCHOL, V12, P75, DOI 10.1016/0010-0285(80)90004-3; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Finney DJ, 1952, PROBIT ANAL STAT TRE; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Getzmann S, 2007, PERCEPTION, V36, P1089, DOI 10.1068/p5741; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; GROSSBERG S, 1992, PSYCHOL REV, V99, P78, DOI 10.1037/0033-295X.99.1.78; Harrar V, 2008, PERCEPT PSYCHOPHYS, V70, P807, DOI 10.3758/PP.70.5.807; HIKOSAKA O, 1993, VISION RES, V33, P1219, DOI 10.1016/0042-6989(93)90210-N; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jaskoski P, 2000, CONSCIOUS COGN, V9, P435, DOI 10.1006/ccog.2000.0461; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kanabus M, 2002, ACTA NEUROBIOL EXP, V62, P263; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Keetels M, 2005, EXP BRAIN RES, V167, P635, DOI 10.1007/s00221-005-0067-1; KLEIN RM, 1977, J EXP PSYCHOL HUMAN, V3, P365, DOI 10.1037/0096-1523.3.3.365; LARSEN A, 1983, PSYCHOL RES-PSYCH FO, V45, P11, DOI 10.1007/BF00309348; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Mattes S, 1998, PERCEPT PSYCHOPHYS, V60, P1305, DOI 10.3758/BF03207993; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Petrini K, 2009, COGNITION, V110, P432, DOI 10.1016/j.cognition.2008.11.015; Poppel E., 1988, MINDWORKS TIME CONSC; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; RAMACHANDRAN VS, 1986, SCI AM, V254, P102, DOI 10.1038/scientificamerican0686-102; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P389, DOI 10.3758/BF03211906; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; STRYBEL TZ, 1990, PERCEPT PSYCHOPHYS, V47, P439, DOI 10.3758/BF03208177; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; WATSON AB, 1986, J OPT SOC AM A, V3, P300, DOI 10.1364/JOSAA.3.000300; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	54	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110224	10.1371/journal.pone.0110224	http://dx.doi.org/10.1371/journal.pone.0110224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25295594	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000118
J	Lu, Y; Wu, ZT; Peng, QL; Ma, LP; Zhang, XL; Zhao, JY; Qin, X; Li, S				Lu, Yu; Wu, Zhitong; Peng, Qiliu; Ma, Liping; Zhang, Xiaolian; Zhao, Jiangyang; Qin, Xue; Li, Shan			Role of IL-4 Gene Polymorphisms in HBV-Related Hepatocellular Carcinoma in a Chinese Population	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; INTERLEUKIN-4 GENE; ASSOCIATION; RECEPTOR; CYTOKINES; SUSCEPTIBILITY; INFECTION; RISK; INFLAMMATION; ACTIVATION	Background: Interleukin-4 (IL-4) is best known as an important mediator and modulator of immune and inflammatory responses. Hepatocellular carcinoma (HCC) is a typical inflammation-related cancer, and genetic variations in the IL-4 gene may be associated with the risk of hepatitis B virus (HBV)-related HCC. However, few studies have been conducted on their association. Objectives: To clarify the effects of IL-4 gene polymorphisms on the risk of HBV-related HCC, two common variants, -590C/T (rs2243250) and -33C/T (rs2070874), and their relationship with HBV-related disease risk were investigated in a Chinese population. Methods: IL-4 -590C/T and -33C/T polymorphisms were examined in 154 patients with HBV-related HCC, 62 patients with HBV-induced liver cirrhosis (LC), 129 patients with chronic hepatitis B (CHB), and 94 healthy controls, using the polymerase chain reaction-restriction fragment length polymorphism method and DNA sequencing. Results: Overall, no significant differences were observed regarding the IL-4 -590C/T and -33C/T polymorphism genotypes, alleles, or haplotypes between the patient groups and the healthy controls. However, the CC genotypes of IL-4 -590C/T and -33C/T polymorphisms were observed to be significantly associated with CHB in subgroup analysis in males [CC versus TT (OR: 4.193, 95% CI: 1.094-16.071, P = 0.037; and OR: 3.438, 95% CI: 1.032-11.458, P = 0.044) and CC versus TT+ CT (OR: 4.09, 95% CI: 1.08-15.49, P = 0.038; and OR: 3.43, 95% CI: 1.04-11.28, P = 0.042)]. Conclusions: These findings suggest that genetic variants in IL-4 -590C/T and -33C/T polymorphisms may be a risk factor for CHB in Chinese males but not for HBV-related LC or HCC.	[Lu, Yu; Peng, Qiliu; Ma, Liping; Zhang, Xiaolian; Zhao, Jiangyang; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Wu, Zhitong] Guigang Peoples Hosp, Dept Clin Lab, Guigang, Guangxi, Peoples R China	Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			National Natural Science Foundation of China [81260302]; Youth Science Foundation of Guangxi Medical University [GXMUYSF201334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Guangxi Medical University	This research was supported by National Natural Science Foundation of China (No. 81260302) and Youth Science Foundation of Guangxi Medical University (GXMUYSF201334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 2004, HEPATOLOGY, V39, P1430, DOI 10.1002/hep.20205; Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204; Chemin I, 2009, CANCER LETT, V286, P52, DOI 10.1016/j.canlet.2008.12.003; Chen LP, 2012, EUR J CANCER, V48, P1977, DOI 10.1016/j.ejca.2012.01.015; Chen TY, 2007, TRANSL RES, V150, P116, DOI 10.1016/j.trsl.2007.01.007; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Cui W, 2013, GENE, V525, P35, DOI 10.1016/j.gene.2013.04.065; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; Gao QJ, 2009, WORLD J GASTROENTERO, V15, P5610, DOI 10.3748/wjg.15.5610; Gao QJ, 2012, MED PHARM J CLIN PEO, V24, P8; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Han YF, 2011, WORLD J GASTROENTERO, V17, P4258, DOI 10.3748/wjg.v17.i38.4258; Iseki M, 2012, INT IMMUNOL, V24, P183, DOI 10.1093/intimm/dxr113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kelly-Welch Ann, 2005, Sci STKE, V2005, pcm8, DOI 10.1126/stke.2932005cm8; Landi S, 2007, EUR J CANCER, V43, P762, DOI 10.1016/j.ejca.2006.10.024; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu Q, 2007, CHIN J INTEGR TRADIT, V17, P211; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Naslednikova IO, 2007, B EXP BIOL MED+, V143, P706, DOI 10.1007/s10517-007-0220-x; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nieters A, 2005, CANCER, V103, P740, DOI 10.1002/cncr.20842; Ognjanovic S, 2009, CARCINOGENESIS, V30, P758, DOI 10.1093/carcin/bgn286; Peng QL, 2013, INFECT GENET EVOL, V16, P1, DOI 10.1016/j.meegid.2013.01.015; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Puthothu B, 2006, J INFECT DIS, V193, P438, DOI 10.1086/499316; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suppiah V, 2005, INT J IMMUNOGENET, V32, P383, DOI 10.1111/j.1744-313X.2005.00542.x; Takabayashi A, 1999, J HUM GENET, V44, P352, DOI 10.1007/s100380050176; Tang Z Y YQ, 2009, STROKE NEVOUS DIS, V16, P11; Tsai MH, 2005, J CLIN LAB ANAL, V19, P93, DOI 10.1002/jcla.20060; Wang K, 2006, CHIN J CURR ADV GEN, V9, P171; Wierenga EA, 2000, AM J RESP CRIT CARE, V162, pS81, DOI 10.1164/ajrccm.162.supplement_2.ras-5; Wu MC, 2003, LUPUS, V12, P21, DOI 10.1191/0961203303lu249oa; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; Zeng Z, 2014, WORLD J GASTROENTERO, V20, P7696, DOI 10.3748/wjg.v20.i24.7696; Zheng Z, 2013, DNA CELL BIOL, V32, P443, DOI 10.1089/dna.2013.2020; Zhu QR, 2005, CHINESE MED J-PEKING, V118, P1604	51	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110061	10.1371/journal.pone.0110061	http://dx.doi.org/10.1371/journal.pone.0110061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295591	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000111
J	Sei, JJ; Ochoa, AS; Bishop, E; Barlow, JW; Golde, WT				Sei, Janet J.; Ochoa, Amanda S.; Bishop, Elizabeth; Barlow, John W.; Golde, William T.			Phenotypic, Ultra-Structural, and Functional Characterization of Bovine Peripheral Blood Dendritic Cell Subsets	PLOS ONE			English	Article							INTERFERON-PRODUCING-CELLS; MONOCLONAL-ANTIBODY NLDC-145; TOLL-LIKE RECEPTORS; AFFERENT LYMPH; CROSS-PRESENTATION; CD8 EXPRESSION; MOUSE THYMUS; I INTERFERON; IFN-ALPHA; T-CELLS	Dendritic cells (DC) are multi-functional cells that bridge the gap between innate and adaptive immune systems. In bovine, significant information is lacking on the precise identity and role of peripheral blood DC subsets. In this study, we identify and characterize bovine peripheral blood DC subsets directly ex vivo, without further in vitro manipulation. Multi-color flow cytometric analysis revealed that three DC subsets could be identified. Bovine plasmacytoid DC were phenotypically identified by a unique pattern of cell surface protein expression including CD4, exhibited an extensive endoplasmic reticulum and Golgi apparatus, efficiently internalized and degraded exogenous antigen, and were the only peripheral blood cells specialized in the production of type I IFN following activation with Toll-like receptor (TLR) agonists. Conventional DC were identified by expression of a different pattern of cell surface proteins including CD11c, MHC class II, and CD80, among others, the display of extensive dendritic protrusions on their plasma membrane, expression of very high levels of MHC class II and co-stimulatory molecules, efficient internalization and degradation of exogenous antigen, and ready production of detectable levels of TNF-alpha in response to TLR activation. Our investigations also revealed a third novel DC subset that may be a precursor of conventional DC that were MHC class II+ and CD11c(-). These cells exhibited a smooth plasma membrane with a rounded nucleus, produced TNF-alpha in response to TLR-activation (albeit lower than CD11C(+) DC), and were the least efficient in internalization/degradation of exogenous antigen. These studies define three bovine blood DC subsets with distinct phenotypic and functional characteristics which can be analyzed during immune responses to pathogens and vaccinations of cattle.	[Sei, Janet J.; Bishop, Elizabeth; Golde, William T.] USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA; [Sei, Janet J.; Ochoa, Amanda S.; Barlow, John W.] Univ Vermont, Dept Anim Sci, Burlington, VT 05405 USA	United States Department of Agriculture (USDA); University of Vermont	Golde, WT (corresponding author), USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA.	william.golde@ars.usda.gov	Barlow, John W/C-4876-2013	Barlow, John W/0000-0002-7815-9383	United States Department of Agriculture (USDA), Agricultural Research Service [CRIS 1940-32000-057-00D]; National Science Foundation under the BREAD program [0965346]	United States Department of Agriculture (USDA), Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation under the BREAD program	This work was funded by the United States Department of Agriculture (USDA), Agricultural Research Service under CRIS 1940-32000-057-00D (WTG). This work was also funded in part by the National Science Foundation grant #0965346, under the BREAD program (JWB, WTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Artz J, 2014, VIROLOGY, V452-453, P12; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bajer AA, 2003, J LEUKOCYTE BIOL, V73, P100, DOI 10.1189/jlb.0302128; Balmelli C, 2005, EUR J IMMUNOL, V35, P2406, DOI 10.1002/eji.200525998; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Bautista EM, 2007, VET IMMUNOL IMMUNOP, V115, P56, DOI 10.1016/j.vetimm.2006.09.010; Bautista EM, 2002, VET IMMUNOL IMMUNOP, V88, P131, DOI 10.1016/S0165-2427(02)00152-6; Brooke GP, 1998, EUR J IMMUNOL, V28, P1, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;1::AID-IMMU1&gt;3.0.CO;2-V; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; Franchini M, 2006, VET IMMUNOL IMMUNOP, V110, P37, DOI 10.1016/j.vetimm.2005.09.002; Fray MD, 2001, J IMMUNOL METHODS, V249, P235, DOI 10.1016/S0022-1759(00)00359-8; Gibson A, 2012, DEV COMP IMMUNOL, V36, P332, DOI 10.1016/j.dci.2011.05.002; Gliddon DR, 2004, IMMUNOLOGY, V111, P262, DOI 10.1111/j.0019-2805.2004.01820.x; Griebel PJ, 2005, VET IMMUNOL IMMUNOP, V108, P11, DOI 10.1016/j.vetimm.2005.07.012; Guzylack-Piriou L, 2004, IMMUNOLOGY, V112, P28, DOI 10.1111/j.1365-2567.2004.01856.x; Guzylack-Piriou L, 2006, EUR J IMMUNOL, V36, P1674, DOI 10.1002/eji.200635866; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heller MC, 2012, VET IMMUNOL IMMUNOP, V149, P255, DOI 10.1016/j.vetimm.2012.07.006; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hope JC, 2006, NAT PROTOC, V1, P982, DOI 10.1038/nprot.2006.125; Hope JC, 2001, J LEUKOCYTE BIOL, V69, P271; Howard CJ, 1997, J IMMUNOL, V159, P5372; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kalady MF, 2004, J SURG RES, V116, P24, DOI 10.1016/j.jss.2003.09.003; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Lahoud MH, 2012, P NATL ACAD SCI USA, V109, P16270, DOI 10.1073/pnas.1208796109; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lee SR, 2008, COMP IMMUNOL MICROB, V31, P403, DOI 10.1016/j.cimid.2007.06.006; Lorenzi S, 2011, J IMMUNOL, V186, P5142, DOI 10.4049/jimmunol.1004163; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McCurley N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011949; MCKEEVER DJ, 1991, J IMMUNOL, V147, P3703; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Megjugorac NJ, 2004, J LEUKOCYTE BIOL, V75, P504, DOI 10.1189/jlb.0603291; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mirkovitch J, 2006, VET IMMUNOL IMMUNOP, V114, P1, DOI 10.1016/j.vetimm.2006.06.004; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Miyazawa K, 2006, RES VET SCI, V81, P40, DOI 10.1016/j.rvsc.2005.09.003; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Nfon CK, 2010, VIRAL IMMUNOL, V23, P29, DOI 10.1089/vim.2009.0078; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pinchuk LM, 2003, COMP IMMUNOL MICROB, V26, P233, DOI 10.1016/S0147-9571(02)00061-9; Reid E, 2011, J VIROL, V85, P4297, DOI 10.1128/JVI.02495-10; Renjifo X, 1997, VET IMMUNOL IMMUNOP, V60, P77, DOI 10.1016/S0165-2427(97)00092-5; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SIMMONS D, 1988, NATURE, V333, P568, DOI 10.1038/333568a0; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Steinman RM, 2006, NOVART FDN SYMP, V279, P216, DOI [10.1002/9780470035399, DOI 10.1002/9780470035399, DOI 10.1002/9780470035399.CH9]; Stephens SA, 2003, IMMUNOLOGY, V110, P48, DOI 10.1046/j.1365-2567.2003.01712.x; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; SWIGGARD WJ, 1995, CELL IMMUNOL, V165, P302, DOI 10.1006/cimm.1995.1218; Tel J, 2011, EUR J IMMUNOL, V41, P1014, DOI 10.1002/eji.201040790; THOMAS R, 1993, J IMMUNOL, V151, P6840; THOMAS R, 1994, J IMMUNOL, V153, P4016; Toka FN, 2011, J IMMUNOL, V186, P4853, DOI 10.4049/jimmunol.1003599; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Vremec D, 1997, J IMMUNOL, V159, P565; Werling D, 2002, J LEUKOCYTE BIOL, V72, P297; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513	74	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109273	10.1371/journal.pone.0109273	http://dx.doi.org/10.1371/journal.pone.0109273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295753	gold, Green Submitted, Green Published			2022-12-25	WOS:000345204000056
J	Nakamura, K; Islam, MR; Takayanagi, M; Yasumuro, H; Inami, W; Kunahong, A; Casco-Robles, RM; Toyama, F; Chiba, C				Nakamura, Kenta; Islam, Md. Rafiqul; Takayanagi, Miyako; Yasumuro, Hirofumi; Inami, Wataru; Kunahong, Ailidana; Casco-Robles, Roman M.; Toyama, Fubito; Chiba, Chikafumi			A Transcriptome for the Study of Early Processes of Retinal Regeneration in the Adult Newt, Cynops pyrrhogaster	PLOS ONE			English	Article							PIGMENT EPITHELIUM-CELLS; RNA-BINDING PROTEIN; MEK-ERK; EXPRESSION; MUSASHI-1; INDUCTION; URODELA	Retinal regeneration in the adult newt is a useful system to uncover essential mechanisms underlying the regeneration of body parts of this animal as well as to find clues to treat retinal disorders such as proliferative vitreoretinopathy. Here, to facilitate the study of early processes of retinal regeneration, we provide a de novo assembly transcriptome and inferred proteome of the Japanese fire bellied newt (Cynops pyrrhogaster), which was obtained from eyeball samples of day 0-14 after surgical removal of the lens and neural retina. This transcriptome (237,120 in silico transcripts) contains most information of cDNAs/ESTs which has been reported in newts (C. pyrrhogaster, Pleurodeles waltl and Notophthalmus viridescence) thus far. On the other hand, de novo assembly transcriptomes reported lately for N. viridescence only covered 16-31% of this transcriptome, suggesting that most constituents of this transcriptome are specific to the regenerating eye tissues of C. pyrrhogaster. A total of 87,102 in silico transcripts of this transcriptome were functionally annotated. Coding sequence prediction in combination with functional annotation revealed that 76,968 in silico transcripts encode protein/ peptides recorded in public databases so far, whereas 17,316 might be unique. qPCR and Sanger sequencing demonstrated that this transcriptome contains much information pertaining to genes that are regulated in association with cell reprogramming, cell-cycle re-entry/proliferation, and tissue patterning in an early phase of retinal regeneration. This data also provides important insight for further investigations addressing cellular mechanisms and molecular networks underlying retinal regeneration as well as differences between retinal regeneration and disorders. This transcriptome can be applied to ensuing comprehensive gene screening steps, providing candidate genes, regardless of whether annotated or unique, to uncover essential mechanisms underlying early processes of retinal regeneration.	[Islam, Md. Rafiqul; Takayanagi, Miyako; Yasumuro, Hirofumi; Inami, Wataru; Kunahong, Ailidana; Casco-Robles, Roman M.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Kenta; Chiba, Chikafumi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Toyama, Fubito] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 321, Japan	University of Tsukuba; University of Tsukuba; Utsunomiya University	Toyama, F (corresponding author), Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 321, Japan.	fubito@is.utsunomiya-u.ac.jp; chichiba@biol.tsukuba.ac.jp	Chiba, Chikafumi/GWV-8167-2022		Ministry of Education, Culture, Sports, Science and Technology [23124502, 221S0002]; Japan Society for the Promotion of Science [24650229, 25870096, 21300150, 24240062]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (23124502; 221S0002) and the Japan Society for the Promotion of Science (24650229; 25870096; 21300150; 24240062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Casco-Robles MM, 2011, NAT PROTOC, V6, P600, DOI 10.1038/nprot.2011.334; Chiba C, 2006, J COMP NEUROL, V495, P391, DOI 10.1002/cne.20880; Chiba Chakafumi, 2007, P15; Chiba C, 2014, EXP EYE RES, V123, P107, DOI 10.1016/j.exer.2013.07.009; Eguchi G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1389; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Islam MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06043; Kaneko J, 2009, NEUROSCI LETT, V450, P252, DOI 10.1016/j.neulet.2008.11.031; Litvinchuk SN, 2007, GENOME, V50, P333, DOI 10.1139/G07-010; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mizuno A, 2012, NEUROSCI LETT, V523, P39, DOI 10.1016/j.neulet.2012.06.037; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Susaki K, 2007, PIGM CELL RES, V20, P364, DOI 10.1111/j.1600-0749.2007.00407.x; Susaki K, 2009, EXP EYE RES, V88, P347, DOI 10.1016/j.exer.2008.06.019; Tominaga A, 2013, MOL PHYLOGENET EVOL, V66, P654, DOI 10.1016/j.ympev.2012.10.015; Tsonis PA, 2011, NAT PROTOC, V6, P593, DOI 10.1038/nprot.2011.341; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshikawa T, 2012, PIGM CELL MELANOMA R, V25, P66, DOI 10.1111/j.1755-148X.2011.00935.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	30	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109831	10.1371/journal.pone.0109831	http://dx.doi.org/10.1371/journal.pone.0109831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290450	gold, Green Published, Green Submitted			2022-12-25	WOS:000342798000093
J	Seridi, L; Ryu, T; Ravasi, T				Seridi, Loqmane; Ryu, Taewoo; Ravasi, Timothy			Dynamic Epigenetic Control of Highly Conserved Noncoding Elements	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; GENOMIC REGULATORY BLOCKS; ULTRACONSERVED ELEMENTS; DROSOPHILA-MELANOGASTER; ARABIDOPSIS-THALIANA; REPLICATION ORIGINS; GENUS DROSOPHILA; HISTONE H3.3; GENES; BINDING	Background: Many noncoding genomic loci have remained constant over long evolutionary periods, suggesting that they are exposed to strong selective pressures. The molecular functions of these elements have been partially elucidated, but the fundamental reason for their extreme conservation is still unknown. Results: To gain new insights into the extreme selection of highly conserved noncoding elements (HCNEs), we used a systematic analysis of multi-omic data to study the epigenetic regulation of such elements during the development of Drosophila melanogaster. At the sequence level, HCNEs are GC-rich and have a characteristic oligomeric composition. They have higher levels of stable nucleosome occupancy than their flanking regions, and lower levels of mononucleosomes and H3.3, suggesting that these regions reside in compact chromatin. Furthermore, these regions showed remarkable modulations in histone modification and the expression levels of adjacent genes during development. Although HCNEs are primarily initiated late in replication, about 10% were related to early replication origins. Finally, HCNEs showed strong enrichment within lamina-associated domains. Conclusion: HCNEs have distinct and protective sequence properties, undergo dynamic epigenetic regulation, and appear to be associated with the structural components of the chromatin, replication origins, and nuclear matrix. These observations indicate that such elements are likely to have essential cellular functions, and offer insights into their epigenetic properties.	[Seridi, Loqmane; Ryu, Taewoo; Ravasi, Timothy] King Abdullah Univ Sci & Technol, Div Appl Math & Comp Sci, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Ravasi, Timothy] Univ Calif San Diego, Dept Med, Div Genet, La Jolla, CA 92093 USA	King Abdullah University of Science & Technology; University of California System; University of California San Diego	Ryu, T (corresponding author), King Abdullah Univ Sci & Technol, Div Appl Math & Comp Sci, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia.	taewoo.ryu@kaust.edu.sa; timothy.ravasi@kaust.edu.sa	Ravasi, Timothy/B-8777-2008; Ryu, Taewoo/AAN-2634-2020	Seridi, Loqmane/0000-0001-7028-3024; Ravasi, Timothy/0000-0002-9950-465X	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This was supported by King Abdullah University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; ANDERSEN AH, 1985, NUCLEIC ACIDS RES, V13, P1543, DOI 10.1093/nar/13.5.1543; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; De Grassi A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000275; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; DOLECKI GJ, 1988, NUCLEIC ACIDS RES, V16, P11543, DOI 10.1093/nar/16.24.11543; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Frisch M, 2002, GENOME RES, V12, P349, DOI 10.1101/gr.206602.ArticlepublishedonlinebeforeprintinJanuary2002; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Harmston N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0021; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kenigsberg E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003512; Kenigsberg E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001039; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kritsas K, 2012, GENOME RES, V22, P2455, DOI 10.1101/gr.129346.111; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEHNER CF, 1987, J CELL BIOL, V105, P577, DOI 10.1083/jcb.105.1.577; Lin MB, 2012, CANCER-AM CANCER SOC, V118, P6188, DOI 10.1002/cncr.27653; Linnemann AK, 2009, HUM MOL GENET, V18, P645, DOI 10.1093/hmg/ddn394; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; Royo JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024824; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Martinez F, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-54; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meier I, 2007, J EXP BOT, V58, P27, DOI 10.1093/jxb/erl009; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rowntree RK, 2006, MOL CELL BIOL, V26, P3707, DOI 10.1128/MCB.26.10.3707-3717.2006; Ryu T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-236; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Sakuraba Y, 2008, MAMM GENOME, V19, P703, DOI 10.1007/s00335-008-9152-7; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; St Pierre SE, 2013, NUCL ACIDS RES; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Tetko IV, 2006, PLOS COMPUT BIOL, V2, P136, DOI 10.1371/journal.pcbi.0020021; Tracy RB, 1997, GENE DEV, V11, P3423, DOI 10.1101/gad.11.24.3423; Tseng HHE, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-432; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Walter K, 2005, TRENDS GENET, V21, P436, DOI 10.1016/j.tig.2005.06.003; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Westenberger SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-610; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Yang RX, 2008, CARCINOGENESIS, V29, P351, DOI 10.1093/carcin/bgm290	73	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109326	10.1371/journal.pone.0109326	http://dx.doi.org/10.1371/journal.pone.0109326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289637	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000054
J	Sohya, S; Kamioka, T; Fujita, C; Maki, T; Ohta, Y; Kuroda, Y				Sohya, Shihori; Kamioka, Tetsuya; Fujita, Chisako; Maki, Tei; Ohta, Yoshihiro; Kuroda, Yutaka			Biochemical and Biophysical Characterization of an Unexpected Bacteriolytic Activity of VanX, a Member of the Vancomycin-resistance vanA Gene Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EGG-WHITE; AUTOLYSIS; LYSOZYME; LYSIS; IDENTIFICATION; MICROSCOPY; MECHANISM; PROTEIN; VARIANT	VanX is a D-alanyl-D-alanine (D-Ala-D-Ala) dipeptidase encoded in the vancomycin-resistance vanA gene cluster. Here we report that strong bacteriolysis occurred when isolated VanX was expressed in Escherichia coli at temperatures lower than 30 degrees C, which was unexpected because the vanA operon confers vancomycin resistance by protecting the cell wall. Therefore, we monitored cell lysis by measuring sample turbidity with absorbance at 590 nm and VanX expression using SDS-PAGE. No cell lysis was observed when VanX was expressed, even in large quantities, in the cell inclusion bodies at 37 degrees C, suggesting that a natively folded VanX is required for lysis. In addition, VanX mutants with suppressed dipeptidase activity did not lyse E. coli cells, confirming that bacteriolysis originated from the dipeptidase activity of VanX. We also observed shape changes in E. coli cells undergoing VanX-mediated lysis with optical microscopy and classified these changes into three classes: bursting, deformation, and leaking fluid. Optical microscopic image analysis fully corroborated our interpretation of the turbidity changes in the samples. From a practical perspective, the finding that VanX expressed in isolation induces cell lysis suggests that inhibitors of VanA and VanH that act downstream from VanX could provide a new class of therapeutic chemicals against bacteria expressing the vancomycin-resistance gene cluster.	[Sohya, Shihori; Kamioka, Tetsuya; Fujita, Chisako; Ohta, Yoshihiro; Kuroda, Yutaka] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Maki, Tei] Tokyo Univ Agr & Technol, Res Ctr Sci & Technol, Koganei, Tokyo 1848588, Japan; [Maki, Tei] JEOL Ltd, EM Business Unit, Tokyo 1968558, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Jeol Ltd; JEOL Japan	Kuroda, Y (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	ykuroda@cc.tuat.ac.jp	Kuroda, Yutaka/G-1094-2013; Ohta, Yoshihiro/C-8741-2013	Kuroda, Yutaka/0000-0002-3221-4295; Ohta, Yoshihiro/0000-0001-7416-0507				Akiyama S, 2012, BIOCHEMISTRY-US, V51, P7974, DOI 10.1021/bi300580j; ALOBEID S, 1990, ANTIMICROB AGENTS CH, V34, P252, DOI 10.1128/AAC.34.2.252; CANFIELD RE, 1963, J BIOL CHEM, V238, P2698; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Hsieh ML, 2006, ANAL BIOCHEM, V354, P104, DOI 10.1016/j.ab.2006.03.054; Islam MM, 2008, P NATL ACAD SCI USA, V105, P15334, DOI 10.1073/pnas.0802699105; Islam MM, 2009, PROTEINS, V77, P962, DOI 10.1002/prot.22522; Jang B, 2007, J MICROBIOL, V45, P593; Jovetic S, 2010, TRENDS BIOTECHNOL, V28, P596, DOI 10.1016/j.tibtech.2010.09.004; Kamioka T, 2013, ANAL BIOCHEM, V439, P212, DOI 10.1016/j.ab.2013.04.007; KELLENBERGER E, 1958, J BIOPHYS BIOCHEM CY, V4, P323, DOI 10.1083/jcb.4.3.323; LEDUC M, 1980, J BACTERIOL, V142, P52, DOI 10.1128/JB.142.1.52-59.1980; Lessard IAD, 1999, P NATL ACAD SCI USA, V96, P11028, DOI 10.1073/pnas.96.20.11028; Liu XY, 2009, P NATL ACAD SCI USA, V106, P21550, DOI 10.1073/pnas.0911953106; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Morikawa D, 2014, BIOMED OPT EXPRESS, V5, P848, DOI 10.1364/BOE.5.000848; Nakakoshi M, 2011, J ELECTRON MICROSC, V60, P401, DOI 10.1093/jmicro/dfr084; Okanojo M, 2005, J BIOSCI BIOENG, V100, P556, DOI 10.1263/jbb.100.556; Park T, 2006, P NATL ACAD SCI USA, V103, P19713, DOI 10.1073/pnas.0600943103; SCHINDLER M, 1977, BIOCHEMISTRY-US, V16, P423, DOI 10.1021/bi00622a013; Sova M, 2009, BIOORG MED CHEM LETT, V19, P1376, DOI 10.1016/j.bmcl.2009.01.034	23	2	2	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35686	35694		10.1074/jbc.M114.590265	http://dx.doi.org/10.1074/jbc.M114.590265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25294880	hybrid, Green Published			2022-12-25	WOS:000346897900002
J	De la Fuente, IM; Cortes, JM; Valero, E; Desroches, M; Rodrigues, S; Malaina, I; Martinez, L				De la Fuente, Ildefonso M.; Cortes, Jesus M.; Valero, Edelmira; Desroches, Mathieu; Rodrigues, Serafim; Malaina, Iker; Martinez, Luis			On the Dynamics of the Adenylate Energy System: Homeorhesis vs Homeostasis	PLOS ONE			English	Article							ADENINE-NUCLEOTIDE CONCENTRATIONS; EXTRACELLULAR ATP ACCUMULATION; LONG-RANGE CORRELATIONS; PANCREATIC BETA-CELL; INTRACELLULAR ATP; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; BIOCHEMICAL OSCILLATIONS; AUTONOMOUS OSCILLATIONS; MOLECULAR PHYSIOLOGY	Biochemical energy is the fundamental element that maintains both the adequate turnover of the biomolecular structures and the functional metabolic viability of unicellular organisms. The levels of ATP, ADP and AMP reflect roughly the energetic status of the cell, and a precise ratio relating them was proposed by Atkinson as the adenylate energy charge (AEC). Under growth-phase conditions, cells maintain the AEC within narrow physiological values, despite extremely large fluctuations in the adenine nucleotides concentration. Intensive experimental studies have shown that these AEC values are preserved in a wide variety of organisms, both eukaryotes and prokaryotes. Here, to understand some of the functional elements involved in the cellular energy status, we present a computational model conformed by some key essential parts of the adenylate energy system. Specifically, we have considered (I) the main synthesis process of ATP from ADP, (II) the main catalyzed phosphotransfer reaction for interconversion of ATP, ADP and AMP, (III) the enzymatic hydrolysis of ATP yielding ADP, and (IV) the enzymatic hydrolysis of ATP providing AMP. This leads to a dynamic metabolic model (with the form of a delayed differential system) in which the enzymatic rate equations and all the physiological kinetic parameters have been explicitly considered and experimentally tested in vitro. Our central hypothesis is that cells are characterized by changing energy dynamics (homeorhesis). The results show that the AEC presents stable transitions between steady states and periodic oscillations and, in agreement with experimental data these oscillations range within the narrow AEC window. Furthermore, the model shows sustained oscillations in the Gibbs free energy and in the total nucleotide pool. The present study provides a step forward towards the understanding of the fundamental principles and quantitative laws governing the adenylate energy system, which is a fundamental element for unveiling the dynamics of cellular life.	[De la Fuente, Ildefonso M.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [De la Fuente, Ildefonso M.; Martinez, Luis] Univ Basque Country, UPV EHU, Dept Math, Leioa, Spain; [De la Fuente, Ildefonso M.] Univ Basque Country, Biophys Unit, CSIC, UPV EHU, Leioa, Spain; [De la Fuente, Ildefonso M.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa, Spain; [De la Fuente, Ildefonso M.; Cortes, Jesus M.; Malaina, Iker; Martinez, Luis] Hosp Univ Cruces, Biocruces Hlth Res Inst, Baracaldo, Spain; [Cortes, Jesus M.] Ikerbasque, Basque Fdn Sci, Bilbao, Basque Country, Spain; [Valero, Edelmira] Univ Castilla La Mancha, Sch Ind Engn, Dept Phys Chem, Albacete, Spain; [Desroches, Mathieu] INRIA Paris Rocquencourt Ctr, Paris, France; [Rodrigues, Serafim] Univ Plymouth, Sch Comp & Math, Plymouth PL4 8AA, Devon, England; [Malaina, Iker] Univ Basque Country, UPV EHU, Dept Physiol, Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Hospital Universitario Cruces; Basque Foundation for Science; Universidad de Castilla-La Mancha; University of Plymouth; University of Basque Country	De la Fuente, IM (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	mtpmadei@ehu.es	Malaina, Iker/AAQ-1997-2020; Valero, Edelmira/M-7424-2014; Rodrigues, Serafim/M-7404-2016; Martínez, Luis/G-6266-2012; Cortes, Jesus/D-9949-2012	Malaina, Iker/0000-0002-1305-6623; Valero, Edelmira/0000-0001-8636-4574; Rodrigues, Serafim/0000-0002-3601-5760; Martínez, Luis/0000-0002-6297-1449; Cortes, Jesus/0000-0002-9059-8194; De la Fuente, Ildefonso/0000-0001-6548-7583	University of Basque Country (UPV/EHU): University-Society grant [US11/13]; Ministerio de Economia y Competitividad (Spain) [BFU2013-44095-P]	University of Basque Country (UPV/EHU): University-Society grant; Ministerio de Economia y Competitividad (Spain)(Spanish Government)	This study was funded by the University of Basque Country (UPV/EHU): University-Society grant US11/13 and Ministerio de Economia y Competitividad (Spain), Project No. BFU2013-44095-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusci P, 2007, EXP HEMATOL, V35, P1182, DOI 10.1016/j.exphem.2007.05.004; Aden J, 2013, BIOCHEMISTRY-US, V52, P1055, DOI 10.1021/bi301460k; Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; AKITAYA T, 1985, J GEN MICROBIOL, V131, P195; ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; BALL WJ, 1975, J BACTERIOL, V121, P975, DOI 10.1128/JB.121.3.975-982.1975; BARIL EF, 1968, J NUTR, V95, P228, DOI 10.1093/jn/95.2.228; BARRETTE WC, 1988, J BACTERIOL, V170, P3655, DOI 10.1128/jb.170.8.3655-3659.1988; BEAMAN KD, 1981, J BACTERIOL, V146, P1055, DOI 10.1128/JB.146.3.1055-1058.1981; Bernard C., 1865, INTRO ETUDE MED EXPT; Bernard C., 1957, INTRO LIT CORRES TON; Bhatt DP, 2012, J CHROMATOGR B, V889, P110, DOI 10.1016/j.jchromb.2012.02.005; Biegniewska A, 2010, J APPL ICHTHYOL, V26, P674, DOI 10.1111/j.1439-0426.2010.01537.x; Blackwell KT, 2013, J NEUROSCI METH, V220, P131, DOI 10.1016/j.jneumeth.2013.05.008; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Boender LGM, 2011, BBA-MOL CELL RES, V1813, P2133, DOI 10.1016/j.bbamcr.2011.07.008; Bonsdorff T, 2004, ANIM GENET, V35, P438, DOI 10.1111/j.1365-2052.2004.01201.x; BONZON M, 1981, PLANTA, V152, P189, DOI 10.1007/BF00385143; BRODSKY VY, 1992, J CELL SCI, V103, P363; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; BULTHUIS BA, 1993, ANTON LEEUW INT J G, V63, P1, DOI 10.1007/BF00871725; Burkeen JF, 2011, J NEUROSCI, V31, P8432, DOI 10.1523/JNEUROSCI.6576-10.2011; Burnstock G, 1999, PROG BRAIN RES, V120, P3; Burnstock G, 2012, BRIT J PHARMACOL, V167, P238, DOI 10.1111/j.1476-5381.2012.02008.x; Cannon W.B., 1932, WISDOM BODY; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chapman A G, 1977, Adv Microb Physiol, V15, P253, DOI 10.1016/S0065-2911(08)60318-5; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Chen BS, 2009, MATH BIOSCI, V222, P92, DOI 10.1016/j.mbs.2009.09.004; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen YY, 2007, BIOMED CHROMATOGR, V21, P628, DOI 10.1002/bmc.798; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; CHING TM, 1972, PLANT PHYSIOL, V50, P536, DOI 10.1104/pp.50.5.536; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; Curien G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.29; Dai RH, 2008, TOXICON, V51, P649, DOI 10.1016/j.toxicon.2007.11.021; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De la Fuente IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058284; De la Fuente IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030162; De la Fuente IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027224; De la Fuente IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009484; De la Fuente IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007510; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; De la Fuente IM, 1998, FRACTALS, V6, P95, DOI 10.1142/S0218348X98000110; de la Fuente IM, 1998, ACTA BIOTHEOR, V46, P37, DOI 10.1023/A:1000899820111; De La Fuente IM, 1998, B MATH BIOL, V60, P689; De la Fuentea IM, 1999, J BIOL SYST, V7, P113, DOI 10.1142/S0218339099000103; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DERR RF, 1972, BIOCHEM BIOPH RES CO, V49, P1385, DOI 10.1016/0006-291X(72)90492-5; Dinesh R, 2006, CURR SCI INDIA, V90, P1258; Dong K, 2012, EXP DERMATOL, V21, P231, DOI 10.1111/j.1600-0625.2011.01439.x; DOSPASSOS JB, 1992, BIOCHIM BIOPHYS ACTA, V1136, P57; Edwards JM, 2012, J EXP BOT, V63, P4389, DOI 10.1093/jxb/ers114; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Ercan N, 1996, ARCH BIOCHEM BIOPHYS, V328, P255, DOI 10.1006/abbi.1996.0171; Ercan-Fang N, 2002, AM J PHYSIOL-ENDOC M, V283, pE29, DOI 10.1152/ajpendo.00425.2001; Erlinge D, 2010, EXTRACELLULAR ATP AND ADENOSINE AS REGULATORS OF ENDOTHELIAL CELL FUNCTION, P1, DOI 10.1007/978-90-481-3435-9_1; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Forsyth AM, 2011, P NATL ACAD SCI USA, V108, P10986, DOI 10.1073/pnas.1101315108; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P237, DOI 10.3109/13813459409003936; GARCIAMUNOZ A, 1993, EXP BRAIN RES, V97, P325; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Geryk J, 2013, INT J DATA MIN BIOIN, V8, P188, DOI 10.1504/IJDMB.2013.055500; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Getty-Kaushik L, 2005, DIABETES, V54, P629, DOI 10.2337/diabetes.54.3.629; Gilbert D. A., 2008, P105, DOI 10.1007/978-1-4020-8352-5_4; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; GOLDBETER A, 1974, FEBS LETT, V43, P327, DOI 10.1016/0014-5793(74)80672-1; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; GONZALEZ F, 1989, FEMS MICROBIOL LETT, V58, P21; Gottlieb A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020361; Guimaraes PMR, 2008, YEAST, V25, P47, DOI 10.1002/yea.1556; Hagen J, 2006, IND CATALYSIS PRACTI, V2nd; Haimovich AD, 2006, J COMPUT BIOL, V13, P1289, DOI 10.1089/cmb.2006.13.1289; HANHIJARVI AM, 1995, PHYSIOL PLANTARUM, V93, P493, DOI 10.1111/j.1399-3054.1995.tb06848.x; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hardie DG, 2011, NATURE, V472, P176, DOI 10.1038/472176a; Harold F. M., 1986, VITAL FORCE STUDY BI; Hartig K, 2005, PLANT BIOLOGY, V7, P33, DOI 10.1055/s-2004-830474; Hochachka PW, 1997, J EXP BIOL, V200, P381; Holert J, 2011, ENV MICROBIOL REP, V3, P136, DOI 10.1111/j.1758-2229.2010.00199.x; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Hungerbuehler AK, 2007, EUKARYOT CELL, V6, P473, DOI 10.1128/EC.00273-06; Hunken M, 2005, PHYCOLOGIA, V44, P249, DOI 10.2216/0031-8884(2005)44[249:DOTAEC]2.0.CO;2; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Jacob T, 2005, EUR J VASC ENDOVASC, V29, P470, DOI 10.1016/j.ejvs.2005.01.030; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jin JP, 1998, J VIROL, V72, P10011, DOI 10.1128/JVI.72.12.10011-10019.1998; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; KAHRU A, 1982, ARCH MICROBIOL, V133, P142, DOI 10.1007/BF00413528; Kazachenko VN, 2007, BIOL MEMBRANY, V24, P175; Kennedy RT, 2002, DIABETES, V51, pS152, DOI 10.2337/diabetes.51.2007.S152; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Kwon HJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.20; Kwon HJ, 2013, CELL BIOCHEM FUNCT, V31, P75, DOI 10.1002/cbf.2862; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; LANGE G, 1988, EUR J BIOCHEM, V178, P61, DOI 10.1111/j.1432-1033.1988.tb14429.x; Lange PR, 2008, PLANT PHYSIOL, V146, P492, DOI 10.1104/pp.107.114702; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Lim EL, 2010, NMR BIOMED, V23, P952, DOI 10.1002/nbm.1519; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; Lloyd D, 2006, FEBS LETT, V580, P2830, DOI 10.1016/j.febslet.2006.02.066; Locasale JW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-108; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; Mamontov E, 2007, MATH COMPUT MODEL, V45, P694, DOI 10.1016/j.mcm.2006.07.015; Mamontov E, 2006, ACTA BIOTHEOR, V54, P61, DOI 10.1007/s10441-006-8263-3; Mamontov E, 2006, MATH COMPUT MODEL, V44, P595, DOI 10.1016/j.mcm.2006.01.028; Mamontov E, 2011, PHYS LIFE REV, V8, P24, DOI 10.1016/j.plrev.2011.01.007; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; de la Fuente IM, 2010, INT J MOL SCI, V11, P3540, DOI 10.3390/ijms11093540; MCKEE KL, 1984, PHYSIOL PLANTARUM, V62, P1, DOI 10.1111/j.1399-3054.1984.tb05914.x; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; MILLS DCB, 1969, NATURE, V222, P991, DOI 10.1038/222991a0; Moller AC, 1998, BIOPHYS CHEM, V72, P63, DOI 10.1016/S0301-4622(98)00123-9; Moran LA, 2011, PRINCIPLES BIOCH; MORI Y, 1986, PROTOPLASMA, V135, P31, DOI 10.1007/BF01277050; de la Fuente IM, 2014, SPRINGER SER BIOPHYS, V16, P179, DOI 10.1007/978-3-642-38505-6_8; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Nath S, 2000, BIOCHEM BIOPH RES CO, V272, P629, DOI 10.1006/bbrc.2000.2774; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Peiying Z, 2007, MODELING AIRWAY SURF; Petty HR, 2001, P NATL ACAD SCI USA, V98, P3145, DOI 10.1073/pnas.061014298; Piotrowska MJ, 2008, MATH COMPUT MODEL, V48, P1122, DOI 10.1016/j.mcm.2007.12.020; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Plaideau C, 2012, FASEB J, V26, P2685, DOI 10.1096/fj.11-198168; POMEROY MK, 1986, PLANT PHYSIOL, V81, P361, DOI 10.1104/pp.81.2.361; PRADET A, 1983, ANNU REV PLANT PHYS, V34, P199, DOI 10.1146/annurev.pp.34.060183.001215; PRIVALLE LS, 1983, J BACTERIOL, V154, P351, DOI 10.1128/JB.154.1.351-355.1983; Psiuk-Maksymowicz K, 2008, MATH COMPUT MODEL, V47, P580, DOI 10.1016/j.mcm.2007.02.029; Rajab P, 2000, AM J PHYSIOL-REG I, V279, pR1076, DOI 10.1152/ajpregu.2000.279.3.R1076; Rakotonirainy MS, 2008, LUMINESCENCE, V23, P182, DOI 10.1002/bio.1021; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; RAPOPORT TA, 1976, BIOCHEM J, V154, P449, DOI 10.1042/bj1540449; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; REICH JG, 1974, FEBS LETT, V43, pS119; Rengan R, 1999, BIOCHEM BIOPH RES CO, V262, P479, DOI 10.1006/bbrc.1999.1222; Richard P, 1996, YEAST, V12, P731; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Samaey G, 2000, 305 TW; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; SELKOV E, 1975, EUR J BIOCHEM, V59, P151, DOI 10.1111/j.1432-1033.1975.tb02436.x; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shaul O, 1996, P NATL ACAD SCI USA, V93, P4868, DOI 10.1073/pnas.93.10.4868; Sheng XR, 1999, J BIOL CHEM, V274, P22238, DOI 10.1074/jbc.274.32.22238; SINGH J, 1981, PLANT PHYSIOL, V67, P906, DOI 10.1104/pp.67.5.906; SKJOLDAL HR, 1981, MAR BIOL, V62, P119, DOI 10.1007/BF00388173; SMITH BA, 1980, J BACTERIOL, V142, P1007, DOI 10.1128/JB.142.3.1007-1009.1980; Smrcinova M, 1998, INT J BIFURCAT CHAOS, V8, P2467, DOI 10.1142/S0218127498001984; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Srividhya J, 2007, BIOPHYS CHEM, V125, P286, DOI 10.1016/j.bpc.2006.09.001; Steigmiller S, 2008, P NATL ACAD SCI USA, V105, P3745, DOI 10.1073/pnas.0708356105; Steven WE, 1978, J GEN MICROBIOL, V108, P197; Sung MH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00616; Suska M, 2010, VET MED INT, V2010; SWEDES JS, 1975, J BIOL CHEM, V250, P6930; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; THUMA E, 1972, BIOCHIM BIOPHYS ACTA, V268, P81, DOI 10.1016/0005-2744(72)90200-8; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tonozuka H, 2001, J BIOCHEM-TOKYO, V130, P589, DOI 10.1093/oxfordjournals.jbchem.a003023; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; UEDA T, 1987, EXP CELL RES, V169, P191, DOI 10.1016/0014-4827(87)90237-0; Valero E, 2006, FEBS J, V273, P3598, DOI 10.1111/j.1742-4658.2006.05366.x; Versees W, 2003, CURR OPIN STRUC BIOL, V13, P731, DOI 10.1016/j.sbi.2003.10.002; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Waddington C H, 1957, STRATEGY GENES DISCU; WADDINGTON CH, 1968, NATURE, V218, P525, DOI 10.1038/218525a0; WALKERSIMMONS M, 1977, J BACTERIOL, V130, P676, DOI 10.1128/JB.130.2.676-683.1977; Weber J, 2005, MICROBIOL-SGM, V151, P707, DOI 10.1099/mic.0.27482-0; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Xu Z, 2011, CHEM-ASIAN J, V6, P2113, DOI 10.1002/asia.201100120; Xu ZJ, 2004, BIOCHEM J, V383, P171, DOI 10.1042/BJ20040967; Yang JH, 2008, J BIOL CHEM, V283, P36321, DOI 10.1074/jbc.M804794200; Yildirim N, 2003, BIOPHYS J, V84, P2841, DOI 10.1016/S0006-3495(03)70013-7; YOSHIMOTO Y, 1981, PROTOPLASMA, V109, P159, DOI 10.1007/BF01287637; Ytting CK, 2012, INTEGR BIOL-UK, V4, P99, DOI 10.1039/c1ib00108f; Zubatkina IS, 2008, J EVOL BIOCHEM PHYS+, V44, P763, DOI 10.1134/S0022093008060136	204	51	52	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108676	10.1371/journal.pone.0108676	http://dx.doi.org/10.1371/journal.pone.0108676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303477	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400021
J	Rist, CL; Arriola, CS; Rubin, C				Rist, Cassidy Logan; Arriola, Carmen Sofia; Rubin, Carol			Prioritizing Zoonoses: A Proposed One Health Tool for Collaborative Decision-Making	PLOS ONE			English	Article							INFECTIOUS-DISEASES; PUBLIC-HEALTH; METHODOLOGY	Emerging and re-emerging zoonotic diseases pose a threat to both humans and animals. This common threat is an opportunity for human and animal health agencies to coordinate across sectors in a more effective response to zoonotic diseases. An initial step in the collaborative process is identification of diseases or pathogens of greatest concern so that limited financial and personnel resources can be effectively focused. Unfortunately, in many countries where zoonotic diseases pose the greatest risk, surveillance information that clearly defines burden of disease is not available. We have created a semi-quantitative tool for prioritizing zoonoses in the absence of comprehensive prevalence data. Our tool requires that human and animal health agency representatives jointly identify criteria (e.g., pandemic potential, human morbidity or mortality, economic impact) that are locally appropriate for defining a disease as being of concern. The outcome of this process is a ranked disease list that both human and animal sectors can support for collaborative surveillance, laboratory capacity enhancement, or other identified activities. The tool is described in a five-step process and its utility is demonstrated for the reader.	[Rist, Cassidy Logan; Arriola, Carmen Sofia; Rubin, Carol] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Rubin, C (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	chr1@cdc.gov	Rist, Cassidy/AAT-1611-2020	Rist, Cassidy/0000-0002-7558-8094				[Anonymous], COMMUN DIS REP CDR S; Balabanova Y., 2011, PLOS ONE, V6; Batsukh Z, 2013, CURR TOP MICROBIOL, V366, P123, DOI 10.1007/82_2012_253; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Cediel N, 2013, REV PANAM SALUD PUBL, V33, P316, DOI 10.1590/S1020-49892013000500002; Doherty J A, 2000, Can J Infect Dis, V11, P21; Eliot and Associates, 2005, GUID COND FOC GROUP; Gilsdorf A, 2011, EUROSURVEILLANCE, V16, P15; Gore SM, 1987, MED RES COUNC NEWS, V35, P19; Grace D., 2012, MAPPING POVERTY LIKE; Grace D., 2011, ZOONOSES WILDLIFE LI ZOONOSES WILDLIFE LI; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Hsu C. C., 2007, CREATING MARKET SOCI; Humblet M.F., 2012, EMERG INFECT DIS, V18; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Krause G, 2008, EURO SURVEILL, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Kurowicka D, 2010, RISK ANAL, V30, P715, DOI 10.1111/j.1539-6924.2010.01378.x; Maino M, 2012, REV SCI TECH OIE, V31, P889; McKenzie J, 2007, PREV VET MED, V81, P194, DOI 10.1016/j.prevetmed.2007.04.003; Mourits MCM, 2010, PREV VET MED, V96, P201, DOI 10.1016/j.prevetmed.2010.06.010; Ng V, 2012, PLOS ONE, V7; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Sekar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017120; Sharken Simon J, 1999, CONDUCT FOCUS GROUP; Skinner DC, 2009, INTRO DECISION ANAL, P150; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Toloie-Eshlaghy A., 2011, AM J SCI RES, V24, P6; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	32	47	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109986	10.1371/journal.pone.0109986	http://dx.doi.org/10.1371/journal.pone.0109986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302612	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400101
J	Wang, SS; Wang, JJ; Wang, PX; Chen, RL				Wang, Shan-Shan; Wang, Jia-Ji; Wang, Pei-Xi; Chen, Ruoling			Determinants of Fatigue after First-Ever lschemic Stroke NE during Acute Phase	PLOS ONE			English	Article							POSTSTROKE FATIGUE; FOLLOW-UP; SEVERITY SCALE; YOUNG-ADULTS; FREQUENCY; DEPRESSION	Background and Purpose: Fatigue after stroke is common and has a negative impact on rehabilitation and survival. However, its pathogenesis and contributing factors remain unclear. The purpose of this study was to identify factors influencing the occurrence of fatigue after first-ever ischemic stroke in acute phase. Methods: We examined 265 consecutive patients with first-ever ischemic stroke during acute phase (within 2 weeks) in two tertiary stroke care hospitals in Henan, China. We documented patients demographic and clinical characteristics through face-to-face interviews using structured questionnaires and reviews of medical records. Post-stroke fatigue was defined as a score of >4 using the Fatigue Severity Scale. Multivariate logistic regression was used to examine post-stroke fatigue in relation to socio-demographic, lifestyle, clinical characteristics and family function. Results: About 40% first-ever ischemic stroke patients experienced post-stroke fatigue in acute phase. Post-stroke fatigue was associated with lack of exercise before stroke (adjusted odds ratio 4.01, 95% Cl 1.95-8.24), family dysfunction (2.63, 1.20-5.80), depression (2.39, 1.02-5.58), the presence of pre-stroke fatigue (4.89, 2.13-11.21), use of sedative medications (4.14, 1.58-10.88), coronary heart disease (3.38, 1.46-7.79) and more severe Modified Rankin Scale (2.55, 1.65-3.95). Conclusions:The causes of post-stroke fatigue are multifaceted. More physical exercise, improving family function, reducing depression and appropriate use of sedative medications may be helpful in preventing post-stroke fatigue.	[Wang, Shan-Shan; Wang, Pei-Xi] Henan Univ, Sch Nursing, Inst Publ Hlth, Kaifeng, Peoples R China; [Wang, Jia-Ji; Wang, Pei-Xi] Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China; [Chen, Ruoling] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Chen, Ruoling] Wolverhampton Univ, CHSCI, Wolverhampton WV1 1DJ, W Midlands, England	Henan University; Guangzhou Medical University; University of London; King's College London; University of Wolverhampton	Wang, PX (corresponding author), Henan Univ, Sch Nursing, Inst Publ Hlth, Kaifeng, Peoples R China.	peixi001@163.com; ruoling.chen@kcl.ac.uk	WANG, Jia Ji/E-9059-2015	Chen, Ruoling/0000-0002-3033-8753				Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Andersen G, 2012, ACTA NEUROL SCAND, V125, P248, DOI 10.1111/j.1600-0404.2011.01557.x; Annoni JM, 2008, NEUROL SCI, V29, pS244, DOI 10.1007/s10072-008-0951-0; Appelros P, 2006, INT J REHABIL RES, V29, P329, DOI 10.1097/MRR.0b013e328010c7b8; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bellon Saameno J A, 1996, Aten Primaria, V18, P289; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; Choi-Kwon S, 2011, INT J STROKE, V6, P328, DOI 10.1111/j.1747-4949.2011.00624.x; Christensen D, 2008, CEREBROVASC DIS, V26, P134, DOI 10.1159/000139660; Craig LE, 2010, STROKE, V41, P2632, DOI 10.1161/STROKEAHA.110.588244; Crosby GA, 2012, DISABIL REHABIL, V34, P633, DOI 10.3109/09638288.2011.613517; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Gardner W, 2001, J FAM PRACTICE, V50, P19; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Horton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065752; Jaracz K, 2007, NEUROL NEUROCHIR POL, V41, P36; 박연환, 2002, [Korean Journal of Adult Nursing, 성인간호학회지], V14, P348; Lerdal A, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/126275; Lerdal A, 2011, INT J NURS STUD, V48, P1258, DOI 10.1016/j.ijnurstu.2011.02.019; Lerdal A, 2011, DISABIL REHABIL, V33, P334, DOI 10.3109/09638288.2010.490867; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Naess H, 2006, STROKE, V37, P1232, DOI 10.1161/01.STR.0000217652.42273.02; Naess H, 2005, CEREBROVASC DIS, V20, P245, DOI 10.1159/000087706; Naess H, 2012, J NEUROL SCI, V312, P138, DOI 10.1016/j.jns.2011.08.002; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Snaphaan L, 2011, EUR J NEUROL, V18, P611, DOI 10.1111/j.1468-1331.2010.03217.x; Soyuer F, 2011, ARCH GERONTOL GERIAT, V53, pE164, DOI 10.1016/j.archger.2010.08.006; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2011, ARCH PHYS MED REHAB, V92, P1336, DOI 10.1016/j.apmr.2011.02.018; The neuroscience society, 1996, CHIN J NEUROLOGY, V29, P379; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vigil JM, 2008, J FAM PSYCHOL, V22, P176, DOI 10.1037/0893-3200.22.1.176	35	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110037	10.1371/journal.pone.0110037	http://dx.doi.org/10.1371/journal.pone.0110037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25302807	gold, Green Submitted, Green Published			2022-12-25	WOS:000343730400103
J	Li, Z; Yu, X; Liang, JQ; Wu, WKK; Yu, J; Shen, JX				Li, Zheng; Yu, Xin; Liang, Jinqian; Wu, William Ka Kei; Yu, Jun; Shen, Jianxiong			Leptin Downregulates Aggrecan through the p38-ADAMST Pathway in Human Nucleus Pulposus Cells	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; LOW-BACK-PAIN; HUMAN CHONDROCYTES; GENE-EXPRESSION; ADAMTS FAMILY; DEGENERATION; MAPK; PROLIFERATION; OBESITY; CLONING	The mechanistic basis of obesity-associated intervertebral disc degeneration (IDD) is unclear. Aberrant expression of aggrecan and its degrading enzymes ADAMTS-4 and ADAMTS-5 is implicated in the development of IDD. Here, we investigated the effect of leptin, a hormone with increased circulating levels in obesity, on the expression of aggrecan and ADAMTSs in primary human nucleus pulposus (NP) cells. Real-time PCR and Western blots showed that leptin increased the mRNA and protein expression of ADAMTS-4 and ADAMTS-5 and reduced the level of aggrecan in NP cells, accompanied by a prominent induction of p38 phosphorylation. Treatment of NP cells with SB203580 (a p38 inhibitor) abolished the regulation of aggrecan and ADAMTSs by leptin. Knockdown of ADAMTS-4 and ADAMTS-5 by siRNAs also attenuated the degradation of aggrecan in leptin-stimulated NP cells. To conclude, we demonstrated that leptin induces p38 to upregulate ADAMTSs and thereby promoting aggrecan degradation in human NP cells. These results provide a novel mechanistic insight into the molecular pathogenesis of obesity-associated IDD.	[Li, Zheng; Yu, Xin; Liang, Jinqian; Shen, Jianxiong] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100021, Peoples R China; [Yu, Xin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yu, Xin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, William Ka Kei; Yu, Jun] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese University of Hong Kong	Shen, JX (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100021, Peoples R China.	shenjianxiong@medmail.com.cn	wu, william/HII-5817-2022; Yu, Jun/D-8569-2015; Shen, Jianxiong/AAH-6200-2019; Sánchez-Margalet, Victor/AAB-9986-2021; Wu, William K.K./A-3277-2009	Yu, Jun/0000-0001-5008-2153; Sánchez-Margalet, Victor/0000-0001-8638-8680; Wu, William K.K./0000-0002-5662-5240	National Natural Science Foundation of P.R. China [81272053, 81330044, 81301596, 81401847]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Numbers: 81272053, 81330044, 81301596 and 81401847). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbah SA, 2011, SPINE PHILA PA 1976; Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akhatib B, 2013, J BIOL CHEM, V288, P19280, DOI 10.1074/jbc.M112.443010; Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; Bateman JF, 2013, ARTHRITIS RHEUM-US, V65, P1547, DOI 10.1002/art.37900; Cabraja M, 2013, J NEUROSURG SCI, V57, P307; Carlton ED, 2012, HORM BEHAV; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Freitas VM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-2; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Furtwangler T, 2013, SPINE PHILA PA 1976; Gruber HE, 2007, SPINE J, V7, P437, DOI 10.1016/j.spinee.2006.08.001; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; Hou N, 2011, CLIN EXP PHARMACOL P, V38, P905, DOI 10.1111/j.1440-1681.2011.05619.x; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Hsieh AH, 2010, J BIOMECH, V43, P137, DOI 10.1016/j.jbiomech.2009.09.019; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; l'Allemand D, 2002, EUR J ENDOCRINOL, V146, P537, DOI 10.1530/eje.0.1460537; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Liang C, 2013, INT IMMUNOPHARMACOL, V15, P620, DOI 10.1016/j.intimp.2013.01.014; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Radons J, 2006, INT J MOL MED, V17, P661; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Saito T, 2013, OSTEOARTHR CARTILAGE, V21, P165, DOI 10.1016/j.joca.2012.09.003; Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Speed C, 2004, BRIT MED J, V328, P1119, DOI 10.1136/bmj.328.7448.1119; Thompson KJ, 2011, HPB, V13, P225, DOI 10.1111/j.1477-2574.2010.00259.x; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Zhao CQ, 2008, SPINE, V33, pE858, DOI 10.1097/BRS.0b013e31818338e5	37	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109595	10.1371/journal.pone.0109595	http://dx.doi.org/10.1371/journal.pone.0109595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299465	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200062
J	Osakabe, A; Takahashi, Y; Murakami, H; Otawa, K; Tachiwana, H; Oma, Y; Nishijima, H; Shibahara, K; Kurumizaka, H; Harata, M				Osakabe, Akihisa; Takahashi, Yuichiro; Murakami, Hirokazu; Otawa, Kenji; Tachiwana, Hiroaki; Oma, Yukako; Nishijima, Hitoshi; Shibahara, Kei-ich; Kurumizaka, Hitoshi; Harata, Masahiko			DNA Binding Properties of the Actin-Related Protein Arp8 and Its Role in DNA Repair	PLOS ONE			English	Article							STRAND BREAK REPAIR; CHROMATIN-REMODELING COMPLEXES; REPLICATION FORKS; INO80 COMPLEX; HOMOLOGOUS RECOMBINATION; CELLULAR-RESPONSE; DAMAGE; NUCLEUS; IDENTIFICATION; ORGANIZATION	Actin and actin-related proteins (Arps), which are members of the actin family, are essential components of many of these remodeling complexes. Actin, Arp4, Arp5, and Arp8 are found to be evolutionarily conserved components of the INO80 chromatin remodeling complex, which is involved in transcriptional regulation, DNA replication, and DNA repair. A recent report showed that Arp8 forms a module in the INO80 complex and this module can directly capture a nucleosome. In the present study, we showed that recombinant human Arp8 binds to DNAs, and preferentially binds to single-stranded DNA. Analysis of the binding of adenine nucleotides to Arp8 mutants suggested that the ATP-binding pocket, located in the evolutionarily conserved actin fold, plays a regulatory role in the binding of Arp8 to DNA. To determine the cellular function of Arp8, we derived tetracycline-inducible Arp8 knockout cells from a cultured human cell line. Analysis of results obtained after treating these cells with aphidicolin and camptothecin revealed that Arp8 is involved in DNA repair. Together with the previous observation that Arp8, but not gamma-H2AX, is indispensable for recruiting INO80 complex to DSB in human, results of our study suggest an individual role for Arp8 in DNA repair.	[Takahashi, Yuichiro; Murakami, Hirokazu; Oma, Yukako; Harata, Masahiko] Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Sendai, Miyagi 980, Japan; [Osakabe, Akihisa; Otawa, Kenji; Tachiwana, Hiroaki; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan; [Nishijima, Hitoshi; Shibahara, Kei-ich] Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 411, Japan	Tohoku University; Waseda University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan.	kurumizaka@waseda.jp; mharata@biochem.tohoku.ac.jp	Harata, Masahiko/T-5281-2019; Tachiwana, Hiroaki/AHB-3091-2022	Tachiwana, Hiroaki/0000-0001-9227-7653; Kurumizaka, Hitoshi/0000-0001-7412-3722; Osakabe, Akihisa/0000-0002-2526-3398	Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Human Frontier Science Program [RGP0017]; Waseda Research Institute for Science and Engineering	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Waseda Research Institute for Science and Engineering	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas from the Japanese Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and by the Human Frontier Science Program (RGP0017). H. Kurumizaka was also supported by the Waseda Research Institute for Science and Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama N, 2008, EXP CELL RES, V314, P859, DOI 10.1016/j.yexcr.2007.11.020; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bennett G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3084; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bhatia S, 2010, GENES CELLS, V15, P725, DOI 10.1111/j.1365-2443.2010.01416.x; Boyer LA, 2000, BIOESSAYS, V22, P666, DOI 10.1002/1521-1878(200007)22:7<666::AID-BIES9>3.0.CO;2-Y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chambers AL, 2012, PROG MOL BIOL TRANSL, V110, P229, DOI 10.1016/B978-0-12-387665-2.00009-2; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Kashiwaba S, 2010, BIOCHEM BIOPH RES CO, V402, P619, DOI 10.1016/j.bbrc.2010.10.066; Kast DJ, 2011, EMBO J, V30, P2097, DOI 10.1038/emboj.2011.150; Kawashima S, 2007, BIOCHEM BIOPH RES CO, V355, P835, DOI 10.1016/j.bbrc.2007.02.036; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Nishijima H, 2009, BIOSCI TRENDS, V3, P161; Nishimoto N, 2012, J CELL SCI; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Oma Y, 2011, NUCLEUS-PHILA, V2, P38, DOI 10.4161/nucl.2.1.14510; Ono T, 2009, J BIOTECHNOL, V141, P1, DOI 10.1016/j.jbiotec.2008.12.010; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Yonetani Y, 2005, NUCLEIC ACIDS RES, V33, P4544, DOI 10.1093/nar/gki766	39	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108354	10.1371/journal.pone.0108354	http://dx.doi.org/10.1371/journal.pone.0108354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299602	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200015
J	Alonso-Ayuso, M; Gabriel, JL; Quemada, M				Alonso-Ayuso, Maria; Luis Gabriel, Jose; Quemada, Miguel			The Kill Date as a Management Tool for Cover Cropping Success	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; VETCH-RYE MIXTURE; SOIL-MOISTURE; HAIRY VETCH; VEGETABLE CROPS; CAPACITANCE PROBES; N AVAILABILITY; WINTER CEREAL; CATCH CROPS; CORN	Integrating cover crops (CC) in rotations provides multiple ecological services, but it must be ensured that management does not increase pre-emptive competition with the subsequent crop. This experiment was conducted to study the effect of kill date on: (i) CC growth and N content; (ii) the chemical composition of residues; (iii) soil inorganic N and potentially mineralizable N; and (iv) soil water content. Treatments were fallow and a CC mixture of barley (Hordeum vulgare L.) and vetch (Vicia sativa L.) sown in October and killed on two different dates in spring. Above-ground biomass and chemical composition of CC were determined at harvest, and ground cover was monitored based on digital image analysis. Soil mineral N was determined before sowing and after killing the CC, and potentially mineralizable N was measured by aerobic incubation at the end of the experiment. Soil water content was monitored daily to a depth of 1.1 m using capacitance sensors. Under the present conditions of high N availability, delaying kill date increased barley above-ground biomass and N uptake from deep soil layers; little differences were observed in vetch. Postponing kill date increased the C/N ratio and the fiber content of plant residues. Ground cover reached >80% by the first kill date (similar to 1250 degrees C days). Kill date was a means to control soil inorganic N by balancing the N retained in the residue and soil, and showed promise for mitigating N losses. The early kill date decreased the risk of water and N pre-emptive competition by reducing soil depletion, preserving rain harvested between kill dates and allowing more time for N release in spring. The soil potentially mineralizable N was enhanced by the CC and kill date delay. Therefore kill date is a crucial management variable for maximizing the CC benefits in agricultural systems.	[Alonso-Ayuso, Maria; Luis Gabriel, Jose; Quemada, Miguel] Tech Univ Madrid, Sch Agr Engn, Madrid, Spain	Universidad Politecnica de Madrid	Quemada, M (corresponding author), Tech Univ Madrid, Sch Agr Engn, Madrid, Spain.	miguel.quemada@upm.es	Quemada, Miguel/K-4214-2014; Alonso-Ayuso, María/D-8899-2016; Gabriel, Jose Luis/B-9605-2013	Quemada, Miguel/0000-0001-5793-2835; Alonso-Ayuso, María/0000-0002-4401-790X; Gabriel, Jose Luis/0000-0002-5508-4120	Spanish Comision Interministerial de Ciencia y Tecnologia [AGL 2011-24732]; Regional Government of Madrid [S2009/AGR-1630]	Spanish Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Regional Government of Madrid	This work was funded by the Spanish Comision Interministerial de Ciencia y Tecnologia (project AGL 2011-24732) and the Regional Government of Madrid (Project AGRISOST, S2009/AGR-1630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abawi GS, 2000, APPL SOIL ECOL, V15, P37, DOI 10.1016/S0929-1393(00)00070-6; Arregui LM, 2008, AGRON J, V100, P277, DOI 10.2134/agronj2007.0187; Benincasa P, 2010, J SUSTAIN AGR, V34, P705, DOI 10.1080/10440046.2010.507452; Benincasa P, 2011, HORTTECHNOLOGY, V21, P266, DOI 10.21273/HORTTECH.21.3.266; Bodner G, 2010, AGRON SUSTAIN DEV, V30, P455, DOI 10.1051/agro/2009029; Clark AJ, 2007, AGRON J, V99, P43, DOI 10.2134/agronj2005.0362; Clark AJ, 1997, AGRON J, V89, P434, DOI 10.2134/agronj1997.00021962008900030011x; CLARK AJ, 1994, AGRON J, V86, P1065, DOI 10.2134/agronj1994.00021962008600060025x; Clark AJ, 1997, AGRON J, V89, P427, DOI 10.2134/agronj1997.00021962008900030010x; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; CROOKE WM, 1971, J SCI FOOD AGR, V22, P9, DOI 10.1002/jsfa.2740220104; Gabriel JL, 2012, AGR ECOSYST ENVIRON, V155, P50, DOI 10.1016/j.agee.2012.03.021; Gabriel JL, 2011, EUR J AGRON, V34, P133, DOI 10.1016/j.eja.2010.11.006; Goering H.R., 1970, AGR HDB ARS USDA, V379; Keeney D.R, 1982, AGRON MONOGR, P643; Krueger ES, 2011, AGRON J, V103, P316, DOI 10.2134/agronj2010.0327; Kuo S, 1997, SOIL SCI SOC AM J, V61, P145, DOI 10.2136/sssaj1997.03615995006100010022x; Loeppert H.R., 1996, METHODS SOIL ANAL, P437, DOI DOI 10.2136/SSSAB00KSER5.3.C15; Gabriel JL, 2010, SOIL SCI SOC AM J, V74, P593, DOI 10.2136/sssaj2009.0157; McGuire AM, 1998, AGRON J, V90, P404, DOI 10.2134/agronj1998.00021962009000030015x; Mitchell JP, 1999, J SUSTAIN AGR, V15, P19, DOI 10.1300/J064v15n02_04; Nelson D.W., 1996, METHODS SOIL ANAL PA, V5, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; OFORI F, 1987, FIELD CROP RES, V16, P43, DOI 10.1016/0378-4290(87)90052-9; Paltineanu IC, 1997, SOIL SCI SOC AM J, V61, P1576, DOI 10.2136/sssaj1997.03615995006100060006x; Papadakis J., 1966, CLIMATES WORLD THEIR; QUEMADA M, 1995, SOIL SCI SOC AM J, V59, P1059, DOI 10.2136/sssaj1995.03615995005900040015x; Quemada M, 1997, AGRON J, V89, P723, DOI 10.2134/agronj1997.00021962008900050003x; QUEMADA M, 1995, SOIL SCI SOC AM J, V59, P471, DOI 10.2136/sssaj1995.03615995005900020029x; Quemada M, 2002, PLANT SOIL, V238, P295, DOI 10.1023/A:1014404003851; Quemada M, 2007, COMMUN SOIL SCI PLAN, V38, P2061, DOI 10.1080/00103620701548795; Quinton JN, 1997, SOIL USE MANAGE, V13, P143, DOI 10.1111/j.1475-2743.1997.tb00575.x; Ramirez-Garcia J, 2015, J AGR SCI-CAMBRIDGE, V153, P1174, DOI 10.1017/S0021859614000811; Ramirez-Garcia J, 2012, PLANT SOIL ENVIRON, V58, P385, DOI 10.17221/195/2012-PSE; Richardson MD, 2001, CROP SCI, V41, P1884, DOI 10.2135/cropsci2001.1884; Saini M, 2008, SO CONSERVATION AGR, P137; Salmeron M, 2011, FIELD CROP RES, V123, P89, DOI 10.1016/j.fcr.2011.05.006; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; Stipesevic B, 2005, PLANT SOIL ENVIRON, V51, P255, DOI 10.17221/3583-PSE; Stubbs TL, 2009, AGRON J, V101, P538, DOI 10.2134/agronj2008.0107x; TEASDALE JR, 1993, AGRON J, V85, P673, DOI 10.2134/agronj1993.00021962008500030029x; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; THORUPKRISTENSEN K, 1994, FERT RES, V37, P227, DOI 10.1007/BF00748941; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Tosti G., 2010, Italian Journal of Agronomy, V5, P239; Tosti G, 2014, EUR J AGRON, V54, P34, DOI 10.1016/j.eja.2013.11.012; Tosti G, 2012, EUR J AGRON, V43, P136, DOI 10.1016/j.eja.2012.06.004; Unkovich M., 2008, Measuring plant-associated nitrogen fixation in agricultural systems; Vazquez N, 2006, AGR ECOSYST ENVIRON, V112, P313, DOI 10.1016/j.agee.2005.07.009; Vazquez N, 2005, PLANT SOIL, V269, P297, DOI 10.1007/s11104-004-0630-8; WAGGER MG, 1989, AGRON J, V81, P236, DOI 10.2134/agronj1989.00021962008100020020x; Wagger MG, 1998, J SOIL WATER CONSERV, V53, P214; WHITMORE AP, 1991, J SOIL SCI, V42, P289, DOI 10.1111/j.1365-2389.1991.tb00410.x	53	93	93	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109587	10.1371/journal.pone.0109587	http://dx.doi.org/10.1371/journal.pone.0109587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296333	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000081
J	Heinicke, K; Dimitrov, IE; Romain, N; Cheshkov, S; Ren, JM; Malloy, CR; Haller, RG				Heinicke, Katja; Dimitrov, Ivan E.; Romain, Nadine; Cheshkov, Sergey; Ren, Jimin; Malloy, Craig R.; Haller, Ronald G.			Reproducibility and Absolute Quantification of Muscle Glycogen in Patients with Glycogen Storage Disease by C-13 NMR Spectroscopy at 7 Tesla	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MCARDLE-DISEASE; EXERCISE; DEFICIENCY; METABOLISM; INVIVO	Carbon-13 magnetic resonance spectroscopy (C-13 MRS) offers a noninvasive method to assess glycogen levels in skeletal muscle and to identify excess glycogen accumulation in patients with glycogen storage disease (GSD). Despite the clinical potential of the method, it is currently not widely used for diagnosis or for follow-up of treatment. While it is possible to perform acceptable C-13 MRS at lower fields, the low natural abundance of C-13 and the inherently low signal-to-noise ratio of C-13 MRS makes it desirable to utilize the advantage of increased signal strength offered by ultra-high fields for more accurate measurements. Concomitant with this advantage, however, ultra-high fields present unique technical challenges that need to be addressed when studying glycogen. In particular, the question of measurement reproducibility needs to be answered so as to give investigators insight into meaningful inter-subject glycogen differences. We measured muscle glycogen levels in vivo in the calf muscle in three patients with McArdle disease (MD), one patient with phosphofructokinase deficiency (PFKD) and four healthy controls by performing C-13 MRS at 7T. Absolute quantification of the MRS signal was achieved by using a reference phantom with known concentration of metabolites. Muscle glycogen concentration was increased in GSD patients (31.5 +/- 2.9 g/kg w. w.) compared with controls (12.4 +/- 2.2 g/kg w. w.). In three GSD patients glycogen was also determined biochemically in muscle homogenates from needle biopsies and showed a similar 2.5-fold increase in muscle glycogen concentration in GSD patients compared with controls. Repeated inter-subject glycogen measurements yield a coefficient of variability of 5.18%, while repeated phantom measurements yield a lower 3.2% system variability. We conclude that noninvasive ultra-high field C-13 MRS provides a valuable, highly reproducible tool for quantitative assessment of glycogen levels in health and disease.	[Heinicke, Katja; Romain, Nadine; Haller, Ronald G.] Texas Hlth Presbyterian Hosp, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA; [Heinicke, Katja; Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Dimitrov, Ivan E.; Cheshkov, Sergey; Ren, Jimin; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Dimitrov, Ivan E.] Philips Med Syst, Cleveland, OH USA; [Haller, Ronald G.] North Texas VA Med Ctr, Dept Neurol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Philips; Philips Healthcare; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Heinicke, K (corresponding author), Texas Hlth Presbyterian Hosp, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA.	katjaheinicke@hotmail.com		Romain, Nadine/0000-0003-2492-549X; Malloy, Craig/0000-0001-5077-0642; Dimitrov, Ivan/0000-0003-2686-6884	Muscular Dystrophy Association; Giant Tiger Foundation; Texas Health Presbyterian Hospital Dallas; National Center for Research Resources; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [DK058398, EB015908]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Giant Tiger Foundation; Texas Health Presbyterian Hospital Dallas; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by the Muscular Dystrophy Association, the Giant Tiger Foundation, Texas Health Presbyterian Hospital Dallas, National Center for Research Resources, and the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health through Grant Number DK058398 and EB015908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ST, 2008, ARCH NEUROL-CHICAGO, V65, P786, DOI 10.1001/archneur.65.6.786; AVISON MJ, 1988, P NATL ACAD SCI USA, V85, P1634, DOI 10.1073/pnas.85.5.1634; BECKMANN N, 1990, MAGN RESON MED, V16, P150, DOI 10.1002/mrm.1910160114; BERGSTROM J, 1966, NATURE, V210, P309, DOI 10.1038/210309a0; Boesch C, 2007, J MAGN RESON IMAGING, V25, P321, DOI 10.1002/jmri.20806; Di Mauro S, 2007, Acta Myol, V26, P35; DIMAURO S, 1979, ANN NEUROL, V5, P422, DOI 10.1002/ana.410050504; Haller R, 2004, MYOLOGY, V3rd, P665; Haller RG, 2004, NEUROLOGY, V62, P82, DOI 10.1212/WNL.62.1.82; Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395; Haller RG, 2006, ANN NEUROL, V59, P922, DOI 10.1002/ana.20881; JEHENSON P, 1995, J CHIM PHYS PCB, V92, P1797, DOI 10.1051/jcp/1995921797; Jehenson P, 1991, Neuromuscul Disord, V1, P99, DOI 10.1016/0960-8966(91)90056-X; Kreis R, 1997, PROG NUCL MAG RES SP, V31, P155, DOI 10.1016/S0079-6565(97)00014-9; Lucia A, 2008, NAT CLIN PRACT NEURO, V4, P568, DOI 10.1038/ncpneuro0913; Mate-Munoz JL, 2007, CLIN J SPORT MED, V17, P297; MENDEZ J, 1960, METABOLISM, V9, P184; Murphy E, 2000, NUTR REV, V58, P304, DOI 10.1111/j.1753-4887.2000.tb01825.x; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Sharp LJ, 2014, NEUROL CLIN, V32, P777, DOI 10.1016/j.ncl.2014.05.001; Stephenson MC, 2011, WORLD J RADIOL, V3, P105, DOI 10.4329/wjr.v3.i4.105; TAYLOR R, 1992, MAGNET RESON MED, V27, P13, DOI 10.1002/mrm.1910270103; VISSING J, 1992, J APPL PHYSIOL, V72, P1773; Wary C, 2003, NEUROMUSCULAR DISORD, V13, P545, DOI 10.1016/S0960-8966(03)00069-5; ZANG LH, 1990, BIOCHEMISTRY-US, V29, P6815, DOI 10.1021/bi00481a009	25	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108706	10.1371/journal.pone.0108706	http://dx.doi.org/10.1371/journal.pone.0108706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296331	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000018
J	Leng, YX; Zhang, K; Fan, J; Yi, M; Ge, QG; Chen, L; Zhang, L; Yao, GQ				Leng, Yuxin; Zhang, Kuo; Fan, Jie; Yi, Min; Ge, Qinggang; Chen, Li; Zhang, Lu; Yao, Gaiqi			Effect of Acute, Slightly Increased Intra-Abdominal Pressure on Intestinal Permeability and Oxidative Stress in a Rat Model	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; CRITICALLY-ILL PATIENTS; BACTERIAL TRANSLOCATION; INTERNATIONAL-CONFERENCE; BLOOD-FLOW; HYPERTENSION; GUT; INJURY; ISCHEMIA; HYPOPERFUSION	Introduction: Intra-abdominal hypertension (IAH) is known as a common, serious complication in critically ill patients. Bacterial translocation and permeability changes are considered the pathophysiological bases for IAH-induced enterogenic endotoxemia and subsequent multiorgan failure. Nevertheless, the effects of slightly elevated intra-abdominal pressures (IAPs) on the intestinal mucosa and the associated mechanisms remain unclear. Methods: To investigate the acute effects of different nitrogen pneumoperitoneum grades on colonic mucosa, male Sprague-Dawley rats were assigned to six groups with different IAPs (0 [control], 4, 8, 12, 16, and 20 mmHg, n=6/group). During 90 min of exposure, we dynamically monitored the heart rate and noninvasive hemodynamic parameters. After gradual decompression, arterial blood gas analyses were conducted. Thereafter, structural injuries to the colonic mucosa were identified using light microscopy. Colon permeability was determined using the expression of tight junction proteins, combined with fluorescein isothiocyanate dextran (FD-4) absorption. The pro-oxidant-antioxidant balance was determined based on the levels of malondialdehyde (MDA) and antioxidant enzymes. Results: IAH significantly affected the histological scores of the colonic mucosa, tight junction protein expression, mucosal permeability, and pro-oxidant-antioxidant balance. Interestingly, elevations of IAP that were lower than the threshold for IAH also showed a similar, undesirable effect. In the 8 mmHg group, mild hyponatremia, hypocalcemia, and hypoxemia occurred, accompanied by reduced blood and abdominal perfusion pressures. Mild microscopic inflammatory infiltration and increased MDA levels were also detected. Moreover, an 8-mm Hg IAP markedly inhibited the expression of tight junction proteins, although no significant differences in FD-4 permeability were observed between the 0- and 8-mmHg groups. Conclusions: Acute exposure to slightly elevated IAP may result in adverse effects on intestinal permeability and the pro-oxidant-antioxidant balance. Therefore, in patients with critical illnesses, IAP should be dynamically monitored and corrected, as soon as possible, to prevent intestinal mucosal injury and subsequent gut-derived sepsis.	[Leng, Yuxin; Fan, Jie; Yi, Min; Ge, Qinggang; Yao, Gaiqi] Peking Univ, Hosp 3, Dept Intens Care Unit, Beijing 100871, Peoples R China; [Zhang, Kuo] Peking Univ, Hlth Sci Ctr, Lab Anim Ctr, Beijing 100871, Peoples R China; [Chen, Li] Peking Univ, Hosp 3, Dept Cent Lab, Beijing 100871, Peoples R China; [Zhang, Lu] Peking Univ, Hosp 3, Dept Gastroenterol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Leng, YX (corresponding author), Peking Univ, Hosp 3, Dept Intens Care Unit, Beijing 100871, Peoples R China.	Lengyuxin1980@126.com; bngzhaoo@126.com	leng, yuxin/AFS-0190-2022	leng, yuxin/0000-0001-5634-8936	Peking University - Tsinghua University Joint Center for Life Sciences; Beijing science and technology plan [Z141107002514020]	Peking University - Tsinghua University Joint Center for Life Sciences; Beijing science and technology plan	The work was supported by the following: Peking University - Tsinghua University Joint Center for Life Sciences and Beijing science and technology plan - Z141107002514020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahrani AZ, 2010, PANCREAS, V39, P1064, DOI 10.1097/MPA.0b013e3181da8d51; Ameloot K, 2012, SURG CLIN N AM, V92, P207, DOI 10.1016/j.suc.2012.01.009; Baroncini S, 2002, Minerva Anestesiol, V68, P406; Blobner M, 1999, ANASTH INTENSIV NOTF, V34, P94; Cheatham ML, 2007, INTENS CARE MED, V33, P951, DOI 10.1007/s00134-007-0592-4; Cheng Jun-tao, 2003, Zhonghua Shao Shang Za Zhi, V19, P229; Cheng JT, 2013, CRIT CARE, V17, DOI 10.1186/cc13146; Chionh JJL, 2006, ANZ J SURG, V76, P1106, DOI 10.1111/j.1445-2197.2006.03849.x; Claiborne Robert A, 1985, CRC HDB METHODS OXYG, P283; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; DEITCH EA, 1990, J TRAUMA, V30, pS184; DEITCH EA, 1990, SURGERY, V107, P411; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; DEVASAGAYAM TPA, 1986, BIOCHIM BIOPHYS ACTA, V876, P507, DOI 10.1016/0005-2760(86)90038-X; DIEBEL LN, 1992, J TRAUMA, V33, P45, DOI 10.1097/00005373-199207000-00010; Duzgun AP, 2006, DIGEST DIS SCI, V51, P2400, DOI 10.1007/s10620-006-9334-7; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; Fanning AS, 1999, J AM SOC NEPHROL, V10, P1337; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gong GW, 2011, J TRAUMA, V70, P775, DOI 10.1097/TA.0b013e318210fa1c; Gong GW, 2009, J INVEST SURG, V22, P362, DOI 10.1080/08941930903214719; Gong GW, 2009, FREE RADICAL RES, V43, P470, DOI 10.1080/10715760902846157; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Ihtiyar E, 2011, J SURG RES, V167, P113, DOI 10.1016/j.jss.2009.09.048; IKEDA K, 1991, LAB ANIM-UK, V25, P26, DOI 10.1258/002367791780808176; Kao RLC, 2011, J TRAUMA, V71, pS456, DOI 10.1097/TA.0b013e318232e782; Kaussen T, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S17; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Kim IB, 2012, ANAESTH INTENS CARE, V40, P79, DOI 10.1177/0310057X1204000107; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Kotidis E, 2012, J SURG RES, V176, P102, DOI 10.1016/j.jss.2011.07.020; Li GZ, 2012, WORLD J GASTROENTERO, V18, P5042, DOI 10.3748/wjg.v18.i36.5042; Madl C, 2003, BEST PRACT RES CL GA, V17, P445, DOI 10.1016/S1521-6918(03)00022-2; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Marshall JC, 1998, CAN J PHYSIOL PHARM, V76, P479, DOI 10.1139/cjpp-76-5-479; Mogilner JG, 2008, EUR J PEDIATR SURG, V18, P380, DOI 10.1055/s-2008-1038920; Moore-Olufemi SD, 2005, SHOCK, V23, P571, DOI 10.1097/01.shk.0000161388.61935.e6; Olofsson PH, 2009, CRIT CARE MED, V37, P230, DOI 10.1097/CCM.0b013e318192ff51; Ortiz-Diaz E, 2014, SHOCK, V41, P175, DOI 10.1097/SHK.0000000000000100; PARK PO, 1990, SURGERY, V107, P574; Polat CK, 2003, YONSEI MED J, V44, P259, DOI 10.3349/ymj.2003.44.2.259; Sanchez NC, 2001, AM SURGEON, V67, P243; Schachtrupp A, 2007, ACTA CLIN BELG, V62, P225, DOI 10.1179/acb.2007.62.s1.031; Scheffe H, 1959, ANAL VARIANCE; SFEZ M, 1995, PAEDIATR ANAESTH, V5, P89, DOI 10.1111/j.1460-9592.1995.tb00250.x; Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007; SHIROYAMA Y, 1991, Neurological Surgery, V19, P407; Sugerman H, 1997, J INTERN MED, V241, P71, DOI 10.1046/j.1365-2796.1997.89104000.x; Sukhotnik I, 2006, J LAPAROENDOSC ADV S, V16, P404, DOI 10.1089/lap.2006.16.404; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Vogel HG, 2007, DRUG DISCOVERY EVALU, V3rd; Wang L, 2007, AM J PHYSIOL-GASTR L, V292, pG1559, DOI 10.1152/ajpgi.00567.2006; Yagci Gokhan, 2005, J Chin Med Assoc, V68, P172	53	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109350	10.1371/journal.pone.0109350	http://dx.doi.org/10.1371/journal.pone.0109350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295715	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000063
J	Booher, RN; Hatch, H; Dolinski, BM; Nguyen, T; Harmonay, L; Al-Assaad, AS; Ayers, M; Nebozhyn, M; Loboda, A; Hirsch, HA; Zhang, T; Shi, B; Merkel, CE; Angagaw, MH; Wang, YL; Long, BJ; Lennon, XQ; Miselis, N; Pucci, V; Monahan, JW; Lee, J; Kondic, AG; Im, EK; Mauro, D; Blanchard, R; Gilliland, G; Fawell, SE; Zawel, L; Schuller, AG; Strack, P				Booher, Robert N.; Hatch, Harold; Dolinski, Brian M.; Nguyen, Thi; Harmonay, Lauren; Al-Assaad, Ali-Samer; Ayers, Mark; Nebozhyn, Michael; Loboda, Andrey; Hirsch, Heather A.; Zhang, Theresa; Shi, Bin; Merkel, Carrie E.; Angagaw, Minilik H.; Wang, Yaolin; Long, Brian J.; Lennon, Xianlu Q.; Miselis, Nathan; Pucci, Vincenzo; Monahan, James W.; Lee, Junghoon; Kondic, Anna Georgieva; Im, Eun Kyung; Mauro, David; Blanchard, Rebecca; Gilliland, Gary; Fawell, Stephen E.; Zawel, Leigh; Schuller, Alwin G.; Strack, Peter			MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; CELL-CYCLE; SCH 727965; POTENT; PROLIFERATION; EXPRESSION; MECHANISM; ABT-263; GROWTH; BAX	Dinaciclib is a potent CDK1, 2, 5 and 9 inhibitor being developed for the treatment of cancer. Additional understanding of antitumor mechanisms and identification of predictive biomarkers are important for its clinical development. Here we demonstrate that while dinaciclib can effectively block cell cycle progression, in vitro and in vivo studies, coupled with mouse and human pharmacokinetics, support a model whereby induction of apoptosis is a main mechanism of dinaciclib's antitumor effect and relevant to the clinical duration of exposure. This was further underscored by kinetics of dinaciclib-induced downregulation of the antiapoptotic BCL2 family member MCL1 and correlation of sensitivity with the MCL1-to-BCLxL mRNA ratio or MCL1 amplification in solid tumor models in vitro and in vivo. This MCL1-dependent apoptotic mechanism was additionally supported by synergy with the BCL2, BCL-xL and BCL-w inhibitor navitoclax (ABT-263). These results provide the rationale for investigating MCL1 and BCL-xL as predictive biomarkers for dinaciclib antitumor response and testing combinations with BCL2 family member inhibitors.	[Booher, Robert N.; Hatch, Harold; Dolinski, Brian M.; Nguyen, Thi; Harmonay, Lauren; Al-Assaad, Ali-Samer; Fawell, Stephen E.; Zawel, Leigh; Strack, Peter] Merck Res Labs, Discovery Oncol, Boston, MA 02115 USA; [Ayers, Mark; Nebozhyn, Michael; Loboda, Andrey; Hirsch, Heather A.; Zhang, Theresa] Merck Res Labs, BioInformatics, Boston, MA USA; [Shi, Bin; Merkel, Carrie E.; Angagaw, Minilik H.; Wang, Yaolin; Long, Brian J.; Schuller, Alwin G.] Merck Res Labs, In Vivo Pharmacol, Boston, MA USA; [Lennon, Xianlu Q.; Miselis, Nathan] Merck Res Labs, Biomarkers, Boston, MA USA; [Pucci, Vincenzo; Monahan, James W.] Merck Res Labs, Pharmacokinet Pharmacodynam & Drug Metab, Boston, MA USA; [Lee, Junghoon; Kondic, Anna Georgieva] Merck Res Labs, Quantitat Pharmacol & Pharmacometr, Boston, MA USA; [Im, Eun Kyung; Mauro, David; Blanchard, Rebecca; Gilliland, Gary] Merck Res Labs, Clin Oncol, Boston, MA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Strack, P (corresponding author), Merck Res Labs, Discovery Oncol, Boston, MA 02115 USA.	cpstrack@verizon.net		Pucci, Vincenzo/0000-0002-1222-8366; Strack, Peter/0000-0003-4042-0416				Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blachly JS, 2013, LEUKEMIA LYMPHOMA, V54, P2133, DOI 10.3109/10428194.2013.783911; Bose P, 2013, EXPERT OPIN INV DRUG, V22, P723, DOI 10.1517/13543784.2013.789859; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Chen R, 2009, BLOOD, V113, P4637, DOI 10.1182/blood-2008-12-190256; Desai BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059588; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Graidist P, 2004, J BIOL CHEM, V279, P40868, DOI 10.1074/jbc.M401454200; Guha M, 2012, NAT REV DRUG DISCOV, V11, P892, DOI 10.1038/nrd3908; Gutierrez MI, 1999, CANCER RES, V59, P696; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hardwick JS, 2005, MOL CANCER THER, V4, P413; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; Horiuchi D, 2012, P NATL ACAD SCI USA, V109, pE1019, DOI 10.1073/pnas.1111317109; Hussain A, 2003, HAEMATOLOGICA, V88, P167; Johnson AJ, 2012, LEUKEMIA, V26, P2554, DOI 10.1038/leu.2012.144; Kutuk O, 2010, EUR J CANCER, V46, P2494, DOI 10.1016/j.ejca.2010.06.011; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; Mita M, 2013, CLIN BREAST CANCER, V10.01, P1; Mpakou VE, 2013, LEUKEMIA RES, V37, P175, DOI 10.1016/j.leukres.2012.10.011; Nemunaitis JJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-259; Nguyen TK, 2014, MOL CANCER THER, V13, P662, DOI 10.1158/1535-7163.MCT-13-0714; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Shi B, 2010, J HISTOTECHNOL, V33, P15, DOI 10.1179/his.2010.33.1.15; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Stephenson JJ, 2014, LUNG CANCER, V83, P219, DOI 10.1016/j.lungcan.2013.11.020; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Thomas LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045088; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559	42	40	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108371	10.1371/journal.pone.0108371	http://dx.doi.org/10.1371/journal.pone.0108371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289887	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000014
J	Dorrie, J; Krug, C; Hofmann, C; Muller, I; Wellner, V; Knippertz, I; Schierer, S; Thomas, S; Zipperer, E; Printz, D; Fritsch, G; Schuler, G; Schaft, N; Geyeregger, R				Doerrie, Jan; Krug, Christian; Hofmann, Christian; Mueller, Ina; Wellner, Verena; Knippertz, Ilka; Schierer, Stephan; Thomas, Simone; Zipperer, Elke; Printz, Dieter; Fritsch, Gerhard; Schuler, Gerold; Schaft, Niels; Geyeregger, Rene			Human Adenovirus-Specific gamma/delta and CD8(+) T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article							TCR GENE-TRANSFER; GAMMA-DELTA; ADOPTIVE IMMUNOTHERAPY; DENDRITIC CELLS; VIRAL-INFECTIONS; IFN-GAMMA; LYMPHOCYTES; ANTIGEN; RNA; CANCER	Human adenovirus infection is life threatening after allogeneic haematopoietic stem cell transplantation (HSCT). Immunotherapy with donor-derived adenovirus-specific T cells is promising; however, 20% of all donors lack adenovirus-specific T cells. To overcome this, we transfected alpha/beta T cells with mRNA encoding a T-cell receptor (TCR) specific for the HLA-A*0101-restricted peptide LTDLGQNLLY from the adenovirus hexon protein. Furthermore, since allo-reactive endogenous TCR of donor T lymphocytes would induce graft-versus-host disease (GvHD) in a mismatched patient, we transferred the TCR into gamma/delta T cells, which are not allo-reactive. TCR-transfected gamma/delta T cells secreted low quantities of cytokines after antigen-specific stimulation, which were increased dramatically after co-transfection of CD8 alpha-encoding mRNA. In direct comparison with TCR-transfected alpha/beta T cells, TCR-CD8 alpha-co-transfected gamma/delta T cells produced more tumor necrosis factor (TNF), and lysed peptide-loaded target cells as efficiently. Most importantly, TCR-transfected alpha/beta T cells and TCR-CD8 alpha-co-transfected gamma/delta T cells efficiently lysed adenovirus-infected target cells. We show here, for the first time, that not only alpha/beta T cells but also gamma/delta T cells can be equipped with an adenovirus specificity by TCR-RNA electroporation. Thus, our strategy offers a new means for the immunotherapy of adenovirus infection after allogeneic HSCT.	[Doerrie, Jan; Krug, Christian; Hofmann, Christian; Mueller, Ina; Wellner, Verena; Schierer, Stephan; Schuler, Gerold; Schaft, Niels] Univ Klinikum Erlangen, Dept Dermatol, Erlangen, Germany; [Knippertz, Ilka] Univ Klinikum Erlangen, Dept Dermatol, Dept Immune Modulat, Erlangen, Germany; [Zipperer, Elke; Printz, Dieter; Fritsch, Gerhard; Geyeregger, Rene] St Anna Kinderkrebsforsch eV, Childrens Canc Res Inst, Vienna, Austria; [Fritsch, Gerhard] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Thomas, Simone] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany; [Krug, Christian; Schuler, Gerold; Schaft, Niels] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Saint Anna Children's Hospital; Medical University of Vienna; University of Regensburg; University of Erlangen Nuremberg	Schaft, N (corresponding author), Univ Klinikum Erlangen, Dept Dermatol, Erlangen, Germany.	niels.schaft@uk-erlangen.de	Schaft, Niels/H-3713-2011; Dörrie, Jan/H-3678-2011; Thomas, Simone/G-7445-2019	Schaft, Niels/0000-0001-8236-9298; Dörrie, Jan/0000-0002-3478-0741; Thomas, Simone/0000-0001-6308-3649	German Research Foundation [DFG] [SCHA-1247/1-1]; Bayerisches Immuntherapie-Netzwerk [D2-F5121.7.1.1/10/12]; Children's Cancer Research Institute in Vienna, Austria	German Research Foundation [DFG](German Research Foundation (DFG)); Bayerisches Immuntherapie-Netzwerk; Children's Cancer Research Institute in Vienna, Austria	This work was supported by the German Research Foundation [DFG SCHA-1247/1-1] to NS, www.dfg.de; Bayerisches Immuntherapie-Netzwerk [D2-F5121.7.1.1/10/12] to NS and JD, www.bayimmunet.de; and the Children's Cancer Research Institute in Vienna, Austria to RG, www.science.ccri.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden Bernhard, 1995, Immunogenetics, V42, P455; Birkholz K, 2009, GENE THER, V16, P596, DOI 10.1038/gt.2008.189; Birkholz K, 2009, J IMMUNOL METHODS, V346, P45, DOI 10.1016/j.jim.2009.05.001; Breuer S, 2012, MOL DIAGN THER, V16, P63, DOI 10.2165/11631490-000000000-00000; Dorrie J, 2008, CANCER IMMUNOL IMMUN, V57, P467, DOI 10.1007/s00262-007-0385-1; Dokouhaki P, 2010, CANCER LETT, V297, P126, DOI 10.1016/j.canlet.2010.05.005; Eiz-Vesper B, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00410; Felzmann T, 2000, CANCER LETT, V161, P241, DOI 10.1016/S0304-3835(00)00618-2; Feuchtinger T, 2006, BRIT J HAEMATOL, V134, P64, DOI 10.1111/j.1365-2141.2006.06108.x; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Geyeregger R, 2014, J IMMUNOTHER, V37, P245, DOI 10.1097/CJI.0000000000000034; Geyeregger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059592; Hanagiri T, 2012, CANCER SCI, V103, P1414, DOI 10.1111/j.1349-7006.2012.02337.x; Hanley PJ, 2009, BLOOD, V114, P1958, DOI 10.1182/blood-2009-03-213256; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Hofmann C, 2008, AIDS, V22, P1577, DOI 10.1097/QAD.0b013e3283063a17; Hoyer S, 2014, EUR J IMMUNOL, V44, P3543, DOI 10.1002/eji.201444477; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Knippertz I, 2009, J IMMUNOTHER, V32, P524, DOI 10.1097/CJI.0b013e3181a28422; Kobayashi H, 2010, ANTICANCER RES, V30, P575; Koh S, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.43; KONING F, 1987, J EXP MED, V166, P595, DOI 10.1084/jem.166.2.595; Krug C, 2014, CANCER IMMUNOL IMMUN, V63, P999, DOI 10.1007/s00262-014-1572-5; Leen AM, 2004, BLOOD, V104, P2432, DOI 10.1182/blood-2004-02-0646; Leen AM, 2013, BLOOD, V121, P5113, DOI 10.1182/blood-2013-02-486324; Leen AM, 2009, BLOOD, V114, P4283, DOI 10.1182/blood-2009-07-232454; Lehner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031210; Matthes-Martin S, 2012, TRANSPL INFECT DIS, V14, P555, DOI 10.1111/tid.12022; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morris EC, 2005, P NATL ACAD SCI USA, V102, P7934, DOI 10.1073/pnas.0500357102; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Oevermann L, 2012, ANN NY ACAD SCI, V1266, P161, DOI 10.1111/j.1749-6632.2012.06606.x; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Qasim W, 2011, BRIT J HAEMATOL, V154, P150, DOI 10.1111/j.1365-2141.2011.08579.x; SAITO T, 1988, J EXP MED, V168, P1003, DOI 10.1084/jem.168.3.1003; Salot S, 2009, J IMMUNOL METHODS, V347, P12, DOI 10.1016/j.jim.2009.05.006; Schaft N, 2006, INT IMMUNOL, V18, P591, DOI 10.1093/intimm/dxh401; Schaft N, 2006, CANCER IMMUNOL IMMUN, V55, P1132, DOI 10.1007/s00262-005-0098-2; Schierer S, 2008, INT J CANCER, V122, P219, DOI 10.1002/ijc.23074; Schub A, 2009, J IMMUNOL, V183, P6819, DOI 10.4049/jimmunol.0902233; Siegers GM, 2013, CANCER IMMUNOL IMMUN, V62, P571, DOI 10.1007/s00262-012-1353-y; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Sun CJ, 2011, VACCINE, V29, P3837, DOI 10.1016/j.vaccine.2011.03.042; Symeonidis N, 2007, TRANSPL INFECT DIS, V9, P108, DOI 10.1111/j.1399-3062.2006.00184.x; Thomas S, 2012, EUR J IMMUNOL, V42, P3442, DOI 10.1002/eji.201242666; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Tsuda J, 2011, J IMMUNOL, V186, P2003, DOI 10.4049/jimmunol.1001919; Uhlin M, 2012, CLIN INFECT DIS, V55, P1064, DOI 10.1093/cid/cis625; van der Veken LT, 2009, J IMMUNOL, V182, P164, DOI 10.4049/jimmunol.182.1.164; van der Veken LT, 2006, CANCER RES, V66, P3331, DOI 10.1158/0008-5472.CAN-05-4190; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109944	10.1371/journal.pone.0109944	http://dx.doi.org/10.1371/journal.pone.0109944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289687	Green Published, gold			2022-12-25	WOS:000342798000100
J	Sookias, RB; Bohmer, C; Clack, JA				Sookias, Roland B.; Boehmer, Christine; Clack, Jennifer A.			Redescription and Phylogenetic Analysis of the Mandible of an Enigmatic Pennsylvanian (Late Carboniferous) Tetrapod from Nova Scotia, and the Lability of Meckelian Jaw Ossification	PLOS ONE			English	Article							STEM TETRAPOD; CRANIAL MORPHOLOGY; TEMNOSPONDYLI; GREERERPETON; EVOLUTION; ANATOMY; GENUS; SKULL	The lower jaw of an unidentified Pennsylvanian (Late Carboniferous) tetrapod from Nova Scotia - the "Parrsboro jaw" - is redescribed in the light of recent tetrapod discoveries and work on evolution of tetrapod mandibular morphology and placed for the first time in a numerical cladistics analysis. All phylogenetic analyses place the jaw in a crownward polytomy of baphetids, temnospondyls, and embolomeres. Several features resemble baphetids and temnospondyls including dermal ornamentation, absence of coronoid teeth, and presence of coronoid shagreen. Dentary dentition is most similar to Baphetes. An adsymphysial toothplate may not preclude temnospondyl affinity. An apparent large exomeckelian fenestra, with the dorsal foraminal margins formed by an unossified element, echoes the morphology of the stem tetrapod Sigournea and is unusually primitive given the other features of the jaw. The jaw may thus provide an example of an intermediate stage in Meckelian element evolution.	[Sookias, Roland B.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Sookias, Roland B.; Boehmer, Christine] Univ Munich, GeoBioctr, Munich, Germany; [Boehmer, Christine] Univ Munich, Dept Geo & Umweltwissensch, Munich, Germany; [Boehmer, Christine] Bayer Staatssammlung Palaontol & Geol Munchen, Munich, Germany; [Clack, Jennifer A.] Univ Museum Zool Cambridge, Cambridge, England	University of Birmingham; University of Munich; University of Munich; University of Cambridge	Sookias, RB (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	sookias.r.b@gmail.com	Böhmer, Christine/G-2357-2011; Sookias, Roland B./ABC-7840-2021	Böhmer, Christine/0000-0003-1931-0888; Sookias, Roland B./0000-0002-5189-4011	Emmy Noether Programme Award from the Deutschen Forschungsgemeinschaft [BU 2587/3-1]; Studienstiftung des Deutschen Volkes; RIKEN institute; Natural Environment Research Council [NE/J022713/1]; NERC [NE/J022713/1] Funding Source: UKRI	Emmy Noether Programme Award from the Deutschen Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; RIKEN institute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RBS is supported by an Emmy Noether Programme Award from the Deutschen Forschungsgemeinschaft (BU 2587/3-1) to Dr. Richard J. Butler. CB was supported during completion of this work by a doctoral fellowship of the Studienstiftung des Deutschen Volkes (http://www.studienstiftung.de) as well as a collaborative postdoctoral fellowship of the RIKEN institute (http://www.riken.jp) and the Studienstiftung des Deutschen Volkes. JAC is partially supported by Natural Environment Research Council grant NE/J022713/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Anderson J, 2006, J VERTEBR PALEONTOL, V26, p36A; BAIRD D, 1955, SCIENCE, V122, P202, DOI 10.1126/science.122.3161.202; Beaumont EH, 1998, ZOOL J LINN SOC-LOND, V122, P187, DOI 10.1006/zjls.1997.0118; BEAUMONT EH, 1977, PHILOS T ROY SOC B, V280, P29, DOI 10.1098/rstb.1977.0099; Bolt JR, 2006, J PALEONTOL, V80, P717, DOI 10.1666/0022-3360(2006)80[717:SMANST]2.0.CO;2; Bolt JR, 2001, J PALEONTOL, V75, P1016, DOI 10.1666/0022-3360(2001)075<1016:TMOTPT>2.0.CO;2; Carroll RL, 1972, 24 INT GEOL C; CLACK JA, 1987, PHILOS T ROY SOC B, V318, P1, DOI 10.1098/rstb.1987.0082; Clack JA, 2003, CAN J EARTH SCI, V40, P483, DOI 10.1139/E02-065; Clack JA, 2001, T ROY SOC EDIN-EARTH, V92, P75, DOI 10.1017/S0263593300000055; Clack JA, 2004, RECENT ADV ORIGIN EA, P309; Clack JA, 2012, PALAEONTOLOGY, V55, P73, DOI 10.1111/j.1475-4983.2011.01117.x; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; Damiani R, 2009, ZOOL J LINN SOC-LOND, V155, P348, DOI 10.1111/j.1096-3642.2008.00444.x; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; GODFREY SJ, 1989, CAN J EARTH SCI, V26, P1036, DOI 10.1139/e89-084; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff P, 2008, CLADISTICS, V24, P91; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; GROSS W, 1941, ABHANDLUNGEN PREUSSI, V7, P1; HAWORTH A. H, 1825, PHILOS MAGAZINE J, V65, P372; Heaton M, 1980, CURATOR, V23, P95; Holmes RB, 1998, J VERTEBR PALEONTOL, V18, P64, DOI 10.1080/02724634.1998.10011034; Huxley TH., 1880, P R SOC LOND, V43, P649, DOI DOI 10.1111/J.1469-7998.1869.TB07343.X; Lombard R. Eric, 2006, P21; Milner AC, 1998, ZOOL J LINN SOC-LOND, V122, P211, DOI 10.1111/j.1096-3642.1998.tb02530.x; MILNER AR, 1982, J PALEONTOL, V56, P1302; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruta M, 2002, T ROY SOC EDIN-EARTH, V92, P229, DOI 10.1017/S0263593300000249; Sequeira SEK, 2004, T ROY SOC EDIN-EARTH, V94, P21, DOI 10.1017/S0263593300000511; Watson DMS, 1926, PHILOS T R SOC LON B, V214, P189, DOI 10.1098/rstb.1926.0006	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109717	10.1371/journal.pone.0109717	http://dx.doi.org/10.1371/journal.pone.0109717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290449	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000082
J	Li, L; Yao, YC; Gu, XQ; Che, D; Ma, CQ; Dai, ZY; Li, C; Zhou, T; Cai, WB; Yang, ZH; Yang, X; Gao, GQ				Li, Lei; Yao, Ya-Chao; Gu, Xiao-Qiong; Che, Di; Ma, Cai-Qi; Dai, Zhi-Yu; Li, Cen; Zhou, Ti; Cai, Wei-Bin; Yang, Zhong-Han; Yang, Xia; Gao, Guo-Quan			Plasminogen Kringle 5 Induces Endothelial Cell Apoptosis by Triggering a Voltage-dependent Anion Channel 1 (VDAC1) Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; PROTEIN; GROWTH; NEOVASCULARIZATION; RECEPTOR; PATHWAY; ANGIOGENESIS; PERMEABILITY; PLASMALEMMA; EXPRESSION	Human plasminogen kringle 5 (K5) is known to display its potent anti-angiogenesis effect through inducing endothelial cell (EC) apoptosis, and the voltage-dependent anion channel 1 (VDAC1) has been identified as a receptor of K5. However, the exact role and underlying mechanisms of VDAC1 in K5-induced EC apoptosis remain elusive. In the current study, we showed that K5 increased the protein level of VDAC1, which initiated the mitochondrial apoptosis pathway of ECs. Our findings also showed that K5 inhibited the ubiquitin-dependent degradation of VDAC1 by promoting the phosphorylation of VDAC1, possibly at Ser-12 and Thr-107. The phosphorylated VDAC1 was attenuated by the AKT agonist, glycogen synthase kinase (GSK) 3 beta inhibitor, and siRNA, suggesting that K5 increased VDAC1 phosphorylation via the AKT-GSK3 beta pathway. Furthermore, K5 promoted cell surface translocation of VDAC1, and binding between K5 and VDAC1 was observed on the plasma membrane. HKI protein blocked the impact of K5 on the AKT-GSK3 beta pathway by competitively inhibiting the interaction of K5 and cell surface VDAC1. Moreover, K5-induced EC apoptosis was suppressed by VDAC1 antibody. These data show for the first time that K5-induced EC apoptosis is mediated by the positive feedback loop of "VDAC1-AKT-GSK3 beta-VDAC1," which may provide new perspectives on the mechanisms of K5-induced apoptosis.	[Li, Lei; Che, Di; Ma, Cai-Qi; Dai, Zhi-Yu; Li, Cen; Zhou, Ti; Cai, Wei-Bin; Yang, Zhong-Han; Yang, Xia; Gao, Guo-Quan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Li, Lei] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod Med Guangdong Prov, Dept Reprod Med Ctr, Guangzhou 510150, Guangdong, Peoples R China; [Yao, Ya-Chao] Guangdong 2 Prov Peoples Hosp, Lab Ctr, Guangzhou 510317, Guangdong, Peoples R China; [Gu, Xiao-Qiong] Guangzhou Women & Childrens Med Ctr, Dept Lab, Guangzhou 510623, Guangdong, Peoples R China; [Yang, Xia] Sun Yat Sen Univ, Minist Educ, China Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Gao, Guo-Quan] Sun Yat Sen Univ, Dept Educ Guangdong Prov, Key Lab Funct Mol Marine Microorganisms, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Yang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China.	yangxia@mail.sysu.edu.cn; gaogq@mail.sysu.edu.cn	Dai, Zhiyu/H-3453-2019	Dai, Zhiyu/0000-0002-2945-7923	National Nature Science Foundation of China [30973449, 81172163, 81272515, 81272338, 81200706, 81471033, 81400639]; National Key Sci-Tech Special Project of China [2009ZX09103-642, 2013ZX09102053]; Program for Doctoral Station in University [20120171110053, 20130171110053]; Key Project of Nature Science Foundation of Guangdong Province [10251008901000009]; Key Sci-tech Research Project of Guangdong Province [2011B031200006]; Guandong Natural Science Fund [S2012010009250, S2012040006986]; Key Sci-tech Research Project of Guangzhou Municipality [2011Y1-00017-8, 12A52061519]; Innovative talents project of doctoral candidates of Sun Yat-sen University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program for Doctoral Station in University; Key Project of Nature Science Foundation of Guangdong Province; Key Sci-tech Research Project of Guangdong Province; Guandong Natural Science Fund; Key Sci-tech Research Project of Guangzhou Municipality; Innovative talents project of doctoral candidates of Sun Yat-sen University	This work was supported by National Nature Science Foundation of China Grants 30973449, 81172163, 81272515, 81272338, 81200706, 81471033, and 81400639, National Key Sci-Tech Special Project of China Grant 2009ZX09103-642, 2013ZX09102053, Program for Doctoral Station in University Grants 20120171110053 and 20130171110053, Key Project of Nature Science Foundation of Guangdong Province, Grant 10251008901000009, Key Sci-tech Research Project of Guangdong Province, Grant 2011B031200006, Guandong Natural Science Fund Grants S2012010009250 and S2012040006986, Key Sci-tech Research Project of Guangzhou Municipality Grants 2011Y1-00017-8 and 12A52061519, and the Innovative talents project of doctoral candidates of Sun Yat-sen University.	Adachi M, 2004, AM J PHYSIOL-GASTR L, V287, pG695, DOI 10.1152/ajpgi.00415.2003; Adham SAI, 2009, BIOCHEM BIOPH RES CO, V390, P130, DOI 10.1016/j.bbrc.2009.09.081; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Bathori G, 1999, J BIOL CHEM, V274, P29607, DOI 10.1074/jbc.274.42.29607; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297; Cai WB, 2005, J CELL BIOCHEM, V96, P1254, DOI 10.1002/jcb.20601; Cai WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053152; Campochiaro PA, 2004, EXPERT OPIN BIOL TH, V4, P1395, DOI 10.1517/14712598.4.9.1395; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; De Pinto Vito, 2003, Ital J Biochem, V52, P17; EARP HS, 1986, J BIOL CHEM, V261, P4777; ERIKSSON A, 1991, J BIOL CHEM, V266, P21138; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gao LJ, 2011, INT J ONCOL, V39, P1265, DOI 10.3892/ijo.2011.1108; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Gu XQ, 2011, APOPTOSIS, V16, P846, DOI 10.1007/s10495-011-0618-9; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kerner J, 2012, BBA-BIOMEMBRANES, V1818, P1520, DOI 10.1016/j.bbamem.2011.11.013; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lin CS, 2010, CLIN VACCINE IMMUNOL, V17, P1548, DOI 10.1128/CVI.00064-10; Liu XY, 2005, MOL THER, V11, P531, DOI 10.1016/j.ymthe.2004.12.003; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Schwarzer C, 2000, INT J BIOCHEM CELL B, V32, P1075, DOI 10.1016/S1357-2725(00)00047-9; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; THINNES FP, 1989, BIOL CHEM H-S, V370, P1253; Wang RQ, 2011, J IMMUNOL, V187, P5964, DOI 10.4049/jimmunol.1101205; Xu G, 2010, ALLERGY, V65, P581, DOI 10.1111/j.1398-9995.2009.02252.x; Xu G, 2007, LARYNGOSCOPE, V117, P960, DOI 10.1097/mlg.0b013e318041549c; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Yanamandra N, 2011, J PHARMACOL EXP THER, V337, P636, DOI 10.1124/jpet.110.172809; Yang Y, 2006, CANCER BIOL THER, V5, P399; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	45	30	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.567792	http://dx.doi.org/10.1074/jbc.M114.567792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296756	Green Published, hybrid			2022-12-25	WOS:000345335000021
J	Kamei, Y; Tamada, Y; Nakayama, Y; Fukusaki, E; Mukai, Y				Kamei, Yuka; Tamada, Yoshihiro; Nakayama, Yasumune; Fukusaki, Eiichiro; Mukai, Yukio			Changes in Transcription and Metabolism During the Early Stage of Replicative Cellular Senescence in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Senescence; Metabolomics; Saccharomyces cerevisiae; Transcriptomics; Tricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle); Branched-chain Amino Acids; Replicative Lifespan	GENE-EXPRESSION PROFILES; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; STATIONARY-PHASE; CITRATE SYNTHASE; CELLS; STRAINS; IDENTIFICATION; PATHWAYS; SEQUENCE	Background: Senescence is the biological process of age-related cellular and organismal deterioration in function. Results: The transcriptome and metabolome at early stages of replicative senescence of yeast cells were measured. Conclusion: The transcriptomic and metabolomic profiles drastically changed at about half of the average replicative lifespan. Significance: This is the first integrated information on transcriptome and metabolome of aging yeast cells. Age-related damage accumulates and a variety of biological activities and functions deteriorate in senescent cells. However, little is known about when cellular aging behaviors begin and what cellular aging processes change. Previous research demonstrated age-related mRNA changes in budding yeast by the 18th to 20th generation, which is the average replicative lifespan of yeast (i.e. about half of the population is dead by this time point). Here, we performed transcriptional and metabolic profiling for yeast at early stages of senescence (4th, 7th, and 11th generation), that is, for populations in which most cells are still alive. Transcriptional profiles showed up- and down-regulation for approximate to 20% of the genes profiled after the first four generations, few further changes by the 7th generation, and an additional 12% of the genes were up- and down-regulated after 11 generations. Pathway analysis revealed that these 11th generation cells had accumulated transcripts coding for enzymes involved in sugar metabolism, the TCA cycle, and amino acid degradation and showed decreased levels of mRNAs coding for enzymes involved in amino acid biosynthetic pathways. These observations were consistent with the metabolomic profiles of aging cells: an accumulation of pyruvic acid and TCA cycle intermediates and depletion of most amino acids, especially branched-chain amino acids. Stationary phase-induced genes were highly expressed after 11 generations even though the growth medium contained adequate levels of nutrients, indicating deterioration of the nutrient sensing and/or signaling pathways by the 11th generation. These changes are presumably early indications of replicative senescence.	[Kamei, Yuka; Mukai, Yukio] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, Nagahama, Shiga 5260829, Japan; [Tamada, Yoshihiro; Nakayama, Yasumune; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Osaka University	Mukai, Y (corresponding author), Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, 1266 Tamura Cho, Nagahama, Shiga 5260829, Japan.	y_mukai@nagahama-i-bio.ac.jp	Nakayama, Yasumune/H-2982-2019	Nakayama, Yasumune/0000-0002-6810-4354; Mukai, Yukio/0000-0003-1265-0839	 [24510279];  [2410171]; Grants-in-Aid for Scientific Research [24510279] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Scientific Research (C) 24510279 (to Y. M.) and a Grant-in-aid for Japan Society for the Promotion of Science Fellows 2410171 (to Y. K.).	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Brachmann CB, 1998, YEAST, V14, P115; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Filetici P, 1996, YEAST, V12, P1359, DOI 10.1002/(SICI)1097-0061(199610)12:13<1359::AID-YEA3>3.0.CO;2-5; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Jazwinski SM, 2004, FEMS YEAST RES, V5, P119, DOI 10.1016/j.femsyr.2004.04.005; Jazwinski SM, 2001, MECH AGEING DEV, V122, P865, DOI 10.1016/S0047-6374(01)00244-5; Jia YK, 1997, MOL MICROBIOL, V24, P53, DOI 10.1046/j.1365-2958.1997.3011669.x; Kamei Y, 2011, BIOCHEM BIOPH RES CO, V407, P185, DOI 10.1016/j.bbrc.2011.02.136; KIM KS, 1986, MOL CELL BIOL, V6, P1936, DOI 10.1128/MCB.6.6.1936; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Klinkenberg LG, 2005, EUKARYOT CELL, V4, P649, DOI 10.1128/EC.4.4.649-660.2005; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Lam YT, 2011, FREE RADICAL BIO MED, V50, P963, DOI 10.1016/j.freeradbiomed.2011.01.013; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MORTIMER RK, 1986, GENETICS, V113, P35; MOTIZUKI M, 1992, MECH AGEING DEV, V64, P235, DOI 10.1016/0047-6374(92)90081-N; NIU XD, 1988, P NATL ACAD SCI USA, V85, P7546, DOI 10.1073/pnas.85.20.7546; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Padilla PA, 1998, J BACTERIOL, V180, P5718, DOI 10.1128/JB.180.21.5718-5726.1998; Park PU, 2002, METHOD ENZYMOL, V351, P468; Rachidi N, 2000, MOL MICROBIOL, V35, P1421, DOI 10.1046/j.1365-2958.2000.01807.x; RAMOS F, 1985, EUR J BIOCHEM, V149, P401, DOI 10.1111/j.1432-1033.1985.tb08939.x; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; WALKER ME, 1991, BIOCHEM BIOPH RES CO, V176, P1210, DOI 10.1016/0006-291X(91)90414-3; Yiu G, 2008, J GERONTOL A-BIOL, V63, P21, DOI 10.1093/gerona/63.1.21; Yoshida R, 2010, AGING CELL, V9, P616, DOI 10.1111/j.1474-9726.2010.00590.x; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	39	27	27	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32081	32093		10.1074/jbc.M114.600528	http://dx.doi.org/10.1074/jbc.M114.600528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25294875	Green Published, hybrid			2022-12-25	WOS:000345314700037
J	McCasker, N; Humphries, P; Meredith, S; Klomp, N				McCasker, Nicole; Humphries, Paul; Meredith, Shaun; Klomp, Nicholas			Contrasting Patterns of Larval Mortality in Two Sympatric Riverine Fish Species: A Test of the Critical Period Hypothesis	PLOS ONE			English	Article							EARLY-LIFE; SURVIVAL; SIZE; RECRUITMENT; RATES; ONTOGENY; BEHAVIOR; GROWTH; HYPSELEOTRIS; TEMPERATURE	Understanding the causal mechanisms that determine recruitment success is critical to the effective conservation of wild fish populations. Although recruitment strength is likely determined during early life when mortality is greatest, few studies have documented age-specific mortality rates for fish during this period. We investigated age-specific mortality of individual cohorts of two species of riverine fish from yolksac larvae to juveniles, assaying for the presence of a "critical period": A time when mortality is unusually high. Early life stages of carp gudgeons (Hypseleotris spp.) and unspecked hardyhead (Craterocephalus stercusmuscarum fulvus)-two fishes that differ in fecundity, egg size and overlap between endogenous and exogenous feeding-were collected every second day for four months. We fitted survivorship curves to 22 carp gudgeon and 15 unspecked hardyhead four-day cohorts and tested several mortality functions. Mortality rates declined with age for carp gudgeon, with mean instantaneous mortality rates (-Z) ranging from 1.40-0.03. In contrast, mortality rates for unspecked hardyhead were constant across the larval period, with a mean -Z of 0.15. There was strong evidence of a critical period for carp gudgeon larvae from hatch until 6 days old, and no evidence of a critical period for unspecked hardyhead. Total larval mortality for carp gudgeon and unspecked hardyhead up to 24 days of age was estimated to be 97.8 and 94.3%, respectively. We hypothesise that life history strategy may play an important role in shaping overall mortality and the pattern of mortality during early life in these two fishes.	[McCasker, Nicole; Humphries, Paul] Charles Sturt Univ, Sch Environm Sci, Albury, NSW, Australia; [McCasker, Nicole; Humphries, Paul] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia; [Klomp, Nicholas] Univ Canberra, Bruce, ACT, Australia	Charles Sturt University; Charles Sturt University; University of Canberra	McCasker, N (corresponding author), Charles Sturt Univ, Sch Environm Sci, Albury, NSW, Australia.	nmccasker@csu.edu.au		Humphries, Paul/0000-0003-1850-6707; Klomp, Nicholas/0000-0002-2367-0125; McCasker, Nicole/0000-0002-5175-7615	Murray Darling Freshwater Research Centre, Lower Basin Laboratory, Mildura, Australia	Murray Darling Freshwater Research Centre, Lower Basin Laboratory, Mildura, Australia	A PhD scholarship for Nicole McCasker was funded by the Murray Darling Freshwater Research Centre, Lower Basin Laboratory, Mildura, Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1971, AUST J MAR FRESH RES, V22, P139; Bertozzi T, 2000, MAR FRESHWATER RES, V51, P805, DOI 10.1071/MF00039; BRY C, 1995, J FISH BIOL, V46, P99, DOI 10.1111/j.1095-8649.1995.tb05949.x; Bunnell DB, 2003, CAN J FISH AQUAT SCI, V60, P1314, DOI [10.1139/f03-112, 10.1139/F03-112]; BUTLER JL, 1991, CAN J FISH AQUAT SCI, V48, P1713, DOI 10.1139/f91-203; CADA GF, 1980, T AM FISH SOC, V109, P479, DOI 10.1577/1548-8659(1980)109<479:NMROFD>2.0.CO;2; Castro LR, 2000, T AM FISH SOC, V129, P1107, DOI 10.1577/1548-8659(2000)129<1107:ELSOTA>2.0.CO;2; Chambers RC, 2001, J SEA RES, V45, P231, DOI 10.1016/S1385-1101(01)00058-2; CHAMBERS RC, 1989, CAN J FISH AQUAT SCI, V46, P1633, DOI 10.1139/f89-208; Chesney EJ, 2008, J EXP MAR BIOL ECOL, V362, P117, DOI 10.1016/j.jembe.2008.06.011; CRECCO V, 1983, CAN J FISH AQUAT SCI, V40, P1719, DOI 10.1139/f83-199; DAHLBERG MD, 1979, MAR FISH REV, V41, P1; FORTIER L, 1985, MAR ECOL PROG SER, V25, P245, DOI 10.3354/meps025245; FRANK KT, 1994, ANNU REV ECOL SYST, V25, P401, DOI 10.1146/annurev.es.25.110194.002153; Fuiman L.A., 2002, FISHERY SCI UNIQUE C; Fuiman LA, 2003, ECOLOGY, V84, P53, DOI 10.1890/0012-9658(2003)084[0053:BARSIF]2.0.CO;2; GULLAND JA, 1965, SPEC PUBL INT COMM N, V6, P365; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; JOHNSTON TA, 1994, ENVIRON BIOL FISH, V40, P189, DOI 10.1007/BF00002545; Jordaan A, 2003, CAN J FISH AQUAT SCI, V60, P1289, DOI [10.1139/f03-108, 10.1139/F03-108]; Kelso William E., 1996, P255; King AJ, 2005, MAR FRESHWATER RES, V56, P215, DOI 10.1071/MF04117; King AJ, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P159; Lake J. S., 1967, MARINE FRESHWATER RE, V18, P155, DOI [10.1071/MF9670155, DOI 10.1071/MF9670155]; Laurel BJ, 2001, J FISH BIOL, V59, P884, DOI 10.1006/jfbi.2001.1704; Letcher BH, 1997, CAN J FISH AQUAT SCI, V54, P405, DOI 10.1139/cjfas-54-2-405; Lintermans M., 2007, FISHES MURRAY DARLIN; LLEWELLYN L C, 1979, Australian Zoologist, V20, P269; LO NCH, 1986, FISH B-NOAA, V84, P395; Low M, 2009, J ANIM ECOL, V78, P761, DOI 10.1111/j.1365-2656.2009.01543.x; MARR JOHN C., 1956, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V21, P160; May R.C., 1974, EARLY LIFE HIST FISH, P3, DOI [10.1007/978-3-642-65852-5_1, DOI 10.1007/978-3-642-65852-5_1]; May R.C., 1974, EARLY LIFE HIST FISH; Mccallum Hamish, 2008, POPULATION PARAMETER, DOI 10.1002/9780470757468; McCasker NG, 2009, THESIS C STURT U ALB; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; MILLER TJ, 1992, CAN J FISH AQUAT SCI, V49, P805, DOI 10.1139/f92-091; MILLS CA, 1982, J FISH BIOL, V20, P645, DOI 10.1111/j.1095-8649.1982.tb03974.x; PEPIN P, 1993, CAN J FISH AQUAT SCI, V50, P2166, DOI 10.1139/f93-242; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; Power M, 1996, FISH RES, V25, P77, DOI 10.1016/0165-7836(95)00395-9; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; PURCELL JE, 1987, MAR BIOL, V94, P157, DOI 10.1007/BF00392927; Quinlan John A., 1999, Fisheries Oceanography, V8, P124; R Core Team, 2022, R LANG ENV STAT COMP; Remmel T, 2009, J ANIM ECOL, V78, P973, DOI 10.1111/j.1365-2656.2009.01566.x; SECOR DH, 1995, ESTUARIES, V18, P527, DOI 10.2307/1352370; Semple GP, 1985, FISH SAHUL, V3, P97; Sibly RM, 2009, AM NAT, V173, pE185, DOI 10.1086/598680; TAGGART CT, 1987, MAR ECOL PROG SER, V41, P205, DOI 10.3354/meps041205; THORISSON K, 1994, ENVIRON BIOL FISH, V40, P23, DOI 10.1007/BF00002180; Tonkin Z, 2008, ECOL FRESHW FISH, V17, P312, DOI 10.1111/j.1600-0633.2007.00283.x; TREASURER JW, 1989, J FISH BIOL, V34, P913, DOI 10.1111/j.1095-8649.1989.tb03374.x; Unmack PJ, 2000, FISH SAHUL, V14, P645; VLADIMIROV V I, 1975, Journal of Ichthyology, V15, P851; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; WINEMILLER KO, 1993, AM NAT, V142, P585, DOI 10.1086/285559	59	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109317	10.1371/journal.pone.0109317	http://dx.doi.org/10.1371/journal.pone.0109317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299441	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200046
J	Wei, ZQ; Wu, SH; Yan, X; Zhou, SL				Wei, Zongqiang; Wu, Shaohua; Yan, Xiao; Zhou, Shenglu			Density and Stability of Soil Organic Carbon beneath Impervious Surfaces in Urban Areas	PLOS ONE			English	Article							UNITED-STATES; NITROGEN; STORAGE; MINERALIZATION; ECOSYSTEMS; MATTER; FLUXES; STOCKS; POOLS; CHINA	Installation of impervious surfaces in urban areas has attracted increasing attention due to its potential hazard to urban ecosystems. Urban soils are suggested to have robust carbon (C) sequestration capacity; however, the C stocks and dynamics in the soils covered by impervious surfaces that dominate urban areas are still not well characterized. We compared soil organic C (SOC) densities and their stabilities under impervious surface, determined by a 28-d incubation experiment, with those in open areas in Yixing City, China. The SOC density (0-20 cm) under impervious surfaces was, on average, 68% lower than that in open areas. Furthermore, there was a significantly (P<0.05) positive correlation between the densities of SOC and total nitrogen (N) in the open soils, whereas the correlation was not apparent for the impervious-covered soils, suggesting that the artificial soil sealing in urban areas decoupled the cycle of C and N. Cumulative CO2-C evolved during the 28-d incubation was lower from the impervious-covered soils than from the open soils, and agreed well with a first-order decay model (C-t = C-1+C-0(1-e(-kt))). The model results indicated that the SOC underlying capped surfaces had weaker decomposability and lower turnover rate. Our results confirm the unique character of urban SOC, especially that beneath impervious surface, and suggest that scientific and management views on regional SOC assessment may need to consider the role of urban carbon stocks.	[Wei, Zongqiang; Wu, Shaohua; Zhou, Shenglu] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Wei, Zongqiang; Yan, Xiao] Jiangxi Agr Univ, Sch Environm & Land Resource Management, Nanchang, Peoples R China	Nanjing University; Jiangxi Agricultural University	Wu, SH (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.	shaohuawu@126.com	zhou, sheng/GYJ-6012-2022	Wei, Zongqiang/0000-0002-7680-4617; Wu, shaohua/0000-0002-8202-836X	National Natural Science Foundation of China [41001047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (41001047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, SOILS YIX COUNT; Beesley L, 2012, J ENVIRON MANAGE, V104, P158, DOI 10.1016/j.jenvman.2012.03.024; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Churkina G, 2010, GLOBAL CHANGE BIOL, V16, P135, DOI 10.1111/j.1365-2486.2009.02002.x; Edmondson JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00963; Elvidge CD, 2007, SENSORS-BASEL, V7, P1962, DOI 10.3390/s7091962; Gee G.W., 2002, METHODS SOIL ANAL 4, P255, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Goyal S, 1999, BIOL FERT SOILS, V29, P196, DOI 10.1007/s003740050544; Haile-Mariam S, 2008, SOIL SCI SOC AM J, V72, P370, DOI 10.2136/sssaj2007.0126; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; IUSS Working Group WRB, 2007, WORLD SOIL RES REP; Jo HK, 2002, J ENVIRON MANAGE, V64, P115, DOI 10.1006/jema.2001.0491; JONES CA, 1984, COMMUN SOIL SCI PLAN, V15, P23, DOI 10.1080/00103628409367451; Kaye JP, 2008, ECOL APPL, V18, P132, DOI 10.1890/06-1952.1; Liu Y, 2013, CHINESE GEOGR SCI, V23, P26, DOI 10.1007/s11769-013-0585-x; Lorenz K, 2005, SOIL BIOL BIOCHEM, V37, P1373, DOI 10.1016/j.soilbio.2004.12.009; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Pan XZ, 2007, CATENA, V69, P65, DOI 10.1016/j.catena.2006.04.016; Pouyat R, 2002, ENVIRON POLLUT, V116, pS107, DOI 10.1016/S0269-7491(01)00263-9; Pouyat RV, 2006, J ENVIRON QUAL, V35, P1566, DOI 10.2134/jeq2005.0215; Raciti SM, 2012, ECOL APPL, V22, P1015, DOI 10.1890/11-1250.1; Raciti SM, 2012, ENVIRON POLLUT, V164, P248, DOI 10.1016/j.envpol.2012.01.046; Raciti SM, 2011, ECOSYSTEMS, V14, P287, DOI 10.1007/s10021-010-9409-3; Rao P, 2013, URBAN ECOSYST, V16, P593, DOI 10.1007/s11252-013-0291-6; Rossi AM, 2008, SOIL SCI SOC AM J, V72, P1591, DOI 10.2136/sssaj2008.0072N; Scalenghe R, 2009, LANDSCAPE URBAN PLAN, V90, P1, DOI 10.1016/j.landurbplan.2008.10.011; Scalenghe R, 2011, ENVIRON SCI TECHNOL, V45, P5112, DOI 10.1021/es1039437; Su SL, 2011, REG ENVIRON CHANGE, V11, P651, DOI 10.1007/s10113-010-0197-2; Townsend-Small A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041675; UN, 2008, WORLD URB PROSP 2007; Wei ZQ, 2014, PEDOSPHERE, V24, P56, DOI 10.1016/S1002-0160(13)60080-6; Wei ZQ, 2013, SOIL RES, V51, P59, DOI 10.1071/SR12089; Zhang ZD, 2010, CAN J SOIL SCI, V90, P551, DOI 10.4141/CJSS09081	34	23	24	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109380	10.1371/journal.pone.0109380	http://dx.doi.org/10.1371/journal.pone.0109380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299685	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200049
J	McCluney, KE; Sabo, JL				McCluney, Kevin E.; Sabo, John L.			Sensitivity and Tolerance of Riparian Arthropod Communities to Altered Water Resources along a Drying River	PLOS ONE			English	Article							SAN-PEDRO RIVER; MIDDLE RIO-GRANDE; DESERT STREAM; SOUTHEASTERN ARIZONA; BRACHINUS COLEOPTERA; FLOW INTERMITTENCY; SPECIES-DIVERSITY; TERRESTRIAL PREY; AQUATIC INSECTS; NEW-MEXICO	Background: Rivers around the world are drying with increasing frequency, but little is known about effects on terrestrial animal communities. Previous research along the San Pedro River in southeastern AZ, USA, suggests that changes in the availability of water resources associated with river drying lead to changes in predator abundance, community composition, diversity, and abundance of particular taxa of arthropods, but these observations have not yet been tested manipulatively. Methods and Results:In this study, we constructed artificial pools in the stream bed adjacent to a drying section of the San Pedro River and maintained them as the river dried. We compared pitfall trapped arthropods near artificial pools to adjacent control sites where surface waters temporarily dried. Assemblage composition changed differentially at multiple taxonomic levels, resulting in different assemblages at pools than at control sites, with multiple taxa and richness of carabid beetle genera increasing at pools but not at controls that dried. On the other hand, predator biomass, particularly wolf spiders, and diversity of orders and families were consistently higher at control sites that dried. These results suggest an important role for colonization dynamics of pools, as well as the ability of certain taxa, particularly burrowing wolf spiders, to withstand periods of temporary drying. Conclusions: Overall, we found some agreement between this manipulative study of water resources and a previous analysis of river drying that showed shifts in composition, changes in diversity, and declines in abundance of certain taxa (e.g. carabid beetles). However, colonization dynamics of pools, as well as compensatory strategies of predatory wolf spiders seem to have led to patterns that do not match previous research, with control sites maintaining high diversity, despite drying. Tolerance of river drying by some species may allow persistence of substantial diversity in the face of short-term drying. The long-term effects of drying remain to be investigated.	[McCluney, Kevin E.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	McCluney, KE (corresponding author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	kmcclun@bgsu.edu		McCluney, Kevin/0000-0002-3574-0354	EPA STAR [FP-91649201]; Brian Daniel Corrigan Foundation	EPA STAR(United States Environmental Protection Agency); Brian Daniel Corrigan Foundation	This study was funded by EPA STAR grant FP-91649201 to K. McCluney and the Brian Daniel Corrigan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2006, J ARID ENVIRON, V64, P626, DOI 10.1016/j.jaridenv.2005.06.022; ARMS K, 1974, SCIENCE, V185, P372, DOI 10.1126/science.185.4148.372; Arnett RH, 2000, AM BEETLES; Arscott DB, 2010, J N AM BENTHOL SOC, V29, P530, DOI 10.1899/08-124.1; Bastow JL, 2002, OECOLOGIA, V131, P261, DOI 10.1007/s00442-002-0879-7; Boersma KS, 2014, FRESHWATER BIOL, V59, P491, DOI 10.1111/fwb.12280; Bogan MT, 2013, FRESHWATER BIOL, V58, P1016, DOI 10.1111/fwb.12105; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonn A, 2002, RIVER RES APPL, V18, P43, DOI 10.1002/rra.632; Borror D.J., 1992, INTRO STUDY INSECTS; Cartron JLE, 2003, ENVIRON ENTOMOL, V32, P1075, DOI 10.1603/0046-225X-32.5.1075; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clarke A, 2010, CAN J FISH AQUAT SCI, V67, P1649, DOI 10.1139/F10-087; Colby B, 2005, NAT RESOUR J, V45, P15; Corti R, 2014, FRESHWATER BIOL, V59, P666, DOI 10.1111/fwb.12294; DeVito J, 2004, CAN J ZOOL, V82, P1119, DOI 10.1139/Z04-090; Ellis LM, 2001, REGUL RIVER, V17, P1, DOI 10.1002/1099-1646(200101/02)17:1&lt;1::AID-RRR603&gt;3.0.CO;2-L; Ellis LM, 2000, SOUTHWEST NAT, V45, P456, DOI 10.2307/3672594; Gleick PH, 2002, WORLDS WATER 2002 20; Glennon Robert Jerome, 2002, WATER FOLLIES GROUND; Graham AK, 2003, J ARACHNOL, V31, P78, DOI 10.1636/0161-8202(2003)031[0078:HAOSLN]2.0.CO;2; Greenwood MJ, 2010, FRESHWATER BIOL, V55, P2062, DOI 10.1111/j.1365-2427.2010.02462.x; Hadley N. F, 1994, WATER RELATIONS TERR; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HUMPHREYS WF, 1975, OECOLOGIA, V21, P291, DOI 10.1007/BF00345823; IPCC, 2007, AR4 SYNTH REP; JULIANO S A, 1984, Coleopterists Bulletin, V38, P358; JULIANO SA, 1985, CAN J ZOOL, V63, P1683, DOI 10.1139/z85-250; JULIANO SA, 1986, CAN J ZOOL, V64, P73, DOI 10.1139/z86-011; Kearsley M.J., 2003, INVENTORY MONITORING; Lambeets K, 2008, BIODIVERS CONSERV, V17, P3133, DOI 10.1007/s10531-007-9313-0; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Lite SJ, 2005, BIOL CONSERV, V125, P153, DOI 10.1016/j.biocon.2005.01.020; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; McCluney KE, 2010, IMPACTS ALTERED WATE; McCluney KE, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3201; McCluney KE, 2012, BIOL REV, V87, P563, DOI 10.1111/j.1469-185X.2011.00209.x; Mccluney KE, 2012, FRESHWATER BIOL, V57, P91, DOI 10.1111/j.1365-2427.2011.02698.x; McCluney KE, 2009, ECOLOGY, V90, P1463, DOI 10.1890/08-1626.1; McKinnon S, 2007, WORRIES INCREASE SAN; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; Paetzold A, 2005, J N AM BENTHOL SOC, V24, P395, DOI 10.1899/04-049.1; Paetzold A, 2008, J APPL ECOL, V45, P894, DOI 10.1111/j.1365-2664.2008.01463.x; Paetzold A, 2006, FRESHWATER BIOL, V51, P1103, DOI 10.1111/j.1365-2427.2006.01559.x; Pearce F, 2006, RIVERS RUN DRY WATER; Pool D, 1999, HYDROGEOLOGIC INVEST; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Reznikova Z, 2004, PEDOBIOLOGIA, V48, P15, DOI 10.1016/j.pedobi.2003.06.002; Rothenbucher J, 2006, BASIC APPL ECOL, V7, P398, DOI 10.1016/j.baae.2006.05.005; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Sabo JL, 2002, J N AM BENTHOL SOC, V21, P336, DOI 10.2307/1468420; Sabo JL, 2002, ECOLOGY, V83, P3023, DOI 10.1890/0012-9658(2002)083[3023:NROLTA]2.0.CO;2; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Sabo JL, 2008, ECOL MONOGR, V78, P615, DOI 10.1890/07-1382.1; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; Sponseller RA, 2010, GLOBAL CHANGE BIOL, V16, P2891, DOI 10.1111/j.1365-2486.2010.02200.x; STANLEY EH, 1994, AM MIDL NAT, V131, P288, DOI 10.2307/2426255; Stromberg J, 1998, J ARID ENVIRON, V40, P133, DOI 10.1006/jare.1998.0438; Stromberg J, 2013, ECOSYSTEMS, P1; Stromberg J. C, 2009, ECOLOGY CONSERVATION; Stromberg JC, 2005, RIVER RES APPL, V21, P925, DOI 10.1002/rra.858; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Ubick D, 2005, SPIDERS N AM IDENTIF; Valeix M, 2008, AFR J ECOL, V46, P402, DOI 10.1111/j.1365-2028.2007.00874.x	69	6	6	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109276	10.1371/journal.pone.0109276	http://dx.doi.org/10.1371/journal.pone.0109276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295874	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000057
J	Valentini, S; Castagnetti, C; Musella, V; Spinella, G				Valentini, Simona; Castagnetti, Carolina; Musella, Vincenzo; Spinella, Giuseppe			Assessment of Intraocular Measurements in Neonatal Foals and Association with Gender, Laterality, and Body Weight: A Clinical Study	PLOS ONE			English	Article							CORNEAL DIAMETER; KERATOMETRY; PREDICTION	Objective of this study was to describe intraocular measurements in newly born foals (17 days of age) and assess the association between globe measurements and gender, laterality, and body weight. B-scan ultrasonographic biometry was performed on both eyes of 22 healthy foals (44 eyes) ages 17 days using a 10-MHz transducer. Intraocular measurements (anterior chamber depth, central lens thickness, vitreous chamber depth, axial globe length, longitudinal globe length, lens poles distance) were carried out using the ultrasound internal calipers. The influence of gender (male or female), laterality (right or left eye), and body weight (light <48 kg; heavy >= 48 kg) on ocular measurements was analysed by the Student t test. Values of P<0.05 were accepted as significant for all analyses. Mean anterior chamber depth was 2.2 +/- 0.5 mm (Standard Deviation); central lens thickness was 9.9 +/- 0.8 mm; vitreous chamber depth was 15.5 +/- 1.1 mm; axial globe length was 27.6 +/- 1.6 mm; longitudinal globe length was 35.8 +/- 1.2 mm, and lens poles distance was 16.4 +/- 1.0 mm. Intraocular measurements were not influenced by gender, laterality nor body weight. This study provides reference values for intraocular measurements in neonatal foals and may be useful in the diagnosis and treatment of congenital and acquired pathologies involving the globe.	[Valentini, Simona; Castagnetti, Carolina; Spinella, Giuseppe] Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, BO, Italy; [Musella, Vincenzo] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Germaneto, CZ, Italy	University of Bologna; Magna Graecia University of Catanzaro	Valentini, S (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, BO, Italy.	simona.valentini@unibo.it		CASTAGNETTI, CAROLINA/0000-0001-5533-7637; Musella, Vincenzo/0000-0002-4448-8832				Barsotti G, 2013, VET OPHTHALMOL, V16, P245, DOI 10.1111/j.1463-5224.2012.01063.x; Grinninger P, 2010, AM J VET RES, V71, P677, DOI 10.2460/ajvr.71.6.677; Labelle AL, 2011, JAVMA-J AM VET MED A, V239, P486, DOI 10.2460/javma.239.4.486; McMullen RJ, 2006, VET OPHTHALMOL, V9, P357, DOI 10.1111/j.1463-5224.2006.00493.x; Mouney MC, 2012, AM J VET RES, V73, P1977, DOI 10.2460/ajvr.73.12.1977; Plummer CE, 2003, AM J VET RES, V64, P661, DOI 10.2460/ajvr.2003.64.661; Renaudin C D, 2000, J Reprod Fertil Suppl, P651; Scotty N. C., 2005, Clinical Techniques in Equine Practice, V4, P106, DOI 10.1053/j.ctep.2005.03.007; Townsend WM, 2012, EQUINE VET J, V44, P238, DOI 10.1111/j.2042-3306.2011.00392.x; Turner RM, 2006, THERIOGENOLOGY, V66, P331, DOI 10.1016/j.theriogenology.2005.11.019; Valentini S, 2010, J EQUINE VET SCI, V30, P150, DOI 10.1016/j.jevs.2010.01.058	11	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109491	10.1371/journal.pone.0109491	http://dx.doi.org/10.1371/journal.pone.0109491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296286	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000074
J	Liao, CL; Zhang, WC; Yang, M; Ma, QF; Li, GW; Zhong, WX				Liao, Chenlong; Zhang, Wenchuan; Yang, Min; Ma, Qiufeng; Li, Guowei; Zhong, Wenxiang			Surgical Decompression of Painful Diabetic Peripheral Neuropathy: The Role of Pain Distribution	PLOS ONE			English	Article							NERVE DECOMPRESSION; AXONAL-TRANSPORT; LOWER-EXTREMITY; TINEL SIGN; MECHANISMS; MANAGEMENT; COMPRESSION; VALIDATION; SURGERY; UTILITY	Objective: To investigate the effect of surgical decompression on painful diabetic peripheral neuropathy (DPN) patients and discuss the role which pain distribution and characterization play in the management of painful DPN as well as the underlying mechanism involved. Methods: A total of 306 patients with painful diabetic lower-extremity neuropathy were treated with Dellon surgical nerve decompression in our department. Clinical evaluation including Visual analogue scale (VAS), Brief Pain Inventory Short Form for diabetic peripheral neuropathy (BPI-DPN) questionnaire, two-point discrimination (2-PD), nerve conduction velocity (NCV) and high-resolution ultrasonography (cross-sectional area, CSA) were performed in all cases preoperatively, and at 6 month intervals for 2 years post-decompression. The patients who underwent surgery were retrospectively assigned into two subgroups (focal and diffuse pain) according to the distribution of the diabetic neuropathic pain. The control group included 92 painful DPN patients without surgery. Results: The levels of VAS, scores in BPI-DPN, 2-PD, NCV results and CSA were all improved in surgical group when compared to the control group (P < 0.05). More improvement of VAS, scores in BPI-DPN and CSA was observed in focal pain group than that in diffuse group (P < 0.05). Conclusions: Efficacy of decompression of multiple lower-extremity peripheral nerves in patients with painful diabetic neuropathy was confirmed in this study. While both focal and diffuse group could benefit from surgical decompression, pain relief and morphological restoration could be better achieved in focal group.	[Liao, Chenlong; Zhang, Wenchuan; Yang, Min; Ma, Qiufeng; Li, Guowei; Zhong, Wenxiang] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, WC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China.	zhangwench88@hotmail.com			National Science Foundation of China;  [81371373]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This study was supported by the grant from the National Science Foundation of China. The grant number: 81371373. The URL of the funder's website: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Aszmann O, 2004, ANN PLAS SURG, V53, P517, DOI 10.1097/01.sap.0000143605.60384.4e; Aszmann OC, 2000, PLAST RECONSTR SURG, V106, P816, DOI 10.1097/00006534-200009040-00010; Barrett Stephen L, 2010, Foot Ankle Spec, V3, P132, DOI 10.1177/1938640010368028; Biddinger Kent R, 2004, Foot Ankle Clin, V9, P239, DOI 10.1016/j.fcl.2003.12.001; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Caffee HH, 2000, PLAST RECONSTR SURG, V106, P813, DOI 10.1097/00006534-200009040-00009; Chaudhry V, 2006, NEUROLOGY, V66, P1805, DOI 10.1212/01.wnl.0000219631.89207.a9; Chaudhry V, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006152.pub2; Cornblath DR, 2007, DIABETES CARE, V30, P421, DOI 10.2337/dc06-2324; DAHLIN LB, 1986, DIABETOLOGIA, V29, P181, DOI 10.1007/BF02427090; DEJONG RN, 1977, POSTGRAD MED, V61, P101, DOI 10.1080/00325481.1977.11714510; Dellon AL, 2012, J RECONSTR MICROSURG, V28, P235, DOI 10.1055/s-0032-1306371; DELLON AL, 1992, PLAST RECONSTR SURG, V89, P689, DOI 10.1097/00006534-199204000-00018; Eaton SEM, 2001, LANCET, V358, P35, DOI 10.1016/S0140-6736(00)05268-5; FINK DJ, 1987, DIABETES, V36, P996, DOI 10.2337/diabetes.36.9.996; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; JAKOBSEN J, 1978, DIABETOLOGIA, V14, P113, DOI 10.1007/BF01263449; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Kapur D, 2003, DIABETES-METAB RES, V19, pS9, DOI 10.1002/dmrr.359; Karagoz H, 2008, J RECONSTR MICROSURG, V24, P95, DOI 10.1055/s-2008-1064923; Lee CH, 2004, ANN PLAS SURG, V53, P523, DOI 10.1097/01.sap.0000141379.55618.87; MEDORI R, 1985, P NATL ACAD SCI USA, V82, P7716, DOI 10.1073/pnas.82.22.7716; Melenhorst WB, 2009, ANN PLAS SURG, V63, P217, DOI 10.1097/SAP.0b013e31818ba768; Quattrini C, 2003, DIABETES-METAB RES, V19, pS2, DOI 10.1002/dmrr.360; Rader AJ, 2005, J AM PODIAT MED ASSN, V95, P446, DOI 10.7547/0950446; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Siemionow M, 2006, ANN PLAS SURG, V57, P385, DOI 10.1097/01.sap.0000221979.13847.30; Suzuki C, 2000, NEUROLOGY, V54, P1932, DOI 10.1212/WNL.54.10.1932; Tesfaye S, 2005, DIABETOLOGIA, V48, P805, DOI 10.1007/s00125-005-1721-7; Tesfaye S, 1996, DIABETOLOGIA, V39, P329; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; THOMAS P K, 1973, Journal of the Royal College of Physicians of London, V7, P154; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; UPTON ARM, 1973, LANCET, V2, P359, DOI 10.1016/S0140-6736(73)93196-6; Valdivia JMV, 2013, ANN PLAS SURG, V70, P675, DOI 10.1097/SAP.0b013e3182764fb0; Vinik A, 2010, J CLIN ENDOCR METAB, V95, P4802, DOI 10.1210/jc.2010-0892; Vinik AI, 2013, DIABETES METAB SYNDR, V6, P57, DOI 10.2147/DMSO.S24825; Vinik AI, 2000, DIABETOLOGIA, V43, P957, DOI 10.1007/s001250051477; WIEMAN TJ, 1995, ANN SURG, V221, P660, DOI 10.1097/00000658-199506000-00005; Wood William A, 2003, J Foot Ankle Surg, V42, P268, DOI 10.1016/S1067-2516(03)00313-2; Zelman DC, 2005, J VASC NURS, V23, P97, DOI 10.1016/j.jvn.2005.06.004; Zhang W, 2013, BR J NEUROSURG	46	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109827	10.1371/journal.pone.0109827	http://dx.doi.org/10.1371/journal.pone.0109827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290338	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000092
J	MacNeil, LG; Glover, E; Bergstra, TG; Safdar, A; Tarnopolsky, MA				MacNeil, Lauren G.; Glover, Elisa; Bergstra, T. Graham; Safdar, Adeel; Tarnopolsky, Mark A.			The Order of Exercise during Concurrent Training for Rehabilitation Does Not Alter Acute Genetic Expression, Mitochondrial Enzyme Activity or Improvements in Muscle Function	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; RESISTANCE EXERCISE; AEROBIC EXERCISE; ADAPTIVE RESPONSES; PROTEIN-SYNTHESIS; NEUROMUSCULAR ADAPTATIONS; LIMB IMMOBILIZATION; MOLECULAR RESPONSES; ENDURANCE EXERCISE; YOUNG MEN	Concurrent exercise combines different modes of exercise (e.g., aerobic and resistance) into one training protocol, providing stimuli meant to increase muscle strength, aerobic capacity and mass. As disuse is associated with decrements in strength, aerobic capacity and muscle size concurrent training is an attractive modality for rehabilitation. However, interference between the signaling pathways may result in preferential improvements for one of the exercise modes. We recruited 18 young adults (10 O*, 8 female) to determine if order of exercise mode during concurrent training would differentially affect gene expression, protein content and measures of strength and aerobic capacity after 2 weeks of knee-brace induced disuse. Concurrent exercise sessions were performed 3x/week for 6 weeks at gradually increasing intensities either with endurance exercise preceding (END>RES) or following (RES>END) resistance exercise. Biopsies were collected from the vastus lateralis before, 3 h after the first exercise bout and 48 h after the end of training. Concurrent exercise altered the expression of genes involved in mitochondrial biogenesis (PGC-1 alpha, PRC, PPAR gamma), hypertrophy (PGC-1 alpha 4, REDD2, Rheb) and atrophy (MuRF-1, Runx1), increased electron transport chain complex protein content, citrate synthase and mitochondrial cytochrome c oxidase enzyme activity, muscle mass, maximum isometric strength and VO2peak. However, the order in which exercise was completed (END>RES or RES>END) only affected the protein content of mitochondrial complex II subunit. In conclusion, concurrent exercise training is an effective modality for the rehabilitation of the loss of skeletal muscle mass, maximum strength, and peak aerobic capacity resulting from disuse, regardless of the order in which the modes of exercise are performed.	[MacNeil, Lauren G.; Glover, Elisa; Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Bergstra, T. Graham] McMaster Univ, Dept Hlth Sci, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	tarnopol@mcmaster.ca		Safdar, Adeel/0000-0003-2469-0467	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada [CHRP 365655-2009]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Financial support for this study was awarded to MT as a Collaborative Health Research Project from Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada (CHRP 365655-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P39, DOI 10.1111/j.1600-0838.2010.01197.x; Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Alkner BA, 2004, EUR J APPL PHYSIOL, V93, P294, DOI 10.1007/s00421-004-1172-8; Allen J, 2011, CLIN GERIATR MED, V27, P661, DOI 10.1016/j.cger.2011.07.010; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Balabinis CP, 2003, J STRENGTH COND RES, V17, P393, DOI 10.1519/00124278-200305000-00030; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Berg HE, 1996, ACTA PHYSIOL SCAND, V157, P63, DOI 10.1046/j.1365-201X.1996.476217000.x; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Campbell EL, 2013, BIOGERONTOLOGY, V14, P247, DOI 10.1007/s10522-013-9427-6; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Coffey VG, 2009, AM J PHYSIOL-REG I, V297, pR1441, DOI 10.1152/ajpregu.00351.2009; Coffey VG, 2009, J APPL PHYSIOL, V106, P1187, DOI 10.1152/japplphysiol.91221.2008; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Creer A, 2005, J APPL PHYSIOL, V99, P950, DOI 10.1152/japplphysiol.00110.2005; Cunha TF, 2012, J APPL PHYSIOL, V112, P1839, DOI 10.1152/japplphysiol.00346.2011; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Di Donato DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1025, DOI 10.1152/ajpendo.00487.2013; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Glover EI, 2010, APPL PHYSIOL NUTR ME, V35, P125, DOI 10.1139/H09-137; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hakkinen K, 2003, EUR J APPL PHYSIOL, V89, P42, DOI 10.1007/s00421-002-0751-9; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Hawley JA, 2009, APPL PHYSIOL NUTR ME, V34, P355, DOI 10.1139/H09-023; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; Hu SM, 2012, MOL ENDOCRINOL, V26, P977, DOI 10.1210/me.2011-1253; Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Loviscach M, 2000, DIABETOLOGIA, V43, P304, DOI 10.1007/s001250050048; Lundberg TR, 2012, MED SCI SPORT EXER, V44, P1680, DOI 10.1249/MSS.0b013e318256fbe8; Lundberg TR, 2014, ACTA PHYSL OXF; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; McCarthy JP, 2002, MED SCI SPORT EXER, V34, P511, DOI 10.1097/00005768-200203000-00019; MCCARTHY JP, 1995, MED SCI SPORT EXER, V27, P429; Mortensen OH, 2007, J APPL PHYSIOL, V103, P1536, DOI 10.1152/japplphysiol.00575.2007; Murakami T, 2011, BIOCHEM BIOPH RES CO, V405, P615, DOI 10.1016/j.bbrc.2011.01.078; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Oates BR, 2010, MUSCLE NERVE, V42, P539, DOI 10.1002/mus.21721; Park KS, 1997, DIABETES, V46, P1230, DOI 10.2337/diabetes.46.7.1230; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stefanetti RJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00030; Stefanetti RJ, 2014, J APPL PHYSL; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; Ydfors M, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.140	66	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109189	10.1371/journal.pone.0109189	http://dx.doi.org/10.1371/journal.pone.0109189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289940	gold, Green Submitted, Green Published			2022-12-25	WOS:000342798000047
J	Matsuda, T; Morishita, M; Hinomoto, N; Gotoh, T				Matsuda, Tomoko; Morishita, Maiko; Hinomoto, Norihide; Gotoh, Tetsuo			Phylogenetic Analysis of the Spider Mite Sub-Family Tetranychinae (Acari: Tetranychidae) Based on the Mitochondrial COI Gene and the 18S and the 5 ' End of the 28S rRNA Genes Indicates That Several Genera Are Polyphyletic	PLOS ONE			English	Article							SPECIES ACARI; LIFE-HISTORY; SEQUENCES; DIVERSITY; INFERENCE; DNA; IDENTIFICATION; PROSTIGMATA; ARTHROPODS; EVOLUTION	The spider mite sub-family Tetranychinae includes many agricultural pests. The internal transcribed spacer (ITS) region of nuclear ribosomal RNA genes and the cytochrome c oxidase subunit I (COI) gene of mitochondrial DNA have been used for species identification and phylogenetic reconstruction within the sub-family Tetranychinae, although they have not always been successful. The 18S and 28S rRNA genes should be more suitable for resolving higher levels of phylogeny, such as tribes or genera of Tetranychinae because these genes evolve more slowly and are made up of conserved regions and divergent domains. Therefore, we used both the 18S (1,825-1,901 bp) and 28S (the 5' end of 646-743 bp) rRNA genes to infer phylogenetic relationships within the sub-family Tetranychinae with a focus on the tribe Tetranychini. Then, we compared the phylogenetic tree of the 18S and 28S genes with that of the mitochondrial COI gene (618 bp). As observed in previous studies, our phylogeny based on the COI gene was not resolved because of the low bootstrap values for most nodes of the tree. On the other hand, our phylogenetic tree of the 18S and 28S genes revealed several well-supported clades within the sub-family Tetranychinae. The 18S and 28S phylogenetic trees suggest that the tribes Bryobiini, Petrobiini and Eurytetranychini are monophyletic and that the tribe Tetranychini is polyphyletic. At the genus level, six genera for which more than two species were sampled appear to be monophyletic, while four genera (Oligonychus, Tetranychus, Schizotetranychus and Eotetranychus) appear to be polyphyletic. The topology presented here does not fully agree with the current morphology-based taxonomy, so that the diagnostic morphological characters of Tetranychinae need to be reconsidered.	[Matsuda, Tomoko; Morishita, Maiko; Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ibaraki, Japan; [Hinomoto, Norihide] Natl Agr & Food Res Org, NARO Agr Res Ctr, Ibaraki, Japan	Ibaraki University; National Agriculture & Food Research Organization - Japan	Gotoh, T (corresponding author), Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ibaraki, Japan.	gotoh@mx.ibaraki.ac.jp	HINOMOTO, Norihide/K-8828-2012; Hinomoto, Norihide/T-9465-2019	HINOMOTO, Norihide/0000-0001-9767-3225; Matsuda, Tomoko/0000-0002-4709-4302	Japan Society for the Promotion of Science [25292033]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding provided by Grant number 25292033, Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David T, 2007, EXP APPL ACAROL, V41, P169, DOI 10.1007/s10493-007-9058-1; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; Bolland H.R., 1998, WORLD CATALOGUE SPID; Burger TD, 2013, TICKS TICK-BORNE DIS, V4, P265, DOI 10.1016/j.ttbdis.2013.02.002; Burger TD, 2012, MOL PHYLOGENET EVOL, V64, P45, DOI 10.1016/j.ympev.2012.03.004; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ehara Shozo, 1996, Journal of the Acarological Society of Japan, V5, P17; Ehara Shozo, 1999, Species Diversity, V4, P63; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; HELLE W, 1985, SPIDER MITES THEIR B, V1; Helle W., 1985, SPIDER MITES THEIR A, V1; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Klicka J, 2005, MOL PHYLOGENET EVOL, V34, P486, DOI 10.1016/j.ympev.2004.10.001; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Matsuda T, 2013, J ECON ENTOMOL, V106, P463, DOI 10.1603/EC12328; Matsuda T, 2012, J ECON ENTOMOL, V105, P1043, DOI 10.1603/EC11404; Migeon A., 2006, SPIDER MITES WEB COM; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; Navajas M, 2003, P ROY SOC B-BIOL SCI, V270, pS124, DOI 10.1098/rsbl.2003.0034; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Palumbi Stephen R., 1996, P205; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Rambaut A, 2013, TRACER V1 6; Ros VID, 2007, EXP APPL ACAROL, V42, P239, DOI 10.1007/s10493-007-9092-z; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Tanabe AS, 2008, MRBAYES5D; Toda S, 2000, EXP APPL ACAROL, V24, P821, DOI 10.1023/A:1006484018547; Wauthy G, 1998, ACAROLOGIA, V39, P233; Zhang Zhi-Qiang, 2000, Systematic and Applied Acarology, V5, P69; Zhang ZhiQiang, 2003, Mites of greenhouses: identification, biology and control, DOI 10.1079/9780851995908.0000; Zhao YE, 2012, PARASITOL RES, V111, P2109, DOI 10.1007/s00436-012-3058-8	39	49	51	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108672	10.1371/journal.pone.0108672	http://dx.doi.org/10.1371/journal.pone.0108672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289639	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000021
J	Stothart, CR; Simons, DJ; Boot, WR; Kramer, AF				Stothart, Cary R.; Simons, Daniel J.; Boot, Walter R.; Kramer, Arthur F.			Is the Effect of Aerobic Exercise on Cognition a Placebo Effect?	PLOS ONE			English	Article							OLDER-ADULTS; FITNESS	A number of studies and meta-analyses conclude that aerobic fitness (walking) interventions improve cognition. Such interventions typically compare improvements from these interventions to an active control group in which participants engage in non-aerobic activities (typically stretching and toning) for an equivalent amount of time. However, in the absence of a double-blind design, the presence of an active control group does not necessarily control for placebo effects; participants might expect different amounts of improvement for the treatment and control interventions [1]. We conducted a large survey to explore whether people expect greater cognitive benefits from an aerobic exercise intervention compared to a control intervention. If participants expect greater improvement following aerobic exercise, then the benefits of such interventions might be due in part to a placebo effect. In general, expectations did not differ between aerobic and non-aerobic interventions. If anything, some of the results suggest the opposite (e.g., respondents expected the control, non-aerobic intervention to yield bigger memory gains). These results provide the first evidence that cognitive improvements following aerobic fitness training are not due to differential expectations.	[Stothart, Cary R.; Boot, Walter R.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Simons, Daniel J.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Champaign, IL USA	State University System of Florida; Florida State University; University of Illinois System; University of Illinois Urbana-Champaign	Stothart, CR (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	stothart@psy.fsu.edu	Simons, Daniel J./P-3625-2019; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724; Stothart, Cary/0000-0001-6620-3298	NIA, Project CREATE III - Center for Research and Education on Aging and Technology Enhancement [3 PO1 AG017211]; NATIONAL INSTITUTE ON AGING [P01AG017211] Funding Source: NIH RePORTER	NIA, Project CREATE III - Center for Research and Education on Aging and Technology Enhancement; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA 3 PO1 AG017211, Project CREATE III - Center for Research and Education on Aging and Technology Enhancement (www.create-center.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baniqued PL, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01010; Baym CL, 2014, J COGNITIVE NEUROSCI; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Boot Walter R., 2013, FRONTIERS PSYCHOL, V4; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Hindin SB, 2012, J AM GERIATR SOC, V60, P136, DOI 10.1111/j.1532-5415.2011.03761.x; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001	10	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109557	10.1371/journal.pone.0109557	http://dx.doi.org/10.1371/journal.pone.0109557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25289674	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000067
J	Garcia-Pardo, J; Grana-Montes, R; Fernandez-Mendez, M; Ruyra, A; Roher, N; Aviles, FX; Lorenzo, J; Ventura, S				Garcia-Pardo, Javier; Grana-Montes, Ricardo; Fernandez-Mendez, Marc; Ruyra, Angels; Roher, Nerea; Aviles, Francesc X.; Lorenzo, Julia; Ventura, Salvador			Amyloid Formation by Human Carboxypeptidase D Transthyretin-like Domain under Physiological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Carboxypeptidase; Protein Aggregation; Protein Misfolding; Protein Stability; Transthyretin	SENILE SYSTEMIC AMYLOIDOSIS; B-VIRUS-PARTICLES; CRYSTAL-STRUCTURE; FIBRIL FORMATION; GLOBULAR-PROTEINS; AGGREGATION; METALLOCARBOXYPEPTIDASES; INTERMEDIATE; ASSOCIATION; PROPENSITY	Background: Proteins can form amyloid aggregates from initially folded states. Results: The transthyretin-like domain of human carboxypeptidase D forms amyloid aggregates without extensive unfolding. Conclusion: The monomeric transthyretin fold has an inherent propensity to aggregate due to the presence of preformed amyloidogenic structural elements. Significance: Generic aggregation from initially folded states would have a huge impact on cell proteostasis. Protein aggregation is linked to a growing list of diseases, but it is also an intrinsic property of polypeptides, because the formation of functional globular proteins comes at the expense of an inherent aggregation propensity. Certain proteins can access aggregation-prone states from native-like conformations without the need to cross the energy barrier for unfolding. This is the case of transthyretin (TTR), a homotetrameric protein whose dissociation into its monomers initiates the aggregation cascade. Domains with structural homology to TTR exist in a number of proteins, including the M14B subfamily carboxypeptidases. We show here that the monomeric transthyretin-like domain of human carboxypeptidase D aggregates under close to physiological conditions into amyloid structures, with the population of folded but aggregation-prone states being controlled by the conformational stability of the domain. We thus confirm that the TTR fold keeps a generic residual aggregation propensity upon folding, resulting from the presence of preformed amyloidogenic -strands in the native state. These structural elements should serve for functional/structural purposes, because they have not been purged out by evolution, but at the same time they put proteins like carboxypeptidase D at risk of aggregation in biological environments and thus can potentially lead to deposition diseases.	[Garcia-Pardo, Javier; Grana-Montes, Ricardo; Fernandez-Mendez, Marc; Ruyra, Angels; Roher, Nerea; Aviles, Francesc X.; Lorenzo, Julia; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Garcia-Pardo, Javier; Grana-Montes, Ricardo; Fernandez-Mendez, Marc; Aviles, Francesc X.; Lorenzo, Julia; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Roher, Nerea] Univ Autonoma Barcelona, Dept Biol Cellular Immunol & Fisiol Anim, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Lorenzo, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	julia.lorenzo@uab.es	Garcia-Pardo, Javier/D-8911-2018; Ventura, Salvador/AAY-3170-2021; Lorenzo, Julia/E-9015-2011; Aviles, Francesc Xavier/F-3482-2019; Avilés, Francesc Xavier/A-2664-2015; Garcia-Pardo, Javier/U-3311-2019; Roher, Nerea/F-3216-2016; Garcia-Pardo, Javier/ABB-7574-2021; Ventura, Salvador/C-7021-2008	Garcia-Pardo, Javier/0000-0001-9179-6371; Ventura, Salvador/0000-0002-9652-6351; Lorenzo, Julia/0000-0001-5659-6008; Aviles, Francesc Xavier/0000-0002-1399-6789; Avilés, Francesc Xavier/0000-0002-1399-6789; Roher, Nerea/0000-0002-6659-4038; Garcia-Pardo, Javier/0000-0001-9179-6371; Ventura, Salvador/0000-0002-9652-6351; Grana-Montes, Ricardo/0000-0003-1932-1077	Spanish Ministry of Science and Innovation [BFU2010-14901, BIO2010-22321, AGL2012-33877]; Network of Excellence of the Generalitat de Catalunya; MINECO [FPI BES-2011-044872, FPU AP2009-0948]; Fundacion Ramon Areces; MINECO; ICREA	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Network of Excellence of the Generalitat de Catalunya; MINECO(Spanish Government); Fundacion Ramon Areces; MINECO(Spanish Government); ICREA(ICREA)	This work was supported in part by Spanish Ministry of Science and Innovation Grants BFU2010-14901, BIO2010-22321, and AGL2012-33877 and by the Network of Excellence of the Generalitat de Catalunya.; Recipient of Ph.D. fellowship FPI BES-2011-044872 from MINECO.; Recipient of Fellowship FPU AP2009-0948 from MINECO.; Recipient of a Ph.D. fellowship from Fundacion Ramon Areces.; Recipient of a Ramon y Cajal grant from MINECO.; Recipient of an ICREA academia award.	Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Beerten J, 2012, CURR TOP MED CHEM, V12, P2470; Bemporad F, 2008, BBA-PROTEINS PROTEOM, V1784, P1986, DOI 10.1016/j.bbapap.2008.08.021; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Castillo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058297; Castillo V, 2011, BIOTECHNOL J, V6, P674, DOI 10.1002/biot.201000331; Castillo V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000476; Chatani E, 2012, J BIOL CHEM, V287, P22827, DOI 10.1074/jbc.M111.333310; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CORNWELL GG, 1988, BIOCHEM BIOPH RES CO, V154, P648, DOI 10.1016/0006-291X(88)90188-X; De Baets G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002090; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez D, 2010, BIOCHIMIE, V92, P1484, DOI 10.1016/j.biochi.2010.05.002; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Ferreira P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082484; Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Harata K, 1996, ACTA CRYSTALLOGR D, V52, P1136, DOI 10.1107/S0907444996008438; Hornberg A, 2004, BBA-PROTEINS PROTEOM, V1700, P93, DOI 10.1016/j.bbapap.2004.04.004; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Invernizzi G, 2012, INT J BIOCHEM CELL B, V44, P1541, DOI 10.1016/j.biocel.2012.05.023; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kang YY, 2012, GENE DEV, V26, P1339, DOI 10.1101/gad.187815.112; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; KUROKI K, 1995, J BIOL CHEM, V270, P15022, DOI 10.1074/jbc.270.25.15022; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10039, DOI 10.1021/bi970468n; Pallares I, 2004, J MOL BIOL, V342, P321, DOI 10.1016/j.jmb.2004.06.089; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Ramirez-Alvarado M, 2003, PROTEIN SCI, V12, P567, DOI 10.1110/ps.0227403; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Sabate R, 2012, BIOCHIMIE, V94, P1730, DOI 10.1016/j.biochi.2012.03.027; Sabate R, 2012, BIOMACROMOLECULES, V13, P1916, DOI 10.1021/bm3004385; Sabate R, 2012, BIOMACROMOLECULES, V13, P474, DOI 10.1021/bm201527m; SARAIVA MJM, 1983, T ASSOC AM PHYSICIAN, V96, P261; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sidyelyeva G, 2006, J BIOL CHEM, V281, P13844, DOI 10.1074/jbc.M513499200; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Tanco S, 2010, J MOL BIOL, V401, P465, DOI 10.1016/j.jmb.2010.06.035; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhuravlev PI, 2014, J MOL BIOL, V426, P2653, DOI 10.1016/j.jmb.2014.05.007	67	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33783	33796		10.1074/jbc.M114.594804	http://dx.doi.org/10.1074/jbc.M114.594804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25294878	Green Published, hybrid			2022-12-25	WOS:000346077600006
J	Tal, O; Trabelcy, B; Gerchman, Y; Adir, N				Tal, Ofir; Trabelcy, Beny; Gerchman, Yoram; Adir, Noam			Investigation of Phycobilisome Subunit Interaction Interfaces by Coupled Cross-linking and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-TRANSFER PATHWAYS; CRYSTAL-STRUCTURE; CYANOBACTERIAL PHYCOBILISOMES; C-PHYCOCYANIN; 2.2 ANGSTROM; WEB SERVER; MODEL; ALLOPHYCOCYANIN; PHYCOBILIPROTEINS; PHYCOERYTHRIN	The phycobilisome (PBS) is an extremely large light-harvesting complex, common in cyanobacteria and red algae, composed of rods and core substructures. These substructures are assembled from chromophore-bearing phycocyanin and allophycocyanin subunits, nonpigmented linker proteins and in some cases additional subunits. To date, despite the determination of crystal structures of isolated PBS components, critical questions regarding the interaction and energy flow between rods and core are still unresolved. Additionally, the arrangement of minor PBS components located inside the core cylinders is unknown. Different models of the general architecture of the PBS have been proposed, based on low resolution images from electron microscopy or high resolution crystal structures of isolated components. This work presents a model of the assembly of the rods onto the core arrangement and for the positions of inner core components, based on cross-linking and mass spectrometry analysis of isolated, functional intact Thermosynechococcus vulcanus PBS, as well as functional crosslinked adducts. The experimental results were utilized to predict potential docking interactions of different protein pairs. Combining modeling and cross-linking results, we identify specific interactions within the PBS subcomponents that enable us to suggest possible functional interactions between the chromophores of the rods and the core and improve our understanding of the assembly, structure, and function of PBS.	[Tal, Ofir; Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Trabelcy, Beny; Gerchman, Yoram] Univ Haifa, Fac Nat Sci, Dept Biol, IL-36006 Tivon, Israel	Technion Israel Institute of Technology; University of Haifa	Adir, N (corresponding author), Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel.	nadir@tx.technion.ac.il	Adir, Noam/ABE-6990-2020; Gerchman, Yoram/H-4698-2019; Gerchman, Yoram/F-5226-2015	Gerchman, Yoram/0000-0002-8637-9589	United States-Israel Binational Science Fund [2009406]; Israel Science Foundation [1576/12]; Nancy and Stephen Grand Technion Energy Program; Technion Russell Berrie Nanotechnology Institute	United States-Israel Binational Science Fund; Israel Science Foundation(Israel Science Foundation); Nancy and Stephen Grand Technion Energy Program; Technion Russell Berrie Nanotechnology Institute	This work was supported by United States-Israel Binational Science Fund Grant 2009406 and Israel Science Foundation Grant 1576/12. We also acknowledge the support from the Nancy and Stephen Grand Technion Energy Program and the Technion Russell Berrie Nanotechnology Institute.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N, 2003, J BIOL CHEM, V278, P25926, DOI 10.1074/jbc.M302838200; Adir N., 2008, PHOTOSYNTHETIC PROTE, P243, DOI DOI 10.1002/9783527623464.CH11; Adir N., 2006, COMPLEX INTRACELLULA, VVolume 2, P47; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BRYANT DA, 1979, ARCH MICROBIOL, V123, P113, DOI 10.1007/BF00446810; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Chen M, 2009, FEBS LETT, V583, P2535, DOI 10.1016/j.febslet.2009.07.012; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; Cogdell RJ, 2008, PHOTOCH PHOTOBIO SCI, V7, P1150, DOI 10.1039/b807201a; Cogdell RJ, 2004, PHOTOSYNTH RES, V81, P207, DOI 10.1023/B:PRES.0000036883.56959.a9; Collins AM, 2012, PLANT PHYSIOL, V158, P1600, DOI 10.1104/pp.111.192849; Croce R, 2013, PHOTOSYNTH RES, V116, P153, DOI 10.1007/s11120-013-9838-x; Curutchet C, 2011, J AM CHEM SOC, V133, P3078, DOI 10.1021/ja110053y; David L, 2014, BBA-BIOENERGETICS, V1837, P385, DOI 10.1016/j.bbabio.2013.12.014; David L, 2011, J MOL BIOL, V405, P201, DOI 10.1016/j.jmb.2010.10.036; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dong CX, 2009, BBA-BIOENERGETICS, V1787, P1122, DOI 10.1016/j.bbabio.2009.04.007; EDWARDS MR, 1971, J CELL BIOL, V50, P896, DOI 10.1083/jcb.50.3.896; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Figueroa M, 2012, PROTEIN SCI, V21, P1921, DOI 10.1002/pro.2176; Fournier CT, 2012, J PROTEOME RES, V11, P5712, DOI 10.1021/pr300538f; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; Gao X, 2012, MOL MICROBIOL, V85, P907, DOI 10.1111/j.1365-2958.2012.08152.x; Gao X, 2011, MOL MICROBIOL, V82, P698, DOI 10.1111/j.1365-2958.2011.07844.x; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1983, ANN INST PASTEUR MIC, VB134, P159, DOI 10.1016/S0769-2609(83)80103-3; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; HOLZWARTH AR, 1990, BIOPHYS J, V57, P133, DOI 10.1016/S0006-3495(90)82514-5; Jallet D, 2012, BBA-BIOENERGETICS, V1817, P1418, DOI 10.1016/j.bbabio.2011.11.020; Jiang T, 1999, PROTEINS, V34, P224; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kondo K, 2005, PHOTOSYNTH RES, V84, P269, DOI 10.1007/s11120-004-7762-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogmann DW, 2007, PHOTOSYNTH RES, V93, P27, DOI 10.1007/s11120-007-9133-9; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Marx A, 2013, BBA-BIOENERGETICS, V1827, P311, DOI 10.1016/j.bbabio.2012.11.006; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Matamala AR, 2007, J COMPUT CHEM, V28, P1200, DOI 10.1002/jcc.20628; McGregor A, 2008, J MOL BIOL, V384, P406, DOI 10.1016/j.jmb.2008.09.018; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Noy D, 2008, PHOTOSYNTH RES, V95, P23, DOI 10.1007/s11120-007-9269-7; Ren YL, 2013, J COMPUT CHEM, V34, P1005, DOI 10.1002/jcc.23221; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; SAUER K, 1988, BIOCHIM BIOPHYS ACTA, V936, P157, DOI 10.1016/0005-2728(88)90232-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SUTER GW, 1987, BIOPHYS J, V52, P673, DOI 10.1016/S0006-3495(87)83262-9; Tian LJ, 2012, BIOPHYS J, V102, P1692, DOI 10.1016/j.bpj.2012.03.008; Tian LJ, 2011, J AM CHEM SOC, V133, P18304, DOI 10.1021/ja206414m; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van Amerongen H, 2013, PHOTOSYNTH RES, V116, P251, DOI 10.1007/s11120-013-9824-3; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Womick JM, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3457378; Xu H, 2009, BIOINFORMATICS, V25, P1341, DOI 10.1093/bioinformatics/btp155; Zhang H, 2014, BIOCHEMISTRY-US, V53, P13, DOI 10.1021/bi401539w	64	15	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33084	33097		10.1074/jbc.M114.595942	http://dx.doi.org/10.1074/jbc.M114.595942			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296757	hybrid, Green Published			2022-12-25	WOS:000345636600003
J	Sinha, A; Kohrer, C; Weber, MHW; Masuda, I; Mootha, VK; Hou, YM; RajBhandary, UL				Sinha, Akesh; Koehrer, Caroline; Weber, Michael H. W.; Masuda, Isao; Mootha, Vamsi K.; Hou, Ya-Ming; RajBhandary, Uttam L.			Biochemical Characterization of Pathogenic Mutations in Human Mitochondrial Methionyl-tRNA Formyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATOR TRANSFER-RNA; FORMYLMETHIONINE TRANSFER-RNA; ACID INSERTION MODULE; COMPLEX I DEFICIENCY; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; MAMMALIAN MITOCHONDRIA; SUPPRESSOR MUTATIONS; CRYSTAL-STRUCTURE; MESSENGER-RNA	N-Formylation of initiator methionyl-tRNA (Met-tRNA(Met)) by methionyl-tRNA formyltransferase (MTF) is important for translation initiation in bacteria, mitochondria, and chloroplasts. Unlike all other translation systems, the metazoan mitochondrial system is unique in using a single methionine tRNA (tRNA(Met)) for both initiation and elongation. A portion of Met-tRNA(Met) is formylated for initiation, whereas the remainder is used for elongation. Recently, we showed that compound heterozygous mutations within the nuclear gene encoding human mitochondrial MTF (mt-MTF) significantly reduced mitochondrial translation efficiency, leading to combined oxidative phosphorylation deficiency and Leigh syndrome in two unrelated patients. Patient P1 has a stop codon mutation in one of the MTF genes and an S209L mutation in the other MTF gene. P2 has a S125L mutation in one of the MTF genes and the same S209L mutation as P1 in the other MTF gene. Here, we have investigated the effect of mutations at Ser-125 and Ser-209 on activities of human mt-MTF and of the corresponding mutations, Ala-89 or Ala-172, respectively, on activities of Escherichia coli MTF. The S125L mutant has 653-fold lower activity, whereas the S209L mutant has 36-fold lower activity. Thus, both patients depend upon residual activity of the S209L mutant to support low levels of mitochondrial protein synthesis. We discuss the implications of these and other results for whether the effect of the S209L mutation on mitochondrial translational efficiency is due to reduced activity of the mutant mt-MTF and/or reduced levels of the mutant mt-MTF.	[Sinha, Akesh; Koehrer, Caroline; Weber, Michael H. W.; RajBhandary, Uttam L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Masuda, Isao; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Jefferson University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	RajBhandary, UL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Rm 68-671, Cambridge, MA 02139 USA.	bhandary@mit.edu	Masuda, Isao/X-8797-2019	Masuda, Isao/0000-0001-9385-4424; Hou, Ya-Ming/0000-0001-6546-2597	National Institutes of Health [GM17151, 5RNIAG042169, GM097136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097136, R37GM017151, R01GM108972, R01GM017151, F32GM017151, R56GM017151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM17151 (to U. L. R.), 5RNIAG042169 (to Y. M. H.), and GM097136 (to V. K. M.).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; CANONACO MA, 1986, FEBS LETT, V207, P198, DOI 10.1016/0014-5793(86)81488-0; Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gite S, 2000, BIOCHEMISTRY-US, V39, P2218, DOI 10.1021/bi9926072; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; GUILLON JM, 1992, J BACTERIOL, V174, P4294, DOI 10.1128/JB.174.13.4294-4301.1992; Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hanahan D., 1985, DNA CLONING PRACTICA, P109; Hou Ya-Ming, 2012, Methods Mol Biol, V941, P195, DOI 10.1007/978-1-62703-113-4_15; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; KAHN D, 1980, EUR J BIOCHEM, V105, P489, DOI 10.1111/j.1432-1033.1980.tb04524.x; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; KOZAK M, 1983, MICROBIOL REV, V47, P1; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Li Y, 2000, BIOCHEMISTRY-US, V39, P8039, DOI 10.1021/bi000625+; Lightowlers RN, 2014, FEBS LETT, V588, P2496, DOI 10.1016/j.febslet.2014.05.054; MANDAL N, 1992, J BACTERIOL, V174, P7827, DOI 10.1128/JB.174.23.7827-7830.1992; MANGROO D, 1995, J BIOL CHEM, V270, P12203, DOI 10.1074/jbc.270.20.12203; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Neeve VCM, 2013, MITOCHONDRION, V13, P743, DOI 10.1016/j.mito.2013.03.002; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nilsson AI, 2006, P NATL ACAD SCI USA, V103, P6976, DOI 10.1073/pnas.0602171103; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; Ramesh V, 1997, P NATL ACAD SCI USA, V94, P13524, DOI 10.1073/pnas.94.25.13524; Ramesh V, 1998, BIOCHEMISTRY-US, V37, P15925, DOI 10.1021/bi981873x; Sambrook J., 2002, MOL CLONING LAB MANU; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Schmitt E, 1996, EMBO J, V15, P4749, DOI 10.1002/j.1460-2075.1996.tb00852.x; SCHOFIEL.P, 1968, BIOCHIM BIOPHYS ACTA, V155, P410, DOI 10.1016/0005-2787(68)90185-8; SCHULMAN LH, 1985, BIOCHEMISTRY-US, V24, P7309, DOI 10.1021/bi00346a043; SEONG BL, 1987, P NATL ACAD SCI USA, V84, P8859, DOI 10.1073/pnas.84.24.8859; SEONG BL, 1987, P NATL ACAD SCI USA, V84, P334, DOI 10.1073/pnas.84.2.334; Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUNDARI RM, 1976, J BIOL CHEM, V251, P3338; Takeuchi N, 2001, J BIOL CHEM, V276, P20064, DOI 10.1074/jbc.M101007200; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Thain A, 1996, TRENDS GENET, V12, P209, DOI 10.1016/S0168-9525(96)90022-0; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; VARSHNEY U, 1991, J BIOL CHEM, V266, P18018; VARSHNEY U, 1990, P NATL ACAD SCI USA, V87, P1586, DOI 10.1073/pnas.87.4.1586; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Woriax VL, 1996, BBA-GENE STRUCT EXPR, V1307, P66, DOI 10.1016/0167-4781(95)00240-5; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	55	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.610626	http://dx.doi.org/10.1074/jbc.M114.610626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288793	Green Published, hybrid			2022-12-25	WOS:000345335000029
J	Ying, MY; Tilghman, J; Wei, YY; Guerrero-Cazares, H; Quinones-Hinojosa, A; Ji, HK; Laterra, J				Ying, Mingyao; Tilghman, Jessica; Wei, Yingying; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Ji, Hongkai; Laterra, John			Kruppel-like Factor-9 (KLF9) Inhibits Glioblastoma Stemness through Global Transcription Repression and Integrin alpha 6 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GROWTH-FACTOR RECEPTOR; IN-VITRO; CELLS; CANCER; NETWORK; GENE; COMPLEX; IDENTIFICATION; HETEROGENEITY	It is increasingly important to understand the molecular basis for the plasticity of neoplastic cells and their capacity to transition between differentiated and stemlike phenotypes. Kruppel-like factor-9 (KLF9), a member of the large KLF transcription factor family, has emerged as a regulator of oncogenesis, cell differentiation, and neural development; however, the molecular basis for the diverse contextual functions of KLF9 remains unclear. This study focused on the functions of KLF9 in human glioblastoma stemlike cells. We established for the first time a genome-wide map of KLF9-regulated targets in human glioblastoma stemlike cells and show that KLF9 functions as a transcriptional repressor and thereby regulates multiple signaling pathways involved in oncogenesis and stem cell regulation. A detailed analysis of one such pathway, integrin signaling, showed that the capacity of KLF9 to inhibit glioblastoma cell stemness and tumorigenicity requires ITGA6 repression. These findings enhance our understanding of the transcriptional networks underlying cancer cell stemness and differentiation and identify KLF9-regulated molecular targets applicable to cancer therapeutics.	[Ying, Mingyao; Tilghman, Jessica; Laterra, John] Kennedy Krieger, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Ying, Mingyao; Laterra, John] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Tilghman, Jessica; Quinones-Hinojosa, Alfredo; Laterra, John] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Quinones-Hinojosa, Alfredo; Laterra, John] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Ji, Hongkai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Wei, Yingying] Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chinese University of Hong Kong	Laterra, J (corresponding author), Kennedy Krieger Res Inst, 707 North Broadway, Baltimore, MD 21205 USA.	laterra@kennedykrieger.org	Wei, Yingying/S-8001-2018	Wei, Yingying/0000-0003-3826-336X; Guerrero-Cazares, Hugo/0000-0003-1307-719X	National Institutes of Health [RO1NS076759, RO1NS073611, RO1 5R01NS070024, R01HG006841]; James S. McDonnell Foundation; Maryland Stem Cell Research Fund; American Brain Tumor Association discovery grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076759, R01NS073611, R01NS070024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Maryland Stem Cell Research Fund; American Brain Tumor Association discovery grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS076759 and RO1NS073611 (to J. L.), RO1 5R01NS070024 (to A. Q. H. and H. G. C.), and R01HG006841 (to H. J.). This work was also supported by the James S. McDonnell Foundation (to J. L.), the Maryland Stem Cell Research Fund (to M. Y. and J. L.), and an American Brain Tumor Association discovery grant (to M. Y.).	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chen SY, 2013, DEVELOPMENT, V140, P255, DOI 10.1242/dev.083139; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Dugas JC, 2012, MOL CELL NEUROSCI, V50, P45, DOI 10.1016/j.mcn.2012.03.007; Ehtesham M, 2013, J NEURO-ONCOL, V113, P153, DOI 10.1007/s11060-013-1108-4; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Guemar L, 2007, DEV BIOL, V310, P113, DOI 10.1016/j.ydbio.2007.07.031; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; HOGERVORST F, 1993, J CELL BIOL, V121, P179, DOI 10.1083/jcb.121.1.179; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kang L, 2008, PATHOL INT, V58, P334, DOI 10.1111/j.1440-1827.2008.02233.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Liu LN, 2011, BIOCHEM BIOPH RES CO, V413, P426, DOI 10.1016/j.bbrc.2011.08.108; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mitchell DL, 2010, MOL BIOL CELL, V21, P2780, DOI 10.1091/mbc.E10-04-0290; Nancy V, 1999, J BIOL CHEM, V274, P8737, DOI 10.1074/jbc.274.13.8737; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Prabakaran I, 2011, J THROID RES, V2011, DOI 10.4061/2011/979840; Qian H, 2006, BLOOD, V107, P3503, DOI 10.1182/blood-2005-10-3932; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Seo S, 2012, J BIOL CHEM, V287, P12723, DOI 10.1074/jbc.M112.351395; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Simmons CD, 2011, BIOL REPROD, V85, P378, DOI 10.1095/biolreprod.110.090654; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Thomas Sterling, 2010, Human Genomics, V4, P353; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uchida D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-62; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	76	50	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.588988	http://dx.doi.org/10.1074/jbc.M114.588988			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288800	Green Published, hybrid			2022-12-25	WOS:000345335000030
J	Cappi, C; Hounie, AG; Mariani, DB; Diniz, JB; Silva, ART; Reis, VNS; Busso, AF; Silva, AG; Fidalgo, F; Rogatto, SR; Miguel, EC; Krepischi, AC; Brentani, H				Cappi, Carolina; Hounie, Ana Gabriela; Mariani, Daniel B.; Diniz, Juliana Belo; Silva, Aderbal R. T.; Reis, Viviane N. S.; Busso, Ariane F.; Silva, Amanda Goncalves; Fidalgo, Felipe; Rogatto, Silvia Regina; Miguel, Euripedes C.; Krepischi, Ana C.; Brentani, Helena			An Inherited Small Microdeletion at 15q13.3 in a Patient with Early- Onset Obsessive-Compulsive Disorder	PLOS ONE			English	Article							COPY NUMBER VARIATION; DE-NOVO CNVS; TOURETTE SYNDROME; STRUCTURAL VARIATION; AUTISM; VARIANTS; GENES; CHROMOSOMES; DNA; SCHIZOPHRENIA	Copy number variations (CNVs) have been previously associated with several different neurodevelopmen al psychiatric disorders, such as autism, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The present study consisted of pilot genorne-wide screen for CNVs in a cohort of 16 patients with early-onset obsessive-compulsive disorder (OCD) and 2 mentally healthy individuals, using array-based comparative enomic hybridization (aCGH) on 44K arrays. A small rare nal inherited microdeletion (-64 kb) was identified in chromosome 15q13.3 of one male patient with very early onset have OCD. The deletion encompassed part of the FA/IN1 gene, which is involved with the glutamatergic system This finding supports the hypothesis of a complex network of several genes expressed in the brain cant ibuting for h genetic risk of OCD, and also supports the glutamatergic involvement in OCD, which has been previsously reported in the literature.	[Cappi, Carolina; Hounie, Ana Gabriela; Diniz, Juliana Belo; Silva, Aderbal R. T.; Reis, Viviane N. S.; Miguel, Euripedes C.; Brentani, Helena] Univ Sao Paulo, Sch Med, Inst & Dept Psychiat, Sao Paulo, Brazil; [Mariani, Daniel B.] Univ Sao Paulo, Inst Math & Stat, Inter Inst Grad Program Bioinformat, Sao Paulo, Brazil; [Silva, Amanda Goncalves; Fidalgo, Felipe; Krepischi, Ana C.] AC Camargo Canc Ctr, Int Res Ctr, Sao Paulo, Brazil; [Rogatto, Silvia Regina] Sao Paulo State Univ, Sch Med, Sao Paulo, Brazil; [Hounie, Ana Gabriela] Univ Fed Sao Paulo, UPIA, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Cappi, C (corresponding author), Univ Sao Paulo, Sch Med, Inst & Dept Psychiat, Sao Paulo, Brazil.	carolinacappi@gmail.com	Diniz, Juliana Belo/D-2503-2011; Krepischi, Ana C V/E-4976-2012; Rogatto, Silvia R/E-6535-2012; Brentani, Helena/G-6839-2011; Reis, Viviane/J-3996-2014; Busso-Lopes, Ariane Fidelis/K-1383-2015; Miguel, Euripedes C/B-2871-2008; Hounie, Ana G/D-2931-2014; Cappi, Carolina/P-1811-2017; Ruy T. Silva, Aderbal/K-6503-2012	Diniz, Juliana Belo/0000-0001-9486-3779; Krepischi, Ana C V/0000-0003-2931-8605; Brentani, Helena/0000-0001-5192-4682; Reis, Viviane/0000-0002-4959-2954; Busso-Lopes, Ariane Fidelis/0000-0003-2280-1848; Hounie, Ana G/0000-0002-5026-2880; Rogatto, Silvia/0000-0003-4637-5687; Cappi, Carolina/0000-0001-6661-3756; Ruy T. Silva, Aderbal/0000-0003-1158-5617	Foundation for Research Support of the State of Sao Paulo (FAPESP) [2008/11537-7]; Brazilian National Council for Scientific and Technological Development (CNPq) [MCT/CNPq 14/2008]	Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants to Dras Cappi and Brentani from the Foundation for Research Support of the State of Sao Paulo (FAPESP); grant number 2008/11537-7, and from the Brazilian National Council for Scientific and Technological Development (CNPq; protocol number MCT/CNPq 14/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2013, MOL PSYCHIAT; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnold PD, 2009, BRAIN IMAGING BEHAV, V3, P64, DOI 10.1007/s11682-008-9050-3; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Coe BP, 2012, CURR OPIN NEUROBIOL; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Coppola A, 2013, EPILEPSIA, V54, pe69, DOI 10.1111/epi.12130; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Crespi BJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-15; Delorme R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-100; Derwinska K, 2009, CLIN GENET, V75, P199, DOI 10.1111/j.1399-0004.2008.01077.x; Engels H, 2007, NEUROLOGY, V68, P743, DOI 10.1212/01.wnl.0000256367.70365.e0; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hoexter MQ, 2009, REV BRAS PSIQUIATR, V31, P345; Hooper SD, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-123; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Le Pichon JB, 2013, EUR J HUM GENET; Lesch KP, 2011, MOL PSYCHIATR, V16, P491, DOI 10.1038/mp.2010.29; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McGrath LM, 2014, J AM ACAD CHILD PSY, V53, P910, DOI 10.1016/j.jaac.2014.04.022; Melchior L, 2013, AM J MED GENET B, V162, P825, DOI 10.1002/ajmg.b.32186; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Miguel EC, 2008, REV BRAS PSIQUIATR, V30, P185, DOI 10.1590/S1516-44462008000300003; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nestadt G, 2012, AM J MED GENET B, V159B, P53, DOI 10.1002/ajmg.b.32001; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Pauls DL, 2008, AM J MED GENET C, V148C, P133, DOI 10.1002/ajmg.c.30168; Pauls DL, 2014, NAT REV NEUROSCI, V15, P410, DOI 10.1038/nrn3746; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ross J, 2011, HUM GENET, V130, P795, DOI 10.1007/s00439-011-1033-6; Rucker JJH, 2012, DEV PSYCHOPATHOL, V24, P1335, DOI 10.1017/S0954579412000740; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, NAT GENET, V39, pS3, DOI 10.1038/ng2095; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Shugart YY, 2006, MOL PSYCHIATR, V11, P763, DOI 10.1038/sj.mp.4001847; Simon-Areces J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021825; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stewart SE, 2013, AM J MED GENET B; Stewart SE, 2012, MOL PSYCHIAT; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Taylor S, 2012, MOL PSYCHIAT; Ting Jonathan T, 2008, Curr Chem Genomics, V2, P62; Veenstra-VanderWeele J, 2012, PSYCHIAT GENET, V22, P256, DOI 10.1097/YPG.0b013e328353fb63; Walitza S, 2012, J NEURAL TRANSM, V119, P507, DOI 10.1007/s00702-011-0699-1; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	58	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110198	10.1371/journal.pone.0110198	http://dx.doi.org/10.1371/journal.pone.0110198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303678	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400121
J	Fabrizii, M; Moinfar, F; Jelinek, HF; Karperien, A; Ahammer, H				Fabrizii, Markus; Moinfar, Farid; Jelinek, Herbert F.; Karperien, Audrey; Ahammer, Helmut			Fractal Analysis of Cervical Intraepithelial Neoplasia	PLOS ONE			English	Article							EUROPEAN GUIDELINES; CLINICAL MANAGEMENT; QUALITY-ASSURANCE; DIMENSIONS; CYTOLOGY	Introduction: Cervical intraepithelial neoplasias (CIN) represent precursor lesions of cervical cancer. These neoplastic lesions are traditionally subdivided into three categories CIN 1, CIN 2, and CIN 3, using microscopical criteria. The relation between grades of cervical intraepithelial neoplasia (CIN) and its fractal dimension was investigated to establish a basis for an objective diagnosis using the method proposed. Methods: Classical evaluation of the tissue samples was performed by an experienced gynecologic pathologist. Tissue samples were scanned and saved as digital images using Aperio scanner and software. After image segmentation the box counting method as well as multifractal methods were applied to determine the relation between fractal dimension and grades of CIN. A total of 46 images were used to compare the pathologist's neoplasia grades with the predicted groups obtained by fractal methods. Results: Significant or highly significant differences between all grades of CIN could be found. The confusion matrix, comparing between pathologist's grading and predicted group by fractal methods showed a match of 87.1%. Multifractal spectra were able to differentiate between normal epithelium and low grade as well as high grade neoplasia. Conclusion: Fractal dimension can be considered to be an objective parameter to grade cervical intraepithelial neoplasia.	[Fabrizii, Markus; Ahammer, Helmut] Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria; [Moinfar, Farid] Med Univ Graz, Inst Pathol, Unit Breast & Gynaecol Pathol, Graz, Austria; [Moinfar, Farid] Hosp Sisters Char, Dept Pathol, Linz, Austria; [Jelinek, Herbert F.; Karperien, Audrey] Charles Sturt Univ, Ctr Res Complex Syst, Albury, NSW, Australia; [Jelinek, Herbert F.] Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia	Medical University of Graz; Medical University of Graz; Charles Sturt University; Charles Sturt University	Ahammer, H (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria.	helmut.ahammer@medunigraz.at	Jelinek, Herbert/AAQ-6825-2020; Jelinek, Herbert F/S-6779-2019; Karperien, Audrey/H-2142-2013	Jelinek, Herbert F/0000-0001-5457-6193; Ahammer, Helmut/0000-0001-5400-294X; Karperien, Audrey/0000-0002-8190-6327				Ahammer H, 2011, CHAOS SOLITON FRACT, V44, P86, DOI 10.1016/j.chaos.2010.12.004; American College of Obstetricians and Gynecologists Committee, 2010, OBSTET GYNECOL, V116, P469; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Aslani FS, 2013, IRAN J MED SCI, V38, P15; Baish JW, 2000, CANCER RES, V60, P3683; Chalut KJ, 2009, CANCER RES, V69, P1199, DOI 10.1158/0008-5472.CAN-08-3079; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Feder J, 1988, FRACTALS; Fritz A, 2000, INT CLASSIFICATION D; Jayalalitha G, 2011, FRACTALS, V19, P125, DOI 10.1142/S0218348X11005154; Jelinek H.F., 2012, P 9 IASTED INT C BIO, P25, DOI [10.2316/P.2012.764-039, DOI 10.2316/P.2012.764-039]; Jelinek HF, 2013, ADV INTELL SYST, V187, P177; Jelinek Herbert F., 2006, ComPlexUs, V3, P66, DOI 10.1159/000094189; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Jordan J, 2009, CYTOPATHOLOGY, V20, P5, DOI 10.1111/j.1365-2303.2008.00636.x; Karperien A, 2013, FRACLAC IMAGEJ VERSI; Mashiah A, 2008, ACTA HAEMATOL-BASEL, V119, P142, DOI 10.1159/000125551; Metze K, 2013, EXPERT REV MOL DIAGN, V13, P719, DOI 10.1586/14737159.2013.828889; Regitnig P, 2007, PATHOLOGE, V28, P339, DOI 10.1007/s00292-007-0931-9; Reishofer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041148; Sedivy R, 1999, GYNECOL ONCOL, V75, P78, DOI 10.1006/gyno.1999.5516; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Solomon D, 2004, BETHESDA SYSTEM REPO, P191; Waliszewski P, 2005, BIOSYSTEMS, V82, P61, DOI 10.1016/j.biosystems.2005.05.011; Waliszewski P, 2003, CHAOS SOLITON FRACT, V16, P665, DOI 10.1016/S0960-0779(02)00469-1	26	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108457	10.1371/journal.pone.0108457	http://dx.doi.org/10.1371/journal.pone.0108457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302712	Green Published, gold			2022-12-25	WOS:000343730400014
J	Fletcher, TL; Kolias, AG; Hutchinson, PJ; Sutcliffe, MPF				Fletcher, Tim L.; Kolias, Angelos G.; Hutchinson, Peter J.; Sutcliffe, Michael P. F.			A New Improved Method for Assessing Brain Deformation after Decompressive Craniectomy	PLOS ONE			English	Article							INJURY; PLATFORM	Background: Decompressive craniectomy (DC) is a surgical intervention used following traumatic brain injury to prevent or alleviate raised intracranial pressure. However the clinical effectiveness of the intervention remains in doubt. The location of the craniectomy (unilateral or bifrontal) might be expected to change the brain deformation associated with the operation and hence the clinical outcome. As existing methods for assessing brain deformation have several limitations, we sought to develop and validate a new improved method. Methods: Computed tomography (CT) scans were taken from 27 patients who underwent DC (17 bifrontal patients and 10 unilateral patients). Pre-operative and post-operative images were processed and registered to determine the change in brain position associated with the operation. The maximum deformation in the herniated brain, the change in volume and estimates of the craniectomy area were determined from the images. Statistical comparison was made using the Pearson's correlation coefficient r and a Welch's two-tailed T-test, with statistical significance reported at the 5% level. Results: There was a reasonable correlation between the volume increase and the maximum brain displacement (r = 0.64), a low correlation between the volume increase and the craniectomy area (r = 0.30) and no correlation between the maximum displacement and the craniectomy area (r = -0.01). The maximum deformation was significantly lower (P = 0.023) in the bifrontal patients (mean = 22.5 mm) compared with the unilateral patients (mean = 29.8 mm). Herniation volume was significantly lower (P = 0.023) in bifrontal (mean = 50.0 ml) than unilateral patients (mean = 107.3 ml). Craniectomy area was not significantly different for the two craniectomy locations (P = 0.29). Conclusions: A method has been developed to quantify changes in brain deformation due to decompressive craniectomy from CT images and allow comparison between different craniectomy locations. Measured displacement is a reasonable way to characterise volume changes.	[Fletcher, Tim L.; Sutcliffe, Michael P. F.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Sutcliffe, MPF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mpfs@eng.cam.ac.uk		Hutchinson, Peter/0000-0002-2796-1835; Sutcliffe, Michael/0000-0001-9729-4460; Kolias, Angelos/0000-0003-3992-0587	Engineering and Physical Sciences Research Council (EPSRC); Royal College of Surgeons of England Research Fellowship - Freemasons and the Rosetrees Trust; National Institute of Health Research (NIHR) Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research Centre; Medical Research Council [G0601025] Funding Source: researchfish; National Institute for Health Research [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish; MRC [G0601025] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal College of Surgeons of England Research Fellowship - Freemasons and the Rosetrees Trust; National Institute of Health Research (NIHR) Academic Clinical Fellowship(National Institute for Health Research (NIHR)); Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TLF acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC). AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), a National Institute of Health Research (NIHR) Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Frise E, 2008, LEVEL SETS FAST MARC; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Johnson H., 2007, INSIGHT JOUR, P2, DOI [10.54294/hmb052, DOI 10.54294/HMB052]; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Pieper S, 2006, I S BIOMED IMAGING, P698; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Quintus K, 2010, MODULES LABELSTATIST; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Vashu R, 2011, ACTA NEUROCHIR, V153, P2065, DOI 10.1007/s00701-011-1101-7; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wirtz CR, 1997, NEUROSURG FOCUS, V2	22	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110408	10.1371/journal.pone.0110408	http://dx.doi.org/10.1371/journal.pone.0110408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303305	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400129
J	Holtgrawe, D; Sorensen, TR; Viehover, P; Schneider, J; Schulz, B; Borchardt, D; Kraft, T; Himmelbauer, H; Weisshaar, B				Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Viehover, Prisca; Schneider, Jessica; Schulz, Britta; Borchardt, Dietrich; Kraft, Thomas; Himmelbauer, Heinz; Weisshaar, Bernd			Reliable In Silico Identification of Sequence Polymorphisms and Their Application for Extending the Genetic Map of Sugar Beet (Beta vulgaris)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; WIDE SNP DISCOVERY; LINKAGE GROUPS; L.; TRANSCRIPTOME; POPULATIONS; GENERATION	Molecular markers are a highly valuable tool for creating genetic maps. Like in many other crops, sugar bee Beta vulgar's L. breeding is increasingly supported by the application of such genetic markers. Single nucleotide polymorphism (SNP) based markers have a high potential for automated analysis and high-throughout genotyping. We developed a workflow that uses Sanger and 2nd-generation sequence data for detection, evaluation and verification of new transcript-associated SNPs from sugar beet. RNAseq data from one parent of an established mapping population were produced by 454-FLX sequencing and compared to Sanger ESTs derived from the other parent. The workflow established or SNP detection considers the quality values of both types of reads, provides polymorphic alignments as well as selection criteria for reliable SNP detection and allows painless generation of new genetic markers within genes. We obtained a total of 14,323 genic SNPs and InDels. According to empirically optimised settings for the quality parameters, we classified these SNPs into four usability categories. Validation of a subset of the in silico genotyping the mapping population indicated a high success rate of the SNP detection Finally, a total of 307 new markers were integrated with existing data into a new genetic map of sugar beet which offers proved resolution and the integration of terminal markers.	[Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Viehover, Prisca; Schneider, Jessica; Weisshaar, Bernd] Univ Bielefeld, CeBiTec, Bielefeld, Germany; [Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Viehover, Prisca; Schneider, Jessica; Weisshaar, Bernd] Univ Bielefeld, Dept Biol, Bielefeld, Germany; [Schulz, Britta; Borchardt, Dietrich] KWS Saat AG, Mol Breeding Sugarbeet, Einbeck, Germany; [Kraft, Thomas] Syngenta Seeds AB, Landskrona, Sweden; [Himmelbauer, Heinz] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Himmelbauer, Heinz] Ctr Genom Regulat, Barcelona, Spain	University of Bielefeld; University of Bielefeld; KWS Saat AG; Syngenta; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Holtgrawe, D (corresponding author), Univ Bielefeld, CeBiTec, Bielefeld, Germany.	dholtgra@cebitec.uni-bielefeld.de	Weisshaar, Bernd/B-3859-2014	Weisshaar, Bernd/0000-0002-7635-3473; Holtgrawe, Daniela/0000-0002-1062-4576; Himmelbauer, Heinz/0000-0001-8897-2928	Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI-Beet Physical map' [FKZ 0313127A, FKZ 0313127D]; Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI BeetSeq' [FKZ 0315069A, FKZ 0315069B]	Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI-Beet Physical map'; Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI BeetSeq'	This work was supported by the Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI-Beet Physical map', FKZ 0313127A and FKZ 0313127D and by the 'Verbundprojekt GABI BeetSeq', FKZ 0315069A and FKZ 0315069B. Co-authors BS and DB are employed by KWS Saat AG. KWS Saat AG provided support in the form of salaries for authors BS and DB, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. TK is employed by Syngenta Seeds AB. Syngenta Seeds AB provided support in the form of salary for author TK, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; [Anonymous], GS FLX TIT GEN LIB P; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barker G, 2003, BIOINFORMATICS, V19, P421, DOI 10.1093/bioinformatics/btf881; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Dohm JC, 2012, PLANT J, V70, P528, DOI 10.1111/j.1365-313X.2011.04898.x; Dohm JC, 2009, PLANT J, V57, P14, DOI 10.1111/j.1365-313X.2008.03665.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Herwig R, 2002, PLANT J, V32, P845, DOI 10.1046/j.1365-313X.2002.01457.x; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lange C, 2010, THEOR APPL GENET, V121, P549, DOI 10.1007/s00122-010-1329-2; Le Dantec L, 2004, PLANT MOL BIOL, V54, P461, DOI 10.1023/B:PLAN.0000036376.11710.6f; Liang S, 2012, BIORESOURCE TECHNOL, V125, P312, DOI 10.1016/j.biortech.2012.08.097; Magana C, 2011, BIORESOURCE TECHNOL, V102, P9542, DOI 10.1016/j.biortech.2011.07.045; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mutasa-Gottgens ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-99; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Paesold S, 2012, PLANT J, V72, P600, DOI 10.1111/j.1365-313X.2012.05102.x; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider K, 2007, THEOR APPL GENET, V115, P601, DOI 10.1007/s00122-007-0591-4; Schondelmaier J, 1997, THEOR APPL GENET, V95, P590, DOI 10.1007/s001220050600; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Telles GP, 2001, GENET MOL BIOL, V24, P17, DOI 10.1590/S1415-47572001000100004; Van K, 2005, J HERED, V96, P529, DOI 10.1093/jhered/esi069; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wurschum T, 2011, THEOR APPL GENET, V123, P1121, DOI 10.1007/s00122-011-1653-1; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59	39	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110113	10.1371/journal.pone.0110113	http://dx.doi.org/10.1371/journal.pone.0110113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302600	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400112
J	Kiss, T; Krajcs, N; Pirger, Z; Hernadi, L				Kiss, Tibor; Krajcs, Nora; Pirger, Zsolt; Hernadi, Laszlo			Nicotinic Acetylcholine Receptors Containing the alpha 7-Like Subunit Mediate Contractions of Muscles Responsible for Space Positioning of the Snail, Helix pomatia L. Tentacle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SALIVARY-GLAND CELLS; APLYSIA NEURONS; CAENORHABDITIS-ELEGANS; SYNAPTIC TRANSMISSION; SEPIA-OFFICINALIS; LYMNAEA-STAGNALIS; FLEXOR MUSCLES; BUCCAL MUSCLES; SMOOTH-MUSCLE	Three recently discovered tentacle muscles are crucial to perform patterned movements of upper tentacles of the terrestrial snail, Helix pomatia. The muscles receive central and peripheral excitatory cholinergic innervation lacking inhibitory innervation. Here, we investigate the pharmacology of acetylcholine (ACh) responses in muscles to determine the properties of the ACh receptor (AChR), the functional availability of which was assessed using isotonic contraction measurement. Using broad spectrum of nicotinic and muscarinic ligands, we provide the evidence that contractions in the muscles are attributable to the activation of nAChRs that contain the alpha 7-like subunit. Contractions could be evoked by nicotine, carbachol, succinylchloride, TMA, the selective alpha 7-nAChR agonist choline chloride, 3-Bromocytisine and PNU-282987, and blocked by nAChR selective antagonists such as mytolon, hexamethonium, succinylchloride, d-tubocurarine, hemicholinium, DMDA (decamethonium), methyllycaconitine, alpha-Bungarotoxin (alpha BgTx) and alpha-Conotoxin IMI. The specific muscarinic agonist oxotremorine and arecoline failed to elicit contractions. Based on these pharmacological properties we conclude that the Na+ and Ca2+ permeable AChRs of the flexor muscle are nicotinic receptors that contain the alpha 7-like subunit. Immunodetection experiments confirmed the presence of alpha 7-or alpha 7-like AChRs in muscle cells, and alpha 4-AChRs in nerves innervating the muscle. These results support the conclusion that the slowly desensitizing alpha BgTx-sensitive responses obtained from flexor muscles are produced by activation of alpha 7- like AChRs. This is the first demonstration of postsynaptic expression and an obligatory role for a functional alpha 7-like nAChR in the molluscan periphery.	[Kiss, Tibor; Krajcs, Nora; Hernadi, Laszlo] MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Expt Zool, Chem Ecol & Neurobiol Grp, Tihany, Hungary; [Pirger, Zsolt] Natl Brain Project Team, Adapt Neuroetol MTA CER, Tihany, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute	Kiss, T (corresponding author), MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Expt Zool, Chem Ecol & Neurobiol Grp, Tihany, Hungary.	kiss.tibor@okologia.mta.hu	Pirger, Zsolt/AAH-7907-2021; PIRGER, Zsolt/AAH-4045-2020; Krajcs, Nora/O-2617-2019	PIRGER, Zsolt/0000-0001-9039-6966; 	 [TAMOP-4.2.2.A-/11/1 KONV-2012-0024]		TAMOP-4.2.2.A-/11/1 KONV-2012-0024 grant to T. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJIMAL GS, 1981, COMP BIOCHEM PHYS C, V68, P133, DOI 10.1016/0306-4492(81)90007-1; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ASCHER P, 1978, J PHYSIOL-LONDON, V278, P177, DOI 10.1113/jphysiol.1978.sp012299; BAHLS F, 1987, CELL MOL NEUROBIOL, V7, P35, DOI 10.1007/BF00734988; Ballivet M, 1996, J MOL BIOL, V258, P261, DOI 10.1006/jmbi.1996.0248; BARBER A, 1985, COMP BIOCHEM PHYS C, V80, P175, DOI 10.1016/0742-8413(85)90151-3; Bellanger C, 2005, NEUROSCI LETT, V387, P162, DOI 10.1016/j.neulet.2005.06.017; BUCKETT KJ, 1990, J NEUROPHYSIOL, V63, P1426, DOI 10.1152/jn.1990.63.6.1426; CAREW TJ, 1974, J NEUROPHYSIOL, V37, P1020, DOI 10.1152/jn.1974.37.5.1020; COHEN JL, 1978, J NEUROPHYSIOL, V41, P157, DOI 10.1152/jn.1978.41.1.157; COTTRELL GA, 1968, COMP BIOCHEM PHYSIOL, V27, P787, DOI 10.1016/0010-406X(68)90618-X; CRAVEIRO JPM, 1990, COMP BIOCHEM PHYS C, V95, P91, DOI 10.1016/0742-8413(90)90087-P; D'Este L, 2008, J COMP NEUROL, V509, P566, DOI 10.1002/cne.21761; De La Porte S, 1998, EUR J NEUROSCI, V10, P1631; EVANS T G, 1971, Comparative and General Pharmacology, V2, P5, DOI 10.1016/0010-4035(71)90062-0; Francis MM, 1996, NEUROPHARMACOLOGY, V35, P1547, DOI 10.1016/S0028-3908(96)00103-7; Gebauer M, 1998, COMP BIOCHEM PHYS C, V119, P13, DOI 10.1016/S0742-8413(97)00162-X; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; Herber DL, 2004, J HISTOCHEM CYTOCHEM, V52, P1367, DOI 10.1369/jhc.4A6319.2004; Hernadi L, 2012, ACTA BIOL HUNG, V63, P123, DOI 10.1556/ABiol.63.2012.Suppl.2.16; HILL RB, 1974, J EXP BIOL, V61, P629; Holden-Dye L, 2013, PARASITOL INT, V62, P606, DOI 10.1016/j.parint.2013.03.004; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; JORDAN R, 1993, J EXP ZOOL, V265, P496, DOI 10.1002/jez.1402650505; KEHOE J, 1972, J PHYSIOL-LONDON, V225, P115, DOI 10.1113/jphysiol.1972.sp009931; Kehoe J, 1998, J NEUROSCI, V18, P8198; KEHOE J, 1972, J PHYSIOL-LONDON, V225, P147, DOI 10.1113/jphysiol.1972.sp009932; KELLY JS, 1985, NEUROTRANSMITTER ACT, P143; Kelly JS, 1985, ACETYLCHOLINE; KISS I, 1978, COMP BIOCHEM PHYS C, V60, P89, DOI 10.1016/0306-4492(78)90033-3; KISS T, 1972, Annales Instituti Biologici (Tihany) Hungaricae Academiae Scientiarum, V39, P29; Kobayashi M, 1977, COMP BIOCH PHYSL C, V60C, P115; Kozak JA, 1996, J NEUROPHYSIOL, V75, P660, DOI 10.1152/jn.1996.75.2.660; Krajcs N, 2014, INVERTEBR NEUROSCI, V14, P59, DOI 10.1007/s10158-013-0164-y; Krajcs N, 2012, ACTA BIOL HUNG, V63, P129, DOI 10.1556/ABiol.63.2012.Suppl.2.17; Laurienti PJ, 1999, J NEUROPHYSIOL, V82, P778, DOI 10.1152/jn.1999.82.2.778; LINDSTROM J, 1995, ANN NY ACAD SCI, V757, P100, DOI 10.1111/j.1749-6632.1995.tb17467.x; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; MURRAY TF, 1988, BRAIN RES BULL, V21, P181, DOI 10.1016/0361-9230(88)90230-4; NELSON ID, 1992, GEN PHARMACOL, V23, P317, DOI 10.1016/0306-3623(92)90089-3; PANCHIN YV, 1995, J NEUROPHYSIOL, V73, P1924, DOI 10.1152/jn.1995.73.5.1924; PETERS M, 1979, COMP BIOCHEM PHYS C, V62, P181, DOI 10.1016/0306-4492(79)90007-8; RAM JL, 1983, BRAIN RES, V288, P177, DOI 10.1016/0006-8993(83)90092-6; RAM JL, 1994, COMP BIOCHEM PHYS C, V107, P235, DOI 10.1016/1367-8280(94)90046-9; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TWAROG BM, 1960, J PHYSIOL-LONDON, V152, P236, DOI 10.1113/jphysiol.1960.sp006484; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Vulfius CA, 2005, NEUROSCI LETT, V373, P232, DOI 10.1016/j.neulet.2004.10.010; Vulfius CA, 2001, NEUROSCI LETT, V309, P189, DOI 10.1016/S0304-3940(01)02081-X; Walker RJ, 1996, PARASITOLOGY, V113, pS3, DOI 10.1017/S0031182000077878; WELLS DW, 1980, COMP BIOCHEM PHYS C, V67, P97, DOI 10.1016/0306-4492(80)90003-9; Wright TJ, 2002, J COMP PHYSIOL B, V172, P237, DOI 10.1007/s00360-001-0248-6; YAROWSKY PJ, 1978, J NEUROPHYSIOL, V41, P531	55	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109538	10.1371/journal.pone.0109538	http://dx.doi.org/10.1371/journal.pone.0109538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303328	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400064
J	Li, B; Yang, JX; Wei, DP; Chen, SB; Li, JM; Ma, YB				Li, Bo; Yang, Junxing; Wei, Dongpu; Chen, Shibao; Li, Jumei; Ma, Yibing			Field Evidence of Cadmium Phytoavailability Decreased Effectively by Rape Straw and/or Red Mud with Zinc Sulphate in a Cd-Contaminated Calcareous Soil	PLOS ONE			English	Article							GENOTYPIC VARIATIONS; POLLUTED SOIL; ZN; PB; ACCUMULATION; VEGETABLES; METALS; CU; MOBILITY; PHYTOREMEDIATION	To reduce Cd phytoavailability in calcareous soils, the effects of soil amendments ed mud, rape straw, and corn s combination with zinc fertilization on Cd extractability and phytoavailability to spinach, tomato, Chinese cabbage and dish were investigated in a calcareous soil with added Cd at 1.5 mg kg(-1). The results showed that water soluble and exchangeable Cd in soils was significantly decreased by the amendments themselves from 26% to 70%, which resulted in arked decrease by approximately from 34% to 77% in Cd concentration in vegetables. The amendments plus Zn lization further decreased the Cd concentration in vegetables. Also cruciferous rape straw was more effective than ramineous corn straw. In all treatments, rape straw piLls red mLld combined with Zn fertilization was most effective in decreasing Cd phytoavailabill y in soils and it is potential to be an efficient and cost-effective measure to ensure food safety or vegetable production in mildly Cd-contaminated calcareous sods	[Li, Bo; Yang, Junxing; Wei, Dongpu; Chen, Shibao; Li, Jumei; Ma, Yibing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Soil Fertil & Fertilizer Effects Long Term M, Beijing 100193, Peoples R China; [Li, Bo] Liaoning Acad Agr Sci, Inst Plant Nutr & Environm Resources, Shenyang, Peoples R China; [Yang, Junxing] Chinese Acad Agr Sci, Inst Geog Sci & Nat Resources Res, Ctr Environm Remediat, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Ma, YB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Soil Fertil & Fertilizer Effects Long Term M, Beijing 100193, Peoples R China.	ybma@caas.ac.cn		Ma, Yibing/0000-0002-9340-8181; chen, shibao/0000-0003-0159-2434	Special Fund for Public Industry in China (Agriculture) [200903015]; Natural Science Foundation of China [41201312, 41401361]	Special Fund for Public Industry in China (Agriculture); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the Special Fund for Public Industry in China (Agriculture, 200903015) and the Natural Science Foundation of China (41201312 and 41401361) for financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELSABOUR MF, 1988, SOIL SCI, V145, P424, DOI 10.1097/00010694-198806000-00004; Alexander PD, 2006, ENVIRON POLLUT, V144, P736, DOI 10.1016/j.envpol.2006.03.001; Almas A, 1999, J ENVIRON QUAL, V28, P1742, DOI 10.2134/jeq1999.00472425002800060008x; Basta N, 2000, J SOIL CONTAM, V9, P149, DOI 10.1080/10588330008984181; Castaldi P, 2005, CHEMOSPHERE, V60, P365, DOI 10.1016/j.chemosphere.2004.11.098; Castaldi P, 2009, GEODERMA, V151, P241, DOI 10.1016/j.geoderma.2009.04.009; Chen S B, 2012, CHINA ENV SCI, V32, P1309; Cui YS, 2008, GEODERMA, V146, P370, DOI 10.1016/j.geoderma.2008.06.010; Demirezen D, 2006, J FOOD QUALITY, V29, P252, DOI 10.1111/j.1745-4557.2006.00072.x; Friesl W, 2006, ENVIRON POLLUT, V144, P40, DOI 10.1016/j.envpol.2006.01.012; Friesl W, 2003, J PLANT NUTR SOIL SC, V166, P191, DOI 10.1002/jpln.200390028; Friesl-Hanl W, 2009, ENVIRON GEOCHEM HLTH, V31, P581, DOI 10.1007/s10653-009-9256-3; Garau G, 2011, J HAZARD MATER, V185, P1241, DOI 10.1016/j.jhazmat.2010.10.037; Giordani C, 2005, ENVIRON MANAGE, V36, P675, DOI 10.1007/s00267-004-0171-1; Harada E, 2002, J PLANT PHYSIOL, V159, P445, DOI 10.1078/0176-1617-00733; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Hooda Peter S., 2010, TRACE ELEMENTS SOILS; Jackson M.L., 1958, SOIL CHEM ANAL, DOI DOI 10.1002/JPLN.19590850311; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Koleli N, 2004, ENVIRON POLLUT, V131, P453, DOI 10.1016/j.envpol.2004.02.012; KUBOI T, 1986, PLANT SOIL, V92, P405, DOI 10.1007/BF02372488; Lee SH, 2011, GEODERMA, V161, P1, DOI 10.1016/j.geoderma.2010.11.008; Li B, 2010, THESIS CHINESE ACAD; Li J, 2006, ENVIRON GEOCHEM HLTH, V28, P37, DOI 10.1007/s10653-005-9009-x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Liu YJ, 2011, GEODERMA, V163, P1, DOI 10.1016/j.geoderma.2011.04.002; Lombi E, 2003, ENVIRON SCI TECHNOL, V37, P979, DOI 10.1021/es026083w; Lombi E, 2002, ENVIRON POLLUT, V118, P445, DOI 10.1016/S0269-7491(01)00295-0; Lombi E, 2002, ENVIRON POLLUT, V118, P135; Luo L, 2011, ENVIRON POLLUT, V159, P1108, DOI 10.1016/j.envpol.2011.02.019; Marchiol L, 2004, WATER AIR SOIL POLL, V158, P345, DOI 10.1023/B:WATE.0000044862.51031.fb; McLaughlin MJ, 1999, FIELD CROP RES, V60, P143, DOI 10.1016/S0378-4290(98)00137-3; OLIVER DP, 1994, J ENVIRON QUAL, V23, P705, DOI 10.2134/jeq1994.00472425002300040013x; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; Tandy S, 2009, ENVIRON POLLUT, V157, P690, DOI 10.1016/j.envpol.2008.08.006; TLUSTOS P, 1995, ROST VYROBA, V41, P31; Wang G, 2006, ENVIRON POLLUT, V144, P127, DOI 10.1016/j.envpol.2005.12.023; Wang L Q, 2009, THESIS CAPITAL NORMA; Wu FL, 2011, AGR SCI CHINA, V10, P267, DOI 10.1016/S1671-2927(11)60004-7; Yang JX, 2011, SOIL SEDIMENT CONTAM, V20, P400, DOI 10.1080/15320383.2011.571314; Yang JX, 2010, J ENVIRON SCI, V22, P1246, DOI 10.1016/S1001-0742(09)60245-X; Yang JX, 2014, FRONT ENV S IN PRESS	42	14	17	9	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109967	10.1371/journal.pone.0109967	http://dx.doi.org/10.1371/journal.pone.0109967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303439	Green Submitted, gold, Green Published			2022-12-25	WOS:000343730400098
J	Li, TT; Hu, YY; Du, XH; Tang, H; Shen, CH; Wu, JS				Li, Tingting; Hu, Yuanyuan; Du, Xuhua; Tang, Hui; Shen, Chaohua; Wu, Jiasheng			Salicylic Acid Alleviates the Adverse Effects of Salt Stress in Torreya grandis cv. Merrillii Seedlings by Activating Photosynthesis and Enhancing Antioxidant Systems	PLOS ONE			English	Article							CARBON ASSIMILATION; OSMOTIC-STRESS; GAS-EXCHANGE; SALINITY; TOLERANCE; GROWTH; PLANTS; NACL; ADAPTATION; CULTIVARS	Background: Salt stress is a major factor limiting plant growth and productivity. Salicylic acid (SA) has been shown to ameliorate the adverse effects of environmental stress on plants. To investigate the protective role of SA in ameliorating salt stress on Torreya grandis (T. grandis) trees, a pot experiment was conducted to analyze the biomass, relative water content (RWC), chlorophyll content, net photosynthesis (Pn), gas exchange parameters, relative leakage conductivity (REC), malondialdehyde (MDA) content, and activities of superoxide dismutase (SOD) and peroxidase (POD) of T. grandis under 0.2% and 0.4% NaCl conditions with and without SA. Methodology/Principal Findings: The exposure of T. grandis seedlings to salt conditions resulted in reduced growth rates, which were associated with decreases in RWC and Pn and increases in REC and MDA content. The foliar application of SA effectively increased the chlorophyll (chl (a+b)) content, RWC, net CO2 assimilation rates (Pn), and proline content, enhanced the activities of SOD, CAT and POD, and minimized the increases in the REC and MDA content. These changes increased the capacity of T. grandis in acclimating to salt stress and thus increased the shoot and root dry matter. However, when the plants were under 0% and 0.2% NaCl stress, the dry mass of the shoots and roots did not differ significantly between SA-treated plants and control plants. Conclusions: SA induced the salt tolerance and increased the biomass of T. grandis cv. by enhancing the chlorophyll content and activity of antioxidative enzymes, activating the photosynthetic process, and alleviating membrane injury. A better understanding about the effect of salt stress in T. grandis is vital, in order gain knowledge over expanding the plantations to various regions and also for the recovery of T. grandis species in the future.	[Li, Tingting; Hu, Yuanyuan; Tang, Hui; Shen, Chaohua; Wu, Jiasheng] Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China; [Li, Tingting; Hu, Yuanyuan; Tang, Hui; Shen, Chaohua; Wu, Jiasheng] Zhejiang A&F Univ, Sch Forestry & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Du, Xuhua] China Natl Bamboo Res Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang A&F University; Zhejiang A&F University; Chinese Academy of Forestry; China National Bamboo Research Center, CAF	Wu, JS (corresponding author), Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China.	wujs@zafu.edu.cn	du, xuhua/L-3423-2013; xuhua, du/AAE-2404-2021	du, xuhua/0000-0003-3156-3968; 	Fruit Innovation Team Project of Zhejiang Province [2009R50033-7]; Major Project of National Spark Plan of China [2012GA700001]	Fruit Innovation Team Project of Zhejiang Province; Major Project of National Spark Plan of China	This project was supported in part by the Fruit Innovation Team Project of Zhejiang Province (2009R50033-7) and the Major Project of National Spark Plan of China (2012GA700001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Arfan M, 2007, J PLANT PHYSIOL, V164, P685, DOI 10.1016/j.jplph.2006.05.010; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUGNOLI E, 1992, PLANTA, V187, P335, DOI 10.1007/BF00195657; Chen BQ, 2006, FITOTERAPIA, V77, P262, DOI 10.1016/j.fitote.2006.03.019; Cheng XiaoJian, 2007, Journal of Zhejiang Forestry College, V24, P383; Costa H, 2002, PLANT SCI, V162, P939, DOI 10.1016/S0168-9452(02)00051-1; El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1; Fariduddin Q, 2003, PHOTOSYNTHETICA, V41, P281, DOI 10.1023/B:PHOT.0000011962.05991.6c; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Gonzalez L, 2001, HANDBOOK OF PLANT ECOPHYSIOLOGY TECHNIQUES, P207; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; Gunes A, 2007, J PLANT PHYSIOL, V164, P728, DOI 10.1016/j.jplph.2005.12.009; Gutierrez-Coronado MA, 1998, PLANT PHYSIOL BIOCH, V36, P563, DOI 10.1016/S0981-9428(98)80003-X; Hayat Q, 2010, ENVIRON EXP BOT, V68, P14, DOI 10.1016/j.envexpbot.2009.08.005; He Y, 2014, PLANT PHYSIOL BIOCH, V74, P118, DOI 10.1016/j.plaphy.2013.11.008; Huang YJ, 2001, FEMS IMMUNOL MED MIC, V31, P163, DOI 10.1111/j.1574-695X.2001.tb00513.x; Idrees M, 2011, ACTA PHYSIOL PLANT, V33, P987, DOI 10.1007/s11738-010-0631-6; Iqbal M, 2006, J INTEGR PLANT BIOL, V48, P181, DOI 10.1111/j.1744-7909.2006.00181.x; Jaleel CA, 2008, TURK J BIOL, V32, P79; KAISER WM, 1981, PLANTA, V153, P423, DOI 10.1007/BF00394980; Kaydan D, 2007, J AGR SCI-TARIM BILI, V13, P114, DOI 10.1501/Tarimbil_0000000444; Khan MIR, 2014, PLANT PHYSIOL BIOCH, V80, P67, DOI 10.1016/j.plaphy.2014.03.026; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Khodary S. E. A., 2004, International Journal of Agriculture and Biology, V6, P5; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu AiRong, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P126; Mishra A, 1999, BIOL PLANTARUM, V42, P409, DOI 10.1023/A:1002469303670; Misra N, 2009, PLANT SCI, V177, P181, DOI 10.1016/j.plantsci.2009.05.007; Nazar R, 2011, J PLANT PHYSIOL, V168, P807, DOI 10.1016/j.jplph.2010.11.001; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Saeed MK, 2007, EX LINDL J APP SCI, V7, P269; Saleh B, 2012, SOIL ENVRON, V31, P113; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Shi Q, 2006, PLANT GROWTH REGUL, V48, P127, DOI 10.1007/s10725-005-5482-6; Steduto P, 2000, ENVIRON EXP BOT, V44, P243, DOI 10.1016/S0098-8472(00)00071-X; Stevens J, 2006, PLANT GROWTH REGUL, V49, P77, DOI 10.1007/s10725-006-0019-1; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Syeed S, 2011, ACTA PHYSIOL PLANT, V33, P877, DOI 10.1007/s11738-010-0614-7; Tang D, 2007, J ARID ENVIRON, V71, P312, DOI 10.1016/j.jaridenv.2007.05.004; Wang LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-34; Wolff RL, 1998, J AM OIL CHEM SOC, V75, P1637, DOI 10.1007/s11746-998-0105-9; Yusuf M, 2008, J INTEGR PLANT BIOL, V50, P1096, DOI 10.1111/j.1744-7909.2008.00697.x; Zheng B, 2006, RES METHODOLOGY MODE, P189; Zhou XianRong, 2012, Journal of Northeast Forestry University, V40, P42	49	136	152	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109492	10.1371/journal.pone.0109492	http://dx.doi.org/10.1371/journal.pone.0109492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302987	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400060
J	Nair, ADS; Cheng, CM; Jaworski, DC; Willard, LH; Sanderson, MW; Ganta, RR				Nair, Arathy D. S.; Cheng, Chuanmin; Jaworski, Deborah C.; Willard, Lloyd H.; Sanderson, Michael W.; Ganta, Roman R.			Ehrlichia chaffeensis Infection in the Reservoir Host (White-Tailed Deer) and in an Incidental Host (Dog) Is Impacted by Its Prior Growth in Macrophage and Tick Cell Environments	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; ODOCOILEUS-VIRGINIANUS; PERSISTENT INFECTION; NATURAL-HISTORY; ETIOLOGIC AGENT; MEMBRANE; TRANSMISSION; PATHOGEN; IXODIDAE; MOUSE	Ehrlichia chaffeensis, transmitted from Amblyomma americanum ticks, causes human monocytic ehrlichiosis. It also infects white-tailed deer, dogs and several other vertebrates. Deer are its reservoir hosts, while humans and dogs are incidental hosts. E. chaffeensis protein expression is influenced by its growth in macrophages and tick cells. We report here infection progression in deer or dogs infected intravenously with macrophage- or tick cell-grown E. chaffeensis or by tick transmission in deer. Deer and dogs developed mild fever and persistent rickettsemia; the infection was detected more frequently in the blood of infected animals with macrophage inoculum compared to tick cell inoculum or tick transmission. Tick cell inoculum and tick transmission caused a drop in tick infection acquisition rates compared to infection rates in ticks fed on deer receiving macrophage inoculum. Independent of deer or dogs, IgG antibody response was higher in animals receiving macrophage inoculum against macrophage- derived Ehrlichia antigens, while it was significantly lower in the same animals against tick cell-derived Ehrlichia antigens. Deer infected with tick cell inoculum and tick transmission caused a higher antibody response to tick cell cultured bacterial antigens compared to the antibody response for macrophage cultured antigens for the same animals. The data demonstrate that the host cell-specific E. chaffeensis protein expression influences rickettsemia in a host and its acquisition by ticks. The data also reveal that tick cell-derived inoculum is similar to tick transmission with reduced rickettsemia, IgG response and tick acquisition of E. chaffeensis.	[Nair, Arathy D. S.; Cheng, Chuanmin; Jaworski, Deborah C.; Willard, Lloyd H.; Sanderson, Michael W.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Jaworski, Deborah C.] Oklahoma State Univ, Noble Res Ctr, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Kansas State University; Oklahoma State University System; Oklahoma State University - Stillwater	Ganta, RR (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			National Institutes of Health, USA [AI070908]; Oklahoma Agricultural Experiment Station [OKL02623]; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Agricultural Experiment Station; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health, USA grant #AI070908 and the Oklahoma Agricultural Experiment Station #OKL02623. Publication of this article was supported in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BE, 1993, AM J TROP MED HYG, V49, P239, DOI 10.4269/ajtmh.1993.49.239; Breitschwerdt EB, 1998, J CLIN MICROBIOL, V36, P2645, DOI 10.1128/JCM.36.9.2645-2651.1998; Chapes SK, 2008, VET PARASITOL, V158, P344, DOI 10.1016/j.vetpar.2008.09.028; CHEN SM, 1995, INFECT IMMUN, V63, P647, DOI 10.1128/IAI.63.2.647-655.1995; Cheng C, 2008, CURR PROTOC MICROBIO, V3; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cohen SB, 2010, VECTOR-BORNE ZOONOT, V10, P435, DOI 10.1089/vbz.2009.0058; Davidson WR, 2001, J WILDLIFE DIS, V37, P538, DOI 10.7589/0090-3558-37.3.538; DAWSON JE, 1994, J CLIN MICROBIOL, V32, P2725, DOI 10.1128/JCM.32.11.2725-2728.1994; Dawson JE, 1996, AM J VET RES, V57, P1175; Dedonder SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036749; Dugan VG, 2000, J CLIN MICROBIOL, V38, P448; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; DUMLER JS, 1995, CLIN INFECT DIS, V20, P1102, DOI 10.1093/clinids/20.5.1102; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; EWING SA, 1995, J MED ENTOMOL, V32, P368, DOI 10.1093/jmedent/32.3.368; Faburay B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-83; Fritzen CM, 2011, AM J TROP MED HYG, V85, P718, DOI 10.4269/ajtmh.2011.10-0583; Gaines DN, 2014, VECTOR-BORNE ZOONOT, V14, P307, DOI 10.1089/vbz.2013.1509; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jaworski DC, 2013, VECTOR-BORNE ZOONOT, V13, P193, DOI 10.1089/vbz.2011.0868; Kocan A, 2000, EMERG INFECT DIS, V6, P477, DOI 10.3201/eid0605.000505; Kumar DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003666; Kuriakose JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024136; Li JSY, 2001, J IMMUNOL, V166, P1855; Lockhart JM, 1997, J PARASITOL, V83, P887, DOI 10.2307/3284284; McQuiston JH, 2003, J AM VET MED ASSOC, V223, P1750, DOI 10.2460/javma.2003.223.1750; Miura K, 2011, INFECT IMMUN, V79, P4947, DOI 10.1128/IAI.05640-11; Mixson TR, 2006, J MED ENTOMOL, V43, P1261, DOI 10.1603/0022-2585(2006)43[1261:POEBAR]2.0.CO;2; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Pavelites JJ, 2011, FORENSIC SCI MED PAT, V7, P287, DOI 10.1007/s12024-010-9219-0; SAMBROOK J, 2000, MOL CLONING LAB MANU; Seo GM, 2008, INFECT IMMUN, V76, P4823, DOI 10.1128/IAI.00484-08; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Stone JH, 2004, JAMA-J AM MED ASSOC, V292, P2263, DOI 10.1001/jama.292.18.2263; Telford SR, 1996, VET MICROBIOL, V52, P103, DOI 10.1016/0378-1135(96)00064-8; Varela AS, 2005, VECTOR-BORNE ZOONOT, V5, P48, DOI 10.1089/vbz.2005.5.48; Varela AS, 2003, J WILDLIFE DIS, V39, P881, DOI 10.7589/0090-3558-39.4.881; Varela-Stokes AS, 2006, VECTOR-BORNE ZOONOT, V6, P140, DOI 10.1089/vbz.2006.6.140; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Winslow GM, 2005, ANN NY ACAD SCI, V1063, P395, DOI 10.1196/annals.1355.071; Winslow GM, 2005, CURR OPIN INFECT DIS, V18, P217, DOI 10.1097/01.qco.0000168381.86024.cf; Winslow GM, 1998, INFECT IMMUN, V66, P3892, DOI 10.1128/IAI.66.8.3892-3899.1998; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Yu DH, 2008, VECTOR-BORNE ZOONOT, V8, P355, DOI 10.1089/vbz.2007.0226; Zhang HZ, 2004, INFECT IMMUN, V72, P498, DOI 10.1128/IAI.72.1.498-507.2004; Zhang XF, 2003, J MED MICROBIOL, V52, P1021, DOI 10.1099/jmm.0.05234-0; ZUBLER MA, 1987, ARCH INTERN MED, V147, P197, DOI 10.1001/archinte.1987.00370020017008	55	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109056	10.1371/journal.pone.0109056	http://dx.doi.org/10.1371/journal.pone.0109056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303515	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400043
J	Olle-Monge, M; Munoz, X; Vanoirbeek, JAJ; Gomez-Olles, S; Morell, F; Cruz, MJ				Olle-Monge, Marta; Munoz, Xavier; Vanoirbeek, Jeroen A. J.; Gomez-Olles, Susana; Morell, Ferran; Cruz, Maria-Jesus			Persistence of Asthmatic Response after Ammonium Persulfate-Induced Occupational Asthma in Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; TRIMELLITIC ANHYDRIDE; MOUSE MODELS; EXPOSURE; SENSITIZATION; CELLS; SALTS; HAIRDRESSERS; ALLERGEN; AGENTS	Introduction:Since persulfate salts are an important cause of occupational asthma (OA), we aimed to study the persistence of respiratory symptoms after a single exposure to ammonium persulfate (AP) in AP-sensitized mice. Material and Methods: BALB/c mice received dermal applications of AP or dimethylsulfoxide (DMSO) on days 1 and 8. On day 15, they received a single nasal instillation of AP or saline. Airway hyperresponsiveness (AHR) was assessed using methacholine provocation, while pulmonary inflammation was evaluated in bronchoalveolar lavage (BAL), and total serum immunoglobulin E (IgE), IgG1 and IgG2a were measured in blood at 1, 4, 8, 24 hours and 4, 8, 15 days after the single exposure to the causal agent. Histological studies of lungs were assessed. Results: AP-treated mice showed a sustained increase in AHR, lasting up to 4 days after the challenge. There was a significant increase in the percentage of neutrophils 8 hours after the challenge, which persisted for 24 hours in AP-treated mice. The extent of airway inflammation was also seen in the histological analysis of the lungs from challenged mice. Slight increases in total serum IgE 4 days after the challenge were found, while IgG gradually increased further 4 to 15 days after the AP challenge in AP-sensitized mice. Conclusions: In AP-sensitized mice, an Ig-independent response is induced after AP challenge. AHR appears immediately, but airway neutrophil inflammation appears later. This response decreases in time; at early stages only respiratory and inflammatory responses decrease, but later on immunological response decreases as well.	[Olle-Monge, Marta; Munoz, Xavier; Gomez-Olles, Susana; Morell, Ferran; Cruz, Maria-Jesus] Hosp Univ Vall Hebron, Serv Neumol, Barcelona, Spain; [Olle-Monge, Marta; Munoz, Xavier; Gomez-Olles, Susana; Morell, Ferran; Cruz, Maria-Jesus] CIBER Enfermedades Resp CibeRes, Barcelona, Spain; [Olle-Monge, Marta] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Vanoirbeek, Jeroen A. J.] Katholieke Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; KU Leuven; Autonomous University of Barcelona	Cruz, MJ (corresponding author), Hosp Univ Vall Hebron, Serv Neumol, Barcelona, Spain.	mj.cruz@vhir.org	Vanoirbeek, Jeroen/D-5183-2016; Cruz, Maria Jesus/I-9073-2014	Vanoirbeek, Jeroen/0000-0001-5508-3518; Cruz, Maria Jesus/0000-0001-9759-5466; Munoz, Xavier/0000-0002-8693-022X; Morell Brotad, Ferran/0000-0002-7206-4543	Miguel Servet programme from Instituto de Salud Carlos III [CP12/03101]; Fundacio Catalana de Pneumologia (FUCAP); FIS [PI10/00782]	Miguel Servet programme from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacio Catalana de Pneumologia (FUCAP); FIS(Instituto de Salud Carlos III)	MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101). This project was supported by the Fundacio Catalana de Pneumologia (FUCAP) and FIS PI10/00782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto-Korte K, 2003, CONTACT DERMATITIS, V49, P22, DOI 10.1111/j.0105-1873.2003.00134.x; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Bettiol J, 2002, ALLERGY, V57, P1145, DOI 10.1034/j.1398-9995.2002.23586.x; BLAINEY AD, 1986, THORAX, V41, P42, DOI 10.1136/thx.41.1.42; Cruz MJ, 2009, CONTACT DERMATITIS, V60, P85, DOI 10.1111/j.1600-0536.2008.01477.x; de Groene GJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006308.pub3; De Vooght V, 2010, THORAX, V65, P252, DOI 10.1136/thx.2009.121293; FISHER AA, 1976, ARCH DERMATOL, V112, P1407, DOI 10.1001/archderm.112.10.1407; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hawrylowicz CM, 2005, J EXP MED, V202, P1459, DOI 10.1084/jem.20052211; Hox V, 2014, ALLERGY, V69, P282, DOI 10.1111/all.12347; Hox V, 2013, AM J RESP CRIT CARE, V187, P486, DOI 10.1164/rccm.201208-1358OC; Janssenheininger YM, 2012, J ALLERGY THER S1, V2012; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kariyawasam HH, 2007, AM J RESP CRIT CARE, V175, P896, DOI 10.1164/rccm.200609-1260OC; Kogevinas M, 2007, LANCET, V370, P336, DOI 10.1016/S0140-6736(07)61164-7; Lemiere C, 2003, ANN ALLERG ASTHMA IM, V90, P52, DOI 10.1016/S1081-1206(10)61650-X; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Maes T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-7; Maghni K, 2004, AM J RESP CRIT CARE, V169, P367, DOI 10.1164/rccm.200309-1238OC; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Moscato G, 2005, CHEST, V128, P3590, DOI 10.1378/chest.128.5.3590; Munoz X, 2003, CHEST, V123, P2124, DOI 10.1378/chest.123.6.2124; Munoz X, 2008, ARCH BRONCONEUMOL, V44, P140, DOI 10.1016/S1579-2129(08)60028-2; Nicholson PJ, 2005, OCCUP ENVIRON MED, V62, P290, DOI 10.1136/oem.2004.016287; Park HS, 1999, J ALLERGY CLIN IMMUN, V104, P847, DOI 10.1016/S0091-6749(99)70297-6; PEPYS J, 1976, CLIN ALLERGY, V6, P399, DOI 10.1111/j.1365-2222.1976.tb01922.x; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Pralong JA, 2012, J ALLERGY, V2012; Redlich CA, 2002, AM J RESP CELL MOL, V27, P385, DOI 10.1165/rcmb.F249; Sehra S, 2003, J IMMUNOL, V171, P2080, DOI 10.4049/jimmunol.171.4.2080; Tarlo SA, 2003, ANN ALLERG ASTHMA IM, V90, P19, DOI 10.1016/S1081-1206(10)61643-2; Toren Kjell, 2009, BMC Pulm Med, V9, P7, DOI 10.1186/1471-2466-9-7; Uter W, 2003, CONTACT DERMATITIS, V49, P236, DOI 10.1111/j.0105-1873.2003.0233.x; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Yawalkar N, 1999, ANN ALLERG ASTHMA IM, V82, P401, DOI 10.1016/S1081-1206(10)63291-7; Zhang XD, 2002, ALLERGY, V57, P620, DOI 10.1034/j.1398-9995.2002.03548.x	40	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109000	10.1371/journal.pone.0109000	http://dx.doi.org/10.1371/journal.pone.0109000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303285	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400041
J	Rogers, L; Koch, A				Rogers, Lock; Koch, Alan			Condition Dependent Effects on Sex Allocation and Reproductive Effort in Sequential Hermaphrodites	PLOS ONE			English	Article							MATERNAL DOMINANCE; NATURAL-SELECTION; RATIO; SIZE; EVOLUTION	Theory predicts he optimal timing of sex change will be the age or size at h h half of an individual's expected fitness comes through reproduction as a male and half through reprodLiction as a female. In this way, sex allocation across lifetime of a sequential hermaphrodite parallels the sex allocation of an outbreeding species exhibiting a 1:1 ratio of sons daughters. However, the expectation of a 1:1 sex ratio is sensitive to variation in individual condition. If individuals within population vary in condition, high-condition individuals are predicted to make increased allocations to the sex with higher variance in reproductive success. An oft-cited example of this effect is seen in red deer, Cervus elaphus, in which not hers of high condition are more likely to produce sons, while those in low condition are more likely to produce daughters. Here, we show that individual condition is predicted to similarly affect the pattern of sex allocation, and thus the allocation of reproductive effort, in sequential hermaphrodites. High-condition sex-changers are expected to obtain more than half of their fitness in the high-payoff second sex and, as a result, are expected to reduce the allocation of reproductive fort in the initial sex. While the sex ratio in populations of sequential hermaphrodites is always skewed towards an excess of the initial sex, condition dependence is predicted to increase this effect.	[Rogers, Lock] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Koch, Alan] Agnes Scott Coll, Dept Math, Decatur, GA 30030 USA		Rogers, L (corresponding author), Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA.	lrogers@agnesscott.edu						ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bellman R., 1957, DYNAMIC PROGRAMMING; CHARNOV E L, 1982; CHARNOV EL, 1986, J THEOR BIOL, V119, P283, DOI 10.1016/S0022-5193(86)80141-2; CHARNOV EL, 1989, J THEOR BIOL, V139, P431, DOI 10.1016/S0022-5193(89)80063-3; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Fisher R.A., 1930, GENETICAL THEORY NAT; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; GHISELIN MT, 1969, Q REV BIOL, V44, P189, DOI 10.1086/406066; LEIGH EG, 1976, P NATL ACAD SCI USA, V73, P3656, DOI 10.1073/pnas.73.10.3656; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Mangel M., 1988, DYNAMIC MODELING BEH; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Roff Derek A., 1992; Rogers L, 2003, BEHAV ECOL, V14, P447, DOI 10.1093/beheco/14.3.447; Rogers L, 2001, AM NAT, V158, P543, DOI 10.1086/323119; Rogers L, 2011, EVOL ECOL RES, V13, P387; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Stearns S.C., 1992, pi; StMary CM, 1997, AM NAT, V150, P73, DOI 10.1086/286057; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WARNER RR, 1980, EVOLUTION, V34, P508, DOI 10.1111/j.1558-5646.1980.tb04840.x; WARNER RR, 1975, AM NAT, V109, P61, DOI 10.1086/282974; WARNER RR, 1975, SCIENCE, V190, P633, DOI 10.1126/science.1188360; Warner RR., 1978, SMITHSON CONTRIB ZOO, V254, P1, DOI [10.5479/si.00810282.254, DOI 10.5479/SI.00810282.254]; Williams G. C., 1966, P307; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002	32	0	0	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109626	10.1371/journal.pone.0109626	http://dx.doi.org/10.1371/journal.pone.0109626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302941	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400071
J	Sano, O; Ito, S; Kato, R; Shimizu, Y; Kobayashi, A; Kimura, Y; Kioka, N; Hanada, K; Ueda, K; Matsuo, M				Sano, Osamu; Ito, Shiho; Kato, Reiko; Shimizu, Yuji; Kobayashi, Aya; Kimura, Yasuhisa; Kioka, Noriyuki; Hanada, Kentaro; Ueda, Kazumitsu; Matsuo, Michinori			ABCA1, ABCG1, and ABCG4 Are Distributed to Distinct Membrane Meso-Domains and Disturb Detergent-Resistant Domains on the Plasma Membrane	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; CELLULAR CHOLESTEROL EFFLUX; CASSETTE TRANSPORTERS G1; LIPID RAFTS; TANGIER-DISEASE; P-GLYCOPROTEIN; EXTRACELLULAR DOMAIN; MEDIATE CHOLESTEROL; ATPASE ACTIVITY	ATP-binding cassette A1 (ABCA1), ABCG1, and ABCG4 are lipid transporters that mediate the efflux of cholesterol from cells. To analyze the characteristics of these lipid transporters, we examined and compared their distributions and lipid efflux activity on the plasma membrane. The efflux of cholesterol mediated by ABCA1 and ABCG1, but not ABCG4, was affected by a reduction of cellular sphingomyelin levels. Detergent solubility and gradient density ultracentrifugation assays indicated that ABCA1, ABCG1, and ABCG4 were distributed to domains that were solubilized by Triton X-100 and Brij 96, resistant to Triton X-100 and Brij 96, and solubilized by Triton X-100 but resistant to Brij 96, respectively. Furthermore, ABCG1, but not ABCG4, was colocalized with flotillin-1 on the plasma membrane. The amounts of cholesterol extracted by methyl-beta-cyclodextrin were increased by ABCA1, ABCG1, or ABCG4, suggesting that cholesterol in non-raft domains was increased. Furthermore, ABCG1 and ABCG4 disturbed the localization of caveolin-1 to the detergent-resistant domains and the binding of cholera toxin subunit B to the plasma membrane. These results suggest that ABCA1, ABCG1, and ABCG4 are localized to distinct membrane meso-domains and disturb the meso-domain structures by reorganizing lipids on the plasma membrane; collectively, these observations may explain the different substrate profiles and lipid efflux roles of these transporters.	[Sano, Osamu; Ito, Shiho; Kato, Reiko; Shimizu, Yuji; Kobayashi, Aya; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu; Matsuo, Michinori] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo, Kyoto, Japan; [Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo, Kyoto, Japan; [Matsuo, Michinori] Kyoto Womens Univ, Fac Home Econ, Dept Food & Nutr, Kyoto, Japan	Kyoto University; National Institute of Infectious Diseases (NIID); Kyoto University; Kyoto Womens University	Matsuo, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo, Kyoto, Japan.	matsuomi@kyoto-wu.ac.jp	Kobayashi, Aya/AAA-2530-2020	Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X; Kimura, Yasuhisa/0000-0001-6466-1324; Hanada, Kentaro/0000-0003-1383-2781	JSPS KAKENHI [21688007, 24580139, 26660071, 20056016]; World Premier International Research Center Initiative (WPI initiative) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; BRAIN (the Bio-oriented Technology Research Advancement Institution)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); World Premier International Research Center Initiative (WPI initiative) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; BRAIN (the Bio-oriented Technology Research Advancement Institution)	This work was supported by a Grant-in-aid for Scientific Research for Young Scientists (A) (JSPS KAKENHI Grant Number 21688007), by a Grant-in-aid for Scientific Research (B), by a Grant-in-aid for Scientific Research (B) (JSPS KAKENHI Grant Number 24580139), by a Grant-in-aid for Exploratory Research (JSPS KAKENHI Grant Number 26660071), by a Grant-in-aid for Scientific Research on Priority Areas (MEXT KAKENHI Grant Number 20056016), and by the World Premier International Research Center Initiative (WPI initiative) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants from BRAIN (the Bio-oriented Technology Research Advancement Institution). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; ALVAREZ E, 1993, MECH AGEING DEV, V71, P1, DOI 10.1016/0047-6374(93)90030-U; Bacso Z, 2004, CYTOM PART A, V61A, P105, DOI 10.1002/cyto.a.20081; Baldan A, 2006, J BIOL CHEM, V281, P29401, DOI 10.1074/jbc.M606597200; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; DRESSLER KA, 1991, J BIOL CHEM, V266, P11522; Feigenson GW, 2006, NAT CHEM BIOL, V2, P560, DOI 10.1038/nchembio1106-560; Fielding CJ, 2003, BBA-BIOMEMBRANES, V1610, P219, DOI 10.1016/S0005-2736(03)00020-8; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gu HM, 2014, BBA-MOL CELL BIOL L, V1841, P847, DOI 10.1016/j.bbalip.2014.02.002; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hirata T, 2009, BIOSCI BIOTECH BIOCH, V73, P619, DOI 10.1271/bbb.80694; Hirayama H, 2013, J LIPID RES, V54, P496, DOI 10.1194/jlr.M033209; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Ismair MG, 2009, HEPATOLOGY, V49, P1673, DOI 10.1002/hep.22807; Jacobs C, 2004, FEBS LETT, V565, P70, DOI 10.1016/j.febslet.2004.03.076; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Matsuo M, 2011, BBA-MOL CELL BIOL L, V1811, P31, DOI 10.1016/j.bbalip.2010.10.004; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Nagao K, 2007, J BIOL CHEM, V282, P14868, DOI 10.1074/jbc.M611230200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; OKWU AK, 1994, J LIPID RES, V35, P644; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Radeva G, 2005, FEBS J, V272, P4924, DOI 10.1111/j.1742-4658.2005.04905.x; RICARDO MJ, 1986, J IMMUNOL, V136, P1054; Rocchi E, 2000, BIOCHEM BIOPH RES CO, V271, P42, DOI 10.1006/bbrc.2000.2590; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sano O, 2007, J LIPID RES, V48, P2377, DOI 10.1194/jlr.M700139-JLR200; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Seres L, 2008, BBA-BIOMEMBRANES, V1778, P2378, DOI 10.1016/j.bbamem.2008.06.010; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Terasaka N, 2010, ARTERIOSCL THROM VAS, V30, P2219, DOI 10.1161/ATVBAHA.110.213215; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Wojcik AJ, 2008, J IMMUNOL, V180, P4273, DOI 10.4049/jimmunol.180.6.4273; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, CIRC RES, V106, P1861, DOI 10.1161/CIRCRESAHA.110.217281; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	67	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109886	10.1371/journal.pone.0109886	http://dx.doi.org/10.1371/journal.pone.0109886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302608	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400090
J	Tseng, CH				Tseng, Chin-Hsiao			Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; POPULATION-BASED COHORT; 12-YEAR FOLLOW-UP; BLADDER-CANCER; INSULIN USE; PANCREATIC-CANCER; INHIBITS GROWTH; MORTALITY; SMOKING; CARCINOMA	Background: Whether metformin may affect thyroid cancer risk has not been studied. This study investigated the association between metformin use and thyroid cancer risk in Taiwanese patients with type 2 diabetes mellitus. Methods: The reimbursement databases of all diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2006 and 1,414,723 patients with type 2 diabetes were followed for thyroid cancer incidence until the end of 2009. Incidences for ever-users, never-users and subgroups of metformin exposure using tertile cutoffs for cumulative duration of therapy and cumulative dose were calculated and adjusted hazard ratios were estimated by Cox regression. Additional sensitivity analyses were conducted. Results: There were 795,321 ever-users and 619,402 never-users, with respective numbers of incident thyroid cancer of 683 (0.09%) and 1,614 (0.26%), and respective incidence of 24.09 and 87.33 per 100,000 person-years. The overall fully adjusted hazard ratio (95% confidence interval) was 0.683 (0.598-0.780), and all categories of the dose-response parameters showed significantly lower risk with P-trends <0.0001. The protective effect of metformin on thyroid cancer incidence was also supported by sensitivity analyses, disregarding age (<50 or >= 50 years) and sex; and was not affected by excluding users of insulin, sulfonylurea, and insulin and/or sulfonylurea respectively, by previous diagnosis of other cancers or by potential detection examinations that might lead to differential diagnosis of thyroid cancer. Conclusions: This study provides evidence for the first time that metformin use in patients with type 2 diabetes may reduce the risk of thyroid cancer.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net		TSENG, CHIN-HSIAO/0000-0001-9545-7123	National Science Council of Taiwan [NSC102-2314-B-002-067]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the National Science Council (NSC102-2314-B-002-067) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2012, PHARMACOL THERAPEUT, V133, P108, DOI 10.1016/j.pharmthera.2011.09.004; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Cappelli C, EUR J ENDOCRINOL, V167, P261; Chen GF, 2012, J CLIN ENDOCR METAB, V97, pE510, DOI 10.1210/jc.2011-1754; Diez JJ, 2013, CLIN ENDOCRINOL, V78, P505, DOI 10.1111/j.1365-2265.2012.04468.x; Dong XQ, 2012, CANCER EPIDEMIOL, V36, P206, DOI 10.1016/j.canep.2011.05.013; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Gursoy A, 2010, MED HYPOTHESES, V74, P35, DOI 10.1016/j.mehy.2009.08.021; Ittermann T, 2013, EUR J ENDOCRINOL, V169, P9, DOI 10.1530/EJE-13-0101; Klubo-Gwiezdzinska J, 2013, J CLIN ENDOCR METAB, V98, P3269, DOI 10.1210/jc.2012-3799; Klubo-Gwiezdzinska J, 2012, ENDOCR-RELAT CANCER, V19, P447, DOI 10.1530/ERC-12-0046; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Malaguarnera R, 2011, J CLIN ENDOCR METAB, V96, P766, DOI 10.1210/jc.2010-1255; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; Nar A, 2009, ACTA DIABETOL, V46, P113, DOI 10.1007/s00592-008-0067-2; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Rezzonico J, 2011, METAB SYNDR RELAT D, V9, P69, DOI 10.1089/met.2010.0026; Rizos CV, 2013, EUR J PHARMACOL, V705, P96, DOI 10.1016/j.ejphar.2013.02.038; Shih SR, 2012, EXP DIABETES RES, DOI 10.1155/2012/578285; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2011, DIABETOLOGIA, V54, P2009, DOI 10.1007/s00125-011-2171-z; Tseng CH, 2014, EUR J CLIN INVEST, V44, P736, DOI 10.1111/eci.12290; Tseng CH, 2014, BREAST CANCER RES TR, V145, P785, DOI 10.1007/s10549-014-2985-8; Tseng CH, 2014, ACTA DIABETOL, V51, P295, DOI 10.1007/s00592-014-0562-6; Tseng CH, 2014, J ENVIRON SCI HEAL C, V32, P1, DOI 10.1080/10590501.2014.877645; Tseng CH, 2013, ACTA DIABETOL, V50, P879, DOI 10.1007/s00592-013-0471-0; Tseng CH, 2013, CLIN GENITOURIN CANC, V11, P508, DOI 10.1016/j.clgc.2013.04.019; Tseng CH, 2013, HEPATOL INT, V7, P693, DOI 10.1007/s12072-012-9405-0; Tseng CH, 2013, CANCER EPIDEMIOL, V37, P385, DOI 10.1016/j.canep.2013.03.013; Tseng CH, 2013, EUR J CLIN INVEST, V43, P595, DOI 10.1111/eci.12086; Tseng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053096; Tseng CH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-7; Tseng CH, 2013, PANCREAS, V42, P42, DOI 10.1097/MPA.0b013e3182571ba9; Tseng CH, 2012, J ENVIRON SCI HEAL C, V30, P368, DOI 10.1080/10590501.2012.735519; Tseng CH, 2012, EUR J ENDOCRINOL, V167, P409, DOI 10.1530/EJE-12-0369; Tseng CH, 2012, METABOLISM, V61, P1003, DOI 10.1016/j.metabol.2011.11.015; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Tseng CH, 2011, GUT, V60, P774, DOI 10.1136/gut.2010.226522; Tseng CH, 2009, ANN MED, V41, P371, DOI 10.1080/07853890902729778; Vigersky RA, 2006, J CLIN ENDOCR METAB, V91, P225, DOI 10.1210/jc.2005-1210; Willey CJ, 2006, AM J MANAG CARE, V12, P435; Wurth R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/126586; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050	43	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109852	10.1371/journal.pone.0109852	http://dx.doi.org/10.1371/journal.pone.0109852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303400	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400087
J	Vandervoort, KG; Brelles-Marino, G				Vandervoort, Kurt G.; Brelles-Marino, Graciela			Plasma-Mediated Inactivation of Pseudomonas aeruginosa Biofilms Grown on Borosilicate Surfaces under Continuous Culture System	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE; STERILIZATION	Biofilms are microbial communities attached to a surface and embedded in a matrix composed of exopolysaccharides and excreted nucleic acids. Bacterial biofilms are responsible for undesirable effects such as disease, prostheses colonization, biofouling, equipment damage, and pipe plugging. Biofilms are also more resilient than free-living cells to regular sterilization methods and therefore it is indispensable to develop better ways to control and remove them. The use of gas discharge plasmas is a good alternative since plasmas contain a mixture of reactive agents well-known for their decontamination potential against free microorganisms. We have previously reported that Pseudomonas aeruginosa biofilms were inactivated after a 1-min plasma exposure. We determined that the adhesiveness and the thickness of Pseudomonas biofilms grown on borosilicate were reduced. We also reported sequential morphological changes and loss of viability upon plasma treatment. However, the studies were carried out in batch cultures. The use of a continuous culture results in a more homogenous environment ensuring reproducible biofilm growth. The aim of this work was to study plasma-mediated inactivation of P. aeruginosa biofilms grown on borosilicate in a continuous culture system. In this paper we show that biofilms grown on glass under continuous culture can be inactivated by using gas discharge plasma. Both biofilm architecture and cell culturabilty are impacted by the plasma treatment. The inactivation kinetics is similar to previously described ones and cells go through sequential changes ranging from minimal modification without loss of viability at short plasma exposure times, to major structure and viability loss at longer exposure times. We report that changes in biofilm structure leading to the loss of culturability and viability are related to a decrease of the biofilm matrix adhesiveness. To our knowledge, there has been no attempt to evaluate the inactivation/sterilization of biofilms grown in a continuous system.	[Vandervoort, Kurt G.] Calif State Polytech Univ Pomona, Dept Phys & Astron, Pomona, CA 91768 USA; [Brelles-Marino, Graciela] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona; California State University System; California State Polytechnic University Pomona	Brelles-Marino, G (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Ctr Res & Dev Ind Fermentat, La Plata, Argentina.	gbrelles@biotec.quimica.unlp.edu.ar			National Institutes of Health Grant SCORE SC3 [1SC3GM088070]; National Science Foundation Nanotechnology Undergraduate Education Program [0406533]; Agencia Nacional de Promocion Cientifica y Tecnologica Proyectos de Investigacion Cientifica y Tecnologica Argentina [PICT-2009-0047]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM088070] Funding Source: NIH RePORTER	National Institutes of Health Grant SCORE SC3(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Nanotechnology Undergraduate Education Program(National Science Foundation (NSF)); Agencia Nacional de Promocion Cientifica y Tecnologica Proyectos de Investigacion Cientifica y Tecnologica Argentina; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant SCORE SC3 # 1SC3GM088070 to GBM, National Science Foundation Nanotechnology Undergraduate Education Program, award # 0406533 to KGV and Agencia Nacional de Promocion Cientifica y Tecnologica Proyectos de Investigacion Cientifica y Tecnologica Argentina PICT-2009-0047 to GBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Akishev, 2012, PLASMA BIODECONTAMIN, P135, DOI DOI 10.1007/978-94-007-2852-3_11; Akishev YS, 2005, P 2 INT WORKSH COLD, P69; Akishev Y, 2008, PURE APPL CHEM, V80, P1953, DOI 10.1351/pac200880091953; Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Becker K, 2005, PLASMA PHYS CONTR F, V47, pB513, DOI 10.1088/0741-3335/47/12B/S37; Brelles-Marino G, 2010, ENVIRON RES ADV, P75; BRELLESMARINO G, 2005, P 2 INT WORKSH COLD, P69; Bryers JD, 2004, ASM NEWS, V70, P232; Davies D, 1999, CLIN MICROBIAL INFEC, V5, p5S7; Gillis RJ, 2004, J CLIN MICROBIOL, V42, P5842, DOI 10.1128/JCM.42.12.5842-5845.2004; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; International Standard, 2000, 14937 ISO; ISO, 1994, 11134 ISO; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Jones R, 2002, LANGMUIR, V18, P8045, DOI 10.1021/la0259196; Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482; Laroussi M, 1996, IEEE T PLASMA SCI, V24, P1188, DOI 10.1109/27.533129; Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899; Laroussi M, 2010, BIOL ENV APPL GAS DI, P3; Oh YJ, 2009, ULTRAMICROSCOPY, V109, P874, DOI 10.1016/j.ultramic.2009.03.042; Park SR, 2001, WATER RES, V35, P1624, DOI 10.1016/S0043-1354(00)00582-0; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887; Tanaka G, 2000, CHEMOTHERAPY, V46, P36, DOI 10.1159/000007254; Tummler B, 1999, MOL MED TODAY, V5, P351, DOI 10.1016/S1357-4310(99)01506-3; Vandervoort KG, 2008, IEEE T PLASMA SCI, V36, P1296, DOI 10.1109/TPS.2008.917953; Zelaya AJ, 2010, IEEE T PLASMA SCI, V38, P3398, DOI 10.1109/TPS.2010.2082570; Zhao LM, 2005, APPL ENVIRON MICROB, V71, P955, DOI 10.1128/AEM.71.2.955-960.2005	30	32	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108512	10.1371/journal.pone.0108512	http://dx.doi.org/10.1371/journal.pone.0108512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302815	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400015
J	Xie, ZZ; Ling, X; Wang, DD; Fang, C; Liu, QY; Li, ZH; Liu, XC; Zhang, Y; Li, SS; Lin, HR				Xie Zhenzhen; Xiao Ling; Wang Dengdong; Fang Chao; Liu Qiongyu; Li Zihao; Liu Xiaochun; Zhang Yong; Li Shuisheng; Lin Haoran			Transcriptome Analysis of the Trachinotus ovatus: Identification of Reproduction, Growth and Immune-Related Genes and Microsatellite Markers	PLOS ONE			English	Article							DISEASE RESISTANCE; SEX DETERMINATION; FISH; TOOL; POLYMORPHISM; ASSOCIATION; EXPRESSION; DISCOVERY; MYOSTATIN; ENHANCE	Background: The Trachinotus ovatus (Teleostei, Carangidae) is an economically important marine fish species in the world. However, the lack of genomic information regarding this species limits our understanding of the genetics and biological mechanisms in Trachinotus ovatus. In this study, high throughput transcriptome sequencing was used to obtain comprehensive genomic information in Trachinotus ovatus. Principal Findings: Transcriptome sequencing was performed by using Illumina paired-end sequencing technology. The 98,534,862 high quality reads were yielded, and were de novo assembled into 156,094 unigenes with an average sequence length of 1179 bp. Transcriptome annotation revealed that 75,586 and 67,923 unigenes were functionally annotated in the NCBI non-redundant database and Swiss-Prot protein database, respectively. Functional analysis demonstrated that 67,923 unigenes were grouped into 25 Cluster of Orthologous Groups (COG) functional categories, 37,976 unigenes were clustered into 61 Gene Ontology (GO) terms, and 38,172 unigenes were assigned to 275 different Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Based on the transcriptome dataset, a large number of unigenes associated with reproduction, growth and immunity were identified. Furthermore, a total number of 38,794 simple sequence repeats (SSRs) were discovered and 16 polymorphic loci were characterized in Trachinotus ovatus. Conclusion/Significance: The present study is the first transcriptome analysis of a fish species belonging to the genus Trachinotus and provides a valuable genomic resource for novel gene discovery, gene expression and regulation studies, and the identification of genetic markers in Trachinotus ovatus and the other fish of the genus Trachinotus.	[Xie Zhenzhen; Xiao Ling; Wang Dengdong; Fang Chao; Liu Qiongyu; Li Zihao; Liu Xiaochun; Zhang Yong; Li Shuisheng; Lin Haoran] Sun Yat Sen Univ, Sch Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Xie Zhenzhen; Xiao Ling; Wang Dengdong; Fang Chao; Liu Qiongyu; Li Zihao; Liu Xiaochun; Zhang Yong; Li Shuisheng; Lin Haoran] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou 510275, Guangdong, Peoples R China; [Lin Haoran] Coll Ocean, Haikou, Hainan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lshuish@mail.sysu.edu.cn; lsszy@mail.sysu.edu.cn	lin, haoran/GXH-3030-2022; Wang, Dengdong/Y-1351-2019	Wang, Dengdong/0000-0002-6026-2083	National 863 Program of China [2012AA10A407]; Special Fund for Agro-scientific Research in the Public Interest [201403008]	National 863 Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National 863 Program of China (No. 2012AA10A407) and Special Fund for Agro-scientific Research in the Public Interest (201403008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Campion CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095087; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; FAO, GLOB AQ PROD ONL QUE; Froese R, 2014, FISHBASE GLOBAL INFO; Gabillard JC, 2013, GEN COMP ENDOCR, V194, P45, DOI 10.1016/j.ygcen.2013.08.012; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Howe JR, 1997, HISTOL HISTOPATHOL, V12, P595; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; JORY D, 1985, J WORLD MARIC SOC, V16, P87, DOI DOI 10.1111/J.1749-7345.1985.TB00190.X; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Li P, 2013, GENE, V532, P63, DOI 10.1016/j.gene.2013.09.014; Li WS, 2010, SCI CHINA LIFE SCI, V53, P462, DOI 10.1007/s11427-010-0084-6; Lin SM, 2012, FISH SHELLFISH IMMUN, V32, P909, DOI 10.1016/j.fsi.2012.02.019; Lind CE, 2009, AQUACULTURE, V286, P12, DOI 10.1016/j.aquaculture.2008.09.009; Long Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056998; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma ZH, 2014, FISH PHYSL IN PRESS; Meng ZN, 2012, GENET MOL RES, V11, P3869, DOI 10.4238/2012.November.12.4; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nadjar-Boger E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-22; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ou YouJun, 2013, Journal of Fisheries of China, V37, P961; [彭敏 PENG Min], 2011, [西南农业学报, Southwest China Journal of Agricultural Sciences], V24, P1152; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Rance NE, 2013, FRONT NEUROENDOCRIN, V34, P211, DOI 10.1016/j.yfrne.2013.07.003; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousseau K, 2007, NEUROENDOCRINOLOGY, V86, P165, DOI 10.1159/000101029; Rozen S, 2000, Methods Mol Biol, V132, P365; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sirko A, 2011, INT J MOL SCI, V12, P3536, DOI 10.3390/ijms12063536; Sun LY, 2011, CONSER GENET RES, V5, P1107; Sun YH, 2012, INT J MOL SCI, V13, P14956, DOI 10.3390/ijms131114956; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veith AM, 2006, ZEBRAFISH, V3, P325, DOI 10.1089/zeb.2006.3.325; Wagh V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.273; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Wang RX, 2013, VET MICROBIOL, V162, P957, DOI 10.1016/j.vetmic.2012.09.020; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xu TJ, 2009, FISH SHELLFISH IMMUN, V27, P192, DOI 10.1016/j.fsi.2009.04.009; Yaron Z, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1500; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang Q, 2014, FISH SHELLFISH IMMUN, V38, P7, DOI 10.1016/j.fsi.2014.02.008; Zhang YX, 2006, MAR BIOTECHNOL, V8, P600, DOI 10.1007/s10126-005-6185-8; Zhou YC, 2001, MAR SCI, V25, P40	66	46	51	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109419	10.1371/journal.pone.0109419	http://dx.doi.org/10.1371/journal.pone.0109419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303650	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400055
J	Bautista-Espana, D; Anastacio-Marcelino, E; Horta-Valerdi, G; Celestino-Montes, A; Kojic, M; Negrete-Abascal, E; Reyes-Cervantes, H; Vazquez-Cruz, C; Guzman, P; Sanchez-Alonso, P				Bautista-Espana, Dolores; Anastacio-Marcelino, Estela; Horta-Valerdi, Guillermo; Celestino-Montes, Antonio; Kojic, Milorad; Negrete-Abascal, Erasmo; Reyes-Cervantes, Hortensia; Vazquez-Cruz, Candelario; Guzman, Plinio; Sanchez-Alonso, Patricia			The Telomerase Reverse Transcriptase Subunit from the Dimorphic Fungus Ustilago maydis	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; DNA-REPAIR; IN-VITRO; MAINTENANCE; RECOMBINATION; PROTEINS; SYSTEM; CELLS; HAPLOINSUFFICIENCY	In this study, we investigated the reverse transcriptase subunit of telomerase in the dimorphic fungus Ustilago maydis. This protein (Trt1) contains 1371 amino acids and all of the characteristic TERT motifs. Mutants created by disrupting trt1 had senescent traits, such as delayed growth, low replicative potential, and reduced survival, that were reminiscent of the traits observed in est2 budding yeast mutants. Telomerase activity was observed in wild-type fungus sporidia but not those of the disruption mutant. The introduction of a self-replicating plasmid expressing Trt1 into the mutant strain restored growth proficiency and replicative potential. Analyses of trt1 crosses in planta suggested that Trt1 is necessary for teliospore formation in homozygous disrupted diploids and that telomerase is haploinsufficient in heterozygous diploids. Additionally, terminal restriction fragment analysis in the progeny hinted at alternative survival mechanisms similar to those of budding yeast.	[Bautista-Espana, Dolores; Anastacio-Marcelino, Estela; Horta-Valerdi, Guillermo; Celestino-Montes, Antonio; Vazquez-Cruz, Candelario; Sanchez-Alonso, Patricia] Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Inst Ciencias, Puebla, Mexico; [Guzman, Plinio] Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Irapuato, Guanajuato, Mexico; [Kojic, Milorad] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Negrete-Abascal, Erasmo] UNAM, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Reyes-Cervantes, Hortensia] Benemerita Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Belgrade; Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Sanchez-Alonso, P (corresponding author), Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Inst Ciencias, Puebla, Mexico.	maria.sanchez@correo.buap.mx		horta valerdi, guillermo manuel/0000-0003-3152-2947; Vazquez-Cruz, Candelario/0000-0002-9105-5669; Kojic, Milorad/0000-0002-0507-4231	CONACyT [46378-Q, CB106140-P2]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT 46378-Q and CONACyT CB106140-P2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Chen XF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000535; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Choudhary Bibha, 2012, Front Biosci (Schol Ed), V4, P16; Christensen JJ., 1963, AM PHYTOPATHOLOGY SO, V2, P1, DOI DOI 10.5962/BHL.TITLE.62035; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cifuentes-Rojas C, 2012, MUTAT RES-FUND MOL M, V730, P20, DOI 10.1016/j.mrfmmm.2011.10.003; Cukusic A, 2008, CYTOGENET GENOME RES, V122, P263, DOI 10.1159/000167812; Dalla Torre CA, 2002, BRAZ J MED BIOL RES, V35, P65, DOI 10.1590/S0100-879X2002000100009; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Ding DQ, 2013, FEBS J, V280, P3205, DOI 10.1111/febs.12258; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; GOLD SE, 1994, GENE, V142, P225, DOI 10.1016/0378-1119(94)90265-8; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; GUZMAN PA, 1994, MICROBIOL-UK, V140, P551, DOI 10.1099/00221287-140-3-551; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Holliday R, 2004, DNA REPAIR, V3, P671, DOI 10.1016/j.dnarep.2004.02.002; HOLLIDAY R, 1974, HDB GENETICS, P575; Holloman WK, 2008, FUNGAL GENET BIOL, V45, pS31, DOI 10.1016/j.fgb.2008.04.006; Hu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003208; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Kalmbach KH, 2013, FERTIL STERIL, V99, P23, DOI 10.1016/j.fertnstert.2012.11.039; KAMPER J, 1995, CELL, V81, P73, DOI 10.1016/0092-8674(95)90372-0; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lendvay TS, 1996, GENETICS, V144, P1399; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Makovets S, 2008, GENETICS, V178, P245, DOI 10.1534/genetics.107.083030; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; Gomez DLM, 2013, INT J ONCOL, V43, P1351, DOI 10.3892/ijo.2013.2104; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; PUHALLA JE, 1968, GENETICS, V60, P461; Redon S, 2013, NUCLEIC ACIDS RES, V41, P9117, DOI 10.1093/nar/gkt695; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez-Alonso P, 1998, GENETICS, V148, P1043; SanchezAlonso P, 1996, MICROBIOL-SGM, V142, P2931, DOI 10.1099/13500872-142-10-2931; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; SPELLIG T, 1994, EMBO J, V13, P1620, DOI 10.1002/j.1460-2075.1994.tb06425.x; Teng SC, 1999, MOL CELL BIOL, V19, P8083; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; VazquezCruz C, 1997, J BACTERIOL, V179, P6341, DOI 10.1128/jb.179.20.6341-6348.1997; Vollmeister E, 2012, FEMS MICROBIOL REV, V36, P59, DOI 10.1111/j.1574-6976.2011.00296.x; Walbot V, 2010, SEX PLANT REPROD, V23, P1, DOI 10.1007/s00497-009-0109-0; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yu EY, 2013, DNA REPAIR, V12, P472, DOI 10.1016/j.dnarep.2013.04.027; Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055	57	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109981	10.1371/journal.pone.0109981	http://dx.doi.org/10.1371/journal.pone.0109981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299159	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200091
J	Bohn, AB; Wittenborn, T; Brems-Eskildsen, AS; Laurberg, T; Bertelsen, LB; Nielsen, T; Stodkilde-Jorgensen, H; Moller, BK; Horsman, MR				Bohn, Anja Bille; Wittenborn, Thomas; Brems-Eskildsen, Anne Sofie; Laurberg, Tinne; Bertelsen, Lotte Bonde; Nielsen, Thomas; Stodkilde-Jorgensen, Hans; Moller, Bjarne Kuno; Horsman, Michael R.			A Combretastatin-Mediated Decrease in Neutrophil Concentration in Peripheral Blood and the Impact on the Anti-Tumor Activity of This Drug in Two Different Murine Tumor Models	PLOS ONE			English	Article							VASCULAR-TARGETING AGENT; A-4 DISODIUM PHOSPHATE; PHASE-I TRIAL; A4 PHOSPHATE; NORMAL-TISSUES; THERAPEUTIC GAIN; ADVANCED CANCER; COMBINATION; ANGIOGENESIS; THERAPIES	The vascular disrupting agent combretastatin A-4 disodium phosphate (CA4P) induces fluctuations in peripheral blood neutrophil concentration. Because neutrophils have the potential to induce both vascular damage and angiogenesis we analyzed neutrophil involvement in the anti-tumoral effects of CA4P in C3H mammary carcinomas in CDF1 mice and in SCCVII squamous cell carcinomas in C3H/HeN mice. Flow cytometry analyses of peripheral blood before and up to 144 h after CA4P administration (25 and 250 mg/kg) revealed a decrease 1 h after treatment, followed by an early (3-6 h) and a late (. 72 h) increase in the granulocyte concentration. We suggest that the early increase (3-6 h) in granulocyte concentration was caused by the initial decrease at 1 h and found that the late increase was associated with tumor size, and hence independent of CA4P. No alterations in neutrophil infiltration into the C3H tumor after CA4P treatment (25 and 250 mg/kg) were found. Correspondingly, neutrophil depletion in vivo, using an anti-neutrophil antibody, followed by CA4P treatment (25 mg/kg) did not increase the necrotic fraction in C3H tumors significantly. However, by increasing the CA4P dose to 250 mg/kg we found a significant increase of 359% in necrotic fraction when compared to neutrophil-depleted mice; in mice with no neutrophil depletion CA4P induced an 89% change indicating that the presence of neutrophils reduced the effect of CA4P. In contrast, neither CA4P nor 1A8 affected the necrotic fraction in the SCCVII tumors significantly. Hence, we suggest that the initial decrease in granulocyte concentration was caused by non-tumor-specific recruitment of neutrophils and that neutrophils may attenuate CA4P-mediated anti-tumor effect in some tumor models.	[Bohn, Anja Bille; Wittenborn, Thomas; Laurberg, Tinne; Nielsen, Thomas; Horsman, Michael R.] Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark; [Brems-Eskildsen, Anne Sofie] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Bertelsen, Lotte Bonde; Stodkilde-Jorgensen, Hans] Aarhus Univ Hosp, MR Res Ctr, DK-8000 Aarhus, Denmark; [Moller, Bjarne Kuno] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Horsman, MR (corresponding author), Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark.	mike@oncology.dk		Horsman, Michael/0000-0003-1578-5691; Laurberg, Tinne/0000-0002-7555-2665; Stodkilde-Jorgensen, Hans/0000-0002-8649-4173; Bertelse, Lotte Bonde/0000-0002-2491-3184	Danish Cancer Society; Danish Council for Independent Research: Medical Sciences; Radiumstationens research foundation; foundation in memory of Sigvald and Edith Anelise Celine Kristine Rasmussen, born Poulsen	Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research: Medical Sciences(Det Frie Forskningsrad (DFF)); Radiumstationens research foundation; foundation in memory of Sigvald and Edith Anelise Celine Kristine Rasmussen, born Poulsen	Financial support for this study was provided by The Danish Cancer Society (www.cancer.dk), The Danish Council for Independent Research: Medical Sciences (www.fivu.dk), Radiumstationens research foundation, and The foundation in memory of Sigvald and Edith Anelise Celine Kristine Rasmussen, born Poulsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2008, J NAT PROD, V71, P492, DOI 10.1021/np0705716; Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bilenker JH, 2005, CLIN CANCER RES, V11, P1527, DOI 10.1158/1078-0432.CCR-04-1434; Bohn AB, 2012, AM J PHYSIOL-REG I, V303, pR186, DOI 10.1152/ajpregu.00572.2011; Busk M, 2011, VASC PHARMACOL, V54, P13, DOI 10.1016/j.vph.2010.10.002; Chaplin DJ, 1999, ANTICANCER RES, V19, P189; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dark GG, 1997, CANCER RES, V57, P1829; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Dowlati A, 2002, CANCER RES, V62, P3408; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gaudry M, 1997, BLOOD, V90, P4153, DOI 10.1182/blood.V90.10.4153; He XX, 2011, BRIT J CLIN PHARMACO, V71, P860, DOI 10.1111/j.1365-2125.2011.03928.x; HIRST DG, 1982, BRIT J CANCER, V46, P109, DOI 10.1038/bjc.1982.172; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Horsman MR, 2000, ADV EXP MED BIOL, V476, P311; Horsman MR, 2002, INT J RADIAT ONCOL, V54, P1518, DOI 10.1016/S0360-3016(02)03926-3; KANAZAWA H, 1988, CANCER RES, V48, P3158; Korbelik M, 1999, CANCER LETT, V137, P91, DOI 10.1016/S0304-3835(98)00349-8; Li L, 2002, ACTA ONCOL, V41, P91, DOI 10.1080/028418602317314127; Murata R, 2001, RADIOTHER ONCOL, V60, P155, DOI 10.1016/S0167-8140(01)00384-X; Murata R, 2001, INT J RADIAT BIOL, V77, P195; Nathan P, 2012, CLIN CANCER RES, V18, P3428, DOI 10.1158/1078-0432.CCR-11-3376; OVERGAARD J, 1980, INT J RADIAT ONCOL, V6, P1507, DOI 10.1016/0360-3016(80)90008-5; OVERGAARD K, 1972, EUR J CANCER, V8, P65, DOI 10.1016/0014-2964(72)90085-0; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Parkins CS, 2000, BRIT J CANCER, V83, P811, DOI 10.1054/bjoc.2000.1361; Prise VE, 2002, INT J ONCOL, V21, P717; Reichel CA, 2012, BLOOD, V120, P880, DOI 10.1182/blood-2012-01-402164; Rustin GJS, 2003, J CLIN ONCOL, V21, P2815, DOI 10.1200/JCO.2003.05.185; Salmon BA, 2007, EUR J CANCER, V43, P1622, DOI 10.1016/j.ejca.2007.03.018; Salmon HW, 2006, CLIN CANCER RES, V12, P4090, DOI 10.1158/1078-0432.CCR-06-0163; Siemann DW, 2005, CLIN CANCER RES, V11, P416; Stevenson JP, 2003, J CLIN ONCOL, V21, P4428, DOI 10.1200/JCO.2003.12.986; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Taylor M, 2012, CANCER DISCOV, V2, P434, DOI 10.1158/2159-8290.CD-11-0171; Tozer GM, 1999, CANCER RES, V59, P1626; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang LCS, 2009, NEOPLASIA, V11, P793, DOI 10.1593/neo.09506; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; WESTLIN WF, 1993, AM J PATHOL, V142, P117	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110091	10.1371/journal.pone.0110091	http://dx.doi.org/10.1371/journal.pone.0110091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299269	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200101
J	Fallesen, P; Emanuel, N; Wildeman, C				Fallesen, Peter; Emanuel, Natalia; Wildeman, Christopher			Cumulative Risks of Foster Care Placement for Danish Children	PLOS ONE			English	Article							MALTREATMENT; OUTCOMES; IMPACT	Although recent research suggests that the cumulative risk of foster care placement is far higher for American children than originally suspected, little is known about the cumulative risk of foster care placement in other countries, which makes it difficult to gauge the degree to which factor foster care placement is salient in other contexts. In this article, we provide companion estimates to those provided in recent work on the US by using Danish registry data and synthetic cohort life tables to show how high and unequally distributed the cumulative risk of foster care placement is for Danish children. Results suggest that at the beginning of the study period (in 1998) the cumulative risk of foster care placement for Danish children was roughly in line with the risk for American children. Yet, by the end of the study period (2010), the risk had declined to half the risk for American children. Our results also show some variations by parental ethnicity and sex, but these differences are small. Indeed, they appear quite muted relative to racial/ethnic differences in these risks in the United States. Last, though cumulative risks are similar between Danish and American children (especially at the beginning of the study period), the age-specific risk profiles are markedly different, with higher risks for older Danish children than for older American children.	[Fallesen, Peter] Rockwool Fdn Res Unit, Copenhagen, Denmark; [Fallesen, Peter] Univ Copenhagen, Dept Sociol, Copenhagen, Denmark; [Emanuel, Natalia] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Wildeman, Christopher] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY USA	University of Copenhagen; Yale University; Cornell University	Fallesen, P (corresponding author), Rockwool Fdn Res Unit, Copenhagen, Denmark.	pf@rff.dk	Fallesen, Peter/AAO-4801-2021	Fallesen, Peter/0000-0003-0544-9977	Rockwool Foundation	Rockwool Foundation	The study was funded by the Rockwool Foundation (http://www.rockwoolfonden.dk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S. H., 2010, NAR MAN ANBRINGER BA, P13; Andersen SH, 2014, SOC FORCES, V93, P269, DOI 10.1093/sf/sou027; Berger LM, 2009, CHILD DEV, V80, P1856, DOI 10.1111/j.1467-8624.2009.01372.x; Dalsgaard S, 2013, J CHILD ADOL PSYCHOP, V23, P432, DOI 10.1089/cap.2012.0111; Doyle JJ, 2008, J POLITICAL EC, V116, P1583; Doyle JJ, 2007, AM ECON REV, V97, P1583, DOI 10.1257/aer.97.5.1583; Ejrnaes M, 2011, CHILD INDIC RES, V4, P21, DOI 10.1007/s12187-010-9066-2; Fallesen P, 2013, J ADOLESCENCE, V36, P1003, DOI 10.1016/j.adolescence.2013.08.010; Frederiksen S., 2012, THESIS AARHUS U; Harman JS, 2000, ARCH PEDIAT ADOL MED, V154, P1114, DOI 10.1001/archpedi.154.11.1114; Hestbak A.D., 2011, CHILD PROTECTION SYS, P131; Kvist AP, 2013, SOC SCI MED, V88, P30, DOI 10.1016/j.socscimed.2013.04.001; Lery B, 2009, CHILD YOUTH SERV REV, V31, P331, DOI 10.1016/j.childyouth.2008.08.001; Magruder J, 2008, CHILD WELFARE, V87, P169; Preston S., 2000, DEMOGRAPHY MEASURING; Putnam-Hornstein E, 2011, CHILD MALTREATMENT, V16, P163, DOI 10.1177/1077559511411179; Putnam-Hornstein E, 2011, CHILD ABUSE REV, V20, P256, DOI 10.1002/car.1191; Sabol W, 2004, CHILD ABUSE NEGLECT, V28, P967, DOI 10.1016/j.chiabu.2004.03.014; Simkiss DE, 2013, CHILD CARE HLTH DEV, V39, P628, DOI 10.1111/cch.12010; Statistics Denmark, 2013, QUAL DECL ASS CHILDR; Swann CA, 2006, DEMOGRAPHY, V43, P309, DOI 10.1353/dem.2006.0019; U. S. Department of Health and Human Services, 2006, 12 AFCARS US DEP HLT; U.S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2012, FED REP SYST AD FOST; U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics CDC WONDER Online Database, 2011, BRIDG RAC POP EST 19; United States Department of Health and Human Services), 2012, 19 AFCARS US DEP HLT; US Dep. Health Hum. Serv, 2012, TRENDS FOST CAR AD F; WALD MS, 1988, PROTECTING ABUSED NE; Waldfogel Jane, 2004, REV ECON HOUSEHOLD, V2, P387, DOI DOI 10.1007/S11150-004-5654-6; Warburton WP, 2014, CAN J ECON, V47, P35, DOI 10.1111/caje.12064; Wildeman C, 2014, ANN REV SOC IN PRESS; Wildeman C, 2004, JAMA PEDIAT IN PRESS; Wildeman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092785; Wulczyn F, 2009, FUTURE CHILD, V19, P39	33	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109207	10.1371/journal.pone.0109207	http://dx.doi.org/10.1371/journal.pone.0109207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299657	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200041
J	Garstang, M; Davis, RE; Leggett, K; Frauenfeld, OW; Greco, S; Zipser, E; Peterson, M				Garstang, Michael; Davis, Robert E.; Leggett, Keith; Frauenfeld, Oliver W.; Greco, Steven; Zipser, Edward; Peterson, Michael			Response of African Elephants (Loxodonta africana) to Seasonal Changes in Rainfall	PLOS ONE			English	Article							DESERT-DWELLING ELEPHANTS; HOANIB RIVER; MOVEMENT; DISTRIBUTIONS; DYNAMICS	The factors that trigger sudden, seasonal movements of elephants are uncertain. We hypothesized that savannah elephant movements at the end of the dry season may be a response to their detection of distant thunderstorms. Nine elephants carrying Global Positioning System (GPS) receivers were tracked over seven years in the extremely dry and rugged region of northwestern Namibia. The transition date from dry to wet season conditions was determined annually from surface- and satellite-derived rainfall. The distance, location, and timing of rain events relative to the elephants were determined using the Tropical Rainfall Measurement Mission (TRMM) satellite precipitation observations. Behavioral Change Point Analysis (BCPA) was applied to four of these seven years demonstrating a response in movement of these elephants to intra- and inter-seasonal occurrences of rainfall. Statistically significant changes in movement were found prior to or near the time of onset of the wet season and before the occurrence of wet episodes within the dry season, although the characteristics of the movement changes are not consistent between elephants and years. Elephants in overlapping ranges, but following separate tracks, exhibited statistically valid non-random near-simultaneous changes in movements when rainfall was occurring more than 100 km from their location. While the environmental trigger that causes these excursions remains uncertain, rain-system generated infrasound, which can travel such distances and be detected by elephants, is a possible trigger for such changes in movement.	[Garstang, Michael; Davis, Robert E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Leggett, Keith] Univ New S Wales, Sch Biol Earth & Environm Sci, Fowlers Gap Arid Zone Res Stn, Kensington, NSW 2033, Australia; [Frauenfeld, Oliver W.] Texas A&M Univ, Dept Geog, College Stn, TX USA; [Greco, Steven] Simpson Weather Associates Inc, Charlottesville, VA USA; [Zipser, Edward; Peterson, Michael] Univ Utah, Dept Atmospher Sci, Salt Lake City, UT USA	University of Virginia; University of New South Wales Sydney; Texas A&M University System; Texas A&M University College Station; Utah System of Higher Education; University of Utah	Garstang, M (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	mxg@swa.com	Frauenfeld, Oliver W./ABE-9259-2020; Frauenfeld, Oliver W./AAE-1869-2020; Davis, Robert/A-9078-2008; Zixuan, Huang/ABI-3557-2020	/0000-0002-6079-2658; Peterson, Michael/0000-0002-7683-0655; Greco, Steven/0000-0001-7934-8779	Simpson Weather Associates; Department of Environmental Sciences, University of Virginia	Simpson Weather Associates; Department of Environmental Sciences, University of Virginia	The communities and conservancies of northwestern Namibia, and the Ministry of Environment and Tourism are thanked for their previous support of the tracking studies used in this paper. We also acknowledge Earthwatch Institute, Denver Zoo, U.S. Fish and Wildlife Service, Wilderness Trust, Wildlife Conservation society, Ikahirongo Elephant Lodge, and Wilderness Safaris for their previous support. We wish to thank E. Gurarie for his guidance and provision of the BCPA program. Our thanks also go to Mary Morris for all of her bibliographic research, preparation and production of the manuscript and to Simpson Weather Associates and the Department of Environmental Sciences, University of Virginia for their support of this research. We would also wish to acknowledge and thank the Editor and three reviewers for their careful and critical reading of earlier drafts of this manuscript.	Birkett PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038363; Boettiger AN, 2011, ECOLOGY, V92, P1648; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Christo C, 2009, WALKING THUNDER FOOT; Dominoni DM, 2014, J ANIM ECOL, V83, P681, DOI 10.1111/1365-2656.12150; Fleming CH, 2014, AM NAT, V183, pE154, DOI 10.1086/675504; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Groning K., 1999, ELEPHANTS CULTURAL N; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Johnson DS, 2011, J AGR BIOL ENVIR ST, V16, P357, DOI 10.1007/s13253-011-0056-8; Kelley Michael C., 2013, Animals, V3, P349, DOI 10.3390/ani3020349; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Leggett K, 2005, J ARID ENVIRON, V62, P587, DOI 10.1016/j.jaridenv.2005.01.020; Leggett K, 2003, AFR ZOOL, V38, P305; Leggett K., 2006, PACHYDERM, V40, P40; Leggett K, 2010, AFR J ECOL, V48, P197, DOI 10.1111/j.1365-2028.2009.01101.x; Leggett KEA, 2011, PACHYDERM, P20; LINDEQUE M, 1991, AFR J ECOL, V29, P196, DOI 10.1111/j.1365-2028.1991.tb01002.x; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Love TB, 2004, AMS 14 C APPL MET SE; Moss CJ, 2011, AMBOSELI ELEPHANT EL, P292; Otter LB, 2002, ATMOS ENVIRON, V36, P4265, DOI 10.1016/S1352-2310(02)00333-3; Scholes R. J., 2008, ELEPHANT MANAGEMENT; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; VILJOEN PJ, 1989, J ZOOL, V219, P1, DOI 10.1111/j.1469-7998.1989.tb02561.x; VILJOEN PJ, 1990, S AFR J WILDL RES, V20, P69; Yackulic CB, 2011, J ANIM ECOL, V80, P1088, DOI 10.1111/j.1365-2656.2011.01851.x; Zipser EJ, 2006, B AM METEOROL SOC, V87, P1057, DOI 10.1175/BAMS-87-8-1057	29	17	17	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108736	10.1371/journal.pone.0108736	http://dx.doi.org/10.1371/journal.pone.0108736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299514	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200022
J	Jin, JH; Lin, FM; Liao, SY; Bao, QY; Ni, LY				Jin, Jianhua; Lin, Faming; Liao, Shiyu; Bao, Qiyu; Ni, Liyan			Effects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), Smoking, and Drinking on Susceptibility to Laryngeal Cancer among Han Chinese	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CYTOCHROME P4501B1; GENETIC POLYMORPHISMS; INCREASED RISK; NECK-CANCER; CYP1B1 GENE; HEAD; ASSOCIATION; CYP2E1; 1B1	Purpose: This study was conducted to explore the effects of genetic polymorphisms (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C) and environmental factors (smoking and drinking) on susceptibility to laryngeal cancer in a Han Chinese study group. Methods: This case-control study included 552 Han Chinese patients diagnosed with laryngeal cancer and 666 healthy control subjects of the same ethnicity, similar age, and gender. Genetic polymorphisms were examined using multi-PCR and Matrix Assisted Laser Desorption Ionization - Time of Flight (MALDI-TOF MS) methodology. The association of these genetic and environmental factors with susceptibility to laryngeal cancer was evaluated using a statistical approach. Results: The frequencies of all three polymorphisms in the patient cohort were significantly different from those in the control cohort. Compared to the control cohort, carriers of variant alleles of CYP1B1*2 355T and CYP2E1*5 -1293C showed a higher risk for developing laryngeal cancer (for CYP1B1*2 355T, adjusted OR = 2.657, P <0.001; for CYP2E1*5 -1293C, adjusted OR = 1.938, P <0.001), while carriers of mutation allele CYP1B1*3 4326G showed a lower risk (adjusted OR = 0.562, P <0.001). Joint effects of these polymorphisms were observed. When compared to haplotype G(355)C(4326)G(-1293), haplotypes T(355)C(4326)G(-1293) (adjusted OR = 1.809, P <0.001), G(355)C(4326)C(-1293) (adjusted OR = 1.644, P = 0.044), and T355C4326C-1293 (adjusted OR = 3.104, P <0.001) were associated with a significantly higher laryngeal cancer risk. The adjusted ORs for nonsmokers, non-drinkers, smokers, and drinkers with the GT/TT genotype at CYP1B1*2 G355T were 2.190 (P = 0.006), 2.008 (P = 0.001), 5.875 (P <0.001), and 4.518 (P <0.001), respectively. Conclusions: CYP1B1*2 355T and CYP2E1*5 -1293C are associated with an increased laryngeal cancer risk, while CYP1B1*3 4326G is associated with a decreased risk. These polymorphisms showed joint effects on laryngeal cancer risk. Smoking and drinking showed collaborative effects with two high risk alleles (CYP1B1*2 355T and CYP1B1*3 4326G) for promoting laryngeal cancer risk.	[Jin, Jianhua] Wenzhou Med Univ, Sch Basic Med, Wenzhou, Peoples R China; [Lin, Faming; Liao, Shiyu; Ni, Liyan] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China; [Bao, Qiyu] Wenzhou Med Univ, Sch Life Sci, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Ni, LY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China.	nily2001@126.com	Bao, Qiyu/AAH-6113-2020	Bao, Qiyu/0000-0001-6523-8763	Science and Technology Foundation of Wenzhou City, Zhejiang Province, China [H20090025]; Science and Technology Foundation of Health bureau of Zhejiang Province, China [2012ZB106]	Science and Technology Foundation of Wenzhou City, Zhejiang Province, China; Science and Technology Foundation of Health bureau of Zhejiang Province, China	This work is supported by the Science and Technology Foundation of Wenzhou City, Zhejiang Province, China (H20090025, URL: http://www.wzkj.gov.cn) and the Science and Technology Foundation of Health bureau of Zhejiang Province, China (2012ZB106, URL: http://zgj.zjtcm.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklillu E, 2002, MOL PHARMACOL, V61, P586, DOI 10.1124/mol.61.3.586; Bin B, 2009, CHINESE J CANC PREVE, V16, P315; Buters JTM, 2002, CHEM RES TOXICOL, V15, P1127, DOI 10.1021/tx020017q; Chen B, 2010, LUNG CANCER, V70, P247, DOI 10.1016/j.lungcan.2010.03.011; Cury NM, 2012, MOL BIOL REP, V39, P1055, DOI 10.1007/s11033-011-0831-1; Gajecka M, 2005, MUTAT RES-FUND MOL M, V574, P112, DOI 10.1016/j.mrfmmm.2005.01.027; Ghoshal U, 2013, GASTRIC CANC; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Guo Li-ke, 2012, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V34, P390, DOI 10.3881/j.issn.1000-503X.2012.04.015; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Helmig S, 2010, EUR J EPIDEMIOL, V25, P867, DOI 10.1007/s10654-010-9505-x; Huang LP, 2010, ALCOHOL, V6, P57; Ickstadt K, 2008, J TOXICOL ENV HEAL A, V71, P803, DOI 10.1080/15287390801985745; INGELMANSUNDBERG M, 1993, ALCOHOL, V10, P447, DOI 10.1016/0741-8329(93)90063-T; Jaworowska E, 2006, BREAST CANCER RES TR, V97, P215, DOI 10.1007/s10549-005-9116-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ko Y, 2001, CANCER RES, V61, P4398; Lu D, 2011, MOL BIOL REP, V38, P2409, DOI 10.1007/s11033-010-0375-9; Ohshima H, 2005, MUTAT RES-FUND MOL M, V591, P110, DOI 10.1016/j.mrfmmm.2005.03.030; Roos Peter H, 2005, Expert Opin Drug Metab Toxicol, V1, P187, DOI 10.1517/17425255.1.2.187; Ruwali M, 2009, ENVIRON MOL MUTAGEN, V50, P473, DOI 10.1002/em.20488; Salinas-Sanchez AS, 2012, J UROLOGY, V187, P700, DOI 10.1016/j.juro.2011.10.063; Shah PP, 2008, MUTAT RES-FUND MOL M, V643, P4, DOI 10.1016/j.mrfmmm.2008.05.001; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Shimada T, 2001, XENOBIOTICA, V31, P163, DOI 10.1080/00498250110043490; Singh AP, 2008, MUTAT RES-FUND MOL M, V639, P11, DOI 10.1016/j.mrfmmm.2007.10.007; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Sun Qian, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P3; Tai J, 2010, CANCER GENET CYTOGEN, V196, P76, DOI 10.1016/j.cancergencyto.2009.08.015; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Teng Y, 2013, INT J GYNECOL CANCER, V23, P422, DOI 10.1097/IGC.0b013e3182849e0d; Trubicka J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-420; Ulusoy G, 2007, ARCH TOXICOL, V81, P711, DOI 10.1007/s00204-007-0200-y; Wu RM, 2002, J NEURAL TRANSM, V109, P1403, DOI 10.1007/s00702-002-0721-8; Xu WH, 2012, MOL BIOL REP, V39, P2821, DOI 10.1007/s11033-011-1041-6; Yoo Wonsuk, 2012, Int J Appl Sci Technol, V2, P268; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]	39	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e106580	10.1371/journal.pone.0106580	http://dx.doi.org/10.1371/journal.pone.0106580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299224	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200004
J	Loohuis, LO; Caravagna, G; Graudenzi, A; Ramazzotti, D; Mauri, G; Antoniotti, M; Mishra, B				Loohuis, Loes Olde; Caravagna, Giulio; Graudenzi, Alex; Ramazzotti, Daniele; Mauri, Giancarlo; Antoniotti, Marco; Mishra, Bud			Inferring Tree Causal Models of Cancer Progression with Probability Raising	PLOS ONE			English	Article							ONCOGENETIC TREE; PATHWAYS; HYBRIDIZATION; CONSTRUCTION; ALGORITHMS; DISTANCE; GENES	Existing techniques to reconstruct tree models of progression for accumulative processes, such as cancer, seek to estimate causation by combining correlation and a frequentist notion of temporal priority. In this paper, we define a novel theoretical framework called CAPRESE (CAncer PRogression Extraction with Single Edges) to reconstruct such models based on the notion of probabilistic causation defined by Suppes. We consider a general reconstruction setting complicated by the presence of noise in the data due to biological variation, as well as experimental or measurement errors. To improve tolerance to noise we define and use a shrinkage-like estimator. We prove the correctness of our algorithm by showing asymptotic convergence to the correct tree under mild constraints on the level of noise. Moreover, on synthetic data, we show that our approach outperforms the state-of-the-art, that it is efficient even with a relatively small number of samples and that its performance quickly converges to its asymptote as the number of samples increases. For real cancer datasets obtained with different technologies, we highlight biologically significant differences in the progressions inferred with respect to other competing techniques and we also show how to validate conjectured biological relations with progression models.	[Loohuis, Loes Olde] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Caravagna, Giulio; Graudenzi, Alex; Ramazzotti, Daniele; Mauri, Giancarlo; Antoniotti, Marco] Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy; [Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY USA	University of California System; University of California Los Angeles; University of Milano-Bicocca; New York University	Loohuis, LO (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	l.oldeloohuis@gmail.com	Mauri, Giancarlo/M-3258-2013; Graudenzi, Alex/AAY-5241-2020; Caravagna, Giulio/F-5011-2015	Mauri, Giancarlo/0000-0003-3520-4022; Graudenzi, Alex/0000-0001-5452-1918; Caravagna, Giulio/0000-0003-4240-3265; RAMAZZOTTI, DANIELE/0000-0002-6087-2666	National Science Foundation [CCF-0836649, CCF-0926166]; Regione Lombardia (Italy) under ASTIL [12-4-5148000-40]; NEDD [ID14546A Rif SAL-7]	National Science Foundation(National Science Foundation (NSF)); Regione Lombardia (Italy) under ASTIL; NEDD	This work was supported by the National Science Foundation grants CCF-0836649 and CCF-0926166 and by Regione Lombardia (Italy) under the research projects RetroNet through the ASTIL [12-4-5148000-40]; U.A 053 and NEDD Project [ID14546A Rif SAL-7] Fondo Accordi Istituzionali 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerenwinkel N, 2005, J COMPUT BIOL, V12, P584, DOI 10.1089/cmb.2005.12.584; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P2106, DOI 10.1093/bioinformatics/bti274; Beerenwinkel N, 2007, BERNOULLI, V13, P893, DOI 10.3150/07-BEJ6133; Bell D, 2011, NATURE; CARTWRIGHT N, 1979, NOUS, V13, P419, DOI 10.2307/2215337; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Desper R, 2000, J COMPUT BIOL, V7, P789, DOI 10.1089/10665270050514936; Efron B, 2013, LARGE SCALE INFERENC; Efron B., 1982, JACKKNIFE BOOTSTRAP; Frank S, 2007, DYNAMICS CANC; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Gunawan B, 2007, J PATHOL, V211, P463, DOI 10.1002/path.2128; Gupta A, 2008, IEEE ACM T COMPUT BI, V5, P172, DOI 10.1109/TCBB.2007.70233; Hainke K, 2012, BIOMETRICAL J, V54, P617, DOI 10.1002/bimj.201100186; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hitchcock C., 2012, STANFORD ENCY PHILOS; Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Ionita I, 2006, AM J HUM GENET, V79, P13, DOI 10.1086/504354; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; Kleinberg S., 2012, CAUSALITY PROBABILIT; Longerich T, 2012, INT J CANCER, V130, P575, DOI 10.1002/ijc.26063; Loohuis LO, 2014, INFORM COMPUT, V236, P68, DOI 10.1016/j.ic.2014.01.013; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Pathare S, 2009, INT J CANCER, V124, P2864, DOI 10.1002/ijc.24267; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Radmacher MD, 2001, J THEOR BIOL, V212, P535, DOI 10.1006/jtbi.2001.2395; Ramakrishnan N, 2010, P NATL ACAD SCI USA, V107, P12511, DOI 10.1073/pnas.1006283107; Reichenbach H., 1956, DIRECTION TIME; Samuelson E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-352; Suppes P., 1970, PROBABILISTIC THEORY; Szabo A, 2002, MATH BIOSCI, V176, P219, DOI 10.1016/S0025-5564(02)00086-X; Szabo A., 2008, HDB CANC MODELS APPL; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Von Heydebreck A, 2004, BIOSTATISTICS, V5, P545, DOI 10.1093/biostatistics/kxh007; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; ZHANG KZ, 1989, SIAM J COMPUT, V18, P1245, DOI 10.1137/0218082	45	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108358	10.1371/journal.pone.0108358	http://dx.doi.org/10.1371/journal.pone.0108358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299648	Green Submitted, gold, Green Published			2022-12-25	WOS:000343941200016
J	Narumi, M; Kashiwagi, Y; Namba, H; Ohe, R; Yamakawa, M; Yamashita, H				Narumi, Mari; Kashiwagi, Yoshiko; Namba, Hiroyuki; Ohe, Rintaro; Yamakawa, Mitsunori; Yamashita, Hidetoshi			Contribution of Corneal Neovascularization to Dendritic Cell Migration into the Central Area during Human Corneal Infection	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; ACTIVIN-A; SECRETION	Compared with the peripheral corneal limbus, the human central cornea lacks blood vessels, which is responsible for its immunologically privileged status and high transparency. Dendritic cells (DCs) are present in the central avascular area of inflamed corneas, but the mechanisms of their migration to this location are poorly understood. Here, we investigated the contribution of vessel formation to DC migration into the central cornea, and analyzed the DC chemotactic factors produced by human corneal epithelial (HCE) cells. Using human eyes obtained from surgical procedures, we then assessed vessel formation, DC distribution, and activin A expression immunohistochemically. The results demonstrated increased numbers of vessels and DCs in the central area of inflamed corneas, and a positive correlation between the number of vessels and DCs. Activin A was expressed in the subepithelial space and the endothelium of newly formed blood vessels in the inflamed cornea. In infected corneas, DCs were present in the central area but no vascularization was observed, suggesting the presence of chemotactic factors that induced DC migration from the limbal vessels. To test this hypothesis, we assessed the migration of monocyte-derived DCs toward HCE cell supernatants with or without lipopolysaccharide (LPS) stimulation of HCE cells and inflammatory cytokines (released by HCE cells). DCs migrated toward tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-6, and activin A, as well as LPS-stimulated HCE cell supernatants. The supernatant contained elevated TNF-alpha, IL-6, and activin A levels, suggesting that they were produced by HCE cells after LPS stimulation. Therefore, vessels in the central cornea might constitute a DC migration route, and activin A expressed in the endothelium of newly formed vessels might contribute to corneal vascularization. Activin A also functions as a chemotactic factor, similar to HCE-produced TNF-alpha and IL-6. These findings enhance our understanding of the pathophysiology of corneal inflammation during infection.	[Narumi, Mari; Namba, Hiroyuki; Yamashita, Hidetoshi] Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata 990, Japan; [Kashiwagi, Yoshiko] Yamagata Prefectural Yonezawa Womens Jr Coll, Dept Hlth & Nutr, Yamagata, Japan; [Ohe, Rintaro; Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan	Yamagata University; Yamagata University	Narumi, M (corresponding author), Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata 990, Japan.	mari.narumi1101@gmail.com	Ohe, Rintaro/AAP-1604-2020	Ohe, Rintaro/0000-0002-8035-791X	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2008, CELLULAR MOL IMMUNOL, V5th, P94; Davis AA, 2000, MOL CELL NEUROSCI, V15, P11, DOI 10.1006/mcne.1999.0806; Ebihara N, 2011, INVEST OPHTH VIS SCI, V52, P8549, DOI 10.1167/iovs.11-7956; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Gibbs S, 2013, TOXICOL IN VITRO, V27, P1170, DOI 10.1016/j.tiv.2012.05.016; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; Henry CR, 2012, OPHTHALMOLOGY, V119, P2443, DOI 10.1016/j.ophtha.2012.06.030; Knickelbein JE, 2009, OPHTHALMOL EYE DIS, V1, P45; Lu JM, 2012, MOL VIS, V18, P2255; Luisi S, 2001, EUR J ENDOCRINOL, V145, P225, DOI 10.1530/eje.0.1450225; Mastropasqua L, 2006, AM J OPHTHALMOL, V142, P736, DOI 10.1016/j.ajo.2006.06.057; Mayer WJ, 2007, INVEST OPHTH VIS SCI, V48, P4459, DOI 10.1167/iovs.06-1184; Nakao S, 2012, J OPTHALMOL, DOI [10.1155/2012/783163, DOI 10.1155/2012/783163.]; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Poulaki V, 2004, AM J PATHOL, V164, P1293, DOI 10.1016/S0002-9440(10)63216-6; Regina M, 2007, CLIN EXP OPHTHALMOL, V35, P541, DOI 10.1111/j.1442-9071.2007.01549.x; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Salogni L, 2009, BLOOD, V113, P5848, DOI 10.1182/blood-2008-12-194597; Scutera S, 2008, EUR CYTOKINE NETW, V19, P60, DOI 10.1684/ecn.2008.0121; Ueta M, 2010, BRAIN RES BULL, V81, P219, DOI 10.1016/j.brainresbull.2009.10.001; Yamagami S, 2005, INVEST OPHTH VIS SCI, V46, P4489, DOI 10.1167/iovs.05-0054; Yamashita H, 1997, JPN J OPHTHALMOL, V101, P927; Zhang J, 2005, CURR EYE RES, V30, P527, DOI 10.1080/02713680590968150	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109859	10.1371/journal.pone.0109859	http://dx.doi.org/10.1371/journal.pone.0109859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299318	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200077
J	Palanichamy, MG; Mitra, B; Debnath, M; Agrawal, S; Chaudhuri, TK; Zhang, YP				Palanichamy, Malliya Gounder; Mitra, Bikash; Debnath, Monojit; Agrawal, Suraksha; Chaudhuri, Tapas Kumar; Zhang, Ya-Ping			Tamil Merchant in Ancient Mesopotamia	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; MACROHAPLOGROUP-M; INDIA; PHYLOGENY; EXPANSION; ASIA	Recent analyses of ancient Mesopotamian mitochondrial genomes have suggested a genetic link between the Indian subcontinent and Mesopotamian civilization. There is no consensus on the origin of the ancient Mesopotamians. They may be descendants of migrants, who founded regional Mesopotamian groups like that of Terqa or they may be merchants who were involved in trans Mesopotamia trade. To identify the Indian source population showing linkage to the ancient Mesopotamians, we screened a total of 15,751 mitochondrial DNAs (11,432 from the literature and 4,319 from this study) representing all major populations of India. Our results although suggest that south India (Tamil Nadu) and northeast India served as the source of the ancient Mesopotamian mtDNA gene pool, mtDNA of these ancient Mesopotamians probably contributed by Tamil merchants who were involved in the Indo-Roman trade.	[Palanichamy, Malliya Gounder; Mitra, Bikash; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Debnath, Monojit; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Mitra, Bikash; Chaudhuri, Tapas Kumar] Univ N Bengal, Cellular Immunol Lab, Darjeeling, India; [Agrawal, Suraksha] Sanjay Gandhi Inst Med Sci, Dept Med Genet, Lucknow, Uttar Pradesh, India	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; University of North Bengal; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Palanichamy, MG (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China.	empalani@yahoo.com; zhangyp1@263.net.cn	Debnath, Monojit/G-2725-2010		Yunnan University; Yunnan provincial Science and Technology Department; National Natural Science Foundation of China [31060156, 31240018]	Yunnan University; Yunnan provincial Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Yunnan University and the Yunnan provincial Science and Technology Department, as well as from grants from National Natural Science Foundation of China (31060156 and 31240018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Blue L., 2012, NAVIGATED SPACES CON, P91; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Eaaswarkhanth M, 2010, EUR J HUM GENET, V18, P354, DOI 10.1038/ejhg.2009.168; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Gazi NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075064; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Prasad M, 2011, INDIAS FOREIGN TRADE, P21; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Rej P., 2013, MEASURING MITOCHONDR; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Selvakumar V., 2009, MIGRATION TRADE PE 1, P29; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Summerer M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-17; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Witas HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073682	19	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109331	10.1371/journal.pone.0109331	http://dx.doi.org/10.1371/journal.pone.0109331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AS0AP	25299580	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200047
J	Raft, S; Coate, TM; Kelley, MW; Crenshaw, EB; Wu, DK				Raft, Steven; Coate, Thomas M.; Kelley, Matthew W.; Crenshaw, E. Bryan, III; Wu, Doris K.			Pou3f4-Mediated Regulation of Ephrin-B2 Controls Temporal Bone Development in the Mouse	PLOS ONE			English	Article							PROGRESSIVE MIXED DEAFNESS; CONDUCTIVE HEARING-LOSS; X-LINKED DEAFNESS; INNER-EAR; PERILYMPHATIC GUSHER; CELL-PROLIFERATION; OTIC CAPSULE; MIDDLE-EAR; GENE-EXPRESSION; JOINT FORMATION	The temporal bone encases conductive and sensorineural elements of the ear. Mutations of POU3F4 are associated with unique temporal bone abnormalities and X-linked mixed deafness (DFNX2/DFN3). However, the target genes and developmental processes controlled by POU3F4 transcription factor activity have remained largely uncharacterized. Ephrin-B2 (Efnb2) is a signaling molecule with well-documented effects on cell adhesion, proliferation, and migration. Our analyses of targeted mouse mutants revealed that Efnb2 loss-of-function phenocopies temporal bone abnormalities of Pou3f4 hemizygous null neonates: qualitatively identical malformations of the stapes, styloid process, internal auditory canal, and cochlear capsule were present in both mutants. Using failed/insufficient separation of the stapes and styloid process as a quantitative trait, we found that single gene Efnb2 loss-of-function and compound Pou3f4/Efnb2 loss-of-function caused a more severe phenotype than single gene Pou3f4 loss-of-function. Pou3f4 and Efnb2 gene expression domains overlapped at the site of impending stapes-styloid process separation and at subcapsular mesenchyme surrounding the cochlea; at both these sites, Efnb2 expression was attenuated in Pou3f4 hemizygous null mutants relative to control. Results of immunoprecipitation experiments using chromatin isolated from nascent middle ear mesenchyme supported the hypothesis of a physical association between Pou3f4 and specific non-coding sequence of Efnb2. We propose that Efnb2 is a target of Pou3f4 transcription factor activity and an effector of mesenchymal patterning during temporal bone development.	[Raft, Steven; Wu, Doris K.] NIDCD, Sect Sensory Cell Regenerat & Dev, NIH, Bethesda, MD 20892 USA; [Coate, Thomas M.; Kelley, Matthew W.] NIDCD, Lab Cochlear Dev, NIH, Bethesda, MD USA; [Crenshaw, E. Bryan, III] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Raft, S (corresponding author), NIDCD, Sect Sensory Cell Regenerat & Dev, NIH, Bethesda, MD 20892 USA.	rafts@nidcd.nih.gov; wud@nidcd.nih.gov			Intramural Program of the National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC013107, ZIADC000021, ZIADC000059] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work was funded by the Intramural Program of the National Institute on Deafness and Other Communication Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. C., 2010, SCHUKNECHTS PATHOLOG, P54; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Amin S, 2006, DEV DYNAM, V235, P1326, DOI 10.1002/dvdy.20666; Amin S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-134; Ann KJ, 2009, GENESIS, V47, P137, DOI 10.1002/dvg.20454; BACH I, 1992, AM J HUM GENET, V51, P38; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Braunstein EM, 2000, J ASS RES OTOLARYGOL, V9, P33; Bush JO, 2010, GENE DEV, V24, P2068, DOI 10.1101/gad.1963210; Cauldwell EW, 1942, ARCHIV OTOLARYNGOL, V36, P891; Choi BY, 2013, EUR ARCH OTO-RHINO-L, V270, P3057, DOI 10.1007/s00405-013-2386-3; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Cowan CA, 2004, DEV BIOL, V271, P263, DOI 10.1016/j.ydbio.2004.03.026; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; CREMERS CWRJ, 1985, ARCH OTOLARYNGOL, V111, P249; CREMERS CWRJ, 1985, AM J OTOL, V6, P243; CREMERS CWRJ, 1983, CLIN OTOLARYNGOL, V8, P235, DOI 10.1111/j.1365-2273.1983.tb01434.x; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Depew M.J., 2002, MOUSE DEV PATTERNING, P421; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gerety SS, 2002, DEVELOPMENT, V129, P1397; GLASSCOC.ME, 1973, ARCH OTOLARYNGOL, V98, P82; HANSON JR, 1962, ARCHIV OTOLARYNGOL, V76, P200; Heydemann A, 2001, DEV BRAIN RES, V128, P83, DOI 10.1016/S0165-3806(01)00137-7; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; HUBER I, 1994, HUM MOL GENET, V3, P1151, DOI 10.1093/hmg/3.7.1151; Hwang CH, 2008, HUM MOL GENET, V17, P844, DOI 10.1093/hmg/ddm356; Jeong J, 2008, DEVELOPMENT, V135, P2905, DOI 10.1242/dev.019778; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; MCPHEE JR, 1985, ANAT REC, V213, P566, DOI 10.1002/ar.1092130413; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; Merchant SN, 2008, OTOL NEUROTOL, V29, P282, DOI 10.1097/mao.0b013e318161ab24; Miko IJ, 2008, HEARING RES, V235, P39, DOI 10.1016/j.heares.2007.09.003; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Mroz K, 1999, DEV BIOL, V207, P229, DOI 10.1006/dbio.1998.9160; NANCE W E, 1971, Birth Defects Original Article Series, V7, P64; Nandapalan V, 2000, AM J OTOL, V21, P71, DOI 10.1016/S0196-0709(00)80115-5; Naranjo S, 2010, HUM GENET, V128, P411, DOI 10.1007/s00439-010-0864-x; O'Gorman S, 2005, DEV DYNAM, V234, P124, DOI 10.1002/dvdy.20402; Ohashi M, 2006, HEARING RES, V213, P11, DOI 10.1016/j.heares.2005.11.007; Okazawa H, 1996, P NATL ACAD SCI USA, V93, P11933, DOI 10.1073/pnas.93.21.11933; Sanchez-Guardado LO, 2011, J COMP NEUROL, V519, P125, DOI 10.1002/cne.22508; PHELPS PD, 1991, NEURORADIOLOGY, V33, P326, DOI 10.1007/BF00587816; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Phippard D, 1998, HEARING RES, V120, P77, DOI 10.1016/S0378-5955(98)00059-8; Phippard D, 2000, HUM MOL GENET, V9, P79, DOI 10.1093/hmg/9.1.79; PIUSSAN C, 1995, AM J HUM GENET, V56, P224; Raft S, 2014, DEV BIOL, V390, P51, DOI 10.1016/j.ydbio.2014.02.019; Robert-Moreno A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015907; Rodriguez-Vazquez JF, 2005, J ANAT, V207, P165, DOI 10.1111/j.1469-7580.2005.00441.x; Ruest LB, 2009, DEV BIOL, V328, P94, DOI 10.1016/j.ydbio.2009.01.005; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Samadi DS, 2005, HEARING RES, V199, P11, DOI 10.1016/j.heares.2004.07.013; SNIK AFM, 1995, AM J OTOL, V16, P241; Sobal SE, 2005, ARCH OTOLARYNGOL, V131, P41, DOI 10.1001/archotol.131.1.41; Sohl M, 2009, GENE, V437, P54, DOI 10.1016/j.gene.2009.02.017; Song MH, 2011, BIOCHEM BIOPH RES CO, V404, P528, DOI 10.1016/j.bbrc.2010.12.019; Thompson H, 2012, DEV DYNAM, V241, P1396, DOI 10.1002/dvdy.23831; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xu NJ, 2012, SEMIN CELL DEV BIOL, V23, P58, DOI 10.1016/j.semcdb.2011.10.024; Zhou CQ, 2011, LARYNGOSCOPE, V121, P1541, DOI 10.1002/lary.21861	69	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109043	10.1371/journal.pone.0109043	http://dx.doi.org/10.1371/journal.pone.0109043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299585	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200031
J	Szilagyi, A; Kun, A; Szathmary, E				Szilagyi, Andras; Kun, Adam; Szathmary, Eoers			Local Neutral Networks Help Maintain Inaccurately Replicating Ribozymes	PLOS ONE			English	Article							IN-VITRO SELECTION; HEPATITIS-C-VIRUS; HIGH-AFFINITY APTAMERS; PROTEIN-KINASE-C; RNA APTAMERS; MOLECULAR RECOGNITION; BINDING RNA; INHIBITS TRANSLATION; DIRECTED EVOLUTION; ACTIVE-SITE	The error threshold of replication limits the selectively maintainable genome size against recurrent deleterious mutations for most fitness landscapes. In the context of RNA replication a distinction between the genotypic and the phenotypic error threshold has been made; where the latter concerns the maintenance of secondary structure rather than sequence. RNA secondary structure is treated as a proxy for function. The phenotypic error threshold allows higher per digit mutation rates than its genotypic counterpart, and is known to increase with the frequency of neutral mutations in sequence space. Here we show that the degree of neutrality, i.e. the frequency of nearest-neighbour (one-step) neutral mutants is a remarkably accurate proxy for the overall frequency of such mutants in an experimentally verifiable formula for the phenotypic error threshold; this we achieve by the full numerical solution for the concentration of all sequences in mutation-selection balance up to length 16. We reinforce our previous result that currently known ribozymes could be selectively maintained by the accuracy known from the best available polymerase ribozymes. Furthermore, we show that in silico stabilizing selection can increase the mutational robustness of ribozymes due to the fact that they were produced by artificial directional selection in the first place. Our finding offers a better understanding of the error threshold and provides further insight into the plausibility of an ancient RNA world.	[Szilagyi, Andras; Kun, Adam; Szathmary, Eoers] Parmenides Ctr Conceptual Foundat Sci, Munich, Germany; [Szilagyi, Andras; Szathmary, Eoers] MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Budapest, Hungary; [Szathmary, Eoers] Eotvos Lorand Univ, Inst Biol, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary; [Kun, Adam] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Eotvos Lorand University; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH)	Szathmary, E (corresponding author), Parmenides Ctr Conceptual Foundat Sci, Munich, Germany.	szathmary.eors@gmail.com	Kun, Ádám/A-5571-2011; Szathmary, Eors/AAS-1202-2021	Kun, Ádám/0000-0002-8409-8521; Szathmary, Eors/0000-0001-5227-2997; Szilagyi, Andras/0000-0002-6894-4652	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC [294332]; Hungarian National Office for Research and Technology (NAP) [2005/KCKHA005]; European Union; European Social Fund [TAMOP 4.2.1/B-09/1/KMR-2010-0003]	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Hungarian National Office for Research and Technology (NAP); European Union(European Commission); European Social Fund(European Social Fund (ESF))	Financial support has been provided by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no [294332] and the Hungarian National Office for Research and Technology (NAP 2005/KCKHA005). AS and AK acknowledge support by the European Union and co-financed by the European Social Fund (grant agreement no. TAMOP 4.2.1/B-09/1/KMR-2010-0003). This work was carried out as part of EU COST action CM1304 "Emergence and Evolution of Complex Chemical Systems''. AK gratefully acknowledges a Ja nos Bolyai Research Fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/NCHEM.1781, 10.1038/nchem.1781]; Balay S, 2008, PETSC USERS MANUAL; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; Bell SD, 1998, J BIOL CHEM, V273, P14309, DOI 10.1074/jbc.273.23.14309; Berens C, 2001, BIOORGAN MED CHEM, V9, P2549, DOI 10.1016/S0968-0896(01)00063-3; Bernhardt HS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-23; Bridonneau P, 1998, J MED CHEM, V41, P778, DOI 10.1021/jm970579k; Brockstedt U, 2004, BIOCHEM BIOPH RES CO, V313, P1004, DOI 10.1016/j.bbrc.2003.12.030; Cech TR, 2005, RNA WORLD; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Chumachenko NV, 2009, J AM CHEM SOC, V131, P5257, DOI 10.1021/ja809419f; Coleman TM, 2002, CHEM BIOL, V9, P1227, DOI 10.1016/S1074-5521(02)00264-8; Conn MM, 1996, J AM CHEM SOC, V118, P7012, DOI 10.1021/ja961249c; Conrad R, 1996, ANAL BIOCHEM, V242, P261, DOI 10.1006/abio.1996.0462; CONRAD R, 1994, J BIOL CHEM, V269, P32051; Cox JC, 1998, BIOTECHNOL PROGR, V14, P845, DOI 10.1021/bp980097h; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Czaran T., 2000, GEOMETRY ECOLOGICAL, P116, DOI [10.1017/cbo9780511525537.009, DOI 10.1017/CBO9780511525537.009]; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Dworkin JP, 2003, J THEOR BIOL, V222, P127, DOI 10.1016/S0022-5193(03)00020-1; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 1988, J PHYS CHEM, V92; Eulberg D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni044; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Flintoft L, 2005, NAT REV GENET, V6, P724, DOI 10.1038/nrg1712; FONTANA W, 1993, BIOPOLYMERS, V33, P1389, DOI 10.1002/bip.360330909; Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x; Fusz S, 2005, CHEM BIOL, V12, P941, DOI 10.1016/j.chembiol.2005.06.008; Gal SW, 1998, EUR J BIOCHEM, V252, P553, DOI 10.1046/j.1432-1327.1998.2520553.x; Gebhardt K, 2000, BIOCHEMISTRY-US, V39, P7255, DOI 10.1021/bi000295t; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Gening LV, 2006, NUCLEIC ACIDS RES, V34, P2579, DOI 10.1093/nar/gkl326; Gevertz J, 2005, RNA, V11, P853, DOI 10.1261/rna.7271405; Gruner W, 1996, MONATSH CHEM, V127, P375, DOI 10.1007/BF00810882; Hager AJ, 1997, CHEM BIOL, V4, P607, DOI 10.1016/S1074-5521(97)90246-5; Haller AA, 1997, P NATL ACAD SCI USA, V94, P8521, DOI 10.1073/pnas.94.16.8521; Hamm J, 1997, P NATL ACAD SCI USA, V94, P12839, DOI 10.1073/pnas.94.24.12839; Hartmann R, 1998, J BIOL CHEM, V273, P3236, DOI 10.1074/jbc.273.6.3236; Hayden EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045351; Hernandez V, 2005, ACM T MATH SOFTWARE, V31, P351, DOI 10.1145/1089014.1089019; Hesselberth JR, 2000, J BIOL CHEM, V275, P4937, DOI 10.1074/jbc.275.7.4937; Hirao I, 2004, BIOCHEMISTRY-US, V43, P3214, DOI 10.1021/bi0356146; Hirao I, 1998, MOL DIVERS, V4, P75, DOI 10.1023/A:1026401917416; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hornung V, 1998, BIOCHEMISTRY-US, V37, P7260, DOI 10.1021/bi972969e; Huang FQ, 1997, BIOCHEMISTRY-US, V36, P6557, DOI 10.1021/bi970475b; Huang FQ, 2000, BIOCHEMISTRY-US, V39, P15548, DOI 10.1021/bi002061f; Hubai AG, 2013, EMERGENCE EVOLUTION; Hwang B, 2002, BIOCHEM BIOPH RES CO, V290, P656, DOI 10.1006/bbrc.2001.6252; Illangasekare M, 1999, RNA, V5, P1482, DOI 10.1017/S1355838299991264; Illangasekare M, 1999, P NATL ACAD SCI USA, V96, P5470, DOI 10.1073/pnas.96.10.5470; Jadhav VR, 2002, BIOCHEMISTRY-US, V41, P723, DOI 10.1021/bi011803h; Jayasena VK, 1997, P NATL ACAD SCI USA, V94, P10612, DOI 10.1073/pnas.94.20.10612; Jenne A, 1998, CHEM BIOL, V5, P23, DOI 10.1016/S1074-5521(98)90084-9; Jeong S, 2001, BIOCHEM BIOPH RES CO, V281, P237, DOI 10.1006/bbrc.2001.4327; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; JONES BL, 1976, B MATH BIOL, V38, P15; Jones LA, 2006, ANTIMICROB AGENTS CH, V50, P3019, DOI 10.1128/AAC.01603-05; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Katahira M, 1999, Nucleic Acids Symp Ser, P269; Khvorova A, 1999, P NATL ACAD SCI USA, V96, P10649, DOI 10.1073/pnas.96.19.10649; Kikuchi K, 2005, NUCLEIC ACIDS RES, V33, P683, DOI 10.1093/nar/gki215; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V291, P925, DOI 10.1006/bbrc.2002.6521; Kimoto M, 2002, EUR J BIOCHEM, V269, P697, DOI 10.1046/j.0014-2956.2001.02703.x; Konnyu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020931; Koizumi M, 2000, BIOCHEMISTRY-US, V39, P8983, DOI 10.1021/bi000149n; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; Kumar PKR, 1997, VIROLOGY, V237, P270, DOI 10.1006/viro.1997.8773; Kumar RK, 2001, BIOCHEMISTRY-US, V40, P6998, DOI 10.1021/bi010710x; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; KUN A, 2005, APTAMER HDB, P54; Lafontaine DA, 2002, BIOCHEM SOC T, V30, P1170, DOI 10.1042/bst0301170; Lee JF, 2004, NUCLEIC ACIDS RES, V32, pD95, DOI 10.1093/nar/gkh094; Lee SK, 2005, BIOCHEM BIOPH RES CO, V327, P294, DOI 10.1016/j.bbrc.2004.12.011; Legiewicz M, 2005, J BIOL CHEM, V280, P19815, DOI 10.1074/jbc.M502329200; Li N, 2005, BIOCHEMISTRY-US, V44, P4582, DOI 10.1021/bi047576b; Lorger M, 2003, EUKARYOT CELL, V2, P84, DOI 10.1128/EC.2.1.84-94.2003; Lupold SE, 2002, CANCER RES, V62, P4029; Mannironi C, 2000, RNA, V6, P520, DOI 10.1017/S1355838200991763; Maurel MC, 2005, ADV ASTROBIOL BIOGEO, P571, DOI 10.1007/10913406_17; Maynard Smith John., 1995, MAJOR TRANSITION EVO; Meli M, 2003, J BIOL CHEM, V278, P9835, DOI 10.1074/jbc.M213058200; Meyers LA, 2004, J MOL EVOL, V58, P681, DOI 10.1007/s00239-004-2590-2; Missailidis S, 2005, J IMMUNOL METHODS, V296, P45, DOI 10.1016/j.jim.2004.10.011; Miyakawa S, 2006, RNA, V12, P1825, DOI 10.1261/rna.2169406; Murphy MB, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng110; NOWAK M, 1989, J THEOR BIOL, V137, P375, DOI 10.1016/S0022-5193(89)80036-0; Ogawa A, 2004, BIOORG MED CHEM LETT, V14, P4001, DOI 10.1016/j.bmcl.2004.05.042; Piganeau N, 2001, J MOL BIOL, V312, P1177, DOI 10.1006/jmbi.2001.4981; Rajamani S, 2010, J AM CHEM SOC, V132, P5880, DOI 10.1021/ja100780p; Reidys C, 2001, B MATH BIOL, V63, P57, DOI 10.1006/bulm.2000.0206; Ryu Y, 2006, CHEM COMMUN, P1439, DOI 10.1039/b517160a; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Santos M, 2004, J MOL EVOL, V59, P507, DOI 10.1007/s00239-004-2642-7; Schurer H, 2001, BIOORGAN MED CHEM, V9, P2557, DOI 10.1016/S0968-0896(01)00030-X; SCHUSTER P, 1988, B MATH BIOL, V50, P635, DOI 10.1016/S0092-8240(88)80059-4; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Schuster P, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-374153-0.00001-1; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Seiwert SD, 2000, CHEM BIOL, V7, P833, DOI 10.1016/S1074-5521(00)00032-6; Sengle G, 2001, CHEM BIOL, V8, P459, DOI 10.1016/S1074-5521(01)00026-6; SMITH JM, 1983, PROC R SOC SER B-BIO, V219, P315, DOI 10.1098/rspb.1983.0076; Soukup GA, 2000, J MOL BIOL, V298, P623, DOI 10.1006/jmbi.2000.3704; Stich M, 2011, J THEOR BIOL, V280, P117, DOI 10.1016/j.jtbi.2011.03.010; Sun LL, 2002, CHEM BIOL, V9, P619, DOI 10.1016/S1074-5521(02)00141-2; Swetina J, 1982, BIOPHYSICAL CHEM, V46, P187; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 1987, J THEORETICAL BIOL, V128; Tahiri-Alaoui A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e45; Takeuchi N, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-9; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Thomas M, 1997, J BIOL CHEM, V272, P27980, DOI 10.1074/jbc.272.44.27980; THOMPSON C J, 1974, Mathematical Biosciences, V21, P127, DOI 10.1016/0025-5564(74)90110-2; Tok JBH, 2000, NUCLEIC ACIDS RES, V28, P2902, DOI 10.1093/nar/28.15.2902; Tuschl T, 1998, EMBO J, V17, P2637, DOI 10.1093/emboj/17.9.2637; Ulrich H, 1998, P NATL ACAD SCI USA, V95, P14051, DOI 10.1073/pnas.95.24.14051; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Urvil PT, 1997, EUR J BIOCHEM, V248, P130, DOI 10.1111/j.1432-1033.1997.t01-1-00130.x; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Wallace ST, 1998, RNA, V4, P112; Wang Y, 1996, BIOCHEMISTRY-US, V35, P12338, DOI 10.1021/bi960878w; Wecker M, 1996, RNA, V2, P982; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Welch M, 1997, BIOCHEMISTRY-US, V36, P6614, DOI 10.1021/bi963135j; White RR, 2003, P NATL ACAD SCI USA, V100, P5028, DOI 10.1073/pnas.0831159100; Wilke CO, 2001, PHYS REP, V349, P395, DOI 10.1016/S0370-1573(00)00118-6; WILLIAMS KP, 1995, EMBO J, V14, P4551, DOI 10.1002/j.1460-2075.1995.tb00134.x; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Yarus M., 2011, LIFE RNA WORLD ANCES; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	135	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109987	10.1371/journal.pone.0109987	http://dx.doi.org/10.1371/journal.pone.0109987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299454	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000343941200094
J	Bayati, M; Braverman, M; Gillam, M; Mack, KM; Ruiz, G; Smith, MS; Horvitz, E				Bayati, Mohsen; Braverman, Mark; Gillam, Michael; Mack, Karen M.; Ruiz, George; Smith, Mark S.; Horvitz, Eric			Data-Driven Decisions for Reducing Readmissions for Heart Failure: General Methodology and Case Study	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAMS; HOSPITAL READMISSION; 30-DAY READMISSION; RANDOMIZED TRIAL; RISK PREDICTION; OLDER PATIENTS; INTERVENTION; METAANALYSIS; PREVENT; SUPPORT	Background: Several studies have focused on stratifying patients according to their level of readmission risk, fueled in part by incentive programs in the U.S. that link readmission rates to the annual payment update by Medicare. Patient-specific predictions about readmission have not seen widespread use because of their limited accuracy and questions about the efficacy of using measures of risk to guide clinical decisions. We construct a predictive model for readmissions for congestive heart failure (CHF) and study how its predictions can be used to perform patient-specific interventions. We assess the cost-effectiveness of a methodology that combines prediction and decision making to allocate interventions. The results highlight the importance of combining predictions with decision analysis. Methods: We construct a statistical classifier from a retrospective database of 793 hospital visits for heart failure that predicts the likelihood that patients will be rehospitalized within 30 days of discharge. We introduce a decision analysis that uses the predictions to guide decisions about post-discharge interventions. We perform a cost-effectiveness analysis of 379 additional hospital visits that were not included in either the formulation of the classifiers or the decision analysis. We report the performance of the methodology and show the overall expected value of employing a real-time decision system. Findings: For the cohort studied, readmissions are associated with a mean cost of $13,679 with a standard error of $1,214. Given a post-discharge plan that costs $1,300 and that reduces 30-day rehospitalizations by 35%, use of the proposed methods would provide an 18.2% reduction in rehospitalizations and save 3.8% of costs. Conclusions: Classifiers learned automatically from patient data can be joined with decision analysis to guide the allocation of post-discharge support to CHF patients. Such analyses are especially valuable in the common situation where it is not economically feasible to provide programs to all patients.	[Bayati, Mohsen] Stanford Univ, Stanford, CA 94305 USA; [Braverman, Mark] Princeton Univ, Princeton, NJ 08544 USA; [Gillam, Michael; Mack, Karen M.; Ruiz, George; Smith, Mark S.] MedStar Hlth, Washington, DC USA; [Gillam, Michael; Mack, Karen M.; Ruiz, George; Smith, Mark S.] Washington Hosp Ctr, Washington, DC 20010 USA; [Horvitz, Eric] Microsoft Res, Redmond, WA 98052 USA; [Horvitz, Eric] Univ Washington, Sch Med, Redmond, WA USA	Stanford University; Princeton University; MedStar Washington Hospital Center; Microsoft; University of Washington	Horvitz, E (corresponding author), Microsoft Res, Redmond, WA 98052 USA.	horvitz@microsoft.com		Mack, Karen/0000-0002-2839-5812; Bayati, Mohsen/0000-0002-7280-912X	Microsoft Research, a basic science research unit of Microsoft; Microsoft Research; National Science Foundation [1216011]; Natural Science and Engineering Research Council of Canada; Alfred P. Sloan Fellowship; National Science Foundation; Division of Computing and Communication Foundations [1216011] Funding Source: National Science Foundation	Microsoft Research, a basic science research unit of Microsoft(Microsoft); Microsoft Research(Microsoft); National Science Foundation(National Science Foundation (NSF)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The research was supported as a project at Microsoft Research (http://research.microsoftcom/en-us/), a basic science research unit of Microsoft. Microsoft Research is an open research laboratory (with no publication controls) exploring curiosity-driven research with multiple concentrations in basic and applied computer science. MBa was also a postdoctoral researcher in Microsoft Research during 2007-2009 and received research support from Microsoft Research during 2010-12. MBa also received support by National Science Foundation award number 1216011. MBr was a postdoctoral researcher in Microsoft Research during 2008-2010 and received research support from Microsoft Research during 2010-11. MBr was also supported by a Natural Science and Engineering Research Council of Canada through its Discovery Grant program. MBr was supported by Microsoft Research (http://research.microsoft.com/en-us/) and also by the Natural Science and Engineering Research Council of Canada through its Discovery Grant program, by the Alfred P. Sloan Fellowship and by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Anderson Cheryl, 2005, Congest Heart Fail, V11, P315, DOI 10.1111/j.1527-5299.2005.04458.x; Boutwell A, 2009, EFFECTIVE INTERVENTI; Center for Medicare and Medicaid Services, 2009, FED REG, V74, P24166; Chen S., 1994, SIGN SYST COMP 1994, V1, P41; Coglianese EE, 2012, AM J CARDIOL, V109, P241, DOI 10.1016/j.amjcard.2011.08.037; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Giamouzis G, 2011, J CARD FAIL, V17, P54, DOI 10.1016/j.cardfail.2010.08.010; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jovicic Aleksandra, 2006, BMC Cardiovasc Disord, V6, P43, DOI 10.1186/1471-2261-6-43; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Koelling Todd M, 2005, Evid Based Cardiovasc Med, V9, P138; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Medicare Payment Advisory Commission, 2013, PROM GREAT EFF MED R; Peikes D, 2002, JAMA-J AM MED ASSOC, V301, P603; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vaduganathan M, 2012, CIRC-HEART FAIL, V5, P750, DOI 10.1161/CIRCHEARTFAILURE.112.970525; VanWalraven C, 2010, CMAJ, V6, P51; Wang L, 2012, AM J CARDIOL, V110, P1342, DOI 10.1016/j.amjcard.2012.06.038	27	58	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109264	10.1371/journal.pone.0109264	http://dx.doi.org/10.1371/journal.pone.0109264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295524	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000054
J	Hodulova, M; Sedova, L; Krenova, D; Liska, F; Krupkova, M; Kazdova, L; Tremblay, J; Hamet, P; Kren, V; Seda, O				Hodulova, Miloslava; Sedova, Lucie; Krenova, Drahomira; Liska, Frantisek; Krupkova, Michaela; Kazdova, Ludmila; Tremblay, Johanne; Hamet, Pavel; Kren, Vladimir; Seda, Ondrej			Genomic Determinants of Triglyceride and Cholesterol Distribution into Lipoprotein Fractions in the Rat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SPONTANEOUSLY HYPERTENSIVE-RAT; RECOMBINANT INBRED STRAINS; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; INDUCED HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; GENETIC-DETERMINANTS; LINKAGE ANALYSIS	The plasma profile of major lipoprotein classes and its subdivision into particular fractions plays a crucial role in the pathogenesis of atherosclerosis and is a major predictor of coronary artery disease. Our aim was to identify genomic determinants of triglyceride and cholesterol distribution into lipoprotein fractions and lipoprotein particle sizes in the recombinant inbred rat set PXO, in which alleles of two rat models of the metabolic syndrome (SHR and PD inbred strains) segregate together with those from Brown Norway rat strain. Adult male rats of 15 PXO strains (n = 8-13/strain) and two progenitor strains SHR-Lx (n = 13) and BXH2/Cub (n = 18) were subjected to one-week of high-sucrose diet feeding. We performed association analyses of triglyceride (TG) and cholesterol (C) concentrations in 20 lipoprotein fractions and the size of major classes of lipoprotein particles utilizing 704 polymorphic microsatellite markers, the genome-wide significance was validated by 2,000 permutations per trait. Subsequent in silico focusing of the identified quantitative trait loci was completed using a map of over 20,000 single nucleotide polymorphisms. In most of the phenotypes we identified substantial gradient among the strains (e.g. VLDL-TG from 5.6 to 66.7 mg/dl). We have identified 14 loci (encompassing 1 to 65 genes) on rat chromosomes 3, 4, 7, 8, 11 and 12 showing suggestive or significant association to one or more of the studied traits. PXO strains carrying the SHR allele displayed significantly higher values of the linked traits except for LDL-TG and adiposity index. Cholesterol concentrations in large, medium and very small LDL particles were significantly associated to a haplotype block spanning part of a single gene, low density lipoprotein receptor-related protein 1B (Lrp1b). Using genome-wide association we have identified new genetic determinants of triglyceride and cholesterol distribution into lipoprotein fractions in the recombinant inbred panel of rat model strains.	[Hodulova, Miloslava; Sedova, Lucie; Krenova, Drahomira; Liska, Frantisek; Krupkova, Michaela; Kren, Vladimir; Seda, Ondrej] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Hodulova, Miloslava; Sedova, Lucie; Krenova, Drahomira; Liska, Frantisek; Krupkova, Michaela; Kren, Vladimir; Seda, Ondrej] Gen Teaching Hosp, Prague, Czech Republic; [Kazdova, Ludmila] Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic; [Tremblay, Johanne; Hamet, Pavel] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Hodulova, Miloslava; Seda, Ondrej] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Institute for Clinical & Experimental Medicine (IKEM); Universite de Montreal; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Seda, O (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.	oseda@lf1.cuni.cz	Cossette, Suzanne/I-8008-2016; Liska, Frantisek/N-9192-2017; Krupkova, Michaela/L-2373-2017; Seda, Ondrej/A-2058-2008; Sedova, Lucie/D-1089-2017	Liska, Frantisek/0000-0002-9588-806X; Krupkova, Michaela/0000-0002-9371-2511; Seda, Ondrej/0000-0001-8498-5895; Sedova, Lucie/0000-0003-3783-2946	Ministry of Education, Youth and Sports of the Czech Republic [LK11217]; Charles University in Prague [PRVOUK-P25/LF1/2, GAUK 434313]; European Regional Development Fund [CZ.1.05/1.1.0/02.0109]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; European Regional Development Fund(European Commission)	This work was supported by Project LK11217 from the Ministry of Education, Youth and Sports of the Czech Republic; PRVOUK-P25/LF1/2 and GAUK 434313 research projects of Charles University in Prague, and by the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.0/02.0109), from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell C, 2013, J LIPID RES, V54, P984, DOI 10.1194/jlr.M033035; Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Asahina M, 2005, J LIPID RES, V46, P2289, DOI 10.1194/jlr.M500257-JLR200; Austin MA, 1998, AM J HUM GENET, V62, P406, DOI 10.1086/301712; Baguhl R, 2009, OBESITY, V17, P1215, DOI 10.1038/oby.2008.658; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bottger A, 1996, J CLIN INVEST, V98, P856, DOI 10.1172/JCI118858; Burgdorf KS, 2012, DIABETOLOGIA, V55, P105, DOI 10.1007/s00125-011-2320-4; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cox A, 2010, HEREDITY, V105, P426, DOI 10.1038/hdy.2010.75; Damasceno NRT, 2013, ATHEROSCLEROSIS, V230, P347, DOI 10.1016/j.atherosclerosis.2013.08.014; Festa A, 2005, CIRCULATION, V111, P3465, DOI 10.1161/CIRCULATIONAHA.104.512079; Frazier-Wood AC, 2013, HUM GENET, V132, P405, DOI 10.1007/s00439-012-1256-1; Gardner J, 2012, BIOCHEM BIOPH RES CO, V418, P1, DOI 10.1016/j.bbrc.2011.11.117; Gibson S, 2013, CRIT REV FOOD SCI, V53, P591, DOI 10.1080/10408398.2012.691574; Greenawalt DM, 2012, AM J EPIDEMIOL, V176, P423, DOI 10.1093/aje/kws123; Guay SP, 2013, ATHEROSCLEROSIS, V228, P413, DOI 10.1016/j.atherosclerosis.2013.03.033; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Haas J, 2011, ATHEROSCLEROSIS, V216, P342, DOI 10.1016/j.atherosclerosis.2011.02.030; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hamet P, 1998, KIDNEY INT, V53, P1488, DOI 10.1046/j.1523-1755.1998.00938.x; Herrera VLM, 2007, J HYPERTENS, V25, P1608, DOI 10.1097/HJH.0b013e328182df1a; Hirayama S, 2012, CLIN CHIM ACTA, V414, P215, DOI 10.1016/j.cca.2012.09.010; Holmes M.V., 2014, EUR HEART J; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Johnson MP, 2013, MOL HUM REPROD, V19, P423, DOI 10.1093/molehr/gat011; Kaess B, 2008, J LIPID RES, V49, P715, DOI 10.1194/jlr.M700338-JLR200; Kemlink D, 2003, FOLIA BIOL-PRAGUE, V49, P165; Kikkawa K, 2014, CLIN CHIM ACTA; Klevstig MJ, 2011, MOL CELL BIOCHEM, V357, P163, DOI 10.1007/s11010-011-0886-2; Kloting I, 2001, BIOCHEM BIOPH RES CO, V284, P150, DOI 10.1006/bbrc.2001.4932; Kovacs P, 1998, ARCH BIOCHEM BIOPHYS, V354, P139, DOI 10.1006/abbi.1998.0686; Kovacs P, 2000, BIOCHEM BIOPH RES CO, V269, P660, DOI 10.1006/bbrc.2000.2352; Krupkova M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-38; Krupkova M, 2009, PHARMACOGENOMICS, V10, P1915, DOI 10.2217/PGS.09.113; Kulkarni H, 2013, HYPERTENSION, V62, P621, DOI 10.1161/HYPERTENSIONAHA.113.01396; Langley SR, 2013, CARDIOVASC RES, V97, P653, DOI 10.1093/cvr/cvs329; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Mashimo T, 2007, PHYSIOL GENOMICS, V30, P95, DOI 10.1152/physiolgenomics.00211.2006; Melenovsky Vojtech, 2002, Am Heart J, V144, pE6, DOI 10.1016/S0002-8703(02)00142-4; Mishina H, 2014, CIRC RES, V114, P493, DOI 10.1161/CIRCRESAHA.114.302319; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Nsengimana J, 2007, EUR J HUM GENET, V15, P313, DOI 10.1038/sj.ejhg.5201752; Ogino T, 2000, GENOMICS, V70, P19, DOI 10.1006/geno.2000.6349; Okazaki M, 2006, CLIN CHEM, V52, P2049, DOI 10.1373/clinchem.2006.070094; Osborn O, 2012, J CLIN INVEST, V122, P2444, DOI 10.1172/JCI61953; Petersen AK, 2012, HUM MOL GENET, V21, P1433, DOI 10.1093/hmg/ddr580; Printz MP, 2003, J APPL PHYSIOL, V94, P2510, DOI 10.1152/japplphysiol.00064.2003; Robinson JG, 2014, FUTUR CARDIOL, V10, P149, DOI [10.2217/fca.14.8, 10.2217/FCA.14.8]; Ruel IL, 2002, ARTERIOSCL THROM VAS, V22, P1181, DOI 10.1161/01.ATV.0000020677.33243.1C; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Seda O, 2005, PHYSIOL GENOMICS, V21, P243, DOI 10.1152/physiolgenomics.00230.2004; Seda O, 2002, FOLIA BIOL-PRAGUE, V48, P81; Seda O, 2006, Prague Med Rep, V107, P251; Seda O, 2006, PHYSIOL GENOMICS, V27, P95, DOI 10.1152/physiolgenomics.00039.2006; Sedova L, 2000, FOLIA BIOL-PRAGUE, V46, P99; Sedova L, 2007, AM J PHYSIOL-ENDOC M, V292, pE1318, DOI 10.1152/ajpendo.00526.2006; Shah S, 2013, CIRC-CARDIOVASC GENE, V6, P63, DOI 10.1161/CIRCGENETICS.112.963140; Simonis M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r31; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stancakova A, 2011, DIABETES, V60, P1608, DOI 10.2337/db10-1655; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003; Usui S, 2002, J LIPID RES, V43, P805; VRANA A, 1993, ANN NY ACAD SCI, V683, P57, DOI 10.1111/j.1749-6632.1993.tb35692.x; Watanabe T, 2005, BIOCHEM BIOPH RES CO, V329, P879, DOI 10.1016/j.bbrc.2005.02.053; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wood RJ, 2006, J NUTR, V136, P384, DOI 10.1093/jn/136.2.384; Zhang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-704	70	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109983	10.1371/journal.pone.0109983	http://dx.doi.org/10.1371/journal.pone.0109983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296178	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000108
J	Jones, NRV; Conklin, AI; Suhrcke, M; Monsivais, P				Jones, Nicholas R. V.; Conklin, Annalijn I.; Suhrcke, Marc; Monsivais, Pablo			The Growing Price Gap between More and Less Healthy Foods: Analysis of a Novel Longitudinal UK Dataset	PLOS ONE			English	Article							ENERGY-DENSITY; COST; DIET; AFFORDABILITY; OBESITY; TRENDS; POLICY	Objectives: The UK government has noted the public health importance of food prices and the affordability of a healthy diet. Yet, methods for tracking change over time have not been established. We aimed to investigate the prices of more and less healthy foods over time using existing government data on national food prices and nutrition content. Methods: We linked economic data for 94 foods and beverages in the UK Consumer Price Index to food and nutrient data from the UK Department of Health's National Diet and Nutrition Survey, producing a novel dataset across the period 2002-2012. Each item was assigned to a food group and also categorised as either "more healthy" or "less healthy" using a nutrient profiling model developed by the Food Standards Agency. We tested statistical significance using a t-test and repeated measures ANOVA. Results: The mean (standard deviation) 2012 price/1000 kcal was 2.50 pound (0.29) for less healthy items and 7.49 pound (1.27) for more healthy items. The ANOVA results confirmed that all prices had risen over the period 2002-2012, but more healthy items rose faster than less healthy ones in absolute terms:0.17 pound compared to 0.07 pound/1000 kcal per year on average for more and less healthy items, respectively (p<0.001). Conclusions: Since 2002, more healthy foods and beverages have been consistently more expensive than less healthy ones, with a growing gap between them. This trend is likely to make healthier diets less affordable over time, which may have implications for individual food security and population health, and it may exacerbate social inequalities in health. The novel data linkage employed here could be used as the basis for routine food price monitoring to inform public health policy.	[Jones, Nicholas R. V.; Conklin, Annalijn I.; Suhrcke, Marc; Monsivais, Pablo] Univ Cambridge, Sch Clin Med, Addenbrookes Treatment Ctr, UKCRC Ctr Diet & Act Res,Dept MRC Epidemiol, Cambridge, England; [Suhrcke, Marc] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of East Anglia	Monsivais, P (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Treatment Ctr, UKCRC Ctr Diet & Act Res,Dept MRC Epidemiol, Cambridge Biomed Campus, Cambridge, England.	pm491@medschl.cam.ac.uk	Suhrcke, Marc/AAE-9024-2019	Monsivais, Pablo/0000-0002-7088-6674; Suhrcke, Marc/0000-0001-7263-8626; Conklin, Annalijn/0000-0002-6532-8790	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under the UK Clinical Research Collaboration; Gates Cambridge Trust; Economic and Social Research Council [1166526, ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under the UK Clinical Research Collaboration(Wellcome Trust); Gates Cambridge Trust; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The present study was undertaken by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. The authors gratefully acknowledge the funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration. AIC was fully supported by the Gates Cambridge Trust. The funding sources had no role in the design and conduct of the study or in the collection, management, analysis, and interpretation of the data.	Andreyeva T, 2008, HEALTH AFFAIR, V27, P1381, DOI 10.1377/hlthaff.27.5.1381; [Anonymous], 2013, FOOD STAT POCK 2013; [Anonymous], 2011, LIVEWELL BALANCE HLT; Anriquez G, 2010, MEASURING DIETARY EN; Burns C, 2008, AUST NZ J PUBL HEAL, V32, P450, DOI 10.1111/j.1753-6405.2008.00278.x; Carlson A., 2012, ARE HLTH FOODS REALL; Change4Life, 2013, HLTH LIV TIPS BEN YO; Department for Environment Food and Rural Affairs, 2010, UK FOOD SEC ASS DET; Department of Health, 2012, NAT DIET NUTR SURV H; Department of Health, 2011, NAT DIET NUTR SURV Y; Dowler E, 2008, P NUTR SOC, V67, P289, DOI 10.1017/S0029665108008586; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; European Union, 2007, COMM ORG AGR MARK; Griffith R., 2012, FOOD PURCHASES NUTR; Harrison M, 2010, AUST NZ J PUBL HEAL, V34, P179, DOI 10.1111/j.1753-6405.2010.00504.x; Kuchler F., 2008, PRICE TRENDS ARE SIM; Lee A, 2013, OBES REV, V14, P82, DOI 10.1111/obr.12078; Lee JH, 2011, NUTR DIET, V68, P248, DOI 10.1111/j.1747-0080.2011.01554.x; Lloyd-Williams F, 2008, B WORLD HEALTH ORGAN, V86, P535, DOI 10.2471/BLT.08.053728; Monsivais P, 2007, J AM DIET ASSOC, V107, P2071, DOI 10.1016/j.jada.2007.09.009; Monsivais P, 2010, FOOD POLICY, V35, P514, DOI 10.1016/j.foodpol.2010.06.004; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; National Health Service, EATW PLAT; Ni Mhurchu Cliona, 2007, N Z Med J, V120, pU2388; O'Dowd A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3578; Office for National Statistics, 2012, CONS PRIC IND TECHN; Office for National Statistics, 2012, LIV COST FOOD SURV; Pinstrup-Andersen P, 2009, FOOD SECUR, V1, P5, DOI 10.1007/s12571-008-0002-y; R Core Team, 2022, R LANG ENV STAT COMP; Rao M, 2013, HLTH FOODS DIET PATT; Rayner M, 2009, UK OFCOM NUTR PROFIL; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P337, DOI 10.1017/S1368980007666671; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; StataCorp, 2011, STAT STAT SOFTW REL, P173; Taylor-Robinson D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7157; The World Bank, MEAS POV LIN; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; UK Data Service, NAT DIET NUTR SURV 2; United States Department of Agriculture, 1975, AGR HDB, V102; Veerman JL, 2006, EUR J PUBLIC HEALTH, V16, P31, DOI 10.1093/eurpub/cki166; WFS, 1996, WORLD FOOD SUMM IT; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams P, 2009, NUTR DIET, V66, P27, DOI 10.1111/j.1747-0080.2008.01314.x; World Health Organization, 2004, GLOB STRAT DIET PHYS	45	123	124	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109343	10.1371/journal.pone.0109343	http://dx.doi.org/10.1371/journal.pone.0109343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296332	gold, Green Published, Green Accepted			2022-12-25	WOS:000345204000060
J	Kowshile, J; Baba, AB; Giri, H; Reddy, GD; Dixit, M; Nagini, S				Kowshile, J.; Baba, Abdul Basit; Giri, Hemant; Reddy, G. Deepak; Dixit, Madhulika; Nagini, Siddavaram			Astaxanthin Inhibits JAK/STAT-3 Signaling to Abrogate Cell Proliferation, Invasion and Angiogenesis in a Hamster Model of Oral Cancer	PLOS ONE			English	Article							NF-KAPPA-B; INDUCE INTRINSIC APOPTOSIS; IN-VITRO; HEPATOCELLULAR-CARCINOMA; WNT/BETA-CATENIN; STAT3 ACTIVATION; ANIMAL-MODEL; PATHWAY; TRANSCRIPTION; CAROTENOIDS	Identifying agents that inhibit STAT-3, a cytosolic transcription factor involved in the activation of various genes implicated in tumour progression is a promising strategy for cancer chemoprevention. In the present study, we investigated the effect of dietary astaxanthin on JAK-2/STAT-3 signaling in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model by examining the mRNA and protein expression of JAK/STAT-3 and its target genes. Quantitative RT-PCR, immunoblotting and immunohistochemical analyses revealed that astaxanthin supplementation inhibits key events in JAK/STAT signaling especially STAT-3 phosphorylation and subsequent nuclear translocation of STAT-3. Furthermore, astaxanthin downregulated the expression of STAT-3 target genes involved in cell proliferation, invasion and angiogenesis, and reduced microvascular density, thereby preventing tumour progression. Molecular docking analysis confirmed inhibitory effects of astaxanthin on STAT signaling and angiogenesis. Cell culture experiments with the endothelial cell line ECV304 substantiated the role of astaxanthin in suppressing angiogenesis. Taken together, our data provide substantial evidence that dietary astaxanthin prevents the development and progression of HBP carcinomas through the inhibition of JAK-2/STAT-3 signaling and its downstream events. Thus, astaxanthin that functions as a potent inhibitor of tumour development and progression by targeting JAK/STAT signaling may be an ideal candidate for cancer chemoprevention.	[Kowshile, J.; Baba, Abdul Basit; Nagini, Siddavaram] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India; [Giri, Hemant; Dixit, Madhulika] Indian Inst Technol, Dept Biotechnol, Lab Vasc Biol, Chennai 600036, Tamil Nadu, India; [Reddy, G. Deepak] Vishnu Inst Pharmaceut Educ & Res, Med Chem Res Div, Narsapur, India	Annamalai University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Nagini, S (corresponding author), Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India.	s_nagini@yahoo.com	Giri, Hemant/Y-8093-2019	Gade, Deepak Reddy/0000-0003-2999-0151	Department of Biotechnology, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by a grant from the Department of Biotechnology, New Delhi, India under the 7th FP of the Indo-EU Joint Collaborative Project on 'FUNCFOOD'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Anitha P, 2013, EUR J NUTR, V52, P75, DOI 10.1007/s00394-011-0288-y; Aparicio-Siegmund S, 2014, ONCOTARGET, V5, P2131, DOI 10.18632/oncotarget.1852; Ben-Yosef Y, 2002, CIRC RES, V90, P784, DOI 10.1161/01.RES.0000015588.70132.DC; Bhatia D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/371813; Bournazou Eirini, 2013, JAKSTAT, V2, pe23828, DOI 10.4161/jkst.23828; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Denley SM, 2013, J GASTROINTEST SURG, V17, P887, DOI 10.1007/s11605-013-2168-7; Gurbuz V, 2014, ONCOL LETT, V7, P755, DOI 10.3892/ol.2014.1795; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; Izumi-Nagai K, 2008, INVEST OPHTH VIS SCI, V49, P1679, DOI 10.1167/iovs.07-1426; Jeon KS, 2005, BIOCHEM BIOPH RES CO, V330, P1268, DOI 10.1016/j.bbrc.2005.03.109; Kavitha K, 2013, BBA-GEN SUBJECTS, V1830, P4433, DOI 10.1016/j.bbagen.2013.05.032; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Lamy S, 2012, EXP CELL RES, V318, P1586, DOI 10.1016/j.yexcr.2012.04.004; Legrand-Poels S, 2000, BIOCHEM J, V349, P765, DOI 10.1042/bj3490765; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maoka T, 2012, MAR DRUGS, V10, P1391, DOI 10.3390/md10061391; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nagendraprabhu P, 2011, INVEST NEW DRUG, V29, P207, DOI 10.1007/s10637-009-9342-5; Prabhu PN, 2009, FUND CLIN PHARMACOL, V23, P225, DOI 10.1111/j.1472-8206.2009.00669.x; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rajendran P, 2012, CANCER PREV RES, V5, P631, DOI 10.1158/1940-6207.CAPR-11-0420; Samsonov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068391; Senggunprai L, 2014, PHYTOTHER RES, V28, P841, DOI 10.1002/ptr.5061; Shklar G, 1999, J DENT RES, V78, P1768; Siddavaram N, 2012, CELL ONCOL, V35, P385, DOI 10.1007/s13402-012-0099-z; Silver-Morse L., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.26090; Song XD, 2011, BIOL PHARM BULL, V34, P839, DOI 10.1248/bpb.34.839; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Tanaka T, 2012, MOLECULES, V17, P3202, DOI 10.3390/molecules17033202; Thiyagarajan P, 2012, FOOD CHEM TOXICOL, V50, P867, DOI 10.1016/j.fct.2011.12.019; Trecul A, 2012, GENES NUTR, V7, P111, DOI 10.1007/s12263-012-0281-y; Tu YY, 2011, MED ONCOL, V28, P15, DOI 10.1007/s12032-010-9435-1; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050508; Wang MR, 2013, FOOD CHEM TOXICOL, V56, P450, DOI 10.1016/j.fct.2013.03.004; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; You ZB, 2012, CLIN TRANSL ONCOL, V14, P143, DOI 10.1007/s12094-012-0774-6; Zgheib A, 2013, J BIOL CHEM, V288, P13378, DOI 10.1074/jbc.M113.456533; Zhang J, 2014, FOOD FUNCT, V5, P413, DOI 10.1039/c3fo60607d; Zhang X, 2011, ARCH BIOCHEM BIOPHYS, V512, P96, DOI 10.1016/j.abb.2011.05.004	49	93	101	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109114	10.1371/journal.pone.0109114	http://dx.doi.org/10.1371/journal.pone.0109114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296162	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000038
J	Li, L; Lin, M; Krassilnikova, M; Ostrow, K; Bader, A; Radbill, B; Uribarri, J; Tokita, J; Leisman, S; Lapsia, V; Albrecht, RA; Garcia-Sastre, A; Branch, AD; Heeger, PS; Mehrotra, A				Li, Lily; Lin, Marvin; Krassilnikova, Maria; Ostrow, Katya; Bader, Amanda; Radbill, Brian; Uribarri, Jaime; Tokita, Joji; Leisman, Staci; Lapsia, Vijay; Albrecht, Randy A.; Garcia-Sastre, Adolfo; Branch, Andrea D.; Heeger, Peter S.; Mehrotra, Anita			Effect of Cholecalciferol Supplementation on Inflammation and Cellular Alloimmunity in Hemodialysis Patients: Data from a Randomized Controlled Pilot Trial	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; T-CELL; ALLOGRAFT SURVIVAL; MINERAL METABOLISM; DIFFERENTIATION; POSTTRANSPLANT; MATURATION; REJECTION; IMMUNITY; BARRIER	Background: Memory T-cells are mediators of transplant injury, and no therapy is known to prevent the development of cross-reactive memory alloimmunity. Activated vitamin D is immunomodulatory, and vitamin D deficiency, common in hemodialysis patients awaiting transplantation, is associated with a heightened alloimmune response. Thus, we tested the hypothesis that vitamin D-3 supplementation would prevent alloreactive T-cell memory formation in vitamin D-deficient hemodialysis patients. Methods and Findings: We performed a 12-month single-center pilot randomized, controlled trial of 50,000 IU/week of cholecalciferol (D-3) versus no supplementation in 96 hemodialysis patients with serum 25(OH)D<25 ng/mL, measuring effects on serum 25(OH) D and phenotypic and functional properties of T-cells. Participants were randomized 2: 1 to active treatment versus control. D-3 supplementation increased serum 25(OH) D at 6 weeks (13.5 [ 11.2] ng/mL to 42.5 [ 18.5] ng/mL, p<0.001) and for the duration of the study. No episodes of sustained hypercalcemia occurred in either group. Results of IFN gamma ELISPOT-based panel of reactive T-cell assays (PRT), quantifying alloreactive memory, demonstrated greater increases in the controls over 1 year compared to the treatment group (delta PRT in treatment 104.8+/2330.8 vs 252.9+/2431.3 in control), but these changes in PRT between groups did not reach statistical significance (p = 0.25). Conclusions: D-3 supplements are safe, effective at treating vitamin D deficiency, and may prevent time-dependent increases in T-cell alloimmunity in hemodialysis patients, but their effects on alloimmunity need to be confirmed in larger studies. These findings support the routine supplementation of vitamin D-deficient transplant candidates on hemodialysis and highlight the need for large-scale prospective studies of vitamin D supplementation in transplant candidates and recipients.	[Li, Lily; Lin, Marvin; Krassilnikova, Maria; Ostrow, Katya; Bader, Amanda; Radbill, Brian; Uribarri, Jaime; Tokita, Joji; Leisman, Staci; Lapsia, Vijay; Heeger, Peter S.; Mehrotra, Anita] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA; [Li, Lily; Lin, Marvin; Krassilnikova, Maria; Ostrow, Katya; Bader, Amanda; Radbill, Brian; Uribarri, Jaime; Tokita, Joji; Leisman, Staci; Lapsia, Vijay; Garcia-Sastre, Adolfo; Branch, Andrea D.; Heeger, Peter S.; Mehrotra, Anita] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Heeger, Peter S.] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, New York, NY 10029 USA; [Heeger, Peter S.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Branch, Andrea D.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mehrotra, A (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA.	anita.mehrotra@mssm.edu	Li, Lily/AAN-6297-2020; Albrecht, Randy A./H-5119-2019	Li, Lily/0000-0002-9794-8468; Albrecht, Randy A./0000-0003-4008-503X; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Doris Duke Charitable Foundation; National Kidney Foundation; American Heart Association; National Institute of Health from the National Center for Advancing Translational Sciences [DK090317, DA0301095, U01AI063594, U19AI089987, UL1TR000067]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089987, U01AI063594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090317] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Kidney Foundation; American Heart Association(American Heart Association); National Institute of Health from the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Doris Duke Charitable Foundation (LL), National Kidney Foundation (PSH), American Heart Association (AM), and National Institute of Health: DK090317, DA0301095 (ADB), U01AI063594 (PSH), U19AI089987 (AG-S, RA), and UL1TR000067 from the National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Adorini L, 2001, TRANSPLANT P, V33, P58, DOI 10.1016/S0041-1345(00)02262-4; Augustine JF, 2007, J AM SOC NEPHROL, V18, P1602, DOI 10.1681/ASN.2006101105; BHALLA AK, 1984, J IMMUNOL, V133, P1748; Bienaime F, 2013, J AM SOC NEPHROLOGY; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; de Baey A, 2001, EUR J IMMUNOL, V31, P1646, DOI 10.1002/1521-4141(200106)31:6<1646::AID-IMMU1646>3.0.CO;2-X; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Heeger PS, 1999, J IMMUNOL, V163, P2267; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2; Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x; Jean G, 2008, NEPHROL DIAL TRANSPL, V23, P3670, DOI 10.1093/ndt/gfn339; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Kim H, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-22; Lavin PJ, 2007, RENAL FAILURE, V29, P785, DOI 10.1080/08860220701540417; Lee JR, 2014, TRANSPLANTATION, V98, P292, DOI 10.1097/TP.0000000000000055; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Looker Anne C, 2011, NCHS Data Brief, P1; Matias PJ, 2010, CLIN J AM SOC NEPHRO, V5, P905, DOI 10.2215/CJN.06510909; Nadazdin O, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002093; Nair V, 2012, CLIN TRANSPLANT, V26, pE261, DOI 10.1111/j.1399-0012.2012.01657.x; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Poggio ED, 2007, TRANSPLANTATION, V83, P847, DOI 10.1097/01.tp.0000258730.75137.39; Pramyothin P, 2012, CURR OPIN GASTROEN, V28, P139, DOI 10.1097/MOG.0b013e32835004dc; Saab G, 2007, NEPHRON CLIN PRACT, V105, P132, DOI 10.1159/000098645; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Sawinski D, 2010, AM J TRANSPLANT, V10, P2287, DOI 10.1111/j.1600-6143.2010.03264.x; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; Wasse H, 2012, AM J CLIN NUTR, V95, P522, DOI 10.3945/ajcn.111.025502; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Zand MS, 2005, AM J TRANSPLANT, V5, P76, DOI 10.1111/j.1600-6143.2003.00637.x; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	36	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109998	10.1371/journal.pone.0109998	http://dx.doi.org/10.1371/journal.pone.0109998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296334	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000109
J	Nakano, K; Park, K; Zheng, RC; Fang, F; Ohori, M; Nakamura, H; Kumagai, Y; Okada, H; Teramura, K; Nakayama, S; Irimajiri, A; Taoka, H; Okada, S				Nakano, Kimihiko; Park, Kaechang; Zheng, Rencheng; Fang, Fang; Ohori, Masanori; Nakamura, Hiroki; Kumagai, Yasuhiho; Okada, Hiroshi; Teramura, Kazuhiko; Nakayama, Satoshi; Irimajiri, Akinori; Taoka, Hiroshi; Okada, Satoshi			Leukoaraiosis Significantly Worsens Driving Performance of Ordinary Older Drivers	PLOS ONE			English	Article							SERIAL ADDITION TEST; WORKING-MEMORY; SAFETY IMPLICATIONS; ATTENTION; YOUNG; FOCUS	Background: Leukoaraiosis is defined as extracellular space caused mainly by atherosclerotic or demyelinated changes in the brain tissue and is commonly found in the brains of healthy older people. A significant association between leukoaraiosis and traffic crashes was reported in our previous study; however, the reason for this is still unclear. Method: This paper presents a comprehensive evaluation of driving performance in ordinary older drivers with leukoaraiosis. First, the degree of leukoaraiosis was examined in 33 participants, who underwent an actual-vehicle driving examination on a standard driving course, and a driver skill rating was also collected while the driver carried out a paced auditory serial addition test, which is a calculating task given verbally. At the same time, a steering entropy method was used to estimate steering operation performance. Results: The experimental results indicated that a normal older driver with leukoaraiosis was readily affected by external disturbances and made more operation errors and steered less smoothly than one without leukoaraiosis during driving; at the same time, their steering skill significantly deteriorated. Conclusions: Leukoaraiosis worsens the driving performance of older drivers because of their increased vulnerability to distraction.	[Nakano, Kimihiko] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Park, Kaechang] Kochi Univ Technol, Res Org Reg Alliances, Traff Med Lab, Kami, Kochi, Japan; [Park, Kaechang] Kochi Kenshin Clin, Brain Checkup Ctr, Kochi, Japan; [Zheng, Rencheng; Fang, Fang; Ohori, Masanori] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Nakamura, Hiroki] Kanagawa Univ, Fac Engn, Yokohama, Kanagawa, Japan; [Kumagai, Yasuhiho] Kochi Univ Technol, Res Org Reg Alliances, Reg ITS Res Lab, Kami, Kochi, Japan; [Okada, Hiroshi; Teramura, Kazuhiko; Nakayama, Satoshi; Irimajiri, Akinori; Taoka, Hiroshi; Okada, Satoshi] Kochi Prefectural Police Dept, Drivers License Ctr, Kochi, Japan	University of Tokyo; Kochi University Technology; University of Tokyo; Kanagawa University; Kochi University Technology	Nakano, K (corresponding author), Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan.	knakano@iis.u-tokyo.ac.jp			Japan Society for the Promotion of Science [22656114, 23656161, 21360248]; Grants-in-Aid for Scientific Research [26289177] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Exploratory Research (no. 22656114), Grant-in-Aid for Exploratory Research (no. 23656161), and Grant-in-Aid for Scientific Research (B) (no. 21360248) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Bellinger DB, 2009, TRANSPORT RES F-TRAF, V12, P441, DOI 10.1016/j.trf.2009.08.007; Boer E. R., 2005, P 3 INT DRIV S HUM F, P25, DOI DOI 10.17077/DRIVINGASSESSMENT.1139; Boer ER, 2001, P 1 INT DRIV S HUM F, P1; Brain dock guideline, 2008, BRAIN DOCK GUID; BROUWER WH, 1991, HUM FACTORS, V33, P573, DOI 10.1177/001872089103300508; Cooper PJ, 1999, ACCIDENT ANAL PREV, V22, P499; Donmez B, 2007, ACCIDENT ANAL PREV, V39, P581, DOI 10.1016/j.aap.2006.10.003; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Griffith HR, 2013, J GERIATR PSYCH NEUR, V26, P259, DOI 10.1177/0891988713509138; Hachinski VC, 2013, ARCH NEUROL-CHICAGO, V26, P259; Hakamies-Blomqvist L., 2002, TRANSP RES F, V5, P271, DOI [10.1016/S1369-8478(03)00005-6, DOI 10.1016/S1369-8478(03)00005-6]; Lamble D, 1999, ACCIDENT ANAL PREV, V31, P617, DOI 10.1016/S0001-4575(99)00018-4; Nakayama O, 1999, DEV STEERING ENTRO 1, V1, P1686, DOI DOI 10.4271/1999-01-0892; Park K, 2007, NEUROLOGY, V69, P974, DOI 10.1212/01.wnl.0000266562.54684.bf; Park KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052779; Parmenter BA, 2006, J INT NEUROPSYCH SOC, V12, P677, DOI 10.1017/S1355617706060826; Paul A., 2005, P 3 INT DRIV S HUM F, P441, DOI [10.17077/drivingassessment.1196, DOI 10.17077/DRIVINGASSESSMENT.1196]; Pavlou D, 2013, P 3 INT C DRIV DISTR; Ponds RW, 1998, J GERONTOL, V43, P151; Radford K, 2004, DISABIL REHABIL, V26, P65, DOI 10.1080/09638280310001629633; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Uc EY, 2006, NEUROLOGY, V67, P1774, DOI 10.1212/01.wnl.0000245086.32787.61; Uc EY, 2009, NEUROLOGY, V73, P2112, DOI 10.1212/WNL.0b013e3181c67b77; Verhaeghen P, 2005, Q J EXP PSYCHOL-A, V58, P134, DOI 10.1080/02724980443000241; Wiens AN, 1997, J CLIN EXP NEUROPSYC, V19, P473, DOI 10.1080/01688639708403737; Zhang J, 1998, PUBLIC HEALTH, V112, P289, DOI 10.1038/sj.ph.1900485	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108333	10.1371/journal.pone.0108333	http://dx.doi.org/10.1371/journal.pone.0108333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295736	gold, Green Published			2022-12-25	WOS:000345204000014
J	Safo, MK; Musayev, FN; Mosier, PD; Zhou, QB; Xie, H; Desai, UR				Safo, Martin K.; Musayev, Faik N.; Mosier, Philip D.; Zhou, Qibing; Xie, Hang; Desai, Umesh R.			Crystal Structures of Influenza A Virus Matrix Protein M1: Variations on a Theme	PLOS ONE			English	Article							NUCLEAR EXPORT; LOW PH; ELECTRON-MICROSCOPY; NS2 PROTEIN; MEMBRANE; BINDING; LOCALIZATION; TRANSPORT; DOMAIN; RIBONUCLEOPROTEINS	Matrix protein 1 (M1) of the influenza A virus plays multiple roles in virion assembly and infection. Interest in the pH dependence of M1's multiple functions led us to study the effect of subtle pH changes on M1 structure, resulting in the elucidation of a unique low-pH crystal structure of the N1-165-domain of A/WSN/33 (H1N1) M1 that has never been reported. Although the 2.2 angstrom crystal structure of M1 N-terminus shows a dimer with the two monomers interacting in a face-to-face fashion at low pH as observed earlier, a 44 degrees rotation of the second monomer has led to a significantly different dimer interface that possibly affects dimer stability. More importantly, while one of the monomers is fully defined, the N-terminal half of the second monomer shows considerable disorder that appears inherent in the protein and is potentially physiologically relevant. Such disorder has not been observed in any other previously reported structure at either low or high pH conditions, despite similar crystallization pH conditions. By comparing our novel N1-165-domain structure with other low-pH or neutral-pH M1 structures, it appears that M1 can energetically access different monomer and dimer conformations, as well as oligomeric states, with varying degree of similarities. The study reported here provides further insights into M1 oligomerization that may be essential for viral propagation and infectivity.	[Safo, Martin K.; Musayev, Faik N.; Mosier, Philip D.; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA; [Safo, Martin K.; Musayev, Faik N.; Mosier, Philip D.; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Zhou, Qibing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Mat Med, Wuhan, Hubei, Peoples R China; [Xie, Hang] US FDA, Div Viral Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	Virginia Commonwealth University; Virginia Commonwealth University; Huazhong University of Science & Technology; US Food & Drug Administration (FDA)	Safo, MK (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA.	msafo@vcu.edu; Hang.Xie@fda.hhs.gov	Musayev, Faik/AAY-2010-2020; Safo, Martin/AAJ-9833-2020; Xie, Hang/AAC-9092-2019; Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Xie, Hang/0000-0001-8318-5554	National Institutes of Health [P01 HL107152, CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	URD acknowledges the research support provided by grant P01 HL107152 from the National Institutes of Health. Structural biology resources were provided in part by National Institutes of Health grant CA16059 to the VCU Massey Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Arzt S, 2004, VIRUS RES, V99, P115, DOI 10.1016/j.virusres.2003.10.010; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Das SC, 2012, J VIROL, V86, P1522, DOI 10.1128/JVI.06230-11; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Fontana J, 2013, J VIROL, V87, P5621, DOI 10.1128/JVI.00276-13; Fontana J, 2012, J VIROL, V86, P2919, DOI 10.1128/JVI.06698-11; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; KEMLER I, 1994, VIROLOGY, V202, P1028, DOI 10.1006/viro.1994.1432; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; Ponstingl H, 2000, PROTEINS, V41, P47; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Sakaguchi A, 2003, VIROLOGY, V306, P244, DOI 10.1016/S0042-6822(02)00013-2; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; WARD AC, 1995, ARCH VIROL, V140, P2067, DOI 10.1007/BF01322693; Whittaker G, 1996, J VIROL, V70, P2743, DOI 10.1128/JVI.70.5.2743-2756.1996; WRIGLEY NG, 1979, BRIT MED BULL, V35, P35, DOI 10.1093/oxfordjournals.bmb.a071539; Xie H, 2013, J VIROL, V87, P345, DOI 10.1128/JVI.02024-12; YASUDA J, 1993, VIROLOGY, V196, P249, DOI 10.1006/viro.1993.1473; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786; ZHIRNOV OP, 1992, VIROLOGY, V186, P324, DOI 10.1016/0042-6822(92)90090-C	37	27	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109510	10.1371/journal.pone.0109510	http://dx.doi.org/10.1371/journal.pone.0109510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295515	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000075
J	Di, Z; Klop, MJD; Rogkoti, VM; Le Devedec, SE; van de Water, B; Verbeek, FJ; Price, LS; Meerman, JHN				Di, Zi; Klop, Maarten J. D.; Rogkoti, Vasiliki-Maria; Le Devedec, Sylvia E.; van de Water, Bob; Verbeek, Fons J.; Price, Leo S.; Meerman, John H. N.			Ultra High Content Image Analysis and Phenotype Profiling of 3D Cultured Micro-Tissues	PLOS ONE			English	Article							CANCER CELL-LINES; BREAST-CANCER; MODELS; RECOGNITION; DISCOVERY; NETWORKS; SUBTYPES; SCREENS	In many situations, 3D cell cultures mimic the natural organization of tissues more closely than 2D cultures. Conventional methods for phenotyping such 3D cultures use either single or multiple simple parameters based on morphology and fluorescence staining intensity. However, due to their simplicity many details are not taken into account which limits system-level study of phenotype characteristics. Here, we have developed a new image analysis platform to automatically profile 3D cell phenotypes with 598 parameters including morphology, topology, and texture parameters such as wavelet and image moments. As proof of concept, we analyzed mouse breast cancer cells (4T1 cells) in a 384-well plate format following exposure to a diverse set of compounds at different concentrations. The result showed concentration dependent phenotypic trajectories for different biologically active compounds that could be used to classify compounds based on their biological target. To demonstrate the wider applicability of our method, we analyzed the phenotypes of a collection of 44 human breast cancer cell lines cultured in 3D and showed that our method correctly distinguished basal-A, basal-B, luminal and ERBB2+ cell lines in a supervised nearest neighbor classification method.	[Di, Zi; Rogkoti, Vasiliki-Maria; Le Devedec, Sylvia E.; van de Water, Bob; Price, Leo S.; Meerman, John H. N.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands; [Klop, Maarten J. D.; Price, Leo S.] OcellO BV, Bio Partner Ctr Leiden, Leiden, Netherlands; [Verbeek, Fons J.] Leiden Univ, Leiden Inst Adv Comp Sci, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Price, LS (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands.	lsprice@lacdr.leidenuniv.nl	Le Dévédec, Sylvia/AAC-1208-2020	Le Dévédec, Sylvia/0000-0002-0615-9616; Price, Leo/0000-0002-4562-9086	Netherlands Toxicogenomics Centre, Dutch Genomics Initiative	Netherlands Toxicogenomics Centre, Dutch Genomics Initiative	This work was supported by a Grant from the Netherlands Toxicogenomics Centre which is part of the Dutch Genomics Initiative. http://www.toxicogenomics.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Bilgin CC, 2013, BIOINFORMATICS, V29, P3087, DOI 10.1093/bioinformatics/btt535; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Cao L, 2011, LECT N BIOINFORMAT, V7036, P330, DOI 10.1007/978-3-642-24855-9_29; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; Duda R.O., 2006, PATTERN CLASSIFICATI; Gaggioli C, 2007, PIGM CELL RES, V20, P161, DOI 10.1111/j.1600-0749.2007.00378.x; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hollestelle A, 2010, BREAST CANCER RES TR, V122, P125, DOI 10.1007/s10549-009-0545-4; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Kuan Yan, 2012, Leveraging Applications of Formal Methods, Verification and Validation. Applications and Case Studies. Proceedings of the 5th International Symposium, ISoLA 2012, P25, DOI 10.1007/978-3-642-34032-1_4; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu CJ, 2000, IEEE T IMAGE PROCESS, V9, P132, DOI 10.1109/83.817604; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niblack W., 1986, INTRO DIGITAL IMAGE, P115; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Rajaram S, 2012, NAT METHODS, V9, P635, DOI 10.1038/nmeth.2097; Raudys S, 1998, PATTERN RECOGN LETT, V19, P385, DOI 10.1016/S0167-8655(98)00016-6; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Wang J, 2008, J BIOMOL SCREEN, V13, P29, DOI 10.1177/1087057107311223; Webb A. R., 2002, STAT PATTERN RECOGNI, P123; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9	33	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109688	10.1371/journal.pone.0109688	http://dx.doi.org/10.1371/journal.pone.0109688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289886	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000079
J	Jiang, GM; Jiang, XQ; Lu, PT; Liu, JT; Gao, JP; Zhang, CQ				Jiang, Guimei; Jiang, Xinqiang; Lu, Peitao; Liu, Jitao; Gao, Junping; Zhang, Changqing			The Rose (Rosa hybrida) NAC Transcription Factor 3 Gene, RhNAC3, Involved in ABA Signaling Pathway Both in Rose and Arabidopsis	PLOS ONE			English	Article							DROUGHT STRESS TOLERANCE; ACTING REGULATORY ELEMENTS; ABSCISIC-ACID; OSMOTIC-STRESS; ABIOTIC STRESS; TRANSGENIC ARABIDOPSIS; DEHYDRATION TOLERANCE; FUNCTIONAL-ANALYSIS; POSITIVE REGULATOR; BZIP PROTEIN	Plant transcription factors involved in stress responses are generally classified by their involvement in either the abscisic acid (ABA)-dependent or the ABA-independent regulatory pathways. A stress-associated NAC gene from rose (Rosa hybrida), RhNAC3, was previously found to increase dehydration tolerance in both rose and Arabidopsis. However, the regulatory mechanism involved in RhNAC3 action is still not fully understood. In this study, we isolated and analyzed the upstream regulatory sequence of RhNAC3 and found many stress-related cis-elements to be present in the promoter, with five ABA-responsive element (ABRE) motifs being of particular interest. Characterization of Arabidopsis thaliana plants transformed with the putative RhNAC3 promoter sequence fused to the beta-glucuronidase (GUS) reporter gene revealed that RhNAC3 is expressed at high basal levels in leaf guard cells and in vascular tissues. Moreover, the ABRE motifs in the RhNAC3 promoter were observed to have a cumulative effect on the transcriptional activity of this gene both in the presence and absence of exogenous ABA. Overexpression of RhNAC3 in A. thaliana resulted in ABA hypersensitivity during seed germination and promoted leaf closure after ABA or drought treatments. Additionally, the expression of 11 ABA-responsive genes was induced to a greater degree by dehydration in the transgenic plants overexpressing RhNAC3 than control lines transformed with the vector alone. Further analysis revealed that all these genes contain NAC binding cis-elements in their promoter regions, and RhNAC3 was found to partially bind to these putative NAC recognition sites. We further found that of 219 A. thaliana genes previously shown by microarray analysis to be regulated by heterologous overexpression RhNAC3, 85 are responsive to ABA. In rose, the expression of genes downstream of the ABA-signaling pathways was also repressed in RhNAC3-silenced petals. Taken together, we propose that the rose RhNAC3 protein could mediate ABA signaling both in rose and in A. thaliana.	[Jiang, Guimei; Lu, Peitao; Liu, Jitao; Gao, Junping; Zhang, Changqing] China Agr Univ, Dept Ornamental Hort, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Jiang, Xinqiang] Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao, Peoples R China	China Agricultural University; Qingdao Agricultural University	Zhang, CQ (corresponding author), China Agr Univ, Dept Ornamental Hort, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	chqzhang@cau.edu.cn	Lü, Peitao/B-4641-2019	Lu, Peitao/0000-0002-4894-6458	National Natural Science Foundation of China [31372096]; Beijing Nova Program [2009B51]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China (Grant No. 31372096) and Beijing Nova Program (Grant No. 2009B51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Bonetta D, 1998, TRENDS PLANT SCI, V3, P231, DOI 10.1016/S1360-1385(98)01241-2; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ithal N, 2004, PLANT SCI, V166, P1505, DOI 10.1016/j.plantsci.2004.02.002; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Ji XY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-151; Jiang XQ, 2014, PLANT BIOTECHNOL J, V12, P38, DOI 10.1111/pbi.12114; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kim SJ, 2012, BIOCHEM BIOPH RES CO, V420, P141, DOI 10.1016/j.bbrc.2012.02.131; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li YH, 2009, PLANT CELL REP, V28, P185, DOI 10.1007/s00299-008-0629-3; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Ryu MY, 2010, PLANT PHYSIOL, V154, P1983, DOI 10.1104/pp.110.164749; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Xian LH, 2014, PLANTA, V239, P61, DOI 10.1007/s00425-013-1963-4; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yan F, 2012, PLANT GROWTH REGUL, V68, P383, DOI 10.1007/s10725-012-9727-x; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang LC, 2012, J EXP BOT, V63, P5873, DOI 10.1093/jxb/ers237	50	15	19	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109415	10.1371/journal.pone.0109415	http://dx.doi.org/10.1371/journal.pone.0109415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290154	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000059
J	Kassas, A; Moura, IC; Yamashita, Y; Scheffel, J; Guerin-Marchand, C; Blank, U; Sims, PJ; Wiedmer, T; Monteiro, RC; Rivera, J; Charles, N; Benhamou, M				Kassas, Asma; Moura, Ivan C.; Yamashita, Yumi; Scheffel, Jorg; Guerin-Marchand, Claudine; Blank, Ulrich; Sims, Peter J.; Wiedmer, Therese; Monteiro, Renato C.; Rivera, Juan; Charles, Nicolas; Benhamou, Marc			Regulation of the Tyrosine Phosphorylation of Phospholipid Scramblase 1 in Mast Cells That Are Stimulated through the High-Affinity IgE Receptor	PLOS ONE			English	Article							LEUKEMIA RBL-2H3 CELLS; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; FC-RECEPTORS; TRANSBILAYER MOVEMENT; MONOCLONAL-ANTIBODIES; HISTAMINE-RELEASE; APOPTOTIC CELLS; GENE-EXPRESSION; PROTEIN	Engagement of high-affinity immunoglobulin E receptors (Fc epsilon RI) activates two signaling pathways in mast cells. The Lyn pathway leads to recruitment of Syk and to calcium mobilization whereas the Fyn pathway leads to phosphatidylinositol 3-kinase recruitment. Mapping the connections between both pathways remains an important task to be completed. We previously reported that Phospholipid Scramblase 1 (PLSCR1) is phosphorylated on tyrosine after cross-linking Fc epsilon RI on RBL-2H3 rat mast cells, amplifies mast cell degranulation, and is associated with both Lyn and Syk tyrosine kinases. Here, analysis of the pathway leading to PLSCR1 tyrosine phosphorylation reveals that it depends on the FcR gamma chain. Fc epsilon RI aggregation in Fyn-deficient mouse bone marrow-derived mast cells (BMMC) induced a more robust increase in Fc epsilon RI-dependent tyrosine phosphorylation of PLSCR1 compared to wild-type cells, whereas PLSCR1 phosphorylation was abolished in Lyn-deficient BMMC. Lyn association with PLSCR1 was not altered in Fyn-deficient BMMC. PLSCR1 phosphorylation was also dependent on the kinase Syk and significantly, but partially, dependent on detectable calcium mobilization. Thus, the Lyn/Syk/calcium axis promotes PLSCR1 phosphorylation in multiple ways. Conversely, the Fyn-dependent pathway negatively regulates it. This study reveals a complex regulation for PLSCR1 tyrosine phosphorylation in Fc epsilon RI-activated mast cells and that PLSCR1 sits at a crossroads between Lyn and Fyn pathways.	[Kassas, Asma; Moura, Ivan C.; Guerin-Marchand, Claudine; Blank, Ulrich; Monteiro, Renato C.; Charles, Nicolas; Benhamou, Marc] Univ Paris 07, INSERM, U1149, Paris, France; [Kassas, Asma; Moura, Ivan C.; Guerin-Marchand, Claudine; Blank, Ulrich; Monteiro, Renato C.; Charles, Nicolas; Benhamou, Marc] Univ Paris Diderot, Sorbonne Paris Cite, Lab Excellence INFLAMEX, DHU FIRE, Paris, France; [Yamashita, Yumi; Scheffel, Jorg; Rivera, Juan] NIAMSD, Immunogenet Mol Lab, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sims, Peter J.; Wiedmer, Therese] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Rochester	Charles, N (corresponding author), Univ Paris 07, INSERM, U1149, Paris, France.	nicolas.charles@inserm.fr; marc.benhamou@inserm.fr	CHARLES, Nicolas/P-5430-2014; Monteiro, Renato C/U-8633-2017; CHARLES, Nicolas/S-2214-2019; Cruz Moura, Ivan/A-9510-2013	CHARLES, Nicolas/0000-0002-5416-5834; Monteiro, Renato C/0000-0001-5202-5646; CHARLES, Nicolas/0000-0002-5416-5834; Cruz Moura, Ivan/0000-0002-8418-2803; Moura, Ivan/0000-0002-2977-0354; Blank, Ulrich/0000-0002-2661-2983; Benhamou, Marc/0000-0001-7763-3795	Fondation de France [2002004544]; Ligue Nationale Contre le Cancer; Intramural Research Program, NIAMS, NIH; Investissements d'Avenir programme [ANR-11-IDEX-0005-02]; Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX	Fondation de France(Fondation de France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Intramural Research Program, NIAMS, NIH; Investissements d'Avenir programme(French National Research Agency (ANR)); Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX	This work was supported in part by a grant from the Fondation de France (2002004544). N.C. was supported in part by a grant from the Ligue Nationale Contre le Cancer. The work of Y.Y., J.S. and J.R. was supported by the Intramural Research Program, NIAMS, NIH. A.K. was supported by Investissements d'Avenir programme ANR-11-IDEX-0005-02, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BEAVEN MA, 1984, J BIOL CHEM, V259, P7129; Ben-Efraim I, 2004, BIOCHEMISTRY-US, V43, P3518, DOI 10.1021/bi0356911; BENHAMOU M, 1992, J BIOL CHEM, V267, P7310; Bevers EM, 1998, BIOL CHEM, V379, P973; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Charles N, 2004, J BIOL CHEM, V279, P12312, DOI 10.1074/jbc.M309456200; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; EISEMAN E, 1992, NATURE, V355, P78; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Furumoto Y, 2004, IMMUNOL RES, V30, P241, DOI 10.1385/IR:30:2:241; Furumoto Y, 2006, J IMMUNOL, V176, P5167, DOI 10.4049/jimmunol.176.9.5167; Kasukabe T, 1997, BLOOD, V89, P2975, DOI 10.1182/blood.V89.8.2975; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Launay P, 1999, J BIOL CHEM, V274, P7216, DOI 10.1074/jbc.274.11.7216; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; MONTEIRO RC, 1992, J IMMUNOL, V148, P1764; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; PFEFFERKORN LC, 1994, J IMMUNOL, V153, P3228; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Sahu SK, 2009, BBA-GEN SUBJECTS, V1790, P1274, DOI 10.1016/j.bbagen.2009.06.008; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Silverman RH, 2002, CANCER RES, V62, P397; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; Stout JG, 1998, BIOCHEMISTRY-US, V37, P14860, DOI 10.1021/bi9812930; STRACKE ML, 1987, MOL IMMUNOL, V24, P347, DOI 10.1016/0161-5890(87)90176-3; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yokoyama A, 2004, LEUKEMIA RES, V28, P149, DOI 10.1016/S0145-2126(03)00189-9; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhou QS, 2000, BLOOD, V95, P2593, DOI 10.1182/blood.V95.8.2593.008k32_2593_2599; Zhou QS, 1998, BIOCHEMISTRY-US, V37, P2356, DOI 10.1021/bi972625o; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	53	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109800	10.1371/journal.pone.0109800	http://dx.doi.org/10.1371/journal.pone.0109800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289695	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000089
J	Kenchington, E; Murillo, FJ; Lirette, C; Sacau, M; Koen-Alonso, M; Kenny, A; Ollerhead, N; Wareham, V; Beazley, L				Kenchington, Ellen; Javier Murillo, Francisco; Lirette, Camille; Sacau, Mar; Koen-Alonso, Mariano; Kenny, Andrew; Ollerhead, Neil; Wareham, Vonda; Beazley, Lindsay			Kernel Density Surface Modelling as a Means to Identify Significant Concentrations of Vulnerable Marine Ecosystem Indicators	PLOS ONE			English	Article							SEA SPONGE GROUNDS; NORTHWEST ATLANTIC; FLEMISH PASS; WATER CORALS; GRAND-BANKS; HOME-RANGE; DEEP; ABUNDANCE; PROTECTION; DIVERSITY	The United Nations General Assembly Resolution 61/105, concerning sustainable fisheries in the marine ecosystem, calls for the protection of vulnerable marine ecosystems (VME) from destructive fishing practices. Subsequently, the Food and Agriculture Organization (FAO) produced guidelines for identification of VME indicator species/taxa to assist in the implementation of the resolution, but recommended the development of case-specific operational definitions for their application. We applied kernel density estimation (KDE) to research vessel trawl survey data from inside the fishing footprint of the Northwest Atlantic Fisheries Organization (NAFO) Regulatory Area in the high seas of the northwest Atlantic to create biomass density surfaces for four VME indicator taxa: large-sized sponges, sea pens, small and large gorgonian corals. These VME indicator taxa were identified previously by NAFO using the fragility, life history characteristics and structural complexity criteria presented by FAO, along with an evaluation of their recovery trajectories. KDE, a non-parametric neighbour-based smoothing function, has been used previously in ecology to identify hotspots, that is, areas of relatively high biomass/abundance. We present a novel approach of examining relative changes in area under polygons created from encircling successive biomass categories on the KDE surface to identify "significant concentrations" of biomass, which we equate to VMEs. This allows identification of the VMEs from the broader distribution of the species in the study area. We provide independent assessments of the VMEs so identified using underwater images, benthic sampling with other gear types (dredges, cores), and/or published species distribution models of probability of occurrence, as available. For each VME indicator taxon we provide a brief review of their ecological function which will be important in future assessments of significant adverse impact on these habitats here and elsewhere.	[Kenchington, Ellen; Javier Murillo, Francisco; Lirette, Camille; Beazley, Lindsay] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Javier Murillo, Francisco] Univ Santiago de Compostela, Fac Biol, Dept Zool & Antropol Fis, Santiago De Compostela, Spain; [Sacau, Mar] Ctr Oceanog Vigo, Inst Espanol Oceanog, Programa Pesquerias Lejanas, Vigo, Spain; [Koen-Alonso, Mariano; Ollerhead, Neil; Wareham, Vonda] Northwest Atlant Fisheries Ctr, Dept Fisheries & Oceans, St John, NF, Canada; [Kenny, Andrew] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Universidade de Santiago de Compostela; Spanish Institute of Oceanography; Fisheries & Oceans Canada; Centre for Environment Fisheries & Aquaculture Science	Kenchington, E (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	Ellen.Kenchington@dfo-mpo.gc.ca	Sacau Cuadrado, M del Mar/L-9002-2014; Murillo, Francisco Javier/C-7182-2019; Sacau, Mar/AAD-4137-2020	Sacau Cuadrado, M del Mar/0000-0002-6529-3110; Sacau, Mar/0000-0002-6529-3110	International Governance Strategy (IGS) of the Department of Fisheries and Oceans	International Governance Strategy (IGS) of the Department of Fisheries and Oceans	Funding was received from the International Governance Strategy (IGS) fund of the Department of Fisheries and Oceans to EK. The purpose of this fund is to strengthen scientific research in support of international governance of fisheries resources, support healthy ocean ecosystems, protect Canada's economic and environmental interests and position Canada as a global leader in high-seas issues. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillon S, 2012, FRONT ECOL ENVIRON, V10, P351, DOI 10.1890/120022; Beazley LI, 2013, 1376 NAFO SCR; Beazley LI, 2013, ICES J MAR SCI, V70, P1471, DOI 10.1093/icesjms/fst124; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; BIRKELAND C, 1974, ECOL MONOGR, V44, P211, DOI 10.2307/1942312; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Downs JA, 2012, COMPUT ENVIRON URBAN, V36, P302, DOI 10.1016/j.compenvurbsys.2011.12.001; Edinger EN, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P101; FAO Food and Agriculture Organization of the United Nations; Rome, 2009, INT GUID MAN DEEP SE; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Frojan CRSB, 2012, ICES J MAR SCI, V69, P213, DOI 10.1093/icesjms/fss004; Fuller S.D., 2008, 0822 NAFO SCR; Murillo FJ, 2012, MAR BIOL RES, V8, P842, DOI 10.1080/17451000.2012.682583; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kenchington E, 2013, MAR ECOL PROG SER, V477, P217, DOI 10.3354/meps10127; Kenchington E, 2011, 1175 NAFO SCR; Kenchington E, 2009, 096 NAFO SCR; Knudby A, 2013, 1378 NAFO SCR; Knudby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082306; KRIEGER KJ, 1993, FISH B-NOAA, V91, P87; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Murillo F. J., 2010, 1007 NAFO SCR; Murillo F. J., 2011, 1173 NAFO SCR; NAFO, 2008, SCI COUNC M 22 30 OC; NAFO, 2012, SCI COUNC M 2012; NAFO, 2011, 1024 NAFO SCR; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; O'Brien SH, 2012, BIOL CONSERV, V156, P15, DOI 10.1016/j.biocon.2011.12.033; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; Rooper CN, 2014, MAR ECOL PROG SER, V503, P157, DOI 10.3354/meps10710; Tissot BN, 2006, FISH B-NOAA, V104, P167	33	49	51	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109365	10.1371/journal.pone.0109365	http://dx.doi.org/10.1371/journal.pone.0109365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289667	Green Published, gold			2022-12-25	WOS:000342798000055
J	Kim, MA; Lee, YS; Seo, K				Kim, Min-A; Lee, You Sun; Seo, Kyung			Assessment of Predictive Markers for Placental Inflammatory Response in Preterm Births	PLOS ONE			English	Article							AMNIOTIC-FLUID INTERLEUKIN-6; NEUTROPHIL-LYMPHOCYTE RATIO; C-REACTIVE PROTEIN; BLOOD-CELL COUNT; CHORIOAMNIONITIS; INFECTION; LABOR; LESIONS; PARTURITION; FUNISITIS	Placental inflammatory response (PIR) is associated with adverse neonatal outcomes such as sepsis, cerebral palsy, low birth weight, preterm birth, and neonatal mortality. However, there is an urgent need for noninvasive and sensitive biomarkers for prediction of PIR. In this study, we evaluated the clinical usefulness of maternal serum inflammatory markers for prediction of PIR in women with impending preterm birth. We conducted a retrospective cohort study of 483 patients who delivered preterm neonates. Serum levels of leukocyte differential counts, C-reactive protein (CRP), and neutrophil to lymphocyte ratio (NLR) were compared between women with no placental inflammation and women with PIR. The mean neutrophil counts, CRP levels, and NLR in both the patients with histologic chorioamnionitis (HCA) alone and those with HCA with funisitis were significantly higher than those in women with no placental inflammation. Compared to leukocyte subset or CRP, NLR in women with funisitis was significantly higher than in women with HCA alone and showed higher predictive accuracy, along with 71.4% sensitivity, 77.9% specificity, 80.7% positive predictive value, and 67.8% negative predictive value for prediction of PIR. On Kaplan-Meier survival analysis, women with both an elevated level of CRP and a high NLR had a shorter admission-to-delivery interval compared to women with either an elevated level of CRP or a high NLR alone. NLR may be a predictive marker of PIR and could be used as a cost-effective parameter for identifying women at risk of PIR.	[Kim, Min-A; Lee, You Sun; Seo, Kyung] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol,Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System	Seo, K (corresponding author), Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol,Gangnam Severance Hosp, Seoul, South Korea.	kyungseo@yuhs.ac						BERRY SM, 1995, AM J OBSTET GYNECOL, V173, P1315, DOI 10.1016/0002-9378(95)91378-5; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Chaiworapongsa T, 2002, AM J OBSTET GYNECOL, V186, P1178, DOI 10.1067/mob.2002.124042; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; De Felice C, 2001, J PEDIATR-US, V138, P101, DOI 10.1067/mpd.2001.109605; GAUTHIER DW, 1992, AM J OBSTET GYNECOL, V167, P1092, DOI 10.1016/S0002-9378(12)80044-5; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; Holcroft CJ, 2004, AM J OBSTET GYNECOL, V191, P2010, DOI 10.1016/j.ajog.2004.05.005; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Kemp K, 2002, INFECT IMMUN, V70, P5019, DOI 10.1128/IAI.70.9.5019-5025.2002; Kim MA, 2011, EUR J CLIN INVEST, V41, P773, DOI 10.1111/j.1365-2362.2011.02469.x; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445; Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019; Park KH, 2000, KOREAN J OBSTET GYNE, V43, P1019; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E; ROMERO R, 1990, J CLIN INVEST, V85, P1392, DOI 10.1172/JCI114583; SEO K, 1992, OBSTET GYNECOL, V79, P75; Trochez-Martinez RD, 2007, BJOG-INT J OBSTET GY, V114, P796, DOI 10.1111/j.1471-0528.2007.01385.x; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Watterberg KL, 1996, PEDIATRICS, V97, P210; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Yoon BH, 1996, OBSTET GYNECOL, V87, P231, DOI 10.1016/0029-7844(95)00380-0	27	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107880	10.1371/journal.pone.0107880	http://dx.doi.org/10.1371/journal.pone.0107880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291377	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000009
J	Lieu, FK; Lin, CY; Wang, PS; Jian, CY; Yeh, YH; Chen, YA; Wang, KL; Lin, YC; Chang, LL; Wang, GJ; Wang, SW				Lieu, Fu-Kong; Lin, Chih-Yung; Wang, Paulus S.; Jian, Cai-Yun; Yeh, Yung-Hsing; Chen, Yi-An; Wang, Kai-Lee; Lin, Yi-Chun; Chang, Ling-Ling; Wang, Guei-Jane; Wang, Shyi-Wu			Effect of Swimming on the Production of Aldosterone in Rats	PLOS ONE			English	Article							ZONA GLOMERULOSA CELLS; ANGIOTENSIN-II; GRADED-EXERCISE; RENIN-ACTIVITY; LACTATE; SECRETION; BLOOD; RESPONSES; SODIUM; CAMP	It has been demonstrated that exercise is one of the stresses known to increase the aldosterone secretion. Both potassium and angiotensin II (Ang II) levels are shown to be correlated with aldosterone production during exercise, but the mechanism is still unclear. In an in vivo study, male rats were catheterized via right jugular vein (RJV), and divided into four groups namely water immersion, swimming, lactate infusion (13 mg/kg/min) and pyruvate infusion (13 mg/kg/min) groups. Each group was treated for 10 min. Blood samples were collected at 0, 10, 15, 30, 60 and 120 min from RJV after administration. In an in vitro study, rat zona glomerulosa (ZG) cells were challenged by lactate (1-10 mM) in the presence or absence of Ang II (10(-8) M) for 60 min. The levels of aldosterone in plasma and medium were measured by radioimmunoassay. Cell lysates were analyzed by immunoblotting assay. After exercise and lactate infusion, plasma levels of aldosterone and lactate were significantly higher than those in the control group. Swimming for 10 min significantly increased the plasma Ang II levels in male rats. Administration of lactate plus Ang II significantly increased aldosterone production and enhanced protein expression of steroidogenic acute regulatory protein (StAR) in ZG cells. These results demonstrated that acute exercise led to the increase of both aldosterone and Ang II secretion, which is associated with lactate action on ZG cells and might be dependent on the activity of renin-angiotensin system.	[Lieu, Fu-Kong; Lin, Yi-Chun] Cheng Hsin Gen Hosp, Dept Rehabil, Taipei, Taiwan; [Lin, Chih-Yung; Wang, Paulus S.; Jian, Cai-Yun; Yeh, Yung-Hsing; Chen, Yi-An; Wang, Kai-Lee] Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei 112, Taiwan; [Wang, Paulus S.] China Med Univ, Coll Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Wang, Paulus S.] China Med Univ Hosp, Med Ctr Aging Res, Taichung, Taiwan; [Chang, Ling-Ling] Chinese Culture Univ, Coll Engn, Dept Chem Engn, Taipei, Taiwan; [Wang, Shyi-Wu] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Wang, Guei-Jane] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Guei-Jane] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Guei-Jane] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Wang, Paulus S.] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Wang, Paulus S.] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan	Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chinese Culture University; Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Asia University Taiwan; Taipei Veterans General Hospital	Wang, SW (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan.	swwang@mail.cgu.edu.tw		Wang, Kai-Lee/0000-0002-3058-3804	Cheng Hsin General Hospital [101F195cy16]; China Medical University [DMR-102-124]; Chang Gung Memorial Hospital, Taiwan, ROC [CMRPD100041, CMRPD100042]	Cheng Hsin General Hospital; China Medical University(China Medical University); Chang Gung Memorial Hospital, Taiwan, ROC(Chang Gung Memorial Hospital)	This study was supported by the grant (No. 101F195cy16) from Cheng Hsin General Hospital, the grant (DMR-102-124) from China Medical University, and the grant (CMRPD100041 and CMRPD100042) from Chang Gung Memorial Hospital, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1993, J STEROID BIOCHEM, V45, P147, DOI 10.1016/0960-0760(93)90134-I; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang LL, 2008, J BIOMED SCI, V15, P463, DOI 10.1007/s11373-008-9241-3; Chang LL, 2008, J CELL BIOCHEM, V104, P359, DOI 10.1002/jcb.21627; Chang LL, 2012, ADAPT MED, V4, P75; Ciampone S, 2011, J RENIN-ANGIO-ALDO S, V12, P394, DOI 10.1177/1470320311408750; Clark BJ, 1999, ENDOCRINOLOGY, V140, P4390, DOI 10.1210/en.140.10.4390; Clark BJ, 2004, ENDOCR RES, V30, P685, DOI 10.1081/ERC-200043973; CONVERTINO VA, 1981, J APPL PHYSIOL, V50, P123, DOI 10.1152/jappl.1981.50.1.123; Costill D L, 1977, Ann N Y Acad Sci, V301, P160, DOI 10.1111/j.1749-6632.1977.tb38195.x; Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166; Dullaart RPF, 2008, CLIN ENDOCRINOL, V69, P359, DOI 10.1111/j.1365-2265.2008.03196.x; Elsworth R, 1996, BODY FLUID BALANCE E, P352; FRANCESCONI RP, 1983, J APPL PHYSIOL, V55, P1790, DOI 10.1152/jappl.1983.55.6.1790; Ganong WH, 2003, REV MED PHYSL, P366; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Kau MM, 1999, J CELL BIOCHEM, V72, P286, DOI 10.1002/(SICI)1097-4644(19990201)72:2<286::AID-JCB13>3.0.CO;2-4; Kau MM, 1999, J CELL BIOCHEM, V73, P137, DOI 10.1002/(SICI)1097-4644(19990401)73:1<137::AID-JCB15>3.0.CO;2-7; KELLY KP, 1995, MED SCI SPORT EXER, V27, P65; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Lee TH, 2008, J ETHNOPHARMACOL, V116, P518, DOI 10.1016/j.jep.2007.12.019; Lin H, 2001, J CELL BIOCHEM, V83, P147, DOI 10.1002/jcb.1213; LIN YS, 1995, MED SCI SPORT EXER, V27, P73; Lo MJ, 1998, AM J PHYSIOL-ENDOC M, V274, pE238, DOI 10.1152/ajpendo.1998.274.2.E238; Lu SS, 1997, MED SCI SPORT EXER, V29, P1048, DOI 10.1097/00005768-199708000-00010; MAHER JT, 1975, J APPL PHYSIOL, V39, P18; Meier RK, 2012, ENDOCRINOLOGY, V153, P1256, DOI 10.1210/en.2011-1744; MELIN B, 1980, EUR J APPL PHYSIOL O, V44, P141, DOI 10.1007/BF00421092; Moura LZ, 2010, ARQ BRAS CARDIOL, V95, P381, DOI 10.1590/S0066-782X2010005000110; Oopik V, 2010, APPL PHYSIOL NUTR ME, V35, P278, DOI 10.1139/H10-018; Otis M, 2007, MOL CELL ENDOCRINOL, V265, P126, DOI 10.1016/j.mce.2006.12.008; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pu H.F., 2012, ADAPT MED, V4, P245; QUINN SJ, 1988, ANNU REV PHYSIOL, V50, P409, DOI 10.1146/annurev.ph.50.030188.002205; Ragnarsson O, 2013, EUR J ENDOCRINOL, V168, P243, DOI 10.1530/EJE-12-0873; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Sharp RL, 2006, J AM COLL NUTR, V25, p231S, DOI 10.1080/07315724.2006.10719572; Steel R, 1960, PRINCIPLES PROCEDURE, P86; Thrivikraman KV, 2002, BRAIN RES PROTOC, V10, P84, DOI 10.1016/S1385-299X(02)00185-X; Wang GJ, 2007, J ETHNOPHARMACOL, V112, P221, DOI 10.1016/j.jep.2007.02.025; WHITE PC, 1994, NEW ENGL J MED, V331, P250; WHITEHOUSE BJ, 1994, J MOL ENDOCRINOL, V12, P195, DOI 10.1677/jme.0.0120195; Williams JS, 2003, J CLIN ENDOCR METAB, V88, P2364, DOI 10.1210/jc.2003-030490	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e87080	10.1371/journal.pone.0087080	http://dx.doi.org/10.1371/journal.pone.0087080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289701	gold, Green Submitted, Green Published			2022-12-25	WOS:000342798000001
J	Liu, CH; Liu, W; Feng, ZB; Li, DM				Liu, Chunhong; Liu, Wen; Feng, Zhibiao; Li, Dongmei			Aggregation of Whey Protein Hydrolysate Using Alcalase 2.4 L	PLOS ONE			English	Article							PLASTEIN REACTION; INFRARED-SPECTROSCOPY; SOY PROTEIN; MECHANISM; GLYCININ; PAPAIN; PH	Here, we describe peptide aggregation, which is also known as enzymatic protein resynthesis. Whey protein hydrolysate (WPH) is the starting material for assembling peptides. Analyses of the involved amino acids, intrinsic fluorescence, fluorescence phase diagram, secondary structure, turbidity, and surface hydrophobicity were performed to investigate the reaction process. The aggregation mechanism consists of two parts: 1) formation and 2) aggregation of the building blocks that form the ordered secondary beta-sheet structure. Constructing the building blocks requires at least one intermediate state, which is formed after 0.5 hours. Non-synergistic changes in the secondary and tertiary structures then allow the intermediate state to emerge.	[Liu, Chunhong; Liu, Wen; Feng, Zhibiao; Li, Dongmei] Northeast Agr Univ, Dept Appl Chem, Coll Sci, Harbin, Peoples R China	Northeast Agricultural University - China	Feng, ZB (corresponding author), Northeast Agr Univ, Dept Appl Chem, Coll Sci, Harbin, Peoples R China.	fengzhibiao@neau.edu.cn	feng, zhibiao/G-4594-2018; Liu, Chunhong/ABB-2942-2021	feng, zhibiao/0000-0001-5553-1077; 	Youth Natural Science Fund of Heilongjiang Province, China [QC2010029]; Science Fund of NEAU	Youth Natural Science Fund of Heilongjiang Province, China; Science Fund of NEAU	Funding was provided by the Youth Natural Science Fund of Heilongjiang Province, China (Project No: QC2010029), and the Science Fund of NEAU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott TP, 1996, J AGR FOOD CHEM, V44, P2220, DOI 10.1021/jf950340h; ANDREWS AT, 1990, FOOD CHEM, V35, P243, DOI 10.1016/0308-8146(90)90015-V; [Anonymous], 1994, DET AM AC FOODS; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Arternova NV, 2008, BIOCHEM BIOPH RES CO, V377, P595, DOI 10.1016/j.bbrc.2008.10.015; BYLER DM, 1988, J IND MICROBIOL, V3, P73, DOI 10.1007/BF01569549; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; da Costa EL, 2007, INT DAIRY J, V17, P632, DOI 10.1016/j.idairyj.2006.09.003; EDWARDS JH, 1978, J FOOD SCI, V43, P1215, DOI 10.1111/j.1365-2621.1978.tb15272.x; Graveland-Bikker JF, 2006, NANO LETT, V6, P616, DOI 10.1021/nl052205h; Guo J, 2012, J AGR FOOD CHEM, V60, P3782, DOI 10.1021/jf300409y; Gustot A, 2013, CELL MOL LIFE SCI, V70, P2999, DOI 10.1007/s00018-012-1245-5; Imm JY, 1999, J AGR FOOD CHEM, V47, P2360, DOI 10.1021/jf9811020; JACKSON M, 1991, BIOCHEMISTRY-US, V30, P9681, DOI 10.1021/bi00104a016; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Milto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068684; Otte J, 1997, J AGR FOOD CHEM, V45, P4889, DOI 10.1021/jf9704571; Ringgenberg E, 2013, FOOD HYDROCOLLOID, V30, P463, DOI 10.1016/j.foodhyd.2012.05.011; Stevenson DE, 1998, ENZYME MICROB TECH, V22, P100, DOI 10.1016/S0141-0229(97)00135-X; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; SUKAN G, 1982, J DAIRY RES, V49, P279, DOI 10.1017/S0022029900022378; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Synowiecki J, 1996, FOOD CHEM, V57, P435, DOI 10.1016/S0308-8146(96)00005-2; Vonhoff S, 2010, J PHARMACEUT BIOMED, V51, P39, DOI 10.1016/j.jpba.2009.07.031; YAMASHITA M, 1979, J AGR FOOD CHEM, V27, P52, DOI 10.1021/jf60221a045; YAMASHITA M, 1975, J AGR FOOD CHEM, V23, P27, DOI 10.1021/jf60197a027; Yuan Y, 2013, LWT-FOOD SCI TECHNOL, V50, P657, DOI 10.1016/j.lwt.2012.07.034	28	4	5	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109439	10.1371/journal.pone.0109439	http://dx.doi.org/10.1371/journal.pone.0109439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290460	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000061
J	Usenko, T; Chan, G; Torlakovic, E; Klingmuller, U; Neel, BG				Usenko, Tatiana; Chan, Gordon; Torlakovic, Emina; Klingmueller, Ursula; Neel, Benjamin G.			Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice	PLOS ONE			English	Article							PTPN11; RECEPTOR; SIGNALS; CELLS; SHP2	Src homology 2 (SH2) domain-containing phosphatase 2 (SHP2), encoded by PTPN11, regulates signaling networks and cell fate in many tissues. Expression of oncogenic PTPN11 in the hematopoietic compartment causes myeloproliferative neoplasm (MPN) in humans and mice. However, the stage-specific effect(s) of mutant Ptpn11 on erythroid development have remained unknown. We found that expression of an activated, leukemogenic Ptpn11 allele, Ptpn11(D61Y), specifically in the erythroid lineage causes dyserythropoiesis in mice. Ptpn11(D61Y) progenitors produce excess cKIT(+) CD71(+) Ter119(-) cells and aberrant numbers of cKIT(Io) CD71(+) erythroblasts. Mutant erythroblasts show elevated activation of ERK, AKT and STAT3 in response to EPO stimulation, and MEK inhibitor treatment blocks Ptpn11(D61Y)-evoked erythroid hyperproliferation in vitro. Thus, the expression of oncogenic Ptpn11 causes dyserythropoiesis in a cell-autonomous manner in vivo.	[Usenko, Tatiana; Chan, Gordon; Neel, Benjamin G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Torlakovic, Emina] Univ Hlth Network, Toronto Gen Hosp, Dept Lab Hematol, Toronto, ON, Canada; [Klingmueller, Ursula] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Neel, Benjamin G.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University of Toronto	Neel, BG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	bneel@uhnresearch.ca	Klingmüller, Ursula/G-8477-2013	Klingmüller, Ursula/0000-0001-9845-3099	 [RO1 CA114945];  [R37CA49132]; NATIONAL CANCER INSTITUTE [R01CA114945] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by RO1 CA114945 (www.nih.gov), and R37CA49132 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun BS, 2006, BLOOD, V108, P2041, DOI 10.1182/blood-2006-01-013490; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Klingmuller U, 1997, EUR J BIOCHEM, V249, P637, DOI 10.1111/j.1432-1033.1997.t01-1-00637.x; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Neel B. G., 2009, HDB CELL SIGNALING, P771; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Zhang J, 2007, BLOOD, V109, P5238, DOI 10.1182/blood-2006-09-047050; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	15	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109682	10.1371/journal.pone.0109682	http://dx.doi.org/10.1371/journal.pone.0109682			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289670	Green Submitted, gold, Green Published			2022-12-25	WOS:000342798000077
J	Wang, WM; Luo, JQ; Xiang, F; Liu, XT; Jiang, ML; Liao, LJ; Hu, JY				Wang, Wenmeng; Luo, Junqing; Xiang, Fang; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Hu, Jinyue			Nucleolin Down-Regulation Is Involved in ADP-Induced Cell Cycle Arrest in S Phase and Cell Apoptosis in Vascular Endothelial Cells	PLOS ONE			English	Article							BCL-2 MESSENGER-RNA; G-RICH OLIGONUCLEOTIDES; PROTEIN-KINASE PATHWAYS; NUCLEOTIDE RECEPTORS; EXTRACELLULAR NUCLEOTIDES; NASOPHARYNGEAL CARCINOMA; SURFACE NUCLEOLIN; PLATELET-FUNCTION; P2Y(12) RECEPTOR; LEUKEMIA-CELLS	High concentration of extracellular ADP has been reported to induce cell apoptosis, but the molecular mechanisms remain not fully elucidated. In this study, we found by serendipity that ADP treatment of human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC) down-regulated the protein level of nucleolin in a dose- and time-dependent manner. ADP treatment did not decrease the transcript level of nucloelin, suggesting that ADP might induce nucleolin protein degradation. HUVEC and HAEC expressed ADP receptor P2Y13 receptor, but did not express P2Y1 or P2Y12 receptors. However, P2Y1, 12, 13 receptor antagonists MRS2179, PSB0739, MRS2211 did not inhibit ADP-induced down-regulation of nucleolin. Moreover, MRS2211 itself down-regulated nucleolin protein level. In addition, 2-MeSADP, an agonist for P2Y1, 12 and 13 receptors, did not down-regulate nucleolin protein. These results suggested that ADP-induced nucleolin down-regulation was not due to the activation of P2Y1, 12, or 13 receptors. We also found that ADP treatment induced cell cycle arrest in S phase, cell apoptosis and cell proliferation inhibition via nucleolin down-regulation. The overexpression of nucleolin by gene transfer partly reversed ADP-induced cell cycle arrest, cell apoptosis and cell proliferation inhibition. Furthermore, ADP sensitized HUVEC to cisplatin-induced cell death by the down-regulation of Bcl-2 expression. Taken together, we found, for the first time to our knowledge, a novel mechanism by which ADP regulates cell proliferation by induction of cell cycle arrest and cell apoptosis via targeting nucelolin.	[Wang, Wenmeng; Luo, Junqing; Xiang, Fang] Hunan Armed Police Forces Hosp, Dept Internal Med, Changsha, Hunan, Peoples R China; [Wang, Wenmeng; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Hu, Jinyue] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China		Hu, JY (corresponding author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.	jinyueh@yahoo.com			National Natural Science Foundation of China [81172042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81172042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Amisten S, 2010, DIABETOLOGIA, V53, P1927, DOI 10.1007/s00125-010-1807-8; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Battista AG, 2009, J NEUROCHEM, V111, P600, DOI 10.1111/j.1471-4159.2009.06352.x; Ben Addi A, 2010, J IMMUNOL, V185, P5900, DOI 10.4049/jimmunol.0901799; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; Cancio-Lonches C, 2011, J VIROL, V85, P8056, DOI 10.1128/JVI.01878-10; Czajkowski R, 2004, BRIT J PHARMACOL, V141, P497, DOI 10.1038/sj.bjp.0705639; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; Gachet C, 1997, THROMB HAEMOSTASIS, V78, P271; Ginisty H, 1999, J CELL SCI, V112, P761; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Kudirka JC, 2007, J CELL PHYSIOL, V213, P54, DOI 10.1002/jcp.21087; Lee YH, 2010, J CELL SCI, V123, P1634, DOI 10.1242/jcs.063545; Lv QS, 2012, MOLECULES, V17, P3599, DOI 10.3390/molecules17043599; Lyubchenko T, 2011, AM J PHYSIOL-CELL PH, V300, pC266, DOI 10.1152/ajpcell.00237.2010; Maaser K, 2002, BRIT J CANCER, V86, P636, DOI 10.1038/sj.bjc.6600100; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Otake Y, 2005, MOL PHARMACOL, V67, P319, DOI 10.1124/mol.104.006080; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Rong WF, 2003, J NEUROSCI, V23, P11315; Sagou K, 2010, J VIROL, V84, P2110, DOI 10.1128/JVI.02007-09; Schafer R, 2006, FEBS J, V273, P3756, DOI 10.1111/j.1742-4658.2006.05384.x; Schwartz TR, 2008, OLIGONUCLEOTIDES, V18, P51, DOI 10.1089/oli.2007.0109; Sellers LK, 2001, J BIOL CHEM, V276, P16379, DOI 10.1074/jbc.M006617200; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Song QB, 2013, INT IMMUNOPHARMACOL, V16, P148, DOI 10.1016/j.intimp.2013.03.034; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Strang BL, 2010, J VIROL, V84, P1771, DOI 10.1128/JVI.01510-09; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Tan CY, 2010, CELL MOL LIFE SCI, V67, P445, DOI 10.1007/s00018-009-0191-3; Tayyari F, 2011, NAT MED; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vitolo OV, 1998, BRAIN RES, V809, P297, DOI 10.1016/S0006-8993(98)00713-6; von Albertini M, 1998, BIOCHEM BIOPH RES CO, V248, P822, DOI 10.1006/bbrc.1998.9055; WANG DJ, 1992, J CELL PHYSIOL, V153, P221, DOI 10.1002/jcp.1041530202; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Watanabe T, 2010, BIOL PHARM BULL, V33, P796, DOI 10.1248/bpb.33.796; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Zhang Y, 2009, CANCER BIOL THER, V8, P1826, DOI 10.4161/cbt.8.19.9437; Zhuo W, 2010, J PATHOL, V222, P249, DOI 10.1002/path.2760	55	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e110101	10.1371/journal.pone.0110101	http://dx.doi.org/10.1371/journal.pone.0110101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290311	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000103
J	Wanrooij, K; Boersma, P; van Zuijen, TL				Wanrooij, Karin; Boersma, Paul; van Zuijen, Titia L.			Distributional Vowel Training Is Less Effective for Adults than for Infants. A Study Using the Mismatch Response	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; PHONEME REPRESENTATIONS; SELECTIVE-ATTENTION; SPEECH-PERCEPTION; LEARNING PHONEMES; BRAIN RESPONSES; 1ST YEAR; NEGATIVITY; MATURATION; WORDS	Distributional learning of speech sounds (i.e., learning from simple exposure to frequency distributions of speech sounds in the environment) has been observed in the lab repeatedly in both infants and adults. The current study is the first attempt to examine whether the capacity for using the mechanism is different in adults than in infants. To this end, a previous even-trelated potential study that had shown distributional learning of the English vowel contrast /ae/similar to/epsilon/ in 2-to-3-month old Dutch infants was repeated with Dutch adults. Specifically, the adults were exposed to either a bimodal distribution that suggested the existence of the two vowels (as appropriate in English), or to a unimodal distribution that did not (as appropriate in Dutch). After exposure the participants were tested on their discrimination of a representative [ae] and a representative [epsilon], in an oddball paradigm for measuring mismatch responses (MMRs). Bimodally trained adults did not have a significantly larger MMR amplitude, and hence did not show significantly better neural discrimination of the test vowels, than unimodally trained adults. A direct comparison between the normalized MMR amplitudes of the adults with those of the previously tested infants showed that within a reasonable range of normalization parameters, the bimodal advantage is reliably smaller in adults than in infants, indicating that distributional learning is a weaker mechanism for learning speech sounds in adults (if it exists in that group at all) than in infants.	[Wanrooij, Karin; Boersma, Paul] Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands; [van Zuijen, Titia L.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Wanrooij, K (corresponding author), Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands.	karin.wanrooij@uva.nl	van Zuijen, Titia/F-5063-2012	van Zuijen, Titia/0000-0002-2578-4396; Wanrooij, Karin/0000-0002-9247-9850	Netherlands Organization for Scientific Research [277.70.008]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by grant 277.70.008 from the Netherlands Organization for Scientific Research (http://www.nwo.nl/en) awarded to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN O, 1987, BIOL PSYCHOL, V24, P197, DOI 10.1016/0301-0511(87)90002-0; Aaltonen O, 1997, J ACOUST SOC AM, V101, P1090, DOI 10.1121/1.418031; Adank P, 2004, J ACOUST SOC AM, V116, P1729, DOI 10.1121/1.1779271; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Boersma P., 2014, PRAAT DOING PHONETIC; Broersma M, 2005, J ACOUST SOC AM, V117, P3890, DOI 10.1121/1.1906060; Capel D. J. H., 2011, SOUND SOUNDS STUDIES, P33; Carral V, 2005, EUR J NEUROSCI, V21, P3201, DOI 10.1111/j.1460-9568.2005.04144.x; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 1998, INT J PSYCHOPHYSIOL, V29, P217, DOI 10.1016/S0167-8760(98)00017-8; Cheour M, 2002, SCAND J PSYCHOL, V43, P33, DOI 10.1111/1467-9450.00266; Cheour M, 1997, DEV NEUROPSYCHOL, V13, P167, DOI 10.1080/87565649709540676; CHEOURLUHTANEN M, 1995, HEARING RES, V82, P53, DOI 10.1016/0378-5955(94)00164-L; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P449, DOI 10.1162/089892900562264; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; Escudero P, 2008, J PHONETICS, V36, P345, DOI 10.1016/j.wocn.2007.11.002; Escudero P, 2011, J ACOUST SOC AM, V130, pEL206, DOI 10.1121/1.3629144; Escudero P, 2010, LANG SPEECH, V53, P343, DOI 10.1177/0023830910371447; Fikkert P., 2010, LAB PHONOLOGY10 VARI, P227, DOI DOI 10.1515/9783110224917.3.227; Friederici AD, 2002, NEUROREPORT, V13, P1251, DOI 10.1097/00001756-200207190-00006; Friedrich M, 2004, PSYCHOPHYSIOLOGY, V41, P772, DOI 10.1111/j.1469-8986.2004.00202.x; Guenther FH, 1996, J ACOUST SOC AM, V100, P1111, DOI 10.1121/1.416296; Gulian M., 2007, P INT C PHON SCI SAA; Halle PA, 1996, INFANT BEHAV DEV, V19, P463, DOI 10.1016/S0163-6383(96)90007-7; Hawkins S., 2005, J INT PHON ASSOC, V35, P183, DOI DOI 10.1017/S0025100305002124; Hayes-Harb R, 2007, SECOND LANG RES, V23, P65, DOI 10.1177/0267658307071601; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; JAMIESON DG, 1986, PERCEPT PSYCHOPHYS, V40, P205, DOI 10.3758/BF03211500; Jusczyk PW, 1997, SCIENCE, V277, P1984, DOI 10.1126/science.277.5334.1984; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kondaurova MV, 2010, J PHONETICS, V38, P569, DOI 10.1016/j.wocn.2010.08.003; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kraus N, 1999, J SPEECH LANG HEAR R, V42, P1042, DOI 10.1044/jslhr.4205.1042; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kushnerenko E, 2002, NEUROREPORT, V13, P47, DOI 10.1097/00001756-200201210-00014; Kushnerenko E., 2003, THESIS U HELSINKI; Lacerda F., 1995, P 13 INT C PHON SCI, V2, P140; Lahiri A, 2010, J PHONETICS, V38, P44, DOI 10.1016/j.wocn.2010.01.002; Leussen van J. W., 2011, P 17 INT C PHON SCI, P1194; Martynova O, 2003, NEUROSCI LETT, V340, P75, DOI 10.1016/S0304-3940(02)01401-5; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Maye J, 2001, PROC ANN BUCLD, P480; Maye J, 2000, PROC ANN BUCLD, P522; Maye J, 2008, DEVELOPMENTAL SCI, V11, P122, DOI 10.1111/j.1467-7687.2007.00653.x; Moore JK, 2007, INT J AUDIOL, V46, P460, DOI 10.1080/14992020701383019; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; Moore JK, 2001, JARO-J ASSOC RES OTO, V2, P297, DOI 10.1007/s101620010052; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R., 2018, ATTENTION BRAIN FUNC; Pakarinen S, 2009, BIOL PSYCHOL, V82, P219, DOI 10.1016/j.biopsycho.2009.07.008; Pang EW, 1998, INT J PSYCHOPHYSIOL, V29, P227, DOI 10.1016/S0167-8760(98)00018-X; Partanen E, 2013, CLIN NEUROPHYSIOL, V124, P1578, DOI 10.1016/j.clinph.2013.02.014; Polka L, 1996, J ACOUST SOC AM, V100, P577, DOI 10.1121/1.415884; Polka L, 2003, SPEECH COMMUN, V41, P221, DOI 10.1016/S0167-6393(02)00105-X; Pons F, 2006, J EXP PSYCHOL ANIM B, V32, P97, DOI 10.1037/0097-7403.32.1.97; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Roelfsema PR, 2011, SCIENCE, V332, P1512, DOI 10.1126/science.1208564; Schouten M. E. H., 1975, THESIS UTRECHT U; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Shafer VL, 2011, J PHONETICS, V39, P527, DOI 10.1016/j.wocn.2010.11.010; van Zuijen TL, 2013, DEVELOPMENTAL SCI, V16, P554, DOI 10.1111/desc.12049; Wanrooij K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00077; Wanrooij K, 2013, J PHONETICS, V41, P307, DOI 10.1016/j.wocn.2013.03.005; Wanrooij K, 2013, J ACOUST SOC AM, V133, pEL398, DOI 10.1121/1.4798618; Weber A, 2004, J MEM LANG, V50, P1, DOI 10.1016/S0749-596X(03)00105-0; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; Werner LA, 1996, EAR HEARING, V17, P438, DOI 10.1097/00003446-199610000-00010; WERNER LA, 1990, INFANT BEHAV DEV, V13, P355, DOI 10.1016/0163-6383(90)90040-F; Winkler I, 1999, COGNITIVE BRAIN RES, V7, P357, DOI 10.1016/S0926-6410(98)00039-1; Yoshida KA, 2010, INFANCY, V15, P420, DOI 10.1111/j.1532-7078.2009.00024.x	78	17	17	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109806	10.1371/journal.pone.0109806	http://dx.doi.org/10.1371/journal.pone.0109806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25289935	gold, Green Published, Green Submitted			2022-12-25	WOS:000342798000090
J	Yang, ES; Jin, MU; Hong, JH; Kim, YS; Choi, SY; Kim, TH; Cho, YS; Bae, YC				Yang, Eun Sun; Jin, Myoung Uk; Hong, Jae Hyun; Kim, Yun Sook; Choi, So Young; Kim, Tae Heon; Cho, Yi Sul; Bae, Yong Chul			Expression of Vesicular Glutamate Transporters VGLUT1 and VGLUT2 in the Rat Dental Pulp and Trigeminal Ganglion following Inflammation	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; DORSAL-ROOT GANGLIA; PRIMARY AFFERENT NEURONS; GENE-RELATED PEPTIDE; SPINAL-CORD; TOOTH-PULP; MECHANICAL ALLODYNIA; MUSTARD-OIL; SUBSTANCE-P; RELEASE	Background: There is increasing evidence that peripheral glutamate signaling mechanism is involved in the nociceptive transmission during pathological conditions. However, little is known about the glutamate signaling mechanism and related specific type of vesicular glutamate transporter (VGLUT) in the dental pulp following inflammation. To address this issue, we investigated expression and protein levels of VGLUT1 and VGLUT2 in the dental pulp and trigeminal ganglion (TG) following complete Freund's adjuvant (CFA) application to the rat dental pulp by light microscopic immunohistochemistry and Western blot analysis. Results: The density of VGLUT2-immunopositive (+) axons in the dental pulp and the number of VGLUT2+ soma in the TG increased significantly in the CFA-treated group, compared to control group. The protein levels of VGLUT2 in the dental pulp and TG were also significantly higher in the CFA-treated group than control group by Western blot analysis. The density of VGLUT1+ axons in the dental pulp and soma in the TG remained unchanged in the CFA-treated group. Conclusions: These findings suggest that glutamate signaling that is mediated by VGLUT2 in the pulpal axons may be enhanced in the inflamed dental pulp, which may contribute to pulpal axon sensitization leading to hyperalgesia following inflammation.	[Yang, Eun Sun; Jin, Myoung Uk; Hong, Jae Hyun; Kim, Yun Sook; Choi, So Young; Kim, Tae Heon; Cho, Yi Sul; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea	Kyungpook National University	Bae, YC (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea.	ycbae@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012-0009328]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-0009328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Beirith A, 2002, BRAIN RES, V924, P219, DOI 10.1016/S0006-8993(01)03240-1; Bereiter DA, 1996, PAIN, V67, P451, DOI 10.1016/0304-3959(96)03156-9; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; BYERS MR, 1984, INT REV NEUROBIOL, V25, P39, DOI 10.1016/S0074-7742(08)60677-7; Chiang CY, 1998, J NEUROPHYSIOL, V80, P2621, DOI 10.1152/jn.1998.80.5.2621; Chiang CY, 2005, J NEUROPHYSIOL, V94, P1751, DOI 10.1152/jn.00223.2005; Curi TCP, 1997, AM J PHYSIOL-CELL PH, V273, pC1124, DOI 10.1152/ajpcell.1997.273.4.C1124; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Du JH, 2001, PAIN, V89, P187, DOI 10.1016/S0304-3959(00)00362-6; Fehrenbacher JC, 2009, PAIN, V144, P253, DOI 10.1016/j.pain.2009.03.027; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; FRIED K, 1988, BRAIN RES, V463, P118, DOI 10.1016/0006-8993(88)90533-1; FRIED K, 1989, NEUROSCIENCE, V33, P101, DOI 10.1016/0306-4522(89)90314-X; Fried K, 2011, PAIN, V152, P2685, DOI 10.1016/j.pain.2011.08.004; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4; JACKSON DL, 1995, EUR J PHARMACOL, V284, P321, DOI 10.1016/0014-2999(95)00449-U; Jackson DL, 1999, J DENT RES, V78, P54, DOI 10.1177/00220345990780010801; Jean YH, 2008, OSTEOARTHR CARTILAGE, V16, P1442, DOI 10.1016/j.joca.2008.04.008; Jin YH, 2006, NEUROSCIENCE, V138, P1329, DOI 10.1016/j.neuroscience.2005.12.049; Klegeris A, 1997, J NEUROSCI RES, V49, P229, DOI 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W; Kumar N, 2013, NEUROCHEM INT, V62, P831, DOI 10.1016/j.neuint.2013.02.022; Lagerstrom MC, 2011, P NATL ACAD SCI USA, V108, P5789, DOI 10.1073/pnas.1013602108; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; Lawand NB, 2000, PAIN, V86, P69, DOI 10.1016/S0304-3959(99)00311-5; Leo S, 2009, EUR J PAIN, V13, P1008, DOI 10.1016/j.ejpain.2008.12.001; Li JL, 2003, J COMP NEUROL, V463, P212, DOI 10.1002/cne.10755; Li JL, 2003, J COMP NEUROL, V457, P236, DOI 10.1002/cne.10556; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; LOUIS SM, 1989, NEUROSCI LETT, V102, P257, DOI 10.1016/0304-3940(89)90088-8; Malet M, 2013, NEUROSCIENCE, V248, P95, DOI 10.1016/j.neuroscience.2013.05.044; MARFURT CF, 1984, J COMP NEUROL, V223, P535, DOI 10.1002/cne.902230406; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; Narita N, 2012, NEUROSCIENCE, V218, P359, DOI 10.1016/j.neuroscience.2012.05.016; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; Paik SK, 2009, NEUROSCIENCE, V162, P1279, DOI 10.1016/j.neuroscience.2009.05.046; Paik SK, 2012, J ENDODONT, V38, P470, DOI 10.1016/j.joen.2011.12.012; PARPURA V, 1995, J NEUROSCI, V15, P5831; PRIGENT AF, 1990, EUR J CLIN INVEST, V20, P323, DOI 10.1111/j.1365-2362.1990.tb01864.x; Rogoz K, 2012, PAIN, V153, P1525, DOI 10.1016/j.pain.2012.04.017; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Scott A, 2008, J ORTHOP RES, V26, P685, DOI 10.1002/jor.20536; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Spang C, 2012, INFLAMMATION, V35, P39, DOI 10.1007/s10753-010-9287-z; SUGIMOTO T, 1988, PAIN, V32, P375, DOI 10.1016/0304-3959(88)90050-4; Svensson P, 2003, PAIN, V101, P221, DOI 10.1016/S0304-3959(02)00079-9; Takeda M, 2005, PAIN, V116, P375, DOI 10.1016/j.pain.2005.05.007; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yasuda M, 2012, NEUROSCI LETT, V528, P67, DOI 10.1016/j.neulet.2012.08.067	53	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109723	10.1371/journal.pone.0109723	http://dx.doi.org/10.1371/journal.pone.0109723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290694	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000083
J	Zhang, YX; Cai, W; Song, JM; Miao, L; Zhang, B; Xu, Q; Zhang, LJ; Yao, H				Zhang, Yuexin; Cai, Wen; Song, Jiangmei; Miao, Lei; Zhang, Bei; Xu, Qin; Zhang, Lijuan; Yao, Hua			Association between the PNPLA3 I148M Polymorphism and Non-Alcoholic Fatty Liver Disease in the Uygur and Han Ethnic Groups of Northwestern China	PLOS ONE			English	Article							HEPATIC STEATOSIS; GENETIC-VARIATION; SUSCEPTIBILITY; POPULATION; RISK; PREVALENCE; RS738409	Objective: Multiple common gene variants play a role in non-alcoholic fatty liver disease (NAFLD) susceptibility. Our goal was to investigate the association between variants polymorphisms and NAFLD in the Uygur and Han from Northwestern China. Methods: Eight tag single nucleotide polymorphisms (tSNPs) previously reported to be associated with NAFLD were characterized in 396 NAFLD individuals and 399 controls. The association of variants with NAFLD in the Uygur and Han was assessed using the chi-squared (chi(2)) test in different gene models. Unconditional logistic regression analysis was performed to obtain the odds ratios (ORs) for risk of NAFLD and their 95% confidence intervals (CI), adjusted for confounding factors. Finally, stratified analysis was used to explore the potential gene-environment interactions on the risk of NAFLD. Results: In a recessive model, we found a potential association between rs738409 and NAFLD in both ethnic groups: Chinese Han (OR = 1.84, 95% CI: 1.03-3.27, p = 0.036), Uygur (OR = 2.25, 95% CI: 1.23-4.09, p = 0.006). The multiple logistic regression revealed that PNPLA3 rs738409 GG genotype may increase the risk of NAFLD by adjusting some confounding factors: Han (OR = 5.22, 95% CI: 1.94-14.04, p = 0.001), Uygur (OR = 4.29, 95% CI: 1.60-11.48, p = 0.004). Stratified analysis found that rs738409 polymorphism appeared to have interaction with sex, smoking status in Uygur, and have interaction with sex, age, BMI stage, lifestyle in Han. Conclusion: Our data suggest the PNPLA3 I148M polymorphism influences susceptibility to NAFLD in the Han and Uygur of Northwestern China.	[Zhang, Yuexin; Song, Jiangmei; Xu, Qin; Zhang, Lijuan] Xinjiang Med Univ, Ctr Infect Dis, Affiliated Hosp 1, Urumqi, Peoples R China; [Cai, Wen] Xinjiang Med Univ, Sch Nursing, Urumqi, Peoples R China; [Miao, Lei] Xinjiang Med Univ, Sch Publ Hlth, Urumqi, Peoples R China; [Zhang, Bei] Xinjiang Med Univ, Sch Basic Med, Urumqi, Peoples R China; [Yao, Hua] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Yao, H (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China.	huayao1959@163.com	Zhang, Li/GWM-7501-2022		National Key Basic Research and Development Program (973 Program) of China [2012CB722403]; National Natural Science Foundation of China [81160115]	National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The sources of funding are National Key Basic Research and Development Program (also called the 973 Program) of China (No. 2012CB722403) and the National Natural Science Foundation of China (No. 81160115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Charatcharoenwitthaya Phunchai, 2007, Clin Liver Dis, V11, P37, DOI 10.1016/j.cld.2007.02.014; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Cox AJ, 2011, DIABETES METAB, V37, P452, DOI 10.1016/j.diabet.2011.05.001; Fan JG, 2007, HEPATOB PANCREAT DIS, V6, P572; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Hyysalo J, 2012, J GASTROEN HEPATOL, V27, P951, DOI 10.1111/j.1440-1746.2011.07045.x; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Li YL, 2012, HEPATOLOGY, V55, P327, DOI 10.1002/hep.24659; Lin YC, 2011, J PEDIATR-US, V158, P740, DOI 10.1016/j.jpeds.2010.11.016; Liu Pengju, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P53, DOI 10.3760/cma.j.issn.1007-3418.2014.01.012; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Mottin CC, 2004, OBES SURG, V14, P635, DOI 10.1381/096089204323093408; Niu TH, 2014, WORLD J GASTROENTERO, V20, P3655, DOI 10.3748/wjg.v20.i13.3655; Peng XE, 2014, LIVER INT, V34, P118, DOI 10.1111/liv.12220; Peng XE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050256; Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030; Rae-Whitcombe SM, 2010, BIOCHEM BIOPH RES CO, V402, P767, DOI 10.1016/j.bbrc.2010.10.106; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Romero-Gomez M, 2011, J HEPATOL, V55, P1184, DOI 10.1016/j.jhep.2011.06.003; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Zhou YJ, 2010, J GASTROEN HEPATOL, V25, P772, DOI 10.1111/j.1440-1746.2009.06144.x	28	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108381	10.1371/journal.pone.0108381	http://dx.doi.org/10.1371/journal.pone.0108381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290313	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000016
J	Resetca, D; Haftchenary, S; Gunning, PT; Wilson, DJ				Resetca, Diana; Haftchenary, Sina; Gunning, Patrick T.; Wilson, Derek J.			Changes in Signal Transducer and Activator of Transcription 3 (STAT3) Dynamics Induced by Complexation with Pharmacological Inhibitors of Src Homology 2 (SH2) Domain Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; SMALL MOLECULES; ABL KINASE; BINDING; MOTIONS; CANCER; PHOSPHORYLATION; RECOGNITION; PROTEINS	The activity of the transcription factor signal transducer and activator of transcription 3 (STAT3) is dysregulated in a number of hematological and solid malignancies. Development of pharmacological STAT3 Src homology 2 (SH2) domain interaction inhibitors holds great promise for cancer therapy, and a novel class of salicylic acid-based STAT3 dimerization inhibitors that includes orally bioavailable drug candidates has been recently developed. The compounds SF-1-066 and BP-1-102 are predicted to bind to the STAT3 SH2 domain. However, given the highly unstructured and dynamic nature of the SH2 domain, experimental confirmation of this prediction was elusive. We have interrogated the protein-ligand interaction of STAT3 with these small molecule inhibitors by means of time-resolved electrospray ionization hydrogen-deuterium exchange mass spectrometry. Analysis of site-specific evolution of deuterium uptake induced by the complexation of STAT3 with SF-1-066 or BP-1-102 under physiological conditions enabled the mapping of the in silico predicted inhibitor binding site to the STAT3 SH2 domain. The binding of both inhibitors to the SH2 domain resulted in significant local decreases in dynamics, consistent with solvent exclusion at the inhibitor binding site and increased rigidity of the inhibitor-complexed SH2 domain. Interestingly, inhibitor binding induced hot spots of allosteric perturbations outside of the SH2 domain, manifesting mainly as increased deuterium uptake, in regions of STAT3 important for DNA binding and nuclear localization.	[Resetca, Diana; Wilson, Derek J.] York Univ, Dept Chem, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada; [Haftchenary, Sina; Gunning, Patrick T.] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada	York University - Canada; University of Toronto; University Toronto Mississauga	Wilson, DJ (corresponding author), York Univ, Dept Chem, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	dkwilson@yorku.ca		Resetca, Diana/0000-0003-0007-7828	National Sciences and Engineering Research Council (NSERC) [257588]; Ontario Ministry of Research and Innovation; NSERC; Canadian Institutes of Health Research; Canadian Breast Cancer Research Foundation	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Foundation	This work was supported in part by National Sciences and Engineering Research Council (NSERC) Discovery Grant 257588 and an Ontario Ministry of Research and Innovation early researcher award (to D. J. W.).; Supported by an NSERC postgraduate scholarship-doctoral.; Supported by the NSERC, Canadian Institutes of Health Research, and Canadian Breast Cancer Research Foundation.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Engen JR, 1999, BIOCHEMISTRY-US, V38, P8926, DOI 10.1021/bi982611y; Finerty PJ, 2005, BIOCHEMISTRY-US, V44, P694, DOI 10.1021/bi048641k; Fletcher S, 2011, CHEMMEDCHEM, V6, P1459, DOI 10.1002/cmdc.201100194; Fletcher S, 2009, CHEMBIOCHEM, V10, P1959, DOI 10.1002/cbic.200900172; Haan S, 1999, J BIOL CHEM, V274, P1342, DOI 10.1074/jbc.274.3.1342; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Liuni P, 2012, ANGEW CHEM INT EDIT, V51, P9666, DOI 10.1002/anie.201204903; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Montelione GT, 2000, NAT STRUCT BIOL, V7, P982, DOI 10.1038/80768; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; Nkansah E, 2013, FEBS LETT, V587, P833, DOI 10.1016/j.febslet.2013.01.065; Page BDG, 2011, BIOORG MED CHEM LETT, V21, P5605, DOI 10.1016/j.bmcl.2011.06.056; Page BDG, 2011, EXPERT OPIN THER PAT, V21, P65, DOI 10.1517/13543776.2011.539205; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Ren ZY, 2008, BIOCHEM BIOPH RES CO, V374, P1, DOI 10.1016/j.bbrc.2008.04.049; Resetca D, 2013, FEBS J, V280, P5616, DOI 10.1111/febs.12332; Rob T, 2013, LAB CHIP, V13, P2528, DOI 10.1039/c3lc00007a; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Wilson DJ, 2003, ANAL CHEM, V75, P6408, DOI 10.1021/ac0346757; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001	34	29	29	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.595454	http://dx.doi.org/10.1074/jbc.M114.595454			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288792	hybrid, Green Published			2022-12-25	WOS:000345335000013
J	Habauzit, D; Le Quement, C; Zhadobov, M; Martin, C; Aubry, M; Sauleau, R; Le Drean, Y				Habauzit, Denis; Le Quement, Catherine; Zhadobov, Maxim; Martin, Catherine; Aubry, Marc; Sauleau, Ronan; Le Drean, Yves			Transcriptome Analysis Reveals the Contribution of Thermal and the Specific Effects in Cellular Response to Millimeter Wave Exposure	PLOS ONE			English	Article							T-CELL; GENE-EXPRESSION; MOBILE PHONES; BRAIN-TUMORS; CYCLOPHOSPHAMIDE; GHZ; METALLOPROTEINASES; RISK	Radiofrequency radiations constitute a new form of environmental pollution. Among them, millimeter waves (MMW) will be widely used in the near future for high speed communication systems. This study aimed therefore to evaluate the biocompatibility of MMW at 60 GHz. For this purpose, we used a whole gene expression approach to assess the effect of acute 60 GHz exposure on primary cultures of human keratinocytes. Controls were performed to dissociate the electromagnetic from the thermal effect of MMW. Microarray data were validated by RT-PCR, in order to ensure the reproducibility of the results. MMW exposure at 20 mW/cm(2), corresponding to the maximum incident power density authorized for public use (local exposure averaged over 1 cm(2)), led to an increase of temperature and to a strong modification of keratinocyte gene expression (665 genes differentially expressed). Nevertheless, when temperature is artificially maintained constant, no modification in gene expression was observed after MMW exposure. However, a heat shock control did not mimic exactly the MMW effect, suggesting a slight but specific electromagnetic effect under hyperthermia conditions (34 genes differentially expressed). By RT-PCR, we analyzed the time course of the transcriptomic response and 7 genes have been validated as differentially expressed: ADAMTS6, NOG, IL7R, FADD, JUNB, SNAI2 and HIST1H1A. Our data evidenced a specific electromagnetic effect of MMW, which is associated to the cellular response to hyperthermia. This study raises the question of co-exposures associating radiofrequencies and other environmental sources of cellular stress.	[Habauzit, Denis; Le Quement, Catherine; Martin, Catherine; Le Drean, Yves] Univ Rennes 1, INSERM, IRSET Inst Res Environm & Occupat Hlth, Transcript Environm & Canc Grp,U1085, Rennes, France; [Zhadobov, Maxim; Sauleau, Ronan] Univ Rennes 1, IETR, UMR CNRS 6164, Rennes, France; [Aubry, Marc] Univ Rennes 1, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Rennes; Universite de Rennes	Le Drean, Y (corresponding author), Univ Rennes 1, INSERM, IRSET Inst Res Environm & Occupat Hlth, Transcript Environm & Canc Grp,U1085, Rennes, France.	yves.le-drean@univ-rennes1.fr	Martin, Catherine/K-1925-2015; Habauzit, Denis/K-1779-2015; Aubry, Marc/GNW-2661-2022; Le Dréan, Yves/L-4822-2015; Zhadobov, Maxim/P-6492-2016	Habauzit, Denis/0000-0001-8101-3839; Sauleau, Ronan/0000-0001-7510-9762; Zhadobov, Maxim/0000-0002-3809-110X	French National Research Agency (Agence Nationale de la Recherche, ANR) [09-RPDOC-003-01, 10-CESA-017-01]	French National Research Agency (Agence Nationale de la Recherche, ANR)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (Agence Nationale de la Recherche, ANR), under grants number 09-RPDOC-003-01 (Bio-CEM project) and number 10-CESA-017-01 (BioREF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Alekseev SI, 2010, BIOELECTROMAGNETICS, V31, P180, DOI 10.1002/bem.20547; Ashbaugh JJ, 2013, J IMMUNOL, V190, P4525, DOI 10.4049/jimmunol.1203214; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Badot V, 2011, J CELL MOL MED, V15, P2335, DOI 10.1111/j.1582-4934.2010.01228.x; Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; Cardis E, 2011, OCCUP ENVIRON MED, V68, P631, DOI 10.1136/oemed-2011-100155; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Debouzy JC, 2007, PATHOL BIOL, V55, P246, DOI 10.1016/j.patbio.2006.02.006; Gonzalez-Garcia S, 2012, CURR TOP MICROBIOL, V360, P47, DOI 10.1007/82_2012_231; Hardell L, 2011, INT J EPIDEMIOL, V40, P1126, DOI 10.1093/ije/dyq246; Hardell Lennart, 2009, Pathophysiology, V16, P113, DOI 10.1016/j.pathophys.2009.01.003; IARC (International Agency for Research on Cancer), 2013, IARC MONOGRAPHS EVAL, V102; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Le Drean Y, 2013, CR PHYS, V14, P402, DOI 10.1016/j.crhy.2013.02.005; Le Quement C, 2012, BIOELECTROMAGNETICS, V33, P147, DOI 10.1002/bem.20693; Lee AS, 2013, GENE, V527, P440, DOI 10.1016/j.gene.2013.05.069; Logani MK, 2012, IMMUNOPHARM IMMUNOT, V34, P107, DOI 10.3109/08923973.2011.583252; Makar V, 2003, BIOELECTROMAGNETICS, V24, P356, DOI 10.1002/bem.10104; Makar VR, 2006, BIOELECTROMAGNETICS, V27, P458, DOI 10.1002/bem.20230; Makar VR, 2005, BIOELECTROMAGNETICS, V26, P10, DOI 10.1002/bem.20046; Millenbaugh NJ, 2008, RADIAT RES, V169, P288, DOI 10.1667/RR1121.1; Moulder JE, 2012, RADIAT RES, V177, P723, DOI 10.1667/RR2897.1; Nicolaz CN, 2009, BIOELECTROMAGNETICS, V30, P365, DOI 10.1002/bem.20481; Pellegrini A, 2013, IEEE ANTENN PROPAG M, V55, P262, DOI 10.1109/MAP.2013.6645205; Pongratz G, 2013, ANN RHEUM DIS; Przemyslaw L, 2013, BMB REP, V46, P139, DOI 10.5483/BMBRep.2013.46.3.176; Radzievsky AA, 2000, LIFE SCI, V66, P2101, DOI 10.1016/S0024-3205(00)00536-1; Ribeiro Daniel, 2013, Adv Biol Regul, V53, P211, DOI 10.1016/j.jbior.2012.10.005; Rifas L, 2007, J CELL BIOCHEM, V100, P824, DOI 10.1002/jcb.21132; Rojavin MA, 1998, QJM-MON J ASSOC PHYS, V91, P57, DOI 10.1093/qjmed/91.1.57; ROTKOVSKA D, 1993, ENVIRON HEALTH PERSP, V101, P134, DOI 10.2307/3431422; Sakurai T, 2011, J RADIAT RES, V52, P185, DOI 10.1269/jrr.10116; Swerdlow AJ, 2011, ENVIRON HEALTH PERSP, V119, P1534, DOI 10.1289/ehp.1103693; Usichenko TI, 2003, ACUPUNCTURE ELECTRO, V28, P11, DOI 10.3727/036012903815901723; Vo NV, 2013, SPINE J, V13, P331, DOI 10.1016/j.spinee.2012.02.027; Zhadobov M, 2007, BIOELECTROMAGNETICS, V28, P188, DOI 10.1002/bem.20285; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P55, DOI 10.1002/bem.20685; Zhadobov M, 2011, INT J MICROW WIREL T, V3, P237, DOI 10.1017/S1759078711000122	39	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109435	10.1371/journal.pone.0109435	http://dx.doi.org/10.1371/journal.pone.0109435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302706	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400058
J	Heidrich, B; Wiegand, SB; Buggisch, P; Hinrichsen, H; Link, R; Moller, B; Boker, KHW; Teuber, G; Klinker, H; Zehnter, E; Naumann, U; Busch, HW; Maasoumy, B; Baum, U; Hardtke, S; Manns, MP; Wedemeyer, H; Petersen, J; Cornberg, M				Heidrich, Benjamin; Wiegand, Steffen B.; Buggisch, Peter; Hinrichsen, Holger; Link, Ralph; Moeller, Bernd; Boeker, Klaus H. W.; Teuber, Gerlinde; Klinker, Hartwig; Zehnter, Elmar; Naumann, Uwe; Busch, Heiner W.; Maasoumy, Benjamin; Baum, Undine; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; Petersen, Joerg; Cornberg, Markus		HepNet Study Grp	Treatment of Naive Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA	PLOS ONE			English	Article							PEGINTERFERON ALPHA-2B; HCV GENOTYPE-2; SOFOSBUVIR; EPIDEMIOLOGY	Evidence based clinical guidelines are implemented to treat patients efficiently that include efficacy, tolerability but also health economic considerations. This is of particular relevance to the new direct acting antiviral agents that have revolutionized treatment of chronic hepatitis C. For hepatitis C genotypes 2/3 interferon free treatment is already available with sofosbuvir plus ribavirin. However, treatment with sofosbuvir-based regimens is 10-20 times more expensive compared to pegylated interferon alfa and ribavirin (PegIFN/RBV). It has to be discussed if PegIFN/RBV is still an option for easy to treat patients. We assessed the treatment of patients with chronic hepatitis C genotypes 2/3 with PegIFN/RBV in a real world setting according to the latest German guidelines. Overall, 1006 patients were recruited into a prospective patient registry with 959 having started treatment. The intention-to-treat analysis showed poor SVR (GT2 61%, GT3 47%) while patients with adherence had excellent SVR in the per protocol analysis (GT2 96%, GT3 90%). According to guidelines, 283 patients were candidates for shorter treatment duration, namely a treatment of 16 weeks (baseline HCV-RNA <800.000 IU/mL, no cirrhosis and RVR). However, 65% of these easy to treat patients have been treated longer than recommended that resulted in higher costs but not higher SVR rates. In conclusion, treatment with PegIFN/RBV in a real world setting can be highly effective yet similar effective than PegIFN +/- sofosbuvir/RBV in well-selected naive G2/3 patients. Full adherence to guidelines could be further improved, because it would be important in the new era with DAA, especially to safe resources.	[Heidrich, Benjamin; Wiegand, Steffen B.; Maasoumy, Benjamin; Baum, Undine; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Heidrich, Benjamin; Wiegand, Steffen B.; Maasoumy, Benjamin; Baum, Undine; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus] German Liver Fdn, HepNet Study House, Hannover, Germany; [Buggisch, Peter] German Ctr Infect Res DZIF, Braunschweig, Germany; [Hinrichsen, Holger] Gastroenterol Schwerpunkt Praxis, Kiel, Germany; [Link, Ralph] St Josefs Hosp, Offenburg, Germany; [Boeker, Klaus H. W.] Leberpraxis, Hannover, Germany; [Klinker, Hartwig] Univ Wurzburg, Dept Internal Med 2, D-97070 Wurzburg, Germany; [Naumann, Uwe] Praxiszentrum Kaiserdamm, Ctr Addiction Med Hepatol & HIV, Berlin, Germany	Hannover Medical School; German Center for Infection Research; University of Wurzburg	Cornberg, M (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Cornberg.Markus@mh-hannover.de	Klinker, Hartwig/AAC-1134-2021; Cornberg, Markus/AAN-6939-2021	Cornberg, Markus/0000-0002-9141-8001; Maasoumy, Benjamin/0000-0002-3250-3177	MSD Sharp Dohme GmbH; German Center for Infectious Disease Research (DZIF)	MSD Sharp Dohme GmbH; German Center for Infectious Disease Research (DZIF)	This registry was financially supported by MSD Sharp & Dohme GmbH (manufacturer of pegylated interferon alpha-2b) (http://www.msd.de/). The protocol and the contracts did not intend to influence the decision to treat patients with pegylated interferon alpha-2b. The HepNet study house of the German Liver Foundation, which was supported by the German Center for Infectious Disease Research (DZIF), coordinated and formally sponsored the registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD & IDSA, 2014, REC TEST MAN TREAT H; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Cornberg Markus, 2006, Expert Rev Anti Infect Ther, V4, P781, DOI 10.1586/14787210.4.5.781; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975; Dusheiko G, 2012, GUT, V61, P1647, DOI 10.1136/gutjnl-2012-302910; Hadziyannis SJ, 2004, HEPATOL RES, V29, P129, DOI 10.1016/j.hepres.2004.02.011; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Lawitz E, HEPATOL BALTIM MD, V58; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Maasoumy B, 2012, BEST PRACT RES CL GA, V26, P401, DOI 10.1016/j.bpg.2012.09.009; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns M, 2011, J HEPATOL, V55, P554, DOI 10.1016/j.jhep.2010.12.024; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; The price of good health, 2014, NAT MED, V20, P319, DOI [10.1038/nm.3538, DOI 10.1038/NM.3538/NM.3538]; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Zeuzem S, 2013, HEPATOLOGY, V58, p733A	21	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108751	10.1371/journal.pone.0108751	http://dx.doi.org/10.1371/journal.pone.0108751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302676	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400025
J	Al Dhaheri, Y; Attoub, S; Ramadan, G; Arafat, K; Bajbouj, K; Karuvantevida, N; AbuQamar, S; Eid, A; Iratni, R				Al Dhaheri, Yusra; Attoub, Samir; Ramadan, Gaber; Arafat, Kholoud; Bajbouj, Khuloud; Karuvantevida, Noushad; AbuQamar, Synan; Eid, Ali; Iratni, Rabah			Carnosol Induces ROS-Mediated Beclin1-Independent Autophagy and Apoptosis in Triple Negative Breast Cancer	PLOS ONE			English	Article							CELL-DEATH; DOWN-REGULATION; HISTONE H3; RESVERATROL; INDUCTION; MECHANISMS; EXPRESSION; P21	Background: In this study we investigated the in vitro and in vivo anticancer effect of carnosol, a naturally occurring polyphenol, in triple negative breast cancer. Results: We found that carnosol significantly inhibited the viability and colony growth induced G2 arrest in the triple negative MDA-MB-231. Blockade of the cell cycle was associated with increased p21/WAF1 expression and downregulation of p27. Interestingly, carnosol was found to induce beclin1-independent autophagy and apoptosis in MDA-MB-231 cells. The coexistence of both events, autophagy and apoptosis, was confirmed by electron micrography. Induction of autophagy was found to be an early event, detected within 3 h post-treatment, which subsequently led to apoptosis. Carnosol treatment also caused a dose-dependent increase in the levels of phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2). Moreover, we show that carnosol induced DNA damage, reduced the mitochondrial potential and triggered the activation of the intrinsic and extrinsic apoptotic pathway. Furthermore, we found that carnosol induced a dose-dependent generation of reactive oxygen species (ROS) and inhibition of ROS by tiron, a ROS scavenger, blocked the induction of autophagy and apoptosis and attenuated DNA damage. To our knowledge, this is the first report to identify the induction of autophagy by carnosol. Conclusion: In conclusion our findings provide strong evidence that carnosol may be an alternative therapeutic candidate against the aggressive form of breast cancer and hence deserves more exploration.	[Al Dhaheri, Yusra; Ramadan, Gaber; Bajbouj, Khuloud; Karuvantevida, Noushad; AbuQamar, Synan; Iratni, Rabah] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Attoub, Samir; Arafat, Kholoud] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Eid, Ali] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar	United Arab Emirates University; United Arab Emirates University; Qatar University	Iratni, R (corresponding author), United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates.	R_iratni@uaeu.ac.ae	Attoub, Samir/N-6852-2018; Eid, Ali Hussein/ABD-6291-2021; Karuvantevida, Noushad/GOP-3177-2022; AbuQamar, Synan/AAV-1229-2021	Eid, Ali Hussein/0000-0003-3004-5675; AbuQamar, Synan/0000-0002-2129-7689; Karuvantevida, Noushad/0000-0002-9836-0316; Bajbouj, Khuloud/0000-0001-7344-6095	UAEU Program for Advanced Research [31S111-UPAR]; Faculty of Science interdisciplinary research grant UAE University [31S033-FOS]	UAEU Program for Advanced Research; Faculty of Science interdisciplinary research grant UAE University	This work was supported by UAEU Program for Advanced Research (Grant 31S111-UPAR) and the Faculty of Science interdisciplinary research grant UAE University (Grant 31S033-FOS) to Rabah Iratni. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2013, ONCOL REP, V29, P1333, DOI 10.3892/or.2013.2242; Al Dhaheri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056649; Al Dhaheri Y, 2013, BBA-GEN SUBJECTS, V1830, P3121, DOI 10.1016/j.bbagen.2013.01.010; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Dorrie J, 2001, CANCER LETT, V170, P33, DOI 10.1016/S0304-3835(01)00549-3; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Johanson JJ, 2011, CANC LETT, V305, P1; Johnson JH, 2011, VENICE INCOGNITO: MASKS IN THE SERENE REPUBLIC, P3; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Kaczirek K, 2004, J CLIN ENDOCR METAB, V89, P2397, DOI 10.1210/jc.2003-031314; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Karna P, 2010, J BIOL CHEM, V285, P18737, DOI 10.1074/jbc.M109.091694; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Li X, 2012, INT J BIOL SCI, V8, P901, DOI 10.7150/ijbs.4554; Ling LU, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.12; Lopez-Jimenez A, 2013, EUR J NUTR, V52, P85, DOI 10.1007/s00394-011-0289-x; Martin KR, 2006, EXP BIOL MED, V231, P117; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Park KW, 2014, INT J ONCOL, V44, P1309, DOI 10.3892/ijo.2014.2281; Puissant A, 2012, AM J CANCER RES, V2, P397; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Rabi T, 2009, BREAST CANCER RES TR, V115, P223, DOI 10.1007/s10549-008-0118-y; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Reuben SC, 2012, MOL NUTR FOOD RES, V56, P14, DOI 10.1002/mnfr.201100619; Rikiishi Hidemi, 2012, Int J Cell Biol, V2012, P317645, DOI 10.1155/2012/317645; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Shrivastava A, 2011, MOL CANCER THER, V10, P1161, DOI 10.1158/1535-7163.MCT-10-1100; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang L, 2012, BREAST CARE, V7, P13, DOI 10.1159/000336539	41	70	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109630	10.1371/journal.pone.0109630	http://dx.doi.org/10.1371/journal.pone.0109630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299698	Green Published, gold			2022-12-25	WOS:000343941200065
J	Carsillo, T; Huey, D; Levinsky, A; Obojes, K; Schneider-Schaulies, J; Niewiesk, S				Carsillo, Thomas; Huey, Devra; Levinsky, Amy; Obojes, Karola; Schneider-Schaulies, Juergen; Niewiesk, Stefan			Cotton Rat (Sigmodon hispidus) Signaling Lymphocyte Activation Molecule (CD150) Is an Entry Receptor for Measles Virus	PLOS ONE			English	Article							CELLULAR RECEPTOR; IMMUNE SUPPRESSION; SLAM CDW150; WILD-TYPE; REPLICATION; CD46; MORBILLIVIRUSES; GLYCOPROTEINS; STRAINS; SPREAD	Cotton rats (Sigmodon hispidus) replicate measles virus (MV) after intranasal infection in the respiratory tract and lymphoid tissue. We have cloned the cotton rat signaling lymphocytic activation molecule (CD150, SLAM) in order to investigate its role as a potential receptor for MV. Cotton rat CD150 displays 58% and 78% amino acid homology with human and mouse CD150, respectively. By staining with a newly generated cotton rat CD150 specific monoclonal antibody expression of CD150 was confirmed in cotton rat lymphoid cells and in tissues with a pattern of expression similar to mouse and humans. Previously, binding of MV hemagglutinin has been shown to be dependent on amino acids 60, 61 and 63 in the V region of CD150. The human molecule contains isoleucine, histidine and valine at these positions and binds to MV-H whereas the mouse molecule contains valine, arginine and leucine and does not function as a receptor for MV. In the cotton rat molecule, amino acids 61 and 63 are identical with the mouse molecule and amino acid 60 with the human molecule. After transfection with cotton rat CD150 HEK 293 T cells became susceptible to infection with single cycle VSV pseudotype virus expressing wild type MV glycoproteins and with a MV wildtype virus. After infection, cells expressing cotton rat CD150 replicated virus to lower levels than cells expressing the human molecule and formed smaller plaques. These data might explain why the cotton rat is a semipermissive model for measles virus infection.	[Carsillo, Thomas; Huey, Devra; Levinsky, Amy; Niewiesk, Stefan] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Carsillo, Thomas; Huey, Devra; Levinsky, Amy; Niewiesk, Stefan] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Obojes, Karola; Schneider-Schaulies, Juergen] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Wurzburg	Niewiesk, S (corresponding author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.	Niewiesk.1@osu.edu		Schneider-Schaulies, Jurgen/0000-0001-7713-5518	National Institute of Allergy and Infectious Disease [R03AI065971-01]; NIH/NIAID [1-T32-AI-065411]; NRSA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065971, T32AI065411] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institute of Allergy and Infectious Disease award #R03AI065971-01. T.C. was supported by NIH/NIAID award #1-T32-AI-065411, a NRSA training grant administered by the Center for Microbial Interface Biology (CMIB), at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 1999, VET MICROBIOL, V69, P3, DOI 10.1016/S0378-1135(99)00080-2; Bieringer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057488; Carsillo M, 2010, J VIROL, V84, P2180, DOI 10.1128/JVI.01316-09; Castro AG, 1999, J IMMUNOL, V163, P5860; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Erlenhofer C, 2002, J GEN VIROL, V83, P1431, DOI 10.1099/0022-1317-83-6-1431; Johnston ICD, 1999, J VIROL, V73, P6903, DOI 10.1128/JVI.73.8.6903-6915.1999; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; MENEZES J, 1975, BIOMEDICINE, V22, P276; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Navaratnarajah CK, 2009, CURR TOP MICROBIOL, V329, P59; Niewiesk S, 1997, J VIROL, V71, P7214, DOI 10.1128/JVI.71.10.7214-7219.1997; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ohno S, 2003, J GEN VIROL, V84, P2381, DOI 10.1099/vir.0.19248-0; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Ono N, 2001, J VIROL, V75, P1594, DOI 10.1128/JVI.75.4.1594-1600.2001; Pfeuffer J, 2003, J VIROL, V77, P150, DOI 10.1128/JVI.77.1.150-158.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICHARDSON CD, 1980, VIROLOGY, V105, P205, DOI 10.1016/0042-6822(80)90168-3; Rima BK, 1997, J GEN VIROL, V78, P97, DOI 10.1099/0022-1317-78-1-97; Shields MJ, 1998, TISSUE ANTIGENS, V51, P567, DOI 10.1111/j.1399-0039.1998.tb02994.x; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takeda M, 2008, J CLIN INVEST, V118, P2386, DOI 10.1172/JCI36251; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Tatsuo H, 2000, J VIROL, V74, P4139, DOI 10.1128/JVI.74.9.4139-4145.2000; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; WYDE PR, 1992, P SOC EXP BIOL MED, V201, P80, DOI 10.3181/00379727-201-43483; Wyde PR, 1999, P SOC EXP BIOL MED, V221, P53, DOI 10.1046/j.1525-1373.1999.d01-54.x; Yanagi Y, 2009, CURR TOP MICROBIOL, V329, P13	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110120	10.1371/journal.pone.0110120	http://dx.doi.org/10.1371/journal.pone.0110120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295727	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000112
J	Freitag, J; Heink, S; Roth, E; Wittmann, J; Jack, HM; Kamradt, T				Freitag, Jenny; Heink, Sylvia; Roth, Edith; Wittmann, Juergen; Jaeck, Hans-Martin; Kamradt, Thomas			Towards the Generation of B-Cell Receptor Retrogenic Mice	PLOS ONE			English	Article							TRANSGENIC MICE; AVIAN LYSOZYME; IN-VIVO; CLEAVAGE; LYMPHOCYTES; EXPRESSION; POLYPROTEIN; ANTIBODIES; PROTEINS; FURIN	Transgenic expression of B- and T-cell receptors (BCRs and TCRs, respectively) has been a standard tool to study lymphocyte development and function in vivo. The generation of transgenic mice is time-consuming and, therefore, a faster method to study the biology of defined lymphocyte receptors in vivo would be highly welcome. Using 2A peptide-linked multicistronic retroviral vectors to transduce stem cells, TCRs can be expressed rapidly in mice of any background. We aimed at adopting this retrogenic technology to the in vivo expression of BCRs. Using a well characterised BCR specific for hen egg lysozyme (HEL), we achieved surface expression of the retrogenically encoded BCR in a Rag-deficient pro B-cell line in vitro. In vivo, retrogenic BCRs were detectable only intracellularly but not on the surface of B cells from wild type or Rag2-deficient mice. This data, together with the fact that no BCR retrogenic mouse model has been published in the 7 years since the method was originally published for TCRs, strongly suggests that achieving BCR-expression in vivo with retrogenic technology is highly challenging if not impossible.	[Freitag, Jenny; Heink, Sylvia; Kamradt, Thomas] Univ Hosp Jena, Dept Immunol, Jena, Germany; [Roth, Edith; Wittmann, Juergen; Jaeck, Hans-Martin] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany	Friedrich Schiller University of Jena; University of Erlangen Nuremberg	Kamradt, T (corresponding author), Univ Hosp Jena, Dept Immunol, Jena, Germany.	thomas.kamradt@med.uni-jena.de	Kamradt, Thomas/E-9971-2018	Jack, Hans-Martin/0000-0002-6332-8463; Heink, Sylvia/0000-0002-3276-6313; Kamradt, Thomas/0000-0001-8443-5893	Deutsche Forschungsgemeinschaft [KA 755/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is supported by KA 755/5-1, www.dfg.de, Deutsche Forschungsgemeinschaft (TK, JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bettini ML, 2012, IMMUNOLOGY, V136, P265, DOI 10.1111/j.1365-2567.2012.03574.x; BOYD AW, 1981, J IMMUNOL, V126, P2466; Corfe SA, 2007, J IMMUNOL METHODS, V325, P9, DOI 10.1016/j.jim.2007.05.010; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Dylke J, 2007, IMMUNOL LETT, V112, P47, DOI 10.1016/j.imlet.2007.06.005; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Haan C, 2000, BIOCHEM J, V349, P261, DOI 10.1042/0264-6021:3490261; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kim JH, 2011, PLOS ONE, V6; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Milne CD, 2008, J IMMUNOL, V180, P2839, DOI 10.4049/jimmunol.180.5.2839; Nakagawa R, 2006, NAT PROTOC, V1, P1185, DOI 10.1038/nprot.2006.178; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; ROEBROEK AJM, 1994, BIOCHIMIE, V76, P210, DOI 10.1016/0300-9084(94)90148-1; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; SMITHGILL SJ, 1984, J IMMUNOL, V132, P963; SMITHGILL SJ, 1984, J IMMUNOL, V133, P384; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109199	10.1371/journal.pone.0109199	http://dx.doi.org/10.1371/journal.pone.0109199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296340	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000046
J	Kelsey, TW; Li, LQ; Mitchell, RT; Whelan, A; Anderson, RA; Wallaces, WHB				Kelsey, Thomas W.; Li, Lucy Q.; Mitchell, Rod T.; Whelan, Ashley; Anderson, Richard A.; Wallaces, W. Hamish B.			A Validated Age-Related Normative Model for Male Total Testosterone Shows Increasing Variance but No Decline after Age 40 Years	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HORMONE-BINDING GLOBULIN; COMMUNITY-DWELLING MEN; SERUM TESTOSTERONE; OLDER MEN; AGING MEN; REFERENCE INTERVALS; SEX-HORMONES; ELDERLY-MEN; LONGITUDINAL CHANGES	The diagnosis of hypogonadism in human males includes identification of low serum testosterone levels, and hence there is an underlying assumption that normal ranges of testosterone for the healthy population are known for all ages. However, to our knowledge, no such reference model exists in the literature, and hence the availability of an applicable biochemical reference range would be helpful for the clinical assessment of hypogonadal men. In this study, using model selection and validation analysis of data identified and extracted from thirteen studies, we derive and validate a normative model of total testosterone across the lifespan in healthy men. We show that total testosterone peaks [mean (2.597.5 percentile)] at 15.4 (7.231.1) nmol/L at an average age of 19 years, and falls in the average case [mean (2.597.5 percentile)] to 13.0 (6.6-25.3) nmol/L by age 40 years, but we find no evidence for a further fall in mean total testosterone with increasing age through to old age. However we do show that there is an increased variation in total testosterone levels with advancing age after age 40 years. This model provides the age related reference ranges needed to support research and clinical decision making in males who have symptoms that may be due to hypogonadism.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland; [Li, Lucy Q.; Whelan, Ashley] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Mitchell, Rod T.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Mitchell, Rod T.; Anderson, Richard A.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Wallaces, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Edinburgh	Wallaces, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; Li, Lucy/0000-0002-1572-8470; Mitchell, Rod/0000-0003-4650-3765; wallace, william, hamish/0000-0001-8080-5674	EPSRC [EP/H004092/1]; Wellcome Trust Intermediate Clinical Fellowship [098522]; MRC [G1002118, G1002033] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004092/1] Funding Source: researchfish; Medical Research Council [G1002033, G1002118] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TWK is supported by EPSRC grant EP/H004092/1. http://gosw.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef = EP/H004092/1. RTM is supported by a Wellcome Trust Intermediate Clinical Fellowship (Grant No 098522) http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Fellowships/Clinical-fellowships/wtd004402.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahaman A, 2005, METABOLISM, V54, P91, DOI 10.1016/j.metabol.2004.07.018; Altman D.G., 1991, PRACTICAL STATISTIC; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Bergada I, 2006, J CLIN ENDOCR METAB, V91, P4092, DOI 10.1210/jc.2006-1079; BOLTON NJ, 1989, CLIN ENDOCRINOL, V31, P201, DOI 10.1111/j.1365-2265.1989.tb01243.x; Boyce MJ, 2004, BJU INT, V94, P881, DOI 10.1111/j.1464-410X.2004.05051.x; Brawer Michael K, 2004, Rev Urol, V6 Suppl 6, pS9; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Carnahan RM, 2004, DRUG AGING, V21, P361, DOI 10.2165/00002512-200421060-00002; Casey R, 2008, CUAJ-CAN UROL ASSOC, V2, P47; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Elmlinger MW, 2005, CLIN LAB, V51, P625; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Fleming R, 2012, FERTIL STERIL, V98, P1097, DOI 10.1016/j.fertnstert.2012.07.1114; FOREST MG, 1973, J CLIN ENDOCR METAB, V36, P1132, DOI 10.1210/jcem-36-6-1132; FOREST MG, 1974, J CLIN INVEST, V53, P819, DOI 10.1172/JCI107621; Friedrich N, 2008, J ANDROL, V29, P610, DOI 10.2164/jandrol.108.005561; Frost M, 2013, CLIN ENDOCRINOL, V78, P743, DOI 10.1111/cen.12042; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Halmenschlager G, 2011, WORLD J UROL, V29, P541, DOI 10.1007/s00345-011-0724-x; Handelsman DJ, 2013, J CLIN ENDOCR METAB, V98, P3971, DOI 10.1210/jc.2013-3375; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Huhtaniemi IT, 2012, EUR J ENDOCRINOL, V166, P983, DOI 10.1530/EJE-11-1051; Janse F, 2011, EUR J ENDOCRINOL, V165, P925, DOI 10.1530/EJE-11-0482; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Kelsey TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071465; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Kyriakopoulou L, 2013, CLIN BIOCHEM, V46, P642, DOI 10.1016/j.clinbiochem.2013.01.002; Leifke E, 2000, CLIN ENDOCRINOL, V53, P689, DOI 10.1046/j.1365-2265.2000.01159.x; Liverman CT, 2004, TESTOSTERONE AGING C; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Mohr BA, 2005, CLIN ENDOCRINOL, V62, P64, DOI 10.1111/j.1365-2265.2004.02174.x; Morales A, 2008, CUAJ-CAN UROL ASSOC, V2, P43; Morley JE, 1997, METABOLISM, V46, P410, DOI 10.1016/S0026-0495(97)90057-3; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Orwoll E, 2006, J CLIN ENDOCR METAB, V91, P1336, DOI 10.1210/jc.2005-1830; PHILLIPS GB, 1994, ARTERIOSCLER THROMB, V14, P701, DOI 10.1161/01.ATV.14.5.701; Pierik FH, 2009, INT J ANDROL, V32, P453, DOI 10.1111/j.1365-2605.2008.00877.x; Pye SR, 2013, J CLIN ENDOCR METAB; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Rohrmann S, 2011, CLIN ENDOCRINOL, V75, P232, DOI 10.1111/j.1365-2265.2011.04043.x; Rosano G M C, 2005, J Endocrinol Invest, V28, P32; Rucker D, 2004, CLIN ENDOCRINOL, V60, P491, DOI 10.1111/j.1365-2265.2004.02006.x; Ruige JB, 2013, J CLIN ENDOCR METAB, V98, P4300, DOI 10.1210/jc.2013-1970; Sartorius G, 2012, CLIN ENDOCRINOL, V77, P755, DOI 10.1111/j.1365-2265.2012.04432.x; Scaglia HE, 2012, REV ARG ENDOCRINOL M, V49, P159; Schatzl G, 2003, UROLOGY, V61, P629, DOI 10.1016/S0090-4295(02)02252-5; SHARPE RM, 1984, BIOL REPROD, V30, P29, DOI 10.1095/biolreprod30.1.29; Shi ZM, 2013, J CLIN ENDOCR METAB, V98, P3289, DOI 10.1210/jc.2012-3842; SIMON D, 1992, AM J EPIDEMIOL, V135, P783, DOI 10.1093/oxfordjournals.aje.a116365; Snyder PJ, 2008, J CLIN ENDOCR METAB, V93, P2477, DOI 10.1210/jc.2008-0922; Swerdloff RS, 2004, BEST PRACT RES CL EN, V18, P349, DOI 10.1016/j.beem.2004.03.011; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Wespes E, 2002, INT J IMPOT RES, V14, pS93, DOI 10.1038/sj.ijir.3900798; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108; Yeap BB, 2007, EUR J ENDOCRINOL, V156, P585, DOI 10.1530/EJE-06-0714; Yeap BB, 2014, J CLIN ENDOCR METAB, V99, pE9, DOI 10.1210/jc.2013-3272	63	77	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109346	10.1371/journal.pone.0109346	http://dx.doi.org/10.1371/journal.pone.0109346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295520	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000061
J	Simmons, SC; Jamsa, H; Silva, D; Cortez, CM; McKenzie, EA; Bitu, CC; Salo, S; Nurmenniemi, S; Nyberg, P; Risteli, J; deAlmeida, CEB; Brenchley, PEC; Salo, T; Missailidisi, S				Simmons, Suzanne C.; Jaemsae, Hannaleena; Silva, Dilson; Cortez, Celia M.; McKenzie, Edward A.; Bitu, Carolina C.; Salo, Sirpa; Nurmenniemi, Sini; Nyberg, Pia; Risteli, Juha; deAlmeida, Carlos E. B.; Brenchley, Paul E. C.; Salo, Tuula; Missailidisi, Sotiris			Anti-Heparanase Aptamers as Potential Diagnostic and Therapeutic Agents for Oral Cancer	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EXTRACELLULAR-MATRIX; MAMMALIAN HEPARANASE; PROTEIN INTERACTIONS; DNA APTAMERS; LASER-DESORPTION/IONIZATION; MASS-SPECTROMETRY; CELL CARCINOMA; IN-VIVO; EXPRESSION	Heparanase is an endoglycosidase enzyme present in activated leucocytes, mast cells, placental tissue, neutrophils and macrophages, and is involved in tumour metastasis and tissue invasion. It presents a potential target for cancer therapies and various molecules have been developed in an attempt to inhibit the enzymatic action of heparanase. In an attempt to develop a novel therapeutic with an associated diagnostic assay, we have previously described high affinity aptamers selected against heparanase. In this work, we demonstrated that these anti-heparanase aptamers are capable of inhibiting tissue invasion of tumour cells associated with oral cancer and verified that such inhibition is due to inhibition of the enzyme and not due to other potentially cytotoxic effects of the aptamers. Furthermore, we have identified a short 30 bases aptamer as a potential candidate for further studies, as this showed a higher ability to inhibit tissue invasion than its longer counterpart, as well as a reduced potential for complex formation with other non-specific serum proteins. Finally, the aptamer was found to be stable and therefore suitable for use in human models, as it showed no degradation in the presence of human serum, making it a potential candidate for both diagnostic and therapeutic use.	[Simmons, Suzanne C.; deAlmeida, Carlos E. B.] Open Univ, Dept Chem & Analyt Sci, Milton Keynes MK7 6AA, Bucks, England; [Silva, Dilson; Cortez, Celia M.] Univ Estado Rio De Janeiro, Inst Math & Stat, Rio De Janeiro, Brazil; [McKenzie, Edward A.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Jaemsae, Hannaleena; Bitu, Carolina C.; Salo, Sirpa; Nurmenniemi, Sini; Nyberg, Pia; Salo, Tuula] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Jaemsae, Hannaleena; Bitu, Carolina C.; Nyberg, Pia; Salo, Tuula] Med Res Ctr, Oulu, Finland; [Jaemsae, Hannaleena; Bitu, Carolina C.; Nyberg, Pia; Salo, Tuula] Oulu Univ Hosp, Oulu, Finland; [Risteli, Juha] Univ Oulu, Dept Clin Chem, Inst Diagnost, Oulu, Finland; [deAlmeida, Carlos E. B.] Inst Radioprotecao & Dosimetria, Radiobiol Lab, Rio De Janeiro, Brazil; [Brenchley, Paul E. C.] Univ Manchester, Renal Res Grp, Manchester, Lancs, England; [Salo, Tuula] Univ Estadual Campinas, Piracicaba Dent Sch, Grad Program Estomatopatol, Sao Paulo, Brazil; [Salo, Tuula] Univ Helsinki, Inst Dent, Helsinki, Finland; [Missailidisi, Sotiris] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil	Open University - UK; Universidade do Estado do Rio de Janeiro; University of Manchester; University of Oulu; University of Oulu; University of Oulu; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; University of Manchester; Universidade Estadual de Campinas; University of Helsinki; Universidade Federal do Rio de Janeiro	Salo, T (corresponding author), Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland.	tuula.salo@oulu.fi; sotirismissailidis@gmail.com	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/M-7511-2013; , tuula/ABG-2051-2021; De Marco, Paulo/B-2209-2009; Vilela, Bruno/L-1594-2015; Nemésio, André/D-1920-2012; Silva, Daniel Paiva/F-8052-2010; Cortez, Celia/X-3247-2018	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/0000-0003-0108-3998; De Marco, Paulo/0000-0002-3628-6405; Vilela, Bruno/0000-0003-4072-0558; Silva, Daniel Paiva/0000-0002-2457-6245; Brenchley, Paul/0000-0003-1290-9919; Salo, Sirpa/0000-0002-4113-4000; Cortez, Celia/0000-0002-7857-1167; Salo, Tuula/0000-0001-6039-0088; Silva, Dilson/0000-0001-9726-2442	Conselho Nacional de Pesquisa Cientifica - CNPq; Academy of Finland; Finnish Cancer Organisations; Finnish Dental Society Apollonia; Oulu University Hospital KEVO	Conselho Nacional de Pesquisa Cientifica - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Finnish Dental Society Apollonia; Oulu University Hospital KEVO	Dr. Bonacossa was supported by a post-doctoral fellowship from Conselho Nacional de Pesquisa Cientifica - CNPq, on the scope of the programme Science with no Borders, MCTI, Brazil. Dr. Missailidis would like to acknowledge the financial support from Conselho Nacional de Pesquisa Cientifica - CNPq, on the scope of a senior visiting researcher programme at FIOCRUZ for part of this project. The research group of Prof. Salo was supported by the Academy of Finland, the Finnish Cancer Organisations, Finnish Dental Society Apollonia and the Oulu University Hospital KEVO grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; Aberem MB, 2006, ADV MATER, V18, P2703, DOI 10.1002/adma.200601651; ADAMS DH, 1994, LANCET, V343, P831, DOI 10.1016/S0140-6736(94)92029-X; Arnold S, 2012, BIOL CHEM, V393, P343, DOI 10.1515/hsz-2011-0253; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; Cole JR, 2007, ANAL CHEM, V79, P273, DOI 10.1021/ac061256b; Cortez CM, 2012, SPECTROCHIM ACTA A, V95, P270, DOI 10.1016/j.saa.2012.04.053; Courtney SM, 2005, BIOORG MED CHEM LETT, V15, P2295, DOI 10.1016/j.bmcl.2005.03.014; Da Pieve C, 2010, BIOCONJUGATE CHEM, V21, P169, DOI 10.1021/bc900397s; Dick LW, 2004, ANAL CHEM, V76, P3037, DOI 10.1021/ac049860e; ELDOR A, 1987, SEMIN THROMB HEMOST, V13, P475, DOI 10.1055/s-2007-1003524; Famulok M, 1999, CURR TOP MICROBIOL, V243, P123; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; He XT, 2004, CANCER RES, V64, P3928, DOI 10.1158/0008-5472.CAN-03-2718; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hianik T, 2005, BIOORG MED CHEM LETT, V15, P291, DOI 10.1016/j.bmcl.2004.10.083; Hicke BJ, 2006, J NUCL MED, V47, P668; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ikuta M, 2001, ORAL ONCOL, V37, P177, DOI 10.1016/S1368-8375(00)00077-4; Ishida K, 2004, MOL CANCER THER, V3, P1069; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Kawde AN, 2005, ELECTROCHEM COMMUN, V7, P537, DOI 10.1016/j.elecom.2005.03.008; Koliopanos A, 2001, CANCER RES, V61, P4655; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Li JP, 2009, THROMB HAEMOSTASIS, V102, P823, DOI 10.1160/TH09-02-0091; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Marchetti D, 2001, ADV ENZYME REGUL, V41, P343, DOI 10.1016/S0065-2571(00)00016-9; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; McKenzie E, 2003, BIOCHEM J, V373, P423, DOI 10.1042/BJ20030318; Meirovitz A, 2013, FEBS J, V280, P2307, DOI 10.1111/febs.12184; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; Missailidis S, 2005, J IMMUNOL METHODS, V296, P45, DOI 10.1016/j.jim.2004.10.011; Nurmenniemi S, 2012, ORAL ONCOL, V48, P136, DOI 10.1016/j.oraloncology.2011.09.002; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Pisano C, 2014, BIOCH PHARM; PUCHALSKI MM, 1991, FRESEN J ANAL CHEM, V340, P341, DOI 10.1007/BF00321578; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Scaggiante B, 2013, CURR DRUG METAB, V14, P565, DOI 10.2174/13892002113149990010; Silva D, 2013, J PHOTOCH PHOTOBIO B, V127, P68, DOI 10.1016/j.jphotobiol.2013.06.015; Simmons SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037938; Tang WH, 2002, MODERN PATHOL, V15, P593, DOI 10.1038/modpathol.3880571; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Wang YH, 2011, BIOSENS BIOELECTRON, V26, P3536, DOI 10.1016/j.bios.2011.01.041; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Zeng C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0403-9	65	46	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e96846	10.1371/journal.pone.0096846	http://dx.doi.org/10.1371/journal.pone.0096846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295847	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000001
J	Wongtrakool, C; Grooms, K; Bijli, KM; Crothers, K; Fitzpatrick, AM; Hart, CM				Wongtrakool, Cherry; Grooms, Kora; Bijli, Kaiser M.; Crothers, Kristina; Fitzpatrick, Anne M.; Hart, C. Michael			Nicotine Stimulates Nerve Growth Factor in Lung Fibroblasts through an NF kappa B-Dependent Mechanism	PLOS ONE			English	Article							MESENCHYMAL TROPHIC UNIT; TRACHEAL SMOOTH-MUSCLE; TOBACCO-SMOKE EXPOSURE; AIRWAY HYPERRESPONSIVENESS; PULMONARY-FUNCTION; CIGARETTE-SMOKE; PROTEIN-KINASE; ASTHMA; ACTIVATION; EXPRESSION	Rationale: Airway hyperresponsiveness (AHR) is classically found in asthma, and persistent AHR is associated with poor asthma control. Although airway smooth muscle (ASM) cells play a critical pathophysiologic role in AHR, the paracrine contributions of surrounding cells such as fibroblasts to the contractile phenotype of ASM cells have not been examined fully. This study addresses the hypothesis that nicotine promotes a contractile ASM cell phenotype by stimulating fibroblasts to increase nerve growth factor (NGF) secretion into the environment. Methods: Primary lung fibroblasts isolated from wild type and alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) deficient mice were treated with nicotine (50 mu g/ml) in vitro for 72 hours. NGF levels were measured in culture media and in bronchoalveolar lavage (BAL) fluid from asthmatic, smoking and non-smoking subjects by ELISA. The role of the NF kappa B pathway in nicotine-induced NGF expression was investigated by measuring NF kappa B nuclear translocation, transcriptional activity, chromatin immunoprecipitation assays, and si-p65 NF kappa B knockdown. The ability of nicotine to stimulate a fibroblast-mediated, contractile ASM cell phenotype was confirmed by examining expression of contractile proteins in ASM cells cultured with fibroblast-conditioned media or BAL fluid. Results: NGF levels were elevated in the bronchoalveolar lavage fluid of nicotine-exposed mice, current smokers, and asthmatic children. Nicotine increased NGF secretion in lung fibroblasts in vitro in a dose-dependent manner and stimulated NF kappa B nuclear translocation, p65 binding to the NGF promoter, and NF kappa B transcriptional activity. These responses were attenuated in alpha 7 nAChR deficient fibroblasts and in wild type fibroblasts following NF kappa B inhibition. Nicotine-treated, fibroblast-conditioned media increased expression of contractile proteins in ASM cells. Conclusion: Nicotine stimulates NGF release by lung fibroblasts through alpha 7 nAChR and NF kappa B dependent pathways. These novel findings suggest that the nicotine-alpha 7 nAChR-NF kappa B-NGF axis may provide novel therapeutic targets to attenuate tobacco smoke-induced AHR.	[Wongtrakool, Cherry; Bijli, Kaiser M.; Hart, C. Michael] Atlanta VA Med Ctr, Decatur, GA 30033 USA; [Wongtrakool, Cherry; Grooms, Kora; Bijli, Kaiser M.; Hart, C. Michael] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Crothers, Kristina] Univ Washington, Seattle, WA 98195 USA; [Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; University of Washington; University of Washington Seattle; Emory University	Wongtrakool, C (corresponding author), Atlanta VA Med Ctr, Decatur, GA 30033 USA.	cwongtr@emory.edu		Crothers, Kristina/0000-0001-9702-0371; Fitzpatrick, Anne/0000-0002-2933-5926; Hart, C. Michael/0000-0002-9145-9938	Department of Veterans Affairs [BX001306, BX001910]; National Institutes of Health [HL102167, DK074518, HL090342]; American Thoracic Society Foundation Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167, R01HL090342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074518] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001910, IK2BX001306] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society Foundation Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Department of Veterans Affairs: BX001306 (CW) and BX001910 (CMH); National Institutes of Health: HL102167 (CMH), DK074518 (CMH), HL090342 (KC); American Thoracic Society Foundation Research Program (CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Bijli KM, 2012, AM J RESP CELL MOL, V47, P660, DOI 10.1165/rcmb.2012-0047OC; Braun A, 2001, INT ARCH ALLERGY IMM, V124, P205, DOI 10.1159/000053711; Bullo M, 2007, EUR J ENDOCRINOL, V157, P303, DOI 10.1530/EJE-06-0716; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chitano P, 2005, PEDIATR PULM, V39, P108, DOI 10.1002/ppul.20150; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; EBERT RV, 1983, JAMA-J AM MED ASSOC, V250, P2840, DOI 10.1001/jama.250.20.2840; Eisner MD, 2002, ENVIRON HEALTH PERSP, V110, P765, DOI 10.1289/ehp.02110765; Eisner MD, 2002, CHEST, V122, P826, DOI 10.1378/chest.122.3.826; Evans MJ, 1999, AM J RESP CELL MOL, V21, P655, DOI 10.1165/ajrcmb.21.6.3807; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Fu XW, 2009, AM J RESP CELL MOL, V41, P93, DOI 10.1165/rcmb.2008-0352OC; Garrido R, 2003, NEUROSCI RES, V47, P349, DOI 10.1016/S0168-0102(03)00222-0; GOLDSTEIN RA, 1990, AM REV RESPIR DIS, V142, P481; Hazari MS, 2007, AM J PHYSIOL-LUNG C, V292, pL992, DOI 10.1152/ajplung.00216.2006; Hoglund CO, 2002, EUR RESPIR J, V20, P1110, DOI 10.1183/09031936.02.00205402; Hoglund CO, 2002, PULM PHARMACOL THER, V15, P51, DOI 10.1006/pupt.2001.0314; Holgate ST, 2001, INT ARCH ALLERGY IMM, V124, P253, DOI 10.1159/000053726; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Koh YY, 2002, AM J RESP CRIT CARE, V166, P340, DOI 10.1164/rccm.2101158; KONG SK, 1990, AM J PHYSIOL, V259, pL53, DOI 10.1152/ajplung.1990.259.2.L53; Liu J, 2011, AM J PHYSIOL-LUNG C, V300, pL710, DOI 10.1152/ajplung.00337.2010; MCNABB ME, 1982, JAMA-J AM MED ASSOC, V248, P865, DOI 10.1001/jama.248.7.865; Michalik M, 2009, MED SCI MONITOR, V15, pBR194; Nakao S, 2009, ARCH ORAL BIOL, V54, P251, DOI 10.1016/j.archoralbio.2008.11.006; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Olgart C, 2001, EUR RESPIR J, V18, P115, DOI 10.1183/09031936.01.00069901; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Roman J, 2004, FASEB J, V18, P1436, DOI 10.1096/fj.03-0826fje; ROWELL PP, 1983, J PHARMACOL METHOD, V9, P249, DOI 10.1016/0160-5402(83)90064-5; Sekhon HS, 2005, CELL TISSUE RES, V320, P287, DOI 10.1007/s00441-005-1077-9; Sekhon HS, 2001, AM J RESP CRIT CARE, V164, P989, DOI 10.1164/ajrccm.164.6.2011097; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Sheller JR, 2009, EXP LUNG RES, V35, P883, DOI 10.3109/01902140903019710; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Urrego F, 2009, PEDIATR PULM, V44, P1075, DOI 10.1002/ppul.21099; Vernon MK, 2012, J ASTHMA, V49, P991, DOI 10.3109/02770903.2012.738268; Vestbo J, 2001, THORAX, V56, P11; Volbeda F, 2013, THORAX, V68, P19, DOI 10.1136/thoraxjnl-2012-201861; Wongtrakool C, 2007, AM J PHYSIOL-LUNG C, V293, pL611, DOI 10.1152/ajplung.00038.2007; Wongtrakool C, 2012, AM J RESP CELL MOL, V46, P695, DOI 10.1165/rcmb.2011-0028OC; Wu ZX, 2012, AM J PHYSIOL-LUNG C, V302, pL152, DOI 10.1152/ajplung.00071.2011; Xu Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-13	50	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109602	10.1371/journal.pone.0109602	http://dx.doi.org/10.1371/journal.pone.0109602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296021	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000086
J	Rocha, SC; Pessoa, MTC; Neves, LDR; Alves, SLG; Silva, LM; Santos, HL; Oliveira, SMF; Taranto, AG; Comar, M; Gomes, IV; Santos, FV; Paixao, N; Quintas, LEM; Noel, F; Pereira, AF; Tessis, ACSC; Gomes, NLS; Moreira, OC; Rincon-Heredia, R; Varotti, FP; Blanco, G; Villar, JAFP; Contreras, RG; Barbosa, LA				Rocha, Sayonarah C.; Pessoa, Marco T. C.; Neves, Luiza D. R.; Alves, Silmara L. G.; Silva, Luciana M.; Santos, Herica L.; Oliveira, Soraya M. F.; Taranto, Alex G.; Comar, Moacyr; Gomes, Isabella V.; Santos, Fabio V.; Paixao, Natasha; Quintas, Luis E. M.; Noel, Francois; Pereira, Antonio F.; Tessis, Ana C. S. C.; Gomes, Natalia L. S.; Moreira, Otacilio C.; Rincon-Heredia, Ruth; Varotti, Fernando P.; Blanco, Gustavo; Villar, Jose A. F. P.; Contreras, Ruben G.; Barbosa, Leandro A.			21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na, K-ATPase and Epithelial Tight Junctions	PLOS ONE			English	Article							OUABAIN INDUCES ENDOCYTOSIS; CARDIAC-GLYCOSIDES; BREAST-CANCER; IN-VITRO; NA+/K+-ATPASE; ADHESION MOLECULE; POLARIZED EXPRESSION; GROWTH-INHIBITION; CRYSTAL-STRUCTURE; CYCLE ARREST	Cardiotonic steroids are used to treat heart failure and arrhythmia and have promising anticancer effects. The prototypic cardiotonic steroid ouabain may also be a hormone that modulates epithelial cell adhesion. Cardiotonic steroids consist of a steroid nucleus and a lactone ring, and their biological effects depend on the binding to their receptor, Na, K-ATPase, through which, they inhibit Na+ and K+ ion transport and activate of several intracellular signaling pathways. In this study, we added a styrene group to the lactone ring of the cardiotonic steroid digoxin, to obtain 21-benzylidene digoxin (21-BD), and investigated the effects of this synthetic cardiotonic steroid in different cell models. Molecular modeling indicates that 21-BD binds to its target Na, K-ATPase with low affinity, adopting a different pharmacophoric conformation when bound to its receptor than digoxin. Accordingly, 21-DB, at relatively high mu M amounts inhibits the activity of Na, K-ATPase alpha(1), but not alpha(2) and alpha(3) isoforms. In addition, 21-BD targets other proteins outside the Na, K-ATPase, inhibiting the multidrug exporter Pdr5p. When used on whole cells at low mu M concentrations, 21-BD produces several effects, including: 1) up-regulation of Na, K-ATPase expression and activity in HeLa and RKO cancer cells, which is not found for digoxin, 2) cell specific changes in cell viability, reducing it in HeLa and RKO cancer cells, but increasing it in normal epithelial MDCK cells, which is different from the response to digoxin, and 3) changes in cell-cell interaction, altering the molecular composition of tight junctions and elevating transepithelial electrical resistance of MDCK monolayers, an effect previously found for ouabain. These results indicate that modification of the lactone ring of digoxin provides new properties to the compound, and shows that the structural change introduced could be used for the design of cardiotonic steroid with novel functions.	[Rocha, Sayonarah C.; Pessoa, Marco T. C.; Neves, Luiza D. R.; Santos, Herica L.; Barbosa, Leandro A.] Univ Fed Sao Joao del Rei, Lab Bioquim Celular, Divinopolis, MG, Brazil; [Alves, Silmara L. G.; Villar, Jose A. F. P.] Univ Fed Sao Joao del Rei, Lab Sintese Organ, Divinopolis, MG, Brazil; [Oliveira, Soraya M. F.; Taranto, Alex G.; Comar, Moacyr] Univ Fed Sao Joao del Rei, Lab Bioinformat, Divinopolis, MG, Brazil; [Gomes, Isabella V.; Santos, Fabio V.] Univ Fed Sao Joao del Rei, Lab Biol Celular & Mutagenicidade, Divinopolis, MG, Brazil; [Varotti, Fernando P.] Univ Fed Sao Joao del Rei, Lab Bioquim Parasitos, Divinopolis, MG, Brazil; [Silva, Luciana M.] Fundacao Ezequiel Dias, Lab Biol Celular & Inovacao Biotecnol, Belo Horizonte, MG, Brazil; [Paixao, Natasha; Quintas, Luis E. M.; Noel, Francois] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Bioquim & Mol, Rio De Janeiro, RJ, Brazil; [Pereira, Antonio F.; Tessis, Ana C. S. C.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Lab Bioquim Microbiana, Rio De Janeiro, RJ, Brazil; [Tessis, Ana C. S. C.] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro IFR, Rio De Janeiro, RJ, Brazil; [Gomes, Natalia L. S.; Moreira, Otacilio C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, Rio De Janeiro, RJ, Brazil; [Rincon-Heredia, Ruth; Contreras, Ruben G.] CINVESTAV, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Mexico City 14000, DF, Mexico; [Blanco, Gustavo] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Kansas; University of Kansas Medical Center	Contreras, RG (corresponding author), CINVESTAV, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Mexico City 14000, DF, Mexico.	rcontrer@fisio.cinvestav.mx; leaugust@yahoo.com.br	Silva, Luciana M/R-6340-2018; Silva, Luciana M/I-4353-2014; Taranto, Alex/GMW-4021-2022; Comar, Moacyr/H-7462-2017; Noël, François/C-3402-2009; Taranto, Alex G/F-8618-2012; Barbosa, Leandro/K-1008-2013; Villar, José Augusto Ferreira Perez/AAB-5849-2019; Santos, Fabio V/G-4912-2011; Moreira, Otacilio/AAS-5839-2020; Quintas, Luis Eduardo M/C-3308-2009; Ferreira-Pereira, Antonio/A-2910-2011; Contreras, Rubén G./F-2309-2018; Varotti, Fernando/J-4764-2015; Santos, Fabio Vieira dos/ABG-2051-2020; Villar, José Augusto F. P. Ferreira Perez/V-4142-2018	Silva, Luciana M/0000-0002-2038-0405; Silva, Luciana M/0000-0002-2038-0405; Taranto, Alex/0000-0002-6086-1043; Noël, François/0000-0001-6813-1347; Taranto, Alex G/0000-0002-6086-1043; Barbosa, Leandro/0000-0002-4631-0130; Villar, José Augusto Ferreira Perez/0000-0003-1580-0644; Santos, Fabio V/0000-0003-0389-1737; Moreira, Otacilio/0000-0002-5340-8697; Quintas, Luis Eduardo M/0000-0002-0767-1240; Ferreira-Pereira, Antonio/0000-0002-0474-8388; Contreras, Rubén G./0000-0001-7311-1615; Varotti, Fernando/0000-0002-2939-7780; Santos, Fabio Vieira dos/0000-0003-0389-1737; Villar, José Augusto F. P. Ferreira Perez/0000-0003-1580-0644; RINCON-HEREDIA, RUTH/0000-0002-5070-938X; Carvalho Rocha, Sayonarah/0000-0001-9453-0536	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [APQ-01114-12, APQ-02596-12]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [472394/2012-6]; NIH [DK081431]; University of Sao Paulo through the NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081431] Funding Source: NIH RePORTER	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Sao Paulo through the NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) APQ-01114-12, APQ-02596-12, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) 472394/2012-6 and NIH DK081431. The authors are grateful for the financial and structural support offered by the University of Sao Paulo through the NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Alonso E, 2013, STEROIDS, V78, P1110, DOI 10.1016/j.steroids.2013.07.010; [Anonymous], 2010, DISC STUD 3 1 HELP; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bettero GM, 2011, PLANTA MED, V77, P1702, DOI 10.1055/s-0030-1271084; Bielawski K, 2006, BIOL PHARM BULL, V29, P1493, DOI 10.1248/bpb.29.1493; BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367, DOI 10.1152/ajpcell.1993.264.6.C1367; Brambilla G, 2009, MUTAT RES-REV MUTAT, V681, P209, DOI 10.1016/j.mrrev.2008.09.002; BROWER LP, 1974, NATURE, V249, P280, DOI 10.1038/249280b0; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cereijido M, 2012, AM J PHYSIOL-CELL PH, V302, pC473, DOI 10.1152/ajpcell.00083.2011; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Chen JQ, 2006, BREAST CANCER RES TR, V96, P1, DOI 10.1007/s10549-005-9053-3; Chen ZC, 2013, HORM METAB RES, V45, P364, DOI 10.1055/s-0032-1330021; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Conseil G, 2003, BBA-BIOMEMBRANES, V1614, P131, DOI 10.1016/S0005-2736(03)00193-7; Contreras RG, 1999, J CELL SCI, V112, P4223; CONTRERAS RG, 1989, AM J PHYSIOL, V257, pC896, DOI 10.1152/ajpcell.1989.257.5.C896; Cunha GA, 2010, TOXICON, V56, P339, DOI 10.1016/j.toxicon.2010.03.021; da Silva FR, 2011, J NAT PROD, V74, P279, DOI 10.1021/np1006247; Didiot MC, 2013, J BIOMOL SCREEN, V18, P407, DOI 10.1177/1087057112466698; Ding Lei, 2013, Cancer Manag Res, V5, P367, DOI 10.2147/CMAR.S38294; DULLEY JR, 1975, ANAL BIOCHEM, V67, P91, DOI 10.1016/0003-2697(75)90275-4; Efferth T, 2002, BLOOD CELL MOL DIS, V28, P160, DOI 10.1006/bcmd.2002.0492; Elbaz HA, 2012, TOXICOL APPL PHARM, V258, P51, DOI 10.1016/j.taap.2011.10.007; EMERIT I, 1994, FREE RADICAL BIO MED, V16, P99, DOI 10.1016/0891-5849(94)90246-1; Escudero-Esparza A, 2011, FRONT BIOSCI-LANDMRK, V16, P1069, DOI 10.2741/3736; Fiske CH, 1925, J BIOL CHEM, V66, P375; Flores-Benitez D, 2009, AM J PHYSIOL-CELL PH, V297, pC611, DOI 10.1152/ajpcell.00622.2008; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Garcia O, 2004, MUTAT RES-FUND MOL M, V556, P25, DOI 10.1016/j.mrfmmm.2004.06.035; Garcia-Hernandez V, 2014, J CELL PHYSL; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Gupta S, 2012, HYPERTENSION, V59, P665, DOI 10.1161/HYPERTENSIONAHA.111.176727; Haux J, 1999, MED HYPOTHESES, V53, P543, DOI 10.1054/mehy.1999.0985; Hilario FF, 2011, CHEM BIOL DRUG DES, V78, P477, DOI 10.1111/j.1747-0285.2011.01154.x; Hinds JW, 2013, CHEMMEDCHEM, V8, P63, DOI 10.1002/cmdc.201200465; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ihenetu K, 2007, CLIN CHEM, V53, P1315, DOI 10.1373/clinchem.2006.082081; Ikari A, 2012, J CELL BIOCHEM, V113, P499, DOI 10.1002/jcb.23373; Jensen M, 2011, BIOORGAN MED CHEM, V19, P2407, DOI 10.1016/j.bmc.2011.02.016; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kwon MJ, 2013, INT J MOL SCI, V14, P18148, DOI 10.3390/ijms140918148; Langenhan JM, 2005, P NATL ACAD SCI USA, V102, P12305, DOI 10.1073/pnas.0503270102; Langenhan JM, 2011, CARBOHYD RES, V346, P2663, DOI 10.1016/j.carres.2011.09.019; Larre I, 2011, P NATL ACAD SCI USA, V108, P20591, DOI 10.1073/pnas.1102617108; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lelievre SA, 2010, J MAMMARY GLAND BIOL, V15, P49, DOI 10.1007/s10911-010-9168-y; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Liu B, 2013, FEBS J, V280, P3632, DOI 10.1111/febs.12355; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu LJ, 2005, J GEN PHYSIOL, V126, p72A; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Mijatovic T, 2007, DRUG DEVELOP RES, V68, P164, DOI 10.1002/ddr.20178; Mijatovic T, 2006, NEOPLASIA, V8, P402, DOI 10.1593/neo.05850; Mijatovic T, 2013, PLANTA MED, V79, P189, DOI 10.1055/s-0032-1328243; Mijatovic T, 2009, CANCER LETT, V282, P30, DOI 10.1016/j.canlet.2009.02.048; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nasu K, 2005, MOL HUM REPROD, V11, P817, DOI 10.1093/molehr/gah249; Nocedal JWS, 1999, NUMERICAL OPTMIZATIO; Noel F, 2011, N-S ARCH PHARMACOL, V383, P101, DOI 10.1007/s00210-010-0578-6; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; Padilla-Benavides T, 2010, MOL BIOL CELL, V21, P2217, DOI 10.1091/mbc.E10-01-0081; Perez-Victoria FJ, 2003, CELL MOL LIFE SCI, V60, P526, DOI 10.1007/s000180300044; Piacente S, 2009, J NAT PROD, V72, P1087, DOI 10.1021/np800810f; Platonova A, 2011, J MEMBRANE BIOL, V241, P145, DOI 10.1007/s00232-011-9371-9; Pocas ESC, 2003, BIOCHEM PHARMACOL, V66, P2169, DOI 10.1016/j.bcp.2003.08.005; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Ramirez-Ortega M, 2006, EUR J PHARMACOL, V534, P71, DOI 10.1016/j.ejphar.2006.01.035; Rangel LP, 2010, FEMS YEAST RES, V10, P244, DOI [10.1111/j.1567-1364.2009.00603.x, 10.1111/j.1567-1364.2010.00603.x]; Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x; Rincon-Heredia R, 2014, EXP CELL RES, V320, P108, DOI 10.1016/j.yexcr.2013.10.008; Rosen H, 2004, MOL BIOL CELL, V15, P1044, DOI 10.1091/mbc.E03-06-0391; Runkle EA, 2013, CANCER LETT, V337, P41, DOI 10.1016/j.canlet.2013.05.038; Sanchez G, 2006, J ANDROL, P42; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; SHIRATORI O, 1967, GANN, V58, P521; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; Shoshani L, 2005, J GEN PHYSIOL, V126, p40A; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snyder RD, 2001, MUTAT RES-REV MUTAT, V488, P151, DOI 10.1016/S1383-5742(01)00055-2; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; STENKVIST B, 1980, ANAL QUANT CYTOL, V2, P49; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sun L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep082; Takai N, 2008, INT J MOL MED, V21, P637; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; TICE RR, 1991, ADV EXP MED BIOL, V283, P157; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Van Quaquebeke E, 2005, J MED CHEM, V48, P849, DOI 10.1021/jm049405a; Wang HYL, 2011, ACS MED CHEM LETT, V2, P264, DOI 10.1021/ml100290d; Wang HYL, 2011, ACS MED CHEM LETT, V2, P259, DOI 10.1021/ml100291n; Ward SC, 2002, HYPERTENSION, V39, P536, DOI 10.1161/hy0202.103048; WATSKY MA, 1992, CELL TISSUE RES, V269, P57, DOI 10.1007/BF00384726; Winnicka K, 2008, BIOL PHARM BULL, V31, P1131, DOI 10.1248/bpb.31.1131; Winnicka K, 2007, ARCH PHARM RES, V30, P1216, DOI 10.1007/BF02980262; Winnicka K, 2010, NAT PROD RES, V24, P274, DOI 10.1080/14786410902991878; Xu HW, 2007, ORG BIOMOL CHEM, V5, P1247, DOI 10.1039/b701051f; Yang PY, 2009, MOL CANCER THER, V8, P2319, DOI 10.1158/1535-7163.MCT-08-1085; Ye M, 2004, J STEROID BIOCHEM, V91, P87, DOI 10.1016/j.jsbmb.2004.01.010; Yu CH, 2008, CANCER SCI, V99, P2467, DOI 10.1111/j.1349-7006.2008.00966.x; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201; Zhao M, 2007, J NAT PROD, V70, P1098, DOI 10.1021/np068066g	120	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108776	10.1371/journal.pone.0108776	http://dx.doi.org/10.1371/journal.pone.0108776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290152	gold, Green Published			2022-12-25	WOS:000342798000025
J	Wang, FL; Gao, S; Chen, F; Fu, ZY; Yin, H; Lu, X; Yu, J; Lu, C				Wang, Fengliang; Gao, Sheng; Chen, Fei; Fu, Ziyi; Yin, Hong; Lu, Xun; Yu, Jing; Lu, Cheng			Mammary Fat of Breast Cancer: Gene Expression Profiling and Functional Characterization	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GLAND DEVELOPMENT; DIFFERENTIATION; PROGRESSION; GROWTH; TISSUE; ROLES; MICROENVIRONMENT; CARCINOGENESIS; THERMOGENESIS	Mammary fat is the main composition of breast, and is the most probable candidate to affect tumor behavior because the fat produces hormones, growth factors and adipokines, a heterogeneous group of signaling molecules. Gene expression profiling and functional characterization of mammary fat in Chinese women has not been reported. Thus, we collected the mammary fat tissues adjacent to breast tumors from 60 subjects, among which 30 subjects had breast cancer and 30 had benign lesions. We isolated and cultured the stromal vascular cell fraction from mammary fat. The expression of genes related to adipose function (including adipogenesis and secretion) was detected at both the tissue and the cellular level. We also studied mammary fat browning. The results indicated that fat tissue close to malignant and benign lesions exhibited distinctive gene expression profiles and functional characteristics. Although the mammary fat of breast tumors atrophied, it secreted tumor growth stimulatory factors. Browning of mammary fat was observed and browning activity of fat close to malignant breast tumors was greater than that close to benign lesions. Understanding the diversity between these two fat depots may possibly help us improve our understanding of breast cancer pathogenesis and find the key to unlock new anticancer therapies.	[Wang, Fengliang; Gao, Sheng; Chen, Fei; Fu, Ziyi; Yin, Hong; Lu, Cheng] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Lu, Xun] Jinling High Sch, Nanjing, Jiangsu, Peoples R China; [Yu, Jing] Nanjing Med Univ, Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yu, J (corresponding author), Nanjing Med Univ, Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China.	tianqu1981@126.com; lucheng66@126.com	Yu, Jing/AAL-5498-2021	Yu, Jing/0000-0002-5062-7069	national natural science foundation of China [81172501]; science and technology development foundation of Nanjing Medical University [2012NJMU186]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); science and technology development foundation of Nanjing Medical University	Funding support from the national natural science foundation of China (81172501) and science and technology development foundation of Nanjing Medical University (2012NJMU186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann MW, 1997, J MOL MED, V75, P429, DOI 10.1007/s001090050128; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Bujalska IJ, 1999, ENDOCRINOLOGY, V140, P3188, DOI 10.1210/en.140.7.3188; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon Barbara, 2008, V456, P109, DOI 10.1007/978-1-59745-245-8_8; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Gonzalez-Perez Ruben Rene, 2013, Cancers (Basel), V5, P1140, DOI 10.3390/cancers5031140; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lago CU, 2012, ONCOGENE, V31, P4725, DOI 10.1038/onc.2011.630; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; Miyoshi Y, 2006, INT J CANCER, V118, P1414, DOI 10.1002/ijc.21543; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Robbins D, 2011, INT J MOL SCI, V12, P5285, DOI 10.3390/ijms12085285; Russo IH, 1998, J MAMMARY GLAND BIOL, V3, P49, DOI 10.1023/A:1018770218022; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P172, DOI 10.4161/cc.23058; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431	29	33	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109742	10.1371/journal.pone.0109742	http://dx.doi.org/10.1371/journal.pone.0109742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291184	Green Submitted, gold, Green Published			2022-12-25	WOS:000342798000085
J	Woolery, AR; Yu, XB; LaBaer, J; Orth, K				Woolery, Andrew R.; Yu, Xiaobo; LaBaer, Joshua; Orth, Kim			AMPylation of Rho GTPases Subverts Multiple Host Signaling Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO EFFECTOR PROTEIN; NADPH OXIDASE; RAC; ACTIVATION; COMPLEMENT; KINASES; BINDING; FAMILY; ARRAYS; DOMAIN	Rho GTPases are frequent targets of virulence factors as they are keystone signaling molecules. Herein, we demonstrate that AMPylation of Rho GTPases by VopS is a multifaceted virulence mechanism that counters several host immunity strategies. Activation of NF kappa B, Erk, and JNK kinase signaling pathways were inhibited in a VopS-dependent manner during infection with Vibrio parahaemolyticus. Phosphorylation and degradation of IKB alpha were inhibited in the presence of VopS as was nuclear translocation of the NF kappa B subunit p65. AMPylation also prevented the generation of superoxide by the phagocytic NADPH oxidase complex, potentially by inhibiting the interaction of Rac and p67. Furthermore, the interaction of GTPases with the E3 ubiquitin ligases cIAP1 and XIAP was hindered, leading to decreased degradation of Rac and RhoA during infection. Finally, we screened for novel Rac1 interactions using a nucleic acid programmable protein array and discovered that Rac1 binds to the protein C1QA, a protein known to promote immune signaling in the cytosol. Interestingly, this interaction was disrupted by AMPylation. We conclude that AMPylation of Rho Family GTPases by VopS results in diverse inhibitory consequences during infection beyond the most obvious phenotype, the collapse of the actin cytoskeleton.	[Woolery, Andrew R.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yu, Xiaobo; LaBaer, Joshua] Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Arizona State University; Arizona State University-Tempe	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Yu, Xiaobo/F-5997-2015; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; yu, xiaobo/0000-0003-2352-9866	National Institutes of Health [R01-AI087808]; Early Detection Research Network Grant [5U01CA117374]; Welch Foundation [I-1561]; Cell and Molecular Biology Training Grant [5T32GM008203]; NATIONAL CANCER INSTITUTE [U01CA117374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network Grant; Welch Foundation(The Welch Foundation); Cell and Molecular Biology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI087808 (to K. O.) and Early Detection Research Network Grant 5U01CA117374 (to J. L.). This work was also supported by the Welch Foundation (Grant I-1561 to K. O.).; Supported by Cell and Molecular Biology Training Grant 5T32GM008203.	Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Broberg CA, 2010, SCIENCE, V329, P1660, DOI 10.1126/science.1192850; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Estornes Y, 2015, SEMIN CELL DEV BIOL, V39, P106, DOI 10.1016/j.semcdb.2014.03.035; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Higa N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003142; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Miersch S, 2013, J PROTEOMICS, V94, P486, DOI 10.1016/j.jprot.2013.10.018; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Reddick LE, 2014, MOL CELL, V54, P321, DOI 10.1016/j.molcel.2014.03.010; Roos D, 2014, CLIN EXP IMMUNOL, V175, P139, DOI 10.1111/cei.12202; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Salomon D, 2013, CURR OPIN MICROBIOL, V16, P213, DOI 10.1016/j.mib.2013.01.013; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Sreelatha A, 2013, P NATL ACAD SCI USA, V110, P11559, DOI 10.1073/pnas.1307032110; Wang YT, 2012, IMMUNOLOGY, V136, P78, DOI 10.1111/j.1365-2567.2012.03561.x; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yu XB, 2014, MOL CELL PROTEOMICS, V13, P3164, DOI 10.1074/mcp.M114.041103; Yu XB, 2014, THERANOSTICS, V4, P808, DOI 10.7150/thno.8255; Zhang LL, 2013, CURR OPIN MICROBIOL, V16, P70, DOI 10.1016/j.mib.2013.02.002; Zhang LL, 2012, CELL REP, V1, P453, DOI 10.1016/j.celrep.2012.04.004	40	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.601310	http://dx.doi.org/10.1074/jbc.M114.601310			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301945	Green Published, hybrid			2022-12-25	WOS:000345335000048
J	Ding, Y; Dellisanti, CD; Ko, MH; Czajkowski, C; Puglielli, L				Ding, Yun; Dellisanti, Cosma D.; Ko, Mi Hee; Czajkowski, Cynthia; Puglielli, Luigi			The Endoplasmic Reticulum-based Acetyltransferases, ATase1 and ATase2, Associate with the Oligosaccharyltransferase to Acetylate Correctly Folded Polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A (acetyl-CoA); Acetyltransferase; Endoplasmic Reticulum (ER); Oligosaccharyltransferase; Post-translational Modification (PTM)	BETA-SECRETASE BACE1; LYSINE ACETYLATION; THERAPEUTIC TARGET; COA TRANSPORTER; QUALITY-CONTROL; PROTEIN; MEMBRANE; GOLGI; PATHWAY; LUMEN	Background: The acetyltransferases ATase1 and ATase2 acetylate ER-transiting and -resident proteins. Results: ATase1 and ATase2 form homo- and heterodimers, associate with the oligosaccharyltransferase (OST) complex, and modify correctly folded polypetides. Conclusion: The ATases are novel members of the broad ER translocation machinery. Significance: The ATases act in concert with (and perhaps sequentially to) the OST to mark correctly folded glycoproteins. The endoplasmic reticulum (ER) has two membrane-bound acetyltransferases responsible for the endoluminal N-E-lysine acetylation of ER-transiting and -resident proteins. Mutations that impair the ER-based acetylation machinery are associated with developmental defects and a familial form of spastic paraplegia. Deficient ER acetylation in the mouse leads to defects of the immune and nervous system. Here, we report that both ATase1 and ATase2 form homo- and heterodimers and associate with members of the oligosaccharyltransferase (OST) complex. In contrast to the OST, the ATases only modify correctly folded polypetides. Collectively, our studies suggest that one of the functions of the ATases is to work in concert with the OST and select correctly folded from unfolded/misfolded transiting polypeptides.	[Ding, Yun; Ko, Mi Hee; Puglielli, Luigi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Dellisanti, Cosma D.; Czajkowski, Cynthia] Univ Wisconsin, Dept Neurosci, Madison, WI 53705 USA; [Ding, Yun; Czajkowski, Cynthia; Puglielli, Luigi] Univ Wisconsin, Neurosci Training Program, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health [AG033514, NS34727]; Veterans Affairs Merit Award [BX001638]; Thome Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727, R56NS034727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG033514] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); Thome Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AG033514 (to L. P.) and NS34727 (to C. C.). This work was also supported by Veterans Affairs Merit Award BX001638 (to L. P.) and funds from the Thome Memorial Foundation (to L. P.).	Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; Ding Y, 2012, J BIOL CHEM, V287, P8424, DOI 10.1074/jbc.M111.310136; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Huppke P, 2012, AM J HUM GENET, V90, P61, DOI 10.1016/j.ajhg.2011.11.030; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KUMAR V, 1994, J BIOL CHEM, V269, P13451; Lalioti VS, 2013, J CELL PHYSIOL, V228, P1907, DOI 10.1002/jcp.24355; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Mak AB, 2014, J MOL BIOL, V426, P2175, DOI 10.1016/j.jmb.2014.02.012; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Pehar M, 2013, BBA-MOL CELL RES, V1833, P686, DOI 10.1016/j.bbamcr.2012.12.004; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Pehar M, 2012, J BIOL CHEM, V287, P22436, DOI 10.1074/jbc.C112.362871; Peng YJ, 2014, J NEUROSCI, V34, P6772, DOI 10.1523/JNEUROSCI.0077-14.2014; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Puglielli L, 1999, J BIOL CHEM, V274, P12665, DOI 10.1074/jbc.274.18.12665; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wang HB, 2013, TRENDS PHARMACOL SCI, V34, P215, DOI 10.1016/j.tips.2013.01.008; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yang XJ, 2007, EMBO REP, V8, P556, DOI 10.1038/sj.embor.7400977; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	36	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32044	32055		10.1074/jbc.M114.585547	http://dx.doi.org/10.1074/jbc.M114.585547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25301944	Green Published, hybrid			2022-12-25	WOS:000345314700033
J	Chowdhury, FA; Woldman, W; FitzGerald, THB; Elwes, RDC; Nashef, L; Terry, JR; Richardson, MP				Chowdhury, Fahmida A.; Woldman, Wessel; FitzGerald, Thomas H. B.; Elwes, Robert D. C.; Nashef, Lina; Terry, John R.; Richardson, Mark P.			Revealing a Brain Network Endophenotype in Families with Idiopathic Generalised Epilepsy	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; ELECTROENCEPHALOGRAPHIC RECORDINGS; FUNCTIONAL CONNECTIVITY; 15Q13.3 MICRODELETIONS; ABSENCE SEIZURES; EEG; CHILDHOOD; DYNAMICS; GENETICS	Idiopathic generalised epilepsy (IGE) has a genetic basis. The mechanism of seizure expression is not fully known, but is assumed to involve large-scale brain networks. We hypothesised that abnormal brain network properties would be detected using EEG in patients with IGE, and would be manifest as a familial endophenotype in their unaffected first-degree relatives. We studied 117 participants: 35 patients with IGE, 42 unaffected first-degree relatives, and 40 normal controls, using scalp EEG. Graph theory was used to describe brain network topology in five frequency bands for each subject. Frequency bands were chosen based on a published Spectral Factor Analysis study which demonstrated these bands to be optimally robust and independent. Groups were compared, using Bonferroni correction to account for nonindependent measures and multiple groups. Degree distribution variance was greater in patients and relatives than controls in the 6-9 Hz band (p = 0.0005, p = 0.0009 respectively). Mean degree was greater in patients than healthy controls in the 6-9 Hz band (p = 0.0064). Clustering coefficient was higher in patients and relatives than controls in the 6-9 Hz band (p = 0.0025, p = 0.0013). Characteristic path length did not differ between groups. No differences were found between patients and unaffected relatives. These findings suggest brain network topology differs between patients with IGE and normal controls, and that some of these network measures show similar deviations in patients and in unaffected relatives who do not have epilepsy. This suggests brain network topology may be an inherited endophenotype of IGE, present in unaffected relatives who do not have epilepsy, as well as in affected patients. We propose that abnormal brain network topology may be an endophenotype of IGE, though not in itself sufficient to cause epilepsy.	[Chowdhury, Fahmida A.; FitzGerald, Thomas H. B.; Richardson, Mark P.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Chowdhury, Fahmida A.; Elwes, Robert D. C.; Nashef, Lina; Richardson, Mark P.] Kings Coll London, Ctr Epilepsy, London, England; [Woldman, Wessel; Terry, John R.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [FitzGerald, Thomas H. B.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of London; King's College London; University of London; King's College London; University of Exeter; University of London; University College London	Richardson, MP (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.	mark.richardson@kcl.ac.uk	Terry, John/ABA-2609-2020; Richardson, Mark P/E-5385-2010; Terry, John/P-6585-2014	Terry, John/0000-0002-6829-5736; Richardson, Mark P/0000-0001-8925-3140; FitzGerald, Thomas/0000-0002-3855-1591	Clinical Research Training Fellowship from the Medical Research Council UK [G0701310]; National Institute for Health Research Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust; Medical Research Council UK Programme Grant [MR/K013998/1]; MRC [G0701310, MR/K013998/1] Funding Source: UKRI; Medical Research Council [G0701310, MR/K013998/1] Funding Source: researchfish	Clinical Research Training Fellowship from the Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust; Medical Research Council UK Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FAC was funded by a Clinical Research Training Fellowship from the Medical Research Council UK (G0701310, www.mrc.ac.uk). MPR was supported in part by the National Institute for Health Research Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust (http://www.nihr.ac.uk/infrastructure/Pages/infrastructure_biomedical_ research_centres.aspx). MPR and JRT are supported by a Medical Research Council UK Programme Grant (MR/K013998/1, www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; Andermann F, 2001, EPILEPSIA, V42, P317, DOI 10.1046/j.1528-1157.2001.36400.x; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chahboune H, 2009, NEUROIMAGE, V47, P459, DOI 10.1016/j.neuroimage.2009.04.060; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Chowdhury FA, EPILEPSIA IN PRESS; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; DEGEN R, 1990, EPILEPSIA, V31, P784, DOI 10.1111/j.1528-1157.1990.tb05520.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dibbens LM, 2009, HUM MOL GENET, V18, P3626, DOI 10.1093/hmg/ddp311; DOOSE H, 1987, NEUROPEDIATRICS, V18, P1, DOI 10.1055/s-2008-1052489; GERKEN H, 1973, NEUROPADIATRIE, V4, P88, DOI 10.1055/s-0028-1091730; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GREGORY RP, 1993, ELECTROEN CLIN NEURO, V86, P75, DOI 10.1016/0013-4694(93)90069-8; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Jayalakshmi SS, 2006, SEIZURE-EUR J EPILEP, V15, P177, DOI 10.1016/j.seizure.2005.12.011; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Motelow Joshua E., 2009, V489, P189, DOI 10.1007/978-1-59745-543-5_9; O'Muircheartaigh J, 2011, NEUROLOGY, V76, P34, DOI 10.1212/WNL.0b013e318203e93d; Pal DK, 2008, EPILEPSIA, V49, P386, DOI 10.1111/j.1528-1167.2007.01416.x; Peraza LR, 2012, J NEUROSCI METH, V207, P189, DOI 10.1016/j.jneumeth.2012.04.007; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Quraan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068609; Richardson M, 2010, CLIN NEUROPHYSIOL, V121, P1153, DOI 10.1016/j.clinph.2010.01.004; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shackman AJ, 2010, NEUROIMAGE, V51, P1319, DOI 10.1016/j.neuroimage.2010.03.037; Smit DJA, 2010, BEHAV GENET, V40, P167, DOI 10.1007/s10519-009-9330-8; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; TUUNAINEN A, 1995, EPILEPSIA, V36, P817, DOI 10.1111/j.1528-1157.1995.tb01620.x; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	43	61	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110136	10.1371/journal.pone.0110136	http://dx.doi.org/10.1371/journal.pone.0110136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302690	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000343730400113
J	Lina, TT; Khajanchi, BK; Azmi, IJ; Islam, MA; Mahmood, B; Akter, M; Banik, A; Alim, R; Navarro, A; Perez, G; Cravioto, A; Talukder, KA				Lina, Taslima T.; Khajanchi, Bijay K.; Azmi, Ishrat J.; Islam, Mohammad Aminul; Mahmood, Belal; Akter, Mahmuda; Banik, Atanu; Alim, Rumana; Navarro, Armando; Perez, Gabriel; Cravioto, Alejandro; Talukder, Kaisar A.			Phenotypic and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; GRAM-NEGATIVE BACTERIA; KLEBSIELLA-PNEUMONIAE; FLUOROQUINOLONE RESISTANCE; TRANSFERABLE RESISTANCE; MULTIDRUG-RESISTANT; FECAL CARRIAGE; PREVALENCE; STRAINS; ENTEROBACTERIACEAE	Background: Resistance to cephalosporins in Enterobacteriaceae is mainly due to the production of extended-spectrum beta-lactamase (ESBL). Little is known about ESBL-producing bacteria in Bangladesh. Therefore, the study presents results of phenotypic and molecular characterization of ESBL-producing Escherichia coli from hospitals in Bangladesh. Methods: A total of 339 E. coli isolated from patients with urinary tract and wound infections attending three different medical hospitals in urban and rural areas of Bangladesh between 2003-2007 were screened for ESBL-production by the double disk diffusion test. Isolates with ESBL-phenotype were further characterized by antibiotic susceptibility testing, PCR and sequencing of different beta-lactamase and virulence genes, serotyping, and XbaI-macrorestriction followed by pulsed-field gel electrophoresis (PFGE). Results: We identified 40 E. coli with ESBL phenotype. These isolates were resistant to ceftriaxone, ceftazidime, cefotaxime, aztreonam, cefepime, and nalidixic acid but remained susceptible to imipenem. All but one isolate were additionally resistant to ciprofloxacin, and 3 isolates were resistant to cefoxitin. ESBL genes of blaCTX-M-1-group were detected in all isolates; blaTEM-type and blaOXA-1-type genes were detected in 33 (82.5%) and 19 (47.5%) isolates, respectively. Virulence genes that are present in diarrhoeagenic E. coli were not found. Class-1 integron was present in 20 (50%) isolates. All the ESBL-producing E. coli isolates harbored plasmids ranging between 1.1 and 120 MDa. PFGE-typing revealed 26 different pulsotypes, but identical pulsotype showed 6 isolates of serotype O25:H4. Conclusion: The prevalence of multidrug-resistant ESBL-producing E. coli isolates appears to be high and the majority of the isolates were positive for bla(CTX-M). Although there was genetic heterogeneity among isolates, presence of a cluster of isolates belonging to serotype O25: H4 indicates dissemination of the pandemic uropathogenic E. coli clone in Bangladesh.	[Lina, Taslima T.; Khajanchi, Bijay K.; Azmi, Ishrat J.; Islam, Mohammad Aminul; Mahmood, Belal; Akter, Mahmuda; Banik, Atanu; Alim, Rumana; Cravioto, Alejandro; Talukder, Kaisar A.] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh; [Navarro, Armando; Perez, Gabriel] Univ Nacl Autonoma Mexico, Fac Med, Dept Publ Hlth, Mexico City 04510, DF, Mexico	International Centre for Diarrhoeal Disease Research (ICDDR); Universidad Nacional Autonoma de Mexico	Talukder, KA (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, GPO Box 128, Dhaka 1000, Bangladesh.	kaisar@icddrb.org	Navarro, Armando/AAE-3832-2022; NAVARRO, ARMANDO/AAO-7368-2020	NAVARRO, ARMANDO/0000-0002-6693-7168	icddr,b; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by icddr,b and its donors which provide unrestricted support to icddr,b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). We gratefully acknowledge these donors for their support and commitment to icddr, b's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Boyd DA, 2006, J ANTIMICROB CHEMOTH, V58, P224, DOI 10.1093/jac/dkl154; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610; Canton R, 2003, CURR OPIN INFECT DIS, V16, P315, DOI 10.1097/00001432-200308000-00003; Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07; Chakraborty S, 2001, J CLIN MICROBIOL, V39, P3241, DOI 10.1128/JCM.39.9.3241-3246.2001; Clinical and Laboratory Standard Institute (CLSI), 2010, M100S20U CLSI; Coudron PE, 1997, J CLIN MICROBIOL, V35, P2593, DOI 10.1128/JCM.35.10.2593-2597.1997; Dashti AA, 2006, J MED MICROBIOL, V55, P417, DOI 10.1099/jmm.0.46177-0; Doublet B, 2009, ANTIMICROB AGENTS CH, V53, P1944, DOI 10.1128/AAC.01581-08; Dromigny JA, 2005, J ANTIMICROB CHEMOTH, V56, P236, DOI 10.1093/jac/dki158; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Forbes B. A., 2001, BAILEY SCOTTS DIAGNO; Guerra B, 2001, ANTIMICROB AGENTS CH, V45, P1305, DOI 10.1128/AAC.45.4.1305-1308.2001; Hasan B, 2014, VET MICROBIOL, V168, P221, DOI 10.1016/j.vetmic.2013.09.033; Hernandez JR, 2005, ANTIMICROB AGENTS CH, V49, P2122, DOI 10.1128/AAC.49.5.2122-2125.2005; Heuvelink AE DBE, 1994, WARE CHEM, V24, P25; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Islam MA, 2012, EUR J CLIN MICROBIOL, V31, P2593, DOI 10.1007/s10096-012-1601-2; JACOBY GA, 1991, ANTIMICROB AGENTS CH, V35, P164, DOI 10.1128/AAC.35.1.164; JARLIER V, 1988, REV INFECT DIS, V10, P867; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P291, DOI 10.1093/jac/dkm448; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Machado E, 2005, ANTIMICROB AGENTS CH, V49, P1823, DOI 10.1128/AAC.49.5.1823-1829.2005; Mehrgan H, 2008, INT J ANTIMICROB AG, V31, P147, DOI 10.1016/j.ijantimicag.2007.09.008; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; Mugnaioli C, 2006, ANTIMICROB AGENTS CH, V50, P2700, DOI 10.1128/AAC.00068-06; Muzaheed, 2008, J ANTIMICROB CHEMOTH, V61, P1393, DOI 10.1093/jac/dkn109; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; Prelog M, 2008, INFECTION, V36, P362, DOI 10.1007/s15010-008-7309-7; Radice M, 2002, ANTIMICROB AGENTS CH, V46, P602, DOI 10.1128/AAC.46.2.602-604.2002; Rahman MM, 2004, INT J ANTIMICROB AG, V24, P508, DOI 10.1016/j.ijantimicag.2004.05.007; Ryoo NH, 2005, J ANTIMICROB CHEMOTH, V56, P698, DOI 10.1093/jac/dki324; Salyers WD, 2005, BACTERIAL PATHOGENES; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Talukdar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061090; Talukder KA, 2006, CURR MICROBIOL, V52, P108, DOI 10.1007/s00284-005-0140-9; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valverde A, 2004, J CLIN MICROBIOL, V42, P4769, DOI 10.1128/JCM.42.10.4769-4775.2004; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Villa L, 2000, ANTIMICROB AGENTS CH, V44, P2911, DOI 10.1128/AAC.44.10.2911-2914.2000	50	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108735	10.1371/journal.pone.0108735	http://dx.doi.org/10.1371/journal.pone.0108735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302491	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400023
J	Reinwarth, M; Avrutina, O; Fabritz, S; Kolmar, H				Reinwarth, Michael; Avrutina, Olga; Fabritz, Sebastian; Kolmar, Harald			Fragmentation Follows Structure: Top-Down Mass Spectrometry Elucidates the Topology of Engineered Cystine-Knot Miniproteins	PLOS ONE			English	Article							COLLISION-INDUCED DISSOCIATION; ELECTRON-CAPTURE DISSOCIATION; PROTONATED PEPTIDES; TRYPSIN-INHIBITOR; QUADRUPOLE-TIME; DRUG DESIGN; DISULFIDE; PROTEINS; SCAFFOLD; IDENTIFICATION	Over the last decades the field of pharmaceutically relevant peptides has enormously expanded. Among them, several peptide families exist that contain three or more disulfide bonds. In this context, elucidation of the disulfide patterns is extremely important as these motifs are often prerequisites for folding, stability, and activity. An example of this structure-determining pattern is a cystine knot which comprises three constrained disulfide bonds and represents a core element in a vast number of mechanically interlocked peptidic structures possessing different biological activities. Herein, we present our studies on disulfide pattern determination and structure elucidation of cystine-knot miniproteins derived from Momordica cochinchinensis peptide MCoTI-II, which act as potent inhibitors of human matriptase-1. A top-down mass spectrometric analysis of the oxidised and bioactive peptides is described. Following the detailed sequencing of the peptide backbone, interpretation of the MS3 spectra allowed for the verification of the knotted topology of the examined miniproteins. Moreover, we found that the fragmentation pattern depends on the knottin's folding state, hence, tertiary structure, which to our knowledge has not been described for a top-down MS approach before.	[Reinwarth, Michael; Avrutina, Olga; Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany; [Fabritz, Sebastian] AB Sciex Germany GmbH, Darmstadt, Germany	Technical University of Darmstadt	Fabritz, S (corresponding author), AB Sciex Germany GmbH, Darmstadt, Germany.	Sebastian.Fabritz@absciex.com; Kolmar@Biochemie-TUD.de	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993				Aina OH, 2007, MOL PHARMACEUT, V4, P631, DOI 10.1021/mp700073y; ATHERTON E, 1975, J AM CHEM SOC, V97, P6584, DOI 10.1021/ja00855a053; Berkowitz SA, 2012, NAT REV DRUG DISCOV, V11, P527, DOI 10.1038/nrd3746; Boyd R, 2010, J AM SOC MASS SPECTR, V21, P1275, DOI 10.1016/j.jasms.2010.04.017; Castagnola M, 2012, J MATERN-FETAL NEO M, V25, P27, DOI 10.3109/14767058.2012.714647; Chait BT, 2006, SCIENCE, V314, P65, DOI 10.1126/science.1133987; Chen JZ, 2012, J AM SOC MASS SPECTR, V23, P225, DOI 10.1007/s13361-011-0294-6; Chen JZ, 2010, ANAL CHEM, V82, P6079, DOI 10.1021/ac1006766; Cheng CF, 2000, MASS SPECTROM REV, V19, P398; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; Chrisman PA, 2005, J AM SOC MASS SPECTR, V16, P1020, DOI 10.1016/j.jasms.2005.02.010; Chrisman PA, 2002, J PROTEOME RES, V1, P549, DOI 10.1021/pr025561z; Combes A, 2009, EUR J MASS SPECTROM, V15, P517, DOI 10.1255/ejms.1000; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; Giang KTN, 2011, J BIOL CHEM, V286, P44833, DOI 10.1074/jbc.M111.290296; Ginter JM, 2004, J AM SOC MASS SPECTR, V15, P1478, DOI 10.1016/j.jasms.2004.07.004; Glotzbach B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076956; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Goyder MS, 2013, EXPERT REV PROTEOMIC, V10, P489, DOI 10.1586/14789450.2013.837663; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Gupta K, 2010, ANAL CHEM, V82, P8313, DOI 10.1021/ac101867e; Guthals A, 2012, MOL CELL PROTEOMICS, V11, P550, DOI 10.1074/mcp.R112.018556; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hofmeyer T, 2013, MOL BIOTECHNOL; Kellie JF, 2010, MOL BIOSYST, V6, P1532, DOI 10.1039/c000896f; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Klotz U, 2006, INT J CLIN PHARM TH, V44, P478; Korner R, 1996, J AM SOC MASS SPECTR, V7, P150, DOI 10.1016/1044-0305(95)00626-5; Lam KS, 2003, ACCOUNTS CHEM RES, V36, P370, DOI 10.1021/ar0201299; Lanucara F, 2013, MASS SPECTROM REV, V32, P27, DOI 10.1002/mas.21348; Lioe H, 2007, J AM SOC MASS SPECTR, V18, P1109, DOI 10.1016/j.jasms.2007.03.003; Macht M, 2009, BIOANALYSIS, V1, P1131, DOI [10.4155/bio.09.93, 10.4155/BIO.09.93]; Paizs B, 2005, MASS SPECTROM REV, V24, P508, DOI 10.1002/mas.20024; Pan JX, 2013, PROTEOMICS, V13, P974, DOI 10.1002/pmic.201200246; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; Peng Y, 2013, J MUSCLE RES CELL MO; Raska CS, 2002, J AM SOC MASS SPECTR, V13, P1034, DOI 10.1016/S1044-0305(02)00433-6; Reinwarth M, 2013, CHEMBIOCHEM, V14, P137, DOI 10.1002/cbic.201200604; Reinwarth M, 2012, MOLECULES, V17, P12533, DOI 10.3390/molecules171112533; Seidler J, 2010, PROTEOMICS, V10, P634, DOI 10.1002/pmic.200900459; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Switzar L, 2013, J PROTEOME RES, V12, P1067, DOI 10.1021/pr301201x; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wells JM, 2000, INT J MASS SPECTROM, V203, pA1, DOI 10.1016/S1387-3806(00)00389-4; Werle M, 2007, INT J PHARMACEUT, V332, P72, DOI 10.1016/j.ijpharm.2006.09.028; Werle M, 2006, J DRUG TARGET, V14, P137, DOI 10.1080/10611860600648254; Wu SL, 2009, ANAL CHEM, V81, P112, DOI 10.1021/ac801560k; Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R; Zhang H, 2011, CIRC-CARDIOVASC GENE, V4, P711, DOI 10.1161/CIRCGENETICS.110.957829; Zubarev RA, 1999, J AM CHEM SOC, V121, P2857, DOI 10.1021/ja981948k	59	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108626	10.1371/journal.pone.0108626	http://dx.doi.org/10.1371/journal.pone.0108626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303319	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400020
J	Stone, KD; Gonzalez, CLR				Stone, Kayla D.; Gonzalez, Claudia L. R.			Grasping without Sight: Insights from the Congenitally Blind	PLOS ONE			English	Article							PREHENSION MOVEMENTS; TACTILE PERCEPTION; HAND PREFERENCE; HEMISPHERIC-SPECIALIZATION; CEREBRAL COMMISSUROTOMY; HAPTIC DISCRIMINATION; VISUAL FEEDBACK; REACHING TASK; CHILDREN; RECOGNITION	We reach for and grasp different sized objects numerous times per day. Most of these movements are visually-guided, but some are guided by the sense of touch (i.e. haptically-guided), such as reaching for your keys in a bag, or for an object in a dark room. A marked right-hand preference has been reported during visually-guided grasping, particularly for small objects. However, little is known about hand preference for haptically-guided grasping. Recently, a study has shown a reduction in right-hand use in blindfolded individuals, and an absence of hand preference if grasping was preceded by a short haptic experience. These results suggest that vision plays a major role in hand preference for grasping. If this were the case, then one might expect congenitally blind (CB) individuals, who have never had a visual experience, to exhibit no hand preference. Two novel findings emerge from the current study: first, the results showed that contrary to our expectation, CB individuals used their right hand during haptically-guided grasping to the same extent as visually-unimpaired (VU) individuals did during visually-guided grasping. And second, object size affected hand use in an opposite manner for haptically-versus visually-guided grasping. Big objects were more often picked up with the right hand during haptically-guided, but less often during visually-guided grasping. This result highlights the different demands that object features pose on the two sensory systems. Overall the results demonstrate that hand preference for grasping is independent of visual experience, and they suggest a left-hemisphere specialization for the control of grasping that goes beyond sensory modality.	[Stone, Kayla D.; Gonzalez, Claudia L. R.] Univ Lethbridge, Dept Kinesiol, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Stone, KD (corresponding author), Univ Lethbridge, Dept Kinesiol, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada.	kayla.stone@uleth.ca	Stone, Kayla/AAD-3525-2020	Stone, Kayla/0000-0001-9212-2782	Natural Sciences and Engineering Research Council of Canada (NSERC Fund) [14367]; University of Lethbridge	Natural Sciences and Engineering Research Council of Canada (NSERC Fund); University of Lethbridge	The current study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC Fund # 14367) and the University of Lethbridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Bennett KM, 1994, INSIGHTS REACH GRASP, P390; BENTON AL, 1973, NEUROLOGY, V23, P1248, DOI 10.1212/WNL.23.11.1248; BENTON AL, 1978, NEUROPSYCHOLOGIA, V16, P109, DOI 10.1016/0028-3932(78)90049-0; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; Brown S, 2006, MAMM GENOME, V17, P1, DOI 10.1007/s00335-005-0900-7; Bryden PJ, 2006, DEV PSYCHOBIOL, V48, P121, DOI 10.1002/dev.20120; Caliskan E, 2009, LATERALITY, V14, P205, DOI 10.1080/13576500802586251; Calvert G A, 1998, Laterality, V3, P255, DOI 10.1080/135765098397287; Carlier M, 2006, BRAIN COGNITION, V61, P255, DOI 10.1016/j.bandc.2006.01.007; CASTIELLO U, 1993, EXP BRAIN RES, V96, P152, DOI 10.1007/BF00230448; Collignon O, 2009, CAN J EXP PSYCHOL, V63, P287, DOI 10.1037/a0015415; Connolly JD, 1999, EXP BRAIN RES, V125, P281, DOI 10.1007/s002210050684; Cormier JM, 2013, LATERALITY, V18, P365, DOI 10.1080/1357650X.2012.701631; DODDS AG, 1978, NEUROPSYCHOLOGIA, V16, P247, DOI 10.1016/0028-3932(78)90115-X; FAGOT J, 1993, BRAIN COGNITION, V21, P212, DOI 10.1006/brcg.1993.1017; FAGOT J, 1994, PERCEPT PSYCHOPHYS, V56, P347, DOI 10.3758/BF03209768; FAGOT J, 1993, PERCEPTION, V22, P847, DOI 10.1068/p220847; Fiehler K, 2009, CEREB CORTEX, V19, P1, DOI 10.1093/cercor/bhn067; Gabbard C, 2003, INT J NEUROSCI, V113, P143, DOI 10.1080/00207450390161994; Gabbard C, 2001, DEV NEUROPSYCHOL, V19, P41, DOI 10.1207/S15326942DN1901_4; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Gonzalez CLR, 2009, NEUROPSYCHOLOGIA, V47, P3182, DOI 10.1016/j.neuropsychologia.2009.07.019; Grant AC, 2000, PERCEPT PSYCHOPHYS, V62, P301, DOI 10.3758/BF03205550; Harada T, 2004, J NEUROSCI, V24, P7524, DOI 10.1523/JNEUROSCI.1395-04.2004; Heath M, 1998, CAN J EXP PSYCHOL, V52, P163, DOI 10.1037/h0087289; Heller MA, 1996, PERCEPT PSYCHOPHYS, V58, P310, DOI 10.3758/BF03211884; HELLER MA, 1993, PERCEPT PSYCHOPHYS, V53, P422, DOI 10.3758/BF03206785; HERMELIN B, 1971, NEUROPSYCHOLOGIA, V9, P431, DOI 10.1016/0028-3932(71)90007-8; ITTYERAH M, 1993, Q J EXP PSYCHOL-A, V46, P35, DOI 10.1080/14640749308401066; Ittyerah M, 2000, LATERALITY, V5, P221, DOI 10.1080/713754379; Ittyerah M, 2009, J DEV PHYS DISABIL, V21, P329, DOI 10.1007/s10882-009-9146-8; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Karl JM, 2013, EXP BRAIN RES, V225, P465, DOI 10.1007/s00221-012-3386-z; Kudoh N, 1997, EXP BRAIN RES, V117, P457, DOI 10.1007/s002210050241; KUMAR S, 1977, CORTEX, V13, P55, DOI 10.1016/S0010-9452(77)80053-1; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; MILLAR S, 1987, CORTEX, V23, P111, DOI 10.1016/S0010-9452(87)80023-0; MILNER B, 1972, NEUROPSYCHOLOGIA, V10, P1, DOI 10.1016/0028-3932(72)90038-3; OBOYLE MW, 1987, BRAIN COGNITION, V6, P474, DOI 10.1016/0278-2626(87)90141-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overvliet KE, 2011, EXP BRAIN RES, V208, P245, DOI 10.1007/s00221-010-2475-0; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; Pettypiece CE, 2009, EXP BRAIN RES, V195, P473, DOI 10.1007/s00221-009-1807-4; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Rand MK, 2007, EXP BRAIN RES, V181, P447, DOI 10.1007/s00221-007-0945-9; Ricciardi E, 2013, NEUROSCI BIOBEHAV RE; RIEGE WH, 1980, NEUROPSYCHOLOGIA, V18, P707, DOI 10.1016/0028-3932(80)90112-8; Sacrey LAR, 2012, INFANT BEHAV DEV, V35, P543, DOI 10.1016/j.infbeh.2012.05.006; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; Squeri V, 2012, J NEUROPHYSIOL, V107, P544, DOI 10.1152/jn.00756.2010; Stone KD, 2014, EXP BRAIN RES, V232, P385, DOI 10.1007/s00221-013-3746-3; Stone KD, 2013, EXP BRAIN RES, V224, P455, DOI 10.1007/s00221-012-3325-z; Theurel A, 2013, J EXP PSYCHOL-APPL, V19, P233, DOI 10.1037/a0034255; Theurel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040251; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Tomlinson SP, 2011, NEUROPSYCHOLOGIA, V49, P2703, DOI 10.1016/j.neuropsychologia.2011.05.018; Vainio L, 2006, EXP BRAIN RES, V173, P395, DOI 10.1007/s00221-006-0378-x; VARNEY NR, 1975, NEUROPSYCHOLOGIA, V13, P449, DOI 10.1016/0028-3932(75)90068-8; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Withagen A, 2013, ATTEN PERCEPT PSYCHO; Woods AT, 2004, J PHYSIOL-PARIS, V98, P147, DOI 10.1016/j.jphysparis.2004.03.006	66	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110175	10.1371/journal.pone.0110175	http://dx.doi.org/10.1371/journal.pone.0110175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303211	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400117
J	Thorbjornsen, GH; Riise, T; Oyen, J				Thorbjornsen, Gunhild Hervik; Riise, Trond; Oyen, Jannike			Bodyweight Changes Are Associated with Reduced Health Related Quality of Life: The Hordaland Health Study	PLOS ONE			English	Article							JOLLY FAT HYPOTHESIS; BODY-MASS INDEX; WEIGHT-LOSS; PHYSICAL-ACTIVITY; DEPRESSIVE SYMPTOMS; STYLE FACTORS; OBESITY; WOMEN; OVERWEIGHT; ADULTS	There is lack of studies investigating the association between bodyweight changes and health related quality of life (HRQL). The aim was to study the effect of relative changes in bodyweight over time on HRQL. In the Hordaland Health Study, 9276 men and 10433 women aged 40-47 years were included. Weight and height were measured and information on bodyweight changes during the last 5 years, physical activity and smoking was obtained from self-administered questionnaires including the Medical Outcomes Study MOS short form-12 including a Physical health Composite Score (PCS) and a Mental health Composite Score (MCS). Increasing bodyweight changes were associated with marked reduced scores in PCS and MCS also after adjustment for body mass index (BMI), physical activity and smoking. Men and women with a variation in weight with more than 15% during the last 5 years reported a mean score of MCS that was 0.48 standard deviation (SD) (3.9/8.1) and 0.35 SD (3.1/8.9) lower than those reporting a variation in weight less than 5%. No major differences were found between those who at date of examination were at the lower and higher end of the reported weight interval. There were no significant differences in the associations between men and women. Our findings confirm that increasing bodyweight changes are associated with reduced physical and mental health beyond what is related to BMI itself.	[Thorbjornsen, Gunhild Hervik; Riise, Trond; Oyen, Jannike] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Oyen, Jannike] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Oyen, J (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	jannike.oyen@igs.uib.no	Øyen, Jannike/H-9857-2018; Riise, Trond/H-1390-2018; Øyen, Jannike/G-4156-2017	Øyen, Jannike/0000-0002-5590-5136; Riise, Trond/0000-0001-9644-5140; Øyen, Jannike/0000-0002-5590-5136	Research Council of Norway; Western Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority	The Hordaland Health Study was funded by the Research Council of Norway. JO was supported by the Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildso CG, 2010, PREV CHRONIC DIS, V7; Arrebola E, 2011, NUTR CLIN PRACT, V26, P316, DOI 10.1177/0884533611405993; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Cash SW, 2013, QUAL LIFE RES, V22, P2381, DOI 10.1007/s11136-013-0389-6; Coakley EH, 1998, INT J OBESITY, V22, P89, DOI 10.1038/sj.ijo.0800549; Coakley EH, 1998, INT J OBESITY, V22, P958, DOI 10.1038/sj.ijo.0800698; Dishman RK, 2003, QUAL LIFE RES, V12, P43, DOI 10.1023/A:1023517303411; Fine JT, 1999, JAMA-J AM MED ASSOC, V282, P2136, DOI 10.1001/jama.282.22.2136; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; Herman KM, 2012, MED SCI SPORT EXER, V44, P625, DOI 10.1249/MSS.0b013e31823a90ae; Hurst NP, 1998, BRIT J RHEUMATOL, V37, P862; Hwu CM, 2011, J CHIN MED ASSOC, V74, P149, DOI 10.1016/j.jcma.2011.01.033; Jasienska G, 2005, WOMEN HEALTH ISS, V15, P145, DOI 10.1016/j.whi.2005.02.002; Kalter-Leibovici O, 2010, ARCH INTERN MED, V170, P970, DOI 10.1001/archinternmed.2010.103; Kruger J, 2007, INT J OBESITY, V31, P321, DOI 10.1038/sj.ijo.0803386; Lasikiewicz N, 2014, APPETITE, V72, P123, DOI 10.1016/j.appet.2013.09.017; Lee PH, 2006, J ADV NURS, V53, P295, DOI 10.1111/j.1365-2648.2006.03726.x; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002; Morimoto T, 2006, QUAL LIFE RES, V15, P537, DOI 10.1007/s11136-005-3033-2; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Pan A, 2014, AM J EPIDEMIOL, V180, P254, DOI 10.1093/aje/kwu136; Pan HJ, 2011, J CHIN MED ASSOC, V74, P169, DOI 10.1016/j.jcma.2011.01.038; Perusse-Lachance E, 2010, APPL PHYSIOL NUTR ME, V35, P498, DOI 10.1139/H10-035; Riise T, 2003, J OCCUP ENVIRON MED, V45, P324, DOI 10.1097/01.jom.0000052965.43131.c3; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rippe JM, 1998, J AM DIET ASSOC, V98, pS31, DOI 10.1016/S0002-8223(98)00708-1; Ross R, 2009, NAT REV ENDOCRINOL, V5, P319, DOI 10.1038/nrendo.2009.78; Samsa GP, 2001, AM J MANAG CARE, V7, P875; Soltoft F, 2009, QUAL LIFE RES, V18, P1293, DOI 10.1007/s11136-009-9541-8; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wu CH, 2009, ASIA PAC J CLIN NUTR, V18, P423	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110173	10.1371/journal.pone.0110173	http://dx.doi.org/10.1371/journal.pone.0110173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303082	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400116
J	Kellner, E; Gall, P; Gunther, M; Reisert, M; Mader, I; Fleysher, R; Kiselev, VG				Kellner, Elias; Gall, Peter; Guenther, Matthias; Reisert, Marco; Mader, Irina; Fleysher, Roman; Kiselev, Valerij G.			Blood Tracer Kinetics in the Arterial Tree	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; ULTRASOUND TECHNIQUES; BOLUS DISPERSION; VASCULAR TREES; CONTRAST MRI; SCALING LAWS; FLOW; QUANTIFICATION; HEMODYNAMICS; BIFURCATION	Evaluation of blood supply of different organs relies on labeling blood with a suitable tracer. The tracer kinetics is linear: Tracer concentration at an observation site is a linear response to an input somewhere upstream the arterial flow. The corresponding impulse response functions are currently treated empirically without incorporating the relation to the vascular morphology of an organ. In this work we address this relation for the first time. We demonstrate that the form of the response function in the entire arterial tree is reduced to that of individual vessel segments under approximation of good blood mixing at vessel bifurcations. The resulting expression simplifies significantly when the geometric scaling of the vascular tree is taken into account. This suggests a new way to access the vascular morphology in vivo using experimentally determined response functions. However, it is an ill-posed inverse problem as demonstrated by an example using measured arterial spin labeling in large brain arteries. We further analyze transport in individual vessel segments and demonstrate that experimentally accessible tracer concentration in vessel segments depends on the measurement principle. Explicit expressions for the response functions are obtained for the major middle part of the arterial tree in which the blood flow in individual vessel segments can be treated as laminar. When applied to the analysis of regional cerebral blood flow measurements for which the necessary arterial input is evaluated in the carotid arteries, present theory predicts about 20% underestimation, which is in agreement with recent experimental data.	[Kellner, Elias; Reisert, Marco; Kiselev, Valerij G.] Univ Med Ctr Freiburg, Dept Radiol, Freiburg, Germany; [Gall, Peter] Siemens AG, Healthcare Sect, Erlangen, Germany; [Guenther, Matthias] Inst Med Image Comp, Fraunhofer MEVIS, Bremen, Germany; [Mader, Irina] Univ Med Ctr Freiburg, Dept Neuroradiol, Freiburg, Germany; [Fleysher, Roman] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, New York, NY USA	University of Freiburg; Siemens AG; Siemens Germany; University of Freiburg; Yeshiva University	Kellner, E (corresponding author), Univ Med Ctr Freiburg, Dept Radiol, Freiburg, Germany.	elias.kellner@uniklinik-freiburg.de	Kiselev, Valerij G./E-5535-2014	Kiselev, Valerij G./0000-0002-5349-5399	National Institutes of Health (NIH) [2P01AG003949-26A2]; COST Action on ASL in Dementia (AID) [BM1103]; NATIONAL INSTITUTE ON AGING [P01AG003949] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COST Action on ASL in Dementia (AID); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	RF was supported in part by National Institutes of Health (NIH) grant 2P01AG003949-26A2. Collaboration between two German groups (VGK and MG) was partially supported by COST Action BM1103 on ASL in Dementia (AID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Bosworth R, 1948, PHILOS MAG, V39, P847; Calamante F, 2005, J MAGN RESON IMAGING, V22, P718, DOI 10.1002/jmri.20454; Calamante F, 2002, STROKE, V33, P1146, DOI 10.1161/01.STR.0000014208.05597.33; Calamante F, 2000, MAGN RESON MED, V44, P466, DOI 10.1002/1522-2594(200009)44:3<466::AID-MRM18>3.0.CO;2-M; Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; Cassot F, 2009, MICROCIRCULATION, V16, P331, DOI 10.1080/10739680802662607; Cassot F, 2010, BRAIN RES, V1313, P62, DOI 10.1016/j.brainres.2009.12.007; Gallichan D, 2008, MAGN RESON MED, V60, P53, DOI 10.1002/mrm.21654; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Hudetz AG, 1997, MICROCIRCULATION, V4, P233, DOI 10.3109/10739689709146787; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Kellner E, 2013, MAGN RESON MED; Kellner E, 2013, MAGN RESON MED, V69, P771, DOI 10.1002/mrm.24319; Kinsman JM, 1929, AM J PHYSIOL, V89, P322, DOI 10.1152/ajplegacy.1929.89.2.322; Kirbas C, 2004, ACM COMPUT SURV, V36, P81, DOI 10.1145/1031120.1031121; KU DN, 1987, J BIOMECH, V20, P407, DOI 10.1016/0021-9290(87)90048-0; Liu J, 2013, HYPERTENSION, V62, P973, DOI 10.1161/HYPERTENSIONAHA.113.01867; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Meckel S, 2013, NEURORADIOLOGY, V55, P389, DOI 10.1007/s00234-012-1103-z; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Mouannes-Srour JJ, 2012, MAGN RESON MED, V68, P495, DOI 10.1002/mrm.23257; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Murray CD, 1926, J GEN PHYSIOL, V9, P835, DOI 10.1085/jgp.9.6.835; Oktar SO, 2006, AM J NEURORADIOL, V27, P363; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; PAWLIK G, 1981, BRAIN RES, V208, P35, DOI 10.1016/0006-8993(81)90619-3; Qian H, 2000, J THEOR BIOL, V205, P261, DOI 10.1006/jtbi.2000.2060; SHEPPARD C W, 1954, Minn Med, V37, P93; Shin WY, 2007, MAGN RESON MED, V58, P1232, DOI 10.1002/mrm.21420; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P568, DOI 10.1002/mrm.10370; Sommer K, 2014, ANN BIOMED ENG, V42, P787, DOI 10.1007/s10439-013-0950-z; Srour JM, 2011, J CEREBR BLOOD F MET, V31, P1272, DOI 10.1038/jcbfm.2010.215; Stewart G N, 1893, J Physiol, V15, P1; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; Vakil P, 2013, RADIOLOGY, V266, P879, DOI 10.1148/radiol.12120756; Varela M, 2011, NMR BIOMED, V24, P80, DOI 10.1002/nbm.1559; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wetzel S, 2007, AM J NEURORADIOL, V28, P433; Wu Y, 2007, J CEREBR BLOOD F MET, V27, P632, DOI 10.1038/sj.jcbfm.9600374; Yang J, 2010, AM J PHYSIOL-HEART C, V298, pH1249, DOI 10.1152/ajpheart.00363.2009; Zierler K, 2000, ANN BIOMED ENG, V28, P836, DOI 10.1114/1.1308496	47	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109230	10.1371/journal.pone.0109230	http://dx.doi.org/10.1371/journal.pone.0109230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299048	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200042
J	Bazzini, C; Benedetti, L; Civello, D; Zanoni, C; Rossetti, V; Marchesi, D; Garavaglia, ML; Paulmichi, M; Francolini, M; Meyer, G; Rodighiero, S				Bazzini, Claudia; Benedetti, Lorena; Civello, Davide; Zanoni, Chiara; Rossetti, Valeria; Marchesi, Davide; Garavaglia, Maria Lisa; Paulmichi, Markus; Francolini, Maura; Meyer, Giuliano; Rodighiero, Simona			ICln: A New Regulator of Non-Erythroid 4.1R Localisation and Function	PLOS ONE			English	Article							CELL-VOLUME REGULATION; PROTEIN 4.1R-DEFICIENT MICE; RED-BLOOD-CELLS; ERYTHROCYTE-MEMBRANE; CHLORIDE CHANNEL; ANION CHANNELS; MULTIPROTEIN COMPLEX; SURFACE EXPRESSION; ACTIN-FILAMENT; BINDING-SITE	To optimise the efficiency of cell machinery, cells can use the same protein (often called a hub protein) to participate in different cell functions by simply changing its target molecules. There are large data sets describing protein-protein interactions ("interactome") but they frequently fail to consider the functional significance of the interactions themselves. We studied the interaction between two potential hub proteins, ICln and 4.1R (in the form of its two splicing variants 4.1R(80) and 4.1R(135)), which are involved in such crucial cell functions as proliferation, RNA processing, cytoskeleton organisation and volume regulation. The sub-cellular localisation and role of native and chimeric 4.1R over-expressed proteins in human embryonic kidney (HEK) 293 cells were examined. ICln interacts with both 4.1R(80) and 4.1R(135) and its over-expression displaces 4.1R from the membrane regions, thus affecting 4.1R interaction with beta-actin. It was found that 4.1R(80) and 4.1R(135) are differently involved in regulating the swelling activated anion current (I-Cl,I-swell) upon hypotonic shock, a condition under which both isoforms are dislocated from the membrane region and thus contribute to I-Cl,I-swell current regulation. Both 4.1R isoforms are also differently involved in regulating cell morphology, and ICln counteracts their effects. The findings of this study confirm that 4.1R plays a role in cell volume regulation and cell morphology and indicate that ICln is a new negative regulator of 4.1R functions.	[Bazzini, Claudia; Civello, Davide; Rossetti, Valeria; Garavaglia, Maria Lisa; Meyer, Giuliano] Univ Milan, Dept Biosci, Milan, Italy; [Benedetti, Lorena; Francolini, Maura] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Benedetti, Lorena; Marchesi, Davide; Francolini, Maura; Rodighiero, Simona] Fdn Filarete Biosci & Innovat, Milan, Italy; [Zanoni, Chiara] Univ Milan, Pharmaceut Sci Dept DISFARM, Milan, Italy; [Paulmichi, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria	University of Milan; University of Milan; University of Milan; Paracelsus Private Medical University	Rodighiero, S (corresponding author), Fdn Filarete Biosci & Innovat, Milan, Italy.	simona.rodighiero@fondazionefilarete.com	Rodighiero, Simona/AAP-9816-2020; Garavaglia, Maria Lisa/AFV-3214-2022	Benedetti, Lorena/0000-0003-3510-0258; CIVELLO, DAVIDE ANTONIO/0000-0003-4133-8211; Rodighiero, Simona/0000-0003-4236-7823; FRANCOLINI, MAURA/0000-0002-3126-1575	Italian Ministry of Education, Universities and Research [PRIN 2008 - Prot. 2008W5AZEC_002]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by grant PRIN 2008 - Prot. 2008W5AZEC_002 from the Italian Ministry of Education, Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; Baines AJ, 2013, BIOCH BIOPHYS ACTA; Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Baines AJ, 2009, BLOOD CELL MOL DIS, V42, P211, DOI 10.1016/j.bcmd.2009.01.016; Ben Soussia I, 2012, PFLUG ARCH EUR J PHY, V464, P273, DOI 10.1007/s00424-012-1139-2; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buyse G, 1996, BIOCHEM BIOPH RES CO, V218, P822, DOI 10.1006/bbrc.1996.0146; Byfield FJ, 2006, ACTA PHYSIOL, V187, P285, DOI 10.1111/j.1748-1716.2006.01555.x; Cai S, 1998, AM J PHYSIOL-CELL PH, V275, pC1349, DOI 10.1152/ajpcell.1998.275.5.C1349; Calinisan V, 2006, FRONT BIOSCI-LANDMRK, V11, P1646, DOI 10.2741/1911; Cantiello HF, 1997, J EXP ZOOL, V279, P425, DOI 10.1002/(SICI)1097-010X(19971201)279:5<425::AID-JEZ4>3.0.CO;2-Q; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen LX, 2011, J CELL SCI, V124, P2478, DOI 10.1242/jcs.078170; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; CORREAS I, 1986, J BIOL CHEM, V261, P3362; Cunha SR, 2008, CIRC RES, V103, P779, DOI 10.1161/CIRCRESAHA.108.186460; Demion M, 2006, J CARDIOVASC ELECTR, V17, P60, DOI 10.1111/j.1540-8167.2005.00255.x; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Douyard J, 2007, J COMP NEUROL, V502, P141, DOI 10.1002/cne.21294; Du XY, 1999, PFLUG ARCH EUR J PHY, V437, P227, DOI 10.1007/s004240050773; Elsing C, 2007, ACTA PHYSIOL, V190, P199, DOI 10.1111/j.1748-1716.2007.01682.x; Emma F, 1998, BBA-MOL CELL RES, V1404, P321, DOI 10.1016/S0167-4889(98)00073-1; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Furst J, 2006, ACTA PHYSIOL, V187, P43, DOI 10.1111/j.1748-1716.2006.01549.x; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Furst J, 2000, PFLUG ARCH EUR J PHY, V440, P100; Gadella, 2009, FRET FLIM TECHN; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; Gauthier E, 2011, BIOCHEMISTRY-US, V50, P4561, DOI 10.1021/bi200154g; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Grimm C, 2013, MOL CELL, V49, P692, DOI 10.1016/j.molcel.2012.12.009; GSCHWENTNER M, 1995, PFLUG ARCH EUR J PHY, V430, P464, DOI 10.1007/BF00373882; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hoffmann EK, 2011, CELL PHYSIOL BIOCHEM, V28, P1061, DOI 10.1159/000335843; Huang SC, 2005, MOL BIOL CELL, V16, P117, DOI 10.1091/mbc.E04-05-0426; Hubert MD, 2000, BBA-BIOMEMBRANES, V1466, P105, DOI 10.1016/S0005-2736(00)00177-2; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; Jung Y, 2012, BIOCHEM BIOPH RES CO, V426, P578, DOI 10.1016/j.bbrc.2012.08.129; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Klausen TK, 2006, AM J PHYSIOL-CELL PH, V291, pC757, DOI 10.1152/ajpcell.00029.2006; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Kurbannazarova RS, 2011, INT J MOL SCI, V12, P9125, DOI 10.3390/ijms12129125; Lang F, 1998, CELL PHYSIOL BIOCHEM, V8, P1, DOI 10.1159/000016269; Larkin D, 2004, J BIOL CHEM, V279, P27286, DOI 10.1074/jbc.M402159200; Larkin D, 2009, BRIT J HAEMATOL, V144, P580, DOI 10.1111/j.1365-2141.2008.07483.x; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li CH, 1998, J GEN PHYSIOL, V112, P727, DOI 10.1085/jgp.112.6.727; Liu CR, 2013, J BIOL CHEM, V288, P11407, DOI 10.1074/jbc.M112.436659; Livshits Leonid, 2012, Rev Diabet Stud, V9, P94, DOI 10.1900/RDS.2012.9.94; Lospitao E, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-51; Luque CM, 2003, J BIOL CHEM, V278, P2686, DOI 10.1074/jbc.M201521200; Luque CM, 2000, J CELL SCI, V113, P2485; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Mullins RD, 2013, CURR OPIN CELL BIOL, V25, P6, DOI 10.1016/j.ceb.2012.11.007; Musch MW, 1998, PFLUG ARCH EUR J PHY, V436, P415, DOI 10.1007/s004240050651; Nunomura W, 2006, FRONT BIOSCI-LANDMRK, V11, P1522, DOI 10.2741/1901; Nunomura W, 2012, BIOCHEM J, V446, P427, DOI 10.1042/BJ20120535; Nunomura W, 2009, BIOCHEM J, V417, P141, DOI 10.1042/BJ20081372; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Parra MK, 2012, MOL CELL BIOL, V32, P2044, DOI 10.1128/MCB.05716-11; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Pedersen SF, 2011, J AM SOC NEPHROL, V22, P1587, DOI 10.1681/ASN.2010121284; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Pu WT, 2000, J BIOL CHEM, V275, P12363, DOI 10.1074/jbc.275.17.12363; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; REID ME, 1990, BLOOD, V75, P2229; Ritter M, 2003, J BIOL CHEM, V278, P50163, DOI 10.1074/jbc.M300374200; Rivera A, 2006, AM J PHYSIOL-CELL PH, V291, pC880, DOI 10.1152/ajpcell.00436.2005; Rodighiero S, 2008, CELL PHYSIOL BIOCHEM, V21, P489, DOI 10.1159/000129642; Rose M, 2008, J NEUROCHEM, V105, P2375, DOI 10.1111/j.1471-4159.2008.05331.x; Ruiz-Saenz A, 2011, J CELL SCI, V124, P2529, DOI 10.1242/jcs.083634; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Schedlbauer A, 2011, CELL PHYSIOL BIOCHEM, V28, P1203, DOI 10.1159/000335852; Schischmanoff PO, 1997, J BIOL CHEM, V272, P10254, DOI 10.1074/jbc.272.15.10254; Schwartz RS, 1997, BIOCHEM J, V327, P609; Seo PS, 2009, BBA-MOL CELL RES, V1793, P281, DOI 10.1016/j.bbamcr.2008.09.012; Shen L, 2000, J NEUROSCI, V20, P7932; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Takakuwa Y, 2000, INT J HEMATOL, V72, P298; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V28, P1191, DOI 10.1159/000335851; Tang CJC, 1998, BLOOD, V92, P1442, DOI 10.1182/blood.V92.4.1442.416k14_1442_1447; Tang T K, 1988, Adv Exp Med Biol, V241, P81; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; VENEZIA ND, 1992, J CLIN INVEST, V90, P1713, DOI 10.1172/JCI116044; Verveer PJ, 2006, CSH PROTOC, V2006; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Wang GX, 2005, J MEMBRANE BIOL, V208, P15, DOI 10.1007/s00232-005-0815-y; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940	104	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108826	10.1371/journal.pone.0108826	http://dx.doi.org/10.1371/journal.pone.0108826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295618	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000020
J	Ding, MZ; Yan, HF; Li, LF; Zhai, F; Shang, LQ; Yin, Z; Yuan, YJ				Ding, Ming-zhu; Yan, Hui-fang; Li, Lin-feng; Zhai, Fang; Shang, Lu-qing; Yin, Zheng; Yuan, Ying-jin			Biosynthesis of Taxadiene in Saccharomyces cerevisiae : Selection of Geranylgeranyl Diphosphate Synthase Directed by a Computer-Aided Docking Strategy	PLOS ONE			English	Article							ANTIMALARIAL-DRUG PRECURSOR; MEVALONATE PATHWAY; GENES; CHAIN; YEAST; OVERPRODUCTION; MILTIRADIENE; EXPRESSION; OXYGEN; LEVEL	Identification of efficient key enzymes in biosynthesis pathway and optimization of the fitness between functional modules and chassis are important for improving the production of target compounds. In this study, the taxadiene biosynthesis pathway was firstly constructed in yeast by transforming ts gene and overexpressing erg20 and thmgr. Then, the catalytic capabilities of six different geranylgeranyl diphosphate synthases (GGPPS), the key enzyme in mevalonic acid (MVA) pathway catalyzing famesyl diphosphate (FPP) to geranylgeranyl diphosphate (GGPP), were predicted using enzyme-substrate docking strategy. GGPPSs from Taxus baccata x Taxus cuspidate (GGPPSbc), Erwinia herbicola (GGPPSeh), and S. cerevisiae (GGPPSsc) which ranked 1st, 4th and 6th in docking with FPP were selected for construction. The experimental results were consistent with the computer prediction that the engineered yeast with GGPPSbc exhibited the highest production. In addition, two chassis YSG50 and W303-1A were chosen, and the titer of taxadiene reached 72.8 mg/L in chassis YSG50 with GGPPSbc. Metabolomic study revealed that the contents of tricarboxylic acid cycle (TCA) intermediates and their precursor amino acids in chassis YSG50 was lower than those in W303-1A, indicating less carbon flux was divided into TCA cycle. Furthermore, the levels of TCA intermediates in the taxadiene producing yeasts were lower than those in chassis YSG50. Thus, it may result in more carbon flux in MVA pathway in chassis YSG50, which suggested that YSG50 was more suitable for engineering the taxadiene producing yeast. These results indicated that computer-aided protein modeling directed isoenzyme selection strategy and metabolomic study could guide the rational design of terpenes biosynthetic cells.	[Ding, Ming-zhu; Yan, Hui-fang; Zhai, Fang; Yuan, Ying-jin] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; [Ding, Ming-zhu; Yan, Hui-fang; Zhai, Fang; Yuan, Ying-jin] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Tianjin 300072, Peoples R China; [Ding, Ming-zhu; Yan, Hui-fang; Li, Lin-feng; Zhai, Fang; Shang, Lu-qing; Yin, Zheng; Yuan, Ying-jin] Collaborat Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China; [Li, Lin-feng; Shang, Lu-qing; Yin, Zheng] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Li, Lin-feng; Shang, Lu-qing; Yin, Zheng] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Tianjin University; Tianjin University; Nankai University; Nankai University	Yin, Z (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	zheng_yin@nankai.edu.cn; yjyuan@tju.edu.cn	yin, zheng/A-4825-2012	yin, zheng/0000-0002-7346-6325; Li, Linfeng/0000-0001-6185-4999	Ministry of Science and Technology of China [2012AA02A701, 2012CB721105]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was funded by the Ministry of Science and Technology of China ("863" Program: 2012AA02A701 and "973" Program: 2012CB721105). The authors also thank Huimin Zhao of University of Illinois at Urbana-Champaign for kindly providing yeast YSG50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Albertsen L, 2011, APPL ENVIRON MICROB, V77, P1033, DOI 10.1128/AEM.01361-10; Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Asadollahi MA, 2010, BIOTECHNOL BIOENG, V106, P86, DOI 10.1002/bit.22668; Boghigian BA, 2012, APPL MICROBIOL BIOT, V93, P2063, DOI 10.1007/s00253-011-3725-1; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Carrau FM, 2005, FEMS MICROBIOL LETT, V243, P107, DOI 10.1016/j.femsle.2004.11.050; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Conolly JD, 1991, DICT TERPENOIDS; Dai ZB, 2012, BIOTECHNOL BIOENG, V109, P2845, DOI 10.1002/bit.24547; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Ding MZ, 2012, METABOLOMICS, V8, P232, DOI 10.1007/s11306-011-0303-6; Ding MZ, 2010, METABOLOMICS, V6, P42, DOI 10.1007/s11306-009-0173-3; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; JIANG Y, 1995, J BIOL CHEM, V270, P21793, DOI 10.1074/jbc.270.37.21793; Kampranis SC, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210006; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Rico J, 2010, APPL ENVIRON MICROB, V76, P6449, DOI 10.1128/AEM.02987-09; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wang CW, 1999, BIOTECHNOL BIOENG, V62, P235, DOI 10.1002/(SICI)1097-0290(19990120)62:2<235::AID-BIT14>3.0.CO;2-U; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486	35	43	51	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109348	10.1371/journal.pone.0109348	http://dx.doi.org/10.1371/journal.pone.0109348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295588	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000062
J	Drogemuller, M; Jagannathan, V; Welle, MM; Graubner, C; Straub, R; Gerber, V; Burger, D; Signer-Hasler, H; Poncet, PA; Klopfenstein, S; von Niederhausern, R; Tetens, J; Thaller, G; Rieder, S; Drogemuller, C; Leeb, T				Drogemuller, Michaela; Jagannathan, Vidhya; Welle, Monika M.; Graubner, Claudia; Straub, Reto; Gerber, Vinzenz; Burger, Dominik; Signer-Hasler, Heidi; Poncet, Pierre-Andre; Klopfenstein, Stephane; von Niederhaeusern, Ruedi; Tetens, Jens; Thaller, Georg; Rieder, Stefan; Drogemuller, Cord; Leeb, Tosso			Congenital Hepatic Fibrosis in the Franches-Montagnes Horse Is Associated with the Polycystic Kidney and Hepatic Disease 1 (PKHD1) Gene	PLOS ONE			English	Article							CAROLIS-DISEASE; LIVER FIBROSIS; PROTEIN; GENOME; DYSGENESIS; ALIGNMENT; ENCODES; BILIARY; ARPKD; MODEL	Congenital hepatic fibrosis has been described as a lethal disease with monogenic autosomal recessive inheritance in the Swiss Franches-Montagnes horse breed. We performed a genome-wide association study with 5 cases and 12 controls and detected an association on chromosome 20. Subsequent homozygosity mapping defined a critical interval of 952 kb harboring 10 annotated genes and loci including the polycystic kidney and hepatic disease 1 (autosomal recessive) gene (PKHD1). PKHD1 represents an excellent functional candidate as variants in this gene were identified in human patients with autosomal recessive polycystic kidney and hepatic disease (ARPKD) as well as several mouse and rat mutants. Whereas most pathogenic PKHD1 variants lead to polycystic defects in kidney and liver, a small subset of the human ARPKD patients have only liver symptoms, similar to our horses with congenital hepatic fibrosis. The PKHD1 gene is one of the largest genes in the genome with multiple alternative transcripts that have not yet been fully characterized. We sequenced the genomes of an affected foal and 46 control horses to establish a comprehensive list of variants in the critical interval. We identified two missense variants in the PKHD1 gene which were strongly, but not perfectly associated with congenital hepatic fibrosis. We speculate that reduced penetrance and/or potential epistatic interactions with hypothetical modifier genes may explain the imperfect association of the detected PKHD1 variants. Our data thus indicate that horses with congenital hepatic fibrosis represent an interesting large animal model for the liver-restricted subtype of human ARPKD.	[Drogemuller, Michaela; Jagannathan, Vidhya; Drogemuller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Drogemuller, Michaela; Jagannathan, Vidhya; Signer-Hasler, Heidi; von Niederhaeusern, Ruedi; Rieder, Stefan; Drogemuller, Cord; Leeb, Tosso] Univ Bern, Bern Univ Appl Sci HAFL & Agroscope, Swiss Competence Ctr Anim Breeding & Genet, Bern, Switzerland; [Welle, Monika M.] Univ Bern, Inst Anim Pathol, Bern, Switzerland; [Graubner, Claudia; Straub, Reto; Gerber, Vinzenz; Burger, Dominik] Univ Bern & Agroscope, Swiss Inst Equine Med, Bern, Switzerland; [Signer-Hasler, Heidi] Bern Univ Appl Sci HAFL, Zollikofen, Switzerland; [Poncet, Pierre-Andre] HIPPOP, Lignerolle, Switzerland; [Klopfenstein, Stephane] Swiss Franches Montagnes Breeding Assoc, Avenches, Switzerland; [von Niederhaeusern, Ruedi; Rieder, Stefan] Swiss Natl Stud Farm, Avenches, Switzerland; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	University of Bern; Swiss Federal Research Station Agroscope; University of Bern; University of Bern; Swiss Federal Research Station Agroscope; University of Bern; University of Kiel	Leeb, T (corresponding author), Univ Bern, Inst Genet, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Welle, Monika Maria/ABF-6113-2021; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X	Swiss Federal Office for Agriculture; Swiss Federal Food Safety and Veterinary Office; Swiss Franches-Montagnes Breeding Association	Swiss Federal Office for Agriculture; Swiss Federal Food Safety and Veterinary Office; Swiss Franches-Montagnes Breeding Association	This study was financed in part by contributions from the Swiss Federal Office for Agriculture, the Swiss Federal Food Safety and Veterinary Office, and the Swiss Franches-Montagnes Breeding Association. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva M, 2006, MEDICINE, V85, P1, DOI 10.1097/01.md.0000200165.90373.9a; Bourque AC, 2001, CAN VET J, V42, P145; Brown DL, 2010, VET PATHOL, V47, P102, DOI 10.1177/0300985809353313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Haechler S, 2000, VET PATHOL, V37, P669, DOI 10.1354/vp.37-6-669; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moser M, 2005, HEPATOLOGY, V41, P1113, DOI 10.1002/hep.20655; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Stocker H, 1996, Tierarztl Prax, V24, P44; Straub R, 2003, TIERAERZTL PRAX G N, V31, P162; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wallace S, 2009, VET PATHOL, V46, P84, DOI 10.1354/vp.46-1-84; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Yoshikawa H, 2002, VET PATHOL, V39, P143, DOI 10.1354/vp.39-1-143; Zandvliet MMJM, 2005, J VET INTERN MED, V19, P765, DOI 10.1892/0891-6640(2005)19[765:APSICS]2.0.CO;2; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101	25	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110125	10.1371/journal.pone.0110125	http://dx.doi.org/10.1371/journal.pone.0110125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295861	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000113
J	Lee, S; Rahnenfuhrer, J; Lang, M; De Preter, K; Mestdagh, P; Koster, J; Versteeg, R; Stallings, RL; Varesio, L; Asgharzadeh, S; Schulte, JH; Fielitz, K; Schwermer, M; Morik, K; Schramm, A				Lee, Sangkyun; Rahnenfuehrer, Joerg; Lang, Michel; De Preter, Katleen; Mestdagh, Pieter; Koster, Jan; Versteeg, Rogier; Stallings, Raymond L.; Varesio, Luigi; Asgharzadeh, Shahab; Schulte, Johannes H.; Fielitz, Kathrin; Schwermer, Melanie; Morik, Katharina; Schramm, Alexander			Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling	PLOS ONE			English	Article							HUMAN NEUROBLASTOMA-CELLS; MITOTIC CHECKPOINT GENES; BREAST-CANCER; CLINICOPATHOLOGICAL SIGNIFICANCE; VARIABLE SELECTION; MESSENGER-RNA; HUMAN LUNG; EXPRESSION; REGRESSION; STABILITY	Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org).	[Lee, Sangkyun; Morik, Katharina] TU Dortmund Univ, Dept Comp Sci, Dortmund, Germany; [Rahnenfuehrer, Joerg; Lang, Michel] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [De Preter, Katleen; Mestdagh, Pieter] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Varesio, Luigi] Giannina Gaslini Inst, Mol Biol Lab, Genoa, Italy; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Schulte, Johannes H.; Fielitz, Kathrin; Schwermer, Melanie; Schramm, Alexander] Univ Childrens Hosp Essen, Dept Pediat Oncol & Hematol, Essen, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Schulte, Johannes H.] German Canc Consortium DKTK, Heidelberg, Germany; [Schulte, Johannes H.] German Canc Res Ctr, Heidelberg, Germany	Dortmund University of Technology; Dortmund University of Technology; Ghent University; Ghent University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Royal College of Surgeons - Ireland; University of Genoa; IRCCS Istituto Giannina Gaslini; Children's Hospital Los Angeles; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Lee, S (corresponding author), TU Dortmund Univ, Dept Comp Sci, Dortmund, Germany.	sangkyun.lee@tu-dortmund.de	Stallings, Raymond/A-7213-2008; Versteeg, Rogier/AAQ-1765-2020; Schwermer, Melanie/AAG-1810-2021; varesio, luigi/J-8261-2016; Koster, Jan/C-5934-2008; De Preter, Katleen/I-7135-2013; Lee, Sangkyun/AAE-5272-2019; Schulte, Johannes H./V-2474-2018; Schramm, Alexander/G-5688-2010	varesio, luigi/0000-0001-5659-2218; Koster, Jan/0000-0002-0890-7585; De Preter, Katleen/0000-0002-7726-5096; Lee, Sangkyun/0000-0001-8415-6368; Schramm, Alexander/0000-0001-7670-7529; Rahnenfuhrer, Jorg/0000-0002-8947-440X; Mestdagh, Pieter/0000-0001-7821-9684; Lang, Michel/0000-0001-9754-0393; Versteeg, Rogier/0000-0001-7172-0388; Asgharzadeh, Shahab/0000-0002-0510-3848; Schulte, Johannes Hubertus/0000-0003-0671-1201	Deutsche Forschungs-gemeinschaft (DFG) within the Collaborative Research Center [SFB 876]; Italian Association for Cancer Research; ENCCA network; Italian Ministry of Health	Deutsche Forschungs-gemeinschaft (DFG) within the Collaborative Research Center(German Research Foundation (DFG)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); ENCCA network; Italian Ministry of Health(Ministry of Health, Italy)	The authors acknowledge the support of Deutsche Forschungs-gemeinschaft (DFG) within the Collaborative Research Center SFB 876 (http://sfb876.tu-dortmund.de) "Providing Information by Resource-Constrained Analysis", projects A3 and Cl. L. Varesio was supported by grants from the Italian Association for Cancer Research, the ENCCA network, the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Alaminos M, 2003, CANCER RES, V63, P4538; Asgharzadeh S, 2012, J CLIN ONCOL, V30, P3525, DOI 10.1200/JCO.2011.40.9169; Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bischl B, 2014, J STAT SOFTWARE; Bogdanova N, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-12; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boukovinas I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003695; Bravo HC, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-272; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Broom BM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S10; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Cao F, 2013, ASIAN PAC J CANCER P, V14, P195, DOI 10.7314/APJCP.2013.14.1.195; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; COX DR, 1972, J R STAT SOC B, V34, P187; Cox dr, 1984, ANAL SURVIVAL DATA, DOI DOI 10.1201/9781315137438; CZERWINSKI M, 1994, CANCER RES, V54, P1085; Davis CA, 2006, BIOINFORMATICS, V22, P2356, DOI 10.1093/bioinformatics/btl400; Decock A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R95, 10.1186/gb-2012-13-10-r95]; DibHajj SD, 1996, FEBS LETT, V384, P78, DOI 10.1016/0014-5793(96)00273-6; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gatta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015965; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haruki N, 2001, CANCER LETT, V162, P201, DOI 10.1016/S0304-3835(00)00675-3; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jurman G, 2008, BIOINFORMATICS, V24, P258, DOI 10.1093/bioinformatics/btm550; Kalousis A, 2007, KNOWL INF SYST, V12, P95, DOI 10.1007/s10115-006-0040-8; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Ko JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086569; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Lin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018608; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; MATSUI T, 1993, J CLIN INVEST, V92, P1153, DOI 10.1172/JCI116684; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-137; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mefford D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037646; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Mishra PK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002303; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Paul D, 2008, ANN STAT, V36, P1595, DOI 10.1214/009053607000000578; Planck M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078614; Pupa SM, 2007, CANCER RES, V67, P4271, DOI 10.1158/0008-5472.CAN-06-4162; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Scifo E, 2013, J PROTEOME RES, V12, P2101, DOI 10.1021/pr301125k; Stav D, 2007, INT J BIOL MARKER, V22, P108, DOI 10.1177/172460080702200204; Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739; Volchenboum SL, 2009, CANCER RES, V69, P4143, DOI 10.1158/0008-5472.CAN-08-3112; Vrekoussis T, 2007, ONCOL REP, V17, P1115; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075083; Yang MY, 2013, CELL REP, V3, P1457, DOI 10.1016/j.celrep.2013.04.019; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhao P, 2006, J MACH LEARN RES, V7, P2541; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	70	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108818	10.1371/journal.pone.0108818	http://dx.doi.org/10.1371/journal.pone.0108818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295525	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000019
J	Parsons, LM; Mizanur, RM; Jankowska, E; Hodgkin, J; O'Rourke, D; Stroud, D; Ghosh, S; Cipollo, JF				Parsons, Lisa M.; Mizanur, Rahman M.; Jankowska, Ewa; Hodgkin, Jonathan; O'Rourke, Delia; Stroud, Dave; Ghosh, Salil; Cipollo, John F.			Caenorhabditis elegans Bacterial Pathogen Resistant bus-4 Mutants Produce Altered Mucins	PLOS ONE			English	Article							O-GLYCANS; GENES; BINDING; IDENTIFICATION; GLYCOPROTEINS; VIRULENCE; ADHESION; REVEALS; CUTICLE; WORM	Caenorabditis elegans bus-4 glycosyltransferase mutants are resistant to infection by Microbacterium nematophilum, Yersinia pestis and Yersinia pseudotuberculosis and have altered susceptibility to two Leucobacter species Verde1 and Verde2. Our objective in this study was to define the glycosylation changes leading to this phenotype to better understand how these changes lead to pathogen resistance. We performed MALDI-TOF MS, tandem MS and GC/MS experiments to reveal fine structural detail for the bus-4 N- and O-glycan pools. We observed dramatic changes in O-glycans and moderate ones in N-glycan pools compared to the parent strain. Ce core-I glycans, the nematode's mucin glycan equivalent, were doubled in abundance, halved in charge and bore shifts in terminal substitutions. The fucosyl O-glycans, Ce core-II and neutral fucosyl forms, were also increased in abundance as were fucosyl N-glycans. Quantitative expression analysis revealed that two mucins, let-653 and osm-8, were upregulated nearly 40 fold and also revealed was a dramatic increase in GDP-Man 4,6 dehydratease expression. We performed detailed lectin binding studies that showed changes in glycoconjugates in the surface coat, cuticle surface and intestine. The combined changes in cell surface glycoconjugate distribution, increased abundance and altered properties of mucin provide an environment where likely the above pathogens are not exposed to normal glycoconjugate dependent cues leading to barriers to these bacterial infections.	[Parsons, Lisa M.; Mizanur, Rahman M.; Jankowska, Ewa; Ghosh, Salil; Cipollo, John F.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Hodgkin, Jonathan; O'Rourke, Delia; Stroud, Dave] Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	US Food & Drug Administration (FDA); University of Oxford	Cipollo, JF (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	John.Cipollo@fda.hhs.gov	Jankowska, Ewa/ABD-4073-2021; Jankowska, Ewa A/AAY-3040-2020	Jankowska, Ewa A/0000-0002-9202-432X	Oak Ridge Institute for Scientific Education (ORISE); Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA); Medical Research Council UK [G0600238]; MRC [G0600238, MR/J001309/1] Funding Source: UKRI; Medical Research Council [MR/J001309/1, G0600238] Funding Source: researchfish	Oak Ridge Institute for Scientific Education (ORISE); Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported in part by Oak Ridge Institute for Scientific Education (ORISE), and the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA). The work from JH is supported by Medical Research Council UK, Grant G0600238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashline D, 2005, ANAL CHEM; Barrows BD, 2007, J INVERTEBR PATHOL, V95, P198, DOI 10.1016/j.jip.2007.04.002; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; BORGONIE G, 1994, HISTOCHEMISTRY, V101, P379, DOI 10.1007/BF00269000; BRENNER S, 1974, GENETICS, V77, P71; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I, 2009, OGALNAC GLYCANS; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Cipollo JF, 2002, J BIOL CHEM, V277, P49143, DOI 10.1074/jbc.M208020200; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Costello CE, 2007, J AM SOC MASS SPECTR, V18, P1799, DOI 10.1016/j.jasms.2007.07.016; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; ELWOOD PC, 1988, ANAL BIOCHEM, V175, P202, DOI 10.1016/0003-2697(88)90379-X; Gravato-Nobre MJ, 2011, GENETICS, V187, P141, DOI 10.1534/genetics.110.122002; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Gravato-Nobre MJ, 2010, GLYCOSYLATION UNPUB; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; HASLAM SM, 2002, BIOCH SOC S, V69, P117; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Hodgkin J, 2013, CURR BIOL, V23, P2157, DOI 10.1016/j.cub.2013.08.060; Hoeflich J, 2004, J BIOL CHEM; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; KAMERLING JP, 1975, BIOCHEM J, V151, P491, DOI 10.1042/bj1510491; KARLSSON KA, 1992, APMIS, V100, P71; Kimura T, 2012, RADIAT RES, V178, P313, DOI 10.1667/RR2989.1; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; LINK CD, 1992, GENETICS, V131, P867; Palaima E, 2010, J BIOL CHEM, V285, P17662, DOI 10.1074/jbc.M109.065433; Parsons LM, 2014, MICROBES INFECT, V16, P356, DOI 10.1016/j.micinf.2014.01.002; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; POLITZ SM, 1990, P NATL ACAD SCI USA, V87, P2901, DOI 10.1073/pnas.87.8.2901; PRESANT CA, 1972, J BIOL CHEM, V247, P6937; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Vanmaele RP, 1999, INFECT IMMUN, V67, P3302, DOI 10.1128/IAI.67.7.3302-3307.1999; Venkatakrishnan V, 2013, EXPERT REV RESP MED, V7, P553, DOI 10.1586/17476348.2013.837752; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Zhang R., 2013, ISRN MICROBIOL, V2013	47	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107250	10.1371/journal.pone.0107250	http://dx.doi.org/10.1371/journal.pone.0107250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296196	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000004
J	Sancini, G; Farina, F; Battaglia, C; Cifola, I; Mangano, E; Mantecca, P; Camatini, M; Palestini, P				Sancini, Giulio; Farina, Francesca; Battaglia, Cristina; Cifola, Ingrid; Mangano, Eleonora; Mantecca, Paride; Camatini, Marina; Palestini, Paola			Health Risk Assessment for Air Pollutants: Alterations in Lung and Cardiac Gene Expression in Mice Exposed to Milano Winter Fine Particulate Matter (PM2.5)	PLOS ONE			English	Article							OXIDATIVE STRESS; MESSENGER-RNA; PHYSICOCHEMICAL CHARACTERIZATION; CARDIOVASCULAR-DISEASE; HYDROCARBON RECEPTOR; HEART-FAILURE; POLLUTION; URBAN; MYELOPEROXIDASE; INFLAMMATION	Oxidative stress, pulmonary and systemic inflammation, endothelial cell dysfunction, atherosclerosis and cardiac autonomic dysfunction have been linked to urban particulate matter exposure. The chemical composition of airborne pollutants in Milano is similar to those of other European cities though with a higher PM2.5 fraction. Milano winter fine particles (PM2.5win) are characterized by the presence of nitrate, organic carbon fraction, with high amount of polycyclic aromatic hydrocarbons and elements such as Pb, Al, Zn, V, Fe, Cr and others, with a negligible endotoxin presence. In BALB/c mice, we examined, at biochemical and transcriptomic levels, the adverse effects of repeated Milano PM2.5win exposure in lung and heart. We found that ET-1, Hsp70, Cyp1A1, Cyp1B1 and Hsp-70, HO-1, MPO respectively increased within lung and heart of PM2.5win-treated mice. The PM2.5win exposure had a strong impact on global gene expression of heart tissue (181 upregulated and 178 down-regulated genes) but a lesser impact on lung tissue (14 up-regulated genes and 43 downregulated genes). Focusing on modulated genes, in lung we found two-to three-fold changes of those genes related to polycyclic aromatic hydrocarbons exposure and calcium signalling. Within heart the most striking aspect is the twofold to threefold increase in collagen and laminin related genes as well as in genes involved in calcium signaling. The current study extends our previous findings, showing that repeated instillations of PM2.5win trigger systemic adverse effects. PM2.5win thus likely poses an acute threat primarily to susceptible people, such as the elderly and those with unrecognized coronary artery or structural heart disease. The study of genomic responses will improve understanding of disease mechanisms and enable future clinical testing of interventions against the toxic effects of air pollutant.	[Sancini, Giulio; Farina, Francesca; Palestini, Paola] Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci, Monza, Italy; [Battaglia, Cristina] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy; [Mantecca, Paride; Camatini, Marina] Univ Milano Bicocca, POLARIS Res Ctr, Dept Environm Sci, Milan, Italy; [Battaglia, Cristina; Cifola, Ingrid; Mangano, Eleonora] CNR, Inst Biomed Technol, Segrate, Italy	University of Milano-Bicocca; University of Milan; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Farina, F (corresponding author), Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci, Monza, Italy.	francesca.farina1@unimib.it	Palestini, PAOLA/AAD-9376-2019; Sancini, Giulio/I-5136-2012; Battaglia, Cristina/E-5166-2017; Mangano, Eleonora/P-7028-2018	Palestini, PAOLA/0000-0002-1045-8838; Sancini, Giulio/0000-0003-2567-109X; Battaglia, Cristina/0000-0003-3025-9657; Mangano, Eleonora/0000-0002-4040-4654; Mantecca, Paride/0000-0002-6962-049X; CIFOLA, INGRID/0000-0003-2819-1171	TOSCA Project, Cariplo Foundation	TOSCA Project, Cariplo Foundation	This work is funded by TOSCA Project (MC, PP), Cariplo Foundation, http://www.fondazionecariplo.it/it/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas I, 2013, J APPL TOXICOL, V33, P109, DOI 10.1002/jat.1722; ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; Backes C, 2007, GENETRAIL ADV GENE S; BARRY WH, 1993, CIRCULATION, V87, P1806, DOI 10.1161/01.CIR.87.6.1806; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283; Billet S, 2007, ENVIRON RES, V105, P212, DOI 10.1016/j.envres.2007.03.001; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Bourotte Christine Laure Marie, 2011, Rev. bras. meteorol., V26, P419, DOI 10.1590/S0102-77862011000300008; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cao Q, 2007, TOXICOL LETT, V171, P126, DOI 10.1016/j.toxlet.2007.05.007; Chen Qing-Wen, 2004, Yaoxue Xuebao, V39, P500; Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9; Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916; Dergham M, 2012, CHEM RES TOXICOL, V25, P904, DOI 10.1021/tx200529v; Dieme D, 2012, ENVIRON RES, V113, P1, DOI 10.1016/j.envres.2011.11.009; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636; Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031; FELDMAN AM, 1991, CIRCULATION, V83, P1866, DOI 10.1161/01.CIR.83.6.1866; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Garcon G, 2006, TOXICOL IN VITRO, V20, P519, DOI 10.1016/j.tiv.2005.09.012; Goldie RG, 1999, RESP PHARM PHARMACOT; Golubinskaya V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/128046; Graff DW, 2004, ENVIRON HEALTH PERSP, V112, P792, DOI 10.1289/ehp.112-1241994; Gualtieri M, 2012, TOXICOL LETT, V209, P136, DOI 10.1016/j.toxlet.2011.11.015; Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908; Harrigan JA, 2004, TOXICOL SCI, V77, P307, DOI 10.1093/toxsci/kfh030; Holloway JW, 2012, RESPIROLOGY, V17, P590, DOI 10.1111/j.1440-1843.2012.02164.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito T, 2008, TOXICOLOGY, V243, P271, DOI 10.1016/j.tox.2007.10.013; JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kim GB, 1998, ENVIRON POLLUT, V99, P255, DOI 10.1016/S0269-7491(97)00121-8; Kress S, 1997, CANCER RES, V57, P1264; Lin P, 2003, LUNG CANCER-J IASLC, V42, P255, DOI 10.1016/S0169-5002(03)00359-3; Liu W, 2009, EXP LUNG RES, V35, P29, DOI 10.1080/01902140802395757; LOGAN WPD, 1953, LANCET, V264, P336; Longhin E, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-63; Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002; Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023; MATSUBARA H, 1988, BIOCHEM BIOPH RES CO, V156, P619, DOI 10.1016/S0006-291X(88)80888-X; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nemery B, 2001, LANCET, V357, P704, DOI 10.1016/S0140-6736(00)04135-0; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Oh SM, 2011, MUTAT RES-GEN TOX EN, V723, P142, DOI 10.1016/j.mrgentox.2011.04.003; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Perrone MG, 2012, SCI TOTAL ENVIRON, V414, P343, DOI 10.1016/j.scitotenv.2011.11.026; Perrone MG, 2010, CHEMOSPHERE, V78, P1368, DOI 10.1016/j.chemosphere.2009.12.071; Pessah IN, 2001, PEST MANAG SCI, V57, P941, DOI 10.1002/ps.391; Pessah IN, 2001, MOL PHARMACOL, V59, P506, DOI 10.1124/mol.59.3.506; Pleil JD, 2010, J CHROMATOGR B, V878, P1753, DOI 10.1016/j.jchromb.2010.04.035; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rojas M, 2001, CARCINOGENESIS, V22, P1015, DOI 10.1093/carcin/22.7.1015; Rudolph V, 2010, CLIN CHEM, V56, P881, DOI 10.1373/clinchem.2010.147231; Saarikoski ST, 1998, INT J CANCER, V77, P33, DOI 10.1002/(SICI)1097-0215(19980703)77:1<33::AID-IJC7>3.0.CO;2-0; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Shah SJ, 2014, AM J PHYSIOL-HEART C, V306, pH88, DOI 10.1152/ajpheart.00642.2013; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Tankersley CG, 2013, TOXICOL SCI, V131, P95, DOI 10.1093/toxsci/kfs273; Tsukue N, 2010, TOXICOL IN VITRO, V24, P363, DOI 10.1016/j.tiv.2009.11.004; Wang T, 2008, ENVIRON HEALTH PERSP, V116, P1500, DOI 10.1289/ehp.11229; Watterson TL, 2007, J TOXICOL ENV HEAL A, V70, P1731, DOI 10.1080/15287390701457746; Watterson TL, 2009, TOXICOL SCI, V112, P111, DOI 10.1093/toxsci/kfp186; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wong Simon S, 2011, Res Rep Health Eff Inst, P3; Zhang YY, 2013, AQUAT TOXICOL, V142, P26, DOI 10.1016/j.aquatox.2013.07.014	74	70	74	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109685	10.1371/journal.pone.0109685	http://dx.doi.org/10.1371/journal.pone.0109685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296036	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000093
J	Li, YL; Shi, WM; Wang, XX				Li, Yilin; Shi, Weiming; Wang, Xingxiang			New Insights into How Increases in Fertility Improve the Growth of Rice at the Seedling Stage in Red Soil Regions of Subtropical China	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; NITROGEN-USE EFFICIENCY; OXYGEN-EXCHANGE; CULTIVARS; ARCHAEA; NITRIFICATION; RHIZOSPHERE; ROOTS; METHANE; MICROSENSOR	The differences in rhizosphere nitrification activities between high-and low-fertility soils appear to be related to differences in dissolved oxygen concentrations in the soil, implying a relationship to differences in the radial oxygen loss (ROL) of rice roots in these soils. A miniaturised Clark-type oxygen microelectrode system was used to determine rice root ROL and the rhizosphere oxygen profile, and rhizosphere nitrification activity was studied using a short-term nitrification activity assay. Rice planting significantly altered the oxygen cycling in the water-soil system due to rice root ROL. Although the oxygen content in control high-fertility soil (without rice plants) was lower than that in control low-fertility soil, high rice root ROL significantly improved the rhizosphere oxygen concentration in the high-fertility soil. High soil fertility improved the rice root growth and root porosity as well as rice root ROL, resulting in enhanced rhizosphere nitrification. High fertility also increased the content of nitrification-induced nitrate in the rhizosphere, resulting in enhanced ammonium uptake and assimilation in the rice. Although high ammonium pools in the high-fertility soil increased rhizosphere nitrification, rice root ROL might also contribute to rhizosphere nitrification improvement. This study provides new insights into the reasons that an increase in soil fertility may enhance the growth of rice. Our results suggest that an amendment of the fertiliser used in nutrient-and nitrification-poor paddy soils in the red soil regions of China may significantly promote rice growth and rice N nutrition.	[Li, Yilin; Shi, Weiming; Wang, Xingxiang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Wang, Xingxiang] Jiangxi Key Lab Ecol Res Red Soil, Yingtan, Jiangxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS	Wang, XX (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	xxwang@issas.ac.cn			National Natural Science Foundation of China [31471948]; Special Fund for Agro-scientific Research in the Public Interest [201203050-3]; GanPo 555 Talents Program of Jiangxi Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; GanPo 555 Talents Program of Jiangxi Province, China	This research was financially supported by the National Natural Science Foundation of China (No. 31471948), the Special Fund for Agro-scientific Research in the Public Interest (No. 201203050-3) and the GanPo 555 Talents Program of Jiangxi Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 1998, PLANT SOIL, V200, P265, DOI 10.1023/A:1004398520150; Alef K, 1995, ASSAY NITRIFICATION, P241; ARMSTRONG W, 1991, AQUAT BOT, V39, P57, DOI 10.1016/0304-3770(91)90022-W; ARMSTRONG W, 1964, NATURE, V204, P801, DOI 10.1038/204801b0; ARMSTRONG W, 1971, PHYSIOL PLANTARUM, V25, P192, DOI 10.1111/j.1399-3054.1971.tb01427.x; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; Arth I, 2000, BIOL FERT SOILS, V31, P427, DOI 10.1007/s003749900190; Baluska F, 2010, TRENDS PLANT SCI, V15, P402, DOI 10.1016/j.tplants.2010.04.007; BERG P, 1985, BIOL FERT SOILS, V1, P131, DOI 10.1007/BF00301780; Briones AM, 2002, APPL ENVIRON MICROB, V68, P3067, DOI 10.1128/AEM.68.6.3067-3075.2002; Chen XP, 2008, ENVIRON MICROBIOL, V10, P1978, DOI 10.1111/j.1462-2920.2008.01613.x; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; Colmer TD, 1998, PLANT CELL ENVIRON, V21, P240, DOI 10.1046/j.1365-3040.1998.00261.x; Duan YH, 2007, ANN BOT-LONDON, V99, P1153, DOI 10.1093/aob/mcm051; Fan XR, 2007, J EXP BOT, V58, P1729, DOI 10.1093/jxb/erm033; FAO, 1998, FAO WORLD SOIL RES R, V84; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; FRENZEL P, 1992, BIOL FERT SOILS, V14, P84, DOI 10.1007/BF00336255; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; JENSEN CR, 1969, AGRON J, V61, P474, DOI 10.2134/agronj1969.00021962006100030045x; Kim JD, 1999, BOT BULL ACAD SINICA, V40, P185; KLUDZE HK, 1993, SOIL SCI SOC AM J, V57, P386, DOI 10.2136/sssaj1993.03615995005700020017x; KLUDZE HK, 1994, AGRON J, V86, P483, DOI 10.2134/agronj1994.00021962008600030005x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kronzucker HJ, 1999, PLANT PHYSIOL, V119, P1041, DOI 10.1104/pp.119.3.1041; Kronzucker HJ, 2000, NEW PHYTOL, V145, P471, DOI 10.1046/j.1469-8137.2000.00606.x; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li YL, 2007, BIOL FERT SOILS, V43, P417, DOI 10.1007/s00374-006-0119-0; Li YL, 2008, PLANT CELL ENVIRON, V31, P73, DOI 10.1111/j.1365-3040.2007.01737.x; Mugnai S, 2012, PLANT CELL PHYSIOL, V53, P912, DOI 10.1093/pcp/pcs034; Ogawa T, 1999, PLANT CELL REP, V18, P576, DOI 10.1007/s002990050625; RAMAN DR, 1995, BIORESOURCE TECHNOL, V53, P125, DOI 10.1016/0960-8524(95)98138-E; Ratering S, 2001, ENVIRON MICROBIOL, V3, P100, DOI 10.1046/j.1462-2920.2001.00163.x; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Revsbech NP, 1999, BIOL FERT SOILS, V29, P379, DOI 10.1007/s003740050568; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Sorrell BK, 1999, PLANT CELL ENVIRON, V22, P1587, DOI 10.1046/j.1365-3040.1999.00517.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang YA, 2009, SYST APPL MICROBIOL, V32, P27, DOI 10.1016/j.syapm.2008.09.007; Wang YueFu, 2003, Plant Nutrition and Fertilizer Science, V9, P39; Yuan F, 2005, BIOL FERT SOILS, V41, P22, DOI 10.1007/s00374-004-0802-y; Zhang CF, 1997, PLANT SCI, V125, P163, DOI 10.1016/S0168-9452(97)00075-7; Zhang MK, 2005, SOIL TILL RES, V80, P13, DOI 10.1016/j.still.2004.02.019; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001	44	3	3	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109161	10.1371/journal.pone.0109161	http://dx.doi.org/10.1371/journal.pone.0109161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291182	gold, Green Published, Green Submitted			2022-12-25	WOS:000342798000042
J	Raghunathan, VK; Dreier, B; Morgan, JT; Tuyen, BC; Rose, BW; Reilly, CM; Russell, P; Murphy, CJ				Raghunathan, Vijay Krishna; Dreier, Britta; Morgan, Joshua T.; Tuyen, Binh C.; Rose, Brad W.; Reilly, Christopher M.; Russell, Paul; Murphy, Christopher J.			Involvement of YAP, TAZ and HSP90 in Contact Guidance and Intercellular Junction Formation in Corneal Epithelial Cells	PLOS ONE			English	Article							NANOSCALE TOPOGRAPHY; EXTRACELLULAR-MATRIX; TGF-BETA; TRABECULAR MESHWORK; BASEMENT-MEMBRANE; MESENCHYMAL TRANSITION; MECHANOTRANSDUCERS YAP; SUBSTRATUM TOPOGRAPHY; STEM-CELLS; E-CADHERIN	The extracellular environment possesses a rich milieu of biophysical and biochemical signaling cues that are simultaneously integrated by cells and influence cellular phenotype. Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (WWTR1; TAZ), two important signaling molecules of the Hippo pathway, have been recently implicated as nuclear relays of cytoskeletal changes mediated by substratum rigidity and topography. These proteins intersect with other important intracellular signaling pathways (e.g. Wnt and TGF beta). In the cornea, epithelial cells adhere to the stroma through a 3-dimensional topography-rich basement membrane, with features in the nano-submicron size-scale that are capable of profoundly modulating a wide range of fundamental cell behaviors. The influences of substratum-topography, YAP/TAZ knockdown, and HSP90 inhibition on cell morphology, YAP/TAZ localization, and the expression of TGF beta 2 and CTGF, were investigated. The results demonstrate (a) that knockdown of TAZ enhances contact guidance in a YAP dependent manner, (b) that CTGF is predominantly regulated by YAP and not TAZ, and (c) that TGF beta 2 is regulated by both YAP and TAZ in these cells. Additionally, inhibition of HSP90 resulted in nuclear localization and subsequent transcriptional-activation of YAP, formation of cell-cell junctions and co-localization of E-cadherin and beta-catenin at adherens junctions. Results presented in this study reflect the complexities underlying the molecular relationships between the cytoskeleton, growth factors, heat shock proteins, and co-activators of transcription that impact mechanotransduction. The data reveal the importance of YAP/TAZ on the cell behaviors, and gene and protein expression.	[Raghunathan, Vijay Krishna; Dreier, Britta; Morgan, Joshua T.; Tuyen, Binh C.; Rose, Brad W.; Russell, Paul; Murphy, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Reilly, Christopher M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Med, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Murphy, CJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	cjmurphy@ucdavis.edu	Raghunathan, Vijaykrishna/D-2911-2015	Raghunathan, Vijaykrishna/0000-0003-1702-591X; Morgan, Joshua/0000-0001-8033-0285	National Institutes of Health through grants from the National Eye Institute [R01EY01613404, R01EY019970, P30EY12576]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY012576, R01EY019970] Funding Source: NIH RePORTER	National Institutes of Health through grants from the National Eye Institute; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was supported by the National Institutes of Health through grants from the National Eye Institute R01EY01613404, R01EY019970 and P30EY12576 and by an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2002, CELLS TISSUES ORGANS, V170, P251, DOI 10.1159/000047929; Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049; Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Calzado-Martin A, 2011, ACTA BIOMATER, V7, P1890, DOI 10.1016/j.actbio.2010.11.035; Carter RT, 2007, CORNEA, V26, P1213, DOI 10.1097/ICO.0b013e31814b8a28; Chen YM, 2012, INT J CLIN EXP PATHO, V5, P522; Chou CL, 2012, TISSUE ENG A; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8; Dreier B, 2013, AM J PHYSL CELL PHYS; Dreier B, 2012, ACTA BIOMATER, V8, P4285, DOI 10.1016/j.actbio.2012.07.004; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Fraser SA, 2008, J BIOMED MATER RES A, V86A, P725, DOI 10.1002/jbm.a.31519; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; Garrana RMR, 1999, INVEST OPHTH VIS SCI, V40, P1266; Gipson I K, 1995, Curr Opin Ophthalmol, V6, P3; Hau JC, 2013, CHEMBIOCHEM, V14, P1218, DOI 10.1002/cbic.201300163; Hong W, 2012, YAP TAZ TRANSCRIPTIO; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Kantarci A, 2006, J PATHOL, V210, P59, DOI 10.1002/path.2000; Karuri NW, 2008, SCANNING, V30, P405, DOI 10.1002/sca.20123; Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744; Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P3372, DOI 10.1167/iovs.09-4321; McKee CT, 2011, BIOPHYS J, V101, P2139, DOI 10.1016/j.bpj.2011.09.042; Meng W.X., 2009, COLD SPRING HARBOR P, V1; Morgan JT, 2013, EXP EYE RES, V115, P1, DOI 10.1016/j.exer.2013.06.012; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Myrna KE, 2012, INVEST OPHTH VIS SCI, V53, P811, DOI 10.1167/iovs.11-7982; Nakamura K, 2002, INVEST OPHTH VIS SCI, V43, P2603; Nakamura K, 2001, BRIT J OPHTHALMOL, V85, P209, DOI 10.1136/bjo.85.2.209; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Nicolay BN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000918; Odom TW, 2002, LANGMUIR, V18, P5314, DOI 10.1021/la020169l; Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Pot SA, 2010, INVEST OPHTH VIS SCI, V51, P1373, DOI 10.1167/iovs.09-4074; Raghunathan VK, 2013, J BIOMED MATER RES A, V101, P1069, DOI 10.1002/jbm.a.34417; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Raghunathan V, 2013, TISSUE ENG PT A, V19, P1713, DOI [10.1089/ten.tea.2012.0584, 10.1089/ten.TEA.2012.0584]; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Rajnicek AM, 1997, J CELL SCI, V110, P2915; Reka AK, 2011, J THORAC ONCOL, V6, P1784, DOI 10.1097/JTO.0b013e31822adfb0; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Russell P, 2008, INVEST OPHTH VIS SCI, V49, P629, DOI 10.1167/iovs.07-1192; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Sugioka K, 2010, TOHOKU J EXP MED, V222, P45, DOI 10.1620/tjem.222.45; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suzuki K, 2000, INVEST OPHTH VIS SCI, V41, P2495; Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044; Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Terai K, 2011, INVEST OPHTH VIS SCI, V52, P8208, DOI 10.1167/iovs.11-8017; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Tocce EJ, 2013, ACTA BIOMATER, V9, P5040, DOI 10.1016/j.actbio.2012.10.007; Tocce EJ, 2012, J BIOMED MATER RES A, V100A, P84, DOI 10.1002/jbm.a.33233; Tocce EJ, 2010, BIOMATERIALS, V31, P4064, DOI 10.1016/j.biomaterials.2010.01.101; Tomcik M, 2013, ANN RHEUMATIC DIS; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wallace DM, 2013, INVEST OPHTH VIS SCI, V54, P7836, DOI 10.1167/iovs.13-12494; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wilbanks GA, 2005, EUROPEAN J IMMUNOLOG, V22, P165; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070	90	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109811	10.1371/journal.pone.0109811	http://dx.doi.org/10.1371/journal.pone.0109811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290150	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000091
J	Vazquez-Munoz, R; Avalos-Borja, M; Castro-Longoria, E				Vazquez-Munoz, Roberto; Avalos-Borja, Miguel; Castro-Longoria, Ernestina			Ultrastructural Analysis of Candida albicans When Exposed to Silver Nanoparticles	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; INFECTIOUS-DISEASES; ANTIFUNGAL ACTIVITY; ANTIBIOTICS; CYTOTOXICITY; EPIDEMIOLOGY; MECHANISMS; GENERATION	Candida albicans is the most common fungal pathogen in humans, and recently some studies have reported the antifungal activity of silver nanoparticles (AgNPs) against some Candida species. However, ultrastructural analyses on the interaction of AgNPs with these microorganisms have not been reported. In this work we evaluated the effect of AgNPs on C. albicans, and the minimum inhibitory concentration (MIC) was found to have a fungicidal effect. The IC50 was also determined, and the use of AgNPs with fluconazole (FLC), a fungistatic drug, reduced cell proliferation. In order to understand how AgNPs interact with living cells, the ultrastructural distribution of AgNPs in this fungus was determined. Transmission electron microscopy (TEM) analysis revealed a high accumulation of AgNPs outside the cells but also smaller nanoparticles (NPs) localized throughout the cytoplasm. Energy dispersive spectroscopy (EDS) analysis confirmed the presence of intracellular silver. From our results it is assumed that AgNPs used in this study do not penetrate the cell, but instead release silver ions that infiltrate into the cell leading to the formation of NPs through reduction by organic compounds present in the cell wall and cytoplasm.	[Vazquez-Munoz, Roberto; Castro-Longoria, Ernestina] Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico; [Avalos-Borja, Miguel] Inst Potosino Invest Cient & Tecnol IPICYT, Div Mat Avanzados, San Luis Potosi, Slp, Mexico; [Avalos-Borja, Miguel] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Nacional Autonoma de Mexico	Castro-Longoria, E (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	Vazquez-Muñoz, Roberto/L-8502-2017; Vazquez Muñoz, Roberto/C-7966-2018; Castro-Longoria, Ernestina/GYV-4776-2022	Vazquez-Muñoz, Roberto/0000-0002-3847-1305; Vazquez Muñoz, Roberto/0000-0002-3847-1305; Avalos-Borja, Miguel/0000-0003-4515-6415	SEP-CONACyT grant [CB2011/169154]; CONACyT	SEP-CONACyT grant; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by a SEP-CONACyT grant (CB2011/169154). The authors also thank CONACyT for a grant to Roberto Vazquez-Munoz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Buhler V, 2005, EXCIPIENTS PHARM POV, P1; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cassell GH, 2001, JAMA-J AM MED ASSOC, V285, P601, DOI 10.1001/jama.285.5.601; Cuellar-Cruz M, 2012, EUR J CLIN MICROBIOL, V31, P2513, DOI 10.1007/s10096-012-1634-6; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; de Souza A, 2006, CURR SCI INDIA, V91, P926; El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n; Espinel-Ingroff A, 2009, J CLIN MICROBIOL, V47, P2766, DOI 10.1128/JCM.00654-09; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Fothergill AW, 2006, INFECT DIS CLIN N AM, V20, P699, DOI 10.1016/j.idc.2006.06.008; Gajbhiye M, 2009, NANOMED-NANOTECHNOL, V5, P382, DOI 10.1016/j.nano.2009.06.005; Ghosh S, 2010, CARBOHYD RES, V345, P2220, DOI 10.1016/j.carres.2010.08.001; Graybill JR, 1997, EUR J CLIN MICROBIOL, V16, P42, DOI 10.1007/BF01575120; Hidalgo E, 1998, TOXICOL LETT, V98, P169, DOI 10.1016/S0378-4274(98)00114-3; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Hwang IS, 2012, FEBS J, V279, P1327, DOI 10.1111/j.1742-4658.2012.08527.x; Ishida K, 2013, MEM I O CRUZ, P1; Jain J, 2009, MOL PHARMACEUT, V6, P1388, DOI 10.1021/mp900056g; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Kwon HB, 2009, ANN DERMATOL, V21, P308, DOI 10.5021/ad.2009.21.3.308; Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17; Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082; Lionakis MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003079; Martinez-Gutierrez F, 2013, BIOFOULING, V29, P651, DOI 10.1080/08927014.2013.794225; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Moran G, 2012, CANDIDA CANDIDIASIS, P387; Nadworny PL, 2008, NANOMED-NANOTECHNOL, V4, P241, DOI 10.1016/j.nano.2008.04.006; Nasrollahi A, 2011, INT J NANO DIMENS, V1, P233, DOI 10.7508/ijnd.2010.03.007; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Papon N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003550; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295; Roe D, 2008, J ANTIMICROB CHEMOTH, V61, P869, DOI 10.1093/jac/dkn034; Rogers JV, 2008, NANOSCALE RES LETT, V3, P129, DOI 10.1007/s11671-008-9128-2; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stevanovic MM, 2012, POLYMER, V53, P2818, DOI 10.1016/j.polymer.2012.04.057; Stevens DA, 2005, DIAGN MICR INFEC DIS, V51, P173, DOI 10.1016/j.diagmicrobio.2004.10.006; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; White JML, 2003, CLIN EXP DERMATOL, V28, P254, DOI 10.1046/j.1365-2230.2003.01214.x; White RJ., 2001, BR J NURS, V10, pS3, DOI [10.12968/bjon.2001.10.sup4.16079, DOI 10.12968/BJON.2001.10.SUP4.16079, 10.12968/bjon.2001.10.Sup4.16079]	49	97	99	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108876	10.1371/journal.pone.0108876	http://dx.doi.org/10.1371/journal.pone.0108876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290909	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000029
J	Ginsburg, DS; Anlembom, TE; Wang, JN; Patel, SR; Li, B; Hinnebusch, AG				Ginsburg, Daniel S.; Anlembom, Timi Elvuchio; Wang, Jianing; Patel, Sanket R.; Li, Bing; Hinnebusch, Alan G.			NuA4 Links Methylation of Histone H3 Lysines 4 and 36 to Acetylation of Histones H4 and H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR GCN4P; POL II CTD; SACCHAROMYCES-CEREVISIAE; SAGA COMPLEX; GENOME-WIDE; H2B MONOUBIQUITINATION; CRYPTIC TRANSCRIPTION; DEACETYLASE COMPLEX; CODING REGIONS; GENE DELETION	Cotranscriptional methylation of histone H3 lysines 4 and 36 by Set1 and Set2, respectively, stimulates interaction between nucleosomes and histone deacetylase complexes to block cryptic transcription in budding yeast. We previously showed that loss of all H3K4 and H3K36 methylation in a set1 Delta set2 Delta mutant reduces interaction between native nucleosomes and the NuA4 lysine acetyltransferase (KAT) complex. We now provide evidence that NuA4 preferentially binds H3 tails mono- and dimethylated on H3K4 and di- and trimethylated on H3K36, an H3 methylation pattern distinct from that recognized by the RPD3C(S) and Hos2/Set3 histone deacetylase complexes (HDACs). Loss of H3K4 or H3K36 methylation in set1 Delta or set2 Delta mutants reduces NuA4 interaction with bulk nucleosomes in vitro and in vivo, and reduces NuA4 occupancy of transcribed coding sequences at particular genes. We also provide evidence that NuA4 acetylation of lysine residues in the histone H4 tail stimulates SAGA interaction with nucleosomes and its recruitment to coding sequences and attendant acetylation of histone H3 in vivo. Thus, H3 methylation exerts opposing effects of enhancing nucleosome acetylation by both NuA4 and SAGA as well as stimulating nucleosome deacetylation by multiple HDACs to maintain the proper level of histone acetylation in transcribed coding sequences.	[Ginsburg, Daniel S.; Anlembom, Timi Elvuchio; Wang, Jianing; Patel, Sanket R.] LIU Post, Dept Biomed Sci, Brookville, NY 11548 USA; [Li, Bing] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Hinnebusch, Alan G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ginsburg, DS (corresponding author), Dept Biomed Sci, 720 Northern Blvd, Brookville, NY 11548 USA.	daniel.ginsburg@liu.edu		wang, jianing/0000-0002-2191-5627	National Institutes of Health Intramural Research Program; LIU Post Campus Faculty Research Committee; National Institutes of Health [R01GM090077]; Welch Foundation [I-1713]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090077] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LIU Post Campus Faculty Research Committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and the LIU Post Campus Faculty Research Committee.; W.A. "Tex" Moncrief, Jr. Scholar in Medical Research and supported by National Institutes of Health Grant R01GM090077 and Welch Foundation Grant I-1713.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Rasband W., 2006, IMAGEJ; REID GA, 1982, J BIOL CHEM, V257, P3056; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	54	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.585588	http://dx.doi.org/10.1074/jbc.M114.585588			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301943	Green Published, hybrid			2022-12-25	WOS:000345335000023
J	He, LJ; Lou, WJ; Ji, LH; Liang, W; Zhou, ML; Xu, GS; Zhao, LJ; Huang, C; Li, R; Wang, HM; Chen, XM; Sun, SR				He, Lijie; Lou, Weijuan; Ji, Lihua; Liang, Wei; Zhou, Meilan; Xu, Guoshang; Zhao, Lijuan; Huang, Chen; Li, Rong; Wang, Hanmin; Chen, Xiangmei; Sun, Shiren			Serum Response Factor Accelerates the High Glucose-Induced Epithelial-to-Mesenchymal Transition (EMT) via Snail Signaling in Human Peritoneal Mesothelial Cells	PLOS ONE			English	Article							MYOFIBROBLAST DIFFERENTIATION; DIALYSIS; EXPRESSION; MECHANISM; CARCINOMA; MEMBRANE; OVEREXPRESSION; RESISTANCE	Background: Epithelial-to-Mesenchymal Transition (EMT) induced by glucose in human peritoneal mesothelial cells (HPMCs) is a major cause of peritoneal membrane (PM) fibrosis and dysfunction. Methods: To investigate serum response factor (SRF) impacts on EMT-derived fibrosis in PM, we isolated HPMCs from the effluents of patients with end-stage renal disease (ESRD) to analyze alterations during peritoneal dialysis (PD) and observe the response of PM to SRF in a rat model. Results: Our results demonstrated the activation and translocation of SRF into the nuclei of HPMCs under extensive periods of PD. Accordingly, HPMCs lost their epithelial morphology with a decrease in E-cadherin expression and an increase in alpha-smooth muscle actin (alpha-SMA) expression, implying a transition in phenotype. PD with 4.25% glucose solution significantly induced SRF up-regulation and increased peritoneal thickness. In immortal HPMCs, high glucose (HG, 60 mmol/L) stimulated SRF overexpression in transformed fibroblastic HPMCs. SRF-siRNA preserved HPMC morphology, while transfection of SRF plasmid into HPMCs caused the opposite effects. Evidence from electrophoretic mobility shift, chromatin immunoprecipitation and reporter assays further supported that SRF transcriptionally regulated Snail, a potent inducer of EMT, by directly binding to its promoter. Conclusions: Our data suggested that activation of SRF/Snail pathway might contribute to the progressive PM fibrosis during PD.	[He, Lijie; Lou, Weijuan; Ji, Lihua; Liang, Wei; Zhou, Meilan; Xu, Guoshang; Zhao, Lijuan; Huang, Chen; Li, Rong; Wang, Hanmin; Chen, Xiangmei; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Shaan Xi, Peoples R China; [He, Lijie; Lou, Weijuan; Ji, Lihua; Liang, Wei; Wang, Hanmin; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Shaan Xi, Peoples R China; [Ji, Lihua] Fourth Hosp Yulin, Xingyuan Hosp, Dept Nephrol, Yulin, Shaan Xi, Peoples R China; [Liang, Wei] Ninth Hosp Xian, Dept Nephrol, Xian, Shaan Xi, Peoples R China; [Chen, Xiangmei] Chinese PLA Gen Hosp & Med Coll, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Chen, XM (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Shaan Xi, Peoples R China.	xmchen301@126.com; sunshiren@gmail.com	Xu, Guoshuang/GQH-0472-2022		National Scientific Foundation of China [81270849, 81270768, 2012K16-08-05, 81170670, 2011BAI10B08]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Scientific Foundation of China (81270849, 81270768, 2012K16-08-05, 81170670, 2011BAI10B08). All of the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Bezdekova M, 2012, INT J MOL SCI, V13, P1632, DOI 10.3390/ijms13021632; Bidmon B, 2004, KIDNEY INT, V66, P2300, DOI 10.1111/j.1523-1755.2004.66040.x; Choi HN, 2009, ONCOL REP, V21, P57, DOI 10.3892/or_00000189; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Dennis M, 2012, OTOLARYNG HEAD NECK, V147, P726, DOI 10.1177/0194599812446407; Dong C, 2012, ONCOGENE; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Harney AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032318; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Li CX, 2012, NEPHROL DIAL TRANSPL, V27, P4119, DOI 10.1093/ndt/gfs049; Lopez-Cabrera M, 2006, PERITON DIALYSIS INT, V26, P26; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Park MY, 2007, INT J ONCOL, V31, P1309; Peinado H, NAT REV CANC, V7, P415; Saka M, 2006, CLIN EXP PHARMACOL P, V33, P1164, DOI 10.1111/j.1440-1681.2006.04508.x; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Weber CE, 2012, J BURN CARE RES, V33, P311, DOI 10.1097/BCR.0b013e318240541e; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang Y, 2003, AM J RESP CELL MOL, V29, P583, DOI 10.1165/rcmb.2002-0315OC; Yu MA, 2009, J AM SOC NEPHROL, V20, P567, DOI 10.1681/ASN.2008040424; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200	35	22	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108593	10.1371/journal.pone.0108593	http://dx.doi.org/10.1371/journal.pone.0108593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303231	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400018
J	Landgraf, SS; Silva, LS; Peruchetti, DB; Sirtoli, GM; Moraes-Santos, F; Portella, VG; Silva, JL; Pinheiro, CS; Abreu, TP; Takiya, CM; Benjamin, CF; Pinheiro, AAS; Canetti, C; Caruso-Neves, C				Landgraf, Sharon Schilling; Silva, Leandro Souza; Peruchetti, Diogo Barros; Sirtoli, Gabriela Modenesi; Moraes-Santos, Felipe; Portella, Viviane Gomes; Silva-Filho, Joao Luiz; Pinheiro, Carla Silva; Abreu, Thiago Pereira; Takiya, Christina Maeda; Benjamin, Claudia Farias; Sa Pinheiro, Ana Acacia; Canetti, Claudio; Caruso-Neves, Celso			5-Lypoxygenase Products Are Involved in Renal Tubulointerstitial Injury Induced by Albumin Overload in Proximal Tubules in Mice	PLOS ONE			English	Article							NF-KAPPA-B; 5-LIPOXYGENASE ACTIVATING PROTEIN; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; LEUKOTRIENE B-4; ENDOGENOUS INTERLEUKIN-6; IMMUNOMODULATOR AS101; MEDIATED ENDOCYTOSIS; OXIDATIVE STRESS; ANGIOTENSIN-II	The role of albumin overload in proximal tubules (PT) in the development of tubulointerstitial injury and, consequently, in the progression of renal disease has become more relevant in recent years. Despite the importance of leukotrienes (LTs) in renal disease, little is known about their role in tubulointerstitial injury. The aim of the present work was to investigate the possible role of LTs on tubulointerstitial injury induced by albumin overload. An animal model of tubulointerstitial injury challenged by bovine serum albumin was developed in SV129 mice (wild-type) and 5-lipoxygenase-deficient mice (5-LO-/-). The changes in glomerular morphology and nestin expression observed in wild-type mice subjected to kidney insult were also observed in 5-LO-/- mice. The levels of urinary protein observed in the 5-LO-/- mice subjected or not to kidney insult were lower than those observed in respective wild-type mice. Furthermore, the increase in lactate dehydrogenase activity, a marker of tubule damage, observed in wild-type mice subjected to kidney insult did not occur in 5-LO-/- mice. LTB4 and LTD4, 5-LO products, decreased the uptake of albumin in LLC-PK1 cells, a well-characterized porcine PT cell line. This effect correlated with activation of protein kinase C and inhibition of protein kinase B. The level of proinflammatory cytokines, tumor necrosis factor-alpha and interleukin (IL)-6, increased in mice subjected to kidney insult but this effect was not modified in 5-LO-/- mice. However, 5-LO-/- mice subjected to kidney insult presented lower macrophage infiltration and higher levels of IL-10 than wild-type mice. Our results reveal that LTs have an important role in tubulointerstitial disease induced by albumin overload.	[Landgraf, Sharon Schilling; Silva, Leandro Souza; Peruchetti, Diogo Barros; Sirtoli, Gabriela Modenesi; Moraes-Santos, Felipe; Portella, Viviane Gomes; Silva-Filho, Joao Luiz; Pinheiro, Carla Silva; Abreu, Thiago Pereira; Sa Pinheiro, Ana Acacia; Canetti, Claudio; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, Rio De Janeiro, Brazil; [Landgraf, Sharon Schilling] Inst Fed Educ Ciencia & Tecnol, Rio De Janeiro, Brazil; [Takiya, Christina Maeda; Benjamin, Claudia Farias] Univ Fed Rio de Janeiro, CCS, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Sa Pinheiro, Ana Acacia] Inst Nacl Pesquisa Translac Saude & Ambiente Regi, CCS, Dept Fisiol & Biofis, Rio De Janeiro, Brazil; [Caruso-Neves, Celso] Inst Nacl Ciencia Tecnol & Biol & Bioimagem, CCS, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto Federal do Sertao Pernambucano; Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, Rio De Janeiro, Brazil.	caruso@biof.ufrj.br	Peruchetti, Diogo B/L-3706-2017; Benjamim, Claudia/T-5090-2019; Takiya, Christina/AAU-5959-2021; Caruso-Neves, Celso/C-4014-2013; Silva-Filho, João Luiz/I-5704-2016; Claudio, Canetti A/C-2774-2009; Sila, Leandro/B-1381-2018	Peruchetti, Diogo B/0000-0002-7572-9731; Benjamim, Claudia/0000-0001-6247-9596; Takiya, Christina/0000-0002-8019-628X; Caruso-Neves, Celso/0000-0002-2415-7753; Silva-Filho, João Luiz/0000-0003-4762-2205; Sila, Leandro/0000-0001-8720-0088; Pinheiro, Ana Acacia/0000-0002-3894-1645	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INBEB/CNPq/MCT); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INBEB/CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Abreu TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093634; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Aoki Y, 1998, AM J PHYSIOL-LUNG C, V274, pL1030, DOI 10.1152/ajplung.1998.274.6.L1030; Atakan A, 2008, TRANSPL P, V40, P279, DOI 10.1016/j.transproceed.2007.11.026; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; BRACH MA, 1992, EUR J IMMUNOL, V22, P2705, DOI 10.1002/eji.1830221034; Brock TG, 2005, J CELL BIOCHEM, V96, P1203, DOI 10.1002/jcb.20662; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Camara NOS, 2009, CURR OPIN NEPHROL HY, V18, P21, DOI 10.1097/MNH.0b013e32831a9df7; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Choi YK, 2003, GENE THER, V10, P559, DOI 10.1038/sj.gt.3301926; Christman JW, 2000, BRAIN PATHOL, V10, P153; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dahle MK, 2004, INFECT IMMUN, V72, P5704, DOI 10.1128/IAI.72.10.5704-5711.2004; EDDY AA, 1989, AM J PATHOL, V135, P719; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Gekle M, 1998, J AM SOC NEPHROL, V9, P960; Gekle M, 1997, AM J PHYSIOL-RENAL, V272, pF668, DOI 10.1152/ajprenal.1997.272.5.F668; Goulet JL, 2001, J IMMUNOL, V167, P6631, DOI 10.4049/jimmunol.167.11.6631; Guasch A, 1999, KIDNEY INT, V56, P261, DOI 10.1046/j.1523-1755.1999.00537.x; Hadi NR, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-70; Hagar HH, 2012, J SURG RES, V178, pE25, DOI 10.1016/j.jss.2012.02.022; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Hedi H, 2004, J BIOMED BIOTECHNOL, P99, DOI 10.1155/S1110724304310041; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Hefler LA, 2001, AM J PHYSIOL-REG I, V280, pR174, DOI 10.1152/ajpregu.2001.280.1.R174; Herrmann O, 2003, J CEREBR BLOOD F MET, V23, P406, DOI 10.1097/01.WCB.0000055177.50448.FA; Ishola DA, 2006, NEPHROL DIAL TRANSPL, V21, P591, DOI 10.1093/ndt/gfi303; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Kalechman Y, 2004, J BIOL CHEM, V279, P24724, DOI 10.1074/jbc.M312006200; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; KATOH T, 1993, J CLIN INVEST, V91, P1507, DOI 10.1172/JCI116356; Kitching AR, 2002, CLIN EXP IMMUNOL, V128, P36, DOI 10.1046/j.1365-2249.2002.01793.x; Lakkis FG, 1996, KIDNEY INT, V49, P117, DOI 10.1038/ki.1996.16; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Lepley RA, 1998, ARCH BIOCHEM BIOPHYS, V356, P71, DOI 10.1006/abbi.1998.0744; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luchtefeld M, 2003, BIOCHEM BIOPH RES CO, V308, P668, DOI 10.1016/S0006-291X(03)01456-6; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; Maalole T, 2011, PROSTAG LEUKOTR ESS, V85, P37, DOI 10.1016/j.plefa.2011.04.004; Matsuyama M, 2009, TRANSPL P, V41, P73, DOI 10.1016/j.transproceed.2008.08.153; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Monteiro APT, 2011, J IMMUNOL, V186, P6562, DOI 10.4049/jimmunol.1002400; MOORE KP, 1991, ADV PROSTAG THROMB L, V21, P697; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Mysliwska J, 2005, EUR CYTOKINE NETW, V16, P117; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Patel NSA, 2004, MOL PHARMACOL, V66, P220, DOI 10.1124/mol.66.2.220; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; PETRIC R, 1995, J LIPID MEDIAT CELL, V11, P231, DOI 10.1016/0929-7855(94)00040-J; Portella VG, 2013, CRIT CARE MED, V41, P1056, DOI 10.1097/CCM.0b013e3182746696; Poudel B, 2012, N AM J MED SCI, V4, P331, DOI 10.4103/1947-2714.99501; Reinhold SW, 2006, AM J PHYSIOL-RENAL, V290, pF864, DOI 10.1152/ajprenal.00169.2005; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Sener G, 2007, PROSTAG OTH LIPID M, V83, P257, DOI 10.1016/j.prostaglandins.2007.01.013; Sener G, 2006, PHARMACOL RES, V54, P65, DOI 10.1016/j.phrs.2006.02.007; Sinuani Inna, 2013, World J Transplant, V3, P91, DOI 10.5500/wjt.v3.i4.91; Su W, 2007, AM J PHYSIOL-REG I, V292, pR1761, DOI 10.1152/ajpregu.00319.2006; Sun ZL, 2003, GASTROENTEROLOGY, V125, P202, DOI 10.1016/S0016-5085(03)00696-6; Taccone-Gallucci M, 2006, KIDNEY INT, V69, P1450, DOI 10.1038/sj.ki.5000291; Taccone-Gallucci M, 2000, CONTRIB NEPHROL, V130, P130; Takada M, 1997, J CLIN INVEST, V99, P2682, DOI 10.1172/JCI119457; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; Valdivielso JM, 2003, J NEPHROL, V16, P85; Won JS, 2005, GLIA, V51, P13, DOI 10.1002/glia.20178; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yokota N, 2003, AM J NEPHROL, V23, P13, DOI 10.1159/000066301; Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023	80	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e107549	10.1371/journal.pone.0107549	http://dx.doi.org/10.1371/journal.pone.0107549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302946	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400005
J	Chalopin, M; Soleti, R; Benameur, T; Tesse, A; Faure, S; Martinez, MC; Andriantsitohaina, R				Chalopin, Matthieu; Soleti, Raffaella; Benameur, Tarek; Tesse, Angela; Faure, Sebastien; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson			Red Wine Polyphenol Compounds Favor Neovascularisation through Estrogen Receptor alpha-Independent Mechanism in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTHELIUM-DEPENDENT VASORELAXATION; NITRIC-OXIDE SYNTHASE; MOUSE MODEL; ANGIOGENESIS; SIRT1; VEGF; RATS; DELPHINIDIN; INVOLVEMENT	Red wine polyphenol compounds (RWPC) exert paradoxical effects depending on the dose on post-ischemic neovascularisation. Low dose RWPC (0.2 mg/kg/day) is pro-angiogenic, whereas high dose (20 mg/kg/day) is anti-angiogenic. We recently reported that the endothelial effect of RWPC is mediated through the activation of a redox-sensitive pathway, mitochondrial biogenesis and the activation of alpha isoform of the estrogen receptor (ER alpha). Here, we investigated the implication of ER alpha on angiogenic properties of RWPC. Using ovariectomized mice lacking ER alpha treated with high dose of RWPC after hindlimb ischemia, we examined blood flow reperfusion, vascular density, nitric oxide (NO) production, expression and activation of proteins involved in angiogenic process and muscle energy sensing network. As expected, high dose of RWPC treatment reduced both blood flow and vascular density in muscles of mice expressing ER alpha. These effects were associated with reduced NO production resulting from diminished activity of eNOS. In the absence of RWPC, ER alpha deficient mice showed a reduced neo-vascularisation associated with a decreased NO production. Surprisingly in mice lacking ER alpha, high dose of RWPC increased blood flow and capillary density in conjunction with increased NO pathway and production as well as VEGF expression. Of particular interest is the activation of Sirt-1, AMPK alpha and PGC-1 alpha/beta axis in ischemic hindlimb from both strains. Altogether, the results highlight a pro-angiogenic property of RWPC via an ER alpha-independent mechanism that is associated with an up-regulation of energy sensing network. This study brings a corner stone of a novel pathway for RWPC to correct cardiovascular diseases associated with failed neovascularisation.	[Chalopin, Matthieu; Soleti, Raffaella; Benameur, Tarek; Tesse, Angela; Faure, Sebastien; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] INSERM, U1063, Angers, France; [Andriantsitohaina, Ramaroson] CHU Angers, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Andriantsitohaina, R (corresponding author), INSERM, U1063, Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	B, T/ABD-6713-2020; SOLETI, RAFFAELLA/ABB-5455-2020; Clere, Nicolas/K-4414-2015; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; soleti, raffaella/AAC-1678-2021; Tesse, Angela/D-4803-2015; BENAMEUR, TAREK/P-9053-2019	SOLETI, RAFFAELLA/0000-0002-0271-0490; Tesse, Angela/0000-0002-2153-4357; andriantsitohaina, ramaroson/0000-0002-4770-3585; Faure, Sebastien/0000-0001-7524-8295; chalopin, matthieu/0000-0002-9285-8869	INSERM; Universite d'Angers; Contrat d'Interface INSERM; French Education Ministry	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Angers; Contrat d'Interface INSERM; French Education Ministry	This work was supported by institutional grants from INSERM and Universite d'Angers. RA was supported by a Contrat d'Interface INSERM. MC is the recipient of a doctoral fellowship from French Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Andriambeloson E, 1998, J NUTR, V128, P2324, DOI 10.1093/jn/128.12.2324; Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brandes RP, 2008, CARDIOVASC RES, V80, P163, DOI 10.1093/cvr/cvn245; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chalopin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008554; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Donnini S, 2006, BRIT J NUTR, V95, P1016, DOI 10.1079/BJN20061753; Duluc L, 2013, INT J BIOCHEM CELL B, V45, P783, DOI 10.1016/j.biocel.2013.01.007; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Favot L, 2003, CARDIOVASC RES, V59, P479, DOI 10.1016/S0008-6363(03)00433-4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jesmin S, 2010, EUR J PHARMACOL, V641, P168, DOI 10.1016/j.ejphar.2010.05.020; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Martin S, 2003, BIOCHEM PHARMACOL, V65, P669, DOI 10.1016/S0006-2952(02)01568-X; Martin S, 2002, BRIT J PHARMACOL, V135, P1579, DOI 10.1038/sj.bjp.0704603; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Ranaivo HR, 2004, BRIT J PHARMACOL, V142, P671, DOI 10.1038/sj.bjp.0705833; Raval AP, 2006, J CEREBR BLOOD F MET, V26, P1141, DOI 10.1038/sj.jcbfm.9600262; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; Robich MP, 2010, SURGERY, V148, P453, DOI 10.1016/j.surg.2010.04.013; Szekanecz Z, 2009, AUTOIMMUNITY, V42, P563, DOI 10.1080/08916930903143083; Walter A, 2010, FASEB J, V24, P3360, DOI 10.1096/fj.09-149419; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188	41	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110080	10.1371/journal.pone.0110080	http://dx.doi.org/10.1371/journal.pone.0110080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299185	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200100
J	Zhi, F; Wang, Q; Deng, DN; Shao, NY; Wang, R; Xue, L; Wang, SN; Xia, XW; Yang, YL				Zhi, Feng; Wang, Qiang; Deng, Danni; Shao, Naiyuan; Wang, Rong; Xue, Lian; Wang, Suinuan; Xia, Xiwei; Yang, Yilin			MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma	PLOS ONE			English	Article							MALIGNANT GLIOMAS; HUMAN CANCERS; MICRORNA-181B; EXPRESSION; RNA; SENSITIVITY; TARGETS; SYNAPSE; PROTEIN; BRAIN	MicroRNAs (miRNAs) are small, short noncoding RNAs that modulate the expression of numerous genes by targeting their mRNA. Numerous abnormal miRNA expression patterns are observed in various human malignancies, and certain miRNAs can act as oncogenes or tumor suppressors. Astrocytoma, the most common neuroepithelial cancer, represents the majority of malignant brain tumors in humans. In our previous studies, we found that the downregulation of miR-181b-5p in astrocytomas is associated with a poor prognosis. The aim of the present study was to investigate the functional role of miR-181b-5p and its possible target genes. miR-181b-5p was significantly downregulated in astrocytoma specimens, and the reduced expression of miR-181b-5p was inversely correlated with the clinical stage. The ectopic expression of miR-181b-5p inhibited proliferation, migration and invasion and induced apoptosis in astrocytoma cancer cells in vitro. The NOVA1 (neuro-oncological ventral antigen 1) gene was further identified as a novel direct target of miR-181b-5p. Specifically, miR-181b-5p bound directly to the 3'-untranslated region (UTR) of NOVA1 and suppressed its expression. In clinical specimens, NOVA1 was overexpressed, and its protein levels were inversely correlated with miR-181b-5p expression. Furthermore, the changing level of NOVA1 was significantly associated with a poor survival outcome. Similar to restoring miR-181b-5p expression, downregulating NOVA1 inhibited cell growth, migration and invasion. Overexpression of NOVA1 reversed the inhibitory effects of miR-181b-5p. Our results indicate that miR-181b-5p is a tumor suppressor in astrocytoma that inhibits tumor progression by targeting NOVA1. These findings suggest that miR-181b-5p may serve as a novel therapeutic target for astrocytoma.	[Zhi, Feng; Deng, Danni; Wang, Rong; Xue, Lian; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China; [Wang, Qiang; Shao, Naiyuan; Wang, Suinuan; Xia, Xiwei] Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Xia, XW (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China.	xia_xiwei@126.com; yilinyang.czfph@gmail.com		Shao, Naiyuan/0000-0001-5523-7142; Deng, Danni/0000-0001-9409-1318	National Natural Science Foundation of China [31071046, 81302197]; Changzhou Social Development Project [CS20092015, CS20102010]; Changzhou Health Bureau Project [ZD200903, ZD201007]; Changzhou Science Technology Bureau Guiding Project [CY20119004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Social Development Project; Changzhou Health Bureau Project; Changzhou Science Technology Bureau Guiding Project	This work was supported by National Natural Science Foundation of China (31071046, 81302197), Changzhou Social Development Project (CS20092015, CS20102010), Changzhou Health Bureau Project (ZD200903, ZD201007), Changzhou Science Technology Bureau Guiding Project (CY20119004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bisso A, 2013, CELL CYCLE, V12, P1679, DOI 10.4161/cc.24757; Cai BB, 2013, ONCOL REP, V29, P1769, DOI 10.3892/or.2013.2297; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen L, 2012, IUBMB LIFE, V64, P628, DOI 10.1002/iub.1030; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gabayan AJ, 2006, NEUROSURGERY, V58, P701, DOI 10.1227/01.NEU.0000194836.07848.69; Guo JX, 2012, ASIAN PAC J CANCER P, V13, P2263, DOI 10.7314/APJCP.2012.13.5.2263; He L, 2013, GENET MOL RES, V12, P1012, DOI 10.4238/2013.April.2.17; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HL, 2013, J HISTOCHEM CYTOCHEM, V61, P45, DOI 10.1369/0022155412461255; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Park E, 2011, J BIOL CHEM, V286, P25301, DOI 10.1074/jbc.M110.206540; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shi ZM, 2013, RNA, V19, P552, DOI 10.1261/rna.035972.112; Takiuchi D, 2013, PANCREATOLOGY, V13, P517, DOI 10.1016/j.pan.2013.06.007; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang J, 2013, CANCER CHEMOTH PHARM, V72, P147, DOI 10.1007/s00280-013-2180-3; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072390; Zhi F, 2012, INT J BIOL SCI, V8, P289, DOI 10.7150/ijbs.3520; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	31	54	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109124	10.1371/journal.pone.0109124	http://dx.doi.org/10.1371/journal.pone.0109124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299073	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200035
J	Zuo, L; Diaz, PT; Chien, MT; Roberts, WJ; Kishek, J; Best, TM; Wagner, PD				Zuo, Li; Diaz, Philip T.; Chien, Michael T.; Roberts, William J.; Kishek, Juliana; Best, Thomas M.; Wagner, Peter D.			PO2 Cycling Reduces Diaphragm Fatigue by Attenuating ROS Formation	PLOS ONE			English	Article							OXYGEN SPECIES FORMATION; TNF-ALPHA OVEREXPRESSION; REACTIVE OXYGEN; SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; MAMMALIAN SKELETAL; MITOCHONDRIA; ANTIOXIDANTS; CONTRACTIONS; METABOLISM	Prolonged muscle exposure to low PO2 conditions may cause oxidative stress resulting in severe muscular injuries. We hypothesize that PO2 cycling preconditioning, which involves brief cycles of diaphragmatic muscle exposure to a low oxygen level (40 Torr) followed by a high oxygen level (550 Torr), can reduce intracellular reactive oxygen species (ROS) as well as attenuate muscle fatigue in mouse diaphragm under low PO2. Accordingly, dihydrofluorescein (a fluorescent probe) was used to monitor muscular ROS production in real time with confocal microscopy during a lower PO2 condition. In the control group with no PO2 cycling, intracellular ROS formation did not appear during the first 15 min of the low PO2 period. However, after 20 min of low PO2, ROS levels increased significantly by similar to 30% compared to baseline, and this increase continued until the end of the 30 min low PO2 condition. Conversely, muscles treated with PO2 cycling showed a complete absence of enhanced fluorescence emission throughout the entire low PO2 period. Furthermore, PO2 cycling-treated diaphragm exhibited increased fatigue resistance during prolonged low PO2 period compared to control. Thus, our data suggest that PO2 cycling mitigates diaphragm fatigue during prolonged low PO2. Although the exact mechanism for this protection remains to be elucidated, it is likely that through limiting excessive ROS levels, PO2 cycling initiates ROS-related antioxidant defenses.	[Zuo, Li; Roberts, William J.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Davis Heart & Lung Res Inst,Radiol Sci & Resp The, Columbus, OH 43210 USA; [Wagner, Peter D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zuo, Li; Roberts, William J.; Kishek, Juliana] Oakland Univ, Dept Biol Sci, Rochester, MI 48063 USA; [Best, Thomas M.] Ohio State Univ, Sports Hlth & Performance Inst, Dept Family Med, Div Sports Med, Columbus, OH 43210 USA; [Chien, Michael T.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49007 USA; [Diaz, Philip T.] Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of California System; University of California San Diego; Oakland University; University System of Ohio; Ohio State University; Kalamazoo College; University System of Ohio; Ohio State University	Zuo, L (corresponding author), Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Davis Heart & Lung Res Inst,Radiol Sci & Resp The, Columbus, OH 43210 USA.	zuo.4@osu.edu			Oakland University General Fund [G110]; Research Excellence Fund of Biomedical Research; Ohio State University-Health and Rehabilitation Sciences fund [013000]	Oakland University General Fund; Research Excellence Fund of Biomedical Research; Ohio State University-Health and Rehabilitation Sciences fund	Funding provided by Oakland University General Fund G110, Research Excellence Fund of Biomedical Research, and The Ohio State University-Health and Rehabilitation Sciences fund 013000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Brotto MAP, 1996, J APPL PHYSIOL, V81, P731, DOI 10.1152/jappl.1996.81.2.731; CALDARERA CM, 1973, B SOC ITAL BIOL SPER, V49, P72; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen CF, 2003, J PHYSIOL-LONDON, V552, P561, DOI 10.1113/jhysiol.2003.045559; Choi YS, 2007, EXP MOL MED, V39, P556, DOI 10.1038/emm.2007.61; CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135; GROSS GJ, 1992, CIRC RES, V70, P223, DOI 10.1161/01.RES.70.2.223; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Henriksen EJ, 2013, METHOD ENZYMOL, V528, P269, DOI 10.1016/B978-0-12-405881-1.00016-1; JENKINS RR, 1984, INT J SPORTS MED, V5, P11, DOI 10.1055/s-2008-1025872; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; MACFARLANE NG, 1992, CIRC RES, V70, P1217, DOI 10.1161/01.RES.70.6.1217; Mohanraj P, 1998, J APPL PHYSIOL, V84, P1960, DOI 10.1152/jappl.1998.84.6.1960; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Muza SR, 2007, MED SCI SPORT EXER, V39, P1625, DOI 10.1249/mss.0b013e3180de49fe; Penheiter AR, 2007, J BIOL CHEM, V282, P4336, DOI 10.1074/jbc.M609499200; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Ravingerova T, 1998, MOL CELL BIOCHEM, V186, P53, DOI 10.1023/A:1006857527652; REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797; Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Roberts WJ, 2012, GSTF JBIO, V2, P42, DOI DOI 10.5176/2251-3140_2.1.20; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; SEN CK, 1995, J APPL PHYSIOL, V79, P675, DOI 10.1152/jappl.1995.79.3.675; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Wagner PD, 2012, EUR J APPL PHYSIOL, V112, P1, DOI 10.1007/s00421-011-1955-7; Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zuo L, 2005, AM J PHYSIOL-CELL PH, V289, pC207, DOI 10.1152/ajpcell.00449.2004; Zuo L, 2002, METHOD ENZYMOL, V352, P307; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058; Zuo L, 2014, AM J PHYSIOL-REG I, V306, pR75, DOI 10.1152/ajpregu.00425.2013; Zuo Li, 2013, [Frontiers in Biology, 生物学前沿], V8, P305; Zuo L, 2013, AM J PHYSIOL-REG I, V304, pR1009, DOI 10.1152/ajpregu.00563.2012; Zuo Li, 2012, [Frontiers in Biology, 生物学前沿], V7, P506; Zuo L, 2011, AM J PHYSIOL-REG I, V301, pR1025, DOI 10.1152/ajpregu.00126.2011; Zuo L, 2011, J APPL PHYSIOL, V111, P898, DOI 10.1152/japplphysiol.00398.2011	40	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109884	10.1371/journal.pone.0109884	http://dx.doi.org/10.1371/journal.pone.0109884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299212	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000343941200084
J	Callieri, C; Bertoni, R; Contesini, M; Bertoni, F				Callieri, Cristiana; Bertoni, Roberto; Contesini, Mario; Bertoni, Filippo			Lake Level Fluctuations Boost Toxic Cyanobacterial "Oligotrophic Blooms"	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; CLIMATE; EUTROPHICATION; PHYTOPLANKTON; LIGHT	Global warming has been shown to strongly influence inland water systems, producing noticeable increases in water temperatures. Rising temperatures, especially when combined with widespread nutrient pollution, directly favour the growth of toxic cyanobacteria. Climate changes have also altered natural water level fluctuations increasing the probability of extreme events as dry periods followed by heavy rains. The massive appearance of Dolichospermum lemmermannii (= planktonic Anabaena), a toxic species absent from the pelagic zone of the subalpine oligotrophic Lake Maggiore before 2005, could be a consequence of the unusual fluctuations of lake level in recent years. We hypothesized that these fluctuations may favour the cyanobacterium as result of nutrient pulses from the biofilms formed in the littoral zone when the lake level is high. To help verify this, we exposed artificial substrates in the lake, and evaluated their nutrient enrichment and release after desiccation, together with measurements of fluctuations in lake level, precipitation and D.lemmermannii population. The highest percentage of P release and the lowest C:P molar ratio of released nutrients coincided with the summer appearance of the D.lemmermannii bloom. The P pulse indicates that fluctuations in level counteract nutrient limitation in this lake and it is suggested that this may apply more widely to other oligotrophic lakes. In view of the predicted increase in water level fluctuations due to climate change, it is important to try to minimize such fluctuations in order to mitigate the occurrence of cyanobacterial blooms.	[Callieri, Cristiana; Bertoni, Roberto; Contesini, Mario] Inst Ecosyst Study CNR, Verbania, Italy; [Bertoni, Filippo] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); University of Amsterdam	Callieri, C (corresponding author), Inst Ecosyst Study CNR, Verbania, Italy.	c.callieri@ise.cnr.it		Bertoni, Filippo/0000-0001-7037-5949	Project INTERREG STRADA Lombardy Region	Project INTERREG STRADA Lombardy Region	Funding provided by Project INTERREG STRADA Lombardy Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 1999, NEW PHYTOL, V144, P3, DOI 10.1046/j.1469-8137.1999.00505.x; Ambrosetti Walter, 2003, Journal of Limnology, V62, P1; Ambrosetti W, 2010, J LIMNOL, V69, P3, DOI 10.4081/jlimnol.2010.3; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Bates B.C., 2008, CLIMATE CHANGE WATER; Bergey EA, 2006, HYDROBIOLOGIA, V563, P247, DOI 10.1007/s10750-006-0016-4; Bertoni R, 1978, MEM I ITAL IDROBIOL, V36, P297; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Cronberg G., 2006, MANUAL AQUATIC CYANO; ENGEL S, 1994, J FRESHWATER ECOL, V9, P97, DOI 10.1080/02705060.1994.9664436; Gallina N, 2013, AQUAT ECOL, V47, P177, DOI 10.1007/s10452-013-9433-4; Guillizoni P., 1989, MEM I ITAL IDROBIOL, V46, P197; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Heriksen P, 1997, TOXICON, V35, P901; Hoeger SJ, 2007, ENVIRON SCI TECHNOL, V41, P2609, DOI 10.1021/es062681p; Mehnert G, 2010, J PLANKTON RES, V32, P1009, DOI 10.1093/plankt/fbq033; Morabito G, 2007, RICERCHE EVOLUZIONE, P97; Morabito Giuseppe, 2002, Journal of Limnology, V61, P129; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Paul VJ, 2008, ADV EXP MED BIOL, V619, P239, DOI 10.1007/978-0-387-75865-7_11; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/NCLIMATE1581, 10.1038/nclimate1581]; REYNOLDS CS, 1987, NEW ZEAL J MAR FRESH, V21, P379, DOI 10.1080/00288330.1987.9516234; Rigosi A, 2014, LIMNOL OCEANOGR, V59, P99, DOI 10.4319/lo.2014.59.1.0099; Rogora M., 2013, RICERCHE SULLEVOLUZI, P119; Salmaso N, 2000, HYDROBIOLOGIA, V438, P43, DOI 10.1023/A:1004157828049; Salmaso N, 2011, ADV OCEANOGR LIMNOL, V1, P29; Salmaso N, 2012, AQUAT SCI, V74, P555, DOI 10.1007/s00027-012-0248-5; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Shiklomanov IA, 1998, WORLD WATER RESOURCE; SMITH VH, 1986, CAN J FISH AQUAT SCI, V43, P148, DOI 10.1139/f86-016; Song KY, 2007, SCI TOTAL ENVIRON, V380, P13, DOI 10.1016/j.scitotenv.2006.11.035; Wacklin P, 2009, FOTTEA, V9, P59, DOI 10.5507/fot.2009.005; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Whitton B. A., 2012, ECOLOGY CYANOBACTERI, V2, P15	36	42	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109526	10.1371/journal.pone.0109526	http://dx.doi.org/10.1371/journal.pone.0109526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295866	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000078
J	Chen, D; Bobko, AA; Gross, AC; Evans, R; Marsh, CB; Khramtsov, VV; Eubank, TD; Friedman, A				Chen, Duan; Bobko, Andrey A.; Gross, Amy C.; Evans, Randall; Marsh, Clay B.; Khramtsov, Valery V.; Eubank, Timothy D.; Friedman, Avner			Involvement of Tumor Macrophage HIFs in Chemotherapy Effectiveness: Mathematical Modeling of Oxygen, pH, and Glutathione	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERFUSED-RAT-LIVER; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; DRUG-RESISTANCE; PROTON-TRANSFER; CELL-LINES; CANCER; HYPOXIA; ANGIOGENESIS	The four variables, hypoxia, acidity, high glutathione (GSH) concentration and fast reducing rate (redox) are distinct and varied characteristics of solid tumors compared to normal tissue. These parameters are among the most significant factors underlying the metabolism and physiology of solid tumors, regardless of their type or origin. Low oxygen tension contributes to both inhibition of cancer cell proliferation and therapeutic resistance of tumors; low extracellular pH, the reverse of normal cells, mainly enhances tumor invasion; and dysregulated GSH and redox potential within cancer cells favor their proliferation. In fact, cancer cells under these microenvironmental conditions appreciably alter tumor response to cytotoxic anti-cancer treatments. Recent experiments measured the in vivo longitudinal data of these four parameters with tumor development and the corresponding presence and absence of tumor macrophage HIF-1 alpha or HIF-2 alpha in a mouse model of breast cancer. In the current paper, we present a mathematical model-based system of (ordinary and partial) differential equations to monitor tumor growth and susceptibility to standard chemotherapy with oxygen level, pH, and intracellular GSH concentration. We first show that our model simulations agree with the corresponding experiments, and then we use our model to suggest treatments of tumors by altering these four parameters in tumor microenvironment. For example, the model qualitatively predicts that GSH depletion can raise the level of reactive oxygen species (ROS) above a toxic threshold and result in inhibition of tumor growth.	[Chen, Duan] Univ N Carolina, Dept Math & Stat, Charlotte, NC 28223 USA; [Bobko, Andrey A.; Gross, Amy C.; Evans, Randall; Marsh, Clay B.; Khramtsov, Valery V.; Eubank, Timothy D.] Ohio State Univ, Coll Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University of North Carolina; University of North Carolina Charlotte; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eubank, TD (corresponding author), Ohio State Univ, Coll Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Tim.Eubank@osumc.edu; afriedman@math.osu.edu	Bobko, Andrey/M-4997-2015	Eubank, Tim/0000-0002-8225-7824	National Science Foundation [0635561]; NCI [5R00CA131552, R01 HL067167]; NATIONAL CANCER INSTITUTE [R00CA131552] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Science Foundation Award 0635561, NCI 5R00CA131552 (TDE) and R01 HL067167 (CBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; ANTUNES F, 1995, FREE RADICAL BIO MED, V19, P669, DOI 10.1016/0891-5849(95)00040-5; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; BARD S, 1986, BRIT J CANCER, V53, P637, DOI 10.1038/bjc.1986.107; Bobko AA, 2012, MAGN RESON MED, V67, P1827, DOI 10.1002/mrm.23196; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Breward CJW, 2001, EUR J APPL MATH, V12, P529, DOI 10.1017/S095679250100448X; Butterworth E A, 1967, BRIT J CANCER, V21; Calvert P, 1998, CHEM-BIOL INTERACT, V112, P213, DOI 10.1016/S0009-2797(98)00008-8; Cameron AC, 1997, J ECONOMETRICS, V77, P329; CASCIARI JJ, 1988, CANCER RES, V48, P3905; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Coso S, 2012, ANTIOXID REDOX SIGN, V16, P1229, DOI 10.1089/ars.2011.4489; Dai L, 2002, J BIOL CHEM, V277, P11368; Eubank TD, 2011, BLOOD, V117, P323, DOI 10.1182/blood-2010-01-261792; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Flohe L, 1978, Ciba Found Symp, P95; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Harguindey S, 2009, ANTICANCER RES, V29, P2127; Hochwald SN, 1997, ANN SURG ONCOL, V4, P303, DOI 10.1007/BF02303579; Hu YM, 2005, J BIOL CHEM, V280, P39485, DOI 10.1074/jbc.M503296200; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; Khramtsov VV, 2014, ANTIOXID REDOX SIGN, V21, P723, DOI 10.1089/ars.2014.5864; Laurent A, 2005, CANCER RES, V65, P948; LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402; LEWIS AD, 1988, CARCINOGENESIS, V9, P1283, DOI 10.1093/carcin/9.7.1283; Li SJ, 2000, CANCER RES, V60, P3927; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; LUZ Z, 1964, J AM CHEM SOC, V86, P4768, DOI 10.1021/ja01076a008; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; MACDOUGALL JD, 1967, NATURE, V215, P1173, DOI 10.1038/2151173a0; Manda G, 2009, CURR CHEM BIOL, V3, P342, DOI DOI 10.2174/187231309787158271; MARTIN GR, 1994, CANCER RES, V54, P5670; Martin NK, 2010, J THEOR BIOL, V267, P461, DOI 10.1016/j.jtbi.2010.08.028; Melillo G, 1999, CANCER RES, V59, P5433; MULCAHY RT, 1994, MOL PHARMACOL, V46, P909; Ng CF, 2007, FREE RADICAL RES, V41, P1201, DOI 10.1080/10715760701625075; OBrien ML, 1996, EUR J CANCER, V32A, P967, DOI 10.1016/0959-8049(96)00051-2; OOKHTENS M, 1985, J CLIN INVEST, V75, P258, DOI 10.1172/JCI111682; Oren H, 2001, PEDIATRICS, V108, P329, DOI 10.1542/peds.108.2.329; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; OSHINO N, 1973, ARCH BIOCHEM BIOPHYS, V154, P117, DOI 10.1016/0003-9861(73)90040-4; Owen MR, 1997, J THEOR BIOL, V189, P63, DOI 10.1006/jtbi.1997.0494; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Plank MJ, 2004, J THEOR BIOL, V229, P435, DOI 10.1016/j.jtbi.2004.04.012; Pyaskovskaya O. N., 2008, Experimental Oncology, V30, P269; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Ribeiro Maria de Lourdes C, 2012, J Nutr Food Sci, V2, P6; Roda JM, 2011, J IMMUNOL, V187, P1970, DOI 10.4049/jimmunol.1100841; Roshchupkina GI, 2008, FREE RADICAL BIO MED, V45, P312, DOI 10.1016/j.freeradbiomed.2008.04.019; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Sekhar RV, 2011, AM J CLIN NUTR, V94, P847, DOI 10.3945/ajcn.110.003483; Smallbone K, 2008, J THEOR BIOL, V255, P106, DOI 10.1016/j.jtbi.2008.08.002; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; STUBBS M, 1992, NMR BIOMED, V5, P351, DOI 10.1002/nbm.1940050606; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tang SS, 2000, CHINESE SCI BULL, V45, P1697, DOI 10.1007/BF02898990; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Utting JC, 2010, CELL BIOCHEM FUNCT, V28, P374, DOI 10.1002/cbf.1660; Vaupel P, 2003, CANCER RES, V63, P7634; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vicioso L, 2006, AM J CLIN PATHOL, V125, P111, DOI 10.1309/0864AF2U3LGPCF3J; Vincensini D, 2007, MAGNETIC RESONANCE I, V25; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wathen KA, 2011, HUM REPROD, V26, P221, DOI 10.1093/humrep/deq304; Wraight CA, 2006, BBA-BIOENERGETICS, V1757, P886, DOI 10.1016/j.bbabio.2006.06.017; Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Xu L, 2002, J BIOL CHEM, V277, P11368, DOI 10.1074/jbc.M108347200; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z	82	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107511	10.1371/journal.pone.0107511	http://dx.doi.org/10.1371/journal.pone.0107511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295611	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000006
J	da Silva, F; Almeida-Neto, M; Arena, MVN				da Silva, Fernando Rodrigues; Almeida-Neto, Mario; Nicolosi Arena, Mariana Victorino			Amphibian Beta Diversity in the Brazilian Atlantic Forest: Contrasting the Roles of Historical Events and Contemporary Conditions at Different Spatial Scales	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; PHYLOGENETIC DIVERSITY; RELATIVE ROLES; BIOGEOGRAPHY; BIODIVERSITY; SPECIATION; RESOLUTION; EVOLUTION; TURNOVER	Current patterns of biodiversity distribution result from a combination of historical and contemporary processes. Here, we compiled checklists of amphibian species to assess the roles of long-term climate stability (Quaternary oscillations), contemporary environmental gradients and geographical distance as determinants of change in amphibian taxonomic and phylogenetic composition in the Brazilian Atlantic Forest. We calculated beta diversity as both variation in species composition (CBD) and phylogenetic differentiation (PBD) among the assemblages. In both cases, overall beta diversity was partitioned into two basic components: species replacement and difference in species richness. Our results suggest that the CBD and PBD of amphibians are determined by spatial turnover. Geographical distance, current environmental gradients and long-term climatic conditions were complementary predictors of the variation in CBD and PBD of amphibian species. Furthermore, the turnover components between sites from different regions and between sites within the stable region were greater than between sites within the unstable region. On the other hand, the proportion of beta-diversity due to species richness difference for both CBD and PBD was higher between sites in the unstable region than between sites in the stable region. The high turnover components from CBD and PBD between sites in unstable vs stable regions suggest that these distinct regions have different biogeographic histories. Sites in the stable region shared distinct clades that might have led to greater diversity, whereas sites in the unstable region shared close relatives. Taken together, these results indicate that speciation, environmental filtering and limited dispersal are complementary drivers of beta-diversity of amphibian assemblages in the Brazilian Atlantic Forest.	[da Silva, Fernando Rodrigues; Nicolosi Arena, Mariana Victorino] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil; [Almeida-Neto, Mario] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Goias	da Silva, F (corresponding author), Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil.	fernandors@ufscar.br	Almeida-Neto, M./A-6389-2009; da Silva, Fernando Rodrigues/G-3026-2012; Arena, Mariana Victorino Nicolosi/AAY-7727-2021; Victorino Nicolosi Arena, Mariana/A-1569-2019	Almeida-Neto, M./0000-0002-2161-2968; da Silva, Fernando Rodrigues/0000-0002-0983-3207; Victorino Nicolosi Arena, Mariana/0000-0003-3455-790X	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo [Proc. 2013/50714-0, Proc. 2011/22618-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [Proc. 483486/2011-6, Proc. 306870/2012-6]	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FRdS and MVNA were supported by Fundacao de Amparo a Pesquisa no Estado de Sao Paulo ((http://www.fapesp.br/), Proc. 2013/50714-0 and Proc. 2011/22618-0, respectively). FRdS and MAN were supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico ((http://www.cnpq.br/), Proc. 483486/2011-6 and Proc. 306870/2012-6, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Baselga A, 2013, BETAPART PARTITIONIN; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fouquet A, 2013, MOL PHYLOGENET EVOL, V67, P445, DOI 10.1016/j.ympev.2013.02.009; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2014, ECOGRAPHY, V37, P711, DOI 10.1111/ecog.00578; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Haddad CFB, 2013, GUIA ANFIBIOS MATA A; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HIjMAns R.J., 2012, DIVA GIS VERSION 7 5; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hua X, 2013, AM NAT, V182, P1, DOI 10.1086/670690; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Kozak KH, 2012, ECOLOGY, V93, pS167, DOI 10.1890/11-0542.1; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; Loyola RD, 2014, ECOGRAPHY, V37, P65, DOI 10.1111/j.1600-0587.2013.00396.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lynch J.D., 1986, P478; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; Mittermeier R. A., 2005, HOTSPOTS EARTHS BIOL; Navas CA, 2004, INT CONGR SER, V1275, P298, DOI 10.1016/j.ics.2004.08.061; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oberdorff T, 1997, J BIOGEOGR, V24, P461, DOI 10.1111/j.1365-2699.1997.00113.x; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peixoto FP, 2014, J BIOGEOGR, V41, P762, DOI 10.1111/jbi.12241; Porto TJ, 2013, DIVERS DISTRIB, V19, P330, DOI 10.1111/j.1472-4642.2012.00944.x; Pyron RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1622; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P1152, DOI 10.1111/geb.12076; R Core Team, 2021, R LANG ENV STAT COMP; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Svenning JC, 2005, J BIOGEOGR, V32, P1019, DOI 10.1111/j.1365-2699.2005.01219.x; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Villalobos F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056073; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	69	26	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109642	10.1371/journal.pone.0109642	http://dx.doi.org/10.1371/journal.pone.0109642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295514	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000089
J	Dienes, L; Kranitz, K; Juhasz, E; Gyenes, A; Takacs, A; Mihaltz, K; Nagy, ZZ; Kovacs, I				Dienes, Lorant; Kranitz, Kinga; Juhasz, Eva; Gyenes, Andrea; Takacs, Agnes; Mihaltz, Kata; Nagy, Zoltan Z.; Kovacs, Illes			Evaluation of Intereye Corneal Asymmetry in Patients with Keratoconus. A Scheimpflug Imaging Study	PLOS ONE			English	Article							UNILATERAL KERATOCONUS; SUBCLINICAL KERATOCONUS; PARAMETERS; THICKNESS; ELEVATION; PENTACAM; EYES; REPEATABILITY; TOMOGRAPHY; TOPOGRAPHY	Purpose: To assess the correlation between keratoconus severity and intereye asymmetry of pachymetric data and posterior elevation values and to evaluate their combined accuracy in discriminating normal corneas from those with keratoconus. Methods: This study included 97 patients: 65 subjects with bilateral normal corneas (NC) and 32 with keratoconus (KC). Central corneal thickness (CCT), thinnest corneal thickness (ThCT) and posterior elevation (PE) at the thinnest point of the cornea were measured in both eyes using Scheimpflug imaging. Intereye asymmetry and its correlation with keratoconus severity were calculated for each variable. The area under the receiver operating characteristic curve (AUROC) was used to compare predictive accuracy of different variables for keratoconus. Results: In normal eyes, intereye differences were significantly lower compared with the keratoconus eyes (p<0.001, for CCT, ThCT and PE). There was a significant exponential correlation between disease severity and intereye asymmetry of steep keratometry (r(2) = 0.55, p<0.001), CCT (r(2) = 0.39, p<0.001), ThCT (r(2) = 0.48, p<0.001) and PE (r(2) = 0.64, p<0.001). After adjustment for keratoconus severity, asymmetry in thinnest pachymetry proved to be the best parameter to characterize intereye corneal asymmetry in keratoconus. This variable had high accuracy and significantly better discriminating ability (AUROC: 0.99) for KC than posterior elevation (AUROC: 0.96), ThCT (AUROC: 0.94) or CCT (AUROC: 0.92) alone. Conclusions: There is an increased intereye asymmetry in keratometry, pachymetry and posterior corneal elevation values in keratoconic patients compared to subjects with normal corneas. Keratoconus patients with more severe disease are also more asymmetric in their disease status which should be taken into account during clinical care.	[Dienes, Lorant; Kranitz, Kinga; Juhasz, Eva; Gyenes, Andrea; Takacs, Agnes; Nagy, Zoltan Z.; Kovacs, Illes] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [Mihaltz, Kata] Karl Landsteiner Inst Proc Optimalizat, Vienna, Austria; [Mihaltz, Kata] QM Cataract Surg, Vienna, Austria	Semmelweis University	Kovacs, I (corresponding author), Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary.	kovacs.illes@med.semmelweis-univ.hu	Nagy, Zoltan Zsolt/T-6180-2017		Hungarian Scientific Research Fund OTKA [NN106649]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund OTKA NN106649 research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio R, 2003, J REFRACT SURG, V19, P24; Ambrosio R, 2011, J REFRACT SURG, V27, P753, DOI 10.3928/1081597X-20110721-01; Ambrosio R, 2010, J REFRACT SURG, V26, P847, DOI 10.3928/1081597X-20101006-01; Bae GH, 2014, AM J OPHTHALMOL, V157, P103, DOI 10.1016/j.ajo.2013.08.014; Berti TB, 2013, J REFRACT SURG, V29, P430, DOI 10.3928/1081597X-20130515-05; Burns DM, 2004, BRIT J OPHTHALMOL, V88, P1252, DOI 10.1136/bjo.2003.033670; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020; De Sanctis U, 2007, AM J OPHTHALMOL, V144, P712, DOI 10.1016/j.ajo.2007.07.021; Demir S, 2013, CORNEA, V32, P1470, DOI 10.1097/ICO.0b013e3182a7387f; Dutta D, 2013, OPHTHALMOLOGY, V120, P457, DOI 10.1016/j.ophtha.2012.08.036; Emre S, 2007, J CATARACT REFR SURG, V33, P1708, DOI 10.1016/j.jcrs.2007.06.020; Fam HB, 2006, J CATARACT REFR SURG, V32, P1281, DOI 10.1016/j.jcrs.2006.02.060; Henriquez MA, 2013, CORNEA, V32, P779, DOI 10.1097/ICO.0b013e31827b14ae; Holland DR, 1997, OPHTHALMOLOGY, V104, P1409, DOI 10.1016/S0161-6420(97)30123-7; Khachikian SS, 2009, OPHTHALMOLOGY, V116, P816, DOI 10.1016/j.ophtha.2009.01.009; LEE LR, 1995, AUST NZ J OPHTHALMOL, V23, P129, DOI 10.1111/j.1442-9071.1995.tb00141.x; Li XH, 2004, OPHTHALMOLOGY, V111, P440, DOI 10.1016/j.ophtha.2003.06.020; McMahon TT, 2006, CORNEA, V25, P794, DOI 10.1097/01.ico.0000226359.26678.d1; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Nichols JJ, 2004, BRIT J OPHTHALMOL, V88, P788, DOI 10.1136/bjo.2003.034520; Nishida T, 2005, CORNEA, V1, P232; Pflugfelder SC, 2002, OPHTHALMOLOGY, V109, P2336, DOI 10.1016/S0161-6420(02)01276-9; Pinero DP, 2012, J CATARACT REFR SURG, V38, P2167, DOI 10.1016/j.jcrs.2012.10.022; Prakash G, 2012, EYE, V26, P650, DOI 10.1038/eye.2011.365; Quisling S, 2006, OPHTHALMOLOGY, V113, P1629, DOI [10.1016/j.ophtha.2006.03.046, 10.1016/j.ophtha.2006.06.046]; RABINOWITZ YS, 1993, OPHTHALMOLOGY, V100, P181; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Smadja D, 2013, AM J OPHTHALMOL, V156, P237, DOI 10.1016/j.ajo.2013.03.034; Ucakhan OO, 2011, J CATARACT REFR SURG, V37, P1116, DOI 10.1016/j.jcrs.2010.12.049; WALTER SD, 1983, AM J EPIDEMIOL, V118, P865, DOI 10.1093/oxfordjournals.aje.a113705; Wei RH, 2011, J REFRACT SURG, V27, P745, DOI 10.3928/1081597X-20110426-01; WILSON SE, 1991, CORNEA, V10, P2; Zadnik K, 2002, CORNEA, V21, P671, DOI 10.1097/00003226-200210000-00008	34	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108882	10.1371/journal.pone.0108882	http://dx.doi.org/10.1371/journal.pone.0108882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296183	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000024
J	Kaprio, T; Hagstrom, J; Mustonen, H; Koskensalo, S; Andersson, LC; Haglund, C				Kaprio, Tuomas; Hagstrom, Jaana; Mustonen, Harri; Koskensalo, Selja; Andersson, Leif C.; Haglund, Caj			REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer	PLOS ONE			English	Article							IV EXPRESSION; GENE FAMILY; PROTEIN; OVEREXPRESSION; GROWTH; SERUM; RELP	Introduction: Colorectal cancer (CRC) is one of the world's three most common cancers and its incidence is rising. To identify patients who benefit from adjuvant therapy requires novel biomarkers. The regenerating islet-derived gene (REG) 4 belongs to a group of small secretory proteins involved in cell proliferation and regeneration. Its up-regulated expression occurs in inflammatory bowel diseases also in gastrointestinal cancers. Reports on the association of REG4 expression with CRC prognosis have been mixed. Our aim was to investigate tumor REG4 expression in CRC patients and its coexpression with other intestinal markers. Methods: Tumor expression of REG4 was evaluated by immunohistochemistry in 840 consecutive surgically treated CRC patients at Helsinki University Central Hospital. Expression of MUC1, MUC2, MUC5AC, synapthophysin, and chromogranin was evaluated in a subgroup of 220 consecutively operated CRC patients. REG4 expression with clinicopathological parameters, other intestinal markers, and the impact of REG4 expression on survival were assessed. Results: REG4 expression associated with favorable clinicopathological parameters and with higher overall survival from non-mucinous CRC (p = 0.019). For such patients under 65, its expression was an independent marker of lower risk of death within 5 years that cancer; univariable hazard ratio (HR) = 0.57; 95% confidence interval (CI) (0.34-0.94); multivariable HR = 0.55; 95% CI (0.33-0.92). In non-mucinous CRC, REG4 associated with positive MUC2, MUC4, and MUC5AC expression. Conclusion: We show, to our knowledge for the first time, that REG4 IHC expression to be an independent marker of favorable prognosis in non-mucinous CRC. Our results contradict those from studies based on quantification of REG4 mRNA levels, a discrepancy warranting further studies.	[Kaprio, Tuomas; Mustonen, Harri; Koskensalo, Selja; Haglund, Caj] Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; [Kaprio, Tuomas; Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Hagstrom, Jaana; Andersson, Leif C.] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; [Hagstrom, Jaana; Andersson, Leif C.] HUSLAB, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kaprio, T (corresponding author), Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.	tuomas.kaprio@helsinki.fi	Kaprio, Tuomas/AAD-8042-2020; Hagström, Jaana/G-1468-2018; Haglund, Caj/N-1240-2019	Kaprio, Tuomas/0000-0002-0377-9975; Hagström, Jaana/0000-0001-6079-7881; Mustonen, Harri Kalevi/0000-0001-5632-6796	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation; Medicinska understodsforeningen Liv och Halsa, K. Albin Johansson Foundation	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medicinska understodsforeningen Liv och Halsa, K. Albin Johansson Foundation	This study was supported by grants from Finska Lakaresallskapet, the Kurt och Doris Palander Foundation, the Sigrid Juselius Foundation, and Medicinska understodsforeningen Liv och Halsa, K. Albin Johansson Foundation, and a special governmental subsidy for research and training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Bockelman C, 2012, CANCER BIOL THER, V13, P289, DOI [10.4161/cbt.18922, 10.4161/cbt.13.5.18922]; Broekaert D, 2002, EUR CYTOKINE NETW, V13, P78; DUSETTI NJ, 1994, GENOMICS, V19, P108, DOI 10.1006/geno.1994.1019; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Heiskala K, 2006, VIRCHOWS ARCH, V448, P295, DOI 10.1007/s00428-005-0105-1; Heiskala K, 2010, HISTOL HISTOPATHOL, V25, P63, DOI 10.14670/HH-25.63; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; Kamarainen M, 2003, AM J PATHOL, V163, P11, DOI 10.1016/S0002-9440(10)63625-5; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Li XH, 2010, HISTOL HISTOPATHOL, V25, P473, DOI 10.14670/HH-25.473; Macadam RCA, 2000, BRIT J CANCER, V83, P188; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Numata M, 2011, J SURG ONCOL, V104, P205, DOI 10.1002/jso.21906; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Sasahira T, 2008, HISTOPATHOLOGY, V53, P667, DOI 10.1111/j.1365-2559.2008.03188.x; Schroder N, 2006, GASTROENTEROLOGY, V130, P902, DOI 10.1053/j.gastro.2005.12.025; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Tao HQ, 2011, HUM PATHOL, V42, P1401, DOI 10.1016/j.humpath.2010.08.023; Zheng HC, 2011, J HISTOCHEM CYTOCHEM, V59, P106, DOI 10.1369/jhc.2010.956961	24	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109600	10.1371/journal.pone.0109600	http://dx.doi.org/10.1371/journal.pone.0109600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295732	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000084
J	Kim, SY; Koh, WJ; Kim, YH; Jeong, BH; Park, HY; Jeon, K; Kim, JS; Cho, SN; Shin, SJ				Kim, Su-Young; Koh, Won-Jung; Kim, Yee Hyung; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman; Kim, Jong-Seok; Cho, Sang-Nae; Shin, Sung Jae			Importance of Reciprocal Balance of T Cell Immunity in Mycobacterium abscessus Complex Lung Disease	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; ACTIVE TUBERCULOSIS; INDUCIBLE PROTEIN-10; PULMONARY-DISEASE; PERIPHERAL-BLOOD; AVIUM COMPLEX; TH17 CELLS; IFN-GAMMA; IN-VIVO; EXPRESSION	Background: Little is known about the nature of the host immune response to Mycobacterium abscessus complex (MABC) infection. The aim of the present study was to investigate whether alterations in serum immunomolecule levels after treating MABC lung disease patients with antibiotics can reflect the disease-associated characteristics. Methods: A total of 22 immunomolecules in 24 MABC lung disease patients before and after antibiotic therapy were quantitatively analyzed using a multiplex bead-based system. Results: In general, the pre-treatment levels of T helper type 1 (Th1)-related cytokines, i.e., interferon (IFN)-gamma and interleukin (IL)-12, and Th2-related cytokines, i.e., IL-4 and IL-13, were significantly decreased in patients compared with control subjects. In contrast, the pre-treatment levels of Th17-related cytokines, i.e., IL-17 and IL-23, were significantly increased in MABC patients. Interestingly, significantly higher levels of IFN-gamma-induced protein (IP)-10 and monokine induced by IFN-gamma protein (MIG) were detected in patients with failure of sputum conversion at post-treatment compared to patients with successful sputum conversion. Conclusion: Reduced Th1 and Th2 responses and enhanced Th17 responses in patients may perpetuate MABC lung disease, and the immunomolecules IP-10 and MIG, induced through IFN-gamma, may serve as key markers for indicating the treatment outcome.	[Kim, Su-Young; Koh, Won-Jung; Kim, Yee Hyung; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Kim, Jong-Seok; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol,Brain Korea PLUS Project Med Sci 2, Seoul 120749, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol,Brain Korea PLUS Project Med Sci 2, Seoul 120749, South Korea.	sjshin@yuhs.ac	Jeon, Kyeongman/F-5963-2019; Kim, Su-Young/GVT-4242-2022; Koh, Won-Jung/D-9586-2018; park, hy/O-5934-2014; Koh, Won Jung/C-9595-2011	Jeon, Kyeongman/0000-0002-4822-1772; Kim, Su-Young/0000-0002-6369-3399; Koh, Won-Jung/0000-0002-4756-3527; Shin, Sung Jae/0000-0003-0854-4582; Jeong, Byeong-Ho/0000-0002-3124-1718	Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A120647]	Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This work was supported by a grant of the Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A120647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand M, 2014, J INFECTION, V68, P62, DOI 10.1016/j.jinf.2013.08.005; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bajoriuniene I, 2012, LUNG, V190, P487, DOI 10.1007/s00408-012-9411-y; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Cho YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081560; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Dheda K, 2008, THORAX, V63, P566, DOI 10.1136/thx.2007.092205; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harada T, 2012, J CLIN MICROBIOL, V50, P3556, DOI 10.1128/JCM.01175-12; Howard ST, 2013, TUBERCULOSIS, V93, pS15, DOI 10.1016/S1472-9792(13)70005-2; Vargas-Rojas MI, 2011, RESP MED, V105, P1648, DOI 10.1016/j.rmed.2011.05.017; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim SY, 2014, CLIN EXP IMMUNOL, V176, P93, DOI 10.1111/cei.12253; Kim TS, 2014, J CLIN IMMUNOL, V34, P212, DOI 10.1007/s10875-013-9978-y; Koh WJ, 2014, INT J TUBERC LUNG D, V18, P1141, DOI 10.5588/ijtld.14.0134; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; Kushwah R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-138; Kwon YS, 2007, LUNG, V185, P337, DOI 10.1007/s00408-007-9040-z; Lande R, 2003, J IMMUNOL, V170, P1174, DOI 10.4049/jimmunol.170.3.1174; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Lim A, 2010, DIS MARKERS, V29, P103, DOI [10.3233/DMA-2010-0732, 10.1155/2010/347142]; Lim A, 2010, CLIN IMMUNOL, V137, P296, DOI 10.1016/j.clim.2010.07.011; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Narumi S, 2000, CYTOKINE, V12, P1007, DOI 10.1006/cyto.1999.0672; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Perna V, 2013, EUR CYTOKINE NETW, V24, P157, DOI 10.1684/ecn.2014.0346; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ryu YJ, 2007, EUR RESPIR J, V30, P736, DOI 10.1183/09031936.00039507; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Shin DM, 2008, CELL MICROBIOL, V10, P1608, DOI 10.1111/j.1462-5822.2008.01151.x; ten Berge B, 2012, RHEUMATOLOGY, V51, P37, DOI 10.1093/rheumatology/ker316; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Vankayalapati R, 2001, J INFECT DIS, V183, P478, DOI 10.1086/318087; Wang XJ, 2012, TUBERCULOSIS, V92, P513, DOI 10.1016/j.tube.2012.06.005; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317	40	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109941	10.1371/journal.pone.0109941	http://dx.doi.org/10.1371/journal.pone.0109941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295870	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000106
J	Siedlecka, M; Klimza, A; Lukowska, M; Wierzchon, M				Siedlecka, Marta; Klimza, Anna; Lukowska, Marta; Wierzchon, Michal			Rubber Hand Illusion Reduces Discomfort Caused by Cold Stimulus	PLOS ONE			English	Article							BODY AWARENESS; PAIN; OWNERSHIP; ATTENTION; FEEL; SELF; UNPLEASANTNESS; ANXIETY; BRAIN; TOUCH	There is a growing interest in body-ownership disruptions and their consequences for subjective experiences such as tactile sensations or pain. Here, we investigated the effect of the rubber hand illusion (RHI) on the perceived discomfort caused by cold stimulus applied to the real hand. The results showed reduced discomfort to cold reflected in behavioural and subjective measures. The stronger the illusion, the later the cold temperature became unpleasant and the less intense the experience was rated. We discuss the link between thermoception and body ownership as well as possible theoretical and methodological implications for studies on pain experience under RHI.	[Siedlecka, Marta; Lukowska, Marta; Wierzchon, Michal] Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland; [Klimza, Anna] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland	Jagiellonian University; SWPS University of Social Sciences & Humanities	Siedlecka, M (corresponding author), Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland.	marta.siedlecka@uj.edu.pl	Siedlecka, Marta/B-9001-2015; Siedlecka, Marta/AAP-2503-2020; Wierzchon, Michal/B-7207-2012	Wierzchon, Michal/0000-0002-7347-2696; Siedlecka, Marta/0000-0002-0688-4500; Lukowska, Marta/0000-0002-0428-8190	National Science Centre, Poland [2012/07/E/HS6/01037]	National Science Centre, Poland(National Science Centre, Poland)	The publication was supported by the National Science Centre, Poland [grant 2012/07/E/HS6/01037] http://www.ncn.gov.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Auvray M, 2010, NEUROSCI BIOBEHAV R, V34, P214, DOI 10.1016/j.neubiorev.2008.07.008; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bunning S, 2005, PROG BRAIN RES, V150, P331, DOI 10.1016/S0079-6123(05)50024-4; Capelari EDP, 2009, PERCEPTION, V38, P92, DOI 10.1068/p5892; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; de Vignemont F, 2011, CONSCIOUS COGN, V20, P82, DOI 10.1016/j.concog.2010.09.004; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2009, PERCEPTION, V38, P310, DOI 10.1068/p6304; Ferri F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1140; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Greenspan JD, 2003, SOMATOSENS MOT RES, V20, P19, DOI 10.1080/0899022031000083807; Guterstam A, 2012, CONSCIOUS COGN, V21, P1037, DOI 10.1016/j.concog.2012.01.018; Guterstam A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017208; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Hansel A, 2011, EUR J PAIN, V15, P874, DOI 10.1016/j.ejpain.2011.03.013; Hegedus G, 2014, EUR J PAIN, V18, P1173, DOI 10.1002/j.1532-2149.2014.00466.x; Hofle M, 2012, PAIN, V153, P1074, DOI 10.1016/j.pain.2012.02.010; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; KLEMENT W, 1992, J PHYSIOL-LONDON, V449, P73, DOI 10.1113/jphysiol.1992.sp019075; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Mohan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052400; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; Moseley GL, 2007, PHYS THER REV, V12, P169, DOI 10.1179/108331907X223010; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; Moseley GL, 2005, NEUROLOGY, V65, P773, DOI 10.1212/01.wnl.0000174515.07205.11; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Perlman DM, 2010, EMOTION, V10, P65, DOI 10.1037/a0018440; Pia L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00298; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Spence C, 2002, BEHAV BRAIN RES, V135, P57, DOI 10.1016/S0166-4328(02)00155-9; Symons FJ, 2001, AM J MENT RETARD, V106, P336, DOI 10.1352/0895-8017(2001)106<0336:PSOAST>2.0.CO;2; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Valenzuela Moguillansky Camila, 2013, Front Hum Neurosci, V7, P659, DOI 10.3389/fnhum.2013.00659; Valenzuela-Moguillansky C, 2011, J CONSCIOUSNESS STUD, V18, P110; van Stralen HE, 2014, COGNITION, V131, P147, DOI 10.1016/j.cognition.2013.11.020; Verhoeven K, 2010, PAIN, V149, P229, DOI 10.1016/j.pain.2010.01.019; Villemure C, 2003, PAIN, V106, P101, DOI 10.1016/S0304-3959(03)00297-5; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005	59	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109909	10.1371/journal.pone.0109909	http://dx.doi.org/10.1371/journal.pone.0109909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25295527	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000103
J	Danek, A; Deorowicz, S; Grabowski, S				Danek, Agnieszka; Deorowicz, Sebastian; Grabowski, Szymon			Indexes of Large Genome Collections on a PC	PLOS ONE			English	Article							COMPRESSION; TEXT; ALIGNMENT; STORAGE; SEARCH; SPACE	The availability of thousands of individual genomes of one species should boost rapid progress in personalized medicine or understanding of the interaction between genotype and phenotype, to name a few applications. A key operation useful in such analyses is aligning sequencing reads against a collection of genomes, which is costly with the use of existing algorithms due to their large memory requirements. We present MuGI, Multiple Genome Index, which reports all occurrences of a given pattern, in exact and approximate matching model, against a collection of thousand(s) genomes. Its unique feature is the small index size, which is customisable. It fits in a standard computer with 16-32 GB, or even 8 GB, of RAM, for the 1000GP collection of 1092 diploid human genomes. The solution is also fast. For example, the exact matching queries (of average length 150 bp) are handled in average time of 39 mu s and with up to 3 mismatches in 373 mu s on the test PC with the index size of 13.4 GB. For a smaller index, occupying 7.4 GB in memory, the respective times grow to 76 mu s and 917 mu s.	[Danek, Agnieszka; Deorowicz, Sebastian] Silesian Tech Univ, Inst Informat, Gliwice, Poland; [Grabowski, Szymon] Lodz Univ Technol, Inst Appl Comp Sci, Lodz, Poland	Silesian University of Technology; Lodz University of Technology	Deorowicz, S (corresponding author), Silesian Tech Univ, Inst Informat, Gliwice, Poland.	sebastian.deorowicz@polsl.pl	Deorowicz, Sebastian/F-8386-2014; Grabowski, Szymon/AAJ-2398-2021	Grabowski, Szymon/0000-0003-1714-1224; Danek, Agnieszka/0000-0003-1953-0880; Deorowicz, Sebastian/0000-0002-9496-733X	Polish Ministry of Science and Higher Education [DEC-2013/09/B/ST6/03117]; European Social Fund [UDA-POKL.04.01.01-00-106/09]; GeCONiI-Upper Silesian Center for Computational Science and Engineering [POIG.02.03.01-24-099/13]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Social Fund(European Social Fund (ESF)); GeCONiI-Upper Silesian Center for Computational Science and Engineering	The work was supported by the Polish Ministry of Science and Higher Education under the project DEC-2013/09/B/ST6/03117 and European Social Fund project UDA-POKL.04.01.01-00-106/09. The work was performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GeCONiI-Upper Silesian Center for Computational Science and Engineering". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brandon MC, 2009, BIOINFORMATICS, V25, P1731, DOI 10.1093/bioinformatics/btp319; Christley S, 2009, BIOINFORMATICS, V25, P274, DOI 10.1093/bioinformatics/btn582; Claude Francisco, 2010, 2010 International Conference on BioInformatics and BioEngineering (BIBE), P86, DOI 10.1109/BIBE.2010.22; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Deorowicz S, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-25; Deorowicz S, 2013, BIOINFORMATICS, V29, P2572, DOI 10.1093/bioinformatics/btt460; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Ferrada H, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0137; Gagie T, 2011, LECT NOTES COMPUT SC, V7074, P653, DOI 10.1007/978-3-642-25591-5_67; Garcia SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016065; Giancarlo R, 2014, BRIEF BIOINFORM, V15, P390, DOI 10.1093/bib/bbt088; Grabowski S, 2014, SAMPLING SUFFIX ARRA; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Hon WK, 2013, J DISCRET ALGORITHMS, V19, P23, DOI 10.1016/j.jda.2012.12.003; Huang L, 2013, BIOINFORMATICS, V29, P361, DOI 10.1093/bioinformatics/btt215; Huang SB, 2010, LECT NOTES COMPUT SC, V6124, P180, DOI 10.1007/978-3-642-14355-7_19; KARKKAINEN J, 1996, LNCS, V1090, P219, DOI DOI 10.1007/3-540-61332-3_; Kreft S, 2013, THEOR COMPUT SCI, V483, P115, DOI 10.1016/j.tcs.2012.02.006; Kuruppu S., 2011, P 34 AUSTR COMP SCI, V113, P91; Kuruppu S, 2010, LECT NOTES COMPUT SC, V6393, P201, DOI 10.1007/978-3-642-16321-0_20; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Navarro G, 2007, ACM COMPUT SURV, V39, DOI 10.1145/1216370.1216372; Pavlichin DS, 2013, BIOINFORMATICS, V29, P2199, DOI 10.1093/bioinformatics/btt362; Rahn R, 2014, BIOINFORMATICS, V30, P3499, DOI 10.1093/bioinformatics/btu438; Sadakane K, 2001, Genome Inform, V12, P175; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Siren J, 2014, IEEE ACM T COMPUT BI, V11, P375, DOI 10.1109/TCBB.2013.2297101; Thachuk C, 2013, THEOR COMPUT SCI, V483, P22, DOI 10.1016/j.tcs.2012.08.011; Vyverman M, 2012, NUCLEIC ACIDS RES, V40, P6993, DOI 10.1093/nar/gks408; Wandelt S, 2013, PROC VLDB ENDOW, V6, P1534, DOI 10.14778/2536258.2536265; Wandelt S, 2013, IEEE ACM T COMPUT BI, V10, P1275, DOI 10.1109/TCBB.2013.122; Yang XC, 2013, PROC INT CONF DATA, P961, DOI 10.1109/ICDE.2013.6544889	38	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109384	10.1371/journal.pone.0109384	http://dx.doi.org/10.1371/journal.pone.0109384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289699	Green Submitted, gold, Green Published			2022-12-25	WOS:000342798000057
J	Mora-Obando, D; Fernandez, J; Montecucco, C; Gutierrez, JM; Lomonte, B				Mora-Obando, Diana; Fernandez, Julian; Montecucco, Cesare; Gutierrez, Jose Maria; Lomonte, Bruno			Synergism between Basic Asp49 and Lys49 Phospholipase A(2) Myotoxins of Viperid Snake Venom In Vitro and In Vivo	PLOS ONE			English	Article							BOTHROPS-ASPER; STRUCTURAL DETERMINANTS; BIOLOGICAL-ACTIVITIES; SYNTHETIC PEPTIDES; MUSCLE NECROSIS; MECHANISMS; EVOLUTION; LYS-49; REGION; TOXIN	Two subtypes of phospholipases A(2) (PLA(2)s) with the ability to induce myonecrosis, 'Asp49' and 'Lys49' myotoxins, often coexist in viperid snake venoms. Since the latter lack catalytic activity, two different mechanisms are involved in their myotoxicity. A synergism between Asp49 and Lys49 myotoxins from Bothrops asper was previously observed in vitro, enhancing Ca2+ entry and cell death when acting together upon C2C12 myotubes. These observations are extended for the first time in vivo, by demonstrating a clear enhancement of myonecrosis by the combined action of these two toxins in mice. In addition, novel aspects of their synergism were revealed using myotubes. Proportions of Asp49 myotoxin as low as 0.1% of the Lys49 myotoxin are sufficient to enhance cytotoxicity of the latter, but not the opposite. Sublytic amounts of Asp49 myotoxin also enhanced cytotoxicity of a synthetic peptide encompassing the toxic region of Lys49 myotoxin. Asp49 myotoxin rendered myotubes more susceptible to osmotic lysis, whereas Lys49 myotoxin did not. In contrast to myotoxic Asp49 PLA(2), an acidic non-toxic PLA(2) from the same venom did not markedly synergize with Lys49 myotoxin, revealing a functional difference between basic and acidic PLA(2) enzymes. It is suggested that Asp49 myotoxins synergize with Lys49 myotoxins by virtue of their PLA(2) activity. In addition to the membrane-destabilizing effect of this activity, Asp49 myotoxins may generate anionic patches of hydrolytic reaction products, facilitating electrostatic interactions with Lys49 myotoxins. These data provide new evidence for the evolutionary adaptive value of the two subtypes of PLA(2) myotoxins acting synergistically in viperid venoms.	[Mora-Obando, Diana; Fernandez, Julian; Gutierrez, Jose Maria; Lomonte, Bruno] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Montecucco, Cesare] Univ Padua, Dept Biomed Sci, Padua, Italy	Universidad Costa Rica; University of Padua	Lomonte, B (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.	bruno.lomonte@ucr.ac.cr	Gutiérrez, José/GSJ-1846-2022; Lomonte, Bruno/B-8862-2019	Lomonte, Bruno/0000-0003-2419-6469; Gutierrez, Jose Maria/0000-0001-8385-3081; MORA OBANDO, DIANA LORENA/0000-0003-4462-9698	Graduate Studies Program, Universidad de Costa Rica; International Centre for Genetic Engineering and Biotechnology, Italy [CRP/COS13-01]; Vicerrectoria de Investigacion, Universidad de Costa Rica [741-B4-100]	Graduate Studies Program, Universidad de Costa Rica; International Centre for Genetic Engineering and Biotechnology, Italy; Vicerrectoria de Investigacion, Universidad de Costa Rica	Funding support by the Graduate Studies Program, Universidad de Costa Rica; International Centre for Genetic Engineering and Biotechnology, Italy (CRP/COS13-01); and Vicerrectoria de Investigacion, Universidad de Costa Rica (741-B4-100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Y, 2005, CELL BIOCHEM FUNCT, V23, P307, DOI 10.1002/cbf.1208; Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2; Angulo Y, 2009, TOXICON, V54, P949, DOI 10.1016/j.toxicon.2008.12.014; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bustillo S, 2012, TOXICON, V59, P338, DOI 10.1016/j.toxicon.2011.11.007; Caccin P, 2013, BIOCHEM BIOPH RES CO, V430, P1289, DOI 10.1016/j.bbrc.2012.11.129; Chioato L, 2003, TOXICON, V42, P869, DOI 10.1016/j.toxicon.2003.11.027; Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092; Cintra-Francischinelli M, 2009, CELL MOL LIFE SCI, V66, P1718, DOI 10.1007/s00018-009-9053-2; Cintra-Francischinelli M, 2010, P NATL ACAD SCI USA, V107, P14140, DOI 10.1073/pnas.1009128107; Cintra-Francischinelli M, 2010, TOXICON, V55, P590, DOI 10.1016/j.toxicon.2009.10.013; DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N; DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; dos Santos JI, 2009, PROTEIN PEPTIDE LETT, V16, P887, DOI 10.2174/092986609788923310; Fernandes CAH, 2010, J STRUCT BIOL, V171, P31, DOI 10.1016/j.jsb.2010.03.019; Fernandez J, 2013, FEBS J, V280, P3878, DOI 10.1111/febs.12386; Fernandez J, 2010, BIOCHIMIE, V92, P273, DOI 10.1016/j.biochi.2009.12.006; FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Gutierrez J.M, 1997, VENOM PHOSPHOLIPASE, P321; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; GUTIERREZ JM, 1984, TOXICON, V22, P115, DOI 10.1016/0041-0101(84)90144-2; GUTIERREZ JM, 1995, EXP MOL PATHOL, V62, P28, DOI 10.1006/exmp.1995.1004; Gutierrez Jose Maria, 1995, P645; HARRIS JB, 1990, ELECTRON MICROSC REV, V3, P183, DOI 10.1016/0892-0354(90)90001-9; Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8; KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2; KIHARA H, 1992, BIOCHEM INT, V28, P895; Kini R., 1997, VENOM PHOSPHOLIPASE, P511; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1; Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008; Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8; Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007; Lomonte B, 2011, ACTA CHIM SLOV, V58, P647; Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006; McCue MD, 2006, COPEIA, P818, DOI 10.1643/0045-8511(2006)6[818:COPVIT]2.0.CO;2; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Mora-Obando D, 2014, PEER J IN PRESS; Morgenstern D, 2013, TOXICON, V63, P120, DOI 10.1016/j.toxicon.2012.11.022; MOURADASILVA AM, 1995, J MOL EVOL, V41, P174, DOI 10.1007/BF00170670; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6; Petan T, 2007, BIOCHEMISTRY-US, V46, P12795, DOI 10.1021/bi701304e; RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018; SCOTT DL, 1992, J BIOL CHEM, V267, P22645; SHEN Z, 1995, INT J BIOCHEM CELL B, V27, P1009, DOI 10.1016/1357-2725(95)00072-W; Soares AM, 2003, TOXICON, V42, P855, DOI 10.1016/j.toxicon.2003.11.004; Tsai IH, 2001, ARCH BIOCHEM BIOPHYS, V394, P236, DOI 10.1006/abbi.2001.2524; Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2	58	54	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109846	10.1371/journal.pone.0109846	http://dx.doi.org/10.1371/journal.pone.0109846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290688	Green Published, gold			2022-12-25	WOS:000342798000094
J	Payne, CJ; Ritchie, EG; Kelly, LT; Nimmo, DG				Payne, Catherine J.; Ritchie, Euan G.; Kelly, Luke T.; Nimmo, Dale G.			Does Fire Influence the Landscape-Scale Distribution of an Invasive Mesopredator?	PLOS ONE			English	Article							FOXES VULPES-VULPES; SMALL VERTEBRATE FAUNA; RED FOXES; HOME-RANGE; BIODIVERSITY CONSERVATION; VEGETATION STRUCTURE; WESTERN-AUSTRALIA; HEIRISSON PRONG; CANIS-LUPUS; HABITAT USE	Predation and fire shape the structure and function of ecosystems globally. However, studies exploring interactions between these two processes are rare, especially at large spatial scales. This knowledge gap is significant not only for ecological theory, but also in an applied context, because it limits the ability of landscape managers to predict the outcomes of manipulating fire and predators. We examined the influence of fire on the occurrence of an introduced and widespread mesopredator, the red fox (Vulpes vulpes), in semi-arid Australia. We used two extensive and complimentary datasets collected at two spatial scales. At the landscape-scale, we surveyed red foxes using sand-plots within 28 study landscapes - which incorporated variation in the diversity and proportional extent of fire-age classes - located across a 104 000 km(2) study area. At the site-scale, we surveyed red foxes using camera traps at 108 sites stratified along a century-long post-fire chronosequence (0-105 years) within a 6630 km(2) study area. Red foxes were widespread both at the landscape and site-scale. Fire did not influence fox distribution at either spatial scale, nor did other environmental variables that we measured. Our results show that red foxes exploit a broad range of environmental conditions within semi-arid Australia. The presence of red foxes throughout much of the landscape is likely to have significant implications for native fauna, particularly in recently burnt habitats where reduced cover may increase prey species' predation risk.	[Payne, Catherine J.; Ritchie, Euan G.; Nimmo, Dale G.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia; [Kelly, Luke T.] Univ Melbourne, Sch Bot, Australian Res Council, Ctr Excellence Environm Decis, Melbourne, Vic, Australia	Deakin University; University of Melbourne	Nimmo, DG (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia.	dale@deakin.edu.au	Ritchie, Euan/N-1088-2014	Ritchie, Euan/0000-0003-4410-8868; Kelly, Luke/0000-0002-3127-3111	Victorian government's Department of Environment and Primary Industries under the Mallee Hawkeye [313764]; Land and Water Australia; Mallee Catchment Management Authority, Parks Victoria; Department Sustainability and Environment Victoria, Department Environment and Heritage SA, Lower Murray-Darling Catchment Management Authority; Department Environment and Climate Change NSW, Australian Wildlife Conservancy and Birds Australia	Victorian government's Department of Environment and Primary Industries under the Mallee Hawkeye; Land and Water Australia; Mallee Catchment Management Authority, Parks Victoria; Department Sustainability and Environment Victoria, Department Environment and Heritage SA, Lower Murray-Darling Catchment Management Authority; Department Environment and Climate Change NSW, Australian Wildlife Conservancy and Birds Australia	Funding for the site-scale study was provided by the Victorian government's Department of Environment and Primary Industries, under the Mallee Hawkeye project (Contract Number 313764). Funding and logistical support for the landscape-scale study was provided by Land and Water Australia, the Mallee Catchment Management Authority, Parks Victoria, Department Sustainability and Environment Victoria, Department Environment and Heritage SA, Lower Murray-Darling Catchment Management Authority, Department Environment and Climate Change NSW, Australian Wildlife Conservancy and Birds Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Arthur AD, 2012, AUSTRAL ECOL, V37, P958, DOI 10.1111/j.1442-9993.2011.02355.x; Avitabile SC, 2013, LANDSCAPE URBAN PLAN, V117, P81, DOI 10.1016/j.landurbplan.2013.04.017; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D, 2012, LME4 LINEAR MIXED EF; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradstock Ross A., 2002, P238; Carter A, 2012, AUST MAMMAL, V34, P175, DOI 10.1071/AM11041; CATLING PC, 1995, WILDLIFE RES, V22, P535, DOI 10.1071/WR9950535; CATLING PC, 1988, AUST WILDLIFE RES, V15, P307, DOI 10.1071/WR9880307; Catling PC, 2001, WILDLIFE RES, V28, P555, DOI 10.1071/WR00041; Clarke MF, 2010, AUST J BOT, V58, P363, DOI 10.1071/BT10051; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Environmental Systems Research Institute, 2007, ARC VIEW VERS 9 2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; Glen A. S., 2006, Australian Mammalogy, V28, P101; Gosper CR, 2013, J APPL ECOL, V50, P1187, DOI 10.1111/1365-2664.12120; Gosselink TE, 2003, J WILDLIFE MANAGE, V67, P90, DOI 10.2307/3803065; Graham CA, 2012, WILDLIFE RES, V39, P661, DOI 10.1071/WR12008; Haslem A, 2011, J APPL ECOL, V48, P247, DOI 10.1111/j.1365-2664.2010.01906.x; Haslem A, 2010, LANDSCAPE URBAN PLAN, V97, P296, DOI 10.1016/j.landurbplan.2010.07.002; ITT, 2005, ENVI VERS 4 2; JOHNSON C, 2006, AUSTR MAMMAL EXTINCT; Kelly LT, 2013, AUSTRAL ECOL, V38, P786, DOI 10.1111/aec.12018; Kelly LT, 2012, J APPL ECOL, V49, P412, DOI 10.1111/j.1365-2664.2012.02124.x; KINNEAR JE, 1988, AUST WILDLIFE RES, V15, P435; Leckie FM, 1998, ECOGRAPHY, V21, P599, DOI 10.1111/j.1600-0587.1998.tb00552.x; Letnic M, 2005, AUSTRAL ECOL, V30, P24, DOI 10.1111/j.1442-9993.2004.01410.x; Letnic M, 2005, J MAMMAL, V86, P689, DOI 10.1644/1545-1542(2005)086[0689:TROMTL]2.0.CO;2; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Lucherini M, 1995, J ZOOL, V237, P577, DOI 10.1111/j.1469-7998.1995.tb05016.x; Meek PD, 2000, WILDLIFE RES, V27, P663, DOI 10.1071/WR98030; Moseby KE, 2009, WILDLIFE RES, V36, P422, DOI 10.1071/WR08098; Nimmo DG, 2013, CONSERV BIOL, V27, P345, DOI 10.1111/j.1523-1739.2012.01958.x; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Pavey CR, 2008, J MAMMAL, V89, P674, DOI 10.1644/07-MAMM-A-168R.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Risbey DA, 1999, WILDLIFE RES, V26, P621; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Smit IPJ, 2010, ECOL APPL, V20, P1865, DOI 10.1890/09-0929.1; Smith AL, 2012, BIOL CONSERV, V145, P139, DOI 10.1016/j.biocon.2011.10.023; Southgate R, 2007, J ARID ENVIRON, V68, P438, DOI 10.1016/j.jaridenv.2006.06.006; Sutherland EF, 1999, WILDLIFE RES, V26, P405, DOI 10.1071/WR97045; Towerton AL, 2011, WILDLIFE RES, V38, P208, DOI 10.1071/WR10213; Watson SJ, 2012, ECOL APPL, V22, P685, DOI 10.1890/11-0850.1; White JG, 2006, WILDLIFE RES, V33, P175, DOI 10.1071/WR05037; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Zuur Alain F., 2009, P1	53	15	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107862	10.1371/journal.pone.0107862	http://dx.doi.org/10.1371/journal.pone.0107862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291186	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000008
J	Savinainen, JR; Patel, JZ; Parkkari, T; Navia-Paldanius, D; Marjamaa, JJT; Laitinen, T; Nevalainen, T; Laitinen, JT				Savinainen, Juha R.; Patel, Jayendra Z.; Parkkari, Teija; Navia-Paldanius, Dina; Marjamaa, Joona J. T.; Laitinen, Tuomo; Nevalainen, Tapio; Laitinen, Jarmo T.			Biochemical and Pharmacological Characterization of the Human Lymphocyte Antigen B-Associated Transcript 5 (BAT5/ABHD16A)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MONOACYLGLYCEROL LIPASE; SERINE HYDROLASES; IN-VIVO; INHIBITORS; DISEASE; GENES; IDENTIFICATION; POLYMORPHISMS; METABOLISM	Background: Human lymphocyte antigen B-associated transcript 5 (BAT5, also known as ABHD16A) is a poorly characterized 63 kDa protein belonging to the alpha/beta-hydrolase domain (ABHD) containing family of metabolic serine hydrolases. Its natural substrates and biochemical properties are unknown. Methodology/Principal Findings: Amino acid sequence comparison between seven mammalian BAT5 orthologs revealed that the overall primary structure was highly (>= 95%) conserved. Activity-based protein profiling (ABPP) confirmed successful generation of catalytically active human (h) and mouse (m) BAT5 in HEK293 cells, enabling further biochemical characterization. A sensitive fluorescent glycerol assay reported hBAT5-mediated hydrolysis of medium-chain saturated (C14:0), long-chain unsaturated (C18:1, C18:2, C20:4) monoacylglycerols (MAGs) and 15-deoxy-Delta(12,14)-prostaglandin J(2)-2-glycerol ester (15d-PGJ(2)-G). In contrast, hBAT5 possessed only marginal diacylglycerol (DAG), triacylglycerol (TAG), or lysophospholipase activity. The best MAG substrates were 1-linoleylglycerol (1-LG) and 15d-PGJ(2)-G, both exhibiting low-micromolar K-m values. BAT5 had a neutral pH optimum and showed preference for the 1(3)-vs. 2-isomers of MAGs C18:1, C18:2 and C20:4. Inhibitor profiling revealed that beta-lactone-based lipase inhibitors were nanomolar inhibitors of hBAT5 activity (palmostatin B. tetrahydrolipstatin. ebelactone A). Moreover, the hormone-sensitive lipase inhibitor C7600 (5-methoxy-3-(4-phenoxyphenyl)-3H-[1,3,4] oxadiazol-2-one) was identified as a highly potent inhibitor (IC50 8.3 nM). Phenyl and benzyl substituted analogs of C7600 with increased BAT5 selectivity were synthesized and a preliminary SAR analysis was conducted to obtain initial insights into the active site dimensions. Conclusions/Significance: This study provides an initial characterization of BAT5 activity, unveiling the biochemical and pharmacological properties with in vitro substrate preferences and inhibitor profiles. Utilization of glycerolipid substrates and sensitivity to lipase inhibitors suggest that BAT5 is a genuine lipase with preference for long-chain unsaturated MAGs and could in this capacity regulate glycerolipid metabolism in vivo as well. This preliminary SAR data should pave the way towards increasingly potent and BAT5-selective inhibitors.	[Savinainen, Juha R.; Navia-Paldanius, Dina; Marjamaa, Joona J. T.; Laitinen, Jarmo T.] Univ Eastern Finland, Fac Hlth Sci, Inst Biomed, Sch Med, Kuopio, Finland; [Patel, Jayendra Z.; Parkkari, Teija; Laitinen, Tuomo; Nevalainen, Tapio] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Laitinen, JT (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Inst Biomed, Sch Med, Kuopio, Finland.	jarmo.laitinen@uef.fi		Laitinen, Tuomo/0000-0003-1539-2142; Laitinen, Jarmo T/0000-0002-9490-3686; Savinainen, Juha/0000-0002-1301-9064; Patel, Jayendra Z./0000-0002-2562-1888	Academy of Finland [139620, 139140]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland (grant 139620 to JTL and grant 139140 to TN) (http://www.aka.fi/en-GB/A/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen N, 2013, CHEM BIOL, V20, P379, DOI 10.1016/j.chembiol.2013.01.012; Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Ben Ali Y, 2006, BIOCHEMISTRY-US, V45, P14183, DOI 10.1021/bi0613978; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Fontanesi L, 2012, J ANIM SCI, V90, P2450, DOI 10.2527/jas.2011-4797; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hsieh YY, 2010, J CLIN LAB ANAL, V24, P262, DOI 10.1002/jcla.20409; Laitinen T, 2014, MOL PHARMACOL, V85, P510, DOI 10.1124/mol.113.090795; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Minkkila A, 2009, CHEMMEDCHEM, V4, P1253, DOI 10.1002/cmdc.200900137; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Parkkari T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098286; Patel JZ, 2013, J MED CHEM, V56, P8484, DOI 10.1021/jm400923s; Point V, 2012, EUR J MED CHEM, V58, P452, DOI 10.1016/j.ejmech.2012.10.040; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Saario SM, 2006, J MED CHEM, V49, P4650, DOI 10.1021/jm060394q; Savinainen JR, 2010, ANAL BIOCHEM, V399, P132, DOI 10.1016/j.ab.2009.12.009; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; SPIES T, 1989, P NATL ACAD SCI USA, V86, P8955, DOI 10.1073/pnas.86.22.8955; SPIES T, 1989, SCIENCE, V243, P214, DOI 10.1126/science.2911734; Wang R, 2013, BIOCHEMISTRY-US, V52, P7559, DOI 10.1021/bi401138s; Xie SQ, 2010, CHEM RES TOXICOL, V23, P1890, DOI 10.1021/tx1002194	30	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109869	10.1371/journal.pone.0109869	http://dx.doi.org/10.1371/journal.pone.0109869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290914	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000095
J	Hooper, C; Jackson, SS; Coughlin, EE; Coon, JJ; Miyamoto, S				Hooper, Christopher; Jackson, Shawn S.; Coughlin, Emma E.; Coon, Joshua J.; Miyamoto, Shigeki			Covalent Modification of the NF-kappa B Essential Modulator (NEMO) by a Chemical Compound Can Regulate Its Ubiquitin Binding Properties in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; ZINC-FINGER; IKK ACTIVATION; TNF-ALPHA; WITHAFERIN; CHAINS; DOMAIN; POLYUBIQUITIN; INHIBITION; COMPLEX	Post-translational modification by ubiquitin plays important roles in multiple physiological and pathological processes. Ubiquitin-binding proteins play a critical role in recognizing and relaying polyubiquitin-based signaling. NEMO (NF-kappa B Essential Modulator) is a central player in canonical NF-kappa B signaling whose major function is to bind to Lys-63-and/or M1- (or linear) linked polyubiquitin chains generated in response to cell stimulation. Here we show that Withaferin A (WA), a steroidal lactone, causes a change in NEMO's interaction with specific types of polyubiquitin chains in vitro. WA induces full-length recombinant NEMO to bind to long Lys-48-linked polyubiquitin chains but not tetra-ubiquitin species. Significantly, the UBAN (ubiquitin binding in ABIN and NEMO) domain, essential for the ability of NEMO to bind M1/Lys-63-linked polyubiquitin, is dispensable for the WA-induced gain-of-function activity. Mass spectrometric analysis demonstrated that WA covalently modifies NEMO on a cysteine residue within the C-terminal zinc finger (ZF) domain. Point mutations to the ZF can reverse the WA-induced Lys-48-polyubiquitin binding phenotype. Our study demonstrates the feasibility of directly altering the ubiquitin interaction properties of an ubiquitin-binding protein by a chemical compound, thereby shedding light on a novel drug class to potentially alter polyubiquitin-based cellular processes.	[Hooper, Christopher; Jackson, Shawn S.; Coon, Joshua J.; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53705 USA; [Jackson, Shawn S.; Miyamoto, Shigeki] Univ Wisconsin, Med Scientist Training Program, Madison, WI 53705 USA; [Hooper, Christopher; Jackson, Shawn S.; Miyamoto, Shigeki] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53705 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Coughlin, Emma E.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miyamoto, S (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res 6159, McArdle Lab Canc Res, Dept Oncol, 1111 Highland Ave, Madison, WI 53705 USA.	smiyamot@wisc.edu		Coughlin, Emma/0000-0001-8774-7876	National Institutes of Health [R01 GM083681, R01 CA077474]; NATIONAL CANCER INSTITUTE [R01CA077474, F31CA186551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, R01GM083681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM083681 and R01 CA077474.	Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chiaravalli J, 2011, BIOCHEM PHARMACOL, V82, P1163, DOI 10.1016/j.bcp.2011.07.083; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ngadjeua F, 2013, J BIOL CHEM, V288, P33722, DOI 10.1074/jbc.M113.483305; Ozorowski G, 2012, BIOL CHEM, V393, P1151, DOI 10.1515/hsz-2012-0184; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wijeratne EMK, 2014, J MED CHEM, V57, P2851, DOI 10.1021/jm401279n; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yoshikawa A, 2009, FEBS LETT, V583, P3317, DOI 10.1016/j.febslet.2009.09.028	37	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33161	33174		10.1074/jbc.M114.582478	http://dx.doi.org/10.1074/jbc.M114.582478			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296760	hybrid, Green Published			2022-12-25	WOS:000345636600011
J	Feng, Y; Hadjikyriacou, A; Clarke, SG				Feng, You; Hadjikyriacou, Andrea; Clarke, Steven G.			Substrate Specificity of Human Protein Arginine Methyltransferase 7 (PRMT7) THE IMPORTANCE OF ACIDIC RESIDUES IN THE DOUBLE E LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 TAT; N-METHYLTRANSFERASE; GENE-EXPRESSION; BREAST-CANCER; HISTONE H4; METHYLATION; REGIONS; CELLS; IDENTIFICATION; TRANSCRIPTION	Protein arginine methyltransferase 7 (PRMT7) methylates arginine residues on various protein substrates and is involved in DNA transcription, RNA splicing, DNA repair, cell differentiation, and metastasis. The substrate sequences it recognizes in vivo and the enzymatic mechanism behind it, however, remain to be explored. Here we characterize methylation catalyzed by a bacterially expressed GST-tagged human PRMT7 fusion protein with a broad range of peptide and protein substrates. After confirming its type III activity generating only omega-N-G-monomethylarginine and its distinct substrate specificity for RXR motifs surrounded by basic residues, we performed site-directed mutagenesis studies on this enzyme, revealing that two acidic residues within the double E loop, Asp-147 and Glu-149, modulate the substrate preference. Furthermore, altering a single acidic residue, Glu-478, on the C-terminal domain to glutamine nearly abolished the activity of the enzyme. Additionally, we demonstrate that PRMT7 has unusual temperature dependence and salt tolerance. These results provide a biochemical foundation to understanding the broad biological functions of PRMT7 in health and disease.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu		Feng, You/0000-0002-4710-7396	National Institutes of Health [GM026020, GM007185]; Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020 (to S. G. C.) and GM007185, a Ruth L. Kirschstein National Research Service Award (to A. H.).	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Baldwin R Mitchell, 2014, World J Biol Chem, V5, P115, DOI 10.4331/wjbc.v5.i2.115; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bleibel WK, 2009, HUM GENET, V125, P173, DOI 10.1007/s00439-008-0607-4; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Buhr N, 2008, ELECTROPHORESIS, V29, P2381, DOI 10.1002/elps.200700738; Cura V, 2014, ACTA CRYSTALLOGR D, V70, P2401, DOI 10.1107/S1399004714014278; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; EBRALIDSE KK, 1988, NATURE, V331, P365, DOI 10.1038/331365a0; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Gros L, 2003, CANCER RES, V63, P164; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kim C, 2010, BBA-GEN SUBJECTS, V1800, P977, DOI 10.1016/j.bbagen.2010.06.004; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lu H, 2012, EPIGENETICS-US, V7, P914, DOI 10.4161/epi.21113; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Truant R, 1999, MOL CELL BIOL, V19, P1210; Verbiest V, 2008, FEBS LETT, V582, P1483, DOI 10.1016/j.febslet.2008.03.031; Wang CY, 2014, STRUCTURE, V22, P756, DOI 10.1016/j.str.2014.03.003; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	41	40	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.609271	http://dx.doi.org/10.1074/jbc.M114.609271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294873	hybrid, Green Published			2022-12-25	WOS:000345335000019
J	Hariharan, P; Guan, L				Hariharan, Parameswaran; Guan, Lan			Insights into the Inhibitory Mechanisms of the Regulatory Protein IIA(Glc) on Melibiose Permease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE PHOSPHOTRANSFERASE SYSTEMS; ESCHERICHIA-COLI; LACTOSE PERMEASE; CATABOLITE REPRESSION; MEMBRANE-VESICLES; SUGAR-TRANSPORT; NA+; PHOSPHOENOLPYRUVATE; ACTIVATION; COMPLEX	The phosphotransfer protein IIA(Glc) of the bacterial phosphoenolpyruvate: carbohydrate phosphotransferase system plays a key role in the regulation of carbohydrate metabolism. Melibiose permease (MelB) is one among several permeases subject to IIA(Glc) regulation. The regulatory mechanisms are poorly understood; in addition, thermodynamic features of IIA(Glc) binding to other proteins are also unknown. Applying isothermal titration calorimetry and amine-specificcross-linking, we show that IIA(Glc) directly binds to MelB of Salmonella typhimurium (MelB(St)) and Escherichia coli MelB (MelB(Ec)) at a stoichiometry of unity in the absence or presence of melibiose. The dissociation constant values are 3-10 mu M for MelBSt and 25 mu M for MelB(Ec). All of the binding is solely driven by favorable enthalpy forces. IIA(Glc) binding to MelB(St) in the absence or presence of melibiose yields a large negative heat capacity change; in addition, the conformational entropy is constrained upon the binding. We further found that the IIA(Glc)-bound MelB(St) exhibits a decreased binding affinity for melibiose or nitrophenyl-alpha-galactoside. It is believed that sugar binding to the permease is involved in an induced fit mechanism, and the transport process requires conformational cycling between different states. Thus, the thermodynamic data are consistent with the interpretation that IIA(Glc) inhibits the induced fit process and restricts the conformational dynamics of MelB(St).	[Hariharan, Parameswaran; Guan, Lan] Texas Tech Univ Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center	Guan, L (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St,STOP 6551, Lubbock, TX 79430 USA.	Lan.Guan@ttuhsc.edu	Parameswaran, Hariharan/P-2496-2015	Parameswaran, Hariharan/0000-0002-6020-1547	National Science Foundation [MCB-1158085]; National Institutes of Health [R01 GM095538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095538] Funding Source: NIH RePORTER; Direct For Biological Sciences [1158085] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1158085 (to L. G.) and the National Institutes of Health Grant R01 GM095538 (to L. G.).	BASSILANA M, 1987, J BIOL CHEM, V262, P16865; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chaptal V, 2011, P NATL ACAD SCI USA, V108, P9361, DOI 10.1073/pnas.1105687108; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Dayem MA, 2003, J BIOL CHEM, V278, P1518, DOI 10.1074/jbc.M210053200; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Feese MD, 1997, BIOCHEMISTRY-US, V36, P16087, DOI 10.1021/bi971999e; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Grainger DC, 2003, MOL MICROBIOL, V48, P335, DOI 10.1046/j.1365-2958.2003.t01-1-03434.x; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Guan L, 2013, ENCY BIOL CHEM, P387; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Guan L, 2012, BIOCHEMISTRY-US, V51, P2950, DOI 10.1021/bi300230h; Guan L, 2011, J BIOL CHEM, V286, P6367, DOI 10.1074/jbc.M110.206227; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Kahramanoglou C, 2006, J BACTERIOL, V188, P3199, DOI 10.1128/JB.188.9.3199-3207.2006; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; KURODA M, 1992, CHEM PHARM BULL, V40, P1637, DOI 10.1248/cpb.40.1637; KURODA M, 1992, J BIOL CHEM, V267, P18336; Kuroda M, 2001, J MOL MICROB BIOTECH, V3, P381; Lengeler JW, 2009, CONTRIB MICROBIOL, V16, P65, DOI 10.1159/000219373; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nie YL, 2006, J BIOL CHEM, V281, P35779, DOI 10.1074/jbc.M607232200; OSUMI T, 1982, ANN INST PASTEUR MIC, VA133, P269; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Pickering BS, 2012, MBIO, V3, DOI 10.1128/mBio.00228-12; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POURCHER T, 1991, BIOCHEM BIOPH RES CO, V178, P1176, DOI 10.1016/0006-291X(91)91016-6; POURCHER T, 1995, BIOCHEMISTRY-US, V34, P4412, DOI 10.1021/bi00013a033; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sondej M, 2003, BIOCHEMISTRY-US, V42, P9153, DOI 10.1021/bi034406a; Sondej M, 2002, BIOCHEMISTRY-US, V41, P5556, DOI 10.1021/bi011990j; TOKUDA H, 1977, BIOCHEMISTRY-US, V16, P2130, DOI 10.1021/bi00629a013; TSUCHIYA T, 1977, BIOCHEM BIOPH RES CO, V76, P26, DOI 10.1016/0006-291X(77)91663-1; WILSON DM, 1987, BIOCHIM BIOPHYS ACTA, V904, P191, DOI 10.1016/0005-2736(87)90368-3; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yousef MS, 2009, P NATL ACAD SCI USA, V106, P15291, DOI 10.1073/pnas.0905516106; Zakariassen H, 2007, THERMOCHIM ACTA, V464, P24, DOI 10.1016/j.tca.2007.07.021; ZANI ML, 1994, J BIOL CHEM, V269, P24883	47	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.609255	http://dx.doi.org/10.1074/jbc.M114.609255			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296751	hybrid, Green Published			2022-12-25	WOS:000345335000051
J	Molkov, YI; Shevtsova, NA; Park, C; Ben-Tal, A; Smith, JC; Rubin, JE; Rybak, IA				Molkov, Yaroslav I.; Shevtsova, Natalia A.; Park, Choongseok; Ben-Tal, Alona; Smith, Jeffrey C.; Rubin, Jonathan E.; Rybak, Ilya A.			A Closed-Loop Model of the Respiratory System: Focus on Hypercapnia and Active Expiration	PLOS ONE			English	Article							MAMMALIAN BRAIN-STEM; FUNCTIONAL ARCHITECTURE; REFLEX PROLONGATION; INTEGRATED MODEL; GAS-EXCHANGE; NEWBORN RAT; RHYTHM; PATTERN; INSPIRATION; NEURONS	Breathing is a vital process providing the exchange of gases between the lungs and atmosphere. During quiet breathing, pumping air from the lungs is mostly performed by contraction of the diaphragm during inspiration, and muscle contraction during expiration does not play a significant role in ventilation. In contrast, during intense exercise or severe hypercapnia forced or active expiration occurs in which the abdominal "expiratory" muscles become actively involved in breathing. The mechanisms of this transition remain unknown. To study these mechanisms, we developed a computational model of the closed-loop respiratory system that describes the brainstem respiratory network controlling the pulmonary subsystem representing lung biomechanics and gas (O-2 and CO2) exchange and transport. The lung subsystem provides two types of feedback to the neural subsystem: a mechanical one from pulmonary stretch receptors and a chemical one from central chemoreceptors. The neural component of the model simulates the respiratory network that includes several interacting respiratory neuron types within the Botzinger and pre-Botzinger complexes, as well as the retrotrapezoid nucleus/parafacial respiratory group (RTN/pFRG) representing the central chemoreception module targeted by chemical feedback. The RTN/pFRG compartment contains an independent neural generator that is activated at an increased CO2 level and controls the abdominal motor output. The lung volume is controlled by two pumps, a major one driven by the diaphragm and an additional one activated by abdominal muscles and involved in active expiration. The model represents the first attempt to model the transition from quiet breathing to breathing with active expiration. The model suggests that the closed-loop respiratory control system switches to active expiration via a quantal acceleration of expiratory activity, when increases in breathing rate and phrenic amplitude no longer provide sufficient ventilation. The model can be used for simulation of closed-loop control of breathing under different conditions including respiratory disorders.	[Molkov, Yaroslav I.] Purdue Univ, Indiana Univ, Dept Math Sci, Indianapolis, IN USA; [Shevtsova, Natalia A.; Rybak, Ilya A.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Park, Choongseok; Rubin, Jonathan E.] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Ben-Tal, Alona] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand; [Smith, Jeffrey C.] NINDS, Cellular & Syst Neurobiol Sect, NIH, Bethesda, MD 20892 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massey University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Rybak, IA (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA.	rybak@drexel.edu	RUBIN, JONATHAN/AAD-9071-2019; smith, jeremy c/B-7287-2012; Molkov, Yaroslav/C-6336-2012	smith, jeremy c/0000-0002-2978-3227; Molkov, Yaroslav/0000-0002-0862-1974; Rubin, Jonathan/0000-0002-1513-1551	National Institutes of Health (NIH) [R01NS069220]; National Science Foundation [DMS 1021701, 1312508]; Indiana University - Purdue University, Indianapolis; NIH, National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003108] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Indiana University - Purdue University, Indianapolis; NIH, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	IAR, AB-T, and NAS are funded by grant R01NS069220 from the National Institutes of Health (NIH) (http://www.nih.gov); JER and CP are funded by grants DMS 1021701 and 1312508 from the National Science Foundation (http://www.nsf.gov); YIM is funded by Indiana University - Purdue University, Indianapolis (http://http://www.iupui.edu); and JCS is funded by Intramural Research Program of the NIH, National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2011, J NEUROSCI, V31, P16410, DOI 10.1523/JNEUROSCI.3280-11.2011; Abdala APL, 2009, J PHYSIOL-LONDON, V587, P3539, DOI 10.1113/jphysiol.2008.167502; Abu-Shaweesh JM, 1999, J APPL PHYSIOL, V87, P484, DOI 10.1152/jappl.1999.87.2.484; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; BAINTON CR, 1979, J PHYSIOL-LONDON, V296, P291, DOI 10.1113/jphysiol.1979.sp013006; Ben-Tal A, 2006, J THEOR BIOL, V238, P474, DOI 10.1016/j.jtbi.2005.06.005; Ben-Tal A, 2008, J THEOR BIOL, V251, P480, DOI 10.1016/j.jtbi.2007.12.018; Ben-Tal A, 2013, WIRES SYST BIOL MED, V5, P687, DOI 10.1002/wsbm.1244; Ben-Tal A, 2010, RESP PHYSIOL NEUROBI, V170, P103, DOI 10.1016/j.resp.2009.10.008; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Cheng LM, 2010, RESP PHYSIOL NEUROBI, V174, P4, DOI 10.1016/j.resp.2010.06.001; CLARK FJ, 1972, J PHYSIOL-LONDON, V222, P267, DOI 10.1113/jphysiol.1972.sp009797; COHEN MI, 1979, PHYSIOL REV, V59, P1105, DOI 10.1152/physrev.1979.59.4.1105; DETROYER A, 1989, J APPL PHYSIOL, V66, P20, DOI 10.1152/jappl.1989.66.1.20; Eldridge FL, 1996, BIOENGINEERING APPROACHES TO PULMONARY PHYSIOLOGY AND MEDICINE, P25, DOI 10.1007/978-0-585-34964-0_2; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; GRODINS FS, 1967, J APPL PHYSIOL, V22, P260, DOI 10.1152/jappl.1967.22.2.260; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Guyenet PG, 2010, RESP PHYSIOL NEUROBI, V173, P244, DOI 10.1016/j.resp.2010.02.005; Hayashi F, 1996, J NEUROSCI, V16, P6526; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; JODKOWSKI JS, 1994, NEUROSCI LETT, V172, P67, DOI 10.1016/0304-3940(94)90664-5; LAWSON EE, 1981, J APPL PHYSIOL, V50, P874, DOI 10.1152/jappl.1981.50.4.874; Longobardo G, 2005, RESP PHYSIOL NEUROBI, V148, P285, DOI 10.1016/j.resp.2005.02.005; Lu K., 2003, CARDIOVASC ENG, V3, P1; Marina N, 2010, J NEUROSCI, V30, P12466, DOI 10.1523/JNEUROSCI.3141-10.2010; Molkov YI, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00016; Molkov YI, 2011, J NEUROPHYSIOL, V105, P3080, DOI 10.1152/jn.00070.2011; Molkov YI, 2010, J NEUROPHYSIOL, V104, P2713, DOI 10.1152/jn.00334.2010; MORRISON SF, 1994, BRAIN RES, V652, P83, DOI 10.1016/0006-8993(94)90320-4; O'Connor R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00264; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; REMMERS JE, 1986, PFLUG ARCH EUR J PHY, V407, P190, DOI 10.1007/BF00580675; Rubin JE, 2011, J COMPUT NEUROSCI, V30, P607, DOI 10.1007/s10827-010-0281-0; Rubin JE, 2009, J NEUROPHYSIOL, V101, P2146, DOI 10.1152/jn.90958.2008; Rybak I.A., 2012, PRIMER AUTONOMIC NER; Rybak IA, 2004, RESP PHYSIOL NEUROBI, V143, P307, DOI 10.1016/j.resp.2004.03.020; Rybak IA, 1997, J NEUROPHYSIOL, V77, P2027, DOI 10.1152/jn.1997.77.4.2027; Rybak IA, 2007, PROG BRAIN RES, V165, P201, DOI 10.1016/S0079-6123(06)65013-9; SAETTA M, 1987, J APPL PHYSIOL, V62, P506, DOI 10.1152/jappl.1987.62.2.506; SEARS TA, 1977, FED PROC, V36, P2412; Smith JC, 2007, J NEUROPHYSIOL, V98, P3370, DOI 10.1152/jn.00985.2007; Smith JC, 2013, TRENDS NEUROSCI, V36, P152, DOI 10.1016/j.tins.2012.11.004; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Takakura AC, 2014, EXP PHYSIOL, V99, P571, DOI 10.1113/expphysiol.2013.076752; Tin C, 2012, RESP PHYSIOL NEUROBI, V181, P79, DOI 10.1016/j.resp.2012.01.008; Topor ZL, 2004, ANN BIOMED ENG, V32, P1530, DOI 10.1114/B:ABME.0000049037.65204.4c; Ursino M, 2001, CLIN PHYSIOL, V21, P447, DOI 10.1046/j.1365-2281.2001.00349.x; West JB., 2008, WESTS RESP PHYSL ESS, V9th; Zhou D, 1996, RESP PHYSIOL, V104, P11, DOI 10.1016/0034-5687(95)00098-4	52	42	43	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109894	10.1371/journal.pone.0109894	http://dx.doi.org/10.1371/journal.pone.0109894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302708	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400091
J	Mudaliar, H; Pollock, C; Ma, J; Wu, HL; Chadban, S; Panchapakesan, U				Mudaliar, Harshini; Pollock, Carol; Ma, Jin; Wu, Huiling; Chadban, Steven; Panchapakesan, Usha			The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DIABETIC-NEPHROPATHY; ADHESION MOLECULES; HYPERGLYCEMIA; EXPRESSION; DYSFUNCTION; ACTIVATION; PROGRESSION; TYPE-1; ICAM-1	Postprandial hyperglycemia induces inflammation and endothelial dysfunction resulting in vascular complications in patients with diabetes. Toll-like receptors (TLRs) are central to the regulation of inflammatory responses through activation of nuclear factor-kappa B (NF-kappa B). This study examined the role of TLR2 and 4 in regulating inflammation and endothelial dysfunction when exposed to fluctuating glucose concentrations. HMEC-1 cells (a human microvascular endothelial cell line) were exposed to control (5 mM), 30 mM (high), fluctuating (5/30 mM) and 11.2 mM glucose (approximate glycaemic criteria for the diagnosis of diabetes mellitus) for 72 h. Cells were assessed for TLR2, 4, high mobility group box -1 (HMGB1), NF-kappa B, monocyte chemoattractant protein-1 (MCP-1), interleukin-8 (IL-8), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Fluctuating glucose concentrations maximally upregulated TLR4 but not TLR2 expression with increased NF-kappa B activation, IL-8 and ICAM-1 expression. HMGB1 was increased in the supernatants of cells exposed to 30 mM and 11.2 mM glucose compared to control. The addition of recombinant HMGB1 induced NF-kappa B activation and synthesis of proinflammatory cytokines and chemokines, which were prevented by TLR2 or 4 signalling inhibition. An additive effect when both TLR2 and 4 signalling pathways were inhibited was observed. However, only inhibition of TLR4 signalling suppressed the synthesis of MCP-1, IL-8 and ICAM-1. In vivo, streptozotocin-induced diabetic mice exhibited an increase in glomerular ICAM-1 which was not evident in TLR2(-/-) or TLR4(-/-) diabetic mice. Collectively, our results suggest that targeting the signalling pathway of TLR2 and 4 may be of therapeutic benefit in attenuating vascular inflammation in diabetic microangiopathy.	[Mudaliar, Harshini; Pollock, Carol; Panchapakesan, Usha] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Grp, St Leonards, NSW 2065, Australia; [Ma, Jin; Wu, Huiling; Chadban, Steven] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Ma, Jin; Wu, Huiling; Chadban, Steven] Univ Sydney, Collaborat Transplant Res Grp, Camperdown, NSW, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney	Panchapakesan, U (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Grp, St Leonards, NSW 2065, Australia.	usha.panchapakesan@sydney.edu.au			National Health and Medical Research Council, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by National Health and Medical Research Council, Australia. URL http://purl.org/au-research/grants/nhmrc/632673. UP, CP, HW and SC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Azuma K, 2006, ARTERIOSCL THROM VAS, V26, P2275, DOI 10.1161/01.ATV.0000239488.05069.03; Bae JS, 2011, BLOOD, V118, P3952, DOI 10.1182/blood-2011-06-360701; Ceriello A, 2004, DIABETES, V53, P701, DOI 10.2337/diabetes.53.3.701; Ceriello A, 2008, US ENDOCRINOL, P63; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Devaraj S, 2011, METABOLISM, V60, P256, DOI 10.1016/j.metabol.2010.01.005; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gluba A, 2010, NAT REV NEPHROL, V6, P224, DOI 10.1038/nrneph.2010.16; Gu Harvest F, 2012, Front Endocrinol (Lausanne), V3, P179, DOI 10.3389/fendo.2012.00179; Hak AE, 2001, J CLIN ENDOCR METAB, V86, P4398, DOI 10.1210/jc.86.9.4398; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kahn R, 2001, DIABETES CARE, V24, P775; Kaur H, 2012, AM J PHYSIOL-RENAL, V303, pF1145, DOI 10.1152/ajprenal.00319.2012; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Li JL, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-90; Matsui H, 1996, DIABETES RES CLIN PR, V32, P1, DOI 10.1016/0168-8227(96)01209-0; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; Mudaliar H, 2013, AM J PHYSIOL-RENAL, V305, pF143, DOI 10.1152/ajprenal.00398.2012; Mullins GE, 2004, SCAND J IMMUNOL, V60, P566, DOI 10.1111/j.0300-9475.2004.01518.x; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Panchapakesan U, 2005, AM J PHYSL RENAL PHY, V289; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Paulis LEM, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-25; Rudofsky G, 2004, DIABETES CARE, V27, P179, DOI 10.2337/diacare.27.1.179; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shichiri M, 2000, DIABETES CARE, V23, pB21; Skrha J, 2012, EXP CLIN ENDOCR DIAB, V120, P277, DOI 10.1055/s-0031-1283161; Stehouwer CDA, 2004, NEPHROL DIAL TRANSPL, V19, P778, DOI 10.1093/ndt/gfh015; Takata S, 2013, ACTA HISTOCHEM CYTOC, V46, P35, DOI 10.1267/ahc.13002; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; Taslipinar A, 2011, SCAND J CLIN LAB INV, V71, P606, DOI 10.3109/00365513.2011.598944; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tuttle K, 2005, J AM SOC NEPHROL, V16, P5; Wang JJ, 2008, AM J PHYSIOL-RENAL, V294, pF1166, DOI 10.1152/ajprenal.00375.2007; Yang J, 2010, MOL CELL BIOCHEM, V345, P189, DOI 10.1007/s11010-010-0572-9; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Zafiriou S, 2004, KIDNEY INT, V65, P1647, DOI 10.1111/j.1523-1755.2004.00574.x; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	45	75	80	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108844	10.1371/journal.pone.0108844	http://dx.doi.org/10.1371/journal.pone.0108844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303153	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400029
J	Nordgren, H; Aaltonen, K; Sironen, T; Kinnunen, PM; Kivisto, I; Raunio-Saarnisto, M; Moisander-Jylha, AM; Korpela, J; Kokkonen, UM; Hetzel, U; Sukura, A; Vapalahti, O				Nordgren, Heli; Aaltonen, Kirsi; Sironen, Tarja; Kinnunen, Paula M.; Kivisto, Ilkka; Raunio-Saarnisto, Mirja; Moisander-Jylha, Anna-Maria; Korpela, Johanna; Kokkonen, Ulla-Maija; Hetzel, Udo; Sukura, Antti; Vapalahti, Olli			Characterization of a New Epidemic Necrotic Pyoderma in Fur Animals and Its Association with Arcanobacterium phocae Infection	PLOS ONE			English	Article							GENUS ARCANOBACTERIUM; EMENDED DESCRIPTION; CANINE PARVOVIRUS; SP NOV.; HAEMOLYTICUM; VIRUS	A new type of pyoderma was detected in Finnish fur animals in 2007. The disease continues to spread within and between farms, with severe and potentially fatal symptoms. It compromises animal welfare and causes considerable economic losses to farmers. A case-control study was performed in 2010-2011 to describe the entity and to identify the causative agent. Altogether 99 fur animals were necropsied followed by pathological and microbiological examination. The data indicated that the disease clinically manifests in mink (Neovison vison) by necrotic dermatitis of the feet and facial skin. In finnraccoons (Nyctereutes procyonoides), it causes painful abscesses in the paws. Foxes (Vulpes lagopus) are affected by severe conjunctivitis and the infection rapidly spreads to the eyelids and facial skin. A common finding at necropsy was necrotic pyoderma. Microbiological analysis revealed the presence of a number of potential causative agents, including a novel Streptococcus sp. The common finding from all diseased animals of all species was Arcanobacterium phocae. This bacterium has previously been isolated from marine mammals with skin lesions but this is the first report of A. phocae isolated in fur animals with pyoderma. The results obtained from this study implicate A. phocae as a potential causative pathogen of fur animal epidemic necrotic pyoderma (FENP) and support observations that the epidemic may have originated in a species - shift of the causative agent from marine mammals. The variable disease pattern and the presence of other infectious agents (in particular the novel Streptococcus sp.) suggest a multifactorial etiology for FENP, and further studies are needed to determine the environmental, immunological and infectious factors contributing to the disease.	[Nordgren, Heli] Finnish Food Safety Author Evira, Prod Anim Sect, Seinajoki, Finland; [Aaltonen, Kirsi; Sironen, Tarja; Kinnunen, Paula M.; Hetzel, Udo; Sukura, Antti; Vapalahti, Olli] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Aaltonen, Kirsi; Sironen, Tarja; Kivisto, Ilkka; Vapalahti, Olli] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Raunio-Saarnisto, Mirja] Finnish Food Safety Author Evira, Seinajoki Lab Sect, Seinajoki, Finland; [Moisander-Jylha, Anna-Maria; Korpela, Johanna] Finnish Breeders Assoc FFBA, Vantaa, Finland; [Kokkonen, Ulla-Maija] Finnish Food Safety Author Evira, Sect Poultry Wild & Lab Anim, Seinajoki, Finland; [Vapalahti, Olli] Hosp Dist Helsinki & Uusimaa, HUSLAB, Dept Virol & Immunol, Helsinki, Finland	Finnish Food Authority; University of Helsinki; University of Helsinki; Finnish Food Authority; Finnish Food Authority; University of Helsinki; Helsinki University Central Hospital	Nordgren, H (corresponding author), Finnish Food Safety Author Evira, Prod Anim Sect, Seinajoki, Finland.	heli.nordgren@profur.fi		Kivisto, Ilkka/0000-0002-9657-0555; Sironen, Tarja/0000-0002-2344-2755; Vapalahti, Olli/0000-0003-2270-6824; Aaltonen, Kirsi/0000-0001-8901-6866; Sukura, Antti Kalle Kalervo/0000-0002-8992-1695	Finnish Fur Breeders' association	Finnish Fur Breeders' association	Co-authors Anna-Maria Moisander-Jylha and Johanna Korpela are employed by the Finnish Fur Breeders' association. The funder provided support in the form of salary for authors Anna-Maria Moisander-Jylha and Johanna Korpela, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	BARRETT T, 1993, VIROLOGY, V193, P1010, DOI 10.1006/viro.1993.1217; Brojer C, 2000, THESIS U GUELPH CANA; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; COLLINS MD, 1982, J GEN MICROBIOL, V128, P1279; Ek-Kommonen C, 1997, VET REC, P383; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Hijazin M, 2013, INT J SYST EVOL MICR, V63, P2019, DOI 10.1099/ijs.0.045591-0; Hijazin M, 2012, INT J SYST EVOL MICR, V62, P2201, DOI 10.1099/ijs.0.037150-0; Johnson SP, 2003, J WILDLIFE DIS, V39, P136, DOI 10.7589/0090-3558-39.1.136; Knuuttila A, 2009, CLIN VACCINE IMMUNOL, V16, P1360, DOI 10.1128/CVI.00148-09; MACKENZIE A, 1995, CLIN INFECT DIS, V21, P177, DOI 10.1093/clinids/21.1.177; Malik R, 2004, VET DERMATOLOGY S, V15, DOI [10.1111/j.1365-3164.2004.00410_5-1.x, DOI 10.1111/J.1365-3164.2004.00410_5-1.X]; Onderka D, 1996, MINK BIOL HLTH DIS, P151; Ramos CP, 1997, INT J SYST BACTERIOL, V32, P419; Skov RL, 1998, EUR J CLIN MICROBIOL, V17, P578, DOI 10.1007/s100960050135; UWATOKO K, 1995, VET MICROBIOL, V43, P315, DOI 10.1016/0378-1135(94)00102-3; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Wagner DC, 1991, PEDIATR INFECT DIS J, V10, P933; Yassin AF, 2011, INT J SYST EVOL MICR, V61, P1265, DOI 10.1099/ijs.0.020032-0	19	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110210	10.1371/journal.pone.0110210	http://dx.doi.org/10.1371/journal.pone.0110210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302603	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000343730400123
J	Wong, AJ; Planck, SR; Choi, DS; Harrington, CA; Troxell, ML; Houghton, DC; Stauffer, P; Wilson, DJ; Grossniklaus, HE; Dailey, RA; Ng, JD; Steele, EA; Harris, GJ; Czyz, C; Foster, JA; White, VA; Dolman, PJ; Kazim, M; Patel, PJ; Edward, DP; al Katan, H; al Hussain, H; Selva, D; Yeatts, RP; Korn, BS; Kikkawa, DO; Rosenbaum, JT				Wong, Amanda J.; Planck, Stephen R.; Choi, Dongseok; Harrington, Christina A.; Troxell, Megan L.; Houghton, Donald C.; Stauffer, Patrick; Wilson, David J.; Grossniklaus, Hans E.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Harris, Gerald J.; Czyz, Craig; Foster, Jill A.; White, Valerie A.; Dolman, Peter J.; Kazim, Michael; Patel, Payal J.; Edward, Deepak P.; al Katan, Hind; al Hussain, Hailah; Selva, Dinesh; Yeatts, R. Patrick; Korn, Bobby S.; Kikkawa, Don O.; Rosenbaum, James T.			IgG4 Immunostaining and Its Implications in Orbital Inflammatory Disease	PLOS ONE			English	Article							IGG4-POSITIVE PLASMA-CELLS; IGG4-RELATED SYSTEMIC-DISEASE; TUBULOINTERSTITIAL NEPHRITIS; SCLEROSING DISEASE; RITUXIMAB THERAPY; NOMENCLATURE; LUNG	Objective: IgG4-related disease is an emerging clinical entity which frequently involves tissue within the orbit. In order to appreciate the implications of IgG4 immunostaining, we analyzed gene expression and the prevalence of IgG4-immunostaining among subjects with orbital inflammatory diseases. Methods: We organized an international consortium to collect orbital biopsies from 108 subjects including 22 with no known orbital disease, 42 with nonspecific orbital inflammatory disease (NSOI), 26 with thyroid eye disease (TED), 12 with sarcoidosis, and 6 with granulomatosis with polyangiitis (GPA). Lacrimal gland and orbital adipose tissue biopsies were immunostained for IgG4 or IgG secreting plasma cells. RNA transcripts were quantified by Affymetrix arrays. Results: None of the healthy controls or subjects with TED had substantial IgG4 staining. Among the 63 others, the prevalence of significant IgG4-immunostaining ranged from 11 to 39% depending on the definition for significant. IgG4 staining was detectable in the majority of tissues from subjects with GPA and less commonly in tissue from subjects with sarcoidosis or NSOI. The detection of IgG4+ cells correlated with inflammation in the lacrimal gland based on histology. IgG4 staining tissue expressed an increase in transcripts associated with inflammation, especially B cell-related genes. Functional annotation analysis confirmed this. Conclusion: IgG4+ plasma cells are common in orbital tissue from patients with sarcoidosis, GPA, or NSOI. Even using the low threshold of 10 IgG4+ cells/high powered field, IgG4 staining correlates with increased inflammation in the lacrimal gland based on histology and gene expression.	[Wong, Amanda J.; Planck, Stephen R.; Choi, Dongseok; Stauffer, Patrick; Wilson, David J.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Planck, Stephen R.; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Planck, Stephen R.; Rosenbaum, James T.] Legacy Hlth Syst, Devers Eye Inst, Portland, OR USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Houghton, Donald C.] Oregon Hlth & Sci Univ, Integrated Genom Lab, Portland, OR 97201 USA; [Troxell, Megan L.; Houghton, Donald C.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Harris, Gerald J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Czyz, Craig] Ohio Univ, Div Ophthalmol, Columbus, OH USA; [Foster, Jill A.] Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA; [White, Valerie A.; Dolman, Peter J.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Kazim, Michael; Patel, Payal J.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Edward, Deepak P.; al Katan, Hind; al Hussain, Hailah] King Khalid Eye Specialist Hosp, Res Dept, Riyadh, Saudi Arabia; [Selva, Dinesh] Royal Adelaide Hosp, Ophthalmol Network, Adelaide, SA 5000, Australia; [Yeatts, R. Patrick] Wake Forest Univ, Dept Ophthalmol, Winston Salem, NC 27109 USA; [Korn, Bobby S.; Kikkawa, Don O.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA	Oregon Health & Science University; Oregon Health & Science University; Devers Eye Institute; Legacy Health; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Emory University; Medical College of Wisconsin; University System of Ohio; Ohio University; University System of Ohio; Ohio State University; University of British Columbia; Columbia University; King Khaled Eye Specialist Hospital; Royal Adelaide Hospital; Wake Forest University; University of California System; University of California San Diego	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	Rosenbaj@ohsu.edu	ALKATAN, HIND M/AAU-3752-2021	ALKATAN, HIND M/0000-0002-9968-4099; Czyz, Craig/0000-0001-6357-8019; Choi, Dongseok/0000-0002-1552-4072	National Institutes of Health [EY020249, EY010572, RR024140]; Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020249, P30EY010572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by funding from National Institutes of Health Grants (www.nih.gov), EY020249 (JTR), EY010572 (JTR) and RR024140 (E.S.Orwoll); and Research to Prevent Blindness (www.rpbusa.org) (Casey Eye Institute, OHSU), the Stan and Madelle Rosenfeld Family Trust (JTR), the William and Mary Bauman Foundation (JTR), the MAS Family Foundation (JTR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2013, JPN J OPHTHALMOL, V57, P573, DOI 10.1007/s10384-013-0266-4; Andrew N, 2013, ACTA OPHTHALMOL, V91, P694, DOI 10.1111/j.1755-3768.2012.02526.x; Chang SY, 2013, HUM PATHOL, V44, P2432, DOI 10.1016/j.humpath.2013.05.023; Cheuk W, 2007, AM J SURG PATHOL, V31, P643, DOI 10.1097/01.pas.0000213445.08902.11; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586, DOI 10.1097/PAS.0b013e318059b87c; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hamed G, 2007, RESPIROLOGY, V12, P455, DOI 10.1111/j.1440-1843.2007.01053.x; Houghton DC, 2011, MODERN PATHOL, V24, P1480, DOI 10.1038/modpathol.2011.101; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Karamchandani JR, 2012, AM J CLIN PATHOL, V137, P699, DOI 10.1309/AJCPE1G8DRHXRPIH; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Khosroshahi A, 2011, AM J MED, V124, pE7, DOI 10.1016/j.amjmed.2011.03.011; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; Lehman JS, 2014, AM J CLIN PATHOL, V141, P234, DOI 10.1309/AJCPTMWTCN04GSJH; Lindfield D, 2012, EYE, V26, P623, DOI 10.1038/eye.2012.4; Matsuo T, 2010, J CLIN EXP HEMATOP, V50, P129, DOI 10.3960/jslrt.50.129; Mehta M, 2009, ARCH PATHOL LAB MED, V133, P1251, DOI 10.1043/1543-2165-133.8.1251; Plaza JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P421, DOI 10.1001/archophthalmol.2011.16; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Sato Y, 2008, PATHOL INT, V58, P465, DOI 10.1111/j.1440-1827.2008.02257.x; Stone JH, 2012, SEMIN DIAGN PATHOL, V29, P177, DOI 10.1053/j.semdp.2012.08.002; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Strehl JD, 2011, J CLIN PATHOL, V64, P237, DOI 10.1136/jcp.2010.085613; Suhler EB, 2014, JAMA OPHTHALMOL, V132, P572, DOI 10.1001/jamaophthalmol.2013.8179; van de Stadt LA, 2013, ARTHRITIS RHEUM; Wallace ZS, 2013, MEDICINE, V92, P206, DOI 10.1097/MD.0b013e31829cce35; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Zen Y, 2005, HUM PATHOL, V36, P710, DOI 10.1016/j.humpath.2005.05.011	30	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109847	10.1371/journal.pone.0109847	http://dx.doi.org/10.1371/journal.pone.0109847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303270	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400085
J	Zhang, CY; Zhao, YX; Xia, RH; Han, J; Wang, BS; Tian, Z; Wang, LZ; Hu, YH; Li, J				Zhang, Chun-Ye; Zhao, Yang-Xing; Xia, Rong-Hui; Han, Jing; Wang, Bing-Shun; Tian, Zhen; Wang, Li-Zhen; Hu, Yu-Hua; Li, Jiang			RASSF1A Promoter Hypermethylation Is a Strong Biomarker of Poor Survival in Patients with Salivary Adenoid Cystic Carcinoma in a Chinese Population	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; DOMAIN FAMILY PROTEIN; HIGH-FREQUENCY; CLINICOPATHOLOGICAL ANALYSIS; EPIGENETIC INACTIVATION; BREAST-CANCER; CHROMOSOME 3P; LUNG-CANCER; METHYLATION; HEAD	In addition to the clinicopathological parameters, molecular biomarkers are becoming increasingly important in the prognostic evaluation of cancer patients. This study aimed to determine the molecular alterations in the RAS association domain family protein1A gene (RASSF1A) in salivary adenoid cystic carcinoma (ACC) and to evaluate the potential of such alterations as prognostic markers. One hundred and sixty-seven ACC tumor tissues and 50 samples of matched normal salivary gland tissues from the same patients were analyzed for RASSF1A promoter methylation status by bisulfite sequencing PCR (BSP) and/or methylation-specific PCR (MSP). Fifty ACC tumor tissues and matched normal salivary gland tissues were analyzed for loss of heterozygosity (LOH) by examining two microsatellite markers (D3S1478, D351621) at 3p21. RASSF1A gene mutations were detected by direct sequencing of all six exons in 50 tumor and normal tissue specimens. Over-all, RASSF1A promoter hypermethylation was detected in 35.3% (59/167) of ACC tissues and was associated with histologically solid tumor pattern (P=0.002) and advanced TNM stage (P=0.014). RASSF1A LOH was observed in 18.0% (9/50 cases, and no somatic mutation of RASSF1A was detected in any cases. RASSF1A promoter methlyation was associated h the poor over-all survival (Log-rank test, P<0.001) and disease-free survival (Log-rank test, P<0.001) and identified as independent predicator of over-all patient survival (P=0.009) and disease-free survival (P<0.001). It was concluded that RASSF1A methylation is involved in the development, differentiation and progression of ACC and is a strong independent biomarker of poor survival in ACC patients in a Chinese population.	[Zhang, Chun-Ye; Xia, Rong-Hui; Han, Jing; Tian, Zhen; Wang, Li-Zhen; Hu, Yu-Hua; Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Oral Pathol, Shanghai 200030, Peoples R China; [Zhao, Yang-Xing] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200030, Peoples R China; [Wang, Bing-Shun] Shanghai Jiao Tong Univ, Sch Med, Dept Biostat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, J (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Oral Pathol, Shanghai 200030, Peoples R China.	lijiang182000@126.com	Wang, Bing-shun/B-8698-2013	Wang, Bingshun/0000-0002-0435-2543	Natural Science Fund of China [81372910, 81302360]; Research Fund for the Doctoral Program of Ministry of Education of China [20120073110085]; Youth Research Foundation of Shanghai Municipal Health Bureau [20134Y057]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Ministry of Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Youth Research Foundation of Shanghai Municipal Health Bureau	This work was supported by 1. The Natural Science Fund of China (Nos. 81372910, 81302360) to JL and CYZ (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list); 2. The Research Fund for the Doctoral Program of Ministry of Education of China (No. 20120073110085) to JL (http://www.cutech.edu.cn/cn/zxgz/2012/12/1354173228992896.htm); and 3. Youth Research Foundation of Shanghai Municipal Health Bureau (20134Y057) (http://www.wsjsw.gov.cn/wsj/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Buckingham L, 2010, INT J CANCER, V126, P1630, DOI 10.1002/ijc.24896; Buhmeida A, 2011, ANTICANCER RES, V31, P2975; Choi CH, 2007, CANCER LETT, V255, P26, DOI 10.1016/j.canlet.2007.03.015; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; de Fraipont F, 2012, CLIN CANCER RES, V18, P2976, DOI 10.1158/1078-0432.CCR-11-2797; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; El Naggar AK, 2005, WHO CLASSIFICATION T, P221; Ellis GLA., 2008, AFIP ATLAS TUMOR PAT, P301; Gobel G, 2011, BREAST CANC RES TREA; Gondivkar SM, 2011, ORAL ONCOL, V47, P231, DOI 10.1016/j.oraloncology.2011.01.009; Grote HJ, 2006, CANCER CYTOPATHOL, V108, P129, DOI 10.1002/cncr.21717; Jiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036780; Karray-Chouayekh S, 2010, J CANCER RES CLIN, V136, P203, DOI 10.1007/s00432-009-0649-6; Kim JS, 2012, CLIN GENITOURIN CANC, V10, P114, DOI 10.1016/j.clgc.2011.12.003; Ku JL, 2011, METHODS MOL BIOL, V791, P23, DOI 10.1007/978-1-61779-316-5_3; Li J, 2004, ARCH PATHOL LAB MED, V128, P1385; Li J, 2005, CANCER-AM CANCER SOC, V104, P771, DOI 10.1002/cncr.21215; Licchesi Julien D. F., 2009, V507, P305, DOI 10.1007/978-1-59745-522-0_22; Lo KW, 2001, CANCER RES, V61, P3877; Miranda E, 2006, BRIT J CANCER, V95, P1101, DOI 10.1038/sj.bjc.6603337; NASCIMENTO AG, 1986, CANCER, V57, P312, DOI 10.1002/1097-0142(19860115)57:2<312::AID-CNCR2820570220>3.0.CO;2-A; Ohshima J, 2012, PEDIAT BLOOD CANC; Oliveira C, 2005, ONCOGENE, V24, P7630, DOI 10.1038/sj.onc.1208906; Pan ZG, 2005, CANCER BIOL THER, V4, P1116, DOI 10.4161/cbt.4.10.2023; Rapidis AD, 2005, ORAL ONCOL, V41, P328, DOI 10.1016/j.oraloncology.2004.12.004; Reed K, 2010, ANAL BIOCHEM, V397, P96, DOI 10.1016/j.ab.2009.10.021; Riquelme E, 2007, CANCER LETT, V250, P100, DOI 10.1016/j.canlet.2006.09.019; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Shen CY, 2012, ORAL ONCOL, V48, P445, DOI 10.1016/j.oraloncology.2011.12.002; Shinozaki M, 2005, CLIN CANCER RES, V11, P2156, DOI 10.1158/1078-0432.CCR-04-1810; SPIRO RH, 1979, AM J SURG, V138, P579, DOI 10.1016/0002-9610(79)90423-9; Tian Z, 2010, INT J ORAL MAX SURG, V39, P235, DOI 10.1016/j.ijom.2009.10.016; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Yeo W, 2005, PATHOLOGY, V37, P125, DOI 10.1080/00313020500058623; Yu MY, 2003, INT J CANCER, V105, P204, DOI 10.1002/ijc.11051; Zhang CY, 2007, CANCER-AM CANCER SOC, V110, P87, DOI 10.1002/cncr.22758; Zhang CY, 2013, OR SURG OR MED OR PA, V115, P368, DOI 10.1016/j.oooo.2012.11.018	40	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110159	10.1371/journal.pone.0110159	http://dx.doi.org/10.1371/journal.pone.0110159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302792	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400114
J	Vermandere, H; Naanyu, V; Mabeya, H; Broeck, DV; Michielsen, K; Degomme, O				Vermandere, Heleen; Naanyu, Violet; Mabeya, Hillary; Broeck, Davy Vanden; Michielsen, Kristien; Degomme, Olivier			Determinants of Acceptance and Subsequent Uptake of the HPV Vaccine in a Cohort in Eldoret, Kenya	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; MIDDLE-INCOME COUNTRIES; CERVICAL-CANCER RISK; VIRUS VACCINE; DELIVERY STRATEGIES; DECISION-MAKING; HIGH COVERAGE; ACCEPTABILITY; PARENTS; KNOWLEDGE	The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight against cervical cancer. Many acceptability studies have revealed high interest in these vaccines, but acceptance is only a precursor of behavior, and many factors, at personal, community and provider level, may inhibit the translation of willingness to vaccinate into actual uptake. Through a longitudinal study in Eldoret, Kenya, HPV vaccine acceptability was measured before a vaccination program (n = 287) and vaccine uptake, as reported by mothers, once the program was finished (n = 256). In between baseline and follow-up, a pilot HPV vaccination program was implemented via the GARDASIL Access Program, in which parents could have their daughter vaccinated for free at the referral hospital. The program was promoted at schools: Health staff informed teachers who were then asked to inform students and parents. Even though baseline acceptance was very high (88.1%), only 31.1% of the women reported at follow-up that their daughter had been vaccinated. The vaccine was declined by 17.7%, while another 51.2% had wanted the vaccination but were obstructed by practical barriers. Being well-informed about the program and baseline awareness of cervical cancer were independently associated with vaccine uptake, while baseline acceptance was correlated in bivariate analysis. Side effects were of great concern, even among those whose daughter was vaccinated. Possible partner disapproval lowered acceptance at baseline, and women indeed reported at follow-up that they had encountered his opposition. In Kenya, women prove to be very willing to have their daughter vaccinated against cervical cancer. However, in this study, uptake was more determined by program awareness than by HPV vaccine acceptance. School-based vaccination might improve coverage since it reduces operational problems for parents. In addition, future HPV vaccination campaigns should address concerns about side effects, targeting men and women, given both their involvement in HPV vaccination decision-making.	[Vermandere, Heleen; Broeck, Davy Vanden; Michielsen, Kristien; Degomme, Olivier] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Naanyu, Violet] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Mabeya, Hillary] Moi Univ, Coll Hlth Sci, Sch Med, Dept Reprod Hlth, Eldoret, Kenya	Ghent University; Moi University; Moi University	Vermandere, H (corresponding author), Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium.	Heleen.vermandere@ugent.be	Mabeya, Hillary/HHC-7512-2022; Naanyu, Violet/GNM-8783-2022; Naanyu, Violet/AAL-6106-2020	Naanyu, Violet/0000-0003-0182-1719; Naanyu, Violet/0000-0003-0182-1719; vermandere, heleen/0000-0003-1274-8537; Michielsen, Kristien/0000-0002-4119-6770	Research Foundation Flanders (FWO) [1194113N]; Moi University (Kenya)-VLIR UOS (Belgium)	Research Foundation Flanders (FWO)(FWO); Moi University (Kenya)-VLIR UOS (Belgium)	Funding of the Research Foundation Flanders (FWO) supported Heleen Vermandere and the study (#1194113N). Funds for the vaccination pilot program were provided by the Moi University (Kenya)-VLIR UOS (Belgium) collaborative program. The vaccines were donated to Moi Teaching and Referral Hospital by Axios Healthcare Development (AHD) as part of the Gardasil Access Program, which was made possible by a pledge from Merck & Co., Inc. This donation was used for the study presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Ayissi CA, 2012, J COMMUN HEALTH, V37, P1127, DOI 10.1007/s10900-012-9554-z; Babirye JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-723; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bingham A, 2009, OPEN VACCINE J; Bingham A, 2009, SOCIOCULTURAL ISSUES; Black LL, 2009, VACCINE, V27, P1668, DOI 10.1016/j.vaccine.2009.01.035; Brabin L, 2008, VACCINE, V26, P4120, DOI 10.1016/j.vaccine.2008.04.055; Brewer NT, 2011, SEX TRANSM DIS, V38, P197, DOI 10.1097/OLQ.0b013e3181f12dbf; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Cover JK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-629; Dempsey AF, 2009, ANN EPIDEMIOL, V19, P531, DOI 10.1016/j.annepidem.2009.03.011; DiAngi YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025481; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090; Galagan SR, 2013, VACCINE, V31, P3072, DOI 10.1016/j.vaccine.2013.04.056; Gerend MA, 2013, HEALTH PSYCHOL, V32, P361, DOI 10.1037/a0026248; Globocan, 2012, EST CANC INC MORT PR; Grabenstein JD, 2013, VACCINE, V31, P2011, DOI 10.1016/j.vaccine.2013.02.026; Harries J, 2009, VACCINE, V27, P38, DOI 10.1016/j.vaccine.2008.10.033; Hendry M, 2013, VACCINE, V31, P5152, DOI 10.1016/j.vaccine.2013.08.091; Hertweck SP, 2013, J PEDIATR ADOL GYNEC, V26, P96, DOI 10.1016/j.jpag.2012.10.009; Hopkins TG, 2013, VACCINE, V31, P1673, DOI 10.1016/j.vaccine.2013.01.028; Iliyasu Z, 2010, J OBSTET GYNAECOL, V30, P857, DOI 10.3109/01443615.2010.511724; Katahoire R A, 2008, Afr J Reprod Health, V12, P159; Ladner J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-670; Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Marlow LAV, 2011, BRIT J CANCER, V105, P486, DOI 10.1038/bjc.2011.272; Moodley I, 2013, SAMJ S AFR MED J, V103, P318, DOI 10.7196/SAMJ.6414; Morhason-Bello Imran O, 2013, Afr J Reprod Health, V17, P150; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Paul P, 2014, VACCINE, V32, P320, DOI 10.1016/j.vaccine.2013.11.070; Perlman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090912; Poole DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056402; Reiter PL, 2013, AM J PUBLIC HEALTH, V103, P1419, DOI 10.2105/AJPH.2012.301189; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Ugwu EO, 2013, NIGER J CLIN PRACT, V16, P249, DOI 10.4103/1119-3077.110141; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Watson M, 2009, AUST NZ J PUBL HEAL, V33, P365, DOI 10.1111/j.1753-6405.2009.00409.x; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045231; Watson-Jones D, 2012, J INFECT DIS, V206, P678, DOI 10.1093/infdis/jis407; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; Winkler JL, 2008, VACCINE, V26, pL73, DOI 10.1016/j.vaccine.2008.05.027; World Health Organization, 2009, WEEKLY EPIDEMIOLOGIC, V84, P117; Young A, 2010, ASIAN PAC J CANCER P, V11, P641; Zimet GD, 2013, PREV MED, V57, P414, DOI 10.1016/j.ypmed.2013.05.013	53	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109353	10.1371/journal.pone.0109353	http://dx.doi.org/10.1371/journal.pone.0109353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299646	Green Published, gold			2022-12-25	WOS:000343941200048
J	Katsev, S; Aaberg, AA; Crowe, SA; Hecky, RE				Katsev, Sergei; Aaberg, Arthur A.; Crowe, Sean A.; Hecky, Robert E.			Recent Warming of Lake Kivu	PLOS ONE			English	Article							DEEP-WATER; CLIMATE; TEMPERATURE; TANGANYIKA	Lake Kivu in East Africa has gained notoriety for its prodigious amounts of dissolved methane and dangers of limnic eruption. Being meromictic, it is also expected to accumulate heat due to rising regional air temperatures. To investigate the warming trend and distinguish between atmospheric and geothermal heating sources, we compiled historical temperature data, performed measurements with logging instruments, and simulated heat propagation. We also performed isotopic analyses of water from the lake's main basin and isolated Kabuno Bay. The results reveal that the lake surface is warming at the rate of 0.12 degrees C per decade, which matches the warming rates in other East African lakes. Temperatures increase throughout the entire water column. Though warming is strongest near the surface, warming rates in the deep waters cannot be accounted for solely by propagation of atmospheric heat at presently assumed rates of vertical mixing. Unless the transport rates are significantly higher than presently believed, this indicates significant contributions from subterranean heat sources. Temperature time series in the deep monimolimnion suggest evidence of convection. The progressive deepening of the depth of temperature minimum in the water column is expected to accelerate the warming in deeper waters. The warming trend, however, is unlikely to strongly affect the physical stability of the lake, which depends primarily on salinity gradient.	[Katsev, Sergei; Hecky, Robert E.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Katsev, Sergei; Aaberg, Arthur A.] Univ Minnesota, Dept Phys, Duluth, MN 55812 USA; [Crowe, Sean A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Hecky, Robert E.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of British Columbia; University of Minnesota System; University of Minnesota Duluth	Katsev, S (corresponding author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.	skatsev@d.umn.edu			University of Minnesota Office of International Programs Seed Grant	University of Minnesota Office of International Programs Seed Grant	The work was supported by the University of Minnesota Office of International Programs Seed Grant to SK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg AA, 2013, THESIS U MINNESOTA D; Borges AV, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001673; CONRAD R, 1990, ARCH MICROBIOL, V155, P94, DOI 10.1007/BF00291281; Damas H, 1937, ANN SOC R ZOOL BELG, V68, P121; Degens ET, 1973, GEOL RUNDSCH, V62, P245, DOI DOI 10.1007/BF01826830; DEUSER WG, 1973, SCIENCE, V181, P51, DOI 10.1126/science.181.4094.51; Halbwachs M, 2002, TECHNICAL REPORT; HECKY RE, 1994, LIMNOL OCEANOGR, V39, P1476, DOI 10.4319/lo.1994.39.6.1476; Hirslund F, 2012, J LIMNOL, V71, P45, DOI 10.4081/jlimnol.2012.e4; Houghton J. T., 2001, CLIMATE CHANGE 2001; Katsev S, 2010, LIMNOL OCEANOGR, V55, P763, DOI 10.4319/lo.2009.55.2.0763; LEHMAN J. T., 1998, ENV CHANGE RESPONSE, P157; Lorke A, 2004, LIMNOL OCEANOGR, V49, P778, DOI 10.4319/lo.2004.49.3.0778; NEWMAN FC, 1976, J PHYS OCEANOGR, V6, P157, DOI 10.1175/1520-0485(1976)006<0157:TSILKA>2.0.CO;2; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Pasche N, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001690; Pasche N, 2009, LIMNOL OCEANOGR, V54, P1863, DOI 10.4319/lo.2009.54.6.1863; REICHERT P, 1994, WATER SCI TECHNOL, V30, P21, DOI 10.2166/wst.1994.0025; Ross KA, 2014, GEOMORPHOLO IN PRESS; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M., 2002, ACTA VULCANOL, V14, P115; Schmid M., 2012, LAKE KIVU LIMNOLOGY; Schmid M, 2012, J LIMNOL, V71, P330, DOI 10.4081/jlimnol.2012.e35; Schmid M, 2010, LIMNOL OCEANOGR, V55, P225, DOI 10.4319/lo.2010.55.1.0225; Schmitz D. M., 1955, ACAD ROY SCI COLONIA, V1, P326; Sommer T, 2013, J GEOPHYS RES-OCEANS, V118, P6092, DOI 10.1002/2013JC009166; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tietze K, 1978, THESIS CHRISTIAN ALB; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846; Verburg P, 2009, LIMNOL OCEANOGR, V54, P2418, DOI 10.4319/lo.2009.54.6_part_2.2418; Vollmer MK, 2005, LIMNOL OCEANOGR, V50, P727, DOI 10.4319/lo.2005.50.2.0727; Zhang YX, 2006, ANNU REV EARTH PL SC, V34, P293, DOI 10.1146/annurev.earth.34.031405.125001	33	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109084	10.1371/journal.pone.0109084	http://dx.doi.org/10.1371/journal.pone.0109084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295730	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000035
J	Kong, HG; Bae, JY; Lee, HJ; Joo, HJ; Jung, EJ; Chung, E; Lee, SW				Kong, Hyun Gi; Bae, Ju Young; Lee, Hyoung Ju; Joo, Hae Jin; Jung, Eun Joo; Chung, Eunsook; Lee, Seon-Woo			Induction of the Viable but Nonculturable State of Ralstonia solanacearum by Low Temperature in the Soil Microcosm and Its Resuscitation by Catalase	PLOS ONE			English	Article							NON-CULTURABLE STATE; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; PSEUDOMONAS-SOLANACEARUM; VIBRIO-CHOLERAE; OXIDATIVE STRESS; GENE-EXPRESSION; TOMATO PLANTS; SURVIVAL; STARVATION; BACTERIA	Ralstonia solanacearum is the causal agent of bacterial wilt on a wide variety of plants, and enters a viable but nonculturable (VBNC) state under stress conditions in soil and water. Here, we adopted an artificial soil microcosm (ASM) to investigate the VBNC state of R. solanacearum induced by low temperature. The culturability of R. solanacearum strains SL341 and GMI1000 rapidly decreased at 4 degrees C in modified ASM (mASM), while it was stably maintained at 25 degrees C in mASM. We hypothesized that bacterial cells at 4 degrees C in mASM are viable but nonculturable. Total protein profiles of SL341 cells at 4 degrees C in mASM did not differ from those of SL341 culturable cells at 25 degrees C in mASM. Moreover, the VBNC cells maintained in the mASM retained respiration activity. Catalase treatment effectively restored the culturability of nonculturable cells in mASM, while temperature increase or other treatments used for resuscitation of other bacteria were not effective. The resuscitated R. solanacearum from VBNC state displayed normal level of bacterial virulence on tomato plants compared with its original culturable bacteria. Expression of omp, oxyR, rpoS, dps, and the 16S rRNA gene quantified by RT-qPCR did not differ significantly between the culturable and VBNC states of R. solanacearum. Our results suggested that the VBNC bacterial cells in mASM induced by low temperature exist in a physiologically unique state.	[Kong, Hyun Gi; Bae, Ju Young; Lee, Hyoung Ju; Joo, Hae Jin; Jung, Eun Joo; Chung, Eunsook; Lee, Seon-Woo] Dong A Univ, Dept Appl Biosci, Pusan, South Korea	Dong A University	Lee, SW (corresponding author), Dong A Univ, Dept Appl Biosci, Pusan, South Korea.	seonlee@dau.ac.kr		Lee, Seon-Woo/0000-0001-6142-7612	National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2012R1A2A2A01045039]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ0082012014]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was supported by the Mid-career Researcher Program through the National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (NRF-2012R1A2A2A01045039) and by a grant from the Next-Generation BioGreen 21 Program (No. PJ0082012014), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander E, 1999, APPL ENVIRON MICROB, V65, P3754; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Alvarez B, 2008, MICROBIOL-SGM, V154, P3590, DOI 10.1099/mic.0.2008/019448-0; Arana I, 2007, FEMS MICROBIOL ECOL, V62, P1, DOI 10.1111/j.1574-6941.2007.00362.x; Artz RRE, 2006, CAN J MICROBIOL, V52, P482, DOI 10.1139/W05-149; Asakura H, 2007, ENVIRON MICROBIOL, V9, P869, DOI 10.1111/j.1462-2920.2006.01206.x; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39; Bogosian G, 2001, EMBO REP, V2, P770, DOI 10.1093/embo-reports/kve182; Caruso P, 2005, APPL ENVIRON MICROB, V71, P140, DOI 10.1128/AEM.71.1.140-148.2005; Chattopadhyay MK, 2011, CURR MICROBIOL, V62, P544, DOI 10.1007/s00284-010-9742-y; Colburn-Clifford JM, 2010, APPL ENVIRON MICROB, V76, P7392, DOI 10.1128/AEM.01742-10; Cook KL, 1997, MICROBIAL ECOL, V34, P237, DOI 10.1007/s002489900053; Coutard F, 2007, ISME J, V1, P111, DOI 10.1038/ismej.2007.1; Ellis RJ, 2004, J MICROBIOL METH, V56, P287, DOI 10.1016/j.mimet.2003.10.005; Fera MT, 2008, APPL ENVIRON MICROB, V74, P3266, DOI 10.1128/AEM.00059-08; Flavier AB, 1998, MOL MICROBIOL, V28, P475, DOI 10.1046/j.1365-2958.1998.00804.x; Flavier AB, 1997, J BACTERIOL, V179, P7089, DOI 10.1128/jb.179.22.7089-7097.1997; Flores-Cruz Z, 2011, APPL ENVIRON MICROB, V77, P64236; Ghezzi JI, 1999, FEMS MICROBIOL ECOL, V30, P203, DOI 10.1111/j.1574-6941.1999.tb00648.x; Gonzalez-Escalona N, 2006, ENVIRON MICROBIOL, V8, P658, DOI 10.1111/j.1462-2920.2005.00943.x; Grey BE, 2001, APPL ENVIRON MICROB, V67, P3866, DOI 10.1128/AEM.67.9.3866-3872.2001; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Imazaki I, 2010, J GEN PLANT PATHOL, V76, P52, DOI 10.1007/s10327-009-0208-7; Imazaki I, 2009, J GEN PLANT PATHOL, V75, P213, DOI 10.1007/s10327-009-0166-0; Jeong Y, 2007, PLANT DIS, V91, P1277, DOI 10.1094/PDIS-91-10-1277; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Makino SI, 2000, APPL ENVIRON MICROB, V66, P5536, DOI 10.1128/AEM.66.12.5536-5539.2000; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; Nieman JKC, 2005, ARCH ENVIRON CON TOX, V49, P283, DOI 10.1007/s00244-004-0138-5; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; OLIVER JD, 1991, APPL ENVIRON MICROB, V57, P2640, DOI 10.1128/AEM.57.9.2640-2644.1991; Ordax M, 2006, APPL ENVIRON MICROB, V72, P3482, DOI 10.1128/AEM.72.5.3482-3488.2006; Reissbrodt R, 2002, APPL ENVIRON MICROB, V68, P4788, DOI 10.1128/AEM.68.10.4788-4794.2002; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801, DOI 10.1128/AEM.58.6.1801-1808.1992; Saddler GS, 2005, MANAGEMENT BACTERIAL, P121; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Taskin B, 2011, APPL ENVIRON MICROB, V77, P4329, DOI 10.1128/AEM.02895-10; Um HY, 2013, PLANT PATHOLOGY J, V29, P374, DOI 10.5423/PPJ.OA.07.2013.0067; van Elsas JD, 2000, PHYTOPATHOLOGY, V90, P1358, DOI 10.1094/PHYTO.2000.90.12.1358; van Elsas JD, 2001, CAN J MICROBIOL, V47, P842, DOI 10.1139/cjm-47-9-842; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241; WALLIS FM, 1978, PHYSIOL PLANT PATHOL, V13, P307, DOI 10.1016/0048-4059(78)90047-4; Wong HC, 2004, FEMS MICROBIOL LETT, V233, P269, DOI 10.1111/j.1574-6968.2004.tb09491.x; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Zhong L, 2009, LETT APPL MICROBIOL, V48, P247, DOI 10.1111/j.1472-765X.2008.02522.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	54	26	29	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109792	10.1371/journal.pone.0109792	http://dx.doi.org/10.1371/journal.pone.0109792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296177	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000094
J	Alexander, BE; Liebrand, K; Osinga, R; van der Geest, HG; Admiraal, W; Cleutjens, JPM; Schutte, B; Verheyen, F; Ribes, M; van Loon, E; de Goeij, JM				Alexander, Brittany E.; Liebrand, Kevin; Osinga, Ronald; van der Geest, Harm G.; Admiraal, Wim; Cleutjens, Jack P. M.; Schutte, Bert; Verheyen, Fons; Ribes, Marta; van Loon, Emiel; de Goeij, Jasper M.			Cell Turnover and Detritus Production in Marine Sponges from Tropical and Temperate Benthic Ecosystems	PLOS ONE			English	Article							STEM-CELLS; TISSUE HOMEOSTASIS; IN-VITRO; DEMOSPONGIAE; KINETICS; CYCLE; DIFFERENTIATION; PROLIFERATION; REGENERATION; CULTIVATION	This study describes in vivo cell turnover (the balance between cell proliferation and cell loss) in eight marine sponge species from tropical coral reef, mangrove and temperate Mediterranean reef ecosystems. Cell proliferation was determined through the incorporation of 5-bromo-2'-deoxyuridine (BrdU) and measuring the percentage of BrdU-positive cells after 6 h of continuous labeling (10 h for Chondrosia reniformis). Apoptosis was identified using an antibody against active caspase-3. Cell loss through shedding was studied quantitatively by collecting and weighing sponge-expelled detritus and qualitatively by light microscopy of sponge tissue and detritus. All species investigated displayed substantial cell proliferation, predominantly in the choanoderm, but also in the mesohyl. The majority of coral reef species (five) showed between 16.1 +/- 15.9% and 19.0 +/- 2.0% choanocyte proliferation (mean +/- SD) after 6 h and the Mediterranean species, C. reniformis, showed 16.6 +/- 3.2% after 10 h BrdU-labeling. Monanchora arbuscula showed lower choanocyte proliferation (8.1 +/- 3.7%), whereas the mangrove species Mycale microsigmatosa showed relatively higher levels of choanocyte proliferation (70.5 +/- 6.6%). Choanocyte proliferation in Haliclona vansoesti was variable (2.8-73.1%). Apoptosis was negligible and not the primary mechanism of cell loss involved in cell turnover. All species investigated produced significant amounts of detritus (2.5-18% detritus bodyweight(-1) d(-1)) and cell shedding was observed in seven out of eight species. The amount of shed cells observed in histological sections may be related to differences in residence time of detritus within canals. Detritus production could not be directly linked to cell shedding due to the degraded nature of expelled cellular debris. We have demonstrated that under steady-state conditions, cell turnover through cell proliferation and cell shedding are common processes to maintain tissue homeostasis in a variety of sponge species from different ecosystems. Cell turnover is hypothesized to be the main underlying mechanism producing sponge-derived detritus, a major trophic resource transferred through sponges in benthic ecosystems, such as coral reefs.	[Alexander, Brittany E.; Liebrand, Kevin; van der Geest, Harm G.; Admiraal, Wim; de Goeij, Jasper M.] Univ Amsterdam, Dept Aquat Ecol & Ecotoxicol, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Alexander, Brittany E.; Osinga, Ronald; de Goeij, Jasper M.] Porifarma BV Poelbos 3, Ede, Netherlands; [Cleutjens, Jack P. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Schutte, Bert] Maastricht Univ, Res Inst Growth & Dev, Dept Mol Cell Biol, Maastricht, Netherlands; [Verheyen, Fons] CRISP, Electron Microscopy Unit, Maastricht, Netherlands; [Ribes, Marta] Inst Ciencies Mar Consejo Super Invest, Barcelona, Spain; [van Loon, Emiel] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Computat Geoecol, Amsterdam, Netherlands	University of Amsterdam; Maastricht University; Maastricht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Amsterdam	Alexander, BE (corresponding author), Univ Amsterdam, Dept Aquat Ecol & Ecotoxicol, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	B.E.Alexander@uva.nl	Cleutjens, Jack P.M./F-6242-2012; van Loon, Emiel/T-3858-2019; Ribes, Marta/B-2495-2013; de Goeij, Jasper/L-6992-2017	Cleutjens, Jack P.M./0000-0002-4346-1785; van Loon, Emiel/0000-0002-8895-0427; Ribes, Marta/0000-0001-9747-295X; Alexander, Brittany/0000-0003-4626-4872; de Goeij, Jasper/0000-0002-3411-3084	European Union Seventh Framework Programme(FP7) [KBBE-2010-266033]; Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI) [863.10.009]; Spanish Government [CGL2010-18466]	European Union Seventh Framework Programme(FP7); Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI); Spanish Government(Spanish GovernmentEuropean Commission)	Porifarma B.V. received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. KBBE-2010-266033 to undertake the research leading to these results. Funding was also received from The Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI; 863.10.009; personal grant to JMdG). Mediterranean sampling was partially funded by the grant CGL2010-18466 from the Spanish Government to MR. BEA, RO, and JMdG are affiliated with Porifarma B.V. Porifarma B.V. provided support in the form of salaries for authors BEA, RO, and JMdG, but no employees of Porifarma B.V. other than BEA, RO, and JMdG had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALDEWACHI HS, 1975, J ANAT, V119, P105; AYLING AL, 1983, BIOL BULL, V165, P343, DOI 10.2307/1541200; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Chaudhary M, 2000, DIGESTION, V61, P223, DOI 10.1159/000007762; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; De Goeij JM, 2009, J EXP BIOL, V212, P3892, DOI 10.1242/jeb.034561; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Ellison AM, 1996, ECOLOGY, V77, P2431, DOI 10.2307/2265744; Funayama N, 2013, DEV GENES EVOL, V223, P23, DOI 10.1007/s00427-012-0417-5; GOODLAD RA, 1987, CLIN SCI, V72, P297, DOI 10.1042/cs0720297; Granek EF, 2009, ECOSYSTEMS, V12, P462, DOI 10.1007/s10021-009-9235-7; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hunting ER, 2010, B MAR SCI, V86, P871, DOI 10.5343/bms.2010.1001; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; Koopmans M, 2011, MAR BIOL, V158, P9, DOI 10.1007/s00227-010-1538-x; Lee Y., 2006, GEN LINEAR MODELS RA; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Luter HM, 2012, HYDROBIOLOGIA, V687, P227, DOI 10.1007/s10750-011-0887-x; Maldonado M, 2012, ADV MAR BIOL, V62, P113, DOI 10.1016/B978-0-12-394283-8.00003-5; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mueller B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090152; Muller WEG, 1998, NATURWISSENSCHAFTEN, V85, P11, DOI 10.1007/s001140050444; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; REISWIG H M, 1981, Marine Ecology, V2, P273, DOI 10.1111/j.1439-0485.1981.tb00271.x; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Ribes M, 1999, MAR ECOL PROG SER, V176, P179, DOI 10.3354/meps176179; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Schippers KJ, 2012, ADV MAR BIOL, V62, P273, DOI 10.1016/B978-0-12-394283-8.00006-0; Schippers KJ, 2011, IN VITRO CELL DEV-AN, V47, P302, DOI 10.1007/s11626-011-9391-x; SCHMIDT T, 1986, J CELL SCI, V85, P197; SHORE RE, 1971, J EXP ZOOL, V177, P359, DOI 10.1002/jez.1401770310; Simpson T., 1984, CELL BIOL SPONGES; Sipkema D, 2006, MAR BIOTECHNOL, V8, P40, DOI 10.1007/s10126-005-5002-8; Sun LM, 2007, CELL TISSUE RES, V328, P223, DOI 10.1007/s00441-006-0342-x; TANAKA K, 1984, ZOOL SCI, V1, P561; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Tepsuporn S, 2003, BIOL BULL-US, V205, P199, DOI 10.2307/1543251; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Vacelet J., 1987, EUROPEAN CONTRIBUTIO, P5; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Weissenfels N, 1976, ZOOMORPHOLOGY, P73; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Wiens M, 2006, CAN J ZOOL, V84, P307, DOI 10.1139/Z05-165; Witte U, 1997, MAR ECOL PROG SER, V154, P241, DOI 10.3354/meps154241; Wong WM, 1999, J CLIN PATHOL, V52, P321, DOI 10.1136/jcp.52.5.321; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141	56	60	61	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109486	10.1371/journal.pone.0109486	http://dx.doi.org/10.1371/journal.pone.0109486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289641	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000065
J	Singh, W; Ornolfsdottir, EB; Stefansson, G				Singh, Warsha; Ornolfsdottir, Erla B.; Stefansson, Gunnar			A Small-Scale Comparison of Iceland Scallop Size Distributions Obtained from a Camera Based Autonomous Underwater Vehicle and Dredge Survey	PLOS ONE			English	Article							PLACOPECTEN-MAGELLANICUS; CHLAMYS-ISLANDICA; SEA SCALLOP; JUVENILE; GULF; EFFICIENCY; ABUNDANCE; ATLANTIC; SOUTHERN; FISHERY	An approach is developed to estimate size of Iceland scallop shells from AUV photos. A small-scale camera based AUV survey of Iceland scallops was conducted at a defined site off West Iceland. Prior to height estimation of the identified shells, the distortions introduced by the vehicle orientation and the camera lens were corrected. The average AUV pitch and roll was 1.3 and 2.3 deg that resulted in <2% error in ground distance rendering these effects negligible. A quadratic polynomial model was identified for lens distortion correction. This model successfully predicted a theoretical grid from a frame photographed underwater, representing the inherent lens distortion. The predicted shell heights were scaled for the distance from the bottom at which the photos were taken. This approach was validated by height estimation of scallops of known sizes. An underestimation of approximately 0.5 cm was seen, which could be attributed to pixel error, where each pixel represented 0.24 x 0.27 cm. After correcting for this difference the estimated heights ranged from 3.8-9.3 cm. A comparison of the height-distribution from a small-scale dredge survey carried out in the vicinity showed non-overlapping peaks in size distribution, with scallops of a broader size range visible in the AUV survey. Further investigations are necessary to evaluate any underlying bias and to validate how representative these surveys are of the true population. The low resolution images made identification of smaller scallops difficult. Overall, the observations of very few small scallops in both surveys could be attributed to low recruitment levels in the recent years due to the known scallop parasite outbreak in the region.	[Singh, Warsha; Stefansson, Gunnar] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Ornolfsdottir, Erla B.] Holar Univ Coll, Holar, Iceland	University of Iceland	Singh, W (corresponding author), Univ Iceland, Inst Sci, Dunhaga 3, IS-107 Reykjavik, Iceland.	singh.warsha@gmail.com	Stefansson, Gunnar/AAV-9432-2020; Stefansson, Gunnar/A-2209-2008	Stefansson, Gunnar/0000-0002-2693-9142; Stefansson, Gunnar/0000-0002-2693-9142; Singh, Warsha/0000-0002-8302-984X	Icelandic Research Fund, Rannis [110209023]; United Nations University - Fisheries Training Programme	Icelandic Research Fund, Rannis; United Nations University - Fisheries Training Programme	This research work was funded by the Icelandic Research Fund, Rannis (grant number 110209023 http://www.rannis.is/) and the United Nations University - Fisheries Training Programme (http://www.unuftp.is/). Grants were received by WS, EBO and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault DJ, 1996, MAR ECOL PROG SER, V140, P115, DOI 10.3354/meps140115; Arsenault DJ, 1996, CAN J FISH AQUAT SCI, V53, P884, DOI 10.1139/f95-234; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Carbines G, 2009, FISH RES, V96, P230, DOI 10.1016/j.fishres.2008.11.007; Carey JD, 2011, J SHELLFISH RES, V30, P569, DOI 10.2983/035.030.0301; Collie JS, 2000, ICES J MAR SCI, V57, P987, DOI 10.1006/jmsc.2000.0584; Fifas S, 1999, ICES J MAR SCI, V56, P489, DOI 10.1006/jmsc.1999.0482; Galand PE, 2000, SARSIA, V85, P183, DOI 10.1080/00364827.2000.10414570; Garcia EG, 2006, ADV MAR BIOL, V51, P1, DOI 10.1016/S0065-2881(06)51001-6; Gavia T, 2010, TECHNICAL REPORT; GIGUERE M, 1994, J SHELLFISH RES, V13, P25; Harris BP, 2006, ICES J MAR SCI, V63, P811, DOI 10.1016/j.icesjms.2006.02.003; Heikkila J, 1997, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.1997.609468; Hrafnkelsson B, 2004, CAN J FISH AQUAT SCI, V61, P1135, DOI 10.1139/F04-049; Jacobson LD, 2010, FISH B-NOAA, V108, P233; Jenkins SR, 2001, MAR ECOL PROG SER, V215, P297, DOI 10.3354/meps215297; Jonasson JP, 2007, ICES J MAR SCI, V64, P298, DOI 10.1093/icesjms/fsl028; Kutner M., 2005, APPL LINEAR STAT MOD; MCLOUGHLIN RJ, 1991, FISH RES, V11, P1, DOI 10.1016/0165-7836(91)90030-J; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosenkranz GE, 2004, FISH RES, V69, P131, DOI 10.1016/j.fishres.2004.01.007; Rosenkranz GE, 2008, FISH RES, V92, P340, DOI 10.1016/j.fishres.2008.03.014; Seiler J, 2012, FISH RES, V129, P64, DOI 10.1016/j.fishres.2012.06.011; Singh W, 2013, J SHELLFISH RES, V32, P725, DOI 10.2983/035.032.0314; Sklyar O., 2011, EBIMAGE IMAGE PROCES; Stokesbury KDE, 2010, J SHELLFISH RES, V29, P369, DOI 10.2983/035.029.0212; Stokesburys KDE, 2002, T AM FISH SOC, V131, P1081, DOI 10.1577/1548-8659(2002)131<1081:EOSSAI>2.0.CO;2; TAYLOR R, 2008, OCEANS, V2008, P1, DOI DOI 10.1109/OCEANS.2008.5152032; Tolimieri Nick, 2008, Alaska Sea Grant Report, V08-03, P129	29	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109369	10.1371/journal.pone.0109369	http://dx.doi.org/10.1371/journal.pone.0109369			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303243	Green Submitted, gold, Green Published			2022-12-25	WOS:000343730400052
J	Liu, Z; Que, FX; Liao, L; Zhou, M; You, LX; Zhao, Q; Li, YY; Niu, H; Wu, SY; Huang, R				Liu, Zhen; Que, Fengxia; Liao, Li; Zhou, Min; You, Lixiang; Zhao, Qing; Li, Yuanyuan; Niu, Hua; Wu, Shuyan; Huang, Rui			Study on the Promotion of Bacterial Biofilm Formation by a Salmonella Conjugative Plasmid and the Underlying Mechanism	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; VIRULENCE; GENE; RESISTANCE; MULTIPLE	To investigate the effect of the pR(ST98) plasmid, originally isolated from Salmonella enterica serovar Typhi (S. Typhi), on biofilm (BF) formation, we carried out in vitro experiments using S. Typhi, Salmonella enterica serovar Typhimurium (S. Typhimurium) and Escherichia coli (E. coli). We further explored the effects of pR(ST98) in vivo by establishing two animal models, a tumor-bearing mouse model and a mouse urethral catheter model. Moreover, we examined the relationship between the quorum-sensing (QS) system and pR(ST98)-mediated BF formation. These studies showed that pR(ST98) enhanced BF formation in different bacteria in vitro. In both animal models, pR(ST98) promoted BF formation and caused more severe pathological changes. It was previously reported that Salmonella senses exogenous N-acylhomoserine lactones (AHLs) through the regulatory protein SdiA and regulates the expression of genes including the virulence gene rck, which is located on the virulence plasmid of some serotypes of Salmonella. In this study, we confirmed the locus of the rck gene on pR(ST98) and found that AHLs increased rck expression in pR(ST98)-carrying strains, thereby enhancing bacterial adherence, serum resistance and bacterial BF formation. In conclusion, the Salmonella conjugative plasmid pR(ST98) promotes bacterial BF formation both in vitro and in vivo, and the mechanism may relate to the AHL-SdiA-Rck signaling pathway.	[Liu, Zhen; Que, Fengxia; Liao, Li; Zhou, Min; You, Lixiang; Zhao, Qing; Li, Yuanyuan; Niu, Hua; Wu, Shuyan; Huang, Rui] Soochow Univ, Coll Med, Suzhou, Peoples R China	Soochow University - China	Wu, SY (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	hruisdm@163.com; shuyanzw@aliyun.com		Niu, Hua/0000-0002-6860-2599	Natural Science Foundation of P. R. China [30972768]; Special Research Fund for the Doctoral Program of High Education [20103201110009]; Natural Science Foundation of Jiangsu province [BK2011286]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Special Research Fund for the Doctoral Program of High Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents	This study was supported by the Natural Science Foundation of P. R. China (No. 30972768), Special Research Fund for the Doctoral Program of High Education (No. 20103201110009), Natural Science Foundation of Jiangsu province (No. BK2011286), and sponsored by Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Cann SAH, 2003, POSTGRAD MED J, V79, P672; Chu Y, 2014, MICROBES INFECT; Cooley W.B., 1893, AM J MED SCI, V105, P487, DOI [10.1097/00000441-189305000-00001, DOI 10.1097/00000441-189305000-00001]; Crull K, 2011, CELL MICROBIOL, V13, P1223, DOI 10.1111/j.1462-5822.2011.01612.x; D'Alvise PW, 2010, FEMS MICROBIOL LETT, V312, P84, DOI 10.1111/j.1574-6968.2010.02105.x; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; He X, 2011, FEMS MICROBIOL LETT, V325, P180, DOI 10.1111/j.1574-6968.2011.02429.x; HEFFERNAN EJ, 1992, J BACTERIOL, V174, P84, DOI 10.1128/jb.174.1.84-91.1992; HEFFERNAN EJ, 1992, J CLIN INVEST, V90, P953, DOI 10.1172/JCI115972; Ho DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027546; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Howe K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-197; Huang R, 2005, CELL MOL IMMUNOL, V2, P136; Huang Rui, 2001, Zhonghua Weishengwuxue He Mianyixue Zazhi, V21, P302; Huang Rui, 2000, Zhonghua Weishengwuxue He Mianyixue Zazhi, V20, P323; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kasinskas RW, 2007, CANCER RES, V67, P3201, DOI 10.1158/0008-5472.CAN-06-2618; Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; May T, 2008, J BACTERIOL, V190, P7479, DOI 10.1128/JB.00823-08; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ong CLY, 2009, APPL ENVIRON MICROB, V75, P6783, DOI 10.1128/AEM.00974-09; Roder HL, 2013, FEMS MICROBIOL LETT, V344, P186, DOI 10.1111/1574-6968.12175; Savage VJ, 2013, ANTIMICROB AGENTS CH, V57, P1968, DOI 10.1128/AAC.02008-12; Steenackers H, 2012, FOOD RES INT, V45, P502, DOI 10.1016/j.foodres.2011.01.038; Teodosio JS, 2012, J APPL MICROBIOL, V113, P373, DOI 10.1111/j.1365-2672.2012.05332.x; Wang R, 2013, J FOOD PROTECT, V76, P1513, DOI 10.4315/0362-028X.JFP-13-077; Wu SY, 2014, FRONT BIOSCI-LANDMRK, V19, P490, DOI 10.2741/4220; Yang XO, 2008, APPL ENVIRON MICROB, V74, P2690, DOI 10.1128/AEM.02809-07; Zautner AE, 2013, EUR J MICROBIOL IMMU, V3, P204, DOI 10.1556/EuJMI.3.2013.3.9	38	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109808	10.1371/journal.pone.0109808	http://dx.doi.org/10.1371/journal.pone.0109808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299072	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200075
J	Firman, RC; Simmons, LW				Firman, Renee C.; Simmons, Leigh W.			No Evidence of Conpopulation Sperm Precedence between Allopatric Populations of House Mice	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; GAMETE RECOGNITION; ADAPTIVE EVOLUTION; RAPID EVOLUTION; MUS-MUSCULUS; FERTILIZATION; COMPETITION; GENUS; COEVOLUTION; MATURATION	Investigations into the evolution of reproductive barriers have traditionally focused on closely related species, and the prevalence of conspecific sperm precedence. The effectiveness of conspecific sperm precedence at limiting gene exchange between species suggests that gametic isolation is an important component of reproductive isolation. However, there is a paucity of tests for evidence of sperm precedence during the earlier stages of divergence, for example among isolated populations. Here, we sourced individuals from two allopatric populations of house mice (Mus domesticus) and performed competitive in vitro fertilisation assays to test for conpopulation sperm precedence specifically at the gametic level. We found that ova population origin did not influence the outcome of the sperm competitions, and thus provide no evidence of conpopulation or heteropopulation sperm precedence. Instead, we found that males from a population that had evolved under a high level of postcopulatory sexual selection consistently outcompeted males from a population that had evolved under a relatively lower level of postcopulatory sexual selection. We standardised the number of motile sperm of each competitor across the replicate assays. Our data therefore show that competitive fertilizing success was directly attributable to differences in sperm fertilizing competence.	[Firman, Renee C.; Simmons, Leigh W.] Univ Western Australia, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia	University of Western Australia	Firman, RC (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia.	renee.firman@uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Ian, 1995, CALMScience, V1, P259; Albuquerque GS, 1996, EVOLUTION, V50, P1598, DOI 10.1111/j.1558-5646.1996.tb03932.x; BIDDLE FG, 1987, GENOME, V29, P389, DOI 10.1139/g87-067; Birkhead TR, 1995, P ROY SOC B-BIOL SCI, V262, P329, DOI 10.1098/rspb.1995.0213; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Boschetto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P813, DOI 10.1007/s00265-010-1085-y; BRITTON J, 1978, BIOCHEM GENET, V16, P213, DOI 10.1007/BF00484079; Brown DV, 2001, EVOLUTION, V55, P2257, DOI 10.1111/j.0014-3820.2001.tb00740.x; Chang AS, 2004, EVOLUTION, V58, P781; Dean MD, 2008, MOL BIOL EVOL, V25, P383, DOI 10.1093/molbev/msm265; Dean MD, 2009, EVOLUTION, V63, P20, DOI 10.1111/j.1558-5646.2008.00499.x; Dixon SM, 2003, MOL ECOL, V12, P1179, DOI 10.1046/j.1365-294X.2003.01742.x; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Firman RC, 2014, P R SOC B, V280; Firman RC, 2008, BEHAV ECOL, V19, P695, DOI 10.1093/beheco/arm158; Firman RC, 2014, AM NAT, V183, P565, DOI 10.1086/675395; Firman RC, 2014, BEHAV ECOL SOCIOBIOL, V68, P283, DOI 10.1007/s00265-013-1643-1; Firman RC, 2013, EVOLUTION, V67, P3061, DOI 10.1111/evo.12164; Firman RC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-19; Fricke C, 2004, ANIM BEHAV, V67, P729, DOI 10.1016/j.anbehav.2003.08.014; Fry CL, 2004, EVOLUTION, V58, P1622, DOI 10.1111/j.0014-3820.2004.tb01743.x; Gasparini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012146; Geyer LB, 2005, EVOLUTION, V59, P97; Gilbert S., 1997, DEV BIOL; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; GREGORY PG, 1994, EVOLUTION, V48, P705, DOI [10.2307/2410480, 10.1111/j.1558-5646.1994.tb01355.x]; Hosken DJ, 2002, P ROY SOC B-BIOL SCI, V269, P1701, DOI 10.1098/rspb.2002.2094; Hosken DJ, 2001, CURR BIOL, V11, P489, DOI 10.1016/S0960-9822(01)00146-4; Howard DJ, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P367, DOI 10.1016/B978-0-12-372568-4.00009-4; HOWARD DJ, 1993, PHILOS T ROY SOC B, V340, P231, DOI 10.1098/rstb.1993.0062; LAMBERT H, 1984, J REPROD FERTIL, V70, P281, DOI 10.1530/jrf.0.0700281; Levitan DR, 2002, EVOLUTION, V56, P1599, DOI 10.1111/j.0014-3820.2002.tb01472.x; Ludlow AM, 2006, P ROY SOC B-BIOL SCI, V273, P2477, DOI 10.1098/rspb.2006.3605; Martin-Coello J, 2008, THERIOGENOLOGY, V70, P1004, DOI 10.1016/j.theriogenology.2008.06.002; Martin-Coello J, 2009, EVOLUTION, V63, P613, DOI 10.1111/j.1558-5646.2008.00585.x; Mayr E., 1942, SYSTEMATICS ORIGIN S; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; PALUMBI SR, 1991, MOL BIOL EVOL, V8, P227; Parker GA, 1998, SEXUAL SELECTION REP, P123; Price CSC, 1997, NATURE, V388, P663, DOI 10.1038/41753; Price CSC, 2001, EVOLUTION, V55, P81, DOI 10.1111/j.0014-3820.2001.tb01274.x; R Core Development Team, 2011, R LANG ENV STAT COMP; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; ROLDAN ERS, 1989, J EXP ZOOL, V250, P321, DOI 10.1002/jez.1402500312; Rowe L, 2003, P ROY SOC B-BIOL SCI, V270, P2009, DOI 10.1098/rspb.2003.2453; Simmons L. W., 2001, MG BEH ECOL; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Tyler F, 2013, MOL ECOL, V22, P1640, DOI 10.1111/mec.12187; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Wedekind C, 1996, HEREDITY, V77, P400, DOI 10.1038/hdy.1996.160; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	54	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107472	10.1371/journal.pone.0107472	http://dx.doi.org/10.1371/journal.pone.0107472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295521	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000005
J	Kurtz, SL; Chou, AY; Kubelkova, K; Cua, DJ; Elkins, KL				Kurtz, Sherry L.; Chou, Alicia Y.; Kubelkova, Klara; Cua, Daniel J.; Elkins, Karen L.			IL-23 p19 Knockout Mice Exhibit Minimal Defects in Responses to Primary and Secondary Infection with Francisella tularensis LVS	PLOS ONE			English	Article							LIVE VACCINE STRAIN; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS INFECTION; ADAPTIVE IMMUNITY; IL-12 P70; AUTOIMMUNE INFLAMMATION; INTRACELLULAR BACTERIUM; GAMMA-INTERFERON; P40 HOMODIMER; HOST-DEFENSE	Our laboratory's investigations into mechanisms of protective immunity against Francisella tularensis Live Vaccine Strain (LVS) have uncovered mediators important in host defense against primary infection, as well as those correlated with successful vaccination. One such potential correlate was IL-12p40, a pleiotropic cytokine that promotes Th1 T cell function as part of IL-12p70. LVS-infected IL-12p40 deficient knockout (KO) mice maintain a chronic infection, but IL-12p35 KO mice clear LVS infection; thus the role that IL-12p40 plays in immunity to LVS is independent of the IL-12p70 heterodimer. IL-12p40 can also partner with IL-23p19 to create the heterodimeric cytokine IL-23. Here, we directly tested the role of IL-23 in LVS resistance, and found IL-23 to be largely dispensable for immunity to LVS following intradermal or intranasal infection. IL-23p19 KO splenocytes were fully competent in controlling intramacrophage LVS replication in an in vitro overlay assay. Further, antibody responses in IL-23p19 KO mice were similar to those of normal wild type mice after LVS infection. IL-23p19 KO mice or normal wild type mice that survived primary LVS infection survived maximal doses of LVS secondary challenge. Thus p40 has a novel role in clearance of LVS infection that is unrelated to either IL-12 or IL-23.	[Kurtz, Sherry L.; Chou, Alicia Y.; Kubelkova, Klara; Elkins, Karen L.] US FDA, Ctr Biol Evaluat & Res, Div Bacterial Parasit & Allergen Prod, Lab Mycobacterial Dis & Cellular Immunol, Rockville, MD 20857 USA; [Cua, Daniel J.] Merck Res Labs, Palo Alto, CA USA	US Food & Drug Administration (FDA); Merck & Company	Elkins, KL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Bacterial Parasit & Allergen Prod, Lab Mycobacterial Dis & Cellular Immunol, Rockville, MD 20857 USA.	Karen.elkins@fda.hhs.gov		Kurtz, Sherry/0000-0002-2281-8984	CBER/U.S. FDA; Ministry of Defence of the Czech Republic via Health Problems of Weapons of Mass Destruction [1011]	CBER/U.S. FDA; Ministry of Defence of the Czech Republic via Health Problems of Weapons of Mass Destruction	This study was funded by CBER/U.S. FDA; Klara Kubelkova was supported by the Ministry of Defence of the Czech Republic via a grant entitled Health Problems of Weapons of Mass Destruction (long-term organization development plan 1011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; Conlan JW, 2011, CURR PROTOC IMMUNOL, V93; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Elkins KL, 2011, CURR PROTOC IMMUNOL, V93, P142511; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Graeber KE, 2012, INFLAMM RES, V61, P87, DOI 10.1007/s00011-011-0419-1; Gran B, 2004, CRIT REV IMMUNOL, V24, P111, DOI 10.1615/CritRevImmunol.v24.i2.20; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Jana M, 2009, IMMUNOLOGY, V127, P312, DOI 10.1111/j.1365-2567.2008.02985.x; Jana M, 2009, MOL IMMUNOL, V46, P773, DOI 10.1016/j.molimm.2008.10.033; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lehmann J, 2001, J IMMUNOL, V167, P5304, DOI 10.4049/jimmunol.167.9.5304; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Lin Y, 2009, IMMUNITY; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Nigg AP, 2007, J IMMUNOL, V178, P7251, DOI 10.4049/jimmunol.178.11.7251; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Stenmark S, 1999, INFECT IMMUN, V67, P1789; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Wozniak TM, 2006, J IMMUNOL, V177, P8684, DOI 10.4049/jimmunol.177.12.8684; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109898	10.1371/journal.pone.0109898	http://dx.doi.org/10.1371/journal.pone.0109898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296161	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000101
J	Munyaka, P; Rabbi, MF; Pavlov, VA; Tracey, KJ; Khafipour, E; Ghia, JE				Munyaka, Pens; Rabbi, Mohammad F.; Pavlov, Valentin A.; Tracey, Kevin J.; Khafipour, Ehsan; Ghia, Jean-Eric			Central Muscarinic Cholinergic Activation Alters Interaction between Splenic Dendritic Cell and CD4(+)CD25(-) T Cells in Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; VAGUS NERVE; ANTIINFLAMMATORY PATHWAY; ULCERATIVE-COLITIS; KAPPA-B; CYTOKINES; NICOTINE; IMMUNE; EXPRESSION; IL-23	Background: The cholinergic anti-inflammatory pathway (CAP) is based on vagus nerve (VN) activity that regulates macrophage and dendritic cell responses in the spleen through alpha-7 nicotinic acetylcholine receptor (a7nAChR) signaling. Inflammatory bowel disease (IBD) patients present dysautonomia with decreased vagus nerve activity, dendritic cell and T cell over-activation. The aim of this study was to investigate whether central activation of the CAP alters the function of dendritic cells (DCs) and sequential CD4(+)/CD25(-)T cell activation in the context of experimental colitis. Methods: The dinitrobenzene sulfonic acid model of experimental colitis in C57BL/6 mice was used. Central, intracerebroventricular infusion of the M1 muscarinic acetylcholine receptor agonist McN-A-343 was used to activate CAP and vagus nerve and/or splenic nerve transection were performed. In addition, the role of alpha 7nAChR signaling and the NF-kB pathway was studied. Serum amyloid protein (SAP)-A, colonic tissue cytokines, IL-12p70 and IL-23 in isolated splenic DCs, and cytokines levels in DC-CD4(+)CD25(-)T cell co-culture were determined. Results: McN-A-343 treatment reduced colonic inflammation associated with decreased pro-inflammatory Th1/Th17 colonic and splenic cytokine secretion. Splenic DCs cytokine release was modulated through alpha 7nAChR and the NF-kB signaling pathways. Cholinergic activation resulted in decreased CD4(+)CD25(-)T cell priming. The anti-inflammatory efficacy of central cholinergic activation was abolished in mice with vagotomy or splenic neurectomy. Conclusions: Suppression of splenic immune cell activation and altered interaction between DCs and T cells are important aspects of the beneficial effect of brain activation of the CAP in experimental colitis. These findings may lead to improved therapeutic strategies in the treatment of IBD.	[Munyaka, Pens; Rabbi, Mohammad F.; Ghia, Jean-Eric] Univ Manitoba, Dept Immunol & Internal Med, Gastroenterol Sect, Winnipeg, MB, Canada; [Pavlov, Valentin A.; Tracey, Kevin J.] Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY USA; [Khafipour, Ehsan] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Ghia, Jean-Eric] Univ Manitoba, Inflammatory Bowel Dis Clin & Res Ctr, Winnipeg, MB, Canada	University of Manitoba; Northwell Health; University of Manitoba; University of Manitoba	Ghia, JE (corresponding author), Univ Manitoba, Dept Immunol & Internal Med, Gastroenterol Sect, Winnipeg, MB, Canada.	jeghia@med.umanitoba.ca	Khafipour, Ehsan/W-9803-2019; Khafipour, Ehsan/E-4140-2016	Khafipour, Ehsan/0000-0003-4673-7633; Khafipour, Ehsan/0000-0003-4673-7633; Pavlov, Valentin/0000-0002-1994-2853; Ghia, Jean-Eric/0000-0002-3018-9719; Tracey, Kevin J/0000-0003-1884-6314	Manitoba Health Research Council; Canada Foundation for Innovation; National Institute of General Medical Sciences, National Institutes of Health [R01GM057226, R01GM089807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226, R01GM089807] Funding Source: NIH RePORTER	Manitoba Health Research Council; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Manitoba Health Research Council and the Canada Foundation for Innovation to JEG. This work was also supported by the following grants from the National Institute of General Medical Sciences, National Institutes of Health: R01GM057226 (to KJT) and R01GM089807 (to VAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Bernstein CN, 2000, AM J GASTROENTEROL, V95, P677; Bonaz B, 2013, Minerva Gastroenterol Dietol, V59, P241; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Camoglio L, 2002, EUR J IMMUNOL, V32, P261, DOI 10.1002/1521-4141(200201)32:1<261::AID-IMMU261>3.0.CO;2-X; Clarencon D, 2014, BRAIN STIMU IN PRESS; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; DAPOIGNY M, 1992, AM J PHYSIOL, V262, pG231, DOI 10.1152/ajpgi.1992.262.2.G231; de Baey A, 2001, EUR J IMMUNOL, V31, P1646, DOI 10.1002/1521-4141(200106)31:6<1646::AID-IMMU1646>3.0.CO;2-X; Dotan I, 2010, GUT, V59, P760, DOI 10.1136/gut.2009.179994; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG711, DOI 10.1152/ajpgi.00240.2007; Ghia JE, 2011, INFLAMM BOWEL DIS, V17, P1474, DOI 10.1002/ibd.21531; GOTTWALD TP, 1995, ADV EXP MED BIOL, V371, P303; Han X, 2007, GUT, V56, P73, DOI 10.1136/gut.2006.094490; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hasler WL, 2011, GASTROENTEROL CLIN N, V40, P21, DOI 10.1016/j.gtc.2010.12.004; Huang ST, 2005, AM J CHINESE MED, V33, P157, DOI 10.1142/S0192415X0500276X; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Ikeda Y, 2001, EUR J GASTROEN HEPAT, V13, P841, DOI 10.1097/00042737-200107000-00013; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; JOYNER K, 1993, AM J PHYSIOL, V264, pR912, DOI 10.1152/ajpregu.1993.264.5.R912; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Koval L M, 2009, Ukr Biokhim Zh (1999), V81, P5; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Kubota Y, 2001, COGNITIVE BRAIN RES, V11, P281, DOI 10.1016/S0926-6410(00)00086-0; Lee ST, 2010, BRAIN RES, V1309, P164, DOI 10.1016/j.brainres.2009.10.076; MACDERMOTT RP, 1994, MED CLIN N AM, V78, P1207, DOI 10.1016/S0025-7125(16)30096-7; Matteoli G, 2014, GUT, V63, P938, DOI 10.1136/gutjnl-2013-304676; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Monteleone I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-122; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Neurath MF, 1998, GUT, V43, P856, DOI 10.1136/gut.43.6.856; Nouri-Shirazi M, 2007, IMMUNOL LETT, V109, P155, DOI 10.1016/j.imlet.2007.02.005; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PAHLIN PE, 1976, ACTA PHYSIOL SCAND, V96, P433, DOI 10.1111/j.1748-1716.1976.tb10213.x; Paul-Labrador M, 2006, ARCH INTERN MED, V166, P1218, DOI 10.1001/archinte.166.11.1218; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Perrier C, 2011, IMMUNOTHERAPY-UK, V3, P1341, DOI [10.2217/imt.11.122, 10.2217/IMT.11.122]; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; ROSENWALD A, 1993, ACTA NEUROPATHOL, V86, P182, DOI 10.1007/BF00334887; Sakai S, 2007, AUTON NEUROSCI-BASIC, V133, P158, DOI 10.1016/j.autneu.2007.01.001; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; The FO, 2011, BRIT J PHARMACOL, V163, P1007, DOI 10.1111/j.1476-5381.2011.01296.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Valdes-Ferrer S, 2010, J IMMUNOL, V184; Van der Zanden EP, 2009, NEUROGASTROENT MOTIL, V21, P6, DOI 10.1111/j.1365-2982.2008.01252.x; Velde AAT, 2003, EUR J IMMUNOL, V33, P143, DOI 10.1002/immu.200390017; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Vukelic M, 2013, J IMMUNOL, V191, P1800, DOI 10.4049/jimmunol.1203467; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	69	59	61	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109272	10.1371/journal.pone.0109272	http://dx.doi.org/10.1371/journal.pone.0109272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295619	Green Published, gold			2022-12-25	WOS:000345204000055
J	Smith, CA; Holahan, MR				Smith, Catherine A.; Holahan, Matthew R.			Reduced Hippocampal Dendritic Spine Density and BDNF Expression following Acute Postnatal Exposure to Di(2-Ethylhexyl) Phthalate in Male Long Evans Rats	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; SYNAPSE DENSITY; DIETHYLHEXYL PHTHALATE; SUPPRESSES ESTRADIOL; INTERNAL EXPOSURE; GONADAL-HORMONES; DENTATE GYRUS; GRANULE CELLS; IN-UTERO; TESTOSTERONE	Early developmental exposure to di(2-ethylhexyl) phthalate (DEHP) has been linked to a variety of neurodevelopmental changes, particularly in rodents. The primary goal of this work was to establish whether acute postnatal exposure to a low dose of DEHP would alter hippocampal dendritic morphology and BDNF and caspase-3 mRNA expression in male and female Long Evans rats. Treatment with DEHP in male rats led to a reduction in spine density on basal and apical dendrites of neurons in the CA3 dorsal hippocampal region compared to vehicle-treated male controls. Dorsal hippocampal BDNF mRNA expression was also down-regulated in male rats exposed to DEHP. No differences in hippocampal spine density or BDNF mRNA expression were observed in female rats treated with DEHP compared to controls. DEHP treatment did not affect hippocampal caspase-3 mRNA expression in male or female rats. These results suggest a gender-specific vulnerability to early developmental DEHP exposure in male rats whereby postnatal DEHP exposure may interfere with normal synaptogenesis and connectivity in the hippocampus. Decreased expression of BDNF mRNA may represent a molecular mechanism underlying the reduction in dendritic spine density observed in hippocampal CA3 neurons. These findings provide initial evidence for a link between developmental exposure to DEHP, reduced levels of BDNF and hippocampal atrophy in male rats.	[Smith, Catherine A.; Holahan, Matthew R.] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Smith, CA (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	catherinesmith@cmail.carleton.ca	Holahan, Matthew/GZK-5814-2022	Holahan, Matthew/0000-0001-7653-9262	National Science and Engineering Research Council of Canada [315827]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by National Science and Engineering Research Council of Canada Discovery to MRH [grant number 315827]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; COTMAN C, 1973, BRAIN RES, V63, P205, DOI 10.1016/0006-8993(73)90089-9; Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4; Danzer SC, 2002, J NEUROSCI, V22, P9754; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Frotscher M, 2000, CEREB CORTEX, V10, P946, DOI 10.1093/cercor/10.10.946; Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909; GOULD E, 1990, J NEUROSCI, V10, P1286; Han BH, 2000, NEUROBIOL DIS, V7, P38; Hatanaka Y, 2009, BIOCHEM BIOPH RES CO, V381, P728, DOI 10.1016/j.bbrc.2009.02.130; Henze DA, 1996, J COMP NEUROL, V369, P331, DOI 10.1002/(SICI)1096-9861(19960603)369:3<331::AID-CNE1>3.0.CO;2-6; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Holahan MR, 2007, HIPPOCAMPUS, V17, P58, DOI 10.1002/hipo.20242; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254; Kellner Y, 2014, FRONT SYNAP IN PRESS; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270; Kovacs EG, 2003, NEUROSCIENCE, V122, P807, DOI 10.1016/j.neuroscience.2003.08.046; Leranth C, 2000, NEUROSCIENCE, V101, P349, DOI 10.1016/S0306-4522(00)00369-9; Leranth C, 2003, J NEUROSCI, V23, P1588; Leranth C, 2004, J NEUROSCI, V24, P495, DOI 10.1523/JNEUROSCI.4516-03.2004; Leranth C, 2002, J COMP NEUROL, V447, P34, DOI 10.1002/cne.10230; Li XJ, 2013, ENVIRON TOXICOL PHAR, V36, P392, DOI 10.1016/j.etap.2013.05.001; Li YF, 2010, ENVIRON TOXICOL PHAR, V29, P32, DOI 10.1016/j.etap.2009.09.003; Lin CH, 2013, GASTROENT RES PRACT, V2013, P1; Lin CH, 2011, TOXICOL LETT, V206, P245, DOI 10.1016/j.toxlet.2011.08.002; Liu ZP, 2001, J COMP NEUROL, V441, P1, DOI 10.1002/cne.1393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Mankidy R, 2013, TOXICOL LETT, V217, P50, DOI 10.1016/j.toxlet.2012.11.025; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Nguyen TVV, 2005, J NEUROCHEM, V94, P1639, DOI 10.1111/j.1471-4159.2005.03318.x; Noriega NC, 2009, TOXICOL SCI, V111, P163, DOI 10.1093/toxsci/kfp129; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x; Pike CJ, 2001, BRAIN RES, V919, P160, DOI 10.1016/S0006-8993(01)03024-4; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Qiao XX, 2001, J NEUROSCI RES, V64, P268, DOI 10.1002/jnr.1075; Richburg JH, 1999, TOXICOL APPL PHARM, V160, P271, DOI 10.1006/taap.1999.8786; Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith CA, 2011, NEUROSCIENCE, V193, P100, DOI 10.1016/j.neuroscience.2011.06.082; Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Tailby C, 2005, P NATL ACAD SCI USA, V102, P4631, DOI 10.1073/pnas.0402747102; Tsurugizawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1345, DOI 10.1016/j.bbrc.2005.09.188; Witter MP, 2007, LEARN MEMORY, V14, P705, DOI 10.1101/lm.725207; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yokoyama Y, 2003, TOXICOL LETT, V144, P371, DOI 10.1016/S0378-4274(03)00256-X; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029	63	54	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109522	10.1371/journal.pone.0109522	http://dx.doi.org/10.1371/journal.pone.0109522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295592	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000076
J	Venugopal, PD; Coffey, PL; Dively, GP; Lamp, WO				Venugopal, P. Dilip; Coffey, Peter L.; Dively, Galen P.; Lamp, William O.			Adjacent Habitat Influence on Stink Bug (Hemiptera: Pentatomidae) Densities and the Associated Damage at Field Corn and Soybean Edges	PLOS ONE			English	Article							HETEROPTERA-PENTATOMIDAE; NEZARA-VIRIDULA; POPULATION-DYNAMICS; SEASONAL ABUNDANCE; EUSCHISTUS-SERVUS; LANDSCAPE CONTEXT; COTTON; QUALITY; YIELD; DISPERSAL	The local dispersal of polyphagous, mobile insects within agricultural systems impacts pest management. In the mid-Atlantic region of the United States, stink bugs, especially the invasive Halyomorpha halys (Stal 1855), contribute to economic losses across a range of cropping systems. Here, we characterized the density of stink bugs along the field edges of field corn and soybean at different study sites. Specifically, we examined the influence of adjacent managed and natural habitats on the density of stink bugs in corn and soybean fields at different distances along transects from the field edge. We also quantified damage to corn grain, and to soybean pods and seeds, and measured yield in relation to the observed stink bug densities at different distances from field edge. Highest density of stink bugs was limited to the edge of both corn and soybean fields. Fields adjacent to wooded, crop and building habitats harbored higher densities of stink bugs than those adjacent to open habitats. Damage to corn kernels and to soybean pods and seeds increased with stink bug density in plots and was highest at the field edges. Stink bug density was also negatively associated with yield per plant in soybean. The spatial pattern of stink bugs in both corn and soybeans, with significant edge effects, suggests the use of pest management strategies for crop placement in the landscape, as well as spatially targeted pest suppression within fields.	[Venugopal, P. Dilip; Coffey, Peter L.; Dively, Galen P.; Lamp, William O.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Venugopal, PD (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	venugopal.dilip@gmail.com	Lamp, William/G-6081-2015	Lamp, William/0000-0002-8565-1560; Venugopal, Dilip/0000-0001-6339-5087	United Soybean Board; Maryland Soybean Board; Maryland Grain Producers Utilization Board; Cosmos Club Foundation; Northeast Sustainable Agriculture Research and Education - Graduate Student grant [GNE-12-047]; Arthur B. Gahan Fellowship, Dept. of Entomology, Univ. of Maryland; United States Department of Agriculture - National Institute of Food & Agriculture Hatch Project [MD-ENTM-1016]; UMD Libraries Open Access Publishing Fund	United Soybean Board; Maryland Soybean Board; Maryland Grain Producers Utilization Board; Cosmos Club Foundation; Northeast Sustainable Agriculture Research and Education - Graduate Student grant; Arthur B. Gahan Fellowship, Dept. of Entomology, Univ. of Maryland; United States Department of Agriculture - National Institute of Food & Agriculture Hatch Project; UMD Libraries Open Access Publishing Fund	This work is supported by the United Soybean Board, http://unitedsoybean.org/ (GPD PDV); Maryland Soybean Board, http://mdsoy.com/ (GPD); Maryland Grain Producers Utilization Board, http://www.marylandgrain.com/ (GPD); Cosmos Club Foundation, http://www.cosmosclubfoundation.org/ (PDV); Northeast Sustainable Agriculture Research and Education - Graduate Student grant - GNE-12-047, http://www.nesare.org/ (PDV, WOL, GPD); Arthur B. Gahan Fellowship, Dept. of Entomology, Univ. of Maryland, http://entomology.umd.edu/academics/graduate/awardopportunities/gahanfellowshipfund (PDV); and United States Department of Agriculture - National Institute of Food & Agriculture Hatch Project #MD-ENTM-1016, http://www.csrees.usda.gov/ (WOL). Funding for Open Access provided by the UMD Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K., 2013, MUMIN MULTIMODEL INT; Bates D., 2013, LME4 LINEAR MIXED EF; BMSB IPM Working Group & Northeastern IPM Center, 2013, HOST PLANTS BROWN MA; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRIER HB, 1991, J AUST ENTOMOL SOC, V30, P123; CABI, 2014, INVASIVE SPECIES COM; CLARKE RG, 1971, J ECON ENTOMOL, V64, P222, DOI 10.1093/jee/64.1.222; Correa-Ferreira BS, 2002, AGR FOREST ENTOMOL, V4, P145, DOI 10.1046/j.1461-9563.2002.00136.x; DAUGHERTY DM, 1964, J ECON ENTOMOL, V57, P719, DOI 10.1093/jee/57.5.719; Ekbom B., 2000, INTERCHANGES INSECTS; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fox J, 2013, EFFECTS EFFECT DISPL; HANWAY JJ, 1963, AGRON J, V55, P487, DOI 10.2134/agronj1963.00021962005500050024x; Harrell FE, 2013, RMS REGRESSION MODEL; Herbert JJ, 2011, ANN ENTOMOL SOC AM, V104, P909, DOI 10.1603/AN11060; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hooks CRR, 2011, AGRON NEWS, V2, P1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JONES WA, 1982, ENVIRON ENTOMOL, V11, P867, DOI 10.1093/ee/11.4.867; Kennedy G. G., 1985, Bulletin of the Entomological Society of America, V31, P21; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kery M., 2010, INTRO WINBUGS ECOLOG; Kuhn M., 2013, CONTRAST COLLECTION; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; MCPHERSON RM, 1979, J ECON ENTOMOL, V72, P188, DOI 10.1093/jee/72.2.188; MCPHERSON RM, 1993, J ENTOMOL SCI, V28, P61, DOI 10.18474/0749-8004-28.1.61; Medrano EG, 2009, CURR MICROBIOL, V59, P405, DOI 10.1007/s00284-009-9452-5; Mitchell PL, 2004, NEOTROP ENTOMOL, V33, P519, DOI 10.1590/S1519-566X2004000500001; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NEGRON JF, 1987, J ECON ENTOMOL, V80, P666, DOI 10.1093/jee/80.3.666; Nestel D, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P45; Ni XZ, 2010, J ECON ENTOMOL, V103, P2072, DOI 10.1603/EC09301; Nielsen AL, 2011, ENVIRON ENTOMOL, V40, P231, DOI 10.1603/EN10187; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Olson DM, 2011, ENTOMOL EXP APPL, V139, P161, DOI 10.1111/j.1570-7458.2011.01116.x; Outward R, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.0901; Owens DR, 2013, J ECON ENTOMOL, V106, P1317, DOI 10.1603/EC12488; PANIZZI AR, 1985, FLA ENTOMOL, V68, P184, DOI 10.2307/3494344; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Pease CG, 2010, J APPL ENTOMOL, V134, P626, DOI 10.1111/j.1439-0418.2009.01452.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reay-Jones FPF, 2010, ENVIRON ENTOMOL, V39, P944, DOI 10.1603/EN09274; Reeves RB, 2010, ENVIRON ENTOMOL, V39, P1420, DOI 10.1603/EN09194; Reisig DD, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.16801; SCHUMANN FW, 1982, J ECON ENTOMOL, V75, P748, DOI 10.1093/jee/75.4.748; STINNER RE, 1983, ANNU REV ENTOMOL, V28, P319, DOI 10.1146/annurev.en.28.010183.001535; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Tillman PG, 2011, ENVIRON ENTOMOL, V40, P1159, DOI 10.1603/EN10243; Tillman PG, 2009, ENVIRON ENTOMOL, V38, P1038, DOI 10.1603/022.038.0411; Tillman PG, 2010, ENVIRON ENTOMOL, V39, P1765, DOI 10.1603/EN09281; TODD JW, 1974, J ECON ENTOMOL, V67, P421, DOI 10.1093/jee/67.3.421; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; Toews MD, 2009, J ECON ENTOMOL, V102, P1515, DOI 10.1603/029.102.0416; TOSCANO NC, 1976, J ECON ENTOMOL, V69, P96, DOI 10.1093/jee/69.1.96; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; USDA National Agricultural Statistics Service, 2014, CROP PRODUCTION; WALTERS H J, 1980, Plant Disease, V64, P961, DOI 10.1094/PD-64-961; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zuur Alain F., 2009, P1	64	65	65	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109917	10.1371/journal.pone.0109917	http://dx.doi.org/10.1371/journal.pone.0109917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295593	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000104
J	Yen, ZH; Dai, CL; Feng, HS; Liu, YF; Wang, SL				Yen, Zhihu; Dai, Caili; Feng, Haishun; Liu, Yifei; Wang, Shilu			Study of the Formation and Solution Properties of Worm-Like Micelles Formed Using Both N-Hexadecyl-N-Methylpiperidinium Bromide-Based Cationic Surfactant and Anionic Surfactant	PLOS ONE			English	Article							IONIC LIQUID; LIVING POLYMERS; DYNAMICS; SYSTEMS; MIXTURES; RHEOLOGY; CRYSTALS; ENERGY	The viscoelastic properties of worm-like micelles formed by mixing the cationic surfactant N-hexadecyl-N-methylpiperidinium bromide (C16MDB) with the anionic surfactant sodium laurate (SL) in aqueous solutions were investigated using rheological measurements. The effects of sodium laurate and temperature on the worm-like micelles and the mechanism of the observed shear thinning phenomenon and pseudoplastic behavior were systematically investigated. Additionally, cryogenic transmission electron microscopy images further ascertained existence of entangled worm-like micelles.	[Yen, Zhihu; Dai, Caili; Feng, Haishun; Liu, Yifei; Wang, Shilu] China Univ Petr Huadong, Sch Petr Engn, Qingdao, Peoples R China	China University of Petroleum	Yen, ZH (corresponding author), China Univ Petr Huadong, Sch Petr Engn, Qingdao, Peoples R China.	zhihuyan@126.com; daicl306@163.com		Dai, Cai li/0000-0002-7477-8865	National Natural Science Foundation of China [51174221, 21303268]; Program for New Century Excellent Talents in University [20110226]; China Postdoctoral Science Foundation [2013T60689]; National Ministry of Education [20120133110010]; Fundamental Research Funds for the Central Universities [14CX02041A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by National Natural Science Foundation of China (51174221, 21303268), the Program for New Century Excellent Talents in University (20110226), China Postdoctoral Science Foundation funded project (2013T60689), Doctoral Fund from National Ministry of Education (No. 20120133110010) and the Fundamental Research Funds for the Central Universities (14CX02041A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araos MU, 2005, J PHYS CHEM B, V109, P14275, DOI 10.1021/jp052862y; CANDAU SJ, 1988, J COLLOID INTERF SCI, V122, P430, DOI 10.1016/0021-9797(88)90377-3; Cates ME, 2006, ADV PHYS, V55, P799, DOI 10.1080/00018730601082029; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; CATES ME, 1988, J PHYS-PARIS, V49, P1593, DOI 10.1051/jphys:019880049090159300; Couillet I, 2004, LANGMUIR, V20, P9541, DOI 10.1021/la049046m; Dreiss CA, 2007, SOFT MATTER, V3, P956, DOI 10.1039/b705775j; Forster S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.017803; Gonzalez YI, 2005, CURR OPIN COLLOID IN, V10, P256, DOI 10.1016/j.cocis.2005.09.007; GRANEK R, 1992, J CHEM PHYS, V96, P4758, DOI 10.1063/1.462787; Lava K, 2009, J PHYS CHEM B, V113, P9506, DOI 10.1021/jp903667e; Lin Z, 1996, LANGMUIR, V12, P1729, DOI 10.1021/la950570q; Lu JM, 2009, PROG POLYM SCI, V34, P431, DOI 10.1016/j.progpolymsci.2008.12.001; Manero O, 2002, J NON-NEWTON FLUID, V106, P1, DOI 10.1016/S0377-0257(02)00082-4; Peters JE, 2008, MACROMOLECULES, V41, P7274, DOI 10.1021/ma8011569; Raghavan SR, 2002, LANGMUIR, V18, P3797, DOI 10.1021/la0115583; Razak NA, 2013, RHEOL ACTA, V52, P927, DOI 10.1007/s00397-013-0731-5; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; Samuel MM, 1999, SPE DRILL COMPLETION, V14, P240, DOI 10.2118/59478-PA; SHINODA K, 1987, LANGMUIR, V3, P135, DOI 10.1021/la00074a001; Snyder SA, 2003, ENVIRON ENG SCI, V20, P449, DOI 10.1089/109287503768335931; UCHEGBU IF, 1995, ADV COLLOID INTERFAC, V58, P1, DOI 10.1016/0001-8686(95)00242-I; Varade D, 2005, COLLOID SURFACE A, V259, P95, DOI 10.1016/j.colsurfa.2005.02.018; Zhao GX, 1996, J COLLOID INTERF SCI, V177, P513, DOI 10.1006/jcis.1996.0065; Zhao MW, 2011, PHYS CHEM CHEM PHYS, V13, P1332, DOI 10.1039/c0cp00342e; Zhao YR, 2009, J PHYS CHEM B, V113, P983, DOI 10.1021/jp809048u	26	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110155	10.1371/journal.pone.0110155	http://dx.doi.org/10.1371/journal.pone.0110155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296131	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000115
J	Ha, CT; Li, XH; Fu, DD; Moroni, M; Fisher, C; Arnott, R; Srinivasan, V; Xiao, M				Ha, Cam T.; Li, Xiang-Hong; Fu, Dadin; Moroni, Maria; Fisher, Carolyn; Arnott, Robert; Srinivasan, Venkataraman; Xiao, Mang			Circulating Interleukin-18 as a Biomarker of Total-Body Radiation Exposure in Mice, Minipigs, and Nonhuman Primates (NHP)	PLOS ONE			English	Article							IONIZING-RADIATION; DELTA-TOCOTRIENOL; BIODOSIMETRY APPLICATIONS; SIGNALING PATHWAYS; GAMMA-IRRADIATION; MODEL; INJURY; MOUSE; IL-1-BETA; FAMILY	We aim to develop a rapid, easy-to-use, inexpensive and accurate radiation dose-assessment assay that tests easily obtained samples (e.g., blood) to triage and track radiological casualties, and to evaluate the radioprotective and therapeutic effects of radiation countermeasures. In the present study, we evaluated the interleukin (IL)-1 family of cytokines, IL-1 beta, IL-18 and IL-33, as well as their secondary cytokines' expression and secretion in CD2F1 mouse bone marrow (BM), spleen, thymus and serum in response to gamma-radiation from sublethal to lethal doses (5, 7, 8, 9, 10, or 12 Gy) at different time points using the enzyme-linked immune sorbent assay (ELISA), immunoblotting, and cytokine antibody array. Our data identified increases of IL-1 beta, IL-18, and/or IL-33 in mouse thymus, spleen and BM cells after total-body irradiation (TBI). However, levels of these cytokines varied in different tissues. Interestingly, IL-18 but not IL-1 beta or IL-33 increased significantly (2.5-24 fold) and stably in mouse serum from day 1 after TBI up to 13 days in a radiation dose-dependent manner. We further confirmed our finding in total-body gamma-irradiated nonhuman primates (NHPs) and minipigs, and demonstrated that radiation significantly enhanced IL-18 in serum from NHPs 2-4 days post-irradiation and in minipig plasma 1-3 days post-irradiation. Finally, we compared circulating IL-18 with the well known hematological radiation biomarkers lymphocyte and neutrophil counts in blood of mouse, minipigs and NHPs and demonstrated close correlations between these biomarkers in response to radiation. Our results suggest that the elevated levels of circulating IL-18 after radiation proportionally reflect radiation dose and severity of radiation injury and may be used both as a potential biomarker for triage and also to track casualties after radiological accidents as well as for therapeutic radiation exposure.	[Ha, Cam T.; Li, Xiang-Hong; Fu, Dadin; Moroni, Maria; Fisher, Carolyn; Arnott, Robert; Srinivasan, Venkataraman; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Xiao, M (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Bethesda, MD 20814 USA.	mang.xiao@usuhs.edu			AFRRI intramural grant [RAB22676]; NIHMS [Y01 AI001759-101]; DMRDP [D10-I-AR-J7-116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001759] Funding Source: NIH RePORTER	AFRRI intramural grant; NIHMS; DMRDP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by AFRRI intramural grant RAB22676 to MX, NIHMS Y01 AI001759-101 to MM, and DMRDP D10-I-AR-J7-116 to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakely WE, 2009, RADIAT RES, V171, P127, DOI 10.1667/RR1549.1; Blakely WF, 2010, HEALTH PHYS, V99, pS184, DOI 10.1097/HP.0b013e3181f26895; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Coleman CN, 2004, SCIENCE, V304, P693, DOI 10.1126/science.1095956; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Farese AM, 2012, HEALTH PHYS, V103, P367, DOI 10.1097/HP.0b013e31825f75a7; Fukumoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058389; Ha CT, 2013, RADIAT RES, V180, P316, DOI 10.1667/RR3326.1; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Ivanov VN, 2010, CELL SIGNAL, V22, P1076, DOI 10.1016/j.cellsig.2010.02.010; Kang S, 2009, CLIN EXP RHEUMATOL, V27, P54; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Li XH, 2013, RADIAT RES, V180, P649, DOI 10.1667/RR13398.1; Li XH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039690, 10.1371/journal.pone.0036604]; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Liew FY, 2002, ANN RHEUM DIS, V61, P100; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Lukens JR, 2012, J IMMUNOL, V188, P3107, DOI 10.4049/jimmunol.1103308; MacVittie TJ, 2012, HEALTH PHYS, V103, P411, DOI 10.1097/HP.0b013e31826525f0; MCBRIDE WH, 1989, CANCER RES, V49, P169; McGeough MD, 2013, J CLIN INVEST; Moroni M, 2013, INT J MOL SCI, V14, P14119, DOI 10.3390/ijms140714119; Moroni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025210; Nasti TH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1111, DOI 10.1111/j.1751-1097.2012.01182.x; Ossetrova NI, 2014, HEALTH PHYS, V106, P772, DOI 10.1097/HP.0000000000000094; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Prasad KN, 2004, EXP BIOL MED, V229, P378, DOI 10.1177/153537020422900505; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Satyamitra MM, 2011, RADIAT RES, V175, P736, DOI 10.1667/RR2460.1; Shan YX, 2007, RADIAT ENVIRON BIOPH, V46, P21, DOI 10.1007/s00411-006-0076-x; Shih KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042389; Somosy Z, 2002, MICRON, V33, P167, DOI 10.1016/S0968-4328(01)00013-0; van de Veerdonk FL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00167; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Williams JP, 2011, INT J RADIAT BIOL, V87, P851, DOI 10.3109/09553002.2011.560996; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Xiao M, 2009, EXP HEMATOL, V37, P52, DOI 10.1016/j.exphem.2008.09.001; Zhang M, 2012, CYTOKINE; Zhang M, 2012, CYTOKINE, V58, P169, DOI 10.1016/j.cyto.2011.12.023	44	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109249	10.1371/journal.pone.0109249	http://dx.doi.org/10.1371/journal.pone.0109249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290447	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000050
J	Jones, KS; Corbin, JG; Huntsman, MM				Jones, Kevin S.; Corbin, Joshua G.; Huntsman, Molly M.			Neonatal NMDA Receptor Blockade Disrupts Spike Timing and Glutamatergic Synapses in Fast Spiking Interneurons in a NMDA Receptor Hypofunction Model of Schizophrenia	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; GABAERGIC INTERNEURONS; INHIBITORY NEURONS; BARREL CORTEX; PREFRONTAL CORTEX; CRITICAL PERIOD; PHENCYCLIDINE; MATURATION; DIVERSITY; NEOCORTEX	The dysfunction of parvalbumin-positive, fast-spiking interneurons (FSI) is considered a primary contributor to the pathophysiology of schizophrenia (SZ), but deficits in FSI physiology have not been explicitly characterized. We show for the first time, that a widely-employed model of schizophrenia minimizes first spike latency and increases GluN2B-mediated current in neocortical FSIs. The reduction in FSI first-spike latency coincides with reduced expression of the Kv1.1 potassium channel subunit which provides a biophysical explanation for the abnormal spiking behavior. Similarly, the increase in NMDA current coincides with enhanced expression of the GluN2B NMDA receptor subunit, specifically in FSIs. In this study mice were treated with the NMDA receptor antagonist, MK-801, during the first week of life. During adolescence, we detected reduced spike latency and increased GluN2B-mediated NMDA current in FSIs, which suggests transient disruption of NMDA signaling during neonatal development exerts lasting changes in the cellular and synaptic physiology of neocortical FSIs. Overall, we propose these physiological disturbances represent a general impairment to the physiological maturation of FSIs which may contribute to schizophrenia-like behaviors produced by this model.	[Jones, Kevin S.] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Jones, Kevin S.; Corbin, Joshua G.] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Huntsman, Molly M.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Huntsman, Molly M.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Howard University; Children's National Health System; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Huntsman, MM (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	Molly.Huntsman@UCDenver.edu			NIH NINDS [R01 NS053719]; NIH NICHD [R01DA020140]; Children's Research Institute: EUNICE KENNEDY SHRIVER NICHD Training Grant [5P30HD040677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, T32HD046388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020140] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Research Institute: EUNICE KENNEDY SHRIVER NICHD Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH NINDS R01 NS053719 (Molly M Huntsman); NIH NICHD R01DA020140 (Joshua G Corbin); Children's Research Institute: EUNICE KENNEDY SHRIVER NICHD Training Grant 5P30HD040677 (Kevin S Jones). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abekawa T, 2007, PSYCHOPHARMACOLOGY, V192, P303, DOI 10.1007/s00213-007-0729-8; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Bacci A, 2003, J NEUROSCI, V23, P859; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Coleman LG, 2009, PHARMACOL BIOCHEM BE, V93, P322, DOI 10.1016/j.pbb.2009.04.017; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dodson PD, 2002, J NEUROSCI, V22, P6953; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Fontaine B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003560; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gittelman JX, 2006, J NEUROPHYSIOL, V96, P1203, DOI 10.1152/jn.00092.2005; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Inan M, 2012, NEUROBIOL DIS; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Laube B, 1998, J NEUROSCI, V18, P2954; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li P, 2014, NEUROSCIENCE, V265, P60, DOI 10.1016/j.neuroscience.2014.01.033; Lim AL, 2012, BEHAV BRAIN RES, V227, P276, DOI 10.1016/j.bbr.2011.10.052; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Owczarek S, 2011, NEUROREPORT, V22, P935, DOI 10.1097/WNR.0b013e32834d2ef7; Pangratz-Fuehrer S, 2011, J NEUROSCI, V31, P10767, DOI 10.1523/JNEUROSCI.6655-10.2011; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Powell SB, 2012, NEUROPHARMACOLOGY, V62, P1322, DOI 10.1016/j.neuropharm.2011.01.049; Qian A, 2005, J PHYSIOL-LONDON, V562, P319, DOI 10.1113/jphysiol.2004.076737; Rotaru DC, 2012, REV NEUROSCIENCE, V23, P97, DOI 10.1515/revneuro-2011-0059; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wang CZ, 2008, NEUROPSYCHOPHARMACOL, V33, P2442, DOI 10.1038/sj.npp.1301647; WESSINGER WD, 1995, EUR J PHARMACOL, V277, P107, DOI 10.1016/0014-2999(95)00107-V; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wintrip N, 1998, NEUROSCI LETT, V242, P151, DOI 10.1016/S0304-3940(98)00069-X; Zhang Z, 2011, DEV NEUROBIOL, V71, P221, DOI 10.1002/dneu.20844	51	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109303	10.1371/journal.pone.0109303	http://dx.doi.org/10.1371/journal.pone.0109303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290690	Green Published, gold			2022-12-25	WOS:000342798000051
J	Koharudin, LMI; Wu, Y; DeLucia, M; Mehrens, J; Gronenborn, AM; Ahn, J				Koharudin, Leonardus M. I.; Wu, Ying; DeLucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.; Ahn, Jinwoo			Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; IMMUNODEFICIENCY-VIRUS TYPE-1; DNTP TRIPHOSPHOHYDROLASE; HIV-1 INFECTION; INHIBITION; PHOSPHORYLATION; REPLICATION; MACROPHAGES; REGULATOR	Sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1) plays a critical role in inhibiting HIV infection, curtailing the pool of dNTPs available for reverse transcription of the viral genome. Recent structural data suggested a compelling mechanism for the regulation of SAMHD1 enzymatic activity and revealed dGTP-induced association of two inactive dimers into an active tetrameric enzyme. Here, we present the crystal structures of SAMHD1 catalytic core (residues 113-626) tetramers, complexed with mixtures of nucleotides, including dGTP/dATP, dGTP/dCTP, dGTP/dTTP, and dGTP/dUTP. The combined structural and biochemical data provide insight into dNTP promiscuity at the secondary allosteric site and how enzymatic activity is modulated. In addition, we present biochemical analyses of GTP-induced SAMHD1 full-length tetramerization and the structure of SAMHD1 catalytic core tetramer in complex with GTP/dATP, revealing the structural basis of GTP-mediated SAMHD1 activation. Altogether, the data presented here advance our understanding of SAMHD1 function during cellular homeostasis.	Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Host Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA.	amg100@pitt.edu; jia12@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM82251]; University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM82251 (to A. M. G. and J. A.). This work was also supported in part by start-up funds from the University of Pittsburgh School of Medicine (to J. A.).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Amie SM, 2013, VIROLOGY, V436, P247, DOI 10.1016/j.virol.2012.11.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Leshinsky-Silver E, 2011, EUR J HUM GENET, V19, P287, DOI 10.1038/ejhg.2010.213; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miazzi C, 2014, J BIOL CHEM, V289, P18339, DOI 10.1074/jbc.M114.571091; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ramantani G, 2011, J CHILD NEUROL, V26, P1425, DOI 10.1177/0883073811408310; Ramesh V, 2010, DEV MED CHILD NEUROL, V52, P725, DOI 10.1111/j.1469-8749.2010.03727.x; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Sze A, 2013, J MOL BIOL, V425, P4981, DOI 10.1016/j.jmb.2013.10.022; Thiele H, 2010, HUM MUTAT, V31, pE1836, DOI 10.1002/humu.21357; Vorontsov II, 2014, J BIOL CHEM, V289, P2815, DOI 10.1074/jbc.M113.524207; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wu L., 2013, ISRN BIOCH, V728392, P1, DOI [10.1155/2013/728392, DOI 10.1155/2013/728392]; Xin BZ, 2011, P NATL ACAD SCI USA, V108, P5372, DOI 10.1073/pnas.1014265108; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	52	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.591958	http://dx.doi.org/10.1074/jbc.M114.591958			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288794	Green Published, hybrid			2022-12-25	WOS:000345335000020
J	Okada, M; Matsuzawa, A; Yoshimura, A; Ichijo, H				Okada, Masahiro; Matsuzawa, Atsushi; Yoshimura, Akihiko; Ichijo, Hidenori			The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1 SIGNALING PATHWAY; I-KAPPA-B; OXIDATIVE STRESS; KINASE CASCADE; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION; TRANSLOCATION; MITOCHONDRIA; CRYSTALS	Lysosome rupture triggers NLRP3 inflammasome activation in macrophages. However, the underlying mechanism is not fully understood. Here we showed that the TAK1-JNK pathway, a MAPK signaling pathway, is activated through lysosome rupture and that this activation is necessary for the complete activation of the NLRP3 inflammasome through the oligomerization of an adapter protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). We also revealed that the activation of the TAK1-JNK pathway is sustained through Ca2+ ions and that calcium/calmodulin-dependent protein kinase type II functions upstream of the TAK1-JNK pathway and specifically regulates lysosome rupture-induced NLRP3 inflammasome activation. These data suggest a novel role for the TAK1-JNK pathway as a critical regulator of NLRP3 inflammasome activation.	[Okada, Masahiro; Matsuzawa, Atsushi; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan; [Okada, Masahiro; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Matsuzawa, Atsushi] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	University of Tokyo; Keio University; Tohoku University	Matsuzawa, A (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	matsushi@m.tohoku.ac.jp	Matsuzawa, Atsushi/GLU-1387-2022; Yoshimura, Akihiko/K-5515-2013	Ichijo, Hidenori/0000-0002-5005-6438; Matsuzawa, Atsushi/0000-0001-8303-3905	KAKENHI from Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Global Center of Education and Research for Chemical Biology of the Diseases; Global Center of Excellence Program (GCOE) Program; Strategic Research Program for Brain Sciences by MEXT; Advanced Research for Medical Products Mining Programme of the National Institute of Bio-medical Innovation; Funding Program for Next Generation World-leading Researchers; Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26114009] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Education and Research for Chemical Biology of the Diseases; Global Center of Excellence Program (GCOE) Program; Strategic Research Program for Brain Sciences by MEXT; Advanced Research for Medical Products Mining Programme of the National Institute of Bio-medical Innovation; Funding Program for Next Generation World-leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology (MEXT), by the Global Center of Education and Research for Chemical Biology of the Diseases, by the Global Center of Excellence Program (GCOE) Program, by the "Understanding of Molecular and Environmental Bases for Brain Health" study conducted under the Strategic Research Program for Brain Sciences by MEXT, by the Advanced Research for Medical Products Mining Programme of the National Institute of Bio-medical Innovation, by the Funding Program for Next Generation World-leading Researchers, by the Nagase Science and Technology Foundation, by the Astellas Foundation for Research on Metabolic Disorders, and by the Takeda Science Foundation.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Giamarellos-Bourboulis EJ, 2009, ANN RHEUM DIS, V68, P273, DOI 10.1136/ard.2007.082222; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Uchimoto T, 1999, APOPTOSIS, V4, P357, DOI 10.1023/A:1009695221038; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	43	123	136	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.579961	http://dx.doi.org/10.1074/jbc.M114.579961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288801	Green Published, hybrid			2022-12-25	WOS:000345335000044
J	Kolic, J; Spigelman, AF; Smith, AM; Fox, JEM; MacDonald, PE				Kolic, Jelena; Spigelman, Aliya F.; Smith, Alannah M.; Fox, Jocelyn E. Manning; MacDonald, Patrick E.			Insulin Secretion Induced by Glucose-dependent Insulinotropic Polypeptide Requires Phosphatidylinositol 3-Kinase gamma in Rodent and Human beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Exocytosis; Insulin; Pancreatic Islet; Phosphatidylinositide 3-Kinase (PI 3-Kinase); Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Type 2 Diabetes	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; PHOSPHOINOSITIDE 3-KINASE; FUNCTIONAL EXPRESSION; INCRETIN HORMONES; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; GRANULE EXOCYTOSIS; GLP-1 RECEPTOR; GROWTH-FACTOR	Background: PI3K is implicated in insulin secretion and actin remodeling and is activated by glucose-dependent insulinotropic polypeptide (GIP). Results: GIP activates Ras-related-C3 botulinum toxin substrate-1 (Rac1), induces actin remodeling, and amplifies -cell insulin secretion in a PI3K-dependent manner. Conclusion: Insulin secretion induced by GIP requires PI3K. Significance: Understanding the -cell signaling pathway will help us understand -cell dysfunction in diabetes. PI3K, a G-protein-coupled type 1B phosphoinositol 3-kinase, exhibits a basal glucose-independent activity in -cells and can be activated by the glucose-dependent insulinotropic polypeptide (GIP). We therefore investigated the role of the PI3K catalytic subunit (p110) in insulin secretion and -cell exocytosis stimulated by GIP. We inhibited p110 with AS604850 (1 mol/liter) or knocked it down using an shRNA adenovirus or siRNA duplex in mouse and human islets and -cells. Inhibition of PI3K blunted the exocytotic and insulinotropic response to GIP receptor activation, whereas responses to the glucagon-like peptide-1 or the glucagon-like peptide-1 receptor agonist exendin-4 were unchanged. Downstream, we find that GIP, much like glucose stimulation, activates the small GTPase protein Rac1 to induce actin remodeling. Inhibition of PI3K blocked these effects of GIP. Although exendin-4 could also stimulate actin remodeling, this was not prevented by p110 inhibition. Finally, forced actin depolymerization with latrunculin B restored the exocytotic and secretory responses to GIP during PI3K inhibition, demonstrating that the loss of GIP-induced actin depolymerization was indeed limiting insulin exocytosis.	Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [MacDonald, Patrick E.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta	MacDonald, PE (corresponding author), Univ Alberta, Alberta Diabet Inst, LKS Ctr Rm 6-126, Edmonton, AB T6G 2E1, Canada.	pmacdonald@ualberta.ca		Kolic, Jelena/0000-0003-4151-1280; Spigelman, Aliya F/0000-0001-6188-2041; MacDonald, Patrick/0000-0002-5439-6288	Canadian Diabetes Association; Alberta Diabetes Foundation; University of Alberta; Alberta Innovates-Health Solutions; Canadian Institutes of Health Research	Canadian Diabetes Association; Alberta Diabetes Foundation; University of Alberta(University of Alberta); Alberta Innovates-Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by an operating grant to PEM from the Canadian Diabetes Association. Human islet isolations were funded in part by the Alberta Diabetes Foundation and the University of Alberta.; Supported by studentships Alberta Innovates-Health Solutions and the Canadian Institutes of Health Research.	Asahara S, 2013, DIABETOLOGIA, V56, P1088, DOI 10.1007/s00125-013-2849-5; Barnett A, 2007, EXPERT OPIN PHARMACO, V8, P2593, DOI 10.1517/14656566.8.15.2593; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Bernstein HG, 1998, CELL MOL BIOL, V44, P973; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; DILLON JS, 1993, ENDOCRINOLOGY, V133, P1907, DOI 10.1210/en.133.4.1907; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Edwards CMB, 2004, J ROY SOC MED, V97, P270, DOI 10.1258/jrsm.97.6.270; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; GREMLICH S, 1995, DIABETES, V44, P1202, DOI 10.2337/diabetes.44.10.1202; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jung ID, 2004, EUR J BIOCHEM, V271, P1557, DOI 10.1111/j.1432-1033.2004.04066.x; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Knop FK, 2007, DIABETES, V56, P1951, DOI 10.2337/db07-0100; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Kolic J, 2013, DIABETOLOGIA, V56, P1339, DOI 10.1007/s00125-013-2882-4; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; McClenaghan NH, 2006, J ENDOCRINOL, V190, P889, DOI 10.1677/joe.1.06949; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; PEDERSON RA, 1976, ENDOCRINOLOGY, V99, P780, DOI 10.1210/endo-99-3-780; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Seino S, 2009, DIABETES OBES METAB, V11, P180, DOI 10.1111/j.1463-1326.2009.01108.x; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Straub SG, 1996, BIOCHEM BIOPH RES CO, V224, P369, DOI 10.1006/bbrc.1996.1035; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Vilsboll Tina, 2007, Ugeskr Laeger, V169, P2101; VOLZ A, 1995, FEBS LETT, V373, P23, DOI 10.1016/0014-5793(95)01006-Z; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wymann MP, 2013, ANN NY ACAD SCI, V1280, P44, DOI 10.1111/nyas.12037; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010	59	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32109	32120		10.1074/jbc.M114.577510	http://dx.doi.org/10.1074/jbc.M114.577510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288806	Green Published, hybrid			2022-12-25	WOS:000345314700039
J	Debruin, EJ; Hughes, MR; Sina, C; Liu, A; Cait, J; Jian, ZQ; Lopez, M; Lo, B; Abraham, T; McNagny, KM				Debruin, Erin J.; Hughes, Michael R.; Sina, Christina; Liu, Alex; Cait, Jessica; Jian, Zhiqi; Lopez, Martin; Lo, Bernard; Abraham, Thomas; McNagny, Kelly M.			Podocalyxin Regulates Murine Lung Vascular Permeability by Altering Endothelial Cell Adhesion	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; IMPAIRS ALVEOLARIZATION; MAJOR SIALOPROTEIN; MOLECULAR-BASIS; MOUSE MODEL; EMPHYSEMA; COLLAGEN; MICE; ELASTIN; MORPHOGENESIS	Despite the widespread use of CD34-family sialomucins (CD34, podocalyxin and endoglycan) as vascular endothelial cell markers, there is remarkably little known of their vascular function. Podocalyxin (gene name Podxl), in particular, has been difficult to study in adult vasculature as germ-line deletion of podocalyxin in mice leads to kidney malformations and perinatal death. We generated mice that conditionally delete podocalyxin in vascular endothelial cells (Podxl(Delta EC) mice) to study the homeostatic role of podocalyxin in adult mouse vessels. Although Podxl(Delta EC) adult mice are viable, their lungs display increased lung volume and changes to the matrix composition. Intriguingly, this was associated with increased basal and inflammation-induced pulmonary vascular permeability. To further investigate the etiology of these defects, we isolated mouse pulmonary endothelial cells. Podxl(Delta EC) endothelial cells display mildly enhanced static adhesion to fibronectin but spread normally when plated on fibronectin-coated transwells. In contrast, Podxl(Delta EC) endothelial cells exhibit a severely impaired ability to spread on laminin and, to a lesser extent, collagen I coated transwells. The data suggest that, in endothelial cells, podocalyxin plays a previously unrecognized role in maintaining vascular integrity, likely through orchestrating interactions with extracellular matrix components and basement membranes, and that this influences downstream epithelial architecture.	[Debruin, Erin J.; Hughes, Michael R.; Sina, Christina; Liu, Alex; Cait, Jessica; Jian, Zhiqi; Lopez, Martin; Lo, Bernard; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Abraham, Thomas] UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC, Canada; [Abraham, Thomas] Penn State Univ, Penn State Coll Med, Hershey, PA USA	University of British Columbia; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	McNagny, KM (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	kelly@brc.ubc.ca	Abraham, Thomas/J-7080-2014; McNagny, Kelly/P-5239-2014; Abraham, Thomas/AAJ-7950-2020; Hughes, Michael/N-6039-2015	Abraham, Thomas/0000-0003-0750-8774; McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070	Canadian Institutes for Health Research [MOP-84545]; Heart and Stroke Foundation of BC; National Science & Engineering Research Council; UBC	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of BC; National Science & Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC	This research was funded by the following sources by a Canadian Institutes for Health Research grant MOP-84545 (http://www.cihr-irsc.gc.ca/e/193.html), & Heart and Stroke Foundation of BC and Yukon Grant in Aid (http://www.hsf.ca/research/en/whats-new). EJD was supported through a National Science & Engineering Research Council Postgraduate Scholarship and a UBC 4-Year Fellowship; KMM is a Michael Smith Foundation for Health Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2011, RESPIROLOGY, V16, P22, DOI 10.1111/j.1440-1843.2010.01898.x; Abraham T, 2010, J STRUCT BIOL, V171, P189, DOI 10.1016/j.jsb.2010.04.006; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL964, DOI 10.1152/ajplung.00421.2002; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Bou-harios G, 2004, CELL PROLIFERAT, V37, P207, DOI [10.1111/j.1365-2184.2004.00306.x, DOI 10.1111/J.1365-2184.2004.00306.X]; Bridges JP, 2006, ILAR J, V47, P22, DOI 10.1093/ilar.47.1.22; CARDOSO WV, 1993, AM REV RESPIR DIS, V147, P975, DOI 10.1164/ajrccm/147.4.975; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chen WC, 2010, CELL TISSUE RES, V342, P75, DOI 10.1007/s00441-010-1035-z; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DeLisser HM, 2006, J BIOL CHEM, V281, P8724, DOI 10.1074/jbc.M511798200; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Finlay GA, 1996, AM J PATHOL, V149, P1405; Galambos C, 2007, PEDIATR DEVEL PATHOL, V10, P1, DOI 10.2350/06-06-0122.1; Goncalves C, 2001, EXP LUNG RES, V27, P533; Grutzmacher C, 2010, AM J PHYSIOL-LUNG C, V299, pL607, DOI 10.1152/ajplung.00390.2009; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hamakawa H, 2011, AM J RESP CELL MOL, V45, P517, DOI 10.1165/rcmb.2010-0473OC; Han RNN, 2004, CIRC RES, V94, P1115, DOI 10.1161/01.RES.0000125624.85852.1E; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Hogg JC, 2002, THORAX, V57, P830, DOI 10.1136/thorax.57.9.830; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14; Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerosuo L, 2004, BRIT J HAEMATOL, V124, P809, DOI 10.1111/j.1365-2141.2004.04840.x; LANG MR, 1994, THORAX, V49, P319, DOI 10.1136/thx.49.4.319; Lucey EC, 1998, AM J RESP CRIT CARE, V158, P555, DOI 10.1164/ajrccm.158.2.9705021; Mahabeleshwar Ganapati H., 2006, V129, P197; Maltby S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018160; Maltby S, 2009, EXP HEMATOL, V37, P10, DOI 10.1016/j.exphem.2008.09.006; Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009; MCGOWAN SE, 1992, FASEB J, V6, P2895, DOI 10.1096/fasebj.6.11.1644255; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; McNagny KM., 2012, PODOCALYXIN DIAGNOSI; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Pena AM, 2007, MICROSC RES TECHNIQ, V70, P162, DOI 10.1002/jemt.20400; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SCHERLE W, 1970, Mikroskopie, V26, P57; Schneider CA, 2013, SERIES CELLULAR CLIN, P373; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; THURLBECK WM, 1994, CAN RESPIR J, V1, P21; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vitureira N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012003; Voelkel Norbert, 2005, Proc Am Thorac Soc, V2, P23, DOI 10.1513/pats.200405-033MS; Voelkel Norbert F, 2011, Pulm Circ, V1, P320, DOI 10.4103/2045-8932.87295; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Weinstein M, 1998, DEVELOPMENT, V125, P3615	60	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108881	10.1371/journal.pone.0108881	http://dx.doi.org/10.1371/journal.pone.0108881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303643	gold, Green Submitted, Green Published			2022-12-25	WOS:000343730400033
J	Duraffourd, C; Kumala, E; Anselmi, L; Brecha, NC; Sternini, C				Duraffourd, Celine; Kumala, Erica; Anselmi, Laura; Brecha, Nicholas C.; Sternini, Catia			Opioid-Induced Mitogen-Activated Protein Kinase Signaling in Rat Enteric Neurons following Chronic Morphine Treatment	PLOS ONE			English	Article							RECEPTOR DESENSITIZATION; MYENTERIC NEURONS; BETA-ARRESTIN; IN-VITRO; ENDOCYTOSIS; INTERNALIZATION; TOLERANCE; TRAFFICKING; MICE; PHOSPHORYLATION	Opioids, acting at mu opioid receptors, are commonly used for pain management. Chronic opioid treatment induces cellular adaptations, which trigger long-term side effects, including constipation mediated by enteric neurons. We tested the hypothesis that chronic opioid treatment induces alterations of t opioid receptor signaling in enteric neurons, which are likely to serve as mechanisms underlying opioid-induced constipation. In cultured rat enteric neurons, either untreated (na ve) or exposed to morphine for 4 days (chronic), we compared the effect of morphine and DAMGO (D-A(1)a(2),MePhe(4),GlyO(1)5 enkephalin) on IA opioid receptor internalization and downstream signaling by examining the activation of the mitogenactivated protein kinase/extracellular signal-regulated kinases 1 and 2 (MAPK/ERK) pathway, cAMP accumulation and transcription factor cAMP Response Element-Binding protein (CREB) expression. ti opioid receptor internalization and MAPK/ERK phosphorylation were induced by DAMGO, but not morphine in na ve neurons, and by both mu opioids in chronic neurons. MAPK/ERK activation was prevented by the receptor antagonist naloxone, by blocking receptor trafficking with hypertonic sucrose, dynamin inhibitor, or neuronal transfection with mutated dynamin, and by MAPK inhibitor. Morphine and DAMGO inhibited cAMP in na ve and chronic enteric neurons, and induced desensitization of cAMP signaling. Chronic morphine treatment suppressed desensitization of cAMP and MAPK signaling, increased CREB phosphorylation through a MAPK/ERK pathway and induced delays of gastrointestinal transit, which was prevented by MAPK/ERK blockade. This study showed that opioids induce endocytosis- and dynamin-dependent MAPK/ERK activation in enteric neurons and that chronic morphine treatment triggers changes at the receptor level and downstream signaling resulting in MAPK/ERK-dependent CREB activation. Blockade of this signaling pathway prevents the development of gastrointestinal motility impairment induced by chronic morphine treatment. These findings suggest that alterations in IA opioid receptor downstream signaling including MAPK/ERK pathway in enteric neurons chronically treated with morphine contribute to the development of opioid-induced constipation.	[Duraffourd, Celine; Kumala, Erica; Anselmi, Laura; Brecha, Nicholas C.; Sternini, Catia] Univ Calif Los Angeles, Div Digest Dis, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Duraffourd, Celine; Kumala, Erica; Anselmi, Laura; Brecha, Nicholas C.; Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Duraffourd, Celine; Kumala, Erica; Brecha, Nicholas C.; Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.; Sternini, Catia] Veteran Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sternini, C (corresponding author), Univ Calif Los Angeles, Div Digest Dis, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA.	csternin@ucla.edu			National Institutes of Health (NIH) [R01-DK054155, P30-DK041301]; UCLA Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK054155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R01-DK054155 and P30-DK041301, and UCLA Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi L, 2009, J NEUROSCI RES, V87, P1107, DOI 10.1002/jnr.21923; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Arttamangkul S, 2008, MOL PHARMACOL, V74, P972, DOI 10.1124/mol.108.048512; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Camilleri M, 2011, AM J GASTROENTEROL, V106, P835, DOI 10.1038/ajg.2011.30; Chen ZX, 2007, INT J PARASITOL, V37, P743, DOI 10.1016/j.ijpara.2006.12.018; Dang VC, 2012, BRIT J PHARMACOL, V165, P1704, DOI 10.1111/j.1476-5381.2011.01482.x; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Eisinger DA, 2002, J NEUROSCI, V22, P10192; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Ho A, 2003, J COMP NEUROL, V458, P404, DOI 10.1002/cne.10606; Holzer P, 2009, REGUL PEPTIDES, V155, P11, DOI 10.1016/j.regpep.2009.03.012; Ignatova EG, 1999, J NEUROSCI, V19, P56, DOI 10.1523/JNEUROSCI.19-01-00056.1999; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kang MH, 2012, J PHARMACOL EXP THER, V340, P567, DOI 10.1124/jpet.111.186320; Karim F, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-2; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; KROMER W, 1990, DIGEST DIS, V8, P361, DOI 10.1159/000171269; Kromer W, 1990, OPIOID PEPTIDES RECE; Kurz A, 2003, DRUGS, V63, P649, DOI 10.2165/00003495-200363070-00003; Lopez de Armentia M, 2007, J NEUROSCI, V27, P13909, DOI 10.1523/JNEUROSCI.3850-07.2007; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MILLER MS, 1981, J PHARMACOL METHOD, V6, P211, DOI 10.1016/0160-5402(81)90110-8; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Patierno S, 2011, GASTROENTEROLOGY, V140, P618, DOI 10.1053/j.gastro.2010.11.005; Polakiewicz RD, 1998, J BIOL CHEM, V273, P12402, DOI 10.1074/jbc.273.20.12402; Robinson C B, 2000, Clin J Oncol Nurs, V4, P79; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Roy S, 1998, MOL BRAIN RES, V56, P281, DOI 10.1016/S0169-328X(98)00051-5; Saccani F, 2012, J NEUROSCI RES, V90, P2146, DOI 10.1002/jnr.23108; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; Walwyn WM, 2006, NEUROSCIENCE, V142, P493, DOI 10.1016/j.neuroscience.2006.06.021; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wood JD, 2004, NEUROGASTROENT MOTIL, V16, P17, DOI 10.1111/j.1743-3150.2004.00554.x; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	49	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110230	10.1371/journal.pone.0110230	http://dx.doi.org/10.1371/journal.pone.0110230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302800	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400125
J	Tan, RZ; Chiam, KH				Tan, Rui Zhen; Chiam, Keng-Hwee			Computational Modeling Reveals that a Combination of Chemotaxis and Differential Adhesion Leads to Robust Cell Sorting during Tissue Patterning	PLOS ONE			English	Article							MORPHOGEN GRADIENTS; POSITIONAL INFORMATION; POTTS-MODEL; ZEBRAFISH; EXPRESSION; MESODERM; EMBRYO; PROLIFERATION; DICTYOSTELIUM; SIMULATION	Robust tissue patterning is crucial to many processes during development. The "French Flag" model of patterning, whereby naive cells in a gradient of diffusible morphogen signal adopt different fates due to exposure to different amounts of morphogen concentration, has been the most widely proposed model for tissue patterning. However, recently, using time-lapse experiments, cell sorting has been found to be an alternative model for tissue patterning in the zebrafish neural tube. But it remains unclear what the sorting mechanism is. In this article, we used computational modeling to show that two mechanisms, chemotaxis and differential adhesion, are needed for robust cell sorting. We assessed the performance of each of the two mechanisms by quantifying the fraction of correct sorting, the fraction of stable clusters formed after correct sorting, the time needed to achieve correct sorting, and the size variations of the cells having different fates. We found that chemotaxis and differential adhesion confer different advantages to the sorting process. Chemotaxis leads to high fraction of correct sorting as individual cells will either migrate towards or away from the source depending on its cell type. However after the cells have sorted correctly, there is no interaction among cells of the same type to stabilize the sorted boundaries, leading to cell clusters that are unstable. On the other hand, differential adhesion results in low fraction of correct clusters that are more stable. In the absence of morphogen gradient noise, a combination of both chemotaxis and differential adhesion yields cell sorting that is both accurate and robust. However, in the presence of gradient noise, the simple combination of chemotaxis and differential adhesion is insufficient for cell sorting; instead, chemotaxis coupled with delayed differential adhesion is required to yield optimal sorting.	[Tan, Rui Zhen; Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, Singapore, Singapore; [Chiam, Keng-Hwee] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore	Chiam, KH (corresponding author), ASTAR, Bioinformat Inst, Singapore, Singapore.	chiamkh@bii.a-star.edu.sg			Agency of Science, Technology and Research (A*STAR) of Singapore; Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore; Singapore Ministry of Education	Agency of Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by the Agency of Science, Technology and Research (A*STAR) of Singapore, as well as the Seed Fund of the Mechanobiology Institute, Research Centre of Excellence financed by the National Research Foundation of Singapore and the Singapore Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Ahtiainen L, 2014, DEV CELL, V28, P588, DOI 10.1016/j.devcel.2014.02.003; Anderson A., 2007, SINGLE CELL BASED MO; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Bollenbach T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018103; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Garrod D R, 1978, Symp Soc Exp Biol, V32, P173; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Jiang Y, 1998, BIOPHYS J, V75, P2615, DOI 10.1016/S0006-3495(98)77707-0; Kafer J, 2006, PLOS COMPUT BIOL, V2, P518, DOI 10.1371/journal.pcbi.0020056; Kay RR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001503; Kim D, 2007, DEV BIOL, V307, P290, DOI 10.1016/j.ydbio.2007.04.051; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; Little SC, 2013, CELL, V153, P509, DOI 10.1016/j.cell.2013.04.021; Maree AFM, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; Murakami T, 2006, DEV DYNAM, V235, P506, DOI 10.1002/dvdy.20622; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Raper KB, 1941, AM J BOT, V28, P69, DOI 10.2307/2437063; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; STERN CD, 1990, NATURE, V343, P273, DOI 10.1038/343273a0; Stott EL, 1999, MATH COMPUT MODEL, V30, P183, DOI 10.1016/S0895-7177(99)00156-9; Streit A, 2002, DEV BIOL, V249, P237, DOI 10.1006/dbio.2002.0739; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wong E, 2002, DEVELOPMENT, V129, P3839; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024999	40	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109286	10.1371/journal.pone.0109286	http://dx.doi.org/10.1371/journal.pone.0109286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302949	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400049
J	Asztalos, BF; Horan, MS; Horvath, KV; McDermott, AY; Chalasani, NP; Schaefer, EJ				Asztalos, Bela F.; Horan, Michael S.; Horvath, Katalin V.; McDermott, Ann Y.; Chalasani, Naga P.; Schaefer, Ernst J.			Obesity Associated Molecular Forms of C-Reactive Protein in Human	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; ENDOTHELIAL-CELLS; BINDING; ATHEROSCLEROSIS; INFLAMMATION; EVENTS	Objective: To describe novel C-reactive protein (CRP) molecular forms (mf) in human plasma. Design and Methods: Five novel CRP-mfs, disctinct from the previously described native (nCRP) and modified (mCRP) C-reactive proteins, were separated from human plasma by polyacrylamide gel electrophoresis and immunodetected by western blot in subjects with or without increased BMI, cardiovascular disease (CVD), and diabetes (n = 1800). Results: Three of the five CRP-mfs were present in all samples. One, CRPmf-4, was present in a subgroup of subjects and its presence was associated with elevated body mass index (BMI). CRP-mf-5 was present in about 2% of the subjects and was not associated with any other parameters. The presence or distribution of the 5 CRP-mfs were not Ca2+-dependent. Crossed immuno-localization experiments indicated that none of the CRP-mfs were complexed with any of the lipoprotein classes or with signature proteins of the complement-factor. Moreover, the distribution of CRP-mfs were not significantly correlated with plasma CRP levels. CRP-mf-4 was significantly associated with increased BMI, but not with other parameters of the metabolic syndrome (HDL-C and triglyceride levels, and diabetes). Conclusions: We have identified five new CRP-mfs out of which CRP-mf-4 was significantly associated with obesity. We have shown that oligomerization of CRP was not calcium dependent. We hypothesize that adipose tissue produces a factor which influences the formation of CRP mf-4. CRP-mfs might be used as an obesity-associated inflammatory marker.	[Asztalos, Bela F.; Horan, Michael S.; Horvath, Katalin V.; McDermott, Ann Y.; Schaefer, Ernst J.] Tufts Univ, Human Nutr Res Ctr Aging, Lipid Metab Lab, Boston, MA 02111 USA; [Chalasani, Naga P.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Tufts University; United States Department of Agriculture (USDA); Indiana University System; Indiana University Bloomington	Asztalos, BF (corresponding author), Tufts Univ, Human Nutr Res Ctr Aging, Lipid Metab Lab, Boston, MA 02111 USA.	bela.asztalos@tufts.edu			United States Department of Agriculture Research Service [53-3K-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064738] Funding Source: NIH RePORTER	United States Department of Agriculture Research Service(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the United States Department of Agriculture Research Service Contract 53-3K-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens I, 2011, BASIC RES CARDIOL, V106, P879, DOI 10.1007/s00395-011-0191-y; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; Devaraj S, 2006, ATHEROSCLEROSIS, V184, P48, DOI 10.1016/j.atherosclerosis.2005.03.031; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Kresl JJ, 1998, INT J BIOCHEM CELL B, V30, P1415, DOI 10.1016/S1357-2725(98)00078-8; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; NUNOMURA W, 1990, Hokkaido Journal of Medical Science, V65, P474; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; PAINTER RH, 1982, ANN NY ACAD SCI, V389, P199, DOI 10.1111/j.1749-6632.1982.tb22138.x; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Swarbrick MM, 2008, DIABETOLOGIA, V51, P1901, DOI 10.1007/s00125-008-1118-5; Taskinen S, 2005, BIOCHEM BIOPH RES CO, V329, P1208, DOI 10.1016/j.bbrc.2005.02.091; WOOD SP, 1988, J MOL BIOL, V202, P169, DOI 10.1016/0022-2836(88)90529-3	26	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109238	10.1371/journal.pone.0109238	http://dx.doi.org/10.1371/journal.pone.0109238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299074	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200043
J	Jiang, CB; Hsi, HC; Fan, CH; Chien, LC				Jiang, Chuen-Bin; Hsi, Hsing-Cheng; Fan, Chun-Hua; Chien, Ling-Chu			Fetal Exposure to Environmental Neurotoxins in Taiwan	PLOS ONE			English	Article							BLOOD LEAD LEVELS; SEYCHELLES CHILD-DEVELOPMENT; BIRTH-WEIGHT INFANTS; FISH CONSUMPTION; ARSENIC EXPOSURE; METHYLMERCURY EXPOSURE; SPONTANEOUS-ABORTION; PRENATAL EXPOSURE; MECONIUM ANALYSIS; MERCURY EXPOSURE	Mercury (Hg), lead (Pb), cadmium (Cd), and arsenic (As) are recognized neurotoxins in children that particularly affect neurodevelopment and intellectual performance. Based on the hypothesis that the fetal basis of adult disease is fetal toxic exposure that results in adverse outcomes in adulthood, we explored the concentrations of key neurotoxins (i. e., Hg, Pb, Cd, and As) in meconium to identify the risk factors associated with these concentrations. From January 2007 to December 2009, 545 mother-infant pairs were recruited. The geometric mean concentrations of Pb and As in the meconium of babies of foreign-born mothers (22.9 and 38.1 mu g/kg dry weight, respectively) were significantly greater than those of babies of Taiwan-born mothers (17.5 and 33.0 mu g/kg dry weight, respectively). Maternal age (>= 30 y), maternal education, use of traditional Chinese herbs during pregnancy, and fish cutlet consumption (>= 3 meals/wk) were risk factors associated with concentrations of key prenatal neurotoxins. The Taiwan government should focus more attention on providing intervention programs for immigrant mothers to help protect the health of unborn babies. Further investigation on how multiple neurotoxins influence prenatal neurodevelopment is warranted.	[Jiang, Chuen-Bin] Taipei Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Jiang, Chuen-Bin] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Hsi, Hsing-Cheng] Natl Taiwan Univ, Grad Inst Environm Engn, Taipei 10764, Taiwan; [Fan, Chun-Hua; Chien, Ling-Chu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taiwan University; Taipei Medical University	Chien, LC (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	lcchien@tmu.edu.tw		Chien, Ling-Chu/0000-0001-5539-8974; Hsi, Hsing-Cheng/0000-0001-5558-2077	National Science Council, Republic of China NSC [98-2314-B-038-025-MY3]	National Science Council, Republic of China NSC	This work was supported by Grants NSC 98-2314-B-038-025-MY3 from the National Science Council, Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DB, 2007, REPROD TOXICOL, V23, P260, DOI 10.1016/j.reprotox.2007.03.003; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Binns HJ, 2007, PEDIATRICS, V120, pE1285, DOI 10.1542/peds.2005-1770; Borja-Aburto VH, 1999, AM J EPIDEMIOL, V150, P590, DOI 10.1093/oxfordjournals.aje.a010057; CALLAHAN CM, 1992, J PEDIATR-US, V120, P763, DOI 10.1016/S0022-3476(05)80245-8; Chien LC, 2006, CHEMOSPHERE, V64, P79, DOI 10.1016/j.chemosphere.2005.11.059; Coscia JM, 2003, CHILD NEUROPSYCHOL, V9, P10, DOI 10.1076/chin.9.1.10.14498; Crump KS, 1998, RISK ANAL, V18, P701, DOI 10.1023/B:RIAN.0000005917.52151.e6; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Gardella C, 2001, OBSTET GYNECOL SURV, V56, P231, DOI 10.1097/00006254-200104000-00024; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Gundacker C, 2010, SCI TOTAL ENVIRON, V408, P5744, DOI 10.1016/j.scitotenv.2010.07.079; Heindel JJ, 2005, BIRTH DEFECTS RES A, V73, P131, DOI 10.1002/bdra.20119; Hertz-Picciotto I, 2000, AM J IND MED, V38, P300, DOI 10.1002/1097-0274(200009)38:3<300::AID-AJIM9>3.0.CO;2-C; Hsu CS, 2007, BJOG-INT J OBSTET GY, V114, P81, DOI 10.1111/j.1471-0528.2006.01142.x; Jiang CB, 2010, SCI TOTAL ENVIRON, V408, P518, DOI 10.1016/j.scitotenv.2009.10.043; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Lin CM, 2011, OCCUP ENVIRON MED, V68, P641, DOI 10.1136/oem.2010.059758; Llanos MN, 2009, REPROD TOXICOL, V27, P88, DOI 10.1016/j.reprotox.2008.11.057; Mahaffey KR, 2009, ENVIRON HEALTH PERSP, V117, P47, DOI 10.1289/ehp.11674; MAYNARD EC, 1991, AM J DIS CHILD, V145, P650, DOI 10.1001/archpedi.1991.02160060068022; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1006/toxs.1998.2436; National Research Council, 2008, PHTHAL CUM RISK ASS; OSTREA EM, 1992, PEDIATRICS, V89, P107; Ostrea EM, 2002, NEUROTOXICOLOGY, V23, P329, DOI 10.1016/S0161-813X(02)00077-3; OSTREA EM, 1993, J PEDIATR-US, V122, P152, DOI 10.1016/S0022-3476(05)83509-7; Ostrea Jr EM, 1998, PEDIATR RES, V43, P224; Paulson JA, 2011, PEDIATRICS, V127, P983, DOI 10.1542/peds.2011-0523; Pueschel SM, 1996, LEAD POISONING CHILD; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Rastogi S, 2007, J PERINAT MED, V35, P492, DOI 10.1515/JPM.2007.131; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; Tian LL, 2009, BIOL TRACE ELEM RES, V132, P51, DOI 10.1007/s12011-009-8391-0; Trasande L, 2005, ENVIRON HEALTH PERSP, V113, P590, DOI 10.1289/ehp.7743; Turker G, 2006, BIOL NEONATE, V89, P244, DOI 10.1159/000089953; U.S. Environmental Protection Agency, 2013, EPA VIEWS CHILDH SEQ; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; von Ehrenstein OS, 2006, AM J EPIDEMIOL, V163, P662, DOI 10.1093/aje/kwj089; Wang SL, 2007, ENVIRON INT, V33, P805, DOI 10.1016/j.envint.2007.03.004; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wu WT, 2009, SCI TOTAL ENVIRON, V407, P5931, DOI 10.1016/j.scitotenv.2009.07.025; Yu XD, 2011, NEUROTOXICOL TERATOL, V33, P437, DOI 10.1016/j.ntt.2011.05.010	46	49	51	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109984	10.1371/journal.pone.0109984	http://dx.doi.org/10.1371/journal.pone.0109984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299345	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200093
J	Daly, R; Smale, MJ; Cowley, PD; Froneman, PW				Daly, Ryan; Smale, Malcolm J.; Cowley, Paul D.; Froneman, Pierre W.			Residency Patterns and Migration Dynamics of Adult Bull Sharks (Carcharhinus leucas) on the East Coast of Southern Africa	PLOS ONE			English	Article							SITE FIDELITY; MOVEMENT PATTERNS; TERM MOVEMENTS; APEX PREDATOR; HABITAT USE; CONSERVATION; ECOSYSTEM; BEHAVIOR; OCEAN; MANAGEMENT	Bull sharks (Carcharhinus leucas) are globally distributed top predators that play an important ecological role within coastal marine communities. However, little is known about the spatial and temporal scales of their habitat use and associated ecological role. In this study, we employed passive acoustic telemetry to investigate the residency patterns and migration dynamics of 18 adult bull sharks (195283 cm total length) tagged in southern Mozambique for a period of between 10 and 22 months. The majority of sharks (n = 16) exhibited temporally and spatially variable residency patterns interspersed with migration events. Ten individuals undertook coastal migrations that ranged between 433 and 709 km (mean = 533 km) with eight of these sharks returning to the study site. During migration, individuals exhibited rates of movement between 2 and 59 km.d(-1) (mean = 17.58 km.d(-1)) and were recorded travelling annual distances of between 450 and 3760 km (mean = 1163 km). Migration towards lower latitudes primarily took place in austral spring and winter and there was a significant negative correlation between residency and mean monthly sea temperature at the study site. This suggested that seasonal change is the primary driver behind migration events but further investigation is required to assess how foraging and reproductive activity may influence residency patterns and migration. Results from this study highlight the need for further understanding of bull shark migration dynamics and suggest that effective conservation strategies for this vulnerable species necessitate the incorporation of congruent trans-boundary policies over large spatial scales.	[Daly, Ryan; Froneman, Pierre W.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Daly, Ryan; Smale, Malcolm J.] Humewood, Port Elizabeth Museum Bayworld, Port Elizabeth, South Africa; [Cowley, Paul D.] SAIAB, Grahamstown, South Africa; [Smale, Malcolm J.] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	Rhodes University; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Nelson Mandela University	Daly, R (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa.	ryandaly.mail@gmail.com	Froneman, William/GLS-0460-2022; Froneman, William/C-9085-2012; Cowley, Paul/M-4264-2017	Froneman, William/0000-0003-0615-1355; Smale, Malcolm/0000-0002-1135-8687; Cowley, Paul/0000-0003-1246-4390	Professional Development Programme of the South African National Research Foundation; Port Elizabeth Museum at Bayworld; Rhodes University; Bayworld Centre for Research and Education; Ocean Tracking Network; Save Our Seas Foundation; National Research Foundation of South Africa	Professional Development Programme of the South African National Research Foundation; Port Elizabeth Museum at Bayworld; Rhodes University; Bayworld Centre for Research and Education; Ocean Tracking Network; Save Our Seas Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa)	Funding and support were provided by the Professional Development Programme of the South African National Research Foundation (www.nrf.ac.za), Port Elizabeth Museum at Bayworld (www.bayworld.co.za), Rhodes University (www.ru.ac.za), and Bayworld Centre for Research and Education who administered the grant, 3 Fathoms Research, the Acoustic Tracking Array Platform maintained by the South African Institute for Aquatic Biodiversity (www.saiab.co.za) with support from the Ocean Tracking Network (www.oceantrackingnetwork.org) funded in part by the Save Our Seas Foundation (www.saveourseas.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the contributing funders of this study (the National Research Foundation of South Africa) only provided funding for one of the authors' salaries (RD). This funding was awarded to the Port Elizabeth Museum at Bayworld and administered by the Bayworld Centre for Research and Education. The Port Elizabeth Museum at Bayworld and Bayworld Centre for Research and Education are not commercial businesses. The Port Elizabeth Museum at Bayworld had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes KG, 2011, MAR ECOL PROG SER, V442, P133, DOI 10.3354/meps09395; Bansemer CS, 2011, MAR FRESHWATER RES, V62, P596, DOI 10.1071/MF10152; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Batschelet E, 1981, CIRCULAR STAT BIOL; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Compagno LJV, 1984, FAO FISHERIES SYNO 2, P250; Daly R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078229; DiGirolamo AL, 2012, J FISH BIOL, V80, P1436, DOI 10.1111/j.1095-8649.2012.03263.x; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Filmalter JD, 2013, MAR BIOL, V160, P2425, DOI 10.1007/s00227-013-2237-1; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Holdo RM, 2011, ANIMAL MIGRATION: A SYNTHESIS, P131; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Kessel ST, 2013, REV FISH BIOL FISHER, P1; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Mann B. Q., 2000, SO AFRICAN MARINE LI; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; RAMSAY PJ, 1994, MAR GEOL, V120, P225, DOI 10.1016/0025-3227(94)90060-4; RIEGL B, 1995, B MAR SCI, V56, P676; Russell GS, 1996, COMMUNICATIONS STAT, V24, P879; Shuter JL, 2011, ANIMAL MIGRATION: A SYNTHESIS, P172; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Sink K, 2004, S AFRICAN NATL SPATI, V4; Smale MJ., 1986, S AFRICAN J MARINE S, V4, P11, DOI [10.2989/025776186784461873, DOI 10.2989/025776186784461873]; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Speed CW, 2012, CORAL REEFS, V31, P357, DOI 10.1007/s00338-011-0850-3; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stevens JD, 1999, FISH MOVEMENT MIGRAT, P65; Turpie JK, 2000, BIOL CONSERV, V92, P59, DOI 10.1016/S0006-3207(99)00063-4; Warkentin IG, 1996, BIOL CONSERV, V77, P143, DOI 10.1016/0006-3207(95)00146-8; Welsh JQ, 2012, CORAL REEFS, V31, P991, DOI 10.1007/s00338-012-0922-z; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Wintner SP, 2002, MAR FRESHWATER RES, V53, P557, DOI 10.1071/MF01062; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	54	58	59	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109357	10.1371/journal.pone.0109357	http://dx.doi.org/10.1371/journal.pone.0109357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295972	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000065
J	Ernest, HB; Vickers, TW; Morrison, SA; Buchalski, MR; Boyce, WM				Ernest, Holly B.; Vickers, T. Winston; Morrison, Scott A.; Buchalski, Michael R.; Boyce, Walter M.			Fractured Genetic Connectivity Threatens a Southern California Puma (Puma concolor) Population	PLOS ONE			English	Article							MOUNTAIN LIONS; EMPIRICAL-EVALUATION; COMPUTER-PROGRAM; RELATEDNESS; SIZE; MICROSATELLITES; ASSIGNMENT; INFERENCE; PARENTAGE; SOFTWARE	Pumas (Puma concolor; also known as mountain lions and cougars) in southern California live among a burgeoning human population of roughly 20 million people. Yet little is known of the consequences of attendant habitat loss and fragmentation, and human-caused puma mortality to puma population viability and genetic diversity. We examined genetic status of pumas in coastal mountains within the Peninsular Ranges south of Los Angeles, in San Diego, Riverside, and Orange counties. The Santa Ana Mountains are bounded by urbanization to the west, north, and east, and are separated from the eastern Peninsular Ranges to the southeast by a ten lane interstate highway (I-15). We analyzed DNA samples from 97 pumas sampled between 2001 and 2012. Genotypic data for forty-six microsatellite loci revealed that pumas sampled in the Santa Ana Mountains (n = 42) displayed lower genetic diversity than pumas from nearly every other region in California tested (n = 257), including those living in the Peninsular Ranges immediately to the east across I-15 (n = 55). Santa Ana Mountains pumas had high average pairwise relatedness, high individual internal relatedness, a low estimated effective population size, and strong evidence of a bottleneck and isolation from other populations in California. These and ecological findings provide clear evidence that Santa Ana Mountains pumas have been experiencing genetic impacts related to barriers to gene flow, and are a warning signal to wildlife managers and land use planners that mitigation efforts will be needed to stem further genetic and demographic decay in the Santa Ana Mountains puma population.	[Ernest, Holly B.; Vickers, T. Winston; Buchalski, Michael R.; Boyce, Walter M.] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; [Ernest, Holly B.; Buchalski, Michael R.] Univ Calif Davis, Sch Vet Med, Vet Genet Lab, Wildlife & Ecol Unit, Davis, CA 95616 USA; [Morrison, Scott A.] Nature Conservancy, San Francisco, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; Nature Conservancy	Ernest, HB (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.	hernest@uwyo.edu	Ernest, Holly/D-5731-2012	Ernest, Holly/0000-0002-0205-8818	California State Parks; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation	California State Parks; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation(National Science Foundation (NSF))	The work was supported by the following: California State Parks (WMB; http://www.parks.ca.gov/), California Department of Fish and Wildlife (HBE, WMB; https://www.dfg.ca.gov/), The Nature Conservancy (WMB, SAM; http://www.nature.org/); The McBeth Foundation (WMB; http://mcbethfoundation.com/); The Anza Borrego Foundation (WMB; http://theabf.org/), Nature Reserve of Orange County (WMB; http://www.naturereserveoc.org/); The National Science Foundation (WMB; http://www.nsf.gov/); and private donors (HBE, WMB). The Nature Conservancy (SAM) helped with sample and data collection and preparation of the manuscript. California Department of Fish and Wildlife, helped with sample and data collection. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho JS, 2010, MOL ECOL RESOUR, V10, P720, DOI 10.1111/j.1755-0998.2010.02830.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; [Anonymous], 1978, MULTIVARIATE ANAL VE; Barbour E, 2002, METROPOLITAN GROWTH, P246; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier Paul, 1996, P293; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ernest HB, 2000, MOL ECOL, V9, P433, DOI 10.1046/j.1365-294x.2000.00890.x; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kurushima JD, 2006, MOL ECOL NOTES, V6, P1260, DOI 10.1111/j.1471-8286.2006.01508.x; Logan K, 2001, DESERT PUMA EVOLUTIO, P464; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Luke C, 2004, REPORT UNPUB; Lynch M, 1999, GENETICS, V152, P1753; Mansfield TM, 1994, P 16 VERT PEST C SAN; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Morrison SA, 2009, CONSERV BIOL, V23, P275, DOI 10.1111/j.1523-1739.2008.01079.x; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2002, DOCUMENTATION STRUCT; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Riley SPD, 2014, CURR BIOL, V24, P1989, DOI 10.1016/j.cub.2014.07.029; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; US Census Bureau, 2012, 2010 CENS POP HOUS S; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2012, GENETICS, V191, P183, DOI 10.1534/genetics.111.138149; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	55	50	50	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107985	10.1371/journal.pone.0107985	http://dx.doi.org/10.1371/journal.pone.0107985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295530	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000012
J	Kiel, S; Glodny, J; Birgel, D; Bulot, LG; Campbell, KA; Gaillard, C; Graziano, R; Kaim, A; Lazar, I; Sandy, MR; Peckmann, J				Kiel, Steffen; Glodny, Johannes; Birgel, Daniel; Bulot, Luc G.; Campbell, Kathleen A.; Gaillard, Christian; Graziano, Roberto; Kaim, Andrzej; Lazar, Iuliana; Sandy, Michael R.; Peckmann, Joern			The Paleoecology, Habitats, and Stratigraphic Range of the Enigmatic Cretaceous Brachiopod Peregrinella	PLOS ONE			English	Article							METHANE-SEEP DEPOSITS; STRONTIUM ISOTOPE STRATIGRAPHY; PLATFORM GARGANO PROMONTORY; MESOZOIC CONVERGENT MARGIN; ANCIENT HYDROCARBON SEEPS; FORE-ARC BASIN; COLD-SEEP; HYDROTHERMAL VENT; ANAEROBIC OXIDATION; ALEXANDER ISLAND	Modern and Cenozoic deep-sea hydrothermal-vent and methane-seep communities are dominated by large tubeworms, bivalves and gastropods. In contrast, many Early Cretaceous seep communities were dominated by the largest Mesozoic rhynchonellid brachiopod, the dimerelloid Peregrinella, the paleoecologic and evolutionary traits of which are still poorly understood. We investigated the nature of Peregrinella based on 11 occurrences world wide and a literature survey. All in situ occurrences of Peregrinella were confirmed as methane-seep deposits, supporting the view that Peregrinella lived exclusively at methane seeps. Strontium isotope stratigraphy indicates that Peregrinella originated in the late Berriasian and disappeared after the early Hauterivian, giving it a geologic range of ca. 9.0 (+1.45/-0.85) million years. This range is similar to that of rhynchonellid brachiopod genera in general, and in this respect Peregrinella differs from seep-inhabiting mollusks, which have, on average, longer geologic ranges than marine mollusks in general. Furthermore, we found that (1) Peregrinella grew to larger sizes at passive continental margins than at active margins; (2) it grew to larger sizes at sites with diffusive seepage than at sites with advective fluid flow; (3) despite its commonly huge numerical abundance, its presence had no discernible impact on the diversity of other taxa at seep sites, including infaunal chemosymbiotic bivalves; and (4) neither its appearance nor its extinction coincides with those of other seep-restricted taxa or with global extinction events during the late Mesozoic. A preference of Peregrinella for diffusive seepage is inferred from the larger average sizes of Peregrinella at sites with more microcrystalline carbonate (micrite) and less seep cements. Because other seep-inhabiting brachiopods occur at sites where such cements are very abundant, we speculate that the various vent- and seep-inhabiting dimerelloid brachiopods since Devonian time may have adapted to these environments in more than one way.	[Kiel, Steffen] Univ Gottingen, Geowissensch Zentrum, Abt Geobiol, D-37073 Gottingen, Germany; [Glodny, Johannes] Deutsch GeoForschungsZentrum GFZ, Sekt Anorgan & Isotopengeochem 4 2, Potsdam, Germany; [Birgel, Daniel; Peckmann, Joern] Univ Vienna, Erdwissensch Zentrum, Dept Geodynam & Sedimentol, Vienna, Austria; [Bulot, Luc G.] Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE CNRS 2761, Marseille, France; [Campbell, Kathleen A.] Univ Auckland, Sch Environm Sci, Geol Programme, Auckland 1, New Zealand; [Gaillard, Christian] Univ Lyon 1, UMR CNRS Paleoenvironm & Paleobiosphere 5125, F-69622 Villeurbanne, France; [Graziano, Roberto] Univ Naples Federico II, Dipartimento Sci Terra Ambiente & Risorse, Naples, Italy; [Kaim, Andrzej] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Lazar, Iuliana] Univ Bucharest, Fac Geol & Geophys, Dept Geol, Bucharest, Romania; [Sandy, Michael R.] Univ Dayton, Dept Geol, Dayton, OH 45469 USA	University of Gottingen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Vienna; UDICE-French Research Universities; Aix-Marseille Universite; University of Auckland; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Naples Federico II; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Bucharest; University of Dayton	Kiel, S (corresponding author), Univ Gottingen, Geowissensch Zentrum, Abt Geobiol, D-37073 Gottingen, Germany.	skiel@uni-goettingen.de	Bulot, Luc G/C-8255-2013; Kaim, Andrzej/G-6244-2010; Bulot, Luc/M-7815-2019; Glodny, Johannes/P-7959-2017; Kiel, Steffen/C-3150-2009	Bulot, Luc G/0000-0002-2817-9327; Kaim, Andrzej/0000-0001-6186-5356; Bulot, Luc/0000-0002-2817-9327; Glodny, Johannes/0000-0002-7812-5933; Kiel, Steffen/0000-0001-6281-100X; Peckmann, Jorn/0000-0002-8572-0060; Lazar, Iuliana/0000-0003-1111-7207; Graziano, Roberto/0000-0002-0318-5835; Campbell, Kathleen/0000-0002-4815-2519	Deutsche Forschungsgemeinschaft [Ki802/6-1]; National Science Centre, Poland [2012/07/B/ST/10/04189]; American Chemical Society - Petroleum Research Fund; Open Access Publication Funds of the Georg-August-University Gottingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Centre, Poland(National Science Centre, Poland); American Chemical Society - Petroleum Research Fund(American Chemical Society); Open Access Publication Funds of the Georg-August-University Gottingen	Financial support was provided by the Deutsche Forschungsgemeinschaft through grant Ki802/6-1 to SK; by the National Science Centre, Poland, through grant 2012/07/B/ST/10/04189 to AK; by the donors of the American Chemical Society - Petroleum Research Fund to MRS; and by the Open Access Publication Funds of the Georg-August-University Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager D. V., 1965, Palaeogeography Palaeoclimatology Palaeoecology, V1, P143, DOI 10.1016/0031-0182(65)90011-8; Ager D.V., 1986, Modern Geology, V10, P377; Agirrezabala LM, 2013, PALAEOGEOGR PALAEOCL, V390, P94, DOI 10.1016/j.palaeo.2012.11.020; Aharon P, 1997, GEOL SOC AM BULL, V109, P568, DOI 10.1130/0016-7606(1997)109<0568:RDOSHS>2.3.CO;2; Amano K, 2007, VELIGER, V49, P270; Amano K, 2007, VELIGER, V49, P84; Anderson F. M., 1938, Geological Society of America Special Paper, V16, P1; ASCHER E., 1906, BEITRAGE PALAONTOLOG, VXIX, P135; Bailey TR, 2000, CHEM GEOL, V167, P313, DOI 10.1016/S0009-2541(99)00235-1; BERKLAND JO, 1973, GEOL SOC AM BULL, V84, P2389, DOI 10.1130/0016-7606(1973)84<2389:RVOSOC>2.0.CO;2; Biernat G., 1957, ACTA PALAEONTOL POL, V2, P19; Birgel D, 2008, GEOLOGY, V36, P543, DOI 10.1130/G24690A.1; Birgel D, 2008, ORG GEOCHEM, V39, P152, DOI 10.1016/j.orggeochem.2007.08.013; Birgel D, 2006, ORG GEOCHEM, V37, P1289, DOI 10.1016/j.orggeochem.2006.02.004; Birgel D, 2008, ORG GEOCHEM, V39, P1659, DOI 10.1016/j.orggeochem.2008.01.023; Bodin S, 2006, PALAEOGEOGR PALAEOCL, V235, P245, DOI 10.1016/j.palaeo.2005.09.030; Boller K., 1963, Eclogae Geologicae Helvetiae, V56, P15; Bosellini A, 1997, CRETACEOUS RES, V18, P51, DOI 10.1006/cres.1996.0049; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; Brooks JM, 2009, 2 US DEP INT MIN MGM; Campbell K.A., 1993, ADV SEDIMENTARY GEOL, V73, P37; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; Campbell KA, 2002, GEOFLUIDS, V2, P63, DOI 10.1046/j.1468-8123.2002.00022.x; Campbell KA, 1995, PALEOBIOLOGY, V21, P461, DOI 10.1017/S0094837300013488; CAMPBELL KA, 1995, GEOLOGY, V23, P321, DOI 10.1130/0091-7613(1995)023<0321:BACBIP>2.3.CO;2; Campbell KA, 2008, J PALEONTOL, V82, P140, DOI 10.1666/05-025.1; Carroll M, 2008, GEO-MAR LETT, V28, P369, DOI 10.1007/s00367-008-0117-3; Chryploff G, 1958, Z ANGEW GEOL, V4, P70; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Gabb W. M., 1869, CALIFORNIA GEOLOGICA, V2, P1; Gabb W.M., 1866, CALIF GEOL SURV PALE, V2, P1; GAILLARD C, 1992, Palaios, V7, P451, DOI 10.2307/3514829; Gischler E, 2003, J PALEONTOL, V77, P293, DOI 10.1666/0022-3360(2003)077<0293:ICFARA>2.0.CO;2; GOOSSENS H, 1984, NATURE, V312, P440, DOI 10.1038/312440a0; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Graziano R, 1999, TERRA NOVA, V11, P245, DOI 10.1046/j.1365-3121.1999.00256.x; Graziano R, 2008, B SOC GEOL ITAL, V127, P407; Hammer O, 2011, PALAEOGEOGR PALAEOCL, V306, P15, DOI 10.1016/j.palaeo.2011.03.019; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Jenkins RG, 2007, GEOBIOLOGY, V5, P127, DOI 10.1111/j.1472-4669.2007.00106.x; Jenkins RG, 2013, ACTA PALAEONTOL POL, V58, P357, DOI 10.4202/app.2011.0026; Kaim A, 2008, ZOOL J LINN SOC-LOND, V154, P421, DOI 10.1111/j.1096-3642.2008.00431.x; Kaim A, 2014, ZOOTAXA, V3861, P401, DOI 10.11646/zootaxa.3861.5.1; Kaim A, 2013, PALAEOGEOGR PALAEOCL, V390, P42, DOI 10.1016/j.palaeo.2013.03.010; Kaim A, 2009, ACTA PALAEONTOL POL, V54, P463, DOI 10.4202/app.2009.0042; Kaim A, 2009, ANTARCT SCI, V21, P279, DOI 10.1017/S0954102009001813; Kaminski M.A., 1998, GRZYBOWSKI FDN SPECI, V6, P1; Keenan KE, 2010, THESIS U CALIFORNIA; Kelly SRA, 2000, GEOL SOC SPEC PUBL, V177, P227, DOI 10.1144/GSL.SP.2000.177.01.13; KELLY SRA, 1995, J SEDIMENT RES A, V65, P274; Kiel S, 2008, PALAIOS, V23, P751, DOI 10.2110/palo.2008.p08-052r; Kiel S, 2008, J PALEONTOL, V82, P1215, DOI 10.1666/08-003.1; Kiel S, 2008, ACTA PALAEONTOL POL, V53, P525, DOI 10.4202/app.2008.0310; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Kiel S, 2013, PALAEOGEOGR PALAEOCL, V390, P17, DOI 10.1016/j.palaeo.2012.10.033; Kiel S, 2013, J MOLLUS STUD, V79, P346, DOI 10.1093/mollus/eyt035; Kiel S, 2013, J PALEONTOL, V87, P589, DOI 10.1666/12-135; Kiel S, 2010, ZOOTAXA, P26, DOI 10.11646/zootaxa.2390.1.2; Kiel S, 2012, GEOLOGY, V40, P839, DOI 10.1130/G33300.1; Kiel S, 2010, PALAEOGEOGR PALAEOCL, V295, P245, DOI 10.1016/j.palaeo.2010.05.042; Kiel S, 2008, ACTA PALAEONTOL POL, V53, P679, DOI 10.4202/app.2008.0412; Lazar I, 2011, FACIES, V57, P627, DOI 10.1007/s10347-010-0261-x; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LEMOINE M, 1982, B SOC GEOL FR, V24, P641, DOI 10.2113/gssgfbull.S7-XXIV.3.641; Little CTS, 1999, GEOLOGY, V27, P167, DOI 10.1130/0091-7613(1999)027<0167:EJHVCF>2.3.CO;2; Luff R, 2003, GEOCHIM COSMOCHIM AC, V67, P3403, DOI 10.1016/S0016-7037(03)00127-3; MACDONALD IR, 1998, STABILITY CHANGE GUL; Macsotay O, 1980, THESIS U CLAUDE BERN; Mancenido MO, 2001, SYST ASSOC SPEC VOL, P189; McArthur JM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P127, DOI 10.1016/B978-0-444-59425-9.00007-X; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; MCARTHUR JM, 1994, TERRA NOVA, V6, P331, DOI 10.1111/j.1365-3121.1994.tb00507.x; Newman WA, 2006, DENISIA, V18, P359; Nielsen SN, 2009, PALAEOGEOGR PALAEOCL, V280, P480, DOI 10.1016/j.palaeo.2009.06.035; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Nobuhara Takami, 2008, Fossils (Tokyo), P47; Ortiz-Hernandez L. E., 2003, REV MEX CIENC GEOL, V20, P27; PAULL CK, 1991, MAR GEOL, V102, P265, DOI 10.1016/0025-3227(91)90011-R; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Peckmann J, 2004, CHEM GEOL, V205, P443, DOI 10.1016/j.chemgeo.2003.12.025; Peckmann J, 2013, PALAEOGEOGR PALAEOCL, V390, P4, DOI 10.1016/j.palaeo.2013.01.003; Peckmann J, 2011, J GEOL, V119, P207, DOI 10.1086/658199; Peckmann J, 2007, PALAIOS, V22, P114, DOI 10.2110/palo.2005.p05-115r; Peckmann J, 2009, GEOLOGY, V37, P847, DOI 10.1130/G25658A.1; Posenato R, 1999, CRETACEOUS RES, V20, P641, DOI 10.1006/cres.1999.0171; Puceat E, 2005, EARTH PLANET SC LETT, V236, P705, DOI 10.1016/j.epsl.2005.03.015; Reinhardt EG, 2000, CHEM GEOL, V164, P331, DOI 10.1016/S0009-2541(99)00147-3; Remes M, 1903, VERHANDLUNGEN KK GEO, V11, P223; Renngarten V., 1924, IZVESTIIA GEOL KOMIT, V42, P119; Sahling H, 2002, MAR ECOL PROG SER, V231, P121, DOI 10.3354/meps231121; Sandy MR, 2012, PALAEOGEOGR PALAEOCL, V323, P42, DOI 10.1016/j.palaeo.2012.01.026; Sandy M.R., 1995, FOLDTANI KOZLONY, V125, P241; Sandy MR, 2010, TOP GEOBIOL, V33, P279, DOI 10.1007/978-90-481-9572-5_9; Sandy MR, 1996, BRACHIOPODS, P239; SANDY MR, 1994, J PALEONTOL, V68, P1243, DOI 10.1017/S0022336000034247; Scotese CR, 2004, J GEOL, V112, P729, DOI 10.1086/424867; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Short EJ, 2005, GEOL SOC AM ABSTR PR, V37, P81; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Stanton T.W., 1895, B US GEOLOGICAL SURV, V133, P1; Sun D, 1986, PALAEONTOLOGIA CATHA, V2, P211; Thayer C.W., 1981, STUDIES GEOLOGY NOTE, V5, P110; THIEULOY J-P, 1972, Geobios (Villeurbanne), V5, P5, DOI 10.1016/S0016-6995(72)80004-4; Thuy B, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2624; Toula F., 1911, Abhandlungen der Geologischen Reichsanstalt Wien, V20; Trumpy R., 1956, Eclogae Geologicae Helvetiae, V49, P573; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD	110	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109260	10.1371/journal.pone.0109260	http://dx.doi.org/10.1371/journal.pone.0109260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296341	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000053
J	Biville, F; Brezillon, C; Giorgini, D; Taha, MK				Biville, Francis; Brezillon, Christophe; Giorgini, Dario; Taha, Muhamed-Kheir			Pyrophosphate-Mediated Iron Acquisition from Transferrin in Neisseria meningitidis Does Not Require TonB Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI; BINDING-PROTEIN; OUTER-MEMBRANE; EXOGENOUS PYROPHOSPHATE; PATHOGENIC NEISSERIA; FERRIC ENTEROBACTIN; EXBD GENES; IN-VITRO; GONORRHOEAE; TRANSPORT	The ability to acquire iron from various sources has been demonstrated to be a major determinant in the pathogenesis of Neisseria meningitidis. Outside the cells, iron is bound to transferrin in serum, or to lactoferrin in mucosal secretions. Meningococci can extract iron from iron-loaded human transferrin by the TbpA/TbpB outer membrane complex. Moreover, N. meningitidis expresses the LbpA/LbpB outer membrane complex, which can extract iron from iron-loaded human lactoferrin. Iron transport through the outer membrane requires energy provided by the ExbB-ExbD-TonB complex. After transportation through the outer membrane, iron is bound by periplasmic protein FbpA and is addressed to the FbpBC inner membrane transporter. Iron-complexing compounds like citrate and pyrophosphate have been shown to support meningococcal growth ex vivo. The use of iron pyrophosphate as an iron source by N. meningitidis was previously described, but has not been investigated. Pyrophosphate was shown to participate in iron transfer from transferrin to ferritin. In this report, we investigated the use of ferric pyrophosphate as an iron source by N. meningitidis both ex vivo and in a mouse model. We showed that pyrophosphate was able to sustain N. meningitidis growth when desferal was used as an iron chelator. Addition of a pyrophosphate analogue to bacterial suspension at millimolar concentrations supported N. meningitidis survival in the mouse model. Finally, we show that pyrophosphate enabled TonB-independent ex vivo use of iron-loaded human or bovine transferrin as an iron source by N. meningitidis. Our data suggest that, in addition to acquiring iron through sophisticated systems, N. meningitidis is able to use simple strategies to acquire iron from a wide range of sources so as to sustain bacterial survival.	[Biville, Francis; Brezillon, Christophe; Giorgini, Dario; Taha, Muhamed-Kheir] Inst Pasteur, Dept Infect & Epidemiol, Unite Infect Bacteriennes Invas, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Biville, F (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Unite Infect Bacteriennes Invas, Paris, France.	fbiville@pasteur.fr			Pasteur Institute; Institut de veille sanitaire	Pasteur Institute; Institut de veille sanitaire	This work was supported by Pasteur Institute and the Institut de veille sanitaire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 1996, J BACTERIOL, V178, P2145, DOI 10.1128/jb.178.7.2145-2149.1996; ARCHIBALD FS, 1980, INFECT IMMUN, V27, P322, DOI 10.1128/IAI.27.2.322-334.1980; Biswas GD, 1997, MOL MICROBIOL, V24, P169, DOI 10.1046/j.1365-2958.1997.3421692.x; BIVILLE F, 1985, FEMS MICROBIOL LETT, V28, P73; Biville F, 2003, J MOL MICROB BIOTECH, V5, P37, DOI 10.1159/000068722; Biville F, 1996, RES MICROBIOL, V147, P597, DOI 10.1016/0923-2508(96)84015-0; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Brook CE, 2005, INORG CHEM, V44, P5183, DOI 10.1021/ic050411m; Carson SDB, 1999, J BACTERIOL, V181, P2895, DOI 10.1128/JB.181.9.2895-2901.1999; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; Harris WR, 2004, J INORG BIOCHEM, V98, P1824, DOI 10.1016/j.jinorgbio.2004.08.008; Jadhav SR, 2013, J COLLOID INTERF SCI, V390, P211, DOI 10.1016/j.jcis.2012.09.031; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Khun HH, 1998, INFECT IMMUN, V66, P2330, DOI 10.1128/IAI.66.5.2330-2336.1998; KONOPKA K, 1980, EUR J BIOCHEM, V107, P433; KONOPKA K, 1980, BIOCHEM BIOPH RES CO, V96, P1408, DOI 10.1016/0006-291X(80)90107-2; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAHTI R, 1983, MICROBIOL REV, V47, P169, DOI 10.1128/MMBR.47.2.169-178.1983; LEFAOU AE, 1991, BIOL MET, V4, P126; LEWIS LA, 1995, J BACTERIOL, V177, P1299, DOI 10.1128/jb.177.5.1299-1306.1995; Matzanke BF, 2004, BIOCHEMISTRY-US, V43, P1386, DOI 10.1021/bi0357661; MIZUNO T, 1983, J BIOL CHEM, V258, P6932; NASSIF X, 1991, J BACTERIOL, V173, P2147, DOI 10.1128/JB.173.7.2147-2154.1991; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Noinaj N, 2012, MOL MICROBIOL, V86, P246, DOI 10.1111/mmi.12002; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Perrotte-Piquemal M, 1999, BIOCHIMIE, V81, P245, DOI 10.1016/S0300-9084(99)80058-3; PYNES GD, 1967, J BIOL CHEM, V242, P2119; Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375; Rohde KH, 2002, MOL MICROBIOL, V43, P335, DOI 10.1046/j.1365-2958.2002.02745.x; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Rudel T, 1996, CELL, V85, P391, DOI 10.1016/S0092-8674(00)81117-4; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; SCHRYVERS AB, 1988, INFECT IMMUN, V56, P1144, DOI 10.1128/IAI.56.5.1144-1149.1988; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Siburt CJP, 2012, BBA-GEN SUBJECTS, V1820, P379, DOI 10.1016/j.bbagen.2011.09.001; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Song JM, 1999, BIOPHYS J, V76, P804, DOI 10.1016/S0006-3495(99)77244-9; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; Stojiljkovic I, 1997, J BACTERIOL, V179, P805, DOI 10.1128/jb.179.3.805-812.1997; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Strange HR, 2011, INFECT IMMUN, V79, P267, DOI 10.1128/IAI.00807-10; Szatanik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022210; TAHA MK, 1988, EMBO J, V7, P4367, DOI 10.1002/j.1460-2075.1988.tb03335.x; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; TOMMASSEN J, 1990, INFECT IMMUN, V58, P1355, DOI 10.1128/IAI.58.5.1355-1359.1990; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Veggi D, 2012, BIOCHEMISTRY-US, V51, P9384, DOI 10.1021/bi301161w; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; YANCEY RJ, 1981, INFECT IMMUN, V32, P592, DOI 10.1128/IAI.32.2.592-599.1981; Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07; Zeth K, 2013, BIOCHEM J, V454, P359, DOI 10.1042/BJ4540359; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000; Zola TA, 2010, INFECT IMMUN, V78, P2429, DOI 10.1128/IAI.00228-10	59	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107612	10.1371/journal.pone.0107612	http://dx.doi.org/10.1371/journal.pone.0107612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290693	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000006
J	Njimona, I; Yang, R; Lamparter, T				Njimona, Ibrahim; Yang, Rui; Lamparter, Tilman			Temperature Effects on Bacterial Phytochrome	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; SIGNAL-TRANSDUCTION; AGROBACTERIUM-TUMEFACIENS; CYANOBACTERIUM SYNECHOCYSTIS; PSEUDOMONAS-AERUGINOSA; ARABIDOPSIS-THALIANA; SENSORY MODULE; GROUND-STATE; RED-LIGHT; CHROMOPHORE	Bacteriophytochromes (BphPs) are light-sensing regulatory proteins encoded in photosynthetic and non-photosynthetic bacteria. This protein class incorporate bilin as their chromophore, with majority of them bearing a light-regulated His kinase or His kinase related module in the C-terminal. We studied the His kinase actives in the temperature range of 5 degrees C to 40 degrees C on two BphPs, Agp1 from Agrobacterium tumefaciens and Cph1 from cyanobacterium Synechocystis PCC 6803. As reported, the phosphorylation activities of the far red (FR) irradiated form of the holoprotein is stronger than that of the red (R) irradiated form in both phytochromes. We observed for the apoprotein and FR irradiated holoprotein of Agp1 an increase in the phosphorylation activities from 5 degrees C to 25 degrees C and a decrease from 25 degrees C to 40 degrees C. At 5 degrees C the activities of the apoprotein were significantly lower than those of the FR irradiated holoprotein, which was opposite at 40 degrees C. A similar temperature pattern was observed for Cph1, but the maximum of the apoprotein was at 20 degrees C while the maximum of the FR irradiated holoprotein was at 10 degrees C. At 40 degrees C, prolonged R irradiation leads to an irreversible bleaching of Cph1, an effect which depends on the C-terminal His kinase module. A more prominent and reversible temperature effect on spectral properties of Agp1, mediated by the His kinase, has been reported before. His kinases in phytochromes could therefore share similar temperature characteristics. We also found that phytochrome B mutants of Arabidopsis have reduced hypocotyl growth at 37 degrees C in darkness, suggesting that this phytochrome senses the temperature or mediates signal transduction of temperature effects.	[Njimona, Ibrahim; Yang, Rui; Lamparter, Tilman] Karlsruhe Inst Technol, Inst Bot, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Lamparter, T (corresponding author), Karlsruhe Inst Technol, Inst Bot, D-76021 Karlsruhe, Germany.	tilman.lamparter@kit.edu	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737	Deutsche Forschungsgemeinschaft [La 799/8-1]; Open Access Publishing Fund of Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	The work was funded by the Deutsche Forschungsgemeinschaft, La 799/8-1. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Barkovits K, 2008, FEMS MICROBIOL LETT, V280, P160, DOI 10.1111/j.1574-6968.2007.01058.x; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Burgie ES, 2014, P NATL ACAD SCI US; COWL JS, 1994, PLANT PHYSIOL, V106, P813, DOI 10.1104/pp.106.2.813; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FIELDING A, 1992, PHOTOCHEM PHOTOBIOL, V56, P623, DOI 10.1111/j.1751-1097.1992.tb02212.x; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Franklin KA, 2009, CURR OPIN PLANT BIOL, V12, P63, DOI 10.1016/j.pbi.2008.09.007; FRY KT, 1971, BIOCHEM BIOPH RES CO, V45, P1466, DOI 10.1016/0006-291X(71)90185-9; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Heyes D. J., 2012, PLOS ONE, V7; Hubschmann T, 2005, FEBS LETT, V579, P1613, DOI 10.1016/j.febslet.2005.01.075; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; JIN SG, 1993, J BACTERIOL, V175, P6830, DOI 10.1128/jb.175.21.6830-6835.1993; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; KAY SA, 1989, NUCLEIC ACIDS RES, V17, P2865, DOI 10.1093/nar/17.7.2865; Kim PW, 2014, BIOCHEMISTRY-US, V53, P2818, DOI 10.1021/bi500108s; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Mironov KS, 2012, BBA-BIOENERGETICS, V1817, P1352, DOI 10.1016/j.bbabio.2011.12.011; Mironov KS, 2014, J PHOTOCHEMISTRY P B; Mizuno T, 1998, J BIOCHEM, V123, P555; Mougel C, 2001, TRENDS BIOCHEM SCI, V26, P582, DOI 10.1016/S0968-0004(01)01969-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Njimona I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025977; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; PAYNE PI, 1972, NATURE-NEW BIOL, V235, P145, DOI 10.1038/newbio235145a0; Poppe C, 1998, PLANT J, V16, P465, DOI 10.1046/j.1365-313x.1998.00322.x; Quail PH, 1997, BIOESSAYS, V19, P571, DOI 10.1002/bies.950190708; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; SCHNEIDERPOETSCH HAW, 1991, FEBS LETT, V281, P245, DOI 10.1016/0014-5793(91)80403-P; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	53	18	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109794	10.1371/journal.pone.0109794	http://dx.doi.org/10.1371/journal.pone.0109794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289638	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000087
J	Dhall, A; Wei, SJ; Fierz, B; Woodcock, CL; Lee, TH; Chatterjee, C				Dhall, Abhinav; Wei, Sijie; Fierz, Beat; Woodcock, Christopher L.; Lee, Tae-Hee; Chatterjee, Champak			Sumoylated Human Histone H4 Prevents Chromatin Compaction by Inhibiting Long-range Internucleosomal Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Modification; Chromatin Structure; Disulfide; Histone; Intein; Post-translational Modification (PTM); Small Ubiquitin-like Modifier (SUMO); Sumoylation; Acetylation; Ligation	SELF-ASSOCIATION; FIBER; BINDING; TAIL; H3; IDENTIFICATION; ACETYLATION; METHYLATION; NUCLEOSOMES; RESOLUTION	Background: Human histone H4 is post-translationally modified at Lys-12 by the small ubiquitin-like modifier protein (SUMO-3). Results: Chemical sumoylation at H4 Lys-12 revealed the inhibition of chromatin compaction and oligomerization by SUMO-3. Conclusion: Sumoylation changes chromatin structure by inhibiting long-range internucleosomal interactions and decreasing the affinity between adjacent nucleosomes. Significance: Learning how sumoylation changes the structure of chromatin suggests that it may mediate gene repression without chromatin compaction. The structure of eukaryotic chromatin directly influences gene function, and is regulated by chemical modifications of the core histone proteins. Modification of the human histone H4 N-terminal tail region by the small ubiquitin-like modifier protein, SUMO-3, is associated with transcription repression. However, the direct effect of sumoylation on chromatin structure and function remains unknown. Therefore, we employed a disulfide-directed strategy to generate H4 homogenously and site-specifically sumoylated at Lys-12 (suH4(ss)). Chromatin compaction and oligomerization assays with nucleosomal arrays containing suH4(ss) established that SUMO-3 inhibits array folding and higher order oligomerization, which underlie chromatin fiber formation. Moreover, the effect of sumoylation differed from that of acetylation, and could be recapitulated with the structurally similar protein ubiquitin. Mechanistic studies at the level of single nucleosomes revealed that, unlike acetylation, the effect of SUMO-3 arises from the attenuation of long-range internucleosomal interactions more than from the destabilization of a compacted dinucleosome state. Altogether, our results present the first insight on the direct structural effects of histone H4 sumoylation and reveal a novel mechanism by which SUMO-3 inhibits chromatin compaction.	[Dhall, Abhinav; Chatterjee, Champak] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Wei, Sijie; Lee, Tae-Hee] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Fierz, Beat] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Massachusetts System; University of Massachusetts Amherst	Woodcock, CL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	chris@bio.umass.edu; txl18@psu.edu; chatterjee@chem.washington.edu	Chatterjee, Champak/R-7214-2017; Lee, Tae-Hee/A-1266-2010; Wei, Sijie/J-6678-2019; Fierz, Beat/H-3143-2012	Wei, Sijie/0000-0003-4882-9566; Fierz, Beat/0000-0002-2991-3044; Chatterjee, Champak/0000-0001-5772-4438; Dhall, Abhinav/0000-0002-7590-2469	National Institutes of Health [1S10RR027217]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110430, R01GM097286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Rachel Klevit for access to a Beckman XL-I Analytical Ultracentrifuge supported by National Institutes of Health Grant 1S10RR027217.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Chen WT, 2013, MOL CELL BIOL, V33, P111, DOI 10.1128/MCB.01024-12; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Correll SJ, 2012, EMBO J, V31, P2416, DOI 10.1038/emboj.2012.80; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dhall A, 2011, ACS CHEM BIOL, V6, P987, DOI 10.1021/cb200142c; Ding HS, 2005, BIOCHEMISTRY-US, V44, P2790, DOI 10.1021/bi0477586; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Flaus A, 1998, J MOL BIOL, V275, P427, DOI 10.1006/jmbi.1997.1464; Galisson F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004796; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Garcia Benjamin A, 2009, Front Biosci (Schol Ed), V1, P142, DOI 10.2741/s14; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Jason LJM, 2001, J BIOL CHEM, V276, P14597, DOI 10.1074/jbc.M011153200; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lee JY, 2011, J BIOL CHEM, V286, P11099, DOI 10.1074/jbc.M110.192047; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li FP, 2011, ANGEW CHEM INT EDIT, V50, P9611, DOI 10.1002/anie.201103754; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Saracco SA, 2007, PLANT PHYSIOL, V145, P119, DOI 10.1104/pp.107.102285; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szerlong HJ, 2011, BIOCHEM CELL BIOL, V89, P24, DOI 10.1139/O10-139; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Woodcock CL, 1998, METHOD CELL BIOL, V53, P167; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhou BO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001272	50	57	58	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33827	33837		10.1074/jbc.M114.591644	http://dx.doi.org/10.1074/jbc.M114.591644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25294883	Green Published, hybrid			2022-12-25	WOS:000346077600010
J	Tang, MF; Li, YJ; Zhang, XY; Deng, TT; Zhou, ZF; Ma, WB; Zhou, SY				Tang, Mengfan; Li, Yujing; Zhang, Xiya; Deng, Tingting; Zhou, Zhifen; Ma, Wenbin; Zhou Songyang			Structural Maintenance of Chromosomes Flexible Hinge Domain Containing 1 (SMCHD1) Promotes Non-homologous End Joining and Inhibits Homologous Recombination Repair upon DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; DNA Damage; DNA Damage Response; DNA Recombination; DNA Repair; Signal Transduction	DOUBLE-STRAND BREAKS; INACTIVE X-CHROMOSOME; HISTONE H2AX; TUMOR-SUPPRESSOR; UBIQUITIN MARK; BRCA1; 53BP1; PROTEINS; GENOME; CELLS	Background: The role of SMCHD1 in DNA damage response is largely unknown. Results: SMCHD1 recruitment to DNA damage foci is regulated by 53BP1. Knocking out SMCHD1 compromised cell survival, and decreased the efficiency of non-homologous end joining (NHEJ) while elevating the efficiency of homologous recombination (HR). Conclusion: SMCHD1 regulates both NHEJ and HR. Significance: Our findings should further understanding of how cells adopt different repair pathways. Structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1) has been shown to be involved in gene silencing and DNA damage. However, the exact mechanisms of how SMCHD1 participates in DNA damage remains largely unknown. Here we present evidence that SMCHD1 recruitment to DNA damage foci is regulated by 53BP1. Knocking out SMCHD1 led to aberrant H2AX foci accumulation and compromised cell survival upon DNA damage, demonstrating the critical role of SMCHD1 in DNA damage repair. Following DNA damage induction, SMCHD1 depletion resulted in reduced 53BP1 foci and increased BRCA1 foci, as well as less efficient non-homologous end joining (NHEJ) and elevated levels of homologous recombination (HR). Taken together, these results suggest an important function of SMCHD1 in promoting NHEJ and repressing HR repair in response to DNA damage.	[Tang, Mengfan; Li, Yujing; Zhang, Xiya; Deng, Tingting; Zhou, Zhifen; Ma, Wenbin; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, SYSU Baylor Coll Med Joint Res Ctr Biomed Sci, Key Lab Gene Engn,Minist Educ,State Key Lab Bioco, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Baylor Coll Med, Verna & Marrs Dept Biochem & Mol Biol, Houston, TX 77030 USA	Sun Yat Sen University; Baylor College of Medicine	Ma, WB (corresponding author), Sun Yat Sen Univ, Sch Life Sci, SYSU Baylor Coll Med Joint Res Ctr Biomed Sci, Key Lab Gene Engn,Minist Educ,State Key Lab Bioco, Guangzhou 510275, Guangdong, Peoples R China.	mawenbin@mail.sysu.edu.cn; songyang@bcm.edu	Li, Yujing/L-2221-2019; Li, yujing/GQA-4109-2022	Li, Yujing/0000-0002-3223-769X; Zhou, Zhifen/0000-0003-2737-6764; Ma, Wenbin/0000-0001-8774-7593	NIGMS National Institutes of Health [GM095599]; Welch Foundation [Q-1673]; CPRIT [RP130135]; CDMRP [BC123368]; National Basic Research Program (973 Program) [2012CB911201]; National Natural Science Foundation [91019020, 81330055, 91213302, 31171397, 31271533, 31371508]; Introduced Innovative R&D Team of Guangdong Province [201001Y0104687244]; "985" project foundation of Sun Yat-sen University [33000-3281303]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095599] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); CPRIT; CDMRP(United States Department of Defense); National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Introduced Innovative R&D Team of Guangdong Province; "985" project foundation of Sun Yat-sen University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIGMS National Institutes of Health Grant GM095599, the Welch Foundation Q-1673, CPRIT RP130135, and CDMRP BC123368. This work was also funded by the National Basic Research Program (973 Program) (2012CB911201), the National Natural Science Foundation (91019020, 81330055, 91213302, 31171397, 31271533, and 31371508) and Introduced Innovative R&D Team of Guangdong Province (201001Y0104687244) and "985" project foundation of Sun Yat-sen University (33000-3281303).	Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bohmdorfer G, 2011, PLANT J, V67, P420, DOI 10.1111/j.1365-313X.2011.04604.x; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chankova SG, 2007, RADIAT ENVIRON BIOPH, V46, P409, DOI 10.1007/s00411-007-0123-2; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Coker H, 2014, J CELL SCI, V127, P1869, DOI 10.1242/jcs.140020; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fernandez-Capetillo O, 2008, MOL CELL, V31, P303, DOI 10.1016/j.molcel.2008.07.004; Foray N, 1999, ONCOGENE, V18, P7334, DOI 10.1038/sj.onc.1203165; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Gendrel AV, 2013, MOL CELL BIOL, V33, P3150, DOI 10.1128/MCB.00145-13; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; Grolimund L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3848; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Leong HS, 2013, CANCER RES, V73, P1591, DOI 10.1158/0008-5472.CAN-12-3019; Li L, 2005, J CELL BIOCHEM, V94, P298, DOI 10.1002/jcb.20355; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Lou ZK, 2005, ADV EXP MED BIOL, V570, P425, DOI 10.1007/1-4020-3764-3_15; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Massah S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097535; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Moynahan ME, 2001, CANCER RES, V61, P4842; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Schubert V, 2009, CYTOGENET GENOME RES, V124, P202, DOI 10.1159/000218126; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192	53	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34024	34032		10.1074/jbc.M114.601179	http://dx.doi.org/10.1074/jbc.M114.601179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25294876	Green Published, hybrid			2022-12-25	WOS:000346077600029
J	Silva, DP; Vilela, B; De Marco, P; Nemesio, A				Silva, Daniel P.; Vilela, Bruno; De Marco, Paulo, Jr.; Nemesio, Andre			Using Ecological Niche Models and Niche Analyses to Understand Speciation Patterns: The Case of Sister Neotropical Orchid Bees	PLOS ONE			English	Article							ATLANTIC FOREST; MOLECULAR PHYLOGENY; SOUTH-AMERICA; CONSERVATISM; HYMENOPTERA; APIDAE; AMAZONIA; CLIMATE; DISTRIBUTIONS; BIOGEOGRAPHY	The role of past connections between the two major South American forested biomes on current species distribution has been recognized a long time ago. Climatic oscillations that further separated these biomes have promoted parapatric speciation, in which many species had their continuous distribution split, giving rise to different but related species (i.e., different potential distributions and realized niche features). The distribution of many sister species of orchid bees follow this pattern. Here, using ecological niche models and niche analyses, we (1) tested the role of ecological niche differentiation on the divergence between sister orchid-bees (genera Eulaema and Eufriesea) from the Amazon and Atlantic forests, and (2) highlighted interesting areas for new surveys. Amazonian species occupied different realized niches than their Atlantic sister species. Conversely, species of sympatric but distantly related Eulaema bees occupied similar realized niches. Amazonian species had a wide potential distribution in South America, whereas Atlantic Forest species were more limited to the eastern coast of the continent. Additionally, we identified several areas in need of future surveys. Our results show that the realized niche of Atlantic-Amazonian sister species of orchid bees, which have been previously treated as allopatric populations of three species, had limited niche overlap and similarity. These findings agree with their current taxonomy, which treats each of those populations as distinct valid species.	[Silva, Daniel P.; Vilela, Bruno] Univ Fed Goias, Dept Ecol, ICB, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [De Marco, Paulo, Jr.] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Theory Metapopulat & Landscape Lab, Goiania, Go, Brazil; [Nemesio, Andre] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Uberlandia	Nemesio, A (corresponding author), Univ Fed Uberlandia, Inst Biol, Rua Ceara ,Campus Umuarama, Uberlandia, MG, Brazil.	andre.nemesio@gmail.com	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/M-7511-2013; , tuula/ABG-2051-2021; De Marco, Paulo/B-2209-2009; Vilela, Bruno/L-1594-2015; Nemésio, André/D-1920-2012; Silva, Daniel Paiva/F-8052-2010; Cortez, Celia/X-3247-2018	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/0000-0003-0108-3998; De Marco, Paulo/0000-0002-3628-6405; Vilela, Bruno/0000-0003-4072-0558; Silva, Daniel Paiva/0000-0002-2457-6245; Brenchley, Paul/0000-0003-1290-9919; Salo, Sirpa/0000-0002-4113-4000; Cortez, Celia/0000-0002-7857-1167; Salo, Tuula/0000-0001-6039-0088; Silva, Dilson/0000-0001-9726-2442	CNPq - Conselho Nacional deDesenvolvimento Cientifico; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior; CNPqgrants	CNPq - Conselho Nacional deDesenvolvimento Cientifico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPqgrants	DPS received a doctorate fellowship from CNPq - Conselho Nacional deDesenvolvimento Cientifico. BV received a doctorate fellowship from CAPES-Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior. PDMJ has been continuously supported by CNPqgrants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AJC, 2007, ZOOL J LINN SOC-LOND, V151, P511, DOI 10.1111/j.1096-3642.2007.00328.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brown K.S. Jr, 1987, Oxford Monographs on Biogeography, P66; Camara ID, 2003, STATE HOTS, P31; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; da Silva JMC., 1996, ORNITOL NEOTROP, V7, P1; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; de Vivo M, 2004, J BIOGEOGR, V31, P943, DOI 10.1111/j.1365-2699.2004.01068.x; de Vivo Mario, 1997, Journal of Comparative Biology, V2, P65; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; DRESSLER RL, 1979, BIOTROPICA, V11, P144, DOI 10.2307/2387794; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Faria LRR, 2012, ZOOLOGIA-CURITIBA, V29, P349, DOI 10.1590/S1984-46702012000400008; Faria LRR, 2011, REV BRAS ENTOMOL, V55, P35, DOI 10.1590/S0085-56262011000100007; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P172, DOI 10.1111/j.1752-4598.2010.00091.x; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Fouquet A, 2012, MOL PHYLOGENET EVOL, V62, P826, DOI 10.1016/j.ympev.2011.11.023; Google Inc, 2013, GOOGL EARTH VERS 7 0; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hinojosa-Diaz IA, 2012, ZOOKEYS, P63, DOI 10.3897/zookeys.221.3659; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lopez-Uribe MM, 2014, MOL ECOL, V23, P1874, DOI 10.1111/mec.12689; Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x; McInerny GJ, 2012, J BIOGEOGR, V39, P2112, DOI 10.1111/jbi.12031; McInerny GJ, 2012, J BIOGEOGR, V39, P2096, DOI 10.1111/jbi.12033; McInerny GJ, 2012, J BIOGEOGR, V39, P2103, DOI 10.1111/jbi.12032; Méio Beatriz B., 2003, Braz. J. Bot., V26, P437, DOI 10.1590/S0100-84042003000400002; Moure J.S., 2003, ACTA BIOL PARANAENSE, V29, P1; MOURE J.S., 2007, CATALOGUE BEES HYMEN, P214; Nemesio A, 2006, J BIOGEOGR, V33, P91, DOI 10.1111/j.1365-2699.2005.01370.x; Nemesio A, 2013, BRAZ J BIOL, V73, P367, DOI 10.1590/S1519-69842013000200017; Nemesio Andre, 2007, Lundiana, V8, P57; Nemesio A, 2012, ZOOTAXA, P35; Nemesio A, 2011, ZOOTAXA, P43, DOI 10.11646/zootaxa.3006.1.2; Nemesio A, 2011, ZOOTAXA, P12; Nemesio A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.2892.1.6; Nemesio A, 2010, ZOOTAXA, P51; Nemesio A, 2011, ZOOTAXA, P1; Nemesio A, 2009, ZOOTAXA, P1; Nemesio A, 2012, ZOOKEYS, P47, DOI 10.3897/zookeys.222.3382; Nemesio A, 2012, J INSECT CONSERV, V16, P745, DOI 10.1007/s10841-012-9459-2; Nemesio A, 2012, BIOSCI J, V28, P118; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Oliveira M.L, 2008, LUNDIANA, V8, P113; Oliveira Marcio Luiz de, 2006, Acta Amaz., V36, P121, DOI 10.1590/S0044-59672006000100015; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pineiro R, 2007, MOL ECOL, V16, P2155, DOI 10.1111/j.1365-294X.2007.03280.x; Prance, 1979, REV BRAS BOT, V2, P19; PRANCE G T, 1973, Acta Amazonica, V3, P5; R Core Team, 2021, R LANG ENV STAT COMP; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; RAW A, 1989, Revista Brasileira de Entomologia, V33, P103; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; REDFORD KH, 1986, BIOTROPICA, V18, P126, DOI 10.2307/2388755; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; ROUBIK DW, 2004, ORCHID BEES TROPICAL; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Silva DP, 2013, APIDOLOGIE, V44, P673, DOI 10.1007/s13592-013-0216-7; Silva JMC, 2003, ATLANTIC FOREST S AM, P43; Simpson GC, 1969, BIOGEOGRAPHY ECOLOGY, V1, P113; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; Tocchio LJ, 2015, ZOOL SCR, V44, P1, DOI 10.1111/zsc.12082; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wielstra B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046671; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; WILEY EO, 1981, PHYLOGENETICS THEORY	91	46	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113246	10.1371/journal.pone.0113246	http://dx.doi.org/10.1371/journal.pone.0113246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25295847	Green Submitted, gold, Green Published			2022-12-25	WOS:000345899700028
J	Chen, QQ; Wang, H; Schwender, H; Zhang, TS; Hetmanski, JB; Chou, YHW; Ye, XQ; Yeow, V; Chong, SS; Zhang, B; Jabs, EW; Parker, MM; Scott, AF; Beaty, TH				Chen, Qianqian; Wang, Hong; Schwender, Holger; Zhang, Tianxiao; Hetmanski, Jacqueline B.; Chou, Yah-Huei Wu; Ye, Xiaoqian; Yeow, Vincent; Chong, Samuel S.; Zhang, Bo; Jabs, Ethylin Wang; Parker, Margaret M.; Scott, Alan F.; Beaty, Terri H.			Joint Testing of Genotypic and Gene-Environment Interaction Identified Novel Association for BMP4 with Non-Syndromic CL/P in an Asian Population Using Data from an International Cleft Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANDIDATE GENES; RISK VARIANTS; LIP; PALATE; POLYMORPHISMS; LIP/PALATE; FAMILY; LOCUS; TDT	Background: Non-syndromic cleft lip with or without cleft palate (NSCL/P) is a common disorder with complex etiology. The Bone Morphogenetic Protein 4 gene (BMP4) has been considered a prime candidate gene with evidence accumulated from animal experimental studies, human linkage studies, as well as candidate gene association studies. The aim of the current study is to test for linkage and association between BMP4 and NSCL/P that could be missed in genome-wide association studies (GWAS) when genotypic (G) main effects alone were considered. Methodology/Principal Findings: We performed the analysis considering G and interactions with multiple maternal environmental exposures using additive conditional logistic regression models in 895 Asian and 681 European complete NSCL/P trios. Single nucleotide polymorphisms (SNPs) that passed the quality control criteria among 122 genotyped and 25 imputed single nucleotide variants in and around the gene were used in analysis. Selected maternal environmental exposures during 3 months prior to and through the first trimester of pregnancy included any personal tobacco smoking, any environmental tobacco smoke in home, work place or any nearby places, any alcohol consumption and any use of multivitamin supplements. A novel significant association held for rs7156227 among Asian NSCL/P and non-syndromic cleft lip and palate (NSCLP) trios after Bonferroni correction which was not seen when G main effects alone were considered in either allelic or genotypic transmission disequilibrium tests. Odds ratios for carrying one copy of the minor allele without maternal exposure to any of the four environmental exposures were 0.58 (95% CI = 0.44, 0.75) and 0.54 (95% CI = 0.40, 0.73) for Asian NSCL/P and NSCLP trios, respectively. The Bonferroni P values corrected for the total number of 117 tested SNPs were 0.0051 (asymptotic P = 4.39*10(-5)) and 0.0065 (asymptotic P = 5.54*10(-5)), accordingly. In European trios, no significant association was seen for any SNPs after Bonferroni corrections for the total number of 120 tested SNPs. Conclusions/Significance: Our findings add evidence from GWAS to support the role of BMP4 in susceptibility to NSCL/P originally identified in linkage and candidate gene association studies.	[Chen, Qianqian; Wang, Hong] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Chen, Qianqian; Wang, Hong] Minist Hlth, Key Lab Reprod Hlth, Beijing, Peoples R China; [Schwender, Holger] Univ Dusseldorf, Math Inst, Dusseldorf, Germany; [Zhang, Tianxiao] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Hetmanski, Jacqueline B.; Parker, Margaret M.; Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chou, Yah-Huei Wu] Chang Gung Mem Hosp, Dept Med Res, Taipei 10591, Taiwan; [Ye, Xiaoqian] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Yeow, Vincent] KK Womens & Childrens Hosp, Dept Plast Surg, Singapore, Singapore; [Chong, Samuel S.] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; [Zhang, Bo] Xi An Jiao Tong Univ, Dept Engn, Xian 710049, Peoples R China; [Jabs, Ethylin Wang] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Peking University; Heinrich Heine University Dusseldorf; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chang Gung Memorial Hospital; Icahn School of Medicine at Mount Sinai; KK Women's & Children's Hospital; National University of Singapore; Xi'an Jiaotong University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University	Wang, H (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	hwang2010@aliyun.com	Zhang, Tianshu/K-6837-2015; Chong, Samuel S./D-8098-2015	Jabs, Ethylin/0000-0001-8983-5466; Chong, Samuel S./0000-0002-1872-5937; Parker, PhD, Margaret/0000-0001-6368-5033	National Natural Science Foundation of China [81273164]; National Institute of Dental & Craniofacial Research [R21-DE-013707, R01-DE-014581]; Fogarty Institution [D43-TW006176]; FOGARTY INTERNATIONAL CENTER [D43TW006176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE013707] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Fogarty Institution; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the National Natural Science Foundation of China(No. 81273164, HW, http://www.nsfc.gov.cn/), the National Institute of Dental & Craniofacial Research (No. R21-DE-013707 and R01-DE-014581, THB, http://www.nidcr.nih.gov/), and Fogarty Institution (No. D43-TW006176, EWJ http://www.fic.nih.gov/Pages/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian AJ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-88; Antunes LS, 2013, CLEFT PALATE-CRAN J, V50, P633, DOI 10.1597/12-048; Araujo TK, 2012, PLAST SURG INT, V2012; Ashique AM, 2002, DEVELOPMENT, V129, P4647; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaty TH, 2013, HUM GENET, V132, P771, DOI 10.1007/s00439-013-1283-6; Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Butali A, 2011, CLEFT PALATE-CRAN J, V48, P646, DOI 10.1597/10-133; Chen QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035347; Cordell HJ, 2009, GENOMICS, V93, P5, DOI 10.1016/j.ygeno.2008.05.002; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Fallin D, 2002, GENET EPIDEMIOL, V23, P458, DOI 10.1002/gepi.10192; Fontoura C, 2012, EUR J ORAL SCI, V120, P553, DOI 10.1111/eos.12001; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lennon CJ, 2012, LARYNGOSCOPE, V122, P2082, DOI 10.1002/lary.23394; Lin JY, 2008, DNA CELL BIOL, V27, P601, DOI 10.1089/dna.2008.0777; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Marazita ML, 2012, ANNU REV GENOM HUM G, V13, P263, DOI 10.1146/annurev-genom-090711-163729; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Mostowska A, 2012, BIRTH DEFECTS RES A, V94, P42, DOI 10.1002/bdra.22862; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P250, DOI 10.1002/(SICI)1098-2272(1999)16:3<250::AID-GEPI2>3.0.CO;2-T; Schwender H, 2012, BIOMETRICS, V68, P766, DOI 10.1111/j.1541-0420.2011.01713.x; Shi M, 2007, AM J HUM GENET, V80, P76, DOI 10.1086/510518; Paiva KBS, 2010, ACTA HISTOCHEM, V112, P508, DOI 10.1016/j.acthis.2009.05.007; Suazo J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-163; Suazo J, 2010, DNA CELL BIOL, V29, P59, DOI 10.1089/dna.2009.0944; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Taghavi N, 2012, IRAN RED CRESCENT ME, V14, P25; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Wang H, 2013, CLEFT PALATE-CRAN J, V50, P96, DOI 10.1597/11-132; Zhang TX, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1717	43	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109038	10.1371/journal.pone.0109038	http://dx.doi.org/10.1371/journal.pone.0109038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303326	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400042
J	Tang, ZX; Li, M; Chen, L; Wang, YY; Ren, ZL; Fu, SL				Tang, Zongxiang; Li, Meng; Chen, Lei; Wang, Yangyang; Ren, Zhenglong; Fu, Shulan			New Types of Wheat Chromosomal Structural Variations NE in Derivatives of Wheat-Rye Hybrids	PLOS ONE			English	Article							TANDEM REPEATS; ADDITION LINES; HETEROCHROMATIN; TRANSLOCATIONS; REARRANGEMENTS; INSTABILITY; SEQUENCES; PATTERNS; SECALE	Background: Chromosomal rearrangements induced by wheat-rye hybridization is a very well investigated research topic. However, the structural alterations of wheat chromosomes in wheat-rye hybrids are seldom reported. Methodology/Principal Findings: Octoploid triticale lines were derived from common wheat Triticum. aestivum L. 'Mianyang11'xrye Seca le cereale L. 'Kustro'. Some progeny were obtained by the controlled backcrossing of triticale with 'Mianyang11' and common wheat T. aestivum L. 'Chuannong27' followed by self-fertilization. Fluorescence in situ hybridization (FISH) and genomic in situ hybridization (GISH) using Oligo-pSc119.2-1, Oligo-pTa535-1 and rye genomic DNA as probes were used to analyze the mitotic chromosomes of these progeny. Alterations of wheat chromosomes including 5A, 6A, 1B, 2B, 6B, 7B, 1D, 3D and 7D were observed. SAL arm carrying intercalary Oligo-pSc119.2-1, Oligo-pTa535-1 or both Oligo-pSc119.2-1 and Oligo-pTa535-1 signals, 6A5, 1BS and 1DL arms containing terminal Oligo-pSc119.2-1 signal, 6B5 and 3D5 arms without terminal Oligo-pSc119.2-1 signal, 785 without subtelomeric Oligo-pSc119.2-1 signal and 7DL with intercalary Oligo-pSc119.2-1 signal have been observed. However, these changed wheat chromosomes have not been detected in 'Mianyang11' and Chuannong 27. The altered 5A, 6A, 7B and 7D chromosomes in this study have not been reported and represent several new karyotype structures of common wheat chromosomes. Conclusions/Significance:These rearranged wheat chromosomes in the present study afford some new genetic variations for wheat breeding program and are valuable materials for studying the biological function of tandem repetitive DNA sequences.	[Tang, Zongxiang; Li, Meng; Chen, Lei; Wang, Yangyang; Ren, Zhenglong; Fu, Shulan] Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Fu, SL (corresponding author), Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China.	fushulan@sicau.edu.cn			National High Technology Research and Development Program ("863" Program) of China [2011AA100101, 2011AA100103]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program ("863" Program) of China (No. 2011AA100101; 2011AA100103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; Alkhimova OG, 2004, CHROMOSOMA, V113, P42, DOI 10.1007/s00412-004-0294-4; APPELS R, 1982, THEOR APPL GENET, V63, P235, DOI 10.1007/BF00304002; Badaeva ED, 2007, GENOME, V50, P907, DOI 10.1139/G07-072; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070483; Fu SL, 2013, J GENET GENOMICS, V40, P413, DOI 10.1016/j.jgg.2013.05.005; GUSTAFSON JP, 1983, CHROMOSOMA, V88, P293, DOI 10.1007/BF00292906; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Hao M, 2013, GENOME, V56, P303, DOI 10.1139/gen-2013-0049; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; KOTA RS, 1988, GENETICS, V120, P1085; LAPITAN NLV, 1984, THEOR APPL GENET, V68, P547, DOI 10.1007/BF00285012; MCCLINTOCK B, 1978, STADLER GENET S, V10, P25; REN ZL, 1990, PLANT BREEDING, V105, P257, DOI 10.1111/j.1439-0523.1990.tb01283.x; Salina EA, 2004, GENOME, V47, P860, DOI 10.1139/G04-044; Schneider A, 2003, PLANT BREEDING, V122, P396, DOI 10.1046/j.1439-0523.2003.00891.x; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P19466, DOI 10.1073/pnas.1319598110	24	27	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110282	10.1371/journal.pone.0110282	http://dx.doi.org/10.1371/journal.pone.0110282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302962	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400126
J	Zhen, Z; Liu, HT; Wang, N; Guo, LY; Meng, J; Ding, N; Wu, GL; Jiang, GM				Zhen, Zhen; Liu, Haitao; Wang, Na; Guo, Liyue; Meng, Jie; Ding, Na; Wu, Guanglei; Jiang, Gaoming			Effects of Manure Compost Application on Soil Microbial Community Diversity and Soil Microenvironments in a Temperate Cropland in China	PLOS ONE			English	Article							LONG-TERM APPLICATION; ORGANIC-MATTER; FUMIGATION-EXTRACTION; LAND MANAGEMENT; BIOMASS; FERTILIZER; DYNAMICS; RHIZOSPHERE; NITROGEN; RESIDUE	The long-term application of excessive chemical fertilizers has resulted in the degeneration of soil quality parameters such as soil microbial biomass, communities, and nutrient content, which in turn affects crop health, productivity, and soil sustainable productivity. The objective of this study was to develop a rapid and efficient solution for rehabilitating degraded cropland soils by precisely quantifying soil quality parameters through the application of manure compost and bacteria fertilizers or its combination during maize growth. We investigated dynamic impacts on soil microbial count, biomass, basal respiration, community structure diversity, and enzyme activity using six different treatments [no fertilizer (CK), N fertilizer (N), N fertilizer + bacterial fertilizer (NB), manure compost (M), manure compost + bacterial fertilizer (MB), and bacterial fertilizer (B)] in the plowed layer (0-20 cm) of potted soil during various maize growth stages in a temperate cropland of eastern China. Denaturing gradient electrophoresis (DGGE) fingerprinting analysis showed that the structure and composition of bacterial and fungi communities in the six fertilizer treatments varied at different levels. The Shannon index of bacterial and fungi communities displayed the highest value in the MB treatments and the lowest in the N treatment at the maize mature stage. Changes in soil microorganism community structure and diversity after different fertilizer treatments resulted in different microbial properties. Adding manure compost significantly increased the amount of cultivable microorganisms and microbial biomass, thus enhancing soil respiration and enzyme activities (p<0.01), whereas N treatment showed the opposite results (p<0.01). However, B and NB treatments minimally increased the amount of cultivable microorganisms and microbial biomass, with no obvious influence on community structure and soil enzymes. Our findings indicate that the application of manure compost plus bacterial fertilizers can immediately improve the microbial community structure and diversity of degraded cropland soils.	[Zhen, Zhen; Liu, Haitao; Guo, Liyue; Meng, Jie; Wu, Guanglei; Jiang, Gaoming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhen, Zhen] Guangdong Ocean Univ, Lab Crop, Zhanjiang, Peoples R China; [Zhen, Zhen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Na] Dev & Promot Ctr, Jinan, Peoples R China; [Ding, Na] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Guangdong Ocean University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Agricultural University	Jiang, GM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	jianggm@126.com	Wu, Guanglei/GXN-0325-2022	Wu, Guanglei/0000-0001-6145-3415	Chinese Academy of Sciences [KSZD-EW-Z-012-2]; State Key Laboratory of Vegetation and Environmental Change [2014ZDFX04]	Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Vegetation and Environmental Change	This research was jointly supported by the Key Strategic Project of the Chinese Academy of Sciences (No. KSZD-EW-Z-012-2) and State Key Laboratory of Vegetation and Environmental Change (2014ZDFX04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, ANN MICROBIOL, V57, P471, DOI 10.1007/BF03175343; Anderson J.P.E., 1982, METHODS SOIL ANAL 2, Vsecond, P831; Bending GD, 2002, SOIL BIOL BIOCHEM, V34, P1073, DOI 10.1016/S0038-0717(02)00040-8; Bhandari AL, 2002, SOIL SCI SOC AM J, V66, P162, DOI 10.2136/sssaj2002.0162; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chaudhry AN, 2009, ASIAN J CHEM, V21, P4997; Dijkstra FA, 2009, SOIL BIOL BIOCHEM, V41, P1080, DOI 10.1016/j.soilbio.2009.02.013; Dinesh R, 2010, BIORESOURCE TECHNOL, V101, P4697, DOI 10.1016/j.biortech.2010.01.108; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Ge Y, 2008, J SOIL SEDIMENT, V8, P43, DOI 10.1065/jss2008.01.270; Gregorich EG, 1996, SOIL SCI SOC AM J, V60, P472, DOI 10.2136/sssaj1996.03615995006000020019x; Guan S., 1986, SOIL ENZYME ITS RES, V1986, P274; Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z; Hedlund K, 2002, SOIL BIOL BIOCHEM, V34, P1299, DOI 10.1016/S0038-0717(02)00073-1; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; Hu JL, 2011, J SOIL SEDIMENT, V11, P271, DOI 10.1007/s11368-010-0308-1; Inselsbacher E, 2010, SOIL BIOL BIOCHEM, V42, P360, DOI 10.1016/j.soilbio.2009.11.019; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Kaur T, 2008, NUTR CYCL AGROECOSYS, V81, P59, DOI 10.1007/s10705-007-9152-0; Leita L, 1999, BIOL FERT SOILS, V28, P371, DOI 10.1007/s003740050506; Leite LFC, 2010, AUST J SOIL RES, V48, P258, DOI 10.1071/SR09122; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; McCaig AE, 2001, FEMS MICROBIOL ECOL, V35, P37, DOI 10.1111/j.1574-6941.2001.tb00786.x; Paul EA., 2006, SOIL MICROBIOLOGY EC, V3rd; Pengthamkeerati P, 2011, APPL SOIL ECOL, V48, P71, DOI 10.1016/j.apsoil.2011.01.005; Philippot L, 2011, GLOBAL CHANGE BIOL, V17, P1497, DOI 10.1111/j.1365-2486.2010.02334.x; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Stark CH, 2008, SOIL BIOL BIOCHEM, V40, P1352, DOI 10.1016/j.soilbio.2007.09.025; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; Wang WW, 2011, POL J ECOL, V59, P37; Wardle DA, 1999, SOIL BIOL BIOCHEM, V31, P1707, DOI 10.1016/S0038-0717(99)00090-5; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Xu G.H., 1986, HDB ANAL METHODS SOI; Zhang QC, 2012, APPL SOIL ECOL, V57, P1, DOI 10.1016/j.apsoil.2012.02.012	43	145	152	11	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108555	10.1371/journal.pone.0108555	http://dx.doi.org/10.1371/journal.pone.0108555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302996	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400016
J	Razali, FN; Ismail, A; Abidin, NZ; Shuib, AS				Razali, Faizan Naeem; Ismail, Amirah; Abidin, Nurhayati Zainal; Shuib, Adawiyah Suriza			Stimulatory Effects of Polysaccharide Fraction from Solanum nigrum on RAW 264.7 Murine Macrophage Cells	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; ANTITUMOR-ACTIVITY; NITRIC-OXIDE; IMMUNOMODULATION; ACTIVATION; PLANTS; INOS	The polysaccharide fraction from Solanum nigrum Linne has been shown to have antitumor activity by enhancing the CD4(+)/CD8(+) ratio of the T-lymphocyte subpopulation. In this study, we analyzed a polysaccharide extract of S. nigrum to determine its modulating effects on RAW 264.7 murine macrophage cells since macrophages play a key role in inducing both innate and adaptive immune responses. Crude polysaccharide was extracted from the stem of S. nigrum and subjected to ion-exchange chromatography to partially purify the extract. Five polysaccharide fractions were then subjected to a cytotoxicity assay and a nitric oxide production assay. To further analyze the ability of the fractionated polysaccharide extract to activate macrophages, the phagocytosis activity and cytokine production were also measured. The polysaccharide fractions were not cytotoxic, but all of the fractions induced nitric oxide in RAW 264.7 cells. Of the five fractions tested, SN-ppF3 was the least toxic and also induced the greatest amount of nitric oxide, which was comparable to the inducible nitric oxide synthase expression detected in the cell lysate. This fraction also significantly induced phagocytosis activity and stimulated the production of tumor necrosis factor-alpha and interleukin-6. Our study showed that fraction SN-ppF3 could classically activate macrophages. Macrophage induction may be the manner in which polysaccharides from S. nigrum are able to prevent tumor growth.	[Razali, Faizan Naeem; Ismail, Amirah; Abidin, Nurhayati Zainal; Shuib, Adawiyah Suriza] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Shuib, Adawiyah Suriza] Univ Malaya, Fac Med, Ctr Prote Res, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Shuib, AS (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	adawiyah@um.edu.my	SHUIB, ADAWIYAH SURIZA/B-8136-2010; ABIDIN, NURHAYATI ZAINAL/B-9429-2010; ISMAIL, AMIRAH/A-1801-2019	Shuib, Adawiyah Suriza/0000-0001-5525-2713; RAZALI, FAIZAN NAEEM/0000-0002-6458-6915	Ministry of Higher Education, Malaysia [FRGS FP001/2011A]; University Malaya Postgraduate Research Grant [PPP PG057-2012B]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); University Malaya Postgraduate Research Grant	This work was funded by the Ministry of Higher Education, Malaysia (FRGS FP001/2011A) and University Malaya Postgraduate Research Grant (PPP PG057-2012B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Soheimi SS, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-58; AKHTAR MS, 1989, J ETHNOPHARMACOL, V27, P163, DOI 10.1016/0378-8741(89)90088-3; Bae IY, 2013, FOOD RES INT, V51, P195, DOI 10.1016/j.foodres.2012.12.008; Batovska DI, 2008, NAT PROD RES, V22, P1237, DOI 10.1080/14786410701725865; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/732860; Cartea ME, 2011, MOLECULES, V16, P251, DOI 10.3390/molecules16010251; Chen HX, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P225, DOI 10.1016/B978-0-12-384937-3.00019-7; Chen JN, 2010, J AGR FOOD CHEM, V58, P12117, DOI 10.1021/jf103576r; Chen RZ, 2010, CARBOHYD POLYM, V80, P845, DOI 10.1016/j.carbpol.2009.12.042; Edmonds J.M., 1997, BLACK NIGHTSHADES SO, DOI DOI 10.1016/j.bcab.2020.101524; Fan YJ, 2011, AFR J PHARM PHARMACO, V5, P415, DOI 10.5897/AJPP11.089; Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Han SB, 2001, INT IMMUNOPHARMACOL, V1, P1969, DOI 10.1016/S1567-5769(01)00124-2; Heo KS, 2004, TOXICOL IN VITRO, V18, P755, DOI 10.1016/j.tiv.2004.03.003; Houghton RA, 1998, LAB HDB FRACTIONATIO; Hu K, 1999, PLANTA MED, V65, P35, DOI 10.1055/s-1999-13958; Jain R, 2011, ALTERN MED REV, V16, P78; Khoo LT, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/614273; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Lee CC, 2005, J ETHNOPHARMACOL, V100, P237, DOI 10.1016/j.jep.2005.01.064; Li JA, 2010, J ETHNOPHARMACOL, V129, P350, DOI 10.1016/j.jep.2010.03.033; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Park HY, 2012, FASEB J, V26, P323; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Shin KS, 1996, PROGR BIOTECHNOL, V14, P623, DOI 10.1016/S0921-0423(96)80295-4; SULTANA S, 1995, J ETHNOPHARMACOL, V45, P189, DOI 10.1016/0378-8741(94)01214-K; Sun X B, 1994, Phytomedicine, V1, P225, DOI 10.1016/S0944-7113(11)80069-3; Thakur M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq012; Xu HS, 2009, CARBOHYD POLYM, V78, P316, DOI 10.1016/j.carbpol.2009.04.007; Yu MY, 2009, EUR FOOD RES TECHNOL, V228, P477, DOI 10.1007/s00217-008-0955-2	35	26	27	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108988	10.1371/journal.pone.0108988	http://dx.doi.org/10.1371/journal.pone.0108988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299340	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200029
J	Watanabe, S; Amiya, E; Watanabe, M; Takata, M; Ozeki, A; Watanabe, A; Kawarasaki, S; Nakao, T; Hosoya, Y; Nagata, K; Nagai, R; Komuro, I				Watanabe, Shogo; Amiya, Eisuke; Watanabe, Masafumi; Takata, Munenori; Ozeki, Atsuko; Watanabe, Aya; Kawarasaki, Shuichi; Nakao, Tomoko; Hosoya, Yumiko; Nagata, Kohzo; Nagai, Ryozo; Komuro, Issei			Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation	PLOS ONE			English	Article							LASER-DOPPLER FLOWMETRY; SYNTHASE MESSENGER-RNA; NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; VASCULAR-RESISTANCE; PRIMARY PREVENTION; OSCILLATIONS; ARTERY; HUMANS; VASODILATION	Purpose: The physiological role of vasomotion, rhythmic oscillations in vascular tone or diameter, and its underlying mechanisms are unknown. We investigated the characteristics of brachial artery vasomotion in patients with ischemic heart disease (IHD). Methods: We performed a retrospective study of 37 patients with IHD. Endothelial function was assessed using flow-mediated dilation (FMD), and power spectral analysis of brachial artery diameter oscillations during FMD was performed. Frequency-domain components were calculated by integrating the power spectrums in three frequency bands (in ms(2)) using the MemCalc (GMS, Tokyo, Japan): very-low frequency (VLF), 0.003-0.04 Hz; low frequency (LF), 0.04-0.15 Hz; and high frequency (HF), 0.15-0.4 Hz. Total spectral power (TP) was calculated as the sum of all frequency bands, and each spectral component was normalized against TP. Results: Data revealed that HF/TP closely correlated with FMD (r = -0.33, p = 0.04), whereas VLF/TP and LF/TP did not. We also explored the relationship between elevated C-reactive protein (CRP) levels and vasomotion. HF/TP was significantly increased in subjects with high CRP levels (CRP;>0.08 mg/dL) compared with subjects with low CRP levels (0.052 +/- 0.026 versus 0.035 +/- 0.022, p<0.05). The HF/TP value closely correlated with CRP (r = 0.24, p = 0.04), whereas the value of FMD did not (r = 0.023, p = 0.84). In addition, elevated CRP levels significantly increased the value of HF/TP after adjustment for FMD and blood pressure (beta = 0.33, p<0.05). Conclusion: The HF component of brachial artery diameter oscillation during FMD measurement correlated well with FMD and increased in the presence of elevated CRP levels in subjects with IHD.	[Watanabe, Shogo; Amiya, Eisuke; Watanabe, Masafumi; Takata, Munenori; Ozeki, Atsuko; Watanabe, Aya; Kawarasaki, Shuichi; Nakao, Tomoko; Hosoya, Yumiko; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Watanabe, Shogo; Nagata, Kohzo] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan; [Nagai, Ryozo] Jichi Med Sch, Mibu, Tochigi, Japan	University of Tokyo; Nagoya University; Jichi Medical University	Amiya, E (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	amiyae-tky@umin.ac.jp	Amiya, Eisuke/O-4981-2019	Amiya, Eisuke/0000-0003-2810-8040	Japan Society for the Promotion of Science; Fukuda Foundation for Medical Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23790837]; Grants-in-Aid for Scientific Research [26860545] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukuda Foundation for Medical Technology(Fukuda Foundation for Medical Technology); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology program, research grants from the Fukuda Foundation for Medical Technology (to E.A.), and Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid 23790837 (to E.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi L, 1997, CARDIOVASC RES, V34, P185, DOI 10.1016/S0008-6363(97)00017-5; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Cary TW, 2014, MED PHYS, V41, DOI 10.1118/1.4862508; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; DIEHL RR, 1991, NEUROSCI LETT, V127, P5, DOI 10.1016/0304-3940(91)90880-3; FUNK W, 1983, INT J MICROCIRC, V2, P11; Gupta NK, 2012, J AM COLL CARDIOL, V60, P1148, DOI 10.1016/j.jacc.2012.04.050; HAYOZ D, 1993, AM J PHYSIOL, V264, pH2080, DOI 10.1152/ajpheart.1993.264.6.H2080; KASTRUP J, 1989, INT J MICROCIRC, V8, P205; Kvandal P, 2003, MICROVASC RES, V65, P160, DOI 10.1016/S0026-2862(03)00006-2; Kvernmo HD, 1999, MICROVASC RES, V57, P298, DOI 10.1006/mvre.1998.2139; Lamboley M, 2003, AM J PHYSIOL-HEART C, V285, pH562, DOI 10.1152/ajpheart.00526.2002; Mauban JRH, 2001, AM J PHYSIOL-HEART C, V280, pH2399, DOI 10.1152/ajpheart.2001.280.5.H2399; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Meyer C, 2002, J APPL PHYSIOL, V92, P888, DOI 10.1152/jappl.2002.92.2.888; Meyer MF, 2003, MICROVASC RES, V65, P88, DOI 10.1016/S0026-2862(02)00015-8; MOHAMED F, 1995, ARTERIOSCL THROM VAS, V15, P52, DOI 10.1161/01.ATV.15.1.52; Pasceri V, 2000, CIRCULATION, V102, P2165; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Podgoreanu MV, 2002, ANESTHESIOLOGY, V97, P1110, DOI 10.1097/00000542-200211000-00012; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Sathish V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023662; Schindler TH, 2004, CIRCULATION, V110, P1069, DOI 10.1161/01.CIR.0000140264.56496.76; Soderstrom T, 2003, AM J PHYSIOL-HEART C, V284, pH1638, DOI 10.1152/ajpheart.00826.2000; Verma S, 2004, EUR HEART J, V25, P1754, DOI 10.1016/j.ehj.2004.06.039; Watanabe S, 2013, CIRC J, V77, P1018, DOI 10.1253/circj.CJ-12-1043; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110013	10.1371/journal.pone.0110013	http://dx.doi.org/10.1371/journal.pone.0110013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299643	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200096
J	Wensink, MJ; Wrycza, TF; Baudisch, A				Wensink, Maarten J.; Wrycza, Tomasz F.; Baudisch, Annette			Interaction Mortality: Senescence May Have Evolved because It Increases Lifespan	PLOS ONE			English	Article							EVOLUTION; AGE; RATES	Given an extrinsic challenge, an organism may die or not depending on how the threat interacts with the organism's physiological state. To date, such interaction mortality has been only a minor factor in theoretical modeling of senescence. We describe a model of interaction mortality that does not involve specific functions, making only modest assumptions. Our model distinguishes explicitly between the physiological state of an organism and potential extrinsic, age-independent threats. The resulting mortality may change with age, depending on whether the organism's state changes with age. We find that depending on the physiological constraints, any outcome, be it 'no senescence' or 'high rate of senescence', can be found in any environment; that the highest optimal rate of senescence emerges for an intermediate physiological constraint, i.e. intermediate strength of trade-off; and that the optimal rate of senescence as a function of the environment is driven by the way the environment changes the effect of the organism's state on mortality. We conclude that knowledge about the environment, physiology and their interaction is necessary before reasonable predictions about the evolution of senescence can be made.	[Wensink, Maarten J.; Wrycza, Tomasz F.; Baudisch, Annette] Max Planck Inst Demog Res, Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany; [Wensink, Maarten J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Baudisch, Annette] Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark	Max Planck Society; University of Southern Denmark	Wensink, MJ (corresponding author), Max Planck Inst Demog Res, Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany.	wensink@demogr.mpg.de	Andersen, Mette Adalheidur/D-5608-2017; Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X				ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; ARTHUR WB, 1984, DEMOGRAPHY, V21, P109, DOI 10.2307/2061031; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Baudisch A, 2012, GERONTOLOGY, V58, P481, DOI 10.1159/000341861; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Bonsall MB, 2006, PHILOS T R SOC B, V361, P119, DOI 10.1098/rstb.2005.1738; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Chen HY, 2012, CURR BIOL, V22, P2140, DOI 10.1016/j.cub.2012.09.021; Drenos F, 2005, MECH AGEING DEV, V126, P99, DOI 10.1016/j.mad.2004.09.026; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Lenart A, 2014, SCAND ACTUAR J, V2014, P255, DOI 10.1080/03461238.2012.687697; Lotka AJ, 1924, ELEMENTS MATH BIOL; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Medawar P., 1952, UNSOLVED PROBLEM BIO; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Moorad JA, 2010, CURR BIOL, V20, pR406, DOI 10.1016/j.cub.2010.03.016; Rozing MP, 2008, AGING CELL, V7, P924, DOI 10.1111/j.1474-9726.2008.00437.x; Sozou PD, 2004, P ROY SOC B-BIOL SCI, V271, P457, DOI 10.1098/rspb.2003.2614; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Wensink M, 2014, ECOL EVOL, V4, P1924, DOI 10.1002/ece3.1074; Wensink M, 2013, BIOGERONTOLOGY, V14, P99, DOI 10.1007/s10522-012-9410-7; Wensink MJ, 2014, J THEOR BIOL, V347, P176, DOI 10.1016/j.jtbi.2013.11.016; Wensink MJ, 2012, BIOGERONTOLOGY, V13, P197, DOI 10.1007/s10522-011-9362-3; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2003, EVOLUTION, V57, P1478	32	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109638	10.1371/journal.pone.0109638	http://dx.doi.org/10.1371/journal.pone.0109638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299047	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200066
J	Yang, H; Wang, B; Wang, T; Xu, LJ; He, CY; Wen, HY; Yan, J; Su, HH; Zhu, XM				Yang, Huan; Wang, Bo; Wang, Tao; Xu, Longjiang; He, Chunyan; Wen, Huiyan; Yan, Jie; Su, Honghong; Zhu, Xueming			Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis	PLOS ONE			English	Article							DENDRITIC CELLS; EXPRESSION; TLR4; ACTIVATION; CARCINOMA; TUMOR; RECOGNITION; INVOLVEMENT; SURVIVAL; INVASION	Toll-like receptor (TLR)4-mediated signaling has been implicated in tumor cell invasion, survival, and metastasis in a variety of cancers. This study investigated the expression and biological role of TLR4 in human breast cancer metastasis. MCF-7 and MDA-MB-231 are human breast cancer cell lines with low and high metastatic potential, respectively. Using lipopolysaccharide (LPS) to stimulate MCF-7 and MDA-MB-231 cells, expression of TLR4 mRNA and protein increased compared with that in control cells. TLR4 activation notably up-regulated expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor(VEGF) mRNA and their secretion in the supernatants of both cell lines. LPS enhanced invasion of MDA-MB-231 cells by transwell assay and MCF-7 cells by wound healing assay. LPS triggered increased expression of TLR4 downstream signaling pathway protein myeloid differentiation factor 88(MyD88) and resulted in interleukin (IL)-6 and IL-10 higher production by human breast cancer cells. Stimulation of TLR4 with LPS promoted tumorigenesis and formed metastatic lesions in liver of nude mice. Moreover, expression of TLR4 and MyD88 as well as invasiveness and migration of the cells could be blocked by TLR4 antagonist. Combined with clinicopathological parameters, TLR4 was overexpressed in human breast cancer tissue and correlated with lymph node metastasis. These findings indicated that TLR4 may participate in the progression and metastasis of human breast cancer and provide a new therapeutic target.	[Yang, Huan; Wang, Tao; He, Chunyan; Wen, Huiyan; Yan, Jie; Su, Honghong; Zhu, Xueming] Soochow Univ, Affiliated Hosp 2, Dept Clin Lab, Suzhou, Jiangsu, Peoples R China; [Wang, Bo] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Jiangsu, Peoples R China; [Xu, Longjiang] Soochow Univ, Affiliated Hosp 2, Dept Pathol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhu, XM (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Clin Lab, Suzhou, Jiangsu, Peoples R China.	zjyhcherry@126.com			Natural Science Foundation of the Jiangsu Province [BK2012609]; Foundation of Academic Excellent Member of the Second affiliated Hospital of Soochow University	Natural Science Foundation of the Jiangsu Province(Natural Science Foundation of Jiangsu Province); Foundation of Academic Excellent Member of the Second affiliated Hospital of Soochow University	This work was supported by the Natural Science Foundation of the Jiangsu Province, grant no. BK2012609, and the Foundation of Academic Excellent Member of the Second affiliated Hospital of Soochow University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, ANN SURG ONCOL, V1, P1; Ahmed A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22945; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Binns C, 2013, ASIA-PAC J PUBLIC HE, V25, P364, DOI 10.1177/1010539513505050; Di Domenico M, 2011, J BIOMED BIOTECHNOL, V2011; Ehsan N, 2013, TUMOR BIOL, V34, P1053, DOI 10.1007/s13277-013-0645-y; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hua D, 2009, MOL IMMUNOL, V46, P2876, DOI 10.1016/j.molimm.2009.06.016; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim SH, 2006, J SURG ONCOL, V93, P330, DOI 10.1002/jso.20461; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Petricevic B, 2012, MED ONCOL, V29, P486, DOI 10.1007/s12032-011-9885-0; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wang G, 2013, CANCER BIOMARK, V13, P21, DOI 10.3233/CBM-130332; Wang L., 2012, CANCER, V119, P782; Wang SQ, 2006, BLOOD, V107, P2432, DOI 10.1182/blood-2005-06-2486; Wang XX, 2013, ASIAN PAC J CANCER P, V14, P2295, DOI 10.7314/APJCP.2013.14.4.2295; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Zhang JJ, 2010, WORLD J GASTROENTERO, V16, P2881, DOI 10.3748/wjg.v16.i23.2881; Zuo YF, 2006, BIOCHEM BIOPH RES CO, V351, P361, DOI 10.1016/j.bbrc.2006.10.043	34	94	99	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109980	10.1371/journal.pone.0109980	http://dx.doi.org/10.1371/journal.pone.0109980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299052	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200090
J	Bandyopadhyay, S; Long, ME; Allent, LAH				Bandyopadhyay, Sarmistha; Long, Matthew E.; Allent, Lee-Ann H.			Differential Expression of microRNAs in Francisella tularensis-Infected Human Macrophages: miR-155-Dependent Downregulation of MyD88 Inhibits the Inflammatory Response	PLOS ONE			English	Article							LIVE VACCINE STRAIN; IN-VIVO; HELICOBACTER-PYLORI; DEPENDENT INDUCTION; MURINE MACROPHAGES; SIGNALING PATHWAYS; RESPIRATORY BURST; CYTOKINE RESPONSE; HUMAN NEUTROPHILS; IMMUNE-RESPONSE	Francisella tularensis is a Gram-negative, facultative intracellular pathogen that replicates in the cytosol of macrophages and is the causative agent of the potentially fatal disease tularemia. A characteristic feature of F. tularensis is its limited proinflammatory capacity, but the mechanisms that underlie the diminished host response to this organism are only partially defined. Recently, microRNAs have emerged as important regulators of immunity and inflammation. In the present study we investigated the microRNA response of primary human monocyte-derived macrophages (MDMs) to F. tularensis and identified 10 microRNAs that were significantly differentially expressed after infection with the live vaccine strain (LVS), as judged by Taqman Low Density Array profiling. Among the microRNAs identified, miR-155 is of particular interest as its established direct targets include components of the Toll-like receptor (TLR) pathway, which is essential for innate defense and proinflammatory cytokine production. Additional studies demonstrated that miR-155 acted by translational repression to downregulate the TLR adapter protein MyD88 and the inositol 5'-phosphatase SHIP-1 in MDMs infected with F. tularensis LVS or the fully virulent strain Schu S4. Kinetic analyses indicated that miR-155 increased progressively 3-18 hours after infection with LVS or Schu S4, and target proteins disappeared after 1218 hours. Dynamic modulation of MyD88 and SHIP-1 was confirmed using specific pre-miRs and anti-miRs to increase and decrease miR-155 levels, respectively. Of note, miR-155 did not contribute to the attenuated cytokine response triggered by F. tularensis phagocytosis. Instead, this microRNA was required for the ability of LVS-infected cells to inhibit endotoxin-stimulated TNF alpha secretion 1824 hours after infection. Thus, our data are consistent with the ability of miR-155 to act as a global negative regulator of the inflammatory response in F. tularensis-infected human macrophages.	[Bandyopadhyay, Sarmistha; Long, Matthew E.; Allent, Lee-Ann H.] Univ Iowa, Inflammat Program, Coralville, IA 52241 USA; [Bandyopadhyay, Sarmistha; Allent, Lee-Ann H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Long, Matthew E.; Allent, Lee-Ann H.] Univ Iowa, Grad Training Program Mol & Cellular Biol, Iowa City, IA USA; [Allent, Lee-Ann H.] Vet Adm Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Allent, LAH (corresponding author), Univ Iowa, Inflammat Program, Coralville, IA 52241 USA.	lee-ann-allen@uiowa.edu		Allen, Lee-Ann/0000-0001-8929-6968; Long, Matthew/0000-0003-4485-019X	National Institutes of Health; National Institute of Allergy and Infectious Diseases [P01 AI044642, U54 AI057160]; Veteran's Administration (Veteran's Administration Merit Review) [I01 BX002108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, U54AI057160] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veteran's Administration (Veteran's Administration Merit Review); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by funds from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grants P01 AI044642 and U54 AI057160), and the Veteran's Administration (Veteran's Administration Merit Review grant I01 BX002108) all awarded to LAHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J INFECT DIS, V187, pS356, DOI 10.1086/374749; Allen LAH, 2005, J LEUKOCYTE BIOL, V78, P220, DOI 10.1189/jlb.0205091; Allen LAH, 2013, J LEUKOCYTE BIOL, V93, P641, DOI 10.1189/jlb.1212661; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barker JH, 2006, INFECT IMMUN, V74, P3277, DOI 10.1128/IAI.02011-05; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Cao JZ, 2013, CANCER RES, V73, P3326, DOI 10.1158/0008-5472.CAN-12-3055; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Crane DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033349; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dai SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003114; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; GREISMAN SE, 1963, J CLIN INVEST, V42, P1064, DOI 10.1172/JCI104792; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Kunkeaw N, 2013, ONCOGENE, V32, P3722, DOI 10.1038/onc.2012.382; Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#; Likhite Neah, 2011, J Biomol Tech, V22, P37; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long ME, 2013, INFECT IMMUN, V81, P850, DOI 10.1128/IAI.00822-12; Loof TG, 2010, AM J PATHOL, V176, P754, DOI 10.2353/ajpath.2010.090422; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McCaffrey RL, 2010, J LEUKOCYTE BIOL, V88, P791, DOI 10.1189/jlb.1209811; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062232; Quinn EM, 2012, J LEUKOCYTE BIOL, V91, P721, DOI 10.1189/jlb.1111571; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Russo BC, 2013, AM J PATHOL, V183, P1223, DOI 10.1016/j.ajpath.2013.06.013; Schnitger AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027435; Scholz G, 2000, J BIOL CHEM, V275, P14615, DOI 10.1074/jbc.275.19.14615; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Schwartz JT, 2012, J IMMUNOL, V189, P3064, DOI 10.4049/jimmunol.1200816; Schwartz JT, 2012, J IMMUNOL, V188, P3351, DOI 10.4049/jimmunol.1102863; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058513; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thompson RC, 2011, J BIOL CHEM, V286, P1675, DOI 10.1074/jbc.M110.177063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	81	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109525	10.1371/journal.pone.0109525	http://dx.doi.org/10.1371/journal.pone.0109525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295729	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000077
J	Dembek, KA; Hurcombe, SD; Frazer, ML; Morresey, PR; Toribio, RE				Dembek, Katarzyna A.; Hurcombe, Samuel D.; Frazer, Michele L.; Morresey, Peter R.; Toribio, Ramiro E.			Development of a Likelihood of Survival Scoring System for Hospitalized Equine Neonates Using Generalized Boosted Regression Modeling	PLOS ONE			English	Article							LACTATE CONCENTRATION; PERIPHERAL PERFUSION; FOALS; SEVERITY; SEPSIS; ASSOCIATION; PROGNOSIS	Background: Medical management of critically ill equine neonates (foals) can be expensive and labor intensive. Predicting the odds of foal survival using clinical information could facilitate the decision-making process for owners and clinicians. Numerous prognostic indicators and mathematical models to predict outcome in foals have been published; however, a validated scoring method to predict survival in sick foals has not been reported. The goal of this study was to develop and validate a scoring system that can be used by clinicians to predict likelihood of survival of equine neonates based on clinical data obtained on admission. Methods and Results: Data from 339 hospitalized foals of less than four days of age admitted to three equine hospitals were included to develop the model. Thirty seven variables including historical information, physical examination and laboratory findings were analyzed by generalized boosted regression modeling (GBM) to determine which ones would be included in the survival score. Of these, six variables were retained in the final model. The weight for each variable was calculated using a generalized linear model and the probability of survival for each total score was determined. The highest (7) and the lowest (0) scores represented 97% and 3% probability of survival, respectively. Accuracy of this survival score was validated in a prospective study on data from 283 hospitalized foals from the same three hospitals. Sensitivity, specificity, positive and negative predictive values for the survival score in the prospective population were 96%, 71%, 91%, and 85%, respectively. Conclusions: The survival score developed in our study was validated in a large number of foals with a wide range of diseases and can be easily implemented using data available in most equine hospitals. GBM was a useful tool to develop the survival score. Further evaluations of this scoring system in field conditions are needed.	[Dembek, Katarzyna A.; Hurcombe, Samuel D.; Toribio, Ramiro E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Frazer, Michele L.] Hagyard Equine Med Inst, Lexington, KY USA; [Morresey, Peter R.] Rood & Riddle Equine Hosp, Lexington, KY USA	University System of Ohio; Ohio State University	Toribio, RE (corresponding author), Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.	toribio.1@osu.edu	Toribio, Ramiro/H-7838-2013	Toribio, Ramiro/0000-0002-9063-540X	Morris Animal Foundation [D14EQ-407]; Equine Research Funds at The Ohio State University; Grayson-Jockey Club Research Foundation	Morris Animal Foundation; Equine Research Funds at The Ohio State University; Grayson-Jockey Club Research Foundation	This work was supported by Morris Animal Foundation, Grant#: D14EQ-407, Equine Research Funds at The Ohio State University and Grayson-Jockey Club Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsnick RJIM, 2011, J VET INTERN MED, V25, P123, DOI 10.1111/j.1939-1676.2010.0636.x; Bouch C, 2008, CONTINUING ED ANAEST, V8, P181; Breiman L., 1983, CART CLASSIFICATION, P156; Breslow MJ, 2012, CHEST, V141, P245, DOI 10.1378/chest.11-0330; BREWER BD, 1988, EQUINE VET J, V20, P18, DOI 10.1111/j.2042-3306.1988.tb01445.x; Castagnetti C, 2010, THERIOGENOLOGY, V73, P343, DOI 10.1016/j.theriogenology.2009.09.018; Corley KTT, 2005, EQUINE VET J, V37, P53, DOI 10.2746/0425164054406856; Dembek KA, 2013, J VET INTERN MED, V27, P331, DOI 10.1111/jvim.12043; Dicken M, 2012, NEW ZEAL VET J, V60, P42, DOI 10.1080/00480169.2011.632340; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Furr M, 1997, J VET INTERN MED, V11, P183, DOI 10.1111/j.1939-1676.1997.tb00088.x; Gartman EJ, 2009, CURR OPIN CRIT CARE, V15, P578, DOI 10.1097/MCC.0b013e328332f50c; Gayle JM, 1998, J VET INTERN MED, V12, P140, DOI 10.1111/j.1939-1676.1998.tb02109.x; HOFFMAN AM, 1992, J VET INTERN MED, V6, P89, DOI 10.1111/j.1939-1676.1992.tb03157.x; Hurcombe SDA, 2008, J VET INTERN MED, V22, P639, DOI 10.1111/j.1939-1676.2008.0090.x; International Business Machines Corporation, 2012, IBM SPSS STAT 21, V21; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lima A, 2009, CRIT CARE MED, V37, P934, DOI 10.1097/CCM.0b013e31819869db; R Core Team, 2012, R LANG ENV STAT COMP; Rohrbach BW, 2006, JAVMA-J AM VET MED A, V228, P1748, DOI 10.2460/javma.228.11.1748; Roy MF, 2004, VET CLIN N AM-EQUINE, V20, P41, DOI 10.1016/j.cveq.2003.12.005; Sanchez LC, 2008, JAVMA-J AM VET MED A, V233, P1446, DOI 10.2460/javma.233.9.1446; Sanchez LC, 2005, VET CLIN N AM-EQUINE, V21, P273, DOI 10.1016/j.cveq.2005.04.007; Steel CM, 1999, J AM VET MED ASSOC, V215, P973; van Genderen ME, 2012, CURR OPIN CRIT CARE, V18, P273, DOI 10.1097/MCC.0b013e3283533924; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wotman K, 2009, J VET INTERN MED, V23, P598, DOI 10.1111/j.1939-1676.2009.0277.x	29	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109212	10.1371/journal.pone.0109212	http://dx.doi.org/10.1371/journal.pone.0109212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295600	gold, Green Submitted, Green Published			2022-12-25	WOS:000345204000048
J	McCormick, ME; Rojas, M; Moser-Katz, T; Tzima, E; Reader, JS				McCormick, Margaret E.; Rojas, Mauricio; Moser-Katz, Tyler; Tzima, Ellie; Reader, John S.			Natural Aminoacyl tRNA Synthetase Fragment Enhances Cardiac Function after Myocardial Infarction	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; HEART-FAILURE; PROGENITOR CELLS; IN-VIVO; ANGIOGENESIS; HYPERTROPHY; ACTIVATION; SURVIVAL	A naturally-occurring fragment of tyrosyl-tRNA synthetase (TyrRS) has been shown in higher eukaryotes to 'moonlight' as a pro-angiogenic cytokine in addition to its primary role in protein translation. Pro-angiogenic cytokines have previously been proposed to be promising therapeutic mechanisms for the treatment of myocardial infarction. Here, we show that systemic delivery of the natural fragment of TyRS, mini-TyrRS, improves heart function in mice after myocardial infarction. This improvement is associated with reduced formation of scar tissue, increased angiogenesis of cardiac capillaries, recruitment of c-kit(pos) cells and proliferation of myocardial fibroblasts. This work demonstrates that mini-TyrRS has beneficial effects on cardiac repair and regeneration and offers support for the notion that elucidation of the ever expanding repertoire of noncanonical functions of aminoacyl tRNA synthetases offers unique opportunities for development of novel therapeutics.	[McCormick, Margaret E.; Moser-Katz, Tyler; Tzima, Ellie; Reader, John S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Rojas, Mauricio; Tzima, Ellie] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Reader, JS (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	jreader@med.unc.edu	Tzima, Ellie/L-9256-2017; , Histology Research Core Facility/ABF-6317-2021; Ariel, Pablo/AGJ-4118-2022	Tzima, Ellie/0000-0002-3437-0902; 	UNC NC TraCS grant	UNC NC TraCS grant	This work was supported by a UNC NC TraCS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero F, 2011, CIRC RES, V109, P272, DOI 10.1161/CIRCRESAHA.111.240820; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bolli R, 2006, CIRCULATION, V114, P239; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cheng G, 2008, AM J PHYSL REGUL INT; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Depre C, 2005, TRENDS CARDIOVAS MED, V15, P101, DOI 10.1016/j.tcm.2005.04.006; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Greenberg Y, 2008, FASEB J, V22, P1597, DOI 10.1096/fj.07-9973com; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; House SL, 2005, AM J PHYSIOL-HEART C, V289, pH2167, DOI 10.1152/ajpheart.00392.2005; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Loughran JH, 2012, CURR ATHEROSCLER REP, V14, P491, DOI 10.1007/s11883-012-0273-9; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Shinde AV, 2013, J MOL CELL CARDIOL; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Smart N, 2013, VASC PHARMACOL, V58, P164, DOI 10.1016/j.vph.2012.08.001; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zeng R, 2011, HEART VESSELS, V26, P69, DOI 10.1007/s00380-010-0032-1; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013	44	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109325	10.1371/journal.pone.0109325	http://dx.doi.org/10.1371/journal.pone.0109325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296172	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000059
J	Tudor-Locke, C; Schuna, JM; Katzmarzyk, PT; Liu, W; Hamrick, KS; Johnson, WD				Tudor-Locke, Catrine; Schuna, John M., Jr.; Katzmarzyk, Peter T.; Liu, Wei; Hamrick, Karen S.; Johnson, William D.			Body Mass Index: Accounting for Full Time Sedentary Occupation and 24-Hr Self-Reported Time Use	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OBESITY; WEIGHT; OVERWEIGHT; VALIDITY; HEALTH; ACCELEROMETER; ADULTS	Objectives: We used linked existing data from the 2006-2008 American Time Use Survey (ATUS), the Current Population Survey (CPS, a federal survey that provides on-going U. S. vital statistics, including employment rates) and self-reported body mass index (BMI) to answer: How does BMI vary across full time occupations dichotomized as sedentary/non-sedentary, accounting for time spent in sleep, other sedentary behaviors, and light, moderate, and vigorous intensity activities? Methods: We classified time spent engaged at a primary job (sedentary or non-sedentary), sleep, and other non-work, non-sleep intensity-defined behaviors, specifically, sedentary behavior, light, moderate, and vigorous intensity activities. Age groups were defined by 20-29, 30-39, 40-49, and 50-64 years. BMI groups were defined by 18.5-24.9, 25.0-27.4, 27.5-29.9, 30.0-34.9, and >= 35.0 kg/m(2). Logistic and linear regression were used to examine the association between BMI and employment in a sedentary occupation, considering time spent in sleep, other non-work time spent in sedentary behaviors, and light, moderate, and vigorous intensity activities, sex, age race/ethnicity, and household income. Results: The analysis data set comprised 4,092 non-pregnant, non-underweight individuals 20-64 years of age who also reported working more than 7 hours at their primary jobs on their designated time use reporting day. Logistic and linear regression analyses failed to reveal any associations between BMI and the sedentary/non-sedentary occupation dichotomy considering time spent in sleep, other non-work time spent in sedentary behaviors, and light, moderate, and vigorous intensity activities, sex, age, race/ethnicity, and household income. Conclusions: We found no evidence of a relationship between self-reported full time sedentary occupation classification and BMI after accounting for sex, age, race/ethnicity, and household income and 24-hours of time use including non-work related physical activity and sedentary behaviors. The various sources of error associated with self-report methods and assignment of generalized activity and occupational intensity categories could compound to obscure any real relationships.	[Tudor-Locke, Catrine; Schuna, John M., Jr.; Katzmarzyk, Peter T.; Liu, Wei; Johnson, William D.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Hamrick, Karen S.] US Dept Agr Econ Res Serv, Washington, DC USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Tudor-Locke, C (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Tudor-Locke@pbrc.edu	Tudor-Locke, Catrine/AAC-2829-2021; Katzmarzyk, Peter T/N-1974-2017; Johnson, William/N-1972-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Johnson, William/0000-0002-3823-4094	USDA Economic Research Service [REE 58-4000-2-0082]; National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center [1 U54 GM104940]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	USDA Economic Research Service(United States Department of Agriculture (USDA)); National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided in part by 1) cooperative agreement REE 58-4000-2-0082 with USDA Economic Research Service, and 2) by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman-Farinelli MA, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-14; [Anonymous], 2008, PHYS ACT GUID REP; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Gillum RF, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-27; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Kaleta Dorota, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P9, DOI 10.2478/v10001-007-0009-1; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; Monda KL, 2008, EUR J CLIN NUTR, V62, P1318, DOI 10.1038/sj.ejcn.1602849; Mummery WK, 2005, AM J PREV MED, V29, P91, DOI 10.1016/j.amepre.2005.04.003; Ogden CL, 2010, NATL VITAL STAT REPO, V6, P1; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2011, J PHYS ACTIVITY HLTH, V8; Tudor-Locke C, 2011, J OCCUP ENVIRON MED, V53, P1382, DOI 10.1097/JOM.0b013e31823c1402; Tudor-Locke C, 2011, J PHYS ACT HEALTH, V8, P693, DOI 10.1123/jpah.8.5.693; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; van der Ploeg HP, 2010, AM J EPIDEMIOL, V172, P1199, DOI 10.1093/aje/kwq265; Van Domelen DR, 2011, AM J PREV MED, V41, P136, DOI 10.1016/j.amepre.2011.03.019; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Zick CD, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-84	22	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109051	10.1371/journal.pone.0109051	http://dx.doi.org/10.1371/journal.pone.0109051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295601	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000034
J	Arokium, H; Kamata, M; Kim, S; Kim, N; Liang, M; Presson, AP; Chen, IS				Arokium, Hubert; Kamata, Masakazu; Kim, Sanggu; Kim, Namshin; Liang, Min; Presson, Angela P.; Chen, Irvin S.			Deep Sequencing Reveals Low Incidence of Endogenous LINE-1 Retrotransposition in Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; SOMATIC RETROTRANSPOSITION; EPIGENETIC MEMORY; IPS CELLS; ELEMENT; LANDSCAPE; INSERTION	Long interspersed element-1 (LINE-1 or L1) retrotransposition induces insertional mutations that can result in diseases. It was recently shown that the copy number of L1 and other retroelements is stable in induced pluripotent stem cells (iPSCs). However, by using an engineered reporter construct over-expressing L1, another study suggests that reprogramming activates L1 mobility in iPSCs. Given the potential of human iPSCs in therapeutic applications, it is important to clarify whether these cells harbor somatic insertions resulting from endogenous L1 retrotransposition. Here, we verified L1 expression during and after reprogramming as well as potential somatic insertions driven by the most active human endogenous L1 subfamily (L1Hs). Our results indicate that L1 over-expression is initiated during the reprogramming process and is subsequently sustained in isolated clones. To detect potential somatic insertions in iPSCs caused by L1Hs retotransposition, we used a novel sequencing strategy. As opposed to conventional sequencing direction, we sequenced from the 3' end of L1Hs to the genomic DNA, thus enabling the direct detection of the polyA tail signature of retrotransposition for verification of true insertions. Deep coverage sequencing thus allowed us to detect seven potential somatic insertions with low read counts from two iPSC clones. Negative PCR amplification in parental cells, presence of a polyA tail and absence from seven L1 germline insertion databases highly suggested true somatic insertions in iPSCs. Furthermore, these insertions could not be detected in iPSCs by PCR, likely due to low abundance. We conclude that L1Hs retrotransposes at low levels in iPSCs and therefore warrants careful analyses for genotoxic effects.	[Arokium, Hubert; Kamata, Masakazu; Kim, Sanggu; Liang, Min; Chen, Irvin S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Presson, Angela P.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California Los Angeles	Chen, IS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017; Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Chen, Irvin/0000-0003-1199-2415; Kamata, Masakazu/0000-0003-0323-3742	UCLA AIDS Institute (UCLA CFAR) [5P30 AI028697]; National Research Foundation of Korea - MSIP of the Korea government [20110030770]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008019, PJ008068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL116234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	UCLA AIDS Institute (UCLA CFAR); National Research Foundation of Korea - MSIP of the Korea government; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the UCLA AIDS Institute (UCLA CFAR Grant 5P30 AI028697), the National Research Foundation of Korea (grant No. 20110030770 funded by the MSIP of the Korea government) and the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (grants No. PJ008019 & PJ008068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Boissinot S, 2005, CYTOGENET GENOME RES, V110, P402, DOI 10.1159/000084972; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kamata M, 2010, HUM GENE THER, V21, P1555, DOI 10.1089/hum.2010.050; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2010, NAT PROTOC, V5, P963, DOI 10.1038/nprot.2010.61	46	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108682	10.1371/journal.pone.0108682	http://dx.doi.org/10.1371/journal.pone.0108682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289675	Green Published, gold			2022-12-25	WOS:000342798000022
J	Yi, JJ; Huang, XY; Yang, YX; Zhu, WG; Gu, W; Luo, JY				Yi, Jingjie; Huang, Xiangyang; Yang, Yuxia; Zhu, Wei-Guo; Gu, Wei; Luo, Jianyuan			Regulation of Histone Acetyltransferase TIP60 Function by Histone Deacetylase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; DNA Damage; Histone Acetylase; Histone Deacetylase 3 (HDAC3); Ubiquitylation (Ubiquitination)	DNA-DAMAGE RESPONSE; TIP60-DEPENDENT ACETYLATION; AUTOACETYLATION; PROTEIN; APOPTOSIS; INTERACTS; RECEPTOR; COMPLEX; REPAIR; DOMAIN	Background: TIP60 can be regulated by autoacetylation and deacetylated by SIRT1. Results: Novel lysine residues of TIP60 autoacetylation were identified, and TIP60 can be functionally regulated by HDAC3 through deacetylation. Conclusion: HDAC3 promotes TIP60 ubiquitination and cytoplasmic localization and protects cells from apoptosis after DNA damage. Significance: Our findings provide a better understanding of TIP60 regulatory mechanisms and its cellular functions. The key member of the MOZ (monocyticleukaemia zinc finger protein), Ybf2/Sas3, Sas2, and TIP60 acetyltransferases family, Tat-interactive protein, 60 kD (TIP60), tightly modulates a wide array of cellular processes, including chromatin remodeling, gene transcription, apoptosis, DNA repair, and cell cycle arrest. The function of TIP60 can be regulated by SIRT1 through deacetylation. Here we found that TIP60 can also be functionally regulated by HDAC3. We identified six lysine residues as its autoacetylation sites. Mutagenesis of these lysines to arginines completely abolishes the autoacetylation of TIP60. Overexpression of HDAC3 increases TIP60 ubiquitination levels. However, unlike SIRT1, HDAC3 increased the half-life of TIP60. Further study found that HDAC3 colocalized with TIP60 both in the nucleus and the cytoplasm, which could be the reason why HDAC3 can stabilize TIP60. The deacetylation of TIP60 by both SIRT1 and HDAC3 reduces apoptosis induced by DNA damage. Knockdown of HDAC3 in cells increased TIP60 acetylation levels and increased apoptosis after DNA damage. Together, our findings provide a better understanding of TIP60 regulation mechanisms, which is a significant basis for further studies of its cellular functions.	[Yi, Jingjie] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Yi, Jingjie; Huang, Xiangyang; Luo, Jianyuan] Univ Maryland, Sch Med, Dept Med & Res Technol, Program Oncol,Marlene & Stewart Greenebaum Canc C, Baltimore, MD 21201 USA; [Yi, Jingjie; Huang, Xiangyang; Luo, Jianyuan] Univ Maryland, Sch Med, Dept Pathol, Program Oncol,Marlene & Stewart Greenebaum Canc C, Baltimore, MD 21201 USA; [Yang, Yuxia; Zhu, Wei-Guo; Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Huang, Xiangyang] Sichuan Univ, West China Sch Med, West China Hosp, Dept Rheumatol, Chengdu 610041, Sichuan, Peoples R China; [Gu, Wei] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Xiamen University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Peking University; Sichuan University; Columbia University; Columbia University	Luo, JY (corresponding author), Univ Maryland, Sch Med, Dept Med & Res Technol, AHB 405A,100 Penn St, Baltimore, MD 21201 USA.	JLuo@som.umaryland.edu	yang, yx/GZM-0464-2022; Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zhu, Wei-Guo/0000-0001-8385-6581	China Scholarship Council; National Basic Research Program of China [81072477]; Scientific and Technical Supporting Program of Sichuan Province [2011SZ0124]; NSFC [81321003]; NCI National Institutes of Health [5RO1CA172023, 5RO1 CA166294, 2P01CA080058]; NATIONAL CANCER INSTITUTE [R01CA166294, P01CA080058, R01CA172023] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Basic Research Program of China(National Basic Research Program of China); Scientific and Technical Supporting Program of Sichuan Province; NSFC(National Natural Science Foundation of China (NSFC)); NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Partially sponsored by the China Scholarship Council.; Partially supported by National Basic Research Program of China Grant 81072477 and Scientific and Technical Supporting Program of Sichuan Province Grant 2011SZ0124.; Partially supported by NSFC Grant 81321003.; Partially supported by NCI National Institutes of Health Grants 5RO1CA172023, 5RO1 CA166294, and 2P01CA080058.	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Arif M, 2007, J PHYS CHEM B, V111, P11877, DOI 10.1021/jp0762931; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Fischle W, 2009, NAT CELL BIOL, V11, P1279, DOI 10.1038/ncb1109-1279; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Lee MS, 2013, CELL DEATH DIFFER, V20, P620, DOI 10.1038/cdd.2012.159; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Sliva D, 1999, BIOCHEM BIOPH RES CO, V263, P149, DOI 10.1006/bbrc.1999.1083; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stiehl DP, 2007, CANCER RES, V67, P2256, DOI 10.1158/0008-5472.CAN-06-3985; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382	32	22	22	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33878	33886		10.1074/jbc.M114.575266	http://dx.doi.org/10.1074/jbc.M114.575266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301942	Green Published, hybrid			2022-12-25	WOS:000346077600018
J	Gabbai, CB; Yeeles, JTP; Marians, KJ				Gabbai, Carolina B.; Yeeles, Joseph T. P.; Marians, Kenneth J.			Replisome-mediated Translesion Synthesis and Leading Strand Template Lesion Skipping Are Competing Bypass Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-II; IRRADIATED ESCHERICHIA-COLI; STALLED REPLICATION FORKS; OKAZAKI FRAGMENT SIZE; POL-IV; LAGGING-STRAND; INDUCED-MUTAGENESIS; SLIDING-CLAMP; ERROR-PRONE; BETA-CLAMP	A number of different enzymatic pathways have evolved to ensure that DNA replication can proceed past template base damage. These pathways include lesion skipping by the replisome, replication fork regression followed by either correction of the damage and origin-independent replication restart or homologous recombination-mediated restart of replication downstream of the lesion, and bypass of the damage by a translesion synthesis DNA polymerase. We report here that of two translesion synthesis polymerases tested, only DNA polymerase IV, not DNA polymerase II, could engage productively with the Escherichia coli replisome to bypass leading strand template damage, despite the fact that both enzymes are shown to be interacting with the replicase. Inactivation of the 3' -> 5' proofreading exonuclease of DNA polymerase II did not enable bypass. Bypass by DNA polymerase IV required its ability to interact with the beta clamp and act as a translesion polymerase but did not require its "little finger" domain, a secondary region of interaction with the beta clamp. Bypass by DNA polymerase IV came at the expense of the inherent leading strand lesion skipping activity of the replisome, indicating that they are competing reactions.	[Gabbai, Carolina B.; Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu		Yeeles, Joseph/0000-0002-2255-2119	National Institutes of Health [GM34557]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034557, R01GM034557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34557 (to K. J. M.).	Banach-Orlowska M, 2005, MOL MICROBIOL, V58, P61, DOI 10.1111/j.1365-2958.2005.04805.x; Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; BONNER CA, 1992, J BIOL CHEM, V267, P11431; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Gawel D, 2008, J BACTERIOL, V190, P1730, DOI 10.1128/JB.01463-07; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; Gupta S, 2014, J BIOL CHEM, V289, P28376, DOI 10.1074/jbc.M114.587881; Gupta S, 2014, J BIOL CHEM, V289, P28388, DOI 10.1074/jbc.M114.587907; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Heltzel JMH, 2012, J BACTERIOL, V194, P3589, DOI 10.1128/JB.00520-12; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; HIASA H, 1994, J BIOL CHEM, V269, P6058; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Ikeda M, 2014, NUCLEIC ACIDS RES, V42, P8461, DOI 10.1093/nar/gku547; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Ippoliti Paul J, 2012, Cells, V1, P799, DOI 10.3390/cells1040799; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kath JE, 2014, P NATL ACAD SCI USA, V111, P7647, DOI 10.1073/pnas.1321076111; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kuban W, 2005, J BACTERIOL, V187, P6862, DOI 10.1128/JB.187.19.6862-6866.2005; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; PazElizur T, 1996, J BIOL CHEM, V271, P24662, DOI 10.1074/jbc.271.40.24662; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Rupp W.D., 1996, ESCHERICHIA COLI SAL, P2277; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wagner J, 2000, EMBO REP, V1, P484; Wagner J, 2009, MOL MICROBIOL, V74, P1143, DOI 10.1111/j.1365-2958.2009.06920.x; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; WICKNER W, 1973, P NATL ACAD SCI USA, V70, P1764, DOI 10.1073/pnas.70.6.1764; WU CA, 1992, J BIOL CHEM, V267, P4030; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	51	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.613257	http://dx.doi.org/10.1074/jbc.M114.613257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301949	hybrid, Green Published			2022-12-25	WOS:000345335000035
J	Cao, X; Irwin, DM; Liu, YH; Cheng, LG; Wang, L; Wang, GD; Zhang, YP				Cao, Xue; Irwin, David M.; Liu, Yan-Hu; Cheng, Lu-Guang; Wang, Lu; Wang, Guo-Dong; Zhang, Ya-Ping			Balancing Selection on CDH2 May Be Related to the Behavioral Features of the Belgian Malinois	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; BINDING-PROTEIN-BETA; HAPLOTYPE RECONSTRUCTION; VARIANTS; MUTATION; GENES; MODEL	The Belgian Malinois (BM) is an excellent working dog that typically shows a circling behavior when placed in a confined space. Moreover, individuals showing moderate running in circles (one kind of obsessive compulsive behavior) in confined spaces typically performance compared to those without the circling behavior or to those with a serious circling behavior (which can be defined as an obsessive compulsive disorder (OCD)). To determine whether the candidate gene CDH2, Cadherin , which is associated with OCD in the Doberman pinscher breed of dogs and in humans was linked with this behavioral character in the BM, population genetic analyses were performed on a BM population and a natural population of the Chinese indigenous dog (CID). Many genetic signals of balancing selection were detected for one specific region of the CDH2 gene, which suggests that a genomic block, which is included in the CDH2 gene, experienced balancing selection in the BM, and that the CDH2 gene might be associated with the behavioral characteristics of the BM dog la balance between circling behavior and work performance). Moreover one specific variant, G63913941A, which creates a predicted transcription factor-binding site, may be the key mutation in the CDH2 gene affecting the behavior of by allowing the binding of a transcription factor and increasing CDH2 expression.	[Cao, Xue; Irwin, David M.; Wang, Guo-Dong; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Cao, Xue; Irwin, David M.; Wang, Guo-Dong; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Animals, Kunming, Peoples R China; [Cao, Xue] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Liu, Yan-Hu; Wang, Lu] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Liu, Yan-Hu; Wang, Lu] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Cheng, Lu-Guang] Minist Publ Secur, Kunming Police Dog Base, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; Yunnan University; Yunnan University; Ministry of Public Security (China)	Wang, GD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	wanggd@mail.kiz.ac.cn; zhangyp@mail.kiz.ac.cn		Irwin, David/0000-0001-6131-4933	Natural Science Foundation of China [31201712]; 973 program [2013CB835200, 2013CB835202]; ministry of public security science and technology special project [2013YYCXKMJQ121]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); ministry of public security science and technology special project	This work was supported by grants from the Natural Science Foundation of China (31201712), the 973 program (2013CB835200 and 2013CB835202), and the ministry of public security science and technology special project 2013YYCXKMJQ121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Khiari HM, 2011, NEUROL SCI, V32, P959, DOI 10.1007/s10072-011-0480-0; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Moya PR, 2013, EUR J HUM GENET, V21, P850, DOI 10.1038/ejhg.2012.245; Overall KL, 2002, J AM VET MED ASSOC, V221, P1445, DOI 10.2460/javma.2002.221.1445; Quardokus E, 2000, SCIENCE, V288, P458, DOI 10.1126/science.288.5465.458; Reilly TJ, 2011, BEHAV BRAIN RES, V222, P375, DOI 10.1016/j.bbr.2011.04.003; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Strohmeyer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086617; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wang GD, 2014, ANNU REV ANIM BIOSCI, V2, P65, DOI 10.1146/annurev-animal-022513-114129; Wang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055469; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	29	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110075	10.1371/journal.pone.0110075	http://dx.doi.org/10.1371/journal.pone.0110075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303325	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400108
J	Chiu, CH; Wen, TH; Chien, LC; Yu, HL				Chiu, Chuan-Hung; Wen, Tzai-Hung; Chien, Lung-Chang; Yu, Hwa-Lung			A Probabilistic Spatial Dengue Fever Risk Assessment by a Threshold-Based-Quantile Regression Method	PLOS ONE			English	Article							SOCIOECONOMIC VULNERABILITY; AEDES-ALBOPICTUS; DISEASE; EPIDEMICS; MORTALITY; MOSQUITOS; DYNAMICS; PATTERNS; AEGYPTI; CALI	Understanding the spatial characteristics of dengue fever (DF) incidences is crucial for governmental agencies to implement effective disease control strategies. We investigated the associations between environmental and socioeconomic factors and DF geographic distribution, are proposed a probabilistic risk assessment approach that uses threshold-based quantile regression to identify the significant risk factors for DF transmission and estimate the spatial distribution of DF risk regarding full probability distributions. To interpret risk, return period was also included to characterize the frequency pattern of DF geographic occurrences. The study area included old Kaohsiung City and Fongshan District, two areas in Taiwan that have been affected by severe DF infections in recent decades. Results indicated that water-related facilities, including canals and ditches, and various types of residential area, as well as the interactions between them, were significant factors that elevated DF risk. By contrast, the increase of per capita income and its associated interactions with residential areas mitigated the DF risk in the study area. Nonlinear associations between these factors and DF risk were present in various quantiles, implying that water-related factors characterized the underlying spatial patterns of DF, and high-density residential areas indicated the potential for high DF incidence (e.g., clustered infections). The spatial distributions of DF risks were assessed in terms of three distinct map presentations: expected incidence rates, incidence rates in various return periods, and return periods at distinct incidence rates. These probability-based spatial risk maps exhibited distinct DF risks associated with environmental factors, expressed as various DF magnitudes and occurrence probabilities across Kaohsiung, and can serve as a reference for local governmental agencies.	[Chiu, Chuan-Hung; Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Wen, Tzai-Hung] Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan; [Chien, Lung-Chang] Univ Texas San Antonio, Div Biostat, Sch Publ Hlth, San Antonio, TX USA; [Chien, Lung-Chang] Univ Texas Hlth Sci Ctr San Antonio, Res Adv Community Hlth Ctr, San Antonio, TX 78229 USA	National Taiwan University; National Taiwan University; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Yu, HL (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	hlyu@ntu.edu.tw	Wen, Tzai-Hung/H-2635-2018	Wen, Tzai-Hung/0000-0002-9151-8336; Yu, Hwa Lung/0000-0001-9558-2100	Taiwan Ministry of Science and Technology [MOST 101-2628-E-002-017-MY3, MOST 102-2221-E-002-140-MY3]; Centers for Disease Control in Taiwan [DOH102-DC-1203]	Taiwan Ministry of Science and Technology; Centers for Disease Control in Taiwan	This study was supported by funds from Taiwan Ministry of Science and Technology (MOST 101-2628-E-002-017-MY3 and MOST 102-2221-E-002-140-MY3), and Centers for Disease Control in Taiwan (DOH102-DC-1203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Aldstadt J, 2007, STOCH ENV RES RISK A, V21, P487, DOI 10.1007/s00477-007-0132-3; Bari RA, 2003, PROBABILISTIC RISK A; Benjamin J., 1970, PROBABILITY STAT DEC; Bhandari KP, 2008, INT ARCH PHOTOGRAM R, V37, P165; Bhatt S, 2013, NATURE; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; Chang SF, 2012, J FORMOS MED ASSOC, V111, P297, DOI 10.1016/j.jfma.2011.12.001; Daniels MJ, 2000, AM J EPIDEMIOL, V152, P397, DOI 10.1093/aje/152.5.397; Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2; Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Hiscox A, 2013, AM J TROP MED HYG, V88, P1070, DOI 10.4269/ajtmh.12-0623; Kienberger S, 2013, GEOSPATIAL HEALTH, V8, P313, DOI 10.4081/gh.2013.76; Kim SY, 2004, ENVIRON RES, V94, P113, DOI 10.1016/j.envres.2003.09.006; Knerer G, 2013, HLTH CARE MANAGEMENT, P1; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 2013, PACKAGE QUANTREG; KOZLOWSKI J, 1985, EKISTICS, V52, P146; KOZLOWSKI J, 1988, LANDSCAPE URBAN PLAN, V15, P327, DOI 10.1016/0169-2046(88)90056-4; Kumamoto H, 1996, PROBABILISTIC RISK A, Vxvii; Lei HuanYao, 2002, Dengue Bulletin, V26, P14; Lifson AR, 1996, LANCET, V347, P1201, DOI 10.1016/S0140-6736(96)90730-8; Maidana NA, 2008, MATH BIOSCI, V215, P64, DOI 10.1016/j.mbs.2008.05.008; Mata J, 1996, EUR ECON REV, V40, P1305, DOI 10.1016/0014-2921(95)00034-8; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Montgomery D.C., 2012, INTRO LINEAR REGRESS, Vfifith; [National Land Surveying and Mapping Center National Land Surveying and Mapping Center], 2012, LAND US CLASS SYST D; [National Land Surveying and Mapping Center Center NLSaM], 2007, LAND INV TAIW; NLSC, 2013, LAND US INV TAIW; Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415; O'Hagan A, 2006, UNCERTAIN JUDGEMENTS, Vxiii; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Rotela C, 2007, ACTA TROP, V103, P1, DOI 10.1016/j.actatropica.2007.05.003; Saifur RGM, 2013, J AM MOSQUITO CONTR, V29, P33, DOI 10.2987/12-6228R.1; Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775; Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478; [Taiwan CDC Welfare MoHa], 2013, GOVT DATA TAIPEI; Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2; Tuan Y-C, 2009, TAIWAN EPIDEMIOLOGY, V25, P462; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; Vanwambeke SO, 2007, J MED ENTOMOL, V44, P133, DOI 10.1603/0022-2585(2007)44[133:LALCFI]2.0.CO;2; Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x; VESELY WE, 2011, PROBABILISTIC RISK A, P253; Wen TH, 2006, SCI TOTAL ENVIRON, V367, P631, DOI 10.1016/j.scitotenv.2006.02.009; Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019; WHO, 1997, DENG HAEM FEV DIAGN; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; Yu HL, 2011, STOCH ENV RES RISK A, V25, P485, DOI 10.1007/s00477-010-0417-9	58	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e106334	10.1371/journal.pone.0106334	http://dx.doi.org/10.1371/journal.pone.0106334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25302582	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400002
J	Holt, V; Caplan, AI; Haynesworth, SE				Holt, Vance; Caplan, Arnold I.; Haynesworth, Stephen E.			Identification of a Subpopulation of Marrow MSC-Derived Medullary Adipocytes That Express Osteoclast-Regulating Molecules: Marrow Adipocytes Express Osteoclast Mediators	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; ADIPOSE-TISSUE; IN-VITRO; CULTURED PREADIPOCYTES; ADIPOGENESIS PROGRAM; MONOCLONAL-ANTIBODY; OSTEOBLAST LINEAGE; RANKL EXPRESSION; PROGENITOR CELLS	Increased marrow medullary adipogenesis and an associated decrease in bone mineral density, usually observed in elderly individuals, is a common characteristic in senile osteoporosis. In this study we investigated whether cells of the medullary adipocyte lineage have the potential to directly support the formation of osteoclasts, whose activity in bone leads to bone degradation. An in vitro mesenchymal stem cell (MSC)-derived medullary adipocyte lineage culture model was used to study the expression of the important osteoclast mediators RANKL, M-CSF, SDF-1, and OPG. We further assessed whether adipocytes at a specific developmental stage were capable of supporting osteoclast-like cell formation in culture. In vitro MSC-derived medullary adipocytes showed an mRNA and protein expression profile of M-CSF, RANKL, and OPG that was dependent on its developmental/metabolic stage. Furthermore, RANKL expression was observed in MSC-derived adipocytes that were at a distinct lineage stage and these cells were also capable of supporting osteoclast-like cell formation in co-cultures with peripheral blood mononuclear cells. These results suggest a connection between medullary adipocytes and osteoclast formation in vivo and may have major significance in regards to the mechanisms of decreased bone density in senile osteoporosis.	[Holt, Vance; Caplan, Arnold I.; Haynesworth, Stephen E.] Case Western Reserve Univ, Coll Arts & Sci, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Holt, V (corresponding author), Case Western Reserve Univ, Coll Arts & Sci, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA.	vxh18@case.edu; seh5@case.edu		Caplan, Arnold/0000-0002-8677-6621	L. David and E. Virginia Baldwin Fund; National Institutes of Health - A Window into the Aging Process [R01 AG021542]; NATIONAL INSTITUTE ON AGING [R01AG021542] Funding Source: NIH RePORTER	L. David and E. Virginia Baldwin Fund; National Institutes of Health - A Window into the Aging Process; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from L. David and E. Virginia Baldwin Fund and the National Institutes of Health - A Window into the Aging Process, Grant number: R01 AG021542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Chowdhury A, 2011, PROSTAG OTH LIPID M, V95, P53, DOI 10.1016/j.prostaglandins.2011.06.002; Chu XQ, 2009, BBA-MOL CELL BIOL L, V1791, P273, DOI 10.1016/j.bbalip.2009.01.022; Cook A, 2009, STEMBOOK, P1; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; CRISTY M, 1981, PHYS MED BIOL, V26, P389, DOI 10.1088/0031-9155/26/3/003; DORHEIM MA, 1993, J CELL PHYSIOL, V154, P317, DOI 10.1002/jcp.1041540215; Fleming JE, 1998, DEV DYNAM, V212, P119, DOI 10.1002/(SICI)1097-0177(199805)212:1<119::AID-AJA11>3.3.CO;2-6; Gagnon A, 2004, HORM METAB RES, V36, P728, DOI 10.1055/s-2004-826023; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Goto H, 2011, BIOMED RES-TOKYO, V32, P37, DOI 10.2220/biomedres.32.37; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Higashio K, 2008, SOCIETY, V141, P3478; Hozumi A, 2009, BIOCHEM BIOPH RES CO, V382, P780, DOI 10.1016/j.bbrc.2009.03.111; HUDSON G, 1965, BRIT J HAEMATOL, V11, P446, DOI 10.1111/j.1365-2141.1965.tb06607.x; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kawai M, 2009, BONE, P216, DOI [10.1007/s12018-009-9050-x, DOI 10.1007/S12018-009-9050-X]; Kawai M, 2010, AM J PHYSIOL-ENDOC M, V299, pE3, DOI 10.1152/ajpendo.00157.2010; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2092, DOI 10.1210/en.139.4.2092; Kim JY, 2005, AM J PHYSIOL-ENDOC M, V288, P267, DOI [10.1152/ajpendo.00265.2004, DOI 10.1152/AJPENDO.00265.2004]; Kim S, 2000, J NUTR, V130, p3110S; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; Lin YF, 2008, CELL PROLIFERAT, V41, P803, DOI 10.1111/j.1365-2184.2008.00542.x; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Mackay DL, 2006, J CELL PHYSIOL, V207, P722, DOI 10.1002/jcp.20617; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Mori K, 2014, BIOMED RES-TOKYO, V35, P153, DOI 10.2220/biomedres.35.153; Motyl KJ, 2011, DISCOV MED, V11, P179; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pachon-Pena G, 2010, J CELL PHYSL, P843; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Riggs BL, 2009, SOCIETY, V141, P4768; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Sugihara H, 1987, CULTURE, V28; Sul HS, 2000, INT J OBESITY, V24, pS15, DOI 10.1038/sj.ijo.0801494; Takagi K, 2008, J BONE MINER METAB, V26, P13, DOI 10.1007/s00774-007-0787-3; Takeshita S, 2014, J BIOL CHEM, V289, P16699, DOI 10.1074/jbc.M114.547919; Tang W, 2008, SCIENCE, P30; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451; Travlos GS, 2006, TOXICOL PATHOL, V34, P566, DOI 10.1080/01926230600964706; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	72	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108920	10.1371/journal.pone.0108920	http://dx.doi.org/10.1371/journal.pone.0108920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302610	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400035
J	Korr, H; Angstman, NB; Born, TB; Bosse, K; Brauns, B; Demmler, M; Fueller, K; Kantor, O; Kever, BM; Rahimyar, N; Salimi, S; Silny, J; Schmitz, C				Korr, Hubert; Angstman, Nicholas B.; Born, Tatjana B.; Bosse, Kerstin; Brauns, Birka; Demmler, Martin; Fueller, Katja; Kantor, Orsolya; Kever, Barbara M.; Rahimyar, Navida; Salimi, Sepideh; Silny, Jiri; Schmitz, Christoph			No Evidence of Persisting Unrepaired Nuclear DNA Single Strand Breaks in Distinct Types of Cells in the Brain, Kidney, and Liver of Adult Mice after Continuous Eight-Week 50 Hz Magnetic Field Exposure with Flux Density of 0.1 mT or 1.0 mT	PLOS ONE			English	Article							GRAIN COUNT CORRECTIONS; THYMIDINE KINASE; NEURON LOSS; REPAIR; IRON; TRANSPORT; DAMAGE	Background: It has been hypothesized in the literature that exposure to extremely low frequency electromagnetic fields (50 or 60 Hz) may lead to human health effects such as childhood leukemia or brain tumors. In a previous study investigating multiple types of cells from brain and kidney of the mouse (Acta Neuropathologica 2004; 107: 257-264), we found increased unrepaired nuclear DNA single strand breaks (nDNA SSB) only in epithelial cells of the choroid plexus in the brain using autoradiographic methods after a continuous eight-week 50 Hz magnetic field (MF) exposure of adult mice with flux density of 1.5 mT. Methods: In the present study we tested the hypothesis that MF exposure with lower flux densities (0.1 mT, i.e., the actual exposure limit for the population in most European countries, and 1.0 mT) shows similar results to those in the previous study. Experiments and data analysis were carried out in a similar way as in our previous study. Results: Continuous eight-week 50 Hz MF exposure with 0.1 mT or 1.0 mT did not result in increased persisting unrepaired nDNA SSB in distinct types of cells in the brain, kidney, and liver of adult mice. MF exposure with 1.0 mT led to reduced unscheduled DNA synthesis (UDS) in epithelial cells in the choroid plexus of the fourth ventricle in the brain (EC-CP) and epithelial cells of the cortical collecting duct in the kidney, as well as to reduced mtDNA synthesis in neurons of the caudate nucleus in the brain and in EC-CP. Conclusion: No evidence was found for increased persisting unrepaired nDNA SSB in distinct types of cells in the brain, kidney, and liver of adult mice after continuous eight-week 50 Hz magnetic field exposure with flux density of 0.1 mT or 1.0 mT.	[Korr, Hubert; Born, Tatjana B.; Bosse, Kerstin; Brauns, Birka; Demmler, Martin; Fueller, Katja; Kantor, Orsolya; Kever, Barbara M.; Rahimyar, Navida; Schmitz, Christoph] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany; [Angstman, Nicholas B.; Schmitz, Christoph] Univ Munich, Dept Neuroanat, Munich, Germany; [Kantor, Orsolya] Semmelweis Univ, Dept Anat Histol & Embryol, H-1085 Budapest, Hungary; [Silny, Jiri] Rhein Westfal TH Aachen, Inst Occupat & Social Med, Femu, Aachen, Germany	RWTH Aachen University; University of Munich; Semmelweis University; RWTH Aachen University	Schmitz, C (corresponding author), Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany.	christoph_schmitz@med.uni-muenchen.de						Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0; BASSUKAS ID, 1987, CELL TISSUE KINET, V20, P527, DOI 10.1111/j.1365-2184.1987.tb01362.x; *BIOINITIATIVE WOR, 2012, BIOINITIATIVE REPORT; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; CAVANAGH JB, 1969, J ANAT, V104, P341; Decker M, 1994, THESIS; FEINENDEGEN LE, 1984, INT J RADIAT BIOL, V45, P205, DOI 10.1080/09553008414550301; FEINENDEGEN LE, 1985, INT J RADIAT BIOL, V47, P723, DOI 10.1080/09553008514550961; HENDERSON C, 1989, J HISTOTECHNOL, V12, P123; HOHNELKARIM K, 1990, INT J RADIAT BIOL, V58, P97, DOI 10.1080/09553009014551461; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Korr H, 1997, ACTA NEUROPATHOL, V94, P557, DOI 10.1007/s004010050750; KORR H, 1989, RADIAT ENVIRON BIOPH, V28, P13, DOI 10.1007/BF01209719; Korr H, 2001, INT J RADIAT BIOL, V77, P567, DOI 10.1080/09553000010028467; Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012; KORR H, 1981, TECHNIQUES NEUROANAT, P218; Lai H, 2004, ENVIRON HEALTH PERSP, V112, P687, DOI 10.1289/ehp.6355; Lai H, 1997, BIOELECTROMAGNETICS, V18, P156, DOI 10.1002/(SICI)1521-186X(1997)18:2<156::AID-BEM8>3.0.CO;2-1; Lai H, 1997, J PINEAL RES, V22, P152, DOI 10.1111/j.1600-079X.1997.tb00317.x; Martin IV, 2002, GENOME BIOL, V3; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; PERA F, 1975, BEITR PATHOL, V156, P145; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Schmitz C, 2004, ACTA NEUROPATHOL, V107, P257, DOI 10.1007/s00401-003-0799-6; Schmitz C, 1999, ACTA NEUROPATHOL, V97, P71, DOI 10.1007/s004010050957; Schmitz C, 1994, THESIS; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Smith Q, 1997, METALS OXIDATIVE DAM, P113; Stam R, 2011, COMPARISON OF INTERN; STILLSTR.J, 1965, INT J APPL RADIAT IS, V16, P357, DOI 10.1016/0020-708X(65)90019-0; STILLSTROM J, 1963, INT J APPL RADIAT IS, V14, P113, DOI 10.1016/0020-708X(63)90104-2; STUMPF WE, 1981, J HISTOCHEM CYTOCHEM, V29, P201, DOI 10.1177/29.1A_Suppl.7288156; WANG RY, 1995, INT J ONCOL, V6, P51; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109774	10.1371/journal.pone.0109774	http://dx.doi.org/10.1371/journal.pone.0109774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302592	Green Published, gold			2022-12-25	WOS:000343730400079
J	Sun, YQ; Tong, T; Cai, SJ; Bi, R; Xin, C; Gu, YJ				Sun, Yiqun; Tong, Tong; Cai, Sanjun; Bi, Rui; Xin, Chao; Gu, Yajia			Apparent Diffusion Coefficient (ADC) Value: A Potential Imaging Biomarker That Reflects the Biological Features of Rectal Cancer	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; PROGNOSTIC-FACTORS; WEIGHTED MRI; SURVIVAL; PREDICTION; EXPRESSION; TUMORS; STAGE; P53	Objective: We elected to analyze the correlation between the pre-treatment apparent diffusion coefficient (ADC) and the clinical, histological, and immunohistochemical status of rectal cancers. Materials and Methods: Forty-nine rectal cancer patients who received surgical resection without neoadjuvant therapy were selected that underwent primary MRI and diffusion-weighted imaging (DWI). Tumor ADC values were determined and analyzed to identify any correlations between these values and pre-treatment CEA or CA19-9 levels, and/or the histological and immunohistochemical properties of the tumor. Results: Inter-observer agreement of confidence levels from two separate observers was suitable for ADC measurement (k = 0.775). The pre-treatment ADC values of different T stage tumors were not equal (p = 0.003). The overall trend was that higher T stage values correlated with lower ADC values. ADC values were also significantly lower for the following conditions: tumors with the presence of extranodal tumor deposits (p = 0.006) and tumors with CA19-9 levels >= 35 g/ml (p = 0.006). There was a negative correlation between Ki-67 LI and the ADC value (r = -0.318, p = 0.026) and between the AgNOR count and the ADC value (r = -0.310, p = 0.030). Conclusion: Significant correlations were found between the pre-treatment ADC values and T stage, extranodal tumor deposits, CA19-9 levels, Ki-67 LI, and AgNOR counts in our study. Lower ADC values were associated with more aggressive tumor behavior. Therefore, the ADC value may represent a useful biomarker for assessing the biological features and possible relationship to the status of identified rectal cancers.	[Sun, Yiqun; Tong, Tong; Xin, Chao; Gu, Yajia] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Radiol,Dept Oncol, Shanghai 200433, Peoples R China; [Cai, Sanjun] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Colorectal Surg,Dept Oncol, Shanghai 200433, Peoples R China; [Bi, Rui] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Pathol,Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Gu, YJ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Radiol,Dept Oncol, Shanghai 200433, Peoples R China.	cjr.guyajia@vip.163.com			Shanghai Science and Technology planning fund [13140902103]; Shanghai Science and Technology guiding fund [124119a0201]; Shanghai Municipal Health Bureau Foundation for youths [20124y099]	Shanghai Science and Technology planning fund; Shanghai Science and Technology guiding fund; Shanghai Municipal Health Bureau Foundation for youths	This study was supported by grants from Shanghai Science and Technology planning fund (No. 13140902103); Shanghai Science and Technology guiding fund (No. 124119a0201); Shanghai Municipal Health Bureau Foundation for youths (No. 20124y099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae H, 2014, INT UROL NEPHROL, V46, P555, DOI 10.1007/s11255-013-0557-1; Boras Z, 2012, COLLEGIUM ANTROPOL, V36, P1355; Chen ZY, 2010, J MAGN RESON IMAGING, V31, P1331, DOI 10.1002/jmri.22175; Choi SY, 2012, BRIT J RADIOL, V85, pE474, DOI 10.1259/bjr/79381464; Curvo-Semedo L, 2012, J MAGN RESON IMAGING, V35, P1365, DOI 10.1002/jmri.23589; Higano S, 2006, RADIOLOGY, V241, P839, DOI 10.1148/radiol.2413051276; Huh JW, 2009, VIRCHOWS ARCH, V454, P381, DOI 10.1007/s00428-009-0752-8; Jeh SK, 2011, J MAGN RESON IMAGING, V33, P102, DOI 10.1002/jmri.22400; Jurach Márcia Teresinha, 2006, Arq. Gastroenterol., V43, P14, DOI 10.1590/S0004-28032006000100006; Kim MS, 2013, J SURG ONCOL, V107, P835, DOI 10.1002/jso.23327; Kobayashi S, 2014, J MAGN RESON IMAGING, V39, P172, DOI 10.1002/jmri.24148; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kozak KR, 2008, J SURG ONCOL, V98, P161, DOI 10.1002/jso.21107; Lebe B, 2005, APPL IMMUNOHISTO M M, V13, P38, DOI 10.1097/00129039-200503000-00007; Lee YC, 2013, DIS COLON RECTUM, V56, P1093, DOI 10.1097/DCR.0b013e318298e36b; Martincich L, 2012, EUR RADIOL, V22, P1519, DOI 10.1007/s00330-012-2403-8; Mesko S, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/717080; MINSKY BD, 1989, INT J RADIAT ONCOL, V17, P311, DOI 10.1016/0360-3016(89)90445-8; Ritu G, 2012, J OBSTET GYN INDIA, V62, P437, DOI 10.1007/s13224-012-0300-3; Schnapauff D, 2009, J MAGN RESON IMAGING, V29, P1355, DOI 10.1002/jmri.21755; Tarantino I, 2012, BRIT J CANCER, V107, P266, DOI 10.1038/bjc.2012.267; Tsigris C, 2002, CANCER LETT, V184, P215, DOI 10.1016/S0304-3835(02)00205-7; Zhang XY, 2011, J MAGN RESON IMAGING, V33, P1171, DOI 10.1002/jmri.22558	23	22	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109371	10.1371/journal.pone.0109371	http://dx.doi.org/10.1371/journal.pone.0109371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303288	gold, Green Submitted, Green Published			2022-12-25	WOS:000343730400053
J	Tumber, AK; Scheerer, NE; Jones, JA				Tumber, Anupreet K.; Scheerer, Nichole E.; Jones, Jeffery A.			Attentional Demands Influence Vocal Compensations to Pitch Errors Heard in Auditory Feedback	PLOS ONE			English	Article							SELECTIVE ATTENTION; DIVIDED ATTENTION; SPATIAL ATTENTION; SPEECH MOTOR; VOICE; RESPONSES; PERFORMANCE; POTENTIALS; MECHANISMS; MAGNITUDE	Auditory feedback is required to maintain fluent speech. At present, it is unclear how attention modulates auditory feedback processing during ongoing speech. In this event-related potential (ERP) study participants vocalized/a/ while they heard their vocal pitch suddenly shifted downward a 1/2 semitone in both single and dual-task conditions. During the single task condition participants passively viewed a visual stream for cues to start and stop vocalizing. In the dual-task condition, participants vocalized while they identified target stimuli in a visual stream of letters. The presentation rate of the visual stream of letters. The presentation rate of the visual stimuli was manipulated in the dual-task condition in order to produce a low, intermediate, and high attentional load. Visual target identification accuracy was lowest in the high attentional load condition, indicating that attentional successfully manipulated. Results further showed that participants who were exposed to the single-task condition prior to the dual-task condition produced target local compensations during the single task condition. Thus, when participants attention was divided less attention was available for the monitoring of their auditory feedback, resulting in smaller compensatory vocal responses. However, P1-N1-P2 ERP responses were not affected by divided attention, suggesting that the effect of attentional load was not on the auditory processing of pitch altered feedback, but instead it interfered with the integration of auditory and motor information, or motor control itself.	[Jones, Jeffery A.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada; Wilfrid Laurier Univ, Laurier Ctr Cognit Neurosci, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University; Wilfrid Laurier University	Jones, JA (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.	jjones@wlu.ca	Scheerer, Nichole E./Y-5522-2019	Scheerer, Nichole/0000-0003-0070-6559	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant awarded to JAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Behroozmand R, 2011, J COGNITIVE NEUROSCI, V23, P1205, DOI 10.1162/jocn.2010.21447; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Burnett TA, 1997, J VOICE, V11, P202, DOI 10.1016/S0892-1997(97)80079-3; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Camacho A, 2007, J ACOUST SOC AM, V122, P2960, DOI [10.1121/1.2942550, DOI 10.1121/1.2942550]; Chen ZC, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-55; Choi I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00115; Chun MM, 2008, BLACKWELL HDB PERCEP, P272; Civier O, 2010, J FLUENCY DISORD, V35, P246, DOI 10.1016/j.jfludis.2010.05.002; Coch D, 2005, CLIN NEUROPHYSIOL, V116, P2184, DOI 10.1016/j.clinph.2005.06.005; DAI HP, 1991, J ACOUST SOC AM, V89, P2837, DOI 10.1121/1.400721; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Dromey C, 2003, J SPEECH LANG HEAR R, V46, P1234, DOI 10.1044/1092-4388(2003/096); Dromey C, 2008, J SPEECH LANG HEAR R, V51, P1171, DOI 10.1044/1092-4388(2008/06-0221); ELMAN JL, 1981, J ACOUST SOC AM, V70, P45, DOI 10.1121/1.386580; Ferlazzo F, 2002, Q J EXP PSYCHOL-A, V55, P937, DOI 10.1080/02724980143000569; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; Hawco CS, 2009, BRAIN RES, V1276, P131, DOI 10.1016/j.brainres.2009.04.033; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HINK RF, 1977, NEUROPSYCHOLOGIA, V15, P597, DOI 10.1016/0028-3932(77)90065-3; HINK RF, 1978, BIOL PSYCHOL, V6, P1, DOI 10.1016/0301-0511(78)90002-9; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Korzyukov O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041216; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; Macdonald JSP, 2011, ATTEN PERCEPT PSYCHO, V73, P1780, DOI 10.3758/s13414-011-0144-4; NAATANEN R, 1991, BEHAV BRAIN SCI, V14, P761; PARASURAMAN R, 1980, BIOL PSYCHOL, V11, P217, DOI 10.1016/0301-0511(80)90057-5; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Scheerer NE, 2013, NEUROSCIENCE, V240, P176, DOI 10.1016/j.neuroscience.2013.02.054; Scheerer NE, 2013, EUR J NEUROSCI, V38, P3189, DOI 10.1111/ejn.12301; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; WALDSTEIN RS, 1990, J ACOUST SOC AM, V88, P2099, DOI 10.1121/1.400107; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; Wickens CD, 2007, IRAL-INT REV APPL LI, V45, DOI [10.1515/iral.2007.008, DOI 10.1515/IRAL.2007.008]; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	42	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109968	10.1371/journal.pone.0109968	http://dx.doi.org/10.1371/journal.pone.0109968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303649	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400099
J	Amo, L; Tomas, G; Parejo, D; Aviles, JM				Amo, Luisa; Tomas, Gustavo; Parejo, Deseada; Miguel Aviles, Jesus			Are Female Starlings Able to Recognize the Scent of Their Offspring?	PLOS ONE			English	Article							PREEN GLAND-FUNCTION; INDIVIDUAL RECOGNITION; KIN RECOGNITION; LAYER FOWLS; ALCA-TORDA; BIRDS; VOLATILES; FINCH; DISCRIMINATION; PREFERENCES	Background: Although there is growing evidence that birds may have individual chemical profiles that can function in several social contexts, offspring recognition based on olfactory cues has never been explored. This ability should be more likely evolved in colonial birds and/or species suffering brood parasitism, in which the risk of being engaged in costly misdirected parental care is high. Methodology/Principal Findings: We performed a choice experiment to examine whether females of the spotless starling, Sturnus unicolor, a species that is colonial, and where a fraction of the population is exposed to intraspecific brood parasitism, can discriminate between the scent of their offspring and that of unrelated nestlings. We also explored whether the development of the uropygial gland secretion may play a role in such olfactory discrimination by performing the choice experiments to females rearing nestlings of two different ages, that is, without and with developed uropygial glands. Results showed that female starlings did not preferentially choose the scent of their offspring, independently of whether the gland of nestlings was developed or not. Conclusions/Significance: Our results suggest that female starlings do not have or do not show the ability to distinguish their offspring based on olfaction, at least up to 12-14 days of nestling age. Further research is needed to examine whether odour-based discrimination may function when fledgling starlings leave the nest and the risk of costly misidentification is likely to increase.	[Amo, Luisa; Tomas, Gustavo; Parejo, Deseada; Miguel Aviles, Jesus] CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Amo, L (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain.	luisa.amo@mncn.csic.es	Amo, Luisa/K-5960-2014; Parejo, Deseada/L-3953-2014; Avilés, Jesús/K-3332-2014; Tomas, Gustavo/J-7559-2012	Amo, Luisa/0000-0003-4621-3493; Parejo, Deseada/0000-0002-7368-2378; Avilés, Jesús/0000-0002-1463-8393; Tomas, Gustavo/0000-0001-6701-2055	Spanish Ministry of Education and Science/FEDER [CGL2008-00718, CGL2011-27561/BOS];  [CGL2010-19233-C03-01]	Spanish Ministry of Education and Science/FEDER(Spanish Government); 	LA and GT were supported by the Juan de la Cierva programme while performing the experiment and LA was supported by the Ramon y Cajal programme while writing. This research was funded by the Spanish Ministry of Education and Science/FEDER (CGL2008-00718 and CGL2011-27561/BOS) to JMA and DP and by CGL2010-19233-C03-01 to J. J. Soler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2012, ANIM BEHAV, V84, P1483, DOI 10.1016/j.anbehav.2012.09.021; Amo L, 2012, J ANIM ECOL, V81, P605, DOI 10.1111/j.1365-2656.2011.01940.x; Aviles JM, 2013, OECOLOGIA, V173, P399, DOI 10.1007/s00442-013-2625-8; BEECHER MD, 1981, ANIM BEHAV, V29, P95, DOI 10.1016/S0003-3472(81)80156-X; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; Beecher MD, 1990, CONT ISSUES COMP PSY, P360; Bonadonna F, 2004, ANIM BEHAV, V67, P893, DOI 10.1016/j.anbehav.2003.08.013; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Calvo JM, 2000, BIRD STUDY, V47, P285, DOI 10.1080/00063650009461188; Campagna S, 2012, CHEM SENSES, V37, P3, DOI 10.1093/chemse/bjr067; Caro SP, 2010, J COMP PHYSIOL A, V196, P751, DOI 10.1007/s00359-010-0534-4; Caspers BA, 2013, ANIM BEHAV, V86, P85, DOI 10.1016/j.anbehav.2013.04.015; Caspers BA, 2011, BIOL LETTERS, V7, P184, DOI 10.1098/rsbl.2010.0775; CHAIKEN M, 1992, BEHAVIOUR, V120, P139, DOI 10.1163/156853992X00255; CLARK L, 1987, ANIM BEHAV, V35, P227, DOI 10.1016/S0003-3472(87)80228-2; Coffin HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025002; Davies JJF, 1962, AUST J ZOOL, V10, P171; De Leon A, 2003, BEHAVIOUR, V140, P925, DOI 10.1163/156853903770238382; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; Hagelin Julie C., 2007, P75; Holmes W.G., 1990, P441; INGOLD P, 1973, BEHAVIOUR, V45, P154, DOI 10.1163/156853974X00633; Insley SJ, 2003, J EXP BIOL, V206, P25, DOI 10.1242/jeb.00072; Jacot A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1515, DOI 10.1007/s00265-010-0965-5; Jourdie V, 2004, NATURE, V431, P262, DOI 10.1038/431262a; KNUDSEN B, 1986, ANIM BEHAV, V34, P77, DOI 10.1016/0003-3472(86)90008-4; Krause ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036615; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Leclaire S, 2012, P ROY SOC B-BIOL SCI, V279, P1185, DOI 10.1098/rspb.2011.1611; Leclaire S, 2011, NATURWISSENSCHAFTEN, V98, P615, DOI 10.1007/s00114-011-0809-9; Lefevre K, 1998, ANIM BEHAV, V55, P925, DOI 10.1006/anbe.1997.0626; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Mardon J, 2010, CHEM SENSES, V35, P309, DOI 10.1093/chemse/bjq021; O'Dwyer TW, 2008, J EXP BIOL, V211, P337, DOI 10.1242/jeb.010512; Parejo D, 2012, BIOL LETTERS, V8, P502, DOI 10.1098/rsbl.2012.0124; R Development Core Team, 2012, R LANG ENV STAT COMP; Reers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018466; RISKA DE, 1984, AUK, V101, P605, DOI 10.1093/auk/101.3.605; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Sandilands V, 2004, BRIT POULTRY SCI, V45, P109, DOI 10.1080/00071660410001668932; Sandilands V, 2004, COMP BIOCHEM PHYS A, V137, P217, DOI 10.1016/j.cbpb.2003.10.004; Shizuka D, 2010, NATURE, V463, P223, DOI 10.1038/nature08655; Soini HA, 2013, J CHROMATOGR A, V1317, P186, DOI 10.1016/j.chroma.2013.08.006; VANELSACKER L, 1988, BEHAVIOUR, V107, P122, DOI 10.1163/156853988X00232; Veiga JP, 2002, ENCICLOPEDIA VIRTUAL; WALLRAFF HG, 1995, CONDOR, V97, P20, DOI 10.2307/1368979; Whelan RJ, 2010, COMP BIOCHEM PHYS B, V156, P183, DOI 10.1016/j.cbpb.2010.03.005; Whittaker DJ, 2013, ANIM BEHAV, V86, P697, DOI 10.1016/j.anbehav.2013.07.025; Whittaker DJ, 2011, BEHAV ECOL, V22, P1256, DOI 10.1093/beheco/arr122; Whittaker DJ, 2010, BEHAV ECOL, V21, P608, DOI 10.1093/beheco/arq033; Zhang JX, 2010, CHEM SENSES, V35, P375, DOI 10.1093/chemse/bjq025; Zhang YH, 2013, BEHAV ECOL, V24, P1271, DOI 10.1093/beheco/art068	54	11	11	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109505	10.1371/journal.pone.0109505	http://dx.doi.org/10.1371/journal.pone.0109505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299305	Green Submitted, gold, Green Published			2022-12-25	WOS:000343941200053
J	Torrente, MP; Castellano, LM; Shorter, J				Torrente, Mariana P.; Castellano, Laura M.; Shorter, James			Suramin Inhibits Hsp104 ATPase and Disaggregase Activity	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE HSP104; AGENT GUANIDINIUM CHLORIDE; PROTEIN DISAGGREGATION; PROMISCUOUS INHIBITORS; NUCLEOTIDE-BINDING; AGGREGATED PROTEINS; FIREFLY LUCIFERASE; PRION PROPAGATION; COMMON MECHANISM; MIDDLE DOMAIN	Hsp104 is a hexameric AAA+ protein that utilizes energy from ATP hydrolysis to dissolve disordered protein aggregates as well as amyloid fibers. Interestingly, Hsp104 orthologues are found in all kingdoms of life except animals. Thus, Hsp104 could represent an interesting drug target. Specific inhibition of Hsp104 activity might antagonize non-metazoan parasites that depend on a potent heat shock response, while producing little or no side effects to the host. However, no small molecule inhibitors of Hsp104 are known except guanidinium chloride. Here, we screen over 16,000 small molecules and identify 16 novel inhibitors of Hsp104 ATPase activity. Excluding compounds that inhibited Hsp104 activity by non-specific colloidal effects, we defined Suramin as an inhibitor of Hsp104 ATPase activity. Suramin is a polysulphonated naphthylurea and is used as an antiprotozoal drug for African Trypanosomiasis. Suramin also interfered with Hsp104 disaggregase, unfoldase, and translocase activities, and the inhibitory effect of Suramin was not rescued by Hsp70 and Hsp40. Suramin does not disrupt Hsp104 hexamers and does not effectively inhibit ClpB, the E. coli homolog of Hsp104, establishing yet another key difference between Hsp104 and ClpB behavior. Intriguingly, a potentiated Hsp104 variant, Hsp104 A503V, is more sensitive to Suramin than wild-type Hsp104. By contrast, Hsp104 variants bearing inactivating sensor-1 mutations in nucleotide-binding domain (NBD) 1 or 2 are more resistant to Suramin. Thus, Suramin depends upon ATPase events at both NBDs to exert its maximal effect. Suramin could develop into an important mechanistic probe to study Hsp104 structure and function.	[Torrente, Mariana P.; Castellano, Laura M.; Shorter, James] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Castellano, Laura M.; Shorter, James] Univ Penn, Perelman Sch Med, Pharmacol Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Stong, Laura/0000-0001-7964-0761	PENN-PORT postdoctoral fellowship [K12GM081259]; NSF graduate research fellowship [DGE-0822];  [R01GM099836]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099836, K12GM081259] Funding Source: NIH RePORTER	PENN-PORT postdoctoral fellowship; NSF graduate research fellowship(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MPT is supported by a PENN-PORT postdoctoral fellowship (K12GM081259). LMC is supported by an NSF graduate research fellowship DGE-0822. JS is supported by grant: R01GM099836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babokhov P, 2013, PATHOG GLOB HEALTH, V107, P242, DOI 10.1179/2047773213Y.0000000105; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Borges S, 2014, BREAST CANCER RES TR, V144, P79, DOI 10.1007/s10549-014-2857-2; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; DeSantis ME, 2014, J BIOL CHEM, V289, P848, DOI 10.1074/jbc.M113.520759; DeSantis ME, 2012, CHEM BIOL, V19, P1400, DOI 10.1016/j.chembiol.2012.09.013; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Galam L, 2007, BIOORGAN MED CHEM, V15, P1939, DOI 10.1016/j.bmc.2007.01.004; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Halbeisen RE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Heallen TR, 2008, DEV CELL, V15, P603, DOI 10.1016/j.devcel.2008.08.005; Ivanov AI, 1998, J BIOL CHEM, V273, P14721, DOI 10.1074/jbc.273.24.14721; Izikki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077073; Jackrel ME, 2014, DIS MODEL MECH, V7, P1175, DOI 10.1242/dmm.016113; Jackrel ME, 2014, CELL CYCLE, V13, P1379, DOI 10.4161/cc.28709; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Kummer E, 2013, FEBS LETT, V587, P810, DOI 10.1016/j.febslet.2013.02.011; Liu N, 2011, CURR CLIN PHARMACOL, V6, P137, DOI 10.2174/157488411796151174; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Maccio A, 2013, EXPERT OPIN PHARMACO, V14, P1839, DOI 10.1517/14656566.2013.813934; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Martin I, 2013, J MED CHEM, V56, P7177, DOI 10.1021/jm400499k; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Naviaux JC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.33; Naviaux RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057380; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Shorter J, 2005, NAT STRUCT MOL BIOL, V12, P4, DOI 10.1038/nsmb0105-4; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; STEIN CA, 1993, CANCER RES, V53, P2239; Sweeny EA, 2011, JOVE-J VIS EXP, V55, pe3190; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Torrente MP, 2013, PRION, V7, P457, DOI 10.4161/pri.27531; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wigle TJ, 2007, BIOORG MED CHEM LETT, V17, P3249, DOI 10.1016/j.bmcl.2007.04.013; Zeymer C, 2013, J BIOL CHEM, V288, P7065, DOI 10.1074/jbc.M112.432583; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	84	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110115	10.1371/journal.pone.0110115	http://dx.doi.org/10.1371/journal.pone.0110115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299406	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200102
J	Arnett, MT; Herman, DH; Mcgee, AW				Arnett, Megan T.; Herman, David H.; McGee, Aaron W.			Deficits in Tactile Learning in a Mouse Model of Fragile X Syndrome	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; FUNCTIONAL ARCHITECTURE; SYNAPTIC PLASTICITY; INTRINSIC SIGNAL; MICE; HYPEREXCITABILITY; TRANSLATION; INHIBITION; PHENOTYPE; AMYGDALA	The fragile X mental retardation 1 mutant mouse (Fmr1 KO) recapitulates several of the neurologic deficits associated with Fragile X syndrome (FXS). As tactile hypersensitivity is a hallmark of FXS, we examined the sensory representation of individual whiskers in somatosensory barrel cortex of Fmr1 KO and wild-type (WT) mice and compared their performance in a whisker-dependent learning paradigm, the gap cross assay. Fmr1 KO mice exhibited elevated responses to stimulation of individual whiskers as measured by optical imaging of intrinsic signals. In the gap cross task, initial performance of Fmr1 KO mice was indistinguishable from WT controls. However, while WT mice improved significantly with experience at all gap distances, Fmr1 KO mice displayed significant and specific deficits in improvement at longer distances which rely solely on tactile information from whiskers. Thus, Fmr1 KO mice possess altered cortical responses to sensory input that correlates with a deficit in tactile learning.	[Arnett, Megan T.; McGee, Aaron W.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles,Saban Res Inst, Dept Pediat,Dev Neurosci Program, Los Angeles, CA 90033 USA; [Herman, David H.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California	Mcgee, AW (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles,Saban Res Inst, Dept Pediat,Dev Neurosci Program, Los Angeles, CA 90033 USA.	amcgee@usc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE to AWM; The Saban Research Institute; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077288] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE to AWM; The Saban Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded in part by grant 1R21N5077288 from the NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE to AWM. AWM is a recipient of a Research Development Career Award from The Saban Research Institute and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brennan FX, 2006, GENES BRAIN BEHAV, V5, P467, DOI 10.1111/j.1601-183X.2005.00183.x; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Goncalves JT, 2013, NAT NEUROSCI, V16, P903, DOI 10.1038/nn.3415; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HAGERMAN RJ, 1991, AM J MED GENET, V38, P283, DOI 10.1002/ajmg.1320380223; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Padmashri R, 2013, J NEUROSCI, V33, P19715, DOI 10.1523/JNEUROSCI.2514-13.2013; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Patel AB, 2014, J NEUROSCI, V34, P3413, DOI 10.1523/JNEUROSCI.2921-13.2014; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Selby L, 2007, NEUROSCI LETT, V412, P227, DOI 10.1016/j.neulet.2006.11.062; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Till SM, 2012, HUM MOL GENET, V21, P2143, DOI 10.1093/hmg/dds030; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008	47	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109116	10.1371/journal.pone.0109116	http://dx.doi.org/10.1371/journal.pone.0109116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296296	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000039
J	Cotton, JA; Motta, JP; Schenck, LP; Hirota, SA; Beck, PL; Buret, AG				Cotton, James A.; Motta, Jean-Paul; Schenck, L. Patrick; Hirota, Simon A.; Beck, Paul L.; Buret, Andre G.			Giardia duodenalis Infection Reduces Granulocyte Infiltration in an In Vivo Model of Bacterial Toxin-Induced Colitis and Attenuates Inflammation in Human Intestinal Tissue	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; NEUTROPHIL TRANSEPITHELIAL MIGRATION; CLOSTRIDIUM-DIFFICILE TOXIN; HUMAN DENDRITIC CELLS; G-CSF; LAMBLIA INFECTIONS; ION-TRANSPORT; MICE; EXPRESSION; CHILDREN	Giardia duodenalis (syn. G. intestinalis, G. lamblia) is a predominant cause of waterborne diarrheal disease that may lead to post-infectious functional gastrointestinal disorders. Although Giardia-infected individuals could carry as much as 10(6) trophozoites per centimetre of gut, their intestinal mucosa is devoid of overt signs of inflammation. Recent studies have shown that in endemic countries where bacterial infectious diseases are common, Giardia infections can protect against the development of diarrheal disease and fever. Conversely, separate observations have indicated Giardia infections may enhance the severity of diarrheal disease from a co-infecting pathogen. Polymorphonuclear leukocytes or neutrophils (PMNs) are granulocytic, innate immune cells characteristic of acute intestinal inflammatory responses against bacterial pathogens that contribute to the development of diarrheal disease following recruitment into intestinal tissues. Giardia cathepsin B cysteine proteases have been shown to attenuate PMN chemotaxis towards IL-8/CXCL8, suggesting Giardia targets PMN accumulation. However, the ability of Giardia infections to attenuate PMN accumulation in vivo and how in turn this effect may alter the host inflammatory response in the intestine has yet to be demonstrated. Herein, we report that Giardia infection attenuates granulocyte tissue infiltration induced by intra-rectal instillation of Clostridium difficile toxin A and B in an isolate-dependent manner. This attenuation of granulocyte infiltration into colonic tissues paralled decreased expression of several cytokines associated with the recruitment of PMNs. Giardia trophozoite isolates that attenuated granulocyte infiltration in vivo also decreased protein expression of cytokines released from inflamed mucosal biopsy tissues collected from patients with active Crohn's disease, including several cytokines associated with PMN recruitment. These results demonstrate for the first time that certain Giardia infections may attenuate PMN accumulation by decreasing the expression of the mediators responsible for their recruitment.	[Cotton, James A.; Motta, Jean-Paul; Buret, Andre G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Cotton, James A.; Motta, Jean-Paul; Buret, Andre G.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Cotton, James A.; Motta, Jean-Paul; Buret, Andre G.] Univ Calgary, Calgary, AB, Canada; [Schenck, L. Patrick] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Schenck, L. Patrick; Beck, Paul L.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hirota, Simon A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Hirota, Simon A.] Univ Calgary, Dept Immunol Microbiol & Infect Dis, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Buret, AG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	aburet@ucalgary.ca	Motta, Jean-Paul/A-8844-2014	Motta, Jean-Paul/0000-0002-9464-0695	NSERC [RT 690446]; Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC) [10000008]; Alberta Innovates [201400554] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC); Alberta Innovates	JA Cotton is a recipient of NSERC Alexander Graham Bell Scholarship graduate student scholarship and a joint IBD studentship from Alberta Innovates Health Solutions (AIHS) and the Crohn's and colitis foundation of Canada (CCFC). Research in AG Buret's lab is funded by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) RT 690446, and the CCFC 10000008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL A, 1989, MOL BIOCHEM PARASIT, V32, P39, DOI 10.1016/0166-6851(89)90127-8; Al-Sadi R, 2013, J IMMUNOL, V190, P6596, DOI 10.4049/jimmunol.1201876; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; ARNDT H, 1992, INFLAMMATION, V16, P549, DOI 10.1007/BF00918979; Banik S, 2013, INFECT IMMUN, V81, P2309, DOI 10.1128/IAI.00004-13; Bartelt LA, 2013, J CLIN INVEST, V123, P2672, DOI 10.1172/JCI67294; Bertelsen LS, 2004, AM J PHYSIOL-GASTR L, V286, pG157, DOI 10.1152/ajpgi.00227.2003; Bhavnani D, 2012, AM J EPIDEMIOL, V176, P387, DOI 10.1093/aje/kws220; Bilenko N, 2004, EUR J EPIDEMIOL, V19, P877, DOI 10.1023/B:EJEP.0000040533.75646.9c; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; CEVALLOS AM, 1995, GASTROENTEROLOGY, V109, P766, DOI 10.1016/0016-5085(95)90383-6; Chen TL, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-26; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Chin AC, 2007, ANNU REV PATHOL-MECH, V2, P111, DOI 10.1146/annurev.pathol.2.010506.091944; Chin AC, 2006, ANN NY ACAD SCI, V1072, P276, DOI 10.1196/annals.1326.018; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Cotton JA, 2014, INFECT IMMUN; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Fisher BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081104; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Hagel I, 2011, ACTA TROP, V117, P189, DOI 10.1016/j.actatropica.2010.12.001; Halliez MCM, 2013, WORLD J GASTROENTERO, V19, P8974, DOI 10.3748/wjg.v19.i47.8974; Hanevik K, 2007, J INFECTION, V55, P524, DOI 10.1016/j.jinf.2007.09.004; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jerlstrom-Hultqvist J, 2010, GUT MICROBES, V1, P379, DOI 10.4161/gmic.1.6.13608; Kamda JD, 2009, INFECT IMMUN, V77, P685, DOI 10.1128/IAI.00718-08; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KELLY CP, 1994, J CLIN INVEST, V93, P1257, DOI 10.1172/JCI117080; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; KOSTMANN R, 1975, ACTA PAEDIATR SCAND, V64, P362, DOI 10.1111/j.1651-2227.1975.tb03847.x; Kuijpers T, 2012, CELL MOL LIFE SCI, V69, P7, DOI 10.1007/s00018-011-0834-z; KUMAR NB, 1982, AM J SURG PATHOL, V6, P523, DOI 10.1097/00000478-198209000-00004; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lee HY, 2012, PARASITE IMMUNOL, V34, P183, DOI 10.1111/j.1365-3024.2012.01354.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; MAYER P, 1993, BLOOD, V81, P3226; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Monis PT, 1999, MOL BIOL EVOL, V16, P1135, DOI 10.1093/oxfordjournals.molbev.a026204; Mukherjee AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/786480; Obendorf J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-317; Oberhelman RA, 2001, PEDIATR INFECT DIS J, V20, P792, DOI 10.1097/00006454-200108000-00014; Oberhuber G, 1997, SCAND J GASTROENTERO, V32, P48, DOI 10.3109/00365529709025062; Panaro MA, 2007, FEMS IMMUNOL MED MIC, V51, P302, DOI 10.1111/j.1574-695X.2007.00304.x; Paul G, 2012, J BIOL CHEM, V287, P2144, DOI 10.1074/jbc.M111.318139; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V305, pF1422, DOI 10.1152/ajprenal.00319.2013; Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005; Roxstrom-Lindquist K, 2005, INFECT IMMUN, V73, P8204, DOI 10.1128/IAI.73.12.8204-8208.2005; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Scott KGE, 2000, INFECT IMMUN, V68, P3412, DOI 10.1128/IAI.68.6.3412-3418.2000; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; Solaymani-Mohammadi S, 2011, J IMMUNOL, V187, P3769, DOI 10.4049/jimmunol.1100606; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Stadelmann B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-256; Stadelmann B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045325; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Szabady RL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00220; Teoh DA, 2000, J PARASITOL, V86, P800; Troeger H, 2007, GUT, V56, P328, DOI 10.1136/gut.2006.100198; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Veenemans J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001158; Wampfler PB, 2014, INT J PARASITOL, V44, P497, DOI 10.1016/j.ijpara.2014.03.008; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Wensaas KA, 2012, GUT, V61, P214, DOI 10.1136/gutjnl-2011-300220; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x; Zhou P, 2003, INFECT IMMUN, V71, P1566, DOI 10.1128/IAI.71.3.1566-1568.2003	85	46	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109087	10.1371/journal.pone.0109087	http://dx.doi.org/10.1371/journal.pone.0109087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289678	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000034
J	Gazzoni, M; Celadon, N; Mastrapasqua, D; Paleari, M; Margaria, V; Ariano, P				Gazzoni, Marco; Celadon, Nicolo; Mastrapasqua, Davide; Paleari, Marco; Margaria, Valentina; Ariano, Paolo			Quantifying Forearm Muscle Activity during Wrist and Finger Movements by Means of Multi-Channel Electromyography	PLOS ONE			English	Article							SURFACE EMG; FORCE; CROSSTALK; ROBUST; INDEPENDENCE; RECORDINGS; SYNERGIES; STRATEGY; SIGNALS	The study of hand and finger movement is an important topic with applications in prosthetics, rehabilitation, and ergonomics. Surface electromyography (sEMG) is the gold standard for the analysis of muscle activation. Previous studies investigated the optimal electrode number and positioning on the forearm to obtain information representative of muscle activation and robust to movements. However, the sEMG spatial distribution on the forearm during hand and finger movements and its changes due to different hand positions has never been quantified. The aim of this work is to quantify 1) the spatial localization of surface EMG activity of distinct forearm muscles during dynamic free movements of wrist and single fingers and 2) the effect of hand position on sEMG activity distribution. The subjects performed cyclic dynamic tasks involving the wrist and the fingers. The wrist tasks and the hand opening/closing task were performed with the hand in prone and neutral positions. A sensorized glove was used for kinematics recording. sEMG signals were acquired from the forearm muscles using a grid of 112 electrodes integrated into a stretchable textile sleeve. The areas of sEMG activity have been identified by a segmentation technique after a data dimensionality reduction step based on Non Negative Matrix Factorization applied to the EMG envelopes. The results show that 1) it is possible to identify distinct areas of sEMG activity on the forearm for different fingers; 2) hand position influences sEMG activity level and spatial distribution. This work gives new quantitative information about sEMG activity distribution on the forearm in healthy subjects and provides a basis for future works on the identification of optimal electrode configuration for sEMG based control of prostheses, exoskeletons, or orthoses. An example of use of this information for the optimization of the detection system for the estimation of joint kinematics from sEMG is reported.	[Gazzoni, Marco; Celadon, Nicolo; Mastrapasqua, Davide] Politecn Torino, Dept Elect & Telecommun, LISiN, Turin, Italy; [Celadon, Nicolo; Paleari, Marco; Margaria, Valentina; Ariano, Paolo] Ist Italiano Tecnol, Ctr Space Human Robot, Turin, Italy	Polytechnic University of Turin; Istituto Italiano di Tecnologia - IIT	Gazzoni, M (corresponding author), Politecn Torino, Dept Elect & Telecommun, LISiN, Turin, Italy.	marco.gazzoni@polito.it; paolo.ariano@iit.it	Gazzoni, Marco/G-3967-2012; Ariano, Paolo/B-9026-2008	Gazzoni, Marco/0000-0001-5939-6212; Ariano, Paolo/0000-0002-7957-8635; margaria, valentina/0000-0001-6125-4926; Paleari, Marco/0000-0002-8387-6678	Compagnia di San Paolo; Fondazione Cassa di Risparmio di Torino	Compagnia di San Paolo(Compagnia di San Paolo); Fondazione Cassa di Risparmio di Torino(Fondazione CRT)	This study was financially supported by the Compagnia di San Paolo and the Fondazione Cassa di Risparmio di Torino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boschmann A, 2012, IEEE ENG MED BIO, P4324, DOI 10.1109/EMBC.2012.6346923; Castellini C, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-41; Castellini C, 2009, BIOL CYBERN, V100, P35, DOI 10.1007/s00422-008-0278-1; Cipriani C, 2011, IEEE T NEUR SYS REH, V19, P260, DOI 10.1109/TNSRE.2011.2108667; Daley H, 2010, J PROSTHET ORTHOT, V22, P244, DOI DOI 10.1097/JP0.0B013E3181F989C2; Daley H, 2012, J ELECTROMYOGR KINES, V22, P478, DOI 10.1016/j.jelekin.2011.12.012; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farina D, 2004, METHOD INFORM MED, V43, P30; Farina D, 2010, IEEE ENG MED BIO, P3591, DOI 10.1109/IEMBS.2010.5627455; Fougner A, 2011, IEEE T NEUR SYS REH, V19, P644, DOI 10.1109/TNSRE.2011.2163529; Geng Y, 2011, J NEUROENG REHABIL, V5, P9; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hargrove L, 2008, BIOMED SIGNAL PROCES, V3, P175, DOI 10.1016/j.bspc.2007.11.005; Huang H, 2008, IEEE T NEUR SYS REH, V16, P37, DOI 10.1109/TNSRE.2007.910282; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Kamper DG, 2002, J BIOMECH, V35, P1581, DOI 10.1016/S0021-9290(02)00229-4; Keen DA, 2004, J NEUROPHYSIOL, V91, P2515, DOI 10.1152/jn.01178.2003; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Leijnse JNAL, 2008, J NEUROPHYSIOL, V100, P64, DOI 10.1152/jn.00706.2007; Leijnse JNAL, 2008, J NEUROPHYSIOL, V100, P3225, DOI 10.1152/jn.90570.2008; Li GL, 2010, IEEE T NEUR SYS REH, V18, P185, DOI 10.1109/TNSRE.2009.2039619; Li ZM, 2004, MOTOR CONTROL, V8, P1; Liu J, 2013, IEEE T NEUR SYS REH, V21, P96, DOI 10.1109/TNSRE.2012.2218832; Lucas MF, 2008, BIOMED SIGNAL PROCES, V3, P169, DOI 10.1016/j.bspc.2007.09.002; Mananas MA, 2005, P ANN INT IEEE EMBS, P5824, DOI 10.1109/IEMBS.2005.1615813; Marateb HR, 2012, MED BIOL ENG COMPUT, V50, P79, DOI 10.1007/s11517-011-0790-7; Mewett DT, 2004, MED BIOL ENG COMPUT, V42, P524, DOI 10.1007/BF02350994; Mogk JPM, 2003, J ELECTROMYOGR KINES, V13, P63, DOI 10.1016/S1050-6411(02)00071-8; Muceli S, 2014, IEEE T NEUR SYS REH, V22, P623, DOI 10.1109/TNSRE.2013.2282898; Muceli S, 2010, IEEE ENG MED BIO, P6066, DOI 10.1109/IEMBS.2010.5627622; Nielsen JLG, 2011, IEEE T BIO-MED ENG, V58, P681, DOI 10.1109/TBME.2010.2068298; Parker P, 2006, J ELECTROMYOGR KINES, V16, P541, DOI 10.1016/j.jelekin.2006.08.006; Peerdeman B, 2011, J REHABIL RES DEV, V48, P719, DOI 10.1682/JRRD.2010.08.0161; Rearick MP, 2003, J NEUROPHYSIOL, V89, P1317, DOI 10.1152/jn.00581.2002; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; SCHIEBER MH, 1995, J NEUROSCI, V15, P284; Tenore FVG, 2009, IEEE T BIO-MED ENG, V56, P1427, DOI 10.1109/TBME.2008.2005485; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; van Vugt JPP, 2001, CLIN NEUROPHYSIOL, V112, P583, DOI 10.1016/S1388-2457(01)00482-5; Vieira TMM, 2010, J BIOMECH, V43, P2149, DOI 10.1016/j.jbiomech.2010.03.049; Zhou P, 2007, J NEUROPHYSIOL, V98, P2974, DOI 10.1152/jn.00178.2007	43	55	57	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109943	10.1371/journal.pone.0109943	http://dx.doi.org/10.1371/journal.pone.0109943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289669	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000099
J	Wang, SS; Wang, JJ; Wang, PX; Chen, R				Wang, S-S; Wang, J-J; Wang, P-X; Chen, R.			Determinants of Fatigue after First-Ever Ischemic Stroke during Acute Phase (vol 9, e110037, 2014)	PLOS ONE			English	Correction									[Chen, R.] Wolverhampton Univ, Ctr Hlth & Social Care Improvement CHSCI, Wolverhampton WV1 1DJ, W Midlands, England	University of Wolverhampton			WANG, Jia Ji/E-9059-2015	Chen, Ruoling/0000-0002-3033-8753				Wang SS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110037, 10.1371/journal.pone.0116461]	1	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e116461	10.1371/journal.pone.0116461	http://dx.doi.org/10.1371/journal.pone.0116461			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25302807	Green Submitted, Green Published, gold			2022-12-25	WOS:000347186200061
J	Zhang, B; Wang, E; Dai, H; Shen, JF; Hsieh, HJ; Lu, XB; Peng, G				Zhang, Bo; Wang, Edward; Dai, Hui; Shen, Jianfeng; Hsieh, Hui-Ju; Lu, Xiongbin; Peng, Guang			Phosphorylation of the BRCA1C Terminus (BRCT) Repeat Inhibitor of hTERT (BRIT1) Protein Coordinates TopBP1 Protein Recruitment and Amplifies Ataxia Telangiectasia-mutated and Rad3-related (ATR) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Cycle; Cell Signaling; DNA Damage; DNA Repair; ATR; BRIT1; MCPH1; TopBP1; Replication Stress	DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; GENOMIC INSTABILITY; HISTONE H2AX; MITOTIC ENTRY; CHECKPOINT; REPLICATION; ACTIVATION; MICROCEPHALIN; CHROMATIN	Background: ATR signaling depends on TopBP1 recruitment to replication stress sites. Results: Interaction between BRIT1 and TopBP1 is required for sustained TopBP1 recruitment to sites of replication stress, which maintains ATR substrate activation. Conclusion: ATR-mediated phosphorylation of BRIT1 and BRIT1 interaction with TopBP1 provide mechanisms of TopBP1 recruitment to promote ATR signaling. Significance: We further the understanding of how ATR signaling is maintained through TopBP1. The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase functions as a central node in the DNA damage response signaling network. The mechanisms by which ATR activity is amplified and/or maintained are not understood. Here we demonstrate that BRIT1/microcephalin (MCPH1), a human disease-related protein, is dispensable for the initiation but essential for the amplification of ATR signaling. BRIT1 interacts with and recruits topoisomerase-binding protein 1 (TopBP1), a key activator of ATR signaling, to the sites of DNA damage. Notably, replication stress-induced ataxia telangiectasia-mutated or ATR-dependent BRIT1 phosphorylation at Ser-322 facilitates efficient TopBP1 recruitment. These results reveal a mechanism that ensures the continuation of ATR-initiated DNA damage signaling. Our study uncovers a previously unknown regulatory axis of ATR signaling in maintaining genomic integrity, which may provide mechanistic insights into the perturbation of ATR signaling in human diseases such as neurodevelopmental defects and cancer.	[Zhang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430022, Hubei Province, Peoples R China; [Wang, Edward; Dai, Hui] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA; [Lu, Xiongbin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Zhang, Bo; Shen, Jianfeng; Hsieh, Hui-Ju; Peng, Guang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Peng, G (corresponding author), Dept Clin Canc Prevent, 1515 Holcombe,Unit 1013, Houston, TX 77030 USA.	gpeng@mdanderson.org	Hsieh, Hui-Ju/Q-1237-2015; Hsieh, Hui-Ju/S-3082-2018	Hsieh, Hui-Ju/0000-0002-2583-7670	National Institutes of Health [R00CA149186]; National Institutes of Health Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R00CA149186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00CA149186 (to G. P.) and National Institutes of Health Cancer Center Support Grant CA016672 (to The University of Texas MD Anderson Cancer Center).	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bhattacharya N, 2013, ANN SURG ONCOL, V20, pS424, DOI 10.1245/s10434-012-2715-6; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Brown EJ, 2000, GENE DEV, V14, P397; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Peng G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4361; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	42	5	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34284	34295		10.1074/jbc.M114.587113	http://dx.doi.org/10.1074/jbc.M114.587113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301947	Green Published, hybrid			2022-12-25	WOS:000346077600050
J	Ishii, A; Tanaka, M; Watanabe, Y				Ishii, Akira; Tanaka, Masaaki; Watanabe, Yasuyoshi			The Neural Mechanisms Underlying the Decision to Rest in the Presence of Fatigue: A Magnetoencephalography Study	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; PHYSICAL FATIGUE; POPULATION; INHIBITION; KAROSHI; EMOTION; JAPAN; TASK; FMRI; GO	Adequate rest is essential to avoid fatigue and disruption of homeostasis. However, the neural mechanisms underlying the decision to rest are not well understood. In the present study, we aimed to clarify the neural mechanisms of this decision-making process using magnetoencephalography. Fifteen healthy volunteers participated in decision and control experiments performed in a cross-over fashion. In the decision experiment, participants performed 1,200 reverse Stroop test trials and were intermittently asked to decide whether they wanted to take a rest or continue. In the control experiments, participants performed 1,200 reverse Stroop test trials and were instructed to press a response button intermittently without making any decision. Changes in oscillatory brain activity were assessed using a narrow-band adaptive spatial filtering method. The levels of decrease in theta (4-8 Hz) band power in left Brodmann's area (BA) 31, alpha (8-13 Hz) band power in left BA 10 and BA 9, and beta (13-25 Hz) band power in right BA 46 and left BA 10 were greater in trials when the participant opted to rest (rest trials) than those in control trials. The decrease in theta band power in BA 31 in the rest trials was positively correlated with the subjective level of fatigue after the decision experiment. These results demonstrated that the dorsolateral prefrontal cortex, frontal pole, and posterior cingulate cortex play a role in the decision to rest in the presence of fatigue. These findings may help clarify the neural mechanisms underlying fatigue and fatigue-related problems.	[Ishii, Akira; Tanaka, Masaaki; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; [Watanabe, Yasuyoshi] RIKEN, Ctr Life Sci Technol, Sayo, Hyogo, Japan	Osaka Metropolitan University; RIKEN	Ishii, A (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan.	a.ishii@med.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [KAKENHI: 25750351]; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [25750351] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientists (B) (KAKENHI: 25750351) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the grant from the Ministry of Health, Labour and Welfare of Japan (URL http://www.jsps.go.jp/j-grantsinaid/index.html http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Caseras X, 2008, PSYCHOL MED, V38, P941, DOI 10.1017/S0033291708003450; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Ishii A, 2014, NEUROSCIENCE, V261, P60, DOI 10.1016/j.neuroscience.2013.12.049; Ishii A, PLOS ONE IN PRESS; Ishii A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095763; Ishii A, 2012, BRAIN RES, V1455, P68, DOI 10.1016/j.brainres.2012.03.031; Iwasaki K, 2006, IND HEALTH, V44, P537, DOI 10.2486/indhealth.44.537; Kondo N, 2010, J EPIDEMIOL COMMUN H, V64, P649, DOI 10.1136/jech.2009.090787; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Nakata H, 2013, CLIN NEUROPHYSIOL, V124, P273, DOI 10.1016/j.clinph.2012.06.019; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; PFURTSCHELLER G, 1992, J CLIN NEUROPHYSIOL, V9, P120, DOI 10.1097/00004691-199201000-00013; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sekihara K, 2008, SER BIOMED ENG, P1; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tanaka M, 2014, MED HYPOTHESES, V82, P567, DOI 10.1016/j.mehy.2014.02.013; Tanaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080731; Tanaka M, 2013, BRAIN RES, V1537, P117, DOI 10.1016/j.brainres.2013.08.054; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Watanabe Y., 2007, FATIGUE SCI HUMAN HL, P5	44	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109740	10.1371/journal.pone.0109740	http://dx.doi.org/10.1371/journal.pone.0109740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303465	gold, Green Submitted, Green Published			2022-12-25	WOS:000343730400076
J	Smid, A; Karas-Kuzelicki, N; Milek, M; Jazbec, J; Mlinaric-Rascan, I				Smid, Alenka; Karas-Kuzelicki, Natasa; Milek, Miha; Jazbec, Janez; Mlinaric-Rascan, Irena			Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy	PLOS ONE			English	Article							INOSINE TRIPHOSPHATE PYROPHOSPHATASE; INFLAMMATORY-BOWEL-DISEASE; THIOPURINE S-METHYLTRANSFERASE; ADVERSE DRUG-REACTIONS; BFM STUDY-GROUP; AZATHIOPRINE THERAPY; KOREAN PATIENTS; CHILDHOOD; MERCAPTOPURINE; POLYMORPHISM	Although the treatment of acute lymphoblastic leukemia (ALL) has improved significantly over recent decades, failure due to treatment-related toxicities and relapse of the disease still occur in about 20% of patients. This retrospective study included 308 pediatric ALL patients undergoing maintenance therapy and investigated the effects of genetic variants of enzymes involved inthe 6-mercaptopurine (6-MP) metabolism and folate pathway on survival and relapse rates. The presence of at least on of the non-functional ITPA alleles (94C>A and/or IVS2+21A>C variant) was associated with longer event-free survival compared to patients with the wild-type ITPA genotype (p=0.033). Furthermore, patients carrying at least one non-functional ITPA allele were shown to be at a lower risk of suffering early (p=0.003) and/or bone marrow relapse (p=0.017). In conclusion, the ITPA genotype may serve as a genetic marker for the improvement of risk stratification and therapy individualization for patients with ALL.	[Smid, Alenka; Karas-Kuzelicki, Natasa; Milek, Miha; Mlinaric-Rascan, Irena] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Jazbec, Janez] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Mlinaric-Rascan, I (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	irena.mlinaric@ffa.uni-lj.si		Milek, Miha/0000-0002-0803-8439; Mlinaric-Rascan, Irena/0000-0002-7459-3502	Slovenian Research Agency [J3-3615]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency grant No. J3-3615. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Breen DP, 2005, LIVER TRANSPLANT, V11, P826, DOI 10.1002/lt.20377; BUHRER C, 1993, MED PEDIATR ONCOL, V21, P470, DOI 10.1002/mpo.2950210703; de Beaumais TA, 2012, EUR J CLIN PHARMACOL, V68, P1233, DOI 10.1007/s00228-012-1251-4; de Beaumais TA, 2011, BRIT J CLIN PHARMACO, V71, P575, DOI 10.1111/j.1365-2125.2010.03867.x; Dorababu P, 2012, EUR J CLIN PHARMACOL, V68, P379, DOI 10.1007/s00228-011-1133-1; Freyer DR, 2011, BLOOD, V117, P3010, DOI 10.1182/blood-2010-07-294678; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P517, DOI 10.1111/j.1365-2125.2008.03248.x; Heller T, 2004, CLIN CHEM, V50, P2182, DOI 10.1373/clinchem.2004.039685; Henderson MJ, 2008, CELL CYCLE, V7, P1315, DOI 10.4161/cc.7.10.5885; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Jung YS, 2010, J HUM GENET, V55, P121, DOI 10.1038/jhg.2009.125; Karas-Kuzelicki N, 2009, LEUKEMIA, V23, P971, DOI 10.1038/leu.2008.317; Karas-Kuzelicki N, 2009, PHARMACOGENOMICS, V10, P1309, DOI 10.2217/PGS.09.78; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045558; Kim JH, 2010, J CLIN GASTROENTEROL, V44, pE242, DOI 10.1097/MCG.0b013e3181d6baf5; Krynetski EY, 1998, AM J HUM GENET, V63, P11, DOI 10.1086/301941; Kuzelicki NK, 2009, LEUKEMIA RES, V33, P1344, DOI 10.1016/j.leukres.2008.12.011; Laks Dani, 2003, J. Pediatr. (Rio J.), V79, P149, DOI 10.1590/S0021-75572003000200010; Malempati S, 2007, J CLIN ONCOL, V25, P5800, DOI 10.1200/JCO.2007.10.7508; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Menezes MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032313; Milek M, 2012, BIOCHEM PHARMACOL, V83, P969, DOI 10.1016/j.bcp.2012.01.010; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Raetz EA, 2012, HEMATOL-AM SOC HEMAT, P129, DOI 10.1182/asheducation-2012.1.129; Reismuller B, 2009, BRIT J HAEMATOL, V144, P559, DOI 10.1111/j.1365-2141.2008.07499.x; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RIEHM H, 1987, KLIN PADIATR, V199, P151, DOI 10.1055/s-2008-1026781; Rosalina WRW, 2012, J CLIN PHARM THER, V37, P237, DOI 10.1111/j.1365-2710.2011.01272.x; Schmiegelow K, 2009, LEUKEMIA, V23, P557, DOI 10.1038/leu.2008.316; Schrappe M, 2000, BLOOD, V95, P3310; Shipkova M, 2011, THER DRUG MONIT, V33, P321, DOI 10.1097/FTD.0b013e31821a7c34; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Stocco G, 2012, HUM MOL GENET, V21, P4793, DOI 10.1093/hmg/dds302; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Uchiyama K, 2009, J GASTROENTEROL, V44, P197, DOI 10.1007/s00535-008-2307-1; van der Veer A, 2013, BLOOD; Zabala-Fernandez W, 2011, J GASTROINTEST LIVER, V20, P247; Zaza G, 2004, BLOOD, V104, P1435, DOI 10.1182/blood-2003-12-4306	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109551	10.1371/journal.pone.0109551	http://dx.doi.org/10.1371/journal.pone.0109551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303517	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400065
J	Costa, J; Teixeira, PG; d'Avo, AF; Santos, C; Verissimo, A				Costa, Joana; Teixeira, Paulo Goncalves; d'Avo, Ana Filipa; Santos Junior, Celio; Verissimo, Antonio			Intragenic Recombination Has a Critical Role on the Evolution of Legionella pneumophila Virulence-Related Effector sidJ	PLOS ONE			English	Article							FALSE DISCOVERY RATE; POPULATION-STRUCTURE; MOLECULAR EVOLUTION; HYDROTHERMAL AREAS; DNA-SEQUENCES; DOTA GENE; PROTEIN; SEROGROUP; SELECTION; SECRETION	SidJ is a Dot/Icm effector involved in the trafficking or retention of ER-derived vesicles to Legionella pneumophila vacuoles whose mutation causes an observable growth defect, both in macrophage and amoeba hosts. Given the crucial role of this effector in L. pneumophila virulence we investigated the mechanisms shaping its molecular evolution. The alignment of SidJ sequences revealed several alleles with amino acid variations that may influence the protein properties. The identification of HGT events and the detection of balancing selection operating on sidJ evolution emerge as a clear result. Evidence suggests that intragenic recombination is an important strategy in the evolutionary adaptive process playing an active role on sidJ genetic plasticity. This pattern of evolution is in accordance with the life style of L. pneumophila as a broad host-range pathogen by preventing host-specialization and contributing to the resilience of the species.	[Costa, Joana; Verissimo, Antonio] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Costa, Joana; d'Avo, Ana Filipa; Verissimo, Antonio] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Teixeira, Paulo Goncalves] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Santos Junior, Celio] Univ Fed Sao Carlos, Dept Mol Biol & Evolutionary Genet, Sao Paulo, Brazil	Universidade de Coimbra; Universidade de Coimbra; Chalmers University of Technology; Universidade Federal de Sao Carlos	Verissimo, A (corresponding author), Univ Coimbra, Dept Life Sci, Coimbra, Portugal.	averiss@ci.uc.pt	Verissimo, Antonio/AAG-1159-2020; Costa, Joana/B-9176-2009; Santos-Júnior, Célio D./F-5580-2013; Veríssimo, António/AAE-6675-2020	Verissimo, Antonio/0000-0003-4996-3185; Costa, Joana/0000-0001-7028-2873; Santos-Júnior, Célio D./0000-0002-1974-1736; Goncalves Teixeira, Paulo/0000-0002-1102-8987	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal; EU-FEDER [PEst-C/SAU/LA0001/2011, PTDC/AGR-TEC/3789/2012]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); EU-FEDER(European Commission)	The research was funded by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal and EU-FEDER through grants PEst-C/SAU/LA0001/2011 and PTDC/AGR-TEC/3789/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Allombert J, 2013, MICROBES INFECT, V15, P981, DOI 10.1016/j.micinf.2013.09.007; Amaro F, 2012, J BACTERIOL, V194, P1613, DOI 10.1128/JB.06626-11; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISSETT ML, 1983, J CLIN MICROBIOL, V17, P887, DOI 10.1128/JCM.17.5.887-891.1983; BOGARDT RA, 1980, J MOL EVOL, V15, P197, DOI 10.1007/BF01732948; BRENNER DJ, 1988, J CLIN MICROBIOL, V26, P1695, DOI 10.1128/JCM.26.9.1695-1703.1988; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buchrieser C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00182; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cianciotto NP, 2014, CURR TOP MICROBIOL, V376, P81, DOI 10.1007/82_2013_339; Coscolla M, 2007, ENVIRON MICROBIOL, V9, P643, DOI 10.1111/j.1462-2920.2006.01184.x; Coscolla M, 2006, ENVIRON MICROBIOL, V8, P1056, DOI 10.1111/j.1462-2920.2006.00997.x; Coscolla M, 2009, INFECT GENET EVOL, V9, P882, DOI 10.1016/j.meegid.2009.05.013; Costa J, 2005, APPL ENVIRON MICROB, V71, P663, DOI 10.1128/AEM.71.2.663-671.2005; Costa J, 2012, ENVIRON MICROBIOL, V14, P2017, DOI 10.1111/j.1462-2920.2011.02646.x; Costa J, 2010, ENVIRON MICROBIOL, V12, P2711, DOI 10.1111/j.1462-2920.2010.02240.x; Costa J, 2010, RES MICROBIOL, V161, P18, DOI 10.1016/j.resmic.2009.10.005; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Edwards MT, 2008, MICROBIOL-SGM, V154, P852, DOI 10.1099/mic.0.2007/012336-0; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Escoll P, 2014, CURR TOP MICROBIOL, V376, P1, DOI 10.1007/82_2013_351; FIELDS BS, 2008, INFEC AGENT, P85; Fu YX, 1997, GENETICS, V147, P915; FU YX, 1993, GENETICS, V134, P1261; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrison TG, 2007, CLIN MICROBIOL INFEC, V13, P78, DOI 10.1111/j.1469-0691.2006.01558.x; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hookey JV, 1996, INT J SYST BACTERIOL, V46, P526, DOI 10.1099/00207713-46-2-526; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JUKES T H, 1969, P21; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Khan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067298; Kimura MA, 1985, NEUTRAL THEORY MOL E; Ko KS, 2002, J BACTERIOL, V184, P2123, DOI 10.1128/JB.184.8.2123-2130.2002; Kozak NA, 2009, J CLIN MICROBIOL, V47, P2525, DOI 10.1128/JCM.02410-08; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Ma J, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00320-13; MARRAO G, 1993, FEMS MICROBIOL ECOL, V12, P25, DOI 10.1016/0168-6496(93)90021-X; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MCKINNEY RM, 1980, J CLIN MICROBIOL, V12, P395, DOI 10.1128/JCM.12.3.395-401.1980; MCKINNEY RM, 1979, ANN INTERN MED, V90, P621, DOI 10.7326/0003-4819-90-4-621; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Molmeret M, 2004, MICROBES INFECT, V6, P129, DOI 10.1016/j.micinf.2003.11.004; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; NEI M, 1986, MOL BIOL EVOL, V3, P418; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Nora T, 2009, FUTURE MICROBIOL, V4, P691, DOI 10.2217/FMB.09.47; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reed FA, 2006, GENETICS, V172, P2011, DOI 10.1534/genetics.105.052183; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH JM, 1992, J MOL EVOL, V34, P126; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao LL, 2013, INFECT IMMUN, V81, P3077, DOI 10.1128/IAI.00252-13; THACKER WL, 1986, J CLIN MICROBIOL, V23, P1146, DOI 10.1128/JCM.23.6.1146-1147.1986; Thomas V, 2010, INTERVIROLOGY, V53, P254, DOI 10.1159/000312910; VERISSIMO A, 1990, J HOSP INFECT, V15, P255, DOI 10.1016/0195-6701(90)90033-K; VERISSIMO A, 1991, APPL ENVIRON MICROB, V57, P2921; Verissimo A, 1996, INT J SYST BACTERIOL, V46, P41, DOI 10.1099/00207713-46-1-41; Yang ZH, 2000, GENETICS, V155, P431	98	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109840	10.1371/journal.pone.0109840	http://dx.doi.org/10.1371/journal.pone.0109840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299187	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200076
J	Schundeln, MM; Goretzki, SC; Hauffa, PK; Wieland, R; Bauer, J; Baeder, L; Eggert, A; Hauffa, BP; Grasemann, C				Schuendeln, Michael M.; Goretzki, Sarah C.; Hauffa, Pia K.; Wieland, Regina; Bauer, Jens; Baeder, Lena; Eggert, Angelika; Hauffa, Berthold P.; Grasemann, Corinna			Impairment of Bone Health in Pediatric Patients with Hemolytic Anemia	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; SICKLE-CELL-DISEASE; MINERAL DENSITY; CHRONIC PAIN; CHILDREN; ADOLESCENTS; MASS	Introduction: Sickle cell anemia and thalassemia result in impaired bone health in both adults and youths. Children with other types of chronic hemolytic anemia may also display impaired bone health. Study Design: To assess bone health in pediatric patients with chronic hemolytic anemia, a cross-sectional study was conducted involving 45 patients with different forms of hemolytic anemia (i.e., 17 homozygous sickle cell disease and 14 hereditary spherocytosis patients). Biochemical, radiographic and anamnestic parameters of bone health were assessed. Results: Vitamin D deficiency with 25 OH-vitamin D serum levels below 20 ng/ml was a common finding (80.5%) in this cohort. Bone pain was present in 31% of patients. Analysis of RANKL, osteoprotegerin (OPG) and osteocalcin levels indicated an alteration in bone modeling with significantly elevated RANKL/OPG ratios (control: 0.08+0.07; patients: 0.26+0.2, P = 0.0007). Osteocalcin levels were found to be lower in patients compared with healthy controls (68.5+39.0 ng/ml vs. 118.0+36.6 ng/ml, P = 0.0001). Multiple stepwise regression analysis revealed a significant (P,<0.025) influence of LDH (partial r(2) = 0.29), diagnosis of hemolytic anemia (partial r(2) = 0.05) and age (partial r(2) = 0.03) on osteocalcin levels. Patients with homozygous sickle cell anemia were more frequently and more severely affected by impaired bone health than patients with hereditary spherocytosis. Conclusion: Bone health is impaired in pediatric patients with hemolytic anemia. In addition to endocrine alterations, an imbalance in the RANKL/OPG system and low levels of osteocalcin may contribute to this impairment.	[Schuendeln, Michael M.; Goretzki, Sarah C.; Hauffa, Pia K.; Wieland, Regina] Univ Klinikum Essen, Dept Pediat Hematol & Oncol, Kinderklin 3, Essen, Germany; [Schuendeln, Michael M.; Goretzki, Sarah C.; Hauffa, Pia K.; Wieland, Regina; Bauer, Jens; Baeder, Lena; Hauffa, Berthold P.; Grasemann, Corinna] Univ Duisburg Essen, Essen, Germany; [Bauer, Jens; Baeder, Lena; Hauffa, Berthold P.; Grasemann, Corinna] Univ Klinikum Essen, Dept Pediat Endocrinol & Diabetol, Kinderklin 3, Essen, Germany; [Eggert, Angelika] Charite, Dept Pediat, Div Hematol & Oncol, D-13353 Berlin, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schundeln, MM (corresponding author), Univ Klinikum Essen, Dept Pediat Hematol & Oncol, Kinderklin 3, Essen, Germany.	michael.schuendeln@uk-essen.de	Grasemann, Corinna/AAG-3861-2021; Eggert, Angelika/AAE-6907-2022; Schündeln, Michael M/W-3455-2018	Eggert, Angelika/0000-0003-3476-8184; Schündeln, Michael M/0000-0001-7495-9060; Grasemann, Corinna/0000-0003-1793-4603	Essen University Hospital Foundation; Faculty of Medicine, University of Duisburg-Essen	Essen University Hospital Foundation; Faculty of Medicine, University of Duisburg-Essen	JB was supported by the Essen University Hospital Foundation 'Stiftung Universitatsmedizin'. MS and CG were supported by an IFORES stipend from the 'Faculty of Medicine, University of Duisburg-Essen'. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Buison AM, 2005, PEDIATRICS, V116, P943, DOI 10.1542/peds.2004-2582; Chapelon E, 2009, EUR J HAEMATOL, V83, P572, DOI 10.1111/j.1600-0609.2009.01333.x; Dhaliwal G, 2004, AM FAM PHYSICIAN, V69, P2599; Ellis KJ, 2001, J BONE MINER RES, V16, P1658, DOI 10.1359/jbmr.2001.16.9.1658; Elmadfa I, 2011, GROSSE GU NAHRWERT K; GOLDING J S, 1956, Ann R Coll Surg Engl, V19, P296; Goodman B, 2010, PREVALENCE VITAMIN D; Guntur Anyonya R, 2013, Bonekey Rep, V2, P437, DOI 10.1038/bonekey.2013.171; HESEKER B, 2007, NAHRSTOFFE LEBENSMIT; KROMEYERHAUSCHI.K, 2001, PERZENTILE BODY MASS, P807; Lal A, 2006, PEDIATR BLOOD CANCER, V47, P901, DOI 10.1002/pbc.20681; Mahachoklertwattana P, 2003, CLIN ENDOCRINOL, V58, P273, DOI 10.1046/j.1365-2265.2003.01707.x; Morabito N, 2004, J BONE MINER RES, V19, P722, DOI 10.1359/JBMR.040113; Moreau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046101; Nouraie M, 2011, HAEMATOL-HEMATOL J, V96, P1092, DOI 10.3324/haematol.2011.042499; Osunkwo I, 2012, BRIT J HAEMATOL, V159, P211, DOI 10.1111/bjh.12019; Osunkwo I, 2011, BRIT J HAEMATOL, V153, P538, DOI 10.1111/j.1365-2141.2010.08458.x; Perisano C, 2012, ANEMIA, V2012, DOI 10.1155/2012/320737; Salama OS, 2006, HEMATOLOGY, V11, P197, DOI 10.1080/10245330600702851; Sarrai M, 2007, BRIT J HAEMATOL, V136, P666, DOI 10.1111/j.1365-2141.2006.06487.x; Soliman AT, 1998, J TROP PEDIATRICS, V44, P194, DOI 10.1093/tropej/44.4.194; Voskaridou E, 2006, HAEMATOLOGICA, V91, P813	23	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108400	10.1371/journal.pone.0108400	http://dx.doi.org/10.1371/journal.pone.0108400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299063	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200018
J	Thompson, DD; Murray, GD; Sudlow, CLM; Dennis, M; Whiteley, WN				Thompson, Douglas D.; Murray, Gordon D.; Sudlow, Cathie L. M.; Dennis, Martin; Whiteley, William N.			Comparison of Statistical and Clinical Predictions of Functional Outcome after Ischemic Stroke	PLOS ONE			English	Article							EXTERNAL VALIDATION; SCORE; MODELS; REGRESSION; MORTALITY	Background: To determine whether the predictions of functional outcome after ischemic stroke made at the bedside using a doctor's clinical experience were more or less accurate than the predictions made by clinical prediction models (CPMs). Methods and Findings: A prospective cohort study of nine hundred and thirty one ischemic stroke patients recruited consecutively at the outpatient, inpatient and emergency departments of the Western General Hospital, Edinburgh between 2002 and 2005. Doctors made informal predictions of six month functional outcome on the Oxford Handicap Scale (OHS). Patients were followed up at six months with a validated postal questionnaire. For each patient we calculated the absolute predicted risk of death or dependence (OHS >= 3) using five previously described CPMs. The specificity of a doctor's informal predictions of OHS >= 3 at six months was good 0.96 (95% CI: 0.94 to 0.97) and similar to CPMs (range 0.94 to 0.96); however the sensitivity of both informal clinical predictions 0.44 (95% CI: 0.39 to 0.49) and clinical prediction models (range 0.38 to 0.45) was poor. The prediction of the level of disability after stroke was similar for informal clinical predictions (ordinal c-statistic 0.74 with 95% CI 0.72 to 0.76) and CPMs (range 0.69 to 0.75). No patient or clinician characteristic affected the accuracy of informal predictions, though predictions were more accurate in outpatients. Conclusions: CPMs are at least as good as informal clinical predictions in discriminating between good and bad functional outcome after ischemic stroke. The place of these models in clinical practice has yet to be determined.	[Thompson, Douglas D.; Murray, Gordon D.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie L. M.; Dennis, Martin; Whiteley, William N.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Thompson, DD (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	D.Thompson-3@sms.ed.ac.uk		Whiteley, William/0000-0002-4816-8991; Sudlow, Cathie/0000-0002-7725-7520	MRC HTMR [G0800803]; MRC Clinician Scientist Fellowship [G0902303]; MRC [G0902303, G0800803] Funding Source: UKRI; Medical Research Council [G0902303, G0800803] Funding Source: researchfish	MRC HTMR(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DDT is supported by an MRC HTMR grant (G0800803). WNW is supported by an MRC Clinician Scientist Fellowship G0902303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, Stroke, V16, P397; Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002; Collins G, 2013, ANESTHESIOLOGY, V118, P1252, DOI 10.1097/ALN.0b013e31828e13e9; Counsell C, 2004, J NEUROL NEUROSUR PS, V75, P401, DOI 10.1136/jnnp.2003.018085; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Goldie FC, 2014, INT J STROKE, V9, P328, DOI 10.1111/ijs.12178; Jackson C, 2008, QJM-INT J MED, V101, P281, DOI 10.1093/qjmed/hcm152; Jackson CA, 2009, STROKE, V40, P3679, DOI 10.1161/STROKEAHA.109.558221; Kahneman D., 2011, THINKING FAST SLOW; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Lee YS, 2009, ARCH GERONTOL GERIAT, V49, pS26, DOI 10.1016/S0167-4943(09)70009-3; Muscari A, 2011, ACTA NEUROL SCAND, V124, P334, DOI 10.1111/j.1600-0404.2010.01479.x; Ntaios G, 2012, NEUROLOGY, V78, P1916, DOI 10.1212/WNL.0b013e318259e221; Papavasileiou V, 2013, STROKE, V44, P1616, DOI 10.1161/STROKEAHA.113.001047; Reid JM, 2010, AGE AGEING, V39, P360, DOI 10.1093/ageing/afq027; Saposnik G, 2013, NEUROLOGY, V81, P448, DOI 10.1212/WNL.0b013e31829d874e; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Van Calster B, 2012, BIOMETRICAL J, V54, P674, DOI 10.1002/bimj.201200026; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Zhang N, 2013, STROKE, V44, P1924, DOI 10.1161/STROKEAHA.111.000172; Zhou XH, 2008, PHILOS T R SOC A, V366, P2405, DOI 10.1098/rsta.2008.0037	25	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110189	10.1371/journal.pone.0110189	http://dx.doi.org/10.1371/journal.pone.0110189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299053	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200106
J	Galimberti, A; De Mattia, F; Bruni, I; Scaccabarozzi, D; Sandionigi, A; Barbuto, M; Casiraghi, M; Labra, M				Galimberti, Andrea; De Mattia, Fabrizio; Bruni, Ilaria; Scaccabarozzi, Daniela; Sandionigi, Anna; Barbuto, Michela; Casiraghi, Maurizio; Labra, Massimo			A DNA Barcoding Approach to Characterize Pollen Collected by Honeybees	PLOS ONE			English	Article							QUALITY-CONTROL METHODS; BEE POLLEN; SPECIES IDENTIFICATION; CHEMICAL-COMPOSITION; CHEMOMETRICS; POLLINATION; MORPHOLOGY; SEQUENCES; TIME; IRAN	In the present study, we investigated DNA barcoding effectiveness to characterize honeybee pollen pellets, a food supplement largely used for human nutrition due to its therapeutic properties. We collected pollen pellets using modified beehives placed in three zones within an alpine protected area (Grigna Settentrionale Regional Park, Italy). A DNA barcoding reference database, including rbcL and trnH-psbA sequences from 693 plant species (104 sequenced in this study) was assembled. The database was used to identify pollen collected from the hives. Fifty-two plant species were identified at the molecular level. Results suggested rbcL alone could not distinguish among congeneric plants; however, psbA-trnH identified most of the pollen samples at the species level. Substantial variability in pollen composition was observed between the highest elevation locality (Alpe Moconodeno), characterized by arid grasslands and a rocky substrate, and the other two sites (Cornisella and Ortanella) at lower altitudes. Pollen from Ortanella and Cornisella showed the presence of typical deciduous forest species; however in samples collected at Ortanella, pollen of the invasive Lonicera japonica, and the ornamental Pelargonium x hortorum were observed. Our results indicated pollen composition was largely influenced by floristic local biodiversity, plant phenology, and the presence of alien flowering species. Therefore, pollen molecular characterization based on DNA barcoding might serve useful to beekeepers in obtaining honeybee products with specific nutritional or therapeutic characteristics desired by food market demands.	[Galimberti, Andrea; De Mattia, Fabrizio; Bruni, Ilaria; Sandionigi, Anna; Barbuto, Michela; Casiraghi, Maurizio; Labra, Massimo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlantLab, Milan, Italy; [Scaccabarozzi, Daniela] Parco Reg Grigna Settentrionale, Barzio, Italy	University of Milano-Bicocca	Labra, M (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlantLab, Milan, Italy.	massimo.labra@unimib.it	Sandionigi, Anna/H-8815-2016; Casiraghi, Maurizio/E-7273-2011; Galimberti, Andrea/ABF-7019-2020; Scaccabarozzi, Daniela/AAK-8101-2021	Sandionigi, Anna/0000-0002-5257-0027; Casiraghi, Maurizio/0000-0002-2733-2094; Galimberti, Andrea/0000-0003-3140-3024; Bruni, Ilaria/0000-0002-9947-0963	Fondazione Cariplo [C91H09000010003]	Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Fondazione Cariplo grant C91H09000010003 with the project entitled "Insetti Pronubi: mezzi di connessione e diffusione di specie vegetali rare ed endemiche del parco regionale della Grigna Settentrionale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aronne G, 2012, FUNCT ECOL, V26, P1186, DOI 10.1111/j.1365-2435.2012.02017.x; Arvanitoyannis IS, 2005, CRIT REV FOOD SCI, V45, P193, DOI 10.1080/10408690590956369; BEATTIE AJ, 1971, PAN-PAC ENTOMOL, V47, P82; Bennett KD, 2006, HOLOCENE, V16, P1031, DOI 10.1177/0959683606069383; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Bruni I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043256; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Campos MGR, 2008, J APICULT RES, V47, P154, DOI 10.3896/IBRA.1.47.2.12; Ceksteryte V, 2008, BIOLOGIJA, V54, P25; Colwell RK., 2013, STAT ESTIMATION SPEC; Conti F, 2005, ANNOTATED CHECKLIST; Cotte JF, 2003, J CHROMATOGR A, V1021, P145, DOI 10.1016/j.chroma.2003.09.005; De Mattia F, 2012, BOT J LINN SOC, V169, P518, DOI 10.1111/j.1095-8339.2012.01251.x; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Estevinho LM, 2012, INT J FOOD SCI TECH, V47, P429, DOI 10.1111/j.1365-2621.2011.02859.x; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Friedman J, 2009, ANN BOT-LONDON, V103, P1515, DOI 10.1093/aob/mcp035; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Giovanetti M, 2011, B INSECTOL, V64, P77; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanner R., 2009, DATA STANDARDS BARCO; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Khansari E, 2012, FLORA, V207, P203, DOI 10.1016/j.flora.2012.01.006; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linskens HF, 1997, ECON BOT, V51, P78, DOI 10.1007/BF02910407; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; MATSUI K, 1991, Plant Species Biology, V6, P117, DOI 10.1111/j.1442-1984.1991.tb00218.x; Matsuki Y, 2007, MOL ECOL NOTES, V7, P194, DOI 10.1111/j.1471-8286.2006.01588.x; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Naciri Y, 2010, MOL ECOL RESOUR, V10, P728, DOI 10.1111/j.1755-0998.2009.02816.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nogueira C, 2012, INT J MOL SCI, V13, P11173, DOI 10.3390/ijms130911173; PAN, 2011, PAN; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Park JY, 2012, BIOCHIP J, V6, P354, DOI 10.1007/s13206-012-6407-x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rossi P, 2005, FLORA GRUPPO GRIGNE; Salmaki Y, 2008, FLORA, V203, P627, DOI 10.1016/j.flora.2007.10.005; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Szczesna T, 2006, J APIC SCI, V50, P81, DOI DOI 10.1016/J.SJBS.2017.06.003; Szczesna T, 2006, J APIC SCI, V50, P65; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tzouros NE, 2001, CRIT REV FOOD SCI, V41, P287, DOI 10.1080/20014091091823; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; Yang K, 2013, J AGR FOOD CHEM, V61, P708, DOI 10.1021/jf304056b; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Zhou LJ, 2007, AM J BOT, V94, P477, DOI 10.3732/ajb.94.3.477	58	76	80	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109363	10.1371/journal.pone.0109363	http://dx.doi.org/10.1371/journal.pone.0109363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296114	gold, Green Submitted, Green Published			2022-12-25	WOS:000345204000066
J	Goode, KJ; Poon, IKH; Phipps, S; Hulett, MD				Goode, Katharine J.; Poon, Ivan K. H.; Phipps, Simon; Hulett, Mark D.			Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; MAMMALIAN HEPARANASE; DEGRADING ENZYME; CELL-MIGRATION; LUNG INJURY; T-CELLS; LIPOPOLYSACCHARIDE; EXPRESSION; ADHESION; ROLES	Heparanase is a beta-D-endoglucuronidase that cleaves heparan sulfate (HS), facilitating degradation of the extracellular matrix (ECM) and the release of HS-bound biomolecules including cytokines. The remodeling of the ECM by heparanase is important for various physiological and pathological processes, including inflammation, wound healing, tumour angiogenesis and metastasis. Although heparanase has been proposed to facilitate leukocyte migration through degradation of the ECM, its role in inflammation by regulating the expression and release of cytokines has not been fully defined. In this study, the role of heparanase in regulating the expression and release of cytokines from human and murine immune cells was examined. Human peripheral blood mononuclear cells treated ex vivo with heparanase resulted in the release of a range of pro-inflammatory cytokines including IL-1 beta, IL-6, IL-8, IL-10 and TNF. In addition, mouse splenocytes treated ex vivo with heparanase resulted in the release of IL-6, MCP-1 and TNF. A similar pattern of cytokine release was also observed when cells were treated with soluble HS. Furthermore, heparanase-induced cytokine release was abolished by enzymatic-inhibitors of heparanase, suggesting this process is mediated via the enzymatic release of cell surface HS fragments. As soluble HS can signal through the Toll-like receptor (TLR) pathway, heparanase may promote the upregulation of cytokines through the generation of heparanase-cleaved fragments of HS. In support of this hypothesis, mouse spleen cells lacking the key TLR adaptor molecule MyD88 demonstrated an abolition of cytokine release after heparanase stimulation. Furthermore, TLR4-deficient spleen cells showed reduced cytokine release in response to heparanase treatment, suggesting that TLR4 is involved in this response. Consistent with these observations, the pathway involved in cytokine upregulation was identified as being NF-kappa beta-dependent. These data identify a new mechanism for heparanase in promoting the release of pro-inflammatory cytokines that is likely to be important in regulating cell migration and inflammation.	[Goode, Katharine J.; Poon, Ivan K. H.; Hulett, Mark D.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia; [Goode, Katharine J.] Cooperat Res Ctr Biomarker Translat, Melbourne, Vic, Australia; [Phipps, Simon] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	La Trobe University; University of Queensland	Hulett, MD (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia.	m.hulett@latrobe.edu.au	Phipps, Simon/F-9170-2010	Phipps, Simon/0000-0002-7388-3612; Hulett, Mark/0000-0003-2072-5968; Poon, Ivan/0000-0002-9119-7173; Goodall, Katharine/0000-0001-5812-8515	Australian National Health and Medical Research Council (NHMRC) [APP418008]; NHMRC [APP1013584]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian National Health and Medical Research Council (NHMRC) Research Grant [APP418008], and Ivan Poon is supported by a NHMRC Training Fellowship [APP1013584]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akbarshahi H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-219; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; Baker AB, 2010, ATHEROSCLEROSIS, V213, P436, DOI 10.1016/j.atherosclerosis.2010.09.003; Bitan M, 2010, MOL IMMUNOL, V47, P1890, DOI 10.1016/j.molimm.2010.03.014; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Campo GM, 2009, ARCH BIOCHEM BIOPHYS, V491, P7, DOI 10.1016/j.abb.2009.09.017; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Courtney SM, 2005, BIOORG MED CHEM LETT, V15, P2295, DOI 10.1016/j.bmcl.2005.03.014; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; de Mestre AM, 2007, J LEUKOCYTE BIOL, V82, P1289, DOI 10.1189/jlb.0507315; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldberg R, 2013, MATRIX BIOL, V32, P234, DOI 10.1016/j.matbio.2013.02.008; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HERSHKOVIZ R, 1995, J AUTOIMMUN, V8, P741, DOI 10.1006/jaut.1995.0055; Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Irie F, 2008, P NATL ACAD SCI USA, V105, P12307, DOI 10.1073/pnas.0801302105; Irony-Tur-Sinai M, 2003, J NEUROL SCI, V206, P49, DOI 10.1016/S0022-510X(02)00318-0; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Konno S, 2005, J INTERF CYTOK RES, V25, P277, DOI 10.1089/jir.2005.25.277; Korpos E, 2010, CELL TISSUE RES, V339, P47, DOI 10.1007/s00441-009-0853-3; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lerner A, 2011, MED HYPOTHESES, V77, P1, DOI 10.1016/j.mehy.2011.04.033; Li RW, 2008, ARTHRITIS RHEUM, V58, P1590, DOI 10.1002/art.23489; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038659; Lygizos MI, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.153; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mitchell MD, 2004, J CLIN ENDOCR METAB, V89, P4149, DOI 10.1210/jc.2004-0373; Mora Carmen, 2006, Curr Diab Rep, V6, P463, DOI 10.1007/s11892-006-0080-1; NAPARSTEK E, 1993, BONE MARROW TRANSPL, V12, P185; Nasser NJ, 2008, CELL MOL LIFE SCI, V65, P1706, DOI 10.1007/s00018-008-7584-6; Novick D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085944; Parish CR, 2013, MATRIX BIOL, V32, P228, DOI 10.1016/j.matbio.2013.02.007; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Poon IKH, 2014, EUR J IMMUNOL, V44, P1016, DOI 10.1002/eji.201343645; Poon IKH, 2010, BLOOD, V115, P2473, DOI 10.1182/blood-2009-07-234013; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Sciumbata T, 1996, INVAS METAST, V16, P132; Sharif MN, 2004, J IMMUNOL, V172, P6476, DOI 10.4049/jimmunol.172.10.6476; Simeonovic CJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00471; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Vanlandschoot P, 2005, J GEN VIROL, V86, P323, DOI 10.1099/vir.0.80605-0; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2013, MATRIX BIOL, V32, P241, DOI 10.1016/j.matbio.2013.03.002; Waterman M, 2007, MODERN PATHOL, V20, P8, DOI 10.1038/modpathol.3800710; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Zcharia E, 2005, FASEB J, V19, P211, DOI 10.1096/fj.04-1970com; Zhang Z, 2014, MOL MED REP, V10, P101, DOI 10.3892/mmr.2014.2226	65	133	139	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109596	10.1371/journal.pone.0109596	http://dx.doi.org/10.1371/journal.pone.0109596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295599	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000083
J	Mercer, KL; Emry, DJ; Snow, AA; Kost, MA; Pace, BA; Alexander, HM				Mercer, Kristin L.; Emry, D. Jason; Snow, Allison A.; Kost, Matthew A.; Pace, Brian A.; Alexander, Helen M.			Fitness of Crop-Wild Hybrid Sunflower under Competitive Conditions: Implications for Crop-to-Wild Introgression	PLOS ONE			English	Article							GENE FLOW; HELIANTHUS-ANNUUS; RISK-ASSESSMENT; LIFE-HISTORY; SEED SIZE; FECUNDITY; PLANT; POPULATIONS; SELECTION; TRANSGENES	Understanding the likelihood and extent of introgression of novel alleles in hybrid zones requires comparison of lifetime fitness of parents and hybrid progeny. However, fitness differences among cross types can vary depending on biotic conditions, thereby influencing introgression patterns. Based on past work, we predicted that increased competition would enhance introgression between cultivated and wild sunflower (Helianthus annuus) by reducing fitness advantages of wild plants. To test this prediction, we established a factorial field experiment in Kansas, USA where we monitored the fitness of four cross types (Wild, F-1, F-2, and BCw hybrids) under different levels of interspecific and intraspecific competition. Intraspecific manipulations consisted both of density of competitors and of frequency of crop-wild hybrids. We recorded emergence of overwintered seeds, survival to reproduction, and numbers of seeds produced per reproductive plant. We also calculated two compound fitness measures: seeds produced per emerged seedling and seeds produced per planted seed. Cross type and intraspecific competition affected emergence and survival to reproduction, respectively. Further, cross type interacted with competitive treatments to influence all other fitness traits. More intense competition treatments, especially related to density of intraspecific competitors, repeatedly reduced the fitness advantage of wild plants when considering seeds produced per reproductive plant and per emerged seedling, and F-2 plants often became indistinguishable from the wilds. Wild fitness remained superior when seedling emergence was also considered as part of fitness, but the fitness of F-2 hybrids relative to wild plants more than quadrupled with the addition of interspecific competitors and high densities of intraspecific competitors. Meanwhile, contrary to prediction, lower hybrid frequency reduced wild fitness advantage. These results emphasize the importance of taking a full life cycle perspective. Additionally, due to effects of exogenous selection, a given hybrid generation may be especially well-suited to hastening introgression under particular environmental conditions.	[Mercer, Kristin L.; Kost, Matthew A.; Pace, Brian A.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Emry, D. Jason; Alexander, Helen M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Emry, D. Jason] Washburn Univ, Topeka, KS 66621 USA; [Snow, Allison A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Kansas; Washburn University; University System of Ohio; Ohio State University	Mercer, KL (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.	mercer.97@osu.edu	Mercer, Kristin/K-2000-2012		University of Kansas Field Station; research unit of the Kansas Biological Survey; University of Kansas; Biotechnology Risk Assessment Grant Program [2006-39454-17438]; State and Federal funds	University of Kansas Field Station; research unit of the Kansas Biological Survey; University of Kansas; Biotechnology Risk Assessment Grant Program; State and Federal funds	The study was conducted at and partially supported by the University of Kansas Field Station, a research unit of the Kansas Biological Survey and the University of Kansas. It was also supported by Biotechnology Risk Assessment Grant Program competitive grant no. 2006-39454-17438 to AAS, KLM, and HMA from the United States Department of Agriculture, National Institute of Food and Agriculture; www.nifa.usda.gov. Salaries and research support also provided by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, Ohio State University: manuscript no. HCS-14-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HM, 2014, AM J BOT, V101, P1176, DOI 10.3732/ajb.1400088; Alexander HM, 2012, J ECOL, V100, P88, DOI 10.1111/j.1365-2745.2011.01917.x; Allainguillaume J, 2009, NEW PHYTOL, V183, P1201, DOI 10.1111/j.1469-8137.2009.02877.x; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; ARIAS DM, 1994, THEOR APPL GENET, V89, P655, DOI 10.1007/BF00223700; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Burke JM, 2002, AM J BOT, V89, P1550, DOI 10.3732/ajb.89.9.1550; Campbell DR, 2007, AM NAT, V169, P298, DOI 10.1086/510758; Campbell LG, 2007, NEW PHYTOL, V173, P648, DOI 10.1111/j.1469-8137.2006.01941.x; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Cummings CL, 2002, OECOLOGIA, V130, P274, DOI 10.1007/s004420100806; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Hails RS, 2005, TRENDS ECOL EVOL, V20, P245, DOI 10.1016/j.tree.2005.02.006; Hauser TP, 2003, AM J BOT, V90, P571, DOI 10.3732/ajb.90.4.571; Heino M, 1998, TRENDS ECOL EVOL, V13, P367, DOI 10.1016/S0169-5347(98)01380-9; Hooftman DAP, 2005, J APPL ECOL, V42, P1086, DOI 10.1111/j.1365-2664.2005.01086.x; Hovick SM, 2012, AM NAT, V179, P192, DOI 10.1086/663684; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kimball S, 2008, J ECOL, V96, P1306, DOI 10.1111/j.1365-2745.2008.01432.x; Laughlin KD, 2009, ECOL APPL, V19, P1091, DOI 10.1890/08-0105.1; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Mercer KL, 2007, ECOL LETT, V10, P383, DOI 10.1111/j.1461-0248.2007.01029.x; Mercer KL, 2006, EVOLUTION, V60, P2044, DOI 10.1111/j.0014-3820.2006.tb01842.x; Mercer KL, 2011, AM J BOT, V98, P975, DOI 10.3732/ajb.1000408; Nagy ES, 1997, EVOLUTION, V51, P1469, DOI [10.1111/j.1558-5646.1997.tb01470.x, 10.2307/2411199]; Pace BA, 2012, THESIS OHIO STATE U; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rieseberg LH, 2001, TAXON, V50, P47, DOI 10.2307/1224511; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Snow AA, 1997, BIOSCIENCE, V47, P86, DOI 10.2307/1313019; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; Snow AA, 1998, AM J BOT, V85, P794, DOI 10.2307/2446414; STANTON ML, 1984, ECOLOGY, V65, P1105, DOI 10.2307/1938318; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; TILMAN D, 1988; Vacher C, 2004, THEOR APPL GENET, V109, P806, DOI 10.1007/s00122-004-1696-7; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Weiss AN, 2013, SEED SCI RES, V23, P241, DOI 10.1017/S0960258513000226; Whitton J, 1997, THEOR APPL GENET, V95, P33, DOI 10.1007/s001220050529; WULFF RD, 1986, J ECOL, V74, P115, DOI 10.2307/2260352; Xiao ZS, 2010, BEHAV ECOL, V21, P169, DOI 10.1093/beheco/arp169; Yang X, 2011, EVOL APPL, V4, P672, DOI 10.1111/j.1752-4571.2011.00190.x	49	21	22	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109001	10.1371/journal.pone.0109001	http://dx.doi.org/10.1371/journal.pone.0109001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295859	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000029
J	Tait, J; Perotto-Baldivieso, HL; McKeown, A; Westcott, DA				Tait, Jessica; Perotto-Baldivieso, Humberto L.; McKeown, Adam; Westcott, David A.			Are Flying-Foxes Coming to Town? Urbanisation of the Spectacled Flying-Fox (Pteropus conspicillatus) in Australia	PLOS ONE			English	Article							NEW-SOUTH-WALES; FRUIT BATS; POLIOCEPHALUS; LANDSCAPE; WILDLIFE; PTEROPODIDAE; ECOLOGY; BIRDS; AVAILABILITY; CONNECTIVITY	Urbanisation of wildlife populations is a process with significant conservation and management implications. While urban areas can provide habitat for wildlife, some urbanised species eventually come into conflict with humans. Understanding the process and drivers of wildlife urbanisation is fundamental to developing effective management responses to this phenomenon. In Australia, flying-foxes (Pteropodidae) are a common feature of urban environments, sometimes roosting in groups of tens of thousands of individuals. Flying-foxes appear to be becoming increasingly urbanised and are coming into increased contact and conflict with humans. Flying-fox management is now a highly contentious issue. In this study we used monitoring data collected over a 15 year period (1998-2012) to examine the spatial and temporal patterns of association of spectacled flying-fox (Pteropus conspicillatus) roost sites (camps) with urban areas. We asked whether spectacled flying-foxes are becoming more urbanised and test the hypothesis that such changes are associated with anthropogenic changes to landscape structure. Our results indicate that spectacled flying-foxes were more likely to roost near humans than might be expected by chance, that over the period of the study the proportion of the flying-foxes in urban-associated camps increased, as did the number of urban camps. Increased urbanisation of spectacled flying-foxes was not related to changes in landscape structure or to the encroachment of urban areas on camps. Overall, camps tended to be found in areas that were more fragmented, closer to human habitation and with more urban land cover than the surrounding landscape. This suggests that urbanisation is a behavioural response rather than driven by habitat loss.	[Tait, Jessica; Perotto-Baldivieso, Humberto L.] Cranfield Univ, Sch Energy Environm & Agrifood, Cranfield MK43 0AL, Beds, England; [McKeown, Adam] CSIRO, Sustainable Land & Water, Smithfield, Qld, Australia; [Tait, Jessica; Westcott, David A.] CSIRO, Sustainable Land & Water, Atherton, Qld, Australia	Cranfield University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Westcott, DA (corresponding author), CSIRO, Sustainable Land & Water, Atherton, Qld, Australia.	David.Westcott@csiro.au	Perotto-Baldivieso, Humberto/M-1123-2019; McKeown, Adam/D-3170-2011; Westcott, David A/G-5559-2010	Perotto-Baldivieso, Humberto/0000-0001-7700-7110; 	Bat Conservation International; Commonwealth of Australia's Department of the Environment; National Environmental Research Program; Rural Industries Research Development Corporation (through Commonwealth of Australia); Rural Industries Research Development Corporation (through State of New South Wales); Rural Industries Research Development Corporation (through State of Queensland under the National Hendra Virus Research Program)	Bat Conservation International; Commonwealth of Australia's Department of the Environment; National Environmental Research Program; Rural Industries Research Development Corporation (through Commonwealth of Australia); Rural Industries Research Development Corporation (through State of New South Wales); Rural Industries Research Development Corporation (through State of Queensland under the National Hendra Virus Research Program)	This research was supported by a grant from Bat Conservation International to JT and funding to DAW from the Commonwealth of Australia's Department of the Environment, the National Environmental Research Program and the Rural Industries Research Development Corporation (through funding from the Commonwealth of Australia, the State of New South Wales and the State of Queensland under the National Hendra Virus Research Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; CRAIG P, 1994, BIOL CONSERV, V69, P261, DOI 10.1016/0006-3207(94)90425-1; Curtis Paul D., 2010, P201; Davis A, 2012, LANDSCAPE URBAN PLAN, V106, P191, DOI 10.1016/j.landurbplan.2012.03.005; Davis A, 2011, LANDSCAPE URBAN PLAN, V100, P295, DOI 10.1016/j.landurbplan.2010.12.017; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; Eby Peggy, 1999, Australian Zoologist, V31, P240; Esselstyn JA, 2006, PAC SCI, V60, P531, DOI 10.1353/psc.2006.0027; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Garnett Stephen, 1999, Australian Zoologist, V31, P38; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Johnston Richard F., 2001, P49; Jokimaki J, 2011, LANDSCAPE URBAN PLAN, V100, P383, DOI 10.1016/j.landurbplan.2011.02.001; Lunney D., 1997, AUSTR EVER CHANGING, P247; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Mahmood-ul-Hassan M, 2010, ACTA CHIROPTEROL, V12, P341, DOI 10.3161/150811010X537927; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; McGarigal K., 2012, TECH REP; McKeown A, 2012, AUSTRAL ECOL, V37, P295, DOI 10.1111/j.1442-9993.2011.02276.x; McKinney RA, 2013, URBAN ECOSYST, V16, P411, DOI 10.1007/s11252-012-0274-z; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Nakamoto A, 2007, ACTA CHIROPTEROL, V9, P237, DOI 10.3161/1733-5329(2007)9[237:FHOOFP]2.0.CO;2; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Parry-Jones KA, 2001, AUSTRAL ECOL, V26, P47, DOI 10.1111/j.1442-9993.2001.01072.pp.x; Parsons JG, 2009, J WILDLIFE MANAGE, V73, P526, DOI 10.2193/2008-268; Perotto-Baldivieso HL, 2009, BIODIVERS CONSERV, V18, P905, DOI 10.1007/s10531-008-9520-3; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Puth LM, 2009, DIVERS DISTRIB, V15, P12, DOI 10.1111/j.1472-4642.2008.00499.x; Queensland Department of Environment and Resource Management, 2010, NAT REC PLAN SPECT F; Queensland Treasury and Trade, 2012, POP DWELL PROF FAR N; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Roberts BJ, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P277; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shilton LA, 2008, AUSTRAL ECOL, V33, P549, DOI 10.1111/j.1442-9993.2008.01910.x; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Stork N., 2009, LIVING DYNAMIC TROPI; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Urbanek RE, 2011, WILDLIFE SOC B, V35, P310, DOI 10.1002/wsb.37; van der Ree R, 2006, J ZOOL, V268, P177, DOI 10.1111/j.1469-7998.2005.00005.x; Westcott D.A., 2001, SPECTACLED FLYING FO; Williams NSG, 2006, AUSTRAL ECOL, V31, P190, DOI 10.1111/j.1442-9993.2006.01590.x; Zuckerberg B, 2011, J ANIM ECOL, V80, P403, DOI 10.1111/j.1365-2656.2010.01780.x	49	44	46	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109810	10.1371/journal.pone.0109810	http://dx.doi.org/10.1371/journal.pone.0109810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295724	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000098
J	Zhu, CP; Pan, FY; Ge, LP; Zhou, J; Chen, LLL; Zhou, T; Zong, RR; Xiao, XY; Dong, N; Yang, MM; Ma, JX; Liu, ZG; Zhou, YP				Zhu, Chengpeng; Pan, Fangyu; Ge, Lianping; Zhou, Jing; Chen, Longlong; Zhou, Tong; Zong, Rongrong; Xiao, Xinye; Dong, Nuo; Yang, Maomin; Ma, Jian-xing; Liu, Zuguo; Zhou, Yueping			SERPINA3K Plays Antioxidant Roles in Cultured Pterygial Epithelial Cells through Regulating ROS System	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; EXPRESSION; PATHWAY; PROLIFERATION; LOCALIZATION; PATHOGENESIS; BEVACIZUMAB; ACTIVATION; MECHANISMS	We recently demonstrated that SERPINA3K, a serine proteinase inhibitor, has antioxidant activity in the cornea. Here we investigated the antioxidant effects of SERPINA3K on the pterygial, which is partially caused by oxidative stress in pathogenesis. The head part of primary pterygial tissue was dissected and then cultured in keratinocyte serum-free defined medium (KSFM). The cultured pterygial epithelial cells (PECs) were treated with SERPINA3K. The cell proliferation and migration of PECs were measured and analyzed. Western blot and quantitative real-time polymerase chain reaction (PCR) assay were performed. It showed that SERPINA3K significantly suppressed the cell proliferation of PECs in a concentration-dependent manner, compared with cultured human conjunctival epithelial cells. SERPINA3K also inhibited the cell migration of PECs. Towards its underlying mechanism, SERPINA3K had antioxidant activities on the PECs by significantly inhibiting NADPH oxidase 4 (NOX4), which is an important enzyme of ROS generation, and by elevating the levels of key antioxidant factors of ROS: such as NAD(P) H dehydrogenase (quinone 1) (NQO1), NF-E2-related factor-2 (NRF2) and superoxide dismutases (SOD2). Meanwhile, SERPINA3K down-regulated the key effectors of Wnt signaling pathway: beta-catenin, nonphospho-beta-catenin, and low-density lipoprotein receptor-related protein 6 (LRP6). We provided novel evidence that SERPINA3K had inhibitory effects on pterygium and SERPINA3K played antioxidant role via regulating the ROS system and antioxidants.	[Zhu, Chengpeng; Pan, Fangyu; Ge, Lianping; Zhou, Jing; Chen, Longlong; Zhou, Tong; Zong, Rongrong; Xiao, Xinye; Liu, Zuguo; Zhou, Yueping] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Inst Eye, Xiamen, Fujian, Peoples R China; [Dong, Nuo; Liu, Zuguo] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Yang, Maomin] Xiamen Kehong Eye Hosp, Xiamen, Fujian, Peoples R China; [Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	Xiamen University; Xiamen University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhou, YP (corresponding author), Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Inst Eye, Xiamen, Fujian, Peoples R China.	ypzhou@yahoo.com			Natural Science Foundation of China [81170818]; National High Technology Research and Development Program of China [2012AA020507]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This project was supported by a grant from Natural Science Foundation of China (grant No. 81170818) and by a grant from National High Technology Research and Development Program of China (grant No. 2012AA020507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balci M, 2011, MOL VIS, V17, P443; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; CHAI KX, 1991, J BIOL CHEM, V266, P16029; Chowers I, 2001, OPHTHALMOLOGY, V108, P985, DOI 10.1016/S0161-6420(00)00651-5; Chui J, 2011, AM J PATHOL, V178, P817, DOI 10.1016/j.ajpath.2010.10.037; Cimpean AM, 2013, MOL VIS, V19, P348; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Kase S, 2007, BRIT J OPHTHALMOL, V91, P958, DOI 10.1136/bjo.2006.110387; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kato N, 2007, INVEST OPHTH VIS SCI, V48, P1511, DOI 10.1167/iovs.06-1060; Khandhadia S, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000164X; Kietzmann T, 2010, ANTIOXID REDOX SIGN, V13, P395, DOI 10.1089/ars.2009.3001; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liang K, 2011, MOL VIS, V17, P1687; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; Nakasato H, 2012, CORNEA, V31, P1339, DOI 10.1097/ICO.0b013e3182408bc7; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ozgurhan EB, 2013, CORNEA, V32, P835, DOI 10.1097/ICO.0b013e3182772d4e; Perra MT, 2006, MOL VIS, V12, P1136; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Schelonka LP, 2000, INVEST OPHTH VIS SCI, V41, P1617; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Tsai YY, 2005, MOL VIS, V11, P71; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu K, 2013, MOL VIS, V19, P604; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhou T, 2011, DIABETOLOGIA, V54, P459, DOI 10.1007/s00125-010-1943-1; Zhou T, 2012, INVEST OPHTH VIS SCI, V53, P5033, DOI 10.1167/iovs.12-9729	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108859	10.1371/journal.pone.0108859	http://dx.doi.org/10.1371/journal.pone.0108859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296038	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000023
J	Bose, AS; Jafari, H; Sosler, S; Narula, APS; Kulkarni, VM; Ramamurty, N; Oommen, J; Jadi, RS; Banpel, RV; Henao-Restrepo, AM				Bose, Anindya Sekhar; Jafari, Hamid; Sosler, Stephen; Narula, Arvinder Pal Singh; Kulkarni, V. M.; Ramamurty, Nalini; Oommen, John; Jadi, Ramesh S.; Banpel, R. V.; Henao-Restrepo, Ana Maria			Case Based Measles Surveillance in Pune: Evidence to Guide Current and Future Measles Control and Elimination Efforts in India	PLOS ONE			English	Article							MORTALITY; AMERICA; VACCINE	Background: According to WHO estimates, 35% of global measles deaths in 2011 occurred in India. In 2013, India committed to a goal of measles elimination by 2020. Laboratory supported case based measles surveillance is an essential component of measles elimination strategies. Results from a case-based measles surveillance system in Pune district (November 2009 through December 2011) are reported here with wider implications for measles elimination efforts in India. Methods: Standard protocols were followed for case identification, investigation and classification. Suspected measles cases were confirmed through serology (IgM) or epidemiological linkage or clinical presentation. Data regarding age, sex, vaccination status were collected and annualized incidence rates for measles and rubella cases calculated. Results: Of the 1011 suspected measles cases reported to the surveillance system, 76% were confirmed measles, 6% were confirmed rubella, and 17% were non-measles, non-rubella cases. Of the confirmed measles cases, 95% were less than 15 years of age. Annual measles incidence rate was more than 250 per million persons and nearly half were associated with outbreaks. Thirty-nine per cent of the confirmed measles cases were vaccinated with one dose of measles vaccine (MCV1). Conclusion: Surveillance demonstrated high measles incidence and frequent outbreaks in Pune where MCV1 coverage in infants was above 90%. Results indicate that even high coverage with a single dose of measles vaccine was insufficient to provide population protection and prevent measles outbreaks. An effective measles and rubella surveillance system provides essential information to plan, implement and evaluate measles immunization strategies and monitor progress towards measles elimination.	[Bose, Anindya Sekhar; Jafari, Hamid; Sosler, Stephen; Narula, Arvinder Pal Singh; Banpel, R. V.] WHO, India Country Off, Natl Polio Surveillance Project, New Delhi, India; [Bose, Anindya Sekhar] Bill & Melinda Gates Fdn, New Delhi, India; [Jafari, Hamid; Henao-Restrepo, Ana Maria] WHO, CH-1211 Geneva, Switzerland; [Sosler, Stephen] GAVI, Vaccine Alliance, Geneva, Switzerland; [Kulkarni, V. M.] Govt Maharashtra, Dept Hlth & Family Welf, Pune, Maharashtra, India; [Ramamurty, Nalini; Oommen, John] WHO, South East Asia Reg Off, New Delhi, India; [Jadi, Ramesh S.] Indian Council Med Res, Natl Inst Virol, Pune, Maharashtra, India	World Health Organization; World Health Organization; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Bose, AS (corresponding author), WHO, India Country Off, Natl Polio Surveillance Project, New Delhi, India.	anindyasbose@gmail.com	Jadi, Ramesh/AAV-2059-2020; Oommen, B. John/P-6323-2017	Jadi, Ramesh/0000-0002-5710-4893; Oommen, B. John/0000-0002-5105-1575; John, Oommen/0000-0002-9008-1726; Bose, Anindya Sekhar/0000-0002-7657-8648	Measles Aerosol Vaccine Project; Bill and Melinda Gates Foundation	Measles Aerosol Vaccine Project; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	WHO-India Country Office received funds from the Measles Aerosol Vaccine Project to set up the surveillance system. World Health Organization Initiative for Vaccine Research (WHO/IVR) coordinated Measles Aerosol Vaccine Project (MAVP). The Centre for Disease Control and Prevention (CDC), USA and the American Red Cross (ARC) are partners in MAVP, which has received financial support from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P29; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P490; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; [Anonymous], 2010, 63 HLTH ASS A63 18; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Clements C, 2004, GLOBAL EPIDEMIOLOGY, P75; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; GPEI, 2013, POL ER ENDG STRAG PL; Gupta SK, 2011, INDIAN PEDIATR, V48, P379, DOI 10.1007/s13312-011-0066-1; Guris D, 2004, J INFECT DIS, V189, pS177, DOI 10.1086/374606; Guris D, 2002, MODULE BEST PRACTICE; Hersh BS, 2000, LANCET, V355, P1943, DOI 10.1016/S0140-6736(00)02325-4; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Ministry Of Health And Family Welfare Goi New Delhi, 2005, MEAS MORT RED IND ST; MOHFW-GOI, 2009, NAT HLTH PROF 2008; [MOHFW-GOI Government Of India Dohfw], 2006, FIELD GUID MEASL SUR; Moss WJ, 2009, IMMUNOLOGICAL BASIS; Murhekar MV, 2011, J INFECT DIS, V204, pS427, DOI 10.1093/infdis/jir062; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Oum S, 2005, TROP MED INT HEALTH, V10, P689, DOI 10.1111/j.1365-3156.2005.01445.x; PAHO, 2005, MEAS EL FIELD GUID; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Singh J, 1999, Indian Pediatr, V36, P249; Singh Jagvir, 1994, Journal of Communicable Diseases, V26, P203; Sosler Stephen, 2011, Morbidity and Mortality Weekly Report, V60, P1315; Sudfeld CR, 2009, INDIAN PEDIATR, V46, P983; UNICEF-India, 2010, COV EV SURV 2009 ALL; WHO-NPSP, 2011, MONTHL MEASL SURV B; World Health Organisation, 2008, WHO REC STAND SURV S; World Health Organization, 2007, MAN LAB DIAGN MEAS R	30	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108786	10.1371/journal.pone.0108786	http://dx.doi.org/10.1371/journal.pone.0108786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290339	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000026
J	Pau, S; Still, CJ				Pau, Stephanie; Still, Christopher J.			Phenology and Productivity of C-3 and C-4 Grasslands in Hawaii	PLOS ONE			English	Article							GREAT-PLAINS; ECOLOGICAL DISTRIBUTION; TALLGRASS PRAIRIE; GRASSES; PHOTOSYNTHESIS; VARIABILITY; PHYLOGENY; CLIMATE; PLANTS; NICHE	Grasslands account for a large proportion of global terrestrial productivity and play a critical role in carbon and water cycling. Within grasslands, photosynthetic pathway is an important functional trait yielding different rates of productivity along environmental gradients. Recently, C-3-C-4 sorting along spatial environmental gradients has been reassessed by controlling for confounding traits in phylogenetically structured comparisons. C-3 and C-4 grasses should sort along temporal environmental gradients as well, resulting in differing phenologies and growing season lengths. Here we use 10 years of satellite data (NDVI) to examine the phenology and greenness (as a proxy for productivity) of C-3 and C-4 grass habitats, which reflect differences in both environment and plant physiology. We perform phylogenetically structured comparisons based on 3,595 digitized herbarium collections of 152 grass species across the Hawaiian Islands. Our results show that the clade identity of grasses captures differences in their habitats better than photosynthetic pathway. Growing season length (GSL) and associated productivity (GSP) were not significantly different when considering photosynthetic type alone, but were indeed different when considering photosynthetic type nested within clade. The relationship between GSL and GSP differed most strongly between C-3 clade habitats, and not between C-3-C-4 habitats. Our results suggest that accounting for the interaction between phylogeny and photosynthetic pathway can help improve predictions of productivity, as commonly used C-3-C-4 classifications are very broad and appear to mask important diversity in grassland ecosystem functions.	[Pau, Stephanie] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA; [Still, Christopher J.] Oregon State Univ, Corvallis, OR 97331 USA	State University System of Florida; Florida State University; Oregon State University	Pau, S (corresponding author), Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA.	spau@fsu.edu		Still, Christopher/0000-0002-8295-4494	NSF [EF-0553768]; University of California, Santa Barbara; State of California; Florida State University's Committee on Faculty Research Support (COFRS) Award; NASA New Investigator Program award	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Florida State University's Committee on Faculty Research Support (COFRS) Award; NASA New Investigator Program award	This work was initiated while SP was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. SP completed revisions with the support of Florida State University's Committee on Faculty Research Support (COFRS) Award. CJS acknowledges the support of a NASA New Investigator Program award that initially supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Angelo CL, 2013, ECOGRAPHY, V36, P551, DOI 10.1111/j.1600-0587.2012.07754.x; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Burnham K.P., 2010, MODEL SELECTION MULT; Cabido M, 2007, J BIOGEOGR, V24, P197; CAVAGNARO JB, 1988, OECOLOGIA, V76, P273, DOI 10.1007/BF00379962; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; CHAZDON RL, 1978, BIOTROPICA, V10, P265, DOI 10.2307/2387678; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Davidson A, 2003, REMOTE SENS ENVIRON, V86, P70, DOI 10.1016/S0034-4257(03)00069-5; Dunn AL, 2007, GLOBAL CHANGE BIOL, V13, P577, DOI 10.1111/j.1365-2486.2006.01221.x; Edwards EJ, 2008, ECOL LETT, V11, P266, DOI 10.1111/j.1461-0248.2007.01144.x; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Epstein HE, 1997, ECOLOGY, V78, P722; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Foody GM, 2007, ECOL INFORM, V2, P89, DOI 10.1016/j.ecoinf.2007.03.009; Foody GM, 2010, INT J REMOTE SENS, V31, P351, DOI 10.1080/01431160902887339; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Goodin DG, 1997, REMOTE SENS ENVIRON, V61, P270, DOI 10.1016/S0034-4257(97)00043-6; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; KEMP PR, 1980, ECOLOGY, V61, P846, DOI 10.2307/1936755; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mooney H. A., 1972, Annual Review of Ecology and Systematics, V3, P315, DOI 10.1146/annurev.es.03.110172.001531; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Newell C, 1968, PHYTOSOCIOLOGICAL ST; Nippert JB, 2012, PLANT SOIL, V355, P385, DOI 10.1007/s11104-011-1112-4; ODE DJ, 1980, ECOLOGY, V61, P1304, DOI 10.2307/1939038; Osborne CP, 2009, P ROY SOC B-BIOL SCI, V276, P1753, DOI 10.1098/rspb.2008.1762; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Powell RL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00162.1; Reed BC, 2009, INFORM SYST, V5, P703; REICH PB, 1991, OECOLOGIA, V86, P16, DOI 10.1007/BF00317383; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Richardson AD, 2012, GLOBAL CHANGE BIOL, V18, P566, DOI 10.1111/j.1365-2486.2011.02562.x; RUNDEL PW, 1980, OECOLOGIA, V45, P354, DOI 10.1007/BF00540205; Sage RF, 1999, C4 PLANT BIOL; Saugier B., 2001, TERRESTRIAL GLOBAL P, P543, DOI [10.1016/B978-0-12-505290-0.X5000-5, DOI 10.1016/B978-012505290-0/50024-7]; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Still CJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P286, DOI 10.1111/geb.12121; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Still CJ, 2003, OECOLOGIA, V136, P347, DOI 10.1007/s00442-003-1274-8; Taylor G, 2008, GLOBAL CHANGE BIOL, V14, P264, DOI 10.1111/j.1365-2486.2007.01473.x; Taylor SH, 2010, NEW PHYTOL, V185, P780, DOI 10.1111/j.1469-8137.2009.03102.x; TIESZEN LL, 1979, OECOLOGIA, V37, P337, DOI 10.1007/BF00347910; Tieszen LL, 1997, ECOL APPL, V7, P59, DOI 10.2307/2269407; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; Wang CZ, 2010, REMOTE SENS ENVIRON, V114, P531, DOI 10.1016/j.rse.2009.10.010; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	58	11	11	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107396	10.1371/journal.pone.0107396	http://dx.doi.org/10.1371/journal.pone.0107396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290341	gold, Green Published			2022-12-25	WOS:000342798000004
J	Qing, J; Yan, D; Zhou, Y; Liu, Q; Wu, WJ; Xiao, Z; Liu, YY; Liu, J; Du, LL; Xie, DH; Liu, XZ				Qing, Jie; Yan, Denise; Zhou, Yuan; Liu, Qiong; Wu, Weijing; Xiao, Zian; Liu, Yuyuan; Liu, Jia; Du, Lilin; Xie, Dinghua; Liu, Xue Zhong			Whole-Exome Sequencing to Decipher the Genetic Heterogeneity of Hearing Loss in a Chinese Family with Deaf by Deaf Mating	PLOS ONE			English	Article							RIBOSOMAL-RNA MUTATION; DOMINANT OPTIC ATROPHY; WOLFRAM-SYNDROME; WFS1 GENE; MISSENSE MUTATION; TRANSMEMBRANE PROTEIN; DIABETES-MELLITUS; NOVO MUTATIONS; IMPAIRMENT; PHENOTYPE	Inherited deafness has been shown to have high genetic heterogeneity. For many decades, linkage analysis and candidate gene approaches have been the main tools to elucidate the genetics of hearing loss. However, this associated study design is costly, time-consuming, and unsuitable for small families. This is mainly due to the inadequate numbers of available affected individuals, locus heterogeneity, and assortative mating. Exome sequencing has now become technically feasible and a cost-effective method for detection of disease variants underlying Mendelian disorders due to the recent advances in next-generation sequencing (NGS) technologies. In the present study, we have combined both the Deafness Gene Mutation Detection Array and exome sequencing to identify deafness causative variants in a large Chinese composite family with deaf by deaf mating. The simultaneous screening of the 9 common deafness mutations using the allele-specific PCR based universal array, resulted in the identification of the 1555A>G in the mitochondrial DNA (mtDNA) 12S rRNA in affected individuals in one branch of the family. We then subjected the mutation-negative cases to exome sequencing and identified novel causative variants in the MYH14 and WFS1 genes. This report confirms the effective use of a NGS technique to detect pathogenic mutations in affected individuals who were not candidates for classical genetic studies.	[Qing, Jie; Zhou, Yuan; Wu, Weijing; Xiao, Zian; Liu, Yuyuan; Liu, Jia; Xie, Dinghua; Liu, Xue Zhong] Cent S Univ, Xiangya Hosp 2, Inst Otol, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Qing, Jie; Yan, Denise; Liu, Qiong; Du, Lilin; Liu, Xue Zhong] Univ Miami, Leonard M Miller Sch Med, Dept Otolaryngol, Miami, FL USA; [Qing, Jie; Yan, Denise; Liu, Qiong; Du, Lilin; Liu, Xue Zhong] Univ Miami, Leonard M Miller Sch Med, Dept Head & Neck Surg, Miami, FL USA	Central South University; University of Miami; University of Miami	Xie, DH (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Otol, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.	dhuaxie@163.com; xliu@med.Miami.edu			Cochlear Implantation Program of Hunan, China; National Basic Research Program of China (973) [2012CB967900, 2012CB967904]; National Institutes of Health (NIH) [R01DC005575, R01DC012546, R01DC012115]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012115, R01DC005575, R01DC012546] Funding Source: NIH RePORTER	Cochlear Implantation Program of Hunan, China; National Basic Research Program of China (973)(National Basic Research Program of China); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants from the Cochlear Implantation Program of Hunan, China, and National Basic Research Program of China (973) (grants 2012CB967900 and 2012CB967904). This work also was supported by National Institutes of Health (NIH) (grant R01DC005575, R01DC012546 and R01DC012115) to XZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bae JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042463; Bespalova IN, 2001, HUM MOL GENET, V10, P2501, DOI 10.1093/hmg/10.22.2501; Bom SJH, 1999, BRIT J AUDIOL, V33, P335, DOI 10.3109/03005369909090117; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Chistiakov Dimitry A, 2010, Rev Diabet Stud, V7, P285, DOI 10.1900/RDS.2010.7.285; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Cryns K, 2002, HUM GENET, V110, P389, DOI 10.1007/s00439-002-0719-1; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; Fuchs SA, 2012, METALLOMICS, V4, P606, DOI 10.1039/c2mt20034a; Fujikawa T, 2010, LARYNGOSCOPE, V120, P166, DOI 10.1002/lary.20691; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goncalves AC, 2014, GENE, V538, P288, DOI 10.1016/j.gene.2014.01.040; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Gurtler N, 2004, J MOL MED, V82, P775, DOI 10.1007/s00109-004-0597-1; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Hogewind BFT, 2010, MOL VIS, V16, P26; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Khanim F, 2001, HUM MUTAT, V17, P357, DOI 10.1002/humu.1110.abs; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kunz J, 2003, MUTAT RES-FUND MOL M, V525, P121, DOI 10.1016/S0027-5107(02)00265-8; Lalwani AK, 1998, ARCH OTOLARYNGOL, V124, P699, DOI 10.1001/archotol.124.6.699; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lesperance MM, 2003, ARCH OTOLARYNGOL, V129, P411, DOI 10.1001/archotol.129.4.411; LESPERANCE MM, 1995, HUM MOL GENET, V4, P1967, DOI 10.1093/hmg/4.10.1967; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Middle F, 2000, AM J MED GENET, V96, P154, DOI 10.1002/(SICI)1096-8628(20000403)96:2<154::AID-AJMG5>3.0.CO;2-F; Pennings RJE, 2003, ARCH OTOLARYNGOL, V129, P421, DOI 10.1001/archotol.129.4.421; Podoly E, 2010, CHEM-BIOL INTERACT, V187, P64, DOI 10.1016/j.cbi.2010.01.003; Rendtorff ND, 2011, AM J MED GENET A, V155A, P1298, DOI 10.1002/ajmg.a.33970; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Shearer AE, 2011, HEARING RES, V282, P1, DOI 10.1016/j.heares.2011.10.001; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Tranebjaerg L, 2004, MOL BIOL HEAR DEAFN; Wasson J, 2008, DIABETOLOGIA, V51, P391, DOI 10.1007/s00125-007-0920-9; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yan D, 2013, GENET TEST MOL BIOMA, V17, P581, DOI 10.1089/gtmb.2012.0464; Yang Rong, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P259, DOI [10.3760/cma.j.issn.1003-940.2010.03.005, 10.3760/cma.j.issn.1003-9406.2010.0.005]; Yang T, 2005, AM J MED GENET A, V139A, P9, DOI 10.1002/ajmg.a.30989; Young TL, 2001, HUM MOL GENET, V10, P2509, DOI 10.1093/hmg/10.22.2509	45	12	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109178	10.1371/journal.pone.0109178	http://dx.doi.org/10.1371/journal.pone.0109178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289672	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000045
J	Bianchini, E; Testoni, S; Gentile, A; Cali, T; Ottolini, D; Villa, A; Brini, M; Betto, R; Mascarello, F; Nissen, P; Sandona, D; Sacchetto, R				Bianchini, Elisa; Testoni, Stefania; Gentile, Arcangelo; Cali, Tito; Ottolini, Denis; Villa, Antonello; Brini, Marisa; Betto, Romeo; Mascarello, Francesco; Nissen, Poul; Sandona, Dorianna; Sacchetto, Roberta			Inhibition of Ubiquitin Proteasome System Rescues the Defective Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA1) Protein Causing Chianina Cattle Pseudomyotonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWITCH SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; BRODY-DISEASE; CONGENITAL PSEUDOMYOTONIA; CRYSTAL-STRUCTURE; CALCIUM-PUMP; CA2+ ATPASE; COS-1 CELLS; DEGRADATION; MUTATION	A missense mutation in ATP2A1 gene, encoding sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1) protein, causes Chianina cattle congenital pseudomyotonia, an exercise-induced impairment of muscle relaxation. Skeletal muscles of affected cattle are characterized by a selective reduction of SERCA1 in sarcoplasmic reticulum membranes. In this study, we provide evidence that the ubiquitin proteasome system is involved in the reduced density of mutated SERCA1. The treatment with MG132, an inhibitor of ubiquitin proteasome system, rescues the expression level and membrane localization of the SERCA1 mutant in a heterologous cellular model. Cells co-transfected with the Ca2+-sensitive probe aequorin show that the rescued SERCA1 mutant exhibits the same ability of wild type to maintain Ca(2+)homeostasis within cells. These data have been confirmed by those obtained ex vivo on adult skeletal muscle fibers from a biopsy from a pseudomyotonia-affected subject. Our data show that the mutation generates a protein most likely corrupted in proper folding but not in catalytic activity. Rescue of mutated SERCA1 to sarcoplasmic reticulum membrane can re-establish resting cytosolic Ca2+ concentration and prevent the appearance of pathological signs of cattle pseudomyotonia.	[Bianchini, Elisa; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Cali, Tito; Ottolini, Denis; Brini, Marisa] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Testoni, Stefania] Univ Padua, Dept Anim Med Prod & Hlth, I-35020 Padua, Italy; [Mascarello, Francesco; Sacchetto, Roberta] Univ Padua, Dept Comparat Biomed & Food Sci, I-35020 Padua, Italy; [Gentile, Arcangelo] Univ Bologna, Dept Vet Med Sci, I-40064 Bologna, Italy; [Villa, Antonello] Univ Milano Bicocca, Consorzio MIA, I-20900 Monza, Italy; [Betto, Romeo] Consiglio Nazl Ric Padova, Inst Neurosci, I-35131 Padua, Italy; [Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus, Denmark	University of Padua; University of Padua; University of Padua; University of Padua; University of Bologna; University of Milano-Bicocca; Aarhus University	Sandona, D (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35131 Padua, Italy.	dorianna.sandona@unipd.it; roberta.sacchetto@unipd.it	Calì, Tito/K-5064-2016; Brini, Marisa/K-5189-2016; sandona, dorianna/AAB-9480-2020	Calì, Tito/0000-0002-8901-1659; Nissen, Poul/0000-0003-0948-6628; Brini, Marisa/0000-0001-5141-0243; Villa, Antonello/0000-0002-3820-8072	University of Padova [2009 CPDA091413]; Italian Telethon Foundation [GEP12058]	University of Padova; Italian Telethon Foundation(Fondazione Telethon)	This work was supported by grants from the University of Padova (Progetto Ateneo 2009 CPDA091413) (to F. M.) and the Italian Telethon Foundation (Project GEP12058) (to D. S.).	Assereto S, 2006, AM J PHYSIOL-CELL PH, V290, pC577, DOI 10.1152/ajpcell.00434.2005; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; BRODY IA, 1969, NEW ENGL J MED, V281, P187, DOI 10.1056/NEJM196907242810403; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grunberg W, 2010, NEUROMUSCULAR DISORD, V20, P467, DOI 10.1016/j.nmd.2010.04.010; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; KARPATI G, 1986, ANN NEUROL, V20, P38, DOI 10.1002/ana.410200108; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Murgiano L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-186; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 2000, HUM GENET, V106, P482, DOI 10.1007/s004390000297; Sacchetto R, 2005, J BIOL CHEM, V280, P7147, DOI 10.1074/jbc.M413574200; Sacchetto R, 2009, AM J PATHOL, V174, P565, DOI 10.2353/ajpath.2009.080659; Sacchetto R, 2012, J STRUCT BIOL, V178, P38, DOI 10.1016/j.jsb.2012.02.008; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Testoni S, 2008, VET REC, V163, P254, DOI 10.1136/vr.163.8.252; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Voermans NC, 2012, NEUROMUSCULAR DISORD, V22, P944, DOI 10.1016/j.nmd.2012.03.012; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	31	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33073	33082		10.1074/jbc.M114.576157	http://dx.doi.org/10.1074/jbc.M114.576157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25288803	Green Published, hybrid			2022-12-25	WOS:000345636600002
J	Shibata, T; Nakashima, F; Honda, K; Lu, YJ; Kondo, T; Ushida, Y; Aizawa, K; Suganuma, H; Oe, S; Tanaka, H; Takahashi, T; Uchida, K				Shibata, Takahiro; Nakashima, Fumie; Honda, Kazuya; Lu, Yu-Jhang; Kondo, Tatsuhiko; Ushida, Yusuke; Aizawa, Koichi; Suganuma, Hiroyuki; Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi; Uchida, Koji			Toll-like Receptors as a Target of Food-derived Anti-inflammatory Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SESQUITERPENE LACTONES; BRASSICA-OLERACEA; CABBAGE EXTRACT; INNATE IMMUNITY; INHIBITION; ENZYMES; SULFORAPHANE; INDUCTION; CELLS	Toll-like receptors (TLRs) play a key role in linking pathogen recognition with the induction of innate immunity. They have been implicated in the pathogenesis of chronic inflammatory diseases, representing potential targets for prevention/treatment. Vegetable-rich diets are associated with the reduced risk of several inflammatory disorders. In the present study, based on an extensive screening of vegetable extracts for TLR-inhibiting activity in HEK293 cells co-expressing TLR with the NF-kappa B reporter gene, we found cabbage and onion extracts to be the richest sources of a TLR signaling inhibitor. To identify the active substances, we performed activity-guiding separation of the principal inhibitors and identified 3-methylsulfinylpropyl isothiocyanate (iberin) from the cabbage and quercetin and quercetin 4'-O-beta-glucoside from the onion, among which iberin showed the most potent inhibitory effect. It was revealed that iberin specifically acted on the dimerization step of TLRs in the TLR signaling pathway. To gain insight into the inhibitory mechanism of TLR dimerization, we developed a novel probe combining an isothiocyanate-reactive group and an alkyne functionality for click chemistry and detected the probe bound to the TLRs in living cells, suggesting that iberin disrupts dimerization of the TLRs via covalent binding. Furthermore, we designed a variety of iberin analogues and found that the inhibition potency was influenced by the oxidation state of the sulfur. Modeling studies of the iberin analogues showed that the oxidation state of sulfur might influence the global shape of the isothiocyanates. These findings establish the TLR dimerization step as a target of food-derived anti-inflammatory compounds.	[Shibata, Takahiro; Nakashima, Fumie; Honda, Kazuya; Lu, Yu-Jhang; Kondo, Tatsuhiko; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ushida, Yusuke; Aizawa, Koichi; Suganuma, Hiroyuki] Kagome Co Ltd, Div Res & Dev, Nasushiobara 3292762, Japan; [Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 1528552, Japan	Nagoya University; Kagome Co., Ltd.; Tokyo Institute of Technology	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Tanaka, Hiroshi/I-2402-2012; Shibata, Takahiro/I-6872-2014	Ushida, Yusuke/0000-0003-4117-929X; Lu, Yu-Jhang/0000-0002-8867-6958; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299; Suganuma, Hiroyuki/0000-0001-6596-9881	Ministry of Education, Culture, Sports, Science, and Technology in Japan	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (to T. S. and K. U.).	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Brennan P, 1998, BIOCHEM PHARMACOL, V55, P965, DOI 10.1016/S0006-2952(97)00535-2; Chuanphongpanich Sarunya, 2006, Chiang Mai Journal of Science, V33, P223; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Comalada M, 2006, BIOCHEM PHARMACOL, V72, P1010, DOI 10.1016/j.bcp.2006.07.016; Carvalho Camilo Amaro de, 2011, Arq. Gastroenterol., V48, P276, DOI 10.1590/S0004-28032011000400011; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gillet LCJ, 2008, MOL CELL PROTEOMICS, V7, P1241, DOI 10.1074/mcp.M700505-MCP200; Haddad JJ, 2005, MOL IMMUNOL, V42, P987, DOI 10.1016/j.molimm.2004.09.029; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jadhav U, 2007, INT J MOL MED, V19, P353; Komatsu W, 2002, NUTR CANCER, V43, P82, DOI 10.1207/S15327914NC431_10; Komatsu W, 1998, LIPIDS, V33, P499, DOI 10.1007/s11745-998-0233-7; Koo JE, 2013, BIOCHEM BIOPH RES CO, V434, P600, DOI 10.1016/j.bbrc.2013.03.123; Lee JY, 2011, J AGR FOOD CHEM, V59, P857, DOI 10.1021/jf1033587; Lee JY, 2006, MOL CELLS, V21, P174; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mas S, 2007, NUTR CANCER, V58, P107, DOI 10.1080/01635580701308257; Morimitsu Y, 2002, J BIOL CHEM, V277, P3456, DOI 10.1074/jbc.M110244200; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162; SCHULTZ O.-E, 1954, ARCH PHARM BER DEUTSCH PHARM GES, V287, P404, DOI 10.1002/ardp.19542870707; Siedle B, 2004, J MED CHEM, V47, P6042, DOI 10.1021/jm049937r; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Staack R, 1998, TOXICOL APPL PHARM, V149, P17, DOI 10.1006/taap.1997.8340; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; STOEWSAND GS, 1995, FOOD CHEM TOXICOL, V33, P537, DOI 10.1016/0278-6915(95)00017-V; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Vazquez-Prieto MA, 2010, MOL ASPECTS MED, V31, P540, DOI 10.1016/j.mam.2010.09.009; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Wang W, 2005, J AGR FOOD CHEM, V53, P1417, DOI 10.1021/jf048153j; Youn HS, 2008, BIOCHEM PHARMACOL, V75, P494, DOI 10.1016/j.bcp.2007.08.033; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P62, DOI 10.1016/j.bcp.2006.03.022; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, CANCER RES, V54, pS1976	52	35	35	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.585901	http://dx.doi.org/10.1074/jbc.M114.585901			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294874	hybrid, Green Published			2022-12-25	WOS:000345335000031
J	Tsukamoto, S; Huang, YH; Umeda, D; Yamada, S; Yamashita, S; Kumazoe, M; Kim, Y; Murata, M; Yamada, K; Tachibana, H				Tsukamoto, Shuntaro; Huang, Yuhui; Umeda, Daisuke; Yamada, Shuhei; Yamashita, Shuya; Kumazoe, Motofumi; Kim, Yoonhee; Murata, Motoki; Yamada, Koji; Tachibana, Hirofumi			67-kDa Laminin Receptor-dependent Protein Phosphatase 2A (PP2A) Activation Elicits Melanoma-specific Antitumor Activity Overcoming Drug Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEA POLYPHENOL EGCG; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; KINASE-C; INHIBITION; CANCER; BRAF; EPIGALLOCATECHIN-3-GALLATE; PROGRESSION; EXPRESSION	The Ras/Raf/MEK/ERK pathway has been identified as a major, druggable regulator of melanoma. Mutational activation of BRAF is the most prevalent genetic alteration in human melanoma, resulting in constitutive melanoma hyperproliferation. A selective BRAF inhibitor showed remarkable clinical activity in patients with mutated BRAF. Unfortunately, most patients acquire resistance to the BRAF inhibitor, highlighting the urgent need for new melanoma treatment strategies. Green tea polyphenol (-)-epigallocatechin-3-O-gallate (EGCG) inhibits cell proliferation independently of BRAF inhibitor sensitivity, suggesting that increased understanding of the anti-melanoma activity of EGCG may provide a novel therapeutic target. Here, by performing functional genetic screening, we identified protein phosphatase 2A (PP2A) as a critical factor in the suppression of melanoma cell proliferation. We demonstrated that tumor-overexpressed 67-kDa laminin receptor (67LR) activates PP2A through adenylate cyclase/cAMP pathway eliciting inhibitions of oncoproteins and activation of tumor suppressor Merlin. Activating 67LR/PP2A pathway leading to melanoma-specific mTOR inhibition shows strong synergy with the BRAF inhibitor PLX4720 in the drug-resistant melanoma. Moreover, SET, a potent inhibitor of PP2A, is overexpressed on malignant melanoma. Silencing of SET enhances 67LR/PP2A signaling. Collectively, activation of 67LR/PP2A signaling may thus be a novel rational strategy for melanoma-specific treatment.	[Tsukamoto, Shuntaro; Huang, Yuhui; Umeda, Daisuke; Yamada, Shuhei; Yamashita, Shuya; Kumazoe, Motofumi; Kim, Yoonhee; Murata, Motoki; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Dept Biosci & Biotechnol, Div Appl Biol Chem, Fac Agr, Fukuoka 8128581, Japan; [Tachibana, Hirofumi] Kyushu Univ, Food Funct Design Res Ctr, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Tachibana, H (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Umeda, Daisuke/0000-0001-6301-9938; Kumazoe, Motofumi/0000-0002-3002-2994	Japan Society for the Promotion of Science [22228002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research (S) Grant 22228002 (to H. T.) and Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science DC2 (to S. T.) and DC1 (to Y. H.).	AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; CHOCHUNG YS, 1990, CANCER RES, V50, P7093; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng W, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00950.x; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; HOLZMAYER TA, 1992, NUCLEIC ACIDS RES, V20, P711, DOI 10.1093/nar/20.4.711; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kiss A, 2013, FEBS J, V280, P612, DOI 10.1111/j.1742-4658.2012.08498.x; Kitano K, 1997, BIOPHYS CHEM, V65, P157, DOI 10.1016/S0301-4622(96)02254-5; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Merkel S, 2006, TRANSPL P, V38, P714, DOI 10.1016/j.transproceed.2006.01.044; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nihal M, 2005, INT J CANCER, V114, P513, DOI 10.1002/ijc.20785; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Qin JC, 2008, CANCER RES, V68, P4150, DOI 10.1158/0008-5472.CAN-08-0839; Salama AKS, 2013, CLIN CANCER RES, V19, P4326, DOI 10.1158/1078-0432.CCR-13-0779; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Takizawa N, 2002, FEBS LETT, V515, P127, DOI 10.1016/S0014-5793(02)02451-1; Tay KH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.79; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Tsukamoto S, 2012, BIOCHEM J, V443, P525, DOI 10.1042/BJ20111837; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; Viacava P, 1997, J PATHOL, V182, P36, DOI 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W; Watanabe Y, 2012, EXP THER MED, V4, P205, DOI 10.3892/etm.2012.587; Zhang Qingxiu, 2012, Enzyme Res, V2012, P659649, DOI 10.1155/2012/659649	40	51	51	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.604983	http://dx.doi.org/10.1074/jbc.M114.604983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294877	Green Published, hybrid			2022-12-25	WOS:000345335000024
J	Bianco, L; Cestaro, A; Sargent, DJ; Banchi, E; Derdak, S; Di Guardo, M; Salvi, S; Jansen, J; Viola, R; Gut, I; Laurens, F; Chagne, D; Velasco, R; van de Weg, E; Troggio, M				Bianco, Luca; Cestaro, Alessandro; Sargent, Daniel James; Banchi, Elisa; Derdak, Sophia; Di Guardo, Mario; Salvi, Silvio; Jansen, Johannes; Viola, Roberto; Gut, Ivo; Laurens, Francois; Chagne, David; Velasco, Riccardo; van de Weg, Eric; Troggio, Michela			Development and Validation of a 20K Single Nucleotide Polymorphism (SNP) Whole Genome Genotyping Array for Apple (Malus x domestica Borkh)	PLOS ONE			English	Article							LINKAGE MAP; CONSTRUCTION; ALIGNMENT; ACCURATE	High-density SNP arrays for genome-wide assessment of allelic variation have made high resolution genetic characterization of crop germplasm feasible. A medium density array for apple, the IRSC 8 K SNP array, has been successfully developed and used for screens of bi-parental populations. However, the number of robust and well-distributed markers contained on this array was not sufficient to perform genome-wide association analyses in wider germplasm sets, or Pedigree-Based Analysis at high precision, because of rapid decay of linkage disequilibrium. We describe the development of an Illumina lnfinium array targeting 20 K SNPs. The SNPs were predicted from re-sequencing data derived from the genomes of 13 Malus x domestica apple cultivars and one accession belonging to a crab apple species (M. micromalus). A pipeline for SNP selection was devised that avoided the pitfalls associated with the inclusion of paralogous sequence variants, supported the construction of robust multi-allelic SNP haploblocics and selected up to 11 entries within narrow genomic regions of 5 kb, termed focal points (FPs). Broad genome coverage was attained by placing FPs at 1 cM intervals on a consensus genetic map, complementing them with FPs to enrich the ends of each of the chromosomes, and by bridging physical intervals greater than 400 Kbps. The selection also included similar to 3.7 K validated SNPs from the IRSC 8 K array. The array has already been used in other studies where similar to 15.8 K SNP markers were mapped with an average of similar to 6.8 K SNPs per full-sib family. The newly developed array with its high density of polymorphic validated SNPs is expected to be of great utility for Pedigree-Based Analysis and Genomic Selection. It will also be a valuable tool to help dissect the genetic mechanisms controlling important fruit quality traits, and to aid the identification of marker-trait associations suitable for the application of Marker Assisted Selection in apple breeding programs.	[Bianco, Luca; Cestaro, Alessandro; Sargent, Daniel James; Banchi, Elisa; Di Guardo, Mario; Viola, Roberto; Velasco, Riccardo; Troggio, Michela] Fdn Edmund Mach, Res & Innovat Ctr, Trento, Italy; [Derdak, Sophia; Gut, Ivo] Parc Cientific Barcelona, CNAG, Barcelona, Spain; [Di Guardo, Mario; van de Weg, Eric] Wageningen Univ, Res Ctr, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Salvi, Silvio] Univ Bologna, DipSA, Bologna, Italy; [Jansen, Johannes] Wageningen Univ, Res Ctr, NL-6700 AP Wageningen, Netherlands; [Laurens, Francois] Inst Rech Hort & Semences, INRA, UMR1345, Beaucouze, France; [Chagne, David] Palmerston North Res Ctr, Palmerston North, New Zealand	Fondazione Edmund Mach; Wageningen University & Research; University of Bologna; Wageningen University & Research; INRAE	Troggio, M (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Trento, Italy.	michela.troggio@fmach.it	Di Guardo, Mario/AAA-7498-2021; Sargent, Daniel James/A-2933-2014; Van de Weg, Eric W/G-3225-2011; Chagne, David/A-2596-2010; Gut, Ivo/ABF-3188-2020; Viola, Roberto/F-3657-2014	Sargent, Daniel James/0000-0002-6686-7147; Van de Weg, Eric W/0000-0002-9443-5974; Chagne, David/0000-0003-4018-0694; Gut, Ivo/0000-0001-7219-632X; Banchi, Elisa/0000-0002-6598-0447; Viola, Roberto/0000-0002-8202-8503; Di Guardo, Mario/0000-0003-3339-2007; Cestaro, Alessandro/0000-0003-1439-5165; Velasco, Riccardo/0000-0002-8760-5031; Bianco, Luca/0000-0002-0196-8422	EU seventh Framework Programme by the FruitBreedomics project [265582]	EU seventh Framework Programme by the FruitBreedomics project	This work has been funded under the EU seventh Framework Programme by the FruitBreedomics project No. 265582: Integrated Approach for increasing breeding efficiency in fruit tree crops. The views expressed in this work are the sole responsibility of the authors and do not necessary reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Bekele WA, 2013, PLANT BIOTECHNOL J, V11, P1112, DOI 10.1111/pbi.12106; Bink MCAM, 2014, THEOR APPL GENET, V127, P1073, DOI 10.1007/s00122-014-2281-3; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Clark MD, 2014, TREE GENET GENOMES, V10, P627, DOI 10.1007/s11295-014-0709-1; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Durel CE, 1998, THEOR APPL GENET, V96, P1077, DOI 10.1007/s001220050842; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evans KM, 2011, MOL BREEDING, V28, P535, DOI 10.1007/s11032-010-9502-5; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; Kumar S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-393; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036674; Lespinasse Y., 1999, Acta Horticulturae, P49; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084329; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Montanari S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077022, 10.1371/journal.pone.0066221]; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Pavy N, 2013, MOL ECOL RESOUR, V13, P324, DOI 10.1111/1755-0998.12062; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Pikunova A, 2014, TREE GENET GENOMES, V10, P261, DOI 10.1007/s11295-013-0679-8; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Salvi S, 2014, MOL BREEDING, V34, P511, DOI 10.1007/s11032-014-0054-y; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Troggio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067407; Van de Weg W, 2014, INT PLANT ANIMAL GEN; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wang ZhenYu, 2012, Acta Agronomica Sinica, V38, P971, DOI 10.3724/SP.J.1006.2012.00971; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]	47	149	154	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110377	10.1371/journal.pone.0110377	http://dx.doi.org/10.1371/journal.pone.0110377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303088	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400127
J	Gu, N; Ma, XW; Zhang, JQ; Dong, AM; Jin, MM; Feng, N; Zhang, H; Guo, XH				Gu, Nan; Ma, Xiaowei; Zhang, Junqing; Dong, Aimei; Jin, Mengmeng; Feng, Nan; Zhang, Hong; Guo, Xiaohui			Obesity Has an Interactive Effect with Genetic Variation in the Activating Transcription Factor 6 Gene on the Risk of Pre-Diabetes in Individuals of Chinese Han Descent	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; POLYMORPHISMS; GLUCOSE; ASSOCIATION; HOMEOSTASIS; ATF6	Endoplasmic reticulum (ER) stress is one of the contributing factors to the development of b-cell failure in type 2 diabetes. ER stress response through ATF6 has been shown to play an important role in insulin resistance and pancreatic beta-cell function. We investigated whether genetic polymorphisms in ATF6 were associated with the risk of pre-diabetes in a Chinese Han population, and whether they had a synergistic effect with obesity. Our samples included 828 individuals who were diagnosed as pre-diabetic, and 620 controls. The minor allele A at rs2340721 was associated with increased risk for pre-diabetes(p = 0.013), and this association was still significant after adjusting for gender, age, body mass index (BMI), and waist-hip ratio (p' = 0.011). BMI, treated as a continuous variable, and rs2340721 had an interactive effect on pre-diabetic risk(p for interaction = 0.003, beta = 0.106). Carriers of GG at rs7522210 were also at a higher risk compared to non-carriers (OR = 1.390, 95%CI:1.2061.818, p = 0.013, adjusted OR' = 1.516, 95%CI:1.1012.006, p' = 0.006). GG homozygotes had increased fasting blood glucose (FBG) levels(GG vs CX: 5.6 +/- 0.52 vs 5.5 +/- 0.57 mmol/L, p = 0.016), lower insulin levels (0,30,120 minutes after glucose load) (p<0.05), and reduced areas under the insulin curve than non-carriers(GG vs CX:67.3(44.2102.3) vs 73.1(49.4111.4), p = 0.014). rs10918270 was associated with FBG, and rs4657103 with 2 hour glucose levels after a 75 g glucose load. We also identified a haplotype of TTAG composed of rs4657103, rs2134697, rs2340721, and rs12079579, which was associated with pre-diabetes. The genetic variation in ATF6 is associated with pre-diabetes and has interactive effects with BMI on pre-diabetes in the Chinese Han population.	[Gu, Nan; Ma, Xiaowei; Zhang, Junqing; Dong, Aimei; Jin, Mengmeng; Feng, Nan; Zhang, Hong; Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China	Peking University	Ma, XW (corresponding author), Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China.	mxiaowei@yahoo.com	FENG, NAN/HGD-3255-2022	Gu, Nan/0000-0001-9852-0060	National Natural Science Foundation of China [NSFC 30771033]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110001120047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (NSFC 30771033) and by Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110001120047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chu WS, 2007, DIABETES, V56, P856, DOI 10.2337/db06-1305; Das SK, 2006, DIABETES, V55, P2631, DOI 10.2337/db05-1369; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Hu C, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-3; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Meex SJR, 2007, J CLIN ENDOCR METAB, V92, P2720, DOI 10.1210/jc.2006-2280; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Teodoro T, 2012, AM J PHYSIOL-CELL PH, V302, pC992, DOI 10.1152/ajpcell.00160.2011; Thameem F, 2006, DIABETES, V55, P839, DOI 10.2337/diabetes.55.03.06.db05-1002; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	21	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109805	10.1371/journal.pone.0109805	http://dx.doi.org/10.1371/journal.pone.0109805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302688	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400080
J	Hussanan, A; Salleh, MZ; Tahar, RM; Khan, I				Hussanan, Abid; Salleh, Mohd Zuki; Tahar, Razman Mat; Khan, Ilyas			Unsteady Boundary Layer Flow and Heat Transfer of a Casson Fluid past an Oscillating Vertical Plate with Newtonian Heating	PLOS ONE			English	Article							SURFACE	In this paper, the heat transfer effect on the unsteady boundary layer flow of a Casson fluid past an infinite oscillating vertical plate with Newtonian heating is investigated. The governing equations are transformed to a systems of linear partial differential equations using appropriate non-dimensional variables. The resulting equations are solved analytically by using the Laplace transform method and the expressions for velocity and temperature are obtained. They satisfy all imposed initial and boundary conditions and reduce to some well-known solutions for Newtonian fluids. Numerical results for velocity, temperature, skin friction and Nusselt number are shown in various graphs and discussed for embedded flow parameters. It is found that velocity decreases as Casson parameters increases and thermal boundary layer thickness increases with increasing Newtonian heating parameter.	[Hussanan, Abid; Salleh, Mohd Zuki] Univ Malaysia Pahang, Fac Ind Sci & Technol, Futures & Trends Res Grp, Kuantan, Pahang, Malaysia; [Tahar, Razman Mat] Univ Malaysia Pahang, Fac Ind Management, Kuantan, Pahang, Malaysia; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia	Universiti Malaysia Pahang; Universiti Malaysia Pahang; Majmaah University	Khan, I (corresponding author), Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia.	ilyaskhanqau@yahoo.com	Hussanan, Abid/J-1817-2019; SALLEH, MOHD ZUKI/F-5440-2012; Khan, Ilyas/C-8770-2019	Hussanan, Abid/0000-0003-4545-3110; SALLEH, MOHD ZUKI/0000-0001-9732-9280; Khan, Ilyas/0000-0002-2056-9371	Universiti Malaysia Pahang, Malaysia [RDU121302, RDU131405]; Majmaah University Saudi Arabia	Universiti Malaysia Pahang, Malaysia; Majmaah University Saudi Arabia	The authors gratefully acknowledge the financial supports received from the Universiti Malaysia Pahang, Malaysia, through vote numbers RDU121302 and RDU131405. The corresponding author is also grateful to Majmaah University Saudi Arabia for the financial support through research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg OA., 2013, HEAT TRANSFER ASIAN, V2013, P1; Casson N., 1959, RHEOL DISPERSE SYST, P84; Chaudhary R. C., 2006, Romanian Journal of Physics, V51, P911; Das S., 2012, INT J COMPUTER APPL, V41, P36, DOI [10.5120/5605-7864, DOI 10.5120/5605-7864]; Ganesh S, 2014, INDIAN J RES, V2, P101; Hassan MA, 2013, J HEAT TRANSFER; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hussanan A., 2013, J APPL MATH, V12, P1; Hussanan A, 2014, HEAT TRANSF RES, V45, P119, DOI 10.1615/HeatTransRes.2013006385; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Jain Anjali, 2014, International Conference on Recent Advances and Innovations in Engineering (ICRAIE-2014), DOI 10.1109/ICRAIE.2014.6909144; Kasim A. R. M., 2012, WORLD ACAD SCI ENG T, V64, P628, DOI DOI 10.5281/ZENODO.1328964; Khan I, 2012, SPEC TOP REV POROUS, V3, P89, DOI 10.1615/SpecialTopicsRevPorousMedia.v3.i1.80; Khan I, 2014, B MALAYS MATH SCI SO, V37, P437; Khan I, 2013, Z NATURFORSCH A, V68, P635, DOI 10.5560/ZNA.2013-0040; KLEPPE J, 1972, J HEAT TRANSF, V94, P371, DOI 10.1115/1.3449954; Malik MY, 2014, APPL NANOSCI, V4, P869, DOI 10.1007/s13204-013-0267-0; Mebine P, 2009, TURK J PHYS, V33, P109, DOI 10.3906/fiz-0809-2; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; Mukhopadhyay S, 2014, CHINESE PHYS B; Mukhopadhyay S, 2013, CHINESE PHYS B; Mustafa M, 2011, HEAT TRANSFER ASIAN, P553; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Olajuwon B.I., 2009, INT J NONLIN SCI NUM, V7, P50; Pramanik S, 2014, AIN SHAMS ENG J, V5, P205, DOI 10.1016/j.asej.2013.05.003; Qasim M, 2013, ALEX ENG J, V52, P571, DOI 10.1016/j.aej.2013.08.004; Qasim M, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14007-5; Salleh MZ, 2011, J ENG MATH, V69, P101, DOI 10.1007/s10665-010-9408-6; Salleh MZ, 2010, J TAIWAN INST CHEM E, V41, P651, DOI 10.1016/j.jtice.2010.01.013; Shehzad SA, 2013, BRAZ J CHEM ENG, V30, P187, DOI 10.1590/S0104-66322013000100020; Venkatesan J, 2013, J APPL MATH, DOI 10.1155/2013/583809; WANG CY, 1989, INT J HEAT FLUID FL, V10, P160, DOI 10.1016/0142-727X(89)90011-8; Zakaria MN, 2013, J TEKNOL, V62	33	72	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108763	10.1371/journal.pone.0108763	http://dx.doi.org/10.1371/journal.pone.0108763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302782	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400026
J	Maier, L; Barthel, M; Stecher, B; Maier, RJ; Gunn, JS; Hardt, WD				Maier, Lisa; Barthel, Manja; Stecher, Baerbel; Maier, Robert J.; Gunn, John S.; Hardt, Wolf-Dietrich			Salmonella Typhimurium Strain ATCC14028 Requires H-2-Hydrogenases for Growth in the Gut, but Not at Systemic Sites	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; COLONIZATION RESISTANCE; ESCHERICHIA-COLI; HYDROGEN; SOPE; MICROBIOTA; MICE; INFECTION; PROVIDES; PROTEIN	Salmonella enterica is a common cause of diarrhea. For eliciting disease, the pathogen has to colonize the gut lumen, a site colonized by the microbiota. This process/initial stage is incompletely understood. Recent work established that one particular strain, Salmonella enterica subspecies 1 serovar Typhimurium strain SL1344, employs the hyb H-2-hydrogenase for consuming microbiota-derived H-2 to support gut luminal pathogen growth: Protons from the H-2-splitting reaction contribute to the proton gradient across the outer bacterial membrane which can be harvested for ATP production or for import of carbon sources. However, it remained unclear, if other Salmonella strains would use the same strategy. In particular, earlier work had left unanswered if strain ATCC14028 might use H-2 for growth at systemic sites. To clarify the role of the hydrogenases, it seems important to establish if H-2 is used at systemic sites or in the gut and if Salmonella strains may differ with respect to the host sites where they require H-2 in vivo. In order to resolve this, we constructed a strain lacking all three H-2-hydrogenases of ATCC14028 (14028(hyd3)) and performed competitive infection experiments. Upon intragastric inoculation, 14028(hyd3) was present at 100-fold lower numbers than 14028(WT) in the stool and at systemic sites. In contrast, i.v. inoculation led to equivalent systemic loads of 14028(hyd3) and the wild type strain. However, the pathogen population spreading to the gut lumen featured again up to 100-fold attenuation of 14028(hyd3). Therefore, ATCC14028 requires H-2-hydrogenases for growth in the gut lumen and not at systemic sites. This extends previous work on ATCC14028 and supports the notion that H-2-utilization might be a general feature of S. Typhimurium gut colonization.	[Maier, Lisa; Barthel, Manja; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Stecher, Baerbel] Max Von Pettenkofer Inst, Munich, Germany; [Stecher, Baerbel] Partner Site LMU Munich, German Ctr Infect Res DZIF, Munich, Germany; [Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA USA; [Gunn, John S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; German Center for Infection Research; University of Munich; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University	Hardt, WD (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	wolf-dietrich.hardt@micro.biol.ethz.ch	Stecher, Bärbel/A-2911-2015; Maier, Lisa/ABH-1893-2021; Stecher, Barbel/B-9940-2019	Stecher, Bärbel/0000-0002-7445-5193; Maier, Lisa/0000-0002-6473-4762; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Swiss National Science Foundation [310030-132997/1]; Sinergia project [CRSII3_136286]; UBS Optimus Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia project; UBS Optimus Foundation	This work was supported in part by the Swiss National Science Foundation (310030-132997/1) and the Sinergia project CRSII3_136286 to WDH) and the UBS Optimus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2013, INFECT GENET EVOL, V16, P314, DOI 10.1016/j.meegid.2013.03.003; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BOHNHOFF M, 1964, J EXP MED, V120, P817, DOI 10.1084/jem.120.5.817; BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; BROWN KJ, 1979, A VAN LEEUW J MICROB, V45, P531, DOI 10.1007/BF00403653; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Carbonero F, 2012, NAT REV GASTRO HEPAT, V9, P504, DOI 10.1038/nrgastro.2012.85; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Gordienko EN, 2013, J BACTERIOL, V195, P2786, DOI 10.1128/JB.02285-12; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lamichhane-Khadka R, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130146; Lamichhane-Khadka R, 2011, J BACTERIOL, V193, P5824, DOI 10.1128/JB.05456-11; Lamichhane-Khadka R, 2010, MBIO, V1, DOI 10.1128/mBio.00284-10; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Maier L, 2013, CELL HOST MICROBE, V14, P641, DOI 10.1016/j.chom.2013.11.002; Maier RJ, 2005, BIOCHEM SOC T, V33, P83, DOI 10.1042/BST0330083; Maier RJ, 2004, INFECT IMMUN, V72, P6294, DOI 10.1128/IAI.72.11.6294-6299.2004; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; MEYNELL GG, 1963, BRIT J EXP PATHOL, V44, P197; Meynell GG, 1955, P R SOC MED; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Mirold S, 2001, J MOL BIOL, V312, P7, DOI 10.1006/jmbi.2001.4950; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Ng KM, 2013, NATURE; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; Pelludat C, 2003, J BACTERIOL, V185, P5182, DOI 10.1128/JB.185.17.5182-5191.2003; Pie S, 1996, INFECT IMMUN, V64, P849, DOI 10.1128/IAI.64.3.849-854.1996; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; Zbell AL, 2008, INFECT IMMUN, V76, P4445, DOI 10.1128/IAI.00741-08; Zbell AL, 2007, MICROBIOL-SGM, V153, P3508, DOI 10.1099/mic.0.2007/009027-0; Zbell AL, 2009, APPL ENVIRON MICROB, V75, P1456, DOI 10.1128/AEM.02064-08; Zhang SP, 2002, FEMS MICROBIOL LETT, V217, P243, DOI 10.1111/j.1574-6968.2002.tb11482.x	57	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110187	10.1371/journal.pone.0110187	http://dx.doi.org/10.1371/journal.pone.0110187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303479	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400120
J	Frahm, GE; Smith, DGS; Kane, A; Lorbetskie, B; Cyr, TD; Girard, M; Johnston, MJW				Frahm, Grant E.; Smith, Daryl G. S.; Kane, Anita; Lorbetskie, Barry; Cyr, Terry D.; Girard, Michel; Johnston, Michael J. W.			Determination of Supplier-to-Supplier and Lot-to-Lot Variability in Glycation of Recombinant Human Serum Albumin Expressed in Oryza sativa	PLOS ONE			English	Article							FATTY-ACIDS; IN-VITRO; THERMAL-STABILITY; CRYSTAL-STRUCTURE; STABILIZATION; FLUORESCENCE; TRANSITIONS; LIPOSOMES; CHAIN	The use of different expression systems to produce the same recombinant human protein can result in expression-dependent chemical modifications (CMs) leading to variability of structure, stability and immunogenicity. Of particular interest are recombinant human proteins expressed in plant-based systems, which have shown particularly high CM variability. In studies presented here, recombinant human serum albumins (rHSA) produced in Oryza sativa (Asian rice) (OsrHSA) from a number of suppliers have been extensively characterized and compared to plasma-derived HSA (pHSA) and rHSA expressed in yeast (Pichia pastoris and Saccharomyces cerevisiae). The heterogeneity of each sample was evaluated using size exclusion chromatography (SEC), reversed-phase high-performance liquid chromatography (RP-HPLC) and capillary electrophoresis (CE). Modifications of the samples were identified by liquid chromatography-mass spectrometry (LC-MS). The secondary and tertiary structure of the albumin samples were assessed with far U/V circular dichroism spectropolarimetry (far U/V CD) and fluorescence spectroscopy, respectively. Far U/V CD and fluorescence analyses were also used to assess thermal stability and drug binding. High molecular weight aggregates in OsrHSA samples were detected with SEC and supplier-to-supplier variability and, more critically, lot-to-lot variability in one manufactures supplied products were identified. LC-MS analysis identified a greater number of hexose-glycated arginine and lysine residues on OsrHSA compared to pHSA or rHSA expressed in yeast. This analysis also showed supplier-to-supplier and lot-to-lot variability in the degree of glycation at specific lysine and arginine residues for OsrHSA. Both the number of glycated residues and the degree of glycation correlated positively with the quantity of non-monomeric species and the chromatographic profiles of the samples. Tertiary structural changes were observed for most OsrHSA samples which correlated well with the degree of arginine/lysine glycation. The extensive glycation of OsrHSA from multiple suppliers may have further implications for the use of OsrHSA as a therapeutic product.	[Frahm, Grant E.; Smith, Daryl G. S.; Kane, Anita; Lorbetskie, Barry; Cyr, Terry D.; Girard, Michel; Johnston, Michael J. W.] Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada	Health Canada	Johnston, MJW (corresponding author), Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada.	michael.johnston@hc-sc.gc.ca			Government of Canada	Government of Canada(CGIAR)	This research is supported by the Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Anraku M, 2004, BBA-PROTEINS PROTEOM, V1702, P9, DOI 10.1016/j.bbapap.2004.07.002; Anraku M, 2001, PHARMACEUT RES, V18, P632, DOI 10.1023/A:1011029226072; Baraka-Vidot J, 2012, BIOCHIMIE, V94, P1960, DOI 10.1016/j.biochi.2012.05.017; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; Bojko B, 2008, INT J BIOL MACROMOL, V42, P314, DOI 10.1016/j.ijbiomac.2007.11.002; Cha SS, 1998, J BIOL CHEM, V273, P2153, DOI 10.1074/jbc.273.4.2153; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Chen Z, BIOCH BIOPHYSICA ACT; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; Digel I, 2006, BIOPHYS J, V91, P3014, DOI 10.1529/biophysj.106.087809; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Frahm GE, 2013, J LIPOSOME RES, V23, P101, DOI 10.3109/08982104.2012.747535; Frahm GE, 2012, J PHYS CHEM B, V116, P4661, DOI 10.1021/jp2125729; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Girard M, 1999, CHROMATOGRAPHIA, V49, pS21, DOI 10.1007/BF02468972; Girard M, 1997, J CHROMATOGR A, V772, P235, DOI 10.1016/S0021-9673(97)00099-X; Girard M., 1998, Biomedical Chromatography, V12, P183, DOI 10.1002/(SICI)1099-0801(199805/06)12:3<183::AID-BMC804>3.0.CO;2-X; GLATZ JFC, 1983, J BIOCHEM BIOPH METH, V8, P57, DOI 10.1016/0165-022X(83)90021-0; Hawe A, 2007, J PHARM SCI-US, V96, P2987, DOI 10.1002/jps.20909; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Hioki A, 2010, BIOL PHARM BULL, V33, P1466, DOI 10.1248/bpb.33.1466; InVitria, 2010, CELL PROD SPEC; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Johnston MJW, 2011, PHARM RES-DORDR, V28, P1661, DOI 10.1007/s11095-011-0402-0; Kang HA, 2000, APPL MICROBIOL BIOT, V53, P575, DOI 10.1007/s002530051659; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; Kobayashi K, 2006, BIOLOGICALS, V34, P55, DOI 10.1016/j.biologicals.2005.08.021; Kobayashi K, 2000, J BIOSCI BIOENG, V89, P55, DOI 10.1016/S1389-1723(00)88050-0; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kuhlmann M, 2006, NEPHROL DIAL TRANSPL, V21, P4, DOI 10.1093/ndt/gfl474; Kuo YC, 2013, INT J MOL SCI, V14, P8719, DOI 10.3390/ijms14058719; Lautenslager GT, 2011, METABOLISM, V60, P1683, DOI 10.1016/j.metabol.2011.03.022; Leggio C, 2009, J PHYS CHEM B, V113, P12590, DOI 10.1021/jp904330v; Liu KS, 2011, J FOOD SCI, V76, pC334, DOI 10.1111/j.1750-3841.2010.02038.x; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Moriyama Y, 2003, J COLLOID INTERF SCI, V257, P41, DOI 10.1016/S0021-9797(02)00017-6; Moriyama Y, 2008, J PHYS CHEM B, V112, P16585, DOI 10.1021/jp8067624; Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338; Nakajou K, 2003, BBA-GEN SUBJECTS, V1623, P88, DOI 10.1016/j.bbagen.2003.08.001; OKABE N, 1994, BIOL PHARM BULL, V17, P16; Petrelli F, 2010, EXPERT OPIN PHARMACO, V11, P1413, DOI 10.1517/14656561003796562; Povey JF, 2008, J STRUCT BIOL, V161, P151, DOI 10.1016/j.jsb.2007.10.004; Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Shrake A, 2006, BIOPOLYMERS, V81, P235, DOI 10.1002/bip.20406; SPECTOR AA, 1968, ARCH BIOCHEM BIOPHYS, V127, P65, DOI 10.1016/0003-9861(68)90202-6; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; Steere AN, 2012, J INORG BIOCHEM, V116, P37, DOI 10.1016/j.jinorgbio.2012.07.005; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Vetter SW, 2011, CLIN CHIM ACTA, V412, P2105, DOI 10.1016/j.cca.2011.07.022; Webster DE, 2012, BIOTECHNOL ADV, V30, P410, DOI 10.1016/j.biotechadv.2011.07.015; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795; Yoshida S., 1981, FUNDAMENTALS RICE CR, P1; Zhu C, 2006, RUSS J PLANT PHYSL+, V53, P198, DOI 10.1134/S1021443706020087	59	9	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109893	10.1371/journal.pone.0109893	http://dx.doi.org/10.1371/journal.pone.0109893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299339	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200085
J	Luo, JM; Bai, YH; Liang, JS; Qu, JH				Luo, Jinming; Bai, Yaohui; Liang, Jinsong; Qu, Jiuhui			Metagenomic Approach Reveals Variation of Microbes with Arsenic and Antimony Metabolism Genes from Highly Contaminated Soil	PLOS ONE			English	Article							ACTIVATED-SLUDGE; OXIDATION; REDUCTION; BACTERIA; INSIGHTS; DETOXIFICATION; FERRIHYDRITE; DIVERSITY	Microbes have great potential for arsenic (As) and antimony (Sb) bioremediation in heavily contaminated soil because they have the ability to biotransform As and Sb to species that have less toxicity or are more easily removed. In this study, we integrated a metagenomic method with physicochemical characterization to elucidate the composition of microbial community and functional genes (related to As and Sb) in a high As (range from 34.11 to 821.23 mg kg(-1)) and Sb (range from 226.67 to 3923.07 mg kg(-1)) contaminated mine field. Metagenomic analysis revealed that microbes from 18 phyla were present in the 5 samples of soil contaminated with high As and Sb. Moreover, redundancy analysis (RDA) of the relationship between the 18 phyla and the concentration of As and Sb demonstrated that 5 phyla of microbes, i.e. Actinobacteria, Firmicutes, Nitrospirae, Tenericutes and Gemmatimonadetes were positively correlated with As and Sb concentration. The distribution, diversity and abundance of functional genes (including arsC, arrA, aioA, arsB and ACR3) were much higher for the samples containing higher As and Sb concentrations. Based on correlation analysis, the results showed a positive relationship between arsC-like (R-2 = 0.871) and aioA-like (R-2 = 0.675) gene abundance and As concentration, and indicated that intracellular As(V) reduction and As(III) oxidation could be the dominant As detoxification mechanism enabling the microbes to survive in the environment. This study provides a direct and reliable reference on the diversity of microbial community and functional genes in an extremely high concentration As- and Sb-contaminated environment.	[Luo, Jinming; Bai, Yaohui; Liang, Jinsong; Qu, Jiuhui] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Key Lab Drinking Water Sci & Technol, Beijing, Peoples R China; [Luo, Jinming; Liang, Jinsong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Qu, JH (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Key Lab Drinking Water Sci & Technol, POB 934, Beijing, Peoples R China.	jhqu@rcees.ac.cn	Luo, Jinming/AAH-1577-2020; Wenxiang, HE/V-6488-2017; liang, jinsong/AAP-5012-2021	Luo, Jinming/0000-0001-8698-7624; 	Major Program of the National Natural Science Foundation of China [51290282]; National High Technology Research and Development Program of China [2012AA062604]	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is financially supported by the Major Program of the National Natural Science Foundation of China (No. 51290282) and National High Technology Research and Development Program of China (No. 2012AA062604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Bertin PN, 2011, ISME J, V5, P1735, DOI 10.1038/ismej.2011.51; Cai L, 2013, APPL MICROBIOL BIOT, V97, P9579, DOI 10.1007/s00253-012-4678-8; Cavalca L, 2013, FUTURE MICROBIOL, V8, P753, DOI [10.2217/FMB.13.38, 10.2217/fmb.13.38]; Chen J, 2013, APPL ENVIRON MICROB, V79, P4493, DOI 10.1128/AEM.01133-13; China SEPAo, 1989, MON AN METH WAT WAST; Cutter GA, 2001, DEEP-SEA RES PT II, V48, P2895, DOI 10.1016/S0967-0645(01)00023-6; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Filella M, 2007, EARTH-SCI REV, V80, P195, DOI 10.1016/j.earscirev.2006.09.003; Flynn HC, 2003, ENVIRON POLLUT, V124, P93, DOI 10.1016/S0269-7491(02)00411-6; GREEN H. H., 1919, Union S. Africa Dept. Agrie. 5th and 6th Repts. Direc. Vet. Research, April 1918., P595; Handley KM, 2009, ENVIRON MICROBIOL, V11, P1601, DOI 10.1111/j.1462-2920.2009.01890.x; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Ito A, 2012, WATER RES, V46, P4825, DOI 10.1016/j.watres.2012.06.013; Jackson CR, 2005, SOIL BIOL BIOCHEM, V37, P2319, DOI 10.1016/j.soilbio.2005.04.010; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Lehr CR, 2007, APPL ENVIRON MICROB, V73, P2386, DOI 10.1128/AEM.02789-06; Leps J, 2003, MULTIVARIATE ANAL EC; Li J, 2013, INT BIODETER BIODEGR, V76, P76, DOI 10.1016/j.ibiod.2012.06.009; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Marcovecchio J.E., 2007, HDB WATER ANAL, V2, P275; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Plewniak F, 2013, MOL ECOL, V22, P4870, DOI 10.1111/mec.12432; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Raven KP, 1998, ENVIRON SCI TECHNOL, V32, P344, DOI 10.1021/es970421p; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Wang QS, 2011, ECOTOXICOLOGY, V20, P9, DOI 10.1007/s10646-010-0551-7; Wang X, 2012, ENVIRON SCI TECHNOL, V46, P11259, DOI 10.1021/es300454b; WAYCHUNAS GA, 1993, GEOCHIM COSMOCHIM AC, V57, P2251, DOI 10.1016/0016-7037(93)90567-G; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Yin XX, 2011, PLANT PHYSIOL, V156, P1631, DOI 10.1104/pp.111.178947; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200; Zobrist J, 2000, ENVIRON SCI TECHNOL, V34, P4747, DOI 10.1021/es001068h	49	126	135	5	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108185	10.1371/journal.pone.0108185	http://dx.doi.org/10.1371/journal.pone.0108185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299175	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200011
J	Pierdominici-Sottile, G; Perez, RC; Galindo, JF; Palma, J				Pierdominici-Sottile, Gustavo; Cossio Perez, Rodrigo; Galindo, Johan F.; Palma, Juliana			QM/MM Molecular Dynamics Study of the Galactopyranose -> Galactofuranose Reaction Catalysed by Trypanosoma cruzi UDP-Galactopyranose Mutase	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; POLYSACCHARIDE CHAIN; REACTION-MECHANISM; CHAGAS-DISEASE; BIOSYNTHESIS; ANTIGEN; BINDING; INTERMEDIATE; METABOLISM; SIMULATION	The enzyme UDP-Galactopyranose Mutase (UGM) catalyses the conversion of galactopyranose into galactofuranose. It is known to be critical for the survival and proliferation of several pathogenic agents, both prokaryotic and eukaryotic. Among them is Trypanosoma cruzi, the parasite responsible for Chagas' disease. Since the enzyme is not present in mammals, it appears as a promising target for the design of drugs to treat this illness. A precise knowledge of the mechanism of the catalysed reaction would be crucial to assist in such design. In this article we present a detailed study of all the putative steps of the mechanism. The study is based on QM/MM free energy calculations along properly selected reaction coordinates, and on the analysis of the main structural changes and interactions taking place at every step. The results are discussed in connection with the experimental evidence and previous theoretical studies.	[Pierdominici-Sottile, Gustavo; Cossio Perez, Rodrigo; Palma, Juliana] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Argentina; [Galindo, Johan F.] Univ Nacl Colombia, Dept Quim, Quantum & Computat Chem Grp, Bogota, Colombia	Universidad Nacional de Colombia	Pierdominici-Sottile, G (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Argentina.	gsottile@unq.edu.ar	Palma, Juliana/J-4386-2019; Palma, Juliana/AAG-4492-2020	Palma, Juliana/0000-0002-0761-0253; Galindo, Johan/0000-0001-9968-362X; Pierdominici-Sottile, Gustavo/0000-0003-3792-4509; Cossio-Perez, Rodrigo/0000-0002-4407-7179	CONICET; Universidad de Quilmes; Agencia Nacional de Promocion Cientifica y Tecnologica for the University of Quilmes [2597]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Quilmes; Agencia Nacional de Promocion Cientifica y Tecnologica for the University of Quilmes	This work was mainly supported by CONICET and Universidad de Quilmes. A part of this work was supported by the grant pict 2010-#2597 of the Agencia Nacional de Promocion Cientifica y Tecnologica for the University of Quilmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED Z, 1993, PHYS REV A, V47, P4761, DOI 10.1103/PhysRevA.47.4761; ALMEIDA IC, 1994, BRAZ J MED BIOL RES, V27, P443; Barlow JN, 1999, J AM CHEM SOC, V121, P6968, DOI 10.1021/ja991582r; Barnett CB, 2010, J PHYS CHEM B, V114, P17142, DOI 10.1021/jp107620h; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; BERST M, 1969, EUR J BIOCHEM, V11, P353, DOI 10.1111/j.1432-1033.1969.tb00779.x; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Biarnes X, 2007, J AM CHEM SOC, V129, P10686, DOI 10.1021/ja068411o; Boechi L, 2013, PROTEIN SCI, V22, P1490, DOI 10.1002/pro.2332; Case DA, 2012, AMBER 12, V12, P142; Chad JM, 2007, BIOCHEMISTRY-US, V46, P6723, DOI 10.1021/bi7002795; Chatfield DC, 1998, THEOCHEM-J MOL STRUC, V423, P79, DOI 10.1016/S0166-1280(96)04875-0; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Cunningham MA, 1997, BIOCHEMISTRY-US, V36, P4800, DOI 10.1021/bi962734n; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002; Dhatwalia R, 2012, BIOCHEMISTRY-US, V51, P4968, DOI 10.1021/bi300498c; Dhatwalia R, 2012, J BIOL CHEM, V287, P9041, DOI 10.1074/jbc.M111.327536; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; DMITRIEV BA, 1977, CARBOHYD RES, V56, P207, DOI 10.1016/S0008-6215(00)84257-3; Dykhuizen EC, 2008, J AM CHEM SOC, V130, P6706, DOI 10.1021/ja8018687; Ferguson MAJ, 1997, PHILOS T ROY SOC B, V352, P1295, DOI 10.1098/rstb.1997.0113; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Hensen C, 2004, J MED CHEM, V47, P6673, DOI 10.1021/jm0497343; Himo F, 2006, THEOR CHEM ACC, V116, P232, DOI 10.1007/s00214-005-0012-1; Huang WJ, 2012, J PHYS CHEM B, V116, P14040, DOI 10.1021/jp310952c; Huang ZH, 2003, BIOORG CHEM, V31, P494, DOI 10.1016/j.bioorg.2003.08.002; Issa VS, 2010, LANCET, V376, P768, DOI 10.1016/S0140-6736(10)61372-4; JANN B, 1994, CARBOHYD RES, V264, P305, DOI 10.1016/S0008-6215(05)80014-X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kizjakina K, 2013, CURR PHARM DESIGN, V19, P2561, DOI 10.2174/1381612811319140007; KOL O, 1991, CARBOHYD RES, V217, P117, DOI 10.1016/0008-6215(91)84122-U; Kruger T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871913; Kruger T, 2005, J CHEM PHYS, V122; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEE FS, 1992, PROTEIN ENG, V5, P215, DOI 10.1093/protein/5.3.215; Lin YL, 2010, BIOCHEMISTRY-US, V49, P84, DOI 10.1021/bi901790e; MacRae JI, 2006, MOL BIOCHEM PARASIT, V147, P126, DOI 10.1016/j.molbiopara.2006.02.011; Major DT, 2006, J AM CHEM SOC, V128, P16345, DOI 10.1021/ja066334r; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; NIKAIDO H, 1971, J BACTERIOL, V105, P1073, DOI 10.1128/JB.105.3.1073-1082.1971; Oppenheimer M, 2011, ENZYME RES, V2011; Oppenheimer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032918; Partha SK, 2010, J MOL BIOL, V403, P578, DOI 10.1016/j.jmb.2010.08.053; Partha SK, 2009, J MOL BIOL, V394, P864, DOI 10.1016/j.jmb.2009.10.013; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Pierdominici-Sottile G, 2008, CHEM PHYS LETT, V456, P243, DOI 10.1016/j.cplett.2008.03.023; Pierdominici-Sottile G, 2014, PROTEINS, V82, P424, DOI 10.1002/prot.24408; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Sun HG, 2012, J BIOL CHEM, V287, P4602, DOI 10.1074/jbc.M111.312538; Tanner JJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P128, DOI 10.1016/j.abb.2013.09.017; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; TEIXEIRA ARL, 1990, AM J TROP MED HYG, V43, P146, DOI 10.4269/ajtmh.1990.43.146; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; TURCO SJ, 1989, J BIOL CHEM, V264, P6711; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van Straaten KE, 2012, ACTA CRYSTALLOGR F, V68, P455, DOI 10.1107/S1744309112006914; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Woodcock HL, 2007, J PHYS CHEM A, V111, P5720, DOI 10.1021/jp0714217; Yuan Y, 2008, J AM CHEM SOC, V130, P3157, DOI 10.1021/ja7104152	69	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109559	10.1371/journal.pone.0109559	http://dx.doi.org/10.1371/journal.pone.0109559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299056	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200058
J	Jonker, JL; Abram, F; Pires, E; Coelho, AV; Grunwald, I; Power, AM				Jonker, Jaimie-Leigh; Abram, Florence; Pires, Elisabete; Coelho, Ana Varela; Grunwald, Ingo; Power, Anne Marie			Adhesive Proteins of Stalked and Acorn Barnacles Display Homology with Low Sequence Similarities	PLOS ONE			English	Article							CEMENT PROTEINS; LEPAS-ANATIFERA; MUSSEL; SPECTROSCOPY; PLAQUE; DOPA; EXPRESSION; BONDS; GENE	Barnacle adhesion underwater is an important phenomenon to understand for the prevention of biofouling and potential biotechnological innovations, yet so far, identifying what makes barnacle glue proteins 'sticky' has proved elusive. Examination of a broad range of species within the barnacles may be instructive to identify conserved adhesive domains. We add to extensive information from the acorn barnacles (order Sessilia) by providing the first protein analysis of a stalked barnacle adhesive, Lepas anatifera (order Lepadiformes). It was possible to separate the L. anatifera adhesive into at least 10 protein bands using SDS-PAGE. Intense bands were present at approximately 30, 70, 90 and 110 kilodaltons (kDa). Mass spectrometry for protein identification was followed by de novo sequencing which detected 52 peptides of 7-16 amino acids in length. None of the peptides matched published or unpublished transcriptome sequences, but some amino acid sequence similarity was apparent between L. anatifera and closely-related Dosima fascicularis. Antibodies against two acorn barnacle proteins (ab-cp-52k and ab-cp-68k) showed cross-reactivity in the adhesive glands of L. anatifera. We also analysed the similarity of adhesive proteins across several barnacle taxa, including Pollicipes pollicipes (a stalked barnacle in the order Scalpelliformes). Sequence alignment of published expressed sequence tags clearly indicated that P. pollicipes possesses homologues for the 19 kDa and 100 kDa proteins in acorn barnacles. Homology aside, sequence similarity in amino acid and gene sequences tended to decline as taxonomic distance increased, with minimum similarities of 18-26%, depending on the gene. The results indicate that some adhesive proteins (e. g. 100 kDa) are more conserved within barnacles than others (20 kDa).	[Jonker, Jaimie-Leigh; Abram, Florence; Power, Anne Marie] Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland; [Pires, Elisabete; Coelho, Ana Varela] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Grunwald, Ingo] Fraunhofer Inst Mfg Technol & Adv Mat, Dept Adhes Bonding & Surfaces, Bremen, Germany	Ollscoil na Gaillimhe-University of Galway; Universidade Nova de Lisboa; Fraunhofer Gesellschaft	Power, AM (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland.	annemarie.power@nuigalway.ie	abram, florence/K-6639-2015; Coelho, Ana V/H-8885-2012; Coelho, Ana V Varela/O-3977-2014; Grunwald, Ingo/C-5662-2012	abram, florence/0000-0001-7522-9158; Coelho, Ana V/0000-0002-6143-4203; Coelho, Ana V Varela/0000-0002-6143-4203; Pires, Elisabete/0000-0001-8646-062X; Power, Anne Marie/0000-0001-7351-2451	Science Foundation Ireland [09RFPMTR2311]; Department of Communications, Marine and Natural Resources, Government of Ireland; European Cooperation in the field of Scientific and Technical Research [TD0906]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Communications, Marine and Natural Resources, Government of Ireland; European Cooperation in the field of Scientific and Technical Research(European Cooperation in Science and Technology (COST))	Funding was provided by Science Foundation Ireland Contract grant number 09RFPMTR2311 awarded to AMP (http://www.sfi.ie/), and Beaufort Marine Research Awards grant-aided by the Department of Communications, Marine and Natural Resources, Government of Ireland, awarded to AMP and co-Pls. Work was also supported by European Cooperation in the field of Scientific and Technical Research (COST Action TD0906). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson KE, 1998, BIOL BULL, V194, P150, DOI 10.2307/1543045; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; BAINBRIDGE V., 1966, P67; Barlow DE, 2012, ANNU REV ANAL CHEM, V5, P229, DOI 10.1146/annurev-anchem-061010-113844; BARNES H, 1976, J EXP MAR BIOL ECOL, V25, P263, DOI 10.1016/0022-0981(76)90128-3; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Benaziz L, 2001, J COLLOID INTERF SCI, V238, P48, DOI 10.1006/jcis.2001.7450; Berglin M, 2003, COLLOID SURFACE B, V28, P107, DOI 10.1016/S0927-7765(02)00149-2; Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Endrizzi BJ, 2009, J ADHESION, V85, P546, DOI 10.1080/00218460902996457; Flammang P, 2006, BIOL ADHEISVES; Flammang P, 2009, J ADHESION, V85, P447, DOI 10.1080/00218460902996358; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; He LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064130; Holowka EP, 2010, MACROMOL BIOSCI, V10, P496, DOI 10.1002/mabi.200900390; Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028; Hwang DS, 2007, J BIOTECHNOL, V127, P727, DOI 10.1016/j.jbiotec.2006.08.005; Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; Jonker J-L, 2013, NATURAL ADHESIVE GOO; Jonker JL, 2012, J MORPHOL, V273, P1377, DOI 10.1002/jmor.20067; Kamino K, 1998, NEW DEVELOPMENTS IN MARINE BIOTECHNOLOGY, P77; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033; Kamino K., 2013, STRUCTURAL INTERFACE, P175, DOI [DOI 10.1007/978-1-4614-3317-0_9, 10.1007/978-1-4614-3317-0_9]; Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3; Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8; Kamino K, 2012, FEBS J, V279, P1750, DOI 10.1111/j.1742-4658.2012.08552.x; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Lin HC, 2013, BIOFOULING; Lin HC, 2014, BIOFOULING, V30, P169, DOI 10.1080/08927014.2013.853051; McEvilly P, 2011, LEPAS ANATIFERA CONC; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mori Y, 2007, FEBS J, V274, P6436, DOI 10.1111/j.1742-4658.2007.06161.x; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; NALDRETT MJ, 1993, J MAR BIOL ASSOC UK, V73, P689, DOI 10.1017/S0025315400033221; Naldrett MJ, 1997, MAR BIOL, V127, P629, DOI 10.1007/s002270050053; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Ohkawa K, 2009, J ADHESION, V85, P770, DOI 10.1080/00218460903291353; PARKER JH, 1967, PHYS REV, V155, P712, DOI 10.1103/PhysRev.155.712; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M, 2008, MOL PHYLOGENET EVOL, V46, P328, DOI 10.1016/j.ympev.2007.10.004; Pilson M.E.Q., 2013, INTRO CHEM SEA, Vsecond, P248, DOI [10.5670/oceanog.2014.31, DOI 10.5670/OCEANOG.2014.31]; Power AM, 2001, ESTUAR COAST SHELF S, V52, P349, DOI 10.1006/ecss.2000.0711; Power AM, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P153, DOI 10.1007/978-3-7091-0286-2_9; Raman S, 2013, INT J ADHES ADHES, V41, P140, DOI 10.1016/j.ijadhadh.2012.11.003; Schweitzer-Stenner R, 2001, J RAMAN SPECTROSC, V32, P711, DOI 10.1002/jrs.757; SNELI JA, 1983, CRUSTACEANA, V45, P306, DOI 10.1163/156854083X00352; Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330; Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d; Suzuki R, 2005, J BIOMOL NMR, V32, P257, DOI 10.1007/s10858-005-7029-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s; Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WALKER G, 1987, SYNTHETIC ADHESIVES, P112; Wiegemann M, 2006, MAR BIOL, V149, P241, DOI 10.1007/s00227-005-0219-7; Wolpert M, 2006, SPECTROCHIM ACTA A, V64, P987, DOI 10.1016/j.saa.2005.08.025; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200; Zheden V, 2014, BIOFOULING; Zheden V, 2012, BIOL BULL-US, V223, P192, DOI 10.1086/BBLv223n2p192	65	18	18	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108902	10.1371/journal.pone.0108902	http://dx.doi.org/10.1371/journal.pone.0108902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295513	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000026
J	Fortunato, TM; Vara, DS; Wheeler-Jones, CP; Pula, G				Fortunato, Tiago M.; Vara, Dina S.; Wheeler-Jones, Caroline P.; Pula, Giordano			Expression of Protease-Activated Receptor 1 and 2 and Anti-Tubulogenic Activity of Protease-Activated Receptor 1 in Human Endothelial Colony-Forming Cells	PLOS ONE			English	Article							PROGENITOR CELLS; UP-REGULATION; MOLECULAR-CLONING; PAR-1 ACTIVATION; GENE-EXPRESSION; IN-VITRO; THROMBIN; VASCULOGENESIS; ANGIOGENESIS; INCREASES	Endothelial colony-forming cells (ECFCs) are obtained from the culture of human peripheral blood mononuclear cell (hPBMNC) fractions and are characterised by high proliferative and pro-vasculogenic potential, which makes them of great interest for cell therapy. Here, we describe the detection of protease-activated receptor (PAR) 1 and 2 amongst the surface proteins expressed in ECFCs. Both receptors are functionally coupled to extracellular signal-regulated kinase (ERK) 1 and 2, which become activated and phosphorylated in response to selective PAR1- or PAR2-activating peptides. Specific stimulation of PAR1, but not PAR2, significantly inhibits capillary-like tube formation by ECFCs in vitro, suggesting that tubulogenesis is negatively regulated by proteases able to stimulate PAR1 (e.g. thrombin). The activation of ERKs is not involved in the regulation of tubulogenesis in vitro, as suggested by use of the MEK inhibitor PD98059 and by the fact that PAR2 stimulation activates ERKs without affecting capillary tube formation. Both qPCR and immunoblotting showed a significant downregulation of vascular endothelial growth factor 2 (VEGFR2) in response to PAR1 stimulation. Moreover, the addition of VEGF (50-100 ng/ml) but not basic Fibroblast Growth Factor (FGF) (25-100 ng/ml) rescued tube formation by ECFCs treated with PAR1-activating peptide. Therefore, we propose that reduction of VEGF responsiveness resulting from down-regulation of VEGFR2 is underlying the anti-tubulogenic effect of PAR1 activation. Although the role of PAR2 remains elusive, this study sheds new light on the regulation of the vasculogenic activity of ECFCs and suggests a potential link between adult vasculogenesis and the coagulation cascade.	[Fortunato, Tiago M.; Vara, Dina S.; Pula, Giordano] Univ Bath, Dept Pharm & Pharmacol, Bath Spa, England; [Wheeler-Jones, Caroline P.] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of Bath; University of London; University of London Royal Veterinary College	Pula, G (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath Spa, England.	G.Pula@bath.ac.uk	Vara, Dina/W-6349-2019; Pula, Giordano/ABE-8596-2020	Vara, Dina/0000-0002-3099-6748	Royal Society [RG120494]; BBSRC [BB/J002690/1]; Biotechnology and Biological Sciences Research Council [BB/J002690/1] Funding Source: researchfish	Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Royal Society provided funds for the reagents utilized for this study (grant number RG120494), whereas BBSRC provided funds for the salary of DV (grant number BB/J002690/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Bennis Y, 2012, J THROMB HAEMOST, V10, P1914, DOI 10.1111/j.1538-7836.2012.04835.x; Benslimane-Ahmim Z, 2011, J THROMB HAEMOST, V9, P834, DOI 10.1111/j.1538-7836.2011.04207.x; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Camerer E, 1996, J BIOL CHEM, V271, P29034, DOI 10.1074/jbc.271.46.29034; Camerer E, 2002, J BIOL CHEM, V277, P16081, DOI 10.1074/jbc.M108555200; Chan B, 2003, MICROVASC RES, V66, P1, DOI 10.1016/S0026-2862(03)00037-2; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Drake CJ, 2000, DEV BIOL, V224, P178, DOI 10.1006/dbio.2000.9744; Evrard SM, 2012, J THROMB HAEMOST, V10, P670, DOI 10.1111/j.1538-7836.2012.04644.x; Hamilton JR, 2001, J CARDIOVASC PHARM, V38, P108, DOI 10.1097/00005344-200107000-00012; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Ritchie E, 2007, BRIT J PHARMACOL, V150, P1044, DOI 10.1038/sj.bjp.0707150; Sbaa E, 2006, CIRC RES, V98, P1219, DOI 10.1161/01.RES.0000220648.80170.8b; Smadja DM, 2007, J CELL MOL MED, V11, P1149, DOI 10.1111/j.1582-4934.2007.00090.x; Smadja DM, 2011, ANGIOGENESIS, V14, P17, DOI 10.1007/s10456-010-9192-y; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Smadja DM, 2009, J CELL MOL MED, V13, P2534, DOI 10.1111/j.1582-4934.2008.00429.x; Smadja DM, 2005, ARTERIOSCL THROM VAS, V25, P2321, DOI 10.1161/01.ATV.0000184762.63888.bd; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Tarzami ST, 2006, J THROMB HAEMOST, V4, P656, DOI 10.1111/j.1538-7836.2006.01788.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Zhou Z, 2007, MOL CANCER RES, V5, P1125, DOI 10.1158/1541-7786.MCR-07-0174	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109375	10.1371/journal.pone.0109375	http://dx.doi.org/10.1371/journal.pone.0109375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289673	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000342798000056
J	Jackson, AR; Shah, A; Kumar, A				Jackson, Austin R.; Shah, Ankit; Kumar, Anil			Methamphetamine Alters the Normal Progression by Inducing Cell Cycle Arrest in Astrocytes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GP120 TRANSGENIC MICE; HIV-1 GP120; DNA-DAMAGE; OXIDATIVE STRESS; BRAIN; ASTROGLIOSIS; INFECTION; APOPTOSIS; STRIATUM	Methamphetamine (MA) is a potent psychostimulant with a high addictive capacity, which induces many deleterious effects on the brain. Chronic MA abuse leads to cognitive dysfunction and motor impairment. MA affects many cells in the brain, but the effects on astrocytes of repeated MA exposure is not well understood. In this report, we used Gene chip array to analyze the changes in the gene expression profile of primary human astrocytes treated with MA for 3 days. Range of genes were found to be differentially regulated, with a large number of genes significantly downregulated, including NEK2, TTK, TOP2A, and CCNE2. Gene ontology and pathway analysis showed a highly significant clustering of genes involved in cell cycle progression and DNA replication. Further pathway analysis showed that the genes downregulated by multiple MA treatment were critical for G2/M phase progression and G1/S transition. Cell cycle analysis of SVG astrocytes showed a significant reduction in the percentage of cell in the G2/M phase with a concomitant increase in G1 percentage. This was consistent with the gene array and validation data, which showed that repeated MA treatment downregulated the genes associated with cell cycle regulation. This is a novel finding, which explains the effect of MA treatment on astrocytes and has clear implication in neuroinflammation among the drug abusers.	[Jackson, Austin R.; Shah, Ankit; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022		National Institute on Drug Abuse [DA025528, DA025011]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025011, R01DA025528] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institute on Drug Abuse (DA025528 and DA025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Muneer PM, 2011, PLOS ONE, V6; Ando H, 2013, BRAIN, V136, P2876, DOI 10.1093/brain/awt183; Atmaca HT, 2014, NEUROSCIENCE, V269, P184, DOI 10.1016/j.neuroscience.2014.03.049; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bento AR, 2011, REJUV RES, V14, P205, DOI 10.1089/rej.2010.1109; Broderick R, 2009, BIOCHEM SOC T, V37, P926, DOI 10.1042/BST0370926; Cadet JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-545; Cekanaviciute E, 2014, J IMMUNOL; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Cisneros IE, 2014, NEUROPHARMACOLOGY; Cisneros IE, 2012, CURR HIV RES, V10, P392, DOI 10.2174/157016212802138832; Cooley ID, 2014, GLIA, V62, P818, DOI 10.1002/glia.22644; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; Friend DM, 2013, J NEUROCHEM, V125, P566, DOI 10.1111/jnc.12201; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Goncalves J., 2014, NEUROPHARMACOLOGY; Granado N, 2011, GLIA, V59, P1850, DOI 10.1002/glia.21229; Guillot TS, 2008, J NEUROCHEM, V106, P2205, DOI 10.1111/j.1471-4159.2008.05568.x; Guo M-F, 2014, J NEUROL SCI; Hadlock GC, 2010, J PHARMACOL EXP THER, V335, P207, DOI 10.1124/jpet.110.166660; Helmuth L, 2001, SCIENCE, V291, P569; Henry BL, 2014, BEHAV PHARMACOL, V25, P12, DOI 10.1097/FBP.0000000000000012; Henry BL, 2013, BEHAV BRAIN RES, V236, P210, DOI 10.1016/j.bbr.2012.08.037; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hostenbach S, 2014, NEUROSCI LETT, V565, P39, DOI 10.1016/j.neulet.2013.10.012; Hu C.-M., 2014, ONCOGENE; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim YH, 2002, BIOCHEM BIOPH RES CO, V290, P730, DOI 10.1006/bbrc.2001.6212; Lang AJ, 1998, GENE, V221, P255, DOI 10.1016/S0378-1119(98)00468-5; Liu X, 2014, ONCOL REP, V31, P745, DOI 10.3892/or.2013.2910; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033822; Ma YF, 2013, BIOCHEM BIOPH RES CO, V441, P958, DOI 10.1016/j.bbrc.2013.11.010; Mandyam CD, 2008, BIOL PSYCHIAT, V64, P958, DOI 10.1016/j.biopsych.2008.04.010; Marshall JF, 2012, TRENDS NEUROSCI, V35, P536, DOI 10.1016/j.tins.2012.05.006; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Pendyala G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037604; Pereira FC, 2012, NEUROTOXICOL TERATOL, V34, P522, DOI 10.1016/j.ntt.2012.07.005; POCH O, 1994, MOL GEN GENET, V243, P641, DOI 10.1007/BF00279573; Quinton MS, 2006, AAPS J, V8, pE337, DOI 10.1208/aapsj080238; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Robson MJ, 2014, EXP NEUROL, V254, P180, DOI 10.1016/j.expneurol.2014.01.020; Shah A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.374; Shah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052060; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sharma A, 2011, J NEUROIMMUNE PHARM, V6, P597, DOI 10.1007/s11481-011-9295-2; Shin OS, 2014, VIRAL IMMUNOL; Silverstein PS, 2012, CURR HIV RES, V10, P369, DOI 10.2174/157016212802138724; Silverstein PS, 2011, J NEUROVIROL, V17, P401, DOI 10.1007/s13365-011-0043-4; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367; Wu CW, 2007, TOXICOL APPL PHARM, V220, P243, DOI 10.1016/j.taap.2007.01.011; Yamanaka S, 2012, CELL CYCLE, V11, P2729, DOI 10.4161/cc.21105; Yeh YH, 2009, ONCOGENE, V28, P1366, DOI 10.1038/onc.2008.477; Yu HS, 2014, ONCOL LETT, V7, P799, DOI 10.3892/ol.2013.1754; Yuan CJ, 2011, PHARMACOL BIOCHEM BE, V100, P98, DOI 10.1016/j.pbb.2011.08.004	59	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109603	10.1371/journal.pone.0109603	http://dx.doi.org/10.1371/journal.pone.0109603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290377	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000071
J	Saen-oon, S; Lee, SG; Jez, JM; Guallar, V				Saen-oon, Suwipa; Lee, Soon Goo; Jez, Joseph M.; Guallar, Victor			An Alternative Mechanism for the Methylation of Phosphoethanolamine Catalyzed by Plasmodium falciparum Phosphoethanolamine Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Crystallography; Enzyme Mechanism; Mutagenesis; Protein Structure	N-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; PHOSPHOLIPID-METABOLISM; MOLECULAR-MECHANICS; PRODUCT SPECIFICITY; FORCE-FIELD; PATHWAY; PROTEIN; INTEGRATION	Background: In Plasmodium, phosphoethanolamine methyltransferase (PfPMT) is essential for normal growth and development. Results: Computational, biochemical, and structural studies suggest catalytic and structural roles for Asp-128 in PfPMT. Conclusion: Asp-128 is critical for specific methylation of phosphoethanolamine and not other phosphobases. Significance: This work provides new insight on the evolution of multiple substrate activity in PMT from different organisms. The phosphobase methylation pathway catalyzed by the phosphoethanolamine methyltransferase in Plasmodium falciparum (PfPMT), the malaria parasite, offers an attractive target for anti-parasitic drug development. PfPMT methylates phosphoethanolamine (pEA) to phosphocholine for use in membrane biogenesis. Quantum mechanics and molecular mechanics (QM/MM) calculations tested the proposed reaction mechanism for methylation of pEA involving the previously identified Tyr-19-His-132 dyad, which indicated an energetically unfavorable mechanism. Instead, the QM/MM calculations suggested an alternative mechanism involving Asp-128. The reaction coordinate involves the stepwise transfer of a proton to Asp-128 via a bridging water molecule followed by a typical S(n)2-type methyl transfer from S-adenosylmethionine to pEA. Functional analysis of the D128A, D128E, D128Q, and D128N PfPMT mutants shows a loss of activity with pEA but not with the final substrate of the methylation pathway. X-ray crystal structures of the PfPMT-D128A mutant in complex with S-adenosylhomocysteine and either pEA or phosphocholine reveal how mutation of Asp-128 disrupts a hydrogen bond network in the active site. The combined QM/MM, biochemical, and structural studies identify a key role for Asp-128 in the initial step of the phosphobase methylation pathway in Plasmodium and provide molecular insight on the evolution of multiple activities in the active site of the PMT.	[Saen-oon, Suwipa; Guallar, Victor] Joint Barcelona Supercomp Ctr, Ctr Genom Regulat, Inst Res, Biomed Res Program, Barcelona 08034, Spain; [Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Guallar, Victor] Catalan Inst Res & Adv Studies, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Washington University (WUSTL); ICREA	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu; victor.guallar@bsc.es	Guallar, Victor/B-1579-2013	Guallar, Victor/0000-0002-4580-1114; saen-oon, suwipa/0000-0002-4101-245X; Lee, Soon Goo/0000-0002-1541-8587	National Institutes of Health [AI-097119]; Barcelona Supercomputer Center; Spanish Ministry of Education and Science [CTQ2013-48287];  [DE-AC02-06CH11357]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barcelona Supercomputer Center; Spanish Ministry of Education and Science(Spanish Government); ; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-097119 (to the Jez laboratory). This work was also supported by funds from the Barcelona Supercomputer Center and the Spanish Ministry of Education and Science through Project CTQ2013-48287 (to the Guallar laboratory). Portions of this work were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research and supported by Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Calas M, 2000, J MED CHEM, V43, P505, DOI 10.1021/jm9911027; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Hur S, 2003, P NATL ACAD SCI USA, V100, P12015, DOI 10.1073/pnas.1534873100; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lee SG, 2014, TRENDS PARASITOL, V30, P241, DOI 10.1016/j.pt.2014.03.001; Lee SG, 2013, STRUCTURE, V21, P1778, DOI 10.1016/j.str.2013.07.023; Lee SG, 2012, BIOORG MED CHEM LETT, V22, P4990, DOI 10.1016/j.bmcl.2012.06.032; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lee SG, 2011, J BIOL CHEM, V286, P38060, DOI 10.1074/jbc.M111.290619; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Schmidt T, 2014, J PHYS CHEM B, V118, P5882, DOI 10.1021/jp5028564; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Velichkova P, 2006, J PHYS CHEM B, V110, P16, DOI 10.1021/jp055120d; Velichkova P, 2005, J PHYS CHEM B, V109, P8216, DOI 10.1021/jp0443254; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zhang XD, 2006, P NATL ACAD SCI USA, V103, P16141, DOI 10.1073/pnas.0607503103; Zhang YK, 2003, J PHYS CHEM B, V107, P4459, DOI 10.1021/jp022525e; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	43	10	10	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33815	33825		10.1074/jbc.M114.611319	http://dx.doi.org/10.1074/jbc.M114.611319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25288796	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000346077600009
J	Brennan-Laun, SE; Li, XL; Ezelle, HJ; Venkataraman, T; Blackshear, PJ; Wilson, GM; Hassel, BA				Brennan-Laun, Sarah E.; Li, Xiao-Ling; Ezelle, Heather J.; Venkataraman, Thiagarajan; Blackshear, Perry J.; Wilson, Gerald M.; Hassel, Bret A.			RNase L Attenuates Mitogen-stimulated Gene Expression via Transcriptional and Post-transcriptional Mechanisms to Limit the Proliferative Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; MESSENGER-RNA; 2-5A-DEPENDENT RNASE; GROWTH-FACTOR; TNF-ALPHA; TRISTETRAPROLIN EXPRESSION; 3'-UNTRANSLATED REGION; BINDING-PROTEINS; CELL; CANCER	The cellular response to mitogens is tightly regulated via transcriptional and post-transcriptional mechanisms to rapidly induce genes that promote proliferation and efficiently attenuate their expression to prevent malignant growth. RNase L is an endoribonuclease that mediates diverse antiproliferative activities, and tristetraprolin (TTP) is a mitogen-induced RNA-binding protein that directs the decay of proliferation-stimulatory mRNAs. In light of their roles as endogenous proliferative constraints, we examined the mechanisms and functional interactions of RNase Land TTP to attenuate a mitogenic response. Mitogen stimulation of RNase L-deficient cells significantly increased TTP transcription and the induction of other mitogen-induced mRNAs. This regulation corresponded with elevated expression of serum-response factor (SRF), a master regulator of mitogen-induced transcription. RNase L destabilized the SRF transcript and formed a complex with SRF mRNA in cells providing a mechanism by which RNase L down-regulates SRF-induced genes. TTP and RNase L proteins interacted in cells suggesting that RNase L is directed to cleave TTP bound RNAs as a mechanism of substrate specificity. Consistent with their concerted function in RNA turnover, the absence of either RNase Lor TTP stabilized SRF mRNA, and a subset of established TTP targets was also regulated by RNase L. RNase L deficiency enhanced mitogen-induced proliferation demonstrating its functional role in limiting the mitogenic response. Our findings support a model of feedback regulation in which RNase L and TTP target SRF mRNA and SRF-induced transcripts. Accordingly, meta-analysis revealed an enrichment of RNase L and TTP targets among SRF-regulated genes suggesting that the RNase L/TTP axis represents a viable target to inhibit SRF-driven proliferation in neoplastic diseases.	[Brennan-Laun, Sarah E.; Ezelle, Heather J.; Wilson, Gerald M.; Hassel, Bret A.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Brennan-Laun, Sarah E.; Ezelle, Heather J.; Venkataraman, Thiagarajan; Hassel, Bret A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Li, Xiao-Ling] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Ezelle, Heather J.; Hassel, Bret A.] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD 21201 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hassel, BA (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 W Baltimore St,HSF I 380, Baltimore, MD 21201 USA.	bhassel@som.umaryland.edu	Wilson, Gerald/AAF-3874-2019; Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529; Venkataraman, Thiagarajan/0000-0003-0921-6345; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health [AI077556]; NCI [T32CA154274]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077556 (to B. A. H.) and NCI T32 Cancer Biology Training Grant T32CA154274 from NCI (to S. E. B.-L.). This work was also supported by a Veterans Affairs Merit Award (to B. A. H.).	Al-Haj L, 2012, NUCLEIC ACIDS RES, V40, P7739, DOI 10.1093/nar/gks545; Andersen JB, 2007, ONCOGENE, V26, P3081, DOI 10.1038/sj.onc.1210111; Andersen JB, 2009, RNA BIOL, V6, P305, DOI 10.4161/rna.6.3.8526; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Benson CC, 2011, PHYSIOL GENOMICS, V43, P1038, DOI 10.1152/physiolgenomics.00098.2011; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; BOURGEADE MF, 1984, CANCER RES, V44, P5355; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brennan-Laun SE, 2014, J INTERF CYTOK RES, V34, P275, DOI 10.1089/jir.2013.0147; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Bros M, 2010, MOL IMMUNOL, V47, P1161, DOI 10.1016/j.molimm.2009.11.002; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Clark KA, 2014, GENE DEV, V28, P926, DOI 10.1101/gad.242420.114; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Domingo-Gil E, 2010, J INTERF CYTOK RES, V30, P171, DOI 10.1089/jir.2009.0037; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 1997, J BIOL CHEM, V272, P22236, DOI 10.1074/jbc.272.35.22236; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Ezelle Heather J, 2012, Front Biosci (Schol Ed), V4, P767; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fabre O, 2012, CELL DEATH DIFFER, V19, P1470, DOI 10.1038/cdd.2012.23; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Hausburg M. A., 2010, THESIS U COLORADO BO; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Hovanessian AG, 2007, CYTOKINE GROWTH F R, V18, P351, DOI 10.1016/j.cytogfr.2007.06.003; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; JACOBSEN H, 1983, P NATL ACAD SCI-BIOL, V80, P4954, DOI 10.1073/pnas.80.16.4954; Jha BK, 2011, J BIOL CHEM, V286, P26319, DOI 10.1074/jbc.M111.253443; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Kim HK, 2012, J BIOL CHEM, V287, P28770, DOI 10.1074/jbc.M112.376483; Kim TW, 2010, BIOCHEM BIOPH RES CO, V391, P963, DOI 10.1016/j.bbrc.2009.11.174; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; KLEIN G, 1993, FASEB J, V7, P821, DOI 10.1096/fasebj.7.10.8344481; Kratochvill F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.93; KRISHNAN I, 1980, P NATL ACAD SCI-BIOL, V77, P6506, DOI 10.1073/pnas.77.11.6506; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Li XL, 2008, P NATL ACAD SCI USA, V105, P20816, DOI 10.1073/pnas.0807265105; Liu W, 2007, EUR J CANCER, V43, P202, DOI 10.1016/j.ejca.2006.08.024; Long TM, 2013, INFLAMM BOWEL DIS, V19, P1295, DOI 10.1097/MIB.0b013e318281f2fd; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Madsen BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002492; Mahat DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033194; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Masuda K, 2009, AGING-US, V1, P681, DOI 10.18632/aging.100073; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meyer MS, 2010, CARCINOGENESIS, V31, P1597, DOI 10.1093/carcin/bgq132; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Ross CR, 2012, AGEING RES REV, V11, P473, DOI 10.1016/j.arr.2012.02.005; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Shi ZD, 2010, J BIOL CHEM, V285, P32415, DOI 10.1074/jbc.M110.164863; SILVERMAN RH, 1988, J BIOL CHEM, V263, P7336; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; Spencer JA, 1999, ONCOGENE, V18, P7319, DOI 10.1038/sj.onc.1203121; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Suswam EA, 2013, J NEURO-ONCOL, V113, P195, DOI 10.1007/s11060-013-1112-8; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VARNUM BC, 1989, ONCOGENE, V4, P119; Volinsky N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009043; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xie L, 2013, J INTERF CYTOK RES, V33, P588, DOI 10.1089/jir.2012.0065; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081269; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200; Zhou AM, 2005, J INTERF CYTOK RES, V25, P595, DOI 10.1089/jir.2005.25.595; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; ZULLO JN, 1985, CELL, V43, P793, DOI 10.1016/0092-8674(85)90252-1	117	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33629	33643		10.1074/jbc.M114.589556	http://dx.doi.org/10.1074/jbc.M114.589556			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301952	hybrid, Green Published			2022-12-25	WOS:000345636600048
J	Sippel, KH; Vyas, NK; Zhang, W; Sankaran, B; Quiocho, FA				Sippel, Katherine H.; Vyas, Nand K.; Zhang, Wei; Sankaran, Banumathi; Quiocho, Florante A.			Crystal Structure of the Human Fatty Acid Synthase Enoyl-Acyl Carrier Protein-Reductase Domain Complexed with Triclosan Reveals Allosteric Protein-Protein Interface Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; BREAST-CANCER CELLS; IN-VITRO; THIOESTERASE DOMAIN; OVEREXPRESSION; CHEMOPREVENTION; CYTOTOXICITY; MECHANISM; ONCOGENE; ANALOGS	Human fatty acid synthase (FAS) is a large, multidomain protein that synthesizes long chain fatty acids. Because these fatty acids are primarily provided by diet, FAS is normally expressed at low levels; however, it is highly up-regulated in many cancers. Human enoyl-acyl carrier protein-reductase (hER) is one of the FAS catalytic domains, and its inhibition by drugs like triclosan (TCL) can increase cytotoxicity and decrease drug resistance in cancer cells. We have determined the structure of hER in the presence and absence of TCL. TCL was not bound in the active site, as predicted, but rather at the protein-protein interface (PPI). TCL binding induces a dimer orientation change that causes downstream structural rearrangement in critical active site residues. Kinetics studies indicate that TCL is capable of inhibiting the isolated hER domain with an IC50 of similar to 55 mu M. Given the hER-TCL structure and the inhibition observed in the hER domain, it seems likely that TCL is observed in the physiologically relevant binding site and that it acts as an allosteric PPI inhibitor. TCL may be a viable scaffold for the development of anti-cancer PPI FAS inhibitors.	[Sippel, Katherine H.; Vyas, Nand K.; Zhang, Wei; Quiocho, Florante A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Quiocho, FA (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	faq@bcm.edu			NIGMS, National Institutes of Health; Welch Foundation [Q-0581]; Howard Hughes Medical Institute; U.S. Department of Energy [DE-AC02-05CH11231]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported, in whole or in part, by a NIGMS, National Institutes of Health grant. This work was also supported by Welch Foundation Grant Q-0581, by the Howard Hughes Medical Institute, and by the U.S. Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adolfsson-Erici M, 2002, CHEMOSPHERE, V46, P1485, DOI 10.1016/S0045-6535(01)00255-7; Afonine P. V., 2013, COMPUT CRYSTALLOGR N, V4, P28; Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Allmyr M, 2008, SCI TOTAL ENVIRON, V393, P162, DOI 10.1016/j.scitotenv.2007.12.006; Allmyr M, 2006, SCI TOTAL ENVIRON, V372, P87, DOI 10.1016/j.scitotenv.2006.08.007; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P303, DOI 10.1289/ehp.10768; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; DAUB GW, 1977, J AM CHEM SOC, V99, P3526, DOI 10.1021/ja00452a069; Dayan AD, 2007, FOOD CHEM TOXICOL, V45, P125, DOI 10.1016/j.fct.2006.08.009; De Schrijver E, 2003, CANCER RES, V63, P3799; Deepa P R, 2010, J Ocul Biol Dis Infor, V3, P117, DOI 10.1007/s12177-011-9065-7; Deepa PR, 2012, BASIC CLIN PHARMACOL, V110, P494, DOI 10.1111/j.1742-7843.2011.00844.x; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dinwiddie MT, 2014, INT J ENV RES PUB HE, V11, P2209, DOI 10.3390/ijerph110202209; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Gao Y, 2006, CANCER BIOL THER, V5, P978, DOI 10.4161/cbt.5.8.2883; Gee RH, 2008, J APPL TOXICOL, V28, P78, DOI 10.1002/jat.1316; Henry ND, 2013, J APPL TOXICOL, V33, P265, DOI 10.1002/jat.1736; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Huang YY, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-171; JAYAKUMAR A, 1995, P NATL ACAD SCI USA, V92, P8695, DOI 10.1073/pnas.92.19.8695; Kapoor N, 2009, IUBMB LIFE, V61, P1083, DOI 10.1002/iub.258; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lenhard JM, 2011, CURR PHARM DESIGN, V17, P325, DOI 10.2174/138161211795164185; Leslie A.G.W., 2007, PROCESSING DIFFRACTI; Li JN, 2001, CANCER RES, V61, P1493; Liu BQ, 2002, CANCER CHEMOTH PHARM, V49, P187, DOI 10.1007/s00280-001-0399-x; Liu HL, 2008, MOL CANCER THER, V7, P263, DOI 10.1158/1535-7163.MCT-07-0445; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Liu XS, 2006, MOL CANCER THER, V5, P494, DOI 10.1158/1535-7163.MCT-05-0049; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Lu SY, 2005, CARCINOGENESIS, V26, P153, DOI 10.1093/carcin/bgh278; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A, 1982, PREPARATION ANAL PRO; Menendez JA, 2006, INT J GYNECOL CANCER, V16, P219, DOI 10.1111/j.1525-1438.2006.00297.x; Menendez JA, 2004, ONCOL REP, V12, P411; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Moss T, 2000, FOOD CHEM TOXICOL, V38, P361, DOI 10.1016/S0278-6915(99)00164-7; Orita H, 2008, CLIN CANCER RES, V14, P2458, DOI 10.1158/1078-0432.CCR-07-4177; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pappenberger G, 2010, J MOL BIOL, V397, P508, DOI 10.1016/j.jmb.2010.01.066; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Pizer ES, 1996, CANCER RES, V56, P1189; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Sandborgh-Englund G, 2006, J TOXICOL ENV HEAL A, V69, P1861, DOI 10.1080/15287390600631706; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; STOOPS JK, 1979, J BIOL CHEM, V254, P7418; STOOPS JK, 1981, J BIOL CHEM, V256, P5128; Tipparaju SK, 2010, J MED CHEM, V53, P6287, DOI 10.1021/jm9017724; Turrado C, 2012, J MED CHEM, V55, P5013, DOI 10.1021/jm2016045; Vandhana S, 2013, BBA-MOL CELL BIOL L, V1831, P1458, DOI 10.1016/j.bbalip.2013.06.005; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Vazquez-Martin A, 2007, ONCOL REP, V18, P973; Wang DZ, 2012, JNCI-J NATL CANCER I, V104, P343, DOI 10.1093/jnci/djs010; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Zhang W, 2011, P NATL ACAD SCI USA, V108, P15757, DOI 10.1073/pnas.1112334108; Zhang YM, 2004, LIPIDS, V39, P1055, DOI 10.1007/s11745-004-1330-3; Zhou WB, 2003, CANCER RES, V63, P7330	68	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33287	33295		10.1074/jbc.M114.608547	http://dx.doi.org/10.1074/jbc.M114.608547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301948	Green Published, hybrid			2022-12-25	WOS:000345636600020
J	Fu, YL; Liu, H; Ng, L; Kim, JW; Hao, H; Swaroop, A; Forrest, D				Fu, Yulong; Liu, Hong; Ng, Lily; Kim, Jung-Woong; Hao, Hong; Swaroop, Anand; Forrest, Douglas			Feedback Induction of a Photoreceptor-specific Isoform of Retinoid-related Orphan Nuclear Receptor beta by the Rod Transcription Factor NRL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FATE; CONE PHOTORECEPTORS; MOUSE RETINA; DIFFERENTIATION FACTOR; GENES; NR2E3; CRX; DEGENERATION; EXPRESSION; AMACRINE	Vision requires the generation of cone and rod photoreceptors that function in daylight and dim light, respectively. The neural retina leucine zipper factor (NRL) transcription factor critically controls photoreceptor fates as it stimulates rod differentiation and suppresses cone differentiation. However, the controls over NRL induction that balance rod and cone fates remain unclear. We have reported previously that the retinoid-related orphan receptor beta gene (Rorb) is required for Nrl expression and other retinal functions. We show that Rorb differentially expresses two isoforms: ROR beta 2 in photoreceptors and ROR beta 1 in photoreceptors, progenitor cells, and other cell types. Deletion of ROR beta 2 or ROR beta 1 increased the cone: rod ratio similar to 2-fold, whereas deletion of both isoforms in Rorb(-/-) mice produced almost exclusively cone-like cells at the expense of rods, suggesting that both isoforms induce Nrl. Electroporation of either ROR beta isoform into retinal explants from Rorb(-/-) neonates reactivated Nrl and rod genes but, in Nrl(-/-) explants, failed to reactivate rod genes, indicating that NRL is the effector for both ROR beta isoforms in rod differentiation. Unexpectedly, ROR beta 2 expression was lost in Nrl(-/-) mice. Moreover, NRL-activated the ROR beta 2-specific promoter of Rorb, indicating that NRL activates Rorb, its own inducer gene. We suggest that feedback activation between Nrl and Rorb genes reinforces the commitment to rod differentiation.	[Fu, Yulong; Liu, Hong; Ng, Lily; Forrest, Douglas] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Kim, Jung-Woong; Hao, Hong; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Forrest, D (corresponding author), NIDDK, Lab Endocrinol & Receptor Biol, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	forrestd@niddk.nih.gov		Swaroop, Anand/0000-0002-1975-1141	NIDDK; NEI at the National Institutes of Health; KaroBio Foundation; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047035] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); KaroBio Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural research programs of the NIDDK (to D. F.) and NEI (to A. S.) at the National Institutes of Health. This work was also supported by the KaroBio Foundation (to D. F.).	Adler R, 2008, BRAIN RES, V1192, P134, DOI 10.1016/j.brainres.2007.03.044; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Baglietto MG, 2014, EUR J MED GENET, V57, P44, DOI 10.1016/j.ejmg.2013.12.001; Boudry-Labis E, 2013, EUR J MED GENET, V56, P163, DOI 10.1016/j.ejmg.2012.12.006; Brooks Matthew J, 2012, Methods Mol Biol, V884, P319, DOI 10.1007/978-1-61779-848-1_23; Brzezinski J., 2010, ENCY EYE, P73, DOI DOI 10.1016/B978-0-12-374203-2.00251-7; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2011, HUM MOL GENET, V20, P4102, DOI 10.1093/hmg/ddr334; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Forrest D, 2012, MOL ENDOCRINOL, V26, P905, DOI 10.1210/me.2012-1010; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jukam D, 2010, CURR OPIN NEUROBIOL, V20, P6, DOI 10.1016/j.conb.2009.11.002; Kautzmann MAI, 2011, J BIOL CHEM, V286, P28247, DOI 10.1074/jbc.M111.257246; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kobayashi M, 2000, MOL CELL BIOL, V20, P8731, DOI 10.1128/MCB.20.23.8731-8739.2000; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Liu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2793; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Matsuda Takahiko, 2008, V423, P259, DOI 10.1007/978-1-59745-194-9_19; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Montana CL, 2013, P NATL ACAD SCI USA, V110, P1732, DOI 10.1073/pnas.1214387110; Montana CL, 2011, J BIOL CHEM, V286, P36921, DOI 10.1074/jbc.M111.279026; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Oeno S., 2005, EXP EYE RES, V81, P751; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Roger JE, 2014, J CLIN INVEST, V124, P631, DOI 10.1172/JCI72722; Roger JE, 2010, J BIOL CHEM, V285, P25637, DOI 10.1074/jbc.M110.142810; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Xiang MQ, 2013, CELL MOL LIFE SCI, V70, P2519, DOI 10.1007/s00018-012-1183-2; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	54	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.605774	http://dx.doi.org/10.1074/jbc.M114.605774			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296752	hybrid, Green Published			2022-12-25	WOS:000345335000007
J	Ma, TC; Barco, A; Ratan, RR; Willis, DE				Ma, Thong C.; Barco, Angel; Ratan, Rajiv R.; Willis, Dianna E.			cAMP-responsive Element-binding Protein (CREB) and cAMP Co-regulate Activator Protein 1 (AP1)-dependent Regeneration-associated Gene Expression and Neurite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; PROMOTES AXONAL REGENERATION; PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLION; C-JUN; CYCLIC-AMP; FUNCTIONAL RECOVERY; SENSORY AXONS; SCHWANN-CELLS; TRANSCRIPTION FACTORS	To regenerate damaged axons, neurons must express a cassette of regeneration-associated genes (RAGs) that increases intrinsic growth capacity and confers resistance to extrinsic inhibitory cues. Here we show that dibutyrl-cAMP or forskolin combined with constitutive-active CREB are superior to either agent alone in driving neurite growth on permissive and inhibitory substrates. Of the RAGs examined, only arginase 1 (Arg1) expression correlated with the increased neurite growth induced by the cAMP/CREB combination, both of which were AP1-dependent. This suggests that cAMP-induced AP1 activity is necessary and interacts with CREB to drive expression of RAGs relevant for regeneration and demonstrates that combining a small molecule (cAMP) with an activated transcription factor (CREB) stimulates the gene expression necessary to enhance axonal regeneration.	[Ma, Thong C.; Ratan, Rajiv R.; Willis, Dianna E.] Burke Cornell Med Res Inst, White Plains, NY 10605 USA; [Barco, Angel] Univ Miguel Hernandez Elche, CSIC, Inst Neurociencias Alicante, Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Willis, DE (corresponding author), Burke Cornell Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	diw2004@med.cornell.edu	Barco, Angel/ABF-1864-2021; Barco, Angel/C-3062-2008	Barco, Angel/0000-0002-0653-3751; Barco, Angel/0000-0002-0653-3751; Ma, Thong/0000-0002-9395-0448	National Institutes of Health [NR010797]; Dr. Miriam and Sheldon G. Adelson Foundation; Center for Research Excellence in Spinal Cord Injury [DOHC019772]; Burke Medical Research Institute Foundation; Spanish Ministry of Science and Innovation [SAF2011-22855]; Generalitat Valenciana [Prometeo/2012/005]; NATIONAL INSTITUTE OF NURSING RESEARCH [K99NR010797, R00NR010797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Foundation; Center for Research Excellence in Spinal Cord Injury; Burke Medical Research Institute Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant NR010797 (to D. W.). This work was also supported by grants from the Dr. Miriam and Sheldon G. Adelson Foundation (to R. R.), The Center for Research Excellence in Spinal Cord Injury (Grant DOHC019772; to R. R.), and the Burke Medical Research Institute Foundation (to D. W.). The Barco laboratory is supported by Grants SAF2011-22855 from the Spanish Ministry of Science and Innovation and Prometeo/2012/005 from the Generalitat Valenciana.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Andersen PL, 2000, EXP NEUROL, V166, P153, DOI 10.1006/exnr.2000.7485; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Anouar Y, 1999, MOL PHARMACOL, V56, P162, DOI 10.1124/mol.56.1.162; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Blesch A, 2012, EXP NEUROL, V235, P162, DOI 10.1016/j.expneurol.2011.12.037; Boeshore KL, 2004, J NEUROBIOL, V59, P216, DOI 10.1002/neu.10308; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Costa LM, 2013, BEHAV BRAIN RES, V243, P66, DOI 10.1016/j.bbr.2012.12.056; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Eid AH, 2008, AM J PHYSIOL-HEART C, V295, pH266, DOI 10.1152/ajpheart.00084.2008; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Jessen BA, 2000, GENE, V254, P77, DOI 10.1016/S0378-1119(00)00291-2; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Lesiak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064658; Li YM, 2003, J NEUROSCI, V23, P7830; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Ma CHE, 2011, J CLIN INVEST, V121, P4332, DOI 10.1172/JCI58675; Ma TC, 2010, J NEUROSCI, V30, P739, DOI 10.1523/JNEUROSCI.5266-09.2010; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Niemi JP, 2013, J NEUROSCI, V33, P16236, DOI 10.1523/JNEUROSCI.3319-12.2013; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Udina E, 2008, EXP NEUROL, V210, P238, DOI 10.1016/j.expneurol.2007.11.007; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Zhu WF, 2010, AM J PHYSIOL-CELL PH, V298, pC952, DOI 10.1152/ajpcell.00466.2009	54	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.582460	http://dx.doi.org/10.1074/jbc.M114.582460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296755	Green Published, hybrid			2022-12-25	WOS:000345335000043
J	Besser, TE; Cassirer, EF; Potter, KA; Lahmers, K; Oaks, JL; Shanthalingam, S; Srikumaran, S; Foreyt, WJ				Besser, Thomas E.; Cassirer, E. Frances; Potter, Kathleen A.; Lahmers, Kevin; Oaks, J. Lindsay; Shanthalingam, Sudarvili; Srikumaran, Subramaniam; Foreyt, William J.			Epizootic Pneumonia of Bighorn Sheep following Experimental Exposure to Mycoplasma ovipneumoniae	PLOS ONE			English	Article							OVIS-CANADENSIS; PASTEURELLA-HAEMOLYTICA; MANNHEIMIA-HAEMOLYTICA; DOMESTIC SHEEP; RESPIRATORY-DISEASE; MICROORGANISMS; IDENTIFICATION; TRANSMISSION; ANTIBODIES; VACCINE	Background: Bronchopneumonia is a population limiting disease of bighorn sheep (Ovis canadensis). The cause of this disease has been a subject of debate. Leukotoxin expressing Mannheimia haemolytica and Bibersteinia trehalosi produce acute pneumonia after experimental challenge but are infrequently isolated from animals in natural outbreaks. Mycoplasma ovipneumoniae, epidemiologically implicated in naturally occurring outbreaks, has received little experimental evaluation as a primary agent of bighorn sheep pneumonia. Methodology/Principal Findings: In two experiments, bighorn sheep housed in multiple pens 7.6 to 12 m apart were exposed to M. ovipneumoniae by introduction of a single infected or challenged animal to a single pen. Respiratory disease was monitored by observation of clinical signs and confirmed by necropsy. Bacterial involvement in the pneumonic lungs was evaluated by conventional aerobic bacteriology and by culture-independent methods. In both experiments the challenge strain of M. ovipneumoniae was transmitted to all animals both within and between pens and all infected bighorn sheep developed bronchopneumonia. In six bighorn sheep in which the disease was allowed to run its course, three died with bronchopneumonia 34, 65, and 109 days after M. ovipneumoniae introduction. Diverse bacterial populations, predominantly including multiple obligate anaerobic species, were present in pneumonic lung tissues at necropsy. Conclusions/Significance:Exposure to a single M. ovipneumoniae infected animal resulted in transmission of infection to all bighorn sheep both within the pen and in adjacent pens, and all infected sheep developed bronchopneumonia. The epidemiologic, pathologic and microbiologic findings in these experimental animals resembled those seen in naturally occurring pneumonia outbreaks in free ranging bighorn sheep.	[Besser, Thomas E.; Potter, Kathleen A.; Lahmers, Kevin; Oaks, J. Lindsay; Shanthalingam, Sudarvili; Srikumaran, Subramaniam; Foreyt, William J.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Besser, Thomas E.; Potter, Kathleen A.; Oaks, J. Lindsay] Washington State Univ, Washington Anim Dis Diagnost Lab, Pullman, WA 99164 USA; [Cassirer, E. Frances] Idaho Dept Fish & Game, Lewiston, ID USA	Washington State University; Washington State University	Besser, TE (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbesser@vetmed.wsu.edu	Lahmers, Kevin/E-8272-2017	Lahmers, Kevin/0000-0002-5290-3426	Wyoming Wildlife/Livestock Disease Partnership; Washington Department of Fish and Wildlife; Idaho Domestic Wildlife Research Oversight Committee; Oregon chapter of the Foundation for North American Wild Sheep	Wyoming Wildlife/Livestock Disease Partnership; Washington Department of Fish and Wildlife; Idaho Domestic Wildlife Research Oversight Committee; Oregon chapter of the Foundation for North American Wild Sheep	These studies were funded by grants from the Wyoming Wildlife/Livestock Disease Partnership (T. E. Besser, S. Srikumaran), the Washington Department of Fish and Wildlife (T. E. Besser), the Idaho Domestic Wildlife Research Oversight Committee (E. F. Cassirer), and the Oregon chapter of the Foundation for North American Wild Sheep (T. E. Besser) or the grant support that made these studies possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Besser TE, 2012, J WILDLIFE DIS, V48, P168, DOI 10.7589/0090-3558-48.1.168; Blodgett R, 2010, BACTERIOLOGIC ANAL M; Buechner H. K., 1960, Wildlife Monographs.; Cassirer EF, 2013, J ANIM ECOL, V82, P518, DOI 10.1111/1365-2656.12031; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Dassanayake RP, 2010, APPL ENVIRON MICROB, V76, P1008, DOI 10.1128/AEM.02086-09; Dassanayake RP, 2009, VET MICROBIOL, V133, P366, DOI 10.1016/j.vetmic.2008.07.015; DEMARTINI JC, 1977, J WILDLIFE DIS, V13, P117, DOI 10.7589/0090-3558-13.2.117; Desrosiers Robert, 2011, Animal Health Research Reviews, V12, P1, DOI 10.1017/S1466252310000204; Festa-Bianchet M, 2008, OVIS CANADENSIS; Fisher MA, 1999, AM J VET RES, V60, P1402; Foreyt WJ, 2009, J WILDLIFE DIS, V45, P272, DOI 10.7589/0090-3558-45.2.272; Foreyt WJ, 1996, J WILDLIFE DIS, V32, P594, DOI 10.7589/0090-3558-32.4.594; FOREYT WJ, 1994, J WILDLIFE DIS, V30, P137, DOI 10.7589/0090-3558-30.2.137; Forrester D. J., 1971, pUnpaginated; GENTRY MJ, 1991, MICROB PATHOGENESIS, V10, P411, DOI 10.1016/0882-4010(91)90086-P; Herrmann LM, 2003, CLIN DIAGN LAB IMMUN, V10, P862, DOI 10.1128/CDLI.10.5.862-865.2003; Kraabel BJ, 1998, J WILDLIFE DIS, V34, P325, DOI 10.7589/0090-3558-34.2.325; Lawrence PK, 2010, J WILDLIFE DIS, V46, P706, DOI 10.7589/0090-3558-46.3.706; MARSH HADLEIGH, 1938, JOUR MAMMAL, V19, P214, DOI 10.2307/1374617; McAuliffe L, 2003, VET REC, V153, P687, DOI 10.1136/vr.153.22.687; Miller MW, 2001, INFECT DIS WILD MAMM, P558; ONDERKA DK, 1988, CAN J VET RES, V52, P439; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; ROSSI CR, 1971, APPL MICROBIOL, V22, P32, DOI 10.1128/AEM.22.1.32-36.1971; Rudolph KM, 2007, J ZOO WILDLIFE MED, V38, P548, DOI 10.1638/2006-0027R.1; Rudolph KM, 2003, J WILDLIFE DIS, V39, P897, DOI 10.7589/0090-3558-39.4.897; Shanthalingam S, 2014, J WILDLIFE DIS, V50, P1, DOI 10.7589/2012-09-225; Subramaniam R, 2011, CLIN VACCINE IMMUNOL, V18, P1689, DOI 10.1128/CVI.05276-11; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Weiser GC, 2003, J WILDLIFE DIS, V39, P536, DOI 10.7589/0090-3558-39.3.536; Ziegler JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095698	36	30	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110039	10.1371/journal.pone.0110039	http://dx.doi.org/10.1371/journal.pone.0110039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302992	gold, Green Published			2022-12-25	WOS:000343730400104
J	Furstenberg-Hagg, J; Zagrobelny, M; Jorgensen, K; Vogel, H; Moller, BL; Bak, S				Furstenberg-Hagg, Joel; Zagrobelny, Mika; Jorgensen, Kirsten; Vogel, Heiko; Moller, Birger Lindberg; Bak, Soren			Chemical Defense Balanced by Sequestration and De Novo Biosynthesis in a Lepidopteran Specialist	PLOS ONE			English	Article							ZYGAENA-FILIPENDULAE LEPIDOPTERA; UDP-GLUCOSYLTRANSFERASE ACTIVITY; CYANOGENIC GLUCOSIDES; LEAF BEETLES; IRIDOID BIOSYNTHESIS; LOTUS-CORNICULATUS; PLANT DEFENSE; LARVAE; LOTAUSTRALIN; LINAMARIN	The evolution of sequestration (uptake and accumulation) relative to de novo biosynthesis of chemical defense compounds is poorly understood, as is the interplay between these two strategies. The Burnet moth Zygaena filipendulae (Lepidoptera) and its food-plant Lotus corniculatus (Fabaceae) poses an exemplary case study of these questions, as Z. filipendulae belongs to the only insect family known to both de novo biosynthesize and sequester the same defense compounds directly from its food-plant. Z. filipendulae and L. corniculatus both contain the two cyanogenic glucosides linamarin and lotaustralin, which are defense compounds that can be hydrolyzed to liberate toxic hydrogen cyanide. The overall amounts and ratios of linamarin and lotaustralin in Z. filipendulae are tightly regulated, and only to a low extent reflect the ratio in the ingested food-plant. We demonstrate that Z. filipendulae adjusts the de novo biosynthesis of CNglcs by regulation at both the transcriptional and protein level depending on food plant composition. Ultimately this ensures that the larva saves energy and nitrogen while maintaining an effective defense system to fend off predators. By using in situ PCR and immunolocalization, the biosynthetic pathway was resolved to the larval fat body and integument, which infers rapid replenishment of defense compounds following an encounter with a predator. Our study supports the hypothesis that de novo biosynthesis of CNglcs in Z. filipendulae preceded the ability to sequester, and facilitated a food-plant switch to cyanogenic plants, after which sequestration could evolve. Preservation of de novo biosynthesis allows fine-tuning of the amount and composition of CNglcs in Z. filipendulae.	[Furstenberg-Hagg, Joel; Zagrobelny, Mika; Jorgensen, Kirsten; Moller, Birger Lindberg; Bak, Soren] Univ Copenhagen, Copenhagen Plant Sci Ctr, Dept Plant & Environm Sci, Plant Biochem Lab, Copenhagen, Denmark; [Furstenberg-Hagg, Joel; Zagrobelny, Mika; Jorgensen, Kirsten; Moller, Birger Lindberg; Bak, Soren] Univ Copenhagen, VILLUM Res Ctr Plant Plast, Dept Plant & Environm Sci, Copenhagen, Denmark; [Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	University of Copenhagen; University of Copenhagen; Max Planck Society	Bak, S (corresponding author), Univ Copenhagen, Copenhagen Plant Sci Ctr, Dept Plant & Environm Sci, Plant Biochem Lab, Copenhagen, Denmark.	bak@plen.ku.dk	Zagrobelny, Mika/L-8679-2015; Bak, Soren/H-4404-2014; Møller, Birger Lindberg/GQI-1792-2022; Møller, Birger Lindberg/H-2657-2014; jorgensen, kirsten/H-4346-2014	Zagrobelny, Mika/0000-0001-5574-2894; Bak, Soren/0000-0003-4100-115X; Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; jorgensen, kirsten/0000-0003-2855-7735	VILLUM Research Center "Proactive-Plants" and "Plant Plasticity"; Danish Council for Independent Research [DFF - 1323-00088]; Villum Fonden [00007523] Funding Source: researchfish	VILLUM Research Center "Proactive-Plants" and "Plant Plasticity"; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	Funding provided by VILLUM Research Center "Proactive-Plants" and "Plant Plasticity" (http://villumfoundation.dk/) to JF-H, MZ, KJ, BLM and SB and the Danish Council for Independent Research (grant # DFF - 1323-00088) (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research) to BLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1977, HEREDITY, V38, P397, DOI 10.1038/hdy.1977.103; AHMAD SA, 1993, COMP BIOCHEM PHYS B, V104, P515, DOI 10.1016/0305-0491(93)90276-B; AHMAD SA, 1992, ARCH INSECT BIOCHEM, V21, P207, DOI 10.1002/arch.940210305; Ahn SJ, 2012, INSECT BIOCHEM MOLEC, V42, P133, DOI 10.1016/j.ibmb.2011.11.006; Armstrong HE, 1913, P R SOC LOND B-CONTA, V86, P262, DOI 10.1098/rspb.1913.0021; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; Burse A, 2008, INSECT BIOCHEM MOLEC, V38, P76, DOI 10.1016/j.ibmb.2007.09.006; Burse A, 2007, INSECT BIOCHEM MOLEC, V37, P255, DOI 10.1016/j.ibmb.2006.11.011; Burse A, 2009, PHYTOCHEMISTRY, V70, P1899, DOI 10.1016/j.phytochem.2009.08.002; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Celorio-Mancera MD, 2012, ENTOMOL EXP APPL, V144, P123, DOI 10.1111/j.1570-7458.2012.01249.x; Corkill L., 1942, NZ J SCI TECHNOL   B, V23, P178; DAVIS RH, 1979, COMP BIOCHEM PHYS B, V64, P395, DOI 10.1016/0305-0491(79)90289-X; DAVIS RH, 1982, COMP BIOCHEM PHYS B, V71, P329, DOI 10.1016/0305-0491(82)90266-8; Davis RH, 1985, COMPREHENSIVE INSECT, V11, P635, DOI DOI 10.1016/B978-0-08-030812-8.50020-4; Discher S, 2009, CHEMBIOCHEM, V10, P2223, DOI 10.1002/cbic.200900226; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Engler-Chaouat HS, 2007, J CHEM ECOL, V33, P25, DOI 10.1007/s10886-006-9207-8; FRANZL S, 1986, J INSECT PHYSIOL, V32, P705, DOI 10.1016/0022-1910(86)90112-5; FRANZL S, 1985, TISSUE CELL, V17, P267, DOI 10.1016/0040-8166(85)90093-X; FRANZL S, 1988, ZOOMORPHOLOGY, V108, P183, DOI 10.1007/BF00363935; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gebrehiwot L, 2001, AGRON J, V93, P603, DOI 10.2134/agronj2001.933603x; Gleadow RM, 2002, J CHEM ECOL, V28, P1301, DOI 10.1023/A:1016298100201; Gleadow RM, 2009, J CHEM ECOL, V35, P476, DOI 10.1007/s10886-009-9617-5; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; JONES DA, 1988, CIBA F SYMP, V140, P151; Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904; Kahn RA, 1999, ARCH BIOCHEM BIOPHYS, V363, P9, DOI 10.1006/abbi.1998.1068; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KEYMER R, 1978, HEREDITY, V40, P189, DOI 10.1038/hdy.1978.21; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; Kunert M, 2008, INSECT BIOCHEM MOLEC, V38, P895, DOI 10.1016/j.ibmb.2008.06.005; Lechtenberg M, 2011, ELS, DOI 10.1002/9780470015902.a0001921.pub2; Luque T, 2002, EUR J BIOCHEM, V269, P819, DOI 10.1046/j.0014-2956.2001.02723.x; MORELLO A, 1979, BIOCHEM J, V177, P809, DOI 10.1042/bj1770809; NAHRSTEDT A, 1986, PHYTOCHEMISTRY, V25, P2299, DOI 10.1016/S0031-9422(00)81683-0; NAHRSTEDT A, 1985, COMP BIOCHEM PHYS B, V82, P745, DOI 10.1016/0305-0491(85)90519-X; Naumann CM, 1999, W PALAEARCTIC ZYGAEN; Niehuis O, 2007, BIOL J LINN SOC, V92, P501, DOI 10.1111/j.1095-8312.2007.00858.x; Oldham NJ, 1996, NATURWISSENSCHAFTEN, V83, P470; Olsen KM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0347; Pasteels JM, 2003, J CHEM ECOL, V29, P337, DOI 10.1023/A:1022629911304; Pentzold S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091337; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rammert U., 1985, UNTERSUCHUNGEN WIRKS; Rammert U., 1992, P 4 S ZYG NANT 11 13, P38; REAL MD, 1991, ANAL BIOCHEM, V194, P349, DOI 10.1016/0003-2697(91)90239-P; ROWELLRAHIER M, 1986, J CHEM ECOL, V12, P1189, DOI 10.1007/BF01639004; Sanchez-Perez R, 2009, PLANT J, V60, P894, DOI 10.1111/j.1365-313X.2009.03997.x; Schappert PJ, 1999, ECOSCIENCE, V6, P511, DOI 10.1080/11956860.1999.11682560; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; WIKLUND C, 1982, EVOLUTION, V36, P998, DOI 10.1111/j.1558-5646.1982.tb05468.x; WRAY V, 1983, Z NATURFORSCH C, V38, P583; Zagrobelny M, 2004, PHYTOCHEMISTRY, V65, P293, DOI 10.1016/j.phytochem.2003.10.016; Zagrobelny M, 2007, INSECT BIOCHEM MOLEC, V37, P1189, DOI 10.1016/j.ibmb.2007.07.008; Zagrobelny M, 2007, INSECT BIOCHEM MOLEC, V37, P10, DOI 10.1016/j.ibmb.2006.09.008; Zagrobelny M, 2014, INSECT BIOCHEM MOLEC, V44, P44, DOI 10.1016/j.ibmb.2013.11.003; Zagrobelny M, 2011, PHYTOCHEMISTRY, V72, P1585, DOI 10.1016/j.phytochem.2011.02.023; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574	67	14	14	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108745	10.1371/journal.pone.0108745	http://dx.doi.org/10.1371/journal.pone.0108745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299618	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200023
J	He, LJ; Tian, XY; Zhang, H; Hu, TY; Huang, XZ; Zhang, LB; Wang, Z; Zhou, B				He, Lingjuan; Tian, Xueying; Zhang, Hui; Hu, Tianyuan; Huang, Xiuzhen; Zhang, Libo; Wang, Zhong; Zhou, Bin			BAF200 Is Required for Heart Morphogenesis and Coronary Artery Development	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEXES; VASCULATURE; MECHANISMS; EXPRESSION; SUBUNIT; LINEAGE; BAF180; CELLS; FORM	ATP-dependent SWI/SNF chromatin remodeling complexes utilize ATP hydrolysis to non-covalently change nucleosome-DNA interactions and are essential in stem cell development, organogenesis, and tumorigenesis. Biochemical studies show that SWI/SNF in mammalian cells can be divided into two subcomplexes BAF and PBAF based on the subunit composition. ARID2 or BAF200 has been defined as an intrinsic subunit of PBAF complex. However, the function of BAF200 in vivo is not clear. To dissect the possible role of BAF200 in regulating embryogenesis and organ development, we generated BAF200 mutant mice and found they were embryonic lethal. BAF200 mutant embryos exhibited multiple cardiac defects including thin myocardium, ventricular septum defect, common atrioventricular valve, and double outlet right ventricle around E14.5. Moreover, we also detected reduced intramyocardial coronary arteries in BAF200 mutants, suggesting that BAF200 is required for proper migration and differentiation of subepicardial venous cells into arterial endothelial cells. Our work revealed that PBAF complex plays a critical role in heart morphogenesis and coronary artery angiogenesis.	[He, Lingjuan; Tian, Xueying; Zhang, Hui; Hu, Tianyuan; Huang, Xiuzhen; Zhang, Libo; Zhou, Bin] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China; [Wang, Zhong] Univ Michigan, Cardiovasc Res Ctr, Dept Cardiac Surg, Ann Arbor, MI 48109 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan	Zhou, B (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China.	zhoubin@sibs.ac.cn		Zhou, Bin/0000-0001-5278-5522	Ministry of Science and Technology [2012CB945102, 2013CB945302]; National Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Chinese Academy of Sciences [KSCX2-EW-R-09]; Organization Department of the CPC Central Committee Bajian Talents Program, Shanghai Pujiang Program [11PJ1411400]; Basic Research Key Project [14JC1407400]; AstraZeneca; Sanofi-Shanghai Institutes for Biological Sciences (SIBS) Fellowship; SIBS Postdoc Fund [2013KIP311]; China Postdoc Fund [2013M541561]; National Institutes of Health [HL109054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Organization Department of the CPC Central Committee Bajian Talents Program, Shanghai Pujiang Program; Basic Research Key Project; AstraZeneca(AstraZeneca); Sanofi-Shanghai Institutes for Biological Sciences (SIBS) Fellowship; SIBS Postdoc Fund; China Postdoc Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Ministry of Science and Technology (2012CB945102 and 2013CB945302), National Science Foundation of China (91339104, 31271552, 31222038, 31301188), Chinese Academy of Sciences (Hundred Talents Program and KSCX2-EW-R-09), Organization Department of the CPC Central Committee Bajian Talents Program, Shanghai Pujiang Program (11PJ1411400) and Basic Research Key Project (14JC1407400), AstraZeneca, Sanofi-Shanghai Institutes for Biological Sciences (SIBS) Fellowship, SIBS Postdoc Fund 2013KIP311, China Postdoc Fund 2013M541561, National Institutes of Health (HL109054, WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Xiong Y, 2013, DEV CELL; Xu F, 2011, J BIOL CHEM; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; YANG JT, 1995, DEVELOPMENT, V121, P549; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	28	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109493	10.1371/journal.pone.0109493	http://dx.doi.org/10.1371/journal.pone.0109493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299188	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200052
J	Jin, S; Deng, Y; Hao, JW; Li, Y; Liu, B; Yu, Y; Shi, FD; Zhou, QH				Jin, Shi; Deng, Yi; Hao, Jun-Wei; Li, Yang; Liu, Bin; Yu, Yan; Shi, Fu-Dong; Zhou, Qing-Hua			NK Cell Phenotypic Modulation in Lung Cancer Environment	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MOLONEY LEUKEMIA-CELLS; PROGNOSTIC-SIGNIFICANCE; IMMUNE SURVEILLANCE; CYTOTOXIC-CELLS; T-CELLS; STATISTICS; NKG2D; SPECIFICITY; RECEPTORS	Background: Nature killer (NK) cells play an important role in anti-tumor immunotherapy. But it indicated that tumor cells impacted possibly on NK cell normal functions through some molecules mechanisms in tumor microenvironment. Materials and methods: Our study analyzed the change about NK cells surface markers (NK cells receptors) through immunofluorescence, flow cytometry and real-time PCR, the killed function from mouse spleen NK cell and human high/low lung cancer cell line by co-culture. Furthermore we certificated the above result on the lung cancer model of SCID mouse. Results: We showed that the infiltration of NK cells in tumor periphery was related with lung cancer patients' prognosis. And the number of NK cell infiltrating in lung cancer tissue is closely related to the pathological types, size of the primary cancer, smoking history and prognosis of the patients with lung cancer. The expression of NK cells inhibitor receptors increased remarkably in tumor micro-environment, in opposite, the expression of NK cells activated receptors decrease magnificently. Conclusions: The survival time of lung cancer patient was positively related to NK cell infiltration degree in lung cancer. Thus, the down-regulation of NKG2D, Ly49I and the up-regulation of NKG2A may indicate immune tolerance mechanism and facilitate metastasis in tumor environment. Our research will offer more theory for clinical strategy about tumor immunotherapy.	[Jin, Shi; Deng, Yi; Li, Yang; Liu, Bin; Zhou, Qing-Hua] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Jin, Shi; Yu, Yan] Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China; [Deng, Yi] Third Mil Med Univ, Res Inst Surg & Daping Hosp, Ctr Canc, Chongqing, Peoples R China; [Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Harbin Medical University; Army Medical University; Tianjin Medical University	Zhou, QH (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.	zhouqh135@163.com		Hao, Junwei/0000-0002-3075-5434	Young People Research Fund from the National Eleventh-Five-Year Key Task Projects of China [2006BAI02A01]; National 973 Program [2010CB529405]; Tianjin Scientific Innovation System Program [07SYSYSF05000, 07SYSYJC27900]; China-Sweden Cooperative Foundation [09ZCZDSF04100]; grant National Natural Scientific Foundation of China [81201828]; Young People Foundation of Heilongjiang Provincial of China [QC2012C013]; Health Department of Heilongjiang Provincial of China [2011-124]; Harbin Medical University Cancer Hospital major project Foundation [JJZ-2010-01]	Young People Research Fund from the National Eleventh-Five-Year Key Task Projects of China; National 973 Program(National Basic Research Program of China); Tianjin Scientific Innovation System Program; China-Sweden Cooperative Foundation; grant National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Young People Foundation of Heilongjiang Provincial of China; Health Department of Heilongjiang Provincial of China; Harbin Medical University Cancer Hospital major project Foundation	This work was supported by Young People Research Fund from the grants the National Eleventh-Five-Year Key Task Projects of China (No. 2006BAI02A01), the National 973 Program (No. 2010CB529405), Tianjin Scientific Innovation System Program (No. 07SYSYSF05000, 07SYSYJC27900), the China-Sweden Cooperative Foundation (No. 09ZCZDSF04100), the grant National Natural Scientific Foundation of China (No 81201828), Young People Foundation of Heilongjiang Provincial of China (No QC2012C013), Health Department of Heilongjiang Provincial of China (No 2011-124) and Harbin Medical University Cancer Hospital major project Foundation (No: JJZ-2010-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campoli M, 2008, TISSUE ANTIGENS, V72, P321, DOI 10.1111/j.1399-0039.2008.01106.x; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dasgupta S, 2005, J IMMUNOL, V175, P5541, DOI 10.4049/jimmunol.175.8.5541; Esendagli G, 2008, LUNG CANCER, V59, P32, DOI 10.1016/j.lungcan.2007.07.022; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Ishigami S, 2000, CANCER LETT, V159, P103, DOI 10.1016/S0304-3835(00)00542-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Levy EM, 2008, INT J ONCOL, V32, P633, DOI 10.3892/ijo.32.3.633; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng Hong, 2011, Zhongguo Fei Ai Za Zhi, V14, P362, DOI 10.3779/j.issn.1009-3419.2011.04.11; Peng YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083913; Ren Yuanrong, 2008, Zhongguo Fei Ai Za Zhi, V11, P321, DOI 10.3779/j.issn.1009-3419.2008.03.012; Richards JO, 2006, BLOOD, V108, P246, DOI 10.1182/blood-2005-11-4535; Salazar-Onfray F, 2007, CYTOKINE GROWTH F R, V18, P171, DOI 10.1016/j.cytogfr.2007.01.015; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Schleypen JS, 2003, INT J CANCER, V106, P905, DOI 10.1002/ijc.11321; Urosevic M, 2008, CANCER RES, V68, P627, DOI 10.1158/0008-5472.CAN-07-2704; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Yang L, 2005, EUR J CANCER PREV, V14, P329, DOI 10.1097/00008469-200508000-00004; Yoshimi I, 2004, JPN J CLIN ONCOL, V34, P759, DOI 10.1093/jjco/hyh144; Zhou Qinghua, 2003, Zhongguo Fei Ai Za Zhi, V6, P464, DOI 10.3779/j.issn.1009-3419.2003.06.13; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	36	49	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109976	10.1371/journal.pone.0109976	http://dx.doi.org/10.1371/journal.pone.0109976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299645	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200088
J	Wang, C; Lei, AP; Zhou, K; Hu, ZY; Hao, WL; Yang, JD				Wang, Chao; Lei, Anping; Zhou, Kai; Hu, Zhengyu; Hao, Wenlong; Yang, Junda			Growth and Nitrogen Uptake Characteristics Reveal Outbreak Mechanism of the Opportunistic Macroalga Gracilaria tenuistipitata	PLOS ONE			English	Article							NITRATE UPTAKE; INORGANIC NITROGEN; COASTAL WATERS; ULVA-LACTUCA; INTERTIDAL SEAWEEDS; NUTRIENT CONTROL; AMMONIUM UPTAKE; UPTAKE KINETICS; AGAR YIELD; J. AGARDH	Macroalgae has bloomed in the brackish lake of Shenzhen Bay, China continuously from 2010 to 2014. Gracilaria tenuistipitata was identified as the causative macroalgal species. The aim of this study was to explore the outbreak mechanism of G. tenuistipitata, by studying the effects of salinity and nitrogen sources on growth, and the different nitrogen sources uptake characteristic. Our experimental design was based on environmental conditions observed in the bloom areas, and these main factors were simulated in the laboratory. Results showed that salinity 12 to 20 % was suitable for G. tenuistipitata growth. When the nitrogen sources' (NH4+, NO3+) concentrations reached 40 mu M or above, the growth rate of G. tenuistipitata was significantly higher. Algal biomass was higher (approximately 1.4 times) when cultured with NH4+ than that with NO3+ addition. Coincidentally, macroalgal bloom formed during times of moderate salinity (similar to 12 %) and high nitrogen conditions. The NH4+ and NO3+ uptake characteristic was studied to understand the potential mechanism of G. tenuistipitata bloom. NH4+ uptake was best described by a linear, rate-unsaturated response, with the slope decreasing with time intervals. In contrast, NO3+ uptake followed a rate-saturating mechanism best described by the Michaelis-Menten model, with kinetic parameters V-max = 37.2 mu M g(-1) DM h(-1) and K-s = 61.5 mu M. Further, based on the isotope N-15 tracer method, we found that N-15 from NH4+ accumulated faster and reached an atom% twice than that of N-15 from NO3+, suggesting when both NH4+ and NO3+ were available, NH4+ was assimilated more rapidly. The results of the present study indicate that in the estuarine environment, the combination of moderate salinity with high ammonium may stimulate bloom formation.	[Wang, Chao; Lei, Anping; Hao, Wenlong; Yang, Junda] Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China; [Wang, Chao; Hu, Zhengyu] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Zhou, Kai] Shenzhen Marine Environm & Resources Monitoring C, Shenzhen, Peoples R China	Shenzhen University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Lei, AP (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China.	aplei@szu.edu.cn; kzhou@tom.com			National Natural Science Foundation of China [31170491]; Shenzhen Municipal Basic research program [JCYJ20130329114940668]; Shenzhen Marine Environment and Resources Monitoring Center [HHZB11025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Basic research program; Shenzhen Marine Environment and Resources Monitoring Center	This work was supported by National Natural Science Foundation of China (31170491), Shenzhen Municipal Basic research program (JCYJ20130329114940668) and a project from Shenzhen Marine Environment and Resources Monitoring Center(HHZB11025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MH, 2011, J EXP MAR BIOL ECOL, V407, P190, DOI 10.1016/j.jembe.2011.06.034; BJORNSATER BR, 1990, J PHYCOL, V26, P603, DOI 10.1111/j.0022-3646.1990.00603.x; Bunsom C, 2012, PHYCOL RES, V60, P169, DOI 10.1111/j.1440-1835.2012.00648.x; Carneiro MAA, 2011, REV BRAS FARMACOGN, V21, P329, DOI 10.1590/S0102-695X2011005000074; Chan TU, 2001, MAR FRESHWATER RES, V52, P869, DOI 10.1071/MF00088; Choi HG, 2006, J APPL PHYCOL, V18, P269, DOI 10.1007/s10811-006-9033-y; CLOERN JE, 1987, CONT SHELF RES, V7, P1367, DOI 10.1016/0278-4343(87)90042-2; DELIA CF, 1978, J PHYCOL, V14, P266, DOI 10.1111/j.1529-8817.1978.tb00297.x; DOWD JE, 1965, J BIOL CHEM, V240, P863; ECOHAB, 1995, EC OC HARM ALG BLOOM; EKMAN P, 1991, BRIT PHYCOL J, V26, P123, DOI 10.1080/00071619100650091; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; FONG P, 1994, MAR ECOL PROG SER, V106, P273, DOI 10.3354/meps106273; Franz DR, 2002, J EXP MAR BIOL ECOL, V271, P209, DOI 10.1016/S0022-0981(02)00045-X; GORDON DM, 1981, BOT MAR, V24, P93, DOI 10.1515/botm.1981.24.2.93; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HAINES KC, 1978, J PHYCOL, V14, P319, DOI 10.1111/j.1529-8817.1978.tb00305.x; HANISAK MD, 1978, J PHYCOL, V14, P450, DOI 10.1111/j.1529-8817.1978.tb02467.x; Harrison PJ, 2001, CAH BIOL MAR, V42, P71; He Li-Hong, 2002, Chinese Journal of Oceanology and Limnology, V20, P365; Hernandez I, 1997, J PHYCOL, V33, P764, DOI 10.1111/j.0022-3646.1997.00764.x; HURD CL, 1995, J PHYCOL, V31, P835, DOI 10.1111/j.0022-3646.1995.00835.x; Israel A, 1999, J APPL PHYCOL, V11, P543, DOI 10.1023/A:1008141906299; Kim JK, 2007, J APPL PHYCOL, V19, P431, DOI 10.1007/s10811-006-9150-7; Kirst GO, 1995, ALGAE ENV HUMAN AFFA, P123; Li Juan, 2007, Xiamen Daxue Xuebao (Ziran Kexue Ban), V46, P221; Liu G, 2013, JING NEWSPAPER; Lotze HK, 2000, J PHYCOL, V36, P287, DOI 10.1046/j.1529-8817.2000.99109.x; Luo MB, 2012, AQUAT BOT, V100, P18, DOI 10.1016/j.aquabot.2012.03.006; Marinho-Soriano E, 2009, BIORESOURCE TECHNOL, V100, P6192, DOI 10.1016/j.biortech.2009.06.102; McClelland JW, 1998, MAR ECOL PROG SER, V168, P259, DOI 10.3354/meps168259; McGlathery KJ, 2001, J PHYCOL, V37, P453, DOI 10.1046/j.1529-8817.2001.037004453.x; McGlathery KJ, 1996, J PHYCOL, V32, P393, DOI 10.1111/j.0022-3646.1996.00393.x; Naldi M, 2002, J PHYCOL, V38, P135, DOI 10.1046/j.1529-8817.2002.01070.x; Nelson TA, 2001, AQUAT BOT, V71, P149, DOI 10.1016/S0304-3770(01)00183-8; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Pedersen MF, 1996, MAR ECOL PROG SER, V142, P261, DOI 10.3354/meps142261; PEDERSEN MF, 1994, J PHYCOL, V30, P980, DOI 10.1111/j.0022-3646.1994.00980.x; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Phillips JC, 2004, J PHYCOL, V40, P534, DOI 10.1111/j.1529-8817.2004.03157.x; Pinchetti JLG, 1998, J APPL PHYCOL, V10, P383, DOI 10.1023/A:1008008912991; Raffaelli D, 1999, AQUAT CONSERV, V9, P219, DOI 10.1002/(SICI)1099-0755(199903/04)9:2<219::AID-AQC334>3.0.CO;2-P; Randall DJ, 2002, MAR POLLUT BULL, V45, P17, DOI 10.1016/S0025-326X(02)00227-8; ROSENBERG G, 1984, AQUAT BOT, V19, P65, DOI 10.1016/0304-3770(84)90008-1; Runcie JW, 2003, AQUAT BOT, V76, P155, DOI 10.1016/S0304-3770(03)00037-8; Smit AJ, 2002, BOT MAR, V45, P196, DOI 10.1515/BOT.2002.019; Smith SL, 2009, MAR ECOL PROG SER, V384, P1, DOI 10.3354/meps08022; THOMAS TE, 1987, J EXP MAR BIOL ECOL, V107, P1, DOI 10.1016/0022-0981(87)90118-3; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P133, DOI 10.1016/S0022-0981(00)00195-7; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; VALIELA I, 1992, ESTUARIES, V15, P443, DOI 10.2307/1352389; WAITE TD, 1972, J SANIT ENG DIV ASCE, V98, P763; Wang C, 2012, HARMFUL ALGAE, V16, P12, DOI 10.1016/j.hal.2011.12.007; Wang C, 2011, CHIN J OCEANOL LIMN, V29, P541, DOI 10.1007/s00343-011-0126-3; Wen SS, 2008, J FISHERIES CHINA, V32, P754; Xu D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033648, 10.1371/journal.pone.0042243]; Yang YF, 2006, AQUACULTURE, V254, P248, DOI 10.1016/j.aquaculture.2005.08.029; [张静 Zhang Jing], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P253; Zhou MJ, 2006, ADV EARTH SCI, V7, P673	59	21	21	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108980	10.1371/journal.pone.0108980	http://dx.doi.org/10.1371/journal.pone.0108980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299123	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200027
J	Zhang, XL; Reed, JL				Zhang, Xiaolin; Reed, Jennifer L.			Adaptive Evolution of Synthetic Cooperating Communities Improves Growth Performance	PLOS ONE			English	Article							ESCHERICHIA-COLI; DYNAMICS; MECHANISMS; CONSORTIA	Symbiotic interactions between organisms are important for human health and biotechnological applications. Microbial mutualism is a widespread phenomenon and is important in maintaining natural microbial communities. Although cooperative interactions are prevalent in nature, little is known about the processes that allow their initial establishment, govern population dynamics and affect evolutionary processes. To investigate cooperative interactions between bacteria, we constructed, characterized, and adaptively evolved a synthetic community comprised of leucine and lysine Escherichia coli auxotrophs. The co-culture can grow in glucose minimal medium only if the two auxotrophs exchange essential metabolites - lysine and leucine (or its precursors). Our experiments showed that a viable co-culture using these two auxotrophs could be established and adaptively evolved to increase growth rates (by similar to 3 fold) and optical densities. While independently evolved co-cultures achieved similar improvements in growth, they took different evolutionary trajectories leading to different community compositions. Experiments with individual isolates from these evolved co-cultures showed that changes in both the leucine and lysine auxotrophs improved growth of the co-culture. Interestingly, while evolved isolates increased growth of co-cultures, they exhibited decreased growth in mono-culture (in the presence of leucine or lysine). A genome-scale metabolic model of the co-culture was also constructed and used to investigate the effects of amino acid (leucine or lysine) release and uptake rates on growth and composition of the co-culture. When the metabolic model was constrained by the estimated leucine and lysine release rates, the model predictions agreed well with experimental growth rates and composition measurements. While this study and others have focused on cooperative interactions amongst community members, the adaptive evolution of communities with other types of interactions (e. g., commensalism, ammensalism or parasitism) would also be of interest.	[Zhang, Xiaolin] Univ Wisconsin, Madison, WI USA; [Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Reed, JL (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	reed@engr.wisc.edu	Reed, Jennifer L/E-5137-2011; Zhang, Xiaolin/N-7139-2017	Reed, Jennifer L/0000-0001-7854-6220; Zhang, Xiaolin/0000-0003-4745-0810	U.S. Department of Energy Genomics: GTL and SciDAC Programs [DE-FG02-04ER25627]; University of WisconsinMadison Graduate School	U.S. Department of Energy Genomics: GTL and SciDAC Programs; University of WisconsinMadison Graduate School	This work was funded by the U.S. Department of Energy Genomics: GTL and SciDAC Programs (DE-FG02-04ER25627) and the University of WisconsinMadison Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baumler DJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-182; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Bull JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004115; Casida L, 1956, U.S. Patent, Patent No. [2771396A, 2771396]; Charusanti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033727; Christensen JE, 2003, J BACTERIOL, V185, P3297, DOI 10.1128/JB.185.11.3297-3306.2003; CONNOR RC, 1995, BIOL REV, V70, P427, DOI 10.1111/j.1469-185X.1995.tb01196.x; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1952, NATURE, V169, P534, DOI 10.1038/169534a0; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Harris D.C., 2003, QUANTITATIVE CHEM AN, P80; Higgins BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096807; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Hosoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017105; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kerner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034032; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Minty JJ, 2013, P NATL ACAD SCI USA, V110, P14592, DOI 10.1073/pnas.1218447110; Mongold JA, 1996, EVOLUTION, V50, P35, DOI 10.1111/j.1558-5646.1996.tb04470.x; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nagarajan H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3809; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pande S, 2014, ISME J, V8, P953, DOI 10.1038/ismej.2013.211; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Salimi F, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-95; Shin CS, 1998, BIOTECHNOL BIOENG, V59, P576, DOI 10.1002/(SICI)1097-0290(19980905)59:5<576::AID-BIT7>3.0.CO;2-7; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; STERNBERG N, 1983, ANNU REV GENET, V17, P123, DOI 10.1146/annurev.ge.17.120183.001011; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Waks Z, 2009, APPL ENVIRON MICROB, V75, P1867, DOI 10.1128/AEM.02009-08; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363	46	28	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108297	10.1371/journal.pone.0108297	http://dx.doi.org/10.1371/journal.pone.0108297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299364	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200013
J	Uthicke, S; Furnas, M; Lonborg, C				Uthicke, Sven; Furnas, Miles; Lonborg, Christian			Coral Reefs on the Edge? Carbon Chemistry on Inshore Reefs of the Great Barrier Reef	PLOS ONE			English	Article							WATER COLUMN NUTRIENTS; OCEAN ACIDIFICATION; BENTHIC FORAMINIFERA; PARTIAL-PRESSURE; CLIMATE-CHANGE; CO2; QUALITY; CALCIFICATION; PRODUCTIVITY; TEMPERATURE	While increasing atmospheric carbon dioxide (CO2) concentration alters global water chemistry (Ocean Acidification; OA), the degree of changes vary on local and regional spatial scales. Inshore fringing coral reefs of the Great Barrier Reef (GBR) are subjected to a variety of local pressures, and some sites may already be marginal habitats for corals. The spatial and temporal variation in directly measured parameters: Total Alkalinity (TA) and dissolved inorganic carbon (DIC) concentration, and derived parameters: partial pressure of CO2 (pCO(2)); pH and aragonite saturation state (Omega(ar)) were measured at 14 inshore reefs over a two year period in the GBR region. Total Alkalinity varied between 2069 and 2364 mu mol kg(-1) and DIC concentrations ranged from 1846 to 2099 mu mol kg(-1). This resulted in pCO(2) concentrations from 340 to 554 mu atm, with higher values during the wet seasons and pCO(2) on inshore reefs distinctly above atmospheric values. However, due to temperature effects, Omega(ar) was not further reduced in the wet season. Aragonite saturation on inshore reefs was consistently lower and pCO(2) higher than on GBR reefs further offshore. Thermodynamic effects contribute to this, and anthropogenic runoff may also contribute by altering productivity (P), respiration (R) and P/R ratios. Compared to surveys 18 and 30 years ago, pCO(2) on GBR mid-and outer-shelf reefs has risen at the same rate as atmospheric values (similar to 1.7 mu atm yr(-1)) over 30 years. By contrast, values on inshore reefs have increased at 2.5 to 3 times higher rates. Thus, pCO(2) levels on inshore reefs have disproportionately increased compared to atmospheric levels. Our study suggests that inshore GBR reefs are more vulnerable to OA and have less buffering capacity compared to offshore reefs. This may be caused by anthropogenically induced trophic changes in the water column and benthos of inshore reefs subjected to land runoff.	[Uthicke, Sven; Furnas, Miles; Lonborg, Christian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Uthicke, S (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	Suthicke@aims.gov.au	Uthicke, Sven/F-1810-2010; Lønborg, Christian/M-4456-2013	Uthicke, Sven/0000-0002-3476-6595; Lønborg, Christian/0000-0001-8380-0238	Australian Government's National Environmental Research Program	Australian Government's National Environmental Research Program(Australian Government)	This work was conducted with the support of funding from the Australian Government's National Environmental Research Program NERP 5.2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2005, ENVIRONM SCI, P187; Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Anthony K, 2011, GLOBAL CHANGE BIOL; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; BARNES DJ, 1983, J EXP MAR BIOL ECOL, V66, P149, DOI 10.1016/0022-0981(83)90036-9; BARNES DJ, 1984, J EXP MAR BIOL ECOL, V79, P213, DOI 10.1016/0022-0981(84)90196-5; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cyronak T, 2014, GEOPHYS RES LETT; Cyronak T, 2013, LIMNOL OCEANOGR, V58, P131, DOI 10.4319/lo.2013.58.1.0131; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Duarte C.M., 2013, ESTUAR COAST, P1; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2008, ECOLOGY, V89, P3163, DOI 10.1890/08-0005.1; Fabricius KE, 2012, MAR POLLUT BULL, V65, P320, DOI 10.1016/j.marpolbul.2011.09.004; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; Friis K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015898; Hintze J., 2001, NCSS PASS NUMBER CRU; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Kawahata H, 2000, MAR CHEM, V72, P257, DOI 10.1016/S0304-4203(00)00085-2; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Kleypas JA, 2011, GLOBAL CHANGE BIOL; KROEKER KJ, 2013, GLOBAL CHANGE BIOL; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; McKinnon AD, 2013, LIMNOL OCEANOGR, V58, P1227, DOI 10.4319/lo.2013.58.4.1227; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nobes K, 2008, J EXP MAR BIOL ECOL, V363, P48, DOI 10.1016/j.jembe.2008.06.015; R Development Core Team, 2012, R LANG ENV STAT COMP; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Robbins PE, 2001, J GEOPHYS RES-OCEANS, V106, P30939, DOI 10.1029/2000JC000451; Russell BD, 2013, MAR POLLUT BULL, V73, P463, DOI 10.1016/j.marpolbul.2013.01.031; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; Schaffelke B., 2011, REEF RESCUE MARINE M; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Shaw EC, 2014, MAR CHEM, V158, P49, DOI 10.1016/j.marchem.2013.11.007; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Suzuki A, 2003, TELLUS B, V55, P428, DOI 10.3402/tellusb.v55i2.16761; Suzuki A, 2001, GEOPHYS RES LETT, V28, P1243, DOI 10.1029/2000GL011875; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; Thomas H, 2005, BIOGEOSCIENCES, V2, P323, DOI 10.5194/bg-2-323-2005; Tyrrell T, 2011, PHILOS T R SOC A, V369, P887, DOI [10.1098/rsta.2010.0334, 10.1098/rsta.2010.0331]; Uthicke S, 2014, CORAL REEFS, V33, P831, DOI 10.1007/s00338-014-1165-y; Uthicke S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01769; Uthicke S, 2008, ESTUAR COAST SHELF S, V78, P763, DOI 10.1016/j.ecss.2008.02.014; Uthicke S, 2010, LIMNOL OCEANOGR, V55, P1681, DOI 10.4319/lo.2010.55.4.1681; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wallace D, 2006, MS EXCEL PROGRAM DEV	55	32	33	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109092	10.1371/journal.pone.0109092	http://dx.doi.org/10.1371/journal.pone.0109092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295864	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000036
J	Chen, H; Zhao, YJ; Li, HT; Zhang, DY; Huang, YZ; Shen, Q; Van Duyne, R; Kashanchi, F; Zeng, C; Liu, SY				Chen, Hao; Zhao, Yunjie; Li, Haotian; Zhang, Dongyan; Huang, Yanzhao; Shen, Qi; Van Duyne, Rachel; Kashanchi, Fatah; Zeng, Chen; Liu, Shiyong			Break CDK2/Cyclin E1 Interface Allosterically with Small Peptides	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; CYCLIN-DEPENDENT KINASE-2; MOLECULAR-DYNAMICS; COMPUTATIONAL DESIGN; STRUCTURAL BASIS; BINDING; ACTIVATION; INHIBITORS; MDM2; P53	Most inhibitors of Cyclin-dependent kinase 2 (CDK2) target its ATP-binding pocket. It is difficult, however, to use this pocket to design very specific inhibitors because this catalytic pocket is highly conserved in the protein family of CDKs. Here we report some short peptides targeting a noncatalytic pocket near the interface of the CDK2/Cyclin complex. Docking and molecular dynamics simulations were used to select the peptides, and detailed dynamical network analysis revealed that these peptides weaken the complex formation via allosteric interactions. Our experiments showed that upon binding to the noncatalytic pocket, these peptides break the CDK2/Cyclin complex partially and diminish its kinase activity in vitro. The binding affinity of these peptides measured by Surface Plasmon Resonance can reach as low as 0.5 mu M.	[Li, Haotian; Zhang, Dongyan; Huang, Yanzhao; Zeng, Chen; Liu, Shiyong] Huazhong Univ Sci & Technol, Dept Phys, Wuhan 430074, Hubei, Peoples R China; [Chen, Hao; Zhao, Yunjie; Zeng, Chen] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Shen, Qi] Peking Univ, Ctr Quantitat Biol, BNLMS, Beijing 100871, Peoples R China; [Van Duyne, Rachel; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA; [Van Duyne, Rachel] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA	Huazhong University of Science & Technology; George Washington University; Chinese Academy of Sciences; Peking University; George Mason University; George Washington University	Liu, SY (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Wuhan 430074, Hubei, Peoples R China.	liushiyong@gmail.com	Van Duyne, Rachel/ABI-2429-2020; Liu, Shiyong/P-1086-2019; liu, shiyong/A-9370-2011; Van Duyne, Rachel/I-7365-2019	Van Duyne, Rachel/0000-0003-2914-6874; Liu, Shiyong/0000-0001-7986-5178; liu, shiyong/0000-0001-7986-5178; 	National Natural Science Foundation of China [31100522]; National High Technology Research and Development Program of China [2012AA020402]; Specialized Research Fund for the Doctoral Program of Higher Education [20110142120038]; Fundamental Research Funds for the Central Universities, [HUST: 2013QN019]; NSFC [11174093]; George Mason University funds; NIH [AI043894]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043894] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities,(Fundamental Research Funds for the Central Universities); NSFC(National Natural Science Foundation of China (NSFC)); George Mason University funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SYL is supported by the National Natural Science Foundation of China [31100522]; and the National High Technology Research and Development Program of China [2012AA020402]; and Specialized Research Fund for the Doctoral Program of Higher Education [20110142120038]; and the Fundamental Research Funds for the Central Universities, HUST: 2013QN019. YZH is supported by NSFC [11174093]. FK is supported by George Mason University funds and NIH grant AI043894. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbottah E, 2006, VIROLOGY, V345, P373, DOI 10.1016/j.virol.2005.09.062; Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Arkin M, 2005, CURR OPIN CHEM BIOL, V9, P317, DOI 10.1016/j.cbpa.2005.03.001; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arris CE, 2000, J MED CHEM, V43, P2797, DOI 10.1021/jm990628o; Barrett CP, 2005, J BIOL CHEM, V280, P13993, DOI 10.1074/jbc.M407371200; Bartova I, 2004, PROTEIN SCI, V13, P1449, DOI 10.1110/ps.03578504; Bartova I, 2008, PROTEIN SCI, V17, P22, DOI 10.1110/ps.072951208; Betzi S, 2011, ACS CHEM BIOL, V6, P492, DOI 10.1021/cb100410m; Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Chen H, 2009, PROTEINS, V74, P122, DOI 10.1002/prot.22136; Dagliyan O, 2011, STRUCTURE, V19, P1837, DOI 10.1016/j.str.2011.09.014; Easley R, 2010, J VIROL, V84, P4755, DOI 10.1128/JVI.00851-09; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Futamura M, 2005, J BIOL CHEM, V280, P5414, DOI 10.1074/jbc.M411719200; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gondeau C, 2005, J BIOL CHEM, V280, P13793, DOI 10.1074/jbc.M413690200; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang L, 2002, PROTEINS, V46, P190, DOI 10.1002/prot.10031; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; London N, 2013, CURR OPIN STRUC BIOL, V23, P894, DOI 10.1016/j.sbi.2013.07.006; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Liu S, 2007, P NATL ACAD SCI USA, V104, P5330, DOI 10.1073/pnas.0606198104; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Slivka PF, 2009, CHEMBIOCHEM, V10, P645, DOI 10.1002/cbic.200800769; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Trellet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058769; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Duyne R, 2008, VIROLOGY, V376, P308, DOI 10.1016/j.virol.2008.02.036; Vanhee P, 2011, TRENDS BIOTECHNOL, V29, P231, DOI 10.1016/j.tibtech.2011.01.004; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verschueren E, 2013, STRUCTURE, V21, P789, DOI 10.1016/j.str.2013.02.023; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winter A, 2012, Q REV BIOPHYS, P1; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Zacharias M, 2012, PROTEINS; Zhang CS, 2013, ANGEW CHEM INT EDIT, V52, P11059, DOI 10.1002/anie.201305963	55	16	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109154	10.1371/journal.pone.0109154	http://dx.doi.org/10.1371/journal.pone.0109154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290691	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000040
J	Gutierrez, E; Richardson, DR; Jansson, PJ				Gutierrez, Elaine; Richardson, Des R.; Jansson, Patric J.			The Anticancer Agent Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone ( Dp44mT) Overcomes Prosurvival Autophagy by Two Mechanisms PERSISTENT INDUCTION OF AUTOPHAGOSOME SYNTHESIS AND IMPAIRMENT OF LYSOSOMAL INTEGRITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL ISONICOTINOYL HYDRAZONE; EFFECTIVE ANTIPROLIFERATIVE AGENTS; SELECTIVE ANTITUMOR-ACTIVITY; BREAST-CANCER CELLS; IRON CHELATORS; OXIDATIVE-STRESS; METASTASIS SUPPRESSOR; INTRALYSOSOMAL IRON; MEDIATED CLEAVAGE; HYDROGEN-PEROXIDE	Autophagy functions as a survival mechanism during cellular stress and contributes to resistance against anticancer agents. The selective antitumor and antimetastatic chelator di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) causes lysosomal membrane permeabilization and cell death. Considering the integral role of lysosomes in autophagy and cell death, it was important to assess the effect of Dp44mT on autophagy to further understand its mechanism of action. Notably, Dp44mT affected autophagy by two mechanisms. First, concurrent with its antiproliferative activity, Dp44mT increased the expression of the classical autophagic marker LC3-II as a result of induced autophagosome synthesis. Second, this effect was supplemented by a reduction in autophagosome degradation as shown by the accumulation of the autophagic substrate and receptor p62. Conversely, the classical iron chelator desferrioxamine induced autophagosome accumulation only by inhibiting autophagosome degradation. The formation of redox-active iron or copper Dp44mT complexes was critical for its dual effect on autophagy. The cytoprotective antioxidant N-acetylcysteine inhibited Dp44mT-induced autophagosome synthesis and p62 accumulation. Importantly, Dp44mT inhibited autophagosome degradation via lysosomal disruption. This effect prevented the fusion of lysosomes with autophagosomes to form autolysosomes, which is crucial for the completion of the autophagic process. The antiproliferative activity of Dp44mT was suppressed by Beclin1 and ATG5 silencing, indicating the role of persistent autophagosome synthesis in Dp44mT-induced cell death. These studies demonstrate that Dp44mT can overcome the prosurvival activity of autophagy in cancer cells by utilizing this process to potentiate cell death.	[Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@sydney.edu.au; patric.jansson@sydney.edu.au		Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	University of Sydney; National Health and Medical Research Council of Australia; Cancer Institute of New South Wales Early Career Research Fellowship	University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales Early Career Research Fellowship	Supported by an Australian Postgraduate Award from the University of Sydney.; Supported by a National Health and Medical Research Council of Australia Senior Principal Research Fellowship and Project Grant funding. To whom correspondence may be addressed. Tel.: 61-2-9036-6548; Fax: 61-2-9036-6549; E-mail: d.richardson@sydney.edu.au.; Supported by a Cancer Institute of New South Wales Early Career Research Fellowship. To whom correspondence may be addressed. Tel.: 61-2-9036-7120; Fax: 61-2-9351-3429; E-mail: patric.jansson@sydney.edu.au.	Altan N, 1999, P NATL ACAD SCI USA, V96, P4432, DOI 10.1073/pnas.96.8.4432; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLATT J, 1987, CANCER RES, V47, P1749; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Cooper G. M., 1997, CELL, P379; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; DONFRANCESCO A, 1990, CANCER RES, V50, P4929; DONFRANCESCO A, 1992, AM J CLIN ONCOL-CANC, V15, P319, DOI 10.1097/00000421-199208000-00009; DORER FE, 1978, J BIOL CHEM, V253, P3140; Doulias PT, 2003, FREE RADICAL BIO MED, V35, P719, DOI 10.1016/S0891-5849(03)00396-4; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Esteve Juan M, 2011, World J Biol Chem, V2, P232, DOI 10.4331/wjbc.v2.i10.232; ESTROV Z, 1987, BLOOD, V69, P757; Farkas E, 1997, J INORG BIOCHEM, V65, P281, DOI 10.1016/S0162-0134(96)00144-4; Ford CHJ, 2011, ANTICANCER RES, V31, P521; Gaal A, 2014, J INORG BIOCHEM, V130, P52, DOI 10.1016/j.jinorgbio.2013.09.016; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Jeong J, 2006, FASEB J, V20, pA49; Kalinowski DS, 2007, J MED CHEM, V50, P6212, DOI 10.1021/jm070839q; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kurz T, 2004, BIOCHEM J, V378, P1039, DOI 10.1042/BJ20031029; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Lamparska-Przybysz M, 2005, J Physiol Pharmacol, V56 Suppl 3, P159; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Persson HL, 2005, EXPERT OPIN INV DRUG, V14, P997, DOI 10.1517/13543784.14.8.997; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Quach P, 2012, MOL PHARMACOL, V82, P105, DOI 10.1124/mol.112.078964; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Rao VA, 2011, CANCER CHEMOTH PHARM, V68, P1125, DOI 10.1007/s00280-011-1587-y; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Sahni S, 2014, J BIOL CHEM, V289, P9692, DOI 10.1074/jbc.M113.529511; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; SAWICKI SG, 1971, J CELL BIOL, V50, P746, DOI 10.1083/jcb.50.3.746; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; SELIG RA, 1993, ANTICANCER RES, V13, P721; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wong VKW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.217; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yelamanchili SV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-52; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12	99	51	53	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33568	33589		10.1074/jbc.M114.599480	http://dx.doi.org/10.1074/jbc.M114.599480			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301941	Green Published, hybrid			2022-12-25	WOS:000345636600043
J	Petrunak, EM; DeVore, NM; Porubsky, PR; Scott, EE				Petrunak, Elyse M.; DeVore, Natasha M.; Porubsky, Patrick R.; Scott, Emily E.			Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							17,20-LYASE ACTIVITY; MICROSOMAL CYTOCHROME-P-450; HUMAN P450C17; ACTIVE-SITE; LYASE ACTIVITY; B(5); ABIRATERONE; CANCER; BIOSYNTHESIS; TARGET	The human cytochrome P450 17A1 (CYP17A1) enzyme operates at a key juncture of human steroidogenesis, controlling the levels of mineralocorticoids influencing blood pressure, glucocorticoids involved in immune and stress responses, and androgens and estrogens involved in development and homeostasis of reproductive tissues. Understanding CYP17A1 multifunctional biochemistry is thus integral to treating prostate and breast cancer, subfertility, blood pressure, and other diseases. CYP17A1 structures with all four physiologically relevant steroid substrates suggest answers to four fundamental aspects of CYP17A1 function. First, all substrates bind in a similar overall orientation, rising similar to 60 degrees with respect to the heme. Second, both hydroxylase substrates pregnenolone and progesterone hydrogen bond to Asn(202) in orientations consistent with production of 17 alpha-hydroxy major metabolites, but functional and structural evidence for an A105L mutation suggests that a minor conformation may yield the minor 16 alpha-hydroxyprogesterone metabolite. Third, substrate specificity of the subsequent 17,20-lyase reaction may be explained by variation in substrate height above the heme. Although 17 alpha-hydroxyprogesterone is only observed farther from the catalytic iron, 17 alpha-hydroxypregnenolone is also observed closer to the heme. In conjunction with spectroscopic evidence, this suggests that only 17 alpha-hydroxypregnenolone approaches and interacts with the proximal oxygen of the catalytic iron-peroxy intermediate, yielding efficient production of dehydroepiandrosterone as the key intermediate in human testosterone and estrogen synthesis. Fourth, differential positioning of 17 alpha-hydroxypregnenolone offers a mechanism whereby allosteric binding of cytochrome b(5) might selectively enhance the lyase reaction. In aggregate, these structures provide a structural basis for understanding multiple key reactions at the heart of human steroidogenesis.	[Petrunak, Elyse M.; DeVore, Natasha M.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Porubsky, Patrick R.] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66047 USA	University of Kansas; University of Kansas	Scott, EE (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu		DeVore, Natasha/0000-0003-0772-8929	National Institutes of Health [RR01778, GM103420, RR00129, GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000129, P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM076343, R01GM102505, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Kansas Protein Structure Laboratory was supported by National Institutes of Health Grants RR01778 and GM103420, and the Stanford Synchrotron Radiation Lightsource was supported by National Institutes of Health Grants RR00129 and GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; Arlt W, 2002, ENDOCRINOLOGY, V143, P4665, DOI 10.1210/en.2002-220456; Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Auchus ML, 2012, J INVEST MED, V60, P495, DOI 10.2310/JIM.0b013e3182408567; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Ferraldeschi R, 2013, CANCER J, V19, P34, DOI 10.1097/PPO.0b013e31827e0b6f; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; Gilep AA, 2011, BBA-PROTEINS PROTEOM, V1814, P200, DOI 10.1016/j.bbapap.2010.06.021; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; Haider SM, 2010, J MOL BIOL, V400, P1078, DOI 10.1016/j.jmb.2010.05.069; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; LAUGHTON CA, 1990, BIOCHEM BIOPH RES CO, V171, P1160, DOI 10.1016/0006-291X(90)90806-X; LEEROBICHAUD P, 1995, BIOCHEM J, V308, P901, DOI 10.1042/bj3080901; LIN D, 1994, MOL ENDOCRINOL, V8, P392, DOI 10.1210/me.8.3.392; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Maitra Anurupa, 2003, Indian Journal of Experimental Biology, V41, P701; Mak PJ, 2014, BIOCHEMISTRY-US, V53, P90, DOI 10.1021/bi4014424; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moon JY, 2013, THER DRUG MONIT, V35, P473, DOI 10.1097/FTD.0b013e318286ee02; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; OGO A, 1991, MOL CELL ENDOCRINOL, V80, P83, DOI 10.1016/0303-7207(91)90145-I; ONODA M, 1982, BIOCHEM BIOPH RES CO, V108, P454, DOI 10.1016/0006-291X(82)90850-6; Pia A, 2013, CANCER TREAT REV, V39, P966, DOI 10.1016/j.ctrv.2013.03.003; Qin KN, 1998, MOL CELL ENDOCRINOL, V145, P111, DOI 10.1016/S0303-7207(98)00177-4; Sandee D, 2011, ENDOCRINOLOGY, V152, P2904, DOI 10.1210/en.2011-0230; Schappach A, 2001, PHARMAZIE, V56, P435; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Strauss JF, 2003, ANN NY ACAD SCI, V997, P42, DOI 10.1196/annals.1290.005; Swart AC, 2010, J STEROID BIOCHEM, V119, P112, DOI 10.1016/j.jsbmb.2009.12.014; SWART P, 1993, J CLIN ENDOCR METAB, V77, P98, DOI 10.1210/jc.77.1.98; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619	55	76	77	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.610998	http://dx.doi.org/10.1074/jbc.M114.610998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301938	Green Published, hybrid			2022-12-25	WOS:000345335000046
J	Li, ZY; Pu-Liu; Chen, ZH; An, FH; Li, LH; Li-Li; Guo, CY; Gu, Y; Liu, Z; Zhu, TB; Wang, LS; Li, CJ; Kong, XQ; Ma, WZ; Yang, ZJ; Jia, EZ				Li, Zhao-Yang; Pu-Liu; Chen, Zhao-Hong; An, Feng-Hui; Li, Li-Hua; Li-Li; Guo, Chang-Yan; Gu, Yan; Liu, Zhe; Zhu, Tie-Bing; Wang, Lian-Sheng; Li, Chun-Jian; Kong, Xiang-Qing; Ma, Wen-Zhu; Yang, Zhi-Jian; Jia, En-Zhi			Combined Effects of Admission Serum Creatinine Concentration with Age and Gender on the Prognostic Significance of Subjects with Acute ST-Elevation Myocardial Infarction in China	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; IN-HOSPITAL MORTALITY; GLOMERULAR-FILTRATION-RATE; RENAL-INSUFFICIENCY; CARDIOVASCULAR-DISEASE; HEART-INSTITUTE; KIDNEY-DISEASE; RISK-FACTOR; ASSOCIATION; CARDIOLOGY	Objective: to explore the impact of admission serum creatinine concentration on the in-hospital mortality and its interaction with age and gender in patients with acute ST-segment elevation myocardial infarction (STEMI) in China. Methods: 1424 acute STEMI patients were enrolled in the study. Anthropometric and laboratory measurements were collected from every patient. A Cox proportional hazards regression model was used to determine the relationships between the admission serum creatinine level (Cr level), age, sex and the in-hospital mortality. A crossover analysis and a stratified analysis were used to determine the combined impact of Cr levels with age and gender. Results: Female (HR 1.687, 95%CI 1.051 similar to 2.708), elevated Cr level (HR 5.922, 95%CI 3.780 similar to 9,279) and old age (1.692, 95%CI 1.402 similar to 2.403) were associated with a high risk of death respectively. After adjusting for other confounders, the renal dysfunction was still independently associated with a higher risk of death (HR 2.48, 95% CI 1.32 similar to 4.63), while female gender (HR 1.19, 95%CI 0.62 similar to 2.29) and old age (HR 1.77, 95%CI 0.92 similar to 3.37) was not. In addition, crossover analysis revealed synergistic effects between elevated Cr level and female gender (SI = 3.01, SIM = 2.10, AP = 0.55). Stratified analysis showed that the impact of renal dysfunction on in-hospital mortality was more pronounced in patients <60 years old (odds ratios 11.10, 95% CI 3.72 to 33.14) compared with patients 60 to 74 years old (odds ratios 5.18, 95% CI 2.48 similar to 10.83) and patients >= 75years old (odds ratios 3.99, 95% CI 1.89 to 8.42). Conclusion: Serum Cr concentration on admission was a strong predictor for in-hospital mortality among Chinese acute STEMI patients especially in the young and the female.	[Li, Zhao-Yang; Li-Li; Guo, Chang-Yan; Gu, Yan; Liu, Zhe; Zhu, Tie-Bing; Wang, Lian-Sheng; Li, Chun-Jian; Kong, Xiang-Qing; Ma, Wen-Zhu; Yang, Zhi-Jian; Jia, En-Zhi] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China; [Pu-Liu; Chen, Zhao-Hong; An, Feng-Hui; Li, Li-Hua] Friendship Hosp Ili Kazakh Autonomous Prefecture, Dept Cardiovasc Med, Yining, Xinjiang, Peoples R China	Nanjing Medical University	Jia, EZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China.	enzhijiacn@aliyun.com	Jia, Enzhi/AGX-9137-2022		National Natural Science Foundation of China [30400173, 30971257, 81170180]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	Support was provided by the National Natural Science Foundation of China, No. 30400173, 30971257, and 81170180. This work was a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2010, J CARD FAIL, V16, P381, DOI 10.1016/j.cardfail.2009.12.020; Assali AR, 2003, CATHETER CARDIO INTE, V59, P195, DOI 10.1002/ccd.10532; Bellomo R, 2007, NEW ENGL J MED, V357, P2205; Benamer H, 2011, EUROINTERVENTION, V6, P1073, DOI 10.4244/EIJV6I9A187; Cardarelli F, 2009, AM J CARDIOL, V103, P766, DOI 10.1016/j.amjcard.2008.11.033; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; French WJ, 2003, J AM COLL CARDIOL, V42, P1544, DOI 10.1016/j.jacc.2003.08.001; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Hiew C, 2010, J INVASIVE CARDIOL, V22, P273; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Izadnegahdar M, 2013, J WOMENS HEALTH; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Marti TM, 2013, MED CLIN-BARCELONA, V140, P395, DOI 10.1016/j.medcli.2012.03.011; Naito K, 2008, J CARD FAIL, V14, P831, DOI 10.1016/j.cardfail.2008.07.233; O'Connor RE, 2010, CIRCULATION, V122, pS787, DOI 10.1161/CIRCULATIONAHA.110.971028; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Yamaguchi J, 2004, AM J CARDIOL, V93, P1526, DOI 10.1016/j.amjcard.2004.02.065; Yamaguchi J, 2007, CIRC J, V71, P1354, DOI 10.1253/circj.71.1354; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhang B, 2013, CHINESE MED J-PEKING, V126, P3481, DOI 10.3760/cma.j.issn.0366-6999.20130381; Zhao L, 2009, J INVASIVE CARDIOL, V21, P493; Zhou CH, 2012, INT J CARDIOL, V162, P59, DOI 10.1016/j.ijcard.2012.09.174	27	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108986	10.1371/journal.pone.0108986	http://dx.doi.org/10.1371/journal.pone.0108986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303229	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400040
J	Sands, B; Jenkins, P; Peria, WJ; Naivar, M; Houston, JP; Brent, R				Sands, Bryan; Jenkins, Patrick; Peria, William J.; Naivar, Mark; Houston, Jessica P.; Brent, Roger			Measuring and Sorting Cell Populations Expressing Isospectral Fluorescent Proteins with Different Fluorescence Lifetimes	PLOS ONE			English	Article							SPATIOTEMPORAL REGULATION; NETWORKS; SYSTEM; PHOSPHORYLATION; ACTIVATION; REPORTERS; MECHANISM; SIGNALS; PROBES; REVEAL	Study of signal transduction in live cells benefits from the ability to visualize and quantify light emitted by fluorescent proteins (XFPs) fused to different signaling proteins. However, because cell signaling proteins are often present in small numbers, and because the XFPs themselves are poor fluorophores, the amount of emitted light, and the observable signal in these studies, is often small. An XFP's fluorescence lifetime contains additional information about the immediate environment of the fluorophore that can augment the information from its weak light signal. Here, we constructed and expressed in Saccharomyces cerevisiae variants of Teal Fluorescent Protein (TFP) and Citrine that were isospectral but had shorter fluorescence lifetimes, similar to 1.5 ns vs similar to 3 ns. We modified microscopic and flow cytometric instruments to measure fluorescence lifetimes in live cells. We developed digital hardware and a measure of lifetime called a pseudophasor that we could compute quickly enough to permit sorting by lifetime in flow. We used these abilities to sort mixtures of cells expressing TFP and the short-lifetime TFP variant into subpopulations that were respectively 97% and 94% pure. This work demonstrates the feasibility of using information about fluorescence lifetime to help quantify cell signaling in living cells at the high throughput provided by flow cytometry. Moreover, it demonstrates the feasibility of isolating and recovering subpopulations of cells with different XFP lifetimes for subsequent experimentation.	[Sands, Bryan; Peria, William J.; Brent, Roger] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Jenkins, Patrick; Houston, Jessica P.] New Mexico State Univ, Dept Chem Engn, Las Cruces, NM 88003 USA; [Naivar, Mark] Darkling X LLC, Los Alamos, NM USA	Fred Hutchinson Cancer Center; New Mexico State University	Brent, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	rbrent@fhcrc.org			National Cancer Institute [U54 CA132381-06A1]; National Institute of General Medical Sciences [RO1 GM097479]; National Institute of Health [RO1 GM086615]; NATIONAL CANCER INSTITUTE [U54CA132381, U54CA132383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086615, R01GM097479] Funding Source: NIH RePORTER; Direct For Biological Sciences [1150202] Funding Source: National Science Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Cancer Institute, grant number U54 CA132381-06A1 to JPH and RB. RB also had significant support from the National Institute of General Medical Sciences, grant number RO1 GM097479. Significant past support came from the National Institute of Health, grant number RO1 GM086615 to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Akinfieva O, 2013, CRIT REV ONCOL HEMAT, V86, P1, DOI 10.1016/j.critrevonc.2012.09.004; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; AMMERER G, 1983, METHOD ENZYMOL, V101, P192; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; Beck R, 2001, IEEE T CIRCUITS-II, V48, P691, DOI 10.1109/82.958339; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Brent R, 2005, SCIENCE, V308, P504, DOI 10.1126/science.1110535; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Bush A, 2013, BIOPHYS J, V104, P727, DOI 10.1016/j.bpj.2012.12.030; Cao RF, 2013, OPT EXPRESS, V21, P14816, DOI 10.1364/OE.21.014816; Chattopadhyay PK, 2010, WIRES NANOMED NANOBI, V2, P334, DOI 10.1002/wnan.75; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; COLICELLI J, 1989, P NATL ACAD SCI USA, V86, P3599, DOI 10.1073/pnas.86.10.3599; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Covey TM, 2013, CYTOM PART A, V83A, P386, DOI 10.1002/cyto.a.22244; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Du J, 2012, STEM CELLS, V30, P1447, DOI 10.1002/stem.1127; EKIMOV AI, 1981, JETP LETT+, V34, P345; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gadella TWJ, 2009, LAB TECH BIOCHEM MOL, V33, P395, DOI 10.1016/S0075-7535(08)00009-0; Gohar AV, 2013, BIOMED OPT EXPRESS, V4, P1390, DOI 10.1364/BOE.4.001390; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Houston J. P., 2009, Proceedings 25th Southern Biomedical Engineering Conference (IFMBE 2009), P261, DOI 10.1007/978-3-642-01697-4_91; Houston JP, 2010, CYTOM PART A, V77A, P861, DOI 10.1002/cyto.a.20930; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kasai RS, 2014, CURR OPIN CELL BIOL, V27, P78, DOI 10.1016/j.ceb.2013.11.008; Kiyokawa E, 2011, ANNU REV PHARMACOL, V51, P337, DOI 10.1146/annurev-pharmtox-010510-100234; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Naivar MA, 2007, CYTOM PART A, V71A, P915, DOI 10.1002/cyto.a.20445; Naivar MA, 2009, CYTOM PART A, V75A, P979, DOI 10.1002/cyto.a.20814; Nakamura T, 2005, METHODS, V37, P146, DOI 10.1016/j.ymeth.2005.05.021; Palazzo AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024592; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; PINSKY BG, 1993, CYTOMETRY, V14, P123, DOI 10.1002/cyto.990140204; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; ROMAN H, 1956, CR TRAV LAB CARLS P, V26, P299; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs K, 2009, IEEE ENG MED BIO, P6624, DOI 10.1109/IEMBS.2009.5332563; Sample V, 2014, J CELL SCI, V127, P1151, DOI 10.1242/jcs.099994; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; STEINKAMP JA, 1993, REV SCI INSTRUM, V64, P3440, DOI 10.1063/1.1144265; STEINKAMP JA, 1993, CYTOMETRY, V14, P210, DOI 10.1002/cyto.990140214; STEINKAMP JA, 2001, P SOC PHOTO-OPT INS, V2, P166; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van der Pol B, 1946, J IEE, V93, P153, DOI DOI 10.1049/JI-3-2.1946.0024; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhou X, 2012, METHOD ENZYMOL, V504, P317, DOI 10.1016/B978-0-12-391857-4.00016-1	66	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109940	10.1371/journal.pone.0109940	http://dx.doi.org/10.1371/journal.pone.0109940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302964	Green Submitted, gold, Green Published			2022-12-25	WOS:000343730400093
J	Yao, B; Hametner, S; van Gelderen, P; Merkl, H; Chen, C; Lassmann, H; Duyn, JH; Bagnato, F				Yao, Bing; Hametner, Simon; van Gelderen, Peter; Merkl, Hellmuth; Chen, Christina; Lassmann, Hans; Duyn, Jeff H.; Bagnato, Francesca			7 Tesla Magnetic Resonance Imaging to Detect Cortical Pathology in Multiple Sclerosis	PLOS ONE			English	Article							HUMAN BRAIN; BIOPHYSICAL MECHANISMS; LESION DETECTION; CEREBRAL-CORTEX; MRI; CONTRAST; IRON; HETEROGENEITY; IDENTIFICATION; DEMYELINATION	Background: Neocortical lesions (NLs) are an important pathological component of multiple sclerosis (MS), but their visualization by magnetic resonance imaging (MRI) remains challenging. Objectives: We aimed at assessing the sensitivity of multi echo gradient echo (ME-GRE) T-2*-weighted MRI at 7.0 Tesla in depicting NLs compared to myelin and iron staining. Methods: Samples from two MS patients were imaged post mortem using a whole body 7T MRI scanner with a 24-channel receive-only array. Isotropic 200 micron resolution images with varying T-2* weighting were reconstructed from the ME-GRE data and converted into R-2* maps. Immunohistochemical staining for myelin (proteolipid protein, PLP) and diaminobenzidine-enhanced Turnbull blue staining for iron were performed. Results: Prospective and retrospective sensitivities of MRI for the detection of NLs were 48% and 67% respectively. We observed MRI maps detecting only a small portion of 20 subpial NLs extending over large cortical areas on PLP stainings. No MRI signal changes suggestive of iron accumulation in NLs were observed. Conversely, R-2* maps indicated iron loss in NLs, which was confirmed by histological quantification. Conclusions: High-resolution post mortem imaging using R-2* and magnitude maps permits detection of focal NLs. However, disclosing extensive subpial demyelination with MRI remains challenging.	[Yao, Bing; van Gelderen, Peter; Merkl, Hellmuth; Duyn, Jeff H.] NINDS, Adv Magnet Resonance Imaging Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Yao, Bing] Kessler Fdn, Ctr Neuroimaging Res, W Orange, NJ USA; [Hametner, Simon; Lassmann, Hans] Med Univ, Ctr Brain Res, Vienna, Austria; [Chen, Christina; Bagnato, Francesca] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Bagnato, Francesca] Vanderbilt Univ, Inst Imaging Sci, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kessler Institute for Rehabilitation; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Vanderbilt University	Bagnato, F (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	fbagnato@umm.edu	Lassmann, Hans/Z-2269-2019; van Gelderen, Peter/U-4535-2019	Lassmann, Hans/0000-0001-8617-5052; 	Intramural Research Program of the NINDS, NIH; Austrian Science Fund [P19854-B02]	Intramural Research Program of the NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Austrian Science Fund(Austrian Science Fund (FWF))	This research was supported by the Intramural Research Program of the NINDS, NIH and by the Austrian Science Fund (Project P19854-B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Bagnato F, 2010, MULT SCLER J, V16, P1203, DOI 10.1177/1352458510377223; Bagnato F, 2009, J NEUROL SCI, V282, P80, DOI 10.1016/j.jns.2009.03.021; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bradl M, 2009, SEMIN IMMUNOPATHOL, V31, P455, DOI 10.1007/s00281-009-0182-3; Chen G, 2012, NEUROIMAGE, V59, P3441, DOI 10.1016/j.neuroimage.2011.10.079; Dawe RJ, 2009, MAGN RESON MED, V61, P810, DOI 10.1002/mrm.21909; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; Dolezal O, 2007, INT REV NEUROBIOL, V79, P475, DOI 10.1016/S0074-7742(07)79021-9; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fishbein KW, 2007, MAGN RESON MED, V57, P1000, DOI 10.1002/mrm.21216; Forge JK, 1998, LIFE SCI, V63, P2271, DOI 10.1016/S0024-3205(98)00512-8; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Geurts JJG, 2008, J NEUROL, V255, P183, DOI 10.1007/s00415-008-0620-5; Haider L, 2014, J NEUROL NE IN PRESS; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hammond KE, 2008, ANN NEUROL, V64, P707, DOI 10.1002/ana.21582; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Kennan RP, 1996, J MAGN RESON SER B, V110, P267, DOI 10.1006/jmrb.1996.0042; Kooi EJ, 2012, NEUROLOGY, V79, P1369, DOI 10.1212/WNL.0b013e31826c1b1c; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Langkammer C, 2012, NEUROIMAGE, V59, P1413, DOI 10.1016/j.neuroimage.2011.08.045; Li TQ, 2006, NEUROIMAGE, V32, P1032, DOI 10.1016/j.neuroimage.2006.05.053; Li TQ, 2009, MAGN RESON MED, V62, P1652, DOI 10.1002/mrm.22156; Mainero C, 2009, NEUROLOGY, V73, P941, DOI 10.1212/WNL.0b013e3181b64bf7; Mike A, 2011, AM J NEURORADIOL, V32, P515, DOI 10.3174/ajnr.A2340; Moraal B, 2008, EUR RADIOL, V18, P2311, DOI 10.1007/s00330-008-1009-7; Nelson F, 2008, MULT SCLER J, V14, P1214, DOI 10.1177/1352458508094644; Nelson F, 2007, AM J NEURORADIOL, V28, P1645, DOI 10.3174/ajnr.A0645; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Schmierer K, 2010, BRAIN, V133, P858, DOI 10.1093/brain/awp335; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Seewann A, 2011, MULT SCLER J, V17, P1202, DOI 10.1177/1352458511406575; Spatz H, 1922, Z GESAMTE NEUROL PSY, V77, P261, DOI 10.1007/BF02865844; Wharton S, 2012, P NATL ACAD SCI USA, V109, P18559, DOI 10.1073/pnas.1211075109; Yablonskiy DA, 2012, P NATL ACAD SCI USA, V109, P14212, DOI 10.1073/pnas.1206037109; Yao B, 2012, RADIOLOGY, V262, P206, DOI 10.1148/radiol.11110601	40	60	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108863	10.1371/journal.pone.0108863	http://dx.doi.org/10.1371/journal.pone.0108863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303286	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400031
J	Joly, M; Ammersdorfer, S; Schmidtke, D; Zimmermann, E				Joly, Marine; Ammersdoerfer, Sandra; Schmidtke, Daniel; Zimmermann, Elke			Touchscreen-Based Cognitive Tasks Reveal Age-Related Impairment in a Primate Aging Model, the Grey Mouse Lemur (Microcebus murinus)	PLOS ONE			English	Article							OPERANT PLATFORM; NONHUMAN PRIMATE; SLEEPING SITES; TAU-PROTEINS; MEMORY; REVERSAL; RATS; DISCRIMINATION; ACQUISITION; PERFORMANCE	Mouse lemurs are suggested to represent promising novel non-human primate models for aging research. However, standardized and cross-taxa cognitive testing methods are still lacking. Touchscreen-based testing procedures have proven high stimulus control and reliability in humans and rodents. The aim of this study was to adapt these procedures to mouse lemurs, thereby exploring the effect of age. We measured appetitive learning and cognitive flexibility of two age groups by applying pairwise visual discrimination (PD) and reversal learning (PDR) tasks. On average, mouse lemurs needed 24 days of training before starting with the PD task. Individual performances in PD and PDR tasks correlate significantly, suggesting that individual learning performance is unrelated to the respective task. Compared to the young, aged mouse lemurs showed impairments in both PD and PDR tasks. They needed significantly more trials to reach the task criteria. A much higher inter-individual variation in old than in young adults was revealed. Furthermore, in the PDR task, we found a significantly higher perseverance in aged compared to young adults, indicating an age-related deficit in cognitive flexibility. This study presents the first touchscreen-based data on the cognitive skills and age-related dysfunction in mouse lemurs and provides a unique basis to study mechanisms of inter-individual variation. It furthermore opens exciting perspectives for comparative approaches in aging, personality, and evolutionary research.	[Joly, Marine; Ammersdoerfer, Sandra; Schmidtke, Daniel; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Zimmermann, E (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	elke.zimmermann@tiho-hannover.de	Joly, Marine/P-5990-2014	Joly, Marine/0000-0002-0784-5167	European Community's 7th Framework Programme [278486]	European Community's 7th Framework Programme	This study is part of a project which has received funding from the European Community's 7th Framework Programme (FP7/2007-2013) under grant agreement no 278486 acronym "DEVELAGE" (http://www.develage.eu/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barense MD, 2002, LEARN MEMORY, V9, P191, DOI 10.1101/lm.48602; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; BONS N, 1995, CR ACAD SCI III-VIE, V318, P741; Boutet I, 2007, J COMP PSYCHOL, V121, P270, DOI 10.1037/0735-7036.121.3.270; Brushfield AM, 2008, BEHAV NEUROSCI, V122, P54, DOI 10.1037/0735-7044.122.1.54; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P957, DOI 10.1037/0735-7044.115.4.957; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; DELACOURTE A, 1995, CR ACAD SCI III-VIE, V318, P85; Dhenain M, 2000, NEUROBIOL AGING, V21, P81, DOI 10.1016/S0197-4580(00)00098-1; Dhenain M, 2003, MAGNET RESON MED, V50, P984, DOI 10.1002/mrm.10612; Dhenain M, 1998, NEUROBIOL AGING, V19, P65, DOI 10.1016/S0197-4580(98)00005-0; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dkhissi-Benyahya O, 2001, J COMP NEUROL, V438, P490, DOI 10.1002/cne.1330; Dubicanac M, 2013, 13 C GES PRIM HAMB 6, P52; Herndon JG, 1997, BEHAV BRAIN RES, V87, P25, DOI 10.1016/S0166-4328(96)02256-5; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Joly M, 2006, NEUROBIOL AGING, V27, P1045, DOI 10.1016/j.neurobiolaging.2005.05.001; Joly M, 2011, BIOL LETTERS, V7, P638, DOI 10.1098/rsbl.2011.0258; Lacreuse A, 2014, NEUROBIOL AGING, V35, P623, DOI 10.1016/j.neurobiolaging.2013.08.036; LAI ZC, 1995, NEUROBIOL AGING, V16, P947, DOI 10.1016/0197-4580(95)02014-4; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; Nagahara AH, 2010, NEUROBIOL AGING, V31, P1020, DOI 10.1016/j.neurobiolaging.2008.07.007; Oomen CA, 2013, NAT PROTOC, V8, P2006, DOI 10.1038/nprot.2013.124; Perret M, 1997, J BIOL RHYTHM, V12, P136, DOI 10.1177/074873049701200205; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; Radespiel U, 1998, AM J PRIMATOL, V46, P77, DOI 10.1002/(SICI)1098-2345(1998)46:1<77::AID-AJP6>3.3.CO;2-#; Radespiel U, 2000, AM J PRIMATOL, V51, P21, DOI 10.1002/(SICI)1098-2345(200005)51:1<21::AID-AJP3>3.0.CO;2-C; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Romberg C, 2013, NEUROBIOL AGING, V34, P731, DOI 10.1016/j.neurobiolaging.2012.08.006; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Schmid J, 1998, BEHAV ECOL SOCIOBIOL, V43, P125, DOI 10.1007/s002650050474; Schoenbaum G, 2006, J NEUROPHYSIOL, V95, P1509, DOI 10.1152/jn.01052.2005; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Spinelli S, 2003, J PSYCHOPHARMACOL, V17, pA60; Trouche SG, 2010, NEUROBIOL LEARN MEM, V94, P100, DOI 10.1016/j.nlm.2010.04.006; Voytko ML, 1999, NEUROBIOL AGING, V20, P617, DOI 10.1016/S0197-4580(99)00097-4; Weed MR, 1999, COGNITIVE BRAIN RES, V8, P185, DOI 10.1016/S0926-6410(99)00020-8; Weiler JA, 2008, LEARN MEMORY, V15, P190, DOI 10.1101/lm.890408; Winters BD, 2010, NEUROBIOL LEARN MEM, V93, P221, DOI 10.1016/j.nlm.2009.10.002; Wrogemann D, 2001, INT J PRIMATOL, V22, P91, DOI 10.1023/A:1026418132281; Zimmermann E, 1998, FOLIA PRIMATOL, V69, P106, DOI 10.1159/000021571; Zimmermann E, DWARF MOUSE LEMURS M; Zimmermann Elke, 2007, P1163, DOI 10.1007/978-3-540-33761-4_38; Zurcher NR, 2010, J NEUROSCI METH, V188, P219, DOI 10.1016/j.jneumeth.2010.02.011	50	49	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109393	10.1371/journal.pone.0109393	http://dx.doi.org/10.1371/journal.pone.0109393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299046	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200050
J	Kazi, AM; Warraich, GJ; Qureshi, S; Khan, MMA; Khan, MMA; Zaidi, AKM				Kazi, Abdul Momin; Warraich, Gohar Javed; Qureshi, Shahida; Qureshi, Huma; Khan, Muhammad Mubashir Ahmad; Zaidi, Anita Kaniz Mehdi		Pakistan Rotavirus Study Grp	Sentinel Hospital-Based Surveillance for Assessment of Burden of Rotavirus Gastroenteritis in Children in Pakistan	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CHILDHOOD DIARRHEA; STRAIN DIVERSITY; VACCINE; DISEASE; EPIDEMIOLOGY; MULTICENTER; BANGLADESH; MORTALITY; ETIOLOGY	Objectives: To determine the burden and molecular epidemiology of rotavirus gastroenteritis in children hospitalized with severe acute watery diarrhea in Pakistan prior to introduction of rotavirus vaccine. Methods: A cross-sectional study was carried out over a period of two years from 2006 - 2008 at five sentinel hospitals in the cities of Karachi, Lahore, Rawalpindi, and Peshawar. Stool samples collected from children under five years of age hospitalized with severe acute watery diarrhea were tested for rotavirus antigen via enzyme immunoassay (EIA) (IDEA REF K6020 Oxoid Ltd (Ely), Cambridge, United Kingdom). A subset of EIA positive stool samples were further processed for genotyping. Results: 6679 children were enrolled and stool specimens of 2039 (30.5%) were positive for rotavirus. Rotavirus positivity ranged from 16.3% to 39.4% in the 5 hospitals with highest positivity in Lahore. 1241 (61%) of all rotavirus cases were in infants under one year of age. Among the strains examined for G-serotypes, the occurrence of G1, G2, G9 and G4 strains was found to be 28%, 24%, 14% and 13%, respectively. Among P-types, the most commonly occurring strains were P6 (31.5%) followed by P8 (20%) and P4 (12%). Prevalent rotavirus genotype in hospitalized children of severe diarrhea were G1P[8] 11.6% (69/593), followed by G2P[4] 10.4% (62/593), and G4P[6] 10.1% (60/593). Conclusions: Approximately one third of children hospitalized with severe gastroenteritis in urban centers in Pakistan have rotavirus. Introduction of rotavirus vaccine in Pakistan's national immunization program could prevent many severe episodes and diarrheal deaths.	[Kazi, Abdul Momin; Warraich, Gohar Javed; Qureshi, Shahida; Zaidi, Anita Kaniz Mehdi] Aga Khan Univ, Karachi, Pakistan; [Qureshi, Huma; Khan, Muhammad Mubashir Ahmad] Pakistan Med Res Council, Islamabad, Pakistan	Aga Khan University; Pakistan Medical Research Council	Zaidi, AKM (corresponding author), Aga Khan Univ, Karachi, Pakistan.	anita.zaidi@aku.edu			Program for Appropriate Technology in Health (PATH), USA; Fogarty International Center, National Institute of Health, USA [ID43 TW0075 85-01]	Program for Appropriate Technology in Health (PATH), USA; Fogarty International Center, National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the Program for Appropriate Technology in Health (PATH), USA. AMK received partial training support from the Fogarty International Center, National Institute of Health, USA (Grant number: ID43 TW0075 85-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboatwalla Mubina, 1995, Indian Journal of Pediatrics, V62, P345, DOI 10.1007/BF02753600; Alam MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067998; [Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P533; Assis ASF, 2013, J PEDIAT-BRAZIL, V89, P470, DOI 10.1016/j.jped.2013.02.019; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Bass ES, 2007, PEDIATR REV, V28, P183, DOI 10.1542/pir.28-5-183; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Ehlken B, 2002, ACTA PAEDIATR, V91, P769, DOI 10.1080/08035250213227; FEIGIN RD, 2003, TXB PEDIAT INFECT DI; Fruhwirth M, 2000, J CLIN MICROBIOL, V38, P1804; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; HUILAN S, 1991, B WORLD HEALTH ORGAN, V69, P549; Iftikhar T, 2012, J MED VIROL, V84, P2003, DOI 10.1002/jmv.23402; Kawai K., 2011, VACCINE; KHALIL K, 1993, ACTA PAEDIATR, V82, P87, DOI 10.1111/j.1651-2227.1993.tb12909.x; KHAN M M A, 1988, Journal of Diarrhoeal Diseases Research, V6, P228; Kilgore A, 2013, VACCINE, V31, P4164, DOI 10.1016/j.vaccine.2013.06.085; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Miles MG, 2012, VACCINE, V30, pA131, DOI 10.1016/j.vaccine.2011.10.002; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Mubashir M, 1990, J Gastroenterol Hepatol, V5, P264; Nakagomi T, 2005, J INFECT DIS, V192, pS106, DOI 10.1086/431503; Ngo TC, 2009, VACCINE, V27, pF75, DOI 10.1016/j.vaccine.2009.08.074; Nyambat B, 2009, VACCINE, V27, pF81, DOI 10.1016/j.vaccine.2009.08.085; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Richardson V, 2011, NEW ENGL J MED, V365, P772, DOI 10.1056/NEJMc1100062; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO, 2005, HDB IMCI INT MAN CHI; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zaman K, 2009, VACCINE, V27, pF31, DOI 10.1016/j.vaccine.2009.08.063	39	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108221	10.1371/journal.pone.0108221	http://dx.doi.org/10.1371/journal.pone.0108221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295613	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000013
J	Smith, AN; Belk, MC; Creighton, JC				Smith, Ashlee N.; Belk, Mark C.; Creighton, J. Curtis			Residency Time as an Indicator of Reproductive Restraint in Male Burying Beetles	PLOS ONE			English	Article							NICROPHORUS-VESPILLOIDES COLEOPTERA; MALE PARENTAL CARE; PATERNAL CARE; BROOD SIZE; TERMINAL INVESTMENT; BODY-SIZE; DURATION; SUCCESS; EVOLUTION; INFANTICIDE	The cost of reproduction theory posits that there are trade-offs between current and future reproduction because resources that are allocated to current offspring cannot be used for future reproductive opportunities. Two adaptive reproductive strategies have been hypothesized to offset the costs of reproduction and maximize lifetime fitness. The terminal investment hypothesis predicts that as individuals age they will allocate more resources to current reproduction as a response to decreasing residual reproductive value. The reproductive restraint hypotheses predicts that as individuals age they will allocate fewer resources to current reproduction to increase the chance of surviving for an additional reproductive opportunity. In this study, we test for adaptive responses to advancing age in male burying beetles, Nicrophorus orbicollis. Burying beetles use facultative biparental care, but the male typically abandons the brood before the female. Previous work in male burying beetles has suggested several factors to explain variation in male residency time, but no study has observed male behavior throughout their entire reproductive lifetimes to determine whether males change residency time in an adaptive way with age. We compared residency time of males that reproduced biparentally, uniparentally, and on differentsized carcasses to determine if they used an adaptive reproductive strategy. Males did not increase residency time as they aged when reproducing biparentally, but decreased residency time with age when reproducing uniparentally. A decrease in parental care with age is consistent with a reproductive restraint strategy. When female age increased over time, males did not increase their residency time to compensate for deteriorating female condition. To our knowledge, this is the first test of adaptive reproductive allocation strategies in male burying beetles.	[Smith, Ashlee N.; Creighton, J. Curtis] Purdue Univ Calumet, Dept Biol Sci, Hammond, IN USA; [Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Purdue University System; Purdue University; Brigham Young University	Smith, AN (corresponding author), Brigham Young Univ, Provo, UT 84602 USA.	ashlee.n.smith@gmail.com		Smith, Ashlee/0000-0001-8941-8574	Purdue University Graduate Studies Department	Purdue University Graduate Studies Department	Funding for this research was provided by the Purdue University Graduate Studies Department through a Graduate Research Grant (http://webs.purduecal.edu/gradschool/graduate-research-awards/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V23, P297, DOI 10.1007/BF00300576; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V22, P429, DOI 10.1007/BF00294981; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Creighton JC, 2009, AM NAT, V174, P673, DOI 10.1086/605963; Creighton JC, 2005, BEHAV ECOL, V16, P1031, DOI 10.1093/beheco/ari084; Eggert Anne-Katrin, 1997, P216; FETHERSTON IA, 1994, ANIM BEHAV, V47, P777, DOI 10.1006/anbe.1994.1110; FETHERSTON IA, 1990, ETHOLOGY, V85, P177, DOI 10.1111/j.1439-0310.1990.tb00398.x; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Koulianos S, 2000, ANN ENTOMOL SOC AM, V93, P836, DOI 10.1603/0013-8746(2000)093[0836:POIAIE]2.0.CO;2; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Muller JK, 1998, ECOL ENTOMOL, V23, P195, DOI 10.1046/j.1365-2311.1998.00119.x; MULLER JK, 1990, ANIM BEHAV, V40, P491, DOI 10.1016/S0003-3472(05)80529-9; Otronen M, 1988, EFFECT BODY SIZE OUT; Rauter CM, 2004, ANIM BEHAV, V68, P695, DOI 10.1016/j.anbehav.2003.09.018; Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; REID ML, 1995, CAN J ZOOL, V73, P1396, DOI 10.1139/z95-164; Robertson IC, 1998, BEHAV ECOL SOCIOBIOL, V43, P379, DOI 10.1007/s002650050505; ROBERTSON IC, 1993, J ZOOL, V231, P583, DOI 10.1111/j.1469-7998.1993.tb01940.x; Roff Derek A., 1992; Safryn SA, 2000, J INSECT BEHAV, V13, P291, DOI 10.1023/A:1007700601095; SCOTT MP, 1993, EVOL ECOL, V7, P362, DOI 10.1007/BF01237868; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SCOTT MP, 1990, ANIM BEHAV, V39, P274, DOI 10.1016/S0003-3472(05)80871-1; SCOTT MP, 1989, J INSECT BEHAV, V2, P133, DOI 10.1007/BF01053623; SCOTT MP, 1990, BEHAV ECOL SOCIOBIOL, V26, P31, DOI 10.1007/BF00174022; Stearns S.C., 1992, pi; Steiger S, 2012, BEHAV ECOL, V23, P1126, DOI 10.1093/beheco/ars082; Suzuki S, 2009, ETHOLOGY, V115, P1, DOI 10.1111/j.1439-0310.2008.01598.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; TRUMBO ST, 1992, ECOL ENTOMOL, V17, P289, DOI 10.1111/j.1365-2311.1992.tb01060.x; TRUMBO ST, 1994, OIKOS, V69, P241, DOI 10.2307/3546144; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004; Ward RJS, 2009, BEHAV ECOL, V20, P1274, DOI 10.1093/beheco/arp132; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILSON DS, 1984, ECOL ENTOMOL, V9, P195, DOI 10.1111/j.1365-2311.1984.tb00715.x	39	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109165	10.1371/journal.pone.0109165	http://dx.doi.org/10.1371/journal.pone.0109165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295755	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000042
J	Rouse, R; Zhang, LS; Shea, K; Zhou, HF; Xu, L; Stewart, S; Rosenzweig, B; Zhang, J				Rouse, Rodney; Zhang, Leshuai; Shea, Katherine; Zhou, Hongfei; Xu, Lin; Stewart, Sharron; Rosenzweig, Barry; Zhang, Jun			Extended Exenatide Administration Enhances Lipid Metabolism and Exacerbates Pancreatic Injury in Mice on a High Fat, High Carbohydrate Diet	PLOS ONE			English	Article							CELL-SPECIFIC TRANSCRIPTION; PEPTIDE-1 RECEPTOR AGONIST; NUCLEAR FACTOR 3-BETA; ACINAR-CELLS; OXIDATIVE STRESS; PDX-1 GENE; BETA; RATS; ACTIVATION; EXENDIN-4	This study expanded upon a previous study in mice reporting a link between exenatide treatment and exocrine pancreatic injury by demonstrating temporal and dose responses and providing an initial mechanistic hypothesis. The design of the present study included varying lengths of exenatide exposure (3, 6 weeks to 12 weeks) at multiple concentrations (3, 10, or 30 mu g/kg) with multiple endpoints (histopathology evaluations, immunoassay for cytokines, immunostaining of the pancreas, serum chemistries and measurement of trypsin, amylase, and, lipase, and gene expression profiles). Time- and dose-dependent exocrine pancreatic injury was observed in mice on a high fat diet treated with exenatide. The morphological changes identified in the pancreas involved acinar cell injury and death (autophagy, apoptosis, necrosis, and atrophy), cell adaptations (hypertrophy and hyperplasia), and cell survival (proliferation/regeneration) accompanied by varying degrees of inflammatory response leading to secondary injury in pancreatic blood vessels, ducts, and adipose tissues. Gene expression profiles indicated increased signaling for cell survival and altered lipid metabolism in exenatide treated mice. Immunohistochemistry supported gene expression findings that exenatide caused and/or exacerbated pancreatic injury in a high fat diet environment potentially by further increasing high fat diet exacerbated lipid metabolism and resulting oxidative stress. Further investigation is required to confirm these findings and determine their relevance to human disease.	[Rouse, Rodney; Zhang, Leshuai; Shea, Katherine; Zhou, Hongfei; Xu, Lin; Stewart, Sharron; Rosenzweig, Barry; Zhang, Jun] US FDA, Div Appl Regulatory Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Rouse, R (corresponding author), US FDA, Div Appl Regulatory Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	rodney.rouse@fda.hhs.gov	Zhang, Leshuai/C-8077-2012		U.S. Food and Drug Administration	U.S. Food and Drug Administration	All funding originated from U.S. congressional appropriation to fund the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2008, NEW ENGL J MED, V358, P1970; Bastien-Dionne PO, 2011, DIABETES, V60, P3217, DOI 10.2337/db11-0101; Bulchandani D, 2009, ENDOCRINOLOGIST, V19, P114, DOI 10.1097/TEN.0b013e3181a48938; Bulter AE, 2013, DIABETES, V62, P2595; Chvanov M, 2005, PHILOS T R SOC B, V360, P2273, DOI 10.1098/rstb.2005.1757; De Leon DD, 2006, PHYSL GENETICS, V4, P233; Ellenbroek JH, 2013, DIABETOLOGIA, V56, P1980, DOI 10.1007/s00125-013-2957-2; Fatehi-Hassanabad Zahra, 2005, Nutr Metab (Lond), V2, P1, DOI 10.1186/1743-7075-2-1; Feng WH, 2013, FOLIA BIOL-PRAGUE, V59, P217; Fisher WE, 2009, SCHWARTZS PRINCIPLES, P1167; Fujimori N, 2011, PEPTIDES, V32, P2067, DOI 10.1016/j.peptides.2011.08.027; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Ghanaat-Pour H, 2011, METABOLOMICS, V1, P102, DOI DOI 10.4172/2153-0769.1000102; Ghanaat-Pour H, 2009, DIABETES-METAB RES, V25, P163, DOI 10.1002/dmrr.896; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Goodwin D, 2014, BIOMAKERS, V25, P1; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Kawasaki Y, 2010, HORM METAB RES, V42, P311, DOI 10.1055/s-0030-1249035; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Koehler JA, 2009, DIABETES, V58, P2148, DOI 10.2337/db09-0626; Kota Sunil K, 2012, Indian J Endocrinol Metab, V16, P141, DOI 10.4103/2230-8210.91211; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031394; Matveyenko AV, 2009, DIABETES, V58, P1604, DOI 10.2337/db09-0058; Nachnani JS, 2010, DIABETOLOGIA, V53, P153, DOI 10.1007/s00125-009-1515-4; Niederau C, 1996, FREE RADICAL BIO MED, V20, P877, DOI 10.1016/0891-5849(95)02153-1; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rouse R, 2014, TOXICOL APPL PHARM, V276, P104, DOI 10.1016/j.taap.2014.01.021; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Seo JY, 2009, ANN NY ACAD SCI, V1171, P570, DOI 10.1111/j.1749-6632.2009.04712.x; Siech M, 2009, AM J PHYSIOL-GASTR L, V297, pG1163, DOI 10.1152/ajpgi.90468.2008; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Tanaka K, 2014, WORLD J GASTROENTERO, V20, P2653, DOI 10.3748/wjg.v20.i10.2653; Weber H, 2005, BIOCHEM PHARMACOL, V70, P1241, DOI 10.1016/j.bcp.2005.06.028; Wei Q, 2012, PEPTIDES, V37, P18, DOI 10.1016/j.peptides.2012.06.018; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yang HP, 2012, ACTA PHARM SIN B, V2, P396, DOI 10.1016/j.apsb.2012.05.003; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang J, 1999, TOXICOL PATHOL, V27, P427; Zhang J, 2014, HISTOL HISTOPATHOL, V29, P1135, DOI 10.14670/HH-29.1135; Zhang LS, 2014, TOXICOL PATHOL, V42, P435, DOI 10.1177/0192623313486967; Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109477	10.1371/journal.pone.0109477	http://dx.doi.org/10.1371/journal.pone.0109477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291183	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000064
J	Stuckey, EM; Stevenson, J; Galactionova, K; Baidjoe, AY; Bousema, T; Odongo, W; Kariuki, S; Drakeley, C; Smith, TA; Cox, J; Chitnis, N				Stuckey, Erin M.; Stevenson, Jennifer; Galactionova, Katya; Baidjoe, Amrish Y.; Bousema, Teun; Odongo, Wycliffe; Kariuki, Simon; Drakeley, Chris; Smith, Thomas A.; Cox, Jonathan; Chitnis, Nakul			Modeling the Cost Effectiveness of Malaria Control Interventions in the Highlands of Western Kenya	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; PLASMODIUM-FALCIPARUM MALARIA; HEALTH SYSTEM; IMPACT; TRANSMISSION; PREVENTION	Introduction: Tools that allow for in silico optimization of available malaria control strategies can assist the decision-making process for prioritizing interventions. The OpenMalaria stochastic simulation modeling platform can be applied to simulate the impact of interventions singly and in combination as implemented in Rachuonyo South District, western Kenya, to support this goal. Methods: Combinations of malaria interventions were simulated using a previously-published, validated model of malaria epidemiology and control in the study area. An economic model of the costs of case management and malaria control interventions in Kenya was applied to simulation results and cost-effectiveness of each intervention combination compared to the corresponding simulated outputs of a scenario without interventions. Uncertainty was evaluated by varying health system and intervention delivery parameters. Results: The intervention strategy with the greatest simulated health impact employed long lasting insecticide treated net (LLIN) use by 80% of the population, 90% of households covered by indoor residual spraying (IRS) with deployment starting in April, and intermittent screen and treat (IST) of school children using Artemether lumefantrine (AL) with 80% coverage twice per term. However, the current malaria control strategy in the study area including LLIN use of 56% and IRS coverage of 70% was the most cost effective at reducing disability-adjusted life years (DALYs) over a five year period. Conclusions: All the simulated intervention combinations can be considered cost effective in the context of available resources for health in Kenya. Increasing coverage of vector control interventions has a larger simulated impact compared to adding IST to the current implementation strategy, suggesting that transmission in the study area is not at a level to warrant replacing vector control to a school-based screen and treat program. These results have the potential to assist malaria control program managers in the study area in adding new or changing implementation of current interventions.	[Stuckey, Erin M.; Galactionova, Katya; Smith, Thomas A.; Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Stuckey, Erin M.; Galactionova, Katya; Smith, Thomas A.; Chitnis, Nakul] Univ Basel, Basel, Switzerland; [Stevenson, Jennifer; Bousema, Teun; Drakeley, Chris; Cox, Jonathan] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Stevenson, Jennifer; Odongo, Wycliffe; Kariuki, Simon] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, Ctr Global Hlth Res, Kisumu, Kenya; [Stevenson, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Baidjoe, Amrish Y.; Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Radboud University Nijmegen	Stuckey, EM (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	erin.stuckey@unibas.ch	Chitnis, Nakul/B-3105-2013; Kariuki, Simon/AFT-6596-2022; Smith, Thomas/B-5569-2015; Bousema, Teun/N-3574-2014	Smith, Thomas/0000-0002-3650-9381; Bousema, Teun/0000-0003-2666-094X; Baidjoe, Amrish/0000-0001-5295-5085; Chitnis, Nakul/0000-0002-1103-9141; Galactionova, Katya/0000-0002-5743-7647	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [45114, 1032350]; Grand Challenge Grant [OPP1024438]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA; Wellcome Trust [091924]	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium; Grand Challenge Grant; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [grants number 45114 and 1032350] and Grand Challenge Grant [grant number OPP1024438]. NC also acknowledges support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA. CD is supported by the Wellcome Trust [grant number 091924]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazili J., 2007, AFR J HLTH SCI, V14, P70; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-372; Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36; Brooker S, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-93; Chitnis N, 2012, B MATH BIOL, V74, P1098, DOI 10.1007/s11538-011-9710-0; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Chuma J, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-22; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; Department of Malaria Control Kenya National Bureau of Statistics ICF Macro, 2011, 2010 KEN MAL IND SUR; Drake TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-273; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Galactionova K, 2013, 9 WORLD C HLTH EC CE; Global Fund to fight AIDS TB and Malaria, 2013, PRIC QUAL REP TOOL; Goodman C, 2000, EC ANAL MALARIA CONT; Government of Kenya, 2013, COMPR PUBL EXP REV 2; Guyatt HL, 2002, HEALTH POLICY PLANN, V17, P144, DOI 10.1093/heapol/17.2.144; Halliday KE, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001594; INDEPTH Network, 2004, MOD LIF TABL SUBS AF; International Association for Impact Assessment, 2006, HLTH IMP ASS INT BES; Kenya Division of Malaria Control, 2006, NAT GUID DIAGN TREAT; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kirigia JM, 1998, TROP MED INT HEALTH, V3, P145, DOI 10.1046/j.1365-3156.1998.00204.x; Kolaczinski J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-37; Kristan M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-231; Mabaso MLH, 2007, AM J TROP MED HYG, V76, P33, DOI 10.4269/ajtmh.2007.76.33; Malaria Vaccine Initiative, 2012, EST EC BURD MAL NIG; Management Sciences for Health, 2011, INT DRUG PRIC IND GU; Mikkelsen-Lopez I, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-13; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Oanda, 2013, HIST EXCH RAT; OpenMalaria, 2010, OPENMALARIA; RTI International, 2013, 1 RTI INT; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001157; Stevenson J, 2012, EMERG INFECT DIS; Stevenson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077641; Stuckey EM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-357; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; UNITAID, 2013, MAL VECT CONTR COMM; Watsierah CA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-295; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO-CHOICE, 2005, AFR E COST EFF RES T; WHO-CHOICE, 2005, ARE E COST EFF RES M; WHO-CHOICE, 2005, AFR E COST EFF RES H; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; World Bank, 2013, IMPL PRIC DEFL GROSS; World Health Organization, 2011, CHOOSING INT AR COST; World Health Organization, 2014, GLOB BURD DIS 2012	56	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107700	10.1371/journal.pone.0107700	http://dx.doi.org/10.1371/journal.pone.0107700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290939	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000342798000007
J	Yang, ND; Tan, SH; Ng, S; Shi, Y; Zhou, J; Tan, KSW; Wong, WSF; Shen, HM				Yang, Nai-Di; Tan, Shi-Hao; Ng, Shukie; Shi, Yin; Zhou, Jing; Tan, Kevin Shyong Wei; Wong, Wai-Shiu Fred; Shen, Han-Ming			Artesunate Induces Cell Death in Human Cancer Cells via Enhancing Lysosomal Function and Lysosomal Degradation of Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IN-VIVO; CYCLE ARREST; ENDOPEROXIDE ANTIMALARIAL; CARCINOMA-CELLS; LUNG-CANCER; IRON; ARTEMISININ; AUTOPHAGY; GROWTH	Artesunate (ART) is an anti-malaria drug that has been shown to exhibit anti-tumor activity, and functional lysosomes are reported to be required for ART-induced cancer cell death, whereas the underlying molecular mechanisms remain largely elusive. In this study, we aimed to elucidate the molecular mechanisms underlying ART-induced cell death. We first confirmed that ART induces apoptotic cell death in cancer cells. Interestingly, we found that ART preferably accumulates in the lysosomes and is able to activate lysosomal function via promotion of lysosomal V-ATPase assembly. Furthermore, we found that lysosomes function upstream of mitochondria in reactive oxygen species production. Importantly, we provided evidence showing that lysosomal iron is required for the lysosomal activation and mitochondrial reactive oxygen species production induced by ART. Finally, we showed that ART-induced cell death is mediated by the release of iron in the lysosomes, which results from the lysosomal degradation of ferritin, an iron storage protein. Meanwhile, overexpression of ferritin heavy chain significantly protected cells from ART-induced cell death. In addition, knockdown of nuclear receptor coactivator 4, the adaptor protein for ferritin degradation, was able to block ART-mediated ferritin degradation and rescue the ART-induced cell death. In summary, our study demonstrates that ART treatment activates lysosomal function and then promotes ferritin degradation, subsequently leading to the increase of lysosomal iron that is utilized by ART for its cytotoxic effect on cancer cells. Thus, our data reveal a new mechanistic action underlying ART-induced cell death in cancer cells.	[Yang, Nai-Di; Tan, Shi-Hao; Ng, Shukie; Shi, Yin; Zhou, Jing; Shen, Han-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Tan, Shi-Hao; Shen, Han-Ming] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Tan, Kevin Shyong Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Wong, Wai-Shiu Fred] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Shen, Han-Ming] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Shen, HM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.	han-ming_shen@nuhs.edu.sg	SHEN, Han-Ming/B-5942-2011	SHEN, Han-Ming/0000-0001-7369-5227; Wong, Wai Shiu Fred/0000-0001-7010-3759; Shi, Yin/0000-0003-3858-8500; ZHOU, JING/0000-0002-2475-7783	Singapore National Medical Research Council [NMRC/1260/2010]; Singapore Biomedical Research Council [BMRC/08/1/21/19/554]; National University of Singapore	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	This work was supported in part by research grants from Singapore National Medical Research Council (NMRC/1260/2010) and the Singapore Biomedical Research Council (BMRC/08/1/21/19/554) (to H. M. S.). K. S. W. T. is founding director of BioLynx Technologies (Singapore), which provided the LynxTag-ART<SUP>TM</SUP>AS<INF>Blue</INF> used in this study.; Supported by a research scholarship from the National University of Singapore.	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Cable H, 1999, J PHARM PHARMACOL, V51, P131, DOI 10.1211/0022357991772231; Chen HH, 2003, PHARMACOL RES, V48, P231, DOI 10.1016/S1043-6618(03)00107-5; Chen K, 2014, ANTI-CANCER DRUG, V25, P652, DOI 10.1097/CAD.0000000000000089; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cheng R, 2013, INVEST OPHTH VIS SCI, V54, P3400, DOI 10.1167/iovs.12-11068; China Cooperative Research Group on Qinghaosu and Its Derivatives as Antimalarials, 1982, J TRADIT CHIN MED, V2, P3; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; Du JH, 2010, CANCER CHEMOTH PHARM, V65, P895, DOI 10.1007/s00280-009-1095-5; Du XX, 2013, BIOMED PHARMACOTHER, V67, P417, DOI 10.1016/j.biopha.2013.01.013; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; Hamacher-Brady A, 2011, J BIOL CHEM, V286, P6587, DOI 10.1074/jbc.M110.210047; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Ho WE, 2014, PHARMACOL THERAPEUT, V142, P126, DOI 10.1016/j.pharmthera.2013.12.001; Ho WE, 2012, FREE RADICAL BIO MED, V53, P498, DOI 10.1016/j.freeradbiomed.2012.05.021; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Hu W, 2014, CANCER LETT, V343, P239, DOI 10.1016/j.canlet.2013.09.035; Hung HI, 2013, J BIOL CHEM, V288, P677, DOI 10.1074/jbc.M112.422667; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kurz T, 2004, BIOCHEM J, V378, P1039, DOI 10.1042/BJ20031029; Lai HC, 2013, INVEST NEW DRUG, V31, P230, DOI 10.1007/s10637-012-9873-z; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; Luo JD, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-84; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mercer AE, 2007, J BIOL CHEM, V282, P9372, DOI 10.1074/jbc.M610375200; Mercer AE, 2011, J BIOL CHEM, V286, P987, DOI 10.1074/jbc.M110.144188; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; PUNNONEN EL, 1990, EXP MOL PATHOL, V52, P87, DOI 10.1016/0014-4800(90)90061-H; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saggu S, 2012, PHOTOCHEM PHOTOBIOL, V88, P461, DOI 10.1111/j.1751-1097.2012.01081.x; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shen HM, 2014, TRENDS BIOCHEM SCI, V39, P61, DOI 10.1016/j.tibs.2013.12.001; Stocks PA, 2007, ANGEW CHEM INT EDIT, V46, P6278, DOI 10.1002/anie.200604697; Terman A, 2013, ANTIOXID REDOX SIGN, V18, P888, DOI 10.1089/ars.2012.4885; Thanaketpaisarn O, 2011, INT J ONCOL, V39, P279, DOI 10.3892/ijo.2011.1017; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Wang Z, 2012, FEBS OPEN BIO, V2, P103, DOI 10.1016/j.fob.2012.05.002; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007472; Zhao YY, 2011, INT IMMUNOPHARMACOL, V11, P2039, DOI 10.1016/j.intimp.2011.08.017; Zhou CJ, 2012, J CELL PHYSIOL, V227, P3778, DOI 10.1002/jcp.24086; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	95	102	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33425	33441		10.1074/jbc.M114.564567	http://dx.doi.org/10.1074/jbc.M114.564567			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25305013	hybrid, Green Published			2022-12-25	WOS:000345636600032
J	Pendlebury, D; Wang, RY; Henin, RD; Hockla, A; Soares, AS; Madden, BJ; Kazanov, MD; Radisky, ES				Pendlebury, Devon; Wang, Ruiying; Henin, Rachel D.; Hockla, Alexandra; Soares, Alexei S.; Madden, Benjamin J.; Kazanov, Marat D.; Radisky, Evette S.			Sequence and Conformational Specificity in Substrate Recognition SEVERAL HUMAN KUNITZ PROTEASE INHIBITOR DOMAINS ARE SPECIFIC SUBSTRATES OF MESOTRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; PROSTATE-CANCER; HUMAN BRAIN; PROTEINASE-INHIBITORS; TUMOR-GROWTH; MESOTRYPSIN; METASTASIS; EXPRESSION	Mesotrypsin is an isoform of trypsin that is uniquely resistant to polypeptide trypsin inhibitors and can cleave some inhibitors rapidly. Previous studies have shown that the amyloid precursor protein Kunitz protease inhibitor domain (APPI) is a specific substrate of mesotrypsin and that stabilization of the APPI cleavage site in a canonical conformation contributes to recognition by mesotrypsin. We hypothesized that other proteins possessing potential cleavage sites stabilized in a similar conformation might also be mesotrypsin substrates. Here we evaluated a series of candidate substrates, including human Kunitz protease inhibitor domains from amyloid precursor-like protein 2 (APLP2), bikunin, hepatocyte growth factor activator inhibitor type 2 (HAI2), tissue factor pathway inhibitor-1 (TFPI1), and tissue factor pathway inhibitor-2 (TFPI2), as well as E-selectin, an unrelated protein possessing a potential cleavage site displaying canonical conformation. We find that Kunitz domains within APLP2, bikunin, and HAI2 are cleaved by mesotrypsin with kinetic profiles of specific substrates. TFPI1 and TFPI2 Kunitz domains are cleaved less efficiently by mesotrypsin, and E-selectin is not cleaved at the anticipated site. Cocrystal structures of mesotrypsin with HAI2 and bikunin Kunitz domains reveal the mode of mesotrypsin interaction with its canonical substrates. Our data suggest that major determinants of mesotrypsin substrate specificity include sequence preferences at the P-1 and P-2' positions along with conformational stabilization of the cleavage site in the canonical conformation. Mesotrypsin up-regulation has been implicated previously in cancer progression, and proteolytic clearance of Kunitz protease inhibitors offers potential mechanisms by which mesotrypsin may mediate pathological effects in cancer.	[Pendlebury, Devon; Wang, Ruiying; Henin, Rachel D.; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Madden, Benjamin J.] Mayo Clin, Med Genome Facil, Prote Core, Rochester, MN 55905 USA; [Kazanov, Marat D.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow 127994, Russia	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory; Mayo Clinic; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Kazanov, Marat D/D-6381-2013	Radisky, Evette S/0000-0003-3121-109X; Kazanov, Marat D/0000-0002-2314-5507	National Institutes of Health [R01CA154387]; Mayo Clinic Cancer Center [P30 CA15083]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; Russian Science Foundation [14-24-00155]; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA154387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Cancer Center; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA154387 (to E. S. R.). Proteomics analysis was conducted at the Medical Genome Facility Proteomics Core, which is supported in part by Mayo Clinic Cancer Center Support Grant P30 CA15083. Diffraction data were measured at beamlines X25 and X29 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health.; Supported by Russian Science Foundation Grant 14-24-00155.	Agard NJ, 2012, P NATL ACAD SCI USA, V109, P1913, DOI 10.1073/pnas.1117158109; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Barkan DT, 2010, BIOINFORMATICS, V26, P1714, DOI 10.1093/bioinformatics/btq267; Belushkin AA, 2014, PROTEOMICS, V14, P42, DOI 10.1002/pmic.201300416; Bergum C, 2010, PROSTATE, V70, P1422, DOI 10.1002/pros.21177; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Chand HS, 2004, J BIOL CHEM, V279, P17500, DOI 10.1074/jbc.M400802200; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Cohen M, 2008, PROTEINS, V72, P741, DOI 10.1002/prot.21960; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gil-Bernabe AM, 2013, BRIT J HAEMATOL, V162, P433, DOI 10.1111/bjh.12381; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076667; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; Jackson RM, 2000, J MOL BIOL, V296, P325, DOI 10.1006/jmbi.1999.3389; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Kobayashi H, 2003, BIOL CHEM, V384, P749, DOI 10.1515/BC.2003.083; KOBAYASHI H, 1994, CANCER RES, V54, P844; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Miyai M, 2014, J INVEST DERMATOL, V134, P1665, DOI 10.1038/jid.2014.3; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy A, 2003, EUR J BIOCHEM, V270, P2101, DOI 10.1046/j.1432-1033.2003.03593.x; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; POTEMPA J, 1989, J BIOL CHEM, V264, P15109; Qin L, 1998, FEBS LETT, V436, P111, DOI 10.1016/S0014-5793(98)01105-3; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Radisky ES, 2013, ASIAN J ANDROL, V15, P439, DOI 10.1038/aja.2013.14; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Tsai CH, 2014, ONCOGENE, V33, P4643, DOI 10.1038/onc.2013.412; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; WAGNER SL, 1992, BIOCHEM BIOPH RES CO, V186, P1138, DOI 10.1016/0006-291X(92)90865-I; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; WRIGHT HT, 1977, EUR J BIOCHEM, V73, P567, DOI 10.1111/j.1432-1033.1977.tb11352.x; Xu F, 2009, J NEUROSCI, V29, P5666, DOI 10.1523/JNEUROSCI.0095-09.2009; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; Yagyu T, 2006, INT J CANCER, V118, P2322, DOI 10.1002/ijc.21293; Yamamoto-Tanaka M, 2014, J BIOL CHEM, V289, P20026, DOI 10.1074/jbc.M113.543421; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	85	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.609560	http://dx.doi.org/10.1074/jbc.M114.609560			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301953	hybrid, Green Published			2022-12-25	WOS:000345335000033
J	Shi, XL; Wang, ZY; Deng, CY; Song, T; Pan, LQ; Chen, ZH				Shi, Xiaolong; Wang, Zhiyu; Deng, Chenyan; Song, Tao; Pan, Linqiang; Chen, Zhihua			A Novel Bio-Sensor Based on DNA Strand Displacement	PLOS ONE			English	Article							AMPLIFICATION; COMPUTATION	DNA strand displacement technology performs well in sensing and programming DNA segments. In this work, we construct DNA molecular systems based on DNA strand displacement performing computation of logic gates. Specifically, a class of so-called "DNA neurons'' are achieved, in which a "smart'' way inspired by biological neurons encoding information is developed to encode and deliver information using DNA molecules. The "DNA neuron'' is bistable, that is, it can sense DNA molecules as input signals, and release "negative'' or "positive'' signals DNA molecules. We design intelligent DNA molecular systems that are constructed by cascading some particularly organized "DNA neurons'', which could perform logic computation, including AND, OR, XOR logic gates, automatically. Both simulation results using visual DSD (DNA strand displacement) software and experimental results are obtained, which shows that the proposed systems can detect DNA signals with high sensitivity and accretion; moreover, the systems can process input signals automatically with complex nonlinear logic. The method proposed in this work may provide a new way to construct a sensitive molecular signal detection system with neurons spiking behavior in vitro, and can be used to develop intelligent molecular processing systems in vivo.	[Shi, Xiaolong; Wang, Zhiyu; Deng, Chenyan; Song, Tao; Pan, Linqiang; Chen, Zhihua] Huazhong Univ Sci & Technol, Sch Automat, Key Lab Image Informat Proc & Intelligent Control, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Song, T (corresponding author), Huazhong Univ Sci & Technol, Sch Automat, Key Lab Image Informat Proc & Intelligent Control, Wuhan 430074, Hubei, Peoples R China.	taosong@hust.edu.cn; lqpan@hust.edu.cn	Pan, Linqiang/E-4714-2011; Song, Tao/T-7360-2018	Pan, Linqiang/0000-0002-4554-455X; Song, Tao/0000-0002-0130-3340	National Science Foundations of China [61272071, 61033003, 61370105, 61402187]	National Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Foundations of China (Grant Nos. 61272071, 61033003, 61370105, and 61402187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; de Vries SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049733; Farsad N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082935; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; LaBean TH, 2007, NANO TODAY, V2, P26, DOI 10.1016/S1748-0132(07)70056-7; Little MC, 1999, CLIN CHEM, V45, P777; Lubrich D, 2009, J AM CHEM SOC, V131, P2422, DOI 10.1021/ja807765v; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Paun Gh., 2002, MEMBRANE COMPUTING I; Phillips A, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0072.focus; Pilo-Pais M, 2011, NANO LETT, V11, P3489, DOI 10.1021/nl202066c; Poli R., 2004, Genetic Programming and Evolvable Machines, V5, P31, DOI 10.1023/B:GENP.0000017010.41337.a7; Pun G., 2010, OXFORD HDB MEMBRANE; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Rowan AE, 1998, ANGEW CHEM INT EDIT, V37, P63, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<63::AID-ANIE63>3.0.CO;2-4; Samano EC, 2011, SOFT MATTER, V7, P3240, DOI 10.1039/c0sm01318h; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Shi XL, 2006, LECT NOTES COMPUT SC, V4115, P258; Shi XL, 2005, LECT NOTES COMPUT SC, V3645, P71; Stuart JA, 2002, SYNTHETIC MET, V127, P3, DOI 10.1016/S0379-6779(01)00586-0; WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691; Wang YF, 2012, J COMPUT THEOR NANOS, V9, P2086, DOI 10.1166/jctn.2012.2620; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957	27	42	43	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108856	10.1371/journal.pone.0108856	http://dx.doi.org/10.1371/journal.pone.0108856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303242	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400030
J	Tang, LL; Guo, R; Zhou, GQ; Sun, Y; Liu, LZ; Lin, AH; Mai, HQ; Shao, JY; Li, L; Ma, J				Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Liu, Li-Zhi; Lin, Ai-Hua; Mai, Haiqiang; Shao, Jianyong; Li, Li; Ma, Jun			Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy	PLOS ONE			English	Article							GENE-EXPRESSION CLASSIFIER; HYPOXIC MODIFICATION; NECK-CANCER; HEAD; TOMOGRAPHY; PATTERNS; CT; CATEGORIES; DISEASE; SPREAD	Background: The development of intensity-modulated radiotherapy (IMRT) has revolutionized the management of nasopharyngeal carcinoma (NPC). The purpose of this study was to evaluate the prognostic value and classification of TNM stage system for retropharyngeal lymph node (RLN) metastasis in NPC in the IMRT era. Material and Methods: We retrospectively reviewed data from 749 patients with biopsy-proven, non-metastatic NPC. All patients received IMRT as the primary treatment. Chemotherapy was administered to 86.2% (424/492) of the patients with stage III or IV disease. Results: The incidence of RLN metastasis was 64.2% (481/749). Significant differences were observed in the 5-year disease-free survival (DFS; 70.6% vs. 85.4%, P<0.001) and distant metastasis-free survival (DMFS; 79.2% vs. 90.1%, P<0.001) rates of patients with and without RLN metastasis. In multivariate analysis, RLN metastasis was an independent prognostic factor for disease failure and distant failure (P = 0.005 and P = 0.026, respectively), but not for locoregional recurrence. Necrotic RLN metastases have a negative effect on disease failure, distant failure and locoregional recurrence in NPC with RLN metastasis (P = 0.003, P = 0.018 and P = 0.005, respectively). Survival curves demonstrated a significant difference in DFS between patients with N0 disease and N1 disease with only RLN metastasis (P = 0.020), and marginally statistically significant differences in DMFS and DFS between N1 disease with only RLN metastasis and other N1 disease (P = 0.058 and P = 0.091, respectively). In N1 disease, no significant differences in DFS were observed between unilateral and bilateral RLN metastasis (P = 0.994). Conclusions: In the IMRT era, RLN metastasis remains an independent prognostic factor for DFS and DMFS in NPC. It is still reasonable for RLN metastasis to be classified in the N1 disease, regardless of laterality. However, there is a need to investigate the feasibility of classifying RLN metastasis as N1a disease in future by a larger cohort study.	[Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Ma, Jun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Ma, Jun] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Ma, Jun] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Liu, Li-Zhi; Li, Li] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Imaging Diag & Intervent Ctr,State Key Lab Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Mai, Haiqiang] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Shao, Jianyong] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Mol Diagnost, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	majun2@mail.sysu.edu.cn			China Scholarship Council [201308440052]; National Natural Science Foundation of China [81101695, 81071836]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Ministry of Education [IRT1297]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Ministry of Education	This work was supported by grants from the China Scholarship Council (No. 201308440052, the National Natural Science Foundation of China (No. 81101695 and No. 81071836), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2010), and the Innovation Team Development Plan of the Ministry of Education (IRT1297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COX DR, 1972, J R STAT SOC B, V34, P187; DON DM, 1995, LARYNGOSCOPE, V105, P669, DOI 10.1288/00005537-199507000-00001; Edge SB, 2010, AJCC CANC STAGING MA, P41, DOI [10.1007/978-0-387-88441-7_4, DOI 10.1007/978-0-387-88441-7_4]; Groome PA, 2001, HEAD NECK-J SCI SPEC, V23, P613, DOI 10.1002/hed.1087; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; King AD, 2004, EUR J RADIOL, V52, P264, DOI 10.1016/j.ejrad.2004.03.004; King AD, 2004, RADIOLOGY, V230, P720, DOI 10.1148/radiol.2303030157; King AD, 2000, HEAD NECK-J SCI SPEC, V22, P275; Kong FF, 2014, EUR ARCH OTO-RHINO-L, V271, P3283, DOI 10.1007/s00405-014-2900-2; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lam WWM, 1997, HEAD NECK-J SCI SPEC, V19, P176, DOI 10.1002/(SICI)1097-0347(199705)19:3<176::AID-HED2>3.3.CO;2-A; Liao XB, 2008, INT J RADIAT ONCOL, V72, P1368, DOI 10.1016/j.ijrobp.2008.03.017; Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; Ng SH, 2004, EUR J NUCL MED MOL I, V31, P1073, DOI 10.1007/s00259-004-1498-9; Ng SH, 1997, NEURORADIOLOGY, V39, P741, DOI 10.1007/s002340050499; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; OLMI P, 1995, INT J RADIAT ONCOL, V32, P795, DOI 10.1016/0360-3016(94)00535-S; Rischin D, 2006, J CLIN ONCOL, V24, P2098, DOI 10.1200/JCO.2005.05.2878; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; SOM PM, 1987, RADIOLOGY, V165, P593, DOI 10.1148/radiology.165.3.3317494; Tang LL, 2008, CANCER, V113, P347, DOI 10.1002/cncr.23555; Tang LL, 2009, CANCER-AM CANCER SOC, V115, P680, DOI 10.1002/cncr.24049; Toustrup K, 2012, RADIOTHER ONCOL, V102, P122, DOI 10.1016/j.radonc.2011.09.010; Toustrup K, 2011, CANCER RES, V71, P5923, DOI 10.1158/0008-5472.CAN-11-1182; VANDENBREKEL MWM, 1990, RADIOLOGY, V177, P379, DOI 10.1148/radiology.177.2.2217772; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X	26	28	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108375	10.1371/journal.pone.0108375	http://dx.doi.org/10.1371/journal.pone.0108375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302611	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400013
J	Zhao, J; Jian, JB; Liu, GN; Wang, JR; Lin, MJ; Ming, Y; Liu, ZG; Chen, YY; Liu, XY; Liu, MJ				Zhao, Jin; Jian, Jianbo; Liu, Guannan; Wang, Jiurui; Lin, Minjuan; Ming, Yao; Liu, Zhiguo; Chen, Yingying; Liu, Xiuyun; Liu, Mengjun			Rapid SNP Discovery and a RAD-Based High-Density Linkage Map in Jujube (Ziziphus Mill.)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC-MAP; DE-NOVO; CONSTRUCTION; MARKERS; IDENTIFICATION; STACKS; TOOL; SEQ; L.	Background: Ziziphus Mill. (jujube), the most valued genus of Rhamnaceae, comprises of a number of economically and ecologically important species such as Z. jujuba Mill., Z. acidojujuba Cheng et Liu and Z. mauritiana Lam. Single nucleotide polymorphism (SNP) markers and a high-density genetic map are of great benefit to the improvement of the crop, mapping quantitative trait loci (QTL) and analyzing genome structure. However, such a high-density map is still absent in the genus Ziziphus and even the family Rhamnaceae. The recently developed restriction-site associated DNA (RAD) marker has been proven to be most powerful in genetic map construction. The objective of this study was to construct a high-density linkage map using the RAD tags generated by next generation sequencing. Results: An interspecific F1 population and their parents (Z. jujuba Mill. 'JMS2' x Z. acidojujuba Cheng et Liu 'Xing 16') were genotyped using a mapping-by-sequencing approach, to generate RAD-based SNP markers. A total of 42,784 putative high quality SNPs were identified between the parents and 2,872 high-quality RAD markers were grouped in genetic maps. Of the 2,872 RAD markers, 1,307 were linked to the female genetic map, 1,336 to the male map, and 2,748 to the integrated map spanning 913.87 centi-morgans (cM) with an average marker interval of 0.34 cM. The integrated map contained 12 linkage groups (LGs), consistent with the haploid chromosome number of the two parents. Conclusion: We first generated a high-density genetic linkage map with 2,748 RAD markers for jujube and a large number of SNPs were also developed. It provides a useful tool for both marker-assisted breeding and a variety of genome investigations in jujube, such as sequence assembly, gene localization, QTL detection and genome structure comparison.	[Zhao, Jin] Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China; [Jian, Jianbo; Ming, Yao] BGI Shenzhen, Shenzhen, Peoples R China; [Liu, Guannan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Wang, Jiurui] Agr Univ Hebei, Coll Forestry, Baoding, Peoples R China; [Liu, Zhiguo; Chen, Yingying; Liu, Xiuyun; Liu, Mengjun] Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Peoples R China; [Liu, Mengjun] Minist Sci & Technol, Natl Agr Engn Ctr North Mt Reg, Baoding, Peoples R China	Hebei Agricultural University; Beijing Genomics Institute (BGI); Nankai University; Hebei Agricultural University; Hebei Agricultural University	Liu, MJ (corresponding author), Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Peoples R China.	lmj1234567@aliyun.com		Jian, Jianbo/0000-0003-2187-5490	National Science and Technology Support Plan of China [2013BAD14B03]; Provincial Key Technology R&D Program of Hebei of China [11230606D-6]	National Science and Technology Support Plan of China; Provincial Key Technology R&D Program of Hebei of China	This study was supported by grants from National Science and Technology Support Plan of China (No. 2013BAD14B03), Provincial Key Technology R&D Program of Hebei of China (No. 11230606D-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; China Agricultural Yearbook Editing Committee, 2012, CHIN AGR YB; Chong ZC, 2012, BIOINFORMATICS, V28, P2732, DOI 10.1093/bioinformatics/bts482; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Leonforte A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-161; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Liu MJ, 2013, ACTA HORTIC, V993, P15, DOI 10.17660/ActaHortic.2013.993.1; Liu M.J., 2009, GERMPLASM RESOURCES; Liu MengJun, 2006, Horticultural Reviews, V32, P229; Pujolar JM, 2013, MOL ECOL RESOUR, V13, P706, DOI 10.1111/1755-0998.12117; Qi Jing, 2009, Scientia Silvae Sinicae, V45, P44; Qu ZZ, 1993, CHINESE FRUIT TREES, p33p; Shen LY, 2005, THESIS AGR U HEBEI; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zhu YL, 2003, GENETICS, V163, P1123; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	29	20	25	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109850	10.1371/journal.pone.0109850	http://dx.doi.org/10.1371/journal.pone.0109850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303289	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400086
J	Belaganahalli, MN; Maan, S; Maan, NS; Pritchard, I; Kirkland, PD; Brownlie, J; Attoui, H; Mertens, PPC				Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Pritchard, Ian; Kirkland, Peter D.; Brownlie, Joe; Attoui, Houssam; Mertens, Peter P. C.			Full Genome Characterization of the Culicoides-Borne Marsupial Orbiviruses: Wallal Virus, Mudjinbarry Virus and Warrego Viruses	PLOS ONE			English	Article							EPIZOOTIC HEMORRHAGIC-DISEASE; BLUETONGUE-VIRUS; COMPLETE SEQUENCE; GENETIC-ANALYSIS; MOSQUITOS; ARBOVIRUSES; REOVIRIDAE; STRATEGIES; MIDGES; CELLS	Viruses belonging to the species Wallal virus and Warrego virus of the genus Orbivirus were identified as causative agents of blindness in marsupials in Australia during 1994/5. Recent comparisons of nucleotide (nt) and amino acid (aa) sequences have provided a basis for the grouping and classification of orbivirus isolates. However, full-genome sequence data are not available for representatives of all Orbivirus species. We report full-genome sequence data for three additional orbiviruses: Wallal virus (WALV); Mudjinabarry virus (MUDV) and Warrego virus (WARV). Comparisons of conserved polymerase (Pol), sub-core-shell 'T2' and core-surface 'T13' proteins show that these viruses group with other Culicoides borne orbiviruses, clustering with Eubenangee virus (EUBV), another orbivirus infecting marsupials. WARV shares <70% aa identity in all three conserved proteins (Pol, T2 and T13) with other orbiviruses, consistent with its classification within a distinct Orbivirus species. Although WALV and MUDV share,<72.86%/67.93% aa/nt identity with other orbiviruses in Pol, T2 and T13, they share >99%/90% aa/nt identities with each other (consistent with membership of the same virus species - Wallal virus). However, WALV and MUDV share, <68% aa identity in their larger outer capsid protein VP2(OC1), consistent with membership of different serotypes within the species - WALV-1 and WALV-2 respectively.	[Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Attoui, Houssam; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Viral Dis Programme, Woking, Surrey, England; [Pritchard, Ian] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Kirkland, Peter D.] Elizabeth Macarthur Agr Inst, Camden, NSW, Australia; [Brownlie, Joe] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of London; University of London Royal Veterinary College	Mertens, PPC (corresponding author), Inst Anim Hlth, Vector Borne Viral Dis Programme, Woking, Surrey, England.	peter.mertens@pirbright.ac.uk	Kirkland, Peter/AAC-6731-2019; Belaganahalli, Manjunatha N/I-1688-2019	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Mertens, Peter/0000-0002-3438-3738; Attoui, Houssam/0000-0001-9639-9981	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/ 940/ 2002]; EMIDA [K1303206]; WildTech [222633-2.]; CSIRO; Dept of Agriculture, Fisheries and Forestry, Australian Government; NSW Department of Primary Industries; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001144, BB/I017259/1, BBS/E/I/00001446] Funding Source: researchfish; BBSRC [BBS/E/I/00001446, BB/I017259/1] Funding Source: UKRI	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); EMIDA; WildTech; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Dept of Agriculture, Fisheries and Forestry, Australian Government(Australian GovernmentDepartment of Agriculture and Water Resources); NSW Department of Primary Industries; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by the Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/) awarded to MB, partly by the Department for Environment, Food and Rural Affairs (Defra)(SE2617) awarded to SM. NSM, PCM and HA were funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the European Union (EU) (SANCO/ 940/ 2002; EMIDA grant OrbiNet - K1303206) and WildTech - Grant no. 222633-2. IP was part of this work, funded by CSIRO & Dept of Agriculture, Fisheries and Forestry, Australian Government. PK was funded by NSW Department of Primary Industries. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Vieira CDA, 2009, J GEN VIROL, V90, P2183, DOI 10.1099/vir.0.010165-0; Anthony SJ, 2011, VIROLOGY, V420, P164, DOI 10.1016/j.virol.2011.09.009; Anthony SJ, 2009, VIRUS RES, V145, P187, DOI 10.1016/j.virusres.2009.07.011; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; Anthony SJ, 2009, VIRUS RES, V145, P211, DOI 10.1016/j.virusres.2009.07.019; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H, 2012, REOVIRIDAE, P497; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Belaganahalli MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070779; Belaganahalli MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031911; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; BORDEN EC, 1971, J GEN VIROL, V13, P261, DOI 10.1099/0022-1317-13-2-261; BROWN SE, 1992, VET MICROBIOL, V32, P241, DOI 10.1016/0378-1135(92)90147-L; Curran G, 1997, EPIDEMIOL SANTE ANIM, V31-32, P1; DELLA-PORTA A J, 1985, P445; DOHERTY RL, 1973, T ROY SOC TROP MED H, V67, P536, DOI 10.1016/0035-9203(73)90084-9; DOHERTY RL, 1978, AUST J BIOL SCI, V31, P97, DOI 10.1071/BI9780097; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gorman B.M., 1983, P287; GORMAN BM, 1978, J GEN VIROL, V41, P333, DOI 10.1099/0022-1317-41-2-333; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hooper PT, 1999, AUST VET J, V77, P529, DOI 10.1111/j.1751-0813.1999.tb12127.x; Hooper PT, 1999, VET MICROBIOL, V68, P89, DOI 10.1016/S0378-1135(99)00064-4; Kapoor A, 2013, J GEN VIROL, V94, P1051, DOI 10.1099/vir.0.046748-0; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Martins LC, 2007, INT J EXP PATHOL, V88, P63, DOI 10.1111/j.1365-2613.2006.00516.x; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens PPC., 2005, VIRUS TAXONOMY, P466; MOORE DL, 1974, AM J VET RES, V35, P1109; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; PEDLEY S, 1988, VIRUS RES, V10, P381, DOI 10.1016/0168-1702(88)90078-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Rose K, 2012, AUST VET J, P90; Rose KA, 2000, P AAZV IAAAM JOINT C, P166; SATO M, 1977, ARCH VIROL, V53, P269, DOI 10.1007/BF01314672; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verwoerd D. W., 1979, Comprehensive virology, volume 14, P285; WALKER PJ, 1980, J VIROL, V34, P583, DOI 10.1128/JVI.34.3.583-591.1980; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yamakawa M, 1999, J GEN VIROL, V80, P937, DOI 10.1099/0022-1317-80-4-937	57	8	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108379	10.1371/journal.pone.0108379	http://dx.doi.org/10.1371/journal.pone.0108379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299687	Green Published, Green Accepted, gold			2022-12-25	WOS:000343941200017
J	Nzeyimana, I; Hartemink, AE; Geissen, V				Nzeyimana, Innocent; Hartemink, Alfred E.; Geissen, Violette			GIS-Based Multi-Criteria Analysis for Arabica Coffee Expansion in Rwanda	PLOS ONE			English	Article							SUITABILITY EVALUATION; SOIL PROPERTIES; LAND EVALUATION; PREDICTION; FRAMEWORK; QUALITY; YIELD; MODEL; CORN	The Government of Rwanda is implementing policies to increase the area of Arabica coffee production. Information on the suitable areas for sustainably growing Arabica coffee is still scarce. This study aimed to analyze suitable areas for Arabica coffee production. We analyzed the spatial distribution of actual and potential production zones for Arabica coffee, their productivity levels and predicted potential yields. We used a geographic information system (GIS) for a weighted overlay analysis to assess the major production zones of Arabica coffee and their qualitative productivity indices. Actual coffee yields were measured in the field and were used to assess potential productivity zones and yields using ordinary kriging with ArcGIS software. The production of coffee covers about 32 000 ha, or 2.3% of all cultivated land in the country. The major zones of production are the Kivu Lake Borders, Central Plateau, Eastern Plateau, and Mayaga agro-ecological zones, where coffee is mainly cultivated on moderate slopes. In the highlands, coffee is grown on steep slopes that can exceed 55%. About 21% percent of the country has a moderate yield potential, ranging between 1.0 and 1.6 t coffee ha(-1), and 70% has a low yield potential (< 1.0 t coffee ha(-1)). Only 9% of the country has a high yield potential of 1.6-2.4 t coffee ha(-1). Those areas are found near Lake Kivu where the dominant soil Orders are Inceptisols and Ultisols. Moderate yield potential is found in the Birunga (volcano), Congo-Nile watershed Divide, Impala and Imbo zones. Low-yield regions (< 1 t ha(-1)) occur in the eastern semi-dry lowlands, Central Plateau, Eastern Plateau, Buberuka Highlands, and Mayaga zones. The weighted overlay analysis and ordinary kriging indicated a large spatial variability of potential productivity indices. Increasing the area and productivity of coffee in Rwanda thus has considerable potential.	[Nzeyimana, Innocent; Geissen, Violette] Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands; [Hartemink, Alfred E.] Univ Wisconsin, Dept Soil Sci, FD Hole Soils Lab, Madison, WI 53706 USA	Wageningen University & Research; University of Wisconsin System; University of Wisconsin Madison	Nzeyimana, I (corresponding author), Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands.	innocent.nzeyimana@wur.nl	Hartemink, Alfred/G-1149-2011	Hartemink, Alfred/0000-0002-5797-6798	NUFFIC; NZEYIMANA at Wageningen University	NUFFIC; NZEYIMANA at Wageningen University	The authors acknowledge NUFFIC of the Netherlands for funding the PhD training of Innocent NZEYIMANA at Wageningen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birasa EC, 1990, SOLS RWANDA ME UNPUB; Boffa J.M., 2009, MOUNTAIN RES DEV, V25, P212; Bosselmann AS, 2009, AGR ECOSYST ENVIRON, V129, P253, DOI 10.1016/j.agee.2008.09.004; Changere A, 1997, J SUSTAIN AGR, V11, P5, DOI 10.1300/J064v11n01_03; Clay J, 2004, WORLD AGR ENV; Coleman A L, 2000, USING GIS AGR LAND U; DELAROSA D, 1992, SOIL USE MANAGE, V8, P89, DOI 10.1111/j.1475-2743.1992.tb00900.x; Descroix F, 2004, GUIDEBOOK GROWERS PR, P164; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; ESRI, 2001, ARCGIS SPAT AN ADV G; ESRI, 2011, ARCGIS DESKT REAL 10; FAO, 2014, FAOSTAT STAT DAT; Food and Agriculture Organization (FAO), 1976, FRAM LAND EV; Gabre-Madhin EZ, 2004, WORLD DEV, V32, P745, DOI 10.1016/j.worlddev.2003.11.004; Genton MG, 2000, MATH GEOLOGY, V32; Genton MG, 1998, MATH GEOLOGY, V30; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; JANSSEN R, 1990, GEOJ LIB, V17, P129; JOERIN F, 2001, INT J GEOGR INF SYST, V10, P321; Kravchenko AN, 2000, AGRON J, V92, P75, DOI 10.1007/s100870050010; Labouisse JP, 2008, GENET RESOUR CROP EV, V55, P1079, DOI 10.1007/s10722-008-9361-7; Li B, 2012, PEDOSPHERE, V22, P122, DOI 10.1016/S1002-0160(11)60198-7; Maji A. K., 1998, Journal of the Indian Society of Soil Science, V46, P260; Maji AK, 2001, INT J APPL EARTH OBS, V3, P69; Malczewski J, 1996, INT J GEOGR INF SYST, V10, P955, DOI 10.1080/026937996137675; Malczewski J, 2004, PROG PLANN, V62, P3, DOI 10.1016/j.progress.2003.09.002; McKinion JM, 2010, COMPUT ELECTRON AGR, V70, P187, DOI 10.1016/j.compag.2009.10.005; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Mueller TG, 2004, SOIL SCI SOC AM J, V68, P2042, DOI 10.2136/sssaj2004.2042; Nzeyimana I, 2013, OUTLOOK AGR, V42, P47, DOI 10.5367/oa.2013.0118; Park SJ, 2002, GEODERMA, V109, P117, DOI 10.1016/S0016-7061(02)00146-5; Ponte S, 2002, WORLD DEV, V30, P1099, DOI 10.1016/S0305-750X(02)00032-3; Rossiter DG, 1996, GEODERMA, V72, P165, DOI 10.1016/0016-7061(96)00031-6; Soltani A, 2013, EUR J AGRON, V48, P101, DOI 10.1016/j.eja.2013.02.010; van Asten PJA, 2011, AGR SYST, V104, P326, DOI 10.1016/j.agsy.2010.12.004; Van Oijen M, 2010, AGROFORESTRY SYSTEMS, P80; Verdoodt A., 2003, LAND EVALUATION AGR; Walke N, 2012, COMPUT GEOSCI-UK, V41, P108, DOI 10.1016/j.cageo.2011.08.020	38	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107449	10.1371/journal.pone.0107449	http://dx.doi.org/10.1371/journal.pone.0107449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299459	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200006
J	Su, H; Han, B; Li, S; Na, B; Ma, W; Xu, TM				Su, Hong; Han, Bing; Li, Sa; Na, Bin; Ma, Wen; Xu, Tian-Min			Factors Predisposing to Maxillary Anchorage Loss: A Retrospective Study of 1403 Cases	PLOS ONE			English	Article							HEAD FILM MEASUREMENTS; CLASS-II MALOCCLUSION; PREMOLAR EXTRACTIONS; ORTHODONTIC TREATMENT; DIFFERENTIAL MOMENTS; SKELETAL ANCHORAGE; TREATMENT OUTCOMES; TOOTH MOVEMENT; IMPLANT; RELIABILITY	Anchorage loss is very disturbing for orthodontists and patients during orthodontic treatment, which usually results in bad treatment effects. Despite the same treatment strategy, different patients show different tendencies toward anchorage loss, which influences the treatment results and should preferably be predicted before the treatment is begun. However, relatively little research has been conducted on which patients are more likely to lose anchorage. The mesial tipping of the first molar marks the onset of anchorage loss, and changes in the angulation of the first molar are closely related to anchorage loss. This cross-sectional study aimed to determine how the mesiodistal angulation of the upper first molars changes during general orthodontic treatment and to identify the individual physiologic factors leading to these changes in a large sample of 1403 patients with malocclusion. The data indicate that the upper first molars tend to be tipped mesially during orthodontic treatment, and this constitutes a type of anchorage loss that orthodontists should consider carefully. Compared to treatment-related factors, patients' physiologic characteristics have a greater influence on changes in the angulation of the upper first molars during orthodontic treatment. The more distally tipped the upper first molars are before treatment, the more they will tip mesially during treatment. Mesial tipping of the upper first molars, and therefore, anchorage loss, is more likely to occur in adolescents, males, patients with class II malocclusion and patients who have undergone maxillary premolar extraction. This finding is of clinical significance to orthodontists who wish to prevent iatrogenic anchorage loss by tipping originally distally tipped upper molars forward, and provides a new perspective on anchorage during orthodontic treatment planning.	[Su, Hong; Han, Bing; Xu, Tian-Min] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China; [Li, Sa] Shenzhen Peoples Hosp, Dept Stomatol, Shenzhen, Peoples R China; [Na, Bin; Ma, Wen] Peking Univ, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Jinan University; Peking University	Xu, TM (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China.	tmxuortho@gmail.com			National Natural Science Foundation of China [NSFC81371192]; Beijing Municipal Science & Technology Commission [Z141107002514054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	The work was supported by National Natural Science Foundation of China (No. NSFC81371192) and Beijing Municipal Science & Technology Commission (No. Z141107002514054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS LF, 1972, AMER J ORTHODONTICS, V62, P296, DOI 10.1016/S0002-9416(72)90268-0; Arat ZM, 2005, ANGLE ORTHOD, V75, P69; BAKER RW, 1972, ANGLE ORTHOD, V42, P129; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P111, DOI 10.1016/0002-9416(71)90028-5; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P505, DOI 10.1016/0002-9416(71)90116-3; BAUMRIND S, 1976, AM J ORTHOD DENTOFAC, V70, P617, DOI 10.1016/0002-9416(76)90224-4; BJORK A, 1972, AMER J ORTHODONTICS, V62, P339, DOI 10.1016/S0002-9416(72)90277-1; Chen K, 2010, AM J ORTHOD DENTOFAC, V138, P770, DOI 10.1016/j.ajodo.2009.01.030; Chen S, 2013, CHIN J ORTHOD, V20, P26; Cho MY, 2010, AM J ORTHOD DENTOFAC, V138, P747, DOI 10.1016/j.ajodo.2008.11.033; DOWNS WB, 1952, AM J ORTHOD DENTOFAC, V38, P162, DOI 10.1016/0002-9416(52)90106-1; Fuziy A, 2006, AM J ORTHOD DENTOFAC, V130, P502, DOI 10.1016/j.ajodo.2004.12.031; Gu Y, 2008, ANGLE ORTHOD, V78, P967, DOI 10.2319/070107-301.1; HART A, 1992, AM J ORTHOD DENTOFAC, V102, P434, DOI 10.1016/S0889-5406(05)81190-4; Hilgers J J, 1992, J Clin Orthod, V26, P706; Iseri H, 1996, EUR J ORTHODONT, V18, P245; Keeling SD, 1998, AM J ORTHOD DENTOFAC, V113, P40, DOI 10.1016/S0889-5406(98)70275-6; Kim YE, 2002, AM J ORTHOD DENTOFAC, V121, P280, DOI 10.1067/mod.2002.119978; Lai EHH, 2008, AM J ORTHOD DENTOFAC, V134, P636, DOI 10.1016/j.ajodo.2007.05.017; Liao Chun-hui, 2010, Hua Xi Kou Qiang Yi Xue Za Zhi, V28, P374; Londhe S M, 2010, Med J Armed Forces India, V66, P220, DOI 10.1016/S0377-1237(10)80041-3; Martinelli FL, 2010, AM J ORTHOD DENTOFAC, V137, P775, DOI 10.1016/j.ajodo.2008.06.037; McKinney JR, 2001, AM J ORTHOD DENTOFAC, V120, P530, DOI 10.1067/mod.2001.118784; Nanda RS, 2006, SEMIN ORTHOD, V12, P25; Ong HB, 2001, ANGLE ORTHOD, V71, P90; Patel MP, 2009, AM J ORTHOD DENTOFAC, V135, P336, DOI 10.1016/j.ajodo.2007.01.035; Proffit W., 2000, CONT ORTHODONTICS; Rajcich MM, 1997, AM J ORTHOD DENTOFAC, V112, P441, DOI 10.1016/S0889-5406(97)70053-2; Roth R H, 1987, J Clin Orthod, V21, P632; Roth R H, 1981, J Clin Orthod, V15, P32; SCHWAB DT, 1971, AMER J ORTHODONTICS, V59, P126, DOI 10.1016/0002-9416(71)90045-5; Steyn CL, 1997, AM J ORTHOD DENTOFAC, V112, P480, DOI 10.1016/S0889-5406(97)70074-X; Su H, 2014, INT J ORAL SCI, V6, P175, DOI 10.1038/ijos.2014.15; Tsourakis AK, 2014, SEMIN ORTHOD, V20, P59, DOI 10.1053/j.sodo.2013.12.006; Upadhyay M, 2008, AM J ORTHOD DENTOFAC, V134, P803, DOI 10.1016/j.ajodo.2006.10.025; Xu TM, 2010, AM J ORTHOD DENTOFAC, V138, P544, DOI 10.1016/j.ajodo.2010.07.004; Yao CCJ, 2008, AM J ORTHOD DENTOFAC, V134, P615, DOI 10.1016/j.ajodo.2006.12.022; Zhang Y, 2008, CHIN J ORTHOD, V15, P162; [张晔 ZHANG Ye], 2007, [哈尔滨医科大学学报, The Journal of Harbin Medical College], V41, P375; ZIEGLER P, 1989, AM J ORTHOD DENTOFAC, V95, P99, DOI 10.1016/0889-5406(89)90388-0; 고신애, 2007, [The Korean Journal of Orthodontics, 대한치과교정학회지], V37, P407	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109561	10.1371/journal.pone.0109561	http://dx.doi.org/10.1371/journal.pone.0109561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299164	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200059
J	Banerjee, P; Mondal, RK; Nandi, M; Ghosh, S; Khatun, M; Chakraborty, N; Bhattacharya, S; RoyChoudhury, A; Banerjee, S; Santra, A; Sil, S; Chowdhury, A; Bhaumik, P; Datta, S				Banerjee, Priyanka; Mondal, Rajiv Kumar; Nandi, Madhuparna; Ghosh, Sumantra; Khatun, Mousumi; Chakraborty, Nabendu; Bhattacharya, Swatilekha; RoyChoudhury, Arindam; Banerjee, Soma; Santra, Amal; Sil, Samir; Chowdhury, Abhijit; Bhaumik, Pradip; Datta, Simanti			A Rare HBV Subgenotype D4 with Unique Genomic Signatures Identified in North-Eastern India -An Emerging Clinical Challenge?	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; BLOOD-DONORS; S GENE; GENOTYPES; MUTATIONS; INFECTION; PREVALENCE; MUTANTS; STRAINS; AFRICA	Background/Aims: HBV has been classified into ten genotypes (A-J) and multiple subgenotypes, some of which strongly influence disease outcome and their distribution also correlate with human migration. HBV infection is highly prevalent in India and its diverse population provides an excellent opportunity to study the distinctiveness of HBV, its evolution and disease biology in variegated ethnic groups. The North-East India, having international frontiers on three sides, is one of the most ethnically and linguistically diverse region of the country. Given the paucity of information on molecular epidemiology of HBV in this region, the study aimed to carry out an in-depth genetic characterization of HBV prevailing in North-East state of Tripura. Methods: From sera of chronically HBV infected patients biochemical/serological tests, HBV DNA quantification, PCR-amplification, sequencing of PreS/S or full-length HBV genomes were done. HBV genotype/subgenotype determination and sequence variability were assessed by MEGA5-software. The evolutionary divergence times of different HBV subgenotypes were estimated by DNAMLK/PHYLIP program while jpHMM method was used to detect any recombination event in HBV genomes. Results: HBV genotypes D (89.5%), C (6.6%) and A (3.9%) were detected among chronic carriers. While all HBV/A and HBV/C isolates belonged to subgenotype-A1 and C1 respectively, five subgenotypes of HBV/D (D1-D5) were identified including the first detection of rare D4. These non-recombinant Indian D4 (IndD4) formed a distinct phylogenetic clade, had 2.7% nucleotide divergence and recent evolutionary radiation than other global D4. Ten unique amino acids and 9 novel nucleotide substitutions were identified as IndD4 signatures. All IndD4 carried T-120 and R-129 in ORF-S that may cause immune/vaccine/diagnostic escape and N-128 in ORF-P, implicated as compensatory Lamivudine resistance mutation. Conclusions: IndD4 has potential to undermine vaccination programs or anti-viral therapy and its introduction to North-East India is believed to be linked with the settlement of ancient Tibeto-Burman migrants from East-Asia.	[Banerjee, Priyanka; Mondal, Rajiv Kumar; Nandi, Madhuparna; Ghosh, Sumantra; Khatun, Mousumi; Banerjee, Soma; Santra, Amal; Datta, Simanti] Inst Post Grad Med Educ & Res, Liver Res Ctr, Sch Digest & Liver Dis, Kolkata, India; [Chakraborty, Nabendu; Bhattacharya, Swatilekha; Bhaumik, Pradip] Agartala Govt Med Coll, Agartala, India; [RoyChoudhury, Arindam] Columbia Univ, New York, NY USA; [Sil, Samir] Tripura Univ, Agartala, India; [Chowdhury, Abhijit] Inst Post Grad Med Educ & Res, Sch Digest & Liver Dis, Dept Hepatol, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Columbia University; Tripura University; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Datta, S (corresponding author), Inst Post Grad Med Educ & Res, Liver Res Ctr, Sch Digest & Liver Dis, Kolkata, India.	seemdatt@gmail.com	Ghosh, Sumantra/H-8897-2015; Mondal, Rajiv Kumar/AAQ-9076-2021	Ghosh, Sumantra/0000-0002-8367-8620; Mondal, Rajiv Kumar/0000-0001-7850-1671	Indian Council of Medical Research [NER/2/2008-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, NER/2/2008-ECD-I [B]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Baha W, 2012, INFECT GENET EVOL, V12, P1157, DOI 10.1016/j.meegid.2012.04.026; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bhowmik P, 2011, EUROASIAN J HEPATO G, V1, P39; Borkakoty BJ, 2008, INDIAN J MED RES, V127, P65; Borkar M, 2011, ANN HUM BIOL, V38, P736, DOI 10.3109/03014460.2011.617389; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Candotti D, 2006, J VIRAL HEPATITIS, V13, P715, DOI 10.1111/j.1365-2893.2006.00741.x; Datta S, 2006, EMERG INFECT DIS, V12, P1954; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; Deka M, 2010, WORLD J GASTROENTERO, V16, P4800, DOI 10.3748/wjg.v16.i38.4800; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Ghosh S, 2013, J VIRAL HEPATITIS, V20, P209, DOI 10.1111/j.1365-2893.2012.01655.x; GILLES PN, 1992, HEPATOLOGY, V16, P655, DOI 10.1002/hep.1840160308; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Kamili S, 2010, ANTIVIR THER, V15, P477, DOI 10.3851/IMP1520; Kumar C, 2009, SCHOLARS VOICE NEW W, V1, P64; Kwange SO, 2013, VIRUS GENES, V47, P448, DOI 10.1007/s11262-013-0976-1; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Osiowy C, 2011, J VIRAL HEPATITIS, V18, pe11, DOI 10.1111/j.1365-2893.2010.01356.x; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Pollicino T, 2009, ANTIVIR THER, V14, P649; Pugach I, 2013, P NATL ACAD SCI USA, V110, P1803, DOI 10.1073/pnas.1211927110; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Sugauchi F, 2001, J GEN VIROL, V82, P883, DOI 10.1099/0022-1317-82-4-883; Utsumi T, 2007, J MED VIROL, V79, P229, DOI 10.1002/jmv.20791; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198	29	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109425	10.1371/journal.pone.0109425	http://dx.doi.org/10.1371/journal.pone.0109425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295865	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000071
J	Skrnjug, I; Guzman, CA; Ruecker, C				Skrnjug, Ivana; Guzman, Carlos Alberto; Ruecker, Christine			Cyclic GMP-AMP Displays Mucosal Adjuvant Activity in Mice	PLOS ONE			English	Article							C-DI-GMP; DNA SENSOR; 2ND-MESSENGER; DINUCLEOTIDE; MODULATION; EXPRESSION; SYNTHASE	The recently discovered mammalian enzyme cyclic GMP-AMP synthase produces cyclic GMP-AMP (cGAMP) after being activated by pathogen-derived cytosolic double stranded DNA. The product can stimulate STING-dependent interferon type I signaling. Here, we explore the efficacy of cGAMP as a mucosal adjuvant in mice. We show that cGAMP can enhance the adaptive immune response to the model antigen ovalbumin. It promotes antigen specific IgG and a balanced Th1/Th2 lymphocyte response in immunized mice. A characteristic of the cGAMP-induced immune response is the slightly reduced induction of interleukin-17 as a hallmark of Th17 activity - a distinct feature that is not observed with other cyclic dinucleotide adjuvants. We further characterize the innate immune stimulation activity in vitro on murine bone marrow-derived dendritic cells and human dendritic cells. The observed results suggest the consideration of cGAMP as a candidate mucosal adjuvant for human vaccines.	[Skrnjug, Ivana; Guzman, Carlos Alberto; Ruecker, Christine] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Ruecker, C (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	christine.rueckert@helmholtz-hzi.de			EU (PANFLUVAC); BMBF; Helmholtz Association (IG-SCID)	EU (PANFLUVAC); BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz Association (IG-SCID)	This work was supported in part by grants from the EU (PANFLUVAC); BMBF in the context of the programs Gerontosys 2 (Gerontoshield), EuroNanoMed (HCVAX) and ERANetRUS (HCRUS), and the Helmholtz Association (IG-SCID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Harandi AM, 2010, CURR HIV RES, V8, P330, DOI 10.2174/157016210791208695; Kang Suk-Jo, 2009, F1000 Biol Rep, V1, P15, DOI 10.3410/B1-15; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Libanova R, 2012, MICROB BIOTECHNOL, V5, P168, DOI 10.1111/j.1751-7915.2011.00306.x; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Malefyt RD, 2009, IMMUNITY, V31, P700, DOI 10.1016/j.immuni.2009.11.002; Medina E, 2000, EUR J IMMUNOL, V30, P768, DOI 10.1002/1521-4141(200003)30:3<768::AID-IMMU768>3.3.CO;2-D; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Montomoli E, 2011, EXPERT REV VACCINES, V10, P1053, DOI [10.1586/erv.11.48, 10.1586/ERV.11.48]; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Rueckert C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003001; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	30	33	41	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110150	10.1371/journal.pone.0110150	http://dx.doi.org/10.1371/journal.pone.0110150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295996	Green Published, gold			2022-12-25	WOS:000345204000114
J	Abdi, AI; Muthui, M; Kiragu, E; Bull, PC				Abdi, Abdirahman I.; Muthui, Michelle; Kiragu, Esther; Bull, Peter C.			Measuring Soluble ICAM-1 in African Populations	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SEVERE MALARIA; ENDOTHELIAL ACTIVATION; GENE; ATHEROSCLEROSIS; POLYMORPHISMS; ASSOCIATION; BIOMARKERS; CHILDREN; RECEPTOR	The level of plasma soluble ICAM-1 (sICAM-1) has been associated with the pathogenesis of several diseases. Previously, a commercial antibody was reported not to recognize an ICAM-1 allele known as ICAM-1(kilifi) prevalent among African populations. However, that study was based on 19 samples from African Americans of whom 13 had the wild type allele, five heterozygotes and one homozygote. Here, we compare plasma sICAM-1 measures using three different commercial antibodies in samples from Kenyan children genotyped for ICAM-1(kilifi) allele. We show that two of these antibodies have some degree of deficiency in detecting the ICAM-1(kilifi) allele. Consideration of the antibody used to measure sICAM-1 is important as up to 30% of the populations in Africa harbour this allele.	[Abdi, Abdirahman I.; Muthui, Michelle; Kiragu, Esther; Bull, Peter C.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Bull, Peter C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Abdi, Abdirahman I.] Pwani Univ, Dept Biochem & Chem, Kilifi, Kenya	University of Oxford; Pwani University	Abdi, AI (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	aabdi@kemri-wellcome.org		Abdi, Abdirahman/0000-0001-7989-2125; Bull, Peter/0000-0002-7674-6752	Wellcome Trust [084535, 077092, 084538/Z/07/B];  [076030]	Wellcome Trust(Wellcome TrustEuropean Commission); 	This work was supported by Wellcome Trust Programme Grants (084535 and 077092 to PCB and Prof Kevin Marsh (KM)) and Project Grant (076030 to PCB and KM). AA was also supported by the Wellcome Trust strategic grant (084538/Z/07/B). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Published with the permission of the director of KEMRI.	Adukpo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084181; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Bielinski SJ, 2008, ATHEROSCLEROSIS, V201, P339, DOI 10.1016/j.atherosclerosis.2008.02.031; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Chen Q, 2009, MICROCIRCULATION, V16, P143, DOI 10.1080/10739680802353850; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Cserti-Gazdewich CM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-233; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; El-Deek SE, 2013, MED PRIN PRACT, V22, P469, DOI 10.1159/000349934; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fisher DT, 2010, IMMUNOL RES, V46, P177, DOI 10.1007/s12026-009-8122-9; Fry AE, 2008, GENES IMMUN, V9, P462, DOI 10.1038/gene.2008.38; Gross MD, 2012, CLIN CHEM, V58, P411, DOI 10.1373/clinchem.2011.168559; Jenkins NE, 2005, CLIN INFECT DIS, V41, P1817, DOI 10.1086/498156; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Mita-Mendoza NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054481; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Park GS, 2012, J PEDIATR INFECT DIS, V1, P16, DOI [10.1093/JPIDS/PIS010, 10.1093/jpids/pis010]; Register TC, 2004, CLIN CHEM, V50, P2185, DOI 10.1373/clinchem.2004.036806; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108956	10.1371/journal.pone.0108956	http://dx.doi.org/10.1371/journal.pone.0108956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289635	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000032
J	Ai, CQ; Zhang, QX; Ren, CC; Wang, G; Liu, XM; Tian, FW; Zhao, JX; Zhang, H; Chen, YQ; Chen, W				Ai, Chunqing; Zhang, Qiuxiang; Ren, Chengcheng; Wang, Gang; Liu, Xiaoming; Tian, Fengwei; Zhao, Jianxin; Zhang, Hao; Chen, Yong Q.; Chen, Wei			Genetically Engineered Lactococcus lactis Protect against House Dust Mite Allergy in a BALB/c Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; ACID BACTERIA; IMMUNOMODULATORY PROPERTIES; LACTOBACILLUS-PLANTARUM; INTESTINAL HOMEOSTASIS; CYTOKINE PRODUCTION; EGG ALLERGY; ASTHMA; IMMUNOTHERAPY; ANTIGEN	Background: Mucosal vaccine based on lactic acid bacteria is an attractive concept for the prevention and treatment of allergic diseases, but their mechanisms of action in vivo are poorly understood. Therefore, we sought to investigate how recombinant major dust mite allergen Der p2-expressing Lactococcus lactis as a mucosal vaccine induced the immune tolerance against house dust mite allergy in a mouse model. Methods: Three strains of recombinant L. lactis producing Der p2 in different cell components (extracellular, intracellular and cell wall) were firstly constructed. Their prophylactic potential was evaluated in a Der p2-sensitised mouse model, and immunomodulation properties at the cellular level were determined by measuring cytokine production in vitro. Results: Der p2 expressed in the different recombinant L. lactis strains was recognized by a polyclonal anti-Der p2 antibody. Oral treatment with the recombinant L. lactis prior sensitization significantly prevented the development of airway inflammation in the Der p2-sensitized mice, as determined by the attenuation of inflammatory cells infiltration in the lung tissues and decrease of Th2 cytokines IL-4 and IL-5 levels in bronchoalveolar lavage. In addition, the serum allergen-specific IgE levels were significantly reduced, and the levels of IL-4 in the spleen and mesenteric lymph nodes cell cultures were also markedly decreased upon allergen stimulation in the mice fed with the recombinant L. lactis strains. These protective effects correlated with a significant up-regulation of regulatory T cells in the mesenteric lymph nodes. Conclusion: Oral pretreatment with live recombinant L. lactis prevented the development of allergen-induced airway inflammation primarily by the induction of specific mucosal immune tolerance.	[Ai, Chunqing; Zhang, Qiuxiang; Ren, Chengcheng; Wang, Gang; Liu, Xiaoming; Tian, Fengwei; Zhao, Jianxin; Zhang, Hao; Chen, Yong Q.; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Chen, Yong Q.; Chen, Wei] Jiangnan Univ, Synergist Innovat Ctr Food Safety & Nutr, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University	Zhang, QX (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	zhangqx@jiangnan.edu.cn; chenwei66@jiangnan.edu.cn	Zhang, Hao/HHM-1940-2022; Chen, Wei/GZK-7348-2022; Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708; Wang, Gang/0000-0003-2007-2143	National Natural Science Foundation of China [31200691]; National Science Fund for Distinguished Young Scholars [31125021]; 111 project [B07029, IRT124]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 111 project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (No. 31200691), the National Science Fund for Distinguished Young Scholars (No. 31125021), the 111 project B07029, IRT124, and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2005, J ALLERGY CLIN IMMUN, V116, P961, DOI 10.1016/j.jaci.2005.09.004; Ando H, 2008, J ALLERGY CLIN IMMUN, V122, P583, DOI 10.1016/j.jaci.2008.06.016; AVERSA G, 1993, J EXP MED, V178, P2213, DOI 10.1084/jem.178.6.2213; Bermudez-Humaran LG, 2004, J MED MICROBIOL, V53, P427, DOI 10.1099/jmm.0.05472-0; Bermudez-Humaran LG, 2003, INFECT IMMUN, V71, P1887, DOI 10.1128/IAI.71.4.1887-1896.2003; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Daniel C, 2006, ALLERGY, V61, P812, DOI 10.1111/j.1398-9995.2006.01071.x; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Eyles JE, 2001, VACCINE, V19, P4732, DOI 10.1016/S0264-410X(01)00220-1; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hage-Hamsten V, 2002, ALLERGY, V57, P375; Huibregtse IL, 2007, GASTROENTEROLOGY, V133, P517, DOI 10.1053/j.gastro.2007.04.073; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kandane-Rathnayake RK, 2009, THORAX, V64, P1025, DOI 10.1136/thx.2009.118430; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Larche M, 2007, CHEST, V132, P1007, DOI 10.1378/chest.06-2434; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Lee CC, 2011, CELL MOL IMMUNOL, V8, P404, DOI 10.1038/cmi.2011.13; Lee P, 2009, MICROBES INFECT, V11, P20, DOI 10.1016/j.micinf.2008.10.002; Lim SHE, 2010, LETT APPL MICROBIOL, V51, P658, DOI 10.1111/j.1472-765X.2010.02950.x; Liu Xiao-yu, 2009, Chinese Journal of Zoonoses, V25, P764; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Martinez HQ, 2009, YEARB INTENSIVE CARE, P372; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nandakumar MP, 2003, J PROTEOME RES, V2, P89, DOI 10.1021/pr025541x; Nelson RP, 1996, J ALLERGY CLIN IMMUN, V98, P258, DOI 10.1016/S0091-6749(96)70148-3; NONAKA M, 1995, J IMMUNOL, V155, P3234; Norton PM, 1996, FEMS IMMUNOL MED MIC, V14, P167, DOI 10.1111/j.1574-695X.1996.tb00284.x; Nouaille Sebastien, 2003, Genet Mol Res, V2, P102; Pauli G, 2006, CLIN EXP ALLERGY, V36, P1206; Piard JC, 1997, J BACTERIOL, V179, P3068, DOI 10.1128/jb.179.9.3068-3072.1997; Pretolani M, 1999, CLIN EXP ALLERGY, V29, P1164, DOI 10.1046/j.1365-2222.1999.00456.x; Rigaux P, 2009, ALLERGY, V64, P406, DOI 10.1111/j.1398-9995.2008.01825.x; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Schabussova I, 2008, CURR OPIN ALLERGY CL, V8, P557, DOI 10.1097/ACI.0b013e328317b88b; Schwarzer M, 2011, ALLERGY, V66, P368, DOI 10.1111/j.1398-9995.2010.02488.x; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; Valenta R, 2002, NAT REV IMMUNOL, V2, P446, DOI 10.1038/nri824; van Scott MR, 2000, AM J PHYSIOL-LUNG C, V278, pL667, DOI 10.1152/ajplung.2000.278.4.L667; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840	49	25	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109461	10.1371/journal.pone.0109461	http://dx.doi.org/10.1371/journal.pone.0109461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290938	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000063
J	Bertolde, FZ; Almeida, AAF; Pirovani, CP				Bertolde, Fabiana Z.; Almeida, Alex-Alan F.; Pirovani, Carlos P.			Analysis of Gene Expression and Proteomic Profiles of Clonal Genotypes from Theobroma cacao Subjected to Soil Flooding	PLOS ONE			English	Article							ORYZA-SATIVA L; WATERLOGGING TOLERANCE; ETHANOLIC FERMENTATION; DEHYDROASCORBATE REDUCTASE; MONILIOPHTHORA-PERNICIOSA; LACTATE-DEHYDROGENASE; PROTEIN EXTRACTION; TRYPSIN-INHIBITOR; ANOXIA TOLERANCE; OXYGEN	Soil flooding causes changes in gene transcription, synthesis and degradation of proteins and cell metabolism. The main objective of this study was to understand the biological events of Theobroma cacao during soil flooding-induced stress, using the analyses of gene expression and activity of key enzymes involved in fermentation, as well as the identification of differentially expressed proteins by mass spectrometry in two contrasting genotypes for flooding tolerance (tolerant - TSA-792 and susceptible - TSH-774). Soil anoxia caused by flooding has led to changes in the expression pattern of genes associated with the biosynthesis of alcohol dehydrogenase (ADH), pyruvate decarboxylase (PDC) and lactate dehydrogenase (LDH) in leaves and roots of the two evaluated genotypes. Significant differences were observed between the enzyme activities of the two genotypes. Leaves and roots of the TSA-792 genotype showed higher ADH activity as compared to the TSH-774 genotype, whereas the activities of PDC and LDH have varied over the 96 h of soil flooding, being higher for TSA-792 genotype, at the initial stage, and TSH-774 genotype, at the final stage. Some of the identified proteins are those typical of the anaerobic metabolism-involved in glycolysis and alcoholic fermentation-and different proteins associated with photosynthesis, protein metabolism and oxidative stress. The ability to maintain glycolysis and induce fermentation was observed to play an important role in anoxia tolerance in cacao and may also serve to distinguish tolerant and susceptible genotypes in relation to this stressor.	[Bertolde, Fabiana Z.] Inst Fed Educ Ciencia & Tecnol, Eunapolis, BA, Brazil; [Almeida, Alex-Alan F.; Pirovani, Carlos P.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil	Instituto Federal do Sertao Pernambucano; Universidade Estadual de Santa Cruz	Bertolde, FZ (corresponding author), Inst Fed Educ Ciencia & Tecnol, Campus Eunapolis, Eunapolis, BA, Brazil.	fzbertolde@yahoo.com.br	Pirovani, Carlos Priminho/N-1153-2019; Almeida, Alex-Alan/AAL-9505-2021; Pirovani, Carlos P/J-3426-2017	Pirovani, Carlos Priminho/0000-0002-6176-4069; Almeida, Alex-Alan/0000-0001-5313-0608; Pirovani, Carlos P/0000-0002-6176-4069	Fundacao de Amparo a Pesquisa da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Universidade Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by Fundacao de Amparo a Pesquisa da Bahia (FAPESB), Universidade Estadual de Santa Cruz (UESC), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2007, PLANT SOIL, V295, P37, DOI 10.1007/s11104-007-9258-9; Alam I, 2010, J BIOSCIENCES, V35, P49, DOI 10.1007/s12038-010-0007-5; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; Benz BR, 2007, AM J BOT, V94, P542, DOI 10.3732/ajb.94.4.542; Bertolde FZ, 2014, GENET MOL RES, V13, P5036, DOI 10.4238/2014.July.4.19; Bertolde FZ, 2012, PHOTOSYNTHETICA, V50, P447, DOI 10.1007/s11099-012-0052-4; Bertolde FZ, 2010, TREE PHYSIOL, V30, P56, DOI 10.1093/treephys/tpp101; Branco-Price C, 2005, ANN BOT-LONDON, V96, P647, DOI 10.1093/aob/mci217; BUCHER M, 1993, PLANT PHYSIOL, V103, P441, DOI 10.1104/pp.103.2.441; Chang WWP, 2000, PLANT PHYSIOL, V122, P295, DOI 10.1104/pp.122.2.295; Chen H, 2003, ENVIRON EXP BOT, V50, P9; CRAWFORD RMM, 1992, ADV ECOL RES, V23, P93, DOI 10.1016/S0065-2504(08)60147-6; DAVIES DD, 1974, PLANTA, V118, P297, DOI 10.1007/BF00385580; de Almeida AAF, 2010, AGR ISSUES POLICIES, P37; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P425, DOI 10.1590/S1677-04202007000400011; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Dubey H, 2003, CURR SCI INDIA, V84, P83; Ellis MH, 2000, AUST J PLANT PHYSIOL, V27, P1041, DOI 10.1071/PP00052; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; Geigenberger P, 2000, BIOL CHEM, V381, P723, DOI 10.1515/BC.2000.093; GOMES ARS, 1986, J HORTIC SCI BIOTECH, V61, P265, DOI 10.1080/14620316.1986.11515700; HOFFMAN NE, 1986, PLANT PHYSIOL, V82, P658, DOI 10.1104/pp.82.3.658; Hou WC, 1997, PLANT SCI, V128, P151, DOI 10.1016/S0168-9452(97)00153-2; Hou WC, 2000, J EXP BOT, V51, P713, DOI 10.1093/jexbot/51.345.713; Huang SB, 2005, ANN BOT-LONDON, V96, P703, DOI 10.1093/aob/mci222; Hunt PW, 2002, P NATL ACAD SCI USA, V99, P17197, DOI 10.1073/pnas.212648799; Jaeger C, 2009, J EXP BOT, V60, P4335, DOI 10.1093/jxb/erp268; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Kato-Noguchi H, 2000, PHYSIOL PLANTARUM, V109, P28, DOI 10.1034/j.1399-3054.2000.100105.x; Kato-Noguchi H, 2007, J PLANT PHYSIOL, V164, P168, DOI 10.1016/j.jplph.2005.09.017; KatoNoguchi H, 1997, J AM SOC HORTIC SCI, V122, P107, DOI 10.21273/JASHS.122.1.107; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Kutter S, 2009, J BIOL CHEM, V284, P12136, DOI 10.1074/jbc.M806228200; Lin KHR, 2004, PLANT SCI, V167, P355, DOI 10.1016/j.plantsci.2004.04.004; Lin KH, 2010, PLANT MOL BIOL REP, V28, P212, DOI 10.1007/s11105-009-0142-z; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MUCKE U, 1995, BIOL CHEM H-S, V376, P111, DOI 10.1515/bchm3.1995.376.2.111; Mustroph A, 2005, ANN BOT-LONDON, V96, P717, DOI 10.1093/aob/mci223; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pechanova O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-674; Pena-Fronteras JT, 2009, ANN BOT-LONDON, V103, P295, DOI 10.1093/aob/mcn085; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; RATCLIFFE RG, 1995, ENV PLANT B, P111; RIVOAL J, 1991, PLANT PHYSIOL, V95, P682, DOI 10.1104/pp.95.3.682; ROBERTS JKM, 1985, PLANT PHYSIOL, V77, P492, DOI 10.1104/pp.77.2.492; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; SACHS MM, 1980, CELL, V20, P761, DOI 10.1016/0092-8674(80)90322-0; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Sairam RK, 2009, J PLANT PHYSIOL, V166, P602, DOI 10.1016/j.jplph.2008.09.005; Shi F, 2008, PHYTOCHEMISTRY, V69, P1295, DOI 10.1016/j.phytochem.2008.01.007; Silva FAC, 2013, GENET MOL RES, V12, P4855, DOI 10.4238/2013.October.22.5; SMITH AM, 1979, PLANTA, V146, P327, DOI 10.1007/BF00387805; Souza Jr JO, 2007, THESIS U SAO PAULO S, P125; Subbaiah CC, 2003, ANN BOT-LONDON, V91, P119, DOI 10.1093/aob/mcf210; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; TASHIRO M, 1978, AGR BIOL CHEM TOKYO, V42, P1119, DOI 10.1080/00021369.1978.10863122; UMEDA M, 1994, PLANT PHYSIOL, V106, P1015, DOI 10.1104/pp.106.3.1015; Villela-Dias C, 2014, PHYSIOL PLANTARUM, V150, P1, DOI 10.1111/ppl.12061; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Zou X, 2010, BMC PLANT BIOL, V10, P1471	67	21	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108705	10.1371/journal.pone.0108705	http://dx.doi.org/10.1371/journal.pone.0108705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289700	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000023
J	Tabatabai, J; Prifert, C; Pfeil, J; Grulich-Henn, J; Schnitzler, P				Tabatabai, Julia; Prifert, Christiane; Pfeil, Johannes; Grulich-Henn, Juergen; Schnitzler, Paul			Novel Respiratory Syncytial Virus (RSV) Genotype ON1 Predominates in Germany during Winter Season 2012-13	PLOS ONE			English	Article							GROUP-A; GENETIC-VARIABILITY; SUBGROUP-B; MOLECULAR CHARACTERIZATION; ATTACHMENT GLYCOPROTEIN; PHYLOGENETIC ANALYSIS; CIRCULATION PATTERNS; SOUTH-AFRICA; STRAINS; IDENTIFICATION	Respiratory syncytial virus (RSV) is the leading cause of hospitalization especially in young children with respiratory tract infections (RTI). Patterns of circulating RSV genotypes can provide a better understanding of the molecular epidemiology of RSV infection. We retrospectively analyzed the genetic diversity of RSV infection in hospitalized children with acute RTI admitted to University Hospital Heidelberg/Germany between October 2012 and April 2013. Nasopharyngeal aspirates (NPA) were routinely obtained in 240 children younger than 2 years of age who presented with clinical symptoms of upper or lower RTI. We analyzed NPAs via PCR and sequence analysis of the second variable region of the RSV G gene coding for the attachment glycoprotein. We obtained medical records reviewing routine clinical data. RSV was detected in 134/240 children. In RSV-positive patients the most common diagnosis was bronchitis/bronchiolitis (75.4%). The mean duration of hospitalization was longer in RSV-positive compared to RSV-negative patients (3.5 vs. 5.1 days; p < 0.01). RSV-A was detected in 82.1%, RSV-B in 17.9% of all samples. Phylogenetic analysis of 112 isolates revealed that the majority of RSV-A strains (65%) belonged to the novel ON1 genotype containing a 72-nucleotide duplication. However, genotype ON1 was not associated with a more severe course of illness when taking basic clinical/laboratory parameters into account. Molecular characterization of RSV confirms the co-circulation of multiple genotypes of subtype RSV-A and RSV-B. The duplication in the G gene of genotype ON1 might have an effect on the rapid spread of this emerging RSV strain.	[Tabatabai, Julia; Schnitzler, Paul] Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany; [Tabatabai, Julia] London Sch Hyg & Trop Med, London WC1, England; [Prifert, Christiane] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Pfeil, Johannes; Grulich-Henn, Juergen] Heidelberg Univ, Dept Pediat, Heidelberg, Germany; [Pfeil, Johannes] German Ctr Infect Dis DZIF, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of London; London School of Hygiene & Tropical Medicine; University of Wurzburg; Ruprecht Karls University Heidelberg; German Center for Infection Research	Schnitzler, P (corresponding author), Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany.	Paul_Schnitzler@med.uni-heidelberg.de	Tabatabai, Julia/AFQ-1931-2022	Pfeil, Johannes/0000-0003-0104-8375				Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Berner R, 2001, EUR J PEDIATR, V160, P541, DOI 10.1007/s004310100801; Blanc A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/s00705-004-0412-x; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; GARCIA O, 1994, J VIROL, V68, P5448; Geis S, 2013, J CLIN MICROBIOL, V51, P155, DOI 10.1128/JCM.02151-12; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Gupta R., 2004, RESEARCHGATE; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pierangeli A, 2014, EURO SURVEILL, V19; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; STORCH GA, 1991, J INFECT DIS, V163, P858, DOI 10.1093/infdis/163.4.858; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; WERTZ GW, 1989, J VIROL, V63, P4767, DOI 10.1128/JVI.63.11.4767-4776.1989	40	73	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109191	10.1371/journal.pone.0109191	http://dx.doi.org/10.1371/journal.pone.0109191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290155	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000048
J	Takase, R; Mikami, B; Kawai, S; Murata, K; Hashimoto, W				Takase, Ryuichi; Mikami, Bunzo; Kawai, Shigeyuki; Murata, Kousaku; Hashimoto, Wataru			Structure-based Conversion of the Coenzyme Requirement of a Short-chain Dehydrogenase/Reductase Involved in Bacterial Alginate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; KETOL-ACID REDUCTOISOMERASE; NUCLEOTIDE SPECIFICITY; MOLECULAR-IDENTIFICATION; FORMATE DEHYDROGENASE; XYLITOL DEHYDROGENASE; COFACTOR SPECIFICITY; ESCHERICHIA-COLI; BINDING-SITE; REDUCTASE	The alginate-assimilating bacterium, Sphingomonas sp. strain A1, degrades the polysaccharides to monosaccharides through four alginate lyase reactions. The resultant monosaccharide, which is nonenzymatically converted to 4-deoxy-L-erythro-5-hexoseulose uronate (DEH), is further metabolized to 2-keto-3-deoxy-D-gluconate by NADPH-dependent reductase A1-R in the short-chain dehydrogenase/reductase (SDR) family. A1-R-deficient cells produced another DEH reductase, designated A1-R', with a preference for NADH. Here, we show the identification of a novel NADH-dependent DEH reductase A1-R' in strain A1, structural determination of A1-R' by x-ray crystallography, and structure-based conversion of a coenzyme requirement inSDRenzymes, A1-R and A1-R'. A1-R' was purified from strain A1 cells and enzymatically characterized. Except for the coenzyme requirement, there was no significant difference in enzyme characteristics between A1-R and A1-R'. Crystal structures of A1-R' and A1-R'-NAD(+) complex were determined at 1.8 and 2.7 angstrom resolutions, respectively. Because of a 64% sequence identity, overall structures of A1-R' and A1-R were similar, although a difference in the coenzyme-binding site (particularly the nucleoside ribose 2' region) was observed. Distinct from A1-R, A1-R' included a negatively charged, shallower binding site. These differences were caused by amino acid residues on the two loops around the site. The A1-R' mutant with the two A1-R-typed loops maintained potent enzyme activity with specificity for NADPH rather than NADH, demonstrating that the two loops determine the coenzyme requirement, and loop exchange is a promising method for conversion of coenzyme requirement in the SDR family.	[Takase, Ryuichi; Kawai, Shigeyuki; Murata, Kousaku; Hashimoto, Wataru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Hashimoto, W (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp		Takase, Ryuichi/0000-0002-7423-9407	Japan Society for the Promotion of Science; Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [26660062] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.), the Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan (to K. M.), the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to R. T.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banta S, 2002, PROTEIN ENG, V15, P131, DOI 10.1093/protein/15.2.131; Baroni S, 2012, BIOCHEMISTRY-US, V51, P3819, DOI 10.1021/bi300078p; BERNARD N, 1995, BIOCHEM BIOPH RES CO, V208, P895, DOI 10.1006/bbrc.1995.1419; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkmann-Chen S, 2013, P NATL ACAD SCI USA, V110, P10946, DOI 10.1073/pnas.1306073110; Capone M, 2011, FEBS J, V278, P2460, DOI 10.1111/j.1742-4658.2011.08172.x; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Chen RD, 1996, P NATL ACAD SCI USA, V93, P12171, DOI 10.1073/pnas.93.22.12171; CLERMONT S, 1993, BIOCHEMISTRY-US, V32, P10178, DOI 10.1021/bi00089a038; Dambe TR, 2006, BIOCHEMISTRY-US, V45, P10030, DOI 10.1021/bi052589q; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Ehrensberger AH, 2006, STRUCTURE, V14, P567, DOI 10.1016/j.str.2005.11.016; Elmore CL, 2002, J BIOL CHEM, V277, P48960, DOI 10.1074/jbc.M210173200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Eppink MHM, 1999, J MOL BIOL, V292, P87, DOI 10.1006/jmbi.1999.3015; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Galkin A, 1997, PROTEIN ENG, V10, P687, DOI 10.1093/protein/10.6.687; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; Hashimoto W, 2005, BIOSCI BIOTECH BIOCH, V69, P673, DOI 10.1271/bbb.69.673; Hashimoto Wataru, 2010, Bioeng Bugs, V1, P97, DOI 10.4161/bbug.1.2.10322; Hisano T, 1996, BIOCHEM BIOPH RES CO, V220, P979, DOI 10.1006/bbrc.1996.0526; Hoelsch K, 2013, APPL MICROBIOL BIOT, V97, P2473, DOI 10.1007/s00253-012-4142-9; Hoffmann F, 2007, DRUG METAB REV, V39, P87, DOI 10.1080/03602530600969440; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kaup B, 2004, APPL MICROBIOL BIOT, V64, P333, DOI 10.1007/s00253-003-1470-9; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KIMBARA K, 1989, J BACTERIOL, V171, P2740, DOI 10.1128/jb.171.5.2740-2747.1989; Kristan K, 2007, J BIOTECHNOL, V129, P123, DOI 10.1016/j.jbiotec.2006.11.025; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lerchner A, 2013, BIOTECHNOL BIOENG, V110, P2803, DOI 10.1002/bit.24956; Colin VL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/601834; Marohnic CC, 2003, BIOCHEMISTRY-US, V42, P11170, DOI 10.1021/bi034819b; Medina M, 2001, J BIOL CHEM, V276, P11902, DOI 10.1074/jbc.M009287200; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Moat AG, 1987, PYRIDINE NUCLEOTID B, P1; Momma K, 2000, J BACTERIOL, V182, P3998, DOI 10.1128/JB.182.14.3998-4004.2000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nedjma M, 2001, ANAL BIOCHEM, V291, P290, DOI 10.1006/abio.2001.5032; Nishitani Y, 2012, BIOCHEMISTRY-US, V51, P3622, DOI 10.1021/bi300194f; Ochiai A, 2006, RES MICROBIOL, V157, P642, DOI 10.1016/j.resmic.2006.02.006; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Petschacher B, 2005, BIOCHEM J, V385, P75, DOI 10.1042/BJ20040363; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Rane MJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P83, DOI 10.1006/abbi.1996.9802; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; RUVKUN GB, 1981, NATURE, V289, P85, DOI 10.1038/289085a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Serov AE, 2002, BIOCHEM J, V367, P841, DOI 10.1042/BJ20020379; Shiraishi N, 1998, ARCH BIOCHEM BIOPHYS, V358, P104, DOI 10.1006/abbi.1998.0827; Stokstad E, 2012, SCIENCE, V335, P273, DOI 10.1126/science.335.6066.273; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Takeda H, 2011, ENERG ENVIRON SCI, V4, P2575, DOI 10.1039/c1ee01236c; Tomita T, 2006, BIOCHEM BIOPH RES CO, V347, P502, DOI 10.1016/j.bbrc.2006.06.131; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vertes A., 2010, BIOMASS BIOFUELS STR, P1; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Watanabe S, 2005, J BIOL CHEM, V280, P10340, DOI 10.1074/jbc.M409443200; Watanabe S, 2007, J BIOTECHNOL, V130, P316, DOI 10.1016/j.jbiotec.2007.04.019; Yaoi T, 1996, J BIOCHEM-TOKYO, V119, P1014; Yoon HJ, 2000, PROTEIN EXPRES PURIF, V19, P84, DOI 10.1006/prep.2000.1226; Zhang L, 1999, BIOCHEMISTRY-US, V38, P11440, DOI 10.1021/bi991101g; Zheng HY, 2013, BIOCHEMISTRY-US, V52, P5876, DOI 10.1021/bi400821s	70	35	35	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33198	33214		10.1074/jbc.M114.585661	http://dx.doi.org/10.1074/jbc.M114.585661			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25288804	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000345636600014
J	Ding, XY; Yang, Z; Han, YW; Yu, H				Ding, Xiaoyan; Yang, Zi; Han, Yiwei; Yu, Huan			Fatty Acid Oxidation Changes and the Correlation with Oxidative Stress in Different Preeclampsia-Like Mouse Models	PLOS ONE			English	Article							PREGNANT RATS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; LIVER-DISEASE; L-NAME; TRIGLYCERIDE; ANTIBODIES; WOMEN; MICE	Background: Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) expression is decreased in placenta of some cases of preeclampsia (PE) which may result in free fatty acid (FFA) increased. High FFA level will induce oxidative stress, so abnormal long-chain fatty acid-oxidation may participate in the pathogenesis of PE through oxidative stress pathway. Methods: PE-like groups were ApoC3 transgenic mice with abnormal fatty acid metabolism, classical PE-like models with injection of Nw-nitro-L-arginine-methyl ester (L-NA) or lipopolysaccharide (LPS) and the antiphospholipid syndrome (APS) mouse model with beta GPI injection (ApoC3+NS, ApoC3+L-NA, L-NA, LPS and beta GPI groups). The control group was wild-type mice with normal saline injection. Except for beta 2GPI mice, the other mice were subdivided into pre-implantation (Pre) and mid-pregnancy (Mid) subgroups by injection time. Results: All PE-like groups showed hypertension and proteinuria except ApoC3+NS mice only showed hypertension. Serum FFA levels increased significantly except in LPS group compared to controls (P<0.05). LCHAD mRNA and protein expression in the liver and placenta was significantly higher for ApoC3+NS, ApoC3+L-NA and beta 2GPI mice and lower for L-NA mice than controls (P<0.05) but did not differ between LPS mice and controls. P47phox mRNA and protein expression in the liver significantly increased in all PE-like groups except LPS group, while P47phox expression in the placenta only significantly increased in L-NA and beta 2GPI groups. Conclusions: Abnormal long-chain fatty acid-oxidation may play a different role in different PE-like models and in some cases participate in the pathogenesis of PE through oxidative stress pathway.	[Ding, Xiaoyan; Yang, Zi; Han, Yiwei; Yu, Huan] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	Peking University	Yang, Z (corresponding author), Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	zi_yang@email.com			National Natural Science Foundation of China [81370723]; Beijing Municipal Natural Science Foundation [7132215]; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China [20130001110111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants to ZY from the National Natural Science Foundation of China (No. 81370723; http://www.nsfc.gov.cn/), Beijing Municipal Natural Science Foundation (No. 7132215; http://www.bjnsf.org/) and the Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China (No. 20130001110111; http://www.cutech.edu.cn/cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha JL, 2012, PLACENTA, V33, P132, DOI 10.1016/j.placenta.2011.11.027; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018; Ding X, 2014, PLACENTA; do Prado AD, 2010, OBSTET GYNECOL, V116, P1433, DOI 10.1097/AOG.0b013e3181fe02ec; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Gallos ID, 2013, BJOG-INT J OBSTET GY, V120, P1321, DOI 10.1111/1471-0528.12375; Gilbert J, 2007, AM J HYPERTENS, V20, P686, DOI 10.1016/j.amjhyper.2006.12.016; Gupta S, 2005, OBSTET GYNECOL SURV, V60, P807, DOI 10.1097/01.ogx.0000193879.79268.59; Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204; Jing Xin-yan, 2013, Chinese Medical Sciences Journal, V28, P233; Kajiwara T, 2007, J AUTOIMMUN, V29, P164, DOI 10.1016/j.jaut.2007.07.003; Khedara A, 1996, J NUTR, V126, P2563, DOI 10.1093/jn/126.10.2563; Lin F, 2012, REPROD TOXICOL, V34, P677, DOI 10.1016/j.reprotox.2012.09.009; Ma RQ, 2011, CHINESE MED J-PEKING, V124, P3141, DOI 10.3760/cma.j.issn.0366-6999.2011.19.033; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Richer C, 1996, BRIT J PHARMACOL, V119, P1642, DOI 10.1111/j.1476-5381.1996.tb16084.x; Robinson NJ, 2009, J HYPERTENS, V27, P1293, DOI 10.1097/HJH.0b013e328329fbfe; Rolfo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013288; Sharp GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070180; Sun Xiao-le, 2011, Zhonghua Yi Xue Za Zhi, V91, P2026; Sunderland N, 2011, AM J REPROD IMMUNOL, V65, P533, DOI 10.1111/j.1600-0897.2010.00929.x; Tonin AM, 2010, NEUROCHEM INT, V56, P930, DOI 10.1016/j.neuint.2010.03.025; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; Wang Jia-lue, 2008, Zhonghua Yi Xue Za Zhi, V88, P1471; WILCKEN B, 1993, LANCET, V341, P407, DOI 10.1016/0140-6736(93)92993-4; Xie WD, 2011, INT IMMUNOPHARMACOL, V11, P136, DOI 10.1016/j.intimp.2010.10.018; Yang Z, 2002, JAMA-J AM MED ASSOC, V288, P2163, DOI 10.1001/jama.288.17.2163; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70; Zhou QJ, 2013, HYPERTENS PREGNANCY, V32, P422, DOI 10.3109/10641955.2013.824978	30	14	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109554	10.1371/journal.pone.0109554	http://dx.doi.org/10.1371/journal.pone.0109554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302499	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400067
J	Gabl, M; Winther, M; Skovbakke, SL; Bylund, J; Dahlgren, C; Forsman, H				Gabl, Michael; Winther, Malene; Skovbakke, Sarah Line; Bylund, Johan; Dahlgren, Claes; Forsman, Huamei			A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTORS; RESPIRATORY BURST PRODUCTS; PROTEIN-COUPLED RECEPTORS; NADPH-OXIDASE; FUNCTIONAL SELECTIVITY; GRANULE MOBILIZATION; INSIGHTS; DESENSITIZATION; PHARMACOLOGY; INHIBITION	We recently described a novel receptor cross-talk mechanism in neutrophils, unique in that the signals generated by the PAF receptor (PAFR) and the ATP receptor (P2Y(2)R) transfer formyl peptide receptor 1 (FPR1) from a desensitized (non-signaling) state back to an actively signaling state (Forsman H et al., PLoS One, 8:e60169, 2013; Onnheim K, et al., Exp Cell Res, 323:209, 2014). In addition to the G-protein coupled FPR1, neutrophils also express the closely related receptor FPR2. In this study we used an FPR2 specific pepducin, proposed to work as an allosteric modulator at the cytosolic signaling interface, to determine whether the cross-talk pathway is utilized also by FPR2. The pepducin used contains a fatty acid linked to a peptide sequence derived from the third intracellular loop of FPR2, and it activates as well as desensensitizes this receptor. We now show that neutrophils desensitized with the FPR2-specific pepducin display increased cellular responses to stimulation with PAF or ATP. The secondary PAF/ATP induced response was sensitive to FPR2-specific inhibitors, disclosing a receptor cross-talk mechanism underlying FPR2 reactivation. The pepducin induced an activity in naive cells similar to that of a conventional FPR2 agonist, but with lower potency (partial efficacy), meaning that the pepducin is a partial agonist. The PAF- or ATP-induced reactivation was, however, much more pronounced when neutrophils had been desensitized to the pepducin as compared to cells desensitized to conventional agonists. The pepducin should thus in this respect be classified as a full agonist. In summary, we demonstrate that desensitized FPR2 can be transferred back to an actively signaling state by receptor cross-talk signals generated through PAFR and P2Y(2)R, and the difference in agonist potency with respect to pepducin-induced direct receptor activation and cross-talk reactivation of FPR2 puts the concept of functional selectivity in focus.	[Gabl, Michael; Winther, Malene; Skovbakke, Sarah Line; Bylund, Johan; Dahlgren, Claes; Forsman, Huamei] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Skovbakke, Sarah Line] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Gothenburg; University of Copenhagen	Forsman, H (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	Huamei.Forsman@Rheuma.gu.se		Skovbakke, Sarah Line/0000-0002-4673-4419	Swedish Medical Research Council; King Gustaf the V 80-Year foundation; Swedish Society of Medicine; Ingabritt and Arne Lundberg foundation; Swedish Government under the ALF-agreement	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); King Gustaf the V 80-Year foundation; Swedish Society of Medicine; Ingabritt and Arne Lundberg foundation; Swedish Government under the ALF-agreement	The work was supported by the Swedish Medical Research Council, the King Gustaf the V 80-Year foundation, the Swedish Society of Medicine, the Ingabritt and Arne Lundberg foundation, and the Swedish Government under the ALF-agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2002, INFECT IMMUN, V70, P2908, DOI 10.1128/IAI.70.6.2908-2914.2002; Bylund J, 2003, J BIOL CHEM, V278, P30578, DOI 10.1074/jbc.M209202200; Bylund J, 2014, INFLAMM CELL SIGNAL, V1, P24; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Eglen RM, 2011, PHARMACEUTICALS, V4, P244, DOI 10.3390/ph4020244; Forsman H, 2013, BBA-MOL CELL RES, V1833, P1914, DOI 10.1016/j.bbamcr.2013.03.026; Forsman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060169; Forsman H, 2012, J IMMUNOL, V189, P629, DOI 10.4049/jimmunol.1101616; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; JESAITIS AJ, 1993, EUR J HAEMATOL, V51, P288; JESAITIS AJ, 1985, J CELL BIOCHEM, V27, P241, DOI 10.1002/jcb.240270306; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Karlsson J, 2010, J IMMUNOL METHODS, V352, P45, DOI 10.1016/j.jim.2009.10.011; Karlsson J, 2009, CELL CALCIUM, V45, P431, DOI 10.1016/j.ceca.2009.02.002; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Kindon N, 1998, Patent No. [WO1998054180, 1998054180]; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Meghani P, 2002, AM CHEM SOC; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Onnheim K, 2014, EXP CELL RES, V323, P209, DOI 10.1016/j.yexcr.2014.01.023; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Seifert R, 2013, BIOCHEM PHARMACOL, V86, P853, DOI 10.1016/j.bcp.2013.07.029; Shukla AK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005021; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Ye R D, 1997, Adv Pharmacol, V39, P221, DOI 10.1016/S1054-3589(08)60073-3; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	42	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109516	10.1371/journal.pone.0109516	http://dx.doi.org/10.1371/journal.pone.0109516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303226	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400062
J	Haring, B; Gronroos, N; Nettleton, JA; von Ballmoos, MCW; Selvin, E; Alonso, A				Haring, Bernhard; Gronroos, Noelle; Nettleton, Jennifer A.; von Ballmoos, Moritz C. Wyler; Selvin, Elizabeth; Alonso, Alvaro			Dietary Protein Intake and Coronary Heart Disease in a Large Community Based Cohort: Results from the Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							MIDDLE-AGED MEN; BLOOD-PRESSURE; MEAT CONSUMPTION; FAT INTAKE; WOMEN; METAANALYSIS; MORTALITY; TRIAL; QUESTIONNAIRE; ASSOCIATION	Background: Prospective data examining the relationship between dietary protein intake and incident coronary heart disease (CHD) are inconclusive. Most evidence is derived from homogenous populations such as health professionals. Large community-based analyses in more diverse samples are lacking. Methods: We studied the association of protein type and major dietary protein sources and risk for incident CHD in 12,066 middle-aged adults (aged 45-64 at baseline, 1987-1989) from four U.S. communities enrolled in the Atherosclerosis Risk in Communities (ARK) Study who were free of diabetes mellitus and cardiovascular disease at baseline. Dietary protein intake was assessed at baseline and after 6 years of follow-up by food frequency questionnaire. Our primary outcome was adjudicated coronary heart disease events or deaths with following up through December 31, 2010. Cox proportional hazard models with multivariable adjustment were used for statistical analyses. Results: During a median follow-up of 22 years, there were 1,147 CHD events. In multivariable analyses total, animal and vegetable protein were not associated with an increased risk for CHD before or after adjustment. In food group analyses of major dietary protein sources, protein intake from red and processed meat, dairy products, fish, nuts, eggs, and legumes were not significantly associated with CHD risk. The hazard ratios [with 95% confidence intervals] for risk of CHD across quintiles of protein from poultry were 1.00 [ref], 0.83 [0.70-0.99], 0.93 [0.75-1.15], 0.88 [0.73-1.06], 0.79 [0.64-0.98], P for trend = 0.16). Replacement analyses evaluating the association of substituting one source of dietary protein for another or of decreasing protein intake at the expense of carbohydrates or total fats did not show any statistically significant association with CHD risk. Conclusion: Based on a large community cohort we found no overall relationship between protein type and major dietary protein sources and risk for CHD.	[Haring, Bernhard] Univ Wurzburg, Dept Internal Med 1, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Bavaria, Germany; [Gronroos, Noelle; Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Nettleton, Jennifer A.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [von Ballmoos, Moritz C. Wyler] Froedtert Mem Hosp, Dept Surg, Milwaukee, WI USA; [von Ballmoos, Moritz C. Wyler] Froedtert Mem Hosp, Div Cardiothorac Surg, Milwaukee, WI USA; [von Ballmoos, Moritz C. Wyler] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA	University of Wurzburg; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Medical College of Wisconsin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Haring, B (corresponding author), Univ Wurzburg, Dept Internal Med 1, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Bavaria, Germany.	Haring_B@ukw.de	Reardon, Michael/ABF-8880-2021; Alonso, Alvaro/A-4917-2010	Alonso, Alvaro/0000-0002-2225-8323	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; German Research Foundation (DFG); University of Wurzburg	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). There are no relationships with industry to declare. Open Access publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Iseki K, 2003, HYPERTENS RES, V26, P289, DOI 10.1291/hypres.26.289; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Kumanyika SK, 2000, HEALTH PSYCHOL, V19, P42, DOI 10.1037/0278-6133.19.Suppl1.42; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; LUEPKER RV, 1994, AM J PUBLIC HEALTH, V84, P1383, DOI 10.2105/AJPH.84.9.1383; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Preis SR, 2010, AM J CLIN NUTR, V92, P1265, DOI 10.3945/ajcn.2010.29626; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; RICHARDSON MT, 1995, INT J EPIDEMIOL, V24, P685, DOI 10.1093/ije/24.4.685; Roussell MA, 2014, J HUM HYPERTENS; Roussell MA, 2012, AM J CLIN NUTR, V95, P9, DOI 10.3945/ajcn.111.016261; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; SNOWDON DA, 1984, PREV MED, V13, P490, DOI 10.1016/0091-7435(84)90017-3; Stamler J, 1996, CIRCULATION, V94, P1629, DOI 10.1161/01.CIR.94.7.1629; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; Stamler J, 1996, CIRCULATION, V94, P2417, DOI 10.1161/01.CIR.94.10.2417; Vega-Lopez Sonia, 2005, Prev Cardiol, V8, P31, DOI 10.1111/j.1520-037X.2005.3923.x; Wang YF, 2008, J HUM HYPERTENS, V22, P745, DOI 10.1038/jhh.2008.64; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Whiteman D, 1999, PUBLIC HEALTH NUTR, V2, P477, DOI 10.1017/S136898009900066X; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	36	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109552	10.1371/journal.pone.0109552	http://dx.doi.org/10.1371/journal.pone.0109552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303709	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400066
J	Martin-Vilchez, S; Rodriguez-Munoz, Y; Lopez-Rodriguez, R; Hernandez-Bartolome, A; Borque-Inurrita, MJ; Molina-Jimenez, F; Garcia-Buey, L; Moreno-Otero, R; Sanz-Cameno, P				Martin-Vilchez, Samuel; Rodriguez-Munoz, Yolanda; Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Jesus Borque-Inurrita, Maria; Molina-Jimenez, Francisca; Garcia-Buey, Luisa; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma			Inhibition of Tyrosine Kinase Receptor Tie2 Reverts HCV-Induced Hepatic Stellate Cell Activation	PLOS ONE			English	Article							C VIRUS-CORE; ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCED VEGF; ANGIOPOIETIN-2 EXPRESSION; PROANGIOGENIC CYTOKINES; LIVER FIBROGENESIS; UP-REGULATION; ANGIOGENESIS; MIGRATION; MECHANISMS	Background: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease (CLD) and is frequently linked to intrahepatic microvascular disorders. Activation of hepatic stellate cells (HSC) is a central event in liver damage, due to their contribution to hepatic renewal and to the development of fibrosis and hepatocarcinoma. During the progression of CLDs, HSC attempt to restore injured tissue by stimulating repair processes, such as fibrosis and angiogenesis. Because HSC express the key vascular receptor Tie2, among other angiogenic receptors and mediators, we analyzed its involvement in the development of CLD. Methods: Tie2 expression was monitored in HSC cultures that were exposed to media from HCV-expressing cells (replicons). The effects of Tie2 blockade on HSC activation by either neutralizing antibody or specific signaling inhibitors were also examined. Results: Media from HCV-replicons enhanced HSC activation and invasion and upregulated Tie2 expression. Notably, the blockade of Tie2 receptor (by a specific neutralizing antibody) or signaling (by selective AKT and MAPK inhibitors) significantly reduced alpha-smooth muscle actin (alpha-SMA) expression and the invasive potential of HCV-conditioned HSC. Conclusions: These findings ascribe a novel profibrogenic function to Tie2 receptor in the progression of chronic hepatitis C, highlighting the significance of its dysregulation in the evolution of CLDs and its potential as a novel therapeutic target.	[Martin-Vilchez, Samuel] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Rodriguez-Munoz, Yolanda; Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Garcia-Buey, Luisa; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IIS IP, Unidad Hepatol, Madrid, Spain; [Rodriguez-Munoz, Yolanda; Lopez-Rodriguez, Rosario; Garcia-Buey, Luisa; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Jesus Borque-Inurrita, Maria; Molina-Jimenez, Francisca] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IIS IP, Unidad Biol Mol, Madrid, Spain	University of Virginia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Sanz-Cameno, P (corresponding author), Hosp Univ Princesa, Inst Invest Sanitaria Princesa IIS IP, Unidad Hepatol, Madrid, Spain.	paloma_march@hotmail.com	Sanz, Paloma/C-7799-2014; Lopez-Rodriguez, Rosario/M-3381-2014; Chaparro, María/I-2500-2016; Martin-Vilchez, Samuel/AFV-2112-2022; López-Rodríguez, Rosario/AAB-2290-2022	Lopez-Rodriguez, Rosario/0000-0002-4713-0633; Chaparro, María/0000-0002-9275-4242; Martin-Vilchez, Samuel/0000-0003-0557-7653; López-Rodríguez, Rosario/0000-0002-4713-0633	CIBER-ehd; Ministerio de Ciencia e Innovacion [SAF2010/21805]; AIO Asociacion Espanola Contra el Cancer; Mutua Madrilena	CIBER-ehd; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); AIO Asociacion Espanola Contra el Cancer; Mutua Madrilena	This work was supported in part by grants: 1) CIBER-ehd to Dr. R. Moreno-Otero, 2) SAF2010/21805 from Ministerio de Ciencia e Innovacion to RM-O, 3) AIO Asociacion Espanola Contra el Cancer to PS-C, 4) Mutua Madrilena to RM-O, and 5) Mutua Madrilena to PS-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Ankoma-Sey V, 1998, ONCOGENE, V17, P115, DOI 10.1038/sj.onc.1201912; Bartenschlager R, 2005, J HEPATOL, V43, P210, DOI 10.1016/j.jhep.2005.05.013; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Cho YJ, 2011, RESPIROLOGY, V16, P284, DOI 10.1111/j.1440-1843.2010.01915.x; Chu VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028551; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; di Bonzo LV, 2009, HISTOL HISTOPATHOL, V24, P1323, DOI 10.14670/HH-24.1323; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Eleuteri E, 2011, EUR J CARDIOV PREV R, V18, P607, DOI 10.1177/1741826710389410; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Forbes SJ, 2011, BEST PRACT RES CL GA, V25, P207, DOI 10.1016/j.bpg.2011.02.006; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2009, EXP MOL MED, V41, P133, DOI 10.3858/emm.2009.41.3.016; Hernandez-Bartolome A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066143; Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li YM, 2010, HEPATOL RES, V40, P1022, DOI 10.1111/j.1872-034X.2010.00712.x; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Martin-Vilchez S, 2008, HEPATOLOGY, V47, P1872, DOI 10.1002/hep.22265; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; Medina J, 2003, J HEPATOL, V38, P660, DOI 10.1016/S0168-8278(03)00053-9; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Novo E, 2009, INT J BIOCHEM CELL B, V41, P2089, DOI 10.1016/j.biocel.2009.03.010; Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002; Phelps ED, 2006, AM J PHYSIOL-CELL PH, V290, pC352, DOI 10.1152/ajpcell.00050.2005; Pietila R, 2012, J CELL SCI, V125, P2212, DOI 10.1242/jcs.098020; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Poynard T, 2000, BEST PRACT RES CL GA, V14, P211, DOI 10.1053/bega.1999.0071; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Salcedo X, 2005, HEPATOLOGY, V42, P696, DOI 10.1002/hep.20828; Salcedo X, 2005, ALIMENT PHARM THER, V22, P23, DOI 10.1111/j.1365-2036.2005.02532.x; Sancho-Bru P, 2010, LIVER INT, V30, P31, DOI 10.1111/j.1478-3231.2009.02161.x; Sanz-Cameno P, 2006, AM J PATHOL, V169, P1215, DOI 10.2353/ajpath.2006.051246; Sanz-Cameno P, 2010, J ONCOL, V2010, DOI 10.1155/2010/272170; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Shin Ju Yeop, 2003, Korean J Gastroenterol, V42, P400; Shin JY, 2005, EXP MOL MED, V37, P138, DOI 10.1038/emm.2005.19; Singh H, 2009, CELL SIGNAL, V21, P1346, DOI 10.1016/j.cellsig.2009.04.002; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V317, P358, DOI 10.1016/j.bbrc.2004.03.050; Watanabe N, 2011, BIOCHEM BIOPH RES CO, V407, P135, DOI 10.1016/j.bbrc.2011.02.125; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347	70	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e106958	10.1371/journal.pone.0106958	http://dx.doi.org/10.1371/journal.pone.0106958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302785	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400004
J	Rico, S; Yepes, A; Rodriguez, H; Santamaria, J; Antoraz, S; Krause, EM; Diaz, M; Santamaria, RI				Rico, Sergio; Yepes, Ana; Rodriguez, Hector; Santamaria, Jorge; Antoraz, Sergio; Krause, Eva M.; Diaz, Margarita; Santamaria, Ramon I.			Regulation of the AbrA1/A2 Two-Component System in Streptomyces coelicolor and the Potential of Its Deletion Strain as a Heterologous Host for Antibiotic Production	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; BIOSYNTHETIC GENE-CLUSTER; RESPONSE REGULATOR; ESCHERICHIA-COLI; OVIEDOMYCIN; EXPRESSION; ORGANIZATION; INTEGRATION; BACTERIA; SEQUENCE	The Two-Component System (TCS) AbrA1/A2 from Streptomyces coelicolor M145 is a negative regulator of antibiotic production and morphological differentiation. In this work we show that it is able to auto-regulate its expression, exerting a positive induction of its own operon promoter, and that its activation is dependent on the presence of iron. The overexpression of the abrA2 response regulator (RR) gene in the mutant DabrA1/A2 results in a toxic phenotype. The reason is an excess of phosphorylated AbrA2, as shown by phosphoablative and phosphomimetic AbrA2 mutants. Therefore, non-cognate histidine kinases (HKs) or small phospho-donors may be responsible for AbrA2 phosphorylation in vivo. The results suggest that in the parent strain S. coelicolor M145 the correct amount of phosphorylated AbrA2 is adjusted through the phosphorylation-dephosphorylation activity rate of the HK AbrA1. Furthermore, the ABC transporter system, which is part of the four-gene operon comprising AbrA1/A2, is necessary to de-repress antibiotic production in the TCS null mutant. Finally, in order to test the possible biotechnological applications of the DabrA1/A2 strain, we demonstrate that the production of the antitumoral antibiotic oviedomycin is duplicated in this strain as compared with the production obtained in the wild type, showing that this strain is a good host for heterologous antibiotic production. Thus, this genetically modified strain could be interesting for the biotechnology industry.	[Rico, Sergio; Rodriguez, Hector; Santamaria, Jorge; Antoraz, Sergio; Diaz, Margarita; Santamaria, Ramon I.] Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Yepes, Ana] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Krause, Eva M.] Univ Bibliothek Marburg, Marburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Wurzburg	Diaz, M (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	mardi@usal.es; santa@usal.es	Martínez, Margarita Díaz/L-3069-2014; Krause, Evamaria/AHB-0043-2022; Santamaria, Ramon I/M-9069-2019; Santamaria, Ramon I/K-2870-2014; Rodríguez, Héctor/E-6887-2013	Martínez, Margarita Díaz/0000-0003-4286-1506; Krause, Evamaria/0000-0002-4946-6544; Santamaria, Ramon I/0000-0002-2181-6776; Santamaria, Ramon I/0000-0002-2181-6776; Rodríguez, Héctor/0000-0002-9948-2497; Santamaria, Jorge/0000-0003-4425-6297; Antoraz, Sergio/0000-0001-8429-5245	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT) [GEN2003-20245-C09-02]; Junta de Castilla y Leon (JCyL) [SA072A07, CSI099A12-1]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17551]; CSIC; Botin Foundation	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon (JCyL)(Junta de Castilla y Leon); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; Botin Foundation	This work was supported by Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT) [GEN2003-20245-C09-02]; Junta de Castilla y Leon (JCyL) [SA072A07, CSI099A12-1]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17551]. SR had a JAE-predoctoral grant from the CSIC. AY was a holder of a predoctoral grant from the Junta de Castilla y Leon. HR had a postdoctoral fellowship from Botin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham SAI, 2001, ARCH MICROBIOL, V177, P91, DOI 10.1007/s00203-001-0365-3; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Chen YH, 2010, APPL MICROBIOL BIOT, V86, P19, DOI 10.1007/s00253-009-2428-3; Cho HS, 2001, CURR OPIN STRUC BIOL, V11, P679, DOI 10.1016/S0959-440X(01)00271-8; Coisne S, 1999, LETT APPL MICROBIOL, V28, P199, DOI 10.1046/j.1365-2672.1999.00509.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Gebhard S, 2012, MOL MICROBIOL, V86, P1295, DOI 10.1111/mmi.12078; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hesketh A, 2009, MOL MICROBIOL, V74, P1427, DOI 10.1111/j.1365-2958.2009.06941.x; Hopwood D. A., 1985, GENETIC MANIPULATION; Hoskisson PA, 2006, TRENDS MICROBIOL, V14, P444, DOI 10.1016/j.tim.2006.08.005; KATZ E, 1983, J GEN MICROBIOL, V129, P2703; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lee LF, 2007, MICROBIOL-SGM, V153, P924, DOI 10.1099/mic.0.2006/000018-0; Liu R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-207; Lombo F, 2004, CHEMBIOCHEM, V5, P1181, DOI 10.1002/cbic.200400073; Lombo F, 2009, CHEMBIOCHEM, V10, P296, DOI 10.1002/cbic.200800425; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Martin J., 2012, 2 COMPONENT SYSTEMS, P315; Medema MH, 2011, NAT REV MICROBIOL, V9, P131, DOI 10.1038/nrmicro2478; Mendez C, 2002, J NAT PROD, V65, P779, DOI 10.1021/np010555n; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Mitrophanov AY, 2010, J MOL BIOL, V401, P671, DOI 10.1016/j.jmb.2010.06.051; Neumuller AM, 2001, EUR J BIOCHEM, V268, P3180, DOI 10.1046/j.1432-1327.2001.02203.x; Pawelczyk S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037737; Rico S, 2014, APPL ENVIRON MICROB, V80, P2417, DOI 10.1128/AEM.03378-13; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rodriguez H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-127; Rodriguez S, 2005, GENE, V351, P1, DOI 10.1016/j.gene.2005.03.007; Sambrook J., 2002, MOL CLONING LAB MANU; Sheridan R. C., 2007, INORG SYN, P23; Sprusansky O, 2005, J BACTERIOL, V187, P664, DOI 10.1128/JB.187.2.664-671.2005; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yepes A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019980; Zerikly M, 2009, CHEMBIOCHEM, V10, P625, DOI 10.1002/cbic.200800389	42	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109844	10.1371/journal.pone.0109844	http://dx.doi.org/10.1371/journal.pone.0109844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303210	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400084
J	Sheng-Fowler, L; Tu, W; Fu, HQ; Murata, H; Lanning, L; Foseh, G; Macauley, J; Blair, D; Hughes, SH; Coffin, JM; Lewis, AM; Peden, K				Sheng-Fowler, Li; Tu, Wei; Fu, Haiqing; Murata, Haruhiko; Lanning, Lynda; Foseh, Gideon; Macauley, Juliete; Blair, Donald; Hughes, Stephen H.; Coffin, John M.; Lewis, Andrew M., Jr.; Peden, Keith			A Mouse Strain Defective in Both T Cells and NK Cells Has Enhanced Sensitivity to Tumor Induction by Plasmid DNA Expressing Both Activated H-Ras and c-Myc	PLOS ONE			English	Article							BLADDER-CARCINOMA CELLS; TRANSFORMING GENE; IN-VIVO; TUMORIGENIC CONVERSION; PAPILLOMAVIRUS DNA; POLYOMA-VIRUS; LINES; CANCER; MICE; ONCOGENES	As part of safety studies to evaluate the risk of residual cellular DNA in vaccines manufactured in tumorigenic cells, we have been developing in vivo assays to detect and quantify the oncogenic activity of DNA. We generated a plasmid expressing both an activated human H-ras gene and murine c-myc gene and showed that 1 mu g of this plasmid, pMSV-T24-H-ras/MSV-c-myc, was capable of inducing tumors in newborn NIH Swiss mice. However, to be able to detect the oncogenicity of dominant activated oncogenes in cellular DNA, a more sensitive system was needed. In this paper, we demonstrate that the newborn CD3 epsilon transgenic mouse, which is defective in both T-cell and NK-cell functions, can detect the oncogenic activity of 25 ng of the circular form of pMSV-T24-H-ras/MSV-c-myc. When this plasmid was inoculated as linear DNA, amounts of DNA as low as 800 pg were capable of inducing tumors. Animals were found that had multiple tumors, and these tumors were independent and likely clonal. These results demonstrate that the newborn CD3 epsilon mouse is highly sensitive for the detection of oncogenic activity of DNA. To determine whether it can detect the oncogenic activity of cellular DNA derived from four human tumor-cell lines (HeLa, A549, HT-1080, and CEM), DNA (100 mu g) was inoculated into newborn CD3 epsilon mice both in the presence of 1 mu g of linear pMSV-T24-H-ras/MSV-c-myc as positive control and in its absence. While tumors were induced in 100% of mice with the positive-control plasmid, no tumors were induced in mice receiving any of the tumor DNAs alone. These results demonstrate that detection of oncogenes in cellular DNA derived from four human tumor-derived cell lines in this mouse system was not possible; the results also show the importance of including a positive-control plasmid to detect inhibitory effects of the cellular DNA.	[Sheng-Fowler, Li; Tu, Wei; Fu, Haiqing; Murata, Haruhiko; Foseh, Gideon; Macauley, Juliete; Lewis, Andrew M., Jr.; Peden, Keith] US FDA, Off Vaccines Res & Review, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Lanning, Lynda] Natl Inst Allergy & Infect Dis, Rockville, MD USA; [Blair, Donald] Natl Canc Inst, Rockville, MD USA; [Hughes, Stephen H.; Coffin, John M.] Natl Canc Inst, Frederick Canc Res Facil, Frederick, MD USA; [Coffin, John M.] Tufts Univ, Boston, MA 02111 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University	Peden, K (corresponding author), US FDA, Off Vaccines Res & Review, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	keith.peden@fda.hhs.gov			Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases; CBER/FDA [YI-AI-4893-02NIAID]; National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research; NCI, NIH [HHSN26120080001E]	Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CBER/FDA; National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a contract from the Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases through an Interagency Agreement with CBER/FDA (contract number YI-AI-4893-02NIAID), program officer Sonnie Kim-Grossman. SHH is supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research, and in part with funds from the NCI, NIH, under contract HHSN26120080001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR DG, 1982, SCIENCE, V218, P1122, DOI 10.1126/science.6293052; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; BOUCHARD L, 1984, VIROLOGY, V135, P53, DOI 10.1016/0042-6822(84)90116-8; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Cupillard L, 2005, VACCINE, V23, P1910, DOI 10.1016/j.vaccine.2004.10.018; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FOLEY GE, 1965, CANCER RES, V25, P1254; GEY G O, 1954, Harvey Lect, V50, P154; GEY G O, 1954, Ann N Y Acad Sci, V58, P976, DOI 10.1111/j.1749-6632.1954.tb45886.x; GEY GO, 1952, CANCER RES, V12, P264; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; Hesketh R., 1997, ONCOGENE TUMOUR SUPP; HILL RP, 1980, BRIT J CANCER, V41, P230; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; ISRAEL MA, 1979, J VIROL, V29, P990, DOI 10.1128/JVI.29.3.990-996.1979; ISRAEL MA, 1979, P NATL ACAD SCI USA, V76, P3713, DOI 10.1073/pnas.76.8.3713; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lewis A M Jr, 2001, Dev Biol (Basel), V106, P513; Lewis AM, 1999, J VIROL METHODS, V79, P41, DOI 10.1016/S0166-0934(98)00182-7; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Liu CZ, 2010, J HEPATOL, V53, P98, DOI 10.1016/j.jhep.2010.02.021; Macville M, 1999, CANCER RES, V59, P141; MARSHALL CJ, 1982, NATURE, V299, P171, DOI 10.1038/299171a0; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; MERL S, 1984, BLOOD, V64, P967; Mortimer I, 1999, GENE THER, V6, P403, DOI 10.1038/sj.gt.3300837; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Petricciani J, 2001, Dev Biol (Basel), V106, P275; PETRICCIANI JC, 1995, BIOLOGICALS, V23, P233, DOI 10.1006/biol.1995.0039; Pillai VB, 2008, VACCINE, V26, P1136, DOI 10.1016/j.vaccine.2007.10.023; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Routes JM, 2000, VIROLOGY, V277, P48, DOI 10.1006/viro.2000.0571; SANTOS E, 1984, FED PROC, V43, P2280; Sheng L, 2008, BIOLOGICALS, V36, P184, DOI 10.1016/j.biologicals.2007.11.003; Sheng-Fowler L, 2010, INT J BIOL SCI, V6, P151; Sheng-Fowler L, 2009, BIOLOGICALS, V37, P259, DOI 10.1016/j.biologicals.2009.04.002; Sheng-Fowler L, 2009, BIOLOGICALS, V37, P190, DOI 10.1016/j.biologicals.2009.02.015; SMALL MB, 1987, MOL CELL BIOL, V7, P1638, DOI 10.1128/MCB.7.5.1638; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; ZERLIN M, 1987, ONCOGENE, V1, P19; ZIETMAN AL, 1988, CANCER RES, V48, P6510	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108926	10.1371/journal.pone.0108926	http://dx.doi.org/10.1371/journal.pone.0108926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302710	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400036
J	Kim, HS; Choi, SI; Jeung, EB; Yoo, YM				Kim, Han Sung; Choi, Seung-Il; Jeung, Eui-Bae; Yoo, Yeong-Min			Cyclosporine A Induces Apoptotic and Autophagic Cell Death in Rat Pituitary GH3 Cells	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; MALIGNANT GLIOMA-CELLS; RENAL TUBULAR CELLS; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISM; MESANGIAL CELLS; IN-VITRO; STRESS; MITOCHONDRIA; NEPHROPATHY	Cyclosporine A (CsA) is a powerful immunosuppressive drug with side effects including the development of chronic nephrotoxicity. In this study, we investigated CsA treatment induced apoptotic and autophagic cell death in pituitary GH3 cells. CsA treatment (0.1 to 10 mu M) decreased survival of GH3 cells in a dose-dependent manner. Cell viability decreased significantly with increasing CsA concentrations largely due to an increase in apoptosis, while cell death rates due to autophagy altered only slightly. Several molecular and morphological features correlated with cell death through these distinct pathways. At concentrations ranging from 1.0 to 10 mu M, CsA induced a dose-dependent increase in expression of the autophagy markers LC3-I and LC3-II. Immunofluorescence staining revealed markedly increased levels of both LC3 and lysosomal-associated membrane protein 2 (Lamp2), indicating increases in autophagosomes. At the same CsA doses, apoptotic cell death was apparent as indicated by nuclear and DNA fragmentation and increased p53 expression. In apoptotic or autophagic cells, p-ERK levels were highest at 1.0 mu M CsA compared to control or other doses. In contrast, Bax levels in both types of cell death were increased in a dose-dependent manner, while Bcl-2 levels showed dose-dependent augmentation in autophagy and were decreased in apoptosis. Manganese superoxide dismutase (Mn-SOD) showed a similar dose-dependent reduction in cells undergoing apoptosis, while levels of the intracellular calcium ion exchange maker calbindin-D9k were decreased in apoptosis (1.0 to 5 mu M CsA), but unchanged in autophagy. In conclusion, these results suggest that CsA induction of apoptotic or autophagic cell death in rat pituitary GH3 cells depends on the relative expression of factors and correlates with Bcl-2 and Mn-SOD levels.	[Kim, Han Sung; Yoo, Yeong-Min] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea; [Choi, Seung-Il] Yonsei Univ, Coll Med, Cornea Dystrophy Res Inst, Seoul, South Korea; [Choi, Seung-Il] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Jeung, Eui-Bae] Chungbuk Natl Univ, Coll Vet Med, Lab Vet Biochem & Mol Biol, Cheongju, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungbuk National University	Jeung, EB (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Lab Vet Biochem & Mol Biol, Cheongju, South Korea.	ebjeung@cbu.ac.kr; yyeongm@hanmail.net		choi, seung-il/0000-0001-7168-8795	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2010-00757]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00956301]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2010-00757) and by a grant from the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (No. PJ00956301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulares AH, 2002, J BIOL CHEM, V277, P372, DOI 10.1074/jbc.M107738200; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Buetler TM, 2000, TRENDS PHARMACOL SCI, V21, P288, DOI 10.1016/S0165-6147(00)01508-X; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Cecka JM, 1991, CLIN TRANSPL, V1991, P1; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Choi KC, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-66; Choi KC, 2008, J CELL MOL MED, V12, P409, DOI 10.1111/j.1582-4934.2007.00209.x; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; Daly PJ, 2009, BJU INT, V103, P254, DOI 10.1111/j.1464-410X.2008.08010.x; de Lema GP, 1998, LIFE SCI, V62, P1745, DOI 10.1016/S0024-3205(98)00136-2; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Galletti P, 2005, NEPHROL DIAL TRANSPL, V20, P1551, DOI 10.1093/ndt/gfh846; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Han SY, 2006, TRANSPLANT P, V38, P2244, DOI 10.1016/j.transproceed.2006.06.029; Han SW, 2008, AM J NEPHROL, V28, P707, DOI 10.1159/000127432; Ito H, 2005, INT J ONCOL, V26, P1401; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; KERR JFR, 1965, J PATHOL BACTERIOL, V90, P419, DOI 10.1002/path.1700900210; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee GS, 2003, CLIN BIOCHEM, V36, P255, DOI 10.1016/S0009-9120(03)00010-9; Lim SW, 2012, TRANSPLANTATION, V94, P218, DOI 10.1097/TP.0b013e31825ace5c; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Longoni B, 2002, FREE RADICAL RES, V36, P357, DOI 10.1080/10715760290019381; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Nguyen TH, 2005, MOL BRAIN RES, V141, P166, DOI 10.1016/j.molbrainres.2005.09.008; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Olyaei A J, 2001, Curr Opin Crit Care, V7, P384, DOI 10.1097/00075198-200112000-00003; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pallet N, 2009, KIDNEY INT, V75, P118, DOI 10.1038/ki.2008.537; Pyrzynska B, 2002, J BIOL CHEM, V277, P14102, DOI 10.1074/jbc.M104443200; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Shihab FS, 1999, KIDNEY INT, V56, P2147, DOI 10.1046/j.1523-1755.1999.00794.x; Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; Tinnanooru P, 2008, MOL CELL ENDOCRINOL, V285, P26, DOI 10.1016/j.mce.2008.01.011; Wolf A, 1997, J PHARMACOL EXP THER, V280, P1328; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81	47	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108981	10.1371/journal.pone.0108981	http://dx.doi.org/10.1371/journal.pone.0108981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299210	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200028
J	Lopes-Pacheco, M; Ventura, TG; de Oliveira, HD; Moncao-Riberio, LC; Gutfilen, B; de Souza, SAL; Rocco, PRM; Borojevic, R; Morales, MM; Takiya, CM				Lopes-Pacheco, Miqueias; Ventura, Tulio G.; de Oliveira, Helena D'Anunciacao; Moncao-Riberio, Leonardo C.; Gutfilen, Bianca; de Souza, Sergio A. L.; Rocco, Patricia R. M.; Borojevic, Radovan; Morales, Marcelo M.; Takiya, Christina M.			Infusion of Bone Marrow Mononuclear Cells Reduces Lung Fibrosis but Not Inflammation in the Late Stages of Murine Silicosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; STEM-CELLS; TGF-BETA; LIVER FIBROSIS; NITRIC-OXIDE; APOPTOSIS; THERAPY; MACROPHAGES; ACTIVATION; SECRETION	We hypothesized that infusion of bone marrow mononuclear cells (BMMCs) in the late stages of silica- induced damage would reduce the remodelling process in a murine model of silicosis. C57BL/6 mice were assigned to 2 groups. In the SIL group, mice were instilled with a silica particle suspension intratracheally. Control (C) mice received saline under the same protocol. On the 40th day, some of the animals from both groups were killed. The others were treated with either saline or BMMCs (1x10(6) cells) intravenously (C+BMMC and SIL+BMMC), and the mice were killed 70 days after the start of the protocol. In the mice in the SIL+BMMC group, collagen deposition, the presence of silica particles inside nodules, the presence of macrophages and cells reactive for inducible nitric oxide synthase were reduced. Lung parameters also improved. Beyond that, the total and differential cellularity of bronchoalveolar lavage fluid, immunoexpression of transforming growth factor-beta, the number of T regulatory cells and apoptosis were increased. However, the presence of male donor cells in lung tissue was not observed using GFP+cells (40d) or Y chromosome DNA (70d). Therefore, BMMC therapy in the late stages of experimental silicosis improved lung function by diminishing fibrosis but inflammatory cells persisted, which could be related to expansion of T regulatory cells, responsible for the beneficial effects of cell therapy.	[Lopes-Pacheco, Miqueias; Ventura, Tulio G.; Borojevic, Radovan; Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Cellular Pathol, Rio De Janeiro, Brazil; [Lopes-Pacheco, Miqueias; de Oliveira, Helena D'Anunciacao; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil; [Lopes-Pacheco, Miqueias; Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Pulm Invest, Rio De Janeiro, Brazil; [Gutfilen, Bianca; de Souza, Sergio A. L.] Univ Fed Rio de Janeiro, Sch Med, Dept Radiol, Rio De Janeiro, Brazil; [Borojevic, Radovan] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Cellular Proliferat & Differentiat, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Morales, MM (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil.	mmorales@biof.ufrj.br	Lopes-Pacheco, Miquéias/I-1290-2017; Gutfilen, Bianca/C-3116-2013; Takiya, Christina/AAU-5959-2021; Rocco, Patricia/I-7460-2012; Borojevic, Radovan/V-8500-2019; de Souza, Sergio Augusto Lopes/A-9431-2013; Oliveira, Helena/AAR-6862-2020; Lopes-Pacheco, Miquéias/AAM-7432-2020	Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Takiya, Christina/0000-0002-8019-628X; Rocco, Patricia/0000-0003-1412-7136; Borojevic, Radovan/0000-0002-2393-7280; de Souza, Sergio Augusto Lopes/0000-0002-7901-4805; Lopes-Pacheco, Miquéias/0000-0002-7444-9359; de Oliveira, Helena/0000-0003-2744-3496	FAPERJ; CAPES; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants of FAPERJ, CAPES and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES JHT, 1985, J APPL PHYSIOL, V59, P732, DOI 10.1152/jappl.1985.59.3.732; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Davis Gerald S., 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P99; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Gossart S, 1996, J IMMUNOL, V156, P1540; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Hisanaga T, 2011, CELL TISSUE RES, V346, P79, DOI 10.1007/s00441-011-1236-0; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Kong QF, 2009, J NEUROIMMUNOL, V207, P83, DOI 10.1016/j.jneuroim.2008.12.005; Kumamoto M, 2009, EUR RESPIR J, V34, P740, DOI 10.1183/09031936.00128508; Lassance RM, 2009, RESP PHYSIOL NEUROBI, V169, P227, DOI 10.1016/j.resp.2009.09.004; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Lopes-Pacheco M, 2013, CELL PHYSIOL BIOCHEM, V32, P1681, DOI 10.1159/000356603; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Maron-Gutierrez T, 2011, EUR RESPIR J, V37, P1217, DOI 10.1183/09031936.00205009; MCDONALD JW, 1995, ARCH PATHOL LAB MED, V119, P242; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Ornellas DS, 2011, RESP PHYSIOL NEUROBI, V178, P304, DOI 10.1016/j.resp.2011.06.029; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Porter DW, 2006, TOXICOL SCI, V90, P188, DOI 10.1093/toxsci/kfj075; Prota LFM, 2010, CELL TRANSPLANT, V19, P965, DOI 10.3727/096368910X506845; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Rejman J, 2009, MOL THER, V17, P1257, DOI 10.1038/mt.2009.96; Rimal B, 2005, CURR OPIN PULM MED, V11, P169, DOI 10.1097/01.mcp.0000152998.11335.24; Semedo P, 2010, LAB INVEST, V90, P685, DOI 10.1038/labinvest.2010.45; Shen HM, 2001, AM J PHYSIOL-LUNG C, V280, pL10, DOI 10.1152/ajplung.2001.280.1.L10; Srivastava KD, 2002, AM J RESP CRIT CARE, V165, P527, DOI 10.1164/ajrccm.165.4.2106009; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yang ZQ, 2009, AM J RESP CELL MOL, V40, P375, DOI 10.1165/rcmb.2008-0300OC; Zhen GH, 2008, FRONT BIOSCI, V13, P3415; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888	48	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109982	10.1371/journal.pone.0109982	http://dx.doi.org/10.1371/journal.pone.0109982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299237	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200092
J	Booiman, T; Jimenez, VC; van Dort, KA; van't Wout, AB; Kootstra, NA				Booiman, Thijs; Jimenez, Viviana Cobos; van Dort, Karel A.; van't Wout, Angelique B.; Kootstra, Neeltje A.			Phosphodiesterase 8a Supports HIV-1 Replication in Macrophages at the Level of Reverse Transcription	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; PRODUCTIVE INFECTION; TYPE-1 REPLICATION; CCR5 EXPRESSION; LYMPHOID-TISSUE; T-CELLS; TRANSMISSION; SAMHD1; PERSISTENCE	Background: HIV-1 infected macrophages play a key role in HIV-1 infection. Even during anti-retroviral treatment, macrophages keep producing virus due to suboptimal tissue penetration and reduced efficacy of antiretrovirals. It is therefore of major importance to understand which host factors are involved in HIV-1 replication in macrophages. Previously, we have shown that genetic polymorphisms in phosphodiesterase 8a (PDE8A) are strongly associated with HIV-1 replication in these cells. Here we analyzed the mechanism and regulation of PDE8A in HIV-1 replication in macrophages. Results: PDE8A mRNA expression strongly increases upon differentiation of monocytes into macrophages, which corresponds to the increased susceptibility of mature macrophages to HIV-1. In parallel, expression of microRNA miR-1455p, predicted to target PDE8A mRNA, strongly decreased. The interaction of miR-145-5p with the 39 UTR of PDE8A mRNA could be experimentally validated, suggesting that indeed miR-145-5p can regulate PDE8A expression levels. Knockdown of PDE8A in macrophages resulted in a decrease in total HIV-1 replication and proviral DNA levels. These observations confirm that PDE8A regulates HIV-1 replication in macrophages and that this effect is mediated through early steps in the viral replication cycle. Conclusions: PDE8A is highly expressed in macrophages, and its expression is regulated by miR-145-5p. Our findings strongly suggest that PDE8A supports HIV-1 replication in macrophages and that this effect is mediated at the level of reverse transcription.	[Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.a.kootstra@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754	Academic Medical Center of the University of Amsterdam; Landsteiner Foundation of Blood Research [0526]	Academic Medical Center of the University of Amsterdam; Landsteiner Foundation of Blood Research	This work was supported by the Academic Medical Center of the University of Amsterdam and the Landsteiner Foundation of Blood Research (registration number 0526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouch A, 2013, P NATL ACAD SCI USA, V110, pE3997, DOI 10.1073/pnas.1306719110; Bol SM, 2011, VIROLOGY, V420, P32, DOI 10.1016/j.virol.2011.08.013; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Brown KM, 2013, P NATL ACAD SCI USA, V110, pE1533, DOI 10.1073/pnas.1303004110; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Cassol E, 2010, J LEUKOCYTE BIOL, V87, P599, DOI 10.1189/jlb.1009673; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Crowe SM, 2010, J LEUKOCYTE BIOL, V87, P589, DOI 10.1189/jlb.0809580; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fisher DA, 1998, BIOCHEM BIOPH RES CO, V246, P570, DOI 10.1006/bbrc.1998.8684; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; HO DD, 1985, NEW ENGL J MED, V313, P1493, DOI 10.1056/NEJM198512123132401; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Huysentruyt LC, 2010, J LEUKOCYTE BIOL, V87, P627, DOI 10.1189/jlb.0809564; Jimenez VC, 2014, PHYSIOL GENOMICS, V46, P91, DOI 10.1152/physiolgenomics.00140.2013; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Kootstra NA, 1999, VIROLOGY, V253, P170, DOI 10.1006/viro.1998.9482; KOOTSTRA NA, 1994, J VIROL, V68, P6967, DOI 10.1128/JVI.68.11.6967-6975.1994; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lambotte O, 2005, AIDS, V19, P217, DOI 10.1097/00002030-200501280-00018; MANN DL, 1990, J IMMUNOL, V144, P2152; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; Montaner LJ, 1999, J IMMUNOL, V162, P4606; MONTANER LJ, 1994, J GEN VIROL, V75, P3393, DOI 10.1099/0022-1317-75-12-3393; Montaner LJ, 1997, J LEUKOCYTE BIOL, V62, P126, DOI 10.1002/jlb.62.1.126; Moreno-Fernandez ME, 2012, AIDS RES HUM RETROV, V28, P49, DOI [10.1089/aid.2011.0265, 10.1089/AID.2011.0265]; NAIF H, 1994, J LEUKOCYTE BIOL, V56, P335, DOI 10.1002/jlb.56.3.335; Naif HM, 1998, J VIROL, V72, P830, DOI 10.1128/JVI.72.1.830-836.1998; NICHOLSON JKA, 1986, J IMMUNOL, V137, P323; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; RICH EA, 1992, J CLIN INVEST, V89, P176, DOI 10.1172/JCI115559; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; SCHUITEMAKER H, 1992, J CLIN INVEST, V89, P1154, DOI 10.1172/JCI115697; Schwartz BG, 2010, CIRCULATION, V122, P88, DOI 10.1161/CIRCULATIONAHA.110.944603; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Thivierge M, 1998, BLOOD, V92, P40, DOI 10.1182/blood.V92.1.40.413k43_40_45; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhang HT, 2009, CURR PHARM DESIGN, V15, P1688, DOI 10.2174/138161209788168092; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	63	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109673	10.1371/journal.pone.0109673	http://dx.doi.org/10.1371/journal.pone.0109673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295610	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000090
J	Hochman-Mendez, C; Cantini, M; Moratal, D; Salmeron-Sanchez, M; Coelho-Sampaio, T				Hochman-Mendez, Camila; Cantini, Marco; Moratal, David; Salmeron-Sanchez, Manuel; Coelho-Sampaio, Tatiana			A Fractal Nature for Polymerized Laminin	PLOS ONE			English	Article							BASEMENT-MEMBRANE; POLYLAMININ; NICHE; EXPRESSION; STABILITY; DIMENSION; PATTERNS	Polylaminin (polyLM) is a non-covalent acid-induced nano- and micro-structured polymer of the protein laminin displaying distinguished biological properties. Polylaminin stimulates neuritogenesis beyond the levels achieved by ordinary laminin and has been shown to promote axonal regeneration in animal models of spinal cord injury. Here we used confocal fluorescence microscopy (CFM), scanning electron microscopy (SEM) and atomic force microscopy (AFM) to characterize its three-dimensional structure. Renderization of confocal optical slices of immunostained polyLM revealed the aspect of a loose flocculated meshwork, which was homogeneously stained by the antibody. On the other hand, an ordinary matrix obtained upon adsorption of laminin in neutral pH (LM) was constituted of bulky protein aggregates whose interior was not accessible to the same anti-laminin antibody. SEM and AFM analyses revealed that the seed unit of polyLM was a flat polygon formed in solution whereas the seed structure of LM was highly heterogeneous, intercalating rod-like, spherical and thin spread lamellar deposits. As polyLM was visualized at progressively increasing magnifications, we observed that the morphology of the polymer was alike independently of the magnification used for the observation. A search for the Hausdorff dimension in images of the two matrices showed that polyLM, but not LM, presented fractal dimensions of 1.55, 1.62 and 1.70 after 1, 8 and 12 hours of adsorption, respectively. Data in the present work suggest that the intrinsic fractal nature of polymerized laminin can be the structural basis for the fractal-like organization of basement membranes in the neurogenic niches of the central nervous system.	[Hochman-Mendez, Camila] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Hochman-Mendez, Camila; Coelho-Sampaio, Tatiana] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Cantini, Marco; Salmeron-Sanchez, Manuel] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland; [Moratal, David] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of Glasgow; Universitat Politecnica de Valencia	Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.	tcsampaio@histo.ufrj.br	Salmeron-Sanchez, Manuel/E-4680-2010; Moratal, David/D-1853-2010	Salmeron-Sanchez, Manuel/0000-0002-8112-2100; Moratal, David/0000-0002-2825-3646; Hochman-Mendez, Camila/0000-0002-1425-594X; Cantini, Marco/0000-0003-0326-1508	Brazilian National Research Council (CNPq) [476772/2008-7]; European Research Council [ERC - 306990]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by a grant from the Brazilian National Research Council (CNPq; 476772/2008-7) to TCS. MSS acknowledges support from the European Research Council through ERC - 306990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Hernandez JCR, 2007, BIOPHYS J, V93, P202, DOI 10.1529/biophysj.106.102491; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Chyba M, 2011, J MATH IND, V3, P79; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Douet V, 2013, CELL PROLIFERAT, V46, P137, DOI 10.1111/cpr.12023; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Freire E, 2002, J CELL SCI, V115, P4867, DOI 10.1242/jcs.00173; Freire E, 2000, J BIOL CHEM, V275, P817, DOI 10.1074/jbc.275.2.817; Freire E, 2012, MACROMOL BIOSCI, V12, P67, DOI 10.1002/mabi.201100125; Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916; GARCIAABREU J, 1995, NEUROREPORT, V6, P761, DOI 10.1097/00001756-199503270-00014; Hausdorff F, 1919, MATH ANN, V79, P157; Hediyeh I, 2012, J PHIS CHEM B, V116, P1951; Hochman-Mendez C, 2014, J NEUROSCI RES, V92, P24, DOI 10.1002/jnr.23298; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Mercier F, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P109, DOI 10.1007/978-4-431-53933-9_4; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palmero CY, 2013, MOL CELL ENDOCRINOL, V376, P12, DOI 10.1016/j.mce.2013.05.020; Qu HT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-135; Barroso MMS, 2008, J BIOL CHEM, V283, P11714, DOI 10.1074/jbc.M709301200; Soille P, 1996, J VIS COMMUN IMAGE R, V7, P217, DOI 10.1006/jvci.1996.0020; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I	38	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109388	10.1371/journal.pone.0109388	http://dx.doi.org/10.1371/journal.pone.0109388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296244	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000345204000067
J	Miller, SH; Zarate, S; Smith, EH; Gaylord, B; Hosfelt, JD; Hill, TM				Miller, Seth H.; Zarate, Sonia; Smith, Edmund H.; Gaylord, Brian; Hosfelt, Jessica D.; Hill, Tessa M.			Effect of Elevated pCO(2) on Metabolic Responses of Porcelain Crab (Petrolisthes cinctipes) Larvae Exposed to Subsequent Salinity Stress	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; LIFE-HISTORY; CO2 LEVELS; IMPACTS; BEHAVIOR; ANOMURA; RECRUITMENT; CRUSTACEANS; SETTLEMENT	Future climate change is predicted to alter the physical characteristics of oceans and estuaries, including pH, temperature, oxygen, and salinity. Investigating how species react to the influence of such multiple stressors is crucial for assessing how future environmental change will alter marine ecosystems. The timing of multiple stressors can also be important, since in some cases stressors arise simultaneously, while in others they occur in rapid succession. In this study, we investigated the effects of elevated pCO(2) on oxygen consumption by larvae of the intertidal porcelain crab Petrolisthes cinctipes when exposed to subsequent salinity stress. Such an exposure mimics how larvae under future acidified conditions will likely experience sudden runoff events such as those that occur seasonally along portions of the west coast of the U.S. and in other temperate systems, or how larvae encounter hypersaline waters when crossing density gradients via directed swimming. We raised larvae in the laboratory under ambient and predicted future pCO(2) levels (385 and 1000 mu atm) for 10 days, and then moved them to seawater at ambient pCO(2) but with decreased, ambient, or elevated salinity, to monitor their respiration. While larvae raised under elevated pCO(2) or exposed to stressful salinity conditions alone did not exhibit higher respiration rates than larvae held in ambient conditions, larvae exposed to elevated pCO(2) followed by stressful salinity conditions consumed more oxygen. These results show that even when multiple stressors act sequentially rather than simultaneously, they can retain their capacity to detrimentally affect organisms.	[Miller, Seth H.; Zarate, Sonia; Smith, Edmund H.; Gaylord, Brian; Hosfelt, Jessica D.; Hill, Tessa M.] Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA; [Gaylord, Brian] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Hosfelt, Jessica D.; Hill, Tessa M.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Miller, SH (corresponding author), Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA.	shmiller@ucdavis.edu	Hill, Tessa Michelle/P-3401-2019	Hill, Tessa Michelle/0000-0003-4159-9104	UC Multicampus Programs & Initiatives Grant; National Science Foundation [OCE-0927255, OCE-1041089]	UC Multicampus Programs & Initiatives Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by a UC Multicampus Programs & Initiatives Grant (http://www.ucop.edu/research-grants-program/programs/multi-campus-research-programs-and-initiatives.html) and the National Science Foundation (grants OCE-0927255 and OCE-1041089) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess SC, 2012, ECOLOGY, V93, P1378; Burgess SC, 2011, J ANIM ECOL, V80, P681, DOI 10.1111/j.1365-2656.2010.01802.x; Byrne M, 2013, INTEGR COMP BIOL, V53, P582, DOI 10.1093/icb/ict049; Carter HA, 2013, J EXP BIOL, V216, P1412, DOI 10.1242/jeb.078162; Ceballos-Osuna L, 2013, J EXP BIOL, V216, P1405, DOI 10.1242/jeb.078154; de la Haye KL, 2011, ANIM BEHAV, V82, P495, DOI 10.1016/j.anbehav.2011.05.030; de la Haye KL, 2012, J EXP MAR BIOL ECOL, V412, P134, DOI 10.1016/j.jembe.2011.11.013; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; Dickinson GH, 2013, J EXP BIOL, V216, P2607, DOI 10.1242/jeb.082909; Dickinson GH, 2012, J EXP BIOL, V215, P29, DOI 10.1242/jeb.061481; Dickson A. G., 2007, PICES SPEC PUB, V3, P1, DOI DOI 10.1159/000331784; Diffenbaugh NS, 2004, P NATL ACAD SCI USA, V101, P27, DOI 10.1073/pnas.0305746101; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donohue PJC, 2012, AQUAT BIOL, V15, P73, DOI 10.3354/ab00408; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hollebone AL, 2007, MAR ECOL PROG SER, V336, P211, DOI 10.3354/meps336211; Intergovernmental Panel on Climate Change (IPCC), 2014, CLIMATE CHANGE 201 A; IPCC, 2007, CLIM CHANG 2004 PHYS; JENSEN GC, 1989, J EXP MAR BIOL ECOL, V131, P223, DOI 10.1016/0022-0981(89)90114-7; JENSEN GC, 1991, MAR ECOL PROG SER, V73, P47, DOI 10.3354/meps073047; JENSEN GC, 1991, J EXP MAR BIOL ECOL, V153, P49, DOI 10.1016/S0022-0981(05)80005-X; Kaldy JE, 2013, BOT MAR, V56, P75, DOI 10.1515/bot-2012-0144; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Lagos ME, 2011, SCI MAR, V75, P273, DOI 10.3989/scimar.2011.75n2273; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Masunari Setuko, 1998, Revista Brasileira de Zoologia, V15, P219; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; Micheletti-Flores C. V., 1999, Revista Brasileira de Biologia, V59, P63; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; Morris R.H., 1980, INTERTIDAL INVERTEBR; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Pansch C, 2013, MAR BIOL, V160, P2023, DOI 10.1007/s00227-012-2069-4; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PELLEGRINO CR, 1984, CRUSTACEANA, V47, P251, DOI 10.1163/156854084X00513; Shanks AL, 2005, ECOL MONOGR, V75, P505, DOI 10.1890/05-0309; Smith SV, 1997, ECOL MONOGR, V67, P509, DOI 10.1890/0012-9615(1997)067[0509:ACAIVO]2.0.CO;2; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Stillman JH, 1996, J EXP BIOL, V199, P1845; Stillman JH, 2009, MOL ECOL, V18, P4206, DOI 10.1111/j.1365-294X.2009.04354.x; Strathmann MF, 1987, REPROD DEV MARINE IN; Styf HK, 2013, ECOL EVOL, V3, P5055, DOI 10.1002/ece3.860; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Yaikin J, 2002, J CRUSTACEAN BIOL, V22, P345, DOI 10.1651/0278-0372(2002)022[0345:ARRAAE]2.0.CO;2; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	56	7	7	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109167	10.1371/journal.pone.0109167	http://dx.doi.org/10.1371/journal.pone.0109167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295878	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000043
J	Nakamura, K; Chung, SW; Kono, Y; Ho, MJ; Hsu, TC; Peng, CI				Nakamura, Koh; Chung, Shih-Wen; Kono, Yoshiko; Ho, Meng-Jung; Hsu, Tian-Chuan; Peng, Ching-I			Ixeridium calcicola (Compositae), a New Limestone Endemic from Taiwan, with Notes on Its Atypical Basic Chromosome Number, Phylogenetic Affinities, and a Limestone Refugium Hypothesis	PLOS ONE			English	Article							YOUNGIA ASTERACEAE; SEQUENCE ALIGNMENT; EVOLUTION; CICHORIEAE; GENUS; DELIMITATION; DIVERGENCE; INFERENCE; MODELS; SPACER	A new species Ixeridium calcicola (Compositae) endemic to middle altitude (ca 1,000-2,000 m asl) limestone mountains of eastcentral Taiwan is described based on morphological and chromosome cytological observations and molecular phylogenetic analyses. Ixeridium calcicola resembles Ixeridium transnokoense, endemic to upper montane and alpine ranges (2,600-3,500 m asl) of Taiwan, in the dwarf habit, but differs in the oblong to lanceolate leaf blades (vs. linear to linear-lanceolate), the presence of mucronulate teeth on the leaf margin and petiole (vs. smooth to very sparse), the dark purple lower leaf surface (vs. greenish), the capitulum with 10 to 12 florets (vs. 5 to 7) and 8 to 10 inner phyllaries (vs. 5, rarely to 7). The basic chromosome number in Ixeridium was known as X = 7. However, the new species has a basic chromosome number of X = 8, as recorded also in the closely related Ixeris. Molecular phylogenetic analyses with the expanded sampling of Ixeridium and Ixeris including both type species supported the monophyly of each of the genera and the placement of the new species in Ixeridium. The result of the phylogenetic analyses and detailed observation of the chromosome morphology revealed that X = 8 in Ixeridium calcicola is derived from centric fission in an ancestral karyomorphotype with X = 7 in Ixeridium. Ixeridium calcicola and Ixeridium transnokoense formed a Taiwan endemic lineage and their estimated divergence time was in the middle Pleistocene. Their common ancestral lineage may have experienced altitudinal distribution shifts in response to glacial-interglacial temperature fluctuation, and a lineage which had not retreated to alpine ranges in an interglacial period likely survived in a limestone refugium, where ordinary plant species did not grow, leading to allopatric speciation.	[Nakamura, Koh; Kono, Yoshiko; Ho, Meng-Jung; Peng, Ching-I] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chung, Shih-Wen; Hsu, Tian-Chuan] Taiwan Forestry Res Inst, Bot Garden Div, Taipei, Taiwan	Academia Sinica - Taiwan	Peng, CI (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	bopeng@sinica.edu.tw			Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This study was supported in part by a postdoctoral fellowship from Academia Sinica to KN, and a research grant from Academia Sinica to CIP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN BG, 1993, AM J BOT, V80, P222, DOI 10.2307/2445043; Chung KF, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-1; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enke N, 2008, TAXON, V57, P756, DOI 10.1002/tax.573008; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goertzen LR, 2003, MOL PHYLOGENET EVOL, V29, P216, DOI 10.1016/S1055-7903(03)00094-0; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho C.-S., 1982, TECTONIC EVOLUTION T; HSIEH CF, 1994, FLORA TAIWAN, V1, P1; Jones K, 1998, BOT REV, V64, P273, DOI 10.1007/BF02856567; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kilian N., 2009, SYSTEMATICS, P343; Kokubugata G, 2010, MOL PHYLOGENET EVOL, V54, P657, DOI 10.1016/j.ympev.2009.09.004; Korea National Arboretum Plant Taxonomic Society of Korea National Plant List Committee and Cultivated Plant List Committee, 2004, KOR PLANT NAM IND; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lu CT, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-57; Mamgain S. K., 1998, Taiwania, V43, P155; Mitsui Y, 2008, ANN BOT-LONDON, V101, P111, DOI 10.1093/aob/mcm267; Nakamura K, 2006, J PLANT RES, V119, P657, DOI 10.1007/s10265-006-0017-4; Nakamura K, 2013, SYST BOT, V38, P507, DOI 10.1600/036364413X666769; Nakamura K, 2012, MOL PHYLOGENET EVOL, V63, P486, DOI 10.1016/j.ympev.2012.01.023; PAK J-H, 1990, Cytologia (Tokyo), V55, P553; PAK J-H, 1990, Acta Phytotaxonomica et Geobotanica, V41, P43; Pak Jae-Hong, 1992, Memoirs of the Faculty of Science Kyoto University Series of Biology, V15, P29; Pelser P.B., 2011, COS DIGITAL FLORA PH; Peng CI, 1999, BOT BULL ACAD SINICA, V40, P53; Peng CI, 1998, FLORA TAIWAN, P995; Peng CI, 1998, FLORA TAIWAN, V4, P993; Peng YL, 2014, PHYTOTAXA, V159, P241, DOI 10.11646/phytotaxa.159.4.1; Petley DN, 1999, GEOL SOC SPEC PUBL, V162, P169, DOI 10.1144/GSL.SP.1999.162.01.14; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Samuel R, 2003, AM J BOT, V90, P496, DOI 10.3732/ajb.90.3.496; Shaw C.L, 1996, ANN REP NATL TAIWAN, V39, P429; Shi C, 2011, FLORA CHINA, V20-21, P328; Shih C, 2011, FLORA CHINA, V20-21, P331; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tremetsberger K, 2013, ORG DIVERS EVOL, V13, P1, DOI 10.1007/s13127-012-0094-2; TSUKADA M, 1966, P NATL ACAD SCI USA, V55, P543, DOI 10.1073/pnas.55.3.543; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yahara Y, 1995, FLORA JAPAN B, VIII, P15	51	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109797	10.1371/journal.pone.0109797	http://dx.doi.org/10.1371/journal.pone.0109797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295587	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000097
J	Bhargava, M; Becker, TL; Viken, KJ; Jagtap, PD; Dey, S; Steinbach, MS; Wu, BL; Kumar, V; Bitterman, PB; Ingbar, DH; Wendt, CH				Bhargava, Maneesh; Becker, Trisha L.; Viken, Kevin J.; Jagtap, Pratik D.; Dey, Sanjoy; Steinbach, Michael S.; Wu, Baolin; Kumar, Vipin; Bitterman, Peter B.; Ingbar, David H.; Wendt, Christine H.			Proteomic Profiles in Acute Respiratory Distress Syndrome Differentiates Survivors from Non-Survivors	PLOS ONE			English	Article							ACUTE LUNG INJURY; BRONCHOALVEOLAR LAVAGE FLUID; MOESIN-DEFICIENT MICE; PULMONARY-EDEMA FLUID; CLARA CELL PROTEIN; CLINICAL-OUTCOMES; ERM PROTEINS; PLASMA; MORTALITY; ADHESION	Acute Respiratory Distress Syndrome (ARDS) continues to have a high mortality. Currently, there are no biomarkers that provide reliable prognostic information to guide clinical management or stratify risk among clinical trial participants. The objective of this study was to probe the bronchoalveolar lavage fluid (BALF) proteome to identify proteins that differentiate survivors from non-survivors of ARDS. Patients were divided into early-phase (1 to 7 days) and late-phase (8 to 35 days) groups based on time after initiation of mechanical ventilation for ARDS (Day 1). Isobaric tags for absolute and relative quantitation (iTRAQ) with LC MS/MS was performed on pooled BALF enriched for medium and low abundance proteins from early-phase survivors (n = 7), early-phase non-survivors (n = 8), and late-phase survivors (n = 7). Of the 724 proteins identified at a global false discovery rate of 1%, quantitative information was available for 499. In early-phase ARDS, proteins more abundant in survivors mapped to ontologies indicating a coordinated compensatory response to injury and stress. These included coagulation and fibrinolysis; immune system activation; and cation and iron homeostasis. Proteins more abundant in early-phase non-survivors participate in carbohydrate catabolism and collagen synthesis, with no activation of compensatory responses. The compensatory immune activation and ion homeostatic response seen in early-phase survivors transitioned to cell migration and actin filament based processes in late-phase survivors, revealing dynamic changes in the BALF proteome as the lung heals. Early phase proteins differentiating survivors from non-survivors are candidate biomarkers for predicting survival in ARDS.	[Bhargava, Maneesh; Becker, Trisha L.; Viken, Kevin J.; Bitterman, Peter B.; Ingbar, David H.; Wendt, Christine H.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Jagtap, Pratik D.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55455 USA; [Dey, Sanjoy; Steinbach, Michael S.; Kumar, Vipin] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Wu, Baolin] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Wendt, Christine H.] Univ Minnesota, Minneapolis VA Med Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Bhargava, M (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	bharg005@umn.edu		Viken, Kevin/0000-0003-3822-2269; Steinbach, Michael/0000-0002-7309-6395; WU, BAOLIN/0000-0001-6676-0422; BITTERMAN, PETER/0000-0002-7995-7117; Bhargava, Maneesh/0000-0002-1294-6181; Ingbar, David H./0000-0003-1695-4493; Jagtap, Pratik/0000-0003-0984-0973	American Heart Association Scientist Development Grant [12SDG8160000]; UMN KL2 Scholars Award [1UL1RR033183-01, 8UL1TR000114-02]; Minnesota Medical Foundation Research Grant [MFN MED FDN/3899-9238-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002492, KL2TR000113, UL1TR000114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033183] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); UMN KL2 Scholars Award; Minnesota Medical Foundation Research Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	12SDG8160000 American Heart Association Scientist Development Grant (MB PI). 1UL1RR033183-01 and 8UL1TR000114-02 UMN KL2 Scholars Award (MB, Blarzar-PI). MFN MED FDN/3899-9238-09 Minnesota Medical Foundation Research Grant (MB PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; ASHBAUGH DG, 1967, LANCET, V2, P319; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bersten AD, 2001, AM J RESP CRIT CARE, V164, P648, DOI 10.1164/ajrccm.164.4.2010111; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87; Calfee CS, 2011, CRIT CARE MED, V39, P711, DOI 10.1097/CCM.0b013e318207ec3c; Calfee C, 2009, INTENS CARE MED, V35, P248, DOI 10.1007/s00134-008-1235-0; Chang DW, 2008, AM J RESP CRIT CARE, V178, P701, DOI 10.1164/rccm.200712-1895OC; Cheng IW, 2003, CRIT CARE MED, V31, P20, DOI 10.1097/00003246-200301000-00003; CLARK JG, 1995, ANN INTERN MED, V122, P17, DOI 10.7326/0003-4819-122-1-199501010-00003; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Connelly KG, 1997, AM J RESP CRIT CARE, V155, P21, DOI 10.1164/ajrccm.155.1.9001283; Cribbs SK, 2008, CRIT CARE MED, V36, P2457, DOI 10.1097/CCM.0b013e318181052a; Determann Rogier M, 2009, BMC Pulm Med, V9, P49, DOI 10.1186/1471-2466-9-49; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; FARJANEL J, 1993, AM REV RESPIR DIS, V147, P1091, DOI 10.1164/ajrccm/147.5.1091; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Gallagher DC, 2008, SHOCK, V29, P656, DOI 10.1097/SHK.0b013e31815dd92f; Gharib SA, 2010, EUR RESPIR J, V35, P1388, DOI 10.1183/09031936.00089409; Ghio AJ, 2003, CRIT CARE MED, V31, P395, DOI 10.1097/01.CCM.0000050284.35609.97; Griffin T, 2013, GALAXY P TRANSFORMIN; Guerin C, 2013, NEW ENGLAND J MED; Hashimoto S, 2008, AM J PHYSIOL-LUNG C, V295, pL566, DOI 10.1152/ajplung.90250.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; Katayama M, 2010, INTENS CARE MED, V36, P479, DOI 10.1007/s00134-009-1719-6; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koeppen M, 2013, MUCOSAL IMMUNOL, V6, P762, DOI 10.1038/mi.2012.114; Kong MYF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022596; Kosanam H, 2012, CLIN BIOCHEM, V45, P223, DOI 10.1016/j.clinbiochem.2011.11.015; Kropski JA, 2009, CHEST, V135, P1440, DOI 10.1378/chest.08-2465; Lagan AL, 2008, CHEST, V133, P1302, DOI 10.1378/chest.07-1117; Lesur O, 2006, INTENS CARE MED, V32, P1167, DOI 10.1007/s00134-006-0235-1; Magi B, 2002, ELECTROPHORESIS, V23, P3434, DOI 10.1002/1522-2683(200210)23:19<3434::AID-ELPS3434>3.0.CO;2-R; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; McClintock DE, 2006, AM J PHYSIOL-LUNG C, V291, pL566, DOI 10.1152/ajplung.00457.2005; Merkel D, 2005, PROTEOMICS, V5, P2972, DOI 10.1002/pmic.200401180; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Okayama T, 2008, BBA-MOL BASIS DIS, V1782, P542, DOI 10.1016/j.bbadis.2008.06.006; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Parsons PE, 2005, AM J PHYSIOL-LUNG C, V288, pL426, DOI 10.1152/ajplung.00302.2004; Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002; Quinlan GJ, 2001, CLIN SCI, V100, P169, DOI 10.1042/CS20000155; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suratt BT, 2006, CLIN CHEST MED, V27, P579, DOI 10.1016/j.ccm.2006.06.005; Suratt BT, 2009, CRIT CARE MED, V37, P1322, DOI 10.1097/CCM.0b013e31819c14fa; The Acute Respiratory Distress Syndrome Network, 2000, NEW ENGLAND J MED, V342, P1301; Torii K, 1997, AM J RESP CRIT CARE, V155, P43, DOI 10.1164/ajrccm.155.1.9001287; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Ware LB, 2010, EUR RESPIR J, V35, P331, DOI 10.1183/09031936.00098709; Ware LB, 2003, AM J PHYSIOL-LUNG C, V285, pL514, DOI 10.1152/ajplung.00442.2002; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Ware LB, 2007, CRIT CARE MED, V35, P1821, DOI 10.1097/01.CCM.0000275386.95968.5F; Ware Lorraine B., 2005, Keio Journal of Medicine, V54, P142, DOI 10.2302/kjm.54.142; Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; Zhang Y, 2006, PROTEOMICS, V6, P1001, DOI 10.1002/pmic.200500105	63	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109713	10.1371/journal.pone.0109713	http://dx.doi.org/10.1371/journal.pone.0109713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290099	Green Submitted, gold, Green Published			2022-12-25	WOS:000342798000080
J	Bishop, MJ; Connolly, A; Plank, G				Bishop, Martin J.; Connolly, Adam; Plank, Gernot			Structural Heterogeneity Modulates Effective Refractory Period: A Mechanism of Focal Arrhythmia Initiation	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; IMPULSE PROPAGATION; ACTIVATION SEQUENCE; REPOLARIZATION; DYNAMICS; GEOMETRY; IMPACT; SPREAD; TOOLS; MODEL	Reductions in electrotonic loading around regions of structural and electrophysiological heterogeneity may facilitate capture of focal triggered activity, initiating reentrant arrhythmias. How electrotonic loading, refractoriness and capture of focal ectopics depend upon the intricate nature of physiological structural anatomy, as well as pathological tissue remodelling, however, is not well understood. In this study, we performed computational bidomain simulations with anatomically-detailed models representing the rabbit left ventricle. We used these models to quantify the relationship between local structural anatomy and spatial heterogeneity in action potential (AP) characteristics, electrotonic currents and effective refractory periods (ERPs) under pacing and restitution protocols. Regions surrounding vessel cavities, in addition to tissue surfaces, had significantly lower peak downstream electrotonic currents than well coupled myocardium (72.6 vs 220.4 mu A/cm(2)), with faster maximum AP upstroke velocities (257.3 vs 147.3 mV/ms), although noticeably very similar APDs (167.7 vs 168.4 ms) and AP restitution properties. Despite similarities in APDs, ERPs in regions of low electrotonic load in the vicinity of surfaces, intramural vessel cavities and endocardial structures were up to 40 ms shorter compared to neighbouring well-coupled tissue, leading to regions of sharp ERP gradients. Consequently, focal extra-stimuli timed within this window of ERP heterogeneity between neighbouring regions readily induced uni-directional block, inducing reentry. Most effective induction sites were within channels of low ERPs between large vessels and epicardium. Significant differences in ERP driven by reductions in electrotonic loading due to fine-scale physiological structural heterogeneity provides an important mechanism of capture of focal activity and reentry induction. Application to pathological ventricles, particularly myocardial infarction, will have important implications in anti-arrhythmia therapy.	[Bishop, Martin J.; Connolly, Adam] Kings Coll London, Div Imaging Sci & Biomed Engn, Dept Biomed Engn, London, England; [Plank, Gernot] Med Univ Graz, Inst Biophys, Graz, Austria; [Plank, Gernot] Univ Oxford, Oxford eRes Ctr, Oxford, England	University of London; King's College London; Medical University of Graz; University of Oxford	Bishop, MJ (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, Dept Biomed Engn, London, England.	martin.bishop@kcl.ac.uk	Plank, Gernot/O-3791-2019; Plank, Gernot/C-9498-2011	Plank, Gernot/0000-0002-7380-6908; Plank, Gernot/0000-0002-7380-6908; Bishop, Martin/0000-0002-6237-1902	United Kingdom Engineering and Physical Sciences Research Council (EPSRC) [EP/K034367/1]; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Centre of Excellence in Medical Engineering - Wellcome Trust and EPSRC [WT 088641/Z/09/Z]; Austrian Science Fund [F3210-N18]; National Heart, Lung, and Blood Institute [RO1-HL-10119601]; Austrian Science Fund (FWF) [F 3201] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K034367/1] Funding Source: researchfish; EPSRC [EP/K034367/1] Funding Source: UKRI	United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Centre of Excellence in Medical Engineering - Wellcome Trust and EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Austrian Science Fund(Austrian Science Fund (FWF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an United Kingdom Engineering and Physical Sciences Research Council (EPSRC) First Grant Award to MJB (EP/K034367/1). MJB \& AC acknowledge the support of the National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London and support from the Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC (Grant WT 088641/Z/09/Z). GP acknowledges Austrian Science Fund Grant F3210-N18 and National Heart, Lung, and Blood Institute Grant RO1-HL-10119601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2001, AM J PHYSIOL-HEART C, V281, pH533, DOI 10.1152/ajpheart.2001.281.2.H533; Bishop MJ, 2011, BIOPHYS J, V101, P2871, DOI 10.1016/j.bpj.2011.10.052; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Bishop MJ, 2010, IEEE T BIO-MED ENG, V57, P2335, DOI 10.1109/TBME.2010.2051227; Bishop MJ, 2010, AM J PHYSIOL-HEART C, V298, pH699, DOI 10.1152/ajpheart.00606.2009; Cherry EM, 2011, J THEOR BIOL, V285, P164, DOI 10.1016/j.jtbi.2011.06.039; CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283; Colli-Franzone P, 2006, MATH BIOSCI, V204, P132, DOI 10.1016/j.mbs.2006.06.002; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; FAST VG, 1995, CARDIOVASC RES, V30, P449, DOI 10.1016/0008-6363(95)00071-2; Fast VG, 1997, CARDIOVASC RES, V33, P258, DOI 10.1016/S0008-6363(96)00216-7; Gibb M, 2009, LECT NOTES COMPUT SC, V5528, P268, DOI 10.1007/978-3-642-01932-6_29; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Kelly A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P809, DOI 10.1161/CIRCEP.113.000334; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Myles RC, 2010, AM J PHYSIOL-HEART C, V299, pH1812, DOI 10.1152/ajpheart.00518.2010; Nguyen TP, 2013, J AMBIENT INTELLIGEN, P1; Plank G, 2009, PHILOS T R SOC A, V367, P2257, DOI 10.1098/rsta.2009.0056; POLLARD AE, 1992, CRIT REV BIOMED ENG, V20, P171; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Sampson KJ, 2005, AM J PHYSIOL-HEART C, V289, pH350, DOI 10.1152/ajpheart.00507.2004; SPACH MS, 1985, IEEE T BIO-MED ENG, V32, P743, DOI 10.1109/TBME.1985.325489; STEVENSON WG, 1995, J CARDIOVASC ELECTR, V6, P942, DOI 10.1111/j.1540-8167.1995.tb00370.x; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Walton RD, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00281; Wilders R, 2000, PFLUG ARCH EUR J PHY, V441, P301, DOI 10.1007/s004240000413; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109754	10.1371/journal.pone.0109754	http://dx.doi.org/10.1371/journal.pone.0109754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291380	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000086
J	Janto, BA; Hiller, NL; Eutsey, RA; Dahlgren, ME; Earl, JP; Powell, E; Ahmed, A; Hu, FZ; Ehrlich, GD				Janto, Benjamin A.; Hiller, N. Luisa; Eutsey, Rory A.; Dahlgren, Margaret E.; Earl, Joshua P.; Powell, Evan; Ahmed, Azad; Hu, Fen Z.; Ehrlich, Garth D.			Development and Validation of an Haemophilus influenzae Supragenome Hybridization (SGH) Array for Transcriptomic Analyses	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; COMPARATIVE GENOMIC ANALYSES; CHINCHILLA-LANIGER MODEL; STREPTOCOCCUS-PNEUMONIAE; PAN-GENOME; VIRULENCE PHENOTYPES; BIOFILM FORMATION; INVASIVE DISEASE; OTITIS-MEDIA; EXPRESSION	We previously carried out the design and testing of a custom-built Haemophilus influenzae supragenome hybridization (SGH) array that contains probe sequences to 2,890 gene clusters identified by whole genome sequencing of 24 strains of H. influenzae. The array was originally designed as a tool to interrogate the gene content of large numbers of clinical isolates without the need for sequencing, however, the data obtained is quantitative and is thus suitable for transcriptomic analyses. In the current study RNA was extracted from H. influenzae strain CZ4126/02 (which was not included in the design of the array) converted to cDNA, and labelled and hybridized to the SGH arrays to assess the quality and reproducibility of data obtained from these custom-designed chips to serve as a tool for transcriptomics. Three types of experimental replicates were analyzed with all showing very high degrees of correlation, thus validating both the array and the methods used for RNA profiling. A custom filtering pipeline for two-condition unpaired data using five metrics was developed to minimize variability within replicates and to maximize the identification of the most significant true transcriptional differences between two samples. These methods can be extended to transcriptional analysis of other bacterial species utilizing supragenome-based arrays.	[Janto, Benjamin A.; Hiller, N. Luisa; Eutsey, Rory A.; Dahlgren, Margaret E.; Earl, Joshua P.; Powell, Evan; Ahmed, Azad; Hu, Fen Z.; Ehrlich, Garth D.] Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Janto, Benjamin A.; Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Pittsburgh, PA USA; [Hiller, N. Luisa] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA	Drexel University; Carnegie Mellon University; Drexel University	Hu, FZ (corresponding author), Allegheny Singer Res Inst, Ctr Genom Sci, 320 E N Ave, Pittsburgh, PA 15212 USA.	fhu168168@gmail.com; garth.ehrlich@drexelmed.edu	Janto, Benjamin/E-7459-2010; Hiller, N. Luisa/A-3739-2016	Janto, Benjamin/0000-0002-3841-4917; Hiller, N. Luisa/0000-0001-6572-1368; Ehrlich, Garth/0000-0003-1140-6594	Allegheny General Hospital; Allegheny-Singer Research Institute; National Institutes of Health [DC002148, DC02148 - 16S1, AI080935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002148] Funding Source: NIH RePORTER	Allegheny General Hospital(General Electric); Allegheny-Singer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Allegheny General Hospital, Allegheny-Singer Research Institute and National Institutes of Health grant numbers DC002148, DC02148 - 16S1, and AI080935 to GDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borneman AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-373; Buchinsky FJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-56; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Davie JJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-70; Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4; Dohar JE, 2009, CURR MED RES OPIN, V25, P287, DOI [10.1185/03007990802603072, 10.1185/03007990802603072 ]; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x; Ehrlich GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-225; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Erwin AL, 2005, INFECT IMMUN, V73, P5853, DOI 10.1128/IAI.73.9.5853-5863.2005; Eutsey RA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-484; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hu FZ, 2008, FUTURE MICROBIOL, V3, P31, DOI 10.2217/17460913.3.1.31; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kelly L, 2011, J MED MICROBIOL, V60, P384, DOI 10.1099/jmm.0.026914-0; Ladhani S, 2010, EMERG INFECT DIS, V16, P455, DOI 10.3201/eid1603.090290; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Pereira M. Beatriz Rotta, 2004, J. Pediatr. (Rio J.), V80, P41, DOI 10.1590/S0021-75572004000100009; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Shuel M, 2010, FEMS IMMUNOL MED MIC, V58, P277, DOI 10.1111/j.1574-695X.2009.00634.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	44	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e105493	10.1371/journal.pone.0105493	http://dx.doi.org/10.1371/journal.pone.0105493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290153	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000003
J	Khanal, S; Anex, RP; Anderson, CJ; Herzmann, DE				Khanal, Sami; Anex, Robert P.; Anderson, Christopher J.; Herzmann, Daryl E.			Streamflow Impacts of Biofuel Policy-Driven Landscape Change	PLOS ONE			English	Article							MISCANTHUS X GIGANTEUS; LAND-COVER CHANGE; BIOENERGY CROPS; CLIMATE-CHANGE; ENERGY; MODEL; WATER; IMPLEMENTATION; ELASTICITY; CYCLE	Likely changes in precipitation (P) and potential evapotranspiration (PET) resulting from policy-driven expansion of bioenergy crops in the United States are shown to create significant changes in streamflow volumes and increase water stress in the High Plains. Regional climate simulations for current and biofuel cropping system scenarios are evaluated using the same atmospheric forcing data over the period 1979-2004 using the Weather Research Forecast (WRF) model coupled to the NOAH land surface model. PET is projected to increase under the biofuel crop production scenario. The magnitude of the mean annual increase in PET is larger than the inter-annual variability of change in PET, indicating that PET increase is a forced response to the biofuel cropping system land use. Across the conterminous U.S., the change in mean streamflow volume under the biofuel scenario is estimated to range from negative 56% to positive 20% relative to a business-as-usual baseline scenario. In Kansas and Oklahoma, annual streamflow volume is reduced by an average of 20%, and this reduction in streamflow volume is due primarily to increased PET. Predicted increase in mean annual P under the biofuel crop production scenario is lower than its inter-annual variability, indicating that additional simulations would be necessary to determine conclusively whether predicted change in P is a response to biofuel crop production. Although estimated changes in streamflow volume include the influence of P change, sensitivity results show that PET change is the significantly dominant factor causing streamflow change. Higher PET and lower streamflow due to biofuel feedstock production are likely to increase water stress in the High Plains. When pursuing sustainable biofuels policy, decision-makers should consider the impacts of feedstock production on water scarcity.	[Khanal, Sami] Ohio State Univ, Sch Environm & Nat Resources, Wooster, OH 44691 USA; [Anex, Robert P.] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI USA; [Anderson, Christopher J.; Herzmann, Daryl E.] Iowa State Univ, Dept Agron, Ames, IA USA	University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison; Iowa State University	Khanal, S (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Wooster, OH 44691 USA.	khanal.3@osu.edu; anex@wisc.edu			National Science Foundation [CBET-1137677]	National Science Foundation(National Science Foundation (NSF))	This work is supported by the National Science Foundation Grant CBET-1137677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2013, GEOPHYS RES LETT, V40, P1217, DOI 10.1002/grl.50179; Anderson CJ, 2012, CLIMATE CHANGE MIDWE; Arora VK, 2002, J HYDROL, V265, P164, DOI 10.1016/S0022-1694(02)00101-4; Bonan GB, 2001, J CLIMATE, V14, P2430, DOI 10.1175/1520-0442(2001)014&lt;2430:OEFROD&gt;2.0.CO;2; Braun M, 2012, J HYDROMETEOROL, V13, P443, DOI 10.1175/JHM-D-11-051.1; Budyko MI, 1963, EVAPORATION NATURAL; Carlisle DM, 2011, FRONT ECOL ENVIRON, V9, P264, DOI 10.1890/100053; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Chiew FHS, 2009, J HYDROL, V379, P172, DOI 10.1016/j.jhydrol.2009.10.004; Chiew FHS, 2006, HYDROLOG SCI J, V51, P613, DOI 10.1623/hysj.51.4.613; Costello C, 2009, ENVIRON SCI TECHNOL, V43, P7985, DOI 10.1021/es9011433; de Elia R, 2008, CLIM DYNAM, V30, P113, DOI 10.1007/s00382-007-0288-z; Dicks M. R., 2009, Journal of Agricultural and Applied Economics, V41, P435; Diffenbaugh NS, 2009, CLIM DYNAM, V33, P945, DOI 10.1007/s00382-009-0566-z; Donner SD, 2007, GLOBAL ENVIRON CHANG, V17, P105, DOI 10.1016/j.gloenvcha.2006.04.005; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Georgescu M, 2011, P NATL ACAD SCI USA, V108, P4307, DOI 10.1073/pnas.1008779108; Guo G, 2007, J HYDROL, V355, P106; Hallgren W, 2013, GEOPHYS RES LETT, V40, P1624, DOI 10.1002/grl.50352; Hess JR, 2003, DOENEID11129; Hill J, 2007, AGRON SUSTAIN DEV, V27, P1, DOI 10.1051/agro:2007006; Hu Q, 2005, ENVIRON MODEL ASSESS, V10, P9, DOI 10.1007/s10666-004-4266-0; Khanal S, 2013, GCB BIOENERGY, V5, P713, DOI 10.1111/gcbb.12050; Klemp J.B., 2008, NCAR TECHNICAL NOTE, DOI [10.5065/D6DZ069T, DOI 10.5065/1DFH-6P97, 10.5065/D68S4MVH]; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Le PVV, 2011, P NATL ACAD SCI USA, V108, P15085, DOI 10.1073/pnas.1107177108; Marland G, 2003, CLIM POLICY, V3, P149, DOI 10.1016/S1469-3062(03)00028-7; Marshall E, 2011, AP054 ERS USDA; Miguez FE, 2012, GCB BIOENERGY, V4, P509, DOI 10.1111/j.1757-1707.2011.01150.x; Mishra V, 2010, INT J CLIMATOL, V30, P2025, DOI 10.1002/joc.2095; Mitchell R, 2012, SWITCHGRASS GREEN EN, P113, DOI DOI 10.1007/978-1-4471-2903-5_5; Ol'Dekop E, 1911, T MET OBS LUREVSKOGO, V4; Perlack R., 2011, US BILLION TON UPDAT; Pielke RA, 2007, TELLUS B, V59, P587, DOI 10.1111/j.1600-0889.2007.00251.x; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Pike J. G., 1964, J HYDROL, V2, P116, DOI [10.1016/0022-1694(64)90022-8, DOI 10.1016/0022-1694(64)90022-8]; RAY DE, 1976, AGR ECON RES, V28, P14; Rosero E, 2011, J HYDROMETEOROL, V12, P45, DOI 10.1175/2010JHM1228.1; Sankarasubramanian A, 2001, WATER RESOUR RES, V37, P1771, DOI 10.1029/2000WR900330; Schaake J. C., 1990, Climate change and US water resources., P177; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schnoor J, 2008, WATER IMPLICATIONS B; Schreiber P., 1904, Z METEOROL, V21, P441; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steiner AL, 2009, CLIM DYNAM, V33, P869, DOI 10.1007/s00382-009-0543-6; Stone KC, 2010, BIORESOURCE TECHNOL, V101, P2014, DOI 10.1016/j.biortech.2009.10.037; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tu J, 2009, J HYDROL, V379, P268, DOI 10.1016/j.jhydrol.2009.10.009; TURC L., 1954, Annales Agronomiques, V5, P491; Twine TE, 2004, J HYDROMETEOROL, V5, P640, DOI 10.1175/1525-7541(2004)005<0640:EOLCCO>2.0.CO;2; Ugarte DGD, 2000, BIOMASS BIOENERG, V18, P291; Vanloocke A, 2010, GCB BIOENERGY, V2, P180, DOI 10.1111/j.1757-1707.2010.01053.x; Vogel RM, 1999, J IRRIG DRAIN ENG, V125, P148, DOI 10.1061/(ASCE)0733-9437(1999)125:3(148); Wu YP, 2012, BIOMASS BIOENERG, V36, P182, DOI 10.1016/j.biombioe.2011.10.030; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zheng HX, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006665	57	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109129	10.1371/journal.pone.0109129	http://dx.doi.org/10.1371/journal.pone.0109129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289698	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000035
J	Swales, C; Athanasou, NA; Knowles, HJ				Swales, Catherine; Athanasou, Nicholas A.; Knowles, Helen J.			Angiopoietin-Like 4 Is Over-Expressed in Rheumatoid Arthritis Patients: Association with Pathological Bone Resorption	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; GENE-EXPRESSION; SYNOVIUM; JOINT; CHONDROCLASTS; MACROPHAGES; ACTIVATION; EROSION; TARGET	Introduction: Osteoclasts are responsible for the bone loss associated with rheumatoid arthritis (RA). The secreted adipokine angiopoietin-like 4 (ANGPTL4) specifically increases osteoclast-mediated bone resorption. We have investigated expression of ANGPTL4 and its regulatory transcription factor, hypoxia-inducible factor-1 alpha (HIF-1 alpha), in osteoclasts and other cells within rheumatoid synovium. We have also examined whether circulating levels of ANGPTL4 differ in RA patients compared with that in normal controls or patients with osteoarthritis (OA). Results: Immunohistochemical analysis revealed that bone-apposing osteoclasts within the rheumatoid synovium express both ANGPTL4 and HIF-1 alpha. ANGPTL4 was also strongly expressed in synovial lining cells, endothelial cells, stromal cells, CD68+ macrophages and plasma cells within RA synovium. Little ANGPTL4 was evident in normal synovial tissue. This reflected the over-expression of HIF-1 alpha in rheumatoid versus normal synovial tissue. The concentration of ANGPTL4 was higher in both the serum and the synovial fluid of RA patients than in patients with OA or normal controls. High serum ANGPTL4 associated with elevated levels of the serum marker of bone resorption, receptor activator for nuclear factor kappa B ligand (RANKL). Conclusions: Over-expression of ANGPTL4 in multiple cell types within the rheumatoid synovium potentially provides a local pool of ANGPTL4 to stimulate osteoclast-mediated bone resorption in RA. Additionally, correlation of high serum ANGPTL4 with circulating RANKL suggests that ANGPTL4 may represent a novel marker for bone destruction in RA.	[Swales, Catherine; Knowles, Helen J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England; [Athanasou, Nicholas A.] Univ Oxford, Dept Pathol, Nuffield Orthopaed Ctr, Oxford, England	University of Oxford; Nuffield Orthopaedic Centre; University of Oxford	Knowles, HJ (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England.	helen.knowles@ndorms.ox.ac.uk	Knowles, Helen/F-3857-2018	Knowles, Helen/0000-0002-9575-6067	Arthritis Research UK [MP/19200]; Oxford National Institute for Health Research (NIHR) Biomedical Research Unit; Versus Arthritis [19200] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Oxford National Institute for Health Research (NIHR) Biomedical Research Unit; Versus Arthritis(Versus Arthritis)	This work was supported by an Arthritis Research UK grant to HJK, grant number MP/19200 (www.arthritisresearchuk.org). Additional support was received from the Oxford National Institute for Health Research (NIHR) Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Corisdeo S, 2001, BIOCHEM BIOPH RES CO, V285, P335, DOI 10.1006/bbrc.2001.5127; Fujikawa Y, 1996, ANN RHEUM DIS, V55, P816, DOI 10.1136/ard.55.11.816; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Giatromanolaki A, 2003, ARTHRITIS RES THER, V5, pR193, DOI 10.1186/ar756; Gough A, 1998, J RHEUMATOL, V25, P1282; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hashimoto A, 2007, ARTHRITIS RHEUM, V56, P1094, DOI 10.1002/art.22450; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Hummel KM, 1998, J RHEUMATOL, V25, P1887; KAARELA K, 1985, SCAND J RHEUMATOL, P5; Kim YG, 2010, ARTHRITIS RHEUM-US, V62, P515, DOI 10.1002/art.27197; Knowles HJ, 2012, VIRCHOWS ARCH, V461, P205, DOI 10.1007/s00428-012-1274-3; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; Knowles HJ, 2009, J PATHOL, V218, P256, DOI 10.1002/path.2534; Lanfant-Weybel K, 2012, JOINT BONE SPINE, V79, P574, DOI 10.1016/j.jbspin.2011.11.006; Larsen H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3934; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Morten KJ, 2013, J PATHOL, V229, P755, DOI 10.1002/path.4159; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Sivakumar B, 2008, J HAND SURG-AM, V33A, P49, DOI 10.1016/j.jhsa.2007.09.002; Tanaka S, 2013, WORLD J ORTHOP, V4, P1, DOI 10.5312/wjo.v4.i1.1; Trebec-Reynolds DP, 2010, J CELL BIOCHEM, V110, P343, DOI 10.1002/jcb.22542; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Troen BR, 2003, EXP GERONTOL, V38, P605, DOI 10.1016/S0531-5565(03)00069-X; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhao XL, 2013, CURR DRUG TARGETS, V14, P700, DOI 10.2174/1389450111314060010	36	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109524	10.1371/journal.pone.0109524	http://dx.doi.org/10.1371/journal.pone.0109524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289668	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000066
J	Rodriguez-Contreras, D; Aslan, H; Feng, XH; Tran, K; Yates, PA; Kamhawi, S; Landfear, SM				Rodriguez-Contreras, Dayana; Aslan, Hamide; Feng, Xiuhong; Tran, Khoa; Yates, Phillip A.; Kamhawi, Shaden; Landfear, Scott M.			Regulation and biological function of a flagellar glucose transporter in Leishmania mexicana: a potential glucose sensor	FASEB JOURNAL			English	Article						environmental sensing; Leishmania parasites; protein expression; transceptor; TaV2A peptide	NUCLEOSIDE TRANSPORTER; TRYPANOSOMA-CRUZI; PRIMARY CILIUM; SEQUENCE; EXPRESSION; NUTRIENT; PROTEIN; HEXOSE; GENE; GENERATION	In Leishmania mexicana parasites, a unique glucose transporter, LmxGT1, is selectively targeted to the flagellar membrane, suggesting a possible sensory role that is often associated with ciliary membrane proteins. Expression of LmxGT1 is down-regulated similar to 20-fold by increasing cell density but is up-regulated similar to 50-fold by depleting glucose from the medium, and the permease is strongly down-regulated when flagellated insect-stage promastigotes invade mammalian macrophages and transform into intracellular amastigotes. Regulation of LmxGT1 expression by glucose and during the lifecycle operates at the level of protein stability. Significantly, Delta lmxgt1 null mutant, grown in abundant glucose, undergoes catastrophic loss of viability when parasites deplete glucose from the medium, a property not exhibited by wild-type or add-back lines. These results suggest that LmxGT1 may function as a glucose sensor that allows parasites to enter the stationary phase when they deplete glucose and that in the absence of this sensor, parasites do not maintain viability when they run out of glucose. However, alternate roles for LmxGT1 in monitoring glucose availability are considered. The absence of known sensory receptors with defined ligands and biologic functions in Leishmania and related kinetoplastid parasites underscores the potential significance of these observations.	[Rodriguez-Contreras, Dayana; Feng, Xiuhong; Tran, Khoa; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Yates, Phillip A.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Aslan, Hamide; Kamhawi, Shaden] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Oregon Health & Science University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu	SUAU, Hamide ASLAN/AAD-7710-2019	SUAU, Hamide ASLAN/0000-0002-8528-0202	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025920, R01AI023682, F32AI096854, R37AI023682] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [S10 RR023432, S10-RR023432] Funding Source: Medline; NIAID NIH HHS [AI023682, R37 AI023682, AI25920, R01 AI023682, F32 AI096854, R01 AI025920] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BATES PA, 1994, EXP PARASITOL, V79, P215, DOI 10.1006/expr.1994.1084; BATES PA, 1993, PARASITOL TODAY, V9, P143, DOI 10.1016/0169-4758(93)90181-E; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Buchanan KT, 2005, J BIOL CHEM, V280, P40104, DOI 10.1074/jbc.M505777200; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; da Silva LM, 2010, P NATL ACAD SCI USA, V107, P11965, DOI 10.1073/pnas.1004599107; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ENGMAN DM, 1989, J BIOL CHEM, V264, P18627; Feng XH, 2013, MOL MICROBIOL, V87, P412, DOI 10.1111/mmi.12106; Feng XH, 2011, MOL BIOCHEM PARASIT, V175, P39, DOI 10.1016/j.molbiopara.2010.08.008; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Gluenz E, 2010, FASEB J, V24, P3117, DOI 10.1096/fj.09-151381; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Heras SR, 2006, CELL MOL LIFE SCI, V63, P1449, DOI 10.1007/s00018-006-6038-2; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kamhawi S, 2000, PARASITOLOGY, V121, P25, DOI 10.1017/S0031182099006125; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Landfear SM, 2011, EUKARYOT CELL, V10, P483, DOI 10.1128/EC.00287-10; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ortiz D, 2010, MOL MICROBIOL, V78, P108, DOI 10.1111/j.1365-2958.2010.07328.x; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; PIPER RC, 1995, J CELL BIOL, V128, P499, DOI 10.1083/jcb.128.4.499; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Rodrigues Juliany Cola Fernandes, 2014, Subcell Biochem, V74, P1, DOI 10.1007/978-94-007-7305-9_1; Rodriguez-Contreras D, 2007, MOL BIOCHEM PARASIT, V153, P9, DOI 10.1016/j.molbiopara.2007.01.010; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Seyfang A, 2000, J BIOL CHEM, V275, P5687, DOI 10.1074/jbc.275.8.5687; Seyfang A, 1999, MOL BIOCHEM PARASIT, V104, P121, DOI 10.1016/S0166-6851(99)00138-3; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; Tran KD, 2012, J CELL SCI, V125, P3293, DOI 10.1242/jcs.103028; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Vince JE, 2011, INT J PARASITOL, V41, P791, DOI 10.1016/j.ijpara.2011.02.003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang WW, 2013, EUKARYOT CELL, V12, P70, DOI 10.1128/EC.00263-12	49	29	29	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					11	24		10.1096/fj.14-251991	http://dx.doi.org/10.1096/fj.14-251991			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25300620	Green Published			2022-12-25	WOS:000347378600003
J	Rigat, KL; Lu, H; Wang, YK; Argyrou, A; Fanslau, C; Beno, B; Wang, Y; Marcinkeviciene, J; Ding, M; Gentles, RG; Gao, M; Abell, LM; Roberts, SB				Rigat, Karen L.; Lu, Hao; Wang, Ying-Kai; Argyrou, Argyrides; Fanslau, Caroline; Beno, Brett; Wang, Yi; Marcinkeviciene, Jovita; Ding, Min; Gentles, Robert G.; Gao, Min; Abell, Lynn M.; Roberts, Susan B.			Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; GENOTYPE 1 INFECTION; TARGET RESIDENCE TIME; DE-NOVO INITIATION; CRYSTAL-STRUCTURE; UNITED-STATES; PRECLINICAL CHARACTERIZATION; ALLOSTERIC INHIBITOR; ANTIVIRAL ACTIVITY; BI 207127	HCV infection is an urgent global health problem that has triggered a drive to discover therapies that specifically target the virus. BMS-791325 is a novel direct antiviral agent specifically targeting HCV NS5B, an RNA-dependent RNA polymerase. Robust viral clearance of HCV was observed in infected patients treated with BMS-791325 in combination with other anti-HCV agents in Phase 2 clinical studies. Biochemical and biophysical studies revealed that BMS-791325 is a time-dependent, noncompetitive inhibitor of the polymerase. Binding studies with NS5B genetic variants (WT, L30S, and P495L) exposed a two-step, slow binding mechanism, but details of the binding mechanism differed for each of the polymerase variants. For the clinically relevant resistance variant (P495L), the rate of initial complex formation and dissociation is similar to WT, but the kinetics of the second step is significantly faster, showing that this variant impacts the final tight complex. The resulting shortened residence time translates into the observed decrease in inhibitor potency. The L30S variant has a significantly different profile. The rate of initial complex formation and dissociation is 7-10 times faster for the L30S variant compared with WT; however, the forward and reverse rates to form the final complex are not significantly different. The impact of the L30S variant on the inhibition profile and binding kinetics of BMS-791325 provides experimental evidence for the dynamic interaction of fingers and thumb domains in an environment that supports the formation of active replication complexes and the initiation of RNA synthesis.	[Rigat, Karen L.; Wang, Ying-Kai; Wang, Yi; Gao, Min; Roberts, Susan B.] Bristol Myers Squibb Co, Dept Virol, Wallingford, CT 06492 USA; [Beno, Brett] Bristol Myers Squibb Co, Dept Comp Assisted Drug Design, Wallingford, CT 06492 USA; [Ding, Min; Gentles, Robert G.] Bristol Myers Squibb Co, Dept Early Discovery Chem, Res & Dev, Wallingford, CT 06492 USA; [Lu, Hao; Argyrou, Argyrides; Fanslau, Caroline; Marcinkeviciene, Jovita; Abell, Lynn M.] Bristol Myers Squibb Co, Dept Mechanist Biochem, Res & Dev, Pennington, NJ 08534 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Roberts, SB (corresponding author), Bristol Myers Squibb Co, Dept Virol, 5 Res Pkwy, Wallingford, CT 06492 USA.	susan.roberts@bms.com	Argyrou, Argyrides/AAC-4156-2020	Argyrou, Argyrides/0000-0003-3141-9122				Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Brainard DM, 2009, HEPATOLOGY, V50, p1026A; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Chinnaswamy S, 2010, VIRUS ADAPT TREAT, V2, P21; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Dahl G, 2013, DRUG DISCOV TODAY, V18, P697, DOI 10.1016/j.drudis.2013.02.010; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Devogelaere B, 2012, ANTIMICROB AGENTS CH, V56, P4676, DOI 10.1128/AAC.00245-12; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Ditah I, 2014, J HEPATOL, V60, P691, DOI 10.1016/j.jhep.2013.11.014; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Erhardt A, 2009, ANTIVIR THER, V14, P23; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Gentles RG, 2014, J MED CHEM, V57, P1855, DOI 10.1021/jm4016894; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Karam P, 2014, J BIOL CHEM, V289, P14399, DOI 10.1074/jbc.M113.529743; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; LaPlante SR, 2010, J AM CHEM SOC, V132, P15204, DOI 10.1021/ja101358s; Larrey D, 2013, ANTIMICROB AGENTS CH, V57, P4727, DOI 10.1128/AAC.00565-13; Larrey D, 2012, J HEPATOL, V57, P39, DOI 10.1016/j.jhep.2012.02.015; Lemm JA, 2014, ANTIMICROB AGENTS CH, V58, P3485, DOI 10.1128/AAC.02495-13; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; McKercher G, 2004, NUCLEIC ACIDS RES, V32, P422, DOI 10.1093/nar/gkh160; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Miyata Y, 2013, ACS CHEM NEUROSCI, V4, P930, DOI 10.1021/cn300210g; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Narjes F, 2011, J MED CHEM, V54, P289, DOI 10.1021/jm1013105; National Institutes of Health, 2012, PHAS 3 STUD BI 20712; National Institutes of Health, 2012, STUD EV SAF TOL EFF; Ranjith-Kumar CT, 2006, RNA, V12, P303, DOI 10.1261/rna.2163106; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Schmitt HM, 1997, BIOSENS BIOELECTRON, V12, P809, DOI 10.1016/S0956-5663(97)00046-8; Sims KD, 2014, ANTIMICROB AGENTS CH, V58, P3496, DOI 10.1128/AAC.02579-13; Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j; Tatum H., 2013, J HEPATOL S1, V58, pS182; Tomei L, 2003, J VIROL, V77, P13225, DOI 10.1128/JVI.77.24.13225-13231.2003; Vendeville S, 2012, BIOORG MED CHEM LETT, V22, P4437, DOI 10.1016/j.bmcl.2012.04.113; Wang YK, 2008, ARCH BIOCHEM BIOPHYS, V470, P146, DOI 10.1016/j.abb.2007.11.012; Wang YK, 2006, ANAL BIOCHEM, V359, P106, DOI 10.1016/j.ab.2006.09.013; Ward JW, 2012, GASTROENTEROLOGY, V143, P887, DOI 10.1053/j.gastro.2012.08.027; World Health Organization, 2012, PREV CONTR VIR HEP I; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zheng XF, 2011, BIOORG MED CHEM LETT, V21, P2925, DOI 10.1016/j.bmcl.2011.03.067; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	54	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33456	33468		10.1074/jbc.M114.613653	http://dx.doi.org/10.1074/jbc.M114.613653			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301950	hybrid, Green Published			2022-12-25	WOS:000345636600034
J	Weatherspoon-Griffin, N; Yang, DZ; Kong, W; Hua, ZC; Shi, YX				Weatherspoon-Griffin, Natasha; Yang, Dezhi; Kong, Wei; Hua, Zichun; Shi, Yixin			The CpxR/CpxA Two-component Regulatory System Up-regulates the Multidrug Resistance Cascade to Facilitate Escherichia coli Resistance to a Model Antimicrobial Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; SIGNAL-TRANSDUCTION PATHWAY; CONTROLS EXPRESSION; MARRAB OPERON; EFFLUX PUMP; CPX REGULON; STRESS; PROTEIN; ACTIVATION; REPRESSOR	A genome-wide susceptibility assay was used to identify specific CpxR-dependent genes that facilitate Escherichia coli resistance to a model cationic antimicrobial peptide, protamine. A total of 115 strains from the Keio Collection, each of which contained a deletion at a demonstrated or predicted CpxR/CpxA-dependent locus, were tested for protamine susceptibility. One strain that exhibited high susceptibility carried a deletion of tolC, a gene that encodes the outer membrane component of multiple tripartite multidrug transporters. Concomitantly, two of these efflux systems, AcrAB/TolC and EmrAB/TolC, play major roles in protamine resistance. Activation of the CpxR/CpxA system stimulates mar transcription, suggesting a new regulatory circuit that enhances the multidrug resistance cascade. Tripartite multidrug efflux systems contribute to bacterial resistance to protamine differently from the Tat system. DNase I footprinting analysis demonstrated that the CpxR protein binds to a sequence located in the -35 and -10 regions of mar promoter. This sequence resembles the consensus CpxR binding site, however, on the opposite strand. aroK, a CpxR-dependent gene that encodes a shikimate kinase in the tryptophan biosynthesis pathway, was also found to facilitate protamine resistance. Specific aromatic metabolites from this pathway, such as indole, can stimulate expression of well studied CpxR-dependent genes degP and cpxP, which are not components of the tripartite multidrug transporters. Thus, we propose a novel mechanism for E. coli to modulate resistance to protamine and likely other cationic antimicrobial peptides in which the CpxR/CpxA system up-regulates mar transcription in response to specific aromatic metabolites, subsequently stimulating the multidrug resistance cascade.	[Weatherspoon-Griffin, Natasha; Yang, Dezhi; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Yang, Dezhi; Kong, Wei; Shi, Yixin] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Yang, Dezhi] Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Inner Mongolia, Peoples R China; [Hua, Zichun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Inner Mongolia University; Nanjing University	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	Yang, Dezhi/HGB-2668-2022; SHI, YIXIN/M-5751-2019	Yang, Dezhi/0000-0003-4653-9856; 	Basic Research Grant of Major Open Topics from Science and Technology Department of Inner Mongolia Autonomous Region, China [20110905]	Basic Research Grant of Major Open Topics from Science and Technology Department of Inner Mongolia Autonomous Region, China	This work was supported in part by Basic Research Grant of Major Open Topics from Science and Technology Department of Inner Mongolia Autonomous Region, China 20110905 (To Y. S.).	Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Ando T, 1973, Mol Biol Biochem Biophys, V12, P1; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Chubiz LM, 2010, J BACTERIOL, V192, P4786, DOI 10.1128/JB.00371-10; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Wulf P, 1999, J BACTERIOL, V181, P6772, DOI 10.1128/JB.181.21.6772-6778.1999; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Gerken H, 2010, MOL MICROBIOL, V75, P1033, DOI 10.1111/j.1365-2958.2009.07042.x; HACHLER H, 1991, J BACTERIOL, V173, P5532; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996; Martin RG, 1999, MOL MICROBIOL, V34, P431, DOI 10.1046/j.1365-2958.1999.01599.x; Miller JH., 1972, EXPT MOL GENETICS; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Nishino K, 2010, ANTIMICROB AGENTS CH, V54, P2239, DOI 10.1128/AAC.01677-09; Oh JT, 2000, BBA-BIOMEMBRANES, V1463, P43, DOI 10.1016/S0005-2736(99)00177-7; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Rosner JL, 2013, J BACTERIOL, V195, P1042, DOI 10.1128/JB.01996-12; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Sikdar R, 2013, J BACTERIOL, V195, P12, DOI 10.1128/JB.00762-12; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; SULAVIK MC, 1995, MOL MED, V1, P436, DOI 10.1007/BF03401581; Warner DM, 2010, MICROBIOL-SGM, V156, P570, DOI 10.1099/mic.0.033415-0; Weatherspoon-Griffin N, 2011, J BIOL CHEM, V286, P5529, DOI 10.1074/jbc.M110.200352; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	47	59	61	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.565762	http://dx.doi.org/10.1074/jbc.M114.565762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294881	Green Published, hybrid			2022-12-25	WOS:000345335000016
J	Macfall, J; Robinette, P; Welch, D				Macfall, Janet; Robinette, Paul; Welch, David			Factors Influencing Bank Geomorphology and Erosion of the Haw River, a High Order River in North Carolina, since European Settlement	PLOS ONE			English	Article							WIDTH ADJUSTMENT; STREAMS; VARIABILITY; VEGETATION; DAMS	The Haw River, a high order river in the southeastern United States, is characterized by severe bank erosion and geomorphic change from historical conditions of clear waters and connected floodplains. In 2014 it was named one of the 10 most threatened rivers in the United States by American Rivers. Like many developed areas, the region has a history of disturbance including extensive upland soil loss from agriculture, dams, and upstream urbanization. The primary objective of this study was to identify the mechanisms controlling channel form and erosion of the Haw River. Field measurements including bank height, bankfull height, bank angle, root depth and density, riparian land cover and slope, surface protection, river width, and bank retreat were collected at 87 sites along 43.5 km of river. A Bank Erosion Hazard Index (BEHI) was calculated for each study site. Mean bank height was 11.8 m, mean width was 84.3 m, and bank retreat for 2005/2007-2011/2013 was 2.3 m. The greatest bank heights, BEHI values, and bank retreat were adjacent to riparian areas with low slope (<2). This is in contrast to previous studies which identify high slope as a risk factor for erosion. Most of the soils in low slope riparian areas were alluvial, suggesting sediment deposition from upland row crop agriculture and/or flooding. Bank retreat was not correlated to bank heights or BEHI values. Historical dams (1.2-3 m height) were not a significant factor. Erosion of the Haw River in the study section of the river (25% of the river length) contributed 205,320 m(3) of sediment and 3759 kg of P annually. Concentration of suspended solids in the river increased with discharge. In conclusion, the Haw River is an unstable system, with river bank erosion and geomodification potential influenced by riparian slope and varied flows.	[Macfall, Janet; Robinette, Paul; Welch, David] Elon Univ, Ctr Environm Studies, Elon, NC 27244 USA	Elon University	Macfall, J (corresponding author), Elon Univ, Ctr Environm Studies, Elon, NC 27244 USA.	macfallj@elon.edu			North Carolina Clean Water Management Trust Fund; Elon University	North Carolina Clean Water Management Trust Fund; Elon University	This work was supported by the North Carolina Clean Water Management Trust Fund (JM). Haw River Assembly was the grant recipient, with funds passed to JM through Elon University to financially support all of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 1998, GEOMORPHOLOGY, V23, P55, DOI 10.1016/S0169-555X(97)00089-5; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Anderson RJ, 2004, J AM WATER RESOUR AS, V40, P1159, DOI 10.1111/j.1752-1688.2004.tb01576.x; [Anonymous], WEB SOIL SURV; [Anonymous], 2011, CAPE FEAR RIVER BASI; [Anonymous], GEOLOGICAL SURVEY PR; Atkinson PM, 2003, GEOGR ANAL, V35, P58, DOI 10.1353/geo.2002.0028; Bennett HH, 1928, GEOGR REV, V18, P579, DOI 10.2307/207949; Beyer PJ, 2005, GEOMORPHOLOGY, V71, P1, DOI 10.1016/j.geomorph.2005.03.004; Bledsoe BP, 2012, J AM WATER RESOUR AS, V48, P788, DOI 10.1111/j.1752-1688.2012.00653.x; Cassebaum AM, 2011, DOWN LONG HAW HIST N; Chilton M, 2008, HIST ATLAS HAW RIVER; Cruise JF, 2010, J AM WATER RESOUR AS, V46, P1159, DOI 10.1111/j.1752-1688.2010.00483.x; Docker BB, 2008, GEOMORPHOLOGY, V100, P401, DOI 10.1016/j.geomorph.2008.01.009; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Florsheim JL, 2011, GEOMORPHOLOGY, V132, P272, DOI 10.1016/j.geomorph.2011.04.037; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Harman W. H., 1999, BANKFULL HYDRAULIC G; Hupp CR, 2013, GEOMORPHOLOGY, V180, P156, DOI 10.1016/j.geomorph.2012.10.007; Hupp CR, 2009, GEOL SOC AM SPEC PAP, V451, P97, DOI 10.1130/2009.2451(06); JACOBSON RB, 1986, AM J SCI, V286, P617, DOI 10.2475/ajs.286.8.617; Jennings G. D, 2001, MEASUREMENT STABILIZ; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kessler AC, 2013, GEOMORPHOLOGY, V201, P312, DOI 10.1016/j.geomorph.2013.07.006; Knox JC, 2001, CATENA, V42, P193, DOI 10.1016/S0341-8162(00)00138-7; Kouli M, 2009, ENVIRON GEOL, V57, P483, DOI 10.1007/s00254-008-1318-9; Lawson J.M., 1925, ENG NEWS-REC, P327; Leopold L.B., 1994, VIEW RIVER; LIGON FK, 1995, BIOSCIENCE, V45, P183, DOI 10.2307/1312557; Parker C, 2008, GEOMORPHOLOGY, V101, P533, DOI 10.1016/j.geomorph.2008.02.007; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Petts GE, 2005, GEOMORPHOLOGY, V71, P27, DOI 10.1016/j.geomorph.2004.02.015; Pollen-Bankhead N, 2010, GEOMORPHOLOGY, V116, P353, DOI 10.1016/j.geomorph.2009.11.013; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Rosgen D., 1996, APPL RIVER MORPHOLOG; Rosgen D, 1996, FLUVIAL PROCESS SEDI, P381; Rosgen D.L., 2001, P 7 FED INT SED C, V2, P9, DOI DOI 10.1007/S13398-014-0173-7.2; Rosgen D.L., 2007, ROSG GEOM CHANN 654, P1; Sass CK, 2012, J AM WATER RESOUR AS, V48, P774, DOI 10.1111/j.1752-1688.2012.00644.x; Schenk ER, 2013, EARTH SURF PROC LAND, V38, P771, DOI 10.1002/esp.3314; Schenk ER, 2009, J AM WATER RESOUR AS, V45, P597, DOI 10.1111/j.1752-1688.2009.00308.x; Schturun A., 1986, INCISED CHANNELS MOR; Simon A, 1996, EARTH SURF PROCESSES, V21, P155, DOI 10.1002/(SICI)1096-9837(199602)21:2<155::AID-ESP610>3.0.CO;2-5; Simon A, 2007, J AM WATER RESOUR AS, V43, P1117, DOI 10.1111/j.1752-1688.2007.00091.x; Simon A., 1986, P 4 FEDERAL INTERAGE, V2, p5; Smith SV, 2002, SCI TOTAL ENVIRON, V299, P21, DOI 10.1016/S0048-9697(02)00222-X; Spoon WL, 1928, MAP ALAMANCE CO; Spoon WL, 1893, MAP ALAMANCE COUNTY; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Thorne CR, 1998, J HYDRAUL ENG-ASCE, V124, P903; Thorne CR, 1998, J HYDRAUL ENG, V124, P881, DOI 10.1061/(ASCE)0733-9429(1998)124:9(881); TRIMBLE SW, 1975, USDA AGR RES SERVI S, V40, P142; Trimble SW, 2008, MAN INDUCED SOIL ERO; U.S. Dept. of Agriculture, 2009, USDA GEOGR AR SER 33; U.S. Dept. of Agriculture, 1952, US CENS AGR 1950 COU; U.S. Dept. of Agriculture, 1913, 13 CENS US TAK YEAR; U.S. Geological Survey, 2013, USGS WAT INF SYST; United States Army Corps of Engineers, 2013, NAT INV DAMS; University T&M, 2014, SOIL WAT ASS TOOL; Walter RC, 2008, SCIENCE, V319, P299, DOI 10.1126/science.1151716; Zaimes G, 2006, STREAM PROCESSES 1	61	12	12	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110170	10.1371/journal.pone.0110170	http://dx.doi.org/10.1371/journal.pone.0110170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302956	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400115
J	Vuorinen, M; Damangir, S; Niskanen, E; Miralbell, J; Rusanen, M; Spulber, G; Soininen, H; Kivipelto, M; Solomon, A				Vuorinen, Miika; Damangir, Soheil; Niskanen, Eini; Miralbell, Julia; Rusanen, Minna; Spulber, Gabriela; Soininen, Hilkka; Kivipelto, Miia; Solomon, Alina			Coronary Heart Disease and Cortical Thickness, Gray Matter and White Matter Lesion Volumes on MRI	PLOS ONE			English	Article							BLOOD-PRESSURE; ALZHEIMERS-DISEASE; ARTERY-DISEASE; RISK-FACTORS; BRAIN MORPHOLOGY; DEMENTIA; ADULTS; SEGMENTATION; METAANALYSIS; DIAGNOSIS	Coronary heart disease (CHD) has been linked with cognitive decline and dementia in several studies. CHD is strongly associated with blood pressure, but it is not clear how blood pressure levels or changes in blood pressure over time affect the relation between CHD and dementia-related pathology. The aim of this study was to investigate relations between CHD and cortical thickness, gray matter volume and white matter lesion (WML) volume on MRI, considering CHD duration and blood pressure levels from midlife to three decades later. The study population included 69 elderly at risk of dementia who participated in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study. CAIDE participants were examined in midlife, re-examined 21 years later, and then after additionally 7 years (in total up to 30 years follow-up). MRIs from the second re-examination were used to calculate cortical thickness, gray matter and WML volume. CHD diagnoses were obtained from the Finnish Hospital Discharge Register. Linear regression analyses were adjusted for age, sex, follow-up time and scanner type, and additionally total intracranial volume in GM volume analyses. Adding diabetes, cholesterol or smoking to the models did not influence the results. CHD was associated with lower thickness in multiple regions, and lower total gray matter volume, particularly in people with longer disease duration (>10 years). Associations between CHD, cortical thickness and gray matter volume were strongest in people with CHD and hypertension in midlife, and those with CHD and declining blood pressure after midlife. No association was found between CHD and WML volumes. Based on these results, long-term CHD seems to have detrimental effects on brain gray matter tissue, and these effects are influenced by blood pressure levels and their changes over time.	[Vuorinen, Miika; Rusanen, Minna; Soininen, Hilkka; Kivipelto, Miia; Solomon, Alina] Univ Eastern Finland, Sch Med, Dept Neurol, Kuopio, Finland; [Damangir, Soheil; Spulber, Gabriela] Karolinska Inst, NVS, Div Clin Geriatr, Stockholm, Sweden; [Niskanen, Eini] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Miralbell, Julia] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Kivipelto, Miia; Solomon, Alina] Karolinska Inst, ADRC, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	University of Eastern Finland; Karolinska Institutet; University of Eastern Finland; University of Barcelona; Karolinska Institutet	Vuorinen, M (corresponding author), Univ Eastern Finland, Sch Med, Dept Neurol, Kuopio, Finland.	miika.vuorinen@uef.fi	Damangir, Soheil/S-3278-2016; Kivipelto, Miia/AAS-3557-2021	Damangir, Soheil/0000-0001-5425-5859; Spulber, Gabriela/0000-0002-0995-7138; Solomon, Alina/0000-0002-7166-9903; Kivipelto, Miia/0000-0003-0992-3875	Graduate School of Molecular Medicine at University of Eastern Finland; strategic funding of University of Eastern Finland for UEFBRAIN; National Graduate School of Clinical Investigation; Swedish Research Council for Medical Research (Vetenskapsradet); EU FP7 project LipiDiDiet [211696]; EVO grant (Finland) [5772720]; Academy of Finland grants [120676, 117458, 251645, 218037, 129395]; Saastamoinen Foundation (Finland); Instrumentarium Foundation (Finland); Maud Kuistila Memorial Foundation (Finland); Stiftelsen Ragnhild och Einar Lundstroms Minne Lindhe's Foundation (Sweden); Stohnes Stiftelse Foundation (Sweden); Gamla Tjanarinnor Foundation (Sweden); Alzheimerfonden (Sweden); Demensfondens Forskningsstipendier (Sweden); Stiftelsen Dementia (Sweden); Novo Nordisk Fonden [NNF12OC1016402, NNF11OC1014884] Funding Source: researchfish	Graduate School of Molecular Medicine at University of Eastern Finland; strategic funding of University of Eastern Finland for UEFBRAIN; National Graduate School of Clinical Investigation; Swedish Research Council for Medical Research (Vetenskapsradet)(Swedish Research Council); EU FP7 project LipiDiDiet; EVO grant (Finland); Academy of Finland grants(Academy of Finland); Saastamoinen Foundation (Finland); Instrumentarium Foundation (Finland); Maud Kuistila Memorial Foundation (Finland); Stiftelsen Ragnhild och Einar Lundstroms Minne Lindhe's Foundation (Sweden); Stohnes Stiftelse Foundation (Sweden); Gamla Tjanarinnor Foundation (Sweden); Alzheimerfonden (Sweden); Demensfondens Forskningsstipendier (Sweden); Stiftelsen Dementia (Sweden); Novo Nordisk Fonden(Novo Nordisk Foundation)	Support was provided by the Graduate School of Molecular Medicine at University of Eastern Finland; strategic funding of University of Eastern Finland for UEFBRAIN; the National Graduate School of Clinical Investigation; the Swedish Research Council for Medical Research (Vetenskapsradet); EU FP7 project LipiDiDiet 211696; EVO grant 5772720 (Finland); the Academy of Finland grants 120676, 117458, 251645, 218037, and 129395; Saastamoinen Foundation (Finland); Instrumentarium Foundation (Finland); Maud Kuistila Memorial Foundation (Finland); Stiftelsen Ragnhild och Einar Lundstroms Minne Lindhe's Foundation (Sweden); Stohnes Stiftelse Foundation (Sweden); Gamla Tjanarinnor Foundation (Sweden); Alzheimerfonden (Sweden); Demensfondens Forskningsstipendier (Sweden) and Stiftelsen Dementia (Sweden). The authors acknowledge the neuGRID infrastructure (www.neugrid4you.eu) for providing resources that were used for preprocessing the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Almeida OP, 2012, EUR HEART J, V33, P1769, DOI 10.1093/eurheartj/ehr467; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bangalore S, 2013, HEART, V99, P601, DOI 10.1136/heartjnl-2012-301968; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Beeri MS, 2006, NEUROLOGY, V66, P1399, DOI 10.1212/01.wnl.0000210447.19748.0b; Blain Jean-Francois, 2004, Expert Rev Neurother, V4, P823, DOI 10.1586/14737175.4.5.823; Bos D, 2011, ARTERIOSCL THROM VAS, V31, P2331, DOI 10.1161/ATVBAHA.111.232728; Damangir S, 2012, J NEUROL SCI, V322, P211, DOI 10.1016/j.jns.2012.07.064; DeCarli C, 1999, STROKE, V30, P1548, DOI 10.1161/01.STR.30.8.1548; DeCarli C, 1999, STROKE, V30, P529, DOI 10.1161/01.STR.30.3.529; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Geerlings MI, 2010, ATHEROSCLEROSIS, V210, P130, DOI 10.1016/j.atherosclerosis.2009.10.039; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Ikram MA, 2008, STROKE, V39, P1421, DOI 10.1161/STROKEAHA.107.501106; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Jochemsen HM, 2013, JAMA NEUROL, V70, P1046, DOI 10.1001/jamaneurol.2013.217; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Morris MC, 2001, ARCH NEUROL-CHICAGO, V58, P1640, DOI 10.1001/archneur.58.10.1640; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Qiu CX, 2009, DEMENT GERIATR COGN, V28, P213, DOI 10.1159/000236913; Ross GW, 1999, NEUROLOGY, V53, P337, DOI 10.1212/WNL.53.2.337; Royall Donald R, 2008, Cleve Clin J Med, V75 Suppl 2, pS97; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SPARKS DL, 1990, NEUROBIOL AGING, V11, P601, DOI 10.1016/0197-4580(90)90024-T; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Tijms BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058921; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; Vidal JS, 2010, STROKE, V41, P891, DOI 10.1161/STROKEAHA.110.579581; Vuorinen M, 2013, NEUROBIOL AGING, V34, P100, DOI 10.1016/j.neurobiolaging.2012.07.014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	48	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109250	10.1371/journal.pone.0109250	http://dx.doi.org/10.1371/journal.pone.0109250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302686	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400047
J	Zhang, YH; Xiao, YP; Wang, P; Liu, QH				Zhang, Yanhua; Xiao, Yaping; Wang, Pan; Liu, Quanhong			Compositions and Anti-Tumor Activity of Pyropolyporus fomentarius Petroleum Ether Fraction In Vitro and In Vivo	PLOS ONE			English	Article							FOMES-FOMENTARIUS; CANCER-CELLS; APOPTOSIS; EXTRACT; MUSHROOM; PATHWAY; FUNGI; DEATH; TUMOR; S180	The chemical compositions and anti-tumour activities of he petroleum ether fraction PE) from mushroom Pyropolyporus formentarius, were studied. Upon gas chromatography-mass spectrometry GC-MS analysis, nine major constituents were identified in the fraction. In vitro, the PE showed cytotoxic activity against murine sarcoma S180 (S180) cells in a dose- and time-dependent manner, and the cytotoxic effects were associated with apoptosis. The mitochondrial membrane potential loss and the intracellular ROS generation were greatly increased in the Pyropolyporus fomentarius PE treated group, suggesting cell apoptosis, induced by the PE in S180 cells, might be mitochondria dependent and ROS mediated. Consistent with in vitro findings, the in vivo study showed that the Pyropolyporus fomentarius PE was also effective in inhibiting the tumour growth induced by S180 cells and had lower immune organ toxicity. We found that the Pyropolyporus famentarius PE has significant anti-tumor activity and great potential in screening anti-tumor drugs.	[Zhang, Yanhua; Xiao, Yaping; Wang, Pan; Liu, Quanhong] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Key Lab Med Resources & Nat Pharmaceut Chem,Minis, Xian, Shaanxi, Peoples R China; [Zhang, Yanhua] Jiangsu Normal Univ, Coll Life Sci, Xuzhou, Jiangsu, Peoples R China	Shaanxi Normal University; Jiangsu Normal University	Liu, QH (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Key Lab Med Resources & Nat Pharmaceut Chem,Minis, Xian, Shaanxi, Peoples R China.	lshaof@snnu.edu.cn			National "Twelfth Five-Year" Plan for Science & Technology Support [2011BAI06B05]; Natural Science Foundation of Shaanxi Province, China [2014JM4137]	National "Twelfth Five-Year" Plan for Science & Technology Support; Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by National "Twelfth Five-Year" Plan for Science & Technology Support (2011BAI06B05) and Natural Science Foundation of Shaanxi Province, China (Grant No. 2014JM4137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Aziz A, 2009, AUST J BASIC APPL SC, V3, P2754; Aikemu A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-157; AOKI M, 1993, BIOSCI BIOTECH BIOCH, V57, P278, DOI 10.1271/bbb.57.278; Bao XL, 2013, CARBOHYD POLYM, V98, P1236, DOI 10.1016/j.carbpol.2013.07.018; Beattie KD, 2011, MYCOLOGIA, V103, P458, DOI 10.3852/10-121; Bok JW, 1999, PHYTOCHEMISTRY, V51, P891, DOI 10.1016/S0031-9422(99)00128-4; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chen W, 2008, FREE RADICAL BIO MED, V45, P60, DOI 10.1016/j.freeradbiomed.2008.03.013; Chen W, 2011, CARBOHYD POLYM, V85, P369, DOI 10.1016/j.carbpol.2011.02.035; Cheng XX, 2012, J ETHNOPHARMACOL, V143, P49, DOI 10.1016/j.jep.2012.05.054; CHIHARA G, 1969, Nature (London), V222, P687; Chung MJ, 2010, NUTR RES PRACT, V4, P177, DOI 10.4162/nrp.2010.4.3.177; Crazzolara R, 2009, CURR CANCER DRUG TAR, V9, P19, DOI 10.2174/156800909787314057; Dou XJ, 2014, CYTOTECHNOLOGY, V66, P107, DOI 10.1007/s10616-013-9543-9; [冯薇 Feng Wei], 2010, [中国药学杂志, Chinese Pharmaceutical Journal], V45, P1528; Ferreira ICFR, 2010, ANTI-CANCER AGENT ME, V10, P424; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada H, 2002, ANTICANCER RES, V22, P2587; Huang TianZi, 2012, Mycosystema, V31, P775; INDAP M A, 1986, Indian Journal of Physiology and Pharmacology, V30, P182; Jabbour E, 2011, HEMATOL ONCOL CLIN N, V25, P981, DOI 10.1016/j.hoc.2011.09.004; Judova J, 2012, FUNGAL BIOL-UK, V116, P155, DOI 10.1016/j.funbio.2011.10.010; Keawsa-ard S, 2012, NAT PROD COMMUN, V7, P955; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lee WY, 2005, B KOREAN CHEM SOC, V26, P1464; Li CF, 2014, BIOPHARM DRUG DISPOS, V35, P50, DOI 10.1002/bdd.1868; Magalhaes HIF, 2006, J PHARM PHARMACOL, V58, P235, DOI 10.1211/jpp.58.2.0011; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Petrova RD, 2008, ONCOL REP, V19, P299; Pezzuto J.M., 1991, METHODS PLANT BIOCH, P71; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; Roussel Bertrand, 2002, Rev Hist Pharm (Paris), V50, P599; SAAR M, 1991, J ETHNOPHARMACOL, V31, P175, DOI 10.1016/0378-8741(91)90003-V; Seniuk OF, 2011, INT J MED MUSHROOMS, V13, P7, DOI 10.1615/IntJMedMushr.v13.i1.20; Shaffer BC, 2012, DRUG RESIST UPDATE, V15, P62, DOI 10.1016/j.drup.2012.02.001; Smith DJ, 2008, IUBMB LIFE, V60, P383, DOI 10.1002/iub.44; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Stewart B.W., 2003, WORLD CANC REPORT; Sun B, 2011, CANCER LETT, V301, P95, DOI 10.1016/j.canlet.2010.10.010; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; W.H.O. (WHO), 2013, GLOBOCAN 2012; Wang J, 2009, CANCER LETT, V283, P193, DOI 10.1016/j.canlet.2009.03.039; Wang X, 2013, AFR J TRADIT COMPLEM, V10, P475, DOI 10.4314/ajtcam.v10i3.14; World Health Organization, 2004, WORLD HLTH REP 2004; Yan H, 2014, HUM EXP TOXICOL, V33, P522, DOI 10.1177/0960327113497771; Yuan HM, 2011, J APPL PHYCOL, V23, P59, DOI 10.1007/s10811-010-9536-4; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Zang Y, 2013, PHYTOCHEMISTRY, V92, P137, DOI 10.1016/j.phytochem.2013.05.003; Zhang JH, 2012, AM J CHINESE MED, V40, P861, DOI 10.1142/S0192415X12500644; Zhao YY, 2011, BIOCHIM BIOPHYS ACTA, V4, P384; Zhao YY, 2010, PLANTA MEDICAX, V26, P1464; Zhong JJ, 2009, ADV BIOCHEM ENG BIOT, V113, P79, DOI 10.1007/10_2008_26; Zhou BR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/513027	56	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109599	10.1371/journal.pone.0109599	http://dx.doi.org/10.1371/journal.pone.0109599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302783	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400070
J	Kumar, M; Duda, JT; Hwang, WT; Kenworthy, C; Ittyerah, R; Pickup, S; Brodkin, ES; Gee, JC; Abel, T; Poptani, H				Kumar, Manoj; Duda, Jeffery T.; Hwang, Wei-Ting; Kenworthy, Charles; Ittyerah, Ranjit; Pickup, Stephen; Brodkin, Edward S.; Gee, James C.; Abel, Ted; Poptani, Harish			High Resolution Magnetic Resonance Imaging for Characterization of the Neuroligin-3 Knock-in Mouse Model Associated with Autism Spectrum Disorder	PLOS ONE			English	Article							DIFFUSION; SOCIABILITY; BALB/CJ; MICE; CHILDREN; GENES; NLGN4; ABNORMALITIES; PHENOTYPES; C57BL/6J	Autism spectrum disorders (ASD) comprise an etiologically heterogeneous set of neurodevelopmental disorders. Neuroligin-3 (NL-3) is a cell adhesion protein that mediates synapse development and has been implicated in ASD. We performed ex-vivo high resolution magnetic resonance imaging (MRI), including diffusion tensor imaging (DTI) and behavioral (social approach and zero maze) tests at 3 different time points (30, 50 and 70 days-of-age) on NL-3 and wild-type littermates to assess developmental brain abnormalities in NL-3 mice. MRI data were segmented in 39 different gray and white matter regions. Volumetric measurements, along with DTI indices from these segmented regions were also performed. After controlling for age and gender, the NL-3 knock-in animals demonstrated significantly reduced sociability and lower anxiety-related behavior in comparison to their wild type littermates. Significantly reduced volume of several white and gray matter regions in the NL-3 knock-in mice were also observed after considering age, gender and time point as covariates. These findings suggest that structural changes in the brain of NL-3 mice are induced by the mutation in the NL-3 gene. No significant differences in DTI indices were observed, which suggests that the NL-3 mutation may not have a profound effect on water diffusion as detected by DTI. The volumetric and DTI studies aid in understanding the biology of disrupting function on an ASD risk model and may assist in the development of imaging biomarkers for ASD.	[Kumar, Manoj; Duda, Jeffery T.; Ittyerah, Ranjit; Pickup, Stephen; Gee, James C.; Poptani, Harish] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hwang, Wei-Ting] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Kenworthy, Charles; Abel, Ted] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Brodkin, Edward S.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Poptani, H (corresponding author), Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	Harish.Poptani@uphs.upenn.edu	Kumar, Manoj/AAU-5893-2020; Abel, Ted/AAX-2825-2021	Kumar, Manoj/0000-0002-2729-7049; Abel, Ted/0000-0003-2423-4592; Poptani, Harish/0000-0002-0593-3235	Pennsylvania Department of Health (SAP) [4100042728];  [R01MH080718];  [R21HD058237];  [1P50MH096891 - subproject 6773];  [5-T32-MH017168]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080718, P50MH096891, T32MH017168] Funding Source: NIH RePORTER	Pennsylvania Department of Health (SAP); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by R01MH080718 (ESB), R21HD058237 (HP), 1P50MH096891 -subproject 6773 (ESB and TA), 5-T32-MH017168 (TA) and the Pennsylvania Department of Health (SAP # 4100042728, TA and ESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bai J, 2012, MAGN RESON IMAGING, V30, P789, DOI 10.1016/j.mri.2012.02.010; Baribeau Danielle A, 2013, Front Psychiatry, V4, P175, DOI 10.3389/fpsyt.2013.00175; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Billeci L, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-148; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Cook PA, 2006, CAMINO OPEN SOURCE D, pP2759; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; El-Kordi A, 2013, BEHAV BRAIN RES, V251, P41, DOI 10.1016/j.bbr.2012.11.016; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Ellegood Jacob, 2012, Front Psychiatry, V3, P37, DOI 10.3389/fpsyt.2012.00037; Ellegood J, 2011, AUTISM RES, V4, P368, DOI 10.1002/aur.215; Fairless AH, 2012, BEHAV BRAIN RES, V228, P299, DOI 10.1016/j.bbr.2011.12.001; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kim S, 2012, NMR BIOMED, V25, P104, DOI 10.1002/nbm.1722; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; Koldewyn K, 2014, P NATL ACAD SCI USA, V111, P1981, DOI 10.1073/pnas.1324037111; Kumar M, 2012, BRAIN RES, V1455, P56, DOI 10.1016/j.brainres.2012.03.041; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li XH, 2012, BRAIN RES BULL, V88, P543, DOI 10.1016/j.brainresbull.2012.05.017; Mori S, 1998, MAGNET RESON MED, V40, P511, DOI 10.1002/mrm.1910400403; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Scheel C, 2011, NEUROIMAGE, V58, P391, DOI 10.1016/j.neuroimage.2011.06.040; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Stein JM, 2006, J NEUROSCI, V26, P2184, DOI 10.1523/JNEUROSCI.4437-05.2006; Stigler KA, 2011, BRAIN RES, V1380, P146, DOI 10.1016/j.brainres.2010.11.076; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Travers BG, 2014, NEUROPSYCHOLOGIA, V53, P137, DOI 10.1016/j.neuropsychologia.2013.11.008; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Verhoeven JS, 2010, NEURORADIOLOGY, V52, P3, DOI 10.1007/s00234-009-0583-y; Walker L, 2012, BIOL PSYCHIAT, V72, P1043, DOI 10.1016/j.biopsych.2012.08.001; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027	44	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109872	10.1371/journal.pone.0109872	http://dx.doi.org/10.1371/journal.pone.0109872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299583	Green Submitted, gold, Green Published			2022-12-25	WOS:000343941200079
J	Lu, H; Zhao, Q; Jiang, H; Zhu, TG; Xia, P; Seffens, W; Aikhionbare, F; Wang, DM; Dou, Z; Yao, XB				Lu, Huan; Zhao, Qun; Jiang, Hao; Zhu, Tongge; Xia, Peng; Seffens, William; Aikhionbare, Felix; Wang, Dongmei; Dou, Zhen; Yao, Xuebiao			Characterization of Ring-Like F-Actin Structure as a Mechanical Partner for Spindle Positioning in Mitosis	PLOS ONE			English	Article							CENTROSOME SEPARATION; CORTICAL DYNEIN; CELL-DIVISION; CENP-E; CHROMOSOME; ORIENTATION; CHECKPOINT; MOVEMENT; MOESIN; PHOSPHORYLATION	Proper spindle positioning and orientation are essential for accurate mitosis which requires dynamic interactions between microtubule and actin filament (F-actin). Although mounting evidence demonstrates the role of F-actin in cortical cytoskeleton dynamics, it remains elusive as to the structure and function of F-actin-based networks in spindle geometry. Here we showed a ring-like F-actin structure surrounding the mitotic spindle which forms since metaphase and maintains in MG132-arrested metaphase HeLa cells. This cytoplasmic F-actin structure is relatively isotropic and less dynamic. Our computational modeling of spindle position process suggests a possible mechanism by which the ring-like F-actin structure can regulate astral microtubule dynamics and thus mitotic spindle orientation. We further demonstrated that inhibiting Plk1, Mps1 or Myosin, and disruption of microtubules or F-actin polymerization perturbs the formation of the ring-like F-actin structure and alters spindle position and symmetric division. These findings reveal a previously unrecognized but important link between mitotic spindle and ring-like F-actin network in accurate mitosis and enables the development of a method to theoretically illustrate the relationship between mitotic spindle and cytoplasmic F-actin.	[Lu, Huan; Jiang, Hao; Zhu, Tongge; Xia, Peng; Wang, Dongmei; Dou, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Anhui, Peoples R China; [Zhu, Tongge; Seffens, William; Aikhionbare, Felix] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine	Yao, XB (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Anhui, Peoples R China.	yaoxb@ustc.edu.cn	DOU, ZHEN/N-2022-2013; Yao, Xuebiao/P-5771-2014	DOU, ZHEN/0000-0003-3303-9393; Xia, Peng/0000-0002-5419-7756	National Institutes of Health [DK56292, CA164133, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB917204, 2014CB964800]; Anhui Province Key Project Grant [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [91313303, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, 31271439]; MOE [20113402130010, PCSIRT-CDCB, WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project Grant; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); MOE(Ministry of Higher Education & Scientific Research (MHESR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, and G12RR03034. This project was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, and 2014CB964800; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 91313303, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, 31271439; and MOE grants (20113402130010, PCSIRT-CDCB, WK2060190018, and WK2340000021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINKLEY BR, 1967, J ULTRA MOL STRUCT R, V19, P1, DOI 10.1016/S0022-5320(67)80057-1; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chew TG, 2012, CYTOSKELETON, V69, P1040, DOI 10.1002/cm.21062; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gundersen GG, 2003, SCIENCE, V300, P2040, DOI 10.1126/science.1084938; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Ma R, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013018; Maier B, 2013, CELL CYCLE, V12, P1457, DOI 10.4161/cc.24602; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Okada S, 2013, DEV CELL, V26, P148, DOI 10.1016/j.devcel.2013.06.015; Pavin N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105025; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Vilmos P, 2009, EUR J CELL BIOL, V88, P609, DOI 10.1016/j.ejcb.2009.05.006; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Zheng Z, 2013, MOL BIOL CELL, V24, P901, DOI 10.1091/mbc.E12-06-0458; Zhu M, 2013, J CELL BIOL, V200, P773, DOI 10.1083/jcb.201207050	46	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e102547	10.1371/journal.pone.0102547	http://dx.doi.org/10.1371/journal.pone.0102547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299690	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200001
J	Nantarat, N; Wade, CM; Jeratthitikul, E; Sutcharit, C; Panha, S				Nantarat, Nattawadee; Wade, Christopher M.; Jeratthitikul, Ekgachai; Sutcharit, Chirasak; Panha, Somsak			Molecular Evidence for Cryptic Speciation in the Cyclophorus fulguratus (Pfeiffer, 1854) Species Complex (Caenogastropoda: Cyclophoridae) with Description of New Species	PLOS ONE			English	Article							LAND SNAILS; MAXIMUM-LIKELIHOOD; BAYESIAN-INFERENCE; SHELL SHAPE; PHYLOGENY; DELIMITATION; CONFIDENCE; EVOLUTION; MOLLUSCA	A high degree of intraspecific variation, both genetic and in shell morphology, of the operculate land snail Cyclophorus fulguratus (Pfeiffer, 1854) suggests that its classification as a single species warrants reconsideration. We sequenced two nuclear (18S and 28S) and two mitochondrial (16S and COI) genes of 46 C. fulguratus specimens and used them to estimate the phylogeny and to determine the validity of species boundaries. Molecular phylogenetic analyses revealed the presence of three lineages corresponding to three geographically disjunctive populations of C. fulguratus in Thailand. Likelihood tests of topologies significantly supported the non-monophyly of the C. fulguratus-complex and Bayesian species delimitation analysis significantly supported the potential representation as distinct species of these three lineages. Discriminant function analysis based on geometric-morphometrics of shell shape allowed for significant distinction of these three candidate species, although they revealed a considerable degree of overlap of shell shape reflecting their crypsis morphologically. The diagnostic characters are provided by color pattern, pattern of protoconch and pattern of jaw. In conclusion, the results support that the C. fulguratus s.l., as currently recognized, consists of three distinct species in Thailand: C. fulguratus s.s., C. rangunensis and C. abditus sp. nov., which are described herein.	[Nantarat, Nattawadee] Chulalongkorn Univ, Biol Sci Program, Fac Sci, Bangkok, Thailand; [Nantarat, Nattawadee; Jeratthitikul, Ekgachai; Sutcharit, Chirasak; Panha, Somsak] Chulalongkorn Univ, Fac Sci, Anim Systemat Res Unit, Dept Biol, Bangkok, Thailand; [Wade, Christopher M.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	Chulalongkorn University; Chulalongkorn University; University of Nottingham	Panha, S (corresponding author), Chulalongkorn Univ, Fac Sci, Anim Systemat Res Unit, Dept Biol, Bangkok, Thailand.	somsak.pan@chula.ac.th	Nantarat, Nattawadee/AAH-8297-2019	Jeratthitikul, Ekgachai/0000-0002-3477-9548; Wade, Christopher/0000-0002-1269-9694	Thailand Research Fund (TRF) under TRF-Senior Research Scholar Grant [RTA 5580001]; Royal Golden Jubilee Ph.D Program [PHD/0315/2550]; UNITAS Malacologica Student Research Awards	Thailand Research Fund (TRF) under TRF-Senior Research Scholar Grant(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D Program(Thailand Research Fund (TRF)); UNITAS Malacologica Student Research Awards	The main funding source for this project was from The Thailand Research Fund (TRF) to SP under TRF-Senior Research Scholar Grant RTA 5580001. TRF and Chulalongkorn University also jointly supported The Royal Golden Jubilee Ph.D Program (PHD/0315/2550) to SP and NN, and the UNITAS Malacologica Student Research Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Blanford W. T., 1864, Annals & Magazine of Natural History, Vxiii, P441; Chiba S, 2004, J EVOLUTION BIOL, V17, P131, DOI 10.1046/j.1420-9101.2004.00639.x; CORNISHBOWDEN A, 1985, NUCLEIC ACIDS RES, V13, P3021, DOI 10.1093/nar/13.9.3021; Corporation MC, 2001, END WILDL PLANTS WOR; Davison A, 2005, PLOS BIOL, V3, P1559, DOI 10.1371/journal.pbio.0030282; Drummond A. J., 2009, TRACER MCMC TRACE AN; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dryden I. L., 1998, STAT SHAPE ANAL; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gude G. K., 1921, P1; Habe T, 1964, FAUNA FLORA RES SOC, V4, P111; Hanley SCT, 1870, CONCHOLOGIA INDICA I; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kameda YC, 2007, MOL PHYLOGENET EVOL, V45, P519, DOI 10.1016/j.ympev.2007.03.021; KASINATHAN R, 1975, Proceedings of the Malacological Society of London, V41, P379; Kessing B., 1989, SIMPLE FOOLS GUIDE P; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kobelt W, 1907, SYSTEMATISCHES CONCH, V1, P401; Kobelt W, 1902, TIERREICH, V16, P1, DOI DOI 10.5962/BHL.TITLE.1227; Kongim B, 2006, INVERTEBR REPROD DEV, V49, P1, DOI 10.1080/07924259.2006.9652188; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; MINATO H, 1982, Venus the Japanese Journal of Malacology, V41, P124; Morgan JAT, 2002, MOL PHYLOGENET EVOL, V25, P477, DOI 10.1016/S1055-7903(02)00280-4; Nantarat N, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.411.7258; Nantarat N, 2014, MOL PHYLOGENET EVOL, V70, P99, DOI 10.1016/j.ympev.2013.09.013; Nevill G., 1878; Oakley KP, 1966, FRAMEWORKS DATING FO; Okusu A, 2003, ORG DIVERS EVOL, V3, P281, DOI 10.1078/1439-6092-00085; Paz V, 2004, SE ASIAN ARCHAEOLOGY; Pfeiffer L, 1854, P ZOOL SOC LOND, V20, P56; Pfeiffer L, 1853, SYSTEMATISCHES CONCH, V1, P229; Pfeiffer LGK, 1866, NOVITATES CONCHOLO 1, V3, P301; PILSBRY H. A., 1926, PROC ACAD NAT SCI PHILADELPHIA, V78, P453; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prasankok P, 2008, BIOCHEM SYST ECOL, V36, P900, DOI 10.1016/j.bse.2008.11.005; Rabett R, 2011, QUATERN INT, V239, P153, DOI 10.1016/j.quaint.2010.01.025; Reeve L, 1861, MONOGRAPH GENUS CYCL, V13; Rohlf F. J., 2012, TPSUTIL VERSION 1 49; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rundell RJ, 2008, PHILOS T R SOC B, V363, P3401, DOI 10.1098/rstb.2008.0110; Serb JM, 2011, ZOOL J LINN SOC-LOND, V163, P571, DOI 10.1111/j.1096-3642.2011.00707.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Solem A, 1959, FIELDIANA ZOOLOGY, V43, P243; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teshima H, 2003, MOL ECOL, V12, P1869, DOI 10.1046/j.1365-294X.2003.01862.x; Thacker RW, 2000, MOL PHYLOGENET EVOL, V16, P263, DOI 10.1006/mpev.2000.0793; Tielecke H., 1940, ARCH NATURGESCH, V9, P317; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; van BENTHEM JUTTING W. S. S., 1949, BULL RAFFLES MUS, V19, P50; Van Benthem Jutting W. S. S., 1948, TREUBIA, V19, P539; Welber L, 1925, FAUNA ANAT CEYLAN, V2, P497; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	64	16	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109785	10.1371/journal.pone.0109785	http://dx.doi.org/10.1371/journal.pone.0109785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299674	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200073
J	Radosevic, M; Fargas, L; Alsina, B				Radosevic, Marija; Fargas, Laura; Alsina, Berta			The Role of her4 in Inner Ear Development and Its Relationship with Proneural Genes and Notch Signalling	PLOS ONE			English	Article							CRANIAL SENSORY GANGLIA; HAIR CELL-DEVELOPMENT; LATERAL INHIBITION; COCHLEAR DEVELOPMENT; MAMMALIAN COCHLEA; NEUROGENIC GENES; NERVOUS-SYSTEM; FATE CHOICES; ZEBRAFISH; EXPRESSION	The generation of sensory neurons and hair cells of the inner ear is under tight control. Different members of the Hairy and Enhancer of Split genes (HES) are expressed in the inner ear, their full array of functions still not being disclosed. We have previously shown that zebrafish her9 acts as a patterning gene to restrict otic neurogenesis to an anterior domain. Here, we disclose the role of another her gene, her4, a zebrafish ortholog of Hes5 that is expressed in the neurogenic and sensory domains of the inner ear. The expression of her4 is highly dynamic and spatiotemporally regulated. We demonstrate by loss of function experiments that in the neurogenic domain her4 expression is under the regulation of neurogenin1 (neurog1) and the Notch pathway. Moreover, her4 participates in lateral inhibition during otic neurogenesis since her4 knockdown results in overproduction of the number of neurog1 and deltaB-positive otic neurons. In contrast, during sensorigenesis her4 is initially Notch-independent and induced by atoh1b in a broad prosensory domain. At later stages her4 expression becomes Notch-dependent in the future sensory domains but loss of her4 does not result in hair cell overproduction, suggesting that there other her genes can compensate its function.	[Radosevic, Marija; Fargas, Laura; Alsina, Berta] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Pompeu Fabra University	Alsina, B (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Parc Recerca Biomed Barcelona, Barcelona, Spain.	berta.alsina@upf.edu	Radosevic, Marija/AAI-2432-2019; Alsina, Berta/A-2632-2010	Radosevic, Marija/0000-0002-8323-6160; Alsina, Berta/0000-0002-6997-1249	Ministerio de Ciencia e Innovacion [BFU2011-27006]; Ministerio de Ciencia e Innovacion; Agencia de gestio d'Ajuts Universitaris de Recerca	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de gestio d'Ajuts Universitaris de Recerca	This work was supported by BFU2011-27006 from Ministerio de Ciencia e Innovacion (http://www.idi.mineco.gob.es/), MR was supported by FPI fellowship from Ministerio de Ciencia e Innovacion and LF was supported by FI from Agencia de gestio d'Ajuts Universitaris de Recerca(http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Adam J, 1998, DEVELOPMENT, V125, P4645; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Chrysostomou E, 2012, DEVELOPMENT, V139, P3764, DOI 10.1242/dev.074476; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Gajewski M, 2006, DEV GENES EVOL, V216, P315, DOI 10.1007/s00427-006-0059-6; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Haddon C, 1998, DEVELOPMENT, V125, P359; Hartman BH, 2009, JARO-J ASSOC RES OTO, V10, P321, DOI 10.1007/s10162-009-0162-2; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jahan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030853; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Madelaine R, 2011, DEV BIOL, V350, P198, DOI 10.1016/j.ydbio.2010.10.025; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Pujades C, 2006, DEV BIOL, V292, P55, DOI 10.1016/j.ydbio.2006.01.001; Radosevic M, 2011, DEVELOPMENT, V138, P397, DOI 10.1242/dev.056093; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Sapede D, 2012, J NEUROSCI, V32, P16424, DOI 10.1523/JNEUROSCI.3686-12.2012; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Scholpp S, 2009, P NATL ACAD SCI USA, V106, P19895, DOI 10.1073/pnas.0910894106; Shailam R, 1999, J NEUROCYTOL, V28, P809, DOI 10.1023/A:1007009803095; So JH, 2009, BIOCHEM BIOPH RES CO, V379, P22, DOI 10.1016/j.bbrc.2008.11.149; TAKEBAYASHI K, 1995, J BIOL CHEM, V270, P1342, DOI 10.1074/jbc.270.3.1342; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Takke C, 1999, DEVELOPMENT, V126, P1811; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109860	10.1371/journal.pone.0109860	http://dx.doi.org/10.1371/journal.pone.0109860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299450	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200078
J	Charest, H; Doualla-Bell, F; Cantin, R; Murphy, DG; Lemieux, L; Brenner, B; Hardy, I; Moisi, D; Lo, E; Baril, JG; Wainberg, MA; Roger, M; Tremblay, C				Charest, Hugues; Doualla-Bell, Florence; Cantin, Regis; Murphy, Donald G.; Lemieux, Linda; Brenner, Bluma; Hardy, Isabelle; Moisi, Daniela; Lo, Ernest; Baril, Jean-Guy; Wainberg, Mark A.; Roger, Michel; Tremblay, Cecile			A Significant Reduction in the Frequency of HIV-1 Drug Resistance in Quebec from 2001 to 2011 Is Associated with a Decrease in the Monitored Viral Load	PLOS ONE			English	Article							TRANSMISSION; PREVALENCE; EMTRICITABINE; LAMIVUDINE; INFECTION; VARIANTS; PROFILES; MUTATION; THERAPY; TRENDS	Background: HIV drug resistance represents a major threat for effective treatment. We assessed the trends in the frequency of drug resistance mutations and the monitored viral load (VL) in treatment-naive (TN) and treatment-experienced (TE) individuals infected with HIV-1 in Quebec, Canada, between 2001 and 2011. Methods and Findings: Resistance data were obtained from 4,105 and 5,086 genotypic tests performed on TN and TE patients, respectively. Concomitantly, 274,161 VL tests were carried out in the Province. Changes over time in drug resistance frequency and in different categories of VL were assessed using univariate logistic regression. Multiple logistic regression was used to evaluate associations between the rates of certain mutations and antiretroviral prescriptions. From 2001 to 2011, the proportion of undetectable VL test results continually increased, from 42.1% to 75.9%, while a significant decrease in the frequency of resistance mutations associated with protease inhibitors [PI (from 54% to 16%)], nucleoside [NRTI (from 78% to 37%) and non-nucleoside reverse transcriptase inhibitors [NNRTI (from 44% to 31%)I was observed in TE patients. In TN individuals, the overall frequency of transmitted drug resistance was 13.1%. A multiple logistic regression analysis indicated that the introduction of co-formulated emtricitabine/tenofovir or emtricitabine/tenofovir/efavirenz was positively associated with the decrease of the frequency of the M184I/V mutations observed overtime (p = 0.0004). Conclusions: We observed a significant decrease in the frequency of drug resistance mutations in TE patients, concomitant with a decrease in the proportion of patients with detectable viremia. These findings may be related to both the increased potencies and adherence to therapy associated with newer antiretroviral regimens. Nevertheless, our data demonstrate that broad use of antiretrovirals does not increase the level of circulating drug resistant variants.	[Charest, Hugues; Doualla-Bell, Florence; Cantin, Regis; Murphy, Donald G.; Lemieux, Linda; Lo, Ernest; Tremblay, Cecile] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Charest, Hugues; Roger, Michel; Tremblay, Cecile] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Doualla-Bell, Florence] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Brenner, Bluma; Moisi, Daniela; Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hardy, Isabelle; Roger, Michel; Tremblay, Cecile] McGill Univ, Ctr Hosp, Montreal, PQ, Canada; [Lo, Ernest] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Baril, Jean-Guy] Clin Quartier Latin, Montreal, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	Charest, H (corresponding author), Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.	hugues.charest@inspq.qc.ca	Brenner, Bluma/I-8714-2019		Ministry of Health (Ministere de la Sante et Services Sociaux du Quebec), Province of Quebec, Canada	Ministry of Health (Ministere de la Sante et Services Sociaux du Quebec), Province of Quebec, Canada	Data generated as part of the Quebec HIV-1 genotyping program was supported by the Ministry of Health (Ministere de la Sante et Services Sociaux du Quebec), Province of Quebec, Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Costagliola D, 2007, JAIDS-J ACQ IMM DEF, V46, P12; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Dieffenbach CW, 2012, CURR OPIN HIV AIDS, V7, P106, DOI 10.1097/COH.0b013e32834f3f13; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Frentz D, 2012, AIDS REV, V14, P17; Gianotti N, 2005, NEW MICROBIOL, V28, P319; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Marcelin AG, 2012, J ANTIMICROB CHEMOTH, V67, P1475, DOI 10.1093/jac/dks047; McColl DJ, 2011, HIV CLIN TRIALS, V12, P61, DOI 10.1310/hct1202-61; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; R Development Core Team, 2012, R LANG ENV STAT COMP; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Ruelle J, 2013, AIDS RES HUM RETROVI; Shafer Robert W, 2001, HIV Seq Compend, V2001, P1; Svicher V, 2010, JAIDS-J ACQ IMM DEF, V55, P336, DOI 10.1097/QAI.0b013e3181e6763f; Truong HHM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025281; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; von Wyl V, 2009, CLIN INFECT DIS, V48, P979, DOI 10.1086/597352; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109420	10.1371/journal.pone.0109420	http://dx.doi.org/10.1371/journal.pone.0109420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295725	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000070
J	Schonberg, A; Bergner, E; Helm, S; Agne, B; Duenschede, B; Schunemann, D; Schutkowski, M; Baginsky, S				Schoenberg, Anna; Bergner, Elena; Helm, Stefan; Agne, Birgit; Duenschede, Beatrix; Schuenemann, Danja; Schutkowski, Mike; Baginsky, Sacha			The Peptide Microarray "ChloroPhos1.0" Identifies New Phosphorylation Targets of Plastid Casein Kinase II (pCKII) in Arabidopsis thaliana	PLOS ONE			English	Article							PHOSPHOPROTEOME PROFILING REVEALS; CHLOROPLAST RNA-POLYMERASE; PROTEIN-KINASE; STRUCTURAL BASIS; STN7 KINASE; SPECIFICITY; SUBSTRATE; CK2; PROTEOMICS; NETWORKS	We report the development of a peptide microarray based on previously determined phosphorylation sites in chloroplast proteins. Altogether, 905 peptides were spotted as 15mers in nine replicates onto glass slides. We used the microarray for in vitro phosphorylation experiments and specifically assessed the peptide substrate spectrum of chloroplast casein kinase II (pCKII). To this end, native pCKII from Arabidopsis thaliana and Sinapis alba chloroplasts was enriched by Heparin-Sepharose chromatography and its activity on the microarray was compared to the activity of a recombinant Arabidopsis pCKII. All three kinase preparations phosphorylated a similar set of peptides that were clearly distinct from those phosphorylated by bovine heart protein kinase A (PKA) in control experiments. The majority of the pCKII phosphorylation targets are involved in plastid gene expression, supporting the earlier denomination of pCKII as plastid transcription kinase (PTK). In addition we identified Alb3 as pCKII substrate that is essential for the integration of light-harvesting complex subunits (LHC) into the thylakoid membrane. Plastid CKII phosphorylation activity was characterized in greater detail in vitro with recombinant wildtype Alb3 and phosphorylation site mutants as substrates, establishing S424 as the pCKII phosphorylation site. Our data show that the peptide microarray ChloroPhos1.0 is a suitable tool for the identification of new kinase downstream targets in vitro that can be validated subsequently by in vivo experiments.	[Schoenberg, Anna; Bergner, Elena; Helm, Stefan; Agne, Birgit; Schutkowski, Mike; Baginsky, Sacha] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Germany; [Duenschede, Beatrix; Schuenemann, Danja] Ruhr Univ Bochum, Bochum, Germany; [Schutkowski, Mike] Steinbeis Forschungszentrum, Peptide Microarrays, Halle, Germany	Martin Luther University Halle Wittenberg; Ruhr University Bochum	Baginsky, S (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Germany.	sacha.baginsky@biochemtech.uni-halle.de		Baginsky, Sacha/0000-0002-5440-3898; Schuenemann, Danja/0000-0001-8894-7685; Schutkowski, MIke/0000-0003-0919-7076	Deutsche Forschungsgemeinschaft (DFG) [BA1902/2-1, SCHU1163/5-1]; European Regional Development fund of the European Commission [W21004490]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Regional Development fund of the European Commission	This work was supported by financial support from the Deutsche Forschungsgemeinschaft (DFG) via grant BA1902/2-1 (AS) and from the European Regional Development fund of the European Commission via grant W21004490 "Land Sachsen-Anhalt" (SH) to SB. Furthermore, the authors are grateful for support from DFG grant SCHU1163/5-1. SB gratefully acknowledges DFG support for the acquisition of a Synapt G2-S mass spectrometer (INST 271/283-1 FUGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; Al Quobaili F, 2012, METABOLISM, V61, P1512, DOI 10.1016/j.metabol.2012.07.011; Baerenfaller K, 2011, INTEGR BIOL-UK, V3, P225, DOI 10.1039/c0ib00078g; Baginsky S, 1997, PLANT MOL BIOL, V34, P181, DOI 10.1023/A:1005802909902; Baginsky S, 1999, PLANT MOL BIOL, V39, P1013, DOI 10.1023/A:1006177807844; Bellafiore S, 2002, PLANT CELL, V14, P2303, DOI 10.1105/tpc.003442; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Fitzpatrick LM, 2001, PLANT J, V27, P59, DOI 10.1046/j.0960-7412.2001.01061.x; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Helm S, 2014, J PROTEOMICS, V98, P79, DOI 10.1016/j.jprot.2013.12.007; Huang YD, 2010, ANAL BIOCHEM, V402, P69, DOI 10.1016/j.ab.2010.03.028; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Ingelsson B, 2012, FEBS LETT, V586, P1265, DOI 10.1016/j.febslet.2012.03.061; Kanekatsu M, 1998, BIOCHEM MOL BIOL INT, V46, P99; KANEKATSU M, 1993, FEBS LETT, V335, P176, DOI 10.1016/0014-5793(93)80724-9; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Loza-Tavera H, 2006, BIOCHIMIE, V88, P1217, DOI 10.1016/j.biochi.2006.03.009; Mulekar JJ, 2012, PLANT SIGNAL BEHAV, V7, P292, DOI 10.4161/psb.18883; Ortelt J, 2014, METHODS MOL BIOL, V1132, P47, DOI 10.1007/978-1-62703-995-6_3; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Pfalz J, 2013, TRENDS PLANT SCI, V18, P186, DOI 10.1016/j.tplants.2012.11.003; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Puthiyaveetil S, 2012, PLANT CELL ENVIRON, V35, P347, DOI 10.1111/j.1365-3040.2011.02349.x; Reiland S, 2011, P NATL ACAD SCI USA, V108, P12955, DOI 10.1073/pnas.1104734108; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Rochaix JD, 2013, ANTIOXID REDOX SIGN, V18, P2184, DOI 10.1089/ars.2012.5110; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P375, DOI 10.1016/j.bbabio.2010.11.010; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Schonberg A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00256; Schutkowski M, 2004, ANGEW CHEM INT EDIT, V43, P2671, DOI 10.1002/anie.200453900; Schweer J, 2010, PLANT J, V62, P192, DOI 10.1111/j.1365-313X.2010.04138.x; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Thiele A, 2009, METHODS MOL BIOL, V570, P203, DOI 10.1007/978-1-60327-394-7_9; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van Wijk KJ, 2011, PLANT PHYSIOL, V155, P1578, DOI 10.1104/pp.111.172932; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Zulawski M, 2013, NUCLEIC ACIDS RES, V41, pD1176, DOI 10.1093/nar/gks1081	45	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108344	10.1371/journal.pone.0108344	http://dx.doi.org/10.1371/journal.pone.0108344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295873	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000015
J	Julian, GS; de Oliveira, RW; Perry, JC; Tufik, S; Chagas, JR				Julian, Guilherme Silva; de Oliveira, Renato Watanabe; Perry, Juliana Cini; Tufik, Sergio; Chagas, Jair Ribeiro			Validation of Housekeeping Genes in the Brains of Rats Submitted to Chronic Intermittent Hypoxia, a Sleep Apnea Model	PLOS ONE			English	Article							RT-PCR; NORMALIZATION; EXPOSURE; CELLS; MICE; 18S	Obstructive sleep apnea (OSA) is a syndrome characterized by intermittent nocturnal hypoxia, sleep fragmentation, hypercapnia and respiratory effort, and it has been associated with several complications, such as diabetes, hypertension and obesity. Quantitative real-time PCR has been performed in previous OSA-related studies; however, these studies were not validated using proper reference genes. We have examined the effects of chronic intermittent hypoxia (CIH), which is an experimental model mainly of cardiovascular consequences of OSA, on reference genes, including beta-actin, beta-2-microglobulin, glyceraldehyde-3-phosphate dehydrogenase, hypoxanthine guanine phosphoribosyl transferase and eukaryotic 18S rRNA, in different areas of the brain. All stability analyses were performed using the geNorm, Normfinder and BestKeeper software programs. With exception of the 18S rRNA, all of the evaluated genes were shown to be stable following CIH exposure. However, gene stability rankings were dependent on the area of the brain that was analyzed and varied according to the software that was used. This study demonstrated that CIH affects various brain structures differently. With the exception of the 18S rRNA, all of the tested genes are suitable for use as housekeeping genes in expression analyses.	[Julian, Guilherme Silva; de Oliveira, Renato Watanabe; Perry, Juliana Cini; Tufik, Sergio; Chagas, Jair Ribeiro] Univ Fed Sao Paulo, Dept Psicobiol, UNIFESP, Sao Paulo, Brazil; [Chagas, Jair Ribeiro] Univ Fed Sao Paulo, Dept Biociencias, UNIFESP Baixada Santista, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Chagas, JR (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, UNIFESP, Sao Paulo, Brazil.	jchagas1@gmail.com	Chagas, Jair Ribeiro/AFV-6501-2022; Chagas, Jair R/A-1701-2012	Chagas, Jair Ribeiro/0000-0002-0357-8276; Chagas, Jair R/0000-0002-0357-8276; Julian, Guilherme/0000-0002-3487-2240	Associacao Fundo de Incentivo a Pesquisa (AFIP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/15060-4, 2011/16011-6]; CNPq [558924/2008-5]	Associacao Fundo de Incentivo a Pesquisa (AFIP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Associacao Fundo de Incentivo a Pesquisa (AFIP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/15060-4 to GSJ and 2011/16011-6 to RWO). JCP (#558924/2008-5), ST, and JRC are recipients of fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersen M.L., 2011, ANIMAL MODELS TOOLS, V1; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Caradec J, 2010, BRIT J CANCER, V103, P591, DOI 10.1038/sj.bjc.6605755; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Carreras A, 2012, AM J PHYSIOL-REG I, V303, pR700, DOI 10.1152/ajpregu.00258.2012; Dumitrascu R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/234631; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Gilliland HE, 1997, CHOICE ANESTHETIC MA, DOI [10.1213/00000539-199712000-00039, DOI 10.1213/00000539-199712000-00039]; Goldbart A, 2003, NEUROSCIENCE, V122, P585, DOI 10.1016/j.neuroscience.2003.08.054; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Iyer S Ramnathan, 2012, J Assoc Physicians India, V60, P42; Kandel E., 2000, PRINCIPLES NEURAL SC; Lal C, 2012, CHEST, V141, P1601, DOI 10.1378/chest.11-2214; Lee KS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-45; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Moraes DJA, 2013, J NEUROSCI, V33, P19223, DOI 10.1523/JNEUROSCI.3041-13.2013; Nagelkerke A, 2010, BRIT J CANCER, V103, P590, DOI 10.1038/sj.bjc.6605754; Nieto F, 2000, MED ASS; Peppard P, 2000, NEW ENGL J; Perry JC, 2013, RESP PHYSIOL NEUROBI, P8; Perry JC, 2007, RESP PHYSIOL NEUROBI, V156, P250, DOI 10.1016/j.resp.2006.10.004; Perry JC, 2011, AUTON NEUROSCI-BASIC, V160, P32, DOI 10.1016/j.autneu.2010.11.006; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Punjabi N, 2002, AM J; Ramasamy S, 2013, ARCH BIOCHEM BIOPHYS, V534, P71, DOI 10.1016/j.abb.2013.02.004; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sunderram J., 2012, Critical Reviews in Biomedical Engineering, V40, P265; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Yao L, 2012, MOL BIOL REP, V39, P569, DOI 10.1007/s11033-011-0772-8; Zhao DJ, 2012, FEBS OPEN BIO, V2, P235, DOI 10.1016/j.fob.2012.08.001	36	32	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109902	10.1371/journal.pone.0109902	http://dx.doi.org/10.1371/journal.pone.0109902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289636	gold, Green Published, Green Submitted			2022-12-25	WOS:000342798000098
J	Wang, DY; Chen, S; Wang, ZM; Ji, CL; Xu, CM; Zhang, XF; Chauhan, BS				Wang, Danying; Chen, Song; Wang, Zaiman; Ji, Chenglin; Xu, Chunmei; Zhang, Xiufu; Chauhan, Bhagirath Singh			Optimizing Hill Seeding Density for High-Yielding Hybrid Rice in a Single Rice Cropping System in South China	PLOS ONE			English	Article							LEAF-AREA INDEX; GRAIN-YIELD; COMPONENTS; NITROGEN; GROWTH	Mechanical hill direct seeding of hybrid rice could be the way to solve the problems of high seeding rates and uneven plant establishment now faced in direct seeded rice; however, it is not clear what the optimum hill seeding density should be for high-yielding hybrid rice in the single-season rice production system. Experiments were conducted in 2010 and 2011 to determine the effects of hill seeding density (25 cm x 15 cm, 25 cm x 17 cm, 25 cm x 19 cm, 25 cm x 21 cm, and 25 cm x 23 cm; three to five seeds per hill) on plant growth and grain yield of a hybrid variety, Nei2you6, in two fields with different fertility (soil fertility 1 and 2). In addition, in 2012 and 2013, comparisons among mechanical hill seeding, broadcasting, and transplanting were conducted with three hybrid varieties to evaluate the optimum seeding density. With increases in seeding spacing from 25 cm x 15 cm to 25 cm x 23 cm, productive tillers per hill increased by 34.2% and 50.0% in soil fertility 1 and 2. Panicles per m(2) declined with increases in seeding spacing in soil fertility 1. In soil fertility 2, no difference in panicles per m 2 was found at spacing ranging from 25 cm x 17 cm to 25 cm x 23 cm, while decreases in the area of the top three leaves and aboveground dry weight per shoot at flowering were observed. Grain yield was the maximum at 25 cm x 17 cm spacing in both soil fertility fields. Our results suggest that a seeding density of 25 cm x 17 cm was suitable for high-yielding hybrid rice. These results were verified through on-farm demonstration experiments, in which mechanical hill-seeded rice at this density had equal or higher grain yield than transplanted rice.	[Wang, Danying; Chen, Song; Ji, Chenglin; Xu, Chunmei; Zhang, Xiufu] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Wang, Zaiman] South China Agr Univ, Key Lab Key Technol Agr Machine & Equipment, Guangzhou, Guangdong, Peoples R China; [Chauhan, Bhagirath Singh] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; South China Agricultural University; University of Queensland	Zhang, XF (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	chais.zju@gmail.com	wang, danying/GQY-7371-2022; Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668	National Rice Industry Technology System [CARS-01-04A]; 3 Nong 6 Fang Program; Five-twelfth National Science and Technology Support Program [2011BAD16B14]	National Rice Industry Technology System; 3 Nong 6 Fang Program; Five-twelfth National Science and Technology Support Program(Chinese Academy of Sciences)	The authors are grateful for grants from the National Rice Industry Technology System (CARS-01-04A), the 3 Nong 6 Fang Program, and the Five-twelfth National Science and Technology Support Program (2011BAD16B14). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baloch A.W., 2008, ASIAN J PLANT SCI, V1, P25, DOI DOI 10.3923/ajps.2002.25.27; Chauhan BS, 2012, ADV AGRON, V117, P315, DOI 10.1016/B978-0-12-394278-4.00007-6; Chen FB., 2011, CHINA RICE, V17, P1; Chen S, 2012, SCI WORLD J, DOI 10.1100/2012/279641; Chen Y, 1959, CHEN YK RICE CULTIVA, P1; [程建平 Cheng Jianping], 2010, [华中农业大学学报, Journal of Huazhong Agricultural University], V29, P1; COUNCE PA, 1989, CROP SCI, V29, P175, DOI 10.2135/cropsci1989.0011183X002900010038x; De Datta SK, 1981, PRINCIPLES PRACTICES, P220; Ding Y, 1961, CHINA RICE CULTIVATI, P53; Ekta Joshi, 2013, Plant Knowledge Journal, V2, P119; FAGADE SO, 1971, AGRON J, V63, P503, DOI 10.2134/agronj1971.00021962006300030047x; Farooq M, 2011, SOIL TILL RES, V111, P87, DOI 10.1016/j.still.2010.10.008; Gong ZiTong, 1999, Pedosphere, V9, P193; Gravios KA, 1982, AGRON J, V84, P1; Hanada K, 1993, SCI RICE PLANT, V1, P222; Horie T., 2003, Rice science: innovations and impact for livelihood. Proceedings of the International Rice Research Conference, Beijing, China, 16-19 September 2002, P117; Huang M, 2011, AGR SCI CHINA, V10, P1537, DOI 10.1016/S1671-2927(11)60149-1; Huang M, 2011, PLANT PROD SCI, V14, P331, DOI 10.1626/pps.14.331; ISLAM MF, 2008, INT J BIOL RES, V5, P60; Jiang P, 1987, CHINESE J RICE SCI, V1, P111; Kabir MH, 2008, INT J BIOL RES, V5, P42; Katsura K, 2007, FIELD CROP RES, V103, P170, DOI 10.1016/j.fcr.2007.06.001; Lei XiaoLong, 2013, Acta Agronomica Sinica, V39, P1814, DOI 10.3724/SP.J.1006.2013.01814; Lin Q, 1982, JIANGSU AGR SCI, V9, P1; Lin XQ, 2009, RICE SCI, V16, P138, DOI 10.1016/S1672-6308(08)60070-0; Ling Q H, 2000, CROP POPULATION QUAL, P42; MILLER BC, 1991, AGRON J, V83, P291, DOI 10.2134/agronj1991.00021962008300020006x; Mithrasena Y. J. P. K., 1986, International Rice Research Newsletter, V11, P20; Nuruzzaman M, 2000, SOIL SCI PLANT NUTR, V46, P381; Oziegbe M., 2007, International Journal of Botany, V3, P317; Pandey S., 2002, DIRECT SEEDING RES S, P3; Shu S, 2009, CHIN AGR SCI B, V25, P142; Chauhan BS, 2013, CROP PROT, V48, P51, DOI 10.1016/j.cropro.2013.02.015; Sittisuang P, 1995, CONSTRAINTS OPPORTUN, P1; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Uphoff N., 2003, International Journal of Agricultural Sustainability, V1, P38, DOI 10.3763/ijas.2003.0105; Wang D, 2010, ACTA AGR ZHEJIANG, V22, P330; Wang D, 2010, CHINA RICE, V16, P22; Wang ZaiMan, 2010, Journal of South China Agricultural University, V31, P91; Wu GW, 1998, AGRON J, V90, P317, DOI 10.2134/agronj1998.00021962009000030001x; Wu W, 2008, J IRON STEEL RES INT, V15, P15, DOI 10.1016/S1006-706X(08)60004-7; Yang ShiMin, 2009, Acta Agronomica Sinica, V35, P93, DOI 10.3724/SP.J.1006.2009.00093; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yoshida S., 1970, Soil Science and Plant Nutrition, V16, P186, DOI 10.1080/00380768.1970.10432838; Yoshinaga S, 2005, JARQ-JPN AGR RES Q, V39, P147, DOI 10.6090/jarq.39.147; [曾山 Zeng Shan], 2014, [华中农业大学学报, Journal of Huazhong Agricultural University], V33, P12; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008; Zhong X, 2002, J AGR SCI, V138, P269, DOI 10.1017/S0021859601001903; Zhong XH, 2003, J PLANT NUTR, V26, P1203, DOI 10.1081/PLN-120020365; Zhu D, 2008, ANHUI AGR SCI B, V14, P133	50	27	31	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109417	10.1371/journal.pone.0109417	http://dx.doi.org/10.1371/journal.pone.0109417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290342	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000060
J	Hong, JY; Lee, SH; Lee, SC; Kim, JW; Kim, KP; Kim, SM; Tapia, N; Lim, KT; Kim, J; Ahn, HS; Ko, K; Shin, CY; Lee, HT; Scholer, HR; Hyun, JK; Han, DW				Hong, Jin Young; Lee, Sung Ho; Lee, Seung Chan; Kim, Jong-Wan; Kim, Kee-Pyo; Kim, Sung Min; Tapia, Natalia; Lim, Kyung Tae; Kim, Jonghun; Ahn, Hong-Sun; Ko, Kinarm; Shin, Chan Young; Lee, Hoon Taek; Schoeler, Hans R.; Hyun, Jung Keun; Han, Dong Wook			Therapeutic Potential of Induced Neural Stem Cells for Spinal Cord Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECOVERY; DIRECT CONVERSION; AXONAL GROWTH; FIBROBLASTS; TRANSPLANTATION; CONNECTIVITY; CONTUSION; NEURONS; CYCLE; RATS	The spinal cord does not spontaneously regenerate, and treatment that ensures functional recovery after spinal cord injury (SCI) is still not available. Recently, fibroblasts have been directly converted into induced neural stem cells (iNSCs) by the forced expression defined transcription factors. Although directly converted iNSCs have been considered to be a cell source for clinical applications, their therapeutic potential has not yet been investigated. Here we show that iNSCs directly converted from mouse fibroblasts enhance the functional recovery of SCI animals. Engrafted iNSCs could differentiate into all neuronal lineages, including different subtypes of mature neurons. Furthermore, iNSC-derived neurons could form synapses with host neurons, thus enhancing the locomotor function recovery. A time course analysis of iNSC-treated SCI animals revealed that engrafted iNSCs effectively reduced the inflammatory response and apoptosis in the injured area. iNSC transplantation also promoted the active regeneration of the endogenous recipient environment in the absence of tumor formation. Therefore, our data suggest that directly converted iNSCs hold therapeutic potential for treatment of SCI and may thus represent a promising cell source for transplantation therapy in patients with SCI.	[Hong, Jin Young; Kim, Jong-Wan; Ahn, Hong-Sun; Hyun, Jung Keun] Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan 330714, South Korea; [Hong, Jin Young; Kim, Jong-Wan; Ahn, Hong-Sun; Hyun, Jung Keun] Dankook Univ, Grad Sch, NBM Global Res Ctr BK21PLUS, Cheonan 330714, South Korea; [Hong, Jin Young; Kim, Jong-Wan; Ahn, Hong-Sun; Hyun, Jung Keun] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea; [Lee, Sung Ho; Lee, Seung Chan; Kim, Sung Min; Lim, Kyung Tae; Kim, Jonghun; Ko, Kinarm; Lee, Hoon Taek; Han, Dong Wook] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea; [Shin, Chan Young] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul 143701, South Korea; [Shin, Chan Young; Han, Dong Wook] Konkuk Univ, Open Innovat Ctr, Inst Biomed Sci & Technol, Seoul 143701, South Korea; [Kim, Kee-Pyo; Tapia, Natalia; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Hyun, Jung Keun] Dankook Univ, Coll Med, Dept Rehabil Med, Cheonan 330714, South Korea	Dankook University; Dankook University; Dankook University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Max Planck Society; University of Munster; Dankook University	Hyun, JK (corresponding author), Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan 330714, South Korea.	rhhyun@dankook.ac.kr; dwhan@konkuk.ac.kr	, HS/AAB-4434-2019; Hyun, Jung Keun/ABB-2173-2020; Lim, Kyungtae/GYU-3532-2022; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Hyun, Jung Keun/0000-0001-9254-4424; Lim, Kyungtae/0000-0001-6044-2191; Kim, Jonghun/0000-0002-9154-5529; Tapia, Natalia/0000-0003-0226-1952; Kim, Sungmin/0000-0002-3249-9075	Korea Health Technology R&D Project, Ministry of Health Welfare [A120392]; Priority Research Center Program of the National Research Foundation of Korea (Ministry of Education, Science and Technology) [2009-0093829]	Korea Health Technology R&D Project, Ministry of Health Welfare; Priority Research Center Program of the National Research Foundation of Korea (Ministry of Education, Science and Technology)	This work was supported by Korea Health Technology R&D Project, Ministry of Health & Welfare Grant A120392 and Priority Research Center Program Grant 2009-0093829) of the National Research Foundation of Korea (Ministry of Education, Science and Technology).	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hyun JK, 2009, J NEUROTRAUM, V26, P1773, DOI [10.1089/neu.2007.0485, 10.1089/neu.2007-0485]; Joo NY, 2012, ACTA BIOMATER, V8, P1802, DOI 10.1016/j.actbio.2012.01.026; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Kumamaru H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2132; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Lu P, 2014, CURR OPIN NEUROBIOL, V27, P103, DOI 10.1016/j.conb.2014.03.010; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Marthaler AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085138; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Siebert JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-148; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Willyard C, 2013, NATURE, V503, pS4, DOI 10.1038/503S4a; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564	29	54	58	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.588871	http://dx.doi.org/10.1074/jbc.M114.588871			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294882	hybrid, Green Published			2022-12-25	WOS:000345335000011
J	Luo, L; Yang, J; Liu, DX				Luo, Lu; Yang, Jun; Liu, Dongxiang			Integration and Oligomerization of Bax Protein in Lipid Bilayers Characterized by Single Molecule Fluorescence Study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; B-cell Lymphoma 2 (Bcl-2) Family; Bax; Lipid Bilayer; Single Molecule Biophysics	OUTER MITOCHONDRIAL-MEMBRANE; CYTOCHROME-C RELEASE; CONFORMATIONAL-CHANGE; BH3 DOMAINS; CELL-DEATH; APOPTOSIS; ACTIVATION; BCL-2; PERMEABILIZATION; INSERTION	Background: The stoichiometry of Bax oligomers on mitochondria and the process of Bax pore formation remain unclear. Results: Bax oligomerization occurs only if tBid is present, and its membrane insertion highly depends on cardiolipin; Bax tends to form tetramer on membrane. Conclusion: Bax pore formation involves two independent steps: Bax oligomerization and membrane insertion. Significance: This study may help elucidate Bax pore formation. Bax is a pro-apoptotic Bcl-2 family protein. The activated Bax translocates to mitochondria, where it forms pore and permeabilizes the mitochondrial outer membrane. This process requires the BH3-only activator protein (i.e. tBid) and can be inhibited by anti-apoptotic Bcl-2 family proteins such as Bcl-x(L). Here by using single molecule fluorescence techniques, we studied the integration and oligomerization of Bax in lipid bilayers. Our study revealed that Bax can bind to lipid membrane spontaneously in the absence of tBid. The Bax pore formation undergoes at least two steps: pre-pore formation and membrane insertion. The activated Bax triggered by tBid or BH3 domain peptide integrates on bilayers and tends to form tetramers, which are termed as pre-pore. Subsequent insertion of the pre-pore into membrane is highly dependent on the composition of cardiolipin in lipid bilayers. Bcl-x(L) can translocate Bax from membrane to solution and inhibit the pore formation. The study of Bax integration and oligomerization at the single molecule level provides new evidences that may help elucidate the pore formation of Bax and its regulatory mechanism in apoptosis.	[Luo, Lu; Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, Shanghai 201203, Peoples R China; [Luo, Lu; Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Yang, Jun] Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Liu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.	dxl@mail.shcnc.ac.cn			National Science Fund [21472206]; State Key Laboratory of Drug Research	National Science Fund; State Key Laboratory of Drug Research	This work was supported by the National Science Fund (Grant 21472206) and the State Key Laboratory of Drug Research.	Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Epand RF, 2002, BIOCHEM J, V367, P849, DOI 10.1042/BJ20020986; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kushnareva Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001394; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Raemy E, 2014, CHEM PHYS LIPIDS, V179, P70, DOI 10.1016/j.chemphyslip.2013.12.002; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shamas-Din A, 2013, J BIOL CHEM, V288, P22111, DOI 10.1074/jbc.M113.482109; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Todt F, 2013, CELL DEATH DIFFER, V20, P333, DOI 10.1038/cdd.2012.131; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang TJ, 2013, BBA-MOL CELL BIOL L, V1831, P1542, DOI 10.1016/j.bbalip.2013.03.001	35	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31708	31718		10.1074/jbc.M114.583393	http://dx.doi.org/10.1074/jbc.M114.583393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288797	Green Published, hybrid			2022-12-25	WOS:000345314700005
J	Guo, F; Han, XH; Zhang, JH; Zhao, XX; Lou, JC; Chen, H; Huang, XL				Guo, Feng; Han, Xiaohua; Zhang, Jinghui; Zhao, Xiuxiu; Lou, Jicheng; Chen, Hong; Huang, Xiaolin			Repetitive Transcranial Magnetic Stimulation Promotes Neural Stem Cell Proliferation via the Regulation of MiR-25 in a Rat Model of Focal Cerebral Ischemia	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; PARKINSONS-DISEASE; ARTERY OCCLUSION; PROGENITOR CELLS; CHRONIC STROKE; MOTOR CORTEX; NEUROGENESIS; MICRORNAS; RTMS; EXCITABILITY	Repetitive transcranial magnetic stimulation (rTMS) has increasingly been studied over the past decade to determine whether it has a therapeutic benefit on focal cerebral ischemia. However, the underlying mechanism of rTMS in this process remains unclear. In the current study, we investigated the effects of rTMS on the proliferation of adult neural stem cells (NSCs) and explored microRNAs (miRNAs) that were affected by rTMS. Our data showed that 10 Hz rTMS significantly increased the proliferation of adult NSCs after focal cerebral ischemia in the subventricular zone (SVZ), and the expression of miR-25 was obviously up-regulated in the ischemic cortex after rTMS. p57, an identified miR-25 target gene that regulates factors linked to NSC proliferation, was also evaluated, and it exhibited down-regulation. To further verify the role of miR-25, rats were injected with a single dose of antagomir-25 and were subjected to focal cerebral ischemia followed by rTMS treatment. The results confirmed that miR-25 could be repressed specifically and could drive the up-regulation of its target gene (p57), which resulted in the inhibition of adult NSC proliferation in the SVZ after rTMS. Thus, our studies strongly indicated that 10 Hz rTMS can promote the proliferation of adult NSCs in the SVZ after focal cerebral ischemia by regulating the miR-25/p57 pathway.	[Guo, Feng; Han, Xiaohua; Zhao, Xiuxiu; Chen, Hong; Huang, Xiaolin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil Med, Wuhan 430074, Peoples R China; [Zhang, Jinghui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China; [Lou, Jicheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Sun Yat Sen University; Huazhong University of Science & Technology	Huang, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil Med, Wuhan 430074, Peoples R China.	xiaolinh2006@126.com	Zhang, Jing/GWZ-7332-2022		National Natural Science Foundation of China [81071601, 81171858, 81070986]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Nos: 81071601, 81171858 and 81070986). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Arias-Carrion Oscar, 2008, Int Arch Med, V1, P2, DOI 10.1186/1755-7682-1-2; Arnold CP, 2011, GENOME RES, V21, P798, DOI 10.1101/gr.111385.110; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Corti M, 2012, AM J PHYS MED REHAB, V91, P254, DOI 10.1097/PHM.0b013e318228bf0c; Deng ZD, 2014, CLIN NEUROPHYSIOL, V125, P1202, DOI 10.1016/j.clinph.2013.11.038; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dziennis S, 2011, METAB BRAIN DIS, V26, P123, DOI 10.1007/s11011-011-9241-2; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Feng SF, 2012, BEHAV BRAIN RES, V232, P245, DOI 10.1016/j.bbr.2012.04.019; Ferrarelli F, 2004, BRAIN RES BULL, V64, P103, DOI 10.1016/j.brainresbull.2004.04.020; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Hiscock A, 2008, NEUROREHAB NEURAL RE, V22, P228, DOI 10.1177/1545968307307115; Hotermans C, 2007, STROKE, V38, P253, DOI 10.1161/01.STR.0000254446.14130.aa; ISAYAMA K, 1991, STROKE, V22, P1394, DOI 10.1161/01.STR.22.11.1394; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Khedr EM, 2006, MOVEMENT DISORD, V21, P2201, DOI 10.1002/mds.21089; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwon TG, 2014, RESTOR NEUROL NEUROS, V32, P223, DOI 10.3233/RNN-130313; Lang N, 2006, CLIN NEUROPHYSIOL, V117, P2292, DOI 10.1016/j.clinph.2006.05.030; Le Q, 2014, AM J PHYS MED REHAB, V93, P422, DOI 10.1097/PHM.0000000000000027; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075561; Linden RD, 1999, J NEUROSURG, V91, P205, DOI 10.3171/spi.1999.91.2.0205; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032230; Lomarev MP, 2007, CLIN NEUROPHYSIOL, V118, P2072, DOI 10.1016/j.clinph.2007.06.016; Lomarev MP, 2006, MOVEMENT DISORD, V21, P325, DOI 10.1002/mds.20713; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Machado S, 2008, FUNCT NEUROL, V23, P113; Mally Judit, 2007, Expert Rev Neurother, V7, P165, DOI 10.1586/14737175.7.2.165; Peck B, 2011, AGING-US, V3, P329, DOI 10.18632/aging.100302; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rooke HM, 2001, PATHOLOGY, V33, P73; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sasaki N, 2013, J STROKE CEREBROVASC, V22, P413, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.004; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Ueyama E, 2011, PSYCHIAT CLIN NEUROS, V65, P77, DOI 10.1111/j.1440-1819.2010.02170.x; Wu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078629; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2; Yozbatiran N, 2009, STROKE, V40, P309, DOI 10.1161/STROKEAHA.108.522144; Zhao ZN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045133	55	60	65	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109267	10.1371/journal.pone.0109267	http://dx.doi.org/10.1371/journal.pone.0109267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302788	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400048
J	Haesebaert, J; Lutringer-Magnin, D; Kalecinski, J; Barone, G; Jacquard, AC; Leocmach, Y; Regnier, V; Vanhems, P; Chauvin, F; Lasset, C				Haesebaert, Julie; Lutringer-Magnin, Delphine; Kalecinski, Julie; Barone, Giovanna; Jacquard, Anne-Carole; Leocmach, Yann; Regnier, Veronique; Vanhems, Philippe; Chauvin, Franck; Lasset, Christine			Disparities of Perceptions and Practices Related to Cervical Cancer Prevention and the Acceptability of HPV Vaccination According to Educational Level in a French Cross-Sectional Survey of 18-65 Years Old Women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; PARENTAL ACCEPTANCE; PREDICTORS; KNOWLEDGE; ATTITUDES; DAUGHTERS; MORTALITY; CHILDREN; MOTHERS	Introduction: We aimed to study the relationships between educational level, women's knowledge about cervical cancer (CC), and acceptance of HPV vaccination for their daughters. Methods: We analysed data from a quantitative (self-administrated questionnaire) and qualitative (semi-structured interviews) cross-sectional study performed in 2008 among 1,229 French 18-65-year-old women recruited by general practitioners. Women were categorized into three educational level groups: low (LEL: 43.9%), medium (MEL: 33.4%) and high (HEL: 22.6%). Results: Knowledge about CC and its prevention was lower among LEL women. In the 180 mothers of 14-18-year-old daughters (99 LEL, 54 MEL, 45 HEL), acceptance of HPV vaccine was higher in LEL (60.4%) and MEL (68.6%) than in HEL mothers (46.8%). Among LEL mothers, those who were favourable to HPV vaccination were more likely to be young (OR = 8.44 [2.10-34.00]), to be vaccinated against hepatitis B (OR = 4.59 [1.14-18.52]), to have vaccinated their children against pneumococcus (OR = 3.52 [0.99-12.48]) and to present a history of abnormal Pap smear (OR = 6.71 [0.70-64.01]). Conclusion: Although LEL women had poorer knowledge about CC and its prevention, they were more likely to accept HPV vaccination than HEL mothers.	[Haesebaert, Julie; Lutringer-Magnin, Delphine; Barone, Giovanna; Vanhems, Philippe; Lasset, Christine] Univ Lyon 1, CNRS, UMR 5558, F-69365 Lyon, France; [Haesebaert, Julie; Lutringer-Magnin, Delphine; Barone, Giovanna; Lasset, Christine] Ctr Leon Berard, F-69373 Lyon, France; [Kalecinski, Julie; Regnier, Veronique; Chauvin, Franck] Inst Cancerol Loire, St Etienne, France; [Kalecinski, Julie; Regnier, Veronique; Chauvin, Franck] Univ St Etienne, IFR 143, St Etienne, France; [Jacquard, Anne-Carole; Leocmach, Yann] Sanofi Pasteur MSD, Lyon, France; [Vanhems, Philippe] Hosp Civils Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UNICANCER; Centre Leon Berard; Institut de Cancerologie de la Loire; Universite Jean Monnet; Sanofi-Aventis; Sanofi France; CHU Lyon	Lasset, C (corresponding author), Univ Lyon 1, CNRS, UMR 5558, F-69365 Lyon, France.	christine.lasset@lyon.unicancer.fr	HAESEBAERT, JULIE/E-7141-2017; Haesebaert, Julie/AAN-1702-2020	HAESEBAERT, JULIE/0000-0001-9109-5604; Haesebaert, Julie/0000-0001-9109-5604; Regnier, veronique/0000-0002-0293-5606	La Ligue contre le cancer	La Ligue contre le cancer(Ligue nationale contre le cancer)	The work was supported by a grant by La Ligue contre le cancer http://www.ligue-cancer.net/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnack JL, 2010, WOMEN HEALTH ISS, V20, P28, DOI 10.1016/j.whi.2009.08.007; Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50; Chao C, 2009, AM J PUBLIC HEALTH, V99, P1137, DOI 10.2105/AJPH.2008.147876; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Dahlstrom LA, 2010, INT J CANCER, V126, P500, DOI 10.1002/ijc.24712; Das A, 2010, VACCINE, V28, P1440, DOI 10.1016/j.vaccine.2009.11.041; Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381; Dempsey A, 2011, VACCINE, V29, P528, DOI 10.1016/j.vaccine.2010.10.051; Downs LS, 2010, GYNECOL ONCOL, V117, P486, DOI 10.1016/j.ygyno.2010.02.011; Duport N, 2005, DEPISTAGE CANC COL U; Gerend MA, 2007, SEX TRANSM DIS, V34, P468, DOI 10.1097/01.olq.0000245915.38315.bd; Haesebaert J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1034; HAS, 2008, REC COLL HAS VACC AN; HAS, 2010, ET LIEUX REC DEP CAN; INCA. Institut National du Cancer, 2009, FRANC FAC DEP CANC; INVS. Institut National de Veille Sanitaire, 2012, PROJ INC MORT CANC F; Lutringer-Magnin D, 2011, VACCINE, V29, P5322, DOI 10.1016/j.vaccine.2011.05.006; Marlow LAV, 2007, BRIT J CANCER, V97, P691, DOI 10.1038/sj.bjc.6603927; Marlow LAV, 2007, HUM VACCINES, V3, P171, DOI 10.4161/hv.3.5.4310; Marlow LAV, 2009, J ADOLESCENT HEALTH, V44, P446, DOI 10.1016/j.jadohealth.2008.09.011; Menvielle G, 2008, BRIT J CANCER, V98, P1012, DOI 10.1038/sj.bjc.6604274; Menvielle G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-260; Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270; Olshen E, 2005, J ADOLESCENT HEALTH, V37, P248, DOI 10.1016/j.jadohealth.2005.05.016; Perkins RB, 2011, J WOMENS HEALTH, V20, P85, DOI 10.1089/jwh.2009.1919; Roberts SA, 2011, EPIDEMIOL INFECT, V139, P400, DOI 10.1017/S095026881000066X; Rosenthal SL, 2008, J ADOLESCENT HEALTH, V43, P239, DOI 10.1016/j.jadohealth.2008.06.009; Rousseau A, 2002, BEH, V19, P81; Shelton RC, 2013, J RELIG HEALTH, V52, P1120, DOI 10.1007/s10943-011-9553-x; Trim K, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/921236; UNESCO, 2006, IND STAND CLASS ED I; Waller J, 2006, CANCER EPIDEM BIOMAR, V15, P1257, DOI 10.1158/1055-9965.EPI-06-0041; Wu JP, 2010, J LOW GENIT TRACT DI, V14, P155, DOI 10.1097/LGT.0b013e3181d4e747	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109320	10.1371/journal.pone.0109320	http://dx.doi.org/10.1371/journal.pone.0109320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303180	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400051
J	Li, L; Yan, J; Xu, J; Liu, CQ; Zhen, ZJ; Chen, HW; Ji, Y; Wu, ZP; Hu, JY; Zheng, LM; Lau, WY				Li, Li; Yan, Jing; Xu, Jing; Liu, Chao-Qun; Zhen, Zuo-Jun; Chen, Huan-Wei; Ji, Yong; Wu, Zhi-Peng; Hu, Jian-Yuan; Zheng, Limin; Lau, Wan Yee			CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma	PLOS ONE			English	Article							CHEMOKINE; CANCER; TISSUE; CELLS; VCC-1; OVEREXPRESSION; VALIDATION; SURVIVAL	CXC ligand 17 (CXCL17) is a novel CXC chemokine whose clinical significance remains largely unknown. In the present study, we characterized the prognostic value of CXCL17 in patients with hepatocellular carcinoma (HCC) and evaluated the association of CXCL17 with immune infiltration. We examined CXCL17 expression in 227 HCC tissue specimens by immunohistochemical staining, and correlated CXCL17 expression patterns with clinicopathological features, prognosis, and immune infiltrate density (CD4 T cells, CD8 T cells, B cells, natural killer cells, neutrophils, macrophages). Kaplan-Meier survival analysis showed that both increased intratumoral CXCL17 (P-0.015 for overall survival [OS], P=0.003 for recurrence-free survival [RFS]) and peritumoral CXCL17 (P=0.002 for OS, P<0.001 for RFS) were associated with shorter OS and RFS. Patients in the CXCL171 W group had significantly lower 5-year recurrence rate compared with patients in the CXCL17hi9h group (peritumoral: 53.1% vs. 77.7%, P<0.001, intratumoral: 58.6% vs. 73.0%, P= 0.001, respectively). Multivariate Cox proportional hazards analysis identified peritumoral CXCL17 as an independent prognostic factor for both OS (hazard ratio [HR] = 2.066, 95% confidence interval [CI] = 1.296-3.292, P=0.002) and RFS (HR = 1.844, 95% CI = 1.218 2.793, P= 0.004). Moreover, CXCL17 expression was associated with more CD68 and less CD4 cell infiltration (both P<0.05). The combination of CXCL17 density and immune infiltration could be used to further classify patients into subsets with different prognosis for RFS. Our results provide the first evidence that tumor-infiltrating CXCL17 cell density is an independent prognostic factor that predicts both OS and RFS in HCC. CXCL17 production correlated with adverse immune infiltration and might be an important target for anti-HCC therapies.	[Li, Li; Zhen, Zuo-Jun; Chen, Huan-Wei; Ji, Yong; Wu, Zhi-Peng; Hu, Jian-Yuan; Lau, Wan Yee] First Peoples Hosp Foshan, Dept Hepat & Pancreat Surg, Foshan, Guangdong, Peoples R China; [Li, Li; Yan, Jing; Xu, Jing; Liu, Chao-Qun; Zheng, Limin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Lau, Wan Yee] Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Chinese University of Hong Kong	Zhen, ZJ (corresponding author), First Peoples Hosp Foshan, Dept Hepat & Pancreat Surg, Foshan, Guangdong, Peoples R China.	zzjun@fsyyy.com; josephlau@cuhk.edu.hk	zheng, limin/HGB-2510-2022	Zheng, Limin/0000-0002-8281-1450	Ministry of Health of China [2012ZX10002-011]; China Postdoctoral Science Foundation [2013M540676]; FoShan Postdoctoral Scientific Research project	Ministry of Health of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); FoShan Postdoctoral Scientific Research project	This work was supported by project grants from the Ministry of Health of China (LZ; 2012ZX10002-011; http://www.moh.gov.cn/publicfiles//business/htmlfiles/wsb/index.htm); China Postdoctoral Science Foundation (JY; 2013M540676; http://res.chinapostdoctor.org.cn/BshWeb/InnerPages_c5a0971c-60a5-4c35-917c-4b5526056791.shtml); and FoShan Postdoctoral Scientific Research project; (LL; 2013; http://www.fshrss.gov.cn/zwgk/tzgg/201312/t20131223_4501821.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Abel EJ, 2014, HUM PATHOL, V45, P1092, DOI 10.1016/j.humpath.2014.01.008; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Bruix J, 2002, HEPATOLOGY, V35, P519, DOI 10.1053/jhep.2002.32089; Ding T, 2011, CANCER-AM CANCER SOC, V117, P4878, DOI 10.1002/cncr.26137; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gao Q, 2012, CANCER RES, V72, P3546, DOI 10.1158/0008-5472.CAN-11-4032; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Huang F, 2010, WORLD J GASTROENTERO, V16, P1832, DOI 10.3748/wjg.v16.i15.1832; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lee WY, 2013, AM J PHYSIOL-ENDOC M, V304, pE32, DOI 10.1152/ajpendo.00083.2012; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Matsui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044080; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Mu X, 2009, ACTA BIOCH BIOPH SIN, V41, P631, DOI 10.1093/abbs/gmp051; Nicholson TM, 2013, DIFFERENTIATION, V85, P140, DOI 10.1016/j.diff.2013.02.006; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Takeishi K, 2011, SURG TODAY, V41, P1016, DOI [10.1007/s00595-011-0058-8, 10.1007/s00595-010-4392-z]; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Weinstein EJ, 2006, BIOCHEM BIOPH RES CO, V350, P74, DOI 10.1016/j.bbrc.2006.08.194; Xu J, 2012, J HEPATOL, V57, P313, DOI 10.1016/j.jhep.2012.03.027; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058006; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhou SL, 2012, HEPATOLOGY, V56, P2242, DOI 10.1002/hep.25907; Zhou ZT, 2012, BIOCHEM BIOPH RES CO, V420, P336, DOI 10.1016/j.bbrc.2012.02.160; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	41	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110064	10.1371/journal.pone.0110064	http://dx.doi.org/10.1371/journal.pone.0110064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303284	gold, Green Submitted, Green Published			2022-12-25	WOS:000343730400107
J	Ohshima, D; Ichikawa, K				Ohshima, Daisuke; Ichikawa, Kazuhisa			Regulation of Nuclear NF-kappa B Oscillation by a Diffusion Coefficient and Its Biological Implications	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ACTIVATION; DYNAMICS; PORES; BETA; CELL; INFLAMMATION; MORPHOMETRY; PROGRESSION; PATHWAYS	The transcription factor NF-kappa B shuttles between the cytoplasm and the nucleus, and nuclear NF-kappa B is known to oscillate with a cycle of 1.5-2.5 h following the application of external stimuli. Oscillation pattern of NF-kappa B is implicated in regulation of the gene expression profile. In a previous report, we found that the oscillation pattern of nuclear NF-kappa B in a computational 3D spherical cell was regulated by spatial parameters such as nuclear to cytoplasmic volume ratio, nuclear transport, locus of protein synthesis, and diffusion coefficient. Here we report analyses and a biological implication for the regulation of oscillation pattern by diffusion coefficient. Our analyses show that the "reset" of nuclear NF-kappa B, defined as the return of nuclear NF-kappa B to the initial level or lower, was crucial for the oscillation; this was confirmed by the flux analysis. In addition, we found that the distant cytoplasmic location from the nucleus acted as a "reservoir" for storing newly synthesized Ian.. When the diffusion coefficient of proteins was large (>= 10(-11) m(2)/s), a larger amount of I kappa B alpha was stored in the "reservoir" with a large flux by diffusion. Subsequently, stored I kappa BB alpha diffused back to the nucleus, where nuclear NF-kappa B was "reset" to the initial state. This initiated the next oscillation cycle. When the diffusion coefficient was small (<= 10(-13) m(2)/s), oscillation of nuclear NF-kappa B was not observed because a smaller amount of lac( was stored in the "reservoir" and there was incomplete "reset" of nuclear NF-kappa B. If the diffusion coefficient for I kappa B alpha was increased to 10(-11) m(2)/5 keeping other proteins at 10(-13) m(2)/s, the oscillation was rescued confirming the "reset" and "reservoir" hypothesis. Finally, we showed altered effective value of diffusion coefficient by diffusion obstacles. Thus, organelle crowding seen in stressed cells possibly changes the oscillation pattern by controlling the effective diffusion coefficient.	[Ohshima, Daisuke; Ichikawa, Kazuhisa] Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan	University of Tokyo	Ichikawa, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan.	kichi@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22117008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Biteen JS, 2010, COLD SPRING HARVOR P; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; CZERNIAK B, 1984, CANCER RES, V44, P3752; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dieteren CEJ, 2011, P NATL ACAD SCI USA, V108, P8657, DOI 10.1073/pnas.1017581108; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; Ichikawa K, 2001, BIOINFORMATICS, V17, P483, DOI 10.1093/bioinformatics/17.5.483; Ichikawa K, 2014, IET SYSTEMS IN PRESS; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; KATSOULIS M, 1995, BRIT J CANCER, V72, P958, DOI 10.1038/bjc.1995.441; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; KOONG AC, 1994, CANCER RES, V54, P1425; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin YC, 2013, CURR OPIN CHEM BIOL, V17, P663, DOI 10.1016/j.cbpa.2013.04.027; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Mazel T, 2009, BIOPHYS J, V96, P1691, DOI 10.1016/j.bpj.2008.10.066; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ohshima D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046911; Oliver KM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2575; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; PIENTA KJ, 1991, CANCER, V68, P2012, DOI 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C; SACKSWILNER R, 1990, ULTRASTRUCT PATHOL, V14, P311, DOI 10.3109/01913129009032246; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Staudt LM, 2010, COLD SPRING HARBOR P, V2; SUGIE S, 1994, CARCINOGENESIS, V15, P95, DOI 10.1093/carcin/15.1.95; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; SVEJDA J, 1975, NEOPLASMA, V22, P385; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Weigum SE, CANC PREV RES PHILA, V3, P518; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	58	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109895	10.1371/journal.pone.0109895	http://dx.doi.org/10.1371/journal.pone.0109895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302804	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400092
J	Yang, XB; Duan, QH; Wang, JJ; Zhang, ZB; Jiang, GF				Yang, Xiaobing; Duan, Qionghong; Wang, Jianjie; Zhang, Zhengbin; Jiang, Gaofeng			Seasonal Variation of Newly Notified Pulmonary Tuberculosis Cases from 2004 to 2013 in Wuhan, China	PLOS ONE			English	Article							VITAMIN-D; CHEMICAL CHARACTERISTICS; DIESEL EXHAUST; DISEASES; HEALTH; PM2.5	Background: Although there was a report about the seasonal variation in Wuhan city, it only analyzed the prevalence data of pulmonary tuberculosis (TB) cases, and just studied the seasonality by subgroup of smear positive and negative from 2006 to 2010 by spectral analysis. In this study, we investigated the seasonality of the total newly notified pulmonary TB cases by subgroups such as time period, sex, age, occupation, district, and sputum smear result from 2004 to 2013 in Wuhan by a popular seasonal adjustment model (TRAMO-SEATS). Methods: Monthly pulmonary TB cases from 2004 to 2013 in Wuhan were analyzed by the TRAMO-SEATS seasonal adjustment program. Seasonal amplitude was calculated and compared within the subgroups. Results: From 2004 to 2013, there were 77.76 thousand newly notified pulmonary TB cases in Wuhan, China. There was a dominant peak spring peak (March) with seasonal amplitude of 56.81% and a second summer peak (September) of 43.40%, compared with the trough month (December). The spring seasonal amplitude in 2004-2008 was higher than that of 2009-2013(P<0.05). There were no statistical differences for spring seasonal amplitude within subgroups of gender, age, district, and sputum smear result (P>0.05). However, there were significant differences in spring seasonal amplitude by occupation, with amplitude ranging from 59.37% to 113.22% (P<0.05). The summer seasonal amplitude in 2004-2008 was higher than that of 2009-2013(P<0.05). There were no statistical differences in summer seasonal amplitude within subgroups of gender, district, sputum smear result(P<0.05). There were significant differences in summer seasonal amplitude by age, with amplitude ranging from 36.05% to 100.09% (P<0.05). Also, there were significant differences in summer seasonal amplitude by occupation, with amplitude ranging from 43.40% to 109.88% (P<0.05). Conclusions: There was an apparent seasonal variation in pulmonary TB cases in Wuhan. We speculated that spring peak in our study was most likely caused by the increased reactivation of the latent TB due to vitamin D deficiency and high PM2.5 concentration, while the summer peak was mainly resulted from the enhanced winter transmission due to indoor crowding in winter, overcrowding of public transportation over the period of the Spring Festival and health care seeking delay in winter.	[Duan, Qionghong; Wang, Jianjie; Zhang, Zhengbin] Wuhan TB Inst, Dept TB Control, Wuhan, Hubei, Peoples R China; [Yang, Xiaobing] Wuhan Ctr Dis Prevent & Control, Dept Infect Dis Prevent & Control, Wuhan, Hubei, Peoples R China; [Jiang, Gaofeng] Wuhan Univ Sci & Technol, Coll Med, Sch Publ Hlth, Wuhan, Hubei, Peoples R China	Wuhan University of Science & Technology	Duan, QH (corresponding author), Wuhan TB Inst, Dept TB Control, Wuhan, Hubei, Peoples R China.	lsdqh@mails.tjmu.edu.cn						Akhtar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-3; Ane-Anyangwe I N, 2006, East Afr Med J, V83, P588; Atun RA, 2005, EUR J PUBLIC HEALTH, V15, P350, DOI 10.1093/eurpub/cki018; Borgdorff MW, 2011, INT J EPIDEMIOL, V40, P964, DOI 10.1093/ije/dyr058; Chen Z, 2009, DI LI KE XUE, V29, P911; Choi CJ, 2013, J CLIN ENDOCR METAB, V98, P1703, DOI 10.1210/jc.2012-3901; DAVIES PDO, 1985, TUBERCLE, V66, P301, DOI 10.1016/0041-3879(85)90068-6; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Duan QiongHong, 2011, Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, V40, P231; Edelson PJ, 2011, TRAVEL MED INFECT DI, V9, P27, DOI 10.1016/j.tmaid.2010.11.001; Eurostat, 2002, SEAS ADJ INT TRAM SE; Hiramatsu K, 2005, EXP LUNG RES, V31, P405, DOI 10.1080/01902140590918786; Hungarian Central Statistical Office, 2007, SEAS ADJ METH PRACT; Kelsey MC, 1999, THORAX, V54, P862; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luo TY, 2013, EPIDEMIOL INFECT, P1; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; Lv XP, 2013, HUNAN KE JI DA XUE X, V28, P104; Martinez L, 2010, TRAVEL MED INFECT DI, V8, P84, DOI 10.1016/j.tmaid.2009.02.005; Mehra M, 2013, INT J TUBERC LUNG D, V17, P1186, DOI 10.5588/ijtld.12.0959; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mohr O, 2012, EUROSURVEILLANCE, V17, P12; Nagayama N, 2006, INT J TUBERC LUNG D, V10, P1117; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509; Smith GS, 2014, INT J ENVIRON HEAL R, V24, P103, DOI 10.1080/09603123.2013.800959; Song YC, 1998, HUA ZHONG SHI FAN DA, V32, P105; STRACHAN DP, 1995, THORAX, V50, P175, DOI 10.1136/thx.50.2.175; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Sun YL, 2004, ATMOS ENVIRON, V38, P5991, DOI 10.1016/j.atmosenv.2004.07.009; Tan JH, 2009, J ENVIRON SCI-CHINA, V21, P774, DOI 10.1016/S1001-0742(08)62340-2; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; World Health Organization, 2013, WHOHTMTB201311; Zhang GL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063486, 10.1371/journal.pone.0080969, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]	41	17	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108369	10.1371/journal.pone.0108369	http://dx.doi.org/10.1371/journal.pone.0108369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303675	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400011
J	Zhao, N; Zhu, DH				Zhao, Nan; Zhu, Donghui			Collagen Self-Assembly on Orthopedic Magnesium Biomaterials Surface and Subsequent Bone Cell Attachment	PLOS ONE			English	Article							IN-VIVO CORROSION; ALLOYS; TITANIUM; ROUGHNESS; BEHAVIOR; VITRO; DIFFERENTIATION; FABRICATION; SCAFFOLDS; SUBSTRATE		[Zhao, Nan; Zhu, Donghui] North Carolina Agr & Tech State Univ, Dept Chem Biol & Bio Engn, Greensboro, NC 27411 USA; [Zhao, Nan; Zhu, Donghui] North Carolina Agr & Tech State Univ, NSF Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC USA	University of North Carolina; North Carolina A&T State University; National Science Foundation (NSF); University of North Carolina; North Carolina A&T State University	Zhu, DH (corresponding author), North Carolina Agr & Tech State Univ, Dept Chem Biol & Bio Engn, Greensboro, NC 27411 USA.	dzhu@ncat.edu	Zhao, Nan/GMX-1019-2022; Zhu, Donghui/H-9058-2017	Zhu, Donghui/0000-0002-3057-1889	National Institute of Health [SC2NS082475]; NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University [NSF-0812348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC2NS082475] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge funding from the National Institute of Health (SC2NS082475) and support from NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) (NSF-0812348) at North Carolina A&T State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Ao HY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0070; Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045; Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9; Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020; Chen XN, 2013, BIOMATERIALS, V34, P8203, DOI 10.1016/j.biomaterials.2013.07.035; Choudhary L, 2012, ACTA BIOMATER, V8, P916, DOI 10.1016/j.actbio.2011.10.031; Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006; Fang M, 2013, LANGMUIR, V29, P2330, DOI 10.1021/la3048104; Ferreira AM, 2009, ACTA MICROSC, V18, P278; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Franz CM, 2011, METHODS MOL BIOL, V736, P97, DOI 10.1007/978-1-61779-105-5_7; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018; Hanada K, 2013, MAT SCI ENG C-MATER, V33, P4746, DOI 10.1016/j.msec.2013.07.033; He LR, 2012, J INORG BIOCHEM, V117, P124, DOI 10.1016/j.jinorgbio.2012.08.017; Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001; Ji DW, 2013, MATER SCI TECH-LOND, V29, P480, DOI 10.1179/1743284712Y.0000000165; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kadler KE, 1996, BIOCHEM J, V316, P1; Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463; Kim WY, 2014, MAT SCI ENG A-STRUCT, V594, P189, DOI 10.1016/j.msea.2013.11.066; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leow WW, 2011, LANGMUIR, V27, P10907, DOI 10.1021/la2018055; Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021; Loo RW, 2008, LANGMUIR, V24, P13276, DOI 10.1021/la803041v; Mao L, 2012, MATER LETT, V88, P1, DOI 10.1016/j.matlet.2012.08.012; MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314; Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073; Mendonca DBS, 2011, BONE, V49, P463, DOI 10.1016/j.bone.2011.04.019; Narayanan B, 2014, LANGMUIR, V30, P1343, DOI 10.1021/la4043364; Nassif N, 2010, CHEM MATER, V22, P3307, DOI 10.1021/cm903594n; NEBE JB, 2007, METALLIC BIOMATERIAL, P215; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]; Perez P, 2013, CORROS SCI, V69, P226, DOI 10.1016/j.corsci.2012.12.007; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Sader MS, 2013, MAT SCI ENG C-MATER, V33, P4188, DOI 10.1016/j.msec.2013.06.006; Seitz JM, 2012, ACTA BIOMATER, V8, P3852, DOI 10.1016/j.actbio.2012.05.024; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046; Walter R, 2013, APPL SURF SCI, V279, P343, DOI 10.1016/j.apsusc.2013.04.096; Walter R, 2011, MATER DESIGN, V32, P2350, DOI 10.1016/j.matdes.2010.12.016; Wang L, 2014, J PHYS CHEM B, V118, P511, DOI 10.1021/jp405035x; Wang ZL, 2013, P I MECH ENG H, V227, P1094, DOI 10.1177/0954411913493845; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Wu LL, 2014, ACTA BIOMATER, V10, P2843, DOI 10.1016/j.actbio.2014.02.010; Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273; Xu SW, 2011, SCRIPTA MATER, V65, P269, DOI 10.1016/j.scriptamat.2011.04.026; Zhao N, 2013, INT J BIOMED ENG TEC, V12, P382, DOI 10.1504/IJBET.2013.057677; Zhao N, 2014, INT J MOL SCI, V15, P5263, DOI 10.3390/ijms15045263; Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001	54	26	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110420	10.1371/journal.pone.0110420	http://dx.doi.org/10.1371/journal.pone.0110420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303459	Green Submitted, gold, Green Published			2022-12-25	WOS:000343730400130
J	Auer, MK; Fuss, J; Hohne, N; Stalla, GK; Sievers, C				Auer, Matthias K.; Fuss, Johannes; Hoehne, Nina; Stalla, Guenter K.; Sievers, Caroline			Transgender Transitioning and Change of Self-Reported Sexual Orientation	PLOS ONE			English	Article							GENDER IDENTITY; TRANSSEXUALISM; BEHAVIOR; AUTOGYNEPHILIA; REASSIGNMENT; DIFFERENCE; TYPOLOGY; HEALTH; BRAIN	Objective: Sexual orientation is usually considered to be determined in early life and stable in the course of adulthood. In contrast, some transgender individuals report a change in sexual orientation. A common reason for this phenomenon is not known. Methods: We included 115 transsexual persons (70 male-to-female "MtF" and 45 female-to-male "FtM") patients from our endocrine outpatient clinic, who completed a questionnaire, retrospectively evaluating the history of their gender transition phase. The questionnaire focused on sexual orientation and recalled time points of changes in sexual orientation in the context of transition. Participants were further asked to provide a personal concept for a potential change in sexual orientation. Results: In total, 32.9% (n = 23) MtF reported a change in sexual orientation in contrast to 22.2% (n = 10) FtM transsexual persons (p = 0.132). Out of these patients, 39.1% (MtF) and 60% (FtM) reported a change in sexual orientation before having undergone any sex reassignment surgery. FtM that had initially been sexually oriented towards males (= androphilic), were significantly more likely to report on a change in sexual orientation than gynephilic, analloerotic or bisexual FtM (p = 0.012). Similarly, gynephilic MtF reported a change in sexual orientation more frequently than androphilic, analloerotic or bisexual MtF transsexual persons (p = 0.05). Conclusion: In line with earlier reports, we reveal that a change in self-reported sexual orientation is frequent and does not solely occur in the context of particular transition events. Transsexual persons that are attracted by individuals of the opposite biological sex are more likely to change sexual orientation. Qualitative reports suggest that the individual's biography, autogynephilic and autoandrophilic sexual arousal, confusion before and after transitioning, social and self-acceptance, as well as concept of sexual orientation itself may explain this phenomenon.	[Auer, Matthias K.; Stalla, Guenter K.; Sievers, Caroline] Max Planck Inst Psychiat, Dept Internal Med Endocrinol & Clin Chem, Munich, Germany; [Fuss, Johannes] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Ctr Psychosocial Med, Hamburg, Germany; [Hoehne, Nina] Max Planck Inst Psychiat, Dept Mol Psychol, Munich, Germany	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society	Auer, MK (corresponding author), Max Planck Inst Psychiat, Dept Internal Med Endocrinol & Clin Chem, Munich, Germany.	mauer@mpipsykl.mpg.de	Auer, Matthias/AAI-5449-2021; Fuss, Johannes/AAI-6580-2021					American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; [Anonymous], 1998, WILL KNOWLEDGE HIST; APA (American Psychiatric Association), 2008, ANSW YOUR QUEST BETT; Auer MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078469; Auer MK, 2013, FERTIL STERIL, V100, P1103, DOI 10.1016/j.fertnstert.2013.05.047; Bailey JM, 2009, NEBRASKA S MOTIVATIO; BLANCHARD R, 1989, ARCH SEX BEHAV, V18, P315, DOI 10.1007/BF01541951; BLANCHARD R, 1989, J NERV MENT DIS, V177, P616, DOI 10.1097/00005053-198910000-00004; BLANCHARD R, 1985, ARCH SEX BEHAV, V14, P247, DOI 10.1007/BF01542107; Bockting W, 2009, ARCH SEX BEHAV, V38, P688, DOI 10.1007/s10508-009-9489-3; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Cohen-Kettenis PT, 1993, J PSYCHOL HUMAN SEX, V5, P55, DOI DOI 10.1300/J056V05N04_; Daskalos CT, 1998, ARCH SEX BEHAV, V27, P605, DOI 10.1023/A:1018725201811; De Cuypere G, 2005, ARCH SEX BEHAV, V34, P679, DOI 10.1007/s10508-005-7926-5; DEVOR H, 1993, J SEX RES, V30, P303, DOI 10.1080/00224499309551717; DOORN CD, 1994, ARCH SEX BEHAV, V23, P185, DOI 10.1007/BF01542098; FREUND K, 1993, BRIT J PSYCHIAT, V162, P558, DOI 10.1192/bjp.162.4.558; Fuss J, 2013, J PSYCHIATR RES, V47, P2015, DOI 10.1016/j.jpsychires.2013.08.023; Hirschfeld M, 1918, SEXUALPATHOLOGIE; Hirschfeld M., 1948, SEXUAL ANOMALIES ORI; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kinnish KK, 2005, ARCH SEX BEHAV, V34, P173, DOI 10.1007/s10508-005-1795-9; Lawrence AA, 2005, ARCH SEX BEHAV, V34, P147, DOI 10.1007/s10508-005-1793-y; Lawrence AA, 2005, ARCH SEX BEHAV, V34, P135, DOI 10.1007/s10508-005-1792-z; Lawrence AA., 2013, MEN TRAPPED MENS BOD, DOI [10.1007/978-1-4614-5182-2, DOI 10.1007/978-1-4614-5182-2]; Lever J., 1994, ADVOCATE, P16; LEVINE SB, 1981, J SEX MARITAL THER, V7, P85, DOI 10.1080/00926238108406096; Meier SC, 2013, ARCH SEX BEHAV, V42, P463, DOI 10.1007/s10508-012-0052-2; Moser C, 2010, J HOMOSEXUAL, V57, P790, DOI 10.1080/00918369.2010.486241; Nieder TO, 2011, J SEX MED, V8, P783, DOI 10.1111/j.1743-6109.2010.02142.x; Pathela P, 2006, ANN INTERN MED, V145, P416; PILLARD RC, 1995, PSYCHIAT CLIN N AM, V18, P71, DOI 10.1016/S0193-953X(18)30071-6; Rowniak S, 2013, ARCH SEX BEHAV, V42, P449, DOI 10.1007/s10508-012-0036-2; Schleifer D., 2006, SEXUALITIES, V9, P57, DOI [DOI 10.1177/1363460706058397, 10.1177/1363460706058397]; SEIL D, 1997, GENDER BLENDING, P137; Seil D., 1996, TXB HOMOSEXUALITY ME, P743; Seil D, 2004, TRANSGENDER SUBJECTI, P99, DOI DOI 10.1080/; Serano JM, 2010, INT J TRANSGENDERISM, V12, P176, DOI 10.1080/15532739.2010.514223; Sigal P, 2000, MOON GOODDESS VIGING; Smith YLS, 2005, PSYCHOL MED, V35, P89, DOI 10.1017/S0033291704002776; Swaab DF, 2007, BEST PRACT RES CL EN, V21, P431, DOI 10.1016/j.beem.2007.04.003; Thompson EM, 2008, DEV PSYCHOL, V44, P15, DOI 10.1037/0012-1649.44.1.15; vanKesteren PJ, 1996, ARCH SEX BEHAV, V25, P589, DOI 10.1007/BF02437841; WEINBERG TS, 1978, J HOMOSEXUAL, V4, P143; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Zucker KJ, 2012, J SEX MARITAL THER, V38, P151, DOI 10.1080/0092623X.2011.611219	47	48	48	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110016	10.1371/journal.pone.0110016	http://dx.doi.org/10.1371/journal.pone.0110016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299675	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200097
J	Joe, B; Nagaraju, A; Gowda, LR; Basrur, V; Lokesh, BR				Joe, Bina; Nagaraju, Anitha; Gowda, Lalitha R.; Basrur, Venkatesha; Lokesh, Belur R.			Mass-Spectrometric Identification of T-Kininogen I/Thiostatin as an Acute-Phase Inflammatory Protein Suppressed by Curcumin and Capsaicin	PLOS ONE			English	Article							RAT PERITONEAL-MACROPHAGES; MOLECULAR-MECHANISMS; LIPID-PEROXIDATION; FATTY-ACIDS; SERUM; INHIBITION; CELLS; LIVER; IRON; GLYCOPROTEIN	Curcumin and capsaicin are dietary xenobiotics with well-documented anti-inflammatory properties. Previously, the beneficial effect of these spice principles in lowering chronic inflammation was demonstrated using a rat experimental model for arthritis. The extent of lowering of arthritic index by the spice principles was associated with a significant shift in macrophage function favoring the reduction of pro-inflammatory molecules such as reactive oxygen species and production and release of anti-inflammatory metabolites of arachidonic acid. Beyond the cellular effects on macrophage function, oral administration of curcumin and capsaicin caused alterations in serum protein profiles of rats injected with adjuvant to develop arthritis. Specifically, a 72 kDa acidic glycoprotein, GpA72, which was elevated in pre-arthritic rats, was significantly lowered by feeding either curcumin or capsaicin to the rats. Employing the tandem mass spectrometric approach for direct sequencing of peptides, here we report the identification of GpA72 as T-kininogen I also known as Thiostatin. Since T-kininogen I is an early acute-phase protein, we additionally tested the efficiency of curcumin and capsaicin to mediate the inflammatory response in an acute phase model. The results demonstrate that curcumin and capsaicin lower the acute-phase inflammatory response, the molecular mechanism for which is, in part, mediated by pathways associated with the lowering of T-kininogen I.	[Joe, Bina; Basrur, Venkatesha] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43606 USA; [Nagaraju, Anitha; Lokesh, Belur R.] Cent Food Technol Res Inst, Dept Lipid Sci & Tradit Foods, Mysore 570013, Karnataka, India; [Gowda, Lalitha R.] Cent Food Technol Res Inst, Dept Prot Chem & Technol, Mysore 570013, Karnataka, India; [Basrur, Venkatesha] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University System of Ohio; University of Toledo; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); University of Michigan System; University of Michigan	Basrur, V (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.	vbasrur@med.umich.edu; belurlokesh821@gmail.com			Department of Science and Technology, New Delhi [SP/SO/B-27/98]; University of Toledo College of Medicine	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); University of Toledo College of Medicine	This work was supported by a grant from Department of Science and Technology, New Delhi (SP/SO/B-27/98). BJ and VB acknowledge support from the University of Toledo College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED M, 1995, REGUL PEPTIDES, V55, P85, DOI 10.1016/0167-0115(94)00095-F; Ahuja KDK, 2006, J AGR FOOD CHEM, V54, P6436, DOI 10.1021/jf061331j; Beltran J, 2007, J IMMUNOL, V178, P3260, DOI 10.4049/jimmunol.178.5.3260; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Cheppudira B, 2013, EXPERT OPIN INVESTIG; COLE T, 1985, FEBS LETT, V182, P57, DOI 10.1016/0014-5793(85)81153-4; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Haanpaa M, 2012, EUR NEUROL, V68, P264, DOI 10.1159/000339944; HUSSAIN MS, 1994, INDIAN J BIOCHEM BIO, V31, P407; Jacob JN, 2013, NAT PROD COMMUN, V8, P359; JOE B, 1994, BBA-MOL CELL RES, V1224, P255, DOI 10.1016/0167-4889(94)90198-8; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Joe B, 1997, MOL CELL BIOCHEM, V169, P125, DOI 10.1023/A:1006877928703; Joe B, 1997, LIPIDS, V32, P1173, DOI 10.1007/s11745-997-0151-8; Joe B, 2000, MOL CELL BIOCHEM, V203, P153, DOI 10.1023/A:1007005605869; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Karaman M, 2012, ALLERGOL IMMUNOPATH, V40, P210, DOI 10.1016/j.aller.2011.04.006; Kempaiah RK, 2004, ANN NUTR METAB, V48, P314, DOI 10.1159/000081198; Khan MS, 2013, J FLUORESC, V23, P451, DOI 10.1007/s10895-013-1158-1; Kim G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062300; Kulac M, 2013, J MOL HISTOL, V44, P83, DOI 10.1007/s10735-012-9452-9; Maine GN, 2010, NAT PROTOC, V5, P1447, DOI 10.1038/nprot.2010.109; Marchiani A, 2013, CURR MED CHEM; MATUCCI CM, 1995, J RHEUMATOL, V22, P1447; Nevius E, 2012, MUCOSAL IMMUNOL, V5, P76, DOI 10.1038/mi.2011.50; Plytycz B, 2003, ARCH IMMUNOL THER EX, V51, P105; Pramanik KC, 2012, ANTIOXID REDOX SIGN, V17, P1417, DOI 10.1089/ars.2011.4369; Qiu JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033032; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; REDDY ACP, 1994, MOL CELL BIOCHEM, V137, P1, DOI 10.1007/BF00926033; REDDY ACP, 1994, FOOD CHEM TOXICOL, V32, P279, DOI 10.1016/0278-6915(94)90201-1; REDDY ACP, 1992, MOL CELL BIOCHEM, V111, P117; Reddy ACP, 1999, LIPIDS, V34, P1025, DOI 10.1007/s11745-999-0453-x; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Shin YH, 2013, J DENT RES, V92, P547, DOI 10.1177/0022034513487376; Sinha D, 2012, CURR DRUG TARGETS, V13, P1799, DOI 10.2174/138945012804545632; Srinivasan K, 2013, FOOD FUNCT, V4, P503, DOI 10.1039/c2fo30249g; Teiten MH, 2013, MOL NUTR FOOD RES; URBAN J, 1979, J BIOL CHEM, V254, P565; Wiwanitkit V, 2012, NUTR CANCER, V64, P781, DOI 10.1080/01635581.2012.688913; Wu BS, 2013, DNA CELL BIOL, V32, P292, DOI 10.1089/dna.2013.2042; Yang CF, 2013, CURR PHARM DESIGN, V19, P1966; Yu JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055934, 10.1371/journal.pone.0057564]; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	46	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107565	10.1371/journal.pone.0107565	http://dx.doi.org/10.1371/journal.pone.0107565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299597	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200007
J	Lee, IP; Evans, AK; Yang, C; Works, MG; Kumar, V; De Miguel, Z; Manley, NC; Sapolsky, RM				Lee, I-Ping; Evans, Andrew K.; Yang, Cissy; Works, Melissa G.; Kumar, Vineet; De Miguel, Zurine; Manley, Nathan C.; Sapolsky, Robert M.			Toxoplasma gondii Is Dependent on Glutamine and Alters Migratory Profile of Infected Host Bone Marrow Derived Immune Cells through SNAT2 and CXCR4 Pathways	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; SYSTEM-A; ADAPTIVE REGULATION; MITOCHONDRIAL METABOLISM; CHEMOKINE RECEPTOR; DENDRITIC CELLS; INHIBITION; INNATE; MUSCLE; ROLES	The obligate intracellular parasite, Toxoplasma gondii, disseminates through its host inside infected immune cells. We hypothesize that parasite nutrient requirements lead to manipulation of migratory properties of the immune cell. We demonstrate that 1) T. gondii relies on glutamine for optimal infection, replication and viability, and 2) T. gondii-infected bone marrow-derived dendritic cells (DCs) display both "hypermotility" and "enhanced migration" to an elevated glutamine gradient in vitro. We show that glutamine uptake by the sodium-dependent neutral amino acid transporter 2 (SNAT2) is required for this enhanced migration. SNAT2 transport of glutamine is also a significant factor in the induction of migration by the small cytokine stromal cell-derived factor-1 (SDF-1) in uninfected DCs. Blocking both SNAT2 and C-X-C chemokine receptor 4 (CXCR4; the unique receptor for SDF-1) blocks hypermotility and the enhanced migration in T. gondii-infected DCs. Changes in host cell protein expression following T. gondii infection may explain the altered migratory phenotype; we observed an increase of CD80 and unchanged protein level of CXCR4 in both T. gondii-infected and lipopolysaccharide (LPS)-stimulated DCs. However, unlike activated DCs, SNAT2 expression in the cytosol of infected cells was also unchanged. Thus, our results suggest an important role of glutamine transport via SNAT2 in immune cell migration and a possible interaction between SNAT2 and CXCR4, by which T. gondii manipulates host cell motility.	[Lee, I-Ping; Evans, Andrew K.; Yang, Cissy; Works, Melissa G.; De Miguel, Zurine; Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kumar, Vineet] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Stanford Stroke Ctr, Stanford, CA 94305 USA; [Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Stanford Inst Neuroinnovat & Translat Neurosci, Stanford, CA 94305 USA; [Sapolsky, Robert M.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University; Stanford University; Stanford University; Stanford University	Lee, IP (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ipinglee@stanford.edu	De Miguel, Zurine/AAH-9544-2019; evans, andrew k/A-7143-2012; Kumar, Vineet/H-3568-2013	De Miguel, Zurine/0000-0002-7006-1445; Evans, Andrew/0000-0003-2986-6476; Kumar, Vineet/0000-0003-2121-3964	Stanley Medical Research Institute [06R-1463]	Stanley Medical Research Institute	This work was supported by The Stanley Medical Research Institute (grant number: 06R-1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, NEURON GLIA BIOL, V6, P263, DOI 10.1017/S1740925X11000093; Badillo AT, 2008, J PEDIATR SURG, V43, P1128, DOI 10.1016/j.jpedsurg.2008.02.043; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bougdour A, 2013, CELL MICROBIOL; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Darde Marie-Laure, 2004, Annali dell'Istituto Superiore di Sanita, V40, P57; Evans K, 2008, J AM SOC NEPHROL, V19, P2119, DOI 10.1681/ASN.2007101108; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; Gazzola RF, 2001, FEBS LETT, V490, P11; Gupta R, 2013, AMINO ACIDS, V44, P757, DOI 10.1007/s00726-012-1400-1; Gupta R, 2009, AMINO ACIDS, V37, P359, DOI 10.1007/s00726-008-0162-2; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jones HN, 2006, REPRODUCTION, V131, P951, DOI 10.1530/rep.1.00808; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kraemer BF, 2010, J MOL MED, V88, P1277, DOI 10.1007/s00109-010-0680-8; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; Lee JY, 2009, J LEUKOCYTE BIOL, V86, P1285, DOI 10.1189/jlb.0309214; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Ling R, 2001, BBA-BIOMEMBRANES, V1512, P15, DOI 10.1016/S0005-2736(01)00310-8; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Manley NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061789; MARONI BJ, 1986, AM J PHYSIOL, V251, pF74, DOI 10.1152/ajprenal.1986.251.1.F74; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Persat F, 2012, J LEUKOCYTE BIOL, V92, P1241, DOI 10.1189/jlb.1211600; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Sheiner L, 2013, CURR OPIN MICROBIOL, V16, P452, DOI 10.1016/j.mib.2013.07.003; Song C, 2011, CYTOTHERAPY, V13, P549, DOI 10.3109/14653249.2010.542457; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tanhoffer RA, 2007, J SPINAL CORD MED, V30, P140, DOI 10.1080/10790268.2007.11753925; Tjader I, 2007, CRIT CARE MED, V35, pS553, DOI 10.1097/01.CCM.0000278602.41352.0E; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983	53	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109803	10.1371/journal.pone.0109803	http://dx.doi.org/10.1371/journal.pone.0109803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299045	Green Published, gold			2022-12-25	WOS:000343941200074
J	Meury, M; Costa, M; Harder, D; Stauffer, M; Jeckelmann, JM; Bruhlmann, B; Rosell, A; Ilgu, H; Kovar, K; Palacin, M; Fotiadis, D				Meury, Marcel; Costa, Meritxell; Harder, Daniel; Stauffer, Mirko; Jeckelmann, Jean-Marc; Bruehlmann, Bela; Rosell, Albert; Ilgue, Hueseyin; Kovar, Karin; Palacin, Manuel; Fotiadis, Dimitrios			Detergent-Induced Stabilization and Improved 3D Map of the Human Heteromeric Amino Acid Transporter 4F2hc-LAT2	PLOS ONE			English	Article							MEMBRANE-PROTEINS; PICHIA-PASTORIS; LIGHT SUBUNIT; MECHANISM; ANTIPORTER; CYSTINE; SYSTEM; FAMILY; RBAT; MUTATIONS	Human heteromeric amino acid transporters (HATs) are membrane protein complexes that facilitate the transport of specific amino acids across cell membranes. Loss of function or overexpression of these transporters is implicated in several human diseases such as renal aminoacidurias and cancer. HATs are composed of two subunits, a heavy and a light subunit, that are covalently connected by a disulphide bridge. Light subunits catalyse amino acid transport and consist of twelve transmembrane alpha-helix domains. Heavy subunits are type II membrane N-glycoproteins with a large extracellular domain and are involved in the trafficking of the complex to the plasma membrane. Structural information on HATs is scarce because of the difficulty in heterologous overexpression. Recently, we had a major breakthrough with the overexpression of a recombinant HAT, 4F2hc-LAT2, in the methylotrophic yeast Pichia pastoris. Microgram amounts of purified protein made possible the reconstruction of the first 3D map of a human HAT by negative-stain transmission electron microscopy. Here we report the important stabilization of purified human 4F2hc-LAT2 using a combination of two detergents, i.e., n-dodecyl-beta-D-maltopyranoside and lauryl maltose neopentyl glycol, and cholesteryl hemisuccinate. The superior quality and stability of purified 4F2hc-LAT2 allowed the measurement of substrate binding by scintillation proximity assay. In addition, an improved 3D map of this HAT could be obtained. The detergent-induced stabilization of the purified human 4F2hc-LAT2 complex presented here paves the way towards its crystallization and structure determination at high-resolution, and thus the elucidation of the working mechanism of this important protein complex at the molecular level.	[Meury, Marcel; Costa, Meritxell; Harder, Daniel; Stauffer, Mirko; Jeckelmann, Jean-Marc; Ilgue, Hueseyin; Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Meury, Marcel; Costa, Meritxell; Harder, Daniel; Stauffer, Mirko; Jeckelmann, Jean-Marc; Ilgue, Hueseyin; Fotiadis, Dimitrios] Univ Bern, Swiss Natl Ctr Competence Res NCCR, Bern, Switzerland; [Bruehlmann, Bela; Kovar, Karin] Zurich Univ Appl Sci ZHAW, Sch Life Sci, Inst Biotechnol, Wadenswil, Switzerland; [Bruehlmann, Bela; Kovar, Karin] Zurich Univ Appl Sci ZHAW, Facil Management, Wadenswil, Switzerland; [Rosell, Albert; Palacin, Manuel] IRB Barcelona, Barcelona, Spain; [Rosell, Albert; Palacin, Manuel] Ctr Invest n Biomed Red Enfermedades Rares, Barcelona, Spain; [Palacin, Manuel] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain	University of Bern; University of Bern; Zurich University of Applied Sciences; Zurich University of Applied Sciences; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona	Palacin, M (corresponding author), IRB Barcelona, Barcelona, Spain.	manuel.palacin@irbbarcelona.org; dimitrios.fotiadis@ibmm.unibe.ch	Palacín, Manuel/G-9786-2015; Ilgu, Huseyin/S-2750-2019; Kovar, Karin/M-9093-2018	Harder, Daniel/0000-0003-4226-9748; Palacin, Manuel/0000-0002-8670-293X; Jeckelmann, Jean-Marc/0000-0001-9973-2700; Stauffer, Mirko/0000-0003-1608-1047	University of Bern; Swiss National Science Foundation [31003A_144168]; Bern University Research Foundation; Novartis Foundation; Marie Curie Actions International Fellowship Program (IFP); NCCR TransCure; Spanish Ministry of Science and Innovation [SAF2012-40080-C02-01]; Fundacion Ramon Areces and the Generalitat de Catalunya [SGR2009-1355]	University of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bern University Research Foundation; Novartis Foundation(Novartis); Marie Curie Actions International Fellowship Program (IFP); NCCR TransCure; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces and the Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the University of Bern, the Swiss National Science Foundation (Grant 31003A_144168), the Bern University Research Foundation, the Novartis Foundation, and the Marie Curie Actions International Fellowship Program (IFP) and the NCCR TransCure (to D. F.), and the Spanish Ministry of Science and Innovation (Grant SAF2012-40080-C02-01), the Fundacion Ramon Areces and the Generalitat de Catalunya (SGR2009-1355) (to M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; BUSCH AE, 1994, J BIOL CHEM, V269, P25581; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Costa M, 2013, PROTEIN EXPRES PURIF, V87, P35, DOI 10.1016/j.pep.2012.10.003; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Harder D, 2012, NAT PROTOC, V7, P1569, DOI 10.1038/nprot.2012.090; Hyka P, 2010, APPL ENVIRON MICROB, V76, P4486, DOI 10.1128/AEM.02475-09; Ilgu H, 2014, BIOPHYS J, V106, P1660, DOI 10.1016/j.bpj.2014.02.024; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; O'Malley MA, 2011, BIOPHYS J, V100, pL11, DOI 10.1016/j.bpj.2010.12.3698; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Rosell A, 2014, P NATL ACAD SCI USA, V111, P2966, DOI 10.1073/pnas.1323779111; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595	35	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109882	10.1371/journal.pone.0109882	http://dx.doi.org/10.1371/journal.pone.0109882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299125	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200083
J	Platonova, N; Miquel, G; Chiu, LY; Taouji, S; Moroni, E; Colombo, G; Chevet, E; Sue, SC; Bikfalvi, A				Platonova, Natalia; Miquel, Geraldine; Chiu, Liang-Yuan; Taouji, Said; Moroni, Elisabetta; Colombo, Giorgio; Chevet, Eric; Sue, Shih-Che; Bikfalvi, Andreas			Dimerization Capacities of FGF2 Purified with or without Heparin-Affinity Chromatography	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SELF-ASSOCIATION; STRUCTURAL BASIS; RECEPTOR; BINDING; MITOGENESIS; RESOLUTION; ROLES	Fibroblast growth factor-2 (FGF2) is a pleiotropic growth factor exhibiting a variety of biological activities. In this article, we studied the capacity of FGF2 purified with or without heparin affinity chromatography to self-associate. Analyzing the NMR HSQC spectra for different FGF2 concentrations, heparin-affinity purified FGF2 showed perturbations that indicate dimerization and are a higher-order oligomerization state. HSQC perturbation observed with different FGF2 concentrations revealed a heparin-binding site and two dimer interfaces. Thus, with increasing protein concentrations, FGF2 monomers make contacts with each other and form dimers or higher order oligomers. On the contrary, FGF2 purified with ion-exchange chromatography did not show similar perturbation indicating that self-association of FGF2 is eliminated if purification is done without heparin-affinity chromatography. The HSQC spectra of heparin-affinity purified FGF2 can be reproduced to some extent by adding heparin tetra-saccharide to ion exchange chromatography purified FGF2. Heparin-affinity purified FGF2 bound to acceptor and donor beads in a tagged form using His-tagged or GST-tagged proteins, also dimerized in the AlphaScreen (TM) assay. This assay was further validated using different experimental conditions and competitors. The assay constitutes an interesting tool to study dimerization of other FGF forms as well.	[Platonova, Natalia; Miquel, Geraldine; Bikfalvi, Andreas] INSERM, U1029, Pessac, France; [Platonova, Natalia; Miquel, Geraldine; Bikfalvi, Andreas] Univ Bordeaux 1, Pessac, France; [Taouji, Said; Chevet, Eric] INSERM, U1053, Team Avenir, Bordeaux, France; [Chiu, Liang-Yuan; Sue, Shih-Che] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Moroni, Elisabetta; Colombo, Giorgio] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; National Tsing Hua University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Bikfalvi, A (corresponding author), INSERM, U1029, Allee Geoffroy St Hilaire, Pessac, France.	andreas.bikfalvi@u-bordeaux.fr	Colombo, Giorgio/A-2730-2012; Moroni, Elisabetta/ABH-7293-2020; chevet, eric/E-4992-2016	Colombo, Giorgio/0000-0002-1318-668X; Moroni, Elisabetta/0000-0002-7705-7457; chevet, eric/0000-0001-5855-4522; TAOUJI, Said/0000-0001-6736-9716	Institut National de la Recherche Scientifique (INSERM) Ligue National Contre le Cancer	Institut National de la Recherche Scientifique (INSERM) Ligue National Contre le Cancer	This work was supported by Institut National de la Recherche Scientifique (INSERM) Ligue National Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche Michele, 1995, Progress in Growth Factor Research, V6, P35, DOI 10.1016/0955-2235(95)00041-0; [Anonymous], 2004, PRACT GUID WORK ALPH; Arkin MR, 2012, ASSAY GUIDANCE MANUA; Batra R, 2001, NAT STRUCT BIOL, V8, P810, DOI 10.1038/nsb0901-810; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Chiu LY, 2014, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j, DOI 10.1016/J]; Davis JC, 1999, BIOCHEM J, V341, P613, DOI 10.1042/0264-6021:3410613; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Hagl CI, 2013, HISTOCHEM CELL BIOL, V139, P47, DOI 10.1007/s00418-012-1023-3; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Herr AB, 1997, J BIOL CHEM, V272, P16382, DOI 10.1074/jbc.272.26.16382; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; Kwan CP, 2001, J BIOL CHEM, V276, P23421, DOI 10.1074/jbc.M010786200; Lee SC, 2005, J BIOL CHEM, V280, P9567, DOI 10.1074/jbc.M412398200; Lozano RM, 2001, J BIOL CHEM, V276, P35723, DOI 10.1074/jbc.M101565200; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Platonova N, 2013, BLOOD, V121, P1229, DOI 10.1182/blood-2012-08-450502; Robinson ML, 2013, INVEST OPHTH VIS SCI, V1, P54; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Sabbieti MG, 2013, ENDOCRINOLOGY, V154, P2723, DOI 10.1210/en.2013-1025; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Van den Berghe L, 1998, BIOCHEM BIOPH RES CO, V252, P420, DOI 10.1006/bbrc.1998.9668	30	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110055	10.1371/journal.pone.0110055	http://dx.doi.org/10.1371/journal.pone.0110055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299071	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200099
J	Adriaens, A; Peremans, K; Waelbers, T; Vandermeulen, E; Croubels, S; Duchateau, L; Dobbeleir, A; Audenaerts, K; Eersels, J; Vermeire, S; De Spiegeleer, B; Polis, I				Adriaens, Antita; Peremans, Kathelijne; Waelbers, Tim; Vandermeulen, Eva; Croubels, Siska; Duchateau, Luc; Dobbeleir, Andre; Audenaerts, Kurt; Eersels, Jos; Vermeire, Simon; De Spiegeleer, Bart; Polis, Ingeborgh			The Effect of Morphine on Regional Cerebral Blood Flow Measured by Tc-99m-ECD SPECT in Dogs	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CYSTEINATE DIMER SPECT; MU-OPIOID RECEPTOR; CONSCIOUS DOGS; NALOXONE; FENTANYL; RAT; REMIFENTANIL; PHARMACOLOGY; METABOLISM	To gain insights into the working mechanism of morphine, regional cerebral blood flow (rCBF) patterns after morphine administration were assessed in dogs. In a randomized cross-over experimental study, rCBF was estimated with Tc-99m-Ethylcysteinate Dimer single photon emission computed tomography in 8 dogs at baseline, at 30 minutes and at 120 minutes after a single bolus of morphine. Perfusion indices (PI) in the frontal, parietal, temporal and occipital cortex and in the subcortical and cerebellar region were calculated. PI was significantly decreased 30 min after morphine compared to baseline in the right frontal cortex. The left parietal cortex and subcortical region showed a significantly increased PI 30 min after morphine compared to baseline. No significant differences were noted for the other regions or at other time points. In conclusion, a single bolus of morphine generated a changing rCBF pattern at different time points.	[Adriaens, Antita; Waelbers, Tim; Polis, Ingeborgh] Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium; [Peremans, Kathelijne; Vandermeulen, Eva; Dobbeleir, Andre; Vermeire, Simon] Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim, Merelbeke, Belgium; [Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Biochem & Toxicol, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Physiol & Biometry, Merelbeke, Belgium; [Audenaerts, Kurt] Univ Ghent, Fac Med & Hlth Sci, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Eersels, Jos] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University; Vrije Universiteit Amsterdam; Ghent University	Adriaens, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium.	Antita.Adriaens@UGent.be	Adriaens, Mieke/F-2520-2013; De Spiegeleer, Bart/A-2001-2008	Adriaens, Mieke/0000-0003-4034-1881; De Spiegeleer, Bart/0000-0001-6794-3108; Eersels, Jos Leon/0000-0001-7521-583X; Croubels, Siska/0000-0001-6357-3517; Vandermeulen, Eva/0000-0001-9215-2869	Ghent University Special Research Fund scholarship (BOF) [01J06109]	Ghent University Special Research Fund scholarship (BOF)	This study was supported by Ghent University Special Research Fund scholarship (BOF no 01J06109, www.ugent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; Adriaens AM, 2012, J NUCL MED, V53, P1969, DOI 10.2967/jnumed.112.103796; Armitage-Chan EA, 2007, J VET EMERG CRIT CAR, V17, P5, DOI 10.1111/j.1476-4431.2006.00194.x; ARMSTEAD WM, 1990, J PHARMACOL EXP THER, V255, P1083; Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; BUCHWEITZ E, 1984, BRAIN RES, V291, P301, DOI 10.1016/0006-8993(84)91262-9; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; Firestone LL, 1996, ANESTH ANALG, V82, P1247, DOI 10.1097/00000539-199606000-00025; FULLER SA, 1991, PHARMACOL BIOCHEM BE, V40, P339, DOI 10.1016/0091-3057(91)90564-I; Gadeyne C, 2011, J VET PHARMACOL THER, V34, P417, DOI 10.1111/j.1365-2885.2010.01264.x; Gerrits RJ, 1998, BRAIN RES, V783, P151, DOI 10.1016/S0006-8993(97)01320-6; Guedes AGP, 2008, J VET PHARMACOL THER, V31, P334, DOI 10.1111/j.1365-2885.2008.00966.x; Guedes AGP, 2007, J VET PHARMACOL THER, V30, P516, DOI 10.1111/j.1365-2885.2007.00911.x; HOFFMAN WE, 1993, ANESTHESIOLOGY, V79, P107, DOI 10.1097/00000542-199307000-00016; HUG CC, 1981, ANESTHESIOLOGY, V54, P38, DOI 10.1097/00000542-198101000-00008; Khalili-Mahani N, 2011, J CEREBR BLOOD F MET, V31, P1321, DOI 10.1038/jcbfm.2010.234; KuKanich B, 2005, AM J VET RES, V66, P1616, DOI 10.2460/ajvr.2005.66.1616; Lamont LA, 2007, LUMB JONES VET ANEST, P241; Maiante AA, 2009, J VET PHARMACOL THER, V32, P317, DOI 10.1111/j.1365-2885.2008.01042.x; MANSOUR A, 1995, J CHEM NEUROANAT, V8, P283, DOI 10.1016/0891-0618(95)00055-C; MARTIN WR, 1983, PHARMACOL REV, V35, P283; MATSUMIYA N, 1983, ANESTHESIOLOGY, V59, P175; Meng ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007742; MILDE LN, 1990, ANESTH ANALG, V70, P138; MILDE LN, 1989, BRIT J ANAESTH, V63, P710, DOI 10.1093/bja/63.6.710; Nikolaishvili L S, 2004, Neurosci Behav Physiol, V34, P467, DOI 10.1023/B:NEAB.0000022631.46176.6b; Ohara PT, 2005, CELL MOL LIFE SCI, V62, P44, DOI 10.1007/s00018-004-4283-9; Peremans K, 2003, EUR J NUCL MED MOL I, V30, P1538, DOI 10.1007/s00259-003-1250-x; Peremans K, 2001, VET RADIOL ULTRASOUN, V42, P562, DOI 10.1111/j.1740-8261.2001.tb00987.x; PEROUTKA SJ, 1980, SCIENCE, V208, P610, DOI 10.1126/science.6102801; ROSEN CL, 1989, AM J PHYSIOL, V256, pH1651, DOI 10.1152/ajpheart.1989.256.6.H1651; TAKESHITA H, 1972, ANESTHESIOLOGY, V37, P605, DOI 10.1097/00000542-197212000-00007; TRUSK TC, 1987, BRAIN RES, V406, P238, DOI 10.1016/0006-8993(87)90788-8; Waelbers T, 2011, RES VET SCI, V91, P138, DOI 10.1016/j.rvsc.2010.08.003; Waelbers T, 2012, J VET BEHAV, V7, P261, DOI 10.1016/j.jveb.2012.05.001; Wagner KJ, 2001, ANESTHESIOLOGY, V94, P732, DOI 10.1097/00000542-200105000-00008; Wagner KJ, 2007, ANESTHESIOLOGY, V106, P548, DOI 10.1097/00000542-200703000-00020; WAHL M, 1985, J CEREBR BLOOD F MET, V5, P451, DOI 10.1038/jcbfm.1985.61; WERNER C, 1991, ANESTH ANALG, V72, P177, DOI 10.1213/00000539-199102000-00006; Whistler JL, 2012, DRUG ALCOHOL DEPEN, V121, P189, DOI 10.1016/j.drugalcdep.2011.10.031; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Yaksh TL, 1997, ACTA ANAESTH SCAND, V41, P94, DOI 10.1111/j.1399-6576.1997.tb04623.x; Zelaya FO, 2012, MAGN RESON MATER PHY, V25, P163, DOI 10.1007/s10334-011-0293-4	43	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109680	10.1371/journal.pone.0109680	http://dx.doi.org/10.1371/journal.pone.0109680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295733	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000091
J	Ghiwot, Y; Degarege, A; Erko, B				Ghiwot, Yirgalem; Degarege, Abraham; Erko, Berhanu			Prevalence of Intestinal Parasitic Infections among Children under Five Years of Age with Emphasis on Schistosoma mansoni in Wonji Shoa Sugar Estate, Ethiopia	PLOS ONE			English	Article							HELMINTH INFECTIONS; DISEASE; BURDEN; NEED	Intestinal parasite infections are major public health problems of children in developing countries causing undernutrition, anemia, intestinal obstruction and mental and physical growth retardation. This study was conducted to assess the prevalence of intestinal helminthic infections among children under five years of age with emphasis on Schistosoma mansoni in Wonji Shoa Sugar Estate, Ethiopia. A cross-sectional parasitological survey was conducted in under-five children living in Wonji Shoa Sugar Estate Ethiopia, April, 2013. Stool samples were collected and examined for intestinal parasites using single Kato-Katz and single Sodium acetate-acetic acid-formalin (SAF) solution concentration methods. Out of 374 children examined using single Kato-Katz and single SAF-concentration methods, 24.3% were infected with at least one intestinal parasite species. About 10.4%, 8.8%, 4.6%, 2.9%, 1.6% and 0.8% of the children were infected with Hymenolepis nana, Schistosoma mansoni, Ascaris lumbricoides, Trichuris trichiura, Enterobius vermicularis and hookworm, respectively. Prevalence of double, triple and quadruple intestinal helminthic infection was 6.4%, 0.54% and 1.1%, respectively. A significant increase in prevalence of S. mansoni (8.3% versus 3.2%) and T. trichiura (2.7% versus 0.5%) infection was observed when determined via the single Kato-Katz method compared to the prevalence of the parasites determined via the single SAF-concentration method. On the other hand, the single SAF-concentration method (9.1%) revealed a significantly higher prevalence of H. nana infection than the single Kato-Katz (1.6%) does. In conclusion, intestinal helminths infections particularly S. mansoni and H. nana were prevalent in under-five children of Wonji Shoa Sugar Estate. Including praziquantel treatment in the deworming program as per the World Health Organization guidelines would be vital to reduce the burden of these diseases in areas where S. mansoni and H. nana infections are prevalent among under-fives. Kato-Katz can be used in estimating the prevalence of S. mansoni and other helminth infections.	[Ghiwot, Yirgalem; Degarege, Abraham; Erko, Berhanu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia	Addis Ababa University	Degarege, A (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	abrahamdegarege@yahoo.com		Degarege, Abraham/0000-0002-1537-6639	Aklilu Lemma Institute of Pathobiology, Addis Ababa University	Aklilu Lemma Institute of Pathobiology, Addis Ababa University	This work was supported by Aklilu Lemma Institute of Pathobiology, Addis Ababa University (www.aau.edu.et/aaubeta/alipb/). BE, AD and YG get the funding from the institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I., 1999, Ethiopian Journal of Health Development, V13, P157; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P141; Asfaw S. T., 2000, Ethiopian Journal of Health Development, V14, P67; Belyhun Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-21; Birrie H, 1998, ETHIOP J HEALTH DEV, V12, P63; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; Girum Tadesse, 2005, Ethiopian Journal of Health Development, V19, P140; Hodges MH, 2012, ACTA TROP, V124, P120, DOI 10.1016/j.actatropica.2012.07.005; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Leggese M, 2004, ETHIOP J HEALTH DEV, V18, P117; Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582; Nyantekyi LA, 2010, ETHIOP J HEALTH DEV, V24, P185; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2010, CLIN MICROBIOL INFEC, V16, P267, DOI 10.1111/j.1469-0691.2009.02782.x; WHO, 2010, WHO TECH REP SER, V949, P1; who, SCHIST FACT SHEET; World Health Organization, 1991, BAS LAB METH MED PAR, P25; World Health Organization (WHO), 2014, SCHIST FACT SHEET	20	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109793	10.1371/journal.pone.0109793	http://dx.doi.org/10.1371/journal.pone.0109793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296337	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000095
J	He, XC; Korytar, T; Zhu, YQ; Pikula, J; Bandouchova, H; Zukal, J; Kollner, B				He, Xiaocui; Korytar, Tomas; Zhu, Yaqing; Pikula, Jiri; Bandouchova, Hana; Zukal, Jan; Koellner, Bernd			Establishment of Myotis myotis Cell Lines - Model for Investigation of Host-Pathogen Interaction in a Natural Host for Emerging Viruses	PLOS ONE			English	Article							BAT LYSSAVIRUS; HUMAN RABIES; FRUIT BATS; INFECTION; INTERFERON; EXPRESSION; RESERVOIRS; SURVEILLANCE; INDUCTION; MICROGLIA	Bats are found to be the natural reservoirs for many emerging viruses. In most cases, severe clinical signs caused by such virus infections are normally not seen in bats. This indicates differences in the virus-host interactions and underlines the necessity to develop natural host related models to study these phenomena. Due to the strict protection of European bat species, immortalized cell lines are the only alternative to investigate the innate anti-virus immune mechanisms. Here, we report about the establishment and functional characterization of Myotis myotis derived cell lines from different tissues: brain (MmBr), tonsil (MmTo), peritoneal cavity (MmPca), nasal epithelium (MmNep) and nervus olfactorius (MmNol) after immortalization by SV 40 large T antigen. The usefulness of these cell lines to study antiviral responses has been confirmed by analysis of their susceptibility to lyssavirus infection and the mRNA patterns of immune-relevant genes after poly I: C stimulation. Performed experiments indicated varying susceptibility to lyssavirus infection with MmBr being considerably less susceptible than the other cell lines. Further investigation demonstrated a strong activation of interferon mediated antiviral response in MmBr contributing to its resistance. The pattern recognition receptors: RIG-I and MDA5 were highly upregulated during rabies virus infection in MmBr, suggesting their involvement in promotion of antiviral responses. The presence of CD14 and CD68 in MmBr suggested MmBr cells are microglia-like cells which play a key role in host defense against infections in the central nervous system (CNS). Thus the expression pattern of MmBr combined with the observed limitation of lyssavirus replication underpin a protective mechanism of the CNS controlling the lyssavirus infection. Overall, the established cell lines are important tools to analyze antiviral innate immunity in M. myotis against neurotropic virus infections and present a valuable tool for a broad spectrum of future investigations in cellular biology of M. myotis.	[He, Xiaocui; Korytar, Tomas; Zhu, Yaqing; Koellner, Bernd] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany; [Pikula, Jiri; Bandouchova, Hana] Univ Vet & Pharmaceut Sci Brno, Fac Vet Hyg & Ecol, Dept Ecol & Dis Game Fish & Bees, Brno, Czech Republic; [Zukal, Jan] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Zukal, Jan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic	Friedrich Loeffler Institute; University of Veterinary Sciences Brno; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Masaryk University Brno	Kollner, B (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany.	bernd.koellner@fli.bund.de	Korytář, Tomáš/AAD-7130-2019; Korytář, Tomáš/AAY-7683-2020; Zukal, Jan/G-1180-2014; Pikula, Jiri/V-8620-2018; Bandouchova, Hana/AAI-1213-2020	Korytář, Tomáš/0000-0002-6913-0415; Zukal, Jan/0000-0003-4967-6880; Pikula, Jiri/0000-0001-8747-9365; Bandouchova, Hana/0000-0003-0373-7940	Bundesministerium fur Forschung und Technologie German Ministry for Research and Technology [01KI1016A]	Bundesministerium fur Forschung und Technologie German Ministry for Research and Technology	Bundesministerium fur Forschung und Technologie German Ministry for Research and Technology Grant 01KI1016A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceballos NA, 2013, EMERG INFECT DIS, V19, P793, DOI 10.3201/eid1905.121071; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carty M, 2013, TRENDS IMMUNOL; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Eckerle I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084679; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Harris SL, 2006, VET REC, V159, P439, DOI 10.1136/vr.159.14.439; He X, 2014, J VIROL, V88, P5444, DOI 10.1128/JVI.03403-13; Heinsohn S, 2005, HAEMATOLOGICA, V90, P94; HOLNESS CL, 1993, BLOOD, V81, P1607; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Johnson N, 2010, VET MICROBIOL, V142, P151, DOI 10.1016/j.vetmic.2010.02.001; Johnson N, 2008, J GEN VIROL, V89, P2662, DOI 10.1099/vir.0.2008/003889-0; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUMIO J, 1986, LANCET, V1, P378; Mackenzie JS, 2004, ARCH VIROL, P97; McColl KA, 2002, AUST VET J, V80, P636, DOI 10.1111/j.1751-0813.2002.tb10973.x; McElhinney LM, 2013, ZOONOSES PUBLIC HLTH, V60, P35, DOI 10.1111/zph.12003; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Mourya DT, 2013, INDIAN J MED RES, V138, P224; Muller MA, 2007, EMERG INFECT DIS, V13, P1367, DOI 10.3201/eid1309.070342; Nakamichi K, 2005, J VIROL, V79, P11801, DOI 10.1128/JVI.79.18.11801-11812.2005; Nathwani D, 2003, CLIN INFECT DIS, V37, P598, DOI 10.1086/376641; Ray NB, 1997, ARCH VIROL, V142, P1011, DOI 10.1007/s007050050136; Rieder M, 2011, ADV VIRUS RES, V79, P91, DOI 10.1016/B978-0-12-387040-7.00006-8; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Schatz J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002835; Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Stantic-Pavlinic M, 2005, Euro Surveill, V10, P217; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Virtue ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022488; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wynne JW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003651; Zhao PS, 2013, INFECT GENET EVOL, V20, P257, DOI 10.1016/j.meegid.2013.09.016; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115; Zukal J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097224	50	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109795	10.1371/journal.pone.0109795	http://dx.doi.org/10.1371/journal.pone.0109795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295526	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000096
J	Kisoka, WJ; Simonsen, PE; Malecela, MN; Tersbol, BP; Mushi, DL; Meyrowitsch, DW				Kisoka, William J.; Simonsen, Paul E.; Malecela, Mwelecele N.; Tersbol, Britt P.; Mushi, Declare L.; Meyrowitsch, Dan W.			Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania	PLOS ONE			English	Article							BANCROFTIAN FILARIASIS; ENDEMIC COMMUNITIES; PROGRAM; ELIMINATION; INFECTION; DISEASE; ORISSA; TRANSMISSION; PREVALENCE; PATTERNS	Background: In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania. Methods: A questionnaire based cross sectional household survey was carried out in two rural and two urban districts in Lindi and Morogoro regions shortly after the 2011 MDA. 3279 adults (>= 15 years) were interviewed about personal characteristics, socio-economic status, MDA drug uptake among themselves and their children, reasons for taking/not taking drugs, and participation in previous MDA activities for LF control. Findings: The overall drug uptake rate was 55.1% (range of 44.5-75.6% between districts). There was no overall major difference between children (54.8%) and adults (55.2%) or between females (54.9%) and males (55.8%), but the role of these and other predictors varied to some extent between study sites. Major overall predictors of drug uptake among the interviewed adults were increasing age and history of previous drug uptake. Being absent from home during drug distribution was the main reason for not taking the drugs (50.2%) followed by clinical contraindications to treatment (10.8%), missing household visits of drug distributors (10.6%), and households not being informed about the distribution (9.0%). Conclusion: Drug uptake relied more on easily modifiable provider-related factors than on individual perceptions and practices in the target population. Limited investments in appropriate timing, dissemination of accurate timing information to recipients and motivation of drug distributors to visit all households (repeatedly when residents are absent) are likely to have considerable potential for increasing drug uptake, in support of successful LF transmission elimination.	[Kisoka, William J.; Malecela, Mwelecele N.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Simonsen, Paul E.] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark; [Tersbol, Britt P.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Kisoka, William J.; Mushi, Declare L.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Meyrowitsch, Dan W.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	National Institute of Medical Research; University of Copenhagen; University of Copenhagen; University of Copenhagen	Meyrowitsch, DW (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.	dame@sund.ku.dk	Mushi, Declare/H-2924-2019	Meyrowitsch, Dan/0000-0003-1108-8987; , Britt Pinkowski Tersbol/0000-0001-8260-1317	Research Council, Denmark (FFU) [09-096LIFE]; Direct For Education and Human Resources [0941984] Funding Source: National Science Foundation; Directorate For Engineering [1343533] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1337525] Funding Source: National Science Foundation	Research Council, Denmark (FFU); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study received financial support from Danida Research Council, Denmark (FFU grant #09-096LIFE). The funder had no role in development of study design, data collection and analysis, interpretation of results, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2001, ACTA TROP, V80, P215, DOI 10.1016/S0001-706X(01)00159-0; Allen T, 2011, THIRD WORLD Q, V32, P91, DOI 10.1080/01436597.2011.543816; Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; [Anonymous], 2011, MON EP ASS MASS DRUG; Anto F, 2014, J BACTERIOL PARASITO, V5, P180, DOI [10.4172/2155-9597.1000180, DOI 10.4172/2155-9597.1000180]; Babu B, 2004, TROP MED INT HEALTH, V9, P702, DOI 10.1111/j.1365-3156.2004.01247.x; Babu BV, 2008, T ROY SOC TROP MED H, V102, P1207, DOI 10.1016/j.trstmh.2008.05.023; Cantey PT, 2010, TROP MED INT HEALTH, V15, P224, DOI 10.1111/j.1365-3156.2009.02443.x; El-Setouhy M, 2007, AM J TROP MED HYG, V77, P1069, DOI 10.4269/ajtmh.2007.77.1069; Gunawardena S, 2007, T ROY SOC TROP MED H, V101, P445, DOI 10.1016/j.trstmh.2006.09.002; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; King JD, 2011, ACTA TROP, V120, pS48, DOI 10.1016/j.actatropica.2010.08.021; Krentel A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002447; Malecela MN., 2009, J LYMPHOEDEMA, V4, P10; Mathieu E, 2006, TROP MED INT HEALTH, V11, P862, DOI 10.1111/j.1365-3156.2006.01626.x; MCMAHON JE, 1981, ANN TROP MED PARASIT, V75, P415, DOI 10.1080/00034983.1981.11687461; Meyrowitsch DW, 1995, ANN TROP MED PARASIT, V89, P653, DOI 10.1080/00034983.1995.11812999; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Minjas J. N., 1991, HLTH DIS TANZANIA, P159; NBS, 2013, POP HOUS CENS 2012, VI; Njomo DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048395; Nujum ZT, 2011, INT HEALTH, V3, P22, DOI 10.1016/j.inhe.2010.12.001; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Parker M, 2013, J BIOSOC SCI, V45, P517, DOI 10.1017/S0021932012000466; Rwegoshora RT, 2005, ANN TROP MED PARASIT, V99, P253, DOI 10.1179/136485905X29675; Simonsen PE, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-335; Simonsen PE, 2013, PARASITOL RES, V112, P35, DOI 10.1007/s00436-012-3226-x; Simonsen PE, 1995, ACTA TROP, V60, P179, DOI 10.1016/0001-706X(95)00126-Y; Simonsen PE, 2002, AM J TROP MED HYG, V66, P550, DOI 10.4269/ajtmh.2002.66.550; Simonsen PE, 2014, MANSONS TROPICAL DIS, P737, DOI DOI 10.1016/B978-0-7020-5101-2.00055-8; WHO, 2021, LYMPHATIC FILARIASIS, Vsecond; WHO, 2006, PREV CHEM HUM HELM; WHO, 2007, GLOB PROGR EL LYMPH; World Health Organization, 2006, QUAL CAR PROC MAK ST	34	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109316	10.1371/journal.pone.0109316	http://dx.doi.org/10.1371/journal.pone.0109316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296034	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000058
J	Yang, DY; Guo, K; Wang, Y; Guo, YY; Yang, XR; Jing, XX; Guo, HK; Tao, Y; Zhu, D; Jonass, JB				Yang, Da Yong; Guo, Kai; Wang, Yan; Guo, Yuan Yuan; Yang, Xian Rong; Jing, Xin Xia; Guo, Hai Ke; Tao, Yong; Zhu, Dan; Jonass, Jost B.			Intraocular Pressure and Associations in Children. The Gobi Desert Children Eye Study	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; SYSTEMIC BLOOD-PRESSURE; INTRACRANIAL-PRESSURE; TONO-PEN; TONOMETER; GLAUCOMA; DETERMINANTS; POPULATION; CURVATURE; INCREASES	Purpose: To assess the intraocular pressure (IOP) and its association in children in a population living in an oasis in the Gobi Desert. Methods: The cross-sectional school-based study included all schools in the Ejina region. The children underwent an ophthalmic examination, non-contact tonometry and measurement of blood pressure and body height and weight. Results: Out of eligible 1911 children, 1565 (81.9%) children with a mean age of 11.9 +/- 3.5 years (range: 6-21 years) participated. Mean spherical refractive error was -1.58 +/- 2.00 diopters. In multivariate analysis, higher IOP (right eye) was associated with younger age (P<0.001; standardized coefficient beta: -0.13; regression coefficient B: -0.13; 95% Confidence interval (CI):-0.18, -0.07), higher diastolic blood pressure (P<0.001;beta:0.13;B:0.05;95%CI:0.03,0.07), higher corneal refractive power (P<0.001;beta:0.11;B:0.23;95%CI:0.12,0.34), more myopic refractive error (P=0.035;beta: -0.06;B: -0.10;95%CI: -0.19, -0.001), and Han Chinese ethnicity of the father (P=0.03;beta:0.06;B:0.42;95%CI:0.04,0.89). If age and diastolic blood pressure were dropped, higher IOP was associated with higher estimated cerebrospinal fluid pressure (CSFP) (P<0.001;beta:0.09; B:0.13;95%CI:0.06,0.21) after adjusting for higher corneal refractive power (P<0.001) and Han Chinese ethnicity of the father (P = 0.04). Correspondingly, higher IOP of the left eye was associated with younger age (P<0.001;beta: -0.15;B: -0.16;95%CI: -0.21, -0.10), female gender (P<0.001;beta:0.09;B:0.65;95%CI:0.30,1.01), higher corneal refractive power (P<0.001;beta:0.08;B:0.19;95%CI:0.06,0.32), more myopic refractive error (P = 0.03;beta: -0.06;B: -0.12;95%CI: -0.22, -0.01), and higher estimated CSFP (P<0.001;beta:0.11;B:0.17;95%CI:0.09,0.24). Conclusions: In school children, higher IOP was associated with steeper corneal curvature and with younger age and higher blood pressure, or alternatively, with higher estimated CSFP. Corneal curvature radius should be included in the correction of IOP measurements. The potential association between IOP and CSFP as also assumed in adults may warrant further research.	[Yang, Da Yong] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Yang, Da Yong; Guo, Hai Ke] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Guo, Kai; Wang, Yan; Guo, Yuan Yuan; Yang, Xian Rong; Jing, Xin Xia; Zhu, Dan] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Tao, Yong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Tao, Yong] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Jonass, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Inner Mongolia Medical University; Peking University; Ruprecht Karls University Heidelberg	Guo, HK (corresponding author), Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	guohaike@medmail.com.cn; drtaoyong@163.com; zhudan1968@163.com		Tao, Yong/0000-0003-1443-2667	Program for New Century Excellent Talents in University (Beijing, China) [NCET-12-0010]; FOK YING TONG education foundation (Hong Kong, China)	Program for New Century Excellent Talents in University (Beijing, China)(Program for New Century Excellent Talents in University (NCET)); FOK YING TONG education foundation (Hong Kong, China)	This study was supported by Program for New Century Excellent Talents in University (No: NCET-12-0010) (Beijing, China) and FOK YING TONG education foundation (Hong Kong, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broman AT, 2007, J GLAUCOMA, V16, P581, DOI 10.1097/IJG.0b013e3180640f40; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; DUCKMAN RH, 1992, OPTOMETRY VISION SCI, V69, P705, DOI 10.1097/00006324-199209000-00007; Edwards MH, 1996, OPHTHAL PHYSL OPT, V16, P243, DOI 10.1016/0275-5408(95)00064-X; EDWARDS MH, 1993, OPTOMETRY VISION SCI, V70, P15, DOI 10.1097/00006324-199301000-00004; EDWARDS MH, 1993, OPTOMETRY VISION SCI, V70, P198, DOI 10.1097/00006324-199303000-00004; Foster PJ, 2003, INVEST OPHTH VIS SCI, V44, P3885, DOI 10.1167/iovs.03-0012; Goss DA, 1999, OPTOMETRY VISION SCI, V76, P286, DOI 10.1097/00006324-199905000-00015; JAAFAR MS, 1993, J PEDIATR OPHTHALMOL, V30, P284; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2011, J GLAUCOMA, V20, P405, DOI 10.1097/IJG.0b013e3181f7af9b; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Klein BEK, 2005, BRIT J OPHTHALMOL, V89, P284, DOI 10.1136/bjo.2004.048710; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Mark HH, 2003, EYE, V17, P617, DOI 10.1038/sj.eye.6700417; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; PENSIERO S, 1992, J PEDIATR OPHTHALMOL, V29, P79, DOI 10.3928/0191-3913-19920301-05; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Sahin A, 2008, J GLAUCOMA, V17, P57, DOI 10.1097/IJG.0b013e31806ab33e; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; SHIOSE Y, 1986, AM J OPHTHALMOL, V101, P714, DOI 10.1016/0002-9394(86)90776-2; Sihota R, 2006, J PEDIAT OPHTH STRAB, V43, P14, DOI 10.3928/01913913-20060101-01; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; WANG Y, 2013, PLOS ONE, V2013; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Yildirim N, 2007, J PEDIAT OPHTH STRAB, V44, P216, DOI 10.3928/01913913-20070701-02; Youn D H, 1990, Korean J Ophthalmol, V4, P26; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	34	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109355	10.1371/journal.pone.0109355	http://dx.doi.org/10.1371/journal.pone.0109355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295855	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000064
J	Gustin, SM; McKay, JG; Petersen, ET; Peck, CC; Murray, GM; Henderson, LA				Gustin, Sylvia M.; McKay, Jamie G.; Petersen, Esben T.; Peck, Chris C.; Murray, Greg M.; Henderson, Luke A.			Subtle Alterations in Brain Anatomy May Change an Individual's Personality in Chronic Pain	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; DECISION-MAKING; DISORDERS; PLASTICITY; REORGANIZATION; FIBROMYALGIA; MYELINATION; TEMPERAMENT; PROFILES; PATTERNS	It is well established that gross prefrontal cortex damage can affect an individual's personality. It is also possible that subtle prefrontal cortex changes associated with conditions such as chronic pain, and not detectable until recent advances in human brain imaging, may also result in subtle changes in an individual's personality. In an animal model of chronic neuropathic pain, subtle prefrontal cortex changes including altered basal dendritic length, resulted in altered decision making ability. Using multiple magnetic resonance imaging techniques, we found in humans, although gray matter volume and on-going activity were unaltered, chronic neuropathic pain was associated with reduced free and bound proton movement, indicators of subtle anatomical changes, in the medial prefrontal cortex, anterior cingulate cortex and mediodorsal thalamus. Furthermore, proton spectroscopy revealed an increase in neural integrity in the medial prefrontal cortex in neuropathic pain patients, the degree of which was significantly correlated to the personality temperament of novelty seeking. These data reveal that even subtle changes in prefrontal cortex anatomy may result in a significant change in an individual's personality.	[Gustin, Sylvia M.] Neurosci Res Australia, Randwick, NSW, Australia; [McKay, Jamie G.; Henderson, Luke A.] Univ Sydney, Dept Anat & Histol, Sydney, NSW 2006, Australia; [Petersen, Esben T.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Petersen, Esben T.] Univ Med Ctr Utrecht, Dept Radiotherapy, Utrecht, Netherlands; [Peck, Chris C.; Murray, Greg M.] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia	Neuroscience Research Australia; University of Sydney; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Sydney	Gustin, SM (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	sylvia.gustin@gmail.com	Petersen, Esben Thade/Q-8266-2019; Gustin, Sylvia M/H-9648-2018	Petersen, Esben Thade/0000-0001-7529-3432; Gustin, Sylvia M/0000-0002-9613-9845; Henderson, Luke/0000-0002-1026-0151; Peck, Christopher Charles/0000-0003-0092-6770	National Health and Medical Research Council of Australia; Australian Dental Research Foundation, Inc.; Early Career Researchers/New Staff grant scheme of the University of Sydney	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Dental Research Foundation, Inc.; Early Career Researchers/New Staff grant scheme of the University of Sydney	This research was supported by the National Health and Medical Research Council of Australia, the Australian Dental Research Foundation, Inc. and the Early Career Researchers/New Staff grant scheme of the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Barker PB, 2001, ANN NEUROL, V49, P423, DOI 10.1002/ana.90; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0; Clarke CE, 2001, EUR J NEUROL, V8, P573, DOI 10.1046/j.1468-1331.2001.00308.x; Cloninger CR, 2012, J AFFECT DISORDERS, V136, P758, DOI 10.1016/j.jad.2011.09.046; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Cloninger RC., 1994, TEMPERAMENT CHARACTE; Conrad R, 2007, PAIN, V133, P197, DOI 10.1016/j.pain.2007.07.024; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Danielsen E.R., 1999, MAGNETIC RESONANCE S, V1st; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; DIETRICH RB, 1988, AM J ROENTGENOL, V150, P889, DOI 10.2214/ajr.150.4.889; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Gustin SM, 2013, J PAIN, V14, P1642, DOI 10.1016/j.jpain.2013.08.005; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Henderson LA, 2013, J NEUROSCI, V33, P7574, DOI 10.1523/JNEUROSCI.0174-13.2013; Iversen SD, 1977, DRUGS NEUROTRANSMITT, P333; Jung RE, 2000, CLIN NEUROPSYCHOL, V14, P535, DOI 10.1076/clin.14.4.535.7198; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Malmgren-Olsson EB, 2006, CLIN J PAIN, V22, P625, DOI 10.1097/01.ajp.0000210907.65170.a3; MATHURDEVRE R, 1984, BRIT J RADIOL, V57, P955, DOI 10.1259/0007-1285-57-683-955; MENZA MA, 1993, NEUROLOGY, V43, P505, DOI 10.1212/WNL.43.3_Part_1.505; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Nurmikko TJ, 2001, BRIT J ANAESTH, V87, P117, DOI 10.1093/bja/87.1.117; ONO J, 1993, BRAIN DEV-JPN, V15, P433, DOI 10.1016/0387-7604(93)90083-K; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Stellar J. R., 1985, NEUROBIOLOGY MOTIVAT; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; Vogt BA, 1993, NEUROBIOLOGY CINGULA; Wang HD, 2008, NEUROPSYCHOPHARMACOL, V33, P1276, DOI 10.1038/sj.npp.1301521; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006; Youssef AM, 2014, PAIN, V155, P467, DOI 10.1016/j.pain.2013.11.008; Zermatten A, 2005, J NERV MENT DIS, V193, P647, DOI 10.1097/01.nmd.0000180777.41295.65	48	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109664	10.1371/journal.pone.0109664	http://dx.doi.org/10.1371/journal.pone.0109664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25291361	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000075
J	Pandyarajan, V; Smith, BJ; Phillips, NB; Whittaker, L; Cox, GP; Wickramasinghe, N; Menting, JG; Wan, ZL; Whittaker, J; Ismail-Beigi, F; Lawrence, MC; Weiss, MA				Pandyarajan, Vijay; Smith, Brian J.; Phillips, Nelson B.; Whittaker, Linda; Cox, Gabriella P.; Wickramasinghe, Nalinda; Menting, John G.; Wan, Zhu-li; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Lawrence, Michael C.; Weiss, Michael A.			Aromatic Anchor at an Invariant Hormone-Receptor Interface FUNCTION OF INSULIN RESIDUE B24 WITH APPLICATION TO PROTEIN DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Mutagenesis; Protein Design; Protein Structure; Receptor Tyrosine Kinase; Hormone; nonstandard mutagenesis	GROWTH-FACTOR-I; AMINO-ACID-SEQUENCE; HUMAN INSULIN; PROTEIN-STRUCTURE; BIOLOGICAL-ACTIVITY; STRUCTURAL SWITCH; SIDE-CHAIN; BINDING; DYNAMICS; SEMISYNTHESIS	Background: Invariant insulin residue Phe(B24) (a site of diabetes-associated mutation) contacts the insulin receptor. Results: Hormonal function requires hydrophobicity rather than aromaticity at this site. Conclusion: The B24 side chain provides a nonpolar anchor at the receptor interface. Significance: Nonstandard aliphatic modification of residue B24 may enhance therapeutic properties of insulin analogs. Crystallographic studies of insulin bound to fragments of the insulin receptor have recently defined the topography of the primary hormone-receptor interface. Here, we have investigated the role of Phe(B24), an invariant aromatic anchor at this interface and site of a human mutation causing diabetes mellitus. An extensive set of B24 substitutions has been constructed and tested for effects on receptor binding. Although aromaticity has long been considered a key requirement at this position, Met(B24) was found to confer essentially native affinity and bioactivity. Molecular modeling suggests that this linear side chain can serve as an alternative hydrophobic anchor at the hormone-receptor interface. These findings motivated further substitution of Phe(B24) by cyclohexanylalanine (Cha), which contains a nonplanar aliphatic ring. Contrary to expectations, [Cha(B24)]insulin likewise exhibited high activity. Furthermore, its resistance to fibrillation and the rapid rate of hexamer disassembly, properties of potential therapeutic advantage, were enhanced. The crystal structure of the Cha(B24) analog, determined as an R-6 zinc-stabilized hexamer at a resolution of 1.5 angstrom, closely resembles that of wild-type insulin. The nonplanar aliphatic ring exhibits two chair conformations with partial occupancies, each recapitulating the role of Phe(B24) at the dimer interface. Together, these studies have defined structural requirements of an anchor residue within the B24-binding pocket of the insulin receptor; similar molecular principles are likely to pertain to insulin-related growth factors. Our results highlight in particular the utility of nonaromatic side chains as probes of the B24 pocket and suggest that the nonstandard Cha side chain may have therapeutic utility.	[Pandyarajan, Vijay; Phillips, Nelson B.; Whittaker, Linda; Wickramasinghe, Nalinda; Wan, Zhu-li; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Cox, Gabriella P.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Menting, John G.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Lawrence, MC (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	lawrence@wehi.edu.au; michael.weiss@case.edu	Lawrence, Michael C/A-5357-2009; Wickramasinghe, Nalinda P/F-9465-2010; Smith, Brian J/F-8282-2011	Smith, Brian J/0000-0003-0498-1910; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801; Wickramasinghe, Nalinda P./0000-0002-8700-2775; Pandyarajan, Vijay/0000-0002-8835-5601	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079233, R01DK040949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q.-X. Hua, W. Jia, and S. H. Nakagawa for advice regarding experimental procedures and P. Arvan, T. L. Blundell, P. De Meyts, P. G. Katsoyannis, M. Liu, D. F. Steiner, and C. Ward for discussion. The crystallographic results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brange I., 1987, GALENICS INSULIN PHY; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Brange J, 1997, Pharm Biotechnol, V10, P343; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen JM, 2001, BIOCHEMISTRY-US, V40, P15280, DOI 10.1021/bi011776v; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Gore SP, 2005, BIOINFORMATICS, V21, P3316, DOI 10.1093/bioinformatics/bti523; GREIDER MH, 1969, J CELL BIOL, V41, P162, DOI 10.1083/jcb.41.1.162; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; HANEDA M, 1985, DIABETES, V34, P568, DOI 10.2337/diabetes.34.6.568; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KATSOYANNIS PG, 1973, J AM CHEM SOC, V95, P6427, DOI 10.1021/ja00800a045; KOBAYASHI M, 1984, BIOMED RES-TOKYO, V5, P267, DOI 10.2220/biomedres.5.267; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Lachenmann MJ, 2004, PROTEIN SCI, V13, P3115, DOI 10.1110/ps.04866404; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MICHAEL J, 1987, J BIOL CHEM, V262, P16531; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; NAKAGAWA SH, 1993, BIOCHEMISTRY-US, V32, P7237, DOI 10.1021/bi00079a021; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olechnovic K, 2011, BIOINFORMATICS, V27, P723, DOI 10.1093/bioinformatics/btq720; Pandyarajan V, 2012, CURR DIABETES REP, V12, P697, DOI 10.1007/s11892-012-0318-z; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; ROY M, 1989, J BIOL CHEM, V264, P19081; SATO A, 1993, INT J PEPT PROT RES, V41, P433; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; SHOELSON S, 1983, P NATL ACAD SCI-BIOL, V80, P7390, DOI 10.1073/pnas.80.24.7390; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; WEITZEL G, 1978, H-S Z PHYSIOL CHEM, V359, P945, DOI 10.1515/bchm2.1978.359.2.945; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050	89	18	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34709	34727		10.1074/jbc.M114.608562	http://dx.doi.org/10.1074/jbc.M114.608562			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25305014	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000346260800027
J	Kanamarlapudi, V				Kanamarlapudi, Venkateswarlu			Exchange Factor EFA6R Requires C-terminal Targeting to the Plasma Membrane to Promote Cytoskeletal Rearrangement through the Activation of ADP-ribosylation Factor 6 (ARF6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE; PH DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; G-PROTEINS; FAMILY; ACTIN; ROLES; CENTAURIN-ALPHA(1); GENES; ARNO	ADP-ribosylation factor 6 (ARF6) small GTPase regulates membrane trafficking and cytoskeleton rearrangements at the plasma membrane (PM) by cycling between the GTP-bound active and GDP-bound inactive conformations. Guanine nucleotide exchange factors (GEFs) activate ARF6. The exchange factor for ARF6 (EFA6) R has been identified as a biomarker for ovarian cancer. EFA6R shares the catalytic Sec7, pleckstrin homology (PH), and coiled coil (CC) domains of the other EFA6 family GEFs. Here we report the functional characterization of EFA6R. Endogenous EFA6R was present in the plasma membrane fraction. The exogenously expressed FLAG-and GFP-tagged EFA6R were targeted to the PM. In vitro, GFP-EFA6R associated weakly but preferentially with phosphatidylinositol 4,5-bisphosphate (PIP2) through the PH domain. EFA6R required both its PH and CC domains localized at the C terminus to target the PM. Consistent with this, EFA6R lacking the CC domain (EFA6R Delta CC) was released from the PM into the cytosol upon PIP2 depletion, whereas EFA6R release from the PM required both PIP2 depletion and actin destabilization. These results suggest that the dual targeting via the PH and CC domains is important for the PM localization of EFA6R. EFA6R specifically catalyzed the GTP loading of ARF6 in mammalian cells. Moreover, EFA6R regulated ARF6 localization and thereby actin stress fiber loss. The GEF activity of EFA6R was dependent on the presence of the Sec7 domain. The PH and CC domains were also required for the in vivo GEF activity of EFA6R but could be functionally replaced by the CAAX motif of K-Ras, suggesting a role for these domains in the membrane targeting of EFA6R.	Swansea Univ, Coll Med, Inst Life Sci 1, Swansea SA2 8PP, W Glam, Wales	Swansea University	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci 1, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483	Biotechnology and Biological Sciences Research Council UK [BB/C515455/2]; Medical Research Council UK [G0401232]; Royal Society UK; MRC [G0401232] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515455/2] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish; Health and Care Research Wales [HS-14-64] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society UK(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Health and Care Research Wales	This work was supported by Biotechnology and Biological Sciences Research Council UK Grant BB/C515455/2, Medical Research Council UK Grant G0401232, and the Royal Society UK.	Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davies JCB, 2014, BIOCHEM PHARMACOL, V90, P406, DOI 10.1016/j.bcp.2014.06.012; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Derrien V, 2002, J CELL SCI, V115, P2867; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Freed EO, 2006, P NATL ACAD SCI USA, V103, P11101, DOI 10.1073/pnas.0604715103; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hiroyama M, 2005, J CELL PHYSIOL, V202, P608, DOI 10.1002/jcp.20156; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043532; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037954; Kanamarlapudi V, 2012, J BIOL CHEM, V287, P20443, DOI 10.1074/jbc.M112.362087; Klein S, 2008, J BIOL CHEM, V283, P30129, DOI 10.1074/jbc.M803375200; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Macia E, 2008, J BIOL CHEM, V283, P19836, DOI 10.1074/jbc.M800781200; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Radhakrishna H, 1999, J CELL SCI, V112, P855; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Sakagami H, 2007, EUR J NEUROSCI, V25, P618, DOI 10.1111/j.1460-9568.2007.05345.x; Sakagami H, 2006, BRAIN RES, V1093, P1, DOI 10.1016/j.brainres.2006.02.058; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Turner CE, 2001, CURR BIOL, V11, pR875, DOI 10.1016/S0960-9822(01)00521-8; van den Boom J, 2006, INT J CANCER, V119, P2330, DOI 10.1002/ijc.22108; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Venkateswarlu K, 2005, METHOD ENZYMOL, V404, P252, DOI 10.1016/S0076-6879(05)04024-3; Venkateswarlu K, 2005, J CELL SCI, V118, P2471, DOI 10.1242/jcs.02369; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	45	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33378	33390		10.1074/jbc.M113.534156	http://dx.doi.org/10.1074/jbc.M113.534156			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296758	hybrid, Green Published			2022-12-25	WOS:000345636600028
J	Curtis, AD; Taslim, N; Reece, SP; Grebenciucova, E; Ray, RH; Rosenbaum, MD; Wardle, RL; Van Scott, MR; Mannie, MD				Curtis, Alan D., II; Taslim, Najla; Reece, Shaun P.; Grebenciucova, Elena; Ray, Richard H.; Rosenbaum, Matthew D.; Wardle, Robert L.; Van Scott, Michael R.; Mannie, Mark D.			The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NONHUMAN PRIMATE MODELS; MULTIPLE-SCLEROSIS; T-CELL; DEMYELINATED LESIONS; RHESUS-MONKEYS; BRAIN-STEM; LEWIS RAT; DISEASE	Atypical models of experimental autoimmune encephalomyelitis (EAE) are advantageous in that the heterogeneity of clinical signs appears more reflective of those in multiple sclerosis (MS). Conversely, models of classical EAE feature stereotypic progression of an ascending flaccid paralysis that is not a characteristic of MS. The study of atypical EAE however has been limited due to the relative lack of suitable models that feature reliable disease incidence and severity, excepting mice deficient in gamma-interferon signaling pathways. In this study, atypical EAE was induced in Lewis rats, and a related approach was effective for induction of an unusual neurologic syndrome in a cynomolgus macaque. Lewis rats were immunized with the rat immunoglobulin variable (IgV)-related extracellular domain of myelin oligodendrocyte glycoprotein (IgV-MOG) in complete Freund's adjuvant (CFA) followed by one or more injections of rat IgV-MOG in incomplete Freund's adjuvant (IFA). The resulting disease was marked by torticollis, unilateral rigid paralysis, forelimb weakness, and high titers of anti-MOG antibody against conformational epitopes of MOG, as well as other signs of atypical EAE. A similar strategy elicited a distinct atypical form of EAE in a cynomolgus macaque. By day 36 in the monkey, titers of IgG against conformational epitopes of extracellular MOG were evident, and on day 201, the macaque had an abrupt onset of an unusual form of EAE that included a pronounced arousal-dependent, transient myotonia. The disease persisted for 6-7 weeks and was marked by a gradual, consistent improvement and an eventual full recovery without recurrence. These data indicate that one or more boosters of IgV-MOG in IFA represent a key variable for induction of atypical or unusual forms of EAE in rat and Macaca species. These studies also reveal a close correlation between humoral immunity against conformational epitopes of MOG, extended confluent demyelinating plaques in spinal cord and brainstem, and atypical disease induction.	[Curtis, Alan D., II; Taslim, Najla; Grebenciucova, Elena; Mannie, Mark D.] E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA; [Reece, Shaun P.; Ray, Richard H.; Wardle, Robert L.; Van Scott, Michael R.] E Carolina Univ, Sch Med, Dept Physiol, Greenville, NC 27858 USA; [Rosenbaum, Matthew D.] E Carolina Univ, Sch Med, Dept Comparat Med, Greenville, NC 27858 USA; [Curtis, Alan D., II; Taslim, Najla; Mannie, Mark D.] E Carolina Univ, Sch Med, Harriet & John Wooten Lab Alzheimers & Neurodegen, Greenville, NC 27858 USA; [Grebenciucova, Elena] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Chicago	Mannie, MD (corresponding author), E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	manniem@ecu.edu		Rosenbaum, Matthew/0000-0003-0777-0510; Mannie, Mark/0000-0003-0475-8516	National Multiple Sclerosis Society [RG3524B7/2]; National Institute of Neurological Disorders and Stroke [R15NS075830, R01-NS072150]; The Harriet and John Wooten Laboratory for Alzheimer's and Neurodegenerative Disease Research [MT7881]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072150, R15NS075830] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); The Harriet and John Wooten Laboratory for Alzheimer's and Neurodegenerative Disease Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Multiple Sclerosis Society (RG3524B7/2), the National Institute of Neurological Disorders and Stroke (R15NS075830 and R01-NS072150), and The Harriet and John Wooten Laboratory for Alzheimer's and Neurodegenerative Disease Research (MT7881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromson-Leeman S, 2004, AM J PATHOL, V165, P1519, DOI 10.1016/S0002-9440(10)63410-4; Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Batoulis H, 2011, APMIS, V119, P819, DOI 10.1111/j.1600-0463.2011.02794.x; Bettelli E, 2007, ANN NY ACAD SCI, V1103, P11, DOI 10.1196/annals.1394.021; BONTROP RE, 1990, J EXP MED, V172, P53, DOI 10.1084/jem.172.1.53; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; de Rosbo NK, 2000, J NEUROIMMUNOL, V110, P83, DOI 10.1016/S0165-5728(00)00306-4; DEROSBO NK, 1995, EUR J IMMUNOL, V25, P985, DOI 10.1002/eji.1830250419; ELFERINK BG, 1993, HUM IMMUNOL, V38, P201, DOI 10.1016/0198-8859(93)90541-8; Fierz W, 1988, Ann N Y Acad Sci, V540, P360, DOI 10.1111/j.1749-6632.1988.tb27099.x; Frohman TC, 2013, NAT REV NEUROL, V9, P535, DOI 10.1038/nrneurol.2013.98; GELUK A, 1993, J EXP MED, V177, P979, DOI 10.1084/jem.177.4.979; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Haanstra KG, 2013, J NEUROIMMUNE PHARM; Hundgeburth LC, 2013, CLIN IMMUNOL, V146, P155, DOI 10.1016/j.clim.2012.12.007; Iglesias A, 2001, GLIA, V36, P220, DOI 10.1002/glia.1111; Jagessar SA, 2010, J NEUROPATH EXP NEUR, V69, P372, DOI 10.1097/NEN.0b013e3181d5d053; Kroenke MA, 2010, EUR J IMMUNOL, V40, P2340, DOI 10.1002/eji.201040489; LASSMANN H, 1988, ACTA NEUROPATHOL, V75, P566, DOI 10.1007/BF00686201; Lassmann H, 2013, J NEUROL SCI, V333, P1, DOI 10.1016/j.jns.2013.05.010; Lee E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-7; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; LININGTON C, 1992, J NEUROIMMUNOL, V40, P219, DOI 10.1016/0165-5728(92)90136-9; LININGTON C, 1988, AM J PATHOL, V130, P443; Mannie Mark, 2009, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1502s85; MANNIE MD, 1990, J NEUROIMMUNOL, V26, P201, DOI 10.1016/0165-5728(90)90002-5; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; MASSACESI L, 1992, J CLIN INVEST, V90, P399, DOI 10.1172/JCI115874; Mathey E, 2004, EUR J IMMUNOL, V34, P2065, DOI 10.1002/eji.200425291; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; MEESON AP, 1994, EXP NEUROL, V129, P299, DOI 10.1006/exnr.1994.1172; MEINL E, 1995, INT IMMUNOL, V7, P1489, DOI 10.1093/intimm/7.9.1489; Menge T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-161; Muhallab S, 2005, J NEUROIMMUNOL, V161, P155, DOI 10.1016/j.jneuroim.2005.01.002; Muller DM, 2000, ACTA NEUROPATHOL, V100, P174, DOI 10.1007/s004019900163; Muller DM, 2005, J NEUROIMMUNOL, V160, P162, DOI 10.1016/j.jneuroim.2004.11.011; Nataf S, 2000, J IMMUNOL, V165, P5867, DOI 10.4049/jimmunol.165.10.5867; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Sakuma H, 2004, BRAIN, V127, P2201, DOI 10.1093/brain/awh260; SCHLUESENER HJ, 1987, J IMMUNOL, V139, P4016; Simmons SB, 2013, TRENDS IMMUNOL, V34, P410, DOI 10.1016/j.it.2013.04.006; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Szalai AJ, 2007, MOL IMMUNOL, V44, P3132, DOI 10.1016/j.molimm.2007.02.002; 't Hart BA, 2005, J NEUROIMMUNOL, V168, P1, DOI 10.1016/j.jneuroim.2005.05.017; t'Hart BA, 2004, LANCET NEUROL, V3, P588, DOI 10.1016/S1474-4422(04)00879-8; tHart BA, 1997, FEBS LETT, V409, P91, DOI 10.1016/S0014-5793(97)00493-6; Tran GT, 2002, J IMMUNOL, V168, P4293, DOI 10.4049/jimmunol.168.9.4293; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; von Budingen HC, 2004, EUR J IMMUNOL, V34, P2072, DOI 10.1002/eji.200425050; Wekerle H, 2008, ANN RHEUM DIS, V67, P56, DOI 10.1136/ard.2008.098020; Wensky AK, 2005, J IMMUNOL, V174, P1416, DOI 10.4049/jimmunol.174.3.1416	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110048	10.1371/journal.pone.0110048	http://dx.doi.org/10.1371/journal.pone.0110048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303101	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400105
J	Rabizadeh, E; Cherny, I; Wolach, O; Sherman, S; Binkovski, N; Peretz, A; Lederfein, D; Inbal, A				Rabizadeh, Esther; Cherny, Izhack; Wolach, Ofir; Sherman, Shany; Binkovski, Natalia; Peretz, Alon; Lederfein, Doron; Inbal, Aida			Increased Activity of Cell Membrane-Associated Prothrombinase, Fibrinogen-Like Protein 2, in Peripheral Blood Mononuclear Cells of B-Cell Lymphoma Patients	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; VENOUS THROMBOSIS; LACTATE-DEHYDROGENASE; T-LYMPHOCYTES; IFN-GAMMA; IMMUNOCHEMOTHERAPY; MALIGNANCIES; CONTRIBUTES; INDUCTION; REJECTION	Fibrinogen like protein 2, FGL-2, was reported to be overexpressed in various cancer tissues, where it acts as a transmembrane prothrombinase. This study aims to determine the prothrombinase activity of FGL-2 in peripheral blood mononuclear cells (PBMC) of patients with B-cell lymphoma. FGL-2 activity was determined in patients with B-cell lymphoma (n=53), and healthy controls (n=145). FGL-2 activity in patients at diagnosis increased 3 +/- 0.3 fold (p<0.001). Sensitivity and specificity of the test was established at 73.6% and 80.7%, respectively, using a cutoff of 150% activity over control. Moreover, FGL-2 activity in 10 of 11 patients in remission decreased by 76%. In contrast, no significant difference was observed in expression levels of fgl-2 gene in patients and controls. Taken together, our study indicates that FGL-2 prothrombinase activity in PBMC of lymphoma patients is increased in active disease and normalizes during remission, thus being a potential marker for follow up of lymphoma patients.	[Rabizadeh, Esther; Cherny, Izhack; Sherman, Shany; Binkovski, Natalia; Lederfein, Doron] Rabin Med Ctr, Felsenstein Med Res Ctr, Hematooncol Lab, Petah Tiqwa, Israel; [Rabizadeh, Esther; Cherny, Izhack; Wolach, Ofir; Sherman, Shany; Binkovski, Natalia; Lederfein, Doron; Inbal, Aida] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Rabizadeh, Esther] Rabin Med Ctr, Hematol Lab, Petah Tiqwa, Israel; [Wolach, Ofir; Sherman, Shany; Inbal, Aida] Rabin Med Ctr, Inst Hematol, Thrombosis & Hemostasis Unit, Petah Tiqwa, Israel; [Peretz, Alon] Rabin Med Ctr, Occupat Hlth Clin, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center; Rabin Medical Center	Inbal, A (corresponding author), Rabin Med Ctr, Inst Hematol, Thrombosis & Hemostasis Unit, Petah Tiqwa, Israel.	aidainbal@hotmail.com		Wolach, Ofir/0000-0002-8662-0707	Nufar grant, Ministry of Health, Israel [44776]	Nufar grant, Ministry of Health, Israel	Funding provided by Nufar grant number 44776, Chief Scientist, Ministry of Health, Israel, http://www.magnet.org.il/article.aspx?id = 687. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, N ENGL J MED, V329, P987; Blom JW, 2006, EUR J CANCER, V42, P410, DOI 10.1016/j.ejca.2005.09.013; Blom JW, 2006, J THROMB HAEMOST, V4, P529, DOI 10.1111/j.1538-7836.2006.01804.x; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Caruso V, 2007, J THROMB HAEMOST, V5, P621, DOI 10.1111/j.1538-7836.2007.02383.x; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chan CWY, 2002, J IMMUNOL, V168, P5170, DOI 10.4049/jimmunol.168.10.5170; Cheson BD, 2005, J CLIN ONCOL, V23, P6283, DOI 10.1200/JCO.2005.08.005; El-Sharkawi D, 2012, LEUKEMIA LYMPHOMA, V53, P1949, DOI 10.3109/10428194.2012.679360; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Geisler CH, 2010, BLOOD, V115, P1530, DOI 10.1182/blood-2009-08-236570; Ghanekar A, 2004, J IMMUNOL, V172, P5693, DOI 10.4049/jimmunol.172.9.5693; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Hancock WW, 2004, P NATL ACAD SCI USA, V101, P3005, DOI 10.1073/pnas.0308369101; Huijgen HJ, 1997, EUR J CLIN CHEM CLIN, V35, P569; Liu YL, 2012, LIVER INT, V32, P1585, DOI 10.1111/j.1478-3231.2012.02865.x; Marazzi S, 1998, J IMMUNOL, V161, P138; Martelli M, 2013, CRIT REV ONCOL HEMAT, V87, P146, DOI 10.1016/j.critrevonc.2012.12.009; Ning Q, 2005, J IMMUNOL, V174, P7403, DOI 10.4049/jimmunol.174.11.7403; RUEGG C, 1995, GENE, V160, P257, DOI 10.1016/0378-1119(95)00240-7; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Smith A, 2011, BRIT J CANCER, V105, P1684, DOI 10.1038/bjc.2011.450; Solal-Celigny Philippe, 2006, Curr Treat Options Oncol, V7, P270, DOI 10.1007/s11864-006-0036-3; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Su K, 2008, WORLD J GASTROENTERO, V14, P5980, DOI 10.3748/wjg.14.5980; Trousseau A., 1865, CLINIQUE M DICALE LH, VVolume 3, P654	26	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109648	10.1371/journal.pone.0109648	http://dx.doi.org/10.1371/journal.pone.0109648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303152	gold, Green Submitted, Green Published			2022-12-25	WOS:000343730400073
J	Tahara, T; Shibata, T; Okubo, M; Ishizuka, T; Nakamura, M; Nagasaka, M; Nakagawa, Y; Ohmiya, N; Arisawa, T; Hirata, I				Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Ishizuka, Takamitsu; Nakamura, Masakatsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Arisawa, Tomiyasu; Hirata, Ichiro			DNA Methylation Status of Epithelial-Mesenchymal Transition (EMT) - Related Genes Is Associated with Severe Clinical Phenotypes in Ulcerative Colitis (UC)	PLOS ONE			English	Article							E-CADHERIN; COLORECTAL-CANCER; EXPRESSION; NEOPLASIA	Background: Epithelial-to-mesenchymal transition (EMT) is a phenomenon that allows the conversion of adherent epithelial cells to a mesenchymal cell phenotype, which enhances migratory capacity and invasiveness. Recent studies have suggested that EMT contributes to the pathogenesis of ulcerative colitis (UC). We investigated the promoter DNA methylation status of EMT-related genes in the colonic mucosa in UC. Methods: Colonic biopsies were obtained from the rectal inflammatory mucosa of 86 UC patients and the noninflammatory proximal colonic mucosa of 10 paired patients. Bisulfite pyrosequencing was used to quantify the methylation of 5 candidate CpG island promoters (NEUROG1, CDX1, miR-1247, CDH1, and CDH13) and LINE1. Results: Using an unsupervised hierarchical clustering analysis, inflamed rectal mucosa was well separated from mucosa that appeared normal. The CDH1 and CDH13 promoters were significantly associated with patient age (p = 0.04, 0.03, respectively). A similar trend was found between those genes and the duration of disease (CDH1: p = 0.07, CDH13: p = 0.0002, mean of both: p<0.00001). Several positive associations were found between hypermethylation and severe clinical phenotypes (CDX1 and miR-1247 and a refractory phenotype: p = 0.04 and 0.006, respectively. miR-1247 and CDH1 hyper methylation and a more severe Mayo endoscopic subscore: miR-1247: p = 0.0008, CDH1: p = 0.03, mean of both: p = 0.003). When the severe clinical phenotype was defined as having any of five phenotypes (hospitalized more than twice, highest Mayo endoscopic subscore, steroid dependence, refractory, or a history of surgery) miR-1247 hypermethylation was associated with the same phenotype (p = 0.008). Conclusions: Our data suggest that variability in the methylation status of EMT-related genes is associated with more severe clinical phenotypes in UC.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Hirata, Ichiro] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan; [Nakamura, Masakatsu; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa, Japan	Fujita Health University; Kanazawa Medical University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan.	tomomiccyu@yahoo.co.jp						Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Head Kathleen A, 2003, Altern Med Rev, V8, P247; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Issa JPJ, 2001, CANCER RES, V61, P3573; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Kim JG, 2014, EPIGENETICS; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Lakatos Laszlo, 2003, Orv Hetil, V144, P1853; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Malouf GG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r144; Saito S, 2011, INFLAMM BOWEL DIS, V17, P1955, DOI 10.1002/ibd.21573; Scharl M, 2011, INFLAMM BOWEL DIS, V17, P1907, DOI [10.1002/ibd.21555, 10.1002/ibd.21913]; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Shiovitz S, 2014, GASTROENTEROLOGY; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Tahara T, 2014, CLIN EXP MED; Tahara T, 2011, VIRCHOWS ARCH, V458, P205, DOI 10.1007/s00428-010-1038-x; Tahara T, 2009, CLIN EXP MED, V9, P125, DOI 10.1007/s10238-008-0025-x; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tominaga K, 2005, CLIN CANCER RES, V11, P8880, DOI 10.1158/1078-0432.CCR-05-1309; Wang Z, 2012, PATHOL ONCOL RES, V18, P263, DOI 10.1007/s12253-011-9437-0	28	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e107947	10.1371/journal.pone.0107947	http://dx.doi.org/10.1371/journal.pone.0107947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303049	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400006
J	Faivre, JP; Maureille, B; Bayle, P; Crevecoeur, I; Duvals, M; Grun, R; Bemilli, C; Bonilauri, S; Coutard, S; Bessoul, M; Limondin-Lozouetn, N; Cottard, A; Deshayes, T; Douillard, A; Henaff, X; Pautret-Homerville, C; Kinsley, L; Trinkaus, E				Faivre, Jean-Philippe; Maureille, Bruno; Bayle, Priscilla; Crevecoeur, Isabelle; Duvals, Mathieu; Gruen, Rainer; Bemilli, Celine; Bonilauri, Stephanie; Coutard, Sylvie; Bessoul, Maryelle; Limondin-Lozouetn, Nicole; Cottard, Antoine; Deshayes, Thierry; Douillard, Aurelie; Henaff, Xavier; Pautret-Homerville, Caroline; Kinsley, Les; Trinkaus, Erik			Middle Pleistocene Human Remains from Tourville-la-Riviere (Normandy, France) and Their Archaeological Context	PLOS ONE			English	Article							HUMAN CRANIUM; LOS HUESOS; PHYLOGENETIC POSITION; HOMINID; ATAPUERCA; EUROPE; SIMA; HOMO; NEANDERTHALS; ROBUSTICITY	Despite numerous sites of great antiquity having been excavated since the end of the 19th century, Middle Pleistocene human fossils are still extremely rare in northwestern Europe. Apart from the two partial crania from Biache-Saint-Vaast in northern France, all known human fossils from this period have been found from ten sites in either Germany or England. Here we report the discovery of three long bones from the same left upper limb discovered at the open-air site of Tourvillela-Riviere in the Seine Valley of northern France. New U-series and combined US-ESR dating on animal teeth produced an age range for the site of 183 to 236 ka. In combination with paleoecological indicators, they indicate an age toward the end of MIS 7. The human remains from Tourville-la-Rivie` re are attributable to the Neandertal lineage based on morphological and metric analyses. An abnormal crest on the left humerus represents a deltoid muscle enthesis. Micro- and or macro-traumas connected to repetitive movements similar to those documented for professional throwing athletes could be origin of abnormality.	[Faivre, Jean-Philippe; Maureille, Bruno; Crevecoeur, Isabelle] Univ Bordeaux, CNRS, PACEA, Culture Environm & Anthropol UMR 5199,Unite Mixte, Talence, France; Univ Bordeaux, PACEA, Culture Environm & Anthropol UMR 5199, Unite Mixte Rech 5199, Talence, France; [Duvals, Mathieu] CENIEH, Burgos, Spain; [Gruen, Rainer] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Bemilli, Celine] INRAP, Ctr Archeolog Grand Quevilly, Grand Quevilly, France; [Bemilli, Celine] Museum Natl Hist Nat, Unite Mixte Rech Archeozool Archeobotan 7209, F-75231 Paris, France; [Bonilauri, Stephanie] ARSCAN, UMR 7071, ANTET, Nanterre, France; [Coutard, Sylvie] INRAP, Ctr Archeol Amiens, Amiens, France; [Coutard, Sylvie] Lab Geogr Phys Environm Quaternaires & Actuels, UMR 8591, Meudon, France; [Bessoul, Maryelle] Univ Bordeaux, PACEA, Prehist Actuel Culture Environm & Anthropol UMR 5, Unite Mixte Rech 5199, Talence, France; [Limondin-Lozouetn, Nicole] CNRS, Lab Geogr Phys Environm Quaternaires & Actuels, Unite Mixte Rech 8591, Meudon, France; [Deshayes, Thierry; Douillard, Aurelie] INRAP, Ctr Archeol Grand Quevilly, Grand Quevilly, France; [Henaff, Xavier; Pautret-Homerville, Caroline] INRAP, Grand Ouest Ctr Archeol Carquefou, Carquefou, France; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Trinkaus, Erik] Washington Univ, Dept Anthropol, St Louis, DC USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Australian National University; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Australian National University	Faivre, JP (corresponding author), Univ Bordeaux, CNRS, PACEA, Culture Environm & Anthropol UMR 5199,Unite Mixte, Talence, France.	jp.faivre@pacea.u-bordeaux1.fr	Duval, Mathieu/U-9446-2018; Grun, Rainer/A-1437-2012	Duval, Mathieu/0000-0003-3181-7753; Grun, Rainer/0000-0003-1366-3674; Maureille, Bruno/0000-0002-7616-0073	Inrap; Universite de Bordeaux [UMR5199 PACEA]; CNRS; MCC; Centre national de la recherche scientifique (CNRS)	Inrap; Universite de Bordeaux; CNRS(Centre National de la Recherche Scientifique (CNRS)); MCC; Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study was funded by Inrap (http://www.inrap.fr), the UMR5199 PACEA - Universite de Bordeaux, CNRS, MCC (http://www.pacea.u-bordeaux1.fr/), the Centre national de la recherche scientifique (CNRS; http://www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alduc D, 1979, B INFORM GEOLOGUES B, V16, P27; Ameloot-Van Der Heijden N, 1994, DOSS DOC ARCHEOL, V18, P63; Antoine P, 1998, QUATERNAIRE, V9, P227; Arsuaga JL, 1997, J HUM EVOL, V33, P105, DOI 10.1006/jhev.1997.0169; Arsuaga JL, 1992, HUMAN EVOLUTION EURO, P283; August Patrick, 2003, Quaternaire, V14, P5; Bak K, 2000, KNEE SURG SPORT TR A, V8, P113, DOI 10.1007/s001670050197; Balescu S, 1997, BOREAS, V26, P61; Balzeau A, 2010, J HUM EVOL, V58, P1, DOI 10.1016/j.jhevol.2009.05.016; Behrensmeyer A.K., 1990, P232; Boeda E, 1990, MEMOIRES MUSEE PREHI, V3, P63; Boeda Eric, 1988, MUTATION, V8, P41; Bonilauri S, 2012, P EUR SOC STUD HUM E, V2, P43; Cahen D, 1984, PEUPLES CHASSEURS BE, P133; CARBONELL E, 1995, SCIENCE, V269, P826, DOI 10.1126/science.7638598; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carpentier G, 1982, B CTRE GEOMORPHO CAE, V26, P31; Carpentier G, 1984, B CTR GEOMORPHOLOGIE, V29, P49; Carretero JM, 1997, J HUM EVOL, V33, P357, DOI 10.1006/jhev.1997.0128; Chung CB, 1999, AM J ROENTGENOL, V173, P351, DOI 10.2214/ajr.173.2.10430134; CLIQUET D, 1991, CR ACAD SCI II, V313, P823; Commandre F, 1977, PATHOLOGIE ABARTICUL; CONARD NJ, 1990, J ANTHROPOL RES, V46, P243, DOI 10.1086/jar.46.3.3630426; Condemi S, 1992, HOMMES FOSSILES SACC; Cordy Jean-Marie, 2003, Quaternaire, V14, P15; Cowgill LW, 2012, INT J OSTEOARCHAEOL, DOI [10.1002/(ISSN)1099-1212, DOI 10.1002/(ISSN)1099-1212]; Czarnetzki Alfred, 1999, Human Evolution, V14, P175, DOI 10.1007/BF02440155; de Lumley H, 2004, ANTHROPOLOGIE, V108, P159, DOI 10.1016/j.anthro.2004.05.001; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; deCastro JMB, 1997, SCIENCE, V276, P1392; Delagnes A, 1996, DAF, V56; Dennell R, 1996, ANTIQUITY, V70, P535, DOI 10.1017/S0003598X00083691; Depaepe P, 2007, MEM SOC PREHIST FR, V41; Descombes JC, 1983, B ASS FRANCAISE ETUD, V20, P161; Descombes JC, 1987, B CTRE GEOMORPHO, V27, P19; Duday H, 2011, ARCHEOLOGY DEAD LECT; Duday H, 1991, SQUELETTE MOUSTERIEN, V2, p[179, 179]; Faivre JP, 2012, P EUR SOC STUD HUM E, V2, P77; Fennell KJ, 1997, J ARCHAEOL SCI, V24, P985, DOI 10.1006/jasc.1996.0176; Fleisig GS, 1996, SPORTS MED, V21, P421, DOI 10.2165/00007256-199621060-00004; Fosse G, 1982, B ASS FRANCAISE ETUD, V19, P83; Gaquerel C, 1984, B CTRE GEOMORPHO CAE, V29, P85; Gouedo JM, 1994, DAF, V47, P84; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; Gran R., 2000, ANCIENT TL, V18, P1; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Guilbaud M, 1995, B SOC PREHISTORIQUE, V3, P289; Guipert G, 2011, CR PALEVOL, V10, P21, DOI 10.1016/j.crpv.2010.10.006; Haidle MN, 2010, QUATERN INT, V223, P143, DOI 10.1016/j.quaint.2010.02.009; Hambucken A, 1993, COMP AVEC HOMME MODE; Hambucken Anne, 1998, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V10, P213, DOI 10.3406/bmsap.1998.2516; HAWKEY DE, 1995, INT J OSTEOARCHAEOL, V5, P324, DOI 10.1002/oa.1390050403; Hirsch EF, 1939, ARCH SURG-CHICAGO, V39, P824, DOI 10.1001/archsurg.1939.01200170135012; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hubling JJ, 1991, THESIS U BORDEAUX I; Hutton Estabrook V, 2013, BIOARCHAEOL IN PRESS; Jurmain R, 2010, DOCUMENT PUBLSIHED O, P2; Lautridou JP, 1982, B CTRE GEOMORPHO CAE, V26; Lautridou JP, 1977, B SOC GEOL NORMANDIE, V4, P119; Lautridou JP, 2003, QUATERNAIRE, V14, P25; Lebel S, 2002, J HUM EVOL, V43, P659, DOI 10.1006/jhev.2002.0598; Locht JL, 1994, DOSS DOC ARCHEOL, V18, P103; Ludewig PM, 2011, JOINT STRUCTURE FUNC, P230; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; Maki JM, 2013, THESIS WASHINGTON U; Mann A, 2008, NEW INSIGHTS KRAPINA, P261; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; McCown TD, 1939, STONE AGE MOUTN CARM; Mednikova MB, 2010, ARCHAEOL ETHNOL ANTH, V38, P102, DOI 10.1016/j.aeae.2010.05.013; Meyer V, 2013, THESIS U BORDEAUX I, P1; Monge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064539; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Oms O, 2000, P NATL ACAD SCI USA, V97, P10666, DOI 10.1073/pnas.180319797; Otte M, 1990, HELINIUM, V24, P3; Patte E, 1957, ENFANT NEANDERTHELAI; Puissegur JJ, 1983, B CTRE GEOMORPHO CAE, V26, P151; Revillion S, 1995, B SOC PREHISTORIQUE, V92, P425, DOI [10.3406/bspf.1995.10058, DOI 10.3406/BSPF.1995.10058]; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; ROEBROEKS W, 1994, ANTIQUITY, V68, P489, DOI 10.1017/S0003598X00047001; ROEBROEKS W, 1992, CURR ANTHROPOL, V33, P551, DOI 10.1086/204113; Rougier H, 2003, ETUDE DESCRIPTIVE CO; Rousseau DD, 1986, B CTR GEOMORPH CAEN, V31, P5; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Schick KD, 1986, BAR INT SERIES; Shang H, 2008, AM J PHYS ANTHROPOL, V135, P431, DOI 10.1002/ajpa.20763; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Spoor F, 1998, AM J PHYS ANTHROPOL, V107, P41, DOI 10.1002/(SICI)1096-8644(199809)107:1<41::AID-AJPA4>3.0.CO;2-G; Stremme HE, 1985, B ASS FRANCAISE ETUD, V2-3, P159; Stringer CB, 1998, J HUM EVOL, V34, P509, DOI 10.1006/jhev.1998.0215; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Thieme H, 2007, THESIS; Trinkaus, 2014, SHANIDAR NEANDERTALS; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P753, DOI 10.1006/jasc.1998.0345; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; TRINKAUS E, 1988, AM J PHYS ANTHROPOL, V75, P15, DOI 10.1002/ajpa.1330750103; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P173, DOI 10.1006/jasc.1998.0314; Trinkaus E, 2014, PEOPLE SUNGHIR BURAI; Trinkaus E, 2008, AM J PHYS ANTHROPOL, V137, P106, DOI 10.1002/ajpa.20833; Tuffreau A, 1994, B SOC PREHISTORIQUE, V91, P23; Tuffreau A, 1988, MEM SOC PREHIST FR, V21; Turq A, 2013, J HUM EVOL, V65, P641, DOI 10.1016/j.jhevol.2013.07.014; Vallin L, 1991, CAHIERS QUATERNAIRE, V16, P241; VANDERMEERSCH B, 1995, J HUM EVOL, V28, P439, DOI 10.1006/jhev.1995.1034; Vandermeersch B, 1982, HOMO ERECTUS PLACE H, P894; Villa P, 2010, J ANTHROPOL RES, V66, P5, DOI 10.3998/jar.0521004.0066.102; Villotte S, 2013, INT J OSTEOARCHAEOL, V23, P135, DOI 10.1002/oa.2289; Villotte S, 2009, BAR INT SERIES; Volpato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043949; Voorhies MR, 1969, U WYOMING CONTRIBUTI, V1, P1, DOI DOI 10.2113/GSROCKY.8.SPECIAL_PAPER_1.1; Weiner J, 1964, SWANSCOMBE SKULL, P175; Wu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059587; Wu XJ, 2011, P NATL ACAD SCI USA, V108, P19558, DOI 10.1073/pnas.1117113108	114	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e104111	10.1371/journal.pone.0104111	http://dx.doi.org/10.1371/journal.pone.0104111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AT8TE	25295956	Green Published, gold			2022-12-25	WOS:000345204000002
J	Saluveer, O; Larsson, P; Ridderstrale, W; Hrafnkelsdottir, TJ; Jern, S; Bergh, N				Saluveer, Ott; Larsson, Pia; Ridderstrale, Wilhelm; Hrafnkelsdottir, Thordis J.; Jern, Sverker; Bergh, Niklas			Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; RECURRENT MYOCARDIAL-INFARCTION; IN-VIVO; ENDOTHELIAL-CELLS; IMPAIRED CAPACITY; PAI-1 COMPLEX; ACUTE RELEASE; RISK-FACTOR; T-PA; HYPERTENSION	Aims: The aim of the study was to test if pharmacological intervention by valproic acid (VPA) treatment can modulate the fibrinolytic system in man, by means of increased acute release capacity of tissue plasminogen activator (t-PA) as well as an altered t-PA/Plasminogen activator inhibitor -1 (PAI-1) balance. Recent data from in vitro research demonstrate that the fibrinolytic system is epigenetically regulated mainly by histone deacetylase (HDAC) inhibitors. HDAC inhibitors, including VPA markedly upregulate t-PA gene expression in vitro. Methods and Results: The trial had a cross-over design where healthy men (n = 10), were treated with VPA (Ergenyl Retard) 500 mg depot tablets twice daily for 2 weeks. Capacity for stimulated t-PA release was assessed in the perfused-forearm model using intra-brachial Substance P infusion and venous occlusion plethysmography. Each subject was investigated twice, untreated and after VPA treatment, with 5 weeks wash-out in-between. VPA treatment resulted in considerably decreased levels of circulating PAI-1 antigen from 22.2 (4.6) to 10.8 (2.1) ng/ml (p<0.05). It slightly decreased the levels of circulating venous t-PA antigen (p<0.05), and the t-PA: PAI-1 antigen ratio increased (p<0.01). Substance P infusion resulted in an increase in forearm blood flow (FBF) on both occasions (p<0.0001 for both). The acute t-PA release in response to Substance P was not affected by VPA (p = ns). Conclusion: Valproic acid treatment lowers plasma PAI-1 antigen levels and changes the fibrinolytic balance measured as tPA/PAI-1 ratio in a profibrinolytic direction. This may in part explain the reduction in incidence of myocardial infarctions by VPA treatment observed in recent pharmacoepidemiological studies.	[Saluveer, Ott; Larsson, Pia; Ridderstrale, Wilhelm; Hrafnkelsdottir, Thordis J.; Jern, Sverker; Bergh, Niklas] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Hrafnkelsdottir, Thordis J.] Landspitali Univ Hosp, Dept Cardiol, Reykjavik, Iceland; [Hrafnkelsdottir, Thordis J.] Univ Iceland, Reykjavik, Iceland	University of Gothenburg; Landspitali National University Hospital; University of Iceland	Saluveer, O (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden.	ott.saluveer@gu.se		Bergh, Niklas/0000-0002-7440-2366; Hrafnkelsdottir, THordis Jona/0000-0002-4398-2898; Larsson, Pia/0000-0001-9115-4213	Swedish Heart-Lung Foundation; Swedish Research Council; Emelle Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Emelle Foundation	The study was supported by research grants from The Swedish Heart-Lung Foundation, the Swedish Research Council, and the Emelle Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2004, ARCH MAL COEUR VAISS, V97, P673; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Brogren H, 2008, THROMB RES, V122, P271, DOI 10.1016/j.thromres.2008.04.008; Brogren H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026762; CARMELIET P, 1995, THROMB HAEMOSTASIS, V74, P429; CHANDLER WL, 1990, BLOOD, V76, P930; Chandler WL, 1997, CIRCULATION, V96, P761; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; EMEIS JJ, 1992, ANN NY ACAD SCI, V667, P249, DOI 10.1111/j.1749-6632.1992.tb51622.x; Fogari R, 2006, AM J HYPERTENS, V19, P1293, DOI 10.1016/j.amjhyper.2006.04.013; HAMSTEN A, 1987, LANCET, V2, P3; Hrafnkelsdottir T, 2004, J THROMB HAEMOST, V2, P1960, DOI 10.1111/j.1538-7836.2004.00948.x; Hrafnkelsdottir T, 1998, LANCET, V352, P1597, DOI 10.1016/S0140-6736(05)61044-6; Hrafnkelsdottir T, 2001, THROMB HAEMOSTASIS, V85, P875; Hrafnkelsdottir T, 2004, HYPERTENSION, V44, P300, DOI 10.1161/01.HYP.0000137380.91476.fb; Koenig S, 2008, BLOOD COAGUL FIBRIN, V19, P375, DOI 10.1097/MBC.0b013e3282f3f9ec; Larsson P, 2013, J THROMB THROMBOLYS, V35, P185, DOI 10.1007/s11239-012-0831-6; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Newby DE, 2001, CIRCULATION, V103, P1936; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P964, DOI 10.1002/pds.2186; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Osterlund B, 2008, ACTA ANAESTH SCAND, V52, P1375, DOI 10.1111/j.1399-6576.2008.01741.x; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Ridderstrale W, 2006, HYPERTENSION, V47, P686, DOI 10.1161/01.HYP.0000210540.35296.62; Ridderstrale W, 2011, J THROMB THROMBOLYS, V32, P399, DOI 10.1007/s11239-011-0595-4; Ridker, 1994, J Thromb Thrombolysis, V1, P35, DOI 10.1007/BF01061993; Robinson SD, 2007, ARTERIOSCL THROM VAS, V27, P1651, DOI 10.1161/ATVBAHA.107.143248; SALOMAA V, 1995, CIRCULATION, V91, P284, DOI 10.1161/01.CIR.91.2.284; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tjarnlund-Wolf A, 2012, STROKE, V43, P2833, DOI 10.1161/STROKEAHA.111.622217; Wall U, 1997, J HYPERTENS, V15, P1641, DOI 10.1097/00004872-199715120-00066; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019	34	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107582	10.1371/journal.pone.0107582	http://dx.doi.org/10.1371/journal.pone.0107582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295869	gold, Green Submitted, Green Published			2022-12-25	WOS:000345204000008
J	Viruel, J; Catalan, P; Segarra-Moragues, JG				Viruel, Juan; Catalan, Pilar; Segarra-Moragues, Jose Gabriel			Latitudinal Environmental Niches and Riverine Barriers Shaped the Phylogeography of the Central Chilean Endemic Dioscorea humilis (Dioscoreaceae)	PLOS ONE			English	Article							LIOLAEMUS-MONTICOLA; GENETIC DIVERSITY; NORTHERN CHILE; MICROSATELLITE; SOFTWARE; DISPERSAL; EPIPETRUM; PATTERNS; MAXIMUM; REFUGIA	The effects of Pleistocene glaciations and geographical barriers on the phylogeographic patterns of lowland plant species in Mediterranean-climate areas of Central Chile are poorly understood. We used Dioscorea humilis (Dioscoreaceae), a dioecious geophyte extending 530 km from the Valparaiso to the Bio-Bio Regions, as a case study to disentangle the spatio-temporal evolution of populations in conjunction with latitudinal environmental changes since the Last Inter-Glacial (LIG) to the present. We used nuclear microsatellite loci, chloroplast (cpDNA) sequences and environmental niche modelling (ENM) to construct current and past scenarios from bioclimatic and geographical variables and to infer the evolutionary history of the taxa. We found strong genetic differentiation at nuclear microsatellite loci between the two subspecies of D. humilis, probably predating the LIG. Bayesian analyses of population structure revealed strong genetic differentiation of the widespread D. humilis subsp. humilis into northern and southern population groups, separated by the Maipo river. ENM revealed that the ecological niche differentiation of both groups have been maintained up to present times although their respective geographical distributions apparently fluctuated in concert with the climatic oscillations of the Last Glacial Maximum (LGM) and the Holocene. Genetic data revealed signatures of eastern and western postglacial expansion of the northern populations from the central Chilean depression, whereas the southern ones experienced a rapid southward expansion after the LGM. This study describes the complex evolutionary histories of lowland Mediterranean Chilean plants mediated by the summed effects of spatial isolation caused by riverine geographical barriers and the climatic changes of the Quaternary.	[Viruel, Juan; Catalan, Pilar] Univ Zaragoza, Escuela Politecn Super Huesca, Dept Agr & Econ Agr, Huesca, Spain; [Catalan, Pilar] Tomsk State Univ, Inst Biol, Dept Bot, Tomsk 634050, Russia; [Segarra-Moragues, Jose Gabriel] CSIC, Ctr Invest Desertificac CIDE, Dept Ecol, Valencia, Spain	University of Zaragoza; Tomsk State University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Segarra-Moragues, JG (corresponding author), CSIC, Ctr Invest Desertificac CIDE, Dept Ecol, Valencia, Spain.	jogasemo@gmail.com	Viruel, Juan/H-4227-2015; Segarra-Moragues, José Gabriel/I-7352-2012; Catalan, Pilar/N-7641-2014; Catalan, Pilar/AAL-8833-2020	Viruel, Juan/0000-0001-5658-8411; Segarra-Moragues, José Gabriel/0000-0003-0061-8647; Catalan Rodriguez, Maria Pilar/0000-0001-7793-5259	Fundacion BBVA BIOCON [05-093/06]; Fundacion BBVA Ph.D. grant; Spanish Aragon Government "Araid"; Spanish Ministry of Science and Innovation "Ramon y Cajal"; Bioflora; Spanish Aragon Government; European Social Fund	Fundacion BBVA BIOCON(BBVA Foundation); Fundacion BBVA Ph.D. grant(BBVA Foundation); Spanish Aragon Government "Araid"; Spanish Ministry of Science and Innovation "Ramon y Cajal"(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bioflora; Spanish Aragon Government(Gobierno de Aragon); European Social Fund(European Social Fund (ESF))	Financial support for this study was provided by a Fundacion BBVA BIOCON 05-093/06 project grant to PC and JGSM. JV was supported by a Fundacion BBVA Ph.D. grant. JGSM was supported by two consecutive Spanish Aragon Government "Araid" and Spanish Ministry of Science and Innovation "Ramon y Cajal" postdoctoral contracts. PC was partially funded by a Bioflora (http://bifi.es/bioflora/) research team grant co-funded by the Spanish Aragon Government and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo J, 1998, PLANT ECOL, V136, P9, DOI 10.1023/A:1009714201917; Belkhir K, 2004, 5000 CNRS UMR LAB GE; Bonilla CA, 2011, J HYDROL, V410, P126, DOI 10.1016/j.jhydrol.2011.09.022; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Bull-Herenu K, 2005, J BIOGEOGR, V32, P1129, DOI 10.1111/j.1365-2699.2004.01209.x; Canestrelli D, 2008, J BIOGEOGR, V35, P1923, DOI 10.1111/j.1365-2699.2008.01946.x; Castillo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-266; Caviedes CN, 1975, J GLACIOL, V14, P155; CLAPPERTON CM, 1994, REV CHIL HIST NAT, V67, P369; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Dillon MO, 2009, J SYST EVOL, V47, P457, DOI 10.1111/j.1759-6831.2009.00040.x; Donato M, 2006, J ARID ENVIRON, V66, P421, DOI 10.1016/j.jaridenv.2006.01.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goudet J, 2001, FSTAT V 2 9 3 2 PROG; GRAF K, 1994, REV CHIL HIST NAT, V67, P405; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HASUMI H, 2004, 1 K1 U TOK CTR CLIM; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jabaily RS, 2010, AM J BOT, V97, P337, DOI 10.3732/ajb.0900107; Lamborot M, 1997, J ZOOL SYST EVOL RES, V35, P105; Lamy F, 1999, QUATERNARY RES, V51, P83, DOI 10.1006/qres.1998.2010; Langella O, 2000, POPULATIONS LOGICIEL; Li YC, 2000, MOL BIOL EVOL, V17, P851, DOI 10.1093/oxfordjournals.molbev.a026365; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Orme A.R., 2007, PHYS GEOGRAPHY S AM, P184; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pease KM, 2009, MOL ECOL, V18, P1848, DOI 10.1111/j.1365-294X.2009.04112.x; Pezoa L, 2003, THESIS U AUSTRAL CHI; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pritchard JK, 2002, DOCUMENTATION STRUCT; Rohlf FJ, 2002, NTSYSPC NUMERICAL TA; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sallaberry-Pincheira N, 2011, DIVERS DISTRIB, V17, P152, DOI 10.1111/j.1472-4642.2010.00729.x; SANTANAAGUILAR M, 1973, B ASS GEOGRAPHY FRAN, V406, P473; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Segarra-Moragues JG, 2005, MOL ECOL, V14, P969, DOI 10.1111/j.1365-294X.2005.02482.x; Segarra-Moragues JG, 2007, J BIOGEOGR, V34, P1893, DOI 10.1111/j.1365-2699.2007.01740.x; SLATKIN M, 1995, GENETICS, V139, P457; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1983, GENETICS, V105, P437; Van Heusen C., 1967, GEOGRAPHISCHE HEFTE, V4, P1; Vasquez M, 2007, HERPETOL J, V17, P149; Veit H, 1996, PALAEOGEOGR PALAEOCL, V123, P107, DOI 10.1016/0031-0182(95)00118-2; VILLAGRAN C, 1991, REV CHIL HIST NAT, V64, P447; Villagran C, 2001, REV CHIL HIST NAT, V74, P783; Viruel J, 2008, NEW ZEAL J BOT, V46, P327, DOI 10.1080/00288250809509771; Viruel J, 2012, J BIOGEOGR, V39, P1073, DOI 10.1111/j.1365-2699.2011.02658.x; Viruel J, 2010, AM J BOT, V97, pE121, DOI 10.3732/ajb.1000304; Viruel J, 2010, SYST BOT, V35, P40, DOI 10.1600/036364410790862579; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zhang ZY, 2007, BIOCHEM SYST ECOL, V35, P506, DOI 10.1016/j.bse.2007.01.014	62	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110029	10.1371/journal.pone.0110029	http://dx.doi.org/10.1371/journal.pone.0110029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295517	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000110
J	Garcia-R, JC; Gibb, GC; Trewick, SA				Garcia-R, Juan C.; Gibb, Gillian C.; Trewick, Steve A.			Eocene Diversification of Crown Group Rails (Aves: Gruiformes: Rallidae)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; FOSSIL RECORD; MODERN BIRDS; EVOLUTIONARY HISTORY; EARLY OLIGOCENE; PHYLOGENY; DNA; TERTIARY; SEQUENCES; BIOGEOGRAPHY	Central to our understanding of the timing of bird evolution is debate about an apparent conflict between fossil and molecular data. A deep age for higher level taxa within Neoaves is evident from molecular analyses but much remains to be learned about the age of diversification in modern bird families and their evolutionary ecology. In order to better understand the timing and pattern of diversification within the family Rallidae we used a relaxed molecular clock, fossil calibrations, and complete mitochondrial genomes from a range of rallid species analysed in a Bayesian framework. The estimated time of origin of Rallidae is Eocene, about 40.5 Mya, with evidence of intrafamiliar diversification from the Late Eocene to the Miocene. This timing is older than previously suggested for crown group Rallidae, but fossil calibrations, extent of taxon sampling and substantial sequence data give it credence. We note that fossils of Eocene age tentatively assigned to Rallidae are consistent with our findings. Compared to available studies of other bird lineages, the rail clade is old and supports an inference of deep ancestry of ground-dwelling habits among Neoaves.	[Garcia-R, Juan C.; Gibb, Gillian C.; Trewick, Steve A.] Massey Univ, Inst Agr & Environm, Phoenix Lab, Ecol Grp, Palmerston North, New Zealand	Massey University	Garcia-R, JC (corresponding author), Massey Univ, Inst Agr & Environm, Phoenix Lab, Ecol Grp, Palmerston North, New Zealand.	j.c.garciaramirez@massey.ac.nz	Garcia-R, Juan C./X-3399-2019; Gibb, Gillian/AAF-9175-2020	Garcia-R, Juan C./0000-0002-6665-9671; Gibb, Gillian/0000-0002-4283-9790; Trewick, Steven/0000-0002-4680-8457	Royal Society of New Zealand; Institute of Agriculture and Environment at Massey University	Royal Society of New Zealand(Royal Society of New Zealand); Institute of Agriculture and Environment at Massey University	This work was assisted by the Hutton Fund (JCGR) of the Royal Society of New Zealand and the Institute of Agriculture and Environment at Massey University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin FL, 2012, PALAEONTOL Z, V86, P85, DOI 10.1007/s12542-011-0112-2; Agnolin FL, 2006, AMEGHINIANA, V43, P245; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Baker AJ, 2014, MOL BIOL EVOL; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton Michael J., 2009, P35; Brocklehurst N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039056; Brown J.W., 2011, LIVING DINOSAURS EVO, P306; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Brown JW, 2007, BIOL LETTERS, V3, P257, DOI 10.1098/rsbl.2006.0611; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clements J.F., 2012, CLEMENTS CHECKLIST B; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; De Pietri VL, 2014, J ZOOL SYS EVOL RES; Drummond A.J., 2012, GENEIOUS V6 05; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dyke GJ, 2008, CLADISTICS, V24, P77, DOI 10.1111/j.1096-0031.2007.00188.x; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; Elzanowski A, 2011, AUK, V128, P138, DOI 10.1525/auk.2011.10113; Eo SH, 2010, P R SOC B; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2007, MOL PHYLOGENET EVOL, V43, P515, DOI 10.1016/j.ympev.2007.02.015; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Fordyce R.E., 1990, P419; FORDYCE RE, 1986, GEOLOGICAL SOC NZ NE, V74, P56; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haddrath O, 2001, P ROY SOC B-BIOL SCI, V268, P939, DOI 10.1098/rspb.2001.1587; Haddrath O, 2012, P R SOC B; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holland BR, 2003, SYST BIOL, V52, P229, DOI 10.1080/10635150390192771; Hou Lianhai, 1990, Vertebrata Palasiatica, V28, P34; HOUDE P, 1986, NATURE, V324, P563, DOI 10.1038/324563a0; HOUDE P, 1981, SCIENCE, V214, P1236, DOI 10.1126/science.214.4526.1236; Houde Peter, 2009, P440; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; JOHNSON NK, 1989, CONDOR, V91, P379, DOI 10.2307/1368317; Jonsson KA, 2010, J BIOGEOGR, V37, P245, DOI 10.1111/j.1365-2699.2009.02220.x; Kan X-Z, CHARACTERIZATI UNPUB; Kirchman JJ, 2012, AUK, V129, P56, DOI 10.1525/auk.2011.11096; Kirchman JJ, 2009, BIOL J LINN SOC, V96, P601, DOI 10.1111/j.1095-8312.2008.01160.x; Krajewski C, 2010, AUK, V127, P440, DOI 10.1525/auk.2009.09045; Ksepka DT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0677; Lanfear R, 2007, P NATL ACAD SCI USA, V104, P15388, DOI 10.1073/pnas.0703359104; Lepage D, 2013, AVIBASE WORLD BIRD D; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Lindow BEK, 2006, BIOL REV, V81, P483, DOI 10.1017/S146479310600707X; Livezey BC, 2003, EVOLUTION FLIGHTLESS; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2006, ARDEA, V94, P23; Mayr G, 2014, J ROY SOC NEW ZEAL, V44, P48, DOI 10.1080/03036758.2013.863788; Mayr G, 2001, GEOBIOS-LYON, V34, P547, DOI 10.1016/S0016-6995(01)80069-3; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2006, CONDOR, V108, P717, DOI 10.1650/0010-5422(2006)108[717:ASSPBF]2.0.CO;2; Mayr G, 2014, PALAEONTOLOGY, V57, P231, DOI 10.1111/pala.12103; Mayr G, 2013, SYST BIODIVERS, V11, P7, DOI 10.1080/14772000.2013.765521; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1977, RAILS WORLD MONOGRAP, P339; OLSON SL, 1973, WILSON BULL, V85, P381; Olson SL, 2003, P BIOL SOC WASH, V116, P732; Olson SL, 1989, P 19 INT ORN C, P2023; Ozaki K, 2010, GENES GENET SYST, V85, P55, DOI 10.1266/ggs.85.55; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pratt RC, 2009, MOL BIOL EVOL, V26, P313, DOI 10.1093/molbev/msn248; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruan LZ, 2012, BIOCHEM GENET, V50, P959, DOI 10.1007/s10528-012-9535-z; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Slikas B, 2002, J AVIAN BIOL, V33, P5, DOI 10.1034/j.1600-048X.2002.330103.x; Smith VS, 2011, BIOL LETTERS, V7, P782, DOI 10.1098/rsbl.2011.0105; Springer MS, 1996, J MOL EVOL, V43, P357; Stidham TA, 1998, NATURE, V396, P29, DOI 10.1038/23841; Tennyson AJD, 2010, REC AUST MUS, V62, P105, DOI 10.3853/j.0067-1975.62.2010.1546; Trewick SA, 1997, PHILOS T R SOC B, V352, P429, DOI 10.1098/rstb.1997.0031; Trewick SA, 2010, IBIS, V152, P226, DOI 10.1111/j.1474-919X.2010.01018.x; Van Perlo, 1998, RAILS GUIDE RAILS CR; Wang ML, 2012, INT CONF SPEECH DATA, P1, DOI 10.1109/ICSDA.2012.6422457; Wetmore A., 1931, Condor Berkeley, V33, P107, DOI 10.2307/1363575; White NE, 2011, MOL PHYLOGENET EVOL, V59, P615, DOI 10.1016/j.ympev.2011.03.011; Worthy TH, 2007, J SYST PALAEONTOL, V5, P1, DOI 10.1017/S1477201906001957; Yang R, 2010, MOL BIOL REP, V37, P3057, DOI 10.1007/s11033-009-9878-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	113	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109635	10.1371/journal.pone.0109635	http://dx.doi.org/10.1371/journal.pone.0109635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291147	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000074
J	McCullough, RM; Almasri, EA; Guan, XJ; Geis, JA; Hicks, SC; Mazloom, AR; Deciu, C; Oeth, P; Bombard, AT; Paxton, B; Dharajiya, N; Saldivar, JS				McCullough, Ron M.; Almasri, Eyad A.; Guan, Xiaojun; Geis, Jennifer A.; Hicks, Susan C.; Mazloom, Amin R.; Deciu, Cosmin; Oeth, Paul; Bombard, Allan T.; Paxton, Bill; Dharajiya, Nilesh; Saldivar, Juan-Sebastian			Non-Invasive Prenatal Chromosomal Aneuploidy Testing - Clinical Experience: 100,000 Clinical Samples	PLOS ONE			English	Article							CONFINED PLACENTAL MOSAICISM; FETAL ANEUPLOIDY; DNA; DIAGNOSIS; AMNIOCENTESIS	Objective: As the first laboratory to offer massively parallel sequencing-based noninvasive prenatal testing (NIPT) for fetal aneuploidies, Sequenom Laboratories has been able to collect the largest clinical population experience data to date, including >100,000 clinical samples from all 50 U.S. states and 13 other countries. The objective of this study is to give a robust clinical picture of the current laboratory performance of the MaterniT21 PLUS LDT. Study Design: The study includes plasma samples collected from patients with high-risk pregnancies in our CLIA-licensed, CAP-accredited laboratory between August 2012 to June 2013. Samples were assessed for trisomies 13, 18, 21 and for the presence of chromosome Y-specific DNA. Sample data and ad hoc outcome information provided by the clinician was compiled and reviewed to determine the characteristics of this patient population, as well as estimate the assay performance in a clinical setting. Results: NIPT patients most commonly undergo testing at an average of 15 weeks, 3 days gestation; and average 35.1 years of age. The average turnaround time is 4.54 business days and an overall 1.3% not reportable rate. The positivity rate for Trisomy 21 was 1.51%, followed by 0.45% and 0.21% rate for Trisomies 18 and 13, respectively. NIPT positivity rates are similar to previous large clinical studies of aneuploidy in women of maternal age >= 35 undergoing amniocentesis. In this population 3519 patients had multifetal gestations (3.5%) with 2.61% yielding a positive NIPT result. Conclusion: NIPT has been commercially offered for just over 2 years and the clinical use by patients and clinicians has increased significantly. The risks associated with invasive testing have been substantially reduced by providing another assessment of aneuploidy status in high-risk patients. The accuracy and NIPT assay positivity rate are as predicted by clinical validations and the test demonstrates improvement in the current standard of care.	[McCullough, Ron M.; Almasri, Eyad A.; Guan, Xiaojun; Geis, Jennifer A.; Hicks, Susan C.; Mazloom, Amin R.; Deciu, Cosmin; Oeth, Paul; Bombard, Allan T.; Paxton, Bill; Dharajiya, Nilesh; Saldivar, Juan-Sebastian] Sequenom Labs, San Diego, CA 92121 USA	Sequenom	McCullough, RM (corresponding author), Sequenom Labs, San Diego, CA 92121 USA.	rmccullough@sequenom.com						Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Devers P, 2012, NONINVASIVE PRENATAL; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; Forabosco A, 2009, EUR J HUM GENET, V17, P897, DOI 10.1038/ejhg.2008.265; Futch T, 2013, PRENATAL DIAG, V33, P569, DOI 10.1002/pd.4123; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Lestou VS, 1998, ARCH DIS CHILD-FETAL, V79, pF223, DOI 10.1136/fn.79.3.F223; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Norwitz Errol R, 2013, Rev Obstet Gynecol, V6, P48; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Tabor A, 2009, ULTRASOUND OBST GYN, V34, P19, DOI 10.1002/uog.6377; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Wilkins-Haug L, 2006, PRENATAL DIAG, V26, P428, DOI 10.1002/pd.1430; ZIMMERMAN B, 2012, PRENATAL DIAGNOSIS, V32, P1	24	89	102	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109173	10.1371/journal.pone.0109173	http://dx.doi.org/10.1371/journal.pone.0109173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289665	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000044
J	Su, BB; Xu, BX; Wan, J				Su, Binbin; Xu, Baixuan; Wan, Jun			Correlation between Long-Term Aspirin Use and F-Fluorodeoxyglucose Uptake in Colorectal Cancer Measured by PET/CT	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUES; LOW-DOSE ASPIRIN; FDG-PET; TUMOR VASCULATURE; EARLY PREDICTION; BREAST-CANCER; F-18-FDG PET; CHEMOTHERAPY; ESOPHAGEAL	Purpose: The aim of this study was to evaluate the relationship between long-term aspirin use with pretreatment 18 Fluorodeoxyglucose (FDG) uptake of primary lesions of Colorectal cancer (CRC) and evaluate their clinical significance. Materials and Methods: We enrolled 84 patients with CRC who underwent 18F-FDG PET/CT scanning before surgery between 1st July 2008 and 1st March 2013 and followed up until 1st March 2014. Maximum standardized uptake value (SUVmax) of the primary tumor was measured by 18F-FDG PET/CT. The history of aspirin taken and other clinicopathogical factors were also obtained and their relationships were examined by Mann-Whitney or chi 2 tests. Progression-free survival (PFS) was determined by standard Kaplan-Meier survival analysis. Cox proportional hazards regression was performed to determine whether history of aspirin taken, pretreatment SUVmax, age, gender, TNM stage, tumor sizes and differentiation influenced outcomes. Results: CRC Patients with long-term history of aspirin use had lower SUVmax of primary lesions than control group (9.74 +/- 2.62 vs. 13.91 +/- 6.18) and showed a trend towards improved PFS after curative surgery. However, pretreatment of SUVmax showed no prognostic value in patients with CRC. Conclusions: Long-term aspirin use is associated with lower pretreatment SUVmax of CRC and is a promising prognostic factor for predicting PFS in patients with CRC.	[Su, Binbin; Wan, Jun] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Xu, Baixuan] Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Xu, BX (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China.	xubxpla@126.com; wanjunpla@126.com			Beijing Municipal Natural Science Foundation of China [14G30118]	Beijing Municipal Natural Science Foundation of China	This work was supported by a grant from Beijing Municipal Natural Science Foundation of China (No. 14G30118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti R, 2014, BREAST, V23, P334, DOI 10.1016/j.breast.2014.01.001; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Bystrom P, 2009, ANN ONCOL, V20, P1057, DOI 10.1093/annonc/mdn744; Cardwell CR, 2014, GASTROENTEROLOGY, V146, P700, DOI 10.1053/j.gastro.2013.11.005; Cerfolio RJ, 2006, ANN THORAC SURG, V82, P391, DOI 10.1016/j.athoracsur.2006.03.045; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Chen SW, 2014, CLIN NUCL MED, V39, P685, DOI 10.1097/RLU.0000000000000481; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; CREAGAN ET, 1991, J CLIN ONCOL, V9, P2104, DOI 10.1200/JCO.1991.9.12.2104; Crippa F, 1998, EUR J NUCL MED, V25, P1429, DOI 10.1007/s002590050319; de Geus-Oei LF, 2008, ANN ONCOL, V19, P348, DOI 10.1093/annonc/mdm470; Dierckx RA, 2008, EUR J NUCL MED MOL I, V35, P1544, DOI 10.1007/s00259-008-0758-5; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Evangelista V, 2006, CIRC RES, V98, P593, DOI 10.1161/01.RES.0000214553.37930.3e; Findlay M, 1996, J CLIN ONCOL, V14, P700, DOI 10.1200/JCO.1996.14.3.700; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Furuta M, 1997, EUR J NUCL MED, V24, P435, DOI 10.1007/BF00881817; Gayed I, 2004, J NUCL MED, V45, P17; HABERKORN U, 1991, J NUCL MED, V32, P1548; Hong D, 2005, CANCER-AM CANCER SOC, V104, P1620, DOI 10.1002/cncr.21356; ICHIYA Y, 1991, J NUCL MED, V32, P1655; Ikenaga N, 2007, AM SURGEON, V73, P1151; Il Na I, 2008, CLIN CANCER RES, V14, P2036, DOI 10.1158/1078-0432.CCR-07-4074; Izuishi K, 2010, J GASTROINTEST SURG, V14, P1151, DOI 10.1007/s11605-010-1207-x; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Kato H, 2009, CANCER-AM CANCER SOC, V115, P3196, DOI 10.1002/cncr.24399; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kumar A, 2012, MOL CELL BIOCHEM, V371, P43, DOI 10.1007/s11010-012-1421-9; Kumar A, 2012, BIOSCIENCE REP, V32, P91, DOI 10.1042/BSR20110027; LEBEAU B, 1993, CANCER, V71, P1741, DOI 10.1002/1097-0142(19930301)71:5<1741::AID-CNCR2820710507>3.0.CO;2-Q; Lee JE, 2012, WORLD J GASTROENTERO, V18, P5072, DOI 10.3748/wjg.v18.i36.5072; McCowan C, 2013, EUR J CANCER, V49, P1049, DOI 10.1016/j.ejca.2012.10.024; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Riedl CC, 2007, J NUCL MED, V48, P771, DOI 10.2967/jnumed.106.037291; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; RUMBLE RH, 1980, BRIT J CLIN PHARMACO, V9, P41, DOI 10.1111/j.1365-2125.1980.tb04794.x; Symeonidis D, 2012, WORLD J GASTRO ENDOS, V4, P409, DOI 10.4253/wjge.v4.i9.409; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Walker AJ, 2012, BRIT J CANCER, V107, P1602, DOI 10.1038/bjc.2012.427	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109459	10.1371/journal.pone.0109459	http://dx.doi.org/10.1371/journal.pone.0109459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290692	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000062
J	Zhang, XL; Wang, Q; Gilliam, FS; Wang, YL; Cha, FN; Li, CH				Zhang, Xuelin; Wang, Qun; Gilliam, Frank S.; Wang, Yilun; Cha, Feina; Li, Chaohai			Spatial Variation in Carbon and Nitrogen in Cultivated Soils in Henan Province, China: Potential Effect on Crop Yield	PLOS ONE			English	Article							ORGANIC-MATTER CONTENT; WATER-RETENTION; STORAGE; PRODUCTIVITY; EROSION; BALANCE; TOPSOIL; REGION; STOCKS	Improved management of soil carbon (C) and nitrogen (N) storage in agro-ecosystems represents an important strategy for ensuring food security and sustainable agricultural development in China. Accurate estimates of the distribution of soil C and N stores and their relationship to crop yield are crucial to developing appropriate cropland management policies. The current study examined the spatial variation of soil organic C (SOC), total soil N (TSN), and associated variables in the surface layer (0-40 cm) of soils from intensive agricultural systems in 19 counties within Henan Province, China, and compared these patterns with crop yield. Mean soil C and N concentrations were 14.9 g kg(-1) and 1.37 g kg(-1), respectively, whereas soil C and N stores were 4.1 kg m(-2) and 0.4 kg m(-2), respectively. Total crop production of each county was significantly, positively related to SOC, TSN, soil C and N store, and soil C and N stock. Soil C and N were positively correlated with soil bulk density but negatively correlated with soil porosity. These results indicate that variations in soil C could regulate crop yield in intensive agricultural systems, and that spatial patterns of C and N levels in soils may be regulated by both climatic factors and agro-ecosystem management. When developing suitable management programs, the importance of soil C and N stores and their effects on crop yield should be considered.	[Zhang, Xuelin; Wang, Qun; Wang, Yilun; Li, Chaohai] Incubation Base Natl Key Lab Physiol Ecol & Genet, Zhengzhou, Peoples R China; [Zhang, Xuelin; Wang, Qun; Wang, Yilun; Li, Chaohai] Henan Agr Univ, Agron Coll, Zhengzhou, Peoples R China; [Gilliam, Frank S.] Marshall Univ, Dept Biol Sci, Huntington, WV USA; [Cha, Feina] Meteorol Bur Zhengzhou, Zhengzhou, Peoples R China	Henan Agricultural University; Marshall University	Zhang, XL (corresponding author), Incubation Base Natl Key Lab Physiol Ecol & Genet, Zhengzhou, Peoples R China.	xuelinzhang1998@163.com	Gilliam, Frank S./M-9767-2019	Gilliam, Frank S./0000-0002-5525-0766	Henan Science and Technology Department of China under the Key Research Project [30200051]	Henan Science and Technology Department of China under the Key Research Project	This study was supported by grants from Henan Science and Technology Department of China under the Key Research Project (30200051). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batjes NH, 2002, SOIL USE MANAGE, V18, P324, DOI 10.1079/SUM2002138; BAUER A, 1994, SOIL SCI SOC AM J, V58, P185, DOI 10.2136/sssaj1994.03615995005800010027x; Dersch G, 2001, NUTR CYCL AGROECOSYS, V60, P49, DOI 10.1023/A:1012607112247; Diaz-Zorita M, 2000, SOIL TILL RES, V54, P121, DOI 10.1016/S0167-1987(00)00089-1; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Duxbury J. M., 2000, Journal of Crop Production, V3, P27, DOI 10.1300/J144v03n02_02; EMERSON WW, 1995, AUST J SOIL RES, V33, P241, DOI 10.1071/SR9950241; Feller C, 1997, GEODERMA, V79, P69, DOI 10.1016/S0016-7061(97)00039-6; Feng S, 2011, J AGR SCI-CAMBRIDGE, V149, P557, DOI 10.1017/S0021859611000323; Gilliam FS, 2004, ENVIRON MANAGE, V33, pS108, DOI 10.1007/s00267-003-9121-6; Gilliam FS, 2003, J VEG SCI, V14, P297, DOI 10.1658/1100-9233(2003)014[0297:MMSOTO]2.0.CO;2; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hairiah K, 2000, NETH J AGR SCI, V48, P3, DOI 10.1016/S1573-5214(00)80001-9; Harper RJ, 1995, ASSESSMENT METHODS S, P577; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Larney FJ, 2000, CAN J SOIL SCI, V80, P515, DOI 10.4141/S99-100; Liao QL, 2009, GLOBAL CHANGE BIOL, V15, P861, DOI 10.1111/j.1365-2486.2008.01792.x; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Maia SMF, 2010, SOIL TILL RES, V106, P177, DOI 10.1016/j.still.2009.12.005; [潘根兴 Pan Genxing], 2005, [地球科学进展, Advance in Earth Sciences], V20, P384; Pan GX, 2005, J ENVIRON SCI, V17, P1; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; POST WM, 1985, NATURE, V317, P613, DOI 10.1038/317613a0; Powlson DS, 2001, NUTR CYCL AGROECOSYS, V61, P41, DOI 10.1023/A:1013338028454; SCHERTZ DL, 1989, J SOIL WATER CONSERV, V44, P604; Smith WN, 2000, GLOBAL CHANGE BIOL, V6, P557, DOI 10.1046/j.1365-2486.2000.00340.x; Wang ZM, 2010, PEDOSPHERE, V20, P80, DOI 10.1016/S1002-0160(09)60285-X; Wu HB, 2009, AGR ECOSYST ENVIRON, V129, P413, DOI 10.1016/j.agee.2008.10.020; Zhang HB, 2007, GEODERMA, V139, P412, DOI 10.1016/j.geoderma.2007.03.003; Zhang XL, 2012, FIELD CROP RES, V130, P28, DOI 10.1016/j.fcr.2012.02.008	34	0	0	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109188	10.1371/journal.pone.0109188	http://dx.doi.org/10.1371/journal.pone.0109188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289703	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000046
J	Pijuan-Galito, S; Tamm, C; Anneren, C				Pijuan-Galito, Sara; Tamm, Christoffer; Anneren, Cecilia			Serum Inter-alpha-inhibitor Activates the Yes Tyrosine Kinase and YAP/TEAD Transcriptional Complex in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GENE-6 TSG-6; HUMAN AMNIOTIC MEMBRANE; SELF-RENEWAL; TRYPSIN-INHIBITOR; HEAVY-CHAINS; EXTRACELLULAR-MATRIX; HUMAN-PLASMA; LUNG INJURY; HYALURONAN; PROTEINS	We have previously demonstrated that the Src family kinase Yes, the Yes-associated protein (YAP) and TEA domain TEAD2 transcription factor pathway are activated by leukemia inhibitory factor (LIF) and contribute to mouse embryonic stem (mES) cell maintenance of pluripotency and self-renewal. In addition, we have shown that fetal bovine serum (FBS) induces Yes autophosphorylation and activation. In the present study we confirm that serum also activates TEAD-dependent transcription in a time-and dose-dependent manner and we identify Inter-alpha-inhibitor (I alpha I) as a component in serum capable of activating the Yes/YAP/TEAD pathway by inducing Yes auto-phosphorylation, YAP nuclear localization and TEAD-dependent transcription. The cleaved heavy chain 2 (HC2) sub-component of I alpha I, is demonstrated to be responsible for this effect. Moreover, I alpha I is also shown to efficiently increase expression of TEAD-downstream target genes including well-known stem cell factors Nanog and Oct 3/4. I alpha I is not produced by the ES cells per se but is added to the cells via the cell culture medium containing serum or serum-derived components such as bovine serum albumin (BSA). In conclusion, we describe a novel function of I alpha I in activating key pluripotency pathways associated with ES cell maintenance and self-renewal.	[Pijuan-Galito, Sara; Tamm, Christoffer; Anneren, Cecilia] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Anneren, Cecilia] GE Healthcare Biosci AB, SE-75184 Uppsala, Sweden	Uppsala University; General Electric	Anneren, C (corresponding author), Dept Med Biochem & Microbiol, Husargatan 3 Box 582, SE-75123 Uppsala, Sweden.	cecilia.anneren@imbim.uu.se		Anneren, Cecilia/0000-0003-3600-6650; Pijuan Galito, Sara/0000-0002-7398-9441	Swedish Research Council; Jaenssons' Foundations; Faculty of Medicine, Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jaenssons' Foundations; Faculty of Medicine, Uppsala University	This work was supported by the Swedish Research Council, the Jaenssons' Foundations, and the Faculty of Medicine, Uppsala University.	Adair JE, 2009, J BIOL CHEM, V284, P16922, DOI 10.1074/jbc.M808560200; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Anneren C, 2008, CLIN SCI, V115, P43, DOI 10.1042/CS20070388; Arakawa T, 2007, J BIOCHEM BIOPH METH, V70, P493, DOI 10.1016/j.jbbm.2006.12.001; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Ilic D, 2006, REGEN MED, V1, P95, DOI 10.2217/17460751.1.1.95; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; JIANG SW, 1995, J BIOL CHEM, V270, P13906, DOI 10.1074/jbc.270.23.13906; Jin YJ, 2011, CELL SIGNAL, V23, P125, DOI 10.1016/j.cellsig.2010.08.012; Josic D, 2006, PROTEOMICS, V6, P2874, DOI 10.1002/pmic.200500563; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei T, 2008, CLIN CHIM ACTA, V388, P173, DOI 10.1016/j.cca.2007.10.034; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Musah S, 2012, ACS NANO, V6, P10168, DOI 10.1021/nn3039148; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; Shimabukuro Y, 2011, J CELL PHYSIOL, V226, P809, DOI 10.1002/jcp.22406; SMITH A, 1991, METHODS CELL SCI, V13, P89; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Tamm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081156; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tan KT, 2011, AESTHET SURG J, V31, P47, DOI 10.1177/1090820X10391778; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Werbowetski-Ogilvie TE, 2006, CANCER RES, V66, P1464, DOI 10.1158/0008-5472.CAN-05-1913; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; Zhang X, 2014, ACS CHEM BIOL, V9, P139, DOI 10.1021/cb400249b; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	51	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33492	33502		10.1074/jbc.M114.580076	http://dx.doi.org/10.1074/jbc.M114.580076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301940	Green Published, hybrid			2022-12-25	WOS:000345636600037
J	Guarino, C; Legowska, M; Epinette, C; Kellenberger, C; Dallet-Choisy, S; Sienczyk, M; Gabant, G; Cadene, M; Zoidakis, J; Vlahou, A; Wysocka, M; Marchand-Adam, S; Jenne, DE; Lesner, A; Gauthier, F; Korkmaz, B				Guarino, Carla; Legowska, Monika; Epinette, Christophe; Kellenberger, Christine; Dallet-Choisy, Sandrine; Sienczyk, Marcin; Gabant, Guillaume; Cadene, Martine; Zoidakis, Jerome; Vlahou, Antonia; Wysocka, Magdalena; Marchand-Adam, Sylvain; Jenne, Dieter E.; Lesner, Adam; Gauthier, Francis; Korkmaz, Brice			New Selective Peptidyl Di(chlorophenyl) Phosphonate Esters for Visualizing and Blocking Neutrophil Proteinase 3 in Human Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Neutrophil; Protease; Protease Inhibitor; Serine Protease; Activity-based Probes; Inflammatory Diseases; Proteinase 3 (Myeloblastin)	HUMAN-LEUKOCYTE ELASTASE; CRYSTAL-STRUCTURE; WEGENERS-GRANULOMATOSIS; CATHEPSIN-G; ANTIGEN PROTEINASE-3; SURFACE EXPRESSION; ACTIVE-SITE; INHIBITOR; POLYANGIITIS; AUTOANTIGEN	Background: Proteinase 3 activity is poorly controlled by physiological inhibitors, and its biological function is not well understood. Results: We have designed irreversible phosphonate inhibitors based on structural differences between proteinase 3 and elastase. Conclusion: They selectively inhibit proteinase 3 in biological fluids and can act as activity-based probes. Significance: These inhibitors will help clarify proteinase 3 function. The function of neutrophil protease 3 (PR3) is poorly understood despite of its role in autoimmune vasculitides and its possible involvement in cell apoptosis. This makes it different from its structural homologue neutrophil elastase (HNE). Endogenous inhibitors of human neutrophil serine proteases preferentially inhibit HNE and to a lesser extent, PR3. We constructed a single-residue mutant PR3 (I217R) to investigate the S4 subsite preferences of PR3 and HNE and used the best peptide substrate sequences to develop selective phosphonate inhibitors with the structure Ac-peptidyl(P)(O-C6H4-4-Cl)(2). The combination of a prolyl residue at P4 and an aspartyl residue at P2 was totally selective for PR3. We then synthesized N-terminally biotinylated peptidyl phosphonates to identify the PR3 in complex biological samples. These inhibitors resisted proteolytic degradation and rapidly inactivated PR3 in biological fluids such as inflammatory lung secretions and the urine of patients with bladder cancer. One of these inhibitors revealed intracellular PR3 in permeabilized neutrophils and on the surface of activated cells. They hardly inhibited PR3 bound to the surface of stimulated neutrophils despite their low molecular mass, suggesting that the conformation and reactivity of membrane-bound PR3 is altered. This finding is relevant for autoantibody binding and the subsequent activation of neutrophils in granulomatosis with polyangiitis (formerly Wegener disease). These are the first inhibitors that can be used as probes to monitor, detect, and control PR3 activity in a variety of inflammatory diseases.	[Guarino, Carla; Epinette, Christophe; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Gauthier, Francis; Korkmaz, Brice] INSERM U 1100 EA 6305 Ctr Etud Pathol Resp, F-37032 Tours, France; [Guarino, Carla; Epinette, Christophe; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Gauthier, Francis; Korkmaz, Brice] Univ Tours, F-37032 Tours, France; [Legowska, Monika; Wysocka, Magdalena; Lesner, Adam] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Kellenberger, Christine] CNRS, UMR, F-13288 Marseille, France; [Sienczyk, Marcin] Wroclaw Univ Technol, Div Med Chem & Microbiol, Fac Chem, PL-50370 Wroclaw, Poland; [Gabant, Guillaume; Cadene, Martine] UPR4301 CNRS, Ctr Biophys Mol, F-45071 Orleans, France; [Zoidakis, Jerome; Vlahou, Antonia] Acad Athens, Div Biotechnol, Biomed Res Fdn, Athens 11527, Greece; [Guarino, Carla; Jenne, Dieter E.] German Ctr Lung Res DZL, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Guarino, Carla; Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Fahrenheit Universities; University of Gdansk; Centre National de la Recherche Scientifique (CNRS); Wroclaw University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Academy of Athens; Max Planck Society	Korkmaz, B (corresponding author), INSERM U 1100 EA 6305 Ctr Etud Pathol Resp, F-37032 Tours, France.	brice.korkmaz@inserm.fr	Zoidakis, Jerome/P-9599-2018; Jenne, Dieter Erich/AAP-1414-2020; Lesner, Adam/M-2732-2019; kellenberger, christine/AAV-9304-2020; Zoidakis, Jerome/AAO-8236-2021	Zoidakis, Jerome/0000-0002-4557-3430; Zoidakis, Jerome/0000-0002-4557-3430; Lesner, Adam/0000-0001-8335-3431; Dallet-Choisy, Sandrine/0000-0002-6530-4107; Vlahou, Antonia/0000-0003-3284-5713; KORKMAZ, BRICE/0000-0002-5159-8706; Wysocka, Magdalena/0000-0003-2216-5597; marchand-adam, sylvain/0000-0002-9522-3738; Cadene, Martine/0000-0003-4936-2662	Ministere de l'Enseignement Superieur et de la Recherche; Region Centre; Fonds Europeen de Developpement Regional (project INFINHI); Polish Ministry of Science and Higher Education [IP2012 0596 72]; European Union [261382]; European Union Commission [601933]; Alexandre von Humboldt Foundation	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Region Centre(Region Centre-Val de Loire); Fonds Europeen de Developpement Regional (project INFINHI); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); European Union Commission(European Commission); Alexandre von Humboldt Foundation	This work was supported by the Ministere de l'Enseignement Superieur et de la Recherche, the Region Centre, and the Fonds Europeen de Developpement Regional (project INFINHI) and Polish Ministry of Science and Higher Education (project IP2012 0596 72; to M. W.). This work was also supported by European Union Seventh Framework Programme (FP7/2007-2013; to D. E. J.) under Grant 261382 and by European Union Commission (FP7/TransBioBC; to J. Z. and A. V.) under Grant 601933.; Supported by the Alexandre von Humboldt Foundation.	Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; BODUSZEK B, 1994, J ENZYM INHIB, V8, P147, DOI 10.3109/14756369409020197; Broemstrup T, 2010, PHYS CHEM CHEM PHYS, V12, P7487, DOI 10.1039/b924117e; Brown CM, 2011, CHEM BIOL, V18, P48, DOI 10.1016/j.chembiol.2010.11.007; CLARK JM, 1980, J CELL BIOL, V84, P102, DOI 10.1083/jcb.84.1.102; CSERNOK E, 1990, AM J PATHOL, V137, P1113; Csernok E, 2013, EXPERT REV CLIN IMMU, V9, P641, DOI 10.1586/1744666X.2013.811052; Derache C, 2012, FEBS J, V279, P4466, DOI 10.1111/febs.12033; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Gabillet J, 2012, J IMMUNOL, V189, P2574, DOI 10.4049/jimmunol.1200600; Grzywa R, 2013, CURR PHARM DESIGN, V19, P1154; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; Hajjar E, 2007, FEBS LETT, V581, P5685, DOI 10.1016/j.febslet.2007.11.029; Hajjar E, 2010, FEBS J, V277, P2238, DOI 10.1111/j.1742-4658.2010.07659.x; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Hinkofer LC, 2013, J BIOL CHEM, V288, P26635, DOI 10.1074/jbc.M113.495770; Jegot G, 2011, FASEB J, V25, P3019, DOI 10.1096/fj.10-176552; JENNE DE, 1990, NATURE, V346, P520, DOI 10.1038/346520a0; Kallenberg CGM, 2008, J AUTOIMMUN, V30, P29, DOI 10.1016/j.jaut.2007.11.005; Kantari C, 2011, J LEUKOCYTE BIOL, V90, P941, DOI 10.1189/jlb.1210695; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Korkmaz B, 2002, J BIOL CHEM, V277, P39074, DOI 10.1074/jbc.M202918200; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Korkmaz B, 2013, INT IMMUNOPHARMACOL, V17, P1198, DOI 10.1016/j.intimp.2013.07.003; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Korkmaz B, 2013, CURR PHARM DESIGN, V19, P966, DOI 10.2174/1381612811319060002; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Korkmaz B, 2009, J BIOL CHEM, V284, P19896, DOI 10.1074/jbc.M901471200; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; OLEKSYSZYN J, 1989, BIOCHEM BIOPH RES CO, V161, P143, DOI 10.1016/0006-291X(89)91572-6; Owen Caroline A, 2008, Int J Chron Obstruct Pulmon Dis, V3, P253; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Sienczyk M, 2006, BIOORG MED CHEM LETT, V16, P2886, DOI 10.1016/j.bmcl.2006.03.002; Sienczyk M, 2009, CURR MED CHEM, V16, P1673, DOI 10.2174/092986709788186246; Sienczyk M, 2011, BIOORGAN MED CHEM, V19, P1277, DOI 10.1016/j.bmc.2010.12.008; TERVAERT JWC, 1993, ANN RHEUM DIS, V52, P115, DOI 10.1136/ard.52.2.115; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; WOODARD SL, 1994, J IMMUNOL, V153, P5016; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	51	30	31	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31777	31791		10.1074/jbc.M114.591339	http://dx.doi.org/10.1074/jbc.M114.591339			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288799	Green Published, hybrid			2022-12-25	WOS:000345314700010
J	Cristina, RT; Hanganu, F; Dumitrescu, E; Muselin, F; Butnariu, M; Constantin, A; Chiurciu, V				Cristina, Romeo Teodor; Hanganu, Flavia; Dumitrescu, Eugenia; Muselin, Florin; Butnariu, Monica; Constantin, Adriana; Chiurciu, Viorica			The Impact of Exogenic Testosterone and Nortestosterone-Decanoate Toxicological Evaluation Using a Rat Model	PLOS ONE			English	Article							NANDROLONE DECANOATE; HERSHBERGER ASSAY; SPERM QUALITY; METABOLISM; TOXICITY; ANDROGEN; HORMONES; CATTLE	The impact of exogenic testosterone (T): 1.5 and 3.0 mg/kg.bw) and 19-nortestosterone 17-decanoate (ND): 1.5 and 7.5 mg/kg.bw) in castrated male rats was evaluated based on: (a) weight increase of the androgen target tissues, respecting the Hershberger methodology; (b) the 17 alpha and beta-testosterone, 17 alpha and beta-estradiol and 17 alpha and beta-nortestosterone levels using the GC-MS/MS technique; and (c) observation of the serum free thyroxine levels (T-4). Results revealed that T and ND significantly increased the weight of androgen target tissues as follows: ND was more influential on seminal vesicles, levator ani-bulbocavernosus muscle (LABC) and Cowper's glands and T (at a dose of 3.0 mg/kg.bw) influenced the weight of the ventral prostate and glans penis. Serum samples analyzed for steroid hormone levels showed the presence of 17 beta-testosterone, 17 beta-estradiol and 17 beta-nor-testosterone, in castrated male rats injected with testosterone and nortestosterone, but no significant differences were found between thyroid responses and thyroid hormone levels. The results of this research proved the disrupting activity of T and ND when administered in high doses and the useful application of the Hershberger bioassay in the case of ND.	[Cristina, Romeo Teodor; Hanganu, Flavia; Dumitrescu, Eugenia] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Pharmacol, Timisoara, Timis, Romania; [Cristina, Romeo Teodor; Hanganu, Flavia; Dumitrescu, Eugenia] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Pharm, Timisoara, Timis, Romania; [Muselin, Florin] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Toxicol, Timisoara, Timis, Romania; [Butnariu, Monica] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Biochem, Timisoara, Timis, Romania; [Constantin, Adriana] Natl Reference Lab A3 Steroids, Constanta, Romania; [Chiurciu, Viorica] Romvac Co, Drugs Prod Dept, Voluntari, Ilfov, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine	Cristina, RT (corresponding author), Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Pharmacol, Timisoara, Timis, Romania.	rtcristina@yahoo.com	Muselin, Florin/H-9761-2014; CRISTINA, Romeo Teodor/G-2067-2011; Dumitrescu, Eugenia/AAY-4279-2021; BUTNARIU, Monica/E-7217-2010; Muselin, Florin/HHC-1662-2022	CRISTINA, Romeo Teodor/0000-0002-5420-1516; BUTNARIU, Monica/0000-0002-2032-5000; Muselin, Florin/0000-0003-2907-4233	Pilot Programme [POSDRU/6/1.5/S/21, 6540]	Pilot Programme	The study was possible due to grant POSDRU/6/1.5/S/21, Project ID 6540, "Pilot Programme for the Support of Scholarship PhD Students Research.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann P, 1986, ENV HLTH PERSPECT, V70, P149; [Anonymous], 1986, EUR CONV PROT VERT A; [Anonymous], 2010, FREE T4 ARCHITECT SY; [Anonymous], 2011, RA 1235 OSSMPC 9 DEC; BELKIEN L, 1985, J STEROID BIOCHEM, V22, P623, DOI 10.1016/0022-4731(85)90215-8; BIJLSMA JWJ, 1982, ACTA ENDOCRINOL-COP, V101, P108, DOI 10.1530/acta.0.1010108; Courant F, 2009, ANALYST, V134, P1637, DOI 10.1039/b901813a; EDSTAC, 2011, END DISR SCREEN TEST; Freyberger Alexius, 2005, Arhiv za Higijenu Rada i Toksikologiju, V56, P131; GATTI GC, 1993, ANAL CHIM ACTA, V275, P105, DOI 10.1016/0003-2670(93)80281-O; GEUSENS P, 1995, CLIN RHEUMATOL, V14, P32, DOI 10.1007/BF02210686; Gray Jr L.E., 2005, CURRENT PROTOCOLS TO, P16; Hale DH, 1972, S AFR J ANIM SCI, V3, P39; Karbalay-Doust S, 2007, ASIAN J ANDROL, V9, P235, DOI 10.1111/j.1745-7262.2007.00203.x; Kennel PF, 2004, REPROD TOXICOL, V18, P63, DOI 10.1016/j.reprotox.2003.10.012; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Kumar V, 2008, TOXICOL APPL PHARM, V226, P60, DOI 10.1016/j.taap.2007.08.023; Le Bizec B, 1999, J CHROMATOGR B, V723, P157, DOI 10.1016/S0378-4347(98)00541-6; Lee DM, 2010, ASIAN AUSTRAL J ANIM, V23, P1566, DOI 10.5713/ajas.2010.10278; Lephart ED, 1996, BRAIN RES REV, V22, P1; Mate? N, 2001, CHIRURG OPERATOARE V, P483; Mulligan K, 2005, ARCH INTERN MED, V165, P578, DOI 10.1001/archinte.165.5.578; OECD, 2013, ORG EC COOP DEV 2011; Oh JA, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-22; Owens W, 2006, ENVIRON HEALTH PERSP, V114, P1259, DOI 10.1289/ehp.8751; Peirce S, 2006, SVH AEC SOP 26 EUTHA; Pritchard JD, 2007, HPACHAPD002; Purkayastha S., 2012, WORLD J LIFE SCI MED, V2, P123; Scarth J, 2009, FOOD ADDIT CONTAM A, V26, P640, DOI 10.1080/02652030802627160; Scarth JP, 2011, FOOD ADDIT CONTAM A, V28, P44, DOI 10.1080/19440049.2010.539628; Schanzer W, 1996, CLIN CHEM, V42, P1001; SCHMIDELY P, 1993, REPROD NUTR DEV, V33, P297, DOI 10.1051/rnd:19930401; Shahidi NT, 2001, CLIN THER, V23, P1355, DOI 10.1016/S0149-2918(01)80114-4; Takahashi M, 2004, ENDOCR J, V51, P425, DOI 10.1507/endocrj.51.425; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Torres-Calleja J, 2001, LIFE SCI, V68, P1769, DOI 10.1016/S0024-3205(01)00972-9; Umano T, 2009, ARCH TOXICOL, V83, P459, DOI 10.1007/s00204-008-0357-z; Yamada T, 2004, TOXICOL SCI, V79, P64, DOI 10.1093/toxsci/kfh093; Yamasaki K, 2002, ARCH TOXICOL, V75, P703, DOI 10.1007/s00204-001-0296-4	39	11	11	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109219	10.1371/journal.pone.0109219	http://dx.doi.org/10.1371/journal.pone.0109219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302584	gold, Green Submitted, Green Published			2022-12-25	WOS:000343730400046
J	Meza, JS; Diaz-Fleischer, F; Sanchez-Velasquez, LR; Zepeda-Cisneros, CS; Handler, AM; Schetelig, MF				Meza, Jose S.; Diaz-Fleischer, Francisco; Sanchez-Velasquez, Lazaro R.; Silvia Zepeda-Cisneros, Cristina; Handler, Alfred M.; Schetelig, Marc F.			Fitness Cost Implications of PhiC31-Mediated Site-Specific Integrations in Target-Site Strains of the Mexican Fruit Fly, Anastrepha ludens (Diptera: Tephritidae)	PLOS ONE			English	Article							CERATITIS-CAPITATA DIPTERA; STERILE INSECT TECHNIQUE; MUTANT LOX SITES; MAMMALIAN-CELLS; GERM-LINE; DROSOPHILA-MELANOGASTER; SEXUAL COMPATIBILITY; TRANSPOSABLE ELEMENT; TRANSGENIC STRAINS; GENE-EXPRESSION	Site-specific recombination technologies are powerful new tools for the manipulation of genomic DNA in insects that can improve transgenesis strategies such as targeting transgene insertions, allowing transgene cassette exchange and DNA mobilization for transgene stabilization. However, understanding the fitness cost implications of these manipulations for transgenic strain applications is critical. In this study independent piggyBac-mediated attP target-sites marked with DsRed were created in several genornic positions in the Mexican fruit fly, Anastrepha lud ens Two of these strains, one having an autosonlal (attP_F7) and the other a Y-linked (attP_2-1V16y) integration, exhibited fitness parameters (dynamic demography and sexual competitiveness) similar to wild type flies. These strains were thus selected for targeted insertion using, for the first time in mexfly, the iahiC *ntegrase recombination system to insert an additional EGFP-marked transgene to determine its effect on host strain fitness. Fitness tests showed that the integration event in the int 2-M6y recombinant strain had no significant effect, while the int_F7 recombinant strain exhibited significantly lower fitness relative to the original attP_F7 target site host strain. These results indicate that while targeted transgene integrations can be achieved withoLit an additional fitness cost, at some genomic positions insertion of additional DNA into a previously integrated transgene can have a significant negative effect. Thus, for targeted transgene insertions fitness costs mList be evaluated both previous to and subsequent to new site-specific insertions in the target-site strain	[Meza, Jose S.; Silvia Zepeda-Cisneros, Cristina] SAGARPA IICA, Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico; [Meza, Jose S.; Diaz-Fleischer, Francisco; Sanchez-Velasquez, Lazaro R.] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa 91000, Veracruz, Mexico; [Handler, Alfred M.; Schetelig, Marc F.] USDA, Ctr Med Agr & Vet Entomol, Agr Res Serv, Gainesville, FL 32614 USA; [Schetelig, Marc F.] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	Universidad Veracruzana; United States Department of Agriculture (USDA); Justus Liebig University Giessen	Schetelig, MF (corresponding author), USDA, Ctr Med Agr & Vet Entomol, Agr Res Serv, Gainesville, FL 32614 USA.	marc.schetelig@agrar.uni-giessen.de	Fleischer, Francisco Díaz/J-9437-2019; Sánchez-Velásquez, Lázaro Rafael/O-9911-2018; Hernández, José Salvador Meza/AAS-2085-2021; Schetelig, Marc F./AAD-2332-2019; Díaz-Fleischer, Francisco/N-1275-2016; Meza Hernández, José Salvador/B-6203-2015	Fleischer, Francisco Díaz/0000-0003-2137-6587; Sánchez-Velásquez, Lázaro Rafael/0000-0002-6014-8731; Hernández, José Salvador Meza/0000-0001-5178-419X; Schetelig, Marc F./0000-0002-9217-394X; Díaz-Fleischer, Francisco/0000-0003-2137-6587; Meza Hernández, José Salvador/0000-0001-5178-419X	Programa Moscafrut/SAGARPA-IICA; "Consejo Nacional de Ciencia y Tecnologia (CONACyT)" [229669]; USDA-NIFA-Biotechnology Risk Assessment Grant Program [2011-39211-30769]; Emmy Noether program of the German Research Foundation [SCHE 1833/1-1]; LOEWE Center for Insect Biotechnology & Bioresources (Hessen State Ministry of Higher Education, Research and the Arts)	Programa Moscafrut/SAGARPA-IICA; "Consejo Nacional de Ciencia y Tecnologia (CONACyT)"(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); USDA-NIFA-Biotechnology Risk Assessment Grant Program; Emmy Noether program of the German Research Foundation(German Research Foundation (DFG)); LOEWE Center for Insect Biotechnology & Bioresources (Hessen State Ministry of Higher Education, Research and the Arts)	The authors thank the staff of "sexado genetico" sub-direction and "validacion tecnologica" of the Programa Moscafrut, SAGARPA-IICA for their invaluable technical support. This research was funded and supported by the Programa Moscafrut/SAGARPA-IICA, the "Consejo Nacional de Ciencia y Tecnologia (CONACyT)" (no. 229669; to JSM), the USDA-NIFA-Biotechnology Risk Assessment Grant Program (no. 2011-39211-30769; to AMH), the Emmy Noether program of the German Research Foundation (SCHE 1833/1-1; to MFS) and the LOEWE Center for Insect Biotechnology & Bioresources (Hessen State Ministry of Higher Education, Research and the Arts; to MFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Araki K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf102; Bhadra U, 1998, GENETICS, V150, P251; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Caswell H, 2004, THEOR POPUL BIOL, V65, P401, DOI 10.1016/j.tpb.2003.09.007; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Cayol JP, 1999, J ECON ENTOMOL, V92, P140, DOI 10.1093/jee/92.1.140; Condon KC, 2007, INSECT MOL BIOL, V16, P573, DOI 10.1111/j.1365-2583.2007.00752.x; Day CD, 2000, GENE DEV, V14, P2869, DOI 10.1101/gad.849600; FRANZ G, 1991, NUCLEIC ACIDS RES, V19, P6646, DOI 10.1093/nar/19.23.6646; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; HAYMER DS, 1986, DEV GENET, V6, P281; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; *IAEA, 1997, 3 RES COORD M TEL AV; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; McInnis DO, 1996, ANN ENTOMOL SOC AM, V89, P739, DOI 10.1093/aesa/89.5.739; Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264; Meza-Hernandez JS, 2006, J ECON ENTOMOL, V99, P1979, DOI 10.1603/0022-0493-99.6.1979; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Paton D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067364; Meza JS, 2011, GENETICA, V139, P53, DOI 10.1007/s10709-010-9484-6; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P790, DOI 10.1016/j.ibmb.2012.07.007; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Schetelig MF, 2013, G3, pG3; Scolari F, 2011, GENETICA, V139, P41, DOI 10.1007/s10709-010-9483-7; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x; Stevens L, 1991, MANUAL STANDORT OPER; Stone CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076228; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Vandermeer J.H., 2003, POPULATION ECOLOGY 1; WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699; White SM, 2010, J APPL ECOL, V47, P1329, DOI 10.1111/j.1365-2664.2010.01880.x; Zhou Q, 2000, GENOME, V43, P434, DOI 10.1139/gen-43-3-434; Zimowska GJ, 2009, INSECT BIOCHEM MOLEC, V39, P508, DOI 10.1016/j.ibmb.2009.05.004	54	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109690	10.1371/journal.pone.0109690	http://dx.doi.org/10.1371/journal.pone.0109690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303238	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400074
J	Blank, PJ; Sample, DW; Williams, CL; Turner, MG				Blank, Peter J.; Sample, David W.; Williams, Carol L.; Turner, Monica G.			Bird Communities and Biomass Yields in Potential Bioenergy Grasslands	PLOS ONE			English	Article							HARVESTING SWITCHGRASS; SPECIES COMPOSITION; LANDSCAPE FACTORS; AREA SENSITIVITY; BIOFUELS; HABITAT; ENERGY; MANAGEMENT; FIELDS; INTENSIFICATION	Demand for bioenergy is increasing, but the ecological consequences of bioenergy crop production on working lands remain unresolved. Corn is currently a dominant bioenergy crop, but perennial grasslands could produce renewable bioenergy resources and enhance biodiversity. Grassland bird populations have declined in recent decades and may particularly benefit from perennial grasslands grown for bioenergy. We asked how breeding bird community assemblages, vegetation characteristics, and biomass yields varied among three types of potential bioenergy grassland fields (grass monocultures, grass-dominated fields, and forb-dominated fields), and assessed tradeoffs between grassland biomass production and bird habitat. We also compared the bird communities in grassland fields to nearby cornfields. Cornfields had few birds compared to perennial grassland fields. Ten bird Species of Greatest Conservation Need (SGCN) were observed in perennial grassland fields. Bird species richness and total bird density increased with forb cover and were greater in forbdominated fields than grass monocultures. SGCN density declined with increasing vertical vegetation density, indicating that tall, dense grassland fields managed for maximum biomass yield would be of lesser value to imperiled grassland bird species. The proportion of grassland habitat within 1 km of study sites was positively associated with bird species richness and the density of total birds and SGCNs, suggesting that grassland bioenergy fields may be more beneficial for grassland birds if they are established near other grassland parcels. Predicted total bird density peaked below maximum biomass yields and predicted SGCN density was negatively related to biomass yields. Our results indicate that perennial grassland fields could produce bioenergy feedstocks while providing bird habitat. Bioenergy grasslands promote agricultural multifunctionality and conservation of biodiversity in working landscapes.	[Blank, Peter J.; Turner, Monica G.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Sample, David W.] Wisconsin Dept Nat Resources, Madison, WI USA; [Williams, Carol L.] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Blank, PJ (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	blankpj@gmail.com	Turner, Monica G/B-2099-2010	Turner, Monica G/0000-0003-1903-2822	Wisconsin Department of Natural Resources Federal Wildlife Restoration [W-160-P]	Wisconsin Department of Natural Resources Federal Wildlife Restoration	Funding for this project came from the Wisconsin Department of Natural Resources Federal Wildlife Restoration Grant W-160-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Anderson-Teixeira KJ, 2012, ECOL APPL, V22, P2035, DOI 10.1890/12-0711.1; Askins Robert A., 2007, Ornithological Monographs, V64, pi; Bates D, 2012, LME4 LINEAR MIXED EF; Behrman KD, 2013, ECOL APPL, V23, P73, DOI 10.1890/12-0436.1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Dauber J, 2010, GCB BIOENERGY, V2, P289, DOI 10.1111/j.1757-1707.2010.01058.x; Davis SK, 2013, J WILDLIFE MANAGE, V77, P908, DOI 10.1002/jwmg.537; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; ESRI, 2011, ARCGIS DESKT REL 10; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fletcher RJ, 2002, J WILDLIFE MANAGE, V66, P1011, DOI 10.2307/3802933; Fletcher RJ, 2011, FRONT ECOL ENVIRON, V9, P161, DOI 10.1890/090091; Garlock RJ, 2012, BIOMASS BIOENERG, V37, P49, DOI 10.1016/j.biombioe.2011.12.036; Gill DE, 2006, WILDLIFE SOC B, V34, P944, DOI 10.2193/0091-7648(2006)34[944:PABBRO]2.0.CO;2; Griffith AP, 2011, AGRON J, V103, P617, DOI 10.2134/agronj2010.0336; Groom MJ, 2008, CONSERV BIOL, V22, P602, DOI 10.1111/j.1523-1739.2007.00879.x; Helzer CJ, 1999, ECOL APPL, V9, P1448; Hull S., 2011, WISCONSIN SUSTAINABL; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Jordan N, 2010, BIOSCIENCE, V60, P60, DOI 10.1525/bio.2010.60.1.10; Karanth KK, 2014, ECOGRAPHY, V37, P626, DOI 10.1111/j.1600-0587.2013.00367.x; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; McCoy TD, 2001, WILDLIFE SOC B, V29, P979; McIntyre NE, 2003, AM MIDL NAT, V150, P291, DOI 10.1674/0003-0031(2003)150[0291:ACOCRP]2.0.CO;2; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Miesel JR, 2012, BIOMASS BIOENERG, V36, P121, DOI 10.1016/j.biombioe.2011.10.018; Mulkey VR, 2008, BIORESOURCE TECHNOL, V99, P609, DOI 10.1016/j.biortech.2006.12.035; Murray LD, 2003, J WILDLIFE MANAGE, V67, P611, DOI 10.2307/3802718; Murray LD, 2003, BIOMASS BIOENERG, V25, P167, DOI 10.1016/S0961-9534(02)00187-3; NOAA, 2013, 2012 WISC YEARL WEAT; NOAA, 2013, MILW SULL UN LOC CLI; Paine LK, 1996, BIOMASS BIOENERG, V10, P231, DOI 10.1016/0961-9534(95)00072-0; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Pinheiro J., 2019, NLME LINEAR NONLINEA; Porter P. A., 2008, GROWING WISCONSIN EN; R Core Development Team, 2013, R LANG ENV STAT COMP; Reese GC, 2013, METHODS ECOL EVOL, V4, P891, DOI 10.1111/2041-210X.12070; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; Ribic CA, 2009, AM MIDL NAT, V161, P110, DOI 10.1674/0003-0031-161.1.110; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Robertson BA, 2013, BIOENERG RES, V6, P311, DOI 10.1007/s12155-012-9258-3; Robertson BA, 2012, CONDOR, V114, P679, DOI 10.1525/cond.2012.110136; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Robertson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016941; Roth AM, 2005, BIOMASS BIOENERG, V28, P490, DOI 10.1016/j.biombioe.2004.11.001; Runge TM, 2013, BIOFUELS-UK, V4, P493, DOI [10.4155/bfs.13.39, 10.4155/BFS.13.39]; Sagar AD, 2007, ANNU REV ENV RESOUR, V32, P131, DOI 10.1146/annurev.energy.32.062706.132042; SAMPLE D, 1989, THESIS U WISCONSIN M; SAMPLE DW, 1997, PUBLSS92597 WISC DEP; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; United States Department of Agriculture (USDA), 2013, WEB SOIL SURV; US EPA, 2011, BIOF ENV 1 TRIENN RE; USDA, 2011, NAT AGR STAT SERV CR; USDA, 1978, SOIL SURV DAN COUNT; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Wang D, 2010, GCB BIOENERGY, V2, P16, DOI 10.1111/j.1757-1707.2010.01035.x; Webster CR, 2010, BIOFUELS-UK, V1, P451, DOI 10.4155/BFS.10.18; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Williams CL, 2013, J SOIL WATER CONSERV, V68, p141A, DOI 10.2489/jswc.68.6.141A; Winter M, 1999, CONSERV BIOL, V13, P1424, DOI 10.1046/j.1523-1739.1999.98430.x; Wisconsin Department of Natural Resources, 2005, WISC STRAT WILDL SPE; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Zuur Alain F., 2009, P1	72	17	17	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109989	10.1371/journal.pone.0109989	http://dx.doi.org/10.1371/journal.pone.0109989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299593	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200095
J	Hong, JT; Wang, XD; Wu, JB				Hong, Jiangtao; Wang, Xiaodan; Wu, Jianbo			Stoichiometry of Root and Leaf Nitrogen and Phosphorus in a Dry Alpine Steppe on the Northern Tibetan Plateau	PLOS ONE			English	Article							SIMULATED CLIMATE-CHANGE; NUTRIENT CONCENTRATION; GLOBAL PATTERNS; SCALE PATTERNS; ARCTIC SOILS; MINERALIZATION; TEMPERATURE; CARBON; GRASSLAND; WORLDWIDE	Leaf nitrogen (N) and phosphorus (P) have been used widely in the ecological stoichiometry to understand nutrient limitation in plant. However, few studies have focused on the relationship between root nutrients and environmental factors. The main objective of this study was to clarify the pattern of root and leaf N and P concentrations and the relationships between plant nitrogen (N) and phosphorus (P) concentrations with climatic factors under low temperature conditions in the northern Tibetan Plateau of China. We conducted a systematic census of N and P concentrations, and the N:P ratio in leaf and root for 139 plant samples, from 14 species and 7 families in a dry Stipa purpurea alpine steppe on the northern Tibetan Plateau of China. The results showed that the mean root N and P concentrations and the N: P ratios across all species were 13.05 mg g(-1), 0.60 mg g(-1) and 23.40, respectively. The mean leaf N and P concentrations and the N:P ratio were 23.20 mg g(-1), 1.38 mg g(-1), and 17.87, respectively. Compared to global plant nutrients concentrations, plants distributing in high altitude area have higher N concentrations and N:P, but lower P concentrations, which could be used to explain normally-observed low growth rate of plant in the cold region. Plant N concentrations were unrelated to the mean annual temperature (MAT). The root and leaf P concentrations were negatively correlated with the MAT, but the N:P ratios were positively correlated with the MAT. It is highly possible this region is not N limited, it is P limited, thus the temperature-biogeochemical hypothesis (TBH) can not be used to explain the relationship between plant N concentrations and MAT in alpine steppe. The results were valuable to understand the bio-geographic patterns of root and leaf nutrients traits and modeling ecosystem nutrient cycling in cold and dry environments.	[Hong, Jiangtao; Wang, Xiaodan; Wu, Jianbo] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Hong, Jiangtao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XD (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China.	wxd@imde.ac.cn			Western Action Plan Project of the Chinese Academy of Sciences [KZCX2-XB3-08]; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences [XDB03030505]	Western Action Plan Project of the Chinese Academy of Sciences; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences	This study was supported by the Western Action Plan Project of the Chinese Academy of Sciences (Grant No. KZCX2-XB3-08), the Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences (Grant No. XDB03030505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; [Anonymous], 1982, CHEM MICROBIOLOGY PR; [白虎志 Bai Huzhi], 2005, [高原气象, Plateau Meteorology], V24, P311; Belnap J, 2001, SOIL BIOLOGY, P371; Buschiazzo DE, 2007, J ARID ENVIRON, V69, P29, DOI 10.1016/j.jaridenv.2006.08.013; CLEIN JS, 1995, SOIL BIOL BIOCHEM, V27, P1231, DOI 10.1016/0038-0717(95)00044-F; Day TA, 2008, GLOBAL CHANGE BIOL, V14, P1827, DOI 10.1111/j.1365-2486.2008.01623.x; Gonzalez E, 2010, PERSPECT PLANT ECOL, V12, P257, DOI 10.1016/j.ppees.2010.07.001; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hartley AE, 1999, OIKOS, V86, P331, DOI 10.2307/3546450; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; Hobbie SE, 1996, BIOGEOCHEMISTRY, V35, P327, DOI 10.1007/BF02179958; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Horst M, 1995, ACTA PHYSIOL PLANT, V17, P393; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; JONASSON S, 1993, OECOLOGIA, V95, P179, DOI 10.1007/BF00323488; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Korner C, 1999, ALPINE PLANT LIFE FU, P1; Larsen KS, 2011, GLOBAL CHANGE BIOL, V17, P1884, DOI 10.1111/j.1365-2486.2010.02351.x; Li FR, 2009, PLANT SOIL, V317, P79, DOI 10.1007/s11104-008-9789-8; Lu CF, 1998, CHINESE B BOT, V15, P17; Marschner H, 1997, BOT ACTA, V110, P265, DOI 10.1111/j.1438-8677.1997.tb00639.x; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; National soil survey office of China, 1998, SOILS CHIN, P483; Neff JC, 2000, BIOGEOCHEMISTRY, V51, P283, DOI 10.1023/A:1006414517212; Neff JC, 2005, ECOL APPL, V15, P87, DOI 10.1890/04-0268; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sardans J, 2011, FOREST ECOL MANAG, V262, P2024, DOI 10.1016/j.foreco.2011.08.019; Sardans J, 2008, GLOBAL CHANGE BIOL, V14, P2304, DOI 10.1111/j.1365-2486.2008.01656.x; Schmidt IK, 1999, APPL SOIL ECOL, V11, P147, DOI 10.1016/S0929-1393(98)00147-4; Schmidt IK, 2002, PLANT SOIL, V242, P93, DOI 10.1023/A:1019642007929; Shaw MR, 2001, GLOBAL CHANGE BIOL, V7, P193, DOI 10.1046/j.1365-2486.2001.00390.x; Shi WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044628; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, P46; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tibet Land Administrative Bureau, 1994, TIB SOIL RES, P151; Wei J., 2000, ACTA PHYTOECOL SIN, V24, P304; Weintraub MN, 2011, SOIL BIOL, V26, P295, DOI 10.1007/978-3-642-15271-9_12; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yuan Z, 2011, NATURE COMMUN, V2, P1; Yuan ZY, 2009, GLOBAL ECOL BIOGEOGR, V18, P11, DOI 10.1111/j.1466-8238.2008.00425.x; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Zhou Peng, 2010, Chinese Journal of Plant Ecology, V34, P7, DOI 10.3773/j.issn.1005-264x.2010.01.003	53	28	41	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109052	10.1371/journal.pone.0109052	http://dx.doi.org/10.1371/journal.pone.0109052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299642	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200032
J	Kim, ES; Mo, EY; Moon, SD; Han, JH				Kim, Eun Sook; Mo, Eun Young; Moon, Sung Dae; Han, Je Ho			Inverse Association between Serum Bilirubin Levels and Arterial Stiffness in Korean Women with Type 2 Diabetes	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; GLYCEMIC CONTROL; MEN; RISK; EVENTS; HYPERTENSION; HEALTH	Background: Considerable evidence suggests that bilirubin is a potent physiologic antioxidant that may provide important protection against cardiovascular disease (CVD) and inflammation. We investigated the relationship between serum total bilirubin (TB) levels and arterial stiffness, measured by the brachial-ankle pulse wave velocity (baPWV), in patients with type 2 diabetes. Methods: We conducted a cross-sectional analysis of 1,711 subjects with type 2 diabetes (807 men and 904 women; mean age, 57.1 years). The subjects were stratified based on gender-specific tertiles of TB values, and a high baPWV was defined as greater than 1,745 cm/s (>75th percentile). Results: The serum TB concentration was negatively correlated with the duration of diabetes, HbA1c, the 10-year Framingham risk score, and baPWV and was positively correlated with high-density lipoprotein cholesterol and the eGFR in both genders. Inverse association between TB categories and unadjusted prevalence of high PWV was only observed in women. After adjusting for confounding factors, the TB levels were inversely associated with a greater risk of a high baPWV, both as a continuous variable [a 1-SD difference; odds ratio (OR), 0.70; 95% confidence interval (CI), 0.54-0.90; P = 0.005] and when categorized in tertiles (the highest vs. the lowest tertile; OR, 0.49; 95% CI, 0.28-0.85; P = 0.011) in women but not in men. The relationship remained significant even after adjusting for retinopathy and nephropathy. Conclusions: Low TB levels were significantly associated with arterial stiffness in Korean women with type 2 diabetes. Our data suggested that bilirubin may protect against macrovascular disease in diabetic women.	[Kim, Eun Sook; Mo, Eun Young; Moon, Sung Dae; Han, Je Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Kim, Eun Sook; Mo, Eun Young; Moon, Sung Dae; Han, Je Ho] Catholic Univ Korea Incheon, St Marys Hosp, Inchon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University Korea Hospital	Moon, SD (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	sungdaem@gmail.com			AJU Pharmaceutical Co. Ltd.	AJU Pharmaceutical Co. Ltd.	This study was supported by AJU Pharmaceutical Co. Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chan KH, 2013, DIABETOLOGIA, V56, P724, DOI 10.1007/s00125-012-2818-4; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Chung JO, 2013, DIABETIC MED; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Dullaart RPF, 2012, CLIN CHIM ACTA, V414, P161, DOI 10.1016/j.cca.2012.08.029; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Endler G, 2003, CLIN CHEM, V49, P1201, DOI 10.1373/49.7.1201; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Hunt SC, 2001, ATHEROSCLEROSIS, V154, P747, DOI 10.1016/S0021-9150(00)00420-2; Hwang HJ, 2011, CLIN CHEM LAB MED, V49, P1823, DOI 10.1515/CCLM.2011.662; IDF, 2019, IDF DIABETES ATLAS; Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b; Jung CH, 2014, METABOLISM, V63, P87, DOI 10.1016/j.metabol.2013.09.011; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; KWAK JY, 1991, BIOCHIM BIOPHYS ACTA, V1076, P369, DOI 10.1016/0167-4838(91)90478-I; Laurent S, 2007, HYPERTENSION, V49, P1202, DOI 10.1161/HYPERTENSIONAHA.106.076166; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li Y, 2013, NUTR METAB CARDIOVAS, V23, P375, DOI 10.1016/j.numecd.2011.09.004; Lundvig DMS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00081; Oda E, 2012, HEART VESSELS, V27, P29, DOI 10.1007/s00380-011-0123-7; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Stehouwer CDA, 2008, DIABETOLOGIA, V51, P527, DOI 10.1007/s00125-007-0918-3; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Yasuda M, 2011, OPHTHALMOLOGY, V118, P1423, DOI 10.1016/j.ophtha.2010.12.009; Yeh SY, 2009, VASC MED, V14, P129, DOI 10.1177/1358863X08098273; Zhang ZY, 2013, HEART VESSELS, V28, P453, DOI 10.1007/s00380-012-0261-6	36	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109251	10.1371/journal.pone.0109251	http://dx.doi.org/10.1371/journal.pone.0109251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299316	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200045
J	Laporta, J; Keil, KP; Vezina, CM; Hernandez, LL				Laporta, Jimena; Keil, Kimberly P.; Vezina, Chad M.; Hernandez, Laura L.			Peripheral Serotonin Regulates Maternal Calcium Trafficking in Mammary Epithelial Cells during Lactation in Mice	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; SENSING RECEPTOR; SUBCLINICAL HYPOCALCEMIA; PLASMA-MEMBRANE; GLAND; TRANSPORT; BONE; METABOLISM; ACTIVATION; LOCALIZATION	Lactation is characterized by massive transcellular flux of calcium, from the basolateral side of the mammary alveolar epithelium (blood) into the ductal lumen (milk). Regulation of calcium transport during lactation is critical for maternal and neonatal health. The monoamine serotonin (5-HT) is synthesized by the mammary gland and functions as a homeostatic regulation of lactation. Genetic ablation of tryptophan hydroxylase 1 (Tph1), which encodes the rate-limiting enzyme in non neuronal serotonin synthesis, causes a deficiency in circulating serotonin. As a consequence maternal calcium concentrations decrease, mammary epithelial cell morphology is altered, and cell proliferation is decreased during lactation. Here we demonstrate that serotonin deficiency decreases the expression and disrupts the normal localization of calcium transporters located in the apical (PMCA2) and basolateral (CaSR, ORAI-1) membranes of the lactating mammary gland. In addition, serotonin deficiency decreases the mRNA expression of calcium transporters located in intracellular compartments (SERCA2, SPCA1 and 2). Mammary expression of serotonin receptor isoform 2b and its downstream pathways (PLC beta 3, PKC and MAP-ERK1/2) are also decreased by serotonin deficiency, which might explain the numerous phenotypic alterations described above. In most cases, addition of exogenous 5-hydroxy-L-tryptophan to the Tph1 deficient mice rescued the phenotype. Our data supports the hypothesis that serotonin is necessary for proper mammary gland structure and function, to regulate blood and mammary epithelial cell transport of calcium during lactation. These findings can be applicable to the treatment of lactation-induced hypocalcemia in dairy cows and can have profound implications in humans, given the wide-spread use of selective serotonin reuptake inhibitors as antidepressants during pregnancy and lactation.	[Laporta, Jimena; Hernandez, Laura L.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Keil, Kimberly P.; Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, LL (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu	Vezina, Chad/GRO-2299-2022; Laporta, Jimena/AAX-3093-2021	Hernandez, Laura/0000-0001-7591-5203; Keil Stietz, Kimberly/0000-0002-7006-9420; Vezina, Chad/0000-0001-7058-5399	University of Wisconsin-Madison startup funds	University of Wisconsin-Madison startup funds	This work was supported by University of Wisconsin-Madison startup funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; [Anonymous], 2013, ONE; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Collier RJ, 2012, DOMEST ANIM ENDOCRIN, V43, P161, DOI 10.1016/j.domaniend.2012.03.006; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Davidson AP, 2012, TOP COMPANION ANIM M, V27, P165, DOI 10.1053/j.tcam.2012.09.002; Ducy P, 2011, CURR OPIN PHARMACOL, V11, P34, DOI 10.1016/j.coph.2011.01.007; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Goff JP, 2008, VET J, V176, P50, DOI 10.1016/j.tvjl.2007.12.020; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hernandez LL, 2008, J DAIRY SCI, V91, P1834, DOI 10.3168/jds.2007-0766; Hernandez LL, 2011, J ENDOCRINOL, V209, P45, DOI 10.1530/JOE-10-0452; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Hernandez LL, 2012, AM J PHYSIOL-ENDOC M, V302, pE1009, DOI 10.1152/ajpendo.00666.2011; Hernandez LL, 2009, J ENDOCRINOL, V203, P123, DOI 10.1677/JOE-09-0187; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Laporta J, 2013, J DAIRY SCI, V96, P5146, DOI 10.3168/jds.2013-6718; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamillapalli R, 2013, ENDOCRINOLOGY, V154, P3031, DOI 10.1210/en.2012-2195; Martinez N, 2012, J DAIRY SCI, V95, P7158, DOI 10.3168/jds.2012-5812; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Neville MC, 2005, J MAMMARY GLAND BIOL, V10, P119, DOI 10.1007/s10911-005-5395-z; Niebert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021395; OETZEL GR, 1988, VET CLIN N AM-FOOD A, V4, P351, DOI 10.1016/S0749-0720(15)31053-7; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Reinhardt TA, 1999, AM J PHYSIOL-CELL PH, V276, pC796, DOI 10.1152/ajpcell.1999.276.4.C796; Reinhardt TA, 2011, VET J, V188, P122, DOI 10.1016/j.tvjl.2010.03.025; Ross DGF, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-57; Rozen S, 2000, Methods Mol Biol, V132, P365; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; VanHouten J, 2004, J CLIN INVEST, V113, P598, DOI 10.1172/JCI200418776; VanHouten JN, 2005, J MAMMARY GLAND BIOL, V10, P129, DOI 10.1007/s10911-005-5396-y; VanHouten JN, 2007, J MAMMARY GLAND BIOL, V12, P223, DOI 10.1007/s10911-007-9057-1; VanHouten JN, 2013, BEST PRACT RES CL EN, V27, P403, DOI 10.1016/j.beem.2013.02.011; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wysolmerski JJ, 2010, ANN NY ACAD SCI, V1192, P161, DOI 10.1111/j.1749-6632.2009.05249.x	43	47	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110190	10.1371/journal.pone.0110190	http://dx.doi.org/10.1371/journal.pone.0110190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299122	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200107
J	Segers, FM; Verdam, FJ; de Jonge, C; Boonen, B; Driessen, A; Shiri-Sverdlov, R; Bouvy, ND; Greve, JWM; Buurman, WA; Rensen, SS				Segers, Filip M.; Verdam, Froukje J.; de Jonge, Charlotte; Boonen, Bas; Driessen, Ann; Shiri-Sverdlov, Ronit; Bouvy, Nicole D.; Greve, Jan Willem M.; Buurman, Wim A.; Rensen, Sander S.			Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; VASCULAR ENDOTHELIAL-CELLS; DECAY-ACCELERATING FACTOR; MEMBRANE-ATTACK COMPLEX; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; PROPERDIN; PROTECTS; SYSTEM; IMMUNE	The innate immune system plays a major role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Recently we reported complement activation in human NASH. However, it remained unclear whether the alternative pathway of complement, which amplifies C3 activation and which is frequently associated with pathological complement activation leading to disease, was involved. Here, alternative pathway components were investigated in liver biopsies of obese subjects with healthy livers (n = 10) or with NASH (n = 12) using quantitative PCR, Western blotting, and immunofluorescence staining. Properdin accumulated in areas where neutrophils surrounded steatotic hepatocytes, and colocalized with the C3 activation product C3c. C3 activation status as expressed by the C3c/native C3 ratio was 2.6-fold higher (p<0.01) in subjects with NASH despite reduced native C3 concentrations (0.94 +/- 0.12 vs. 0.57 +/- 0.09; p<0.01). Hepatic properdin levels positively correlated with levels of C3c (r(s) = 0.69; p<0.05) and C3c/C3 activation ratio (rs = 0.59; p<0.05). C3c, C3 activation status (C3c/C3 ratio) and properdin levels increased with higher lobular inflammation scores as determined according to the Kleiner classification (C3c: p<0.01, C3c/C3 ratio: p<0.05, properdin: p<0.05). Hepatic mRNA expression of factor B and factor D did not differ between subjects with healthy livers and subjects with NASH (factor B: 1.00 +/- 0.19 vs. 0.71 +/- 0.07, p = 0.26; factor D: 1.00 +/- 0.21 vs. 0.66 +/- 0.14, p = 0.29;). Hepatic mRNA and protein levels of Decay Accelerating Factor tended to be increased in subjects with NASH (mRNA: 1.00 +/- 0.14 vs. 2.37 +/- 0.72; p = 0.22; protein: 0.51 +/- 0.11 vs. 1.97 +/- 0.67; p = 0.28). In contrast, factor H mRNA was downregulated in patients with NASH (1.00 +/- 0.09 vs. 0.71 +/- 0.06; p<0.05) and a similar trend was observed with hepatic protein levels (1.12 +/- 0.16 vs. 0.78 +/- 0.07; p = 0.08). Collectively, these data suggest a role for alternative pathway activation in driving hepatic inflammation in NASH. Therefore, alternative pathway factors may be considered attractive targets for treating NASH by inhibiting complement activation.	[Segers, Filip M.; Verdam, Froukje J.; de Jonge, Charlotte; Boonen, Bas; Bouvy, Nicole D.; Buurman, Wim A.; Rensen, Sander S.] Maastricht Univ, Med Ctr, Dept Gen Surg, Maastricht, Netherlands; [de Jonge, Charlotte; Greve, Jan Willem M.] Atrium Med Ctr Parkstad, Dept Surg, Heerlen, Netherlands; [Driessen, Ann] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands; [Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Dept Genet & Cell Biol, Maastricht, Netherlands	Maastricht University; Atrium Medical Center; Maastricht University; Maastricht University	Rensen, SS (corresponding author), Maastricht Univ, Med Ctr, Dept Gen Surg, Maastricht, Netherlands.	s.rensen@maastrichtuniversity.nl	Rensen, Sander/J-3224-2019; Driessen, Ann/D-3768-2017; Bouvy, Nicole/AAD-2844-2021; Shiri-Sverdlov, Ronit/X-2642-2019; Shiri-Sverdlov, Ronit/E-5571-2017	Rensen, Sander/0000-0001-5054-8400; Driessen, Ann/0000-0003-4148-610X; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Verdam, Froukje/0000-0002-3986-5250	Senter Novem IOP Genomics grant [IGE05012A]; Transnational University Limburg grant; Dutch Digestive Foundation [WO 09-46]	Senter Novem IOP Genomics grant; Transnational University Limburg grant; Dutch Digestive Foundation	This work was financially supported by a Senter Novem IOP Genomics grant (http://www.rvo.nl/subsidies-regelingen/iop-genomics) to W.A.B. and J.W.G. (IGE05012A), and a Transnational University Limburg grant and project grant WO 09-46 from the Dutch Digestive Foundation (http://www.mlds.nl) to S.S.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2003, IMMUNOLOGY, V110, P258, DOI 10.1046/j.1365-2567.2003.01733.x; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Emlen W, 2010, SEMIN THROMB HEMOST, V36, P660, DOI 10.1055/s-0030-1262888; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Gauvreau D, 2012, MOL IMMUNOL, V51, P73, DOI 10.1016/j.molimm.2012.02.110; Ikura Y, 2006, HEPATOLOGY, V43, P506, DOI 10.1002/hep.21070; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kemper C, 2008, MOL IMMUNOL, V45, P4048, DOI 10.1016/j.molimm.2008.06.034; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Maslowska M, 2005, VITAM HORM, V70, P309, DOI 10.1016/S0083-6729(05)70010-8; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Naughton MA, 1996, J IMMUNOL, V156, P3051; NOLAN KF, 1993, METHOD ENZYMOL, V223, P35; Pan XM, 2010, HEPATOLOGY, V51, P2061, DOI 10.1002/hep.23581; PHAM BN, 1995, GASTROENTEROLOGY, V108, P495, DOI 10.1016/0016-5085(95)90079-9; Rensen SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052411; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Schwaeble WJ, 1999, IMMUNOL TODAY, V20, P17, DOI 10.1016/S0167-5699(98)01376-0; Somani R, 2012, DIABETES CARE, V35, P894, DOI 10.2337/dc11-1483; Spiller OB, 2000, CLIN EXP IMMUNOL, V121, P234, DOI 10.1046/j.1365-2249.2000.01305.x; Sreekumar R, 2003, HEPATOLOGY, V38, P244, DOI 10.1053/jhep.2003.50290; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Wirthmueller U, 1997, J IMMUNOL, V158, P4444; Wlazlo N, 2012, METABOLISM, V61, P1787, DOI 10.1016/j.metabol.2012.05.015; Yesilova Z, 2005, AM J GASTROENTEROL, V100, P842, DOI 10.1111/j.1572-0241.2005.40838.x	38	21	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110053	10.1371/journal.pone.0110053	http://dx.doi.org/10.1371/journal.pone.0110053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299043	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200098
J	Wang, T; Wang, SW; Zhang, Y; Wu, XF; Peng, Y; Cao, Z; Ge, BY; Wang, X; Wu, Q; Lin, JT; Zhang, WQ; Li, S; Zhao, J				Wang, Tao; Wang, Shi-Wei; Zhang, Yue; Wu, Xue-Fei; Peng, Yan; Cao, Zhen; Ge, Bi-Ying; Wang, Xi; Wu, Qiong; Lin, Jin-Tao; Zhang, Wan-Qin; Li, Shao; Zhao, Jie			Scorpion Venom Heat-Resistant Peptide (SVHRP) Enhances Neurogenesis and Neurite Outgrowth of Immature Neurons in Adult Mice by Up-Regulating Brain-Derived Neurotrophic Factor (BDNF)	PLOS ONE			English	Article							NEURAL STEM-CELLS; BUTHUS-MARTENSII KARSCH; HIPPOCAMPAL-NEURONS; SUBVENTRICULAR ZONE; ADHESION MOLECULE; OLFACTORY-BULB; IN-VITRO; PROLIFERATION; DIFFERENTIATION; EXPRESSION	Scorpion venom heat-resistant peptide (SVHRP) is a component purified from Buthus martensii Karsch scorpion venom. Although scorpions and their venom have been used in Traditional Chinese Medicine (TCM) to treat chronic neurological disorders, the underlying mechanisms of these treatments remain unknown. We applied SVHRP in vitro and in vivo to understand its effects on the neurogenesis and maturation of adult immature neurons and explore associated molecular mechanisms. SVHRP administration increased the number of 5-bromo-2'-dexoxyuridine (BrdU)-positive cells, BrdU- positive/neuron-specific nuclear protein (NeuN)-positive neurons, and polysialylated-neural cell adhesion molecule (PSA-NCAM)-positive immature neurons in the subventricular zone (SVZ) and subgranular zone (SGZ) of hippocampus. Furthermore immature neurons incubated with SVHRP-pretreated astrocyte-conditioned medium exhibited significantly increased neurite length compared with those incubated with normal astrocyte-conditioned medium. This neurotrophic effect was further confirmed in vivo by detecting an increased average single area and whole area of immature neurons in the SGZ, SVZ and olfactory bulb (OB) in the adult mouse brain. In contrast to normal astrocyte-conditioned medium, higher concentrations of brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF) or glial cell line-derived neurotrophic factor (GDNF) was detected in the conditioned medium of SVHRP-pretreated astrocytes, and blocking BDNF using anti-BDNF antibodies eliminated these SVHRP-dependent neurotrophic effects. In SVHRP treated mouse brain, more glial fibrillary acidic protein (GFAP)-positive cells were detected. Furthermore, immunohistochemistry revealed increased numbers of GFAP/BDNF double-positive cells, which agrees with the observed changes in the culture system. This paper describes novel effects of scorpion venom-originated peptide on the stem cells and suggests the potential therapeutic values of SVHRP.	[Wang, Tao; Wang, Shi-Wei; Wu, Xue-Fei; Peng, Yan; Cao, Zhen; Wang, Xi; Wu, Qiong; Zhang, Wan-Qin; Li, Shao; Zhao, Jie] Dalian Med Univ, Dept Physiol, Dalian, Peoples R China; [Wang, Tao; Zhang, Yue; Ge, Bi-Ying; Zhao, Jie] Liaoning Engn Technol Ctr Target based Nat Prod P, Dalian, Peoples R China; [Wang, Shi-Wei] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Lin, Jin-Tao] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China	Dalian Medical University; University of Tasmania; Dalian Medical University	Li, S (corresponding author), Dalian Med Univ, Dept Physiol, Dalian, Peoples R China.	lishao89@hotmail.com; dlzhaoj@163.com			National Natural Science Foundation of China [81371223, 81371437]; Research Fund for the Doctoral Program of Higher Education of China [20122105110010]; Liaoning Province Science and Technology Plan Projects [2011226006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Liaoning Province Science and Technology Plan Projects	The work was supported by the National Natural Science Foundation of China (NO 81371223 and 81371437, http://www.nsfc.gov.cn), the Research Fund for the Doctoral Program of Higher Education of China (20122105110010, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) and Liaoning Province Science and Technology Plan Projects (2011226006, http://www.lninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brannen CL, 2000, NEUROREPORT, V11, P1123, DOI 10.1097/00001756-200004070-00042; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Cologna CT, 2011, TOXICON, V58, P54, DOI 10.1016/j.toxicon.2011.05.001; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Lepore AC, 2006, NEUROSCIENCE, V142, P285, DOI 10.1016/j.neuroscience.2005.12.068; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Liu B, 2000, NEUROSCIENCE, V97, P749, DOI 10.1016/S0306-4522(00)00057-9; Liu YF, 2003, PROTEIN EXPRES PURIF, V27, P253, DOI 10.1016/S1046-5928(02)00609-5; Lu HX, 2008, BRAIN RES BULL, V77, P158, DOI 10.1016/j.brainresbull.2008.02.037; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Mang Xiao-Yun, 2007, Shengli Xuebao, V59, P278; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morrens J, 2012, GLIA, V60, P159, DOI 10.1002/glia.21247; Nacher J, 2013, NEUROCHEM RES, V38, P1122, DOI 10.1007/s11064-013-0977-4; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Qiu YF, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-28; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Wang CG, 2001, EUR J BIOCHEM, V268, P2480, DOI 10.1046/j.1432-1327.2001.02132.x; Wang CM, 2011, NEUROSCI LETT, V488, P70, DOI 10.1016/j.neulet.2010.10.079; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wang Y, 2011, BIOMED CHROMATOGR, V25, P801, DOI 10.1002/bmc.1519; Wang Yue, 2007, Shengli Xuebao, V59, P87; Yu SB, 2009, NEURAL REGEN RES, V4, P1030, DOI 10.3969/j.issn.1673-5374.2009.12.011; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zhang WQ, 2004, METHOD PREPARING EFF; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136; Zhu YH, 2009, STEM CELLS, V27, P1433, DOI 10.1002/stem.65; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070	39	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109977	10.1371/journal.pone.0109977	http://dx.doi.org/10.1371/journal.pone.0109977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299676	Green Submitted, gold, Green Published			2022-12-25	WOS:000343941200089
J	Xia, X; Wu, WD; Zhang, KD; Cen, G; Jiang, T; Cao, J; Huang, KJ; Huang, C; Qiu, ZJ				Xia, Xiang; Wu, Weidong; Zhang, Kundong; Cen, Gang; Jiang, Tao; Cao, Jun; Huang, Kejian; Huang, Chen; Qiu, Zhengjun			Prognostic Significance of Complications after Laparoscopic Colectomy for Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; ANASTOMOTIC LEAKAGE; GASTRIC-CANCER; GASTROESOPHAGEAL JUNCTION; INFLAMMATORY ONCOTAXIS; SURGICAL COMPLICATIONS; CURATIVE RESECTION; BREAST-CANCER; TUMOR-CELLS; SURVIVAL	Aims: This study sought to evaluate the prognostic significance of postoperative complications for colon cancer patients undergoing laparoscopic surgery. Methods: From May 2006 to May 2009, a total 224 patients who underwent laparoscopic curative resection (R0) for colon cancer were included in our retrospective study. Postoperative complications were evaluated according to a standardized grading system. The main outcome measurements of our study were overall survival (OS) and relapse-free survival ( RFS), which were then compared between the no complication and complication groups. Univariate and multivariate analysis were used to assess the correlation between complications and prognosis. Results: Fifty-nine postoperative complications occurred in 43 patients. The overall morbidity rate was 26.3%. The 5-year OS in the complication group was 41.4% compared with 78.5% in the no complication group (P, 0.001). The cumulative incidence of relapse was also more aggressive in patients with complications (5-year RFS: complication group 40.9% vs. no complication group 82.1%, P, 0.001). Multivariate analysis identified complications as a significant factor increasing the risk for both OS (RR 2.737; 95% Cl 1.512-4.952; P = 0.001) and RFS (RR 4.247; 95% Cl 2.291-7.876; P, 0.001). Conclusion: Postoperative complications could pose a significant adverse impact not only on OS but also on RFS in patients with colon cancer even when laparoscopic R0 resection is available.	[Xia, Xiang; Wu, Weidong; Zhang, Kundong; Cen, Gang; Jiang, Tao; Cao, Jun; Huang, Kejian; Huang, Chen; Qiu, Zhengjun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Gen Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Huang, KJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Gen Surg, Shanghai 200030, Peoples R China.	huangkjdoctor@sina.com; qiuzjdoctor@sina.com			National Natural Science Foundation of China [81372640]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81372640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, N ENGL J MED, V350, P2050; CLAVIEN PA, 1992, SURGERY, V111, P518; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; DERHAGOPIAN RP, 1978, JAMA-J AM MED ASSOC, V240, P374, DOI 10.1001/jama.240.4.374; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Huang C, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-127; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kubota T, 2014, ANN SURG ONCOL, V21, P891, DOI 10.1245/s10434-013-3384-9; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marshall JR, 2009, CURR OPIN CLIN NUTR, V12, P539, DOI 10.1097/MCO.0b013e32832d6c5f; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Mimori K, 2008, CLIN CANCER RES, V14, P2609, DOI 10.1158/1078-0432.CCR-07-4354; Murthy BL, 2007, BRIT J CANCER, V97, P1211, DOI 10.1038/sj.bjc.6604004; Paholyuk TD, 2004, EXP ONCOL, V26, P161; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ptok H, 2007, BRIT J SURG, V94, P1548, DOI 10.1002/bjs.5707; Rizk NP, 2004, J AM COLL SURGEONS, V198, P42, DOI 10.1016/j.jamcollsurg.2003.08.007; SHINE T, 1981, CANCER-AM CANCER SOC, V47, P1325, DOI 10.1002/1097-0142(19810315)47:6<1325::AID-CNCR2820470615>3.0.CO;2-B; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Sun J, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-85; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yoo HM, 2011, J SURG ONCOL, V104, P734, DOI 10.1002/jso.22045	26	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108348	10.1371/journal.pone.0108348	http://dx.doi.org/10.1371/journal.pone.0108348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299478	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200014
J	Zhang, ZH; Huang, Y; Xie, H; Pan, JX; Liu, FF; Li, XZ; Chen, WS; Hu, JY; Liu, ZG				Zhang, Zhenhao; Huang, Yue; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo			Benzalkonium Chloride Suppresses Rabbit Corneal Endothelium Intercellular Gap Junction Communication	PLOS ONE			English	Article							CONNEXIN43 PHOSPHORYLATION; DOWN-REGULATION; CELLS; PROTEIN; ZO-1; OCCLUDENS-1; INHIBITION; TRANSITION; EXPRESSION; EPITHELIUM	Purpose: Gap junction intercellular communication (GJIC) plays a critical role in the maintenance of corneal endothelium homeostasis. We determined if benzalkonium chloride (BAK) alters GJIC activity in the rabbit corneal endothelium since it is commonly used as a drug preservative in ocular eyedrop preparations even though it can have cytotoxic effects. Methods: Thirty-six adult New Zealand albino rabbits were randomly divided into three groups. BAK at 0.01%, 0.05%, and 0.1% was applied twice daily to one eye of each of the rabbits in one of the three groups for seven days. The contralateral untreated eyes were used as controls. Corneal endothelial morphological features were observed by in vivo confocal microscopy (IVCM). Immunofluorescent staining resolved changes in gap junction integrity and localization. Western blot analysis and RT-PCR evaluated changes in levels of connexin43 (Cx43) and tight junction zonula occludens-1 (ZO-1) gene and protein expression, respectively. Cx43 and ZO-1 physical interaction was detected by immunoprecipitation (IP). Primary rabbit corneal endothelial cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing BAK for 24 hours. The scrape-loading dye transfer technique (SLDT) was used to assess GJIC activity. Results: Topical administration of BAK (0.05%, 0.1%) dose dependently disrupted corneal endothelial cell morphology, altered Cx43 and ZO-1 distribution and reduced Cx43 expression. BAK also markedly induced increases in Cx43 phosphorylation status concomitant with decreases in the Cx43-ZO-1 protein-protein interaction. These changes were associated with marked declines in GJIC activity. Conclusions: The dose dependent declines in rabbit corneal endothelial GJIC activity induced by BAK are associated with less Cx43-ZO-1 interaction possibly arising from increases in Cx43 phosphorylation and declines in its protein expression. These novel changes provide additional evidence that BAK containing eyedrop preparations should be used with caution to avoid declines in corneal transparency resulting from losses in GJIC activity and endothelial function.	[Zhang, Zhenhao; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Zhang, Zhenhao; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Zhang, Zhenhao; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Xiamen, Fujian, Peoples R China; [Huang, Yue] Xiamen Univ, Coll Med, Inst Stem Cell & Regenerat Med, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Xiamen University	Hu, JY (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	mydear_22000@163.com; zuguoliu@xmu.edu.cn	Huang, Yue/ABD-7847-2021		National Natural Science Foundation of China, Beijing, China [81100638, 81270978]; Key Program of National Natural Science of China, Beijing, China [81330022]; Cross-Straits Science Foundation, Beijing, China [U1205025]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science of China, Beijing, China; Cross-Straits Science Foundation, Beijing, China	This work was supported by National Natural Science Foundation of China, Beijing, China (81100638, 81270978); Key Program of National Natural Science of China, Beijing, China (81330022) and Cross-Straits Science Foundation, Beijing, China (U1205025). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Alves LA, 1996, BLOOD, V88, P328; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bourne WM, 2010, EYE CONTACT LENS, V36, P310, DOI 10.1097/ICL.0b013e3181ee1450; BOURNE WM, 1976, AM J OPHTHALMOL, V81, P482, DOI 10.1016/0002-9394(76)90305-6; Bourne WM, 2004, EXP EYE RES, V78, P561, DOI 10.1016/j.exer.2003.08.002; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; BOURNE WM, 1976, AM J OPHTHALMOL, V82, P44, DOI 10.1016/0002-9394(76)90662-0; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Chen WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026103; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Gomes P, 2006, EXP EYE RES, V83, P1225, DOI 10.1016/j.exer.2006.06.012; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gros DB, 1996, BIOESSAYS, V18, P719, DOI 10.1002/bies.950180907; Grupcheva CN, 2012, INVEST OPHTH VIS SCI, V53, P1130, DOI 10.1167/iovs.11-8711; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 1998, INVEST OPHTH VIS SCI, V39, P2572; Kimura K, 2010, INVEST OPHTH VIS SCI, V51, P1943, DOI 10.1167/iovs.09-3573; LAING RA, 1976, AM J OPHTHALMOL, V82, P459, DOI 10.1016/0002-9394(76)90495-5; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; Miura T, 2004, AM J PHYSIOL-HEART C, V286, pH214, DOI 10.1152/ajpheart.00441.2003; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Oyamada M, 2005, BBA-BIOMEMBRANES, V1719, P6, DOI 10.1016/j.bbamem.2005.11.002; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Richard G, 2005, CLIN DERMATOL, V23, P23, DOI 10.1016/j.clindermatol.2004.09.010; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Roh DS, 2011, INVEST OPHTH VIS SCI, V52, P5174, DOI 10.1167/iovs.11-7272; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sumide T, 2003, J BIOMED MATER RES B, V64B, P57, DOI 10.1002/jbm.b.10510; Tien T, 2013, INVEST OPHTH VIS SCI, V54, P6518, DOI 10.1167/iovs.13-11763; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; Williams KK, 2004, CURR EYE RES, V28, P109, DOI 10.1076/ceyr.28.2.109.26234; Williams KK, 2002, CURR EYE RES, V25, P29	44	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109708	10.1371/journal.pone.0109708	http://dx.doi.org/10.1371/journal.pone.0109708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299343	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200069
J	Diene, O; Sakagami, N; Narisawa, K				Diene, Ousmane; Sakagami, Nobuo; Narisawa, Kazuhiko			The Role of Dark Septate Endophytic Fungal Isolates in the Accumulation of Cesium by Chinese Cabbage and Tomato Plants under Contaminated Environments	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; HETEROCONIUM-CHAETOSPIRA; CS-137; FUKUSHIMA; SOIL; PHYTOREMEDIATION; DEPOSITION; FOREST	Following the 2011 Fukushima Daiichi Nuclear Power Plant accident, the preservation of the food chain from radionuclides contamination has become of crucial importance. The potential of Dark septate endophytic fungi in the management of Cs accumulation in plants under contaminated environments was investigated using Chinese cabbage and tomato plants. Four endophytic fungal isolates of different species, i.e. Pseudosigmoidea ibarakiensis I.4-2-1, Veronaeopsis simplex Y34, Helminthosporium velutinum 41-1, and as yet unidentified taxon 312-6 were tested In Vitro in two levels of Cs (5ppm and 10ppm). On the plant growth, the inoculation of the selected DSEs to both Chinese cabbage and tomato resulted in an increased biomass of up to 82% and 122%, respectively compared to control (non-inoculated) plants. With regards to the Cs accumulation, it varied with the host plant considered. In Chinese cabbage, DSEs inoculation caused higher Cs accumulation in above ground plant parts, whereas in tomato, Cs accumulation decreased significantly with three of the isolates tested, i.e., V. simplex Y34, P. ibarakiensis I.4-2-1, and the as yet unidentified taxon 312-6 suggesting low-risk transfer on the above ground plants parts as a result of high and negative plant reactions rather than high and positive reactions as it is the case with Chinese cabbage. These results suggested that DSEs can be recommended for use with Chinese cabbage to enhance phytoremediation of Cs in surrounding contaminated areas. With tomato, DSEs can be recommended for decreasing the accumulation of Cs in plants under contaminated environments.	[Diene, Ousmane] Minist Agr & Equipement Rural, Direct Protect Vegetaux, Dakar, Senegal; [Sakagami, Nobuo; Narisawa, Kazuhiko] Ibaraki Univ, Coll Agr, Ami, Ibaraki 30003, Japan	Ibaraki University	Diene, O (corresponding author), Minist Agr & Equipement Rural, Direct Protect Vegetaux, Dakar, Senegal.	odiene16@yahoo.com			Japan Society for the Promotion of Science [23380190]; Grants-in-Aid for Scientific Research [25660273] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 23380190) from the Japan Society for the Promotion of Science (to K. N.). http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2004, TOX PROF CES; Baeza A, 2005, J ENVIRON RADIOACTIV, V81, P89, DOI 10.1016/j.jenvrad.2004.12.006; Chen LA, 2010, APPL SOIL ECOL, V46, P383, DOI 10.1016/j.apsoil.2010.10.003; CLINT GM, 1991, MYCOL RES, V95, P1047, DOI 10.1016/S0953-7562(09)80544-3; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Diene O, 2013, MICROBES ENVIRON, V28, P381, DOI 10.1264/jsme2.ME13002; Diene O, 2010, MICROBES ENVIRON, V25, P216, DOI 10.1264/jsme2.ME09165; DIGHTON J, 1991, MYCOL RES, V95, P1052, DOI 10.1016/S0953-7562(09)80545-5; Dubchak S, 2010, SPAN J AGRIC RES, V8, pS103; Entry JA, 1999, ENVIRON POLLUT, V104, P449, DOI 10.1016/S0269-7491(98)00163-8; Environment Protection Agency (EPA), 2002, FACTS CES 137; Gasoni L, 1997, MYCOL RES, V101, P867, DOI 10.1017/S0953756296003462; Glick BR, 2003, BIOTECHNOL ADV, V21, P383, DOI 10.1016/S0734-9750(03)00055-7; Hampton CR, 2004, PLANT PHYSIOL, V136, P3824, DOI 10.1104/pp.104.046672; Hashimoto S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00416; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; Khastini RO, 2012, J MICROBIOL, V50, P618, DOI 10.1007/s12275-012-2105-6; KORDAN HA, 1987, NEW PHYTOL, V107, P395, DOI 10.1111/j.1469-8137.1987.tb00191.x; Leyval C, 2002, MYCORRHIZAL TECHNOLOGY IN AGRICULTURE: FROM GENES TO BIOPRODUCTS, P175; Lotter DW, 2003, J SUSTAIN AGR, V21, P59, DOI 10.1300/J064v21n04_06; Mandyam K, 2005, STUD MYCOL, P173; Mizuno T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01742; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; Nadeem SM, 2014, BIOTECHNOL ADV, V32, P429, DOI 10.1016/j.biotechadv.2013.12.005; Narisawa Kazuhiko, 2007, Mycoscience, V48, P274, DOI 10.1007/s10267-007-0364-6; Nimis P. L., 1996, STUD GEOBOT, V15, P3; ROBISON W L, 1992, Health Physics, V62, P496, DOI 10.1097/00004032-199206000-00002; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rosen K, 2005, SCI TOTAL ENVIRON, V338, P283, DOI 10.1016/j.scitotenv.2004.07.015; Sieber T. N., 2002, Plant roots: the hidden half, P887; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Strandberg M, 1998, J ENVIRON RADIOACTIV, V40, P175, DOI 10.1016/S0265-931X(97)00074-X; Tak HI, 2013, REV ENVIRON CONTAM T, V223, P33, DOI 10.1007/978-1-4614-5577-6_2; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Vinichuk M, 2013, J ENVIRON RADIOACTIV, V115, P151, DOI 10.1016/j.jenvrad.2012.08.004; Wu HB, 2009, J HAZARD MATER, V170, P861, DOI 10.1016/j.jhazmat.2009.05.069; Xiao W, 2012, ENVIRON SCI POLLUT R, V20, P380; Xiao X, 2010, BIORESOURCE TECHNOL, V101, P1668, DOI 10.1016/j.biortech.2009.09.083; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Zhuang XL, 2007, ENVIRON INT, V33, P406, DOI 10.1016/j.envint.2006.12.005	42	16	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109233	10.1371/journal.pone.0109233	http://dx.doi.org/10.1371/journal.pone.0109233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296037	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000051
J	Baicharoen, S; Miyabe-Nishiwaki, T; Arsaithamkul, V; Hirai, Y; Duangsa-ard, K; Siriaroonrat, B; Domae, H; Srikulnath, K; Koga, A; Hirai, H				Baicharoen, Sudarath; Miyabe-Nishiwaki, Takako; Arsaithamkul, Visit; Hirai, Yuriko; Duangsa-ard, Kwanruen; Siriaroonrat, Boripat; Domae, Hiroshi; Srikulnath, Kornsorn; Koga, Akihiko; Hirai, Hirohisa			Locational Diversity of Alpha Satellite DNA and Intergeneric Hybridization Aspects in the Nomascus and Hylobates Genera of Small Apes	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOME REARRANGEMENTS; EVOLUTIONARY HISTORY; TELOMERE REGION; AGILE GIBBONS; PHYLOGENY; HETEROCHROMATIN; PRIMATES; UNIQUE	Recently, we discovered that alpha satellite DNA has unique and genus-specific localizations on the chromosomes of small apes. This study describes the details of alpha satellite localization in the genera Nomascus and Hylobates and explores their usefulness in distinguishing parental genome sets in hybrids between these genera. Fluorescence in situ hybridization was used to establish diagnostic criteria of alpha satellite DNA markers in discriminating small ape genomes. In particular we established the genus specificity of alpha satellite distribution in three species of light-cheeked gibbons (Nomascus leucogenys, N. siki, and N. gabriellae) in comparison to that of Hylobates lar. Then we determined the localization of alpha satellite DNA in a hybrid individual which resulted from a cross between these two genera. In Nomascus the alpha satellite DNA blocks were located at the centromere, telomere, and four interstitial regions. In Hylobates detectable amounts of alpha satellite DNA were seen only at centromeric regions. The differences in alpha satellite DNA locations between Nomascus and Hylobates allowed us to easily distinguish the parental chromosomal sets in the genome of intergeneric hybrid individuals found in Thai and Japanese zoos. Our study illustrates how molecular cytogenetic markers can serve as diagnostic tools to identify the origin of individuals. These molecular tools can aid zoos, captive breeding programs and conservation efforts in managing small apes species. Discovering more information on alpha satellite distribution is also an opportunity to examine phylogenetic and evolutionary questions that are still controversial in small apes.	[Baicharoen, Sudarath] Kasetsart Univ, Fac Sci, Biosci Program, Bangkok, Thailand; [Baicharoen, Sudarath; Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand; [Baicharoen, Sudarath; Arsaithamkul, Visit; Siriaroonrat, Boripat] Zool Pk Org, Conservat Res & Educ Div, Bangkok, Thailand; [Miyabe-Nishiwaki, Takako; Hirai, Yuriko; Koga, Akihiko; Hirai, Hirohisa] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Duangsa-ard, Kwanruen] Chiang Mai Zoo, Chiang Mai, Thailand; [Domae, Hiroshi] Ishikawa Zoo, Noumi, Ishikawa, Japan; [Srikulnath, Kornsorn] Kasetsart Univ, Fac Sci, Dept Genet, Bangkok, Thailand	Kasetsart University; Kasetsart University; Kyoto University; Kasetsart University	Hirai, H (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	hirohisa.hirai.7w@kyoto-u.ac.jp	Srikulnath, Kornsorn/GLU-1326-2022	Srikulnath, Kornsorn/0000-0002-5985-7258	Japan Society for the Promotion of Science [20405016, 22247037, 24255009, 23657165]; Japan Student Service Organization; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Thailand (CASTNAR, NRU-KU, Thailand)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Student Service Organization; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Thailand (CASTNAR, NRU-KU, Thailand)	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (20405016, 22247037, 24255009 to HH; 23657165 to AK) and a Short-Term Stay/Short-Term Visit Program Fellowship to SB from the Japan Student Service Organization. This work was also supported by Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Thailand (CASTNAR, NRU-KU, Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Baicharoen S, 2012, GENOME, V55, P809, DOI 10.1139/gen-2012-0123; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; BROCKELMAN WY, 1984, NATURE, V312, P634, DOI 10.1038/312634a0; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Capozzi O, 2012, GENOME RES, V22, P2520, DOI 10.1101/gr.138651.112; Carbone L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000538; Carbone L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004999; Cellamare A, 2009, MOL BIOL EVOL, V26, P1889, DOI 10.1093/molbev/msp101; Chan YC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-82; Chiarelli B., 1972, P90; COUTURIER J, 1991, FOLIA PRIMATOL, V56, P95, DOI 10.1159/000156533; Detwiler KM, 2005, INT J PRIMATOL, V26, P661, DOI 10.1007/s10764-005-4372-0; Disotell TR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-240; Groves CP, 2001, PRIMATE TAXONOMY; Hirai H, 2005, CHROMOSOME RES, V13, P123, DOI 10.1007/s10577-005-7475-8; Hirai H, 2003, CHROMOSOME RES, V11, P37, DOI 10.1023/A:1022006015379; Hirai H, 2007, HUM GENET, V122, P477, DOI 10.1007/s00439-007-0425-0; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Jolly CJ, 1997, INT J PRIMATOL, V18, P597, DOI 10.1023/A:1026367307470; KOEHLER U, 1995, GENOMICS, V30, P287, DOI 10.1006/geno.1995.9875; Koga A, 2012, HEREDITY, V109, P180, DOI 10.1038/hdy.2012.28; Koga A, 2014, DNA RES, V21, P407, DOI 10.1093/dnares/dsu005; MAIO JJ, 1971, J MOL BIOL, V56, P579, DOI 10.1016/0022-2836(71)90403-7; Marshall J., 1986, P137; Misceo D, 2008, GENOME RES, V18, P1530, DOI 10.1101/gr.078295.108; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; Mootnick Alan R., 2006, Primate Conservation, V21, P103, DOI 10.1896/0898-6207.21.1.103; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; MYERS RH, 1979, SCIENCE, V205, P308, DOI 10.1126/science.451603; PROUTY LA, 1983, CYTOGENET CELL GENET, V35, P141, DOI 10.1159/000131856; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; STANYON R, 1987, FOLIA PRIMATOL, V48, P56, DOI 10.1159/000156285; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Tosi AJ, 2003, EVOLUTION, V57, P1419; VANTUINEN P, 1983, AM J PHYS ANTHROPOL, V61, P453, DOI 10.1002/ajpa.1330610408; Wienberg J, 2005, CYTOGENET GENOME RES, V108, P139, DOI 10.1159/000080811; Wijayanto H, 2005, CHROMOSOME RES, V13, P717, DOI 10.1007/s10577-005-1007-4; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0	40	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109151	10.1371/journal.pone.0109151	http://dx.doi.org/10.1371/journal.pone.0109151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290445	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000039
J	Cai, X; Dai, ZP; Reeves, RS; Caballero-Benitez, A; Duran, KL; Delrow, JJ; Porter, PL; Spies, T; Groh, V				Cai, Xin; Dai, Zhenpeng; Reeves, Rebecca S.; Caballero-Benitez, Andrea; Duran, Kate L.; Delrow, Jeffrey J.; Porter, Peggy L.; Spies, Thomas; Groh, Veronika			Autonomous Stimulation of Cancer Cell Plasticity by the Human NKG2D Lymphocyte Receptor Coexpressed with Its Ligands on Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; POOR-PROGNOSIS; OVARIAN-CANCER; TUMOR-CELLS; PROMOTES; EMT; IDENTIFICATION; METASTASIS; ACTIVATION	The stimulatory NKG2D receptor on lymphocytes promotes tumor immune surveillance by targeting ligands selectively induced on cancer cells. Progressing tumors counteract by employing tactics to disable lymphocyte NKG2D. This negative dynamic is escalated as some human cancer cells co-opt expression of NKG2D, thereby complementing the presence of its ligands for autonomous stimulation of oncogenic signaling. Clinical association data imply relationships between cancer cell NKG2D and metastatic disease. Here we show that NKG2D promotes cancer cell plasticity by induction of phenotypic, molecular, and functional signatures diagnostic of the epithelial-mesenchymal transition, and of stem-like traits via induction of Sox9, a key transcriptional regulator of breast stem cell maintenance. These findings obtained with model breast tumor lines and xenotransplants were recapitulated by ex vivo cancer cells from primary invasive breast carcinomas. Thus, NKG2D may have the capacity to drive high malignancy traits underlying metastatic disease.	[Cai, Xin; Dai, Zhenpeng; Reeves, Rebecca S.; Caballero-Benitez, Andrea; Duran, Kate L.; Delrow, Jeffrey J.; Spies, Thomas; Groh, Veronika] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Porter, Peggy L.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Spies, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	tspies@fhcrc.org			National Institutes of Health [P50 CA083636, R01 CA174470]; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA174470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant P50 CA083636 and National Institutes of Health grant R01 CA174470. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2010, J CELL SCI, V123, P2357, DOI 10.1242/jcs.054296; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Benitez AC, 2011, P NATL ACAD SCI USA, V108, P4081, DOI 10.1073/pnas.1018603108; Cedile O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013466; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duan XH, 2011, MED ONCOL, V28, P466, DOI 10.1007/s12032-010-9480-9; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; El-Gazzar A, 2014, ONCOGENE, V33, P4932, DOI 10.1038/onc.2013.435; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krieg S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00388; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lehner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031210; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McGilvray RW, 2010, INT J CANCER, V127, P1412, DOI 10.1002/ijc.25156; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Oktem G, 2012, INT J GYNECOL CANCER, V22, P23, DOI 10.1097/IGC.0b013e31823228b2; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popa N, 2011, GLIA, V59, P35, DOI 10.1002/glia.21074; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song DG, 2013, HUM GENE THER, V24, P295, DOI 10.1089/hum.2012.143; Spear Paul, 2013, Cancer Immun, V13, P8; Sun L, 2013, STEM CELLS, V31, P1454, DOI 10.1002/stem.1394; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	44	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108942	10.1371/journal.pone.0108942	http://dx.doi.org/10.1371/journal.pone.0108942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291178	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000030
J	Gong, Z; Jain, AD; Tran, D; Yi, DH; Wu, F; Zorn, A; Ratilal, P; Makris, NC				Gong, Zheng; Jain, Ankita D.; Duong Tran; Yi, Dong Hoon; Wu, Fan; Zorn, Alexander; Ratilal, Purnima; Makris, Nicholas C.			Ecosystem Scale Acoustic Sensing Reveals Humpback Whale Behavior Synchronous with Herring Spawning Processes and Re-Evaluation Finds No Effect of Sonar on Humpback Song Occurrence in the Gulf of Maine in Fall 2006	PLOS ONE			English	Article							AMBIENT-SEA-NOISE; MEGAPTERA-NOVAEANGLIAE; CLUPEA-HARENGUS; TRANSMISSION SCINTILLATION; EUBALAENA-GLACIALIS; SOUND-PROPAGATION; RADIATED NOISE; SOUTHERN GULF; OCEAN; SCATTERING	We show that humpback-whale vocalization behavior is synchronous with peak annual Atlantic herring spawning processes in the Gulf of Maine. With a passive, wide-aperture, densely-sampled, coherent hydrophone array towed north of Georges Bank in a Fall 2006 Ocean Acoustic Waveguide Remote Sensing (OAWRS) experiment, vocalizing whales could be instantaneously detected and localized over most of the Gulf of Maine ecosystem in a roughly 400-km diameter area by introducing array gain, of 18 dB, orders of magnitude higher than previously available in acoustic whale sensing. With humpback-whale vocalizations consistently recorded at roughly 2000/day, we show that vocalizing humpbacks (i) were overwhelmingly distributed along the northern flank of Georges Bank, coinciding with the peak spawning time and location of Atlantic herring, and (ii) their overall vocalization behavior was strongly diurnal, synchronous with the formation of large nocturnal herring shoals, with a call rate roughly ten-times higher at night than during the day. Humpback-whale vocalizations were comprised of (1) highly diurnal non-song calls, suited to hunting and feeding behavior, and (2) songs, which had constant occurrence rate over a diurnal cycle, invariant to diurnal herring shoaling. Before and during OAWRS survey transmissions: (a) no vocalizing whales were found at Stellwagen Bank, which had negligible herring populations, and (b) a constant humpback-whale song occurrence rate indicates the transmissions had no effect on humpback song. These measurements contradict the conclusions of Risch et al. Our analysis indicates that (a) the song occurrence variation reported in Risch et al. is consistent with natural causes other than sonar, (b) the reducing change in song reported in Risch et al. occurred days before the sonar survey began, and (c) the Risch et al. method lacks the statistical significance to draw the conclusions of Risch et al. because it has a 98-100% false-positive rate and lacks any true-positive confirmation.	[Gong, Zheng; Duong Tran; Wu, Fan; Zorn, Alexander; Ratilal, Purnima] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Jain, Ankita D.; Yi, Dong Hoon; Makris, Nicholas C.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Northeastern University; Massachusetts Institute of Technology (MIT)	Makris, NC (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	makris@mit.edu	Gong, Zheng/K-5808-2012		National Oceanographic Partnership Program; Census of Marine Life; Office of Naval Research; Alfred P. Sloan Foundation; National Science Foundation; Presidential Early Career Award for Scientists and Engineers; Northeastern University; Massachusetts Institute of Technology	National Oceanographic Partnership Program; Census of Marine Life; Office of Naval Research(Office of Naval Research); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Presidential Early Career Award for Scientists and Engineers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University; Massachusetts Institute of Technology	This research was supported by the National Oceanographic Partnership Program, the Census of Marine Life, the Office of Naval Research, the Alfred P. Sloan Foundation, the National Science Foundation, the Presidential Early Career Award for Scientists and Engineers, Northeastern University, and Massachusetts Institute of Technology. The authors thank David Reed for providing technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2011, COMMENTS DRAKES BAY; Allen JK, 2012, J ACOUST SOC AM, V132, pEL229, DOI 10.1121/1.4739251; Altman D.G., 1999, PRACTICAL STAT MED R; Andrews M, 2011, J ACOUST SOC AM, V130, P1253, DOI 10.1121/1.3614542; Andrews M, 2009, J ACOUST SOC AM, V125, P111, DOI 10.1121/1.3037228; [Anonymous], TECHNICAL REPORT; [Anonymous], ARG DAT; [Anonymous], FURUNO MAR GPS NAV M; [Anonymous], INTR NEFSC FISH AC S; Archer D, 2007, GLOBAL WARMING UNDER, P48; Arveson PT, 2000, J ACOUST SOC AM, V107, P118, DOI 10.1121/1.428344; Ashforth A, 2001, AIDS WITCHCRAFT PROB; Au W.W, 1993, SONAR DOLPHINS, DOI DOI 10.1007/978-1-4612-4356-4; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Au WWL, 2001, TECHNICAL REPORT; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Battista T, 2006, 42 NCCOS, V45, P1; Baumgartner MF, 2011, J ACOUST SOC AM, V129, P2889, DOI 10.1121/1.3562166; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Becker KM, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P2607, DOI 10.1109/OCEANS.2003.178321; Behringer W, 1999, CLIMATIC CHANGE, V43, P335, DOI 10.1023/A:1005554519604; Berger E., 2003, NOISE MANUAL; Born, 2013, PRINCIPLES OPTICS EL; Brekhovskikh L.M., 2003, FUNDAMENTALS OCEAN A, V3; Bretz F., 2010, MULTIPLE COMP USING; Burdic WS, 1984, UNDERWATER ACOUSTIC, V2, P322; BURGESS AS, 1983, J ACOUST SOC AM, V73, P201, DOI 10.1121/1.388840; Cato D., 2006, P ACOUSTICS, V2006, P453; Cato D, 1992, ACOUST AUST, V20, P76; CATO D H, 1991, Memoirs of the Queensland Museum, V30, P277; CATO DH, 1976, J ACOUST SOC AM, V60, P320, DOI 10.1121/1.381109; Cato DH, 1998, J ACOUST SOC AM, V104, P1667, DOI 10.1121/1.424379; Cato DH, 1997, APPL ACOUST, V51, P317, DOI 10.1016/S0003-682X(97)00001-7; Cato DH., 2001, MEM QUEENSL MUS, V47, P481; Cerchio Salvatore, 2001, Bioacoustics, V11, P277; Chia CS, 2000, J ACOUST SOC AM, V108, P2053, DOI 10.1121/1.1308047; Chow S.-C., 1998, DESIGN ANAL CLIN TRI; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Clay CS, 1977, ACOUSTICAL OCEANOGRA, P494; COLLINS MD, 1993, J ACOUST SOC AM, V93, P1736, DOI 10.1121/1.406739; Council NEFM, 2011, TECHNICAL REPORT, V1; Council NR, 1997, TECHNICAL REPORT; Crocker M.J., 1998, HDB ACOUSTICS; CROUCH WW, 1972, J ACOUST SOC AM, V51, P1066, DOI 10.1121/1.1912926; Darling JD, 2006, BEHAVIOUR, V143, P1051, DOI 10.1163/156853906778607381; Dunlop RA, 2008, MAR MAMMAL SCI, V24, P613, DOI 10.1111/j.1748-7692.2008.00208.x; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; Tran D, 2012, J ACOUST SOC AM, V132, P3659, DOI 10.1121/1.4763547; DYER I, 1970, J ACOUST SOC AM, V48, P337, DOI 10.1121/1.1912133; Edds-Walton Peggy L., 1997, Bioacoustics, V8, P47; Edds-Walton Peggy L., 2000, Bioacoustics, V11, P31; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Etter PC, 2013, UNDERWATER ACOUSTIC MODELING AND SIMULATION, 4TH EDITION, P1, DOI 10.1201/b13906; Gerry E, STUDDS STELLWAGEN BA; Glockner DA., 1983, COMMUNICATION BEHAV, P447; Goldman R, 1985, STAT INTRO, P240; Gong Z, 2012, THESIS NE U DEP ELEC; Gong Z, 2013, J ACOUST SOC AM, V134, P3705, DOI 10.1121/1.4821989; Gong Z, 2010, J ACOUST SOC AM, V127, P104, DOI 10.1121/1.3268595; Greene CR, 1995, MARINE MAMMALS NOISE, P437; Greening MV, 2002, J ACOUST SOC AM, V112, P2872, DOI 10.1121/1.1514931; Hare J, TECHNICAL REPORT; Hatch L, 2008, ENVIRON MANAGE, V42, P735, DOI 10.1007/s00267-008-9169-4; HINICH MJ, 1975, J ACOUST SOC AM, V58, P1023, DOI 10.1121/1.380761; Jagannathan S, 2012, J ACOUST SOC AM, V132, P680, DOI 10.1121/1.4726073; Jagannathan S, 2009, MAR ECOL PROG SER, V395, P137, DOI 10.3354/meps08266; Jech JM, 2006, CAN J FISH AQUAT SCI, V63, P2225, DOI 10.1139/F06-126; Jech JM, 2012, AQUAT LIVING RESOUR, V25, P1, DOI 10.1051/alr/2012003; Jensen FB, 2011, MOD ACOUST SIGN PROC, P1, DOI 10.1007/978-1-4419-8678-8; Johnson M, 2008, P ROY SOC B-BIOL SCI, V275, P133, DOI 10.1098/rspb.2007.1190; Kay S., 1998, FUNDAMENTALS STAT SI, V7; KEWLEY DJ, 1990, J ACOUST SOC AM, V88, P1894, DOI 10.1121/1.400212; King J, 2011, MASSACHUSEETS FISHER; Kipple B, 2004, P GLACIER BAY SCI S, P172; Knowlton A., 1991, J ACOUST SOC AM, V89, P1968, DOI [10.1121/1.2029710, DOI 10.1121/1.2029710]; Lai Y, 2004, THESIS MIT; Laurinolli MH, 2003, MAR MAMMAL SCI, V19, P708, DOI 10.1111/j.1748-7692.2003.tb01126.x; Lee S, 2006, J ACOUST SOC AM, V119, P336, DOI 10.1121/1.2139074; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; Levenson C, 1972, 77007706 NAVOCEANO; Li QH, 2012, DIGITAL SONAR DESIGN IN UNDERWATER ACOUSTICS: PRINCIPLES AND APPLICATIONS, P1, DOI 10.1007/978-3-642-18290-7; Lurton X., 2002, INTRO UNDERWATER ACO; Mackinson S, 1999, ICES J MAR SCI, V56, P613, DOI 10.1006/jmsc.1999.0513; Madsen PT, 2002, BEHAV ECOL SOCIOBIOL, V53, P31, DOI 10.1007/s00265-002-0548-1; Makris NC, 1999, J ACOUST SOC AM, V106, P2491, DOI 10.1121/1.428138; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; MAKRIS NC, 1993, J ACOUST SOC AM, V94, P983, DOI 10.1121/1.408200; MAKRIS NC, 1995, J ACOUST SOC AM, V97, P3547, DOI 10.1121/1.412440; Makris NC, 1996, J ACOUST SOC AM, V100, P769, DOI 10.1121/1.416239; MAKRIS NC, 1994, J ACOUST SOC AM, V95, P1865, DOI 10.1121/1.408702; Makris NC, 2003, GEOCLUTTER ACOUSTICS; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Matthews J. N., 2001, Journal of Cetacean Research and Management, V3, P271; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCarthy E, 2004, INT REGULATION UNDER; McCarthy E, 2004, INT REGULATION UNDER; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; Medwin H, 2005, SOUNDS SEA OCEAN ACO; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2000, MAR MAMMAL SCI, V16, P739, DOI 10.1111/j.1748-7692.2000.tb00969.x; Miguel E, 2005, REV ECON STUD, V72, P1153, DOI 10.1111/0034-6527.00365; Milinski Manfred, 1993, Fish and Fisheries Series, V7, P285; Moore D, 2010, INTRO PRACTICE STAT; Mukhopadhyay N, 2013, APPL SEQUENTIAL METH, P11; Nero RW, 2004, ICES J MAR SCI, V61, P323, DOI 10.1016/j.icesjms.2003.09.006; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; Noad M. J., 2001, MEM QUEENSLAND MUS, V47, P507; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Noad MJ., 2004, AUSTR AC SOC ANN C N; Northeast Fisheries Science Center, 2012, 54 NE REG STOCK ASS, P12; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Ocean Studies Board National Research Council, 2000, MAR MAMM LOW FREQ SO; Ocean Studies Board National Research Council, 2000, MAR MAMM LOW FREQ SO; Ocean Studies Board The Division on Earth and Life Studies The National Academies, 2012, SCI REV DRAFT ENV IM; Oster E, 2004, J ECON PERSPECT, V18, P215, DOI 10.1257/089533004773563502; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Pack AA, 2001, TECHNICAL REPORT; Parks S. E., 2011, Endangered Species Research, V15, P63, DOI 10.3354/esr00368; Parks SE, 2005, MAR MAMMAL SCI, V21, P458, DOI 10.1111/j.1748-7692.2005.tb01244.x; Pater LL, 2009, J WILDLIFE MANAGE, V73, P788, DOI 10.2193/2006-235; Pavlac BA, 2009, WITCH HUNTS W WORLD, P1; PAYNE PM, 1990, FISH B-NOAA, V88, P687; Pierce A. D., 1989, ACOUSTICS INTRO ITS; PIGGOTT CL, 1964, J ACOUST SOC AM, V36, P2152, DOI 10.1121/1.1919337; Pol M, 2002, DEV LOW IMPACT SEA S; *R DEV COR TEAM, R LANG ENV STAT COMP; Rankin S, 2007, BIOACOUSTICS, V16, P137, DOI 10.1080/09524622.2007.9753572; Ratilal P, 2005, J ACOUST SOC AM, V117, P1977, DOI 10.1121/1.1799252; Rayleigh L., 1879, LONDON EDINBURGH DUB, V8, P261, DOI [10.1080/14786447908639684, DOI 10.1080/14786447908639684]; Rebull OG, 2006, J ACOUST SOC AM, V120, P2077, DOI 10.1121/1.2336751; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Rose G. A., 2007, COD ECOLOGICAL HIST; Rossing T., 2007, SPRINGER HDB ACOUSTI; Simmen J, 1997, J ACOUST SOC AM, V102, P239, DOI 10.1121/1.419820; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; Stimpert AK, 2011, J ACOUST SOC AM, V129, P476, DOI 10.1121/1.3504708; Swartz SL, 2002, ACOUSTIC VISUAL SURV; Thode A, 2004, J ACOUST SOC AM, V116, P245, DOI 10.1121/1.1758972; Thode A, 2010, J ACOUST SOC AM, V128, P2681, DOI 10.1121/1.3495945; Thode AM, 2006, IEEE J OCEANIC ENG, V31, P696, DOI 10.1109/JOE.2006.880431; THOMPSON PO, 1986, J ACOUST SOC AM, V80, P735, DOI 10.1121/1.393947; Thompson TJ, 1979, MYSTICETE SOUNDS; Tolstoy I, 1966, OCEAN ACOUSTICS THEO; Tukey JW, 1991, STAT SCI, V6, P100, DOI [DOI 10.1214/SS/1177011945, 10.1214/ss/1177011945]; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Tyack PL, 2000, SPR HDB AUD, V12, P156; Urick RJ, 1983, PRINCIPLES UNDERWATE, P29; Urick RJ, 1983, PRINCIPLES UNDERWATE, P343; Van Trees H.L., 2002, DETECTION ESTIMATION, P710; Vanderlaan ASM, 2003, IEEE J OCEANIC ENG, V28, P164, DOI 10.1109/JOE.2003.813943; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Watkins WA, 2004, DEEP-SEA RES PT I, V51, P1889, DOI 10.1016/j.dsr.2004.08.006; Watkins William A., 2000, Oceanography, V13, P62; Weinrich M, 1997, FISH B-NOAA, V95, P826; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Wilson JD, 2006, J ACOUST SOC AM, V119, P168, DOI 10.1121/1.2130961; Wilson JD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033200; Winn H.E., 1970, Proceedings a Conf biol Sonar diving Mamm, V7, P39; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631; Zar J., 1984, BIOSTAT ANAL, V1, P185; Zingarelli R.A., RAM NAVY STANDARD PA	165	17	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e104733	10.1371/journal.pone.0104733	http://dx.doi.org/10.1371/journal.pone.0104733			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289938	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000002
J	Peng, F; You, QG; Xu, MH; Guo, J; Wang, T; Xue, X				Peng, Fei; You, Quangang; Xu, Manhou; Guo, Jian; Wang, Tao; Xue, Xian			Effects of Warming and Clipping on Ecosystem Carbon Fluxes across Two Hydrologically Contrasting Years in an Alpine Meadow of the Qinghai-Tibet Plateau	PLOS ONE			English	Article							SOIL RESPIRATION; CLIMATIC-CHANGE; CO2 FLUXES; TEMPERATURE; NITROGEN; RESPONSES; EXCHANGE; GRASSLANDS; GROWTH; METAANALYSIS	Responses of ecosystem carbon (C) fluxes to human disturbance and climatic warming will affect terrestrial ecosystem C storage and feedback to climate change. We conducted a manipulative experiment to investigate the effects of warming and clipping on soil respiration (Rs), ecosystem respiration (ER), net ecosystem exchange (NEE) and gross ecosystem production (GEP) in an alpine meadow in a permafrost region during two hydrologically contrasting years (2012, with 29.9% higher precipitation than the long-term mean, and 2013, with 18.9% lower precipitation than the long-tem mean). Our results showed that GEP was higher than ER, leading to a net C sink (measured by NEE) over the two growing seasons. Warming significantly stimulated ecosystem C fluxes in 2012 but did not significantly affect these fluxes in 2013. On average, the warming-induced increase in GEP (1.49 mu mol m(-2)s(-1)) was higher than in ER (0.80 mu mol m(-2)s(-1)), resulting in an increase in NEE (0.70 mu mol m(-2)s(-1)). Clipping and its interaction with warming had no significant effects on C fluxes, whereas clipping significantly reduced aboveground biomass (AGB) by 51.5 g m(-2) in 2013. These results suggest the response of C fluxes to warming and clipping depends on hydrological variations. In the wet year, the warming treatment caused a reduction in water, but increases in soil temperature and AGB contributed to the positive response of ecosystem C fluxes to warming. In the dry year, the reduction in soil moisture, caused by warming, and the reduction in AGB, caused by clipping, were compensated by higher soil temperatures in warmed plots. Our findings highlight the importance of changes in soil moisture in mediating the responses of ecosystem C fluxes to climate warming in an alpine meadow ecosystem.	[Peng, Fei; You, Quangang; Xu, Manhou; Guo, Jian; Wang, Tao; Xue, Xian] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Peng, F (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China.	pengguy02@yahoo.com; xianxue@lzb.ac.cn	manhou, xu/AAA-3630-2019; Peng, Fei/AAO-8461-2020; You, Quan Gang/L-8934-2019	Peng, Fei/0000-0002-5816-4898; manhou, xu/0000-0001-7558-6227	Foundation for Excellent Youth Scholars of CAREERI, CAS [351191001]; National Natural Science Foundation of China [41301210, 41201195, 41301211]; Chinese Academy of Sciences (Hundred Talents Program)	Foundation for Excellent Youth Scholars of CAREERI, CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (Hundred Talents Program)(Chinese Academy of Sciences)	Financial support came from the Foundation for Excellent Youth Scholars of CAREERI, CAS (351191001), National Natural Science Foundation of China (41301210, 41201195 and 41301211), and Chinese Academy of Sciences (Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Barr AG, 2002, CAN J FOREST RES, V32, P813, DOI [10.1139/x01-131, 10.1139/X01-131]; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; De Boeck HJ, 2007, ENVIRON EXP BOT, V60, P95, DOI 10.1016/j.envexpbot.2006.07.001; Derner JD, 2006, PLANT SOIL, V280, P77, DOI 10.1007/s11104-005-2554-3; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gilgen AK, 2009, BIOGEOSCIENCES, V6, P2525, DOI 10.5194/bg-6-2525-2009; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; [李娜 Li Na], 2011, [生态学报, Acta Ecologica Sinica], V31, P895; Li Na, 2011, Soil Biology & Biochemistry, V43, P942, DOI 10.1016/j.soilbio.2011.01.009; Li XJ, 2011, ENVIRON EARTH SCI, V64, P1911, DOI 10.1007/s12665-011-1004-1; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Lu M, 2013, ECOLOGY; [陆子建 Lu Zijian], 2006, [冰川冻土, Journal of Glaciology and Geocryology], V28, P642; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2010, ECOLOGY, V91, P3261, DOI 10.1890/09-1634.1; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Niu SL, 2013, ECOSYSTEMS; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; Pang QQ, 2009, COLD REG SCI TECHNOL, V57, P23, DOI 10.1016/j.coldregions.2009.01.005; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; Rogiers N, 2005, THEOR APPL CLIMATOL, V80, P187, DOI 10.1007/s00704-004-0099-7; Ross DJ, 1999, SOIL BIOL BIOCHEM, V31, P803, DOI 10.1016/S0038-0717(98)00180-1; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Sebastia MT, 2007, J APPL ECOL, V44, P158, DOI 10.1111/j.1365-2664.2006.01232.x; Soloman S., 2007, CONTR WORK GROUP 1 4, P749; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Wang GX, 2007, CATENA, V70, P506, DOI 10.1016/j.catena.2007.01.001; Williams M, 2001, TREE PHYSIOL, V21, P287, DOI 10.1093/treephys/21.5.287; Wu QB, 2004, COLD REG SCI TECHNOL, V38, P85, DOI 10.1016/S0165-232X(03)00064-8; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Xu MH, 2014, ENV EXP BOT IN PRESS; Yang G.H., 2000, RESOURCES SCI, V22, P72; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zhang PC, 2009, SOIL BIOL BIOCHEM, V41, P663, DOI 10.1016/j.soilbio.2008.12.026; Zhao W, 2008, PLANT ECOL, V196, P85, DOI 10.1007/s11258-007-9336-3; Zheng D., 2000, MOUNTAIN GEOECOLOGY; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	56	44	57	16	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109319	10.1371/journal.pone.0109319	http://dx.doi.org/10.1371/journal.pone.0109319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291187	gold, Green Published, Green Submitted			2022-12-25	WOS:000342798000053
J	Reischauer, C; Froehlich, JM; Pless, M; Binkert, CA; Koh, DM; Gutzeit, A				Reischauer, Carolin; Froehlich, Johannes Malte; Pless, Miklos; Binkert, Christoph Andreas; Koh, Dow-Mu; Gutzeit, Andreas			Early Treatment Response in Non-Small Cell Lung Cancer Patients Using Diffusion-Weighted Imaging and Functional Diffusion Maps - A Feasibility Study	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; BIOMARKER; CHEMOTHERAPY; PREDICTION; CARCINOMA; THERAPY; CHEMORADIATION; METASTASES; SURVIVAL	Objective: The aim of this study was to prospectively evaluate the feasibility of monitoring treatment response to chemotherapy in patients with non-small cell lung carcinoma using functional diffusion maps (fDMs). Materials and Methods: This study was approved by the Cantonal Research Ethics Committee and informed written consent was obtained from all patients. Nine patients (mean age = 66 years; range = 53-76 years, 5 females, 4 males) with overall 13 lesions were included. Imaging was performed within two weeks before initiation of chemotherapy and at one, two, and six weeks after initiation of chemotherapy. Imaging included a respiratory-triggered diffusion-weighted sequence including three b-factors (100, 600, and 800 s/mm(2)). Treatment response was defined by change in tumor diameter on computed tomography (CT) after two cycles of chemotherapy. Changes in the apparent diffusion coefficient (ADC) on a perlesion basis and the percentages of voxel with significantly increased or decreased ADCs on fDMs were analyzed using repeated measures analysis of variance (ANOVA). Changes in tumor size were used as covariate to examine the ability of ADCs and fDM parameters to predict treatment response. Results: Repeated measures ANOVA revealed that the percentage of voxels with increased ADCs on fDMs (p = 0.002) as well as the mean ADC increase (p = 0.011) were significantly higher in good responders with a large reduction in tumor size on CT. Conclusion: Our results indicate that the percentage of voxels with significantly increased ADCs on fDMs seems to be a promising biomarker for early prediction of treatment response in patients with non-small cell lung carcinoma. Contrary to averaged values, this approach allows the spatial heterogeneity of treatment response to be resolved.	[Reischauer, Carolin; Froehlich, Johannes Malte; Gutzeit, Andreas] Hirslanden Hosp St Anna, Inst Radiol & Nucl Med, Clin Res Unit, Luzern, Switzerland; [Reischauer, Carolin] Cantonal Hosp Winterthur, Dept Radiol, Winterthur, Switzerland; [Reischauer, Carolin; Binkert, Christoph Andreas; Gutzeit, Andreas] Paracelsus Med Univ Salzburg, Dept Radiol, Salzburg, Austria; [Pless, Miklos] Cantonal Hosp Winterthur, Dept Oncol, Winterthur, Switzerland; [Koh, Dow-Mu] Royal Marsden NHS Fdn Trust, Acad Dept Radiol, Sutton, Surrey, England; [Koh, Dow-Mu] Inst Canc Res, CR UK, Sutton, Surrey, England; [Koh, Dow-Mu] Inst Canc Res, EPSRC Canc Imaging Ctr, Sutton, Surrey, England	Paracelsus Private Medical University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK	Reischauer, C (corresponding author), Hirslanden Hosp St Anna, Inst Radiol & Nucl Med, Clin Res Unit, Luzern, Switzerland.	carolin.reischauer@hirslanden.ch	Pless, Miklos/ABC-4054-2021	Koh, Dow-Mu/0000-0001-7654-8011; Reischauer, Carolin/0000-0002-6624-6615				[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; DeVries AF, 2003, INT J RADIAT ONCOL, V56, P958, DOI 10.1016/S0360-3016(03)00208-6; Dudeck O, 2008, J MAGN RESON IMAGING, V27, P1109, DOI 10.1002/jmri.21358; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P1151, DOI 10.1093/neuonc/nor079; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Harry VN, 2008, GYNECOL ONCOL, V111, P213, DOI 10.1016/j.ygyno.2008.07.048; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; Lee KC, 2007, NEOPLASIA, V9, P1003, DOI 10.1593/neo.07954; Lee KC, 2007, CLIN CANCER RES, V13, P443, DOI 10.1158/1078-0432.CCR-06-1888; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Pirker R, 2014, CURR OPIN ONCOL, V26, P145, DOI 10.1097/CCO.0000000000000056; Reischauer C, 2012, J MAGN RESON IMAGING, V36, P1002, DOI 10.1002/jmri.23690; Reischauer C, 2010, RADIOLOGY, V257, P523, DOI 10.1148/radiol.10092469; Stella GM, 2013, LANCET RESP MED, V1, P251, DOI 10.1016/S2213-2600(13)70009-2; Woodhams R, 2010, RADIOLOGY, V254, P357, DOI 10.1148/radiol.2542090405; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503; Yankeelov TE, 2007, MAGN RESON IMAGING, V25, P1, DOI 10.1016/j.mri.2006.09.006	24	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108052	10.1371/journal.pone.0108052	http://dx.doi.org/10.1371/journal.pone.0108052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289671	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000012
J	Manna, JD; Wepy, JA; Hsu, KL; Chang, JW; Cravatt, BF; Marnett, LJ				Manna, Joseph D.; Wepy, James A.; Hsu, Ku-Lung; Chang, Jae Won; Cravatt, Benjamin F.; Marnett, Lawrence J.			Identification of the Major Prostaglandin Glycerol Ester Hydrolase in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Chemical Biology; Enzyme Kinetics; Lipid Metabolism; Prostaglandin; Activity-based Protein Profiling; Endocannabinoids; Prostaglandin Glycerol Esters; Serine Hydrolase	COX-2 OXIDATIVE METABOLITE; ACID AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE; IN-VIVO; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; CANNABINOID RECEPTORS; SYNAPTIC-TRANSMISSION; PROTEIN THIOESTERASE; SERINE HYDROLASES; HYDROLYSIS	Background: Prostaglandin glycerol esters are rapidly hydrolyzed in biological systems. Results: Complementary approaches demonstrated that lysophospholipase A2 hydrolyzes prostaglandin glycerol esters. Conclusion: Lysophospholipase A2 is a major prostaglandin glycerol ester-specific hydrolase in human cancer cells. Significance: Perturbation of lysophospholipase A2 provides a means to understand prostaglandin glycerol ester function in vivo. Prostaglandin glycerol esters (PG-Gs) are produced as a result of the oxygenation of the endocannabinoid, 2-arachidonoylglycerol, by cyclooxygenase 2. Understanding the role that PG-Gs play in a biological setting has been difficult because of their sensitivity to enzymatic hydrolysis. By comparing PG-G hydrolysis across human cancer cell lines to serine hydrolase activities determined by activity-based protein profiling, we identified lysophospholipase A2 (LYPLA2) as a major enzyme responsible for PG-G hydrolysis. The principal role played by LYPLA2 in PGE(2)-G hydrolysis was confirmed by siRNA knockdown. Purified recombinant LYPLA2 hydrolyzed PG-Gs in the following order of activity: PGE(2)-G > PGF(2)-G > PGD(2)-G; LYPLA2 hydrolyzed 1- but not 2-arachidonoylglycerol or arachidonoylethanolamide. Chemical inhibition of LYPLA2 in the mouse macrophage-like cell line, RAW264.7, elicited an increase in PG-G production. Our data indicate that LYPLA2 serves as a major PG-G hydrolase in human cells. Perturbation of this enzyme should enable selective modulation of PG-Gs without alterations in endocannabinoids, thereby providing a means to decipher the unique functions of PG-Gs in biology and disease.	[Manna, Joseph D.; Wepy, James A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA; [Manna, Joseph D.; Wepy, James A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ch, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA; [Manna, Joseph D.; Wepy, James A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ph, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA; [Hsu, Ku-Lung; Chang, Jae Won; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hsu, Ku-Lung; Chang, Jae Won; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Scripps Research Institute; Scripps Research Institute	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Chang, Jae Won/AAN-4139-2020; Hsu, Ku-Lung/L-6256-2019; Hsu, Ku-Lung/J-2885-2014	Hsu, Ku-Lung/0000-0001-5620-3972; Hsu, Ku-Lung/0000-0001-5620-3972	National Institutes of Health [GM15431, DK033760, GM65086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431, T32GM065086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA035864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM15431 (to L. J. M.) and DK033760 (to B. F. C.) and Training Grant GM65086 (to J. D. M.).	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Crow JA, 2012, TOXICOL APPL PHARM, V258, P145, DOI 10.1016/j.taap.2011.10.017; Di Marzo V, 2005, HANDB EXP PHARMACOL, V168, P147; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Di Marzo V, 2007, CHEM BIOL, V14, P741, DOI 10.1016/j.chembiol.2007.05.014; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Ghosh S, 2000, PHYSIOL GENOMICS, V2, P1, DOI 10.1152/physiolgenomics.2000.2.1.1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Kogan N M, 2006, J Endocrinol Invest, V29, P3; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Laitinen T, 2014, MOL PHARMACOL, V85, P510, DOI 10.1124/mol.113.090795; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lu JY, 2006, J LIPID RES, V47, P1352, DOI 10.1194/jlr.R600010-JLR200; Lu JY, 2006, J INHERIT METAB DIS, V29, P119, DOI 10.1007/s10545-006-0225-z; Maccarrone M, 1998, J BIOL CHEM, V273, P32332, DOI 10.1074/jbc.273.48.32332; NATARAJAN V, 1984, J NEUROCHEM, V42, P1613, DOI 10.1111/j.1471-4159.1984.tb12750.x; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Quiroga AD, 2011, TRENDS ENDOCRIN MET, V22, P218, DOI 10.1016/j.tem.2011.03.003; Richie-Jannetta R, 2010, PROSTAG OTH LIPID M, V92, P19, DOI 10.1016/j.prostaglandins.2010.01.003; Ross MK, 2012, ARCH BIOCHEM BIOPHYS, V522, P44, DOI 10.1016/j.abb.2012.04.010; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Savinainen JR, 2014, MOL PHARMACOL, V86, P522, DOI 10.1124/mol.114.094284; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Vila A, 2007, BIOCHEMISTRY-US, V46, P9578, DOI 10.1021/bi7005898; Walker JM, 2002, PHARMACOL THERAPEUT, V95, P127, DOI 10.1016/S0163-7258(02)00252-8; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1437, P157, DOI 10.1016/S1388-1981(99)00012-8; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang R, 2013, BIOCHEMISTRY-US, V52, P7559, DOI 10.1021/bi401138s; Whiteside GT, 2005, EUR J PHARMACOL, V528, P65, DOI 10.1016/j.ejphar.2005.10.043; Xie SQ, 2010, CHEM RES TOXICOL, V23, P1890, DOI 10.1021/tx1002194	47	21	22	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33741	33753		10.1074/jbc.M114.582353	http://dx.doi.org/10.1074/jbc.M114.582353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301951	hybrid, Green Published			2022-12-25	WOS:000346077600003
J	Slavi, N; Rubinos, C; Li, LP; Sellitto, C; White, TW; Mathias, R; Srinivas, M				Slavi, Nefeli; Rubinos, Clio; Li, Leping; Sellitto, Caterina; White, Thomas W.; Mathias, Richard; Srinivas, Miduturu			Connexin 46 (Cx46) Gap Junctions Provide a Pathway for the Delivery of Glutathione to the Lens Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(3) CONNEXIN; KNOCKOUT MICE; RAT LENS; CIRCULATION; CHANNELS; PROTEIN; CATARACT; AGE; TRANSPORTER; SELECTIVITY	Maintenance of adequate levels of glutathione (GSH) in the lens nucleus is critical for protection of lens proteins from the effects of oxidative stress and for lens transparency. How GSH is transported to the nucleus is unknown. We show that GSH diffuses to the nucleus from the outer cortex, where a high concentration of the anti-oxidant is established by synthesis or uptake, via the network of gap junctions. Using electrophysiological measurements, we found that channels formed by Cx46 and Cx50, the two connexin isoforms expressed in the lens, were moderately cation-selective (P-Na/P-Cl similar to 5 for Cx46 and similar to 3 for Cx50). Single channel permeation of the larger GSH anion was low but detectable (P-Na/P-GSH similar to 12 for Cx46 and similar to 8 for Cx50), whereas permeation of divalent anion glutathione disulfide (GSSG) was undetectable. Measurement of GSH levels in the lenses from connexin knock-out (KO) mice indicated Cx46, and not Cx50, is necessary for transport of GSH to the core. Levels of GSH in the nucleus were markedly reduced in Cx46 KO, whereas they were unaffected by Cx50 KO. We also show that GSH delivery to the nucleus is not dependent on the lens microcirculation, which is believed to be responsible for extracellular transport of other nutrients to membrane transporters in the core. These results indicate that glutathione diffuses from cortical fiber cells to the nucleus via gap junction channels formed by Cx46. We present a model of GSH diffusion from outer cells to inner fiber cells through gap junctions.	[Slavi, Nefeli; Rubinos, Clio; Srinivas, Miduturu] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA; [Slavi, Nefeli; Rubinos, Clio; Srinivas, Miduturu] SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10036 USA; [Li, Leping; Sellitto, Caterina; White, Thomas W.; Mathias, Richard] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Optometry; State University of New York (SUNY) System; SUNY Optometry; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Srinivas, M (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	msrinivas@sunyopt.edu	White, Thomas W./R-3605-2019; White, Thomas/GPG-4026-2022; Rubinos, Clio/ABA-9937-2021	White, Thomas/0000-0002-3285-7434; Rubinos, Clio/0000-0002-1680-2302	National Institutes of Health [EY006391, EY013163, EY13869]; NATIONAL EYE INSTITUTE [R01EY013869, R01EY006391, R01EY013163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY006391 (to R. T. M.), EY013163 (to T. W. W.), and EY13869 (to M. S.).	Baldo GJ, 2001, J GEN PHYSIOL, V118, P447, DOI 10.1085/jgp.118.5.447; BALDO GJ, 1992, BIOPHYS J, V63, P518, DOI 10.1016/S0006-3495(92)81624-7; Bova LM, 2001, INVEST OPHTH VIS SCI, V42, P200; Candia OA, 2012, INVEST OPHTH VIS SCI, V53, P7087, DOI 10.1167/iovs.12-10295; DICKERSON JE, 1993, BIOCHIM BIOPHYS ACTA, V1157, P141, DOI 10.1016/0304-4165(93)90057-F; Donaldson PJ, 2010, INVEST OPHTH VIS SCI, V51, P2303, DOI 10.1167/iovs.10-5350; Ganea E, 2006, CURR EYE RES, V31, P1, DOI 10.1080/02713680500477347; Gao JY, 2013, INVEST OPHTH VIS SCI, V54, P7174, DOI 10.1167/iovs.13-12593; Gao JY, 2011, J GEN PHYSIOL, V137, P507, DOI 10.1085/jgp.201010538; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; HARDING JJ, 1969, BIOCHEM J, V114, pP88; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; KANNAN R, 1995, INVEST OPHTH VIS SCI, V36, P1785; Kannan R, 1996, INVEST OPHTH VIS SCI, V37, P2269; Lim J, 2007, INVEST OPHTH VIS SCI, V48, P5142, DOI 10.1167/iovs.07-0649; LOU MF, 1992, EXP EYE RES, V55, P889, DOI 10.1016/0014-4835(92)90015-K; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinez-Wittinghan FJ, 2003, J CELL BIOL, V161, P969, DOI 10.1083/jcb.200303068; Martinez-Wittinghan FJ, 2004, INVEST OPHTH VIS SCI, V45, P3629, DOI 10.1167/iovs.04-0445; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; RATHBUN WB, 1984, CURR EYE RES, V3, P101, DOI 10.3109/02713688408997190; REDDY VN, 1990, EXP EYE RES, V50, P771, DOI 10.1016/0014-4835(90)90127-G; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shi YR, 2011, INVEST OPHTH VIS SCI, V52, P7332, DOI 10.1167/iovs.11-7724; Shi YR, 2009, J CELL SCI, V122, P1607, DOI 10.1242/jcs.045203; Srinivas M, 2005, BIOPHYS J, V88, P1725, DOI 10.1529/biophysj.104.054023; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Sweeney MHJ, 2003, EXP EYE RES, V77, P245, DOI 10.1016/S0014-4835(03)00110-6; Sweeney MHJ, 1998, EXP EYE RES, V67, P587, DOI 10.1006/exer.1998.0549; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Truscott RJW, 2000, OPHTHALMIC RES, V32, P185, DOI 10.1159/000055612; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711	44	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.597898	http://dx.doi.org/10.1074/jbc.M114.597898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294879	Green Published, hybrid			2022-12-25	WOS:000345335000026
J	Pour, MB; Bergstrom, A; Bottai, M; Magnusson, J; Kull, I; Wickman, M; Moradi, T				Pour, Mohsen Besharat; Bergstrom, Anna; Bottai, Matteo; Magnusson, Jessica; Kull, Inger; Wickman, Magnus; Moradi, Tahereh			Body Mass Index Development from Birth to Early Adolescence; Effect of Perinatal Characteristics and Maternal Migration Background in a Swedish Cohort	PLOS ONE			English	Article							CHILDHOOD OVERWEIGHT; SOCIOECONOMIC-STATUS; CHILDREN; OBESITY; IMMIGRANT; WEIGHT; GROWTH; PREDICTORS; INFANTS; TRAJECTORIES	Background: Well documented diversity in risk of developing overweight and obesity between children of immigrant and of native mothers, might be explained by different body mass index (BMI) development trajectories in relation to maternal and perinatal characteristics of offspring. Objectives: To assess BMI development trajectories among children born to immigrant and to Swedish mothers from birth to adolescence in relation to perinatal characteristics. Methods: A cohort of 2517 children born in Stockholm during 1994 to 1996 was followed with repeated measurement of height and weight at eleven time points until age 12 years. We estimated changes over time for BMI in relation to maternal and perinatal characteristics of offspring using mixed linear model analysis for repeated measure data. Results: We observed a significant BMI change over time in children and time interaction with maternal migration status (P<0.0001). Estimated BMI over time adjusted for maternal and perinatal characteristics of offspring, showed slower BMI growth before age of 5, followed by an earlier plateau and steeper BMI growth after 5 years among children of immigrant mothers compared with children of Swedish mothers. These differences in BMI growth were more prominent among children with mothers from outside Europe. Conclusion: Beside reinforcing early childhood as a crucial period in development of overweight, the observed slower BMI development at early childhood among children of immigrants followed by a steeper increase in BMI compared with children of Swedish mothers is important for further studies and for planning of preventive public health programs.	[Pour, Mohsen Besharat; Bergstrom, Anna; Magnusson, Jessica; Kull, Inger; Wickman, Magnus; Moradi, Tahereh] Karolinska Inst, Inst Environm Med, Div Epidemiol, Stockholm, Sweden; [Bottai, Matteo] Karolinska Inst, Inst Environm Med, Biostat Unit, Stockholm, Sweden; [Kull, Inger] Stockholm South Gen Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Kull, Inger; Wickman, Magnus] Stockholm South Gen Hosp, Sachs Children & Youth Hosp, Stockholm, Sweden; [Moradi, Tahereh] Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm County Council	Pour, MB (corresponding author), Karolinska Inst, Inst Environm Med, Div Epidemiol, Stockholm, Sweden.	Mohsen.besharat.pour@ki.se	; Besharat Pour, Mohsen/G-2172-2010	Wickman, Magnus/0000-0003-2710-8620; Kull, Inger/0000-0001-6096-3771; Besharat Pour, Mohsen/0000-0002-3180-1922				Alder J, 2008, EUR J CONTRACEP REPR, V13, P103, DOI 10.1080/13625180701780254; Apfelbacher CJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-171; Balakrishnan R, 2008, J PUBLIC HEALTH-UK, V30, P139, DOI 10.1093/pubmed/fdn013; Balistreri KS, 2009, AM J PUBLIC HEALTH, V99, P2238, DOI 10.2105/AJPH.2007.116103; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; BarnHalsovard, 2012, MAT MATT; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Buekens P, 1998, AM J PUBLIC HEALTH, V88, P808, DOI 10.2105/AJPH.88.5.808; Chivers P, 2009, OBESITY FACTS, V2, P302, DOI 10.1159/000235561; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; Dietz WH, 1998, PEDIATRICS, V101, P518; Ekblom OB, 2004, SCAND J PUBLIC HEALT, V32, P257, DOI 10.1080/1403494031009498; El-Sayed AM, 2011, ETHNIC DIS, V21, P47; Eriksson M, 2008, PAEDIATR PERINAT EP, V22, P379, DOI 10.1111/j.1365-3016.2008.00944.x; Forna F, 2003, INT J GYNECOL OBSTET, V83, P257, DOI 10.1016/S0020-7292(03)00307-2; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Hendrix N, 2008, SEMIN PERINATOL, V32, P161, DOI 10.1053/j.semperi.2008.02.004; Hjern A, 2004, ACTA PAEDIATR, V93, P1535, DOI 10.1080/08035250410022161; Hjern A, 2012, SCAND J PUBLIC HEALT, V40, P255, DOI 10.1177/1403494812459610; Hof MHP, 2011, ANN HUM BIOL, V38, P544, DOI 10.3109/03014460.2011.576701; Huang JS, 2007, MATERN CHILD HLTH J, V11, P461, DOI 10.1007/s10995-006-0141-8; Kallen B., 2003, SWEDISH MED BIRTH RE; Kiess W, 2001, Obes Rev, V2, P29, DOI 10.1046/j.1467-789x.2001.00017.x; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Kirchengast S, 2006, J BIOSOC SCI, V38, P695, DOI 10.1017/S0021932005027094; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Socialstyrelsen, 2004, SOC RIKTL SKOLH; Stillman S, 2012, ECON INQ, V50, P62, DOI 10.1111/j.1465-7295.2009.00284.x; Stockholms Lans Landsting (SLL), 2013, MET BARNH BED TILLV; Stockholms Lans Landsting (SLL), 2013, BARNH BARNH STOCKH L; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Van Hook J, 2007, SOC SCI MED, V65, P976, DOI 10.1016/j.socscimed.2007.04.032; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Will B, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-45; World Health Organization, 2013, GLOB STRAT DIET PHYS	42	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109519	10.1371/journal.pone.0109519	http://dx.doi.org/10.1371/journal.pone.0109519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303283	Green Published, gold			2022-12-25	WOS:000343730400063
J	Yadav, AK; Chaudhari, H; Warke, H; Shah, PK; Dodagatta-Marri, E; Kishore, U; Madan, T				Yadav, Ajit Kumar; Chaudhari, Hemangi; Warke, Himangi; Shah, Premanand Keshavlal; Dodagatta-Marri, Eswari; Kishore, Uday; Madan, Taruna			Differential Expression of Collectins in Human Placenta and Role in Inflammation during Spontaneous Labor	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; MANNOSE-BINDING LECTIN; HUMAN FETAL MEMBRANES; SP-A; D GENE; PRETERM; INNATE; FLUID; LAVAGE; TRANSCRIPTION	Collectins, collagen-containing Ca2+ dependent C-type lectins and a class of secretory proteins including SP-A, SP-D and MBL, are integral to immunomodulation and innate immune defense. In the present study, we aimed to investigate their placental transcript synthesis, labor associated differential expression and localization at feto-maternal interface, and their functional implication in spontaneous labor. The study involved using feto-maternal interface (placental/decidual tissues) from two groups of healthy pregnant women at term (>= 37 weeks of gestation), undergoing either elective C-section with no labor ('NLc' group, n = 5), or normal vaginal delivery with spontaneous labor ('SLv' group, n = 5). The immune function of SP-D, on term placental explants, was analyzed for cytokine profile using multiplexed cytokine array. SP-A, SP-D and MBL transcripts were observed in the term placenta. The 'SLv' group showed significant up-regulation of SP-D (p = 0.001), and down-regulation of SP-A (p = 0.005), transcripts and protein compared to the 'NLc' group. Significant increase in 43 kDa and 50 kDa SP-D forms in placental and decidual tissues was associated with the spontaneous labor (p<0.05). In addition, the MMP-9-cleaved form of SP-D (25 kDa) was significantly higher in the placentae of 'SLv' group compared to the 'NLc' group (p = 0.002). Labor associated cytokines IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, TNF-alpha and MCP-1 showed significant increase (p<0.05) in a dose dependent manner in the placental explants treated with nSP-D and rhSP-D. In conclusion, the study emphasizes that SP-A and SP-D proteins associate with the spontaneous labor and SP-D plausibly contributes to the pro-inflammatory immune milieu of feto-maternal tissues.	[Yadav, Ajit Kumar; Madan, Taruna] Indian Council Med Res, Natl Inst Res Reprod Hlth, Dept Innate Immun, Bombay, Maharashtra, India; [Chaudhari, Hemangi; Warke, Himangi; Shah, Premanand Keshavlal] Seth Gordhandas Sunderdas Med Coll, Dept Obstet & Gynecol, Mumbai, Maharashtra, India; [Chaudhari, Hemangi; Warke, Himangi; Shah, Premanand Keshavlal] King Edward Med KEM Hosp, Mumbai, Maharashtra, India; [Dodagatta-Marri, Eswari; Kishore, Uday] Brunel Univ London, Coll Hlth & Life Sci, Ctr Infect Immun & Dis Mech, Uxbridge, Middx, England	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Brunel University	Madan, T (corresponding author), Indian Council Med Res, Natl Inst Res Reprod Hlth, Dept Innate Immun, Bombay, Maharashtra, India.	taruna_m@hotmail.com	Kishore, Uday/Y-7976-2018	Kishore, Uday/0000-0002-6033-6759	Department of Biotechnology (DBT), Government of India [BT/PR15227/BRB/10/906/2011]; Indian Council of Medical Research (ICMR), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	Funding provided by BT/PR15227/BRB/10/906/2011) Department of Biotechnology (DBT), Government of India http://dbtindia.nic.in/index.asp (TM) and Indian Council of Medical Research (ICMR) Junior Research Fellowship (JRF)/Senior Research Fellowship (SRF), Government of India, www.icmr.nic.in (AKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/484321; Agrawal V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063990; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Bratcher PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041881; Breuiller-Fouche M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1188, DOI 10.1152/ajpendo.00746.2009; Bridges JP, 2000, J BIOL CHEM, V275, P38848, DOI 10.1074/jbc.M005322200; Bulla R, 2010, MOL IMMUNOL, V48, P281, DOI 10.1016/j.molimm.2010.07.016; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P652, DOI 10.1080/14767050802215193; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P663, DOI 10.1080/14767050802215664; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Dulkerian SJ, 1996, AM J RESP CELL MOL, V15, P781, DOI 10.1165/ajrcmb.15.6.8969273; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Han PX, 2013, KIDNEY BLOOD PRESS R, V37, P295, DOI 10.1159/000350157; Han YM, 2007, J PATHOL, V211, P489, DOI 10.1002/path.2131; He C, 2003, PROTEOMICS, V3, P87, DOI 10.1002/pmic.200390013; He YC, 2000, J BIOL CHEM, V275, P31051, DOI 10.1074/jbc.M003499200; IANNUZZI DM, 1993, AM J PHYSIOL, V264, pL236, DOI 10.1152/ajplung.1993.264.3.L236; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Karjalainen MK, 2012, PEDIATR RES, V71, P93, DOI 10.1038/pr.2011.2; Lee CL, 2011, J REPROD IMMUNOL, V90, P29, DOI 10.1016/j.jri.2011.04.007; Lee DC, 2010, J IMMUNOL, V184, P6479, DOI 10.4049/jimmunol.0903867; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Leth-Larsen R, 2004, MOL HUM REPROD, V10, P149, DOI 10.1093/molehr/gah022; LeVine AM, 2002, AM J PHYSIOL-LUNG C, V282, pL563, DOI 10.1152/ajplung.00280.2001; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Mahajan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085046; Mason RJ, 1998, EUR RESPIR J, V12, P1147, DOI 10.1183/09031936.98.12051147; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Naito H, 1999, J BIOCHEM-TOKYO, V126, P1004, DOI 10.1093/oxfordjournals.jbchem.a022543; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Oberley RE, 2004, MOL HUM REPROD, V10, P861, DOI 10.1093/molehr/gah117; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Park SK, 2012, CELL PHYSIOL BIOCHEM, V30, P334, DOI 10.1159/000339068; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Riley JK, 2008, IMMUNOL INVEST, V37, P395, DOI 10.1080/08820130802206066; Salminen A, 2012, CYTOKINE, V60, P423, DOI 10.1016/j.cyto.2012.07.021; Sati L, 2010, HISTOCHEM CELL BIOL, V133, P85, DOI 10.1007/s00418-009-0642-9; Seyfarth J, 2006, MOL IMMUNOL, V43, P962, DOI 10.1016/j.molimm.2005.06.033; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Snegovskikh VV, 2011, J CLIN ENDOCR METAB, V96, pE624, DOI 10.1210/jc.2010-1496; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Sun K, 2006, J CLIN ENDOCR METAB, V91, P4988, DOI 10.1210/jc.2006-1472; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; van de Geijn FE, 2007, HUM REPROD, V22, P362, DOI 10.1093/humrep/del392; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yadav Ajit Kumar, 2011, Front Biosci (Elite Ed), V3, P291, DOI 10.2741/e244	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108815	10.1371/journal.pone.0108815	http://dx.doi.org/10.1371/journal.pone.0108815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303045	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400028
J	Yim, SS; Bang, HB; Kim, YH; Lee, YJ; Jeong, GM; Jeong, KJ				Yim, Sung Sun; Bang, Hyun Bae; Kim, Young Hwan; Lee, Yong Jae; Jeong, Gu Min; Jeong, Ki Jun			Rapid Isolation of Antibody from a Synthetic Human Antibody Library by Repeated Fluorescence-Activated Cell Sorting (FACS)	PLOS ONE			English	Article							PERIPLASMIC EXPRESSION; PROTEIN; CONSTRUCTION; TECHNOLOGY; EXTENSION; DISPLAY; EPITOPE; VIRUS; CDRS	Antibodies and their derivatives are the most important agents in therapeutics and diagnostics. Even after the significant progress in the technology for antibody screening from huge libraries, it takes a long time to isolate an antibody, which prevents a prompt action against the spread of a disease. Here, we report a new strategy for isolating desired antibodies from a combinatorial library in one day by repeated fluorescence-activated cell sorting (FACS). First, we constructed a library of synthetic human antibody in which single-chain variable fragment (scFv) was expressed in the periplasm of Escherichia coli. After labeling the cells with fluorescent antigen probes, the highly fluorescent cells were sorted by using a high-speed cell sorter, and these cells were reused without regeneration in the next round of sorting. After repeating this sorting, the positive clones were completely enriched in several hours. Thus, we screened the library against three viral antigens, including the H1N1 influenza virus, Hepatitis B virus, and Foot-and-mouth disease virus. Finally, the potential antibody candidates, which show K-D values between 10 and 100 nM against the target antigens, could be successfully isolated even though the library was relatively small (similar to 10(6)). These results show that repeated FACS screening without regeneration of the sorted cells can be a powerful method when a rapid response to a spreading disease is required.	[Yim, Sung Sun; Bang, Hyun Bae; Kim, Young Hwan; Lee, Yong Jae; Jeong, Gu Min; Jeong, Ki Jun] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Plus Program BK21, Taejon 305701, South Korea; [Jeong, Ki Jun] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Jeong, KJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Plus Program BK21, Taejon 305701, South Korea.	kjjeong@kaist.ac.kr	JEONG, KI JUN/C-1704-2011	Lee, Yong Jae/0000-0001-9917-8199	National Research Foundation of Korea (NRF) [20110016235]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning (MSIP) [2011-0031955]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning (MSIP)	This research was supported by the National Research Foundation of Korea (NRF) grant (No. 20110016235) and by the Intelligent Synthetic Biology Center of Global Frontier Project (Grant no. 2011-0031955) funded by the Ministry of Science, ICT and Future Planning (MSIP)(http://www.msip.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chen G, 2001, NAT BIOTECHNOL, V19, P537, DOI 10.1038/89281; Daugherty PS, 1999, PROTEIN ENG, V12, P613, DOI 10.1093/protein/12.7.613; Daugherty PS, 2000, J IMMUNOL METHODS, V243, P211, DOI 10.1016/S0022-1759(00)00236-2; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; FUCHS P, 1991, BIO-TECHNOL, V9, P1369, DOI 10.1038/nbt1291-1369; Fuchs P, 1996, IMMUNOTECHNOLOGY, V2, P97, DOI 10.1016/1380-2933(96)85197-9; Ge X, 2010, BIOTECHNOL BIOENG, V106, P347, DOI 10.1002/bit.22712; Gu B, 2009, SMALL, V5, P2407, DOI 10.1002/smll.200900450; Haitjema CH, 2014, ACS SYNTH BIOL, V3, P74, DOI 10.1021/sb400142b; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; HAYASHI N, 1994, BIOTECHNIQUES, V17, P310; Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jang SH, 2011, APPL MICROBIOL BIOT, V92, P327, DOI 10.1007/s00253-011-3423-z; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Johnson G, 2000, NUCLEIC ACIDS RES, V28, P214, DOI 10.1093/nar/28.1.214; Jung JG, 2013, J IND MICROBIOL BIOT, V40, P705, DOI 10.1007/s10295-013-1273-7; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Li M, 2000, NAT BIOTECHNOL, V18, P1251, DOI 10.1038/82355; Park SJ, 1999, BIOTECHNOL PROGR, V15, P164, DOI 10.1021/bp9900108; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; SEEHAUS T, 1992, GENE, V114, P235, DOI 10.1016/0378-1119(92)90580-I; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; TJANDRA JJ, 1990, IMMUNOL CELL BIOL, V68, P367, DOI 10.1038/icb.1990.50; Villa A, 2011, MABS-AUSTIN, V3, P264, DOI 10.4161/mabs.3.3.15616; Wang S, 2011, ANTIBODY TECHNOL J, V1, P1; Yang HY, 2009, MOL CELLS, V27, P225, DOI 10.1007/s10059-009-0028-9; Zheng S, 2010, TALANTA, V82, P803, DOI 10.1016/j.talanta.2010.05.059	33	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108225	10.1371/journal.pone.0108225	http://dx.doi.org/10.1371/journal.pone.0108225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303314	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400009
J	Zhao, Q; Li, T; Qi, JN; Liu, J; Qin, CY				Zhao, Qi; Li, Tao; Qi, Jianni; Liu, Juan; Qin, Chengyong			The miR-545/374a Cluster Encoded in the Ftx IncRNA is Overexpressed in HBV-Related Hepatocellular Carcinoma and Promotes Tumorigenesis and Tumor Progression	PLOS ONE			English	Article							LONG NONCODING RNAS; HEPATITIS-B; EXPRESSION	Hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). Previous studies have shown several long noncoding RNAs (lncRNAs) play various roles in HCC progression, but no research has focused on the expression pattern of microRNA clusters encoded in IncRNAs. The Ftx gene encodes a IncRNA which harbors 2 clusters of microRNAs in its introns, the miR-374b/421 cluster and the miR-545/374a cluster. To date, no research has focused on the role of the miR-545/374a and miR-374b/421 clusters in HBV-related HCC. In this study, 66 pairs of HBV-related HCC tissue and matched non-cancerous liver tissue specimens were analyzed for the expression of the Ftx microRNA clusters. Our results showed that the miR-545/374a cluster was upregulated in HBV-HCC tissue and significantly correlated with prognosis-related clinical features, including histological grade, metastasis and tumor capsule. Transfection studies with microRNA mimics and inhibitors revealed that miR-545/374a expression promoted in vitro cell proliferation, cell migration and invasion. The wild-type HBV-genome-containing plasmid or full-length HBx protein encoding plasmid was transfected into the Bel-7402 cell line and observed for their influence on miR-545/374a expression. We found that transfection of the HBV genome or HBx alone resulted in an increase in miR-545/374a expression. Next, by monitoring the expression of sera miR-545/374a before and after surgical tumor excision, we found serum miR-545/374a was tumor-derived and exhibited a sharp decrease 25 days after tumor excision. We also examined the gender-based difference in miR-545/374a expression among HCC patients and utilized microRNA target prediction software to find the targets of miR-545/374a. One of these targets, namely estrogen-related receptor gamma (ESRRG) was inversely correlated with miR-545 expression. In conclusion, the overexpression of miR-545/374a cluster located in the Ftx IncRNA is partially responsible for a poor prognosis, and monitoring sera levels of miR-545/374a may be a useful diagnostic marker for HCC.	[Zhao, Qi; Liu, Juan; Qin, Chengyong] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan, Peoples R China; [Li, Tao] Shandong Univ, Prov Hosp, Dept Infect Dis, Jinan, Peoples R China; [Qi, Jianni] Shandong Univ, Shandong Prov Hosp, Cent Lab, Jinan, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Qin, CY (corresponding author), Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan, Peoples R China.	chengyongqin016@gmail.com			Shandong Science and Technology Committee of China [2013GG3202192]; Postdoctoral Science Foundation of China [2013M541926]; Postdoctoral Innovation Project Special Foundation of Shandong Province [201302031]	Shandong Science and Technology Committee of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Innovation Project Special Foundation of Shandong Province	This work was supported by grants from the Shandong Science and Technology Committee of China (2013GG3202192), the Postdoctoral Science Foundation of China (2013M541926), and the Postdoctoral Innovation Project Special Foundation of Shandong Province (201302031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; Huang JL, 2013, CARCINOGENESIS; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li C.L., 2014, INT J CANC; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062844; Romito A, 2011, BIOCHIMIE, V93, P1935, DOI 10.1016/j.biochi.2011.07.009; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Xu D, 2013, HEPATOLOGY, V58, P739, DOI 10.1002/hep.26361; Xu XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-276; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Zhao Q, 2013, J VIRAL HEPATITIS, V20, P430, DOI 10.1111/jvh.12048	16	71	71	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109782	10.1371/journal.pone.0109782	http://dx.doi.org/10.1371/journal.pone.0109782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299640	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200072
J	Chudnovskiy, R; Thompson, A; Tharp, K; Hellerstein, M; Napoli, JL; Stahl, A				Chudnovskiy, Rostislav; Thompson, Airlia; Tharp, Kevin; Hellerstein, Marc; Napoli, Joseph L.; Stahl, Andreas			Consumption of Clarified Grapefruit Juice Ameliorates High-Fat Diet Induced Insulin Resistance and Weight Gain in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; METABOLISM; RECEPTORS; OBESITY; DRUGS; FRUIT	To determine the metabolic effects of grapefruit juice consumption we established a model in which C57Bl/6 mice drank 25-50% sweetened GFJ, clarified of larger insoluble particles by centrifugation (cGFJ), ad libitum as their sole source of liquid or isocaloric and sweetened water. cGFJ and control groups consumed similar amounts of liquids and calories. Mice fed a high-fat diet and cGFJ experienced a 18.4% decrease in weight, a 13-17% decrease in fasting blood glucose, a three-fold decrease in fasting serum insulin, and a 38% decrease in liver triacylglycerol values, compared to controls. Mice fed a low-fat diet that drank cGFJ experienced a two-fold decrease in fasting insulin, but not the other outcomes observed with the high-fat diet. cGFJ consumption decreased blood glucose to a similar extent as the commonly used anti-diabetic drug metformin. Introduction of cGFJ after onset of diet-induced obesity also reduced weight and blood glucose. A bioactive compound in cGFJ, naringin, reduced blood glucose and improved insulin tolerance, but did not ameliorate weight gain. These data from a well-controlled animal study indicate that GFJ contains more than one health-promoting neutraceutical, and warrant further studies of GFJ effects in the context of obesity and/or the western diet.	[Chudnovskiy, Rostislav; Thompson, Airlia; Tharp, Kevin; Hellerstein, Marc; Napoli, Joseph L.; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Grad Program Metab Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Grad Program Metab Biol, Berkeley, CA 94720 USA.	jna@berkeley.edu; astahl@berkeley.edu		tharp, kevin/0000-0002-3543-3266	California Grapefruit Growers Cooperative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK036870, T32DK061918] Funding Source: NIH RePORTER	California Grapefruit Growers Cooperative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The California Grapefruit Growers Cooperative provided financial support for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have financial or non-financial competing interests to disclose.	Agosti S, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2010.08.031; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bailey DG, 2013, CAN MED ASSOC J, V185, P309, DOI 10.1503/cmaj.120951; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Diaconu CH, REV MED CHIR SOC MED, V115, P245; Eloranta JJ, 2005, METHOD ENZYMOL, V400, P511, DOI 10.1016/S0076-6879(05)00028-5; Fallingborg J, 1999, DAN MED BULL, V46, P183; Fujioka K, 2006, J MED FOOD, V9, P49, DOI 10.1089/jmf.2006.9.49; Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22; Grande LA, 2009, LANCET, V373, P1222, DOI 10.1016/S0140-6736(09)60289-0; Hanley MJ, 2011, EXPERT OPIN DRUG MET, V7, P267, DOI 10.1517/17425255.2011.553189; Holman RR, 2013, NAT REV ENDOCRINOL, V9, P67, DOI 10.1038/nrendo.2012.243; Hwang YP, 2010, MOL NUTR FOOD RES, V54, P977, DOI 10.1002/mnfr.200900283; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kannappan S, 2010, EUR J NUTR, V49, P101, DOI 10.1007/s00394-009-0054-6; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Mazokopakis EE, 2008, INTERN MED J, V38, P364, DOI 10.1111/j.1445-5994.2007.01550.x; Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404; Pearen MA, 2012, PHYSIOLOGY, V27, P156, DOI 10.1152/physiol.00007.2012; Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026; Risinger FO, 2002, PSYCHOPHARMACOLOGY, V160, P225, DOI 10.1007/s00213-001-0973-2; Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Shirasaka Y, 2013, J PHARM SCI-US, V102, P280, DOI [10.1002/jps.23653, 10.1002/jps.23357]; Silver HJ, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-8; STAROSCIK JA, 1980, J AM DIET ASSOC, V77, P567; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Varady KA, 2010, J NUTR BIOCHEM, V21, P188, DOI 10.1016/j.jnutbio.2008.11.001; Vidal J, 2011, NEUROIMMUNOMODULAT, V18, P191, DOI 10.1159/000323772	34	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108408	10.1371/journal.pone.0108408	http://dx.doi.org/10.1371/journal.pone.0108408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296035	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000016
J	Schneider, SE; Thomas, JH				Schneider, Sean E.; Thomas, James H.			Accidental Genetic Engineers: Horizontal Sequence Transfer from Parasitoid Wasps to Their Lepidopteran Hosts	PLOS ONE			English	Article							SONORENSIS VIRUS-DNA; POLYDNAVIRUS DNA; GENOME; INTEGRATION; EXPRESSION; ORGANIZATION; TRANSPOSONS; BRACONIDAE; ALIGNMENT; ORIGIN	We show here that 105 regions in two Lepidoptera genomes appear to derive from horizontally transferred wasp DNA. We experimentally verified the presence of two of these sequences in a diverse set of silkworm (Bombyx mori) genomes. We hypothesize that these horizontal transfers are made possible by the unusual strategy many parasitoid wasps employ of injecting hosts with endosymbiotic polydnaviruses to minimize the host's defense response. Because these virus-like particles deliver wasp DNA to the cells of the host, there has been much interest in whether genetic information can be permanently transferred from the wasp to the host. Two transferred sequences code for a BEN domain, known to be associated with polydnaviruses and transcriptional regulation. These findings represent the first documented cases of horizontal transfer of genes between two organisms by a polydnavirus. This presents an interesting evolutionary paradigm in which host species can acquire new sequences from parasitoid wasps that attack them. Hymenoptera and Lepidoptera diverged similar to 300 MYA, making this type of event a source of novel sequences for recipient species. Unlike many other cases of horizontal transfer between two eukaryote species, these sequence transfers can be explained without the need to invoke the sequences hitchhiking on a third organism (e.g. retrovirus) capable of independent reproduction. The cellular machinery necessary for the transfer is contained entirely in the wasp genome. The work presented here is the first such discovery of what is likely to be a broader phenomenon among species affected by these wasps.	[Schneider, Sean E.; Thomas, James H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schneider, SE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	seaneric@uw.edu						ALBRECHT U, 1994, J GEN VIROL, V75, P3353, DOI 10.1099/0022-1317-75-12-3353; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Austin AD, 1998, AUST J BOT, V46, P559; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beck MH, 2011, J VIROL, V85, P11685, DOI 10.1128/JVI.05726-11; Belle E, 2002, J VIROL, V76, P5793, DOI 10.1128/JVI.76.11.5793-5796.2002; Bertsch C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-21; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2008, ARCH INSECT BIOCHEM, V67, P172, DOI 10.1002/arch.20219; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Choi JY, 2009, ARCH VIROL, V154, P1313, DOI 10.1007/s00705-009-0441-6; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Doucet D, 2007, J GEN VIROL, V88, P105, DOI 10.1099/vir.0.82314-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espagne E, 2005, J VIROL, V79, P9765, DOI 10.1128/JVI.79.15.9765-9776.2005; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Flegel TW, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-32; FLEMING JAGW, 1986, J VIROL, V57, P552, DOI 10.1128/JVI.57.2.552-562.1986; FLEMING JAGW, 1991, P NATL ACAD SCI USA, V88, P9770, DOI 10.1073/pnas.88.21.9770; Friedman R, 2006, INFECT GENET EVOL, V6, P315, DOI 10.1016/j.meegid.2005.10.001; Gilbert C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4348; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gundersen-Rindal D, 2000, VIRUS RES, V66, P27, DOI 10.1016/S0168-1702(99)00125-2; Gundersen-Rindal DE, 2003, J INSECT PHYSIOL, V49, P453, DOI 10.1016/S0022-1910(03)00062-3; Hepat R, 2011, BIOCHEM BIOPH RES CO, V415, P279, DOI 10.1016/j.bbrc.2011.10.040; INFANTE F, 1995, ANN ENTOMOL SOC AM, V88, P406, DOI 10.1093/aesa/88.4.406; Johnson BR, 2013, CURR BIOL, V23, P2058, DOI 10.1016/j.cub.2013.08.050; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Koonin EV, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-2; Kuraku S, 2012, GENOME BIOL EVOL, V4, P929, DOI 10.1093/gbe/evs069; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; Labropoulou V, 2008, CELL MICROBIOL, V10, P2118, DOI 10.1111/j.1462-5822.2008.01195.x; Le NT, 2003, J INSECT PHYSIOL, V49, P533, DOI 10.1016/S0022-1910(03)00052-0; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Pruijssers AJ, 2009, J EXP BIOL, V212, P2998, DOI 10.1242/jeb.030635; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; Serbielle C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-38; Simon S, 2012, GENOME BIOL EVOL, V4, P1295, DOI 10.1093/gbe/evs104; STOLTZ DB, 1976, CAN J MICROBIOL, V22, P1013, DOI 10.1139/m76-148; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; THEILMANN DA, 1986, J GEN VIROL, V67, P1961, DOI 10.1099/0022-1317-67-9-1961; Theze J, 2011, P NATL ACAD SCI USA, V108, P15931, DOI 10.1073/pnas.1105580108; Thomas J, 2010, GENOME BIOL EVOL, V2, P656, DOI 10.1093/gbe/evq050; Volkoff AN, 2001, J GEN VIROL, V82, P963, DOI 10.1099/0022-1317-82-4-963; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Walsh AM, 2013, P NATL ACAD SCI USA, V110, P1012, DOI 10.1073/pnas.1205856110; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Whitfield JB, 1997, NATURWISSENSCHAFTEN, V84, P502, DOI 10.1007/s001140050434; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	57	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109446	10.1371/journal.pone.0109446	http://dx.doi.org/10.1371/journal.pone.0109446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296163	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000073
J	Attia, SM; Ahmad, SF; Okash, RM; Bakheet, SA				Attia, Sabry Mohamed; Ahmad, Sheikh Fayaz; Okash, Radwa Mohamed; Bakheet, Saleh Abdulrahman			Aneugenic Effects of Epirubicin in Somatic and Germinal Cells of Male Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TELOMERIC DNA PROBES; TOPOISOMERASE-II; MICRONUCLEUS INDUCTION; BREAST-CANCER; CHROMOSOMAL-ABERRATIONS; MALE MEIOSIS; MOUSE SPERM; DOXORUBICIN; ANEUPLOIDY	The ability of the antineoplastic agent epiruibicin to induce aneuploidy and meiotic delay in the somatic and germinal cells of male mice was investigated by fluorescence in situ hybridization assay using labeled DNA probes and BrdU-incorporation assay. Mitomycin C and colchicine were used as positive controls for clastogen and aneugen, respectively, and these compounds produced the expected responses. The fluorescence in situ hybridization assay with a centromeric DNA probe for erythrocyte micronuclei showed that epirubicin is not only clastogenic but also aneugenic in somatic cells in vivo by using the 48 h. Incorporation assay, it could be shown that the meiotic delay caused by epiru ion in germ cells was approximately 48 h. Disornic and diploid sperm were shown in epididyrnal sperm hybridized with DNA probes specific for chromosomes 8, X and Y after epirubicin treatment. The observation that XX- and YY-sperm significantly prevailed over XYperm sperm indicates missegregation during the second meiotic division. The results also suggest that earlier prophase stages contribute less to epirubicin-induced aneuploidy. Both the clastogenic and aneugenic potential of epirubicin can give rise he development of secondary tumors and abnormal reproductive outcomes in cured cancer patients and medical onnel exposed to epirubicin	[Attia, Sabry Mohamed; Ahmad, Sheikh Fayaz; Bakheet, Saleh Abdulrahman] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Attia, Sabry Mohamed] Minist Hlth Cairo, Lab Chem & Clin Pathol, Cairo, Egypt; [Okash, Radwa Mohamed] Al Azhar Univ, Coll Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Al Azhar University	Attia, SM (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia.	attiasm@yahoo.com	Bakheet, Saleh A/AEC-8869-2022; Ahmad, Sheikh Fayaz/R-5853-2017; attia, Sabry M./GRO-6742-2022; Ahmad, Sheikh F./AAC-8750-2021	Bakheet, Saleh A/0000-0003-2008-6377; Ahmad, Sheikh Fayaz/0000-0002-8282-3726; 	National Plan for Science and Technology (NPST) in the Kingdom of Saudi Arabia [12-MED2648-02]	National Plan for Science and Technology (NPST) in the Kingdom of Saudi Arabia	This work was supported by National Plan for Science and Technology (NPST), grant number 12-MED2648-02 in the Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler I.-D., 1984, MUTAGENICITY TESTING, P275; ADLER ID, 1993, MUTAT RES, V287, P131, DOI 10.1016/0027-5107(93)90152-6; Adler ID, 2002, MUTAT RES-FUND MOL M, V504, P173, DOI 10.1016/S0027-5107(02)00090-8; Aly MS, 1999, ENVIRON MOL MUTAGEN, V33, P161, DOI 10.1002/(SICI)1098-2280(1999)33:2<161::AID-EM8>3.0.CO;2-M; AMES MM, 1992, LEUKEMIA, V6, P70; Attia S.M., 2008, SAUDI PHARM J, V16, P1; Attia SM, 2008, MUTAT RES-GEN TOX EN, V651, P105, DOI 10.1016/j.mrgentox.2007.10.011; Attia SM, 2007, TOXICOLOGY, V235, P112, DOI 10.1016/j.tox.2007.03.011; Attia SM, 2011, MUTAT RES-FUND MOL M, V715, P79, DOI 10.1016/j.mrfmmm.2011.07.012; Attia SM, 2010, OXID MED CELL LONGEV, V3, P238, DOI 10.4161/oxim.3.4.13246; Attia SM, 2009, ENVIRON MOL MUTAGEN, V50, P394, DOI 10.1002/em.20451; Attia SM, 2005, MUTAT RES-GEN TOX EN, V583, P158, DOI 10.1016/j.mrgentox.2005.03.010; Attia SM, 2003, ENVIRON MOL MUTAGEN, V41, P99, DOI 10.1002/em.10135; Attia SM, 2002, MUTAT RES-GEN TOX EN, V520, P1, DOI 10.1016/S1383-5718(02)00079-7; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Brumfield JM, 2002, TEX J SCI, V54, P249; Burrello N, 2011, J ENDOCRINOL INVEST, V34, pE121, DOI [10.1007/BF03346719, 10.3275/7224]; CANTONI O, 1989, J CANCER RES CLIN, V115, P373, DOI 10.1007/BF00400965; Chabner BA, 1993, CANC PRINCIPLES PRAC, P374; Coukell AJ, 1997, DRUGS, V53, P453, DOI 10.2165/00003495-199753030-00008; Fritz B, 2001, EUR J HUM GENET, V9, P910, DOI 10.1038/sj.ejhg.5200741; Gamen S, 2000, EXP CELL RES, V258, P223, DOI 10.1006/excr.2000.4924; Ganapathi R, 1996, CANCER GENET CYTOGEN, V86, P116, DOI 10.1016/0165-4608(95)00207-3; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; HACKERKLOM UB, 1986, MUTAT RES, V160, P39, DOI 10.1016/S0027-5107(96)90007-X; Haddy N, 2014, CARCINOGENESIS, V35, P1745, DOI 10.1093/carcin/bgu077; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hastwell PW, 2009, MUTAGENESIS, V24, P455, DOI 10.1093/mutage/gep029; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; Hortobagyi GN, 1997, DRUGS S4, V54, P1; ISLAM MQ, 1993, CANCER GENET CYTOGEN, V65, P35; Jeremic B, 1996, CHEMOTHERAPY, V42, P266, DOI 10.1159/000239454; Kallio M, 1996, MUTAGENESIS, V11, P435, DOI 10.1093/mutage/11.5.435; Marchetti F, 2001, P NATL ACAD SCI USA, V98, P3952, DOI 10.1073/pnas.061404598; Murray WA, 1992, NATURE, V359, P599; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Olinski R, 1997, MOL PHARMACOL, V52, P882, DOI 10.1124/mol.52.5.882; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; OTHMAN OES, 2000, MUTAT RES, V468, P109; Pacchierotti F, 2008, MUTAT RES-GEN TOX EN, V651, P64, DOI 10.1016/j.mrgentox.2007.10.009; PEDERSENBJERGAARD J, 1992, J CLIN ONCOL, V10, P1444, DOI 10.1200/JCO.1992.10.9.1444; PEDERSENBJERGAARD J, 1987, BRIT J HAEMATOL, V66, P199, DOI 10.1111/j.1365-2141.1987.tb01299.x; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Russell LB, 2004, MUTAT RES-GEN TOX EN, V565, P61, DOI 10.1016/j.mrgentox.2004.09.005; Schmid TE, 2001, MUTAGENESIS, V16, P339, DOI 10.1093/mutage/16.4.339; SCHRIEVERSCHWEMMER G, 1994, MUTAGENESIS, V9, P333, DOI 10.1093/mutage/9.4.333; Sen AK, 2010, Z NATURFORSCH C, V65, P211; SEN P, 1990, CANCER RES, V50, P558; Silva LM, 2002, TERATOGEN CARCIN MUT, V22, P257, DOI 10.1002/tcm.10019; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Tempest HG, 2004, CYTOGENET GENOME RES, V107, P83, DOI 10.1159/000079575; Venizelos ID, 2007, ACTA DERMATOVEN ALP, V16, P77; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wolf T, 2008, MUTAT RES-GEN TOX EN, V650, P150, DOI 10.1016/j.mrgentox.2007.11.009	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109942	10.1371/journal.pone.0109942	http://dx.doi.org/10.1371/journal.pone.0109942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303090	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400094
J	Chen, WL; Wang, CC; Wu, LW; Kao, TW; Chan, JYH; Chen, YJ; Yang, YH; Chang, YW; Peng, TC				Chen, Wei-Liang; Wang, Chung-Ching; Wu, Li-Wei; Kao, Tung-Wei; Chan, James Yi-Hsin; Chen, Ying-Jen; Yang, Ya-Hui; Chang, Yaw-Wen; Peng, Tao-Chun			Relationship between Lung Function and Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PULMONARY-FUNCTION; ABDOMINAL OBESITY; NUTRITION EXAMINATION; GENERAL-POPULATION; INSULIN-RESISTANCE; NATIONAL-HEALTH; NORMAL-WEIGHT; ASSOCIATION; CHOLESTEROL	Although the link between impaired lung function and cardiovascular events and type 2 diabetes mellitus has been recognized, the association between impaired lung function and metabolic syndrome has not been comprehensively assessed in the United States (U.S.) population. The aim of our study was to explore the association between impaired lung function and metabolic syndrome in a nationally representative sample of men and women. This cross-sectional population-based study included 8602 participants aged 20-65 years in the Third National Health and Nutrition Examination Survey (NHANES III). We examined the relationship between the different features of metabolic syndrome and lung function, including forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1). After adjusting for potential confounders such as age, body mass index, inflammatory factors, medical condition, and smoking status, participants with more components of metabolic syndrome had lower predicted values of FVC and FEV1 (p for trend <0.001 for both). Impaired pulmonary function was also associated with individual components of metabolic syndrome, such as abdominal obesity, high blood pressure, high triglycerides, and low high density lipoprotein (HDL) cholesterol (p<0.05 for all parameters). These results from a nationally representative sample of US adults suggest that a greater number of features of metabolic syndrome is strongly associated with poorer FVC and FEV1. In clinical practice, more comprehensive management strategies to address subjects with metabolic syndrome and impaired lung function need to be developed and investigated.	[Chen, Wei-Liang; Wang, Chung-Ching; Wu, Li-Wei; Kao, Tung-Wei; Chan, James Yi-Hsin; Chang, Yaw-Wen; Peng, Tao-Chun] Tri Serv Gen Hosp & Sch Med, Natl Def Med Ctr, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Chen, Wei-Liang; Wu, Li-Wei; Kao, Tung-Wei; Chang, Yaw-Wen] Tri Serv Gen Hosp & Sch Med, Natl Def Med Ctr, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Chen, Wei-Liang; Chan, James Yi-Hsin; Chen, Ying-Jen] Grad Inst Med Sci, Natl Def Med Ctr, Taipei, Taiwan; [Yang, Ya-Hui] Fooyin Univ, Dept Occupat Safety & Hyg, Kaohsiung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Fooyin University	Peng, TC (corresponding author), Tri Serv Gen Hosp & Sch Med, Natl Def Med Ctr, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.	koigojaff@gmail.com	Chang, Yaw-Wen/AAF-2630-2020; Peng, Tao‑Chun/AAY-7035-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Ya-Hui/0000-0002-1785-5123				[Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Chen Y, 2007, AM J CLIN NUTR, V85, P35, DOI 10.1093/ajcn/85.1.35; Choi JH, 2011, ENDOCR J, V58, P459, DOI 10.1507/endocrj.K11E-011; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; ERVIN RB, 2009, NATL HLTH STAT REPOR, V13, P1; Faber DR, 2010, ATHEROSCLEROSIS, V212, P274, DOI 10.1016/j.atherosclerosis.2010.04.029; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Klisic AN, 2014, LABMEDICINE, V45, P12, DOI 10.1309/LMI6I2RN7AMPEUUL; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lee HM, 2009, CHEST, V136, P171, DOI 10.1378/chest.08-1901; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; NELSON SB, 1990, CHEST, V97, P288, DOI 10.1378/chest.97.2.288; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Rein P, 2010, DIABETES CARE, V33, P1853, DOI 10.2337/dc09-2376; Rogliani P, 2010, RESP MED, V104, P47, DOI 10.1016/j.rmed.2009.08.009; SAAD MF, 1991, NEW ENGL J MED, V324, P733, DOI 10.1056/NEJM199103143241105; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Thijs W, 2014, RESP MED, V108, P351, DOI 10.1016/j.rmed.2013.10.003; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Yamamoto Y, 2014, JPN CLIN MED, V5, P1, DOI 10.4137/JCM.S13564; Yang T, 2013, ENDOCRINE, V43, P351, DOI 10.1007/s12020-012-9743-7; Yoshimura C, 2012, INTERNAL MED, V51, P2291, DOI 10.2169/internalmedicine.51.7427; Yu D, 2014, DIABETIC MED, V31, P595, DOI 10.1111/dme.12346	36	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108989	10.1371/journal.pone.0108989	http://dx.doi.org/10.1371/journal.pone.0108989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299452	Green Submitted, gold, Green Published			2022-12-25	WOS:000343941200030
J	Fan, ZQ; Li, W; Lee, SR; Meng, QG; Shi, B; Bunch, TD; White, KL; Kong, IK; Wang, ZD				Fan, Zhiqiang; Li, Wei; Lee, Sang R.; Meng, Qinggang; Shi, Bi; Bunch, Thomas D.; White, Kenneth L.; Kong, Il-Keun; Wang, Zhongde			Efficient Gene Targeting in Golden Syrian Hamsters by the CRISPR/Cas9 System	PLOS ONE			English	Article							ONE-STEP GENERATION; GENOME MODIFICATION; CRISPR-CAS9 SYSTEM; CAS SYSTEM; MODEL; EMBRYOS; MICE; KNOCKOUT; ENDONUCLEASES; SPECIFICITY	The golden Syrian hamster is the model of choice or the only rodent model for studying many human diseases. However, the lack of gene targeting tools in hamsters severely limits their use in biomedical research. Here, we report the first successful application of the CRISPR/Cas9 system to efficiently conduct gene targeting in hamsters. We designed five synthetic single-guide RNAs (sgRNAs)-three for targeting the coding sequences for different functional domains of the hamster STAT2 protein, one for KCNQ1, and one for PPP1R12C-and demonstrated that the CRISPR/Cas9 system is highly efficient in introducing site-specific mutations in hamster somatic cells. We then developed unique pronuclear (PN) and cytoplasmic injection protocols in hamsters and produced STAT2 knockout (KO) hamsters by injecting the sgRNA/Cas9, either in the form of plasmid or mRNA, targeting exon 4 of hamster STAT2. Among the produced hamsters, 14.3% and 88.9% harbored germline-transmitted STAT2 mutations from plasmid and mRNA injection, respectively. Notably, 10.4% of the animals produced from mRNA injection were biallelically targeted. This is the first success in conducting site-specific gene targeting in hamsters and can serve as the foundation for developing other genetically engineered hamster models for human disease.	[Fan, Zhiqiang; Li, Wei; Lee, Sang R.; Meng, Qinggang; Shi, Bi; Bunch, Thomas D.; White, Kenneth L.; Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kong, Il-Keun] Gyeongsang Natl Univ, Dept Anim Sci, Div Appl Life Sci, Jinju, Gyeongnam Provi, South Korea; [Kong, Il-Keun] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, Gyeongnam Provi, South Korea; [Wang, Zhongde] Auratus Bio LLC, Canton, SD USA	Utah System of Higher Education; Utah State University; Gyeongsang National University; Gyeongsang National University	Wang, ZD (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	zonda.wang@usu.edu		Wang, Zhongde/0000-0003-2441-4729	Utah Science Technology and Research (USTAR) initiative; Rural Development Administration (RDA) [PJ009587022013]; BK21 plus program, Republic of Korea	Utah Science Technology and Research (USTAR) initiative; Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); BK21 plus program, Republic of Korea	This work was supported by the Utah Science Technology and Research (USTAR) initiative (to ZW); and the Next-Generation Bio-Green 21 Program (No. PJ009587022013) by the Rural Development Administration (RDA) and BK21 plus program, Republic of Korea (to IKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT DK, 1992, BIOL REPROD, V47, P297, DOI 10.1095/biolreprod47.2.297; Best EL, 2012, GUT MICROBES, V3, P145, DOI 10.4161/gmic.19526; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Jove M, 2013, CARDIOVASC RES, V97, P642, DOI 10.1093/cvr/cvs368; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; McKiernan SH, 2000, HUM REPROD, V15, P157, DOI 10.1093/humrep/15.1.157; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Paciello O, 2010, MUSCLE NERVE, V41, P355, DOI 10.1002/mus.21502; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Safronetz D, 2012, ANTIVIR RES, V95, P282, DOI 10.1016/j.antiviral.2012.06.002; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Squirrell JM, 2001, BIOL REPROD, V64, P1845, DOI 10.1095/biolreprod64.6.1845; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Takahashi Mami, 2011, Cancers (Basel), V3, P582, DOI 10.3390/cancers3010582; Takenaka M, 2007, P NATL ACAD SCI USA, V104, P14289, DOI 10.1073/pnas.0706687104; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Valraktaris E, 2008, ORAL ONCOL, V44, P315, DOI 10.1016/j.oraloncology.2007.08.015; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wold WSM, 2012, ADV CANCER RES, V115, P69, DOI 10.1016/B978-0-12-398342-8.00003-3; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825	38	50	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109755	10.1371/journal.pone.0109755	http://dx.doi.org/10.1371/journal.pone.0109755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299451	gold, Green Published			2022-12-25	WOS:000343941200070
J	Kang, D; Yun, JS; Ko, SH; Lim, TS; Ahn, YB; Park, YM; Ko, SH				Kang, Donghoon; Yun, Jae-Seung; Ko, Sun-Hye; Lim, Tae-Seok; Ahn, Yu-Bae; Park, Yong-Moon; Ko, Seung-Hyun			Higher Prevalence of Metformin-Induced Vitamin B-12 Deficiency in Sulfonylurea Combination Compared with Insulin Combination in Patients with Type 2 Diabetes: A Cross-Sectional Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; SERUM CONCENTRATIONS; NATIONAL-HEALTH; ASSOCIATION; DIAGNOSIS; ANEMIA; POLYNEUROPATHY; MALABSORPTION; HOMOCYSTEINE; MANAGEMENT	Long-term and high-dose treatment with metformin is known to be associated with vitamin B-12 deficiency in patients with type 2 diabetes. We investigated whether the prevalence of B-12 deficiency was different in patients treated with different combination of hypoglycemic agents with metformin during the same time period. A total of 394 patients with type 2 diabetes treated with metformin and sulfonylurea (S+M group, n = 299) or metformin and insulin (I+M group, n = 95) were consecutively recruited. The vitamin B-12 and folate levels were quantified using the chemiluminescent enzyme immunoassay. Vitamin B-12 deficiency was defined as vitamin B-12 <= 300 pg/mL without folate deficiency (folate>4 ng/mL). The mean age of and duration of diabetes in the subjects were 59.4 +/- 10.5 years and 12.2 +/- 6.7 years, respectively. The mean vitamin B-12 level of the total population was 638.0 +/- 279.6 pg/mL. The mean serum B12 levels were significantly lower in the S+M group compared with the I+M group (600.0 +/- 266.5 vs. 757.7 +/- 287.6 pg/mL, P<0.001). The prevalence of vitamin B-12 deficiency in the metformin-treated patients was significantly higher in the S+M group compared with the I+M group (17.4% vs. 4.2%, P = 0.001). After adjustment for various factors, such as age, sex, diabetic duration, duration or daily dose of metformin, diabetic complications, and presence of anemia, sulfonylurea use was a significant independent risk factor for B-12 deficiency (OR = 4.74, 95% CI 1.41-15.99, P = 0.012). In conclusion, our study demonstrated that patients with type 2 diabetes who were treated with metformin combined with sulfonylurea require clinical attention for vitamin B-12 deficiency and regular monitoring of their vitamin B-12 levels.	[Kang, Donghoon; Yun, Jae-Seung; Ko, Sun-Hye; Lim, Tae-Seok; Ahn, Yu-Bae; Ko, Seung-Hyun] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ko, SH (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea.	kosh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Kang, Donghoon/0000-0002-7278-2174; Ko, Sun Hye/0000-0003-3387-3986				ADAMS JF, 1983, DIABETOLOGIA, V24, P16, DOI 10.1007/BF00275941; Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Andres E, 2002, ARCH INTERN MED, V162, P2251, DOI 10.1001/archinte.162.19.2251-a; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Bell DSH, 2010, SOUTH MED J, V103, P265, DOI 10.1097/SMJ.0b013e3181ce0e4d; Bouchoucha M, 2011, DIABETES METAB, V37, P90, DOI 10.1016/j.diabet.2010.11.002; CARMEL R, 1988, ARCH INTERN MED, V148, P1712, DOI 10.1001/archinte.148.8.1712; Chan CWJ, 2007, INT J LAB HEMATOL, V29, P163, DOI 10.1111/j.1751-553X.2007.00911.x; de Jager J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2181; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Filioussi Kalitsa, 2003, Aust Fam Physician, V32, P383; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Hermann LS, 2004, BRIT J DIABETES VASC, V4, P401; Hin H, 2006, AGE AGEING, V35, P416, DOI 10.1093/ageing/afl033; Kibirige D, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-17; Ko SH, 2014, DIABETES METAB J, V38, P51, DOI 10.4093/dmj.2014.38.1.51; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Ko SH, 2014, J KOREAN MED SCI, V29, P965, DOI 10.3346/jkms.2014.29.7.965; Leishear K, 2012, J AM GERIATR SOC, V60, P1057, DOI 10.1111/j.1532-5415.2012.03998.x; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Liu KW, 2006, AGE AGEING, V35, P200, DOI 10.1093/ageing/afj042; Long AN, 2012, DIABETES CARE, V35, pE84, DOI 10.2337/dc12-0980; Mazokopakis EE, 2012, DIABETES RES CLIN PR, V97, P359, DOI 10.1016/j.diabres.2012.06.001; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Naha K, 2012, BMJ CASE REP, V2012; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Pflipsen MC, 2009, J AM BOARD FAM MED, V22, P528, DOI 10.3122/jabfm.2009.05.090044; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Sahin M, 2007, J DIABETES COMPLICAT, V21, P118, DOI 10.1016/j.jdiacomp.2005.10.005; Schernthaner G, 2004, EUR J CLIN INVEST, V34, P535, DOI 10.1111/j.1365-2362.2004.01381.x; STABLER SP, 1990, BLOOD, V76, P871; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; TOMKIN GH, 1971, BMJ-BRIT MED J, V2, P685, DOI 10.1136/bmj.2.5763.685; Turner LW, 2014, DIABETES CARE, V37, P985, DOI 10.2337/dc13-2097; Wickramasinghe SN, 2006, BLOOD REV, V20, P299, DOI 10.1016/j.blre.2006.02.002; Wile DJ, 2010, DIABETES CARE, V33, P156, DOI 10.2337/dc09-0606; World Health Organization, 2001, INT CLASS FUNCT DIS, P1; Wulffele MG, 2003, J INTERN MED, V254, P455, DOI 10.1046/j.1365-2796.2003.01213.x	40	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109878	10.1371/journal.pone.0109878	http://dx.doi.org/10.1371/journal.pone.0109878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299054	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200082
J	Keefover-Ring, K; Ahnlund, M; Abreu, IN; Jansson, S; Moritz, T; Albrectsen, BR				Keefover-Ring, Ken; Ahnlund, Maria; Abreu, Ilka Nacif; Jansson, Stefan; Moritz, Thomas; Albrectsen, Benedicte Riber			No Evidence of Geographical Structure of Salicinoid Chemotypes within Populus Tremula	PLOS ONE			English	Article							ADAPTIVE POPULATION DIFFERENTIATION; PHENOLIC GLYCOSIDES; SECONDARY METABOLITES; CHEMICAL DEFENSE; WILLOW SALIX; TIGER SWALLOWTAIL; HERBIVORE DEFENSE; CONDENSED TANNINS; S-ERIOCEPHALA; QUAKING ASPEN	Salicinoids are well-known defense compounds in salicaceous trees and careful screening at the population level is warranted to fully understand their diversity and function. European aspen, Populus tremula, is a foundation species in Eurasia and highly polymorphic in Sweden. We exhaustively surveyed 102 replicated genotypes from the Swedish Aspen collection (SwAsp) for foliar salicinoids using UHPLC-ESI-TOF/MS and identified nine novel compounds, bringing the total to 19 for this species. Salicinoid structure followed a modular architecture of a salicin skeleton with added side groups, alone or in combination. Two main moieties, 2'-cinnamoyl and 2'-acetyl, grouped the SwAsp population into four distinct chemotypes, and the relative allocation of salicinoids was remarkably constant between different environments, implying a highly channeled biosynthesis of these compounds. Slightly more than half of the SwAsp genotypes belonged to the cinnamoyl chemotype. A fraction synthesized the acetyl moiety alone (similar to 7%) or in combination with cinnamoyl (similar to 2%), and close to forty percent lacked either of the two characteristic moieties, and thus resemble P. tremuloides in their salicinoid profile. The two most abundant chemotypes were evenly distributed throughout Sweden, unlike geographical patterns reported for SwAsp phenology traits, plant defense genes, and herbivore community associations. Here we present the salicinoid characterization of the SwAsp collection as a resource for future studies of aspen chemical ecology, salicinoid biosynthesis, and genetics.	[Keefover-Ring, Ken; Abreu, Ilka Nacif; Jansson, Stefan; Albrectsen, Benedicte Riber] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Keefover-Ring, Ken] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Ahnlund, Maria; Abreu, Ilka Nacif; Moritz, Thomas] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Albrectsen, Benedicte Riber] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	Umea University; University of Wisconsin System; University of Wisconsin Madison; Swedish University of Agricultural Sciences; Umea University; University of Copenhagen	Albrectsen, BR (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	benedicte.albrectsen@umu.se	Jansson, Stefan/A-1119-2009	Jansson, Stefan/0000-0002-7906-6891; Albrectsen, Benedicte Riber/0000-0002-9337-4540; Moritz, Thomas/0000-0002-4258-3190; Abreu, Ilka N/0000-0003-4728-0161	Carl Trygger Foundation for Scientific Research; Swedish Foundation for Strategic Research; Swedish Research Foundation	Carl Trygger Foundation for Scientific Research; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Foundation	The authors thank the Carl Trygger Foundation for Scientific Research, the Swedish Foundation for Strategic Research, and the Swedish Research Foundation for funding. The staff of the Swedish Metabolomics Center (www.swedishmetabolomicscentre.se) was instrumental in the completion of chemical analyses for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Albrectsen BR, 2007, ECOL ENTOMOL, V32, P211; Albrectsen BR, 2010, ECOGRAPHY, V33, P483, DOI 10.1111/j.1600-0587.2009.05982.x; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; AUDETTE RCS, 1966, J CHROMATOGR, V25, P367, DOI 10.1016/S0021-9673(01)98254-8; Babst BA, 2010, J CHEM ECOL, V36, P286, DOI 10.1007/s10886-010-9757-7; Bailey JK, 2007, BIOL INVASIONS, V9, P715, DOI 10.1007/s10530-006-9071-z; Bernhardsson C, 2012, MOL ECOL, V21, P2197, DOI 10.1111/j.1365-294X.2012.05524.x; BINNS WW, 1968, PHYTOCHEMISTRY, V7, P1577, DOI 10.1016/S0031-9422(00)88609-4; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Caseys C, 2012, PLANT ECOL DIVERS, V5, P457, DOI 10.1080/17550874.2012.748850; Chen F, 2009, CRIT REV PLANT SCI, V28, P375, DOI 10.1080/07352680903241279; Constabel CP, 2010, PLANT GENET GENOMICS, V8, P279, DOI 10.1007/978-1-4419-1541-2_13; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Fritz RS, 2001, OECOLOGIA, V129, P87, DOI 10.1007/s004420100703; Haikio E, 2009, J CHEM ECOL, V35, P664, DOI 10.1007/s10886-009-9644-2; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hjalten J, 2007, OIKOS, V116, P751, DOI [10.1111/j.2007.0030-1299.15365.x, 10.1111/j.0030-1299.2007.15365.x]; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Keefover-Ring K, 2014, PHYTOCHEM LETT, V7, P212, DOI 10.1016/j.phytol.2013.11.012; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; LINDROTH RL, 1988, ECOLOGY, V69, P814, DOI 10.2307/1941031; Lindroth RL, 1999, J CHEM ECOL, V25, P1331, DOI 10.1023/A:1020926809508; LINDROTH RL, 1986, OECOLOGIA, V70, P13, DOI 10.1007/BF00377106; LINDROTH RL, 1987, BIOCHEM SYST ECOL, V15, P681, DOI 10.1016/0305-1978(87)90046-9; LINDROTH RL, 1987, BIOCHEM SYST ECOL, V15, P677, DOI 10.1016/0305-1978(87)90045-7; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Morse AM, 2007, PHYTOCHEMISTRY, V68, P2043, DOI 10.1016/j.phytochem.2007.05.014; Orians CM, 2000, BIOCHEM SYST ECOL, V28, P619, DOI 10.1016/S0305-1978(99)00101-5; Orians CM, 1997, ENTOMOL EXP APPL, V83, P285, DOI 10.1046/j.1570-7458.1997.00183.x; ORIANS CM, 1995, J CHEM ECOL, V21, P1245, DOI 10.1007/BF02027559; PALO RT, 1984, J CHEM ECOL, V10, P499, DOI 10.1007/BF00988096; Paunonen R, 2009, IND CROP PROD, V29, P261, DOI 10.1016/j.indcrop.2008.05.009; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RANK NE, 1994, OECOLOGIA, V97, P342, DOI 10.1007/BF00317324; Rehill B, 2005, BIOCHEM SYST ECOL, V33, P125, DOI 10.1016/j.bse.2004.06.004; REICHARDT PB, 1990, J CHEM ECOL, V16, P1941, DOI 10.1007/BF01020507; REICHARDT PB, 1992, J NAT PROD, V55, P970, DOI 10.1021/np50085a022; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Robinson KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037679; Ruuhola T, 2003, J CHEM ECOL, V29, P1083, DOI 10.1023/A:1023821304656; Ruuhola T, 2003, J CHEM ECOL, V29, P1565, DOI 10.1023/A:1024266612585; *SAS I, 2003, SAS VERS 9 1; Shelton AL, 2004, EVOL ECOL RES, V6, P709; Shelton AL, 2000, EVOL ECOL RES, V2, P231; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Tegelberg R, 2001, PHYSIOL PLANTARUM, V113, P541, DOI 10.1034/j.1399-3054.2001.1130413.x; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Umetrics, 2012, SIMCA P V 12 0; Wooley S. C., 2008, RANGELANDS, V30, P17	55	29	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107189	10.1371/journal.pone.0107189	http://dx.doi.org/10.1371/journal.pone.0107189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299342	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200005
J	Olsen, E; Fluharty, D; Hoel, AH; Hostens, K; Maes, F; Pecceu, E				Olsen, Erik; Fluharty, David; Hoel, Alf Hakon; Hostens, Kristian; Maes, Frank; Pecceu, Ellen			Integration at the Round Table: Marine Spatial Planning in Multi-Stakeholder Settings	PLOS ONE			English	Article							MANAGEMENT; POLICY; OCEAN; RESOURCES; SEA	Marine spatial planning (MSP) is often considered as a pragmatic approach to implement an ecosystem based management in order to manage marine space in a sustainable way. This requires the involvement of multiple actors and stakeholders at various governmental and societal levels. Several factors affect how well the integrated management of marine waters will be achieved, such as different governance settings (division of power between central and local governments), economic activities (and related priorities), external drivers, spatial scales, incentives and objectives, varying approaches to legislation and political will. We compared MSP in Belgium, Norway and the US to illustrate how the integration of stakeholders and governmental levels differs among these countries along the factors mentioned above. Horizontal integration (between sectors) is successful in all three countries, achieved through the use of neutral 'round-table' meeting places for all actors. Vertical integration between government levels varies, with Belgium and Norway having achieved full integration while the US lacks integration of the legislature due to sharp disagreements among stakeholders and unsuccessful partisan leadership. Success factors include political will and leadership, process transparency and stakeholder participation, and should be considered in all MSP development processes.	[Olsen, Erik] Inst Marine Res, N-5024 Bergen, Norway; [Fluharty, David] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Hoel, Alf Hakon] Inst Marine Res, Tromso, Norway; [Hostens, Kristian; Pecceu, Ellen] ILVO Inst Agr & Fisheries Res, Oostende, Belgium; [Maes, Frank] Univ Ghent, Maritime Inst, B-9000 Ghent, Belgium	Institute of Marine Research - Norway; University of Washington; University of Washington Seattle; Institute of Marine Research - Norway; Institute For Agricultural & Fisheries Research; Ghent University	Olsen, E (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	eriko@imr.no		Olsen, Erik/0000-0002-7552-2335	EU FP-7 research project "Monitoring and evaluation of spatially managed areas (MESMA)''; Institute of Marine Research; University of Washington; Ghent University; Institute for Agricultural and Fisheries Research (ILVO)	EU FP-7 research project "Monitoring and evaluation of spatially managed areas (MESMA)''; Institute of Marine Research; University of Washington(University of Washington); Ghent University(Ghent University); Institute for Agricultural and Fisheries Research (ILVO)	The project was jointly funded by the EU FP-7 research project "Monitoring and evaluation of spatially managed areas (MESMA)'' www.mesma.org, and by internal funding from the authors institutions: the Institute of Marine Research, University of Washington, Ghent University and the Institute for Agricultural and Fisheries Research (ILVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, HELHETLIG FORVALTNIN; [Anonymous], 2013, IMPLEMENTATION; [Anonymous], 2009, IOC MARINE SPATIAL P; [Anonymous], 2001, SEM ERKLAERINGEN SEM; Barange M, 2003, FRONT ECOL ENVIRON, V1, P190, DOI 10.2307/3868063; Bogaert D, 2008, WHOI RULES COAST, P59; Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; Collie JS, 2013, ESTUAR COAST SHELF S, V117, P1, DOI 10.1016/j.ecss.2012.11.010; Day V, 2008, MAR POLICY, V32, P535, DOI 10.1016/j.marpol.2007.10.009; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Environmental Law Institute, 2009, MAR SPAT PLANN US WA; Glazier E, 2011, ECOSYSTEM-BASED FISHERIES MANAGEMENT IN THE WESTERN PACIFIC, P1, DOI 10.1002/9780470959480; Hoel AH, 2012, AMBIO, V41, P85, DOI 10.1007/s13280-011-0229-2; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Kenchington R, 2011, J COAST CONSERV, V15, P271, DOI 10.1007/s11852-011-0147-2; Link JS, 2014, ICES J MAR SCI, V71, P1170, DOI 10.1093/icesjms/fsu026; Lubchenco J, 2010, SCIENCE, V328, P1485, DOI 10.1126/science.1190041; Maes F., 2013, COMPENDIUM COAST SEA, P261; Misund OA, 2013, ICES J MAR SCI, V70, P722, DOI 10.1093/icesjms/fst086; National Ocean Council, 2013, MAR PLANN HDB; Ogden JC, 2010, REV BIOL TROP, V58, P71; Olsen E, 2007, ICES J MAR SCI, V64, P599, DOI 10.1093/icesjms/fsm005; Ottersen G, 2011, MAR POLICY, V35, P389, DOI 10.1016/j.marpol.2010.10.017; Pecceu E, 2013, EVOLUTION MARINE PRO; Portman ME, 2011, ICES J MAR SCI, V68, P2191, DOI 10.1093/icesjms/fsr157; Qiu WF, 2013, MAR POLICY, V39, P182, DOI 10.1016/j.marpol.2012.10.010; Sievanen L, 2011, CONSERV LETT, V4, P298, DOI 10.1111/j.1755-263X.2011.00178.x; United Nations, 2002, REP WORLD SUMM SUST	28	71	71	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109964	10.1371/journal.pone.0109964	http://dx.doi.org/10.1371/journal.pone.0109964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299595	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200087
J	Zabrady, M; Hrdinova, V; Muller, B; Conrad, U; Hejatko, J; Janda, L				Zabrady, Matej; Hrdinova, Vendula; Mueller, Bruno; Conrad, Udo; Hejatko, Jan; Janda, Lubomir			Targeted In Vivo Inhibition of Specific Protein-Protein Interactions Using Recombinant Antibodies	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; SINGLE-CHAIN ANTIBODIES; KINASE CKI1; IMMUNOMODULATION; EXPRESSION; CYTOKININ; SELECTION; DOMAIN; TRANSFORMATION; INTRABODIES	With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated "silencing" represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting recombinant antibodies with a specific purpose in mind, which is to inhibit intrinsic protein-protein interactions in the cytosol of plant cells. Experimental procedures were designed for conveniently evaluating desired properties of recombinant antibodies in consecutive steps. Our selection method was successfully used to develop a recombinant antibody inhibiting the interaction of ARABIDOPSIS HISTIDINE PHOSPHO-TRANSFER PROTEIN 3 with such of its upstream interaction partners as the receiver domain of CYTOKININ INDEPENDENT HISTIDINE KINASE 1. The specific down-regulation of the cytokinin signaling pathway in vivo demonstrates the validity of our approach. This selection method can serve as a prototype for developing unique recombinant antibodies able to interfere with virtually any biomolecule in the living cell.	[Zabrady, Matej; Hrdinova, Vendula; Hejatko, Jan; Janda, Lubomir] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Mueller, Bruno] Univ Zurich, Inst Plant Biol, Zurich, Switzerland; [Mueller, Bruno] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany	Masaryk University Brno; University of Zurich; University of Zurich; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Janda, L (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	ljanda@sci.muni.cz	Hejatko, Jan/H-4296-2014; Janda, Lubomir/D-8048-2012; Mueller, Bruno/E-9888-2017; Hejatko, Jan/AAN-1182-2021; Zábrady, Matej/E-3042-2012	Hejatko, Jan/0000-0002-2622-6046; Mueller, Bruno/0000-0003-2664-7219; Zábrady, Matej/0000-0002-1356-3270	Czech Science Foundation [521/09/1699, P305/11/0756, 13-25280S]; 7th Framework Programme of the EC (BioNMR) [261863]; European Social Fund [CZ.1.07/2.3.00/20.0189]; European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Swiss National Science Foundation [31003A_125118]	Czech Science Foundation(Grant Agency of the Czech Republic); 7th Framework Programme of the EC (BioNMR); European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by grants from the Czech Science Foundation (Grants 521/09/1699; P305/11/0756 and 13-25280S), from the 7th Framework Programme of the EC (BioNMR, no 261863) and from European Social Fund (CZ.1.07/2.3.00/20.0189). This work was also supported by the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund and by a grant from the Swiss National Science Foundation (31003A_125118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist KC, 2004, PLANT BIOTECHNOL J, V2, P189, DOI 10.1111/j.1467-7652.2004.00060.x; Alvarez RD, 2000, CLIN CANCER RES, V6, P3081; BIOCCA S, 1990, EMBO J, V9, P101, DOI 10.1002/j.1460-2075.1990.tb08085.x; Boonrod KJ, 2004, NAT BIOTECHNOL, V22, P856, DOI 10.1038/nbt983; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gronwall C, 2009, J BIOTECHNOL, V140, P254, DOI 10.1016/j.jbiotec.2009.01.014; Harwood C.R., 1990, MOL BIOL METHODS BAC; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; James P, 1996, GENETICS, V144, P1425; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Kontermann R, 2010, ANTIBODY ENG, V2; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Malembic-Maher S, 2005, PLANT SCI, V168, P349, DOI 10.1016/j.plantsci.2004.08.008; MARASCO WA, 1993, P NATL ACAD SCI USA, V90, P7889, DOI 10.1073/pnas.90.16.7889; Miroshnichenko S, 2005, PLANT J, V41, P269, DOI 10.1111/j.1365-313X.2004.02290.x; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Muyldermans S, 2001, J Biotechnol, V74, P277; OWEN M, 1992, BIO-TECHNOL, V10, P790, DOI 10.1038/nbt0792-790; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Pekarova B, 2011, PLANT J, V67, P827, DOI 10.1111/j.1365-313X.2011.04637.x; Portner-Taliana A, 2000, J IMMUNOL METHODS, V238, P161, DOI 10.1016/S0022-1759(00)00145-9; Radchuk R, 2010, PLANT J, V64, P715, DOI 10.1111/j.1365-313X.2010.04376.x; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Santos MO, 2004, MOL BREEDING, V13, P333, DOI 10.1023/B:MOLB.0000034088.64105.13; Schouten A, 2002, J BIOL CHEM, V277, P19339, DOI 10.1074/jbc.M201245200; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; ten Hoopen P, 2007, J EXP BOT, V58, P2525, DOI 10.1093/jxb/erm122; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Urakami E, 2008, PLANTA, V228, P863, DOI 10.1007/s00425-008-0788-z; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Visintin M, 2002, J MOL BIOL, V317, P73, DOI 10.1006/jmbi.2002.5392; Yajima W, 2010, NEW BIOTECHNOL, V27, P816, DOI 10.1016/j.nbt.2010.09.010; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	46	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109875	10.1371/journal.pone.0109875	http://dx.doi.org/10.1371/journal.pone.0109875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299686	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000343941200081
J	Eriksson, PO; Aaltonen, E; Petoral, R; Lauritzson, P; Miyazaki, H; Pietras, K; Mansson, S; Hansson, L; Leander, P; Axelsson, O				Eriksson, Per-Olof; Aaltonen, Emil; Petoral, Rodrigo, Jr.; Lauritzson, Petter; Miyazaki, Hideki; Pietras, Kristian; Mansson, Sven; Hansson, Lennart; Leander, Peter; Axelsson, Oskar			Novel Nano-Sized MR Contrast Agent Mediates Strong Tumor Contrast Enhancement in an Oncogene-Driven Breast Cancer Model	PLOS ONE			English	Article							PERMEABILITY; MNDPDP	The current study was carried out to test the potential of a new nanomaterial (Spago Pix) as a macromolecular magnetic MR contrast agent for tumor detection and to verify the presence of nanomaterial in tumor tissue. Spago Pix, synthesized by Spago Nanomedical AB, is a nanomaterial with a globular shape, an average hydrodynamic diameter of 5 nm, and a relaxivity (r(1)) of approximately 30 (mM Mn)(-1) s(-1) (60 MHz). The material consists of an organophosphosilane hydrogel with strongly chelated manganese (II) ions and a covalently attached PEG surface layer. In vivo MRI of the MMTV-PyMT breast cancer model was performed on a 3 T clinical scanner. Tissues were thereafter analyzed for manganese and silicon content using inductively coupled plasma-atomic emission spectroscopy (ICP-AES). The presence of nanomaterial in tumor and muscle tissue was assessed using an anti-PEG monoclonal antibody. MR imaging of tumor-bearing mice (n = 7) showed a contrast enhancement factor of 1.8 (tumor versus muscle) at 30 minutes post-administration. Contrast was retained and further increased 2-4 hours after administration. ICP-AES and immunohistochemistry confirmed selective accumulation of nanomaterial in tumor tissue. A blood pharmacokinetics analysis showed that the concentration of Spago Pix gradually decreased over the first hour, which was in good agreement with the time frame in which the accumulation in tumor occurred. In summary, we demonstrate that Spago Pix selectively enhances MR tumor contrast in a clinically relevant animal model. Based on the generally higher vascular leakiness in malignant compared to benign tissue lesions, Spago Pix has the potential to significantly improve cancer diagnosis and characterization by MRI.	[Eriksson, Per-Olof; Aaltonen, Emil; Petoral, Rodrigo, Jr.; Lauritzson, Petter; Hansson, Lennart; Axelsson, Oskar] Spago Nanomed, Lund, Sweden; [Miyazaki, Hideki; Pietras, Kristian] Lund Univ, Dept Lab Med Lund, Div Translat Canc Res, Lund, Sweden; [Mansson, Sven] Lund Univ, Skane Univ Hosp, Dept Med Radiat Phys, Malmo, Sweden; [Leander, Peter] Lund Univ, Skane Univ Hosp, Dept Radiol, Malmo, Sweden; [Pietras, Kristian] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet	Aaltonen, E (corresponding author), Spago Nanomed, Lund, Sweden.	emil.aaltonen@spagoimaging.se	Pietras, Kristian/ABG-2097-2021; Pietras, Kristian/ABE-8727-2020; Månsson, Sven/AFU-0486-2022; Månsson, Sven/F-7277-2011	Pietras, Kristian/0000-0001-6738-4705; Månsson, Sven/0000-0002-5706-5142; Månsson, Sven/0000-0002-5706-5142	Vinnova [2011-03146]; Spago Nanomedical AB	Vinnova(Vinnova); Spago Nanomedical AB	The study was funded by a grant to Spago Imaging AB and OA from Vinnova (2011-03146; http://www.vinnova.se/en/). Per-Olof Eriksson, Emil Aaltonen, Rodrigo Petoral Jr., Petter Lauritzson, Lennart Hansson, and Oskar Axelsson are employees at Spago Nanomedical AB. Sven Mansson was financially compensated by Spago Nanomedical AB for operating the MRI instrument, but not for his expertise as an independent scientist in evaluation of the results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson O, 2013, NOVEL MANGANESE COMP; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Beauregard DA, 2001, CANCER RES, V61, P6811; Bumb A, 2010, ACTA RADIOL, V51, P751, DOI 10.3109/02841851.2010.491091; Chabanova E, 2011, OPEN DRUG SAFETY J, V2, P29; Chen JH, 2011, RADIOLOGY, V261, P735, DOI 10.1148/radiol.11110814; Daldrup H, 1998, AM J ROENTGENOL, V171, P941, DOI 10.2214/ajr.171.4.9762973; Daldrup-Link HE, 2000, ACAD RADIOL, V7, P934, DOI 10.1016/S1076-6332(00)80175-0; Daldrup-Link HE, 2003, RADIOLOGY, V229, P885, DOI 10.1148/radiol.2293021045; ELIZONDO G, 1991, RADIOLOGY, V178, P73, DOI 10.1148/radiology.178.1.1898538; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Federle MP, 2000, J MAGN RESON IMAGING, V12, P186, DOI 10.1002/1522-2586(200007)12:1<186::AID-JMRI21>3.0.CO;2-2; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Heijnen LA, 2014, EUR RADIOL, V24, P371, DOI 10.1007/s00330-013-3016-6; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kueny-Stotz M, 2012, EUR J INORG CHEM, P1987, DOI 10.1002/ejic.201101163; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Padhani AR, 2002, J MAGN RESON IMAGING, V16, P407, DOI 10.1002/jmri.10176; Pan DPJ, 2011, TETRAHEDRON, V67, P8431, DOI 10.1016/j.tet.2011.07.076; Rippe B, 2004, PERITON DIALYSIS INT, V24, P10; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Turetschek K, 2003, EUR J NUCL MED MOL I, V30, P448, DOI 10.1007/s00259-002-1000-5; Turetschek K, 2001, J MAGN RESON IMAGING, V14, P237, DOI 10.1002/jmri.1179	26	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107762	10.1371/journal.pone.0107762	http://dx.doi.org/10.1371/journal.pone.0107762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296030	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000009
J	Bahrami, AJ; Gunaje, JJ; Hayes, BJ; Riehle, KJ; Kenerson, HL; Yeung, RS; Stempien-Otero, AS; Campbell, JS; Mahoney, WM				Bahrami, Arya J.; Gunaje, Jagadambika J.; Hayes, Brian J.; Riehle, Kimberly J.; Kenerson, Heidi L.; Yeung, Raymond S.; Stempien-Otero, April S.; Campbell, Jean S.; Mahoney, William M., Jr.			Regulator of G-Protein Signaling-5 Is a Marker of Hepatic Stellate Cells and Expression Mediates Response to Liver Injury	PLOS ONE			English	Article							COLLAGEN GENE-EXPRESSION; BLOOD-PRESSURE; CARBON-TETRACHLORIDE; CIRRHOTIC LIVER; PORTAL PRESSURE; ANIMAL-MODELS; ENDOTHELIN; RGS5; RAT; PROLIFERATION	Liver fibrosis is mediated by hepatic stellate cells (HSCs), which respond to a variety of cytokine and growth factors to moderate the response to injury and create extracellular matrix at the site of injury. G-protein coupled receptor (GPCR)mediated signaling, via endothelin-1 (ET-1) and angiotensin II (AngII), increases HSC contraction, migration and fibrogenesis. Regulator of G-protein signaling-5 (RGS5), an inhibitor of vasoactive GPCR agonists, functions to control GPCR-mediated contraction and hypertrophy in pericytes and smooth muscle cells (SMCs). Therefore we hypothesized that RGS5 controls GPCR signaling in activated HSCs in the context of liver injury. In this study, we localize RGS5 to the HSCs and demonstrate that Rgs5 expression is regulated during carbon tetrachloride (CCl4)-induced acute and chronic liver injury in Rgs5(LacZ/LacZ) reporter mice. Furthermore, CCl4 treated RGS5-null mice develop increased hepatocyte damage and fibrosis in response to CCl4 and have increased expression of markers of HSC activation. Knockdown of Rgs5 enhances ET-1-mediated signaling in HSCs in vitro. Taken together, we demonstrate that RGS5 is a critical regulator of GPCR signaling in HSCs and regulates HSC activation and fibrogenesis in liver injury.	[Bahrami, Arya J.; Gunaje, Jagadambika J.; Hayes, Brian J.; Kenerson, Heidi L.; Yeung, Raymond S.; Stempien-Otero, April S.; Campbell, Jean S.; Mahoney, William M., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Riehle, Kimberly J.; Kenerson, Heidi L.; Yeung, Raymond S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Stempien-Otero, April S.] Univ Washington, Dept Cardiol, Seattle, WA 98195 USA; [Stempien-Otero, April S.; Mahoney, William M., Jr.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Stempien-Otero, April S.; Mahoney, William M., Jr.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mahoney, WM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	wmahoney@uw.edu	Mahoney, William/GQB-0802-2022	Hayes, Brian J/0000-0002-0930-0160; Campbell, Jean/0000-0002-9187-2204	Heart, Blood and Lung Institute of the National Institutes of Health (NIH) [HL087513, HL094374]; University of Washington, Department of Pathology start-up funds; NIH [T32HL007312]; University of Washington-Howard Hughes Medical Institute program in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312, R00HL087513, K99HL087513, P01HL094374] Funding Source: NIH RePORTER	Heart, Blood and Lung Institute of the National Institutes of Health (NIH); University of Washington, Department of Pathology start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington-Howard Hughes Medical Institute program in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the Heart, Blood and Lung Institute of the National Institutes of Health (NIH), under award HL087513 and HL094374 and University of Washington, Department of Pathology start-up funds (WMM). In addition, AJB and BJH were supported by NIH T32HL007312 and the University of Washington-Howard Hughes Medical Institute program in Molecular Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Anger T, 2007, J BIOCHEM MOL BIOL, V40, P899; Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Anselmi K, 2002, J GASTROEN HEPATOL, V17, P589, DOI 10.1046/j.1440-1746.2002.02705.x; Bahde R, 2011, LIVER INT, V31, P642, DOI 10.1111/j.1478-3231.2011.02493.x; Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; BERGASA NV, 1992, LIVER, V12, P168; Bilger A, 2004, GENETICS, V167, P859, DOI 10.1534/genetics.103.024521; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Boss CN, 2007, CLIN CANCER RES, V13, P3347, DOI 10.1158/1078-0432.CCR-06-2156; Boyd R, 2011, AM J PHYSIOL-HEART C, V301, pH2271, DOI 10.1152/ajpheart.00869.2010; Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Breitkopf K, 2005, CYTOKINE, V31, P349, DOI 10.1016/j.cyto.2005.06.005; Cavasin MA, 2010, CAN J PHYSIOL PHARM, V88, P636, DOI 10.1139/Y10-038; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chen X, 2004, MODERN PATHOL, V17, P1198, DOI 10.1038/modpathol.3800167; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Cho JJ, 2000, GASTROENTEROLOGY, V118, P1169, DOI 10.1016/S0016-5085(00)70370-2; Deng W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030256; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Faouzi S, 1999, LAB INVEST, V79, P485; Faruque MU, 2011, J HYPERTENS, V29, P1906, DOI 10.1097/HJH.0b013e32834b000d; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gandhi CR, 2000, EUR J PHARMACOL, V406, P311, DOI 10.1016/S0014-2999(00)00683-X; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Han SS, 2014, ONCOL REP, V31, P641, DOI 10.3892/or.2013.2872; Hellerbrand C, 2013, PFLUG ARCH EUR J PHY, V465, P775, DOI 10.1007/s00424-012-1209-5; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Heron Melonie, 2011, Natl Vital Stat Rep, V59, P1; Holobotovskyy V, 2013, CIRC RES, V112, P781, DOI 10.1161/CIRCRESAHA.111.300142; HSU CT, 1992, J AUTONOM NERV SYST, V37, P163, DOI 10.1016/0165-1838(92)90038-I; Hu MH, 2013, J SURG ONCOL, V108, P192, DOI 10.1002/jso.23367; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; Iankova I, 2008, ENDOCRINOLOGY, V149, P5706, DOI 10.1210/en.2008-0717; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Khimji A, 2011, PHARMACOL RES, V63, P512, DOI 10.1016/j.phrs.2011.03.005; Kitamura K, 2007, J GASTROEN HEPATOL, V22, P2022, DOI 10.1111/j.1440-1746.2006.04735.x; Koda Masahiko, 2006, Comp Hepatol, V5, P5, DOI 10.1186/1476-5926-5-5; Lavelle A, 2009, EUR RESPIR J, V34, P770, DOI 10.1183/09031936.00058409; Lepreux S, 2004, J HEPATOL, V40, P774, DOI 10.1016/j.jhep.2004.01.008; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Li J, 2004, J VASC SURG, V40, P519, DOI 10.1016/j.jvs.2004.06.021; Li MK, 2004, SEMIN LIVER DIS, V24, P21; Li TS, 2012, OTHER TITL APPL MATH, V126, P1; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Mallat A, 1998, J BIOL CHEM, V273, P27300, DOI 10.1074/jbc.273.42.27300; Maschmeyer P, 2011, JOVE-J VIS EXP, DOI 10.3791/2710; May D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021478; Mitchell TS, 2008, ANGIOGENESIS, V11, P141, DOI 10.1007/s10456-007-9085-x; Ning HX, 2011, BIOCHEM BIOPH RES CO, V413, P353, DOI 10.1016/j.bbrc.2011.08.104; Nisancioglu MH, 2008, MOL CELL BIOL, V28, P2324, DOI 10.1128/MCB.01252-07; Oben JA, 2003, BIOCHEM BIOPH RES CO, V308, P284, DOI 10.1016/S0006-291X(03)01360-3; Oben JA, 2003, BIOCHEM BIOPH RES CO, V302, P685, DOI 10.1016/S0006-291X(03)00232-8; Oben JA, 2003, BIOCHEM BIOPH RES CO, V300, P172, DOI 10.1016/S0006-291X(02)02773-0; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Pinzani M, 1996, GASTROENTEROLOGY, V110, P534, DOI 10.1053/gast.1996.v110.pm8566602; Puche JE, 2013, HEPATOLOGY, V57, P340, DOI 10.1002/hep.26053; Reichenbach V, 2012, J HEPATOL, V57, P967, DOI 10.1016/j.jhep.2012.07.012; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; Rockey DC, 1996, J CLIN INVEST, V98, P1381, DOI 10.1172/JCI118925; Rockey DC, 1996, HEPATOLOGY, V24, P233; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; SEGER R, 1994, J BIOL CHEM, V269, P25699; Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155; Sokolov E, 2011, CELL SIGNAL, V23, P1603, DOI 10.1016/j.cellsig.2011.05.012; Starkel P, 2011, BEST PRACT RES CL GA, V25, P319, DOI 10.1016/j.bpg.2011.02.004; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Vinay K, 2005, ROBBINS COTRAN PATHO, P166; Wang X, 2008, J MOL CELL CARDIOL, V44, P539, DOI 10.1016/j.yjmcc.2007.11.019; Watanabe N, 2007, J GASTROENTEROL, V42, P775, DOI 10.1007/s00535-007-2093-1; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhou J, 2001, LIFE SCI, V68, P1457, DOI 10.1016/S0024-3205(01)00939-0; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	86	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108505	10.1371/journal.pone.0108505	http://dx.doi.org/10.1371/journal.pone.0108505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290689	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000018
J	McHarg, S; Hopkins, G; Lim, L; Garrod, D				McHarg, Selina; Hopkins, Gemma; Lim, Lusiana; Garrod, David			Down-Regulation of Desmosomes in Cultured Cells: The Roles of PKC, Microtubules and Lysosomal/Proteasomal Degradation	PLOS ONE			English	Article							PROTEIN-KINASE-C; MDCK EPITHELIAL-CELLS; PEMPHIGUS-VULGARIS; MONOCLONAL-ANTIBODY; ENDOCYTIC VESICLES; E-CADHERIN; ORGANIZATION; DESMOPLAKIN; CENTROSOME; PROTEASOME	Desmosomes are intercellular adhesive junctions of major importance for tissue integrity. To allow cell motility and migration they are down-regulated in epidermal wound healing. Electron microscopy indicates that whole desmosomes are internalised by cells in tissues, but the mechanism of down-regulation is unclear. In this paper we provide an overview of the internalisation of half-desmosomes by cultured cells induced by calcium chelation. Our results show that: (i) half desmosome internalisation is dependent on conventional PKC isoforms; (ii) microtubules transport internalised half desmosomes to the region of the centrosome by a kinesin-dependent mechanism; (iii) desmosomal proteins remain colocalised after internalisation and are not recycled to the cell surface; (iv) internalised desmosomes are degraded by the combined action of lysosomes and proteasomes. We also confirm that half desmosome internalisation is dependent upon the actin cytoskeleton. These results suggest that half desmosomes are not disassembled and recycled during or after internalisation but instead are transported to the centrosomal region where they are degraded. These findings may have significance for the down-regulation of desmosomes in wounds.	[McHarg, Selina; Hopkins, Gemma; Lim, Lusiana; Garrod, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Garrod, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	d.garrod@manchester.ac.uk			Wellcome Trust [08618/Z/08/Z]; Medical Research Council [G0800004]; MRC Research Studentship; Medical Research Council [G9630879] Funding Source: researchfish; MRC [G9630879, G0800004] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Research Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust grant 08618/Z/08/Z, Medical Research Council Grant G0800004 and a MRC Research Studentship to GH. (http://www.wellcome.ac.uk/; http://www.mrc.ac.uk/index.htm) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; ALLEN TD, 1975, J ULTRA MOL STRUCT R, V51, P94, DOI 10.1016/S0022-5320(75)80011-6; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; BROWN CR, 1994, J CELL PHYSIOL, V160, P47, DOI 10.1002/jcp.1041600107; BURDETT IDJ, 1993, J CELL SCI, V106, P1115; Cheeseman KL, 2006, MOL BIOL CELL, V17, P799, DOI 10.1091/mbc.E04-12-1100; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; DEMLEHNER MP, 1995, J CELL BIOL, V131, P745, DOI 10.1083/jcb.131.3.745; Didier C, 2008, MOL BIOL CELL, V19, P1220, DOI 10.1091/mbc.E06-12-1140; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Gillingham AK, 2000, EMBO REP, V1, P524; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOLM PK, 1993, EUR J CELL BIOL, V62, P362; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; KARTENBECK J, 1982, EMBO J, V1, P725, DOI 10.1002/j.1460-2075.1982.tb01237.x; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Kimura TE, 2012, DEV BIOL, V369, P286, DOI 10.1016/j.ydbio.2012.06.025; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; MATTEY DL, 1986, J CELL SCI, V85, P113; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; OVERTON J, 1962, DEV BIOL, V4, P532, DOI 10.1016/0012-1606(62)90056-8; PARRISH EP, 1990, J CELL SCI, V96, P239; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; PASDAR M, 1991, J CELL BIOL, V113, P645, DOI 10.1083/jcb.113.3.645; PASDAR M, 1992, CELL MOTIL CYTOSKEL, V23, P201, DOI 10.1002/cm.970230304; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; STANLEY JR, 1984, J CLIN INVEST, V74, P313, DOI 10.1172/JCI111426; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Sumigray KD, 2011, J CELL BIOL, V194, P631, DOI 10.1083/jcb.201104009; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Thomason HA, 2012, J PATHOL, V227, P346, DOI 10.1002/path.4016; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; VILELA MJ, 1995, J CELL SCI, V108, P1743; VILELA MJ, 1987, J PATHOL, V153, P365, DOI 10.1002/path.1711530410; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WACKER IU, 1992, J CELL BIOL, V117, P813, DOI 10.1083/jcb.117.4.813; Wallis S, 2000, MOL BIOL CELL, V11, P1077, DOI 10.1091/mbc.11.3.1077; Wan H, 2007, EXP CELL RES, V313, P2336, DOI 10.1016/j.yexcr.2007.01.010; WATT FM, 1984, J CELL BIOL, V99, P2211, DOI 10.1083/jcb.99.6.2211; Wigley WC, 1999, J CELL BIOL, V145, P481; Windoffer R, 2002, J CELL SCI, V115, P1717; Yamada H, 2007, MOL BIOL CELL, V18, P4669, DOI 10.1091/mbc.E07-04-0296; Yang Y, 2011, INT J BIOCHEM CELL B, V43, P1147, DOI 10.1016/j.biocel.2011.04.007; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	72	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108570	10.1371/journal.pone.0108570	http://dx.doi.org/10.1371/journal.pone.0108570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291180	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000020
J	Sharma, R; Rawat, V; Suresh, CG				Sharma, Ranu; Rawat, Vimal; Suresh, C. G.			Genome-Wide Identification and Tissue-Specific Expression Analysis of UDP-Glycosyltransferases Genes Confirm Their Abundance in Cicer arietinum (Chickpea) Genome	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; BIOCHEMICAL-CHARACTERIZATION; ANTHOCYANIN BIOSYNTHESIS; HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; SEQUENCE; PROTEIN; HOMOLOGY; FAMILY; ACID	UDP-glycosyltransferases (EC 2.4.1.x; UGTs) are enzymes coded by an important gene family of higher plants. They are involved in the modification of secondary metabolites, phytohormones, and xenobiotics by transfer of sugar moieties from an activated nucleotide molecule to a wide range of acceptors. This modification regulates various functions like detoxification of xenobiotics, hormone homeostasis, and biosynthesis of secondary metabolites. Here, we describe the identification of 96 UGT genes in Cicer arietinum (CaUGT) and report their tissue-specific differential expression based on publically available RNA-seq and expressed sequence tag data. This analysis has established medium to high expression of 84 CaUGTs and low expression of 12 CaUGTs. We identified several closely related orthologs of CaUGTs in other genomes and compared their exon-intron arrangement. An attempt was made to assign functional specificity to chickpea UGTs by comparing substrate binding sites with experimentally determined specificity. These findings will assist in precise selection of candidate genes for various applications and understanding functional genomics of chickpea.	[Sharma, Ranu; Suresh, C. G.] CSIR, Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India; [Rawat, Vimal] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Max Planck Society	Suresh, CG (corresponding author), CSIR, Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India.	cg.suresh@ncl.res.in		rawat, vimal/0000-0002-6566-9253	Council of Scientific and Industrial Research (CSIR), India; CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC); International Max Planck Research School (IMPRS) fellowship	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC); International Max Planck Research School (IMPRS) fellowship	Council of Scientific and Industrial Research (CSIR), India, CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC), and International Max Planck Research School (IMPRS) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cao PJ, 2008, MOL PLANT, V1, P858, DOI 10.1093/mp/ssn052; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ford CM, 1998, J BIOL CHEM, V273, P9224, DOI 10.1074/jbc.273.15.9224; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; FURTEK D, 1988, PLANT MOL BIOL, V11, P473, DOI 10.1007/BF00039028; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Griesser M, 2008, J EXP BOT, V59, P2611, DOI 10.1093/jxb/ern117; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; HUGHES J, 1994, DNA SEQUENCE, V5, P41, DOI 10.3109/10425179409039703; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kahlon T. S., 2012, Food and Nutrition Sciences, V3, P401; KROON J, 1994, PLANT J, V5, P69, DOI 10.1046/j.1365-313X.1994.5010069.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Louveau T, 2011, FEBS J, V278, P390, DOI 10.1111/j.1742-4658.2010.07962.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Morita Y, 2005, PLANT J, V42, P353, DOI 10.1111/j.1365-313X.2005.02383.x; Nakatsuka T, 2008, J EXP BOT, V59, P1241, DOI 10.1093/jxb/ern031; Noguchi A, 2007, J BIOL CHEM, V282, P23581, DOI 10.1074/jbc.M702651200; Ogata J, 2005, NATURE, V435, P757, DOI 10.1038/nature435757a; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schro dinger Suite, 2012, SCHROD SUIT 2011 PRO; Schrodinger Suite, 2012, SCHROD SUIT IMP VERS; Schrodinger Suite, 2012, SCHROD SUIT PRIM VER; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092636; Sharma S, 2011, INT FOOD RES J, V20, P805; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Taguchi G, 2001, EUR J BIOCHEM, V268, P4086, DOI 10.1046/j.1432-1327.2001.02325.x; Tanaka Y, 1996, PLANT CELL PHYSIOL, V37, P711, DOI 10.1093/oxfordjournals.pcp.a029004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WISE RP, 1990, PLANT MOL BIOL, V14, P277, DOI 10.1007/BF00018568; Woo HH, 2007, GENOMICS, V90, P143, DOI 10.1016/j.ygeno.2007.03.014; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x	58	25	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109715	10.1371/journal.pone.0109715	http://dx.doi.org/10.1371/journal.pone.0109715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290312	Green Published, gold			2022-12-25	WOS:000342798000081
J	Kojima, K; Amano, Y; Yoshino, K; Tanaka, N; Sugamura, K; Takeshita, T				Kojima, Katsuhiko; Amano, Yuji; Yoshino, Kazuhisa; Tanaka, Nobuyuki; Sugamura, Kazuo; Takeshita, Toshikazu			ESCRT-0 Protein Hepatocyte Growth Factor-regulated Tyrosine Kinase Substrate (Hrs) Is Targeted to Endosomes Independently of Signal-transducing Adaptor Molecule (STAM) and the Complex Formation with STAM Promotes Its Endosomal Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY FORMATION; RECEPTOR DOWN-REGULATION; E VPS PROTEINS; UBIQUITIN ISOPEPTIDASE; MASTER MOLECULE; CELL-GROWTH; FYVE DOMAIN; MEMBRANE; BINDING; CARGO	The ESCRT-0 complex, consisting of the hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) and the signal-transducing adaptor molecule (STAM) proteins, recognizes ubiquitylated cargo during the initial step of endosomal sorting. The endosomal accumulation of overexpressed Hrs has been reported previously to be associated with endosome enlargement. In this study, we have found that co-expressing exogenous STAM1 in Hrs-overexpressing cells leads to a diffuse localization for a large part of the Hrs accumulated on endosomes and a recovery of the impaired cargo protein degradation process, thus suggesting that exogenous STAM abrogates the abnormalities of the Hrs-positive endosomes. A fluorescently labeled Hrs, introduced into the cells by membrane permeabilization, exhibited endosomal localization in the absence of STAM1 and gradually dissociated from the endosomes upon the sequential addition of recombinant STAM1. Furthermore, when microinjected into cells, the fluorescently labeled Hrs also showed endosomal accumulation; however, ESCRT-0 complexes formed prior to the microinjection did not. Analysis of the state of the complex in HeLa cells using blue-native PAGE revealed that the membrane-associated Hrs exists partly as a monomer and not only in the STAM1-bound form. Thus, our data suggest that the membrane binding and dissociation cycle of the ESCRT-0 proteins on the endosomal membrane is a critical step during the cargo sorting process.	[Kojima, Katsuhiko; Amano, Yuji; Yoshino, Kazuhisa; Takeshita, Toshikazu] Shinshu Univ, Sch Med, Dept Microbiol & Immunol, Matsumoto, Nagano 3908621, Japan; [Tanaka, Nobuyuki] Miyagi Canc Ctr, Res Inst, Div Immunol, Natori, Miyagi 9811293, Japan; [Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan	Shinshu University; Miyagi Cancer Center; Miyagi Cancer Center	Takeshita, T (corresponding author), Shinshu Univ, Sch Med, Dept Microbiol & Immunol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	takesit@shinshu-u.ac.jp	Takeshita, Toshikazu/AAL-1382-2021		 [C_25461586]; Grants-in-Aid for Scientific Research [25461586] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research C_25461586 (to T. T.).	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Fiala GJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2164; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kobayashi H, 2005, J BIOL CHEM, V280, P10468, DOI 10.1074/jbc.M409969200; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Miedema H, 1996, J MEMBRANE BIOL, V152, P159, DOI 10.1007/s002329900094; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	38	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33296	33310		10.1074/jbc.M114.578245	http://dx.doi.org/10.1074/jbc.M114.578245			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296754	hybrid, Green Published			2022-12-25	WOS:000345636600021
J	Krishnan, S; Paredes, JA; Zhou, XS; Kuiper, RV; Hultenby, K; Curbo, S; Karlsson, A				Krishnan, Shuba; Paredes, Joao A.; Zhou, Xiaoshan; Kuiper, Raoul V.; Hultenby, Kjell; Curbo, Sophie; Karlsson, Anna			Long Term Expression of Drosophila melanogaster Nucleoside Kinase in Thymidine Kinase 2-deficient Mice with No Lethal Effects Caused by Nucleotide Pool Imbalances	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISUBSTRATE DEOXYRIBONUCLEOSIDE KINASE; DNA DEPLETION MYOPATHY; MITOCHONDRIAL-DNA; DEOXYNUCLEOSIDE TRIPHOSPHATES; DNTP POOLS; PHOSPHORYLASE; REPLICATION; SAMHD1; CELLS; MNGIE	Mitochondrial DNA depletion caused by thymidine kinase 2 (TK2) deficiency can be compensated by a nucleoside kinase from Drosophila melanogaster (Dm-dNK) in mice. We show that transgene expression of Dm-dNK in Tk2 knock-out (Tk2(-/-)) mice extended the life span of Tk2(-/-) mice from 3 weeks to at least 20 months. The Dm-dNK(+/-)Tk2(-/-) mice maintained normal mitochondrial DNA levels throughout the observation time. A significant difference in total body weight due to the reduction of subcutaneous and visceral fat in the Dm-dNK(+/-)Tk2(-/-) mice was the only visible difference compared with control mice. This indicates an effect on fat metabolism mediated through residual Tk2 deficiency because Dm-dNK expression was low in both liver and fat tissues. Dm-dNK expression led to increased dNTP pools and an increase in the catabolism of purine and pyrimidine nucleotides but these alterations did not apparently affect the mice during the 20 months of observation. In conclusion, Dm-dNK expression in the cell nucleus expanded the total dNTP pools to levels required for efficient mitochondrial DNA synthesis, thereby compensated the Tk2 deficiency, during a normal life span of the mice. The Dm-dNK(+/-) mouse serves as a model for nucleoside gene or enzyme substitutions, nucleotide imbalances, and dNTP alterations in different tissues.	[Krishnan, Shuba; Paredes, Joao A.; Zhou, Xiaoshan; Curbo, Sophie; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, SE-14186 Huddinge, Sweden; [Kuiper, Raoul V.; Hultenby, Kjell] Karolinska Inst, Karolinska Univ Hosp, Div Clin Res Ctr, Dept Lab Med, SE-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Karlsson, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, F68, SE-14186 Huddinge, Sweden.	anna.karlsson@ki.se	Karlsson, Anna/E-7945-2018; curbo, sophie/AAA-8614-2020	curbo, sophie/0000-0002-0964-0712; Kuiper, Raoul/0000-0001-5645-2389; Karlsson, Anna/0000-0001-6843-6685; Paredes, Joao/0000-0002-7788-8939	Swedish Cancer Society [CAN 2011/1277]; Swedish Research Council [2010-2828]; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by Swedish Cancer Society Grant CAN 2011/1277, Swedish Research Council Grant 2010-2828, and the Karolinska Institutet.	Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frangini M, 2013, J BIOL CHEM, V288, P5624, DOI 10.1074/jbc.M112.441147; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002; Hirschhorn R, 1983, Birth Defects Orig Artic Ser, V19, P73; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Krishnan S, 2013, J BIOL CHEM, V288, P5072, DOI 10.1074/jbc.M112.437152; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Marti R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9; Martinon Fabio, 2010, Curr Rheumatol Rep, V12, P135, DOI 10.1007/s11926-010-0092-3; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Paredes JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053698; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Sheikhi M, 2013, FERTIL STERIL, V100, P170, DOI 10.1016/j.fertnstert.2013.03.018; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835; Solaroli N, 2007, MOL PHARMACOL, V72, P1593, DOI 10.1124/mol.107.037051; Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6; Tyynismaa H, 2010, METHODS, V51, P405, DOI 10.1016/j.ymeth.2010.03.009; Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042; Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200; Zheng XY, 2001, MOL PHARMACOL, V60, P262, DOI 10.1124/mol.60.2.262; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133; Zhou XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058843	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.588921	http://dx.doi.org/10.1074/jbc.M114.588921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296759	Green Published, hybrid			2022-12-25	WOS:000345335000037
J	Meng, XF; Dobruchowska, JM; Pijning, T; Lopez, CA; Kamerling, JP; Dijkhuizen, L				Meng, Xiangfeng; Dobruchowska, Justyna M.; Pijning, Tjaard; Lopez, Cesar A.; Kamerling, Johannis P.; Dijkhuizen, Lubbert			Residue Leu(940) Has a Crucial Role in the Linkage and Reaction Specificity of the Glucansucrase GTF180 of the Probiotic Bacterium Lactobacillus reuteri 180	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-CHARACTERIZATION; 121 REUTERANSUCRASE; GLUCAN PRODUCTS; YOUNG-CHILDREN; ACUTE DIARRHEA; EXOPOLYSACCHARIDES; DEXTRANSUCRASE; STRAINS; ENZYMES; ACID	Highly conserved glycoside hydrolase family 70 glucansucrases are able to catalyze the synthesis of alpha-glucans with different structure from sucrose. The structural determinants of glucansucrase specificity have remained unclear. Residue Leu(940) in domain B of GTF180, the glucansucrase of the probiotic bacterium Lactobacillus reuteri 180, was shown to vary in different glucansucrases and is close to the +1 glucosyl unit in the crystal structure of GTF180-Delta N in complex with maltose. Herein, we show that mutations in Leu(940) of wild-type GTF180-Delta N all caused an increased percentage of (alpha 1 -> 6) linkages and a decreased percentage of (alpha 1 -> 3) linkages in the products. alpha-Glucans with potential different physicochemical properties (containing 67-100% of (alpha 1 -> 6) linkages) were produced by GTF180 and its Leu(940) mutants. Mutant L940W was unable to form (alpha 1 -> 3) linkages and synthesized a smaller and linear glucan polysaccharide with only (alpha 1 -> 6) linkages. Docking studies revealed that the introduction of the large aromatic amino acid residue tryptophan at position 940 partially blocked the binding groove, preventing the isomalto-oligosaccharide acceptor to bind in an favorable orientation for the formation of (alpha 1 -> 3) linkages. Our data showed that the reaction specificity of GTF180 mutant was shifted either to increased polysaccharide synthesis (L940A, L940S, L940E, and L940F) or increased oligosaccharide synthesis (L940W). The L940W mutant is capable of producing a large amount of isomalto-oligosaccharides using released glucose from sucrose as acceptors. Thus, residue Leu(940) in domain B is crucial for linkage and reaction specificity of GTF180. This study provides clear and novel insights into the structure-function relationships of glucansucrase enzymes.	[Meng, Xiangfeng; Dobruchowska, Justyna M.; Kamerling, Johannis P.; Dijkhuizen, Lubbert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbial Physiol, NL-9747 AG Groningen, Netherlands; [Pijning, Tjaard; Lopez, Cesar A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Dijkhuizen, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	l.dijkhuizen@rug.nl	Pijning, Tjaard/HDO-3704-2022; Dijkhuizen, Lubbert/E-9454-2014; Pijning, Tjaard/ABA-2929-2021; Dijkhuizen, Lubbert/K-3539-2019; DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021	Pijning, Tjaard/0000-0003-4107-3663; Dijkhuizen, Lubbert/0000-0003-2312-7162; 	Chinese Scholarship Council; European Union [NOVOSIDES FP7-KBBE-2010-4-265854]	Chinese Scholarship Council(China Scholarship Council); European Union(European Commission)	This work was financially supported by the Chinese Scholarship Council (to X. M.), and by European Union project NOVOSIDES FP7-KBBE-2010-4-265854 (to L. D.).	Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dobruchowska JM, 2013, GLYCOBIOLOGY, V23, P1084, DOI 10.1093/glycob/cwt048; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Funane K, 2005, FEBS LETT, V579, P4739, DOI 10.1016/j.febslet.2005.07.050; Galle S, 2012, INT J FOOD MICROBIOL, V155, P105, DOI 10.1016/j.ijfoodmicro.2012.01.009; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hellmuth H, 2008, BIOCHEMISTRY-US, V47, P6678, DOI 10.1021/bi800563r; Irague R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077837; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Kaditzky SB, 2008, FOOD BIOTECHNOL, V22, P398, DOI 10.1080/08905430802470235; Kralj S, 2004, MICROBIOL-SGM, V150, P3681, DOI 10.1099/mic.0.27321-0; Kralj S, 2005, APPL ENVIRON MICROB, V71, P3942, DOI 10.1128/AEM.71.7.3942-3950.2005; Kralj S, 2005, BIOCHEMISTRY-US, V44, P9206, DOI 10.1021/bi050447q; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2006, FEBS J, V273, P3735, DOI 10.1111/j.1742-4658.2006.05376.x; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Leemhuis H, 2012, BIOCATAL BIOTRANSFOR, V30, P366, DOI 10.3109/10242422.2012.676301; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Monchois V, 1999, APPL MICROBIOL BIOT, V52, P660, DOI 10.1007/s002530051575; Monchois V, 2000, APPL ENVIRON MICROB, V66, P1923, DOI 10.1128/AEM.66.5.1923-1927.2000; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; MOOSER G, 1991, J BIOL CHEM, V266, P8916; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322; Olano-Martin E, 2000, BRIT J NUTR, V83, P247, DOI 10.1017/S0007114500000325; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Rosenfeldt V, 2002, PEDIATR INFECT DIS J, V21, P411, DOI 10.1097/00006454-200205000-00012; Shornikova AV, 1997, J PEDIATR GASTR NUTR, V24, P399, DOI 10.1097/00005176-199704000-00008; Thompson J, 2001, CARBOHYD RES, V331, P149, DOI 10.1016/S0008-6215(01)00028-3; Tubelius Py, 2005, Environ Health, V4, P25, DOI 10.1186/1476-069X-4-25; Van Geel-Schutten GH, 1999, APPL ENVIRON MICROB, V65, P3008; van Geel-Schutten GH, 1998, APPL MICROBIOL BIOT, V50, P697, DOI 10.1007/s002530051353; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; van Leeuwen SS, 2009, BIOMACROMOLECULES, V10, P580, DOI 10.1021/bm801240r; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	41	27	34	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.602524	http://dx.doi.org/10.1074/jbc.M114.602524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288798	Green Published, hybrid			2022-12-25	WOS:000345335000032
J	Maher, K; Kokelj, BJ; Butinar, M; Mikhaylov, G; Mancek-Keber, M; Stoka, V; Vasiljeva, O; Turk, B; Grigoryev, SA; Kopitar-Jerala, N				Maher, Katarina; Kokelj, Barbara Jeric; Butinar, Miha; Mikhaylov, Georgy; Mancek-Keber, Mateja; Stoka, Veronika; Vasiljeva, Olga; Turk, Boris; Grigoryev, Sergei A.; Kopitar-Jerala, Natasa			A Role for Stefin B (Cystatin B) in Inflammation and Endotoxemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caspase; Inflammasome; Mitochondria; Reactive Oxygen Species (ROS); Sepsis	PROGRESSIVE MYOCLONUS EPILEPSY; NF-KAPPA-B; NLRP3 INFLAMMASOME; CATHEPSIN-L; PATTERN-RECOGNITION; NALP3 INFLAMMASOME; SIGNAL TRANSDUCER; OXIDATIVE STRESS; GENE-EXPRESSION; TUMOR-CELLS	Background: The lack of cysteine cathepsin inhibitor, stefin B (cystatin B), results in progressive myoclonus epilepsy, type 1. Results: Stefin B deficiency in macrophages resulted in increased inflammasome activation. Conclusion: Stefin B-deficient mice are significantly more sensitive to e LPS-induced sepsis due to increased caspase-11 expression and mitochondrial damage. Significance: Stefin B has an important role in limiting the inflammatory response during LPS-induced sepsis. Stefin B (cystatin B) is an endogenous cysteine cathepsin inhibitor, and the loss-of-function mutations in the stefin B gene were reported in patients with Unverricht-Lundborg disease (EPM1). In this study we demonstrated that stefin B-deficient (StB KO) mice were significantly more sensitive to the lethal LPS-induced sepsis and secreted higher amounts of pro-inflammatory cytokines IL-1 and IL-18 in the serum. We further showed that increased caspase-11 gene expression and better pro-inflammatory caspase-1 and -11 activation determined in StB KO bone marrow-derived macrophages resulted in enhanced IL-1 processing. Pretreatment of macrophages with the cathepsin inhibitor E-64d did not affect secretion of IL-1, suggesting that the increased cathepsin activity determined in StB KO bone marrow-derived macrophages is not essential for inflammasome activation. Upon LPS stimulation, stefin B was targeted into the mitochondria, and the lack of stefin B resulted in the increased destabilization of mitochondrial membrane potential and mitochondrial superoxide generation. Collectively, our study demonstrates that the LPS-induced sepsis in StB KO mice is dependent on caspase-11 and mitochondrial reactive oxygen species but is not associated with the lysosomal destabilization and increased cathepsin activity in the cytosol.	[Maher, Katarina; Kokelj, Barbara Jeric; Butinar, Miha; Mikhaylov, Georgy; Stoka, Veronika; Vasiljeva, Olga; Turk, Boris; Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Maher, Katarina; Kokelj, Barbara Jeric; Butinar, Miha; Mikhaylov, Georgy; Stoka, Veronika] Jozef Stefan Int Postgrad Sch, SI-1000 Ljubljana, Slovenia; [Mancek-Keber, Mateja] Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Mancek-Keber, Mateja] EN FIST Ctr Excellence, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Ctr Excellence Integrated Approaches Chem & Biol, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, SI-1000 Ljubljana, Slovenia; [Maher, Katarina; Grigoryev, Sergei A.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; National Institute of Chemistry - Slovenia; University of Ljubljana; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kopitar-Jerala, N (corresponding author), Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia.	natasa.kopitar@ijs.si	Stoka, Veronika/AAM-2283-2021	Turk, Boris/0000-0002-9007-5764; Vasiljeva, Olga/0000-0003-3648-5460	Slovenian Research Agency [J3-0612, P-0140]; Commissariat a l'Energie Atomique et aux Energies Alternatives France-Slovenia grant; Slovenian Young Researcher Program; EMBO [ASTF 50-2012]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Commissariat a l'Energie Atomique et aux Energies Alternatives France-Slovenia grant; Slovenian Young Researcher Program; EMBO(European Molecular Biology Organization (EMBO))	This work was supported in part by Slovenian Research Agency Grants J3-0612 (to N. K. J.) and P-0140 (to B. T.) and Commissariat a l'Energie Atomique et aux Energies Alternatives France-Slovenia grant (to N. K. J.).; Supported by the Slovenian Young Researcher Program.; Recipient of EMBO Short Term Scholarship ASTF 50-2012 to visit the College of Medicine, Pennsylvania State University, Hershey, PA 17033.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Broz P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003144; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Butinar M, 2014, ONCOGENE, V33, P3392, DOI 10.1038/onc.2013.314; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Istomina NE, 2003, MOL CELL BIOL, V23, P6455, DOI 10.1128/MCB.23.18.6455-6468.2003; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Joensuu T, 2008, EPILEPSIA, V49, P557, DOI 10.1111/j.1528-1167.2007.01422.x; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kopitar-Jerala NA, 2005, FEBS LETT, V579, P2149, DOI 10.1016/j.febslet.2005.03.002; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Lenarcic B, 1998, BIOL CHEM, V379, P105; LEW W, 1988, J IMMUNOL, V140, P1895; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Luciano-Montalvo C, 2009, PLACENTA, V30, P464, DOI 10.1016/j.placenta.2009.03.003; Maher K, 2014, FEBS LETT, V588, P720, DOI 10.1016/j.febslet.2014.01.015; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nekrasov M, 2012, NAT STRUCT MOL BIOL, V19, P1076, DOI 10.1038/nsmb.2424; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Popova E. Y., 2012, PLOS ONE, V7; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Rinne R, 2002, ANN MED, V34, P380, DOI 10.1080/078538902320772124; Rivera-Rivera L, 2012, J NEUROVIROL, V18, P20, DOI 10.1007/s13365-011-0061-2; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHRECK R, 1992, J VIROL, V66, P6288, DOI 10.1128/JVI.66.11.6288-6293.1992; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Spes A, 2012, BIOL CHEM, V393, P1417, DOI 10.1515/hsz-2012-0213; Tegelberg S, 2012, J NEUROPATH EXP NEUR, V71, P40, DOI 10.1097/NEN.0b013e31823e68e1; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wu XY, 2007, CHINESE MED J-PEKING, V120, P893, DOI 10.1097/00029330-200705020-00008; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	68	41	44	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31736	31750		10.1074/jbc.M114.609396	http://dx.doi.org/10.1074/jbc.M114.609396			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288807	Green Published, hybrid			2022-12-25	WOS:000345314700007
J	Burgess, S; Freitag, DF; Khan, H; Gorman, DN; Thompson, SG				Burgess, Stephen; Freitag, Daniel F.; Khan, Hassan; Gorman, Donal N.; Thompson, Simon G.			Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENETIC-VARIANTS; RISK-FACTORS; TRIGLYCERIDES	Background: Previous Mendelian randomization studies have suggested that, while low-density lipoprotein cholesterol (LDL-c) and triglycerides are causally implicated in coronary artery disease (CAD) risk, high-density lipoprotein cholesterol (HDL-c) may not be, with causal effect estimates compatible with the null. Principal Findings: The causal effects of these three lipid fractions can be better identified using the extended methods of 'multivariable Mendelian randomization'. We employ this approach using published data on 185 lipid-related genetic variants and their associations with lipid fractions in 188,578 participants, and with CAD risk in 22,233 cases and 64,762 controls. Our results suggest that HDL-c may be causally protective of CAD risk, independently of the effects of LDL-c and triglycerides. Estimated causal odds ratios per standard deviation increase, based on 162 variants not having pleiotropic associations with either blood pressure or body mass index, are 1.57 (95% credible interval 1.45 to 1.70) for LDL-c, 0.91 (0.83 to 0.99, p-value = 0.028) for HDL-c, and 1.29 (1.16 to 1.43) for triglycerides. Significance: Some interventions on HDL-c concentrations may influence risk of CAD, but to a lesser extent than interventions on LDL-c. A causal interpretation of these estimates relies on the assumption that the genetic variants do not have pleiotropic associations with risk factors on other pathways to CAD. If they do, a weaker conclusion is that genetic predictors of LDL-c, HDL-c and triglycerides each have independent associations with CAD risk.	[Burgess, Stephen; Freitag, Daniel F.; Khan, Hassan; Gorman, Donal N.; Thompson, Simon G.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England	University of Cambridge	Burgess, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England.	sb452@medschl.cam.ac.uk	Khan, Hassan/D-6267-2013	Khan, Hassan/0000-0003-1468-8654; Burgess, Stephen/0000-0001-5365-8760	Wellcome Trust [100114]; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors received no specific funding for this work. Stephen Burgess is supported by a fellowship from the Wellcome Trust (100114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGRIST JD, 2006, J EXPT CRIMINOLOGY, V0002; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Burgess S, 2014, AM J EPIDEMIOL UNPUB; Burgess S, 2014, INT J EPIDEMIOL, V43, P922, DOI 10.1093/ije/dyu005; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; Hindorff L, 2013, TECHNICAL REPORT; Holmes MV, 2014, EUROPEAN HEART J; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; R Core Team, 2014, R LANG ENV STAT COMP; Sarwar N, 2009, CURR OPIN LIPIDOL, V20, P275, DOI 10.1097/MOL.0b013e32832dd4dc; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2011, EPIDEMIOLOGY, V22, P460, DOI 10.1097/EDE.0b013e31821d0426; Taylor F, 2011, COCHRANE DATABASE SY, V1; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wurtz P, 2013, J AM COLL CARDIOL, V62, P1906, DOI 10.1016/j.jacc.2013.07.085	25	59	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108891	10.1371/journal.pone.0108891	http://dx.doi.org/10.1371/journal.pone.0108891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302496	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400034
J	Carstens, M; McCrindle, TK; Adams, N; Diener, A; Guzha, DT; Murray, SL; Parker, JE; Denby, KJ; Ingle, RA				Carstens, Maryke; McCrindle, Tyronne K.; Adams, Nicolette; Diener, Anastashia; Guzha, Delroy T.; Murray, Shane L.; Parker, Jane E.; Denby, Katherine J.; Ingle, Robert A.			Increased Resistance to Biotrophic Pathogens in the Arabidopsis Constitutive Induced Resistance 1 Mutant Is EDS1 and PAD4-Dependent and Modulated by Environmental Temperature	PLOS ONE			English	Article							DISEASE-RESISTANCE; PLANT-DISEASE; TRIGGERED IMMUNITY; DEFENSE; EXPRESSION; PROTEINS; MUTATION; LEADS; ACTIVATION; SALICYLATE	The Arabidopsis constitutive induced resistance 1 (clr1) mutant displays salicylic acid (SA)-dependent constitutive expression of defence genes and enhanced resistance to biotrophic pathogens. To fLirther characterise the role of CIR1 in plant immunity we conducted epistasis analyses with two key components of the SA-signalling branch of the defence network, ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1) and PHYTOALEXIN DEFICIENT4 (PAD4). We demonstrate that the constitutive defence phenotypes of cirl require both EDS1 and PAD4, indicating that CIR1 lies upstream of the EDS1-PAD4 regulatory node in the immune signalling network. In light of this finding we examined EDS1 expression in cirl and observed increased protein, but not mRNA levels in this mutant, suggesting that CIR1 might act as a negative regulator of EDS1 via a posttranscriptional mechanism. Finally, as environmental temperature is known to influence the outcome of plant-pathogen interactions, we analysed cirl plants grown at 18, 22 or 25 degrees C We found that susceptibility to Pseudomonas syringae pv. tomato (Pst) DC3000 is modulated by temperature in ciri. Greatest resistance to this pa hogen (relative to PR-1:LUC control plants) was observed at 18 degrees C, while at 25 degrees C no difference in susceptibility between cirl and control plants was apparent. The increase in resistance to Pst DC3000 at 18 C correlated with a stunted growth phenotype, suggesting that activation of defence responses may be enhanced at lower temperatures in the cir1 mutant.	[Carstens, Maryke; McCrindle, Tyronne K.; Adams, Nicolette; Diener, Anastashia; Guzha, Delroy T.; Murray, Shane L.; Ingle, Robert A.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa; [Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Denby, Katherine J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Denby, Katherine J.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	University of Cape Town; Max Planck Society; University of Warwick; University of Warwick	Ingle, RA (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa.	Robert.ingle@uct.ac.za	Ingle, Robert A/C-5599-2008; Denby, Katherine/P-3464-2014	Ingle, Robert A/0000-0002-8362-3777; Denby, Katherine/0000-0002-7857-6814	National Research Foundation, South Africa [IFR2011032900062]; University of Cape Town; Max-Planck Society; Alexander von Humboldt Foundation	National Research Foundation, South Africa(National Research Foundation - South Africa); University of Cape Town; Max-Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This research was funded by a grant (IFR2011032900062) from the National Research Foundation, South Africa (www.nrEac.za) and by the University of Cape Town (www.uct.ac.za). Experiments carried out in Jane Parker's lab were funded by the Max-Planck Society (www.mpg.de) and an Alexander von Humboldt Foundation (www.humboldt-foundation.de/web/home.html) 'Sofja Kovaleskaja' award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Alcazar R, 2011, TRENDS PLANT SCI, V16, P666, DOI 10.1016/j.tplants.2011.09.001; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bhardwaj V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026968; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Cheng YT, 2011, P NATL ACAD SCI USA, V108, P14694, DOI 10.1073/pnas.1105685108; Clarke JD, 2001, PLANT J, V26, P409, DOI 10.1046/j.1365-313X.2001.2641041.x; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Glazebrook J, 1996, GENETICS, V143, P973; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Ingle RA, 2005, BIOMETALS, V18, P627, DOI 10.1007/s10534-005-2999-0; Jirage D, 2001, PLANT J, V26, P395, DOI 10.1046/j.1365-313X.2001.2641040.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Kwon SI, 2009, PLANT J, V57, P109, DOI 10.1111/j.1365-313X.2008.03669.x; Li X, 2001, MOL PLANT MICROBE IN, V14, P1131, DOI 10.1094/MPMI.2001.14.10.1131; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Murray SL, 2005, MOL PLANT PATHOL, V6, P31, DOI 10.1111/j.1364-3703.2004.00261.x; Murray SL, 2002, MOL PLANT MICROBE IN, V15, P557, DOI 10.1094/MPMI.2002.15.6.557; PARKER JE, 1993, PLANT J, V4, P821, DOI 10.1046/j.1365-313X.1993.04050821.x; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Venugopal SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000545; Wang Y, 2009, MOL PLANT MICROBE IN, V22, P498, DOI 10.1094/MPMI-22-5-0498; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842; Zhu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002318; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	40	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109853	10.1371/journal.pone.0109853	http://dx.doi.org/10.1371/journal.pone.0109853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303634	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400088
J	Wang, HC; Chen, Y; Chen, JB; Zhang, ZT; Lao, WS; Li, XZ; Huang, JS; Wang, T				Wang, Hongcai; Chen, Yan; Chen, Jinbo; Zhang, Zhentao; Lao, Wansheng; Li, Xizhi; Huang, Jinsha; Wang, Tao			Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models	PLOS ONE			English	Article							ENDOREPLICATION; NEURONS; POLYPLOIDY; INSIGHTS; BRAIN; DEATH	In Parkinson's disease (PD), neuronal cells undergo mitotic catastrophe and endoreduplication prior to cell death; however the regulatory mechanisms remain to be defined. In this study, we investigated cell cycle regulation of DNA polymerase (poly beta) in rotenone-based doparninergic cellular and animal models. Incubation with a low concentration (0.25.t,th4) of rotenone for 1.5 to 7 days resulted in a flattened cell body and decreased DNA replication during S phase, whereas a high concentration (2 mu M) of rotenone exposure resulted in enlarged, multi-nucleated cells and converted the mitotic cycle in to endorediaplication. Consistently, DNA poly 13, which is mainly involved in DNA repair synthesis, was upregulated to a high level following exposure to 2 RIVI rotenone. The abrogation of DNA poly ji by siRNiN transfection or dideo)(ycytidine (DDC) treatment attenuated the rotenone-induced endoreduplication. The cell cycle was reactivated in cyclin D-expressing dopaminergic neurons from the substantia nigra (SN) of rats following stereotactic (ST) infusion of rotenone. Increased DNA poly beta expression was observed in the substantia nigra pars compacta (SNc) and the substantia nigra pars reticulate (SNr) of rotenone-treated rats. Collectively, in the in vitro model of rotenone-induced mitotic catastrophe, the overexpression of DNA poly ji promotes endoreduplication; in the in vivo model, the upregulation of DNA poly beta and cell cycle reentry were also observed in the adult rat substantia nigra. Therefore, the cell cycle regulation of DNA poly beta may be involved in the pathological processes of PD, which resLilts in the induction of endoreduplication	[Wang, Hongcai; Chen, Jinbo; Li, Xizhi] Binzhou Med Univ, Affiliated Hosp, Dept Neurol, Binzhou City, Shandong Provin, Peoples R China; [Chen, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China; [Huang, Jinsha; Wang, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Peoples R China; [Zhang, Zhentao] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430072, Peoples R China; [Lao, Wansheng] Yangxin Tradit Chinese Med Hosp, Dept Surg, Binzhou City, Shandong Provin, Peoples R China	Binzhou Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Wang, HC (corresponding author), Binzhou Med Univ, Affiliated Hosp, Dept Neurol, Binzhou City, Shandong Provin, Peoples R China.	whc2891@126.com; wangtaowh@hust.edu.cn		Zhang, Zhentao/0000-0001-6708-1472	National Natural Science Foundation of China [81071021, 31171211, 81100958, 81200983]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (No. 81071021, No. 31171211, No. 81100958 and No. 81200983) from the National Natural Science Foundation of China (to Tao Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canitrot Y, 1999, FASEB J, V13, P1107, DOI 10.1096/fasebj.13.9.1107; Copani A, 2006, J NEUROSCI, V26, P10949, DOI 10.1523/JNEUROSCI.2793-06.2006; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Frade JM, 2010, CELL CYCLE, V9, P1934, DOI 10.4161/cc.9.10.11582; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; MATSUMOTO K, 1993, JPN J GENET, V68, P185, DOI 10.1266/jjg.68.185; Modi PK, 2012, MOL BIOL CELL, V23, P3722, DOI 10.1091/mbc.E12-02-0125; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Roy S, 2007, FEBS J, V274, P2005, DOI 10.1111/j.1742-4658.2007.05744.x; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sykora P, 2013, MECH AGEING DEV, V134, P440, DOI 10.1016/j.mad.2013.04.005; Trembleau A, 1998, BIOL CELL, V90, P39, DOI 10.1016/S0248-4900(98)80231-1; Xiong NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007878; Zhu X, 2008, NEUROPATH APPL NEURO, V34, P457, DOI 10.1111/j.1365-2990.2007.00908.x	16	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109697	10.1371/journal.pone.0109697	http://dx.doi.org/10.1371/journal.pone.0109697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303312	Green Submitted, gold, Green Published			2022-12-25	WOS:000343730400075
J	Yamazaki, T; Mori, M; Arai, S; Tateishi, R; Abe, M; Ban, M; Nishijima, A; Maeda, M; Asano, T; Kai, T; Izumino, K; Takahashi, J; Aoyama, K; Harada, S; Takebayashi, T; Gunji, T; Ohnishi, S; Seto, S; Yoshida, Y; Hiasa, Y; Koike, K; Yamamura, K; Inoue, K; Miyazaki, T				Yamazaki, Tomoko; Mori, Mayumi; Arai, Satoko; Tateishi, Ryosuke; Abe, Masanori; Ban, Mihoko; Nishijima, Akemi; Maeda, Maki; Asano, Takeharu; Kai, Toshihiro; Izumino, Kiyohiro; Takahashi, Jun; Aoyama, Kayo; Harada, Sei; Takebayashi, Toru; Gunji, Toshiaki; Ohnishi, Shin; Seto, Shinji; Yoshida, Yukio; Hiasa, Yoichi; Koike, Kazuhiko; Yamamura, Ken-ichi; Inoue, Ken-ichiro; Miyazaki, Toru			Circulating AIM as an Indicator of Liver Damage and Hepatocellular Carcinoma in Humans	PLOS ONE			English	Article							X-RECEPTOR-ALPHA; FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS; APOPTOSIS INHIBITOR; METABOLIC SYNDROME; GENE-EXPRESSION; NATURAL-HISTORY; HORMONE-THERAPY; MACROPHAGE AIM; ESTROGEN	Background: Hepatocellular carcinoma (HCC), the fifth most common cancer type and the third highest cause of cancer death worldwide, develops in different types of liver injuries, and is mostly associated with cirrhosis. However, non-alcoholic fatty liver disease often causes HCC with less fibrosis, and the number of patients with this disease is rapidly increasing. The high mortality rate and the pathological complexity of liver diseases and HCC require blood biomarkers that accurately reflect the state of liver damage and presence of HCC. Methods and Findings: Here we demonstrate that a circulating protein, apoptosis inhibitor of macrophage (AIM) may meet this requirement. A large-scale analysis of healthy individuals across a wide age range revealed a mean blood AIM of 4.99 +/- 1.8 mu g/ml in men and 6.06 +/- 2.1 mu g/ml in women. AIM levels were significantly augmented in the younger generation (20s-40s), particularly in women. Interestingly, AIM levels were markedly higher in patients with advanced liver damage, regardless of disease type, and correlated significantly with multiple parameters representing liver function. In mice, AIM levels increased in response to carbon tetrachloride, confirming that the high AIM observed in humans is the result of liver damage. In addition, carbon tetrachloride caused comparable states of liver damage in AIM-deficient and wild-type mice, indicating no influence of AIM levels on liver injury progression. Intriguingly, certain combinations of AIM indexes normalized to liver marker score significantly distinguished HCC patients from non-HCC patients and thus could be applicable for HCC diagnosis. Conclusion: AIM potently reveals both liver damage and HCC. Thus, our results may provide the basis for novel diagnostic strategies for this widespread and fatal disease.	[Yamazaki, Tomoko; Mori, Mayumi; Arai, Satoko; Nishijima, Akemi; Kai, Toshihiro; Aoyama, Kayo; Miyazaki, Toru] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan; [Tateishi, Ryosuke; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan; [Ban, Mihoko; Maeda, Maki; Izumino, Kiyohiro; Takahashi, Jun; Seto, Shinji; Inoue, Ken-ichiro] Inoue Hosp, Shunkaikai, Nagasaki, Japan; [Asano, Takeharu; Yoshida, Yukio] Jichi Med Univ, Saitama Med Ctr, Dept Gastroenterol, Omiya, Saitama, Japan; [Harada, Sei; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Gunji, Toshiaki] NTT Med Ctr, Ctr Prevent Med, Tokyo, Japan; [Ohnishi, Shin] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Yamamura, Ken-ichi] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto, Japan; [Miyazaki, Toru] Max Planck Univ Tokyo, Ctr Integrat Inflammol, Tokyo, Japan; [Miyazaki, Toru] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Ehime University; Jichi Medical University; Keio University; Kanto Medical Center NTT EC; National Center for Global Health & Medicine - Japan; Kumamoto University; Japan Science & Technology Agency (JST)	Miyazaki, T (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan.	tm@m.u-tokyo.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Takebayashi, Toru/AAB-9356-2019; Takebayashi, Toru/K-7526-2013; Harada, Sei/ABA-5975-2020; Tateishi, Ryosuke/G-7758-2014	Hiasa, Yoichi/0000-0003-4117-339X; Takebayashi, Toru/0000-0002-8268-8026; Takebayashi, Toru/0000-0002-8268-8026; Harada, Sei/0000-0003-2666-4932; Tateishi, Ryosuke/0000-0003-3021-2517; Mori, Mayumi/0000-0001-6190-9785; Arai, Satoko/0000-0002-6145-8686; Miyazaki, Toru/0000-0003-3842-4362	Japan Society for the Promotion of Science; CREST (JST); ONSENDO Co., Ltd.; Tokyo Biochemical Research Foundation; Takeda Science Foundation; Ono Medical Research Foundation; Grants-in-Aid for Scientific Research [221S0001, 25253056] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ONSENDO Co., Ltd.; Tokyo Biochemical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (A) (Japan Society for the Promotion of Science), CREST (JST), research grants by ONSENDO Co., Ltd. (to TM), Grants-in-Aid for Scientific Research (B) (Japan Society for the Promotion of Science) (to SA), research grants by The Tokyo Biochemical Research Foundation, Takeda Science Foundation and Ono Medical Research Foundation (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Arai S, 2014, SEMIN IMMUNOPATHOL, V36, P3, DOI 10.1007/s00281-013-0405-5; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; BAZIN H, 1969, IMMUNOLOGY, V17, P345; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Chagas AL, 2009, BRAZ J MED BIOL RES, V42, P958, DOI 10.1590/S0100-879X2009005000019; Day C P, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS377, DOI 10.1046/j.1440-1746.17.s3.31.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Gray J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-271; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hage FG, 2013, CURR OPIN CARDIOL, V28, P411, DOI 10.1097/HCO.0b013e32836205e7; Hamada M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4147; Han SI, 2014, HEPATOLOGY, V59, P1791, DOI 10.1002/hep.26951; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hydroglou P, 2007, GASTROENTEROL CLIN N, V36, P867, DOI 10.1016/j.gtc.2007.08.010; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Iwamura Y, 2012, BIOCHEM BIOPH RES CO, V422, P476, DOI 10.1016/j.bbrc.2012.05.018; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097037; Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0; Kim WK, 2008, EXP MOL MED, V40, P677, DOI 10.3858/emm.2008.40.6.677; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008412; Lundholm L, 2004, J MOL ENDOCRINOL, V32, P879, DOI 10.1677/jme.0.0320879; Mera K, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-27; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Miyazaki T, 2011, CIRC J, V75, P2522, DOI 10.1253/circj.CJ-11-0891; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436; Tiano JP, 2012, ENDOCRINOLOGY, V153, P2997, DOI 10.1210/en.2011-1980; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; Torres DM, 2012, SEMIN LIVER DIS, V32, P30, DOI 10.1055/s-0032-1306424; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Wang H, 2014, INT J MOL MED, V33, P550, DOI 10.3892/ijmm.2014.1619; Xu YX, 2012, CELL IMMUNOL, V278, P125, DOI 10.1016/j.cellimm.2012.07.007	48	29	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109123	10.1371/journal.pone.0109123	http://dx.doi.org/10.1371/journal.pone.0109123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302503	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400045
J	Alhassan, A; Makepeace, BL; LaCourse, EJ; Osei-Atweneboana, MY; Carlow, CKS				Alhassan, Andy; Makepeace, Benjamin L.; LaCourse, Elwyn James; Osei-Atweneboana, Mike Y.; Carlow, Clotilde K. S.			A Simple Isothermal DNA Amplification Method to Screen Black Flies for Onchocerca volvulus Infection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GLUTATHIONE-S-TRANSFERASE; PROTEIN DATABASE SEARCHES; IVERMECTIN TREATMENT; SENSITIVE DETECTION; ENDEMIC FOCI; DIAGNOSIS; TRANSMISSION; PCR; PREVALENCE	Onchocerciasis is a debilitating neglected tropical disease caused by infection with the filarial parasite Onchocerca volvulus. Adult worms live in subcutaneous tissues and produce large numbers of microfilariae that migrate to the skin and eyes. The disease is spread by black flies of the genus Simulium following ingestion of microfilariae that develop into infective stage larvae in the insect. Currently, transmission is monitored by capture and dissection of black flies and microscopic examination of parasites, or using the polymerase chain reaction to determine the presence of parasite DNA in pools of black flies. In this study we identified a new DNA biomarker, encoding O. volvulus glutathione S-transferase 1a (OvGST1a), to detect O. volvulus infection in vector black flies. We developed an OvGST1a-based loop-mediated isothermal amplification (LAMP) assay where amplification of specific target DNA is detectable using turbidity or by a hydroxy naphthol blue color change. The results indicated that the assay is sensitive and rapid, capable of detecting DNA equivalent to less than one microfilaria within 60 minutes. The test is highly specific for the human parasite, as no cross-reaction was detected using DNA from the closely related and sympatric cattle parasite Onchocerca ochengi. The test has the potential to be developed further as a field tool for use in the surveillance of transmission before and after implementation of mass drug administration programs for onchocerciasis.	[Alhassan, Andy; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Genome Biol, Ipswich, MA 01938 USA; [Makepeace, Benjamin L.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [LaCourse, Elwyn James] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Osei-Atweneboana, Mike Y.] Water Res Inst, Council Sci & Ind Res, Accra, Ghana	New England Biolabs; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Genome Biol, Ipswich, MA 01938 USA.	carlow@neb.com		LaCourse, James/0000-0001-9261-7136	New England Biolabs	New England Biolabs	CKSC and AA received funding from New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Programme for Onchocerciasis Control APOC, 2009, INF CONS EL ONCH TRA; Alhassan A, 2007, VET PARASITOL, V143, P155, DOI 10.1016/j.vetpar.2006.08.014; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Boatin BA, 1998, ANN TROP MED PARASIT, V92, pS41, DOI 10.1080/00034983.1998.11813364; Boatin BA, 2002, PARASITOLOGY, V125, P545, DOI 10.1017/S0031182002002494; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Bradley JE, 1996, ADV PARASIT, V37, P57, DOI 10.1016/S0065-308X(08)60219-5; Chandrashekar R, 1996, TROP MED INT HEALTH, V1, P575; Coffeng LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002759; Crump A, 2012, TRENDS PARASITOL, V28, P280, DOI 10.1016/j.pt.2012.04.005; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Enomoto Y, 2005, J CLIN MICROBIOL, V43, P951, DOI 10.1128/JCM.43.2.951-955.2005; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Fink DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Gopal H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001712; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Guevara AG, 2003, AM J TROP MED HYG, V68, P222, DOI 10.4269/ajtmh.2003.68.222; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Iseki H, 2007, J MICROBIOL METH, V71, P281, DOI 10.1016/j.mimet.2007.09.019; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; KATHOLI CR, 1995, J INFECT DIS, V172, P1414, DOI 10.1093/infdis/172.5.1414; Krause S, 2001, MOL BIOCHEM PARASIT, V117, P145, DOI 10.1016/S0166-6851(01)00342-5; Krueger A, 2007, ACTA TROP, V101, P1, DOI 10.1016/j.actatropica.2006.11.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Liebau E, 2000, MOL BIOCHEM PARASIT, V109, P101, DOI 10.1016/S0166-6851(00)00232-2; Lindblade KA, 2007, AM J TROP MED HYG, V77, P334, DOI 10.4269/ajtmh.2007.77.334; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MEREDITH SEO, 1991, EXP PARASITOL, V73, P335, DOI 10.1016/0014-4894(91)90105-6; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Mitashi P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002504; Morales-Hojas R, 2006, J HELMINTHOL, V80, P281, DOI 10.1079/JOH2005331; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nagamine K, 2001, CLIN CHEM, V47, P1742; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Osei-Atweneboana MY, 2012, INT J PARASITOL-DRUG, V2, P20, DOI 10.1016/j.ijpddr.2012.01.005; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perbandt M, 2005, J BIOL CHEM, V280, P12630, DOI 10.1074/jbc.M413551200; Perbandt M, 2008, J MOL BIOL, V377, P501, DOI 10.1016/j.jmb.2008.01.029; Pischke S, 2002, TROP MED INT HEALTH, V7, P526, DOI 10.1046/j.1365-3156.2002.00890.x; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Poon LLM, 2006, CLIN CHEM, V52, P303; Rodriguez-Perez MA, 2003, T ROY SOC TROP MED H, V97, P539, DOI 10.1016/S0035-9203(03)80018-4; Rodriguez-Perez MA, 2004, AM J TROP MED HYG, V70, P38, DOI 10.4269/ajtmh.2004.70.38; Rodriguez-Perez MA, 2006, AM J TROP MED HYG, V74, P1026, DOI 10.4269/ajtmh.2006.74.1026; Rodriguez-Perez MA, 2013, PARASITOL RES, V112, P3925, DOI 10.1007/s00436-013-3583-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sommer A, 2001, INFECT IMMUN, V69, P7718, DOI 10.1128/IAI.69.12.7718-7728.2001; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOE L, 1994, AM J TROP MED HYG, V51, P676, DOI 10.4269/ajtmh.1994.51.676; Toe L, 1998, J INFECT DIS, V178, P282, DOI 10.1086/517454; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; TREES AJ, 1992, PARASITOLOGY, V104, P247, DOI 10.1017/S0031182000061680; TREES AJ, 1992, PARASITOL TODAY, V8, P337, DOI 10.1016/0169-4758(92)90068-D; Unnasch T R, 1996, Methods Mol Biol, V50, P293; WAHL G, 1994, VET PARASITOL, V52, P297, DOI 10.1016/0304-4017(94)90121-X; Wahl G, 1998, PARASITOLOGY, V116, P327, DOI 10.1017/S0031182097002333; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; World Health Organization, 2001, CERT EL HUM ONCH CRI; World Health Organization (WHO), 2010, REP WORK OV GLOB IMP; Yameogo L, 1999, AM J TROP MED HYG, V60, P124, DOI 10.4269/ajtmh.1999.60.124; Yang BY, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-38; ZIMMERMAN PA, 1994, MOL BIOL EVOL, V11, P384; ZIMMERMAN PA, 1993, MOL BIOCHEM PARASIT, V58, P259, DOI 10.1016/0166-6851(93)90047-2	71	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108927	10.1371/journal.pone.0108927	http://dx.doi.org/10.1371/journal.pone.0108927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299656	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000343941200024
J	Chaudhari, V; Raghavan, V; Rao, BJ				Chaudhari, Vishalsingh; Raghavan, Vandana; Rao, Basuthkar J.			Preparation of Efficient Excision Repair Competent Cell-Free Extracts from C. reinhardtii Cells	PLOS ONE			English	Article							UV-SENSITIVE MUTANTS; INDUCED DNA-DAMAGE; DARK REPAIR; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS; HOMOLOG; GENE; NUCLEOTIDE; INHIBITION; RADIATION	Chlamydomonas reinhardtii is a prospective model system for understanding molecular mechanisms associated with DNA repair in plants and algae. To explore this possibility, we have developed an in vitro repair system from C. reinhardtii cell-free extracts that can efficiently repair UVC damage (Thymine-dimers) in the DNA. We observed that excision repair (ER) synthesis based nucleotide incorporation, specifically in UVC damaged supercoiled (SC) DNA, was followed by ligation of nicks. Photoreactivation efficiently competed out the ER in the presence of light. In addition, repair efficiency in cell-free extracts from ER deficient strains was several fold lower than that of wild-type cell extract. Interestingly, the inhibitor profile of repair DNA polymerase involved in C. reinhardtii in vitro ER system was akin to animal rather than plant DNA polymerase. The methodology to prepare repair competent cell-free extracts described in the current study can aid further molecular characterization of ER pathway in C. reinhardtii.	[Chaudhari, Vishalsingh; Raghavan, Vandana; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Rao, BJ (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjrao@tifr.res.in	Chaudhari, Vishalsingh/AAA-3269-2019	Chaudhari, Vishalsingh/0000-0002-6421-8602	Tata Institute of Fundamental Research (Department of Atomic Energy); Sir JC Bose Fellowship grant (Department of Science and Technology)	Tata Institute of Fundamental Research (Department of Atomic Energy); Sir JC Bose Fellowship grant (Department of Science and Technology)	Funding support was from the Tata Institute of Fundamental Research (Department of Atomic Energy) and Sir JC Bose Fellowship grant (Department of Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; BRITT AB, 1993, SCIENCE, V261, P1571, DOI 10.1126/science.8372351; Cenkci B, 2003, J BIOL CHEM, V278, P22574, DOI 10.1074/jbc.M303249200; Cordoba-Canero Dolores, 2012, Methods Mol Biol, V920, P263, DOI 10.1007/978-1-61779-998-3_18; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Cordoba-Canero D, 2010, J BIOL CHEM, V285, P7475, DOI 10.1074/jbc.M109.067173; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; DAVIES DR, 1967, MUTAT RES, V4, P765, DOI 10.1016/0027-5107(67)90085-1; Fidantsef AL, 2000, PLANT PHYSIOL, V124, P579, DOI 10.1104/pp.124.2.579; Gallego F, 2000, PLANT J, V21, P507, DOI 10.1046/j.1365-313x.2000.00694.x; Goldschmidt M, 2006, EMBO PRACTICAL COURS; Gutman BL, 2009, J BIOL CHEM, V284, P17006, DOI 10.1074/jbc.M109.008342; HARLOW GR, 1994, PLANT CELL, V6, P227, DOI 10.1105/tpc.6.2.227; Martinez-Macias MI, 2013, J BIOL CHEM, V288, P5496, DOI 10.1074/jbc.M112.427617; Martinez-Macias MI, 2012, MOL CELL, V45, P357, DOI 10.1016/j.molcel.2011.11.034; JENKINS ME, 1995, GENETICS, V140, P725; Li A, 2002, PLANT CELL, V14, P263, DOI 10.1105/tpc.010258; LITVAK S, 1985, PLANT MOL BIOL, V4, P311, DOI 10.1007/BF02418250; Liu ZR, 2000, PLANT J, V21, P519, DOI 10.1046/j.1365-313x.2000.00707.x; Liu ZR, 2003, PLANT PHYSIOL, V132, P1405, DOI 10.1104/pp.103.021808; Liu ZR, 2001, PLANT J, V26, P329, DOI 10.1046/j.1365-313X.2001.01031.x; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V50, P639, DOI 10.1111/j.1751-1097.1989.tb04320.x; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; PATRICK MH, 1977, PHOTOCHEM PHOTOBIOL, V25, P357, DOI 10.1111/j.1751-1097.1977.tb07355.x; Plecenikova A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105482; PODSTAVKOVA S, 1992, MUTAT RES, V293, P65, DOI 10.1016/0921-8777(92)90009-R; RASMUSSEN RE, 1964, NATURE, V203, P1360, DOI 10.1038/2031360a0; Roy S, 2011, PLANT CELL PHYSIOL, V52, P448, DOI 10.1093/pcp/pcr002; Sancar GB, 2000, MUTAT RES-FUND MOL M, V451, P25, DOI 10.1016/S0027-5107(00)00038-5; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; SMALL GD, 1987, MUTAT RES, V181, P31, DOI 10.1016/0027-5107(87)90284-3; SMALL GD, 1977, NUCLEIC ACIDS RES, V4, P2893, DOI 10.1093/nar/4.8.2893; Vlcek D, 1997, MUTAT RES-DNA REPAIR, V385, P243, DOI 10.1016/S0921-8777(97)00052-9; VLCEK D, 1987, MUTAT RES, V183, P169, DOI 10.1016/0167-8817(87)90059-9; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; Vonarx EJ, 1998, MUTAT RES-FUND MOL M, V400, P187, DOI 10.1016/S0027-5107(98)00043-8; Winters TA, 1999, NUCLEIC ACIDS RES, V27, P2423, DOI 10.1093/nar/27.11.2423; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Wood Richard D., 1995, Methods (Orlando), V7, P163, DOI 10.1006/meth.1995.1022; You ZY, 1998, MOL CELL BIOL, V18, P2668, DOI 10.1128/MCB.18.5.2668	42	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109160	10.1371/journal.pone.0109160	http://dx.doi.org/10.1371/journal.pone.0109160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299516	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200039
J	Kinjo, ER; Higa, GSV; Morya, E; Valle, AC; Kihara, AH; Britto, LRG				Kinjo, Erika R.; Higa, Guilherme S. V.; Morya, Edgard; Valle, Angela C.; Kihara, Alexandre H.; Britto, Luiz R. G.			Reciprocal Regulation of Epileptiform Neuronal Oscillations and Electrical Synapses in the Rat Hippocampus	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; PILOCARPINE MODEL; FREQUENCY OSCILLATIONS; INHIBITORY NETWORKS; GABA(A) RECEPTORS; CELL-DEATH; IN-VITRO; EXPRESSION; BRAIN; CARBENOXOLONE	Gap junction (GJ) channels have been recognized as an important mechanism for synchronizing neuronal networks. Herein, we investigated the participation of GJ channels in the pilocarpine-induced status epilepticus (SE) by analyzing electrophysiological activity following the blockade of connexins (Cx)-mediated communication. In addition, we examined the regulation of gene expression, protein levels, phosphorylation profile and distribution of neuronal Cx36, Cx45 and glial Cx43 in the rat hippocampus during the acute and latent periods. Electrophysiological recordings revealed that the GJ blockade anticipates the occurrence of low voltage oscillations and promotes a marked reduction of power in all analyzed frequencies. Cx36 gene expression and protein levels remained stable in acute and latent periods, whereas upregulation of Cx45 gene expression and protein redistribution were detected in the latent period. We also observed upregulation of Cx43 mRNA levels followed by changes in the phosphorylation profile and protein accumulation. Taken together, our results indisputably revealed that GJ communication participates in the epileptiform activity induced by pilocarpine. Moreover, considering that specific Cxs undergo alterations through acute and latent periods, this study indicates that the control of GJ communication may represent a focus in reliable anti-epileptogenic strategies.	[Kinjo, Erika R.; Higa, Guilherme S. V.; Kihara, Alexandre H.; Britto, Luiz R. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol, BR-05508 Sao Paulo, Brazil; [Kinjo, Erika R.; Higa, Guilherme S. V.; Kihara, Alexandre H.] Univ Fed ABC, Ctr Matemat Computacao Cognicao, Sao Paulo, Brazil; [Morya, Edgard] Inst Int Neurociencia Natal Edmond & Lily Safra, Natal, RN, Brazil; [Valle, Angela C.] Univ Sao Paulo, Fac Med, Dept Patol, Lab Neurociencias LIM 01, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Kinjo, ER (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol, BR-05508 Sao Paulo, Brazil.	erikareime@gmail.com; alexandrekihara@gmail.com	Kihara, Alexandre H/C-2458-2012; Morya, Edgard/K-4153-2012; Higa, Guilherme S. V./G-4282-2016; Valle, Angela/L-4400-2017; KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Kinjo, Erika R/C-9381-2014; MORYA, EDGARD/R-1251-2019	Kihara, Alexandre H/0000-0002-4027-7261; Morya, Edgard/0000-0003-0954-5317; Higa, Guilherme S. V./0000-0001-7006-9263; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; MORYA, EDGARD/0000-0003-0954-5317; Kinjo, Erika/0000-0003-2788-0880	FAPESP; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the following funders: FAPESP and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2001, ACTA NEUROPATHOL, V101, P449; Avoli M, 1996, EPILEPSIA, V37, P1035, DOI 10.1111/j.1528-1157.1996.tb01022.x; Beaumont M, 2011, J PHYSIOL-LONDON, V589, P1663, DOI 10.1113/jphysiol.2010.201491; Beheshti S, 2010, PROG NEURO-PSYCHOPH, V34, P510, DOI 10.1016/j.pnpbp.2010.02.006; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Butovas S, 2006, J NEUROPHYSIOL, V96, P1227, DOI 10.1152/jn.01170.2005; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CAVALHEIRO EA, 1995, ITAL J NEUROL SCI, V16, P33, DOI 10.1007/BF02229072; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062952; Collignon F, 2006, J NEUROSURG, V105, P77, DOI 10.3171/jns.2006.105.1.77; Condorelli DF, 2003, EUR J NEUROSCI, V18, P1807, DOI 10.1046/j.1460-9568.2003.02910.x; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; COYLE P, 1978, EXP NEUROL, V58, P549, DOI 10.1016/0014-4886(78)90108-5; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Cusato K, 2003, J NEUROSCI, V23, P6413; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Dere E, 2012, NEUROSCI BIOBEHAV R, V36, P206, DOI 10.1016/j.neubiorev.2011.05.015; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Fujikawa DG, 1996, BRAIN RES, V725, P11, DOI 10.1016/0006-8993(96)00203-X; Gajda Z, 2005, EPILEPSIA, V46, P1581, DOI 10.1111/j.1528-1167.2005.00254.x; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; GAMBARDELLA A, 1995, EPILEPSIA, V36, P122, DOI 10.1111/j.1528-1157.1995.tb00970.x; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Gigout S, 2006, NEUROBIOL DIS, V22, P496, DOI 10.1016/j.nbd.2005.12.011; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; HOSSAIN MZ, 1994, J NEUROCHEM, V62, P2394; Jacobson GM, 2010, BRAIN RES, V1360, P198, DOI 10.1016/j.brainres.2010.09.006; JELLINCK PH, 1993, J STEROID BIOCHEM, V46, P209, DOI 10.1016/0960-0760(93)90296-9; Kihara AH, 2008, DEV NEUROBIOL, V68, P1287, DOI 10.1002/dneu.20652; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Kihara AH, 2010, INT J DEV NEUROSCI, V28, P39, DOI 10.1016/j.ijdevneu.2009.09.006; Kinjo ER, 2013, EXP NEUROL, V248, P546, DOI 10.1016/j.expneurol.2013.07.022; Kirkpatrick MP, 2011, EPILEPSY BEHAV, V20, P392, DOI 10.1016/j.yebeh.2010.11.020; Kohling R, 2001, NEUROSCIENCE, V105, P579, DOI 10.1016/S0306-4522(01)00222-6; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Lehmkuhle MJ, 2009, J NEUROPHYSIOL, V101, P1660, DOI 10.1152/jn.91062.2008; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Maier N, 2002, J PHYSIOL-LONDON, V541, P521, DOI 10.1113/jphysiol.2002.017624; Maxeiner S, 2003, NEUROSCIENCE, V119, P689, DOI 10.1016/S0306-4522(03)00077-0; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Medvedev A, 2000, BRAIN RES BULL, V52, P89, DOI 10.1016/S0361-9230(00)00239-2; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Pais I, 2003, J NEUROPHYSIOL, V89, P2046, DOI 10.1152/jn.00549.2002; Parviainen I, 2002, NEUROLOGY, V59, P1249, DOI 10.1212/01.WNL.0000032253.88378.D7; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Perkins KL, 2002, J NEUROPHYSIOL, V87, P1404, DOI 10.1152/jn.00430.2001; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Postma F, 2011, P NATL ACAD SCI USA, V108, P13770, DOI 10.1073/pnas.1100166108; RAMSAY RE, 1993, EPILEPSIA, V34, pS71, DOI 10.1111/j.1528-1157.1993.tb05908.x; RASHKIN MC, 1987, NEUROLOGY, V37, P500, DOI 10.1212/WNL.37.3.500; Roopun AK, 2010, P NATL ACAD SCI USA, V107, P338, DOI 10.1073/pnas.0912652107; Ross FM, 2000, NEUROSCIENCE, V100, P789, DOI 10.1016/S0306-4522(00)00346-8; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Sohl G, 2000, MOL BRAIN RES, V83, P44, DOI 10.1016/S0169-328X(00)00195-9; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; STERIADE M, 1994, ELECTROEN CLIN NEURO, V90, P1, DOI 10.1016/0013-4694(94)90108-2; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; SWANK RL, 1949, J NEUROPHYSIOL, V12, P137, DOI 10.1152/jn.1949.12.2.137; Szente M, 2002, NEUROSCIENCE, V115, P1067, DOI 10.1016/S0306-4522(02)00533-X; Taira T, 1997, J NEUROPHYSIOL, V77, P2213, DOI 10.1152/jn.1997.77.4.2213; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; TIMOIARIA C, 1970, PHYSIOL BEHAV, V5, P1057, DOI 10.1016/0031-9384(70)90162-9; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 2001, J NEUROPHYSIOL, V85, P1246, DOI 10.1152/jn.2001.85.3.1246; TREIMAN DM, 1990, EPILEPSY RES, V5, P49, DOI 10.1016/0920-1211(90)90065-4; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uusisaaria M, 2002, NEUROPHARMACOLOGY, V43, P563, DOI 10.1016/S0028-3908(02)00156-9; VANNESS PC, 1990, EPILEPSIA, V31, P61; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Volgyi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069426; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Weickert S, 2005, MOL BRAIN RES, V133, P102, DOI 10.1016/j.molbrainres.2004.09.026; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Zhang XL, 2004, J PHYSIOL-LONDON, V558, P825, DOI 10.1113/jphysiol.2004.065649; Zhang Y, 1998, J NEUROSCI, V18, P9256; Zsiros V, 2007, J PHYSIOL-LONDON, V578, P527, DOI 10.1113/jphysiol.2006.123463	96	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109149	10.1371/journal.pone.0109149	http://dx.doi.org/10.1371/journal.pone.0109149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299405	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200038
J	Lovas, TO; Bruusgaard, JC; Oynebraten, I; Gundersen, K; Bogen, B				Lovas, Tom-Ole; Bruusgaard, Jo C.; Oynebraten, Inger; Gundersen, Kristian; Bogen, Bjarne			DNA Vaccines: MHC II-Targeted Vaccine Protein Produced by Transfected Muscle Fibres Induces a Local Inflammatory Cell Infiltrate in Mice	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; IN-VIVO; RECOMBINANT ANTIBODIES; FLUORESCENT PROTEINS; GENE DELIVERY; B-CELLS; ELECTROPORATION; IMMUNOGENICITY; EPITOPES; IMMUNOGLOBULIN	Vaccination with naked DNA holds great promise but immunogenicity needs to be improved. DNA constructs encoding bivalent proteins that bind antigen-presenting cells (APC) for delivery of antigen have been shown to enhance T and B cell responses and protection in tumour challenge experiments. However, the mechanism for the increased potency remains to be determined. Here we have constructed DNA vaccines that express the fluorescent protein mCherry, a strategy which allowed tracking of vaccine proteins. Transfected muscle fibres in mice were visualized, and their relationship to infiltrating mononuclear cells could be determined. Interestingly, muscle fibers that produced MHC class II-specific dimeric vaccine proteins with mCherry were for weeks surrounded by a localized intense cellular infiltrate composed of CD45(+), MHC class II+ and CD11b(+) cells. Increasing numbers of eosinophils were observed among the infiltrating cells from day 7 after immunization. The local infiltrate surrounding mCherry(+) muscle fibers was dependent on the MHC II-specificity of the vaccine proteins since the control, a non-targeted vaccine protein, failed to induce similar infiltrates. Chemokines measured on day 3 in immunized muscle indicate both a DNA effect and an electroporation effect. No influence of targeting was observed. These results contribute to our understanding for why targeted DNA vaccines have an improved immunogenicity.	[Lovas, Tom-Ole; Oynebraten, Inger; Bogen, Bjarne] Univ Oslo, Dept Immunol, Oslo, Norway; [Lovas, Tom-Ole; Oynebraten, Inger; Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Lovas, Tom-Ole; Oynebraten, Inger; Bogen, Bjarne] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Bruusgaard, Jo C.; Gundersen, Kristian] Univ Oslo, Dept Biosci, Oslo, Norway; [Bruusgaard, Jo C.] Kristiania Univ Coll, Norwegian Sch Hlth Sci, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, KG Jebsen Ctr Res Influenza Vaccines, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Kristiania University College; University of Oslo	Lovas, TO (corresponding author), Univ Oslo, Dept Immunol, Oslo, Norway.	tomolel@gmail.com; bjarne.bogen@medisin.uio.no	Øynebråten, Inger/W-3369-2019	Øynebråten, Inger/0000-0001-8914-5676; Bruusgaard, Jo Christiansen/0000-0001-8163-5849	University of Oslo; Medical Student Research Program	University of Oslo; Medical Student Research Program	This study was supported by the University of Oslo, The Medical Student Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; BAIER G, 1995, J VIROL, V69, P2357, DOI 10.1128/JVI.69.4.2357-2365.1995; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Bruusgaard JC, 2005, ACTA PHYSIOL SCAND, V185, P141, DOI 10.1111/j.1365-201X.2005.01462.x; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; CASTEN LA, 1988, J IMMUNOL, V140, P404; Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850; Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Fredriksen AB, 2006, MOL THER, V13, P776, DOI 10.1016/j.ymthe.2005.10.019; Fredriksen AB, 2007, BLOOD, V110, P1797, DOI 10.1182/blood-2006-06-032938; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Grodeland G, 2013, J IMMUNOL, V191, P3221, DOI 10.4049/jimmunol.1300504; Gronevik E, 2005, J GENE MED, V7, P218, DOI 10.1002/jgm.650; Gronevik E, 2003, J GENE MED, V5, P909, DOI 10.1002/jgm.416; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; KAWAMURA H, 1986, J IMMUNOL, V136, P58; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Liu JY, 2008, J VIROL, V82, P5643, DOI 10.1128/JVI.02564-07; Lunde E, 1999, NAT BIOTECHNOL, V17, P670, DOI 10.1038/10883; Lunde E, 1997, MOL IMMUNOL, V34, P1167, DOI 10.1016/S0161-5890(97)00143-0; Lunde E, 2002, J IMMUNOL, V168, P2154, DOI 10.4049/jimmunol.168.5.2154; Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138; Oynebraten I, 2012, SCAND J IMMUNOL, V75, P379, DOI 10.1111/j.1365-3083.2011.02639.x; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Peng BW, 2007, VACCINE, V25, P2064, DOI 10.1016/j.vaccine.2006.11.042; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Rasmussen IB, 2001, P NATL ACAD SCI USA, V98, P10296, DOI 10.1073/pnas.181336898; Rasmussen IB, 2012, PROTEIN ENG DES SEL, V25, P89, DOI 10.1093/protein/gzr063; Ratanamart J, 2010, J GENE MED, V12, P377, DOI 10.1002/jgm.1448; Schjetne KW, 2007, J IMMUNOL, V178, P4169, DOI 10.4049/jimmunol.178.7.4169; Schjetne KW, 2005, EUR J IMMUNOL, V35, P3142, DOI 10.1002/eji.200425947; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SNIDER DP, 1987, J IMMUNOL, V139, P1609; Stan AC, 2001, EUR J IMMUNOL, V31, P301, DOI 10.1002/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K; Tjelle TE, 2004, MOL THER, V9, P328, DOI 10.1016/j.ymthe.2003.12.007; Tunheim G, 2008, INT IMMUNOL, V20, P295, DOI 10.1093/intimm/dxm141; Tunheim G, 2007, VACCINE, V25, P4723, DOI 10.1016/j.vaccine.2007.04.004; Villarreal DO, 2013, EXPERT REV VACCINES, V12, P537, DOI [10.1586/erv.13.33, 10.1586/ERV.13.33]	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108069	10.1371/journal.pone.0108069	http://dx.doi.org/10.1371/journal.pone.0108069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299691	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200009
J	Pandey, S; Johnson, D; Kaplan, R; Klobusicky, J; Menon, G; Gracias, DH				Pandey, Shivendra; Johnson, Daniel; Kaplan, Ryan; Klobusicky, Joseph; Menon, Govind; Gracias, David H.			Self-Assembly of Mesoscale Isomers: The Role of Pathways and Degrees of Freedom	PLOS ONE			English	Article							FOLDING POLYHEDRA; CLUSTER; ARCHITECTURE; CHEMISTRY; SILICON; DESIGN; DNA	The spontaneous self-organization of conformational isomers from identical precursors is of fundamental importance in chemistry. Since the precursors are identical, it is the multi-unit interactions, characteristics of the intermediates, and assembly pathways that determine the final conformation. Here, we use geometric path sampling and a mesoscale experimental model to investigate the self-assembly of a model polyhedral system, an octahedron, that forms two isomers. We compute the set of all possible assembly pathways and analyze the degrees of freedom or rigidity of intermediates. Consequently, by manipulating the degrees of freedom of a precursor, we were able to experimentally enrich the formation of one isomer over the other. Our results suggest a new approach to direct pathways in both natural and synthetic self-assembly using simple geometric criteria. We also compare the process of folding and unfolding in this model with a geometric model for cyclohexane, a well-known molecule with chair and boat conformations.	[Pandey, Shivendra; Gracias, David H.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Johnson, Daniel; Kaplan, Ryan; Klobusicky, Joseph; Menon, Govind] Brown Univ, Div Appl Math, Providence, RI 02912 USA	Johns Hopkins University; Brown University	Menon, G (corresponding author), Brown Univ, Div Appl Math, Providence, RI 02912 USA.	menon@dam.brown.edu; dgracias@jhu.edu	Gracias, David/A-1942-2010	Gracias, David/0000-0003-2735-4725	National Science Foundation [EFRI 10-22730, EFRI 10-22638, CMMI 1200241]; Direct For Mathematical & Physical Scien [0748482] Funding Source: National Science Foundation; Div Of Civil, Mechanical, & Manufact Inn [1200241] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for this work came from National Science Foundation EFRI 10-22730 (http://nsf.gov) to DG and SP. Additional support came from National Science Foundation EFRI 10-22638 (http://nsf.gov) to RK, DJ, JK, and GM. Support for this work came from the National Science Foundation CMMI 1200241 (http://nsf.gov) to DG and SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Boldyrev AI, 1997, J AM CHEM SOC, V119, P4618, DOI 10.1021/ja964063m; Bowden NB, 2001, ACCOUNTS CHEM RES, V34, P231, DOI 10.1021/ar0000760; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Bruice P. Y, 2004, ORGANIC CHEM; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; Connelly R, 1977, PUBL MATH-PARIS, V47, P333, DOI DOI 10.1007/BF02684342; COOK KH, 1979, P NATL ACAD SCI USA, V76, P6157, DOI 10.1073/pnas.76.12.6157; Demaine ED, 2007, GEOMETRIC FOLDING ALGORITHMS: LINKAGES, ORIGAMI, POLYHEDRA, P299, DOI 10.1017/CBO9780511735172.023; EATON PE, 1964, J AM CHEM SOC, V86, P3157, DOI 10.1021/ja01069a041; Gracias DH, 2001, ALGORITHMIC AND COMPUTATIONAL ROBOTICS: NEW DIRECTIONS, P1; Gross R, 2008, P IEEE, V96, P1490, DOI 10.1109/JPROC.2008.927352; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Herman P, 1981, CHEM CATALYTIC HYDRO, P25; Jensen HJ, 2003, SELF ORG CRITICALITY; Jones W, 2008, SUPRAMOLECULAR ORG M; Kaur P, 1996, CHEM COMMUN, P273, DOI 10.1039/cc9960000273; KROTO HW, 1991, CHEM REV, V91, P1213, DOI 10.1021/cr00006a005; Leininger S, 2000, P NATL ACAD SCI USA, V97, P1380, DOI 10.1073/pnas.030264697; Leong TG, 2007, LANGMUIR, V23, P8747, DOI 10.1021/la700913m; Liu YZ, 2011, SCIENCE, V333, P436, DOI 10.1126/science.1204369; MAIER G, 1988, ANGEW CHEM INT EDIT, V27, P309, DOI 10.1002/anie.198803093; Pandey S, 2011, P NATL ACAD SCI USA, V108, P19885, DOI 10.1073/pnas.1110857108; PAQUETTE LA, 1983, J AM CHEM SOC, V105, P5446, DOI 10.1021/ja00354a043; Park SH, 1999, LANGMUIR, V15, P266, DOI 10.1021/la980658e; Popa Dan O., 2004, J MANUF PROCESS, V6, P52, DOI DOI 10.1016/S1526-6125(04)70059-6; Russel CA, 1975, ACS SYM SER, V12, P159; Sachse H., 1890, BER DTSCH CHEM GES, V23, P1363; Shea SL, 2003, PURE APPL CHEM, V75, P1239, DOI 10.1351/pac200375091239; SLEE T, 1989, INORG CHEM, V28, P2256, DOI 10.1021/ic00311a004; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Suzuki K, 2009, CHEM COMMUN, P1638, DOI 10.1039/b822311d; Van der Spek TM, 2006, ANN SCI, V63, P157, DOI 10.1080/00033790500480816; Weck M, 2000, J AM CHEM SOC, V122, P3546, DOI 10.1021/ja994099p; Wei J, 1999, IND ENG CHEM RES, V38, P5019, DOI 10.1021/ie990588m; WEIDENBRUCH M, 1993, ANGEW CHEM INT EDIT, V32, P545, DOI 10.1002/anie.199305451; WILLIAMS RC, 1958, BIOCHIM BIOPHYS ACTA, V28, P464, DOI 10.1016/0006-3002(58)90507-9; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zheng YR, 2011, J AM CHEM SOC, V133, P17045, DOI 10.1021/ja207217t	40	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108960	10.1371/journal.pone.0108960	http://dx.doi.org/10.1371/journal.pone.0108960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299051	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200026
J	Planque, B; Lindstrom, U; Subbey, S				Planque, Benjamin; Lindstrom, Ulf; Subbey, Sam			Non-Deterministic Modelling of Food-Web Dynamics	PLOS ONE			English	Article							ECOSYSTEM; COMPLEXITY; UNCERTAINTY; VALIDATION; PROTOCOL; ECOPATH; LESSONS; SYSTEMS; DIET; END	A novel approach to model food-web dynamics, based on a combination of chance (randomness) and necessity (system constraints), was presented by Mullon et al. in 2009. Based on simulations for the Benguela ecosystem, they concluded that observed patterns of ecosystem variability may simply result from basic structural constraints within which the ecosystem functions. To date, and despite the importance of these conclusions, this work has received little attention. The objective of the present paper is to replicate this original model and evaluate the conclusions that were derived from its simulations. For this purpose, we revisit the equations and input parameters that form the structure of the original model and implement a comparable simulation model. We restate the model principles and provide a detailed account of the model structure, equations, and parameters. Our model can reproduce several ecosystem dynamic patterns: pseudo-cycles, variation and volatility, diet, stock-recruitment relationships, and correlations between species biomass series. The original conclusions are supported to a large extent by the current replication of the model. Model parameterisation and computational aspects remain difficult and these need to be investigated further. Hopefully, the present contribution will make this approach available to a larger research community and will promote the use of non-deterministic-network-dynamics models as 'null models of food-webs' as originally advocated.	[Planque, Benjamin; Lindstrom, Ulf] Inst Marine Res, Tromso, Norway; [Subbey, Sam] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway	Planque, B (corresponding author), Inst Marine Res, Tromso, Norway.	benjamin.planque@imr.no	Lindstrom, Ulf/AAU-1327-2020; Planque, Benjamin/D-2729-2013	Planque, Benjamin/0000-0002-0557-7410; Chiaradia, Andre/0000-0002-6178-4211	Norwegian Research Council [200796/E10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council project 200796/E10 BarEcoRe: Barents Sea Ecosystem Resilience under global environmental change. The Norwegian Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Allen JI, 2007, J MARINE SYST, V64, P3, DOI 10.1016/j.jmarsys.2006.02.010; Aubin JP, 2011, VIABILITY THEORY: NEW DIRECTIONS, SECOND EDITION, P1, DOI 10.1007/978-3-642-16684-6; Bakun A., 1996, OCEAN PROCESSES MARI; Begley J, 2004, 2004FF ICES CM; Black AJ, 2012, TRENDS ECOL EVOL, V27, P337, DOI 10.1016/j.tree.2012.01.014; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Coulson T, 2004, TRENDS ECOL EVOL, V19, P359, DOI 10.1016/j.tree.2004.05.008; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; Cury PM, 2005, ICES J MAR SCI, V62, P577, DOI 10.1016/j.icesjms.2004.10.007; De Martino D, 2013, ARXIV13125228; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; DYER ME, 1988, SIAM J COMPUT, V17, P967, DOI 10.1137/0217060; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gilioli G, 2012, MATH BIOSCI ENG, V9, P75, DOI 10.3934/mbe.2012.9.75; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; HILBORN R, 1992; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Hutchings L, 1998, S AFR J MARINE SCI, V19, P211; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kavanagh P, 2004, ECOL MODEL, V172, P141, DOI 10.1016/j.ecolmodel.2003.09.004; Kearney KA, 2012, ECOL MODEL, V237, P43, DOI 10.1016/j.ecolmodel.2012.04.006; Koen-Alonso Mariano, 2007, P1; Lehuta S, 2013, FISH RES, V143, P57, DOI 10.1016/j.fishres.2013.01.008; Levin SA, 2005, BIOSCIENCE, V55, P1075, DOI 10.1641/0006-3568(2005)055[1075:SATEOC]2.0.CO;2; Lovasz L, 1999, MATH PROGRAM, V86, P443, DOI 10.1007/s101070050099; Monod J, 1970, HASARD NE CESSITE ES; Morris DJ, 2014, ECOL MODEL, V273, P251, DOI 10.1016/j.ecolmodel.2013.11.019; Mullon C., 2014, NETWORK EC MARINE EC; Mullon C, 2009, FISH FISH, V10, P115, DOI 10.1111/j.1467-2979.2008.00296.x; Niiranen S, 2012, AMBIO, V41, P613, DOI 10.1007/s13280-012-0324-z; Pinnegar JK, 2003, J FISH BIOL, V63, P197, DOI 10.1111/j.1095-8649.2003.00204.x; Plaganyi EE., 2007, FAO FISHERIES TECHNI; Plounevez S, 1999, ESTUAR COAST SHELF S, V49, P177, DOI 10.1006/ecss.1999.0497; Polovina J.J., 1984, FISHBYTE, V2, P5; Prigogine I., 1996, FIN CERTITUDES; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; Ulanowicz RE, 2014, ECOL LETT, V17, P127, DOI 10.1111/ele.12216; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	49	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108243	10.1371/journal.pone.0108243	http://dx.doi.org/10.1371/journal.pone.0108243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299245	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200012
J	Schmidt, J; Jentsch, H; Stingu, CS; Sack, U				Schmidt, Jana; Jentsch, Holger; Stingu, Catalina-Suzana; Sack, Ulrich			General Immune Status and Oral Microbiology in Patients with Different Forms of Periodontitis and Healthy Control Subjects	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE; AGGRESSIVE PERIODONTITIS; CYTOKINE; DISEASE; CELLS; INNATE; EXPRESSION; MONOCYTES; RESPONSES; FEATURES	Objective: Immunological processes in the etiopathogenesis of periodontitis, especially the aggressive form, are not well understood. This study examined clinical as well as systemic immunological and local microbiological features in healthy controls and patients with different forms of periodontitis. Materials and Methods: 14 healthy subjects, 15 patients diagnosed with aggressive periodontitis, and 11 patients with chronic periodontitis were recruited. Periodontal examination was performed and peripheral blood was collected from each patient. Lymphocyte populations as well as the release of cytokines by T-helper cells were determined by flow cytometry and enzyme linked immunosorbent spot assay. Subgingival plaque samples were taken from each individual and immediately cultivated for microbiological examination. Results: When stimulating peripheral blood mononuclear cells (PBMCs) with lipopolysaccharide, a higher IL-1 beta release was found in patients with moderate chronic periodontitis compared to the other groups (p<0.01). Numbers of B-cells, naive and transitional B-cells, memory B-cells, and switched memory B-cells were within the reference range for all groups, but patients with chronic periodontitis showed the highest percentage of memory B-cells without class switch (p = 0.01). The subgingival plaque differed quantitatively as well as qualitatively with a higher number of Gram-negative anaerobic species in periodontitis patients. Prevotella denticola was found more often in patients with aggressive periodontitis (p<0.001) but did not show an association to any of the systemic immunological findings. Porphyromonas gingivalis, which was only found in patients with moderate chronic periodontitis, seems to be associated with an activation of the systemic immune response. Conclusion: Differences between aggressive periodontitis and moderate chronic periodontitis are evident, which raises the question of an inadequate balance between systemic immune response and bacterial infection in aggressive periodontitis.	[Sack, Ulrich] Univ Leipzig, Inst Clin Immunol, D-04109 Leipzig, Germany; [Sack, Ulrich] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Schmidt, Jana; Jentsch, Holger] Univ Leipzig, Dept Cariol Endodontol & Periodontol, D-04109 Leipzig, Germany; [Stingu, Catalina-Suzana] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Schmidt, J (corresponding author), Univ Leipzig, Dept Cariol Endodontol & Periodontol, D-04109 Leipzig, Germany.	jana.schmidt@medizin.uni-leipzig.de	Sack, Ulrich/J-6301-2015	Sack, Ulrich/0000-0002-7813-0492	German Federal Ministry of Education and Research (BMBF) [1315883]; Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF 1315883). The study was supported by the Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany (http://www.trm.uni-leipzig.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2010, PERIODONTOL 2000, V53, P12, DOI 10.1111/j.1600-0757.2010.00353.x; Becerik S, 2012, J PERIODONTOL, V83, P1304, DOI 10.1902/jop.2012.110616; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Bostanci N, 2007, ORAL MICROBIOL IMMUN, V22, P52; Brown LJ, 2002, PERIODONTOL 2000, V29, P223, DOI 10.1034/j.1600-0757.2002.290111.x; Chi AC, 2010, AM FAM PHYSICIAN, V82, P1381; Darveau RP, 2009, DNA CELL BIOL, V28, P389, DOI 10.1089/dna.2009.0864; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dias IHK, 2011, J CLIN PERIODONTOL, V38, P1, DOI 10.1111/j.1600-051X.2010.01628.x; Ebersole JL, 2013, PERIODONTOL 2000, V62, P163, DOI 10.1111/prd.12005; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Gaffen SL, 2008, J DENT RES, V87, P817, DOI 10.1177/154405910808700908; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Goncalves TO, 2010, ARCH ORAL BIOL, V55, P975, DOI 10.1016/j.archoralbio.2010.08.002; Gonzales JR, 2007, J CLIN PERIODONTOL, V34, P473, DOI 10.1111/j.1600-051X.2007.01086.x; Guentsch A, 2009, J PERIODONTAL RES, V44, P368, DOI 10.1111/j.1600-0765.2008.01113.x; Imai Kenichi, 2011, J Oral Sci, V53, P1; Kobayashi R, 2011, J DENT RES, V90, P653, DOI 10.1177/0022034510397838; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lafaurie GI, 2007, J PERIODONTOL, V78, P629, DOI 10.1902/jop.2007.060187; Lange D E, 1977, Dtsch Zahnarztl Z, V32, P44; Li XY, 2012, J CELL BIOCHEM, V113, P2822, DOI 10.1002/jcb.24157; Lindhe J, 1999, ANN PERIODONTOL, V4, P38, DOI DOI 10.1902/ANNALS.1999.4.1.38; MARAZITA ML, 1994, J PERIODONTOL, V65, P623, DOI 10.1902/jop.1994.65.6.623; MODLIN RL, 1993, CURR OPIN IMMUNOL, V5, P511, DOI 10.1016/0952-7915(93)90031-M; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P10, DOI 10.1034/j.1600-051X.29.s3.1.x; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Nagasawa T, 2004, J PERIODONTAL RES, V39, P72, DOI 10.1111/j.1600-0765.2004.00713.x; Nakajima T, 2005, J DENT RES, V84, P639, DOI 10.1177/154405910508400711; Ogawa T, 2007, FRONT BIOSCI-LANDMRK, V12, P3795, DOI 10.2741/2353; Ohlrich EJ, 2009, AUST DENT J, V54, pS2, DOI 10.1111/j.1834-7819.2009.01139.x; Papaioannou W, 2009, ORAL MICROBIOL IMMUN, V24, P183, DOI 10.1111/j.1399-302X.2008.00493.x; Pitt T, 2011, ALLERGY ASTHMA CL IM, V7, DOI [10.1186/1710-1492-7-S1-S1, 10.1186/1710-1492-7-S1-S10]; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Rescala B, 2010, J PERIODONTOL, V81, P1308, DOI 10.1902/jop.2010.090643; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Salvi GE, 2008, J CLIN PERIODONTOL, V35, P398, DOI 10.1111/j.1600-051X.2008.01282.x; Scheres N, 2010, J PERIODONTAL RES, V45, P262, DOI 10.1111/j.1600-0765.2009.01229.x; Shiau HJ, 2010, J PERIODONTOL, V81, P1379, DOI 10.1902/jop.2010.100044; Slots J, 2003, INT DENT J, V53, P200, DOI 10.1111/j.1875-595X.2003.tb00771.x; Smedman C, 2009, J IMMUNOL METHODS, V346, P1, DOI 10.1016/j.jim.2009.04.001; Smith M, 2010, PERIODONTOL 2000, V53, P45, DOI 10.1111/j.1600-0757.2010.00354.x; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stingu CS, 2012, QUINTESSENCE INT, V43, pE23; Sugita N, 2012, J PERIODONTAL RES, V47, P105, DOI 10.1111/j.1600-0765.2011.01411.x; Taylor JJ, 2010, PERIODONTOL 2000, V54, P160, DOI 10.1111/j.1600-0757.2009.00344.x; Timmerman M F, 2006, Int J Dent Hyg, V4, P2; Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016; van der Weijden F, 2011, PERIODONTOL 2000, V55, P104, DOI 10.1111/j.1600-0757.2009.00337.x; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yun PLW, 2002, INFECT IMMUN, V70, P5695, DOI 10.1128/IAI.70.10.5695-5705.2002; Zaric S, 2010, INFECT IMMUN, V78, P4151, DOI 10.1128/IAI.00600-10	57	22	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109187	10.1371/journal.pone.0109187	http://dx.doi.org/10.1371/journal.pone.0109187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299619	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200040
J	Velroyen, A; Bech, M; Zanette, I; Schwarz, J; Rack, A; Tympner, C; Herrler, T; Staab-Weijnitz, C; Braunagel, M; Reiser, M; Bamberg, F; Pfeiffer, F; Notohamiprodjo, M				Velroyen, Astrid; Bech, Martin; Zanette, Irene; Schwarz, Jolanda; Rack, Alexander; Tympner, Christiane; Herrler, Tanja; Staab-Weijnitz, Claudia; Braunagel, Margarita; Reiser, Maximilian; Bamberg, Fabian; Pfeiffer, Franz; Notohamiprodjo, Mike			X-Ray Phase-Contrast Tomography of Renal Ischemia-Reperfusion Damage	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; COMPUTED-TOMOGRAPHY; DARK-FIELD; GRATING INTERFEROMETER; DISEASE; CT; MICROTOMOGRAPHY; ERYTHROCYTE; PERFUSION; FAILURE	Purpose: The aim of the study was to investigate microstructural changes occurring in unilateral renal ischemia-reperfusion injury in a murine animal model using synchrotron radiation. Material and Methods: The effects of renal ischemia-reperfusion were investigated in a murine animal model of unilateral ischemia. Kidney samples were harvested on day 18. Grating-Based Phase-Contrast Imaging (GB-PCI) of the paraffin-embedded kidney samples was performed at a Synchrotron Radiation Facility (beam energy of 19 keV). To obtain phase information, a two-grating Talbot interferometer was used applying the phase stepping technique. The imaging system provided an effective pixel size of 7.5 mu m. The resulting attenuation and differential phase projections were tomographically reconstructed using filtered back-projection. Semi-automated segmentation and volumetry and correlation to histopathology were performed. Results: GB-PCI provided good discrimination of the cortex, outer and inner medulla in non-ischemic control kidneys. Post-ischemic kidneys showed a reduced compartmental differentiation, particularly of the outer stripe of the outer medulla, which could not be differentiated from the inner stripe. Compared to the contralateral kidney, after ischemia a volume loss was detected, while the inner medulla mainly retained its volume (ratio 0.94). Post-ischemic kidneys exhibited severe tissue damage as evidenced by tubular atrophy and dilatation, moderate inflammatory infiltration, loss of brush borders and tubular protein cylinders. Conclusion: In conclusion GB-PCI with synchrotron radiation allows for non-destructive microstructural assessment of parenchymal kidney disease and vessel architecture. If translation to lab-based approaches generates sufficient density resolution, and with a time-optimized image analysis protocol, GB-PCI may ultimately serve as a non-invasive, non-enhanced alternative for imaging of pathological changes of the kidney.	[Velroyen, Astrid; Bech, Martin; Zanette, Irene; Schwarz, Jolanda; Pfeiffer, Franz] Dept Phys E17, Chair Biomed Phys, Munich, Bavaria, Germany; [Bech, Martin] Lund Univ, Lund, Sweden; [Rack, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Tympner, Christiane] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Herrler, Tanja] Univ Munich, Hosp Munich, Dept Gen Trauma Hand & Plast Surg, Munich, Germany; [Staab-Weijnitz, Claudia; Braunagel, Margarita; Reiser, Maximilian; Bamberg, Fabian; Notohamiprodjo, Mike] Univ Hosp Munich, Inst Clin Radiol, Munich, Germany; [Staab-Weijnitz, Claudia] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany; [Staab-Weijnitz, Claudia] Helmholtz Zentrum Munich, Munich, Germany; [Bamberg, Fabian; Notohamiprodjo, Mike] Univ Hosp Tuebingen, Dept Radiol, Tubingen, Germany	Lund University; European Synchrotron Radiation Facility (ESRF); University of Munich; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Notohamiprodjo, M (corresponding author), Univ Hosp Munich, Inst Clin Radiol, Munich, Germany.	mike.notohamiprodjo@uni-tuebingen.de	Staab-Weijnitz, Claudia A./P-1148-2016; Alexander, Rack/C-9397-2012; Bech, Martin/K-4331-2012	Staab-Weijnitz, Claudia A./0000-0002-1211-7834; Alexander, Rack/0000-0001-9486-3621; Bech, Martin/0000-0001-9109-7175; Zanette, Irene/0000-0001-6096-6059	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP) [DFG EXC-158]; DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC, FP7) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC, FP7)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP, Grant no. DFG EXC-158), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT, www.kit.edu). A. Velroyen acknowledges the TUM Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYATI A, 1990, ACTA PHYSIOL SCAND, V138, P13, DOI 10.1111/j.1748-1716.1990.tb08808.x; Bech M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03209; Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Bennett EE, 2010, MED PHYS, V37, P6047, DOI 10.1118/1.3501311; Braunagel M, 2013, WORLD J UROL; Chen GH, 2010, OPT EXPRESS, V18, P12960, DOI 10.1364/OE.18.012960; Chen XJ, 2012, ACAD RADIOL, V19, P562, DOI 10.1016/j.acra.2012.01.005; De Greef KE, 2003, KIDNEY INT, V63, P1697, DOI 10.1046/j.1523-1755.2003.00909.x; Diemoz PC, 2011, OPT EXPRESS, V19, P1691, DOI 10.1364/OE.19.001691; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Gang L, 2005, NUCL INSTRUM METH A, V548, P200, DOI 10.1016/j.nima.2005.03.090; Hahn D, 2013, BONE ARTIFACT REDUCT, P416; Hauser N, 2013, INVEST RADIOL; HELLBERG POA, 1990, KIDNEY INT, V37, P1240, DOI 10.1038/ki.1990.107; Herrler T, 2013, CELL TRANSPLANT, V22, P2091, DOI 10.3727/096368912X658700; Herrler T, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-2; Hetterich H, 2013, Z MED PHYS, V23, P194, DOI 10.1016/j.zemedi.2012.12.001; Hoste EAJ, 2007, CONTRIB NEPHROL, V156, P32; Hueper K, 2013, RADIOLOGY; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; Hueper K, 2011, EUR RADIOL, V21, P2427, DOI 10.1007/s00330-011-2189-0; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kang SK, 2013, INVEST RADIOL, V48, P687, DOI 10.1097/RLI.0b013e3182909e7b; KARLBERG L, 1982, SCAND J UROL NEPHROL, V16, P173, DOI 10.3109/00365598209179749; Lanzman RS, 2013, RADIOLOGY, V266, P218, DOI 10.1148/radiol.12112522; MASON J, 1984, KIDNEY INT, V26, P283, DOI 10.1038/ki.1984.171; MASON J, 1987, KIDNEY INT, V31, P65, DOI 10.1038/ki.1987.10; Meinel FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059526; Momose A, 2003, OPT EXPRESS, V11, P2303, DOI 10.1364/OE.11.002303; Momose A, 2009, OPT EXPRESS, V17, P12540, DOI 10.1364/OE.17.012540; Nesch I, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3213621; Noel PB, 2013, Z MED PHYS, V23, P204, DOI 10.1016/j.zemedi.2013.02.006; Nordsletten DA, 2006, AM J PHYSIOL-HEART C, V291, pH296, DOI 10.1152/ajpheart.00814.2005; Notohamiprodjo M, 2011, J MAGN RESON IMAGING, V34, P595, DOI 10.1002/jmri.22640; Notohamiprodjo M, 2010, EUR J RADIOL, V76, P337, DOI 10.1016/j.ejrad.2010.05.033; Notohamiprodjo M, 2010, INVEST RADIOL, V45, P245, DOI 10.1097/RLI.0b013e3181d83abc; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pollard R, 2006, COMPARATIVE MED, V56, P215; Reinhard B., 1850, CHARITE ANN, V1, P185; Rossi C, 2013, INVEST RADIOL, V48, P671, DOI 10.1097/RLI.0b013e31828b9830; Saam T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073513; Schleede S, 2012, P NATL ACAD SCI USA, V109, P17880, DOI 10.1073/pnas.1206684109; Schulz G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00826; Shirai R, 2014, J SYNCHROTRON RADIAT, V21, P795, DOI 10.1107/S1600577514010558; Sidebotham David, 2012, J Extra Corpor Technol, V44, P235; Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Tanaka J, 2013, Z MED PHYS, V23, P222, DOI 10.1016/j.zemedi.2012.11.004; Velroyen A, 2013, PHYS MED BIOL, V58, pN37, DOI 10.1088/0031-9155/58/4/N37; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wallace D, 2008, KIDNEY INT, V73, P778, DOI 10.1038/sj.ki.5002771; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2010, P SPIE, V7804; Wu J, 2009, KIDNEY INT, V75, P945, DOI 10.1038/ki.2009.42; Xie L, 2014, MAGN RESON MED; Yalavarthy Rajesh, 2007, Hemodial Int, V11 Suppl 3, pS7, DOI 10.1111/j.1542-4758.2007.00223.x; Yaroshenko A, 2013, RADIOLOGY, V269, P426, DOI 10.1148/radiol.13122413; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Zimmer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053849	62	21	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109562	10.1371/journal.pone.0109562	http://dx.doi.org/10.1371/journal.pone.0109562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299243	Green Submitted, Green Published, gold			2022-12-25	WOS:000343941200060
J	Weinstock, M; Grimm, I; Dreier, J; Knabbe, C; Vollmer, T				Weinstock, Melanie; Grimm, Imke; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja			Genetic Variants in Genes of the Inflammatory Response in Association with Infective Endocarditis	PLOS ONE			English	Article							TNF-ALPHA; PROMOTER POLYMORPHISM; SEPTIC SHOCK; HEART-VALVES; IL-1-BETA; MORTALITY; SEPSIS; SUSCEPTIBILITY; EXPRESSION; SECRETION	Aims: Inflammation in infective endocarditis (IE) is a complex network including interactions of inflammatory cytokines and other components of host response. Certainly, any variation in this network could influence susceptibility or disease progression of IE. In this study, 14 single nucleotide variants (SNVs) in genes coding for interleukin-1 beta, interleukin-6, interleukin-10, toll-like receptor-4, tumor necrosis factor-alpha, selectin E and intercellular adhesion molecule-1 were analyzed for an association with susceptibility to IE and correlated with disease-related laboratory parameters. Furthermore, the occurrence of SNVs was examined to elucidate pathogen-dependent associations. Methods and Results: The distribution of SNVs was determined in IE-patients and healthy blood donors by RFLP analysis. White blood cells (WBC) were counted using flow cytometry, concentration of C-reactive protein and procalcitonin was measured immunologically. Interleukin-6 c. 471+870G>A genotypes differed significantly between IE patients and controls. The frequency of the heterozygote genotype GA was considerably higher in the patient group (68.9% vs. 43.8%, P-c<0.0003). Interleukin-6 c.-237 minor allele frequency was increased in patients, although not statistically significant. Additionally, we detected a potential relation between interleukin-1 beta c.315C>T and IE. Pathogen-dependent analysis showed no significantly associated subgroup in relation to IE susceptibility, but gave hints towards alterations regarding Enterococcus-caused IE cases. Patients with genotype selectin-E c.-19 GT tend to have higher preoperative WBC counts than patients with genotype GG. We further showed an association between two interleukin-1 beta SNVs and laboratory biomarkers. Conclusion: This study shows genetic predispositions for the establishment of IE. Furthermore, correlation of SNVs with disease-related biomarkers suggests a role of genetic variants regarding the inflammatory response in IE.	[Weinstock, Melanie; Grimm, Imke; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja] Ruhr Univ Bochum, Univ Klinikum, Herz & Diabet Zentrum Nordrhein Westfalen, Inst Lab & Transfus Med, Bad Oeynhausen, Germany	Ruhr University Bochum	Vollmer, T (corresponding author), Ruhr Univ Bochum, Univ Klinikum, Herz & Diabet Zentrum Nordrhein Westfalen, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	tvollmer@hdz-nrw.de	Vollmer, Tanja/F-1149-2013; Dreier, Jens/F-1134-2013	Vollmer, Tanja/0000-0001-7032-5423; Dreier, Jens/0000-0002-1337-7750	Ruhr-Universitat Bochum Medizinische Fakultat (FoRUM)	Ruhr-Universitat Bochum Medizinische Fakultat (FoRUM)	This work was supported by Ruhr-Universitat Bochum Medizinische Fakultat (FoRUM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber RC, 2006, CLIN MED RES, V4, P250, DOI 10.3121/cmr.4.4.250; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Bustamante J, 2011, REV ESP CARDIOL, V64, P1056, DOI [10.1016/j.recesp.2011.02.024, 10.1016/j.rec.2011.02.027]; Cornelissen CG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-272; Daga S, 2011, MICROBES INFECT, V13, P216, DOI 10.1016/j.micinf.2010.10.016; Dahmer Mary K, 2005, Pediatr Crit Care Med, V6, pS61, DOI 10.1097/01.PCC.0000161970.44470.C7; Dankert J, 2006, INFECT IMMUN, V74, P947, DOI 10.1128/IAI.74.2.947-952.2006; Eklund C, 2003, EUR CYTOKINE NETW, V14, P168; Enquobahrie DA, 2009, ATHEROSCLEROSIS, V202, P513, DOI 10.1016/j.atherosclerosis.2008.05.018; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hoen B, 2013, NEW ENGL J MED, V369, P785, DOI 10.1056/NEJMc1307282; Humphries SE, 2001, EUR HEART J, V22, P2243, DOI 10.1053/euhj.2001.2678; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; Jilma B, 2005, BLOOD, V105, P2380, DOI 10.1182/blood-2004-09-3752; Khankhanian P, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-126; Kimura R, 2004, GENES IMMUN, V5, P572, DOI 10.1038/sj.gene.6364128; Kumpf O, 2008, INT J ANTIMICROB AG, V32, pS44, DOI 10.1016/j.ijantimicag.2008.08.002; Mekinian A, 2011, EUR CYTOKINE NETW, V22, P88, DOI 10.1684/ecn.2011.0285; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Muller AM, 2000, J PATHOL, V191, P54, DOI 10.1002/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Sabelnikovs O N-ZL, 2012, J SCI RES REPORTS; Shun CT, 2005, INFECT IMMUN, V73, P3261, DOI 10.1128/IAI.73.6.3261-3270.2005; Sutherland AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7702; Tischendorf JJW, 2007, INT J IMMUNOGENET, V34, P413, DOI 10.1111/j.1744-313X.2007.00712.x; Vollmer T, 2010, EUR HEART J, V31, P1105, DOI 10.1093/eurheartj/ehp600; Vollmer T, 2009, CLIN BIOCHEM, V42, P1413, DOI 10.1016/j.clinbiochem.2009.06.010; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53; Yoshida M, 2003, ARTERIOSCL THROM VAS, V23, P783, DOI 10.1161/01.ATV.0000067427.40133.59	31	15	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110151	10.1371/journal.pone.0110151	http://dx.doi.org/10.1371/journal.pone.0110151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299518	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200103
J	Chazal, M; Nzounza, P; Pique, C; Ramirez, BC				Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia			Loss of Infectivity of HIV-1 Particles Produced by Mobile Lymphocytes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; SPREAD	HIV-1 spreads by cell-free particles and through direct cell contacts. To discriminate between these two modes of dissemination, an assay in which the cells are cultured under shaking conditions impairing cell-to-cell transmission has been described. We addressed the impact of shaking on HIV-1 particle infectivity. Kinetics of HIV-1 infection in static or shaking conditions confirmed that HIV-1 replication is reduced in mobile lymphocyte T cells. Strikingly, the infectivity of viruses produced by mobile lymphocytes was dramatically reduced. In parallel, the amount of envelope protein present on these particles showed a continuous decrease over time. We conclude that inefficient HIV-1 replication in mobile lymphocytes in this experimental system is not only due to avoidance of viral cell-to-cell transfer but also to the loss of infectivity of the viral particles due to the alteration of the composition and functionality of the particles produced by these lymphocytes. It is important to take these observations into account when studying viral transmission under shaking conditions.	[Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia] INSERM, Inst Cochin, U1016, Paris, France; [Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia] CNRS, UMR8104, Paris, France; [Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ramirez, BC (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.	cecilia.ramirez@inserm.fr	Pique, Claudine/O-6088-2017; RAMIREZ, Cecilia/O-6100-2017	Pique, Claudine/0000-0001-8690-2440; RAMIREZ, Cecilia/0000-0002-6670-9827; CHAZAL, Maxime/0000-0002-3144-5032	SIDACTION; Agence National de Recherche contre le SIDA (ANRS)	SIDACTION; Agence National de Recherche contre le SIDA (ANRS)	This study was supported by grants from SIDACTION and the Agence National de Recherche contre le SIDA (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Hammonds J, 2003, VIROLOGY, V314, P636, DOI 10.1016/S0042-6822(03)00467-7; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Keler T, 1996, J ACQ IMMUN DEF SYND, V13, P117, DOI 10.1097/00042560-199610010-00002; Komarova NL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1049; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Nzounza P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030130; Puigdomenech I, 2013, J VIROL, V87, P2846, DOI 10.1128/JVI.02514-12; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	12	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109601	10.1371/journal.pone.0109601	http://dx.doi.org/10.1371/journal.pone.0109601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295863	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000085
J	Kilby, MC; Slobounov, SM; Newell, KM				Kilby, Melissa C.; Slobounov, Semyon M.; Newell, Karl M.			Postural Instability Detection: Aging and the Complexity of Spatial-Temporal Distributional Patterns for Virtually Contacting the Stability Boundary in Human Stance	PLOS ONE			English	Article							TIME-TO-CONTACT; DYNAMICAL STRUCTURE; RISK; DIRECTION; FALLS; SWAY; ASYMMETRY; BALANCE; LIMITS; MODEL	Falls among the older population can severely restrict their functional mobility and even cause death. Therefore, it is crucial to understand the mechanisms and conditions that cause falls, for which it is important to develop a predictive model of falls. One critical quantity for postural instability detection and prediction is the instantaneous stability of quiet upright stance based on motion data. However, well-established measures in the field of motor control that quantify overall postural stability using center-of-pressure (COP) or center-of-mass (COM) fluctuations are inadequate predictors of instantaneous stability. For this reason, 2D COP/COM virtual-time-to-contact (VTC) is investigated to detect the postural stability deficits of healthy older people compared to young adults. VTC predicts the temporal safety margin to the functional stability boundary (= limits of the region of feasible COP or COM displacement) and, therefore, provides an index of the risk of losing postural stability. The spatial directions with increased instability were also determined using quantities of VTC that have not previously been considered. Further, Lempel-Ziv-Complexity (LZC), a measure suitable for on-line monitoring of stability/instability, was applied to explore the temporal structure or complexity of VTC and the predictability of future postural instability based on previous behavior. These features were examined as a function of age, vision and different load weighting on the legs. The primary findings showed that for old adults the stability boundary was contracted and VTC reduced. Furthermore, the complexity decreased with aging and the direction with highest postural instability also changed in aging compared to the young adults. The findings reveal the sensitivity of the time dependent properties of 2D VTC to the detection of postural instability in aging, availability of visual information and postural stance and potential applicability as a predictive model of postural instability during upright stance.	[Kilby, Melissa C.; Slobounov, Semyon M.; Newell, Karl M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Slobounov, Semyon M.; Newell, Karl M.] Penn State Univ, Ctr Sport Concuss Res & Serv, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kilby, MC (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	mck18@psu.edu						Allum JHJ, 2002, J PHYSIOL-LONDON, V542, P643, DOI 10.1113/jphysiol.2001.015644; Blaszczyk JW, 2000, J BIOMECH, V33, P1243, DOI 10.1016/S0021-9290(00)00097-X; Close JCT, 2005, BEST PRACT RES CL RH, V19, P913, DOI 10.1016/j.berh.2005.06.002; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; CUMMING RG, 1994, J AM GERIATR SOC, V42, P774, DOI 10.1111/j.1532-5415.1994.tb06540.x; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Dubowsky S., 2000, P IEEE INT C ROB AUT, V1, P570, DOI DOI 10.1109/R0B0T.2000.844114; Forth KE, 2007, GAIT POSTURE, V25, P56, DOI 10.1016/j.gaitpost.2005.12.008; Gu MJ, 1996, J BIOMECH, V29, P319, DOI 10.1016/0021-9290(95)00052-6; Haddad JM, 2008, EXP BRAIN RES, V190, P431, DOI 10.1007/s00221-008-1483-9; Haibach PS, 2007, EXP BRAIN RES, V177, P471, DOI 10.1007/s00221-006-0703-4; Hasson CJ, 2009, EXP BRAIN RES, V196, P413, DOI 10.1007/s00221-009-1865-7; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; KASPAR F, 1987, PHYS REV A, V36, P842, DOI 10.1103/PhysRevA.36.842; Kazennikov O. V., 2013, Human Physiology, V39, P392, DOI 10.1134/S0362119713030109; King AC, 2012, EXP BRAIN RES, V220, P239, DOI 10.1007/s00221-012-3133-5; KING MB, 1994, J GERONTOL, V49, pM258, DOI 10.1093/geronj/49.6.M258; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Manckoundia P, 2008, CLIN INTERV AGING, V3, P667; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Maurer MS, 2005, J GERONTOL A-BIOL, V60, P1157, DOI 10.1093/gerona/60.9.1157; NEWELL KM, 1993, GAIT POSTURE, V1, P225, DOI 10.1016/0966-6362(93)90050-B; Newell KM, 1998, APPLICATIONS OF NONLINEAR DYNAMICS TO DEVELOPMENTAL PROCESS MODELING, P63; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Park JW, 2014, J PHYS THER SCI, V26, P381, DOI 10.1589/jpts.26.381; Patton JL, 1999, GAIT POSTURE, V9, P38, DOI 10.1016/S0966-6362(98)00037-X; Prado JM, 2011, GAIT POSTURE, V33, P93, DOI 10.1016/j.gaitpost.2010.10.003; RICCIO GE, 1993, VARIABILITY AND MOTOR CONTROL, P317; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Rothwell JC, 1993, CONTROL HUMAN VOLUNT; SHELDON JH, 1963, GERONTOLOGY, V5, P129; Slobounov S, 2008, NEUROSCI LETT, V442, P309, DOI 10.1016/j.neulet.2008.07.021; Slobounov SM, 1997, J MOTOR BEHAV, V29, P263, DOI 10.1080/00222899709600841; Slobounov SM, 1998, J GERONTOL A-BIOL, V53, pB71, DOI 10.1093/gerona/53A.1.B71; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Stalenhoef PA, 2002, J CLIN EPIDEMIOL, V55, P1088, DOI 10.1016/S0895-4356(02)00502-4; Tolkiehn M, 2011, IEEE ENG MED BIO, P369, DOI 10.1109/IEMBS.2011.6090120; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	49	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108905	10.1371/journal.pone.0108905	http://dx.doi.org/10.1371/journal.pone.0108905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295589	Green Submitted, gold, Green Published			2022-12-25	WOS:000345204000027
J	Patel, AV; Hildebrand, JS; Gapstur, SM				Patel, Alpa V.; Hildebrand, Janet S.; Gapstur, Susan M.			Body Mass Index and All-Cause Mortality in a Large Prospective Cohort of White and Black US Adults	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; FOLLOW-UP; ABDOMINAL ADIPOSITY; NATIONAL-HEALTH; WEIGHT CHANGE; OBESITY; WOMEN; OVERWEIGHT; RISK; ASSOCIATION	Remaining controversies on the association between body mass index (BMI) and mortality include the effects of smoking and prevalent disease on the association, whether overweight is associated with higher mortality rates, differences in associations by race and the optimal age at which BMI predicts mortality. To assess the relative risk (RR) of mortality by BMI in Whites and Blacks among subgroups defined by smoking, prevalent disease, and age, 891,572 White and 38,119 Black men and women provided height, weight and other information when enrolled in the Cancer Prevention Study II in 1982. Over 28 years of follow-up, there were 434,400 deaths in Whites and 18,702 deaths in Blacks. Cox proportional-hazards regression was used to estimate multivariable-adjusted relative risks (RR) and 95% confidence intervals (CI). Smoking and prevalent disease status significantly modified the BMI-mortality relationship in Whites and Blacks; higher BMI was most strongly associated with higher risk of mortality among never smokers without prevalent disease. All levels of overweight and obesity were associated with a statistically significantly higher risk of mortality compared to the reference category (BMI 22.5-24.9 kg/m(2)), except among Black women where risk was elevated but not statistically significant in the lower end of overweight. Although absolute mortality rates were higher in Blacks than Whites within each BMI category, relative risks (RRs) were similar between race groups for both men and women (p-heterogeneity by race =0.20 for men and 0.23 for women). BMI was most strongly associated with mortality when reported before age 70 years. Results from this study demonstrate for the first time that the BMI-mortality relationship differs for men and women who smoke or have prevalent disease compared to healthy never-smokers. These findings further support recommendations for maintaining a BMI between 20-25 kg/m(2) for optimal health and longevity.	[Patel, Alpa V.; Hildebrand, Janet S.; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA	American Cancer Society	Patel, AV (corresponding author), Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA.	apatel@cancer.org						Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; CORNONIHUNTLEY JC, 1991, J CLIN EPIDEMIOL, V44, P743, DOI 10.1016/0895-4356(91)90126-T; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; FREEDMAN DS, 1995, AM J EPIDEMIOL, V142, P53, DOI 10.1093/oxfordjournals.aje.a117545; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; Gelber RP, 2007, INT J OBESITY, V31, P1240, DOI 10.1038/sj.ijo.0803564; Hjartaker A, 2005, EUR J EPIDEMIOL, V20, P747, DOI 10.1007/s10654-005-2145-x; Jain MG, 2005, INT J OBESITY, V29, P792, DOI 10.1038/sj.ijo.0802952; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; JOHNSON JL, 1986, AM J EPIDEMIOL, V123, P209, DOI 10.1093/oxfordjournals.aje.a114230; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; Koster A, 2008, AM J CLIN NUTR, V88, P1206, DOI 10.3945/ajcn.2008.26298; Kuriyama S, 2006, J EPIDEMIOL, V16, P139, DOI 10.2188/jea.16.139; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Pan L., 2009, Morbidity and Mortality Weekly Report, V58, P740; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Singh PN, 1998, EPIDEMIOLOGY, V9, P246, DOI 10.1097/00001648-199805000-00007; Song YM, 2007, ANN EPIDEMIOL, V17, P556, DOI 10.1016/j.annepidem.2007.01.028; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; STEVENS J, 1992, ARCH INTERN MED, V152, P1257, DOI 10.1001/archinte.152.6.1257; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; Stevens June, 1998, New England Journal of Medicine, V338, P1, DOI 10.1056/NEJM199801013380101; Weitoft GR, 2008, SCAND J PUBLIC HEALT, V36, P169, DOI 10.1177/1403494807085080; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; 1986, B WHO, V64, P929	52	48	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109153	10.1371/journal.pone.0109153	http://dx.doi.org/10.1371/journal.pone.0109153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295620	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000041
J	Erdoes, G; Huber, C; Basciani, R; Stortecky, S; Windecker, S; Wenaweser, P; Carrel, T; Eberle, B				Erdoes, Gabor; Huber, Christoph; Basciani, Reto; Stortecky, Stefan; Windecker, Stephan; Wenaweser, Peter; Carrel, Thierry; Eberle, Balthasar			The Self-Expanding Symetis Acurate Does Not Increase Cerebral Microembolic Load When Compared to the Balloon-Expandable Edwards Sapien Prosthesis: A Transcranial Doppler Study in Patients Undergoing Transapical Aortic Valve Implantation	PLOS ONE			English	Article							TRANSCATHETER; REPLACEMENT; RISK; EMBOLISM; OUTCOMES; STENOSIS; SILENT	Objectives: The aim of this study was to quantify potential differences in count, frequency and pattern of high-intensity transient signals (HITS) during transapical transcatheter aortic valve implantation (TA-TAVI), by comparing the Symetis Acurate TA (SA) with the balloon-expandable Edwards Sapien XT (ES) system. Background: Recently, the Symetis Acurate TA revalving system has been introduced for TA-TAVI. The Symetis Acurate TA aortic bioprosthesis is self-expanding and is deployed by a specific two-step implantation technique. Whether this novel method increases the load of intraprocedural emboli, detected by transcranial Doppler ultrasound (TCD) as HITS, or not is not clear. Methods: Twenty-two patients (n = 11 in each study arm, median logistic EuroScore 20%, median STS score 7%) displayed continuous TCD signals of good quality throughout the entire TA-TAVI procedure and were included in the final analysis. Data are presented as median with interquartile ranges. Results: No significant differences were detected in total procedural or interval-related HITS load (SA: 303 [200; 594], ES: 499 [285; 941]; p = 0.16). With both devices, HITS peaked during prosthesis deployment (PD), whereas significantly fewer HITS occurred during instrumentation (SA: p = 0.002; ES: <0.001) or post-implantation PI (SA: p = 0.007; ES: <0.001). PD-associated HITS amounted to almost half of the total HITS load. One patient suffered new disabling stroke at 30 days. Thirtyday mortality amounted to 13.6% (3 of 22 patients). Conclusions: Simplified transapical delivery using the self-expanding SA device does not increase HITS, despite of a two-step deployment technique with more interactions with the native aortic valve, when compared to the balloon-expandable ES valve. The similarity in HITS count, frequency and pattern with the two systems suggests a common mechanism for the release of cerebral microemboli.	[Erdoes, Gabor; Basciani, Reto; Eberle, Balthasar] Univ Hosp Bern, Dept Anesthesiol & Pain Therapy, Inselspital, CH-3010 Bern, Switzerland; [Huber, Christoph; Carrel, Thierry] Univ Hosp Bern, Inselspital, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland; [Stortecky, Stefan; Windecker, Stephan; Wenaweser, Peter] Univ Hosp Bern, Inselspital, Dept Cardiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Erdoes, G (corresponding author), Univ Hosp Bern, Dept Anesthesiol & Pain Therapy, Inselspital, CH-3010 Bern, Switzerland.	gabor.erdoes@insel.ch	Carrel, Thierry/AAI-5910-2021; Erdoes, Gabor/J-5742-2014; Stortecky, Stefan/AAS-9140-2021; Wenaweser, Peter/AAN-7009-2021	Erdoes, Gabor/0000-0002-6742-1016; Stortecky, Stefan/0000-0002-5076-0177; Huber, Christoph/0000-0001-9048-849X	Department of Anaesthesiology and Pain Therapy, University Hospital Bern	Department of Anaesthesiology and Pain Therapy, University Hospital Bern	Department of Anaesthesiology and Pain Therapy, University Hospital Bern, provided support for the maintenance of the emboli detection machine (Transcranial Doppler Sonography). This funder did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2010, JACC-CARDIOVASC INTE, V3, P1126, DOI 10.1016/j.jcin.2010.09.008; Buellesfeld L, 2010, EUR HEART J, V31, P984, DOI 10.1093/eurheartj/ehp570; Drews T, 2011, THORAC CARDIOV SURG, V59, P237, DOI 10.1055/s-0030-1250495; Eggebrecht H, 2012, EUROINTERVENTION, V8, P129, DOI 10.4244/EIJV8I1A20; Erdoes G, 2012, EUR J CARDIO-THORAC, V41, P778, DOI 10.1093/ejcts/ezr068; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Huber CH, 2005, J AM COLL CARDIOL, V46, P366, DOI 10.1016/j.jacc.2005.04.028; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kahlert P, 2012, CIRCULATION, V126, P1245, DOI 10.1161/CIRCULATIONAHA.112.092544; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Kempfert J, 2013, EUR J CARDIO-THORAC, V43, P52, DOI 10.1093/ejcts/ezs139; Kempfert J, 2011, EUR J CARDIO-THORAC, V40, P1114, DOI 10.1016/j.ejcts.2011.01.078; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Omran H, 2003, LANCET, V361, P1241, DOI 10.1016/S0140-6736(03)12978-9; Reinsfelt B, 2012, ACTA ANAESTH SCAND, V56, P240, DOI 10.1111/j.1399-6576.2011.02563.x; Rodes-Cabau J, 2011, J AM COLL CARDIOL, V57, P18, DOI 10.1016/j.jacc.2010.07.036; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stortecky S, 2012, EUROINTERVENTION, V8, pQ60, DOI 10.4244/EIJV8SQA11; Walther T, 2009, ANN THORAC SURG, V87, P276, DOI 10.1016/j.athoracsur.2008.08.017	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108191	10.1371/journal.pone.0108191	http://dx.doi.org/10.1371/journal.pone.0108191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289688	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000013
J	Kellogg, CA; Piceno, YM; Tom, LM; DeSantis, TZ; Gray, MA; Andersen, GL				Kellogg, Christina A.; Piceno, Yvette M.; Tom, Lauren M.; DeSantis, Todd Z.; Gray, Michael A.; Andersen, Gary L.			Comparing Bacterial Community Composition of Healthy and Dark Spot-Affected Siderastrea siderea in Florida and the Caribbean	PLOS ONE			English	Article							BLACK BAND DISEASE; CORAL MICROBIAL ECOLOGY; REEF-BUILDING CORALS; WEST-INDIES; SHIFTS; PATTERNS; DOMINICA; DECLINE; SPREAD	Coral disease is one of the major causes of reef degradation. Dark Spot Syndrome (DSS) was described in the early 1990's as brown or purple amorphous areas of tissue on a coral and has since become one of the most prevalent diseases reported on Caribbean reefs. It has been identified in a number of coral species, but there is debate as to whether it is in fact the same disease in different corals. Further, it is questioned whether these macroscopic signs are in fact diagnostic of an infectious disease at all. The most commonly affected species in the Caribbean is the massive starlet coral Siderastrea siderea. We sampled this species in two locations, Dry Tortugas National Park and Virgin Islands National Park. Tissue biopsies were collected from both healthy colonies and those with dark spot lesions. Microbial-community DNA was extracted from coral samples (mucus, tissue, and skeleton), amplified using bacterial-specific primers, and applied to PhyloChip G3 microarrays to examine the bacterial diversity associated with this coral. Samples were also screened for the presence of a fungal ribotype that has recently been implicated as a causative agent of DSS in another coral species, but the amplifications were unsuccessful. S. siderea samples did not cluster consistently based on health state (i.e., normal versus dark spot). Various bacteria, including Cyanobacteria and Vibrios, were observed to have increased relative abundance in the discolored tissue, but the patterns were not consistent across all DSS samples. Overall, our findings do not support the hypothesis that DSS in S. siderea is linked to a bacterial pathogen or pathogens. This dataset provides the most comprehensive overview to date of the bacterial community associated with the scleractinian coral S. siderea.	[Kellogg, Christina A.; Gray, Michael A.] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL 33701 USA; [Piceno, Yvette M.; Tom, Lauren M.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [DeSantis, Todd Z.] Second Genome Inc, San Bruno, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kellogg, CA (corresponding author), US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL 33701 USA.	ckellogg@usgs.gov	Tom, Lauren/E-9739-2015; Andersen, Gary/G-2792-2015; Piceno, Yvette/I-6738-2016	Andersen, Gary/0000-0002-1618-9827; Piceno, Yvette/0000-0002-7915-4699	Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program; United States Department of Energy [DE-AC02-05CH11231]	Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program; United States Department of Energy(United States Department of Energy (DOE))	This project was supported by the Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program (http://marine.usgs.gov). A portion of this work was performed under the auspices of the United States Department of Energy under contract DE-AC02-05CH11231 to Lawrence Berkeley National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Borger JL, 2005, B MAR SCI, V77, P137; Borger JL, 2005, CORAL REEFS, V24, P139, DOI 10.1007/s00338-004-0434-6; Borger JL, 2003, REV BIOL TROP, V51, P25; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Closek CJ, 2014, ISME J IN PRESS; Correa AMS, 2009, CORAL REEFS, V28, P437, DOI 10.1007/s00338-008-0464-6; Croquer A, 2009, DIS AQUAT ORGAN, V87, P33, DOI 10.3354/dao02164; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Galloway SB, 2007, 56 NOAA NOS NCCO; Gantar M, 2009, MICROB ECOL, V58, P856, DOI 10.1007/s00248-009-9540-x; GARZONFERREIRA J, 1998, REEF ENCOUNTER, V24, P10; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; Gil-Agudelo DL, 2004, CORAL HEALTH AND DISEASE, P337; Gil-Agudelo DL, 2001, B MAR SCI, V69, P619; Gochfeld DJ, 2006, DIS AQUAT ORGAN, V69, P53, DOI 10.3354/dao069053; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Gray MA, 2011, FEMS MICROBIOL ECOL, V76, P109, DOI 10.1111/j.1574-6941.2010.01033.x; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hsiang T., 2007, Acta Silvatica & Lignaria Hungarica, VSpecial, P71; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kellogg CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079801; Kellogg CA, 2012, J MICROBIOL METH, V88, P103, DOI 10.1016/j.mimet.2011.10.019; Kramarsky-Winter E, 2013, MICROB ECOL, P1; Lins-de-Barros MM, 2010, MICROB ECOL, V59, P523, DOI 10.1007/s00248-009-9612-y; Lins-de-Barros MM, 2013, MICROB ECOL, V65, P205, DOI 10.1007/s00248-012-0095-x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pollock FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002183; Porter JW, 2011, J EXP MAR BIOL ECOL, V408, P79, DOI 10.1016/j.jembe.2011.07.027; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Rasoulouniriana D, 2009, DIS AQUAT ORGAN, V87, P91, DOI 10.3354/dao02089; Renegar D.A., 2008, P 11 INT COR REEF S, P185; Richardson L.L., 2002, P1225; Rogers CS, 2010, DIS AQUAT ORGAN, V91, P167, DOI 10.3354/dao02261; Rogers C, 2009, P R SOC B, V276, P197, DOI 10.1098/rspb.2008.0606; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Solano Oscar David, 1993, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V22, P97; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Veron J.E.N., 2000, CORALS WORLD, V1-3; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Work T.M., 2014, ECOHEALTH, P1; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011	58	17	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108767	10.1371/journal.pone.0108767	http://dx.doi.org/10.1371/journal.pone.0108767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289937	Green Published, Green Submitted, gold			2022-12-25	WOS:000342798000024
J	Shao, HS; Li, SY; Watkins, SC; Wells, A				Shao, Hanshuang; Li, Shaoyan; Watkins, Simon C.; Wells, Alan			alpha-Actinin-4 Is Required for Amoeboid-type Invasiveness of Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION MATURATION; ALPHA-ACTININ; GENE AMPLIFICATION; CANCER INVASION; MIGRATION; MOTILITY; TUMOR; PROTEOLYSIS; PHOSPHORYLATION; CHEMORESISTANCE	alpha-Actinin-4 (ACTN4), a key regulator of the actin cytoskeleton, is up-regulated in melanoma, though its role in melanoma remains speculative. We have discovered that in WM1158, a highly aggressive melanoma cell line, down-regulation of ACTN4 by shRNA induces a collagen I-dependent amoeboidal-to-mesenchymal transition. Re-expression of low levels of WT ACTN4 but not similar expression levels of ACTN1 successfully restores the amoeboidal morphology and limits collagen I gel compaction. A truncated ACTN4 mutant 1-890, which lacks the C-terminal tail, fails to rescue the amoeboidal morphology and to compact collagen I gel. Interestingly, in three-dimensional collagen I gels, ACTN4 KD cells are more polarized compared with cells in which scrambled shRNA is expressed. Surprisingly, ACTN4 KD cells migrate faster than the ones expressing the scrambled shRNA on a collagen I gel (two-dimensional) although these two cell lines migrate similarly on tissue culture. Most importantly, down-regulation of ACTN4 significantly reduced invasion of WM1158 cells into the three-dimensional collagen I gel, a representative of the dermis. Taken together, these findings suggest that ACTN4 plays an important role in maintaining the amoeboidal morphology of invasive melanoma and thus promoting dissemination through collagen-rich matrices.	[Shao, Hanshuang; Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Li, Shaoyan] Shady Side Acad, Pittsburgh, PA 15238 USA; [Wells, Alan] Pittsburgh Vet Affairs Hlth Syst, Lab & Pathol Serv, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Sch Med, 3550 Terrace St,S713 Scaife Hall, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Wells, Alan/0000-0002-1637-8150	National Institutes of Health (NIGMS); VA Merit Award Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); VA Merit Award Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (NIGMS) and the VA Merit Award Program.	Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Feng YF, 2013, EXP CELL RES, V319, P1124, DOI 10.1016/j.yexcr.2013.02.009; Foley KS, 2013, BIOCHEM J, V452, P477, DOI 10.1042/BJ20121824; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P253, DOI 10.1016/j.ceb.2011.03.001; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Grahovac J, 2014, LAB INVEST, V94, P31, DOI 10.1038/labinvest.2013.132; Grahovac J, 2013, J INVEST DERMATOL, V133, P210, DOI 10.1038/jid.2012.263; GRAZI E, 1994, BIOCHEM J, V298, P129, DOI 10.1042/bj2980129; Hamill KJ, 2013, FASEB J, V27, P546, DOI 10.1096/fj.12-217406; HAMILL KJ, 2012, J INVEST DERMATOL S1, V132, pS35; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hood BL, 2010, J PROTEOME RES, V9, P3656, DOI 10.1021/pr100164x; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Kedracka-Krok S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084621; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Michaud JLR, 2009, CELL MOTIL CYTOSKEL, V66, P166, DOI 10.1002/cm.20339; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Orgaz JL, 2013, PIGM CELL MELANOMA R, V26, P39, DOI 10.1111/pcmr.12041; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao HS, 2013, INT J BIOCHEM CELL B, V45, P1051, DOI 10.1016/j.biocel.2013.02.015; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Sprague CR, 2008, J BIOL CHEM, V283, P9217, DOI 10.1074/jbc.M707436200; Travers T, 2013, BIOPHYS J, V104, P705, DOI 10.1016/j.bpj.2012.12.003; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	41	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.579185	http://dx.doi.org/10.1074/jbc.M114.579185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296750	hybrid, Green Published			2022-12-25	WOS:000345335000028
J	Lee, Y; Stiers, KM; Kain, BN; Beamer, LJ				Lee, Yingying; Stiers, Kyle M.; Kain, Bailee N.; Beamer, Lesa J.			Compromised Catalysis and Potential Folding Defects in in Vitro Studies of Missense Mutants Associated with Hereditary Phosphoglucomutase 1 Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mutation; Genetic Disease; Kinetics; Metabolic Disease; N-linked Glycosylation; Protein Misfolding	LYSOSOMAL STORAGE DISEASES; PHARMACOLOGICAL CHAPERONES; INTRAGENIC RECOMBINATION; EXPRESSION ANALYSIS; MECHANISM; PROTEIN; PGM1; IDENTIFICATION; POLYMORPHISM; STRATEGIES	Background: Phosphoglucomutase 1 deficiency is a newly described inherited disorder in humans. Results:In vitro studies of 13 missense variants associated with disease are presented. Conclusion: Compromised catalysis and differential effects on recombinant protein folding/stability are found. Significance: Biochemical defects are consistent with previous in vivo studies and may have clinical relevance. Recent studies have identified phosphoglucomutase 1 (PGM1) deficiency as an inherited metabolic disorder in humans. Affected patients show multiple disease phenotypes, including dilated cardiomyopathy, exercise intolerance, and hepatopathy, reflecting the central role of the enzyme in glucose metabolism. We present here the first in vitro biochemical characterization of 13 missense mutations involved in PGM1 deficiency. The biochemical phenotypes of the PGM1 mutants cluster into two groups: those with compromised catalysis and those with possible folding defects. Relative to the recombinant wild-type enzyme, certain missense mutants show greatly decreased expression of soluble protein and/or increased aggregation. In contrast, other missense variants are well behaved in solution, but show dramatic reductions in enzyme activity, with k(cat)/K-m often <1.5% of wild-type. Modest changes in protein conformation and flexibility are also apparent in some of the catalytically impaired variants. In the case of the G291R mutant, severely compromised activity is linked to the inability of a key active site serine to be phosphorylated, a prerequisite for catalysis. Our results complement previous in vivo studies, which suggest that both protein misfolding and catalytic impairment may play a role in PGM1 deficiency.	[Lee, Yingying; Stiers, Kyle M.; Kain, Bailee N.; Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	beamerl@missouri.edu		Stiers, Kyle/0000-0001-5542-022X	National Science Foundation [MCB-1409898]	National Science Foundation(National Science Foundation (NSF))	This work was supported National Science Foundation Grant MCB-1409898 (to L. J. B.).	Beamer L, 2015, J INHERIT METAB DIS, V38, P243, DOI 10.1007/s10545-014-9757-9; Boyd RE, 2013, J MED CHEM, V56, P2705, DOI 10.1021/jm301557k; Gamez A, 2000, J BIOL CHEM, V275, P29737, DOI 10.1074/jbc.M003231200; Gloria-Bottini F, 2001, AM J HUM BIOL, V13, P417, DOI 10.1002/ajhb.1066; Gloria-Bottini F, 2007, AM J MED SCI, V334, P421, DOI 10.1097/MAJ.0b013e3180a5e934; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Vega AI, 2011, J INHERIT METAB DIS, V34, P929, DOI 10.1007/s10545-011-9328-2; JENSEN TG, 1995, HUM MUTAT, V6, P226, DOI 10.1002/humu.1380060305; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Jorge-Finnigan A, 2013, HUM MOL GENET, V22, P3680, DOI 10.1093/hmg/ddt217; Leandro J, 2011, BBA-MOL BASIS DIS, V1812, P106, DOI 10.1016/j.bbadis.2010.09.015; Lee Y, 2014, J BIOL CHEM, V289, P4674, DOI 10.1074/jbc.M113.532226; Liu YW, 1997, ACTA CRYSTALLOGR D, V53, P392, DOI 10.1107/S0907444997000875; Maier EM, 2009, HUM MOL GENET, V18, P1612, DOI 10.1093/hmg/ddp079; Majtan T, 2010, J BIOL CHEM, V285, P15866, DOI 10.1074/jbc.M110.107722; MARCH RE, 1993, P NATL ACAD SCI USA, V90, P10730, DOI 10.1073/pnas.90.22.10730; MCALPINE PJ, 1970, ANN HUM GENET, V34, P169, DOI 10.1111/j.1469-1809.1970.tb00230.x; Morava E, 2014, MOL GENET METAB, V112, P275, DOI 10.1016/j.ymgme.2014.06.002; Muntau AC, 2014, J INHERIT METAB DIS, V37, P505, DOI 10.1007/s10545-014-9701-z; Ondruskova N, 2014, NEUROENDOCRINOL LETT, V35, P137; Parenti G, 2013, INT J MOL MED, V31, P11, DOI 10.3892/ijmm.2012.1187; Perez B, 2013, J INHERIT METAB DIS, V36, P535, DOI 10.1007/s10545-012-9525-7; QUICK CB, 1974, EUR J BIOCHEM, V42, P511, DOI 10.1111/j.1432-1033.1974.tb03366.x; RAY WJ, 1990, BIOCHEMISTRY-US, V29, P2770, DOI 10.1021/bi00463a021; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158; TAKAHASHI N, 1993, P NATL ACAD SCI USA, V90, P10725, DOI 10.1073/pnas.90.22.10725; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; Whitehouse DB, 1998, MOL BIOL EVOL, V15, P456, DOI 10.1093/oxfordjournals.molbev.a025942	32	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32010	32019		10.1074/jbc.M114.597914	http://dx.doi.org/10.1074/jbc.M114.597914			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288802	Green Published, hybrid			2022-12-25	WOS:000345314700030
J	Chen, W; Lin, HT; Zhong, XJ; Liu, ZC; Geng, Y; Xie, CF; Chen, WR				Chen, Wan; Lin, Haotian; Zhong, Xiaojian; Liu, Zhaochuan; Geng, Yu; Xie, Chufang; Chen, Weirong			Discrepant Expression of Cytokines in Inflammation- and Age-Related Cataract Patients	PLOS ONE			English	Article							BEHCETS-DISEASE; PRODUCTION PROFILE; UVEITIS PATIENTS; UP-REGULATION; TNF-ALPHA; CELLS; AUTOIMMUNITY; IL-6	Purpose: Inflammatory cataracts secondary to Behcet's disease (BD) or Vogt-Koyanagi-Harada disease (VKH) are thought to result from a pathological dysregulation of cytokines that is different from that of age-related (AR) cataracts. However, little is known about the function of cytokines in the development of inflammatory cataracts. The purpose of this study was to identify possible differences in cytokine expression in inflammation- and age-related cataract patients. Methods: Analysis techniques involving the concomitant use of a cocktail of antibody-coated non-magnetic beads were used to determine the cytokine expression profiles of BD, VKH and AR cataract patients. Furthermore, anterior chamber aqueous flares and inflammatory cells were quantitatively measured with a laser flare cell meter (LFCM). Results: The expressions of interleukin-2 (IL-2), IL-4, IL-6, IL-10, IL-17A, and interferon-7 (IFN-7) were analyzed in aqueous humor (AqH), phytohemagglutinin (PHA)-stimulated and non-PHA-stimulated cultures of peripheral blood mononuclear cells (PBMCs) from the three types of cataract patients. IL-6 and IFN-7 were identified above the detection limits, but, among the BD and VKH cataract patients, only the levels of IL-6 were significantly higher in both the AqH and PBMC non-PHA cultures compared with the levels observed in the AR cataract patients. In contrast, IFN-7 was significantly elevated in the AqH of the BD cataract patients compared with the VKH and AR cataract patients. In the PHA-stimulated PBMC cultures, IL-2, IFN-7, IL-6, and IL-17A were significantly increased, and the IL-6 level was significantly higher in the VKH patients than in the BD and AR cataract patients. The correlation analyses of the cytokines and inflammation indexes of the AqH obtained with the LFCM revealed that only IL-6 was significantly correlated with the inflammation index. Conclusion: Distinct expression profiles of cytokines and the correlations of these profiles with in vivo inflammatory indexes for inflammatory and AR cataract patients were identified.	[Chen, Wan; Lin, Haotian; Zhong, Xiaojian; Liu, Zhaochuan; Geng, Yu; Xie, Chufang; Chen, Weirong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, WR (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	chenwr_q@aliyun.com	Chen, Wei/GZK-7348-2022; Zhong, Xiaojian/J-9727-2016	Zhong, Xiaojian/0000-0002-4201-0747	National Natural Science Foundation of China [81270980]; Guangdong Technology Programs [2009B080701017]; Pearl River Science and Technology New Star Project of Guangzhou City [2014J2200060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Technology Programs; Pearl River Science and Technology New Star Project of Guangzhou City	This study was supported by the National Natural Science Foundation of China (No. 81270980), the Guangdong Technology Programs (No. 2009B080701017) and the Pearl River Science and Technology New Star Project of Guangzhou City (2014J2200060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2011, CLIN IMMUNOL, V139, P177, DOI 10.1016/j.clim.2011.01.014; Akdeniz N, 2004, ANN ACAD MED SINGAP, V33, P596; CASPI RR, 1994, J IMMUNOL, V152, P890; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Commodaro AG, 2010, SCAND J IMMUNOL, V72, P31, DOI 10.1111/j.1365-3083.2010.02401.x; Damico FM, 2009, ARQ BRAS OFTALMOL, V72, P413, DOI 10.1590/S0004-27492009000300028; DEBOER JH, 1992, CURR EYE RES, V11, P181, DOI 10.3109/02713689208999530; Evereklioglu C, 2002, MEDIAT INFLAMM, V11, P87, DOI 10.1080/09629350220131935; Fang W, 2008, BRIT J OPHTHALMOL, V92, P182, DOI 10.1136/bjo.2007.128967; Hamzaoui K, 2002, SCAND J RHEUMATOL, V31, P205, DOI 10.1080/030097402320318387; Hamzaoui K, 2011, MED SCI MONITOR, V17, pCR227, DOI 10.12659/MSM.881720; Imai Yumi, 2002, International Ophthalmology Clinics, V42, P25; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Li B, 2005, BRIT J OPHTHALMOL, V89, P1410, DOI 10.1136/bjo.2005.074062; Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007; Lohmann T, 2002, DIABETES, V51, P2474, DOI 10.2337/diabetes.51.8.2474; Matsuoka K, 2004, GUT, V53, P1303, DOI 10.1136/gut.2003.024190; Misumi M, 2003, CYTOKINE, V24, P210, DOI 10.1016/j.cyto.2003.09.003; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; OSHIKA T, 1989, Nippon Ganka Gakkai Zasshi, V93, P1032; Raziuddin S, 1998, J RHEUMATOL, V25, P329; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; ROMAGNANI S, 1995, J CLIN IMMUNOL, V15, P121, DOI 10.1007/BF01543103; SILMAN AJ, 1990, LANCET, V335, P1078; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; Wang CK, 2012, INVEST OPHTH VIS SCI, V53, P4668, DOI 10.1167/iovs.12-9863; Zhou ZY, 2012, AUTOIMMUN REV, V11, P699, DOI 10.1016/j.autrev.2011.12.005	27	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109647	10.1371/journal.pone.0109647	http://dx.doi.org/10.1371/journal.pone.0109647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303043	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400072
J	Petrovici, MA; Vogginger, B; Muller, P; Breitwieser, O; Lundqvist, M; Muller, L; Ehrlich, M; Destexhe, A; Lansner, A; Schuffny, R; Schemmel, J; Meier, K				Petrovici, Mihai A.; Vogginger, Bernhard; Mueller, Paul; Breitwieser, Oliver; Lundqvist, Mikael; Muller, Lyle; Ehrlich, Matthias; Destexhe, Alain; Lansner, Anders; Schueffny, Rene; Schemmel, Johannes; Meier, Karlheinz			Characterization and Compensation of Network-Level Anomalies in Mixed-Signal Neuromorphic Modeling Platforms	PLOS ONE			English	Article							HORIZONTAL SYNAPTIC CONNECTIONS; HIGH-CONDUCTANCE STATE; SYNCHRONOUS SPIKING; INTEGRATIVE PROPERTIES; PYRAMIDAL NEURONS; PROPAGATION; RAT; SIMULATION; CORTEX; ORGANIZATION	Advancing the size and complexity of neural network models leads to an ever increasing demand for computational resources for their simulation. Neuromorphic devices offer a number of advantages over conventional computing architectures, such as high emulation speed or low power consumption, but this usually comes at the price of reduced configurability and precision. In this article, we investigate the consequences of several such factors that are common to neuromorphic devices, more specifically limited hardware resources, limited parameter configurability and parameter variations due to fixed-pattern noise and trial-to-trial variability. Our final aim is to provide an array of methods for coping with such inevitable distortion mechanisms. As a platform for testing our proposed strategies, we use an executable system specification (ESS) of the BrainScaleS neuromorphic system, which has been designed as a universal emulation back-end for neuroscientific modeling. We address the most essential limitations of this device in detail and study their effects on three prototypical benchmark network models within a well-defined, systematic workflow. For each network model, we start by defining quantifiable functionality measures by which we then assess the effects of typical hardware-specific distortion mechanisms, both in idealized software simulations and on the ESS. For those effects that cause unacceptable deviations from the original network dynamics, we suggest generic compensation mechanisms and demonstrate their effectiveness. Both the suggested workflow and the investigated compensation mechanisms are largely back-end independent and do not require additional hardware configurability beyond the one required to emulate the benchmark networks in the first place. We hereby provide a generic methodological environment for configurable neuromorphic devices that are targeted at emulating large-scale, functional neural networks.	[Petrovici, Mihai A.; Mueller, Paul; Breitwieser, Oliver; Schemmel, Johannes; Meier, Karlheinz] Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany; [Vogginger, Bernhard; Ehrlich, Matthias; Schueffny, Rene] Tech Univ Dresden, Inst Circuits & Syst, D-01062 Dresden, Germany; [Lundqvist, Mikael; Lansner, Anders] Stockholm Univ, Sch Comp Sci & Commun, Dept Computat Biol, S-10691 Stockholm, Sweden; [Lundqvist, Mikael; Lansner, Anders] Royal Inst Technol, Stockholm, Sweden; [Muller, Lyle; Destexhe, Alain] CNRS, Unite Neurosci Informat & Complex, Gif Sur Yvette, France	Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Royal Institute of Technology; Stockholm University; Royal Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Petrovici, MA (corresponding author), Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany.	mpedro@kip.uni-heidelberg.de	; Lansner, Anders/E-4824-2016	Lundqvist, Mikael/0000-0003-1011-5234; Petrovici, Mihai Alexandru/0000-0003-2632-0427; Muller, Lyle/0000-0001-5165-9890; Schemmel, Johannes/0000-0003-1440-4375; Lansner, Anders/0000-0002-2358-7815; Destexhe, Alain/0000-0001-7405-0455	EU [269921]; Manfred Stark Foundation	EU(European Commission); Manfred Stark Foundation	This research was supported by EU grant #269921 (BrainScaleS) and the Manfred Stark Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M, 2004, J COMPUT NEUROSCI, V17, P179, DOI 10.1023/B:JCNS.0000037682.18051.5f; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; [Anonymous], FRONT NEUROINFORM; Berge HKO, 2007, IEEE INT SYMP CIRC S, P857, DOI 10.1109/ISCAS.2007.378041; Bergman K., 2008, EXASCALE COMPUTING S; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bill J, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00129; BONTORIN G, 2007, P 29 ANN INT C IEEE; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Bruderle D, 2009, FRONT NEUROINFORM, V3, P2009; Bruderle D, 2011, BIOL CYBERN, V104, P263, DOI 10.1007/s00422-011-0435-9; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buxhoeveden DP, 2002, BRAIN BEHAV EVOLUT, V60, P125, DOI 10.1159/000065935; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Costas-Santos J, 2007, IEEE T CIRCUITS-I, V54, P1444, DOI 10.1109/TCSI.2007.900179; Delbruck T, 2004, VISION RES, V44, P2083, DOI 10.1016/j.visres.2004.03.021; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Destexhe A, 2009, J COMPUT NEUROSCI, V27, P493, DOI 10.1007/s10827-009-0164-4; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Diesmann M, 2001, NEUROCOMPUTING, V38, P565, DOI 10.1016/S0925-2312(01)00409-X; Diesmann M, 2002, FORSCHUNG WISSCHENSC, V58, P43; Diesmann M., 2002, THESIS RUHR U BOCHUM; Djurfeldt M, 2008, IBM J RES DEV, V52, P31, DOI 10.1147/rd.521.0031; Ehrlich M., 2007, P INT C SENS CIRC IN; Ehrlich M, 2010, ARTIFICIAL NEURAL NETWORKS AND INTELLIGENT INFORMATION PROCESSING, P43; El Boustani S, 2009, NEURAL COMPUT, V21, P46, DOI 10.1162/neco.2009.02-08-710; Eppler JM, 2008, FRONT NEUROINFORM, V2; Fieres J., 2008, P 2008 INT JOINT C N; Furber S. B., 2012, IEEE T COMPUTERS, V99; Galluppi F, 2010, LECT NOTES COMPUT SC, V6443, P58, DOI 10.1007/978-3-642-17537-4_8; Giulioni M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2011.00149; Gonzalez-Burgos G, 2000, CEREB CORTEX, V10, P82, DOI 10.1093/cercor/10.1.82; Hafliger P, 2007, IEEE T NEURAL NETWOR, V18, P551, DOI 10.1109/TNN.2006.884676; Hartmann S., 2010, Proceedings of the 2010 17th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2010), P950, DOI 10.1109/ICECS.2010.5724670; Hasler J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00118; Helias M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00026; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hines M., 2003, NEURON SIMULATION EN, P769; Hines ML, 2009, FRONT NEUROINFORM; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Indiveri G, 2006, IEEE T NEURAL NETWOR, V17, P211, DOI 10.1109/TNN.2005.860850; Indiveri G., 2011, FRONTIERS NEUROSCIEN, V5; Indiveri G, 2008, SENSORS-BASEL, V8, P5352, DOI 10.3390/s8095352; Indiveri G, 2009, COGN COMPUT, V1, P119, DOI 10.1007/s12559-008-9003-6; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kremkow J, 2010, J NEUROSCI, V30, P15760, DOI 10.1523/JNEUROSCI.3874-10.2010; Kremkow J, 2010, J COMPUT NEUROSCI, V28, P579, DOI 10.1007/s10827-010-0240-9; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Laing C., 2009, STOCHASTIC METHODS N; Lande T. S., 1996, Proceedings of the Fifth International Conference on Microelectronics for Neural Networks and Fuzzy Systems. MicroNeuro'96, P271, DOI 10.1109/MNNFS.1996.493802; LEWIS MA, 2000, P INT C ROB AUT; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; McDonnell MD, 2014, P IEEE, V102, P646, DOI 10.1109/JPROC.2014.2314776; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; Mead C.A., 1989, ANALOG VLSI NEURAL S; MEAD CA, 1988, NEURAL NETWORKS, V1, P91, DOI 10.1016/0893-6080(88)90024-X; MEROLLA PA, 2006, P 2006 IEEE INT S CI; Millner S, 2010, ADV NEURAL INFORM PR, V23, P1642; Mitra S, 2009, IEEE T BIOMED CIRC S, V3, P32, DOI 10.1109/TBCAS.2008.2005781; Morrison A, 2005, NEURAL COMPUT, V17, P1776, DOI 10.1162/0899766054026648; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Muller L, 2012, J PHYSIOL-PARIS, V106, P222, DOI 10.1016/j.jphysparis.2012.06.005; MURAKOSHI T, 1993, NEUROSCI LETT, V163, P211, DOI 10.1016/0304-3940(93)90385-X; Netter T, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P129, DOI 10.1109/IRDS.2002.1041376; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Peters A, 1997, J NEUROCYTOL, V26, P779, DOI 10.1023/A:1018518515982; Pfeil T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00011; Pfeil T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00090; RENAUD S, 2007, P 2007 IEEE S CIRC S; Rieke F., 1997, SPIKES EXPLORING NEU; Rocke P, 2008, LECT NOTES COMPUT SC, V5216, P118; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Schemmel J., 2008, P 2008 INT JOINT C N; Schemmel J., 2006, P 2006 INT JOINT C N; Schemmel J, 2007, IEEE INT SYMP CIRC S, P3367, DOI 10.1109/ISCAS.2007.378289; Schemmel J, 2010, IEEE INT SYMP CIRC S, P1947, DOI 10.1109/ISCAS.2010.5536970; Scholze S., 2010, 2010 MIXDES - 17th International Conference "Mixed Design of Integrated Circuits & Systems", P316; Scholze S, 2011, INTEGRATION VLSI J; Scholze S, 2011, FRONT NEUROSCI, V5, P1; Schrader S, 2010, FRONTIERS COMPUTATIO, V4; Serrano-Gotarredona R., 2006, ADV NEURAL INFORM PR, V18, P1217; Serrano-Gotarredona R, 2009, IEEE T NEURAL NETWOR, V20, P1417, DOI 10.1109/TNN.2009.2023653; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Telfeian AE, 2003, NEUROSCI LETT, V343, P121, DOI 10.1016/S0304-3940(03)00379-3; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Vogelstein RJ, 2007, IEEE T NEURAL NETWOR, V18, P253, DOI 10.1109/TNN.2006.883007; Zou Q, 2006, NEUROCOMPUTING, V69, P1137, DOI 10.1016/j.neucom.2005.12.061	98	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108590	10.1371/journal.pone.0108590	http://dx.doi.org/10.1371/journal.pone.0108590			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303102	Green Submitted, gold, Green Published			2022-12-25	WOS:000343730400017
J	Qin, L; Wu, Y; Liu, YT; Chen, YM; Zhang, P				Qin, Liang; Wu, Yang; Liu, Youting; Chen, Yiming; Zhang, Peng			Dual Effects of Alpha-Arbutin on Monophenolase and Diphenolase Activities of Mushroom Tyrosinase	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; SUICIDE-INACTIVATION; POLYPHENOL OXIDASE; INHIBITION; MECHANISM; ACTIVATION; KINETICS; AUTOACTIVATION; OXYGENASES; CATALYSIS	The effects of alpha-arbutin on the monophenolase and diphenolase activities of mushroom tyrosinase were investigated. The results showed that alpha-arbutin inhibited monophenolase activity but it activated diphenolase activity. For monophenolase activity, IC50 value was 4.5 mmol.L-1 and 4.18 mmol.L-1 of alpha-arbutin could extend the lag time from 40.5 s to 167.3 s. Alpha-arbutin is proposed to be regarded as a triphenolic substrate by the enzyme during catalyzation, leading to the suicide inactivation of the active site of tyrosinase. For diphenolase activity, alpha-arbutin acted as an activator and its activation mechanism was mixed type activation. To reveal such activation, it should be mainly refered to the conformational changes in tyrosinase caused by the interaction of alpha-arbutin with residues located at the entrance to the active site, and the decrease of the effect of suicide inactivation.	[Qin, Liang; Wu, Yang; Liu, Youting; Chen, Yiming; Zhang, Peng] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Bioproc Key Lab, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Zhang, P (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Bioproc Key Lab, Beijing 100029, Peoples R China.	zhangpengmark@163.com			Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology	Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology	The authors express our gratitude for financial support from Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASADA N, 1993, INSECT BIOCHEM MOLEC, V23, P515, DOI 10.1016/0965-1748(93)90060-6; ASIMOV I, 1950, J AM CHEM SOC, V72, P820, DOI 10.1021/ja01158a045; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton SG, 2003, TRENDS BIOTECHNOL, V21, P543, DOI 10.1016/j.tibtech.2003.10.006; BURTON SG, 1994, CATAL TODAY, V22, P459, DOI 10.1016/0920-5861(94)80118-5; Chen QX, 2002, J AGR FOOD CHEM, V50, P4108, DOI 10.1021/jf011378z; Cooksey CJ, 1997, J BIOL CHEM, V272, P26226, DOI 10.1074/jbc.272.42.26226; Cornish-Bowden A, 1995, FUNDAMENTALS ENZYME, P203; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Espin JC, 1999, J AGR FOOD CHEM, V47, P2638, DOI 10.1021/jf981055b; FUNAYAMA M, 1995, BIOSCI BIOTECH BIOCH, V59, P143, DOI 10.1271/bbb.59.143; Goldfeder M, 2013, APPL MICROBIOL BIOT, V97, P1953, DOI 10.1007/s00253-012-4050-z; Halaouli S, 2006, J APPL MICROBIOL, V100, P219, DOI 10.1111/j.1365-2672.2006.02866.x; Hernandez-Romero D, 2006, FEBS J, V273, P257, DOI 10.1111/j.1742-4658.2005.05038.x; INGRAHAM LL, 1952, J AM CHEM SOC, V74, P2623, DOI 10.1021/ja01130a047; Jimenez M, 1996, PHYTOCHEMISTRY, V42, P1503, DOI 10.1016/0031-9422(96)00175-6; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; JIMENEZCERVANTES C, 1995, BBA-GEN SUBJECTS, V1243, P421, DOI 10.1016/0304-4165(94)00169-X; JOLLEY RL, 1974, J BIOL CHEM, V249, P335; Kahn V, 1997, J AGR FOOD CHEM, V45, P4460, DOI 10.1021/jf9702858; Kanteev M, 2013, J BIOL INORG CHEM, V18, P895, DOI 10.1007/s00775-013-1034-0; Kawamura-Konishi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1752, DOI 10.1271/bbb.70171; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Land EJ, 2007, TOHOKU J EXP MED, V212, P341, DOI 10.1620/tjem.212.341; Land EJ, 2003, ACCOUNTS CHEM RES, V36, P300, DOI 10.1021/ar020062p; LERCH K, 1981, MET IONS BIOL SYST, V13, P143; Munoz-Munoz JL, 2010, IUBMB LIFE, V62, P539, DOI 10.1002/iub.348; Munoz-Munoz JL, 2009, BBA-PROTEINS PROTEOM, V1794, P244, DOI 10.1016/j.bbapap.2008.10.002; MAEDA K, 1991, J SOC COSMET CHEM, V42, P361; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Mosher DB, 1983, UPDATE DERMATOLOGY G, P205; Munoz-Munoz JL, 2010, BBA-PROTEINS PROTEOM, V1804, P1467, DOI 10.1016/j.bbapap.2010.02.015; Munoz-Munoz JL, 2008, BIOCHEM J, V416, P431, DOI 10.1042/BJ20080892; NISHIMURA T, 1995, YAKUGAKU ZASSHI, V115, P626, DOI 10.1248/yakushi1947.115.8_626; Nolan LC, 2007, BIOTECHNOL LETT, V29, P1045, DOI 10.1007/s10529-007-9365-y; Priestly G. C, 1993, MOL ASPECTS DERMATOL, V3; Ramsden CA, 2010, ARKIVOC, P260, DOI 10.3998/ark.5550190.0011.107; ROBB DA, 1984, COPPER PROTEINS COPP, V2, P207; Robert C, 1997, FOOD CHEM, V59, P355, DOI 10.1016/S0308-8146(96)00179-3; ROSMARTINEZ JR, 1993, BIOCHEM J, V294, P621, DOI 10.1042/bj2940621; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; SEIJI M, 1978, TOHOKU J EXP MED, V125, P233, DOI 10.1620/tjem.125.233; SolerRivas C, 1997, MYCOL RES, V101, P375, DOI 10.1017/S0953756296002729; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sugimoto K, 2003, CHEM PHARM BULL, V51, P798; Taylor SC, 2002, J AM ACAD DERMATOL, V46, pS41, DOI 10.1067/mjd.2002.120790; Tomita Y, 1977, DERMATOLOGY, V4, P245; Wang GL, 2000, FEMS MICROBIOL LETT, V185, P23, DOI 10.1111/j.1574-6968.2000.tb09035.x; Xie LP, 2003, INT J BIOCHEM CELL B, V35, P1658, DOI 10.1016/S1357-2725(03)00006-2	51	17	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109398	10.1371/journal.pone.0109398	http://dx.doi.org/10.1371/journal.pone.0109398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303458	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400054
J	Su, MI; Tsai, CT; Yeh, HI; Chen, CY				Su, Min-I; Tsai, Cheng-Ting; Yeh, Hung-I; Chen, Chun-Yen			The Impact of SYNTAX Score of Non-Infarct-Related Artery on Long-Term Outcome among Patients with Acute ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention	PLOS ONE			English	Article							CHRONIC TOTAL OCCLUSION; PRIMARY ANGIOPLASTY; MULTIVESSEL DISEASE; CLINICAL-OUTCOMES; PROGNOSTIC IMPACT; MEDICAL THERAPY; REPERFUSION; MANAGEMENT; MORTALITY; VESSEL	Objective: We investigated the impact of the severity of stenosis in a non-infarct-related artery (IRA) on the long-term prognosis of patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods: Three hundred one consecutive patients (age: 59.7 +/- 13.2 years, 85.5% men) underwent primary PCI during 2009-2012. Receiver operating characteristic curve analysis found the optimal cutoff for non-IRA SYNTAX score (SS) to be 2.5. We divided the patients into two groups according to this cutoff value. Results: By multivariable analysis, non-IRA SS (>= 2.5) was an independent predictor of major adverse cardiac events (hazard ratio [HR]: 2.15, 95% confidence interval [CI]: 1.21-3.79, P = 0.008) and all-cause mortality (HR: 3.49, 95% CI: 1.13-10.8, P = 0.03). However, the prediction of cardiovascular mortality had only borderline significance (HR: 3.29, 95% CI: 0.90-12.08, P = 0.07). Conclusion: STEMI patients treated with primary PCI and moderate to severe non-IRA stenosis (SS >= 2.5) have more subsequent cardiac events. Those populations should be treated with more aggressive preventive and medical management.	[Su, Min-I; Tsai, Cheng-Ting; Yeh, Hung-I; Chen, Chun-Yen] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yeh, Hung-I; Chen, Chun-Yen] Mackay Med Coll, New Taipei City, Taiwan	Mackay Memorial Hospital; Mackay Medical College	Chen, CY (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	mwplasma@ms9.hinet.net		Su, Min-I/0000-0002-9523-9676				Biondi-Zoccai G, 2010, AM HEART J, V160, DOI 10.1016/j.ahj.2010.10.013; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brown AJ, 2013, ANGIOLOGY; Claessen BE, 2012, EUR HEART J, V33, P768, DOI 10.1093/eurheartj/ehr471; Claessen BEPM, 2010, HEART, V96, P1968, DOI 10.1136/hrt.2010.197673; Claessen BEPM, 2009, JACC-CARDIOVASC INTE, V2, P1128, DOI 10.1016/j.jcin.2009.08.024; DAVIES MJ, 1976, BRIT HEART J, V38, P659; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Head SJ, 2012, JACC-CARDIOVASC INTE, V5, P618, DOI 10.1016/j.jcin.2012.02.013; KAHN JK, 1990, J AM COLL CARDIOL, V16, P1089, DOI 10.1016/0735-1097(90)90537-Y; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071; Lemesle G, 2009, AM J CARDIOL, V103, P1189, DOI 10.1016/j.amjcard.2009.01.029; Lexis CPH, 2011, CATHETER CARDIO INTE, V77, P484, DOI 10.1002/ccd.22664; Magro M, 2011, AM HEART J, V161, P771, DOI 10.1016/j.ahj.2011.01.004; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Moreno R, 1998, REV ESP CARDIOL, V51, P547, DOI 10.1016/S0300-8932(98)74788-8; MULLER DWM, 1991, AM HEART J, V121, P1042, DOI 10.1016/0002-8703(91)90661-Z; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102; Sianos Georgios, 2005, EuroIntervention, V1, P219; Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Schaaf RJD, 2006, HEART, V92, P1760, DOI [10.1136/hrt.2005.086058, 10.1136/hrt.2004.059675]; Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Yang CH, 2013, HEART LUNG CIRC, V22, P341, DOI 10.1016/j.hlc.2012.12.003; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109828	10.1371/journal.pone.0109828	http://dx.doi.org/10.1371/journal.pone.0109828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303079	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400083
J	Suzuki, T; Kazuki, Y; Oshimura, M; Hara, T				Suzuki, Teruhiko; Kazuki, Yasuhiro; Oshimura, Mitsuo; Hara, Takahiko			A Novel System for Simultaneous or Sequential Integration of Multiple Gene-Loading Vectors into a Defined Site of a Human Artificial Chromosome	PLOS ONE			English	Article							HAC VECTOR; CONDITIONAL CENTROMERE; GERMLINE TRANSMISSION; EXPRESSION; RECOMBINASES; FIBROBLASTS; DELIVERY; MOUSE; CELLS	Human artificial chromosomes (HACs) are gene-delivery vectors suitable for introdLicing large DNA fragments mammalian cells. A thou h a HAC theoretically incorporates multiple gene expression cassettes of unlimited DNA size, t application has been limited because the conventional gene-loading system accepts only one gene-loading vector (GLV) into a I-IAC. We report a novel method for the simultaneous or sequential integration of multiple GLVs into a HAC vector (designated as the SIM system) via combined usage of Cre, FLP, Bxb1, and (pC31 recombinase/integrase. As a proof of principle, we first attempted simu i ltaneous ntegration of three GLVs encoding EGFP, Venus, and TdTomata into a geneloading site of a HAC in CHO cells. These cells successfully expressed all three fluorescent proteins. Furthermore, nlicrocell mediated transfer of HACs enabled the expression of those fluorescent proteins in recipient cells. We next demonstrated hat GLVs could be introduced into a HAC cane-by-one via reciprocal usage of recombinase/integrase. Lastly, we introduced a fourth GLV into a HAC after simultaneous integration of three GLVs by FLP-mediated DNA recombination. The SIM system expands the applicability of HAC vectors and is useful for various biomedical studies, including cell reporgramming.	[Suzuki, Teruhiko; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 113, Japan; [Kazuki, Yasuhiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Hara, Takahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Tottori University; Tottori University; Tokyo Medical & Dental University (TMDU)	Suzuki, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 113, Japan.	suzuki-tr@igakuken.or.jp			Japan Society for the Promotion of Science KAKENHI [23390256, 24790696]; Grants-in-Aid for Scientific Research [24790696] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grant numbers 23390256 (T.H.) and 24790696 (T.S.) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Iida Y, 2014, ACS SYNTH BIOL, V3, P83, DOI 10.1021/sb400166j; Iida Y, 2010, DNA RES, V17, P293, DOI 10.1093/dnares/dsq020; Kakeda M, 2011, BIOCHEM BIOPH RES CO, V415, P439, DOI 10.1016/j.bbrc.2011.10.088; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kim JH, 2011, P NATL ACAD SCI USA, V108, P20048, DOI 10.1073/pnas.1114483108; Kitajima K, 2011, BLOOD, V117, P3748, DOI 10.1182/blood-2010-07-298596; Kouprina N, 2014, EXPERT OPIN DRUG DEL, V11, P517, DOI 10.1517/17425247.2014.882314; Kouprina N, 2012, ACS SYNTH BIOL, V1, P590, DOI 10.1021/sb3000436; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Kurosaki H, 2011, J HUM GENET, V56, P727, DOI 10.1038/jhg.2011.88; Miyamoto K, 2014, TRANSGENIC RES, V23, P317, DOI 10.1007/s11248-013-9772-x; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takiguchi M., 2012, ACS SYNTH BIOL; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Toth A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085565; Voet T, 2001, GENOME RES, V11, P124, DOI 10.1101/gr.159901; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	29	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110404	10.1371/journal.pone.0110404	http://dx.doi.org/10.1371/journal.pone.0110404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303219	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400128
J	Hyatt, LD; Wasserman, GA; Rah, YJ; Matsuura, KY; Coleman, FT; Hilliard, KL; Pepper-Cunningham, ZA; Ieong, M; Stumpo, DJ; Blackshear, PJ; Quinton, LJ; Mizgerd, JP; Jones, MR				Hyatt, Lynnae D.; Wasserman, Gregory A.; Rah, Yoon J.; Matsuura, Kori Y.; Coleman, Fadie T.; Hilliard, Kristie L.; Pepper-Cunningham, Zachary Ash; Ieong, Michael; Stumpo, Deborah J.; Blackshear, Perry J.; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.			Myeloid ZFP36L1 Does Not Regulate Inflammation or Host Defense in Mouse Models of Acute Bacterial Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENT; MESSENGER-RNA TURNOVER; ZINC-FINGER PROTEINS; TRISTETRAPROLIN-DEFICIENCY SYNDROME; VENTILATOR-ASSOCIATED PNEUMONIA; ACUTE-PHASE RESPONSE; KAPPA-B RELA; PNEUMOCOCCAL PNEUMONIA; NEUTROPHIL RECRUITMENT	Zinc finger protein 36, C3H type-like 1 (ZFP36L1) is one of several Zinc Finger Protein 36 (Zfp36) family members, which bind AU rich elements within 39 untranslated regions (UTRs) to negatively regulate the post-transcriptional expression of targeted mRNAs. The prototypical member of the family, Tristetraprolin (TTP or ZFP36), has been well-studied in the context of inflammation and plays an important role in repressing pro-inflammatory transcripts such as TNF-alpha. Much less is known about the other family members, and none have been studied in the context of infection. Using macrophage cell lines and primary alveolar macrophages we demonstrated that, like ZFP36, ZFP36L1 is prominently induced by infection. To test our hypothesis that macrophage production of ZFP36L1 is necessary for regulation of the inflammatory response of the lung during pneumonia, we generated mice with a myeloid-specific deficiency of ZFP36L1. Surprisingly, we found that myeloid deficiency of ZFP36L1 did not result in alteration of lung cytokine production after infection, altered clearance of bacteria, or increased inflammatory lung injury. Although alveolar macrophages are critical components of the innate defense against respiratory pathogens, we concluded that myeloid ZFP36L1 is not essential for appropriate responses to bacteria in the lungs. Based on studies conducted with myeloid-deficient ZFP36 mice, our data indicate that, of the Zfp36 family, ZFP36 is the predominant negative regulator of cytokine expression in macrophages. In conclusion, these results imply that myeloid ZFP36 may fully compensate for loss of ZFP36L1 or that Zfp36l1-dependent mRNA expression does not play an integral role in the host defense against bacterial pneumonia.	[Hyatt, Lynnae D.; Wasserman, Gregory A.; Rah, Yoon J.; Matsuura, Kori Y.; Coleman, Fadie T.; Hilliard, Kristie L.; Pepper-Cunningham, Zachary Ash; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Hyatt, Lynnae D.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wasserman, Gregory A.; Coleman, Fadie T.; Hilliard, Kristie L.; Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Stumpo, Deborah J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Quinton, Lee J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University; Boston University; Boston University	Jones, MR (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	mattj@bu.edu	Blackshear, Perry J./C-6206-2019; Mizgerd, Joseph/GRY-6369-2022	Blackshear, Perry J./0000-0002-9561-8529; Wasserman, Gregory/0000-0002-0136-272X; Jones, Matthew/0000-0003-4647-2962; Quinton, Lee/0000-0003-1938-2507; Mizgerd, Joseph/0000-0002-4042-3169	NIH [R00-HL092956, R01-HL111449, T32-HL007035, R01-HL068153, R01-HL079392, R01-HL104053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068153, R01HL111449, R01HL104053, R01HL079392, T32HL007035, R00HL092956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by NIH grants, R00-HL092956 (LJQ), R01-HL111449 (LJQ), T32-HL007035 (for LDH), R01-HL068153 (JPM), R01-HL079392 (JPM), and R01-HL104053 (MRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed QAA, 2001, CLIN CHEST MED, V22, P71, DOI 10.1016/S0272-5231(05)70026-5; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Asakawa D, 2013, J MASS SPECTROM, V48, P352, DOI 10.1002/jms.3182; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Delclaux C, 2003, EUR RESPIR J, V22, p10S, DOI 10.1183/09031936.03.00420203; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Echterbille J, 2013, ANAL CHEM; El Solh AA, 2007, CRIT CARE MED, V35, P490, DOI 10.1097/01.CCM.0000253308.93761.09; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Grommes J, 2010, MOL MED; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Ieong MH, 2000, AM J RESP CRIT CARE, V162, P966, DOI 10.1164/ajrccm.162.3.9912054; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Mizgerd JP, 2002, AM J RESP CELL MOL, V27, P575, DOI 10.1165/rcmb.2002-0015OC; Nasir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052187; Pittet LA, 2011, AM J RESP CELL MOL, V45, P573, DOI 10.1165/rcmb.2010-0210OC; PROBERT L, 1993, J IMMUNOL, V151, P1894; Qiu LQ, 2012, J IMMUNOL, V188, P5150, DOI 10.4049/jimmunol.1103700; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Quinton LJ, 2012, AM J RESP CRIT CARE, V186, P943, DOI 10.1164/rccm.201209-1702ED; Quinton LJ, 2012, J CLIN INVEST, V122, P1758, DOI 10.1172/JCI59408; Quinton LJ, 2009, INFECT IMMUN, V77, P2417, DOI 10.1128/IAI.01300-08; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Shimabukuro DW, 2003, CRIT CARE MED, V31, pS524, DOI 10.1097/01.CCM.0000081437.06466.B3; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Tan FE, 2014, P NATL ACAD SCI USA, V111, pE1740, DOI 10.1073/pnas.1320873111; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC; Yamamoto K, 2013, AM J RESP CELL MOL B; Yamamoto K, 2014, AM J RESP CELL MOL, V50, P253, DOI 10.1165/rcmb.2013-0114OC; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	67	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109072	10.1371/journal.pone.0109072	http://dx.doi.org/10.1371/journal.pone.0109072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299049	Green Submitted, gold, Green Published			2022-12-25	WOS:000343941200034
J	Stone, LS; German, JP; Kitto, KF; Fairbanks, CA; Wilcox, GL				Stone, Laura S.; German, Jonathan P.; Kitto, Kelly F.; Fairbanks, Carolyn A.; Wilcox, George L.			Morphine and Clonidine Combination Therapy Improves Therapeutic Window in Mice: Synergy in Antinociceptive but Not in Sedative or Cardiovascular Effects	PLOS ONE			English	Article							INTRATHECAL MORPHINE; EPIDURAL CLONIDINE; CHRONIC PAIN; ANALGESIA; FENTANYL; POTENTIATION; RECEPTOR; AGONIST; MANAGEMENT; CELECOXIB	Opioids are used to manage all types of pain including acute, cancer, chronic neuropathic and inflammatory pain. Unfortunately, opioid-related adverse effects such as respiratory depression, tolerance, physical dependence and addiction have led to an underutilization of these compounds for adequate pain relief. One strategy to improve the therapeutic utility of opioids is to co-administer them with other analgesic agents such as agonists acting at alpha(2)-adrenergic receptors (alpha(2)ARs). Analgesics acting at alpha(2)ARs and opioid receptors (ORs) frequently synergize when co-administered in vivo. Multimodal analgesic techniques offer advantages over single drug treatments as synergistic combination therapies produce analgesia at lower doses, thus reducing undesired side effects. This inference presumes, however, that the synergistic interaction is limited to the analgesic effects. In order to test this hypothesis, we examined the effects of alpha(2)AR/OR combination therapy in acute antinociception and in the often-undesired side effects of sedation and cardiovascular depression in awake unrestrained mice. Morphine, clonidine or their combination was administered by spinal or systemic injection in awake mice. Antinociception was determined using the warm water tail flick assay (52.5 degrees C). Sedation/motor impairment was evaluated using the accelerating rotarod assay and cardiovascular function was monitored by pulse oximetry. Data were converted to percent maximum possible effect and isobolographic analysis was performed to determine if an interaction was subadditive, additive or synergistic. Synergistic interactions between morphine and clonidine were observed in the antinociceptive but not in the sedative/motor or cardiovascular effects. As a result, the therapeutic window was improved, similar to 200-fold and antinociception was achieved at non-sedating doses with little to no cardiovascular depression. In addition, combination therapy resulted in greater maximum analgesic efficacy over either drug alone. These data support the utility of combination adrenergic/opioid therapy in pain management for antinociceptive efficacy with reduced side-effect liability.	[Stone, Laura S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Anesthesiol, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Fairbanks, Carolyn A.] Univ Minnesota, Coll Pharm, Dept Pharmaceut, Minneapolis, MN 55455 USA; [German, Jonathan P.; Kitto, Kelly F.; Fairbanks, Carolyn A.; Wilcox, George L.] Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; [Fairbanks, Carolyn A.; Wilcox, George L.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Wilcox, George L.] Univ Minnesota, Sch Med, Dept Dermatol, Minneapolis, MN 55455 USA	McGill University; McGill University; McGill University; McGill University; McGill University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stone, LS (corresponding author), McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada.	laura.s.stone@mcgill.ca		Wilcox, George/0000-0002-6411-0423; Fairbanks, Carolyn/0000-0003-4252-8586	National Institute of Health; National Institute of Drug Abuse [R21-DA-017075, R01-DA-04274, R01-DA-15438, K01-DA-00509]; Canadian Institutes for Health Research [MOP-86691]; Fonds de la Recherche en Sante Quebec; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA000509, R01DA015438, R21DA017075, R01DA004274] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Health (www.nih.gov), National Institute of Drug Abuse grants to LSS [R21-DA-017075], GLW [R01-DA-04274, R01-DA-15438] and CAF [K01-DA-00509], Canadian Institutes for Health Research (www.cihr-irsc.gc.ca) Operating Grant [MOP-86691] to LSS and a Fonds de la Recherche en Sante Quebec (www.frsq.gouv.qc.ca) Salary Award to LSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Pain Society, 2006, PAIN CONTR PRIM CAR; BOUAZIZ H, 1995, REGION ANESTH, V20, P121; Chabot-Dore AJ, 2013, J PHARMACOL EXP THER, V347, P773, DOI 10.1124/jpet.113.206581; Chaparro LE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008943.pub2; COOMBS DW, 1986, J NEUROSURG, V64, P890, DOI 10.3171/jns.1986.64.6.0890; COUSINS MJ, 1984, ANESTHESIOLOGY, V61, P276; DRASNER K, 1988, PAIN, V32, P309, DOI 10.1016/0304-3959(88)90042-5; EISENACH JC, 1995, PAIN, V61, P391, DOI 10.1016/0304-3959(94)00209-W; EISENACH JC, 1989, ANESTHESIOLOGY, V71, P647, DOI 10.1097/00000542-198911000-00004; EISENACH JC, 1994, ANESTH ANALG, V79, P285; EISENACH JC, 1989, ANESTHESIOLOGY, V71, P640, DOI 10.1097/00000542-198911000-00003; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Fairbanks CA, 2000, ANESTHESIOLOGY, V93, P765, DOI 10.1097/00000542-200009000-00026; Gilron I, 2013, LANCET NEUROL, V12, P1084, DOI 10.1016/S1474-4422(13)70193-5; Giovannoni MP, 2009, MED RES REV, V29, P339, DOI 10.1002/med.20134; Hassenbusch SJ, 2002, PAIN MED, V3, P85, DOI 10.1046/j.1526-4637.2002.02014.x; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; JANSSEN PAJ, 1963, ARZNEIMITTEL-FORSCH, V13, P502; Kedlaya Divakara, 2002, Best Pract Res Clin Anaesthesiol, V16, P651, DOI 10.1053/bean.2002.0253; LOOMIS CW, 1985, CAN J PHYSIOL PHARM, V63, P656, DOI 10.1139/y85-109; LOOMIS CW, 1988, NEUROPHARMACOLOGY, V27, P191, DOI 10.1016/0028-3908(88)90170-0; MEERT TF, 1994, ANESTHESIOLOGY, V81, P677, DOI 10.1097/00000542-199409000-00022; MENDEZ R, 1990, ANESTHESIOLOGY, V73, P848, DOI 10.1097/00000542-199011000-00009; Meske DS, 2013, NEUROSCIENCE LETT; MONASKY MS, 1990, J PHARMACOL EXP THER, V254, P383; MURGA G, 1994, ANAESTHESIA, V49, P999, DOI 10.1111/j.1365-2044.1994.tb04323.x; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Ossipov MH, 1997, ANESTHESIOLOGY, V86, P196, DOI 10.1097/00000542-199701000-00024; OSSIPOV MH, 1990, ANESTHESIOLOGY, V73, P1227, DOI 10.1097/00000542-199012000-00022; OSSIPOV MH, 1990, J PHARMACOL EXP THER, V255, P1107; OSSIPOV MH, 1990, LIFE SCI, V47, pPL71, DOI 10.1016/0024-3205(90)90530-5; PAALZOW L, 1974, J PHARM PHARMACOL, V26, P361, DOI 10.1111/j.2042-7158.1974.tb09291.x; Paech MJ, 2002, ANESTH ANALG, V95, P1396, DOI 10.1097/00000539-200211000-00054; Paech MJ, 2004, ANESTH ANALG, V98, P1460, DOI 10.1213/01.ANE.0000111208.08867.3C; PLUMMER JL, 1992, PAIN, V49, P145, DOI 10.1016/0304-3959(92)90201-L; Puig MM, 1996, ANESTHESIOLOGY, V85, P1403, DOI 10.1097/00000542-199612000-00022; RAFFA RB, 1993, J PHARMACOL EXP THER, V267, P331; RANDICH A, 1992, J NEUROPHYSIOL, V68, P1027, DOI 10.1152/jn.1992.68.4.1027; RAUCK RL, 1993, ANESTHESIOLOGY, V79, P1163, DOI 10.1097/00000542-199312000-00005; REDDY SVR, 1980, J PHARMACOL EXP THER, V213, P525; REDDY SVR, 1980, BRAIN RES, V189, P391; Reuben SS, 2007, J BONE JOINT SURG AM, V89A, P1343, DOI 10.2106/JBJS.F.00906; Reuben SS, 2006, ANESTH ANALG, V103, P1271, DOI 10.1213/01.ane.0000237279.08847.2d; Roerig SC, 1995, LIFE SCI, V56, pPL115; Siddall PJ, 2000, ANESTH ANALG, V91, P1493, DOI 10.1097/00000539-200012000-00037; SIDDALL PJ, 1994, PAIN, V59, P147, DOI 10.1016/0304-3959(94)90059-0; SOLOMON RE, 1989, J PHARMACOL EXP THER, V251, P27; SOLOMON RE, 1994, ANESTH ANALG, V78, P1164; SOLOMON RE, 1988, J PHARMACOL EXP THER, V245, P444; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Tajerian M, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/150842; Tallarida RJ, 2002, PAIN, V98, P163, DOI 10.1016/S0304-3959(02)00041-6; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; Tallarida RJ, 1987, MANUAL PHARMACOLOGIC, P26; Uhle EI, 2000, STEREOT FUNCT NEUROS, V75, P167, DOI 10.1159/000048402; Walker SM, 2002, ANESTH ANALG, V95, P674, DOI 10.1213/01.ANE.0000023209.14008.5B; WILCOX GL, 1987, BRAIN RES, V405, P84, DOI 10.1016/0006-8993(87)90992-9; YAKSH TL, 1981, ANESTHESIOLOGY, V54, P451, DOI 10.1097/00000542-198106000-00004; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	60	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109903	10.1371/journal.pone.0109903	http://dx.doi.org/10.1371/journal.pone.0109903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299457	gold, Green Submitted, Green Published			2022-12-25	WOS:000343941200086
J	Vickers, TA; Crooke, ST				Vickers, Timothy A.; Crooke, Stanley T.			Antisense Oligonucleotides Capable of Promoting Specific Target mRNA Reduction via Competing RNase H1-Dependent and Independent Mechanisms	PLOS ONE			English	Article							GENE-EXPRESSION; RIBONUCLEASE-H; INHIBITION; INITIATION; COMPLEX; BINDING; PROTEIN	Antisense oligonucleotides (ASOs) are most commonly designed to reduce targeted RNA via RNase H1-dependent degradation. In this paper we demonstrate that cellular proteins can compete for sites targeted by RNase H1-dependent ASOs. We further show that some ASOs designed to mediate RNase H1 cleavage can, in certain instances, promote target reduction both by RNase H1-mediated cleavage and by steric inhibition of binding of splicing factors at a site required for efficient processing of the pre-mRNA. In the latter case, RNase H cleavage was prevented by binding of a second protein, HSPA8, to the ASO/pre-mRNA heteroduplex. In addition, using a precisely controlled minigene system, we directly demonstrated that activity of ASOs targeting sites in introns is strongly influenced by splicing efficiency.	[Vickers, Timothy A.; Crooke, Stanley T.] ISIS Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA USA	Isis Pharmaceuticals Inc	Vickers, TA (corresponding author), ISIS Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA USA.	tvickers@isisph.com			ISIS Pharmaceuticals, Inc.	ISIS Pharmaceuticals, Inc.	This work was supported by ISIS Pharmaceuticals, Inc. The funder provided support in the form of salaries for authors TAV and STC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; BAKER BF, 1992, J BIOL CHEM, V267, P11495; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chou MY, 1999, MOL CELL BIOL, V19, P69; Cook P.D., 1993, ANTISENSE RES APPL, P149; Crooke S.T., 2007, ANTISENSE DRUG TECHN, P3, DOI 10.1201/9780849387951; Crooke ST, 1999, BIOCHIM BIOPHYS ACTA, V1489, P30; Crouch RJ, 1985, NUCLEASES, P211; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Hashimoto JG, 2004, BIOTECHNIQUES, V36, P54, DOI 10.2144/04361BM06; HODGE D, 1995, MOL PHARMACOL, V48, P905; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; KOGOMA T, 1985, MOL GEN GENET, V200, P103, DOI 10.1007/BF00383320; Liang XH, 2014, NUCLEIC ACIDS RES, V42, P7819, DOI 10.1093/nar/gku484; Lima WF, 2007, MOL PHARMACOL, V71, P83, DOI 10.1124/mol.106.025015; Lima WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101752; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Monia BP, 1996, J BIOL CHEM, V271, P14533, DOI 10.1074/jbc.271.24.14533; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Pastor T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023349; Rigo F, 2012, NAT CHEM BIOL, V8, P555, DOI [10.1038/nchembio.939, 10.1038/NCHEMBIO.939]; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sproat BS, 1993, ANTISENSE RES APPLIC, P351; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Tang XY, 2011, MOL CELL BIOCHEM, V357, P55, DOI 10.1007/s11010-011-0875-5; VICKERS T, 1991, NUCLEIC ACIDS RES, V19, P3359, DOI 10.1093/nar/19.12.3359; Vickers TA, 2001, NUCLEIC ACIDS RES, V29, P1293, DOI 10.1093/nar/29.6.1293; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200; Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071006	38	42	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108625	10.1371/journal.pone.0108625	http://dx.doi.org/10.1371/journal.pone.0108625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299183	gold, Green Published, Green Submitted			2022-12-25	WOS:000343941200019
J	Ballestriero, F; Daim, M; Penesyan, A; Nappi, J; Schleheck, D; Bazzicalupo, P; Di Schiavi, E; Egan, S				Ballestriero, Francesco; Daim, Malak; Penesyan, Anahit; Nappi, Jadranka; Schleheck, David; Bazzicalupo, Paolo; Di Schiavi, Elia; Egan, Suhelen			Antinematode Activity of Violacein and the Role of the Insulin/IGF-1 Pathway in Controlling Violacein Sensitivity in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-SPAN; GENES; RESISTANCE; BACTERIA; PREDATION; DEFENSES; IMMUNITY; MUTANTS; ENZYMES; DAF-16	The purple pigment violacein is well known for its numerous biological activities including antibacterial, antiviral, antiprotozoan, and antitumor effects. In the current study we identify violacein as the antinematode agent produced by the marine bacterium Microbulbifer sp. D250, thereby extending the target range of this small molecule. Heterologous expression of the violacein biosynthetic pathway in E. coli and experiments using pure violacein demonstrated that this secondary metabolite facilitates bacterial accumulation in the nematode intestine, which is accompanied by tissue damage and apoptosis. Nematodes such as Caenorhabditis elegans utilise a well-defined innate immune system to defend against pathogens. Using C. elegans as a model we demonstrate the DAF-2/DAF-16 insulin/IGF-1 signalling (IIS) component of the innate immune pathway modulates sensitivity to violacein-mediated killing. Further analysis shows that resistance to violacein can occur due to a loss of DAF-2 function and/or an increased function of DAF-16 controlled genes involved in antimicrobial production (spp-1) and detoxification (sod-3). These data suggest that violacein is a novel candidate antinematode agent and that the IIS pathway is also involved in the defence against metabolites from non-pathogenic bacteria.	[Ballestriero, Francesco; Daim, Malak; Nappi, Jadranka; Egan, Suhelen] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Ballestriero, Francesco; Daim, Malak; Nappi, Jadranka; Egan, Suhelen] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Penesyan, Anahit] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Schleheck, David] Univ Konstanz, Dept Biol, Constance, Germany; [Bazzicalupo, Paolo; Di Schiavi, Elia] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy	University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University; University of Konstanz; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Egan, S (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	s.egan@unsw.edu.au	Di Schiavi, Elia/B-8046-2015; Penesyan, Anahit/Y-6884-2019; Penesyan, Anahit/A-9442-2012	Di Schiavi, Elia/0000-0002-8179-6666; Penesyan, Anahit/0000-0002-2502-0740; Penesyan, Anahit/0000-0002-2502-0740; Egan, Suhelen/0000-0003-3286-4279				Ahmetagic A, 2011, PLASMID, V66, P152, DOI 10.1016/j.plasmid.2011.07.006; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda S, 2011, MICROB ECOL, V62, P446, DOI 10.1007/s00248-011-9840-9; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Ballestriero F, 2010, APPL ENVIRON MICROB, V76, P5710, DOI 10.1128/AEM.00695-10; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; BRENNER S, 1974, GENETICS, V77, P71; Bromberg N, 2010, CHEM-BIOL INTERACT, V186, P43, DOI 10.1016/j.cbi.2010.04.016; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; Durai S, 2011, J MICROBIOL BIOTECHN, V21, P1026, DOI 10.4014/jmb.1102.02006; Duran M, 2012, MED CHEM RES, V21, P1524, DOI 10.1007/s00044-011-9654-9; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, GENETICS, V154, P1597; Hakvag S, 2009, MAR DRUGS, V7, P576, DOI 10.3390/md7040576; Harrington D, 2005, LINEAR RANK TESTS SU; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Jiang PX, 2012, APPL MICROBIOL BIOT, V94, P1521, DOI 10.1007/s00253-012-3960-0; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kawli T, 2010, DIS MODEL MECH, V3, P721, DOI 10.1242/dmm.003871; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kho MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029122; Kleino A, 2012, CELL HOST MICROBE, V11, P320, DOI 10.1016/j.chom.2012.04.002; Konzen M, 2006, BIOORGAN MED CHEM, V14, P8307, DOI 10.1016/j.bmc.2006.09.013; Lu Y, 2009, BIOCHEM ENG J, V43, P135, DOI 10.1016/j.bej.2008.09.009; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MARDEN P, 1985, ARCH MICROBIOL, V142, P326, DOI 10.1007/BF00491898; Marsh EK, 2012, APPL ENVIRON MICROB, V78, P2075, DOI 10.1128/AEM.07486-11; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pantanella F, 2007, J APPL MICROBIOL, V102, P992, DOI 10.1111/j.1365-2672.2006.03155.x; Penesyan A, 2013, MAR DRUGS, V11, P40, DOI 10.3390/md11010040; Penesyan A, 2009, FEMS MICROBIOL ECOL, V69, P113, DOI 10.1111/j.1574-6941.2009.00688.x; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Prichard RK, 2008, NATURE, V452, P157, DOI 10.1038/452157a; Roeder T, 2010, DEV COMP IMMUNOL, V34, P203, DOI 10.1016/j.dci.2009.09.010; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Stiernagle Theresa, 2006, WormBook, P1; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Taylor CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003149; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Yang LH, 2007, LETT APPL MICROBIOL, V44, P625, DOI 10.1111/j.1472-765X.2007.02125.x; Zhang X, 2011, APPL MICROBIOL BIOT, V90, P1963, DOI 10.1007/s00253-011-3203-9; Zhang XD, 2009, CELL HOST MICROBE, V5, P425, DOI 10.1016/j.chom.2009.05.003	61	25	26	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109201	10.1371/journal.pone.0109201	http://dx.doi.org/10.1371/journal.pone.0109201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295516	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000047
J	Lopez-Arbarello, A; Stockar, R; Burgin, T				Lopez-Arbarello, Adriana; Stockar, Rudolf; Buergin, Toni			Phylogenetic Relationships of the Triassic Archaeosemionotus Deecke (Halecomorphi, Ionoscopiformes) from the 'Perledo Fauna'	PLOS ONE			English	Article							MERIDE CANTON TICINO; SOUTHERN SWITZERLAND; FISH HALECOMORPHI; MIDDLE; ACTINOPTERYGII; EVOLUTION; SKELETON; GENUS	The lagerstatten in the Monte San Giorgio have provided excellent fossils representing one of the most important windows to the marine life during the Triassic. Among these fossils, fishes are abundant and extraordinarily well preserved. Most of these fishes represent extinct lineages and were difficult to understand and classify during the early years after discovery. These difficulties usually led to a mixture of species under the same taxonomic name. This is the case of fishes referred to the genus Archaeosemionotus. The name bearing type of A. connectens, the type species of this genus, represents a basal halecomorph, but most other fishes referred to this genus represent basal ginglymodians. Therefore, we conducted this study to clarify the taxonomic status and phylogenetic relationships of A. connectens, which is a member of the family Furidae (Halecomorphi, Ionoscopiformes) representing the second cladistically supported evidence of ionoscopiforms in the Triassic and it is thus one of the two oldest reliable records of this group. Ionoscopiforms have a long stratigraphic range, though their fossil record is rather patchy. In our analysis, the sister taxon of Archaeosemionotus is Robustichthys from the Anisian of China, and they together form a clade with Furo, which is known from several localities ranging from the Early to the Late Jurassic. Other ionoscopiforms are so far known from the Kimmeridgian to the Albian and it is thus evident that recent efforts have concentrated on the later history of the group (Late Jurassic to Cretaceous). The phylogenetic relationships obtained for the Ionoscopiformes do not show a clear palaeobiogeographic pattern, but give important new insights into the origin, divergence date and early history of this clade.	[Lopez-Arbarello, Adriana] Univ Munich, SNSB Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Lopez-Arbarello, Adriana] Univ Munich, GeoBioctr, Munich, Germany; [Stockar, Rudolf] Museo Cantonale Storia Nat, Lugano, Switzerland; [Buergin, Toni] Naturmuseum, Gallen, Switzerland	University of Munich; University of Munich	Lopez-Arbarello, A (corresponding author), Univ Munich, SNSB Bavarian State Collect Palaeontol & Geol, Munich, Germany.	a.Lopez-Arbarello@lrz.uni-muenchen.de	Lopez-Arbarello, Adriana/N-1834-2018	Lopez-Arbarello, Adriana/0000-0002-2924-3319	German Research Foundation [LO1405/3]; Dipartimento del territorio del Cantone Ticino; Swiss Federal Office for the Environment	German Research Foundation(German Research Foundation (DFG)); Dipartimento del territorio del Cantone Ticino; Swiss Federal Office for the Environment	This research has been financed through project LO1405/3 from the German Research Foundation (http://www.dfg.de/) and by the Dipartimento del territorio del Cantone Ticino and the Swiss Federal Office for the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassiz L., 1834, NEUES JB MINERALOGIE, V1834; Alvarado-Ortega J, 2008, J PALEONTOL, V82, P163, DOI 10.1666/04-152.1; Applegate SP, 1988, REV I GEOL UNAM, V7, P200; Balsamo-Crivelli G, 1839, POLITECNICO MILANO, V1, P421; Bartram A. W. H., 1977, Bulletin Br. Mus. nat. Hist. (Geol.), V29, P137; BARTRAM AWH, 1975, ZOOL J LINN SOC-LOND, V56, P183, DOI 10.1111/j.1096-3642.1975.tb00263.x; Bassani F., 1886, ATTI SOCIETA ITALIAN, V29, P15; Bellotti C, 1857, STUDII GEOLOGICI PAL, P491; BELTAN L L, 1972, Memorias de la Real Academia de Ciencias y Artes de Barcelona, V41, P281; Brack P, 2005, EPISODES, V28, P233, DOI 10.18814/epiiugs/2005/v28i4/001; BURGIN T, 1991, ECLOGAE GEOL HELV, V84, P921; Burgin T, 1995, ECLOGAE GEOL HELV, V88, P803; Burgin Toni, 1999, P481; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Cope E.D., 1887, AM NAT, V21, P1014, DOI DOI 10.1086/274597; De Alessandri G., 1910, MEM SOC ITAL SCI NAT, V7, P1; Deecke W., 1889, PALAEONTOGRAPHICA, V35, P13; Furrer H, 1995, ECLOGAE GEOL HELV, V88, P827; Furrer H, 2001, INT M MES FISH 3 SYS, P1; Furrer H, 2009, SO KAM FISH BERG EIN; Furrer Heinz, 2003, Neujahrsblatt der Naturforschenden Gesellschaft in Zuerich, V206, P1; Gaetani M, 1992, RIV ITAL PALEONTOL S, V97, P329; Gardiner Brian G., 1996, P117, DOI 10.1016/B978-012670950-6/50007-2; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; HUTCHINSON P, 1973, B BRIT MUS NAT HIST, V22, P235; Huxley T.H., 1861, MEMOIRS GEOLOGICAL S, V10, P1; Jordan D.S., 1923, STANFORD U PUBL U BS, V3, P77, DOI DOI 10.5962/BHL.TITLE.161386; Kramberger-Gorjanovic K., 1905, Beitraege zur Palaeontologie Oesterreich-Ungarns, Vxviii, P193; Lambers Paul H., 1995, Geobios Memoire Special (Villeurbanne), V19, P201; Lambers Paul H., 1998, Oryctos, V1, P23; Lane JA, 2012, J VERTEBR PALEONTOL, V32, P799, DOI 10.1080/02724634.2012.680325; Lombardo C, 2001, RIV ITAL PALEONTOL S, V107, P345, DOI 10.13130/2039-4942/5439; Lopez-Arbarello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039370; Machado GP, 2013, J VERTEBR PALEONTOL, V33, P482, DOI 10.1080/02724634.2013.729962; Maddison WP, 2011, MESQUITE MODULAR SYS; Muller J., 1846, PHYSIKALISCH MATHEMA, V1846, P117; O'Leary MA, 2012, MORPH BANK 3 0 WEB A; PATTERSON COLIN, 1968, BULL BRIT MUS [NATUR HIS] GEOL, V16, P203; Pinna G., 1991, Natura (Milan), V82, P1; Regan CT, 1923, P ZOOL SOC LOND, V1923, P445; SCHAEFFER BOBB, 1960, AMER MUS NOVITATES, V2011, P1; Schultze Hans-Peter, 1996, P83; SCHULTZE HP, 1989, ZOOL J LINN SOC-LOND, V97, P189, DOI 10.1111/j.1096-3642.1989.tb00547.x; Sieber R, 1950, CARINTHIA, V2, P91; Stockar R, 2012, SWISS J GEOSCI, V105, P85, DOI 10.1007/s00015-012-0093-5; Stockar R, 2010, SWISS J GEOSCI, V103, P101, DOI 10.1007/s00015-010-0008-2; Stutzer PH, 1972, THESIS LUDIWIG MAXIM; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tintori A, 1998, RIV ITAL PALEONTOL S, V104, P417, DOI 10.13130/2039-4942/5342; Tintori A, 2007, RIV ITAL PALEONTOL S, V113, P369, DOI 10.13130/2039-4942/5881; Tintori Andrea, 1999, P495; Wenz S., 1967, Cent Nat Rech Sci Paris, P1; Wenz S, 1986, B MUSEUM NATL HIST C, P77; Woodward A.S., 1895, MEMOIRS GEOLOGICAL S, V9, P1; Xu GH, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0204	55	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108665	10.1371/journal.pone.0108665	http://dx.doi.org/10.1371/journal.pone.0108665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296174	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000017
J	Lu, Q; Wang, JY; Wang, LM; Jiang, XC; Chu, YW				Lu, Qing; Wang, Ji-Yang; Wang, Luman; Jiang, Xuechao; Chu, Yiwei			Self DNA from Lymphocytes That Have Undergone Activation-Induced Cell Death Enhances Murine B Cell Proliferation and Antibody Production	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; SHORT-LIVED PLASMABLASTS; MARGINAL-ZONE; GERMINAL CENTER; INCREASED FREQUENCY; AUTOIMMUNE-DISEASE; IMMUNE-COMPLEXES; DYING CELLS; NZB/W MICE	Systemic lupus erythematosus (SLE) is characterized by prominent autoinflammatory tissue damage associated with impaired removal of dying cells and DNA. Self DNA-containing immune complexes are able to activate both innate and adaptive immune responses and play an important role in the maintenance and exacerbation of autoimmunity in SLE. In this study, we used DNA from lymphocytes that have undergone activation-induced cell death (ALD-DNA) and analyzed its role on the activation and differentiation of B cells from normal BALB/c mice as well as lupus-prone MRL+/+ and MRL/lpr mice. We found that ALD-DNA directly increased the expression of costimulatory molecules and the survival of naive B cells in vitro. Although ALD-DNA alone had little effect on the proliferation of naive B cells, it enhanced LPS-activated B cell proliferation in vitro and in vivo. In addition, ALD-DNA increased plasma cell numbers and IgG production in LPS-stimulated cultures of naive B cells, in part via enhancing IL-6 production. Importantly, B cells from lupus mice were hyperresponsive to ALD-DNA and/or LPS relative to normal control B cells in terminal plasma cell differentiation, as evidenced by increases in CD138(+) cell numbers, IgM production, and mRNA levels of B lymphocyte-induced maturation protein-1 (Blimp-1) and the X-box binding protein 1 (XBP1). Furthermore, ALD-DNA enhanced CD40-activated naive B cell proliferation. Collectively, these data indicate that self DNA can serve as a DAMP (damage-associated molecular pattern) that cooperates with signals from both innate and adaptive immunity to promote polyclonal B cell activation, a common characteristic of autoimmune diseases.	[Lu, Qing; Wang, Ji-Yang; Wang, Luman; Jiang, Xuechao; Chu, Yiwei] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China; [Wang, Ji-Yang; Chu, Yiwei] Fudan Univ, Biotherapy Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chu, YW (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China.	yiwei_chu@126.com			Chinese Natural Sciences Foundation [30872337, 81273215, 81330080]; Grants-in-Aid for Scientific Research [25460604] Funding Source: KAKEN	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by grants from the Chinese Natural Sciences Foundation (Grant 30872337 [QL], 81273215 [YC] and 81330080 [OL]) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Brummel R, 2005, J IMMUNOL, V174, P2429, DOI 10.4049/jimmunol.174.4.2429; Cai YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062465; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Dall'Era MC, 2005, ANN RHEUM DIS, V64, P1692, DOI 10.1136/ard.2004.033753; Dil N, 2009, MOL IMMUNOL, V46, P1970, DOI 10.1016/j.molimm.2009.03.010; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Eisner MD, 1996, SEMIN ARTHRITIS RHEU, V26, P477, DOI 10.1016/S0049-0172(96)80028-X; EMLEN W, 1994, J IMMUNOL, V152, P3685; Finke D, 2007, EUR J IMMUNOL, V37, P1702, DOI 10.1002/eji.200636719; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gergely P, 2002, ARTHRITIS RHEUM-US, V46, P175, DOI 10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Gunn KE, 2006, J IMMUNOL, V177, P3791, DOI 10.4049/jimmunol.177.6.3791; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Jacob N, 2010, AUTOIMMUNITY, V43, P84, DOI 10.3109/08916930903374600; Jiang N, 2005, J LEUKOCYTE BIOL, V77, P296, DOI 10.1189/jlb.0704411; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; KAWANO Y, 1995, IMMUNOLOGY, V84, P278; KLINMAN DM, 1990, J CLIN INVEST, V86, P1249, DOI 10.1172/JCI114831; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marcelletti JF, 1996, J IMMUNOL, V157, P3323; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Ouchida R, 2012, P NATL ACAD SCI USA, V109, pE2699, DOI 10.1073/pnas.1210706109; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Pisetsky DS, 2013, EUR J IMMUNOL, V43, P3163, DOI 10.1002/eji.201344175; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Qian Y, 2006, BLOOD, V108, P974, DOI 10.1182/blood-2005-12-006858; SANO H, 1982, J IMMUNOL, V128, P1341; SANO H, 1989, SCAND J IMMUNOL, V30, P51, DOI 10.1111/j.1365-3083.1989.tb01188.x; Santiago-Raber ML, 2004, AUTOIMMUN REV, V3, P33, DOI 10.1016/S1568-9972(03)00062-4; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schroeder K, 2013, AUTOIMMUNITY, V46, P121, DOI 10.3109/08916934.2012.748751; Su KY, 2009, SCAND J IMMUNOL, V70, P175, DOI 10.1111/j.1365-3083.2009.02300.x; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tuvim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030596; Vinuesa CG, 2013, NAT IMMUNOL, V14, P119, DOI 10.1038/ni.2511; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315	62	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109095	10.1371/journal.pone.0109095	http://dx.doi.org/10.1371/journal.pone.0109095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296026	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000037
J	Sterflinger, K; Lopandic, K; Pandey, RV; Blasi, B; Kriegner, A				Sterflinger, Katja; Lopandic, Ksenija; Pandey, Ram Vinay; Blasi, Barbara; Kriegner, Albert			Nothing Special in the Specialist? Draft Genome Sequence of Cryomyces antarcticus, the Most Extremophilic Fungus from Antarctica	PLOS ONE			English	Article							ROCK-INHABITING FUNGI; EXOPHIALA; EVOLUTION	The draft genome of the Antarctic endemic fungus Cryomyces antarcticus is presented. This rock inhabiting, microcolonial fungus is extremely stress tolerant and it is a model organism for exobiology and studies on stress resistance in Eukaryots. Since this fungus is a specialist in the most extreme environment of the Earth, the analysis of its genome is of important value for the understanding of fungal genome evolution and stress adaptation. A comparison with Neurospora crassa as well as with other microcolonial fungi shows that the fungus has a genome size of 24 Mbp, which is the average in the fungal kingdom. Although sexual reproduction was never observed in this fungus, 34 mating genes are present with protein homologs in the classes Eurotiomycetes, Sordariomycetes and Dothideomycetes. The first analysis of the draft genome did not reveal any significant deviations of this genome from comparative species and mesophilic hyphomycetes.	[Sterflinger, Katja; Lopandic, Ksenija; Blasi, Barbara] Univ Nat Resources & Life Sci, VIBT Extremophile Ctr, Vienna, Austria; [Pandey, Ram Vinay; Kriegner, Albert] Austrian Inst Technol, Vienna, Austria; [Pandey, Ram Vinay] Univ Vet Med, Inst Populat Genet, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Austrian Institute of Technology (AIT); University of Veterinary Medicine Vienna	Sterflinger, K (corresponding author), Univ Nat Resources & Life Sci, VIBT Extremophile Ctr, Vienna, Austria.	Katja.Sterflinger@boku.ac.at	Pandey, Ram Vinay/AAL-1701-2021; Pandey, Ram Vinay/AAA-3544-2022	Blasi, Barbara/0000-0002-3776-6363; Sterflinger, Katja/0000-0002-0296-6728; Lopandic, Ksenija/0000-0003-2674-2849; Pandey, Ram Vinay/0000-0002-2533-8687	city of Vienna (ZID); Austrian Ministry of Science, Research and Economy	city of Vienna (ZID); Austrian Ministry of Science, Research and Economy	The equipment and consumables were funded by a non-profit organisation including the city of Vienna (ZID) and by the Austrian Ministry of Science, Research and Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; De Hoog GS, 2006, ANTON LEEUW INT J G, V90, P257, DOI 10.1007/s10482-006-9080-z; Dhillon B, 2011, METHODS MOL BIOL, V722, P33, DOI 10.1007/978-1-61779-040-9_3; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Gostincar C, 2010, FEMS MICROBIOL ECOL, V71, P2, DOI 10.1111/j.1574-6941.2009.00794.x; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Heitman J, 2013, MYCOLOGIA, V105, P1, DOI 10.3852/12-253; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lenassi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071328; Marzban G, 2013, NAT SCI, V5, P640, DOI DOI 10.4236/NS.2013.55079; Matos T, 2002, MYCOSES, V45, P373, DOI 10.1046/j.1439-0507.2002.00779.x; Matos T, 2003, ANTON LEEUW INT J G, V83, P293, DOI 10.1023/A:1023373329502; Onofri S, 2004, PLANET SPACE SCI, V52, P229, DOI 10.1016/j.pss.2003.08.019; Onofri S, 2008, STUD MYCOL, P99, DOI 10.3114/sim.2008.61.10; Onofri S, 2012, ASTROBIOLOGY, V12, P508, DOI 10.1089/ast.2011.0736; Schoustra SE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030068; Selbmann L, 2005, STUD MYCOL, P1; Selbmann L, 2008, STUD MYCOL, P1, DOI 10.3114/sim.2008.61.01; Selbmann L, 2011, FUNGAL BIOL-UK, V115, P937, DOI 10.1016/j.funbio.2011.02.016; Shear CL, 1927, J AGRIC RES, V34, P1019; Sterflinger K, 1997, ANTON LEEUW INT J G, V72, P349, DOI 10.1023/A:1000570429688; Sterflinger K, 2001, ANTON LEEUW INT J G, V80, P275, DOI 10.1023/A:1013060308809; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; Sterflinger K, 2012, FUNGAL ECOL, V5, P453, DOI 10.1016/j.funeco.2011.12.007; STORCK R, 1966, J BACTERIOL, V91, P227, DOI 10.1128/JB.91.1.227-230.1966; Tesei D, 2012, FUNGAL BIOL-UK, V116, P932, DOI 10.1016/j.funbio.2012.06.004; Zakharova K, 2014, NAT SCI, V5, P640; Zakharova K, 2013, MYCOPATHOLOGIA, V175, P537, DOI 10.1007/s11046-012-9592-1; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06	30	14	15	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109908	10.1371/journal.pone.0109908	http://dx.doi.org/10.1371/journal.pone.0109908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296285	Green Published, gold			2022-12-25	WOS:000345204000102
J	Goswami, A; Chakraborty, U; Mahapatra, T; Mahapatra, S; Mukherjee, T; Das, S; Das, A; Dey, SK; Ray, S; Bhattacharya, B; Pal, NK				Goswami, Avranil; Chakraborty, Urmita; Mahapatra, Tanmay; Mahapatra, Sanchita; Mukherjee, Tapajyoti; Das, Shibali; Das, Aritra; Dey, Subir Kumar; Ray, Sudhin; Bhattacharya, Basudev; Pal, Nishith Kumar			Correlates of Treatment Outcomes and Drug Resistance among Pulmonary Tuberculosis Patients Attending Tertiary Care Hospitals of Kolkata, India	PLOS ONE			English	Article							CHAIN-REACTION PCR; RISK-FACTORS; PREVALENCE; DEFAULT; IDENTIFICATION; RETREATMENT; FAILURE; RELAPSE; SPUTUM	Background: Worldwide highest number of new pulmonary tuberculosis (PTB) cases, was reported from India in 2012. Adverse treatment outcomes and emergence of drug resistance further complicated the prevailing scenario owing to increased duration, cost and toxicity associated with the treatment of drug-resistant cases. Hence to reinforce India's fight against TB, identification of the correlates of adverse treatment outcomes and drug resistance, seemed critical. Methods: To estimate the associations between diagnostic findings, patient types (based on treatment outcomes), drug resistance and socio-demographic characteristics of PTB patients, a cross-sectional study was conducted in two tertiary-care hospitals in Kolkata between April 2010 and March 2013. Altogether, 350 consenting Mycobacterium tuberculosis sputum-culture positive PTB patients were interviewed about their socio-demographic background, evaluated regarding their X-ray findings (minimal/moderately advanced/far advanced/cavities), sputum-smear positivity, and treatment history/outcomes (new/defaulter/relapse/treatment-failure cases). Multiple-allele-specific polymerase chain reaction (MAS-PCR) was conducted to diagnose drug resistance. Results: Among all participants, 31.43% were newly diagnosed, while 44%, 15.43% and 9.14% patients fell into the categories of relapsed, defaulters and treatment-failures, respectively. 12.29% were multi-drug-resistant (MDR: resistant to at least isoniazid and rifampicin), 57.71% had non-MDR two-drug resistance and 12% had single-drug resistance. Subjects with higher BMI had lower odds of being a relapse/defaulter/treatment failure case while females were more likely to be defaulters and older age-groups had more relapse. Elderly, females, unmarried, those with low BMI and higher grade of sputum-smear positivity were more likely to have advanced X-ray features. Higher grade of sputum-smear positivity and advanced chest X-ray findings were associated with relapse/treatment-failures. Elderly, unmarried, relapse/defaulter/treatment-failure cases had higher odds and those with higher BMI and moderately/far advanced X-ray findings had lower odds of having MDR/non-MDR two-drug resistant PTB. Conclusion: Targeted intervention and appropriate counseling are needed urgently to prevent adverse treatment outcomes and development of drug resistance among PTB patients in Kolkata.	[Goswami, Avranil; Chakraborty, Urmita; Bhattacharya, Basudev; Pal, Nishith Kumar] Postgrad Inst Med Educ & Res, Kolkata, India; [Mahapatra, Tanmay; Mahapatra, Sanchita; Das, Aritra] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA USA; [Mukherjee, Tapajyoti] Burdwan Med Coll & Hosp, Burdwan, W Bengal, India; [Das, Shibali] Bose Inst, Kolkata, India; [Dey, Subir Kumar] Calcutta Natl Med Coll, Kolkata, India; [Ray, Sudhin] SSKM Hosp, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; University of California System; University of California Los Angeles; Department of Science & Technology (India); Bose Institute; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Pal, NK (corresponding author), Postgrad Inst Med Educ & Res, Kolkata, India.	nishithkpal53@gmail.com	Das, Shibali/AAA-2683-2021; Das, Aritra/C-9076-2014	Das, Shibali/0000-0003-1263-8178; Das, Aritra/0000-0002-7033-1441	Institute of Postgraduate Medical Education and Research, Kolkata, India	Institute of Postgraduate Medical Education and Research, Kolkata, India	This study was supported by The Institute of Postgraduate Medical Education and Research, Kolkata, India by allowing the authors to use the existing infrastructure of the institute (http://www.ipgmer.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SP, 2005, TUBERCULOSIS CONTROL; Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Bhattacharya B, 2003, TROP MED INT HEALTH, V8, P150, DOI 10.1046/j.1365-3156.2003.01007.x; Chakraborty U, 2013, INT J TUBERC LUNG D, V17, P505, DOI 10.5588/ijtld.12.0196; Chowdhury IH, 2012, J CLIN MICROBIOL, V50, P2082, DOI 10.1128/JCM.06093-11; Della-Latta P, 2007, CLIN MICROBIOLOGY PR, P701; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Hosek J, 2006, VET MED-CZECH, V51, P180, DOI 10.17221/5538-VETMED; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Leitch AG, 2002, CROFTON DOUGLASS RES, P507; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Maurya AK, 2013, INDIAN J MED MICROBI, V31, P40, DOI 10.4103/0255-0857.108720; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Patel D, 2000, OCCUP MED-OXFORD, V50, P395, DOI 10.1093/occmed/50.6.395; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Sharma SK, 2011, INDIAN J MED RES, V133, P312; Sharma SK, 2011, INDIAN J MED RES, V133, P308; SNIDER DE, 1985, AM REV RESPIR DIS, V132, P125; Weyer K, 2007, SAMJ S AFR MED J, V97, P1120; World Health Organization, 2019, 10 HLTH ISS WHO WILL, DOI DOI 10.1016/S2213-2600(19)30418-7; World Health Organization (WHO), 2013, WORLD TB DAY 2013; Yang ZH, 2005, DIAGN MICR INFEC DIS, V53, P201, DOI 10.1016/j.diagmicrobio.2005.06.007; Young J, 2004, HLTH DEV WORLD HLTH; Zaveri HG, 2010, INDIAN J PHARMACOL, V42, P95, DOI 10.4103/0253-7613.64499	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109563	10.1371/journal.pone.0109563	http://dx.doi.org/10.1371/journal.pone.0109563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289974	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000069
J	Lewandowska, L; Matuszkiewicz-Rowinska, J; Jayakumar, C; Oldakowska-Jedynak, U; Looney, S; Galas, M; Dutkiewicz, M; Krawczyk, M; Ramesh, G				Lewandowska, Lidia; Matuszkiewicz-Rowinska, Joanna; Jayakumar, Calpurnia; Oldakowska-Jedynak, Urszula; Looney, Stephen; Galas, Michalina; Dutkiewicz, Malgorzata; Krawczyk, Marek; Ramesh, Ganesan			Netrin-1 and Semaphorin 3A Predict the Development of Acute Kidney Injury in Liver Transplant Patients	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; CYCLE ARREST BIOMARKERS; RISK-FACTORS; DEFINITION; VALIDATION; DIALYSIS; PROTECTS; RIFLE	Acute kidney injury (AKI) is a serious complication after liver transplantation. Currently there are no validated biomarkers available for early diagnosis of AKI. The current study was carried out to determine the usefulness of the recently identified biomarkers netrin-1 and semaphorin 3A in predicting AKI in liver transplant patients. A total of 63 patients' samples were collected and analyzed. AKI was detected at 48 hours after liver transplantation using serum creatinine as a marker. In contrast, urine netrin-1 (897.8 +/- 112.4 pg/mg creatinine), semaphorin 3A (847.9 +/- 93.3 pg/mg creatinine) and NGAL (2172.2 +/- 378.1 ng/mg creatinine) levels were increased significantly and peaked at 2 hours after liver transplantation but were no longer significantly elevated at 6 hours after transplantation. The predictive power of netrin-1, as demonstrated by the area under the receiver-operating characteristic curve for diagnosis of AKI at 2, 6, and 24 hours after liver transplantation was 0.66, 0.57 and 0.59, respectively. The area under the curve for diagnosis of AKI was 0.63 and 0.65 for semaphorin 3A and NGAL at 2 hr respectively. Combined analysis of two or more biomarkers for simultaneous occurrence in urine did not improve the AUC for the prediction of AKI whereas the AUC was improved significantly (0.732) only when at least 1 of the 3 biomarkers in urine was positive for predicting AKI. Adjusting for BMI, all three biomarkers at 2 hours remained independent predictors of AKI with an odds ratio of 1.003 (95% confidence interval: 1.000 to 1.006; P = 0.0364). These studies demonstrate that semaphorin 3A and netrin-1 can be useful early diagnostic biomarkers of AKI after liver transplantation.	[Jayakumar, Calpurnia; Ramesh, Ganesan] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA; [Lewandowska, Lidia; Matuszkiewicz-Rowinska, Joanna] Med Univ Warsaw, Dept Nephrol Dialysis & Internal Dis, Warsaw, Poland; [Oldakowska-Jedynak, Urszula; Galas, Michalina; Krawczyk, Marek] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Warsaw, Poland; [Looney, Stephen] Georgia Regents Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Dutkiewicz, Malgorzata] Med Univ Warsaw, Dept Gen & Nutr Biochem, Warsaw, Poland	University System of Georgia; Augusta University; Medical University of Warsaw; Medical University of Warsaw; University System of Georgia; Augusta University; Medical University of Warsaw	Ramesh, G (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA.	gramesh@gru.edu	Dutkiewicz, Malgorzata/T-9898-2018	Dutkiewicz, Malgorzata/0000-0002-5701-7490	NIH-NIDDK [1R01DK083379 - 01A3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083379] Funding Source: NIH RePORTER	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an R01 grant (1R01DK083379 - 01A3) to Ganesan Ramesh from NIH-NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Bilbao I, 1998, CLIN TRANSPLANT, V12, P123; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; CAREGARO L, 1994, ARCH INTERN MED, V154, P201, DOI 10.1001/archinte.154.2.201; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jayakumar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058446; Jayakumar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026776; Jeong TD, 2012, CLIN TRANSPLANT, V26, P775, DOI 10.1111/j.1399-0012.2012.01610.x; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Li Y, 2012, BIOMARKERS, V17, P336, DOI 10.3109/1354750X.2012.672458; Lima EQ, 2003, RENAL FAILURE, V25, P553, DOI 10.1081/JDI-120022546; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Niemann CU, 2009, LIVER TRANSPLANT, V15, P1852, DOI 10.1002/lt.21938; Portal AJ, 2010, LIVER TRANSPLANT, V16, P1257, DOI 10.1002/lt.22158; Ramesh G, 2010, TRANSPL P, V42, P1519, DOI 10.1016/j.transproceed.2009.11.040; Ramesh G, 2010, CLIN J AM SOC NEPHRO, V5, P395, DOI 10.2215/CJN.05140709; Reeves WB, 2008, AM J PHYSIOL-RENAL, V294, pF731, DOI 10.1152/ajprenal.00507.2007; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; RIMOLA A, 1987, GASTROENTEROLOGY, V93, P148, DOI 10.1016/0016-5085(87)90327-1; Sirota JC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-17; Tapia R, 2008, KIDNEY INT, V73, P733, DOI 10.1038/sj.ki.5002726; Utsumi M, 2013, TRANSPL INT, V26, P842, DOI 10.1111/tri.12138; Wagener G, 2011, NEPHROL DIAL TRANSPL, V26, P1717, DOI 10.1093/ndt/gfq770; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224	30	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107898	10.1371/journal.pone.0107898	http://dx.doi.org/10.1371/journal.pone.0107898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289643	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000010
J	Phillips, A; Cambiano, V; Nakagawa, F; Magubu, T; Miners, A; Ford, D; Pillay, D; De Luca, A; Lundgren, J; Revill, P				Phillips, Andrew; Cambiano, Valentina; Nakagawa, Fumiyo; Magubu, Travor; Miners, Alec; Ford, Debbie; Pillay, Deenan; De Luca, Andrea; Lundgren, Jens; Revill, Paul			Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings	PLOS ONE			English	Article							CD4 CELL COUNT; STRATALL ANRS 12110/ESTHER; RESOURCE-LIMITED SETTINGS; VIRAL LOAD; INFECTED PATIENTS; POTENTIAL IMPACT; OUTCOMES; AFRICA; ADULTS; TRANSMISSION	Background: To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified. Methods: An individual level simulation model of HIV transmission, progression and the effect of ART which accounts for adherence and resistance development was used to compare outcomes of various potential monitoring strategies in a typical low income setting in sub-Saharan Africa. Underlying monitoring strategies considered were based on clinical disease, CD4 count or viral load. Within each we considered a strategy in which no further measures are performed, one with a viral load measure to confirm failure, and one with both a viral load measure and a resistance test. Predicted outcomes were assessed over 2015-2025 in terms of viral suppression, first line failure, switching to second line regimen, death, HIV incidence, disability-adjusted-life-years averted and costs. Potential future low costs of resistance tests ($30) were used. Results: The most effective strategy, in terms of DALYs averted, was one using viral load monitoring without confirmation. The incremental cost-effectiveness ratio for this strategy was $2113 (the same as that for viral load monitoring with confirmation). ART monitoring strategies which involved resistance testing did not emerge as being more effective or cost effective than strategies not using it. The slightly reduced ART costs resulting from use of resistance testing, due to less use of second line regimens, was of similar magnitude to the costs of resistance tests. Conclusion: Use of resistance testing at the time of first line failure as part of the decision whether to switch to second line therapy was not cost-effective, even though the test was assumed to be very inexpensive.	[Phillips, Andrew; Cambiano, Valentina; Nakagawa, Fumiyo] UCL, Res Dept Infect & Populat Hlth, London, England; [Magubu, Travor] Univ Zimbabwe, Clin Res Ctr, Harare, Zimbabwe; [Miners, Alec] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Ford, Debbie] UCL, MRC Clin Trials Unit, London, England; [Pillay, Deenan] Africa Ctr, Kwa Zulu, South Africa; [De Luca, Andrea] Siena Univ Hosp, Univ Div Infect Dis, Siena, Italy; [Lundgren, Jens] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Revill, Paul] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of London; University College London; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Siena; University Hospital of Siena; Rigshospitalet; University of Copenhagen; University of York - UK	Phillips, A (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	andrew.phillips@ucl.ac.uk	De Luca, Andrea/G-8810-2011; Phillips, Andrew N/B-4427-2008; Lundgren, Jens/AAE-6876-2019	De Luca, Andrea/0000-0002-9561-9193; Phillips, Andrew N/0000-0003-2384-4807; Revill, Paul/0000-0001-8632-0600; Nakagawa, Fumiyo/0000-0002-6646-8744; Lundgren, Jens/0000-0001-8901-7850; Pillay, Dorsamy/0000-0003-3640-2573	Bill & Melinda Gates Foundation; MRC [MC_U122886353, MC_UU_12023/17] Funding Source: UKRI; Medical Research Council [MC_UU_12023/17, MC_U122886353] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is funded by the Bill & Melinda Gates Foundation. Bill and Melinda Gates foundation officers were involved in the design of the study, the decision regarding assumptions and scenarios evaluated, but had no role in the conduct of the analyses or interpretation of results or the decision to submit the manuscript for publication. The corresponding author had final responsibility for the decision to submit for publication.	AIDSInfo, 2013, GUID US ANT AG HIV 1; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Boyer S, 2013, LANCET INFECT DIS, V13, P577, DOI 10.1016/S1473-3099(13)70073-2; Braithwaite RS, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-38; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chung M, 2014, COMMUNICATION; Claxton K, 2010, 54 U YORK CTR HLTH E, P54; Cozzi-Lepri A, 2010, CLIN INFECT DIS, V50, P1275, DOI 10.1086/651684; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Estill J, 2012, AIDS, V26, P1403, DOI 10.1097/QAD.0b013e3283536988; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Hamers RL, 2012, AIDS, V26, P1663, DOI 10.1097/QAD.0b013e3283560678; [ICF International Zimbabwe National Statistics Agency (ZIMSTAT)], 2012, ZIMB DEM HLTH SURV 2; Johnston V, 2014, J INFECT DIS, V209, P711, DOI 10.1093/infdis/jit411; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Jourdain G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001494; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Kimmel AD, 2010, JAIDS-J ACQ IMM DEF, V54, P258, DOI 10.1097/QAI.0b013e3181d0db97; Klimkait T, 2013, PLOS ONE, V8; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Levison JH, 2013, CLIN INFECT DIS, V56, P587, DOI 10.1093/cid/cis887; Mabugu T, 2013, COMMUNICATION; Medecins Sans Frontieres, 2013, UNT WEB ANT PRIC RED; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Rosen S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-24; Sabin CA, 2008, AIDS, V22, P1943, DOI 10.1097/QAD.0b013e32830e4cf3; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Walensky RP, 2007, AIDS, V21, P973, DOI 10.1097/QAD.0b013e328011ec53; WHO, 2012, WHO HIV DRUG RES REP; WHO, 2013, GLOB UPD HIV TREATM; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]; World Health Organisation, 2021, CONSOLIDATED GUIDELI	38	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109148	10.1371/journal.pone.0109148	http://dx.doi.org/10.1371/journal.pone.0109148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290340	Green Published, gold			2022-12-25	WOS:000342798000038
J	Uemura, Y; Shibata, R; Kanemura, N; Ohashi, K; Kambara, T; Hiramatsu-Ito, M; Enomoto, T; Yuasa, D; Joki, Y; Matsuo, K; Ito, M; Hayakawa, S; Ogawa, H; Murohara, T; Ouchi, N				Uemura, Yusuke; Shibata, Rei; Kanemura, Noriyoshi; Ohashi, Koji; Kambara, Takahiro; Hiramatsu-Ito, Mizuho; Enomoto, Takashi; Yuasa, Daisuke; Joki, Yusuke; Matsuo, Kazuhiro; Ito, Masanori; Hayakawa, Satoko; Ogawa, Hayato; Murohara, Toyoaki; Ouchi, Noriyuki			Adipose-derived protein omentin prevents neointimal formation after arterial injury	FASEB JOURNAL			English	Article						AMPK; VSMC; remodeling	MUSCLE-CELL PROLIFERATION; KINASE; ASSOCIATION; INFLAMMATION; INHIBITION; INTELECTIN; DISEASE; OBESITY	Obesity is highly linked with the development of vascular diseases. Omentin is a circulating adipokine that is downregulated in patients with cardiovascular diseases. In this study, we investigated the role of omentin in regulation of vascular remodeling in response to injury. Wild-type (WT) mice were treated intravenously with adenoviral vectors encoding human omentin (Ad-OMT) or control beta-gal and subjected to arterial wire injury. Ad-OMT treatment reduced the neointimal thickening and the frequencies of bromodeoxyuridine-positive proliferating cells in injured arteries. Treatment of vascular smooth muscle cells (VSMCs) with human omentin protein at a physiologic concentration led to suppression of growth and ERK phosphorylation after stimulation with various growth factors. Omentin stimulated AMPK signaling in VSMCs, and blockade of AMPK reversed omentin-mediated inhibition of VSMC growth and ERK phosphorylation. Furthermore, fat-specific human omentin transgenic (OMT-TG) mice exhibited reduced neointimal thickening and vascular cell growth following vascular injury. AMPK activation was enhanced in injured arteries in OMT-TG mice, and administration of AMPK inhibitor reversed the reduction of neointimal hyperplasia in OMT-TG mice. These data indicate that omentin attenuates neointimal formation after arterial injury and suppresses VSMC growth through AMPK-dependent mechanisms. Thus, omentin can represent a novel target molecule for the prevention of vascular disorders.	[Uemura, Yusuke; Shibata, Rei; Kanemura, Noriyoshi; Kambara, Takahiro; Hiramatsu-Ito, Mizuho; Enomoto, Takashi; Yuasa, Daisuke; Joki, Yusuke; Matsuo, Kazuhiro; Ito, Masanori; Hayakawa, Satoko; Ogawa, Hayato; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	OHASHI, Koji/I-7307-2014; Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014	Enomoto, Takashi/0000-0002-7370-8013; Hiramatsu-Ito, Mizuho/0000-0003-1740-1794				Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Erlinge D, 1998, GEN PHARMACOL-VASC S, V31, P1, DOI 10.1016/S0306-3623(97)00420-5; Gennaro G, 2004, CIRCULATION, V110, P3367, DOI 10.1161/01.CIR.0000147773.86866.CD; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Kataoka Y, 2014, J AM COLL CARDIOL, V63, P2722, DOI 10.1016/j.jacc.2014.03.032; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Lu JX, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-58; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Miyabe M, 2014, CARDIOVASC RES, V103, P111, DOI 10.1093/cvr/cvu105; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nielsen S, 1997, CURR OPIN LIPIDOL, V8, P200, DOI 10.1097/00041433-199708000-00002; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-37; Shibata R, 2011, HYPERTENS RES, V34, P1309, DOI 10.1038/hr.2011.130; Shibata R, 2011, ATHEROSCLEROSIS, V219, P811, DOI 10.1016/j.atherosclerosis.2011.08.017; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2007, GLYCOBIOLOGY, V17, P1045, DOI 10.1093/glycob/cwm075; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039; Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yoo HJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-103; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P873, DOI 10.1038/aps.2011.26	34	46	50	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					141	151		10.1096/fj.14-258129	http://dx.doi.org/10.1096/fj.14-258129			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25300621				2022-12-25	WOS:000347378600014
J	Armour, KL; Smith, CS; Ip, NCY; Ellison, CJ; Kirton, CM; Wilkes, AM; Williamson, LM; Clark, MR				Armour, Kathryn L.; Smith, Cheryl S.; Ip, Natasha C. Y.; Ellison, Cara J.; Kirton, Christopher M.; Wilkes, Anthony M.; Williamson, Lorna M.; Clark, Michael R.			Clearance of Human IgG1-Sensitised Red Blood Cells In Vivo in Humans Relates to the In Vitro Properties of Antibodies from Alternative Cell Lines	PLOS ONE			English	Article							FC-GAMMA-RIIIA; ANTI-D ANTIBODIES; LOW-FUCOSE IGG1; MONOCLONAL-ANTIBODY; CLINICAL-TRIALS; BINDING; CYTOTOXICITY; AFFINITY; RECOMBINANT; PHARMACOKINETICS	We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma cell line, YB2/0. When human, autologous RhD-positive red blood cells (RBC) were sensitised with this IgG1 antibody and re-injected, they were cleared much more rapidly from the circulation than had been seen earlier with the original human-mouse heterohybridoma-produced Fog-1. Since the IgG have the same amino acid sequence, this disparity is likely to be due to alternative glycosylation that results from the rat and mouse cell lines. By comparing the in vitro properties of YB2/0-produced Fog-1 IgG1 and the same antibody produced in the mouse myeloma cell line NS0, we now have a unique opportunity to pinpoint the cause of the difference in ability to clear RBC in vivo. Using transfected cell lines that express single human Fc gamma R, we showed that IgG1 made in YB2/0 and NS0 cell lines bound equally well to receptors of the Fc gamma RI and Fc gamma RII classes but that the YB2/0 antibody was superior in Fc gamma RIII binding. When measuring complexed IgG binding, the difference was 45-fold for Fc gamma RIIIa 158F, 20-fold for Fc gamma RIIIa 158V and approximately 40-fold for Fc gamma RIIIb. The dissimilarity was greater at 100-fold in monomeric IgG binding assays with Fc gamma RIIIa. When used to sensitise RBC, the YB2/0 IgG1 generated 100-fold greater human NK cell antibody-dependent cell-mediated cytotoxicity and had a 10(3)-fold advantage over the NS0 antibody in activating NK cells, as detected by CD54 levels. In assays of monocyte activation and macrophage adherence/phagocytosis, where Fc gamma RI plays major roles, RBC sensitised with the two antibodies produced much more similar results. Thus, the alternative glycosylation profiles of the Fog-1 antibodies affect only Fc gamma RIII binding and Fc gamma RIII-mediated functions. Relating this to the in vivo studies confirms the importance of Fc gamma RIII in RBC clearance.	[Armour, Kathryn L.; Smith, Cheryl S.; Ip, Natasha C. Y.; Ellison, Cara J.; Kirton, Christopher M.; Clark, Michael R.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Wilkes, Anthony M.] Bristol Inst Transfus Sci, Bristol, Avon, England; [Williamson, Lorna M.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Williamson, Lorna M.] Univ Cambridge, Dept Haematol, Cambridge CB2 1QP, England	University of Cambridge; NHS Blood & Transplant (NHSBT); University of Cambridge	Armour, KL (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	kla22@cam.ac.uk	Clark, Michael R/D-2479-2011	Clark, Michael R/0000-0002-5539-4997; Ellison, Cara/0000-0003-3483-6896	Department of Pathology, University of Cambridge	Department of Pathology, University of Cambridge(University of Cambridge)	The work was supported by funding from the Department of Pathology, University of Cambridge through income that was derived from commercial exploitation of patented antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour KL, 2014, EUR J IMMUNOL, V44, P905, DOI 10.1002/eji.201343825; Armour KL, 2010, J IMMUNOL METHODS, V354, P20, DOI 10.1016/j.jim.2010.01.011; Armour KL, 2006, BLOOD, V107, P2619, DOI 10.1182/blood-2005-03-0989; Armour KL, 2003, MOL IMMUNOL, V40, P585, DOI 10.1016/j.molimm.2003.08.004; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Armour KL, 2000, HEMATOL J S1, V1, P27; Beliard R, 2006, TRANSFUS CLIN BIOL, V13, P58, DOI 10.1016/j.tracli.2006.03.013; Beliard R, 2008, BRIT J HAEMATOL, V141, P109, DOI 10.1111/j.1365-2141.2008.06985.x; Bowles JA, 2006, BLOOD, V108, P2648, DOI 10.1182/blood-2006-04-020057; Brinc Davor, 2009, Hematology Am Soc Hematol Educ Program, P185, DOI 10.1182/asheducation-2009.1.185; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Bux J, 1999, BLOOD, V93, P357, DOI 10.1182/blood.V93.1.357.401k39_357_362; BYE JM, 1992, J CLIN INVEST, V90, P2481, DOI 10.1172/JCI116140; Chapman GE, 2007, CLIN EXP IMMUNOL, V150, P30, DOI 10.1111/j.1365-2249.2007.03458.x; CLARK MR, 1981, SOMAT CELL GENET, V7, P657, DOI 10.1007/BF01538755; CLARKSON SB, 1986, NEW ENGL J MED, V314, P1236, DOI 10.1056/NEJM198605083141907; CLARKSON SB, 1986, J EXP MED, V164, P474, DOI 10.1084/jem.164.2.474; Ernst LK, 2002, J MOL MED, V80, P248, DOI 10.1007/s00109-001-0294-2; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; JEFFERIS R, 1990, BIOCHEM J, V268, P529, DOI 10.1042/bj2680529; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kumpel BM, 2008, CLIN EXP IMMUNOL, V154, P1, DOI 10.1111/j.1365-2249.2008.03735.x; Kumpel BM, 2007, VOX SANG, V93, P99, DOI 10.1111/j.1423-0410.2007.00945.x; Lifely MR, 1995, GLYCOBIOLOGY, V5, P813, DOI 10.1093/glycob/5.8.813; MELAMED MD, 1987, J IMMUNOL METHODS, V104, P245, DOI 10.1016/0022-1759(87)90511-4; MOLLISON PL, 1965, BRIT J HAEMATOL, V11, P461, DOI 10.1111/j.1365-2141.1965.tb06609.x; Niwa R, 2005, J IMMUNOL METHODS, V306, P151, DOI 10.1016/j.jim.2005.08.009; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; Niwa R, 2004, CLIN CANCER RES, V10, P6248, DOI 10.1158/1078-0432.CCR-04-0850; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Quagliaroli D, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1371, DOI 10.1134/S0006297913120080; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Su K, 2002, GENES IMMUN, V3, pS51, DOI 10.1038/sj.gene.6363879; THOMSON A, 1990, LANCET, V336, P1147, DOI 10.1016/0140-6736(90)92767-C; Tobinai K, 2012, CURR HEMATOL MALIG R, V7, P235, DOI 10.1007/s11899-012-0124-3; van Sorge NM, 2003, TISSUE ANTIGENS, V61, P189, DOI 10.1034/j.1399-0039.2003.00037.x; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yamane-Ohnuki N, 2009, MABS-AUSTIN, V1, P230, DOI 10.4161/mabs.1.3.8328; Yver A, 2012, VOX SANG, V103, P213, DOI 10.1111/j.1423-0410.2012.01603.x	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109463	10.1371/journal.pone.0109463	http://dx.doi.org/10.1371/journal.pone.0109463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302805	Green Published, gold			2022-12-25	WOS:000343730400059
J	Bossa, AS; Salemi, VMC; Ribeiro, SP; Rosa, DS; Ferreira, LRP; Ferreira, SC; Nishiya, AS; Mady, C; Kalil, J; Cunha-Neto, E				Bossa, Aline S.; Salemi, Vera M. C.; Ribeiro, Susan P.; Rosa, Daniela S.; Pinto Ferreira, Ludmila Rodrigues; Ferreira, Suzete C.; Nishiya, Anna Shoko; Mady, Charles; Kalil, Jorge; Cunha-Neto, Edecio			Plasma Cytokine Profile in Tropical Endomyocardial Fibrosis: Predominance of TNF-a, IL-4 and IL-10	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; DISEASE; EOSINOPHILIA; ACTIVATION; CARDIOMYOPATHY; INTERLEUKIN-10; ASSOCIATION; MORTALITY	Background: The participation of immune/inflammatory mechanisms in the pathogenesis of tropical endomyocardial fibrosis (EMF) has been suggested by the finding of early blood and myocardial eosinophilia. However, the inflammatory activation status of late-stage EMF patients is still unknown. Methodology/Principal findings: We evaluated pro- and anti-inflammatory cytokine levels in plasma samples from late stage EMF patients. Cytokine levels of Tumor Necrosis Factor (TNF)-alpha, Interferon (IFN)-gamma, Interleukin (IL)-2, IL-4, IL-6, and IL-10 were assayed in plasma samples from 27 EMF patients and compared with those of healthy control subjects. All EMF patients displayed detectable plasma levels of at least one of the cytokines tested. We found that TNF-alpha, IL-6, IL-4, and IL-10 were each detected in at least 74% of tested sera, and plasma levels of IL-10, IL-4, and TNF-alpha were significantly higher than those of controls. Plasma levels of such cytokines positively correlated with each other. Conclusions/Significance: The mixed pro-and anti-inflammatory/Th2circulating cytokine profile in EMF is consistent with the presence of a persistent inflammatory stimulus. On the other hand, the detection of increased levels of TNF-alpha may be secondary to the cardiovascular involvement observed in these patients, whereas IL-4 and IL-10 may have been upregulated as a homeostatic mechanism to buffer both production and deleterious cardiovascular effects of pro-inflammatory cytokines. Further studies might establish whether these findings play a role in disease pathogenesis.	[Bossa, Aline S.; Pinto Ferreira, Ludmila Rodrigues; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Inst Heart InCor, Immunol Lab, Sao Paulo, Brazil; [Bossa, Aline S.; Ribeiro, Susan P.; Pinto Ferreira, Ludmila Rodrigues; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Salemi, Vera M. C.; Ferreira, Suzete C.; Mady, Charles] Univ Sao Paulo, Sch Med, Inst Heart InCor, Cardiomyopathy Unit, Sao Paulo, Brazil; [Nishiya, Anna Shoko] ProSangue Fdn, Sao Paulo, Brazil; [Nishiya, Anna Shoko] Inst Investigat Immunol, INCT, Sao Paulo, Brazil; [Rosa, Daniela S.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Div Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Cunha-Neto, E (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart InCor, Immunol Lab, Sao Paulo, Brazil.	edecunha@usp.br	Salemi, Vera MC/C-9104-2013; Nishiya, Anna/Q-8156-2016; KALIL, JORGE/C-8029-2012; Ferreira, Ludmila Rodrigues Pinto/AAO-7540-2021; Ferreira, Ludmila Rodrigues Pinto/B-4955-2015; Cunha-Neto, Edecio/B-4157-2009; Mady, Charles/C-8870-2012; Ferreira, Ludmila/C-4100-2012; Rosa, Daniela S/D-2190-2012; Salemi, Vera/AAY-5024-2020	Salemi, Vera MC/0000-0002-7152-1810; KALIL, JORGE/0000-0001-8415-4274; Ferreira, Ludmila Rodrigues Pinto/0000-0001-9944-6691; Ferreira, Ludmila Rodrigues Pinto/0000-0001-9944-6691; Cunha-Neto, Edecio/0000-0002-3699-3345; Mady, Charles/0000-0002-8838-199X; Ferreira, Ludmila/0000-0001-9944-6691; Rosa, Daniela S/0000-0003-4536-891X; 	Brazilian Council for Scientific and Technological Development - CNPq; Sao Paulo State Research Funding Agency - FAPESP; Sao Paulo State Research Funding Agency - FAPESP fellowship	Brazilian Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo State Research Funding Agency - FAPESP fellowship	This research was supported by the Brazilian Council for Scientific and Technological Development - CNPq and the Sao Paulo State Research Funding Agency - FAPESP. ASB is recipient of a Sao Paulo State Research Funding Agency - FAPESP fellowship. ECN and JK are recipients of Brazilian Council for Scientific and Technological Development - CNPq productivity awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2010, ISR MED ASSOC J, V12, P158; Andy JJ, 1998, ACTA TROP, V69, P127, DOI 10.1016/S0001-706X(97)00125-3; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; BROCKING.IF, 1972, POSTGRAD MED J, V48, P740, DOI 10.1136/pgmj.48.566.740; DAVIES J N P, 1948, East Afr Med J, V25, P454; Gage JR, 2004, NEUROIMMUNOMODULAT, V11, P173, DOI 10.1159/000076766; Guinjoan SM, 2009, WORLD J BIOL PSYCHIA, V10, P913, DOI 10.1080/15622970802432153; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Iglezias SD, 2008, VIRCHOWS ARCH, V453, P233, DOI 10.1007/s00428-008-0652-3; IVE FA, 1967, Q J MED, V36, P495; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Mann DL, 2003, ANNU REV PHYSIOL, V65, P81, DOI 10.1146/annurev.physiol.65.092101.142249; Mehra VC, 2005, J LEUKOCYTE BIOL, V78, P805, DOI 10.1189/jlb.0405182; Mocelin AO, 2005, EUR J HEART FAIL, V7, P869, DOI 10.1016/j.ejheart.2004.10.014; Muller-Werdan U, 1998, EUR CYTOKINE NETW, V9, P689; Orus J, 2000, J HEART LUNG TRANSPL, V19, P419, DOI 10.1016/S1053-2498(00)00083-8; PATEL AK, 1977, BRIT HEART J, V39, P238; Rauchhaus M, 2000, CIRCULATION, V102, P3060; ROBERTS WC, 1969, AM J MED, V46, P28, DOI 10.1016/0002-9343(69)90055-2; Salemi VMC, 2011, CIRC-CARDIOVASC IMAG, V4, P304, DOI 10.1161/CIRCIMAGING.110.950675; Salemi VM, 2009, EUR J ECHOCARDIOGR, V10, P400, DOI 10.1093/ejechocard/jen297; Salemi VMC, 2004, ARTIF ORGANS, V28, P343, DOI 10.1111/j.1525-1594.2004.47352.x; Sato Y, 1999, CLIN CARDIOL, V22, P811, DOI 10.1002/clc.4960221211; Satoh Mamoru, 2008, Curr Heart Fail Rep, V5, P69, DOI 10.1007/s11897-008-0012-2; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Sliwa K, 2010, CLIN RES CARDIOL, V99, P65, DOI 10.1007/s00392-009-0094-1; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Yamaoka M, 1999, JPN CIRC J, V63, P951, DOI 10.1253/jcj.63.951; Yu LP, 2012, PARASITOL RES, V110, P1547, DOI 10.1007/s00436-011-2661-4	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108984	10.1371/journal.pone.0108984	http://dx.doi.org/10.1371/journal.pone.0108984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303100	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400039
J	Ferenczi, S; Cserhati, M; Krifaton, C; Szoboszlay, S; Kukolya, J; Szoke, Z; Koszegi, B; Albert, M; Barna, T; Mezes, M; Kovacs, KJ; Kriszt, B				Ferenczi, Szilamer; Cserhati, Matyas; Krifaton, Csilla; Szoboszlay, Sandor; Kukolya, Jozsef; Szoke, Zsuzsanna; Koszegi, Balazs; Albert, Mihaly; Barna, Terez; Mezes, Miklos; Kovacs, Krisztina J.; Kriszt, Balazs			A New Ochratoxin A Biodegradation Strategy Using Cupriavidus basilensis Or16 Strain	PLOS ONE			English	Article							BALKAN ENDEMIC NEPHROPATHY; RENAL-CELL CARCINOMA; IN-VITRO; TRICHOSPORON-MYCOTOXINIVORANS; BIOLOGICAL DETOXIFICATION; BROILER CHICKS; FUNGAL TOXINS; HUMAN BLOOD; EXPRESSION; FOOD	Ochratoxin-A (OTA) is a mycotoxin with possibly carcinogenic and nephrotoxic effects in humans and animals. OTA is often found as a contaminant in agricultural commodities. The aim of the present work was to evaluate OTA-degrading and detoxifying potential of Cupriavidus basilensis OR16 strain. In vivo administration of OTA in CD1 male mice (1 or 10 mg/kg body weight for 72 hours or 0.5 mg/kg body weight for 21 days) resulted in significant elevation of OTA levels in the blood, histopathological alterations- and transcriptional changes in OTA-dependent genes (annexinA2, clusterin, sulphotransferase and gadd45 and gadd153) in the renal cortex. These OTA-induced changes were not seen in animals that have been treated with culture supernatants in which OTA was incubated with Cupriavidus basilensis OR16 strain for 5 days. HPLC and ELISA methods identified ochratoxin a as the major metabolite of OTA in Cupriavidus basilensis OR16 cultures, which is not toxic in vivo. This study has demonstrated that Cupriavidus basilensis OR16 efficiently degrade OTA without producing toxic adventitious metabolites.	[Ferenczi, Szilamer; Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary; [Cserhati, Matyas; Krifaton, Csilla; Szoboszlay, Sandor; Kriszt, Balazs] Szent Istvan Univ, Dept Environm Protect & Safety, Godollo, Hungary; [Kukolya, Jozsef] Cent Environm & Food Sci Res Inst, Dept Microbiol, Budapest, Hungary; [Szoke, Zsuzsanna; Koszegi, Balazs] Soft Flow Hungary R&D Ltd, Pecs, Hungary; [Albert, Mihaly] CEVA Phylaxia Ltd, Budapest, Hungary; [Barna, Terez] Univ Debrecen, Dept Genet & Appl Microbiol, H-4012 Debrecen, Hungary; [Mezes, Miklos] Szent Istvan Univ, Dept Nutr, Godollo, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian University of Agriculture & Life Sciences; Ceva Sante Animale; University of Debrecen; Hungarian University of Agriculture & Life Sciences	Ferenczi, S (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary.	ferenczi@koki.hu	barna, terez/R-1357-2018	Szoke, Zsuzsanna/0000-0001-9302-1115; Kriszt, Balazs/0000-0002-9236-2820; Szoboszlay, Sandor/0000-0002-0479-6726; Koszegi, Balazs/0000-0001-6743-0441	TAMOP [4.2.1.B-11/2/KMR-2011-0003, 4.2.1/B-09/1/KONV-2010-0007]; KTIA [AIK_12-1-2013-0017]; Research Centre of Excellence [17586-4/2013/TUDPOL, 8526-5/2014/TUDPOL]; Hungarian Research Fund OTKA [109622];  [109744]	TAMOP; KTIA; Research Centre of Excellence; Hungarian Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); 	This study was supported by the TAMOP-4.2.1.B-11/2/KMR-2011-0003, KTIA-AIK_12-1-2013-0017, Research Centre of Excellence-17586-4/2013/TUDPOL, TAMOP 4.2.1/B-09/1/KONV-2010-0007 and the work was supported by grants from Hungarian Research Fund OTKA 109622 to K.J.K.; 109744 to Sz.F., and Research Centre of Excellence - 8526-5/2014/TUDPOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrunhosa L, 2010, TOXINS, V2, P1078, DOI 10.3390/toxins2051078; Al-Anati L, 2006, J VET PHARMACOL THER, V29, P79, DOI 10.1111/j.1365-2885.2006.00718.x; Aoudia N, 2008, FOOD CHEM TOXICOL, V46, P871, DOI 10.1016/j.fct.2007.10.029; Arbillaga L, 2008, TOXICOL APPL PHARM, V230, P197, DOI 10.1016/j.taap.2008.02.018; Beard SE, 1996, MUTAT RES-GENET TOX, V371, P1, DOI 10.1016/S0165-1218(96)90089-0; Bruinink A., 1998, Natural Toxins, V6, P173, DOI 10.1002/(SICI)1522-7189(199809/10)6:5<173::AID-NT10>3.0.CO;2-4; Castegnaro M, 2005, TOXICOL LETT, V156, P315, DOI 10.1016/j.toxlet.2004.07.016; Clark HA, 2006, J TOXICOL ENV HEAL B, V9, P265, DOI 10.1080/15287390500195570; CREPPY EE, 1983, INFECT IMMUN, V39, P1015, DOI 10.1128/IAI.39.3.1015-1018.1983; Cserhati M, 2012, J BACTERIOL, V194, P2109, DOI 10.1128/JB.06752-11; Cui XQ, 2009, AM J NEPHROL, V30, P413, DOI 10.1159/000235993; DIRHEIMER G, 1991, IARC SCI PUBL, V115, P171; Duarte SC, 2012, VET J, V192, P286, DOI 10.1016/j.tvjl.2011.11.002; ELLING F, 1977, LANCET, V1, P1213; HALD B, 1991, IARC SCI PUBL, V115, P159; Hassan ZU, 2012, J IMMUNOTOXICOL, V9, P56, DOI 10.3109/1547691X.2011.627393; HELLER K, 1978, CAN J MICROBIOL, V24, P466, DOI 10.1139/m78-076; Hickey PW, 2009, J CLIN MICROBIOL, V47, P3091, DOI 10.1128/JCM.00460-09; Karlovsky P, 1999, NAT TOXINS, V7, P1, DOI 10.1002/(SICI)1522-7189(199902)7:1<1::AID-NT37>3.0.CO;2-9; KROGH P, 1973, ACTA PATH MICRO IM B, VB 81, P689; KROGH P, 1977, ACTA PATH MICRO IM B, V85, P238; KROGH P, 1977, NORD VET MED, V29, P402; KUMBLE KD, 1992, CANCER RES, V52, P163; Li S, 1997, TOXICOL APPL PHARM, V145, P82, DOI 10.1006/taap.1997.8155; Luhe A, 2003, TOXICOL SCI, V73, P315, DOI 10.1093/toxsci/kfg073; Mantle PG, 2008, FOOD CHEM TOXICOL, V46, P1808, DOI 10.1016/j.fct.2008.01.020; Miyake H, 2002, J UROLOGY, V167, P703, DOI 10.1016/S0022-5347(01)69130-4; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; Obrecht-Pflumio S, 2000, CHEM-BIOL INTERACT, V127, P29, DOI 10.1016/S0009-2797(00)00169-1; Petchkongkaew A, 2008, J APPL MICROBIOL, V104, P1495, DOI 10.1111/j.1365-2672.2007.03700.x; Piotrowska Malgorzata, 2005, Polish Journal of Microbiology, V54, P279; PITOUT MJ, 1969, BIOCHEM PHARMACOL, V18, P485, DOI 10.1016/0006-2952(69)90224-X; Politis I, 2005, BRIT POULTRY SCI, V46, P58, DOI 10.1080/00071660400023904; Rached E, 2008, TOXICOL SCI, V103, P371, DOI 10.1093/toxsci/kfn040; Raters M, 2005, Mycotoxin Res, V21, P182, DOI 10.1007/BF02959259; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Rodriguez H, 2011, J AGR FOOD CHEM, V59, P10755, DOI 10.1021/jf203061p; RungeMorris MA, 1997, FASEB J, V11, P109, DOI 10.1096/fasebj.11.2.9039952; Schatzmayr G, 2003, Mycotoxin Res, V19, P124, DOI 10.1007/BF02942950; SINGH GSP, 1990, J COMP PATHOL, V103, P399, DOI 10.1016/S0021-9975(08)80028-X; Skouteris GG, 1996, J BIOL CHEM, V271, P27266, DOI 10.1074/jbc.271.44.27266; Stander MA, 2000, J AGR FOOD CHEM, V48, P5736, DOI 10.1021/jf000413j; Stoev SD, 1998, VET HUM TOXICOL, V40, P352; Stoev SD, 2001, VET RES COMMUN, V25, P205, DOI 10.1023/A:1006433709685; Tanaka T, 2000, AM J PATHOL, V156, P2149, DOI 10.1016/S0002-9440(10)65085-7; VANDERME.KJ, 1965, NATURE, V205, P1112, DOI 10.1038/2051112a0; Vega FE, 2006, MYCOLOGIA, V98, P31, DOI 10.3852/mycologia.98.1.31; Walker R, 2002, ADV EXP MED BIOL, V504, P249; Xiao H, 1996, TOXICOL APPL PHARM, V137, P182, DOI 10.1006/taap.1996.0071; Zeljezic D, 2006, BRAZ J MED BIOL RES, V39, P1563, DOI 10.1590/S0100-879X2006005000029; ZIMMERLI B, 1995, J CHROMATOGR B, V666, P85, DOI 10.1016/0378-4347(94)00569-Q	51	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109817	10.1371/journal.pone.0109817	http://dx.doi.org/10.1371/journal.pone.0109817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302950	Green Submitted, gold, Green Published			2022-12-25	WOS:000343730400082
J	Munoz, IM; Szyniarowski, P; Toth, R; Rouse, J; Lachaud, C				Munoz, Ivan M.; Szyniarowski, Piotr; Toth, Rachel; Rouse, John; Lachaud, Christophe			Improved Genome Editing in Human Cell Lines Using the CRISPR Method	PLOS ONE			English	Article							TAL EFFECTORS; DNA; SYSTEMS; CAS9; SPECIFICITY; NUCLEASES; NICKASES	The Cas9/CRISPR system become a popular choice for genome editing. In this system, binding of a single guide (sg) RNA to a cognate genomic sequence enables the Cas9 nuclease to induce a double-strand break at that locus. This break is next repaired by an error-prone mechanism, leading to mutation and gene disruption. In this study we describe a range of refinements of the method, including stable cell lines expressing Cas9, and a PCR based protocol for the generation of the sgRNA. We also describe a simple methodology that allows both elimination of Cas9 from cells after gene disruption and re-intoduction of the disrupted gene. This advance enables easy assessment of the off target effects associated with gene disruption, as well as phenotype-based structure-function analysis. In our study, we used the Fan1 DNA repair gene as control in these experiments. Cas9/CRISPR-mediated Fanl disruption occurred at frequencies of around 29%, and resulted in the anticipated spectrLlm of genotoxin hypersensitivity, which was rescued by re-introduction of Fan1.	[Munoz, Ivan M.; Szyniarowski, Piotr; Toth, Rachel; Rouse, John; Lachaud, Christophe] Univ Dundee, Coll Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee, Scotland	University of Dundee	Rouse, J (corresponding author), Univ Dundee, Coll Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee, Scotland.	j.rouse@dundee.ac.uk; c.lachaud@dundee.ac.uk	Perez, Franck/A-1558-2014; Lachaud, Christophe/ABC-8596-2021	Perez, Franck/0000-0002-9129-9401; Lachaud, Christophe/0000-0003-2762-1619; Munoz Munoz, Ivan/0000-0002-1606-5445	Marie Curie Intra-European fellowship (FanDamAge); Medical Research Council (MRC); Medical Research Council [MC_U127070192, MC_UU_12016/1] Funding Source: researchfish; MRC [MC_U127070192, MC_UU_12016/1] Funding Source: UKRI	Marie Curie Intra-European fellowship (FanDamAge); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Marie Curie Intra-European fellowship (FanDamAge) and the Medical Research Council (MRC). The pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA, Janssen Pharmaceutica and Pfizer) associated with the MRC PPU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	17	34	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109752	10.1371/journal.pone.0109752	http://dx.doi.org/10.1371/journal.pone.0109752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303670	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400077
J	Vafaee, Y; Staniek, A; Mancheno-Solano, M; Warzecha, H				Vafaee, Yavar; Staniek, Agata; Mancheno-Solano, Maria; Warzecha, Heribert			A Modular Cloning Toolbox for the Generation of Chloroplast Transformation Vectors	PLOS ONE			English	Article							TOBACCO CHLOROPLASTS; PLASTID GENOME; HIGHER-PLANTS; SYNTHETIC BIOLOGY; TOMATO PLASTIDS; MESSENGER-RNAS; ONE-POT; EXPRESSION; PROTEIN; IDENTIFICATION	Plastid transformation is a powerful tool for basic research but also for the generation of stable genetically engineered plants producing recombinant proteins at high levels or for metabolic engineering purposes. However, due to the genetic makeup of plastids and the distinct features of the transformation process, vector design, and the use of specific genetic elements, a large set of basic transformation vectors is required, making cloning a tedious and time-consuming effort. Here we describe the adoption of standardized modular cloning (GoldenBraid) to the design and assembly of the full spectrum of plastid transformation vectors. The modular design of genetic elements allows straightforward and time-efficient build-up of transcriptional units as well as construction of vectors targeting any homologous recombination site of choice. In a three-level assembly process, we established a vector fostering gene expression and formation of griffithsin, a potential viral entry inhibitor and HIV prophylactic, in the plastids of tobacco. Successful transformation as transcript and protein production could be shown. In concert with the aforesaid endeavour, a set of modules facilitating plastid transformation was generated thus augmenting the GoldenBraid toolbox. In short he work presented in this study enables efficient application of synthetic biology methods to plastid transformation in plants.	[Vafaee, Yavar; Staniek, Agata; Mancheno-Solano, Maria; Warzecha, Heribert] Tech Univ Darmstadt, Darmstadt, Germany	Technical University of Darmstadt	Warzecha, H (corresponding author), Tech Univ Darmstadt, Darmstadt, Germany.	warzecha@bio.tu-darmstadt.de	Vafaee, Yavar/AGD-6085-2022; Vafaee, Yavar/D-3574-2017	Vafaee, Yavar/0000-0003-2348-9390; Vafaee, Yavar/0000-0003-2348-9390	German Academic Exchange Service	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	W and MM-S were funded by the German Academic Exchange Service, https://www.daad.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel W, 2010, PLANT J, V63, P636, DOI 10.1111/j.1365-313X.2010.04268.x; Bock R, 2010, TRENDS BIOTECHNOL, V28, P246, DOI 10.1016/j.tibtech.2010.01.006; Borchers AMI, 2012, PLANT BIOTECHNOL J, V10, P422, DOI 10.1111/j.1467-7652.2011.00675.x; De Marchis F, 2009, TRANSGENIC RES, V18, P17, DOI 10.1007/s11248-008-9193-4; Elghabi Z, 2011, PLANT BIOTECHNOL J, V9, P599, DOI 10.1111/j.1467-7652.2011.00598.x; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gardner TS, 2013, CURR OPIN CHEM BIOL, V17, P871, DOI 10.1016/j.cbpa.2013.09.013; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Glenz K, 2006, NAT BIOTECHNOL, V24, P76, DOI 10.1038/nbt1170; Gottschamel J, 2013, TRANSGENIC RES, V22, P1273, DOI 10.1007/s11248-013-9726-3; Gray BN, 2009, TRANSGENIC RES, V18, P559, DOI 10.1007/s11248-009-9246-3; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hennig A, 2007, FEBS J, V274, P5749, DOI 10.1111/j.1742-4658.2007.06095.x; Herz S, 2005, TRANSGENIC RES, V14, P969, DOI 10.1007/s11248-005-2542-7; Knight T., 2003, STRUCTURE, V1, P11, DOI 10.21236/ADA457791; Kuroda H, 2001, NUCLEIC ACIDS RES, V29, P970, DOI 10.1093/nar/29.4.970; Lassen LM, 2014, ACS SYNTH BIOL, V3, P1, DOI 10.1021/sb400136f; Lu YH, 2013, P NATL ACAD SCI USA, V110, pE623, DOI 10.1073/pnas.1216898110; Lutz KA, 2007, PLANT PHYSIOL, V145, P1201, DOI 10.1104/pp.107.106963; Monde RA, 2000, PLANT MOL BIOL, V44, P529, DOI 10.1023/A:1026540310934; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Oey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086841; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Patron NJ, 2014, CURR OPIN PLANT BIOL, V19, P14, DOI 10.1016/j.pbi.2014.02.004; Sinagawa-Garcia SR, 2009, PLANT MOL BIOL, V70, P487, DOI 10.1007/s11103-009-9486-x; Rebatchouk D, 1996, P NATL ACAD SCI USA, V93, P10891, DOI 10.1073/pnas.93.20.10891; Renault H, 2014, CURR OPIN PLANT BIOL, V19, P27, DOI 10.1016/j.pbi.2014.03.004; Ruf S, 2001, NAT BIOTECHNOL, V19, P870, DOI 10.1038/nbt0901-870; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Smolke CD, 2009, NAT BIOTECHNOL, V27, P1099, DOI 10.1038/nbt1209-1099; Surowiecki J, 2002, TURN CENTURY WIRED 1; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhou F, 2007, PLANT J, V52, P961, DOI 10.1111/j.1365-313X.2007.03261.x	40	26	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110222	10.1371/journal.pone.0110222	http://dx.doi.org/10.1371/journal.pone.0110222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302695	Green Published, gold			2022-12-25	WOS:000343730400124
J	Favaretto, F; Milan, G; Collin, GB; Marshall, JD; Stasi, F; Maffei, P; Vettor, R; Naggert, JK				Favaretto, Francesca; Milan, Gabriella; Collin, Gayle B.; Marshall, Jan D.; Stasi, Fabio; Maffei, Pietro; Vettor, Roberto; Naggert, Juergen K.			GLUT4 Defects in Adipose Tissue Are Early Signs of Metabolic Alterations in Alms1(GT/GT), a Mouse Model for Obesity and Insulin Resistance	PLOS ONE			English	Article							GTPASE-ACTIVATING-PROTEIN; MUSCLE SATELLITE CELLS; ALSTROM-SYNDROME; GLUCOSE-HOMEOSTASIS; SUBCELLULAR-LOCALIZATION; AMINO-ACIDS; ZUCKER RATS; MICE; ADIPOCYTES; ALMS1	Dysregulation of signaling pathways in adipose tissue leading to insulin resistance can contribute to the development of obesity-related metabolic disorders. Alstrom Syndrome, a recessive ciliopathy, caused by mutations in ALMS1, is characterized by progressive metabolic alterations such as childhood obesity, hyperinsulinemia, and type 2 diabetes. Here we investigated the role of Alms1 disruption in AT expansion and insulin responsiveness in a murine model for Alstrom Syndrome. A gene trap insertion in Alms1 on the insulin sensitive C57BL6/Ei genetic background leads to early hyperinsulinemia and a progressive increase in body weight. At 6 weeks of age, before the onset of the metabolic disease, the mutant mice had enlarged fat depots with hypertrophic adipocytes, but without signs of inflammation. Expression of lipogenic enzymes was increased. Pre-adipocytes isolated from mutant animals demonstrated normal adipogenic differentiation but gave rise to mature adipocytes with reduced insulin-stimulated glucose uptake. Assessment of whole body glucose homeostasis revealed glucose intolerance. Insulin stimulation resulted in proper AKT phosphorylation in adipose tissue. However, the total amount of glucose transporter 4 (SLC4A2) and its translocation to the plasma membrane were reduced in mutant adipose depots compared to wildtype littermates. Alterations in insulin stimulated trafficking of glucose transporter 4 are an early sign of metabolic dysfunction in Alstrom mutant mice, providing a possible explanation for the reduced glucose uptake and the compensatory hyperinsulinemia. The metabolic signaling deficits either reside downstream or are independent of AKT activation and suggest a role for ALMS1 in GLUT4 trafficking. Alstrom mutant mice represent an interesting model for the development of metabolic disease in which adipose tissue with a reduced glucose uptake can expand by de novo lipogenesis to an obese state.	[Favaretto, Francesca; Milan, Gabriella; Stasi, Fabio; Maffei, Pietro; Vettor, Roberto] Univ Padua, Dept Med, Padua, Italy; [Collin, Gayle B.; Marshall, Jan D.; Naggert, Juergen K.] Jackson Lab, Bar Harbor, ME 04609 USA	University of Padua; Jackson Laboratory	Favaretto, F (corresponding author), Univ Padua, Dept Med, Padua, Italy.	francesca.favaretto@unipd.it; gabriella.milan@unipd.it	VETTOR, ROBERTO/K-7121-2016; Milan, Gabriella/AAB-6234-2022	Milan, Gabriella/0000-0001-8987-5310; Vettor, Roberto/0000-0003-0625-6667; Maffei, Pietro/0000-0002-1717-263X	European Union [EU-20101205]; Italian MIUR [2010329EKE_005]; United States National Institute of Health [NIH-HD036878]; EURO-WABB project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036878] Funding Source: NIH RePORTER	European Union(European Commission); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EURO-WABB project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the EURO-WABB project, which has received funding from the European Union, in the framework of the Health Programme [EU-20101205 RV, FF, GM, PM], by the PRIN from the Italian MIUR (2010329EKE_005 to RV, FF, GM, FS) and by the United States National Institute of Health [NIH-HD036878; JKN, GBC, JDM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aston-Mourney K, 2007, DIABETOLOGIA, V50, P2476, DOI 10.1007/s00125-007-0814-x; BAHARY N, 1990, P NATL ACAD SCI USA, V87, P8642, DOI 10.1073/pnas.87.21.8642; Bays H, 2005, FUTUR CARDIOL, V1, P39, DOI 10.1517/14796678.1.1.39; Bettini V, 2012, PEDIATR DIABETES, V13, P59, DOI 10.1111/j.1399-5448.2011.00789.x; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Collin GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037925; Collin GB, 2005, HUM MOL GENET, V14, P2323, DOI 10.1093/hmg/ddi235; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; CUSIN I, 1990, BIOCHEM SOC T, V18, P1127, DOI 10.1042/bst0181127; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Heydet D, 2013, DEV NEUROBIOL, V73, P1, DOI 10.1002/dneu.22031; Huang-Doran I, 2010, INT J OBESITY, V34, P1554, DOI 10.1038/ijo.2010.92; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jurczyk A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011812; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Lodh S, 2014, J CELL SCI; Maffei P, 2007, CLIN ENDOCRINOL, V66, P269, DOI 10.1111/j.1365-2265.2007.02721.x; Marshall JD, 2007, EUR J HUM GENET, V15, P1193, DOI 10.1038/sj.ejhg.5201933; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Marshall JD, 2010, ALSTROM SYNDROME; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mokashi A, 2011, PEDIATR DIABETES, V12, P270, DOI 10.1111/j.1399-5448.2010.00698.x; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; SALANS LB, 1971, J CLIN INVEST, V50, P1399, DOI 10.1172/JCI106623; Sanna M, 2009, CLIN LIPIDOL, V4, P245, DOI 10.2217/CLP.09.8; Scarda A, 2010, INT J OBESITY, V34, P1319, DOI 10.1038/ijo.2010.47; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shenje LT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4416; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Talior-Volodarsky I, 2008, J BIOL CHEM, V283, P25115, DOI 10.1074/jbc.M801750200; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tsuji Y, 2001, DIABETES, V50, P1455, DOI 10.2337/diabetes.50.6.1455; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zulato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019081	53	49	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109540	10.1371/journal.pone.0109540	http://dx.doi.org/10.1371/journal.pone.0109540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299671	Green Published, gold, Green Submitted			2022-12-25	WOS:000343941200057
J	Guardado-Estrada, M; Juarez-Torres, E; Roman-Bassaure, E; Medina-Martinez, I; Alfaro, A; Benuto, RE; Dean, M; Villegas-Sepulveda, N; Berumen, J				Guardado-Estrada, Mariano; Juarez-Torres, Eligia; Roman-Bassaure, Edgar; Medina-Martinez, Ingrid; Alfaro, Ana; Elba Benuto, Rosa; Dean, Michael; Villegas-Sepulveda, Nicolas; Berumen, Jaime			The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; INFECTION; WOMEN; AMPLIFICATION; METAANALYSIS; PREVALENCE; HUMAN-PAPILLOMAVIRUS-16; CARCINOMA; COFACTORS; GENOTYPES	Despite numerous human papillomavirus (HPV) frequency studies in women with cervical cancer (CC), little is known of HPV frequency trends according to patient age. In this work, we compare the mean age and frequency distribution by age of CC patients positive for different HPVs. This study included 462 CC patients. HPVs were detected by PCR and typed using DNA sequencing. A total of 456 patients (98.7%) were positive for HPV: 418 (90.5%) had single and 38 (8.2%) had double HPV infections. HPV16 (46.5%), HPV18 (10.4%), HPV45 (6.7%), and HPV31 (4.1%) were the most frequent viral types in single-infected patients. The mean ages of single-infected patients with HPV16 (49.2 +/- 13.3), HPV18 (47.9 +/- 12.2), HPV45 (47.9 +/- 11.7), or HPV39 (42.6 +/- 8.9) were significantly lower than the mean ages of patients singly (53.9 +/- 12.7; p<0.001, t-test) or doubly (55.4 +/- 12.7; p<0.05, t-test) infected with the remaining HPVs. Three different trends were identified: one for HPV16, another for HPVs18/45/39, and a third for the rest of HPVs. The frequency trend of HPV16 shows two peaks. The first (63.2%) was found in the youngest women (<= 35 years), followed by a decreasing trend until the age of 5560 years (31.1%). The second peak arose at 6165 years (52.5%), followed by a decreasing trend. The trend for HPVs18/45/39 declined from the youngest (19.3%) to the oldest (>70 years; 12.8%) women. In contrast, the trend for the remaining HPVs increased from the youngest (15.8%) to the oldest (46.2%) women. Unlike other life-style factors, low-risk sexual behavior was associated with late onset of CC independent of low-oncogenic HPV types (p<0.05, Wald chi-square statistic). The data indicate that most CCs in young women depend on the presence of high-oncogenic HPVs. In contrast, almost half of CCs in older patients had low-oncogenic HPVs, suggesting they could depend on the presence of other factors.	[Guardado-Estrada, Mariano; Juarez-Torres, Eligia; Medina-Martinez, Ingrid; Alfaro, Ana; Berumen, Jaime] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med, Mexico City 04510, DF, Mexico; [Roman-Bassaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Elba Benuto, Rosa] Acad Mexicana Dermatol, Mexico City, DF, Mexico; [Dean, Michael] NCI, Expt Immunol Lab, Frederick, MD 21701 USA; [Villegas-Sepulveda, Nicolas] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Berumen, Jaime/F-7914-2018; Berumen, Jaime/AAL-5577-2020	Dean, Michael C/0000-0003-2234-0631; Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; Villegas-Sepulveda, Nicolas/0000-0001-9489-2545	National Council of Science and Technology (CONACYT) [8135/A1, 24341]; National University of Mexico [SDI.PTID.05.2]; NATIONAL CANCER INSTITUTE [ZIABC011300] Funding Source: NIH RePORTER	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Council of Science and Technology (CONACYT, www.conacyt.mx), grant numbers 8135/A1, 24341 and the National University of Mexico (www.unam.mx), grant number SDI.PTID.05.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany L, 2012, GYNECOL ONCOL, V124, P512, DOI 10.1016/j.ygyno.2011.11.024; Bekkers RLM, 2003, BRIT J CANCER, V89, P886, DOI 10.1038/sj.bjc.6601204; Bernard E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-373; Berois N, 2013, INT J GYNECOL CANCER, V23, P527, DOI 10.1097/IGC.0b013e318285e753; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Chan PKS, 2010, INT J CANCER, V126, P297, DOI 10.1002/ijc.24731; Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493; Cuzick J, 2010, GYNECOL ONCOL, V117, pS11, DOI 10.1016/j.ygyno.2010.01.025; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garcia-Pineres AJ, 2006, CANCER RES, V66, P11070, DOI 10.1158/0008-5472.CAN-06-2034; Gargano JW, 2012, CANCER EPIDEM BIOMAR, V21, P111, DOI 10.1158/1055-9965.EPI-11-0664; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grassmann K, 1996, VIROLOGY, V223, P185, DOI 10.1006/viro.1996.0467; Gravitt Patti E, 2012, Open Virol J, V6, P198, DOI 10.2174/1874357901206010198; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guan Peng, 2012, Int J Cancer, V131, P2349, DOI 10.1002/ijc.27485; Guardado-Estrada M, 2009, J HUM GENET, V54, P695, DOI 10.1038/jhg.2009.98; Guimera N, 2013, HISTOPATHOLOGY, V63, P287, DOI 10.1111/his.12137; HernandezAvila M, 1997, ARCH MED RES, V28, P265; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kane MA, 2012, VACCINE, V30, pF192, DOI 10.1016/j.vaccine.2012.06.075; Kasamatsu E, 2012, J MED VIROL, V84, P1628, DOI 10.1002/jmv.23373; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kim CJ, 2000, INT J GYNECOL CANCER, V10, P157, DOI 10.1046/j.1525-1438.2000.00016.x; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Lazcano-Ponce E, 2008, CANCER EPIDEM BIOMAR, V17, P2808, DOI 10.1158/1055-9965.EPI-07-2659; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Maglennon Gareth Adam, 2012, Open Virol J, V6, P190, DOI 10.2174/1874357901206010190; Matos A, 2005, EUR J CANCER PREV, V14, P485, DOI 10.1097/01.cej.0000174780.44260.32; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; SANG BC, 1992, P NATL ACAD SCI USA, V89, P8063, DOI 10.1073/pnas.89.17.8063; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2013, INT J CANCER, V132, P2395, DOI 10.1002/ijc.27891; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x	50	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109406	10.1371/journal.pone.0109406	http://dx.doi.org/10.1371/journal.pone.0109406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295590	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000069
J	Ye, ZL; Zheng, Y; Li, BY; Borrusch, MS; Storms, R; Walton, JD				Ye, Zhuoliang; Zheng, Yun; Li, Bingyao; Borrusch, Melissa S.; Storms, Reginald; Walton, Jonathan D.			Enhancement of Synthetic Trichoderma-Based Enzyme Mixtures for Biomass Conversion with an Alternative Family 5 Glycosyl Hydrolase from Sporotrichum thermophile	PLOS ONE			English	Article							THERMOASCUS-AURANTIACUS ENDOGLUCANASE; SUBSTRATE-SPECIFICITY; DEGRADING ENZYMES; CELLULOSE; OPTIMIZATION; DECONSTRUCTION; HYDROLYSIS; POLYSACCHARIDES; MECHANISMS; KINETICS	Enzymatic conversion of lignocellulosic materials to fermentable sugars is a limiting step in the production of biofuels from biomass. We show here that combining enzymes from different microbial sources is one way to identify superior enzymes. Extracts of the thermophilic fungus Sporotrichum thermophile (synonym Myceliophthora thermophila) gave synergistic release of glucose (Glc) and xylose (Xyl) from pretreated corn stover when combined with an 8-component synthetic cocktail of enzymes from Trichoderma reesei. The S. thermophile extracts were fractionated and an enhancing factor identified as endo-beta 1,4-glucanase (StCel5A or EG2) of subfamily 5 of Glycosyl Hydrolase family 5 (GH5_5). In multicomponent optimization experiments using a standard set of enzymes and either StCel5A or the ortholog from T. reesei (TrCel5A), reactions containing StCel5A yielded more Glc and Xyl. In a five-component optimization experiment (i.e., varying four core enzymes and the source of Cel5A), the optimal proportions for TrCel5A vs. StCel5A were similar for Glc yields, but markedly different for Xyl yields. Both enzymes were active on lichenan, glucomannan, and oat beta-glucan; however, StCel5A but not TrCel5A was also active on beta 1,4-mannan, two types of galactomannan, and beta 1,4-xylan. Phylogenetically, fungal enzymes in GH5_5 sorted into two clades, with StCel5A and TrCel5A belonging to different clades. Structural differences with the potential to account for the differences in performance were deduced based on the known structure of TrCel5A and a homology-based model of StCel5A, including a loop near the active site of TrCel5A and the presence of four additional Trp residues in the active cleft of StCel5A. The results indicate that superior biomass-degrading enzymes can be identified by exploring taxonomic diversity combined with assays in the context of realistic enzyme combinations and realistic substrates. Substrate range may be a key factor contributing to superior performance within GH5_5.	[Ye, Zhuoliang; Li, Bingyao; Borrusch, Melissa S.; Walton, Jonathan D.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, Dept Energy, E Lansing, MI 48824 USA; [Ye, Zhuoliang; Li, Bingyao; Borrusch, Melissa S.; Walton, Jonathan D.] Michigan State Univ, Dept Energy Plant, Res Lab, E Lansing, MI 48824 USA; [Zheng, Yun; Storms, Reginald] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Michigan State University; United States Department of Energy (DOE); Michigan State University; Concordia University - Canada	Walton, JD (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, Dept Energy, E Lansing, MI 48824 USA.	walton@msu.edu			United States Department of Energy Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; United States Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences [DE-FG02-91ER200021]	United States Department of Energy Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); United States Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences(United States Department of Energy (DOE))	This work was funded by the United States Department of Energy Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). Additional funding was provided by grant DE-FG02-91ER200021 to the MSU-Plant Research Laboratory from the United States Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Banerjee G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-16; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Banerjee G, 2010, BIORESOURCE TECHNOL, V101, P9097, DOI 10.1016/j.biortech.2010.07.028; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Ding SJ, 2001, EUR J BIOCHEM, V268, P5687, DOI 10.1046/j.0014-2956.2001.02503.x; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Falls M, 2011, BIORESOURCE TECHNOL, V102, P11072, DOI 10.1016/j.biortech.2011.03.035; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao DH, 2010, BIOENERG RES, V3, P67, DOI 10.1007/s12155-009-9066-6; Gusakov AV, 2011, US Patent, Patent No. [7,883,872 B2, 7883872]; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Kim E, 1998, BIOTECHNOL BIOENG, V58, P494, DOI 10.1002/(SICI)1097-0290(19980605)58:5<494::AID-BIT5>3.0.CO;2-8; Kostylev M, 2012, BIOFUELS-UK, V3, P61, DOI 10.4155/BFS.11.150; Lee TM, 2011, PROTEIN SCI, V20, P1935, DOI 10.1002/pro.730; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nagendran S, 2009, FUNGAL GENET BIOL, V46, P427, DOI 10.1016/j.fgb.2009.02.001; Pollet A, 2010, CRIT REV BIOTECHNOL, V30, P176, DOI 10.3109/07388551003645599; Scott-Craig JS, 2011, J BIOL CHEM, V286, P42848, DOI 10.1074/jbc.M111.307397; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; SHEPHERD MG, 1981, BIOCHEM J, V193, P67, DOI 10.1042/bj1930067; Srikrishnan S, 2012, BIOTECHNOL BIOENG, V109, P1595, DOI 10.1002/bit.24414; Takasuka TE, 2012, METHODS MOL IN PRESS; Tambor JH, 2012, APPL MICROBIOL BIOT, V93, P203, DOI 10.1007/s00253-011-3419-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Petegem F, 2002, BIOCHEM BIOPH RES CO, V296, P161, DOI 10.1016/S0006-291X(02)00775-1; WEIMER PJ, 1990, APPL ENVIRON MICROB, V56, P2421, DOI 10.1128/AEM.56.8.2421-2429.1990; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Ye ZL, 2011, BIORESOURCE TECHNOL, V102, P11194, DOI 10.1016/j.biortech.2011.09.044; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang X, 2012, US Patent Application, Patent No. [0208235 A1, 0208235]	44	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109885	10.1371/journal.pone.0109885	http://dx.doi.org/10.1371/journal.pone.0109885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295862	Green Published, gold, Green Submitted			2022-12-25	WOS:000345204000099
J	Jespers, V; Crucitti, T; Menten, J; Verhelst, R; Mwaura, M; Mandaliya, K; Ndayisaba, GF; Delany-Moretlwe, S; Verstraelen, H; Hardy, L; Buve, A; van de Wijgert, J				Jespers, Vicky; Crucitti, Tania; Menten, Joris; Verhelst, Rita; Mwaura, Mary; Mandaliya, Kishor; Ndayisaba, Gilles F.; Delany-Moretlwe, Sinead; Verstraelen, Hans; Hardy, Liselotte; Buve, Anne; van de Wijgert, Janneke		Vaginal Biomarkers Study Grp	Prevalence and Correlates of Bacterial Vaginosis in Different Sub-Populations of Women in Sub-Saharan Africa: A Cross-Sectional Study	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; HIV ACQUISITION; RISK-FACTORS; INFECTIONS; LACTOBACILLI; ASSOCIATION	Background: Clinical development of vaginally applied products aimed at reducing the transmission of HIV and other sexually transmitted infections, has highlighted the need for a better characterisation of the vaginal environment. We set out to characterise the vaginal environment in women in different settings in sub-Saharan Africa. Methods: A longitudinal study was conducted in Kenya, Rwanda and South-Africa. Women were recruited into pre-defined study groups including adult, non-pregnant, HIV-negative women; pregnant women; adolescent girls; HIV-negative women engaging in vaginal practices; female sex workers; and HIV-positive women. Consenting women were interviewed and underwent a pelvic exam. Samples of vaginal fluid and a blood sample were taken and tested for bacterial vaginosis (BV), HIV and other reproductive tract infections (RTIs). This paper presents the cross-sectional analyses of BV Nugent scores and RTI prevalence and correlates at the screening and the enrolment visit. Results: At the screening visit 38% of women had BV defined as a Nugent score of 7-10, and 64% had more than one RTI (N. gonorrhoea, C. trachomatis, T. vaginalis, syphilis) and/or Candida. At screening the likelihood of BV was lower in women using progestin-only contraception and higher in women with more than one RTI. At enrolment, BV scores were significantly associated with the presence of prostate specific antigen (PSA) in the vaginal fluid and with being a self-acknowledged sex worker. Further, sex workers were more likely to have incident BV by Nugent score at enrolment. Conclusions: Our study confirmed some of the correlates of BV that have been previously reported but the most salient finding was the association between BV and the presence of PSA in the vaginal fluid which is suggestive of recent unprotected sexual intercourse.	[Jespers, Vicky; Hardy, Liselotte; Buve, Anne] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Menten, Joris] Inst Trop Med, Dept Clin Sci, Clin Trials Unit, B-2000 Antwerp, Belgium; [Verhelst, Rita] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Mwaura, Mary; Mandaliya, Kishor] ICRH Kenya, Mombasa, Kenya; [Ndayisaba, Gilles F.] Rinda Ubuzima, Kigali, Rwanda; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Verstraelen, Hans] Univ Ghent, Fac Med & Hlth Sci, Dept Obstet & Gynecol, B-9000 Ghent, Belgium; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [van de Wijgert, Janneke] AMC CPCD, Amsterdam, Netherlands	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Ghent University; University of Witwatersrand; Ghent University; University of Liverpool	Jespers, V (corresponding author), Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium.	vjespers@itg.be	Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AEQ-9792-2022; Verstraelen, Hans/AAA-8694-2019; Hardy, Liselotte/AAF-3515-2019; Verstraelen, Hans/A-5602-2008; Crucitti, Tania/AAB-9967-2019; Kestelyn, Evelyne/AAD-6052-2019; Masha, Simon/R-4419-2017	Crucitti, Tania/0000-0002-2235-6038; Verstraelen, Hans/0000-0002-4070-1587; Crucitti, Tania/0000-0002-2235-6038; Kestelyn, Evelyne/0000-0002-5728-0918; Andreasen, Aura/0000-0003-0664-7342; Hardy, Liselotte/0000-0002-8785-5081; Thiongo, Mary/0000-0002-0598-995X; Vaneechoutte, Mario/0000-0002-4586-203X; Masha, Simon/0000-0002-6283-2430; Cools, Piet/0000-0003-2980-5307; Kapiga, Saidi/0000-0003-1753-4060; de Assis Rosa, Debra/0000-0002-9342-2661; Jaoko, Walter/0000-0002-7134-6581; Hayes, Richard/0000-0002-1729-9892; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	European & Developing Countries Clinical Trials Partnership [IP_2007_33070_001]; Research Foundation Flanders [FWO-3GA13210]	European & Developing Countries Clinical Trials Partnership; Research Foundation Flanders(FWO)	The project was funded by the European & Developing Countries Clinical Trials Partnership (IP_2007_33070_001) ( http://www.edctp.org/) and the Research Foundation Flanders (FWO-3GA13210) (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Collett D, 2003, C&H TEXT STAT SCI, P45; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Govender L, 1996, INT J GYNECOL OBSTET, V55, P23, DOI 10.1016/0020-7292(96)02744-0; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; LEPPALUOTO PA, 1971, ACTA CYTOL, V15, P211; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; Rifkin SB, 2009, CONTRACEPTION, V80, P63, DOI 10.1016/j.contraception.2009.01.008; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; Thoma ME, 2011, SEX TRANSM DIS, V38, P111, DOI 10.1097/OLQ.0b013e3181f0bdd0; Thurman Andrea Ries, 2011, Infect Dis Obstet Gynecol, V2011, P1, DOI 10.1155/2011/429403; UNAIDS, 2013, UNAIDSJC25021E; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695	20	66	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109670	10.1371/journal.pone.0109670	http://dx.doi.org/10.1371/journal.pone.0109670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289640	Green Published, gold, Green Accepted			2022-12-25	WOS:000342798000076
J	Kazem, S; van der Meijden, E; Wang, RC; Rosenberg, AS; Pope, E; Benoit, T; Fleckman, P; Feltkamp, MCW				Kazem, Siamaque; van der Meijden, Els; Wang, Richard C.; Rosenberg, Arlene S.; Pope, Elena; Benoit, Taylor; Fleckman, Philip; Feltkamp, Mariet C. W.			Polyomavirus-Associated Trichodysplasia Spinulosa Involves Hyperproliferation, pRB Phosphorylation and Upregulation of p16 and p21	PLOS ONE			English	Article							VIRAL-ASSOCIATED TRICHODYSPLASIA; LARGE TUMOR-ANTIGEN; RETINOBLASTOMA PROTEIN; T-ANTIGEN; SUPPRESSOR; CYCLE; GENE; P53; E6; DIFFERENTIATION	Trichodysplasia spinulosa (TS) is a proliferative skin disease observed in severely immunocompromized patients. It is characterized by papule and trichohyalin-rich spicule formation, epidermal acanthosis and distention of dysmorphic hair follicles overpopulated by inner root sheath cells (IRS). TS probably results from active infection with the TS-associated polyomavirus (TSPyV), as indicated by high viral-load, virus protein expression and particle formation. The underlying pathogenic mechanism imposed by TSPyV infection has not been solved yet. By analogy with other polyomaviruses, such as the Merkel cell polyomavirus associated with Merkel cell carcinoma, we hypothesized that TSPyV T-antigen promotes proliferation of infected IRS cells. Therefore, we analyzed TS biopsy sections for markers of cell proliferation (Ki-67) and cell cycle regulation (p16(ink4a), p21(waf), pRB, phosphorylated pRB), and the putatively transforming TSPyV early large tumor (LT) antigen. Intense Ki-67 staining was detected especially in the margins of TS hair follicles, which colocalized with TSPyV LT-antigen detection. In this area, staining was also noted for pRB and particularly phosphorylated pRB, as well as p16(ink4a) and p21(waf). Healthy control hair follicles did not or hardly stained for these markers. Trichohyalin was particularly detected in the center of TS follicles that stained negative for Ki-67 and TSPyVLT-antigen. In summary, we provide evidence for clustering of TSPyVLT-antigen-expressing and proliferating cells in the follicle margins that overproduce negative cell cycle regulatory proteins. These data are compatible with a scenario of TSPyVT-antigen-mediated cell cycle progression, potentially creating a pool of proliferating cells that enable viral DNA replication and drive papule and spicule formation.	[Kazem, Siamaque; van der Meijden, Els; Feltkamp, Mariet C. W.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, South Holland, Netherlands; [Wang, Richard C.] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA; [Rosenberg, Arlene S.] Case Western Reserve Univ, Dept Dermatol, Metrohlth Med Ctr, Cleveland, OH 44106 USA; [Pope, Elena] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Benoit, Taylor] Med Univ S Carolina, Dept Dermatol, Charleston, SC 29425 USA; [Fleckman, Philip] Univ Washington, Div Dermatol, Seattle, WA 98195 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; MetroHealth System; University of Toronto; Medical University of South Carolina; University of Washington; University of Washington Seattle	Feltkamp, MCW (corresponding author), Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, South Holland, Netherlands.	m.c.w.feltkamp@lumc.nl	Feltkamp, Mariet/A-3788-2010; Wang, Richard/AAW-3066-2021	Feltkamp, Mariet/0000-0001-5993-9846; Wang, Richard/0000-0003-4543-8295	Leiden University Medical Center, The Netherlands; NATIONAL CANCER INSTITUTE [K08CA164047] Funding Source: NIH RePORTER	Leiden University Medical Center, The Netherlands; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Leiden University Medical Center, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit T, 2010, ARCH DERMATOL, V146, P871, DOI 10.1001/archdermatol.2010.175; Boxman ILA, 2001, J INVEST DERMATOL, V117, P1397, DOI 10.1046/j.0022-202x.2001.01602.x; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DYSON N, 1990, J VIROL, V64, P1353, DOI 10.1128/JVI.64.3.1353-1356.1990; Feltkamp MCW, 2013, J GEN VIROL, V94, P482, DOI 10.1099/vir.0.048462-0; Frisque RJ, 2006, ADV EXP MED BIOL, V577, P288; Harris KF, 1998, MOL CELL BIOL, V18, P1746, DOI 10.1128/MCB.18.3.1746; Haycox CL, 1999, J INVEST DERM SYMP P, V4, P268, DOI 10.1038/sj.jidsp.5640227; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Kanitakis J, 2011, EUR J DERMATOL, V21, P453, DOI 10.1684/ejd.2011.1395; Kazem S, 2013, APMIS, V121, P770, DOI 10.1111/apm.12092; Kazem S, 2012, J CLIN VIROL, V53, P225, DOI 10.1016/j.jcv.2011.11.007; Kazem S, 2012, VIRUS RES, V163, P609, DOI 10.1016/j.virusres.2011.12.015; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Malanchi I, 2004, J VIROL, V78, P13769, DOI 10.1128/JVI.78.24.13769-13778.2004; Matthews MR, 2011, J CUTAN PATHOL, V38, P420, DOI 10.1111/j.1600-0560.2010.01664.x; Pipas JM, 2009, VIROLOGY, V384, P294, DOI 10.1016/j.virol.2008.11.024; Pipas JM, 2001, SEMIN CANCER BIOL, V11, P23, DOI 10.1006/scbi.2000.0343; Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Schwieger-Briel A, 2010, PEDIATR DERMATOL, V27, P509, DOI 10.1111/j.1525-1470.2010.01278.x; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shivakumar CV, 1996, ONCOGENE, V13, P323; Struijk L, 2008, J GEN VIROL, V89, P2303, DOI 10.1099/vir.0.83317-0; Todorovic B, 2012, J VIROL, V86, P13313, DOI 10.1128/JVI.01637-12; Topalis D, 2013, ANTIVIR RES, V97, P122, DOI 10.1016/j.antiviral.2012.11.007; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; van Drongelen V, 2014, TISSUE ENG A	29	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108947	10.1371/journal.pone.0108947	http://dx.doi.org/10.1371/journal.pone.0108947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291363	gold, Green Published			2022-12-25	WOS:000342798000031
J	Nakajima-Adachi, H; Kikuchi, A; Fujimura, Y; Shibahara, K; Makino, T; Goseki-Sone, M; Kihara-Fujioka, M; Nochi, T; Kurashima, Y; Igarashi, O; Yamamoto, M; Kunisawa, J; Toda, M; Kaminogawa, S; Sato, R; Kiyono, H; Hachimura, S				Nakajima-Adachi, Haruyo; Kikuchi, Akira; Fujimura, Yoko; Shibahara, Kyoko; Makino, Tsuyoshi; Goseki-Sone, Masae; Kihara-Fujioka, Miran; Nochi, Tomonori; Kurashima, Yosuke; Igarashi, Osamu; Yamamoto, Masafumi; Kunisawa, Jun; Toda, Masako; Kaminogawa, Shuichi; Sato, Ryuichiro; Kiyono, Hiroshi; Hachimura, Satoshi			Peyer's Patches and Mesenteric Lymph Nodes Cooperatively Promote Enteropathy in a Mouse Model of Food Allergy	PLOS ONE			English	Article							RECEPTOR TRANSGENIC MICE; ORAL TOLERANCE; DENDRITIC CELLS; T-CELLS; GASTROINTESTINAL-TRACT; ANTIGEN; IMMUNITY; INFLAMMATION; RESPONSES; DIARRHEA	Background and Objective: To improve the efficacy and safety of tolerance induction for food allergies, identifying the tissues responsible for inducing intestinal inflammation and subsequent oral tolerance is important. We used OVA23-3 mice, which express an ovalbumin-specific T-cell receptor, to elucidate the roles of local and systemic immune tissues in intestinal inflammation. Methods and Results: OVA23-3 mice developed marked enteropathy after consuming a diet containing egg white (EW diet) for 10 days but overcame the enteropathy (despite continued moderate inflammation) after receiving EW diet for a total of 28 days. Injecting mice with anti-IL-4 antibody or cyclosporine A confirmed the involvement of Th2 cells in the development of the enteropathy. To assess the individual contributions of Peyer's patches (PPs), mesenteric lymph nodes (MLNs), and the spleen to the generation of effector CD4(+) T-cells, we analyzed the IL-4 production, proliferation in response to ovalbumin, and CD4(+) T-cell numbers of these tissues. EW feeding for 10 days induced significant IL-4 production in PPs, the infiltration of numerous CD4(+) T-cells into MLNs, and a decrease in CD4(+) T-cell numbers in spleen. On day 28, CD4(+) T-cells from all tissues had attenuated responses to ovalbumin, suggesting tolerance acquisition, although MLN CD4(+) T-cells still maintained IL-4 production with proliferation. In addition, removal of MLNs but not the spleen decreased the severity of enteropathy and PP-disrupted mice showed delayed onset of EW-induced inflammatory responses. Disruption of peripheral lymphoid tissues or of both PPs and MLNs almost completely prevented the enteropathy. Conclusions: PPs and MLNs coordinately promote enteropathy by generating effector T-cells during the initial and exacerbated phases, respectively; the spleen is dispensable for enteropathy and shows tolerogenic responses throughout EW-feeding. The regulation of PPs may suppress the initiation of intestinal inflammation, subsequently restricting MLNs and inhibiting the progression of food-allergic enteropathy.	[Nakajima-Adachi, Haruyo; Kikuchi, Akira; Fujimura, Yoko; Shibahara, Kyoko; Kihara-Fujioka, Miran; Sato, Ryuichiro; Hachimura, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Nakajima-Adachi, Haruyo; Nochi, Tomonori; Kurashima, Yosuke; Igarashi, Osamu; Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Makino, Tsuyoshi] Japan SLC Inc, Biotech Ctr, BT Ctr, Shizuoka, Japan; [Goseki-Sone, Masae] Japan Womens Univ, Fac Human Sci & Design, Dept Food & Nutr, Tokyo 112, Japan; [Kurashima, Yosuke; Kunisawa, Jun; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Yamamoto, Masafumi] Nihon Univ, Sch Dent Matsudo, Dept Microbiol & Immunol, Chiba, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka, Japan; [Toda, Masako] Paul Ehrlich Inst, Vice Presidents Res Grp Mol Allergol, Langen, Germany; [Kaminogawa, Shuichi] Nihon Univ, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Nakajima-Adachi, Haruyo; Shibahara, Kyoko; Hachimura, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Womens University; Japan Science & Technology Agency (JST); Nihon University; University of Tokyo; National Institute of Health Sciences - Japan; Paul Ehrlich Institute; Nihon University; University of Tokyo; University of Tokyo; University of Tokyo	Nakajima-Adachi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.	aryu@mail.ecc.u-tokyo.ac.jp	Nochi, Tomonori/U-2533-2019; Kiyono, Hiroshi/AAC-6735-2022; Toda, Masako/S-9810-2019	Nochi, Tomonori/0000-0003-1800-6972; 	Japan Society for the Promotion of Science; Food Science Institute Foundation and Food Safety Commission	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Food Science Institute Foundation and Food Safety Commission	The authors received financial support from the Restart Postdoctoral Program of the Japan Society for the Promotion of Science and from The Food Science Institute Foundation and Food Safety Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Dourado LPA, 2010, CELL IMMUNOL, V262, P62, DOI 10.1016/j.cellimm.2009.12.010; Beck Lisa A., 2000, Journal of Allergy and Clinical Immunology, V106, pS258; Bedoret D, 2012, MUCOSAL IMMUNOL, V5, P267, DOI 10.1038/mi.2012.5; Blazquez AB, 2010, GASTROENTEROLOGY, V138, P275, DOI 10.1053/j.gastro.2009.09.016; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Burggraf M, 2011, MOL NUTR FOOD RES, V55, P1475, DOI 10.1002/mnfr.201000634; Cardoso CR, 2009, AM J PHYSIOL-GASTR L, V296, pG593, DOI 10.1152/ajpgi.90431.2008; Chambers SJ, 2004, IMMUNOLOGY, V112, P72, DOI 10.1111/j.1365-2567.2004.01846.x; Costes LMM, 2013, ORGANOGENESIS, V9, P216, DOI 10.4161/org.25646; Dubois B, 2005, CELL MOL LIFE SCI, V62, P1322, DOI 10.1007/s00018-005-5036-0; Fecek RJ, 2010, IMMUNOBIOLOGY, V215, P941, DOI 10.1016/j.imbio.2010.02.004; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Haraikawa M, 2011, J NUTR SCI VITAMINOL, V57, P274, DOI 10.3177/jnsv.57.274; Hu W, 2007, ALLERGY, V62, P709, DOI 10.1111/j.1398-9995.2007.01315.x; Knight AK, 2007, AM J PHYSIOL-GASTR L, V293, pG1234, DOI 10.1152/ajpgi.00323.2007; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Mohrenschlager M, 2011, GERONTOLOGY, V57, P33, DOI 10.1159/000316576; Morita H, 2013, ALLERGOL INT, V62, P297, DOI 10.2332/allergolint.13-RA-0542; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Nakajima-Adachi H, 2006, J ALLERGY CLIN IMMUN, V117, P1125, DOI 10.1016/j.jaci.2006.01.016; Nakajima-Adachi H, 2012, BIOSCI BIOTECH BIOCH, V76, P1979, DOI 10.1271/bbb.120349; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Ruiter B, 2012, J ALLERGY CLIN IMMUN, V129, P921, DOI 10.1016/j.jaci.2012.01.080; SATO T, 1994, EUR J IMMUNOL, V24, P1512, DOI 10.1002/eji.1830240708; Scurlock AM, 2010, MUCOSAL IMMUNOL, V3, P345, DOI 10.1038/mi.2010.21; Steele L, 2012, IMMUNOL RES, V54, P75, DOI 10.1007/s12026-012-8308-4; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Ternblay JN, 2007, J ALLERGY CLIN IMMUN, V120, P659, DOI 10.1016/j.jaci.2007.04.044; Wang J, 2011, J CLIN INVEST, V121, P827, DOI [10.1172/JCI45434, 10.1186/1710-1492-7-S1-S7]; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yamamoto M, 2004, J IMMUNOL, V173, P762, DOI 10.4049/jimmunol.173.2.762; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	42	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107492	10.1371/journal.pone.0107492	http://dx.doi.org/10.1371/journal.pone.0107492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290461	Green Submitted, Green Published, gold			2022-12-25	WOS:000342798000005
J	Oliveira, H; Thiagarajan, V; Walmagh, M; Sillankorva, S; Lavigne, R; Neves-Petersen, MT; Kluskens, LD; Azeredo, J				Oliveira, Hugo; Thiagarajan, Viruthachalam; Walmagh, Maarten; Sillankorva, Sanna; Lavigne, Rob; Neves-Petersen, Maria Teresa; Kluskens, Leon D.; Azeredo, Joana			A Thermostable Salmonella Phage Endolysin, Lys68, with Broad Bactericidal Properties against Gram-Negative Pathogens in Presence of Weak Acids	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; LYSOZYME	Resistance rates are increasing among several problematic Gram-negative pathogens, a fact that has encouraged the development of new antimicrobial agents. This paper characterizes a Salmonella phage endolysin (Lys68) and demonstrates its potential antimicrobial effectiveness when combined with organic acids towards Gram-negative pathogens. Biochemical characterization reveals that Lys68 is more active at pH 7.0, maintaining 76.7% of its activity when stored at 4 degrees C for two months. Thermostability tests showed that Lys68 is only completely inactivated upon exposure to 100 degrees C for 30 min, and circular dichroism analysis demonstrated the ability to refold into its original conformation upon thermal denaturation. It was shown that Lys68 is able to lyse a wide panel of Gram-negative bacteria (13 different species) in combination with the outer membrane permeabilizers EDTA, citric and malic acid. While the EDTA/Lys68 combination only inactivated Pseudomonas strains, the use of citric or malic acid broadened Lys68 antibacterial effect to other Gram-negative pathogens (lytic activity against 9 and 11 species, respectively). Particularly against Salmonella Typhimurium LT2, the combinatory effect of malic or citric acid with Lys68 led to approximately 3 to 5 log reductions in bacterial load/CFUs after 2 hours, respectively, and was also able to reduce stationary-phase cells and bacterial biofilms by approximately 1 log. The broad killing capacity of malic/citric acid-Lys68 is explained by the destabilization and major disruptions of the cell outer membrane integrity due to the acidity caused by the organic acids and a relatively high muralytic activity of Lys68 at low pH. Lys68 demonstrates good (thermo) stability properties that combined with different outer membrane permeabilizers, could become useful to combat Gram-negative pathogens in agricultural, food and medical industry.	[Oliveira, Hugo; Sillankorva, Sanna; Kluskens, Leon D.; Azeredo, Joana] Univ Minho, Ctr Biol Engn, Braga, Portugal; [Thiagarajan, Viruthachalam] Bharathidasan Univ, Sch Chem, Tiruchirappalli, Tamil Nadu, India; [Walmagh, Maarten; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Leuven, Belgium; [Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab, Nanomed Dept, Braga, Portugal; [Neves-Petersen, Maria Teresa] Aalborg Univ, Fac Med, Aalborg, Denmark	Universidade do Minho; Bharathidasan University; KU Leuven; International Iberian Nanotechnology Laboratory; Aalborg University	Azeredo, J (corresponding author), Univ Minho, Ctr Biol Engn, Braga, Portugal.	jazeredo@deb.uminho.pt	Viruthachalam, Thiagarajan/I-2503-2013; Sillankorva, Sanna/AAF-9356-2021; INL, Citations/K-3436-2015; Kluskens, Leon/J-3019-2013; Oliveira, Hugo/AAH-1071-2021; Oliveira, Hugo/O-5972-2015; Sillankorva, Sanna/J-2621-2013	Sillankorva, Sanna/0000-0002-8408-8550; INL, Citations/0000-0002-3745-5100; Kluskens, Leon/0000-0002-0070-7837; Oliveira, Hugo/0000-0001-9564-5714; Sillankorva, Sanna/0000-0002-8408-8550; Thiagarajan, Viruthachalam/0000-0003-4197-2255; Azeredo, Joana/0000-0002-5180-7133; Lavigne, Rob/0000-0001-7377-1314; Neves-Petersen, Maria Teresa/0000-0003-3178-3709	"Fundacao para a Ciencia e Tecnologia" (FCT), Portugal [FCOMP-01-0124-FEDER-019446, FCOMP-01-0124-FEDER-027462, PEst-OE/EQB/LA0023/2013]; BioHealth - Biotechnology and Bioengineering approaches to improve health quality [NORTE-07-0124-FEDER-000027]; Programa Operacional Regional do Norte [ON. 2 - O Novo Norte]; QREN; FEDER; FCT [SFRH/BD/63734/2009]; IWT Vlaanderen	"Fundacao para a Ciencia e Tecnologia" (FCT), Portugal(Portuguese Foundation for Science and Technology); BioHealth - Biotechnology and Bioengineering approaches to improve health quality; Programa Operacional Regional do Norte; QREN; FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); IWT Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the projects FCOMP-01-0124-FEDER-019446, FCOMP-01-0124-FEDER-027462 and PEst-OE/EQB/LA0023/2013 from "Fundacao para a Ciencia e Tecnologia" (FCT), Portugal. The authors thank the Project "BioHealth - Biotechnology and Bioengineering approaches to improve health quality", Ref. NORTE-07-0124-FEDER-000027, co-funded by the Programa Operacional Regional do Norte (ON. 2 - O Novo Norte), QREN, FEDER. Hugo Oliveira acknowledges the FCT grant SFRH/BD/63734/2009. Maarten Walmagh held a PhD scholarship of the IWT Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Alakomi HL, 2007, THESIS U HELSINKI; Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Briers Y, 2009, BIOCHEM BIOPH RES CO, V383, P187, DOI 10.1016/j.bbrc.2009.03.161; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Doores S., 1993, ANTIMICROBIALS FOODS, P95; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Kim SA, 2013, APPL ENVIRON MICROB, V79, P6552, DOI 10.1128/AEM.02164-13; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; Lim JA, 2012, RES MICROBIOL, V163, P233, DOI 10.1016/j.resmic.2012.01.002; Mastromatteo M, 2010, J FOOD SCI, V75, pM178, DOI 10.1111/j.1750-3841.2010.01556.x; NAKAGAWA H, 1985, J VIROL, V54, P460, DOI 10.1128/JVI.54.2.460-466.1985; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Schuch Raymond, 2009, V502, P307, DOI 10.1007/978-1-60327-565-1_18; Sillankorva S, 2010, J APPL MICROBIOL, V108, P1175, DOI 10.1111/j.1365-2672.2009.04549.x; Theron MM, 2011, ORGANIC ACIDS FOOD P, P117; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vollmer W, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P15; Walmagh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036991; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Webb H, 2011, PROTEINS, V79, P685, DOI 10.1002/prot.22886; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388; WREN BW, 1991, MOL MICROBIOL, V5, P797, DOI 10.1111/j.1365-2958.1991.tb00752.x	35	108	115	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108376	10.1371/journal.pone.0108376	http://dx.doi.org/10.1371/journal.pone.0108376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290100	Green Published, gold			2022-12-25	WOS:000342798000015
J	Chung, JH; Larsen, AR; Chen, E; Bunz, F				Chung, Jon H.; Larsen, Andrew R.; Chen, Evan; Bunz, Fred			A PTCH1 Homolog Transcriptionally Activated by p53 Suppresses Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSION; DRUG-SENSITIVITY; CANCER-CELLS; HUMAN GENOME; MEDULLOBLASTOMA; GENE; TUMORIGENESIS; ENCYCLOPEDIA; PATTERNS; SUGGESTS	The p53-mediated responses to DNA damage and the Hedgehog (Hh) signaling pathway are each recurrently dysregulated in many types of human cancer. Here we describe PTCH53, a p53 target gene that is homologous to the tumor suppressor gene PTCH1 and can function as a repressor of Hh pathway activation. PTCH53 (previously designated PTCHD4) was highly responsive to p53 in vitro and was among a small number of genes that were consistently expressed at reduced levels in diverse TP53 mutant cell lines and human tumors. Increased expression of PTCH53 inhibited canonical Hh signaling by the G protein-coupled receptor SMO. PTCH53 thus delineates a novel, inducible pathway by which p53 can repress tumorigenic Hh signals.	[Chung, Jon H.; Larsen, Andrew R.; Chen, Evan; Bunz, Fred] Kimmel Canc Ctr Johns Hopkins, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Bunz, F (corresponding author), Kimmel Canc Ctr Johns Hopkins, Dept Radiat Oncol & Mol Radiat Sci, 1550 Orleans St, Baltimore, MD 21231 USA.	fredbunz@jhmi.edu		Chung, Jon/0000-0003-0526-3670	National Institutes of Health [R01CA157535, P30CA006973, P50CA062924]; AACR-Fight Colorectal Cancer fellowship; NATIONAL CANCER INSTITUTE [R01CA157535, P30CA006973, P50CA062924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR-Fight Colorectal Cancer fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA157535 (to F. B.), P30CA006973 (to the Johns Hopkins gastro-intestinal cancer SPORE), and P50CA062924 (to the Sidney Kimmel Comprehensive Cancer Center).; Supported in part by the AACR-Fight Colorectal Cancer fellowship.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Chung JH, 2013, ONCOTARGET, V4, P2208, DOI 10.18632/oncotarget.1651; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hausmann G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000146; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MIYASHITA T, 1995, CELL, V80, P293; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Parikh N, 2014, J PATHOL, V232, P522, DOI 10.1002/path.4321; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Triscott J, 2013, CANCER RES, V73, P6734, DOI 10.1158/0008-5472.CAN-12-4331; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wanshura LEC, 2011, CANCER RES, V71, P5336, DOI 10.1158/0008-5472.CAN-10-2633; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	35	24	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.597203	http://dx.doi.org/10.1074/jbc.M114.597203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296753	Green Published, hybrid			2022-12-25	WOS:000345335000052
J	Ishimoto, T; Fujiwara, K; Niwa, T; Taguchi, H				Ishimoto, Takuya; Fujiwara, Kei; Niwa, Tatsuya; Taguchi, Hideki			Conversion of a Chaperonin GroEL-independent Protein into an Obligate Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chaperone; Protein Aggregation; Protein Evolution; Protein Folding; Protein Misfolding; Chaperonin; GroEL	DEPLETED ESCHERICHIA-COLI; MOLECULAR CHAPERONES; AGGREGATION; EVOLUTION; OVEREXPRESSION; MUTATIONS; MECHANISM; INTERACT; SYNTHASE; NETWORK	Background: Chaperonin GroEL and GroES (GroE) assist a subset of proteins in the cell. Results: Conversion of a GroE-independent MetK into an obligate MetK occurred; GroE dependence was correlated with the propensity to form protein aggregates. Conclusion: Subtle differences, even at single point mutations, determine the GroE dependence. Significance: Buffering the aggregation-prone mutations by GroE plays a role in maintaining diversity of proteins. Chaperones assist protein folding by preventing unproductive protein aggregation in the cell. In Escherichia coli, chaperonin GroEL/GroES (GroE) is the only indispensable chaperone and is absolutely required for the de novo folding of at least approximate to 60 proteins. We previously found that several orthologs of the obligate GroE substrates in Ureaplasma urealyticum, which lacks the groE gene in the genome, are E. coli GroE-independent folders, despite their significant sequence identities. Here, we investigated the key features that define the GroE dependence. Chimera or random mutagenesis analyses revealed that independent multiple point mutations, and even single mutations, were sufficient to confer GroE dependence on the Ureaplasma MetK. Strikingly, the GroE dependence was well correlated with the propensity to form protein aggregates during folding. The results reveal the delicate balance between GroE dependence and independence. The function of GroE to buffering the aggregation-prone mutations plays a role in maintaining higher genetic diversity of proteins.	[Ishimoto, Takuya; Niwa, Tatsuya; Taguchi, Hideki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Fujiwara, Kei] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Tokyo Institute of Technology; Keio University	Taguchi, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B-56,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	taguchi@bio.titech.ac.jp	taguchi, hideki/AAM-2663-2021; FUJIWARA, KEI/U-8308-2019; Taguchi, Hideki/B-6946-2009; FUJIWARA, KEI/G-5467-2010	taguchi, hideki/0000-0002-6612-9339; FUJIWARA, KEI/0000-0001-7308-774X; Taguchi, Hideki/0000-0002-6612-9339; FUJIWARA, KEI/0000-0001-7308-774X; Niwa, Tatsuya/0000-0002-1330-8974	Japan Society for the Promotion of Science (JSPS) [19058002, 17049009]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Mochida Memorial Foundation; Takeda Science Foundation; Uehara Memorial Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-aid for Scientific Research 19058002 and 17049009 (to H. T.) from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This work was also supported by grants from the Mochida Memorial Foundation, Takeda Science Foundation, and Uehara Memorial Foundation (to H. T.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Azia A, 2012, FEBS J, V279, P543, DOI 10.1111/j.1742-4658.2011.08458.x; Bogumil D, 2012, BIOCHEMISTRY-US, V51, P9941, DOI 10.1021/bi3013643; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fujiwara K, 2007, J BACTERIOL, V189, P5860, DOI 10.1128/JB.00493-07; Fujiwara K, 2013, ANAL METHODS-UK, V5, P5918, DOI 10.1039/c3ay41092g; Fujiwara K, 2012, MICROBIOL-SGM, V158, P917, DOI 10.1099/mic.0.055079-0; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Masters M, 2009, RES MICROBIOL, V160, P267, DOI 10.1016/j.resmic.2009.04.002; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sparrer H, 1996, J MOL BIOL, V258, P74, DOI 10.1006/jmbi.1996.0235; Stan G, 2006, P NATL ACAD SCI USA, V103, P4433, DOI 10.1073/pnas.0600433103; TAGUCHI H, 1994, J BIOL CHEM, V269, P8529; Takemoto K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-98; Takusagawa F, 1996, J BIOL CHEM, V271, P136, DOI 10.1074/jbc.271.1.136; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tartaglia GG, 2010, J MOL BIOL, V400, P579, DOI 10.1016/j.jmb.2010.03.066; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wyganowski KT, 2013, J MOL BIOL, V425, P3403, DOI 10.1016/j.jmb.2013.06.028	38	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32073	32080		10.1074/jbc.M114.610444	http://dx.doi.org/10.1074/jbc.M114.610444			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288795	Green Published, hybrid			2022-12-25	WOS:000345314700036
J	Ozek, C; Kanoski, SE; Zhang, ZY; Grill, HJ; Bence, KK				Ozek, Ceren; Kanoski, Scott E.; Zhang, Zhong-Yin; Grill, Harvey J.; Bence, Kendra K.			Protein-tyrosine Phosphatase 1B (PTP1B) Is a Novel Regulator of Central Brain-derived Neurotrophic Factor and Tropomyosin Receptor Kinase B (TrkB) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-derived Neurotrophic Factor (BDNF); Hypothalamus; Metabolism; Phosphotyrosine Signaling; Receptor Tyrosine Kinase; Signal Transduction; Tyrosine-Protein Phosphatase (Tyrosine Phosphatase)	INSULIN SENSITIVITY; ENERGY-EXPENDITURE; BODY-WEIGHT; LEPTIN; BDNF; NUCLEUS; OBESITY; ADIPOSITY; DEPHOSPHORYLATION; DOWNSTREAM	Background: The tropomyosin receptor kinase B (TrkB) is a potential novel substrate of protein-tyrosine phosphatase 1B (PTP1B). Results: PTP1B associates with and plays a modulatory role in BDNF-induced TrkB signaling. Conclusion: PTP1B is a novel negative regulator of central BDNF/TrkB signaling. Significance: This is the first evidence that PTP1B deficiency enhances central TrkB signaling and alters BDNF-induced thermogenesis in vivo. Neuronal protein-tyrosine phosphatase 1B (PTP1B) deficiency in mice results in enhanced leptin signaling and protection from diet-induced obesity; however, whether additional signaling pathways in the brain contribute to the metabolic effects of PTP1B deficiency remains unclear. Here, we show that the tropomyosin receptor kinase B (TrkB) receptor is a direct PTP1B substrate and implicate PTP1B in the regulation of the central brain-derived neurotrophic factor (BDNF) signaling. PTP1B interacts with activated TrkB receptor in mouse brain and human SH-SY5Y neuroblastoma cells. PTP1B overexpression reduces TrkB phosphorylation and activation of downstream signaling pathways, whereas PTP1B inhibition augments TrkB signaling. Notably, brains of Ptpn1(-/-) mice exhibit enhanced TrkB phosphorylation, and Ptpn1(-/-) mice are hypersensitive to central BDNF-induced increase in core temperature. Taken together, our findings demonstrate that PTP1B is a novel physiological regulator of TrkB and that enhanced BDNF/TrkB signaling may contribute to the beneficial metabolic effects of PTP1B deficiency.	[Ozek, Ceren; Bence, Kendra K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Grill, Harvey J.] Univ Penn, Sch Arts & Sci, Dept Psychol, Philadelphia, PA 19104 USA; [Kanoski, Scott E.] Univ So Calif, Human & Evolutionary Biol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA; [Zhang, Zhong-Yin] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	University of Pennsylvania; University of Pennsylvania; University of Southern California; Indiana University System; Indiana University-Purdue University Indianapolis	Bence, KK (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	kbence@vet.upenn.edu		Bence, Kendra/0000-0002-5879-4726	National Institutes of Health [R01DK082417, R01DK021397, K01DK097147, R01CA69202]; University of Pennsylvania Diabetes Endocrinology Research Center Grant [5P30DK019525]; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082417, R01DK021397, K01DK097147, P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Diabetes Endocrinology Research Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK082417 (to K. K. B.), R01DK021397 (to H. J. G.), K01DK097147 (to S. E. K.), and R01CA69202 (to Z. Y. Z.) and University of Pennsylvania Diabetes Endocrinology Research Center Grant 5P30DK019525.	Ambjorn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065371; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Bariohay B, 2009, ENDOCRINOLOGY, V150, P2646, DOI 10.1210/en.2008-1184; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Boubekeur S, 2011, J BIOL CHEM, V286, P19373, DOI 10.1074/jbc.M111.222984; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cordeira J, 2011, MOL NEUROBIOL, V44, P441, DOI 10.1007/s12035-011-8212-2; De Jonghe BC, 2012, AM J PHYSIOL-ENDOC M, V303, pE644, DOI 10.1152/ajpendo.00009.2012; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Fuentes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041536; Gatto G, 2013, J NEUROSCI, V33, P5399, DOI 10.1523/JNEUROSCI.4707-12.2013; Godar R, 2011, NEUROSCIENCE, V194, P36, DOI 10.1016/j.neuroscience.2011.07.079; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kaszubska W, 2002, MOL CELL ENDOCRINOL, V195, P109, DOI 10.1016/S0303-7207(02)00178-8; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KLEIN R, 1990, DEVELOPMENT, V109, P845; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Ma YM, 2011, MOL CELL BIOCHEM, V357, P65, DOI 10.1007/s11010-011-0876-4; Morrison CD, 2007, ENDOCRINOLOGY, V148, P433, DOI 10.1210/en.2006-0672; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; Rusanescu G, 2005, EMBO J, V24, P305, DOI 10.1038/sj.emboj.7600522; Sharma S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00431; Spaeth AM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1252, DOI 10.1152/ajpendo.00025.2012; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tsou RC, 2014, MOL METAB, V3, P301, DOI 10.1016/j.molmet.2014.01.008; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Tsou RC, 2012, ENDOCRINOLOGY, V153, P4227, DOI 10.1210/en.2012-1548; Vanesvki F, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00037; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1037, DOI 10.1152/ajpregu.00125.2007; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR992, DOI 10.1152/ajpregu.00516.2006; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Wang CF, 2010, BRAIN RES, V1336, P66, DOI 10.1016/j.brainres.2010.04.013; Wang CF, 2010, AM J PHYSIOL-REG I, V298, pR1320, DOI 10.1152/ajpregu.00844.2009; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Woo J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-144; Wu CL, 2011, BIOCHEM J, V439, P151, DOI 10.1042/BJ20110799; Xie LP, 2003, BIOCHEMISTRY-US, V42, P12792, DOI 10.1021/bi035238p; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yan Q, 1997, J COMP NEUROL, V378, P135; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	58	40	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31682	31692		10.1074/jbc.M114.603621	http://dx.doi.org/10.1074/jbc.M114.603621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288805	hybrid, Green Published			2022-12-25	WOS:000345314700003
J	Bang, S; Kwon, H; Hwang, HS; Park, KD; Kim, SU; Bahn, YS				Bang, Soohyun; Kwon, Hyojeong; Hwang, Hyun Sook; Park, Ki Duk; Kim, Sung Uk; Bahn, Yong-Sun			9-O-butyl-13-(4-isopropylbenzyl)berberine, KR-72, Is a Potent Antifungal Agent That Inhibits the Growth of Cryptococcus neoformans by Regulating Gene Expression	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; OXYSTEROL-BINDING PROTEIN; MITOCHONDRIAL HSP70; YEAST HOMOLOG; GRPE; OVEREXPRESSION; CHAPERONIN-10; FLUCONAZOLE; RESISTANCE; BERBERINE	In this study we explored the mode of action of KR-72, a 9-O-butyl-13-(4-sopropylbenzyl)berberine derivative previously shown to exhibit potent antifungal activity against a variety of human fLingal pathogens. The DNA microarray data revealed that KR-72 treatment significantly changed the transcription profiles of C. neoformans, affecting the expression of more than 2,000 genes. Genes involved in translation and transcription were mostly upregulated, whereas those involved in the cytoskeleton, intracellular trafficking, and lipid metabolism were dovvnregulated. KR-72 also exhibited a strong synergistic effect with the antifungal agent FK506. KR-72 treatment regulated the expression of several essential genes, including ECM16, NOP14, HSP10 and MGE1 which are required for C. neoformans growth. The KR-72-mediated induction of MGE1 also likely reduced the viability of C. neaformans by impairing cell cycle or the DNA repair system. In conclusion, KR-72 showed antifungal activity by modulating diverse biological processes throLigh a mode of action distinct from those of clinically available antifLingal drugs such as polyene and azole drugs	[Bang, Soohyun; Kwon, Hyojeong; Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea; [Hwang, Hyun Sook; Park, Ki Duk] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Kim, Sung Uk] Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, Taejon, South Korea	Yonsei University; Korea Institute of Science & Technology (KIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, SU (corresponding author), Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, Taejon, South Korea.	kimsu@kribb.re.kr; ysbahn@yonsei.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752	National Research Foundation of Korea from MEST [2010-0029117]; Republic of Korea as well as a grant from the Technology Development Program [S2059210]; Korea Technology & Information Promotion Agency for Small and Medium Enterprises	National Research Foundation of Korea from MEST(National Research Foundation of Korea); Republic of Korea as well as a grant from the Technology Development Program; Korea Technology & Information Promotion Agency for Small and Medium Enterprises	This work was supported, in part, by the National Research Foundation of Korea Grants (No. 2010-0029117) from MEST (to Y.S.B.) in the Republic of Korea as well as a grant from the Technology Development Program (S2059210) for the use of research facilities funded by the Korea Technology & Information Promotion Agency for Small and Medium Enterprises (to S.U.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beh CT, 2001, GENETICS, V157, P1117; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Craig E, 1995, COLD SPRING HARB SYM, V60, P441, DOI 10.1101/SQB.1995.060.01.049; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; HOFMANN M, 1994, EUR J BIOCHEM, V221, P741, DOI 10.1111/j.1432-1033.1994.tb18787.x; HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305; IKEDA E, 1994, FEBS LETT, V339, P265, DOI 10.1016/0014-5793(94)80428-1; JIANG B, 1994, YEAST, V10, P341, DOI 10.1002/yea.320100307; Johnson MD, 2004, ANTIMICROB AGENTS CH, V48, P693, DOI 10.1128/AAC.48.3.693-715.2004; Jung KW, 2011, FUNGAL GENET BIOL, V48, P154, DOI 10.1016/j.fgb.2010.10.006; Kim MS, 2010, GENETICS, V185, P1207, DOI 10.1534/genetics.110.118315; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kontoyiannis DP, 1999, ANTIMICROB AGENTS CH, V43, P2798, DOI 10.1128/AAC.43.11.2798; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Marada A, 2013, MOL BIOL CELL, V24, P692, DOI 10.1091/mbc.E12-10-0719; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park KD, 2006, BIOORG MED CHEM LETT, V16, P3913, DOI 10.1016/j.bmcl.2006.05.033; Park KD, 2010, BIOORG MED CHEM LETT, V20, P6551, DOI 10.1016/j.bmcl.2010.09.045; Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667; Pentchev P G, 1997, Subcell Biochem, V28, P437; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; ROSPERT S, 1993, FEBS LETT, V335, P358, DOI 10.1016/0014-5793(93)80419-U; SCHMALIX WA, 1994, BBA-GENE STRUCT EXPR, V1219, P205, DOI 10.1016/0167-4781(94)90273-9; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Strub A, 2000, BIOL CHEM, V381, P943, DOI 10.1515/BC.2000.115; Upadhya R, 2013, MOL MICROBIOL, V90, P630, DOI 10.1111/mmi.12388; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1	37	6	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109863	10.1371/journal.pone.0109863	http://dx.doi.org/10.1371/journal.pone.0109863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302492	Green Published, Green Submitted, gold			2022-12-25	WOS:000343730400089
J	Chen, XJ; Stojanovic, A; Hua, YJ; Eidet, JR; Hu, D; Wang, JT; Utheim, TP				Chen, Xiangjun; Stojanovic, Aleksandar; Hua, Yanjun; Eidet, Jon Roger; Hu, Di; Wang, Jingting; Utheim, Tor Paaske			Reliability of Corneal Dynamic Scheimpflug Analyser Measurements in Virgin and Post-PRK Eyes	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; BIOMECHANICAL PROPERTIES; INTRAOCULAR-PRESSURE; REFRACTIVE SURGERY; RISK-FACTORS; DEFORMATION; KERATOCONUS; ELASTICITY; STIFFNESS; GLAUCOMA	Purpose: To determine the measurement reliability of CorVis ST, a dynamic Scheimpflug analyser, in virgin and postphotorefractive keratectomy (PRK) eyes and compare the results between these two groups. Methods: Forty virgin eyes and 42 post-PRK eyes underwent CorVis ST measurements performed by two technicians. Repeatability was evaluated by comparing three consecutive measurements by technician A. Reproducibility was determined by comparing the first measurement by technician A with one performed by technician B. Intraobserver and interobserver intraclass correlation coefficients (IC(s) were calculated. Univariate analysis of covariance (ANCOVA) was used to compare measured parameters between virgin and post-PRK eyes. Results: The intraocular pressure (IOP), central corneal thickness (CCT) and 1st applanation time demonstrated good intraobserver repeatability and interobserver reproducibility (ICC >= 0.90) in virgin and post-PRK eyes. The deformation amplitude showed a good or close to good repeatability and reproducibility in both groups (ICC >= 0.88). The (CT correlated positively with 1st applanation time (r 0.437 and 0.483, respectively, p<0.05) and negatively with deformation amplitude (r = -0.384 and -0.375, respectively, p<0.05) in both groups. Compared to post-PRK eyes, virgin eyes showed longer 1st applanation time (7.29 +/- 0.21 vs. 6.96 +/- 0.17 ms, p<0.05) and lower deformation amplitude (1.06 +/- 0.07 vs. 1.17 +/- 0.08 mm, p<0.05). Conclusions: CorVis ST demonstrated reliable measurements for CCT, IOP, and 1st applanation time, as well as relatively reliable measurement for deformation amplitude in both virgin and post-PRK eyes. There were differences in 1st applanation time and deformation amplitude between virgin and post-PRK eyes, which may reflect corneal biomechanical changes occurring after the surgery in the latter.	[Chen, Xiangjun; Stojanovic, Aleksandar] SynsLaser Kirurgi, Oslo, Norway; [Chen, Xiangjun; Stojanovic, Aleksandar] SynsLaser Kirurgi, Tromso, Norway; [Chen, Xiangjun; Stojanovic, Aleksandar] Univ Oslo, Oslo, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Eye Dept, Tromso, Norway; [Hua, Yanjun] Hubei Med Univ, Taihe Hosp, Dept Ophthalmol, Shijiazhuang, Hubei, Peoples R China; [Hua, Yanjun; Hu, Di; Wang, Jingting] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Hua, Yanjun; Hu, Di; Wang, Jingting] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Eidet, Jon Roger; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Tor Paaske] Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway	University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; Wenzhou Medical University; Wenzhou Medical University; University of Oslo; University of Oslo	Chen, XJ (corresponding author), SynsLaser Kirurgi, Oslo, Norway.	chenxiangjun1101@gmail.com	Stojanovic, Aleksandar/AAG-9933-2019	Chen, Xiangjun/0000-0003-0331-9028; HUA, YANJUN/0000-0001-6461-3576				Ali NQ, 2014, INVESTIGATIVE OPHTHA; Asejczyk-Widlicka M, 2008, BRIT J OPHTHALMOL, V92, P1415, DOI 10.1136/bjo.2008.140178; Boyce BL, 2008, BIOMATERIALS, V29, P3896, DOI 10.1016/j.biomaterials.2008.06.011; del Buey MA, 2009, INVEST OPHTH VIS SCI, V50, P3199, DOI 10.1167/iovs.08-3312; Dupps WJ, 2005, J REFRACT SURG, V21, P186; Elsheikh A, 2008, J REFRACT SURG, V24, P178, DOI 10.3928/1081597X-20080201-09; Elsheikh A, 2008, EXP EYE RES, V86, P445, DOI 10.1016/j.exer.2007.12.002; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Guirao A, 2005, J REFRACT SURG, V21, P176; Han ZL, 2014, J REFRACT SURG, V30, P208, DOI 10.3928/1081597X-20140212-02; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Kida T, 2008, AM J OPHTHALMOL, V146, P567, DOI 10.1016/j.ajo.2008.05.026; Klein SR, 2006, CORNEA, V25, P388, DOI 10.1097/01.ico.0000222479.68242.77; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P5078, DOI 10.1167/iovs.13-12509; Leung CKS, 2013, INVEST OPHTH VIS SCI, V54, P2885, DOI 10.1167/iovs.12-11563; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; NASH IS, 1982, EXP EYE RES, V35, P413, DOI 10.1016/0014-4835(82)90040-9; Nemeth G, 2013, J REFRACT SURG, V29, P558, DOI 10.3928/1081597X-20130719-06; Ortiz D, 2007, J CATARACT REFR SURG, V33, P1371, DOI 10.1016/j.jcrs.2007.04.021; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Reznicek L, 2013, BRIT J OPHTHALMOL, V97, P1410, DOI 10.1136/bjophthalmol-2013-303400; Roberts C, 2005, J CATARACT REFR SURG, V31, P2, DOI 10.1016/j.jcrs.2004.11.032; Roy AS, 2013, INDIAN J OPHTHALMOL, V61, P392, DOI 10.4103/0301-4738.116057; Roy AS, 2009, J REFRACT SURG, V25, P875, DOI 10.3928/1081597X-20090917-09; Shen Y, 2014, J REFRACT SURG, V30, P310, DOI 10.3928/1081597X-20140422-01; Sullivan-Mee M, 2008, OPTOMETRY VISION SCI, V85, P463, DOI 10.1097/OPX.0b013e3181784673	26	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109577	10.1371/journal.pone.0109577	http://dx.doi.org/10.1371/journal.pone.0109577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302580	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400068
J	Craiem, D; Chironi, G; Casciaro, ME; Graf, S; Simon, A				Craiem, Damian; Chironi, Gilles; Casciaro, Mariano E.; Graf, Sebastian; Simon, Alain			Calcifications of the Thoracic Aorta on Extended Non-Contrast-Enhanced Cardiac CT	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; HEINZ NIXDORF RECALL; ALL-CAUSE MORTALITY; COMPUTED-TOMOGRAPHY; ATHEROSCLEROSIS MESA; HEART-DISEASE; RISK-FACTORS; BLOOD-FLOW; ARCH; POPULATION	Background: The presence of calcified atherosclerosis in different vascular beds has been associated with a higher risk of mortality. Thoracic aorta calcium (TAC) can be assessed from computed tomography (CT) scans, originally aimed at coronary artery calcium (C AC) assessment. CAC screening improves cardiovascular risk prediction, beyond standard risk assessment, whereas TAC performance remains controversial. However, the curvilinear portion of the thoracic aorta (TA), that includes the aortic arch, is systematically excluded from TAC analysis. We investigated the prevalence and spatial distribution of TAC all along the TA, to see how those segments that remain invisible in standard TA evaluation were affected. Methods and Results: A total of 970 patients (77% men) underwent extended non-contrast cardiac CT scans including the aortic arch. An automated algorithm was designed to extract the vessel centerline and to estimate the vessel diameter in perpendicular planes. Then, calcifications were quantified using the Agatston score and associated with the corresponding thoracic aorta segment. The aortic arch and the proximal descending aorta, "invisible" in routine CAC screening, appeared as two vulnerable sites concentrating 60% of almost 11000 calcifications. The aortic arch was the most affected segment per cm length. Using the extended measurement method, TAC prevalence doubled from 31% to 64%, meaning that 52% of patients would escape detection with a standard scan. In a stratified analysis for CAC and/or TAC assessment, 111 subjects (46% women) were exclusively identified with the enlarged scan. Conclusions: Calcium screening in the TA revealed that the aortic arch and the proximal descending aorta, hidden in standard TA evaluations, concentrated most of the calcifications. Middle-aged women were more prone to have calcifications in those hidden portions and became candidates for reclassification.	[Craiem, Damian; Casciaro, Mariano E.; Graf, Sebastian] Favaloro Univ, Fac Ingn Ciencias Exactas & Nat, CONICET, RA-1033 Buenos Aires, DF, Argentina; [Craiem, Damian; Chironi, Gilles; Simon, Alain] Univ Paris 05, INSERM U970, Hop Europ Georges Pompidou, AP HP, Paris, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Craiem, D (corresponding author), Favaloro Univ, Fac Ingn Ciencias Exactas & Nat, CONICET, RA-1033 Buenos Aires, DF, Argentina.	dcraiem@favaloro.edu.ar	Craiem, Damian/AAN-1069-2021; Casciaro, Mariano/AAS-3757-2021	Craiem, Damian/0000-0003-1065-799X; Casciaro, Mariano/0000-0001-6793-1502	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Grant PIP [11220090100734]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Grant PIP	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (www.conicet.gov.ar), Grant PIP number 11220090100734. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Agmon Y, 2000, CIRCULATION, V102, P2087, DOI 10.1161/01.CIR.102.17.2087; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Budoff MJ, 2011, ATHEROSCLEROSIS, V215, P196, DOI 10.1016/j.atherosclerosis.2010.11.017; Cohen A, 1997, CIRCULATION, V96, P3838; Craiem D, 2013, J HUM HYPERTENS, V27, P504, DOI 10.1038/jhh.2012.69; Craiem D, 2012, ANN BIOMED ENG, V40, P1028, DOI 10.1007/s10439-011-0487-y; de Jong PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102036; Demertzis S, 2010, J ANAT, V217, P588, DOI 10.1111/j.1469-7580.2010.01297.x; Erbel R, 2008, EUR HEART J, V29, P2782, DOI 10.1093/eurheartj/ehn439; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; GIDDENS DP, 1993, J BIOMECH ENG-T ASME, V115, P588, DOI 10.1115/1.2895545; Hartnell GG, 2001, J THORAC IMAG, V16, P35, DOI 10.1097/00005382-200101000-00006; Itani Y, 2004, CIRC J, V68, P538, DOI 10.1253/circj.68.538; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Kalsch H, 2013, INT J CARDIOVAS IMAG, V29, P207, DOI 10.1007/s10554-012-0051-3; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Liu X, 2009, AM J PHYSIOL-HEART C, V297, pH163, DOI 10.1152/ajpheart.00266.2009; Nasir K, 2007, ARTERIOSCL THROM VAS, V27, P1220, DOI 10.1161/ATVBAHA.107.140079; Rivera JJ, 2009, AM J CARDIOL, V103, P1562, DOI 10.1016/j.amjcard.2009.02.004; Santos RD, 2010, ATHEROSCLEROSIS, V209, P131, DOI 10.1016/j.atherosclerosis.2009.08.025; Shahcheraghi N, 2002, J BIOMECH ENG-T ASME, V124, P378, DOI 10.1115/1.1487357; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; TAKASU J, 1992, ATHEROSCLEROSIS, V97, P107, DOI 10.1016/0021-9150(92)90124-Y; Vincent PE, 2011, J R SOC INTERFACE, V8, P1708, DOI 10.1098/rsif.2011.0116; Voros S, 2011, J CARDIOVASC COMPUT, V5, P75, DOI 10.1016/j.jcct.2011.01.003; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong ND, 2009, JACC-CARDIOVASC IMAG, V2, P319, DOI 10.1016/j.jcmg.2008.12.010; Wong ND, 2003, AM J CARDIOL, V92, P951, DOI 10.1016/S0002-9149(03)00976-7; Yeboah J, 2013, EUR J PREV CARDIOL; Zhu Dongxing, 2012, Front Endocrinol (Lausanne), V3, P95, DOI 10.3389/fendo.2012.00095	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109584	10.1371/journal.pone.0109584	http://dx.doi.org/10.1371/journal.pone.0109584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302677	gold, Green Published, Green Submitted			2022-12-25	WOS:000343730400069
J	Dunkel, IJ; Shi, WJ; Salvaggio, K; Marr, BP; Brodie, SE; Gobin, YP; Abramson, DH				Dunkel, Ira J.; Shi, Weiji; Salvaggio, Kim; Marr, Brian P.; Brodie, Scott E.; Gobin, Y. Pierre; Abramson, David H.			Risk Factors for Severe Neutropenia following Intra-Arterial Chemotherapy for Intra-Ocular Retinoblastoma	PLOS ONE			English	Article								Purpose: Intra-arterial chemotherapy is a promising strategy for intra-ocular retinoblastoma. Neutropenia is the most commonly encountered systemic toxicity and in this study we aimed to determine the risk factors associated with the development of severe (>= grade 3) neutropenia. Methods: Retrospective review of 187 evaluable cycles of melphalan-containing intra-arterial chemotherapy from the first three cycles administered to 106 patients with intra-ocular retinoblastoma from May 2006 to June 2011. Cycles were considered to be evaluable if (1) blood count results were available in the 7 to 14 days post-treatment interval and (2) concurrent intravenous chemotherapy was not administered. Toxicity was assessed via the Common Terminology Criteria for Adverse Events version 4.0. Results: 54 cycles (29%) were associated with grade 3 (n = 43) or grade 4 (n = 11) neutropenia. Multivariate stepwise logistic regression revealed that a higher melphalan dose (>0.40 mg/kg) was significantly associated with severe neutropenia during all 3 cycles (odds ratio during cycle one 4.11, 95% confidence interval 1.33-12.73, p = 0.01), but the addition of topotecan and/or carboplatin were not. Prior treatment with systemic chemotherapy was not associated with severe neutropenia risk in any analysis. Conclusions: Intra-arterial melphalan-based chemotherapy can cause severe neutropenia, especially when a dose of greater than 0.40 mg/kg is administered. Further study with a larger sample may be warranted.	[Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Shi, Weiji] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Salvaggio, Kim; Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA; [Marr, Brian P.; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Marr, Brian P.; Abramson, David H.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brodie, Scott E.] Mt Sinai Med Ctr, Dept Ophthalmol, New York, NY 10029 USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Icahn School of Medicine at Mount Sinai	Dunkel, IJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	dunkeli@mskcc.org		Dunkel, Ira/0000-0001-8091-6067	Perry's Promise Fund	Perry's Promise Fund	This work was supported by Perry's Promise Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; REESE AB, 1955, ARCH OPHTHALMOL-CHIC, V53, P505; Schaiquevich P, 2012, INVEST OPHTH VIS SCI, V53, P4205, DOI 10.1167/iovs.12-9501; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013	6	27	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108692	10.1371/journal.pone.0108692	http://dx.doi.org/10.1371/journal.pone.0108692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303673	Green Published, gold, Green Submitted			2022-12-25	WOS:000343730400022
J	Kan, YJ; Danner, EW; Israelachvili, JN; Chen, YF; Waite, JH				Kan, Yajing; Danner, Eric W.; Israelachvili, Jacob N.; Chen, Yunfei; Waite, J. Herbert			Boronate Complex Formation with Dopa Containing Mussel Adhesive Protein Retards pH-Induced Oxidation and Enables Adhesion to Mica	PLOS ONE			English	Article							CROSS-LINKING; STRUCTURAL PROTEINS; CATECHOL; SURFACES; CHEMISTRY; MECHANISM; DYNAMICS; COATINGS; DENSITY; BORATE	The biochemistry of mussel adhesion has inspired the design of surface primers, adhesives, coatings and gels for technological applications. These mussel-inspired systems often focus on incorporating the amino acid 3,4-dihydroxyphenyl-L-alanine (Dopa) or a catecholic analog into a polymer. Unfortunately, effective use of Dopa is compromised by its susceptibility to auto-oxidation at neutral pH. Oxidation can lead to loss of adhesive function and undesired covalent cross-linking. Mussel foot protein 5 (Mfp-5), which contains similar to 30 mole % Dopa, is a superb adhesive under reducing conditions but becomes nonadhesive after pH-induced oxidation. Here we report that the bidentate complexation of borate by Dopa to form a catecholato-boronate can be exploited to retard oxidation. Although exposure of Mfp-5 to neutral pH typically oxidizes Dopa, resulting in a>95% decrease in adhesion, inclusion of borate retards oxidation at the same pH. Remarkably, this Dopa-boronate complex dissociates upon contact with mica to allow for a reversible Dopa-mediated adhesion. The borate protection strategy allows for Dopa redox stability and maintained adhesive function in an otherwise oxidizing environment.	[Kan, Yajing; Chen, Yunfei] Southeast Univ, Jiangsu Key Lab Design & Mfg Micronano Biomed Ins, Nanjing, Jiangsu, Peoples R China; [Kan, Yajing; Chen, Yunfei] Southeast Univ, Sch Mech Engn, Nanjing, Jiangsu, Peoples R China; [Danner, Eric W.; Waite, J. Herbert] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Kan, Yajing; Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Southeast University - China; Southeast University - China; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Chen, YF (corresponding author), Southeast Univ, Jiangsu Key Lab Design & Mfg Micronano Biomed Ins, Nanjing, Jiangsu, Peoples R China.	yunfeichen@seu.edu.cn; waite@lifesci.ucsb.edu	Chen, Yunfei/H-7820-2014; Kan, Yajing/A-9249-2015; wang, xingsong/C-5189-2009	Chen, Yunfei/0000-0002-8682-868X; , Eric/0000-0003-3277-5727	National Institutes of Health [R01 DE018468]; Materials Research Science and Engineering Centers Program of the National Science Foundation [DMR 1121053]; National Basic Research Program of China [2011CB707605]; MRSEC Program of the National Science Foundation [DMR 1121053]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Materials Research Science and Engineering Centers Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Basic Research Program of China(National Basic Research Program of China); MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the National Institutes of Health (R01 DE018468), Materials Research Science and Engineering Centers Program of the National Science Foundation under Award DMR 1121053, and the National Basic Research Program of China (2011CB707605). This work was partially supported by the MRSEC Program of the National Science Foundation under Award No. DMR 1121053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan Y, 2014, ANGEW CHEM INT EDIT, V53, P11253, DOI 10.1002/anie.201406858; Argust P, 1998, BIOL TRACE ELEM RES, V66, P131, DOI 10.1007/BF02783133; BABCOCK L, 1980, INORG CHEM, V19, P56, DOI 10.1021/ic50203a013; BABCOCK L, 1983, INORG CHEM, V22, P174, DOI 10.1021/ic00143a038; BOLT GH, 1957, J PHYS CHEM-US, V61, P1166, DOI 10.1021/j150555a007; Chough S.K., 2000, MARINE GEOLOGY KOREA; Danner EW, 2012, BIOCHEMISTRY-US, V51, P6511, DOI 10.1021/bi3002538; EASTERDAY O, 1961, J PHARMACOL EXP THER, V132, P392; Faghihnejad A, 2013, LANGMUIR, V29, P12443, DOI 10.1021/la402244h; Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; He LH, 2011, CHEM COMMUN, V47, P7497, DOI 10.1039/c1cc11928a; Israelachvili J, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/3/036601; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; JANG HG, 1991, J AM CHEM SOC, V113, P9200, DOI 10.1021/ja00024a028; Joslyn MA, 1935, J AM CHEM SOC, V57, P1779, DOI 10.1021/ja01313a007; Kosmulski M, 2009, J COLLOID INTERF SCI, V337, P439, DOI 10.1016/j.jcis.2009.04.072; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Li SC, 2010, SCIENCE, V328, P882, DOI 10.1126/science.1188328; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Lu QY, 2013, ANGEW CHEM INT EDIT, V52, P3944, DOI 10.1002/anie.201210365; Lu QY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0759; McDowell LM, 1999, J BIOL CHEM, V274, P20293, DOI 10.1074/jbc.274.29.20293; Menyo MS, 2013, SOFT MATTER, V9, P10314, DOI [10.1039/C3SM51824H, 10.1039/c3sm51824h]; Miserez A, 2010, J BIOL CHEM, V285, P38115, DOI 10.1074/jbc.M110.161174; Nakahata M, 2014, ACS MACRO LETT, V3, P337, DOI 10.1021/mz500035w; PIZER R, 1977, INORG CHEM, V16, P1677, DOI 10.1021/ic50173a021; Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343; Shafiq Z, 2012, ANGEW CHEM INT EDIT, V51, P4332, DOI 10.1002/anie.201108629; Su J, 2011, J AM CHEM SOC, V133, P11850, DOI 10.1021/ja203077x; Vatankhah-Varnoosfaderani M, 2014, POLYM CHEM-UK, V5, P512, DOI 10.1039/c3py00788j; Vatankhah-Varnoosfaderani M, 2013, CHEM COMMUN, V49, P4685, DOI 10.1039/c3cc41332b; WAITE JH, 1985, BIOCHEMISTRY-US, V24, P5010, DOI 10.1021/bi00340a008; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; WAITE JH, 1984, METHOD ENZYMOL, V107, P397; Wang DW, 2011, J AM CHEM SOC, V133, P2192, DOI 10.1021/ja108154a; Wang JJ, 2008, ADV MATER, V20, P3872, DOI 10.1002/adma.200801140; YATES DE, 1980, J CHEM SOC FARAD T 1, V76, P9, DOI 10.1039/f19807600009; YOSHINO K, 1979, B CHEM SOC JPN, V52, P3005, DOI 10.1246/bcsj.52.3005; Young GA, 1982, APPL SCI, V6, P13; Yu J, 2013, BIOMACROMOLECULES, V14, P1072, DOI 10.1021/bm301908y; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]; Yu J, 2011, ADV MATER, V23, P2362, DOI 10.1002/adma.201003580; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200	46	38	40	7	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108869	10.1371/journal.pone.0108869	http://dx.doi.org/10.1371/journal.pone.0108869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303409	Green Published, gold			2022-12-25	WOS:000343730400032
J	Santos, DMV; Katzmarzyk, PT; Diego, VP; Blangero, J; Souza, MC; Freitas, DL; Chaves, RN; Gomes, TN; Santos, FK; Maia, JAR				Santos, Daniel M. V.; Katzmarzyk, Peter T.; Diego, Vincent P.; Blangero, John; Souza, Michele C.; Freitas, Duarte L.; Chaves, Raquel N.; Gomes, Thayse N.; Santos, Fernanda K.; Maia, Jose A. R.			Genotype by Sex and Genotype by Age Interactions with Sedentary Behavior: The Portuguese Healthy Family Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; RECEPTOR GENE; QUEBEC FAMILY; ADULTS; INACTIVITY; ADIPOSITY; PEDIGREES; CHILDREN; LOCUS	Sedentary behavior (SB) expression and its underlying causal factors have been progressively studied, as it is a major determinant of decreased health quality. In the present study we applied Genotype x Age (GxAge) and Genotype x Sex (GxSex) interaction methods to determine if the phenotypic expression of different SB traits is influenced by an interaction between genetic architecture and both age and sex. A total of 1345 subjects, comprising 249 fathers, 327 mothers, 334 sons and 325 daughters, from 339 families of The Portuguese Healthy Family Study were included in the analysis. SB traits were assessed by means of a 3-d physical activity recall, the Baecke and IPAQ questionnaires. GxAge and GxSex interactions were analyzed using SOLAR 4.0 software. Sedentary behaviour heritability estimates were not always statistically significant (p>0.05) and ranged from 3% to 27%. The GxSex and GxAge interaction models were significantly better than the single polygenic models for TV (min/day), EEsed (kcal/day), personal computer (PC) usage and physical activty (PA) tertiles. The GxAge model is also significantly better than the polygenic model for Sed (min/day). For EEsed, PA tertiles, PC and Sed, the GxAge interaction was significant because the genetic correlation between SB environments was significantly different from 1. Further, PC and Sed variance heterogeneity among distinct ages were observed. The GxSex interaction was significant for EEsed due to genetic variance heterogeneity between genders and for PC due to a genetic correlation less than 1 across both sexes. Our results suggest that SB expression may be influenced by the interactions between genotype with both sex and age. Further, different sedentary behaviors seem to have distinct genetic architectures and are differentially affected by age and sex.	[Santos, Daniel M. V.; Souza, Michele C.; Gomes, Thayse N.; Santos, Fernanda K.; Maia, Jose A. R.] Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, P-4100 Oporto, Portugal; [Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Diego, Vincent P.; Blangero, John] Texas Biomed Res Inst, San Antonio, TX USA; [Freitas, Duarte L.] Univ Madeira, Sport & Phys Educ Dept, Funchal, Portugal; [Chaves, Raquel N.] Univ Tecnol Fed Parana, Dept Phys Educ, Curitiba, Parana, Brazil	Universidade do Porto; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Texas Biomedical Research Institute; Universidade da Madeira; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana	Santos, DMV (corresponding author), Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	d.monteiro.santos13@gmail.com	de Souza Ribas, Michele/AAG-5110-2021; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020; Katzmarzyk, Peter T/N-1974-2017; Blangero, John/ABA-7175-2021; de Freitas, Duarte Luís/V-7590-2019	Katzmarzyk, Peter T/0000-0002-9280-6022; de Freitas, Duarte Luís/0000-0001-6642-3370; Santos, Daniel/0000-0001-8193-4689; Blangero, John/0000-0001-6250-5723; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238	FCT - Fundacao para a Ciencia e a Tecnologia [PTDC/DES/67569/2006 FCOMP-01-0124-FEDEB-09608]	FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by the FCT - Fundacao para a Ciencia e a Tecnologia (www.fct.pt): PTDC/DES/67569/2006 FCOMP-01-0124-FEDEB-09608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 2004, CHILDR PEER REL DEV, Vxvi; Blangero J, 2009, HUM BIOL, V81, P523, DOI 10.3378/027.081.0603; Blangero J, 2013, ADV GENET, V81, P1, DOI 10.1016/B978-0-12-407677-8.00001-4; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Butte NF, 2006, AM J CLIN NUTR, V84, P646, DOI 10.1093/ajcn/84.3.646; Cai GW, 2006, OBESITY, V14, P1596, DOI 10.1038/oby.2006.184; Casper JM, 2013, ANN BEHAV MED, V45, pS49, DOI 10.1007/s12160-012-9435-9; Christensen U, 2006, SCAND J MED SCI SPOR, V16, P245, DOI 10.1111/j.1600-0838.2005.00459.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Santos DMDE, 2012, BEHAV GENET, V42, P559, DOI 10.1007/s10519-012-9534-1; Diego VP, 2007, AM J HUM GENET, V80, P168, DOI 10.1086/510497; Diego VP, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S34; Diego VP, 2005, GENOTYPE X AGE INTER, P317; Durnin J., 1967, ENERGY WORK LEISURE; Fisher A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010110; Gopinath B, 2012, PEDIATRICS, V130, pE167, DOI 10.1542/peds.2011-3637; Gretebeck RJ, 2012, AM J HEALTH BEHAV, V36, P385, DOI 10.5993/AJHB.36.3.9; Hoed M. D., 2013, AM J CLIN NUTR, V98, P1317; Horimoto AR, 2011, BMC MED GENET, V12, P155, DOI DOI 10.1186/1471-2350-12-155; Judice PB, 2014, J SPORT SCI, V32, P1760, DOI 10.1080/02640414.2014.926382; Katzmarzyk PT, 1998, PEDIATR EXERC SCI, V10, P378, DOI 10.1123/pes.10.4.378; Kesse-Guyot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047831; Klinker Charlotte D, 2014, Int J Behav Nutr Phys Act, V11, P8, DOI 10.1186/1479-5868-11-8; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loos RJF, 2005, INT J OBESITY, V29, P420, DOI 10.1038/sj.ijo.0802869; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Rosa M. J. V., 2010, PORTUGAL NUMEROS; Salvy SJ, 2008, J PEDIATR PSYCHOL, V33, P39, DOI 10.1093/jpepsy/jsm039; Simonen RL, 2003, PHYSIOL BEHAV, V78, P751, DOI 10.1016/S0031-9384(03)00084-2; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110025	10.1371/journal.pone.0110025	http://dx.doi.org/10.1371/journal.pone.0110025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302714	Green Submitted, Green Published, gold			2022-12-25	WOS:000343730400102
J	Yang, N; Hu, F; Zhou, LX; Tang, JJ				Yang, Ning; Hu, Fei; Zhou, Lingxi; Tang, Jijun			Reconstruction of Ancestral Gene Orders Using Probabilistic and Gene Encoding Approaches	PLOS ONE			English	Article							HALVING PROBLEMS; GENOME; SEQUENCES; EVOLUTION	Current tools used in the reconstruction of ancestral gene orders often fall into event-based and adjacency-based methods according to the principles they follow. Event-based methods such as GRAPPA are very accurate but with extremely high complexity, while more recent methods based on gene adjacencies such as InferCARsPro is relatively faster, but often produces an excessive number of chromosomes. This issue is mitigated by newer methods such as GapAdj, however it sacrifices a considerable portion of accuracy. We recently developed an adjacency-based method in the probabilistic framework called PMAG to infer ancestral gene orders. PMAG relies on calculating the conditional probabilities of gene adjacencies that are found in the leaf genomes using the Bayes' theorem. It uses a novel transition model which accounts for adjacency changes along the tree branches as well as a re-rooting procedure to prevent any information loss. In this paper, we improved PMAG with a new method to assemble gene adjacencies into valid gene orders, using an exact solver for traveling salesman problem (TSP) to maximize the overall conditional probabilities. We conducted a series of simulation experiments using a wide range of configurations. The first set of experiments was to verify the effectiveness of our strategy of using the better transition model and re-rooting the tree under the targeted ancestral genome. PMAG was then thoroughly compared in terms of three measurements with its four major competitors including InferCARsPro, GapAdj, GASTS and SCJ in order to assess their performances. According to the results, PMAG demonstrates superior performance in terms of adjacency, distance and assembly accuracies, and yet achieves comparable running time, even all TSP instances were solved exactly. PMAG is available for free at http://phylo.cse.sc.edu.	[Hu, Fei; Zhou, Lingxi; Tang, Jijun] Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China; [Hu, Fei; Zhou, Lingxi; Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Yang, Ning] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi, Peoples R China	Tianjin University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Northwestern Polytechnical University	Tang, JJ (corresponding author), Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China.	jtang@cse.sc.edu	Tang, Jijun/ABH-6528-2020		NSF [IIS 1161586]; Tianjin University, China	NSF(National Science Foundation (NSF)); Tianjin University, China	The authors were funded by NSF IIS 1161586 and an internal grant from Tianjin University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyev MA, 2009, GENOME RES, V19, P943, DOI 10.1101/gr.082784.108; Applegate D., 2003, CONCORDE TSP SOLVER; Biller P, 2013, IEEE ACM T COMPUT BI, V10, P122, DOI 10.1109/TCBB.2012.168; Bourque G, 2002, GENOME RES, V12, P26; Caprara A., 1999, P 3 ANN INT C COMP M, P84; Feijao P, 2009, LECT N BIOINFORMAT, V5724, P85, DOI 10.1007/978-3-642-04241-6_8; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gagnon Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S4; Hannenhalli S., 1995, Proceedings of the Twenty-Seventh Annual ACM Symposium on the Theory of Computing, P178, DOI 10.1145/225058.225112; Hu F., 2011, P 8 IEEE S COMP BIOI, P117; Hu F, 2011, P 9 INT S BIOINF RES, P17; Jahn K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S8; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Lin Y, 2011, J COMPUT BIOL, V18, P1131, DOI 10.1089/cmb.2011.0114; Lin Yu, 2013, Pac Symp Biocomput, P285; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Ma J, 2010, IEEE INT C BIOINFORM, P179, DOI 10.1109/BIBM.2010.5706559; Moret B M, 2001, Pac Symp Biocomput, P583; Muller K, 2008, PLANT BIOLOGY, V6, P477; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tang JJ, 2005, BIBE 2005: 5TH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, P137; Tannier E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-120; Tesler G, 2002, J COMPUT SYST SCI, V65, P587, DOI 10.1016/S0022-0000(02)00011-9; Xu Andrew Wei, 2011, Algorithms in Bioinformatics. Proceedings of the 11th International Workshop, WABI 2011, P351, DOI 10.1007/978-3-642-23038-7_29; Xu AW, 2008, 8 INT WORKSH ALG BIO, P25; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535; YANG ZH, 1995, GENETICS, V141, P1641	27	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108796	10.1371/journal.pone.0108796	http://dx.doi.org/10.1371/journal.pone.0108796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302942	Green Published, gold			2022-12-25	WOS:000343730400027
J	Radosevich, AJ; Mutyal, NN; Rogers, JD; Gould, B; Hensing, TA; Ray, D; Backman, V; Roy, HK				Radosevich, Andrew J.; Mutyal, Nikhil N.; Rogers, Jeremy D.; Gould, Bradley; Hensing, Thomas A.; Ray, Daniel; Backman, Vadim; Roy, Hemant K.			Buccal Spectral Markers for Lung Cancer Risk Stratification	PLOS ONE			English	Article							ENHANCED BACKSCATTERING; BRONCHIAL EPITHELIUM; OPTICAL-PROPERTIES; GENE-EXPRESSION; SPECTROSCOPY; SMOKING; SMOKERS; AIRWAY	Lung cancer remains the leading cause of cancer deaths in the US with >150,000 deaths per year. In order to more effectively reduce lung cancer mortality, more sophisticated screening paradigms are needed. Previously, our group demonstrated the use of low-coherence enhanced backscattering (LEBS) spectroscopy to detect and quantify the micro/nano-architectural correlates of colorectal and pancreatic field carcinogenesis. In the lung, the buccal (cheek) mucosa has been suggested as an excellent surrogate site in the "field of injury". We, therefore, wanted to assess whether LEBS could similarly sense the presence of lung. To this end, we applied a fiber-optic LEBS probe to a dataset of 27 smokers without diagnosed lung cancer (controls) and 46 with lung cancer (cases), which was divided into a training and a blinded validation set (32 and 41 subjects, respectively). LEBS readings of the buccal mucosa were taken from the oral cavity applying gentle contact. The diagnostic LEBS marker was notably altered in patients harboring lung cancer compared to smoking controls. The prediction rule developed on training set data provided excellent diagnostics with 94% sensitivity, 80% specificity, and 95% accuracy. Applying the same threshold to the blinded validation set yielded 79% sensitivity and 83% specificity. These results were not confounded by patient demographics or impacted by cancer type or location. Moreover, the prediction rule was robust across all stages of cancer including stage I. We envision the use of LEBS as the first part of a two-step paradigm shift in lung cancer screening in which patients with high LEBS risk markers are funnelled into more invasive screening for confirmation.	[Radosevich, Andrew J.; Mutyal, Nikhil N.; Gould, Bradley; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Rogers, Jeremy D.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Hensing, Thomas A.; Ray, Daniel] NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA; [Roy, Hemant K.] Boston Univ, Dept Med, Boston, MA 02215 USA	Northwestern University; University of Wisconsin System; University of Wisconsin Madison; NorthShore University Health System; Boston University	Radosevich, AJ (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	arad@u.northwestern.edu	Backman, Vadim/B-6689-2009; Rogers, Jeremy/A-4572-2008; Roy, Hemant/AAC-9096-2020	Rogers, Jeremy/0000-0003-3049-2803; 	National Institutes of Health [R01CA128641, R01CA155284]; National Science Foundation [CBET-1240416]; National Science Foundation Graduate Research Fellowship [DGE-0824162]; NATIONAL CANCER INSTITUTE [R01CA128641, R01CA155284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was made possible by National Institutes of Health grants R01CA128641, R01CA155284 and National Science Foundation grant CBET-1240416. AJR is supported by a National Science Foundation Graduate Research Fellowship under Grant No. DGE-0824162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsky SH, 1998, JNCI-J NATL CANCER I, V90, P1198, DOI 10.1093/jnci/90.16.1198; Blomquist T, 2009, CANCER RES, V69, P8629, DOI 10.1158/0008-5472.CAN-09-1568; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Cherkezyan L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-189; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Ishimaru A., 1997, WAVE PROPAGATION SCA; Kim YL, 2005, APPL OPTICS, V44, P366, DOI 10.1364/AO.44.000366; Kim YL, 2004, OPT LETT, V29, P1906, DOI 10.1364/OL.29.001906; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Metze K, 2013, EXPERT REV MOL DIAGN, V13, P719, DOI 10.1586/14737159.2013.828889; Mutyal NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057206; Mutyal NN, 2012, OPT EXPRESS, V20, P19643, DOI 10.1364/OE.20.019643; Radosevich AJ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.097002; Radosevich AJ, 2012, IEEE J SEL TOP QUANT, V18, P1313, DOI 10.1109/JSTQE.2011.2173659; Radosevich AJ, 2011, OPT LETT, V36, P4737, DOI 10.1364/OL.36.004737; Rogers JD, 2014, SELECTED TOPICS QUAN, V20, P1; Rogers JD, 2011, OPT EXPRESS, V19, P11922, DOI 10.1364/OE.19.011922; Rogers JD, 2009, OPT LETT, V34, P1891, DOI 10.1364/OL.34.001891; Roy HK, 2010, CANCER RES, V70, P7748, DOI 10.1158/0008-5472.CAN-10-1686; Roy HK, 2009, CANCER RES, V69, P4476, DOI 10.1158/0008-5472.CAN-08-4780; Sanz-Ortega J, 2007, HISTOL HISTOPATHOL, V22, P541, DOI 10.14670/HH-22.541; Sidransky D, 2008, CANCER PREV RES, V1, P12, DOI 10.1158/1940-6207.CAPR-08-0093; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Spira A, 2010, CANCER PREV RES, V3, P255, DOI 10.1158/1940-6207.CAPR-10-0013; Sridhar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-259; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Turzhitsky V, 2011, J BIOMED OPT; Turzhitsky V, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3625402; Turzhitsky V, 2010, BIOMED OPT EXPRESS, V1, P1034, DOI 10.1364/BOE.1.001034; Turzhitsky V, 2008, DIS MARKERS, V25, P313, DOI 10.1155/2008/958214; Yi J, 2014, J BIOM IN PRESS 1702	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110157	10.1371/journal.pone.0110157	http://dx.doi.org/10.1371/journal.pone.0110157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299667	gold, Green Published			2022-12-25	WOS:000343941200105
J	Zhang, M; Mahoney, E; Zuo, T; Manchanda, PK; Davuluri, RV; Kirschner, LS				Zhang, Mei; Mahoney, Emilia; Zuo, Tao; Manchanda, Parmeet K.; Davuluri, Ramana V.; Kirschner, Lawrence S.			Protein Kinase A Activation Enhances beta-Catenin Transcriptional Activity through Nuclear Localization to PML Bodies	PLOS ONE			English	Article							INHIBITS OSTEOGENIC DIFFERENTIATION; MCCUNE-ALBRIGHT SYNDROME; MESENCHYMAL STEM-CELLS; CARNEY COMPLEX; CYCLIC-AMP; OSTEOBLASTIC CELLS; WNT; PATHWAY; PHOSPHORYLATION; PROLIFERATION	The Protein Kinase A (PKA) and Wnt signaling cascades are fundamental pathways involved in cellular development and maintenance. In the osteoblast lineage, these pathways have been demonstrated functionally to be essential for the production of mineralized bone. Evidence for PKA-Wnt crosstalk has been reported both during tumorigenesis and during organogenesis, and the nature of the interaction is thought to rely on tissue and cell context. In this manuscript, we analyzed bone tumors arising from mice with activated PKA caused by mutation of the PKA regulatory subunit Prkar1a. In primary cells from these tumors, we observed relocalization of beta-catenin to intranuclear punctuate structures, which were identified as PML bodies. Cellular redistribution of beta-catenin could be recapitulated by pharmacologic activation of PKA. Using 3T3-E1 pre-osteoblasts as a model system, we found that PKA phosphorylation sites on beta-catenin were required for nuclear re-localization. Further, beta-catenin's transport to the nucleus was accompanied by an increase in canonical Wnt-dependent transcription, which also required the PKA sites. PKA-Wnt crosstalk in the cells was bi-directional, including enhanced interactions between beta-catenin and the cAMP-responsive element binding protein (CREB) and transcriptional crosstalk between the Wnt and PKA signaling pathways. Increases in canonical Wnt/beta-catenin signaling were associated with a decrease in the activity of the non-canonical Wnt/Ror2 pathway, which has been shown to antagonize canonical Wnt signaling. Taken together, this study provides a new understanding of the complex regulation of the subcellular distribution of beta-catenin and its differential protein-protein interaction that can be modulated by PKA signaling.	[Zhang, Mei; Mahoney, Emilia; Zuo, Tao; Manchanda, Parmeet K.; Davuluri, Ramana V.; Kirschner, Lawrence S.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Kirschner, Lawrence S.] Ohio State Univ, Div Endocrinol Diabets & Metab, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kirschner, LS (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Lawrence.Kirschner@osumc.edu			National Institutes of Health [CA112268, AR057168, CA16058]; NATIONAL CANCER INSTITUTE [R01CA112268, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following National Institutes of Health grants: CA112268 (LSK), AR057168 (LSK), and CA16058 (to the Ohio State University Comprehensive Cancer Center). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MQ, 2010, MOL CELL ENDOCRINOL; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Brudvik KW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-149; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Ewan KBR, 2008, CURR DRUG TARGETS, V9, P532, DOI 10.2174/138945008784911787; Gupta R, 2011, NUCLEIC ACIDS RES, V39, pD92, DOI 10.1093/nar/gkq1171; Hildesheim J, 2005, J BIOL CHEM, V280, P17221, DOI 10.1074/jbc.M410440200; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kang MA, 2012, J BIOL CHEM, V287, P16246, DOI 10.1074/jbc.M111.337212; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Niehrs C, NAT REV MOL CELL BIO, V13, P767; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Pavel E, 2008, MOL ENDOCRINOL, V22, P430, DOI 10.1210/me.2007-0369; Regard J. B., 2012, COLD SPRING HARB PER, V4; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Rudolf R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00290; Salpea P, 2014, MOL CELL ENDOCRINOL, V386, P85, DOI 10.1016/j.mce.2013.08.022; Satow R, 2012, GASTROENTEROLOGY, V142, P572, DOI 10.1053/j.gastro.2011.11.041; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Sun J, 2013, ONCOL REP, V30, P2785, DOI 10.3892/or.2013.2786; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang M, 2014, MOL ENDOCRINOL, V28, P295, DOI 10.1210/me.2013-1152; Zhang S, 2012, HORM METAB RES, V44, P724, DOI 10.1055/s-0032-1321845	42	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109523	10.1371/journal.pone.0109523	http://dx.doi.org/10.1371/journal.pone.0109523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299576	Green Submitted, gold, Green Published			2022-12-25	WOS:000343941200055
J	Araki, A; Mitsui, T; Miyashita, C; Nakajima, T; Naito, H; Ito, S; Sasaki, S; Cho, K; Ikeno, T; Nonomura, K; Kishi, R				Araki, Atsuko; Mitsui, Takahiko; Miyashita, Chihiro; Nakajima, Tamie; Naito, Hisao; Ito, Sachiko; Sasaki, Seiko; Cho, Kazutoshi; Ikeno, Tamiko; Nonomura, Katsuya; Kishi, Reiko			Association between Maternal Exposure to di(2-ethylhexyl) Phthalate and Reproductive Hormone Levels in Fetal Blood: The Hokkaido Study on Environment and Children's Health	PLOS ONE			English	Article							HUMAN BREAST-MILK; URINARY PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; INTERNAL EXPOSURE; NEONATAL-RATS; HUMAN SERUM; IN-UTERO; METABOLITES; DEHP; BIOMARKERS	Prenatal di(2-ethylhexyl) phthalate (DEHP) exposure can produce reproductive toxicity in animal models. Only limited data exist from human studies on maternal DEHP exposure and its effects on infants. We aimed to examine the associations between DEHP exposure in utero and reproductive hormone levels in cord blood. Between 2002 and 2005, 514 pregnant women agreed to participate in the Hokkaido Study Sapporo Cohort. Maternal blood samples were taken from 23-35 weeks of gestation and the concentration of the primary metabolite of DEHP, mono(2-ethylhexyl) phthalate (MEHP), was measured. Concentrations of infant reproductive hormones including estradiol (E2), total testosterone (T), and progesterone (P4), inhibin B, insulin-like factor 3 (INSL3), steroid hormone binding globulin, follicle-stimulating hormone, and luteinizing hormone were measured from cord blood. Two hundred and two samples with both MEHP and hormones' data were included in statistical analysis. The participants completed a self-administered questionnaire regarding information on maternal characteristics. Gestational age, birth weight and infant sex were obtained from birth records. In an adjusted linear regression analysis fit to all study participants, maternal MEHP levels were found to be associated with reduced levels of T/E2, P4, and inhibin B. For the stratified analyses for sex, inverse associations between maternal MEHP levels T/E2, P4, inhibin B, and INSL3 were statistically significant for males only. In addition, the MEHP quartile model showed a significant p-value trend for P4, inhibin B, and INSL3 decrease in males. Since inhibin B and INSL3 are major secretory products of Sertoli and Leydig cell, respectively, the results of this study suggest that DEHP exposure in utero may have adverse effects on both Sertoli and Leydig cell development in males, which agrees with the results obtained from animal studies. Comprehensive studies investigating phthalates' exposure in humans, as well as their long-term effects on reproductive development are needed.	[Araki, Atsuko; Miyashita, Chihiro; Ito, Sachiko; Ikeno, Tamiko; Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan; [Mitsui, Takahiko] Hokkaido Univ Hosp, Dept Urol, Sapporo, Hokkaido 060, Japan; [Nakajima, Tamie; Naito, Hisao] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Sasaki, Seiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Cho, Kazutoshi] Hokkaido Univ Hosp, Dept Obstet & Genecol, Sapporo, Hokkaido 060, Japan; [Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Nagoya University; Hokkaido University; Hokkaido University; Hokkaido University	Kishi, R (corresponding author), Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan.	rkishi@med.hokudai.ac.jp	Ikeda-Araki, Atsuko/A-4105-2012; , Takahiko/H-6660-2019	Ikeda-Araki, Atsuko/0000-0002-3065-262X; Nakajima, Tamie/0000-0002-0474-7019; Naito, Hisao/0000-0003-4228-637X	Japanese Ministry of Health, Labour and Welfare, Health and Labour Sciences; Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology; Ministry of the Environment, Japan; Grants-in-Aid for Scientific Research [26670321, 25860434, 24390172] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare, Health and Labour Sciences; Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology; Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by a Grant-in Aid from the Japanese Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants (RK), http://mhlw-grants.niph.go.jp/; Grants in Aid of Scientific Research from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology (RK), http://www.jsps.go.jp/english/e-grants/index.html; the Environment Research and Technology Development Fund (5C-1252) from the Ministry of the Environment, Japan (KN), http://www.env.go.jp/policy/kenkyu/suishin/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69; David RM, 2006, TOXICOL PATHOL, V34, P209, DOI 10.1080/01926230600642625; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7; Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656; Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005; Duty SM, 2002, ENV HLTH PERSPECT, V111, P1164; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006; Hart R, 2014, REPRODUCTION, V147, P379, DOI 10.1530/REP-13-0331; Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hayashi Y, 2012, ARCH TOXICOL, V86, P563, DOI 10.1007/s00204-011-0790-2; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515, DOI 10.1289/ehp.02110515; Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009; Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001; Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012; Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7; Ivell R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108969; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Japan Plasticizer Industry Association and Ministry of Economy Trade and Industry, 2012, INF JAP PLAST IND; Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01; Kato K, 2003, J ANAL TOXICOL, V27, P284, DOI 10.1093/jat/27.5.284; Kessler W, 2012, TOXICOL APPL PHARM, V264, P284, DOI 10.1016/j.taap.2012.08.009; Kishi R, 2013, ENV HLTH PREV MED, P1; Kishi R, 2011, INT J EPIDEMIOL, V40, P611, DOI 10.1093/ije/dyq071; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270; Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012; Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Lind PM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-21; Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047; Main KM, 2006, J CLIN ENDOCR METAB, V91, P2732, DOI 10.1210/jc.2005-2443; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; ORTH JM, 1990, ENDOCRINOLOGY, V127, P2812, DOI 10.1210/endo-127-6-2812; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3; Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; TOWNSEND MK, 2013, ENV HLTH, V12; WHO, 2012, END DISR CHILD HLTH; Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012; Wirth JJ, 2008, SYST BIOL REPROD MED, V54, P143, DOI 10.1080/19396360802055921; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009; Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690; Yamashita K, 2007, J CHROMATOGR A, V1173, P120, DOI 10.1016/j.chroma.2007.10.023; Yamashita K, 2007, STEROIDS, V72, P819, DOI 10.1016/j.steroids.2007.07.003; Zhou L, 2013, REPROD TOXICOL, V42, P95, DOI 10.1016/j.reprotox.2013.07.025	55	87	88	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109039	10.1371/journal.pone.0109039	http://dx.doi.org/10.1371/journal.pone.0109039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296284	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000032
J	Han, SB; Ko, JS; Jin, SM; Park, HW; Kim, JM; Joh, JW; Kim, G; Choi, SJ				Han, Sangbin; Ko, Justin Sangwook; Jin, Sang-Man; Park, Hyo-Won; Kim, Jong Man; Joh, Jae-Won; Kim, Gaabsoo; Choi, Soo Joo			Intraoperative Hyperglycemia during Liver Resection: Predictors and Association with the Extent of Hepatocytes Injury	PLOS ONE			English	Article							SURGICAL SITE INFECTION; BLOOD-GLUCOSE CONTROL; PERIOPERATIVE GLUCOSE; HEPATIC RESECTION; PRINGLE MANEUVER; INSULIN; ISCHEMIA; ULTRASTRUCTURE; COMPLICATIONS; METABOLISM	Background: Patients undergoing liver resection are at risk for intraoperative hyperglycemia and acute hyperglycemia is known to induce hepatocytes injury. Thus, we aimed to evaluate whether intraoperative hyperglycemia during liver resection is associated with the extent of hepatic injury. Methods: This 1 year retrospective observation consecutively enrolled 85 patients undergoing liver resection for hepatocellular carcinoma. Blood glucose concentrations were measured at predetermined time points including every start/end of intermittent hepatic inflow occlusion (IHIO) via arterial blood analysis. Postoperative transaminase concentrations were used as surrogate parameters indicating the extent of surgery-related acute hepatocytes injury. Results: Thirty (35.5%) patients developed hyperglycemia (blood glucose > 180 mg/dl) during surgery. Prolonged (>= 3 rounds) IHIO (odds ratio [OR] 7.34, P = 0.004) was determined as a risk factors for hyperglycemia as well as cirrhosis (OR 4.07, P = 0.022), lower prothrombin time (OR 0.01, P = 0.025), and greater total cholesterol level (OR 1.04, P = 0.003). Hyperglycemia was independently associated with perioperative increase in transaminase concentrations (aspartate transaminase, beta 105.1, standard error 41.7, P = 0.014; alanine transaminase, beta 81.6, standard error 38.1, P = 0.035). Of note, blood glucose > 160 or 140 mg/dl was not associated with postoperative transaminase concentrations. Conclusions: Hyperglycemia during liver resection might be associated with the extent of hepatocytes injury. It would be rational to maintain blood glucose concentration < 180 mg/dl throughout the surgery in consideration of parenchymal disease, coagulation status, lipid profile, and the cumulative hepatic ischemia in patients undergoing liver resection for hepatocellular carcinoma.	[Han, Sangbin; Ko, Justin Sangwook; Park, Hyo-Won; Kim, Gaabsoo; Choi, Soo Joo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Jin, Sang-Man] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea; [Kim, Jong Man; Joh, Jae-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	csjoo@skku.edu	kim, jm/O-5935-2014; Kim, Jong Man/AAH-5295-2020; Jin, Sang-Man/AFO-5933-2022	Han, Sangbin/0000-0002-4129-301X; Joh, Jae-Won/0000-0003-1732-6210				Akhtar S, 2010, ANESTH ANALG, V110, P478, DOI 10.1213/ANE.0b013e3181c6be63; Ambiru S, 2008, J HOSP INFECT, V68, P230, DOI 10.1016/j.jhin.2007.12.002; Bai H, 2006, FREE RADICAL BIO MED, V40, P1796, DOI 10.1016/j.freeradbiomed.2006.01.007; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Behrends M, 2010, J GASTROINTEST SURG, V14, P528, DOI 10.1007/s11605-009-1112-3; Chau GY, 2005, WORLD J SURG, V29, P1374, DOI 10.1007/s00268-005-7766-4; Chiolero R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009; David WH, 2000, APPL LOGISTIC REGRES, P92; Derichard A, 2009, BRIT J ANAESTH, V103, P678, DOI 10.1093/bja/aep267; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Dunki-Jacobs EM, 2014, ANN SURG ONCOL, V21, P473, DOI 10.1245/s10434-013-3323-9; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; Giugliano D, 1997, CIRCULATION, V95, P1783; Greenhill C, 2014, NAT REV GASTROENTERO; Han S, 2014, LIVER TRANSPL; Han SB, 2013, TRANSPL INT, V26, P623, DOI 10.1111/tri.12092; Hirose R, 2008, ANESTHESIOLOGY, V108, P402, DOI 10.1097/ALN.0b013e318164cff8; Kaji N, 2013, J VET MED SCI, V75, P1245, DOI 10.1292/jvms.13-0029; Kannerup AS, 2008, J GASTROINTEST SURG, V12, P319, DOI 10.1007/s11605-007-0359-9; Kersten JR, 1998, AM J PHYSIOL-HEART C, V275, pH721, DOI 10.1152/ajpheart.1998.275.2.H721; Kuriyama S, 2007, J CLIN BIOCHEM NUTR, V40, P116, DOI 10.3164/jcbn.40.116; Lippi G, 2009, CLIN BIOCHEM, V42, P118, DOI 10.1016/j.clinbiochem.2008.10.012; Maeda H, 2010, AM J SURG, V199, P8, DOI 10.1016/j.amjsurg.2008.11.046; Man K, 2003, BRIT J SURG, V90, P183, DOI 10.1002/bjs.4027; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martin A, 2006, STROKE, V37, P1288, DOI 10.1161/01.STR.0000217389.55009.f8; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Okabayashi T, 2011, WORLD J SURG, V35, P2773, DOI 10.1007/s00268-011-1299-9; Paolisso G, 1996, DIABETOLOGIA, V39, P357, DOI 10.1007/BF00418354; Parekh J, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/652458; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; Puskas F, 2007, ANN THORAC SURG, V84, P1467, DOI 10.1016/j.athoracsur.2007.06.023; Sato H, 2010, ANESTH ANALG, V110, P1711, DOI 10.1213/ANE.0b013e3181d90087; Shangraw R E, 1996, Liver Transpl Surg, V2, P443, DOI 10.1002/lt.500020607; Sugiyama Y, 2010, BRIT J SURG, V97, P1062, DOI 10.1002/bjs.7039; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Vriesendorp TM, 2004, CRIT CARE, V8, pR437, DOI 10.1186/cc2970	41	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109120	10.1371/journal.pone.0109120	http://dx.doi.org/10.1371/journal.pone.0109120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295519	Green Submitted, Green Published, gold			2022-12-25	WOS:000345204000040
J	Michalowski, JM; Weymar, M; Hamm, AO				Michalowski, Jaroslaw M.; Weymar, Mathias; Hamm, Alfons O.			Remembering the Object You Fear: Brain Potentials during Recognition of Spiders in Spider-Fearful Individuals	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; AFFECTIVE PICTURES; PHOBIA-RELEVANT; MEMORY; EMOTION; AMYGDALA; AROUSAL; MODULATION; ACTIVATION; RESPONSES	In the present study we investigated long-term memory for unpleasant, neutral and spider pictures in 15 spider-fearful and 15 non-fearful control individuals using behavioral and electrophysiological measures. During the initial (incidental) encoding, pictures were passively viewed in three separate blocks and were subsequently rated for valence and arousal. A recognition memory task was performed one week later in which old and new unpleasant, neutral and spider pictures were presented. Replicating previous results, we found enhanced memory performance and higher confidence ratings for unpleasant when compared to neutral materials in both animal fearful individuals and controls. When compared to controls high animal fearful individuals also showed a tendency towards better memory accuracy and significantly higher confidence during recognition of spider pictures, suggesting that memory of objects prompting specific fear is also facilitated in fearful individuals. In line, spider-fearful but not control participants responded with larger ERP positivity for correctly recognized old when compared to correctly rejected new spider pictures, thus showing the same effects in the neural signature of emotional memory for feared objects that were already discovered for other emotional materials. The increased fear memory for phobic materials observed in the present study in spider-fearful individuals might result in an enhanced fear response and reinforce negative beliefs aggravating anxiety symptomatology and hindering recovery.	[Weymar, Mathias; Hamm, Alfons O.] Ernst Moritz Arndt Univ Greifswald, Dept Biol & Clin Psychol, Greifswald, Germany; [Michalowski, Jaroslaw M.] Univ Warsaw, Fac Psychol, Warsaw, Poland	Ernst Moritz Arndt Universitat Greifswald; University of Warsaw	Michalowski, JM (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	jmichalowski@psych.uw.edu.pl	Michałowski, Jarosław/Q-1728-2016	Michałowski, Jarosław/0000-0002-5811-740X; Weymar, Mathias/0000-0002-3968-9656	University of Warsaw [BST 164600/2015]; National Science Centre [2013/11/N/HS6/01401]	University of Warsaw; National Science Centre(National Science Centre, Poland)	The research was supported in part by a grant from the University of Warsaw to the first author, BST 164600/2015 and in part by a grant from the National Science Centre to the first author, 2013/11/N/HS6/01401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahs F, 2011, PSYCHOPHYSIOLOGY, V48, P1463, DOI 10.1111/j.1469-8986.2011.01231.x; Bentz D, 2013, PSYCHONEUROENDOCRINO, V38, P1186, DOI 10.1016/j.psyneuen.2012.12.018; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Carlsson K, 2004, EMOTION, V4, P340, DOI 10.1037/1528-3542.4.4.340; Cowan N., 1995, ATTENTION MEMORY INT; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Craik FIM, 1975, J MEM LANG, V27, P23; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; de Quervain DJF, 2011, P NATL ACAD SCI USA, V108, P6621, DOI 10.1073/pnas.1018214108; Dewhurst SA, 2000, EUR J COGN PSYCHOL, V12, P541, DOI 10.1080/095414400750050222; Dietrich DE, 2001, NEUROPSYCHOBIOLOGY, V43, P96, DOI 10.1159/000054874; Dilger S, 2003, NEUROSCI LETT, V348, P29, DOI 10.1016/S0304-3940(03)00647-5; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Ferrari V, 2013, SOC COGN AFFECT NEUR, V8, P847, DOI 10.1093/scan/nss081; FREDRIKSON M, 1995, PSYCHOPHYSIOLOGY, V32, P43, DOI 10.1111/j.1469-8986.1995.tb03404.x; Fredrikson M, 2003, ANN NY ACAD SCI, V985, P341; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Globisch J, 1999, PSYCHOPHYSIOLOGY, V36, P66, DOI 10.1017/S0048577299970634; Gruhn D, 2007, PSYCHOL AGING, V22, P644, DOI 10.1037/0882-7974.22.3.644; Hadley CB, 2006, J EXP PSYCHOL LEARN, V32, P79, DOI 10.1037/0278-7393.32.1.79; Hamm A., 2006, SPEZIFISCHE PHOBIEN; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; Inaba M, 2005, INT J PSYCHOPHYSIOL, V57, P165, DOI 10.1016/j.ijpsycho.2005.01.002; Johansson M, 2004, J COGNITIVE NEUROSCI, V16, P1840, DOI 10.1162/0898929042947883; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Keil A, 2006, PROG BRAIN RES, V156, P217, DOI 10.1016/S0079-6123(06)56011-X; Kolassa IT, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-38; Kolassa IT, 2005, PSYCHOPHYSIOLOGY, V42, P520, DOI 10.1111/j.1469-8986.2005.00315.x; Kuhlmann S, 2005, J NEUROSCI, V25, P2977, DOI 10.1523/JNEUROSCI.5139-04.2005; Kulas JF, 2003, J ANXIETY DISORD, V17, P103, DOI 10.1016/S0887-6185(02)00177-9; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang P.J., 2008, A8 U FLOR; Leutgeb V, 2009, BIOL PSYCHOL, V82, P293, DOI 10.1016/j.biopsycho.2009.09.003; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Michalowski JM, 2012, INT J PSYCHOPHYSIOL, V85, P55, DOI 10.1016/j.ijpsycho.2011.09.009; Michalowski JM, 2009, EMOTION, V9, P306, DOI 10.1037/a0015550; Miltner WHR, 2005, INT J PSYCHOPHYSIOL, V57, P43, DOI 10.1016/j.ijpsycho.2005.01.012; Muhlberger A, 2006, J ABNORM PSYCHOL, V115, P580, DOI 10.1037/0021-843X.115.3.580; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; Pflugshaupt T, 2007, J ANXIETY DISORD, V21, P353, DOI 10.1016/j.janxdis.2006.05.005; Quevedo J, 2003, NEUROBIOL LEARN MEM, V79, P132, DOI 10.1016/S1074-7427(02)00034-5; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Schaefer A, 2011, NEUROIMAGE, V54, P714, DOI 10.1016/j.neuroimage.2010.07.030; Schienle A, 2005, COGNITION EMOTION, V19, P1229, DOI 10.1080/02699930500286364; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002; Sharot T, 2004, COGN AFFECT BEHAV NE, V4, P294, DOI 10.3758/CABN.4.3.294; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Soravia LM, 2006, P NATL ACAD SCI USA, V103, P5585, DOI 10.1073/pnas.0509184103; Spielberger CD, 1983, MANUAL TRAIT STATE A; Straube T, 2006, BIOL PSYCHIAT, V59, P162, DOI 10.1016/j.biopsych.2005.06.013; Thorpe SJ, 2000, J ANXIETY DISORD, V14, P359, DOI 10.1016/S0887-6185(00)00028-1; Tolin DF, 1999, BEHAV RES THER, V37, P63, DOI 10.1016/S0005-7967(98)00111-9; Voss JL, 2008, NEUROPSYCHOLOGIA, V46, P3021, DOI 10.1016/j.neuropsychologia.2008.07.010; WATTS FN, 1986, BRIT J CLIN PSYCHOL, V25, P253, DOI 10.1111/j.2044-8260.1986.tb00705.x; WATTS FN, 1991, COGNITION EMOTION, V5, P313, DOI 10.1080/02699939108411043; Watts S, 2014, PSYCHOPHYSIOLOGY, V51, P673, DOI 10.1111/psyp.12211; Wendt J, 2008, PSYCHOPHYSIOLOGY, V45, P205, DOI 10.1111/j.1469-8986.2007.00620.x; Weymar M, 2014, SOC COGN AFFECT NEUR, V9, P723, DOI 10.1093/scan/nst044; Weymar M, 2013, ELSEV INSIGHT, P21, DOI 10.1016/B978-0-12-398393-0.00002-X; Weymar M, 2013, PSYCHOPHYSIOLOGY, V50, P139, DOI 10.1111/psyp.12008; Weymar M, 2011, HUM BRAIN MAPP, V32, P632, DOI 10.1002/hbm.21051; Weymar M, 2009, PSYCHOPHYSIOLOGY, V46, P1200, DOI 10.1111/j.1469-8986.2009.00869.x; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.	74	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109537	10.1371/journal.pone.0109537	http://dx.doi.org/10.1371/journal.pone.0109537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296032	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000079
J	Schratzberger, M; Larcombe, P				Schratzberger, Michaela; Larcombe, Piers			The Role of the Sedimentary Regime in Shaping the Distribution of Subtidal Sandbank Environments and the Associated Meiofaunal Nematode Communities: An Example from the Southern North Sea	PLOS ONE			English	Article							BENTHIC DISTURBANCE REGIMES; SIZE DISTRIBUTIONS; CONTINENTAL-SHELF; DIVERSITY; COMPETITION; DISPERSAL; BANKS; WATER; MICROHABITAT; SURROGATES	We combined sediment and faunal data to explore the role of the sedimentary regime in shaping the distribution of subtidal sandbank environments and the associated meiofaunal nematode communities at Broken Bank and Swarte Bank, in the southern North Sea. A variety of sediment transport processes occur in the area, differing in the frequency and magnitude of sediment mobility, and the continuum between erosion, translation and sediment accumulation. The seabed contained a variety of bedforms, including longitudinal furrows, and small to very large sandwaves. The bed sediments were dominated by fine and medium sands, with admixtures of silt and gravel. Based on sedimentary bedforms and grain size analysis, a total of 11 sedimentary facies were delineated, of which 8 were analysed in detail for their relationships with the meiofauna. The sedimentary facies fell clearly into groups of facies, respectively representing high, high-moderate and moderate, and episodic sediment mobility. For those sedimentary facies where daily movement of sediments and bedforms occurred ('high' sediment mobility), the resulting spatially homogeneous environments were dominated by an impoverished nematode community comprising small deposit feeders and large predators. Resistance to sediment movement and the ability to exploit alternative food sources were prominent functional features of the successful colonisers. Those facies characterised by relatively infrequent sediment mobility ('episodic' and 'high-moderate and moderate' sediment mobility) comprised a heterogeneous suite of benthic habitats, containing taxonomically and functionally diverse assemblages of nematodes of various sizes, feeding types and reproductive potential. Faunal distribution patterns here indicated trade-offs between the resistance to sediment movement, environmental tolerance and competitive abilities. Our focus on diverse assemblages of organisms with high turnover times, inhabiting highly dynamic sedimentary environments, has revealed new animal-sediment relationships of relevance to pure and applied science.	[Schratzberger, Michaela] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England; [Larcombe, Piers] RPS MetOcean, Subiaco, WA, Australia	Centre for Environment Fisheries & Aquaculture Science	Schratzberger, M (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England.	michaela.schratzberger@cefas.co.uk		Schratzberger, Michaela/0000-0002-4973-6698; Larcombe, Piers/0000-0003-0964-3144	Department for Environment, Food and Rural Affairs (Defra) [AE1148]; EDF Energy; RPS Met Ocean; Marine Environment Protection Fund (MEPF)	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); EDF Energy; RPS Met Ocean; Marine Environment Protection Fund (MEPF)	The work was supported by the Department for Environment, Food and Rural Affairs (Defra, research project AE1148), by EDF Energy and by RPS Met Ocean. Early work on the manuscript was supported by the Marine Environment Protection Fund (MEPF), a delivery partner of Defra's Aggregate Levy Sustainability Fund (ALSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from EDF Energy does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Balson PS, 1988, 8638 BRIT GEOL SOC; Baptist MJ, 2006, ESTUAR COAST SHELF S, V68, P538, DOI 10.1016/j.ecss.2006.02.023; Belderson R.H., 1982, OFFSHORE TIDAL SANDS, P27; BELDERSON RH, 1972, SONOGRAPHS SEA FLOOR; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongers Tom, 1995, Russian Journal of Nematology, V3, P61; BRANCH GM, 1984, OCEANOGR MAR BIOL, V22, P429; CASTON VND, 1972, SEDIMENTOLOGY, V18, P63, DOI 10.1111/j.1365-3091.1972.tb00003.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clements AJ, 2010, ICES J MAR SCI, V67, P628, DOI 10.1093/icesjms/fsp280; COLLINS MB, 1995, MAR GEOL, V123, P125, DOI 10.1016/0025-3227(95)00010-V; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DELGADO M, 1991, J EXP MAR BIOL ECOL, V145, P221, DOI 10.1016/0022-0981(91)90177-X; Deprez T, 2005, NEMYS DATABASE; Dyer KR, 1999, CONT SHELF RES, V19, P1285, DOI 10.1016/S0278-4343(99)00028-X; Ellis JR, 2011, J MAR BIOL ASSOC UK, V91, P1319, DOI 10.1017/S0025315410001062; Foden J, 2009, MAR ECOL PROG SER, V390, P15, DOI 10.3354/meps08169; FORREST J, 1989, SEDIMENTOLOGY, V36, P711, DOI 10.1111/j.1365-3091.1989.tb02095.x; Galparsoro I, 2010, GEOMORPHOLOGY, V118, P314, DOI 10.1016/j.geomorph.2010.01.012; Giere, 2009, MEIOBENTHOLOGY THE M; HALL SJ, 1994, OCEANOGR MAR BIOL, V32, P179; Harris PT, 2014, MAR GEOL, V353, P169, DOI 10.1016/j.margeo.2014.03.023; Harris PT, 2012, ELSEV INSIGHT, P93, DOI 10.1016/B978-0-12-385140-6.00005-0; Harris PT, 2012, MAR ECOL PROG SER, V449, P13, DOI 10.3354/meps09463; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOGUE EW, 1981, J EXP MAR BIOL ECOL, V53, P181, DOI 10.1016/0022-0981(81)90018-6; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huntley DA, 1991, P EUROMECH SAND TRNA, P17; HUSTON MA, 1996, BIOL DIVERSITY; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2001, MAR ECOL PROG SER, V213, P127, DOI 10.3354/meps213127; JENSEN P, 1987, OECOLOGIA, V71, P564, DOI 10.1007/BF00379298; Johnson MA, 1984, ASSESSMENT OWER BANK; Joint Nature Conservation Committee, 2012, OFFSH SPEC AR CONS N; LANGHORNE DN, 1982, SEDIMENTOLOGY, V29, P571, DOI 10.1111/j.1365-3091.1982.tb01734.x; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Mikkelsen OA, 2007, ESTUAR COAST SHELF S, V72, P615, DOI 10.1016/j.ecss.2006.11.027; Nio S.D., 1991, CLASTIC TIDAL SEDIME, V16, P3; Okada T, 2009, MAR POLLUT BULL, V58, P1164, DOI 10.1016/j.marpolbul.2009.03.023; Orpin AR, 2006, MAR GEOL, V225, P209, DOI 10.1016/j.margeo.2005.09.002; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; PALMER MA, 1985, J MAR RES, V43, P179, DOI 10.1357/002224085788437280; Pedersen SA, 2009, ICES J MAR SCI, V66, P155, DOI 10.1093/icesjms/fsn193; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Platt H.M., 1983, SYNOPSES BRIT FAUNA, V28; Platt H.M., 1988, FREE LIVING MARINE 2; Post AL, 2006, MAR FRESHWATER RES, V57, P469, DOI 10.1071/MF05182; Pravotorov IA, 1983, GEOMORPHOLOGIYA, V2, P39; Raes M, 2006, DEEP-SEA RES PT I, V53, P1880, DOI 10.1016/j.dsr.2006.08.012; Reading HG, 1996, SEDIMENTARY ENV PROC, V5, P36; Reineck H.E., 1980, DEPOSITIONAL SEDIMEN, P5; Riemann F., 1974, MIKROFAUNA MEERESBOD, V40, P1; Rundell RJ, 2010, BIOESSAYS, V32, P430, DOI 10.1002/bies.200900116; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schratzberger M, 2007, MAR ENVIRON RES, V63, P368, DOI 10.1016/j.marenvres.2006.10.006; Semple R K, 1972, 28 OH STAT U DEP GEO; Shennan I, 2000, GEOL SOC SPEC PUBL, V166, P299, DOI 10.1144/GSL.SP.2000.166.01.15; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; SOMERFIELD P, 1996, MEIOFAUNA MARINE POL; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; THISTLE D, 1985, DEEP-SEA RES, V32, P1077, DOI 10.1016/0198-0149(85)90063-9; Thistle D, 1995, VIE MILIEU, V45, P107; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Vanaverbeke J, 2004, MAR ECOL PROG SER, V273, P139, DOI 10.3354/meps273139; Vanaverbeke J, 2008, MAR ENVIRON RES, V66, P240, DOI 10.1016/j.marenvres.2008.02.066; VISSER MJ, 1980, GEOLOGY, V8, P543, DOI 10.1130/0091-7613(1980)8<543:NCRIHS>2.0.CO;2; WARD AR, 1975, MAR BIOL, V30, P217, DOI 10.1007/BF00390744; Ward I, 2008, ENVIRON ARCHAEOL, V13, P59, DOI 10.1179/174963108x279229; WARWICK RM, 1998, FREE LIVING MARINE 3; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wilber DH, 2008, J EXP MAR BIOL ECOL, V365, P13, DOI 10.1016/j.jembe.2008.07.029; Wilson J.B., 1982, OFFSHORE TIDAL SANDS, P126; WILSON WH, 1990, ANNU REV ECOL SYST, V21, P221, DOI 10.1146/annurev.ecolsys.21.1.221; WOOLFE KJ, 1995, COMPUT GEOSCI, V21, P447, DOI 10.1016/0098-3004(94)00092-9; Woolfe KJ, 2000, AUST J EARTH SCI, V47, P301, DOI 10.1046/j.1440-0952.2000.00782.x; WRIGHT KA, 1987, J PARASITOL, V73, P1077, DOI 10.2307/3282284	80	4	4	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109445	10.1371/journal.pone.0109445	http://dx.doi.org/10.1371/journal.pone.0109445			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296029	gold, Green Published, Green Submitted			2022-12-25	WOS:000345204000072
J	Smith, DJ; Hill, GR; Bell, SC; Reid, DW				Smith, Daniel J.; Hill, Geoffrey R.; Bell, Scott C.; Reid, David W.			Reduced Mucosal Associated Invariant T-Cells Are Associated with Increased Disease Severity and Pseudomonas aeruginosa Infection in Cystic Fibrosis	PLOS ONE			English	Article							AIRWAY INFLAMMATION; LUNG-DISEASE; MAIT CELLS; INNATE; TUBERCULOSIS; LYMPHOCYTES; ACTIVATION; DECREASE; IMMUNITY	Background: Primary defects in host immune responses have been hypothesised to contribute towards an inability of subjects with cystic fibrosis (CF) to effectively clear pulmonary infections. Innate T-lymphocytes provide rapid pathogenspecific responses prior to the development of classical MHC class I and II restricted T-cell responses and are essential to the initial control of pulmonary infection. We aimed to examine the relationship between peripheral blood lymphocyte phenotype and clinical outcomes in adults with CF. Methods: We studied 41 subjects with CF and 22, age matched, non-smoking healthy control subjects. Lymphocytes were extracted from peripheral blood samples and phenotyped by flow-cytometry. Lymphocyte phenotype was correlated with sputum microbiology and clinical parameters. Results: In comparison to healthy control subjects, mucosal associated invariant T (MAIT)-lymphocytes were significantly reduced in the peripheral blood of subjects with CF (1.1% versus 2.0% of T-lymphocytes, P = 0.002). MAIT cell concentration was lowest in CF subjects infected with P. aeruginosa and in subjects receiving treatment for a pulmonary exacerbation. Furthermore a reduced MAIT cell concentration correlated with severity of lung disease. Conclusion: Reduced numbers of MAIT cells in subjects with CF were associated with P. aeruginosa pulmonary infection, pulmonary exacerbations and more severe lung disease. These findings provide the impetus for future studies examining the utility of MAIT cells in immunotherapies and vaccine development. Longitudinal studies of MAIT cells as biomarkers of CF pulmonary infection are awaited.	[Smith, Daniel J.; Bell, Scott C.; Reid, David W.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Smith, Daniel J.; Bell, Scott C.; Reid, David W.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Hill, Geoffrey R.] QIMR Berghofer Med Res Inst, Bone Marrow Transplant Lab, Brisbane, Qld, Australia; [Smith, Daniel J.; Reid, David W.] QIMR Berghofer Med Res Inst, Infect & Inflammat Lab, Brisbane, Qld, Australia; [Bell, Scott C.] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Royal Children's Hospital Brisbane	Smith, DJ (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia.	daniel.smith@health.qld.gov.au	Bell, Scott/AAJ-4298-2020; Hill, Geoffrey/O-2630-2016; Reid, David/Y-2343-2018; Smith, Daniel/K-4978-2018	Bell, Scott/0000-0001-8651-7139; Hill, Geoffrey/0000-0003-2994-0429; Reid, David/0000-0001-9517-8212; Smith, Daniel/0000-0002-8945-1531	QIMR Berghofer Medical Research Institute	QIMR Berghofer Medical Research Institute	Internal funding was received from QIMR Berghofer Medical Research Institute. The institute had no role in decision to publish the manuscript.	Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; DALEY L, 1985, J IMMUNOL, V134, P3089; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Grimaldi D, 2014, INTENS CARE MED, V40, P192, DOI 10.1007/s00134-013-3163-x; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hausler M, 2002, RESP MED, V96, P87, DOI 10.1053/rmed.2001.1217; ITO M, 1992, CHEST, V102, P195, DOI 10.1378/chest.102.1.195; Jiang J, 2014, AM J RESP CRIT CARE, V190, P329, DOI 10.1164/rccm.201401-0106OC; Lanier LL, 2013, NAT REV IMMUNOL, V13, P73, DOI 10.1038/nri3389; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Levy H, 2007, PEDIATR PULM, V42, P256, DOI 10.1002/ppul.20563; Lopez-Sagaseta J, 2013, J IMMUNOL, V191, P5268, DOI 10.4049/jimmunol.1301958; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Moser C, 2011, BIOFILM INFECTIONS, P201, DOI 10.1007/978-1-4419-6084-9_12; Novak J., 2014, SCAND J IMMUNOL; Raga S, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-9; Ratner D, 2012, AM J RESP CELL MOL B; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Wesselkamper SC, 2008, J IMMUNOL, V181, P5481, DOI 10.4049/jimmunol.181.8.5481; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	34	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109891	10.1371/journal.pone.0109891	http://dx.doi.org/10.1371/journal.pone.0109891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296025	Green Published, Green Submitted, gold			2022-12-25	WOS:000345204000100
J	Choi, J; Cooper, ML; Alahmari, B; Ritchey, J; Collins, L; Holt, M; DiPersio, JF				Choi, Jaebok; Cooper, Matthew L.; Alahmari, Bader; Ritchey, Julie; Collins, Lynne; Holt, Matthew; DiPersio, John F.			Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BONE-MARROW-TRANSPLANTATION; HOST-DISEASE LETHALITY; JAK2 INHIBITOR; IN-VIVO; MYELOPROLIFERATIVE NEOPLASMS; SUPPRESSOR-CELLS; HODGKIN LYMPHOMA; SOLID TUMORS; MECHANISM	We have recently reported that interferon gamma receptor deficient (IFN gamma R-/-) allogeneic donor T cells result in significantly less graft-versus-host disease (GvHD) than wild-type (WT) T cells, while maintaining an anti-leukemia or graft-versus-leukemia (GvL) effect after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We demonstrated that IFN gamma R signaling regulates alloreactive T cell trafficking to GvHD target organs through expression of the chemokine receptor CXCR3 in alloreactive T cells. Since IFN gamma R signaling is mediated via JAK1/JAK2, we tested the effect of JAK1/JAK2 inhibition on GvHD. While we demonstrated that pharmacologic blockade of JAK1/JAK2 in WT T cells using the JAK1/JAK2 inhibitor, INCB018424 (Ruxolitinib), resulted in a similar effect to IFN gamma R-/- T cells both in vitro (reduction of CXCR3 expression in T cells) and in vivo (mitigation of GvHD after allo-HSCT), it remains to be determined if in vivo administration of INCB018424 will result in preservation of GvL while reducing GvHD. Here, we report that INCB018424 reduces GvHD and preserves the beneficial GvL effect in two different murine MHC-mismatched allo-HSCT models and using two different murine leukemia models (lymphoid leukemia and myeloid leukemia). In addition, prolonged administration of INCB018424 further improves survival after allo-HSCT and is superior to other JAK1/JAK2 inhibitors, such as TG101348 or AZD1480. These data suggest that pharmacologic inhibition of JAK1/JAK2 might be a promising therapeutic approach to achieve the beneficial anti-leukemia effect and overcome HLA-barriers in allo-HSCT. It might also be exploited in other diseases besides GvHD, such as organ transplant rejection, chronic inflammatory diseases and autoimmune diseases.	[Choi, Jaebok; Cooper, Matthew L.; Alahmari, Bader; Ritchey, Julie; Holt, Matthew; DiPersio, John F.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Collins, Lynne] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Collins, Lynne] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Collins, Lynne] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Choi, J (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	jchoi@dom.wustl.edu		Choi, Jaebok/0000-0002-5590-087X; Alahmari, Bader/0000-0002-6026-1347	Siteman Cancer Center Research Development Awards; SPORE-CDP [P50 CA171063-01]; National Cancer Institute [P50 CA171063-01, P50 CA94056-09]; Bryan Thomas Campbell Foundation; NATIONAL CANCER INSTITUTE [P50CA171963, P50CA094056, P01CA023766] Funding Source: NIH RePORTER	Siteman Cancer Center Research Development Awards; SPORE-CDP; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bryan Thomas Campbell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.C. is supported by the Siteman Cancer Center Research Development Awards and SPORE-CDP (P50 CA171063-01). J.F.D. is supported by the National Cancer Institute (P50 CA94056-09 and P50 CA171063-01) and the Bryan Thomas Campbell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Choi J, 2012, BLOOD, V120, P4093, DOI 10.1182/blood-2012-01-403196; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Derenzini E, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.46; Dey BR, 1998, BLOOD, V91, P3315, DOI 10.1182/blood.V91.9.3315.3315_3315_3322; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Hao YS, 2014, CLIN CANCER RES, V20, P2674, DOI 10.1158/1078-0432.CCR-13-3007; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Lee HJ, 2013, CLIN CANCER RES, V19, P327, DOI 10.1158/1078-0432.CCR-12-2087; Markowitz J, 2013, BREAST CANCER RES TR, V140, P13, DOI 10.1007/s10549-013-2618-7; Miller JS, 2010, BIOL BLOOD MARROW TR, V16, P565, DOI 10.1016/j.bbmt.2010.02.005; Paczesny S, 2010, BONE MARROW TRANSPL, V45, P1, DOI 10.1038/bmt.2009.328; Plimack ER, 2013, ONCOLOGIST, V18, P819, DOI 10.1634/theoncologist.2013-0198; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rettig MP, 2004, J IMMUNOL, V173, P3620, DOI 10.4049/jimmunol.173.6.3620; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sonbol MB, 2013, THER ADV HEMATOL, V4, P15, DOI 10.1177/2040620712461047; Spoerl S, 2014, BLOOD; Tyner JW, 2010, BLOOD, V115, P5232, DOI 10.1182/blood-2009-05-223727; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; Vogtenhuber C, 2010, BLOOD, V116, P466, DOI 10.1182/blood-2009-11-252825; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wilson LJ, 2010, EXPERT OPIN THER PAT, V20, P609, DOI 10.1517/13543771003709767; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402	29	88	93	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109799	10.1371/journal.pone.0109799	http://dx.doi.org/10.1371/journal.pone.0109799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289677	Green Published, gold			2022-12-25	WOS:000342798000088
J	Demir, H; Donner, I; Kivipelto, L; Kuismin, O; Schalin-Jantti, C; De Menis, E; Karhu, A				Demir, Hande; Donner, Iikki; Kivipelto, Leena; Kuismin, Outi; Schalin-Jantti, Camilla; De Menis, Ernesto; Karhu, Auli			Mutation Analysis of Inhibitory Guanine Nucleotide Binding Protein Alpha (GNAI) Loci in Young and Familial Pituitary Adenomas	PLOS ONE			English	Article							STIMULATORY G-PROTEIN; MCCUNE-ALBRIGHT SYNDROME; ACTIVATING MUTATIONS; REGULATORY SUBUNIT; SOMATIC MUTATIONS; COUPLED RECEPTORS; ADENYLATE-CYCLASE; UVEAL MELANOMA; CARNEY COMPLEX; GENE-MUTATIONS	Pituitary adenomas are neoplasms of the anterior pituitary lobe and account for 15-20% of all intracranial tumors. Although most pituitary tumors are benign they can cause severe symptoms related to tumor size as well as hypopituitarism and/or hypersecretion of one or more pituitary hormones. Most pituitary adenomas are sporadic, but it has been estimated that 5% of patients have a familial background. Germline mutations of the tumor suppressor gene aryl hydrocarbon receptor-interacting protein (AIP) predispose to hereditary pituitary neoplasia. Recently, it has been demonstrated that AIP mutations predispose to pituitary tumorigenesis through defective inhibitory GTP binding protein (G alpha(i)) signaling. This finding prompted us to examine whether germline loss-of-function mutations in inhibitory guanine nucleotide (GTP) binding protein alpha (GNAI) loci are involved in genetic predisposition of pituitary tumors. To our knowledge, this is the first time GNAI genes are sequenced in order to examine the occurrence of inactivating germline mutations. Thus far, only somatic gain-of-function hot-spot mutations have been studied in these loci. Here, we have analyzed the coding regions of GNAI1, GNAI2, and GNAI3 in a set of young sporadic somatotropinoma patients (n = 32; mean age of diagnosis 32 years) and familial index cases (n = 14), thus in patients with a disease phenotype similar to that observed in AIP mutation carriers. In addition, expression of Gai proteins was studied in human growth hormone (GH), prolactin (PRL), adrenocorticotropic hormone (ACTH)-secreting and non-functional pituitary tumors. No pathogenic germline mutations affecting the Gai proteins were detected. The result suggests that loss-of-function mutations of GNAI loci are rare or nonexistent in familial pituitary adenomas.	[Demir, Hande; Donner, Iikki; Karhu, Auli] Univ Helsinki, Biomed Helsinki, Inst Biomed, Dept Med Genet,Genome Scale Biol Res Program, Helsinki, Finland; [Kivipelto, Leena] Univ Helsinki, Dept Neurosurg, Cent Hosp, Helsinki, Finland; [Kuismin, Outi] Oulu Univ Hosp, Dept Clin Genet, Oulu, Finland; [Schalin-Jantti, Camilla] Univ Helsinki, Dept Med, Cent Hosp, Div Endocrinol, Helsinki, Finland; [De Menis, Ernesto] Gen Hosp, Dept Internal Med, Treviso, Italy	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Helsinki; Helsinki University Central Hospital	Karhu, A (corresponding author), Univ Helsinki, Biomed Helsinki, Inst Biomed, Dept Med Genet,Genome Scale Biol Res Program, Helsinki, Finland.	auli.karhu@helsinki.fi		Kuismin, Outi/0000-0002-0157-8985; Karhu, Auli/0000-0002-7927-0796	Worldwide Cancer Research [13-1075]	Worldwide Cancer Research	This study was supported by the Worldwide Cancer Research (Grant no: 13-1075, http://www.worldwidecancerresearch.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafah BM, 2001, ENDOCR-RELAT CANCER, V8, P287, DOI 10.1677/erc.0.0080287; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Boikos SA, 2007, HUM MOL GENET, V16, pR80, DOI 10.1093/hmg/ddm019; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Cazabat L, 2012, J CLIN ENDOCR METAB, V97, pE663, DOI 10.1210/jc.2011-2291; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P3316, DOI 10.1210/jc.2005-2671; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Georgitsi M, 2008, J CLIN ENDOCR METAB, V93, P4146, DOI 10.1210/jc.2008-1003; GUPTA SK, 1992, MOL BIOL CELL, V3, P123, DOI 10.1091/mbc.3.1.123; Heaney AP, 2004, NAT REV CANCER, V4, P285, DOI 10.1038/nrc1320; Kan Beki, 2003, Pituitary, V6, P75, DOI 10.1023/B:PITU.0000004797.89592.5e; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KOBAYASHI I, 1990, EUR J BIOCHEM, V191, P499, DOI 10.1111/j.1432-1033.1990.tb19149.x; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Petersenn S, 2000, CLIN ENDOCRINOL, V52, P35, DOI 10.1046/j.1365-2265.2000.00880.x; Peverelli E, 2013, J CELL SCI, V126, P638, DOI 10.1242/jcs.116434; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Reid TJ, 2010, CLIN ENDOCRINOL, V72, P203, DOI 10.1111/j.1365-2265.2009.03626.x; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P1419, DOI 10.1210/jc.77.5.1419; Ruggeri RM, 2008, J ENDOCRINOL INVEST, V31, P946, DOI 10.1007/BF03345630; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Shen Y, 1996, J CLIN ENDOCR METAB, V81, P4159, DOI 10.1210/jc.81.11.4159; Spiegel AM, 1996, J CLIN ENDOCR METAB, V81, P2434, DOI 10.1210/jc.81.7.2434; Swearingen B, 1998, J CLIN ENDOCR METAB, V83, P3419, DOI 10.1210/jc.83.10.3419; Tichomirowa MA, 2009, J INTERN MED, V266, P5, DOI 10.1111/j.1365-2796.2009.02109.x; TORDJMAN K, 1993, J CLIN ENDOCR METAB, V77, P765, DOI 10.1210/jc.77.3.765; Tuominen I, 2014, ONCOGENE, DOI [10.1038/onc.2014.50, DOI 10.1038/ONC.2014.50]; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; WILLIAMSON EA, 1995, EUR J CLIN INVEST, V25, P128, DOI 10.1111/j.1365-2362.1995.tb01537.x; WILLIAMSON EA, 1994, CLIN ENDOCRINOL, V41, P815, DOI 10.1111/j.1365-2265.1994.tb02798.x	50	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109897	10.1371/journal.pone.0109897	http://dx.doi.org/10.1371/journal.pone.0109897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291362	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000097
J	Li, YY; Yu, JF; Lu, Q; Xu, J; Ye, H				Li, Yan-Ying; Yu, Jin-Feng; Lu, Qin; Xu, Jin; Ye, Hui			Female and Male Moths Display Different Reproductive Behavior when Facing New versus Previous Mates	PLOS ONE			English	Article							SPERM COMPETITION; SPODOPTERA-LITURA; GENETIC BENEFITS; SEXUAL SELECTION; EVOLUTION; POLYANDRY; DISCRIMINATION; POLYMORPHISM; LEPIDOPTERA; PREFERENCE	Multiple mating allows females to obtain material (more sperm and nutrient) and/or genetic benefits. The genetic benefit models require sperm from different males to fertilize eggs competitively or the offspring be fathered by multiple males. To maximize genetic benefits from multiple mating, females have evolved strategies to prefer novel versus previous mates in their subsequent matings. However, the reproductive behavior during mate encounter, mate choice and egg laying in relation to discrimination and preference between sexes has been largely neglected. In the present study, we used novel and previous mate treatments and studied male and female behavior and reproductive output in Spodoptera litura. The results of this study do not support the sperm and nutrient replenishment hypotheses because neither the number of mates nor the number of copulations achieved by females significantly increased female fecundity, fertility and longevity. However, females showed different oviposition patterns when facing new versus previous mates by slowing down oviposition, which allows the last male has opportunities to fertilize her eggs and the female to promote offspring diversity. Moreover, females that have novel males present called earlier and more than females that have their previous mates present, whereas no significant differences were found on male courtship between treatments. These results suggest that S. litura females can distinguish novel from previous mates and prefer the former, whereas males generally remate regardless of whether the female is a previous mate or not. In S. litura, eggs are laid in large clusters and offspring competition, inbreeding and disease transfer risks are thus increased. Therefore, offspring diversity should be valuable for S. litura, and genetic benefits should be the main force behind the evolution of female behavioral strategies found in the present study.	[Li, Yan-Ying; Yu, Jin-Feng; Xu, Jin] Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Ecosecu, Kunming, Peoples R China; [Lu, Qin; Ye, Hui] Yunnan Univ, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming, Peoples R China	Yunnan University; Yunnan University	Xu, J (corresponding author), Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Ecosecu, Kunming, Peoples R China.	xujin2798@126.com; yehui@ynu.edu.cn			National Natural Science Foundation Program of China [31160434]	National Natural Science Foundation Program of China(National Natural Science Foundation of China (NSFC))	Funding was provided by 31160434, http://www.nsfc.gov.cn/, National Natural Science Foundation Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer MS, 1999, ANIM BEHAV, V58, P669, DOI 10.1006/anbe.1999.1172; Armes NJ, 1997, PESTIC SCI, V50, P240, DOI 10.1002/(SICI)1096-9063(199707)50:3&lt;240::AID-PS579&gt;3.0.CO;2-9; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bateman PW, 1998, ECOL ENTOMOL, V23, P473, DOI 10.1046/j.1365-2311.1998.00156.x; Caspers BA, 2014, MOL ECOL, V23, P239, DOI 10.1111/mec.12577; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Eakley AL, 2004, P ROY SOC B-BIOL SCI, V271, pS299, DOI 10.1098/rsbl.2004.0165; Fromhage L, 2005, NATURWISSENSCHAFTEN, V92, P423, DOI 10.1007/s00114-005-0011-z; Fukuda T, 2007, B ENTOMOL RES, V97, P185, DOI 10.1017/S0007485307004841; Ivy TM, 2005, P ROY SOC B-BIOL SCI, V272, P2475, DOI 10.1098/rspb.2005.3222; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jimenez-Perez A, 2003, J INSECT BEHAV, V16, P797, DOI 10.1023/B:JOIR.0000018321.81949.25; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; LaDage LD, 2007, BEHAVIOUR, V144, P515, DOI 10.1163/156853907780713091; Li C, 2012, GSTF J BIOSCI, V2, P25, DOI DOI 10.5176/2251-3140_2.1.18; Li Guanghong, 1998, Acta Scientiarum Naturalium Universitatis Sunyatseni, V37, P1; Li Wei, 2006, Southwest China Journal of Agricultural Sciences, V19, P85; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Parker G., 1984, SPERM COMPETITION EV, P2; Raina AK, 2000, ARTHROPOD STRUCT DEV, V29, P343, DOI 10.1016/S1467-8039(01)00014-7; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; *SAS I INC, 2006, US MAN; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Seth RK, 2002, PHYSIOL ENTOMOL, V27, P1, DOI 10.1046/j.1365-3032.2002.00260.x; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sun Fan, 2002, Acta Entomologica Sinica, V45, P404; Suzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083278; Tan CKW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1691; Thonhauser KE, 2013, BEHAV ECOL SOCIOBIOL, V67, P1961, DOI 10.1007/s00265-013-1604-8; Thornhill R., 1983, pi; TOOBY J, 1982, J THEOR BIOL, V97, P557, DOI 10.1016/0022-5193(82)90358-7; Wang Q, 1997, ANN ENTOMOL SOC AM, V90, P380, DOI 10.1093/aesa/90.3.380; Wang Q, 2006, J INSECT BEHAV, V19, P337, DOI 10.1007/s10905-006-9027-2; WATANABE M, 1988, Journal of Insect Behavior, V1, P17, DOI 10.1007/BF01052501; Wedell N, 1996, AM NAT, V148, P1075, DOI 10.1086/285972; Wilson N, 1999, J INSECT BEHAV, V12, P295, DOI 10.1023/A:1020883220643; Xu J, 2010, REPROD BEHAV EPHESTI; Xu J, 2011, J INSECT PHYSIOL, V57, P385, DOI 10.1016/j.jinsphys.2010.12.006; Xu J, 2009, ANIM BEHAV, V78, P1309, DOI 10.1016/j.anbehav.2009.09.028; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Yasui Y, 2001, ECOL RES, V16, P605, DOI 10.1046/j.1440-1703.2001.00423.x; Yu JF, 2014, J INSECT BEHAV, V27, P105, DOI 10.1007/s10905-013-9414-4; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zeh JA, 1998, P NATL ACAD SCI USA, V95, P13732, DOI 10.1073/pnas.95.23.13732	49	4	5	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109564	10.1371/journal.pone.0109564	http://dx.doi.org/10.1371/journal.pone.0109564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290195	gold, Green Published, Green Submitted			2022-12-25	WOS:000342798000070
J	Mannucci, S; Ghin, L; Conti, G; Tambalo, S; Lascialfari, A; Orlando, T; Benati, D; Bernardi, P; Betterle, N; Bassi, R; Marzola, P; Sbarbati, A				Mannucci, Silvia; Ghin, Leonardo; Conti, Giamaica; Tambalo, Stefano; Lascialfari, Alessandro; Orlando, Tomas; Benati, Donatella; Bernardi, Paolo; Betterle, Nico; Bassi, Roberto; Marzola, Pasquina; Sbarbati, Andrea			Magnetic Nanoparticles from Magnetospirillum gryphiswaldense Increase the Efficacy of Thermotherapy in a Model of Colon Carcinoma	PLOS ONE			English	Article							AMB-1 MAGNETOTACTIC BACTERIA; CONTRAST AGENTS; IN-VIVO; MAGNETOSOMES; HYPERTHERMIA; CANCER; CELLS; MANIPULATION; FEASIBILITY; CHAINS	Magnetic nanoparticles (MNPs) are capable of generate heating power under the influence of alternating magnetic fields (AMF); this behaviour recently opened new scenarios for advanced biomedical applications, mainly as new promising tumor therapies. In this paper we have tested magnetic nanoparticles called magnetosomes (MNs): a class of MNPs naturally produced by magnetotactic bacteria. We extracted MNs from Magnetospirillum gryphiswaldense strain MSR-1 and tested the interaction with cellular elements and anti-neoplastic activity both in vitro and in vivo, with the aim of developing new therapeutic approaches for neoplastic diseases. In vitro experiments performed on Human Colon Carcinoma HT-29 cell cultures demonstrated a strong uptake of MNs with no evident signs of cytotoxicity and revealed three phases in the interaction: adherence, transport and accumulation in Golgi vesicles. In vivo studies were performed on subcutaneous tumors in mice; in this model MNs are administered by direct injection in the tumor volume, then a protocol consisting of three exposures to an AMF rated at 187 kHz and 23kA/m is carried out on alternate days, over a week. Tumors were monitored by Magnetic Resonance Imaging (MRI) to obtain information about MNs distribution and possible tissue modifications induced by hyperthermia. Histological analysis showed fibrous and necrotic areas close to MNs injection sites in mice subjected to a complete thermotherapy protocol. These results, although concerning a specific tumor model, could be useful to further investigate the feasibility and efficacy of protocols based on MFH. Magnetic nanoparticles naturally produced and extracted from bacteria seem to be promising candidates for theranostic applications in cancer therapy.	[Mannucci, Silvia; Conti, Giamaica; Tambalo, Stefano; Benati, Donatella; Bernardi, Paolo; Sbarbati, Andrea] Univ Verona, Human Anat & Histol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Ghin, Leonardo; Betterle, Nico; Bassi, Roberto] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Tambalo, Stefano; Lascialfari, Alessandro; Orlando, Tomas; Sbarbati, Andrea] Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Florence, Italy; [Lascialfari, Alessandro; Orlando, Tomas] Univ Milan, Dept Phys, Milan, Italy; [Lascialfari, Alessandro; Orlando, Tomas] Univ Pavia, Dept Phys, I-27100 Pavia, Italy; [Marzola, Pasquina] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy	University of Verona; University of Verona; University of Milan; University of Pavia; University of Verona	Sbarbati, A (corresponding author), Univ Verona, Human Anat & Histol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	andrea.sbarbati@univr.it	Orlando, Tomas/J-8161-2019; Betterle, Nico/AAE-1004-2021	Orlando, Tomas/0000-0001-7261-2119; Betterle, Nico/0000-0002-7556-6696; Tambalo, Stefano/0000-0003-2562-1324; MARZOLA, Pasquina/0000-0001-6936-8901; bassi, roberto/0000-0002-4140-8446	AIRC [11993]; Italian MIUR through FIRB [RBAP114AMK]	AIRC; Italian MIUR through FIRB	The authors wish to thank AIRC for the financial support (project number: 11993 Area: targeted therapy, type of grant: IG). The financial support of Italian MIUR through project FIRB Riname RBAP114AMK is also acknowledged. The funders had no role in study design, data collection and analysis.	Alphandery E, 2012, INT J PHARMACEUT, V434, P444, DOI 10.1016/j.ijpharm.2012.06.015; Alphandery E, 2011, ACS NANO, V5, P6279, DOI 10.1021/nn201290k; Bellini  S., 1963, ULTERIORI STUDI BATT; Bellini S., 1963, PARTICOLARE COMPORTA; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Gojzewski H, 2012, SCANNING, V34, P159, DOI 10.1002/sca.20292; Greene SE, 2012, CURR OPIN CELL BIOL, V24, P490, DOI 10.1016/j.ceb.2012.05.008; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Hartung A, 2007, J MAGN MAGN MATER, V311, P454, DOI 10.1016/j.jmmm.2006.10.1153; Hergt R, 2005, J MAGN MAGN MATER, V293, P80, DOI 10.1016/j.jmmm.2005.01.047; Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008; Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1; Johannsen M, 2007, EUR UROL, V52, P1653, DOI 10.1016/j.eururo.2006.11.023; Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559; Jordan A, 2006, J NEURO-ONCOL, V78, P7, DOI 10.1007/s11060-005-9059-z; Lee N, 2011, P NATL ACAD SCI USA, P108; Lisy MR, 2007, INVEST RADIOL, V42, P235, DOI 10.1097/01.rli.0000255832.44443.e7; Liu F, 2014, CHEM COMMUN, V50, P6200, DOI 10.1039/c4cc01266f; Maier-Hauff K, 2011, J NEURO-ONCOL, V103, P317, DOI 10.1007/s11060-010-0389-0; Masotti A, 2009, MAGN RESON MATER PHY, V22, P77, DOI 10.1007/s10334-008-0147-x; Mustafa T, 2013, BIOMATER SCI-UK, V1, P870, DOI 10.1039/c3bm60015g; Pan Y, 2012, CHEM SOC REV, V41, P2912, DOI 10.1039/c2cs15315g; Saokar A, 2006, ABDOM IMAGING, V31, P660, DOI 10.1007/s00261-006-9006-2; Senn MS, 2012, NATURE, V481, P173, DOI 10.1038/nature10704; Shin J, 2014, INTEGR BIOL-UK, V6, P532, DOI 10.1039/c3ib40195b; Timko M, 2009, J MAGN MAGN MATER, V321, P1521, DOI 10.1016/j.jmmm.2009.02.077; Valero E, 2011, J AM CHEM SOC, V133, P4889, DOI 10.1021/ja110014p; Wilhelm C, 2007, J NANOSCI NANOTECHNO, V7, P2933, DOI 10.1166/jnn.2007.668; Won J, 2005, SCIENCE, V309, P121, DOI 10.1126/science.1112869; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Xiang L, 2007, LETT APPL MICROBIOL, V45, P75, DOI 10.1111/j.1472-765X.2007.02143.x; Zeytuni N, 2012, ACTA CRYSTALLOGR F, V68, P927, DOI 10.1107/S1744309112025638	32	42	48	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108959	10.1371/journal.pone.0108959	http://dx.doi.org/10.1371/journal.pone.0108959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289664	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000033
J	Zhang, M; Hou, M; Ge, LH; Miao, CC; Zhang, JF; Jing, XY; Shi, N; Chen, T; Tang, XF				Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Shi, Ni; Chen, Tong; Tang, Xiaofei			Induction of Peroxiredoxin 1 by Hypoxia Regulates Heme Oxygenase-1 via NF-kappa B in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; I EXPRESSION; NUCLEAR; ACTIVATION; ASTROCYTES; GENE; HYPOXIA/REOXYGENATION; KERATINOCYTES; EPIDEMIOLOGY; MICROGLIA	Overexpression of peroxiredoxin 1 (Prx1) has been observed in numerous cancers including oral squamous cell carcinoma (OSCC). The precise molecular mechanism of up-regulation of Prx1 in carcinogenesis, however, is still poorly understood. The objective of this study is to investigate the relationship between Prx1 and hypoxia, and potential mechanism(s) of Prx1 in OSCC cell line SCC15 and xenograft model. We treated wild-type and Prx1 knockdown SCC15 cells with transient hypoxia followed by reoxygenation. We detected the condition of hypoxia, production of reactive oxygen species (ROS), and expression and/or activity of Prx1, heme oxygenase 1 (HO-1) and nuclear factor-kappa B (NF-kappa B). We found that hypoxia induces ROS accumulation, up-regulates Prx1, increases NF-kappa B translocation and DNA binding activity, and down-regulates HO-1 in vitro. In Prx1 knockdown cells, the expression level of HO-1 was increased, while NF kappa B translocation and DNA binding activity were decreased after hypoxia or hypoxia/reoxygenation treatment. Moreover, we mimicked the dynamic oxygenation tumor microenvironment in xenograft model and assessed the above indices in tumors with the maximal diameter of 2 mm, 5 mm, 10 mm or 15 mm, respectively. Our data showed that tumor hypoxic condition and expression of Prx1 are significantly associated with tumor growth. The expression of HO-1 and NF-kappa B, and NF-kappa B DNA binding activity were significantly elevated in 15 mm tumors, and the level of 8-hydroxydeoxyguanosine was increased in 10 mm and 15 mm tumors, compared to those in size of 2 mm. The results from this study provide experimental evidence that overexpression of Prx1 is associated with hypoxia, and Prx1/NF-kappa B/HO-1 signaling pathway may be involved in oral carcinogenesis.	[Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Tang, Xiaofei] Capital Med Univ, Beijing Stomatol Hosp, Inst Dent Res, Beijing, Peoples R China; [Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Tang, Xiaofei] Capital Med Univ, Sch Stomatol, Beijing, Peoples R China; [Shi, Ni; Chen, Tong] Ohio State Univ, Arthur G James Canc Hosp, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Shi, Ni; Chen, Tong] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA	Capital Medical University; Capital Medical University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chen, T (corresponding author), Ohio State Univ, Arthur G James Canc Hosp, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.	tong.chen@osumc.edu; xftang10@yahoo.com	Chen, Tong/E-2879-2011; zhang, min/GQR-1387-2022		National Natural Science Foundation [81070836]; Beijing Natural Science Foundation [7102065]; Beijing Municipal Administration of Hospital Key Medical Development Project [ZYLX201407]; NATIONAL CANCER INSTITUTE [R01CA131073] Funding Source: NIH RePORTER	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Administration of Hospital Key Medical Development Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation (81070836), the Beijing Natural Science Foundation (7102065) and ZYLX201407, Beijing Municipal Administration of Hospital Key Medical Development Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan ME, 2012, CELL BIOCHEM FUNCT, V30, P166, DOI 10.1002/cbf.1832; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Bagan JV, 2008, ORAL ONCOL, V44, P103, DOI 10.1016/j.oraloncology.2008.01.008; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; dos Santos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045228; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Jeong SI, 2010, ARCH PHARM RES, V33, P1867, DOI 10.1007/s12272-010-1120-6; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7; Lee HJ, 2008, J ORAL PATHOL MED, V37, P278, DOI 10.1111/j.1600-0714.2007.00616.x; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mazza E, 2001, J APPL PHYSIOL, V91, P379, DOI 10.1152/jappl.2001.91.1.379; Miyazaki Y, 2008, INT J ONCOL, V32, P145; Miyoshi A, 2006, INT J ONCOL, V29, P1533; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nakaso K, 2000, NEUROSCI LETT, V293, P49, DOI 10.1016/S0304-3940(00)01491-9; Nakayama H, 2001, CANCER, V92, P3037, DOI 10.1002/1097-0142(20011215)92:12<3037::AID-CNCR10171>3.0.CO;2-#; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Riddell JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050394; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Ruiz-Ramos R, 2009, MUTAT RES-GEN TOX EN, V674, P109, DOI 10.1016/j.mrgentox.2008.09.021; Rushworth SA, 2010, CANCER RES, V70, P2973, DOI 10.1158/0008-5472.CAN-09-3407; Stanimirovic D, 2001, J NEUROIMMUNOL, V119, P365, DOI 10.1016/S0165-5728(01)00402-7; Wang XM, 2010, MOL BIOL CELL, V21, P2987, DOI 10.1091/mbc.E10-02-0160; Warnakulasuriya S, 2009, BRIT DENT J, V207, P471, DOI 10.1038/sj.bdj.2009.1009; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yanagawa T, 2005, INT J ORAL MAX SURG, V34, P915, DOI 10.1016/j.ijom.2005.04.015; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1	36	91	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105994	10.1371/journal.pone.0105994	http://dx.doi.org/10.1371/journal.pone.0105994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25295523	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900070
J	Zhao, JP; Levy, E; Fraser, WD; Julien, P; Delvin, E; Montoudis, A; Spahis, S; Garofalo, C; Nuyt, AM; Luo, ZC				Zhao, Jin-Ping; Levy, Emile; Fraser, William D.; Julien, Pierre; Delvin, Edgard; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole; Nuyt, Anne Monique; Luo, Zhong-Cheng			Circulating Docosahexaenoic Acid Levels Are Associated with Fetal Insulin Sensitivity	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GESTATIONAL DIABETES-MELLITUS; ALPHA-LINOLENIC ACID; PHOSPHOLIPID-COMPOSITION; DESATURASE ACTIVITIES; ARACHIDONIC-ACID; PREGNANCY; GLUCOSE; SECRETION; OBESITY	Background: Arachidonic acid (AA; C20: 4 n-6) and docosahexaenoic acid (DHA; C22: 6 n-3) are important long-chain polyunsaturated fatty acids (LC-PUFA) in maintaining pancreatic beta-cell structure and function. Newborns of gestational diabetic mothers are more susceptible to the development of type 2 diabetes in adulthood. It is not known whether low circulating AA or DHA is involved in perinatally "programming'' this susceptibility. This study aimed to assess whether circulating concentrations of AA, DHA and other fatty acids are associated with fetal insulin sensitivity or beta-cell function, and whether low circulating concentrations of AA or DHA are involved in compromised fetal insulin sensitivity in gestational diabetic pregnancies. Methods and Principal Findings: In a prospective singleton pregnancy cohort, maternal (32-35 weeks gestation) and cord plasma fatty acids were assessed in relation to surrogate indicators of fetal insulin sensitivity (cord plasma glucose-to-insulin ratio, proinsulin concentration) and beta-cell function (proinsulin-to-insulin ratio) in 108 mother-newborn pairs. Cord plasma DHA levels (in percentage of total fatty acids) were lower comparing newborns of gestational diabetic (n = 24) vs. nondiabetic pregnancies (2.9% vs. 3.5%, P = 0.01). Adjusting for gestational age at blood sampling, lower cord plasma DHA levels were associated with lower fetal insulin sensitivity (lower glucose-to-insulin ratio, r = 0.20, P = 0.036; higher proinsulin concentration, r = 20.37, P<0.0001). The associations remained after adjustment for maternal and newborn characteristics. Cord plasma saturated fatty acids C18:0 and C20:0 were negatively correlated with fetal insulin sensitivity, but their levels were not different between gestational diabetic and non-diabetic pregnancies. Cord plasma AA levels were not correlated with fetal insulin sensitivity. Conclusion: Low circulating DHA levels are associated with compromised fetal insulin sensitivity, and may be involved in perinatally "programming'' the susceptibility to type 2 diabetes in the offspring of gestational diabetic mothers.	[Zhao, Jin-Ping; Fraser, William D.; Luo, Zhong-Cheng] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Levy, Emile; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Julien, Pierre] Laval Univ Hosp Res Ctr, Quebec City, PQ, Canada; [Julien, Pierre] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Nuyt, Anne Monique] Univ Montreal, Dept Pediat, St Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Luo, Zhong-Cheng] Shanghai Jiao Tong Univ, Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp,Sch Med, Shanghai 200030, Peoples R China	Universite de Montreal; Universite de Montreal; Laval University; Laval University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Shanghai Jiao Tong University	Luo, ZC (corresponding author), Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada.	zc_luo@yahoo.com	Julien, Pierre/AGO-7542-2022; Luo, Zhong-Cheng/T-3882-2017	Julien, Pierre/0000-0002-9247-6676; Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR) [79896, 78879]; Quebec Training Network in Perinatal Research (QTNPR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Quebec Training Network in Perinatal Research (QTNPR)	This work was supported by the Canadian Institutes of Health Research (CIHR grant no. 79896 and 78879). J-P Zhao is the recipient of a Postdoctoral Scholarship from Quebec Training Network in Perinatal Research (QTNPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardenheier BH, 2013, DIABETES CARE, V36, P1209, DOI 10.2337/dc12-0901; Baur LA, 1998, METABOLISM, V47, P106, DOI 10.1016/S0026-0495(98)90202-5; Bergeron K, 2007, J LIPID RES, V48, P2396, DOI 10.1194/jlr.M700166-JLR200; Bitsanis D, 2006, LIPIDS, V41, P341, DOI 10.1007/s11745-006-5104-8; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Burdge GC, 2008, PROSTAG LEUKOTR ESS, V78, P73, DOI 10.1016/j.plefa.2007.10.028; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Decsi T, 2000, LIPIDS, V35, P1179, DOI 10.1007/s11745-000-0634-7; Dixon G, 2004, CLIN SCI, V106, P191, DOI 10.1042/CS20030261; FAAS FH, 1983, LIPIDS, V18, P339, DOI 10.1007/BF02534712; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Innis SM, 2003, AM J CLIN NUTR, V77, P473, DOI 10.1093/ajcn/77.2.473; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Konrad RJ, 1996, PANCREAS, V13, P253, DOI 10.1097/00006676-199610000-00007; KONRAD RJ, 1994, BIOCHEMISTRY-US, V33, P13284, DOI 10.1021/bi00249a015; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; LEPAGE G, 1989, J LIPID RES, V30, P1483; Luo ZC, 2010, DIABETES CARE, V33, P2055, DOI 10.2337/dc10-0819; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Makrides M, 2000, AM J CLIN NUTR, V71, p307S, DOI 10.1093/ajcn/71.1.307S; Miller MR, 2012, J CLIN ENDOCR METAB, V97, P3285, DOI 10.1210/jc.2012-1318; Min Y, 2005, DIABETIC MED, V22, P914, DOI 10.1111/j.1464-5491.2005.01556.x; Min Y, 2004, DIABETOLOGIA, V47, P75, DOI 10.1007/s00125-003-1275-5; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; Ortega-Senovilla H, 2009, DIABETES CARE, V32, P120, DOI 10.2337/dc08-0679; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Spahis S, 2008, PROSTAG LEUKOTR ESS, V79, P47, DOI 10.1016/j.plefa.2008.07.005; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Thomas BA, 2005, PROSTAG LEUKOTR ESS, V72, P335, DOI 10.1016/j.plefa.2005.01.001; Wang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059845; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Welch AA, 2010, AM J CLIN NUTR, V92, P1040, DOI 10.3945/ajcn.2010.29457; Whelan J, 2009, PROSTAG LEUKOTR ESS, V81, P133, DOI 10.1016/j.plefa.2009.05.008; Wijendran V, 2000, LIPIDS, V35, P927, DOI 10.1007/S11745-000-0602-2; Zhang G, 2012, J CLIN ENDOCR METAB, V97, pE973, DOI 10.1210/jc.2011-2997	42	252	260	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85054	10.1371/journal.pone.0085054	http://dx.doi.org/10.1371/journal.pone.0085054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	25303175	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500037
J	Wang, QM; Liu, SP; Tang, Y; Liu, QH; Yao, YJ				Wang, Qingmin; Liu, Shupeng; Tang, Ying; Liu, Qiuhong; Yao, Yongjie			MPT64 Protein from Mycobacterium tuberculosis Inhibits Apoptosis of Macrophages through NF-kB-miRNA21-Bcl-2 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 UP-REGULATION; ANTIGEN MPT64; MICRORNAS; EXPRESSION; VIRULENT; IMMUNITY; NECROSIS; PLAYERS	MPT64 is one of the secreted proteins from Mycobacterium tuberculosis. Little is known about its role in infection by Mycobacterium tuberculosis. In this study, we demonstrated that MPT64 could dose-dependently inhibit the apoptosis of RAW264.7 macrophages induced by PPD-BCG. Quantitative real-time PCR results showed that the expression of bcl-2 increased in macrophages treated with MPT64 compared with PPD-treated cells. Furthermore, the results provided strong evidence that bcl-2 up-regulation was positively controlled by miRNA-21. Finally, NF-kappa B was identified as the transcription factor for miRNA-21 using a ChIP assay. It can be concluded from our study that MPT64 could inhibit the apoptosis of RAW264.7 macrophages through the NF-kappa B-miRNA21-Bcl-2 pathway.	[Wang, Qingmin; Tang, Ying; Liu, Qiuhong; Yao, Yongjie] Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China; [Liu, Shupeng] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Wang, QM (corresponding author), Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China.	wqm_8888@hotmail.com	Woo, Patrick Chiu Yat/C-4449-2009; Lau, Susanna Kar Pui/C-4321-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832; liu, fei/0000-0003-1175-4070; Lau, Susanna Kar Pui/0000-0002-1383-7374	National Natural Science Foundation [31070121]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This article is supported by the grants of National Natural Science Foundation (Nos. 31070121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061925; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hossein A, 2004, J NEUROSCI, V24, P2963; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Lin XJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/258695; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Mogga SJ, 2002, SCAND J IMMUNOL, V56, P383, DOI 10.1046/j.1365-3083.2002.01140.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sanchez A, 2009, SCAND J IMMUNOL, V69, P20, DOI 10.1111/j.1365-3083.2008.02193.x; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001; Yamamoto T, 2006, YAKUGAKU ZASSHI, V126, P1235, DOI 10.1248/yakushi.126.1235; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	36	73	78	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100949	10.1371/journal.pone.0100949	http://dx.doi.org/10.1371/journal.pone.0100949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000291	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300020
J	Li, Y; Yang, D; Wang, JY; Yao, Y; Zhang, WZ; Wang, LJ; Cheng, DC; Yang, FK; Zhang, FM; Zhuang, M; Ling, H				Li, Yan; Yang, Dan; Wang, Jia-Ye; Yao, Yuan; Zhang, Wei-Zhe; Wang, Lu-Jing; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong			Critical Amino Acids within the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein V4 N- and C-Terminals Contribute to Virus Entry	PLOS ONE			English	Article							HIV-1 GP120; NEUTRALIZING ANTIBODIES; DISEASE PROGRESSION; VIRAL ENTRY; V3 LOOP; CORECEPTOR; INFECTION; EVOLUTION; CCR5; REGIONS	The importance of the fourth variable (V4) region of the human immunodeficiency virus 1 (HIV-1) envelope glycoprotein (Env) in virus infection has not been well clarified, though the polymorphism of this region has been found to be associated with disease progression to acquired immunodeficiency syndrome (AIDS). In the present work, we focused on the correlation between HIV-1 gp120 V4 region polymorphism and the function of the region on virus entry, and the possible mechanisms for how the V4 region contributes to virus infectivity. Therefore, we analyzed the differences in V4 sequences along with coreceptor usage preference from CCR5 to CXCR4 and examined the importance of the amino acids within the V4 region for CCR5- and CXCR4-tropic virus entry. In addition, we determined the influence of the V4 amino acids on Env expression and gp160 processing intracellularly, as well as the amount of Env on the pseudovirus surface. The results indicated that V4 tended to have a shorter length, fewer potential N-linked glycosylation sites (PNGS), greater evolutionary distance, and a lower negative net charge when HIV-1 isolates switched from a coreceptor usage preference for CCR5 to CXCR4. The N- and C-terminals of the HIV-1 V4 region are highly conserved and critical to maintain virus entry ability, but only the mutation at position 417 in the context of ADA (a R5-tropic HIV-1 strain) resulted in the ability to utilize CXCR4. In addition, 390L, 391F, 414I, and 416L are critical to maintain gp160 processing and maturation. It is likely that the hydrophobic properties and the electrostatic surface potential of gp120, rather than the conformational structure, greatly contribute to this V4 functionality. The findings provide information to aid in the understanding of the functions of V4 in HIV-1 entry and offer a potential target to aid in the development of entry inhibitors.	[Li, Yan; Wang, Jia-Ye; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Yang, Dan] Harbin Med Univ, Dept Forens Med, Harbin, Peoples R China; [Yao, Yuan] Harbin Inst Technol, Acad Fundamental & Interdisciplinary Sci, Harbin 150006, Peoples R China; [Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China; [Wang, Lu-Jing] Harbin Med Univ, Dept Biochem, Harbin, Peoples R China; [Li, Yan; Wang, Jia-Ye; Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Heilongjiang Prov Educ Bur, Key Lab Etiol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Institute of Technology; Harbin Medical University; Harbin Medical University	Zhuang, M (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China.	zhuangm@ems.hrbmu.edu.cn; lingh@ems.hrbmu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Scientific Research Foundation of Heilongjiang Provincial Education Department [12511184]; Heilongjiang Innovation Program in Graduate Education [YJSCX2009-222HLJ]; Harbin Medical University Innovation Program in Graduate Education [HCXB2009014]; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province [ZJY0601-01]	Scientific Research Foundation of Heilongjiang Provincial Education Department; Heilongjiang Innovation Program in Graduate Education; Harbin Medical University Innovation Program in Graduate Education; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by Scientific Research Foundation of Heilongjiang Provincial Education Department (Grant 12511184); Heilongjiang Innovation Program in Graduate Education (YJSCX2009-222HLJ); Harbin Medical University Innovation Program in Graduate Education (HCXB2009014); Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province (Grant ZJY0601-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Belair M, 2009, AIDS RES HUM RETROV, V25, P199, DOI 10.1089/aid.2008.0162; Berger EA, 1997, AIDS, V11, pS3; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Boonchawalit S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027098; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Castro E, 2008, AIDS RES HUM RETROV, V24, P106, DOI 10.1089/aid.2007.0139; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Guo HY, 2012, J GEN VIROL, V93, P2635, DOI 10.1099/vir.0.046771-0; HATTORI T, 1987, JPN J CANCER RES, V78, P235; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Ling H, 2002, BIOCHEM BIOPH RES CO, V297, P625, DOI 10.1016/S0006-291X(02)02253-2; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Riddle TM, 2006, J VIROL, V80, P10591, DOI 10.1128/JVI.00644-06; Rivera-Amill V, 2007, VIROLOGY, V358, P373, DOI 10.1016/j.virol.2006.08.039; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yeh WW, 2012, J VIROL, V86, P7052, DOI 10.1128/JVI.00107-12; Zhuang M, 2012, J BIOL CHEM, V287, P8297, DOI 10.1074/jbc.M111.324483	39	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86083	10.1371/journal.pone.0086083	http://dx.doi.org/10.1371/journal.pone.0086083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	25299226	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500179
J	Li, YP; Song, B; Fang, H; Gao, Y; Zhao, L; Xu, YM				Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming			External Validation of the A(2)DS(2) Score to Predict Stroke-Associated Pneumonia in a Chinese Population: A Prospective Cohort Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IN-HOSPITAL MORTALITY; MEDICAL COMPLICATIONS; RISK-FACTORS; INFECTION; CARE; TRANSIENT; OUTCOMES; COST	Background and Purpose: The A(2)DS(2) score was recently developed from the Berlin Stroke Registry for predicting in-hospital pneumonia after acute ischemic stroke and performed well in an external validation in the North-west Germany Stroke Registry. It could be a useful tool for risk stratification in clinical practice or stroke trials. We aimed to prospectively validate the predictive value of A(2)DS(2) score in a Chinese stroke population. Methods: The prognostic model was used to predict stroke-associated pneumonia (SAP) from Henan Province Stroke Registry (HNSR) in which data were prospectively collected. The receiver-operating characteristic curves were plotted, and the C statistics were calculated to assess the discrimination ability. The Hosmer-Lemeshow goodness-of-fit test and the plot of observed versus predicted SAP risk were used to assess model calibration. Results: Among 1142 eligible patients, the overall in-hospital SAP was 18.8%, which ranged from 9.0% in patients with lower A(2)DS(2) scores (0-4) to 65.0% in those with higher scores of 5 to 10 (P for trend <0.001). The C statistic was 0.836 (95% confidence interval, 0.803-0.868) through the A(2)DS(2) score, suggesting excellent discrimination in the HNSR. The A(2)DS(2) score also showed excellent calibration (Cox and Snell R-2 = 0.243) in the external validation sample from the HNSR. Conclusions: The A(2)DS(2) score could reliably predict in-hospital SAP in Chinese stroke patients. It might be helpful for the assessment of increased risk monitoring and prophylactic treatment in identified high-risk patients for SAP in clinical routine.	[Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China.	xuyuming@zzu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Health Department of Henan Province [201202005]; Education Department of Henan Province [12A320046]	Health Department of Henan Province; Education Department of Henan Province	This study was funded by the Health Department of Henan Province (201202005) and the Education Department of Henan Province (12A320046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Stroke, V20, P1407; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Forti P, 2013, NEUROLOGY, V80, P29, DOI 10.1212/WNL.0b013e31827b1a41; Galovic M, 2013, STROKE, V44, P2760, DOI 10.1161/STROKEAHA.113.001690; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Grube MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075719; Harms H, 2013, ACTA NEUROL SCAND, V128, P178, DOI 10.1111/ane.12095; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Ji RJ, 2013, STROKE, V44, P1303, DOI 10.1161/STROKEAHA.111.000598; Kammersgaard L P, 2001, J Stroke Cerebrovasc Dis, V10, P217, DOI 10.1053/jscd.2001.30366; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kemmling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071141; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kumar Sandeep, 2010, Lancet Neurol, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Kwon HM, 2006, AM J INFECT CONTROL, V34, P64, DOI 10.1016/j.ajic.2005.06.011; Pandian JD, 2012, J STROKE CEREBROVASC, V21, P695, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.003; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Song B, 2013, STROKE, V44, P1244, DOI 10.1161/STROKEAHA.113.000969; Tong X, 2010, STROKE, V41, P980, DOI 10.1161/STROKEAHA.110.578674; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002	33	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109665	10.1371/journal.pone.0109665	http://dx.doi.org/10.1371/journal.pone.0109665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299226	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200068
J	Zhang, YG; Qiu, L; Li, SJ; Xiang, YC; Chen, JY; Ren, YG				Zhang, Yiguo; Qiu, Lu; Li, Shaojun; Xiang, Yuancai; Chen, Jiayu; Ren, Yonggang			The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1 beta; Both Are Also Inhibited by the Small Dominant-Negative Nrf1 gamma/delta Isoforms that Down-Regulate ARE-Battery Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF1; TNF-ALPHA PROMOTER; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BINDING DOMAIN; BETA-TRCP; KEAP1	The C-terminal domain (CTD, aa 686-741) of nuclear factor-erythroid 2 p45-related factor 1 (Nrf1) shares 53% amino acid sequence identity with the equivalent Neh3 domain of Nrf2, a homologous transcription factor. The Neh3 positively regulates Nrf2, but whether the Neh3-like (Neh3L) CTD of Nrf1 has a similar role in regulating Nrf1-target gene expression is unknown. Herein, we report that CTD negatively regulates the full-length Nrf1 (i.e. 120-kDa glycoprotein and 95-kDa deglycoprotein) and its shorter isoform LCR-F1/Nrf1 beta (55-kDa). Attachment of its CTD-adjoining 112-aa to the C-terminus of Nrf2 yields the chimaeric Nrf2-C112(Nrf1) factor with a markedly decreased activity. Live-cell imaging of GFP-CTD reveals that the extra-nuclear portion of the fusion protein is allowed to associate with the endoplasmic reticulum (ER) membrane through the amphipathic Neh3L region of Nrf1 and its basic c-tail. Thus removal of either the entire CTD or the essential Neh3L portion within CTD from Nrf1, LCR-F1/Nrf1 beta and Nrf2-C112(Nrf1), results in an increase in their transcriptional ability to regulate antioxidant response element (ARE)-driven reporter genes. Further examinations unravel that two smaller isoforms, 36-kDa Nrf1 gamma and 25-kDa Nrf1 delta, act as dominant-negative inhibitors to compete against Nrf1, LCR-F1/Nrf1 beta and Nrf2. Relative to Nrf1, LCR-F1/Nrf1 beta is a weak activator, that is positively regulated by its Asn/Ser/Thr-rich (NST) domain and acidic domain 2 (AD2). Like AD1 of Nrf1, both AD2 and NST domain of LCR-F1/Nrf1 beta fused within two different chimaeric contexts to yield Gal4D:Nrf1 beta(607) and Nrf1 beta:C270(Nrf2), positively regulate their transactivation activity of cognate Gal4- and Nrf2-target reporter genes. More importantly, differential expression of endogenous ARE-battery genes is attributable to up-regulation by Nrf1 and LCR-F1/Nrf1 beta and down-regulation by Nrf1 gamma and Nrf1 delta.	[Zhang, Yiguo] Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; Chongqing Univ, Fac Life Sci, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Zhang, YG (corresponding author), Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China.	yiguozhang@cqu.edu.cn		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	National Natural Science Foundation of China [91129703, 31270879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (key program 91129703 and project 31270879) awarded to Prof. Yiguo Zhang (University of Chongqing, China). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rupert PB, 1998, NAT STRUCT BIOL, V5, P484, DOI 10.1038/nsb0698-484; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; Schultz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087204; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2013, MOL CELL BIOL, V33, P3461, DOI 10.1128/MCB.01271-12; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Xiao H, 2013, CURR CHEM BIOL, V7, P151, DOI [DOI 10.2174/2212796811307020008, 10.2174/2212796811307020008]; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang Y, 2014, MS1305858; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093458; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhang Y, 2009, J BIOL CHEM, V284, P3195, DOI 10.1074/jbc.M805337200; [张玉台 Zhang Yutai], 2009, [管理世界, Management World], P1; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798	71	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109159	10.1371/journal.pone.0109159	http://dx.doi.org/10.1371/journal.pone.0109159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290918	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000041
J	Zhang, YJ; Wang, DM; Yang, LN; Zhou, D; Zhang, JF				Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang			Purification and Characterization of Flavonoids from the Leaves of Zanthoxylum bungeanum and Correlation between Their Structure and Antioxidant Activity	PLOS ONE			English	Article							ALDOSE REDUCTASE; DNA-DAMAGE; EXTRACTS; ALKYLAMIDES; PROTECTION; PERICARPS; QUERCETIN; CHROMATOGRAPHY; CONSTITUENTS; INHIBITION	Nine flavonoids were isolated and characterized from the leaves of Zanthoxylum bungeanum. Their structures were elucidated by spectroscopic techniques as quercetin (1), afzelin (2), quercitrin (3), trifolin (4), quercetin-3-O-beta-D-glucoside (5), isorhamnetin 3-O-alpha-L-rhamnoside (6), hyperoside (7), vitexin (8) and rutin (9). All compounds were isolated from the leaves of Z. bungeanum for the first time. Five compounds (2, 4, 5, 6 and 8) were found for the first time in the genus Zanthoxylum. To learn the mechanisms underlying its health benefits, in vitro (DPPH, ABTS, FRAP and lipid peroxidation inhibition assays) and in vivo (protective effect on Escherichia coli under peroxide stress) antioxidant activities of the nine flavonoids were measured. Quercetin and quercetin glycosides (compounds 1, 3, 5, 7, 9) showed the highest antioxidant activity. Structure-activity relationships indicated that the -OH in 49 position on the B ring and the -OH in 7 position on the A ring possessed high antioxidant activity; B ring and/or A ring with adjacent -OH groups could greatly increase their antioxidant ability. Also, due to the different structures of various flavonoids, they will certainly exhibit different antioxidant capacity when the reactions occur in solution or in oil-in-water emulsion. These findings suggest that Z. bungeanum leaves may have health benefits when consumed. It could become a useful supplement for pharmaceutical products and functional food ingredients in both nutraceutical and food industries as a potential source of natural antioxidants.	[Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Wang, DM (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	dmwli@163.com		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	Special Fund for Forestry Scientific Research in the Public Interest of China [201304811]; Fundamental Research Funds for the Central Universities [ZD2013010]	Special Fund for Forestry Scientific Research in the Public Interest of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to the research fund from the Special Fund for Forestry Scientific Research in the Public Interest of China (201304811) and the Fundamental Research Funds for the Central Universities (ZD2013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Azimova SS, 2013, PHYSICOCHEMCIAL PHAR; Bauer R, 2011, CURR CLIN UROL, P191, DOI 10.1007/978-1-60327-420-3_10; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Chang ZQ, 1981, ACTA PHARM SINICA, V16, P394; Costantino L, 1997, EXPERT OPIN THER PAT, V7, P843, DOI 10.1517/13543776.7.8.843; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; Decker EA, 2005, J AGR FOOD CHEM, V53, P4303, DOI 10.1021/jf058012x; [邓振义 Deng Zhenyi], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P179; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Dorman H. J. D., 1995, Journal of Essential Oil Research, V7, P645; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Duke J. A., 1985, MED PLANTS CHINA, P705; Ferrali M, 1997, FEBS LETT, V416, P123, DOI 10.1016/S0014-5793(97)01182-4; GALVEZ J, 1993, J PHARM PHARMACOL, V45, P157, DOI 10.1111/j.2042-7158.1993.tb03706.x; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HUANG XL, 1993, PHYTOTHER RES, V7, P41, DOI 10.1002/ptr.2650070111; Ibrahim LF, 2002, MOLECULES, V7, P245; Jung HA, 2011, FOOD CHEM TOXICOL, V49, P376, DOI 10.1016/j.fct.2010.11.012; KIMUYA Y, 1981, CHEM PHARM BULL, V29, P2610; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Li H, 2012, FOOD CHEM, V135, P2942, DOI 10.1016/j.foodchem.2012.07.048; Li Y, 2001, Zhong Yao Cai, V24, P572; Ma XF, 2005, J CHROMATOGR A, V1070, P211, DOI 10.1016/j.chroma.2005.02.052; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Miguel G, 2004, FOOD CHEM, V86, P183, DOI 10.1016/j.foodchem.2003.08.031; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2362, DOI 10.1248/cpb.36.2362; Nassar M. I., 2010, Revista Latinoamericana de Quimica, V38, P103; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OSHIMA R, 1982, CARBOHYD RES, V107, P169, DOI 10.1016/S0008-6215(00)80536-4; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1151, DOI 10.1016/S0968-0896(00)00052-3; Ren L, 1981, XAOXUE XUEBAO, V16, P672; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez P, 2010, FITOTERAPIA, V81, P1220, DOI 10.1016/j.fitote.2010.08.007; Smirnova GV, 2010, WORLD J MICROB BIOT, V26, P2269, DOI 10.1007/s11274-010-0417-4; Smirnova GV, 2009, FREE RADICAL BIO MED, V46, P759, DOI 10.1016/j.freeradbiomed.2008.11.017; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Tirillini B., 1994, Journal of Essential Oil Research, V6, P249; TK Lim, 2012, ZANTHOXYLUM SIMULANS, P904; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Wang DM, 2013, ALLELOPATHY J, V32, P67; Wang S, 2011, J LIQ CHROMATOGR R T, V34, P2640, DOI 10.1080/10826076.2011.593219; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; XIONG QB, 1995, PHYTOCHEMISTRY, V39, P723, DOI 10.1016/0031-9422(94)00965-V; Xiong QB, 1997, PHYTOCHEMISTRY, V46, P1123, DOI 10.1016/S0031-9422(97)84398-1; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yeung H., 1985, HDB CHINESE HERBS FO, VVolume 1; Zhou X, 2005, J CHROMATOGR A, V1092, P216, DOI 10.1016/j.chroma.2005.07.064	56	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105725	10.1371/journal.pone.0105725	http://dx.doi.org/10.1371/journal.pone.0105725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25290918	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200055
